case_id,primary_site,tcga_type,patient_id,patient_filename,report_text
BIOCUP_00001,lung,LUSC,TCGA-18-4086,TCGA-18-4086.f83c1343-f2dc-4602-a34c-3a259edfb343,"Amended. SPECIMEN (s) RECEIVED. 1. Soft-Tissue: Wedge Resection- Right Middle Lobe (Quick Section). 2. Lymph node: subcarinal ST7. 3. Lymph node: interlobar ST11. 4. Lymph node: lobar ST12. 5. Lymph node: interlobar ST11. 6. Lymph node: RT low paratracheal ST4R. 7. Lymph node: INF pulm ligament ST9. 8. LUNGS: right lower. lobe. DIAGNOSIS. 1. Lung, wedge resection (right middle Tobe) : a) Lung tissue with patchy interstitial chronic inflammation and. fibrosis, usual interstitial pneumonia (UIP) pattern. b) One lymph node with non-necrotizing granulomatous inflammation. and focal mixed dust nodules (0/1). 2-7. Lymph nodes, resections (ST7 subcarinal, ST11 interlobar, ST12. lobar; ST11 interlobar) ST4R right lower paratracheal, ST9 inferior. pulmonary ligament) : - Lymph nodes with non-necrotizing granulomatous inflammation,. negative for malignancy (x6). - Focal mixed dust nodules with central necrosis and hyalinization. 8. Lung, resection (right lower lobectomy) : a) Pleomorphic carcinoma (squamous cell carcinoma (90%) and spindle. cell carcinoma (10%)] pT2NO, with: i) Maximum tumor dimension: 4.0 cm. ii) Visceral pleural and vascular invasion not. identified. iii) Resection margins negative for tumor (closest margin 18. mm; stapled parenchyma). iv) Five lymph nodes (4 lobar, 1 segmental) with. non-necrotizing granulomas, negative for malignancy (0/5). Status: corrected. Page: 1 of 6. b) Lung tissue with patchy interstitial chronic inflammation and. fibrosis, UIP pattern (see Comment). SYNOPTIC DATA. specimen Type: Lobectomy. Laterality: Right. Tumor Site: RLL. Tumor Size: Greatest dimension: 4.0 cm. Additional dimensions: 3.0x3. cm. stologic Type: Carcinoma with pleomorphic,. urcomatoid, or sarcomatous elements (variant) : squamous cell carcinoma. (90%) spindle cell component (10%). Histologic Grade: G3: Poorly differentiated. Pathologic staging (pTNM) : pT2 : Tumor with any of the following. features of size or extent: greater than 3 cm in greatest dimension;. involves main bronchus, 2 cm or more distal to the carina; invades the. visceral pleura; associated with atelectasis or obstructive pneumonitis. that extends to the hilar region but does not involve the entire lung. pNO: No regional lymph node. metastasis. pMX: Cannot be assessed. Margins: Margins uninvolved by invasive. carcinoma. Distance of invasive carcinoma from. closest margin: 18 mm. Specify margin: stapled. parenchymal margin. Direct Extension of Tumor: None identified. Venous (Large Vessel) Invasion: Absent. Arterial (Large Vessel) Invasion: Absent. Small/Intermediate Blood Vessel Invasion: Absent. Additional Pathologic Findings : Other: interstitial fibrosis, UIP. pattern; numerous non-necrotizing granulomas in lymph nodes. Neoadjuvant Treatment: Unknown. Extension of Tumor: Confined to lung. Page: 2 of 6. COMMENT. This case was initially signed out as a provisional report on. and has been amended to include results of immunohistochemical. stains. The diagnoses have not changed from the original report. The lymph nodes resected in the case (specimen 1-8) show diffuse. involvement with well-formed non-necrotizing granulomatous inflammation. Occasional mixed dust nodules with central hyalinization and focal. central necrosis are also present. Special stains for fungal elements. and acid-fast organisms are negative. There is no evidence of metastatic. carcinoma in any of the lymph nodes examined. :ctions of the tumor in specimen 8 show predominately moderately. differentiated squamous cell carcinoma (90%) with a small component. (10%) of a poorly differentiated spindle cell carcinoma that demonstrates. shows multiple mitoses and severe cytologic atypia. There is no. malignant cartilage, bone, or skeletal muscle identified in the spindle. cell component. Immunohistochemistry shows the squamous cell component. of the tumor to be positive for multiple cytokeratins (HMWK, CK5/6,. E1/AE3) and p63. The spindled component shows weak positive staining. for CK5/6 and p63, with very focal positive staining for CK7. The EGFR. shows strong membranous staining in approximately 90% of both the. moderately differentiated. component and the spindled component. Both. components are negative for p53 and TTF-1. The findings are consistent. with a pleomorphic carcinoma composed of predominantly squamous cell. carcinoma (moderately differentiated, 90%) and pleomorphic spindle-cell. carcinoma (poorly differentiated, 10%), pT2NO. The residual lung parenchyma in both specimen 1 (""wedge resection right. middle lobe"") and specimen 8 (""right lower lobe"") shows patchy. interstitial fibrosis that appears accentuated in a subpleural. distribution, with focal areas of architectural remodeling and cyst. formation (microscopic honeycomb change) There is mild chronic. interstitial inflammation associated with areas of fibrosis. Fibroblastic. foci are readily identified. The blood vessels show focal fibrointimal. thickening, likely secondary to the background inflammatory process, but. no diagnostic evidence of active vasculitis. Granulomas are noted within. an intraparenchymal lymph node (specimen 1), but are not identified in. the lung parenchyma itself. .ne overall findings in the lung tissue are in keeping with pulmonary. Page: 3 of 6. fibrosis of UIP pattern. However, the simultaneous presence of numerous. non-necrotizing granulomas within the lymph nodes is not typical of UIP,. and may indicate a second superimposed process, the differential. diagnosis of which is broad but which could include infections, drug. reactions, and sarcoidosis. Correlation with clinical and microbiologic. findings is recommended. ROSS DESCRIPTION. The specimen container labeled with the patient's name and as"" wedge. resection right middle lobe"" consists of a wedge of lung with 2 staple. line measuring 6.9 x 4 x 1.5 cm. A black nodule, 0.8 cm from the staple. line resection margin, measures 0.9 x 0.5 x 0.4 cm. The remaining. parenchyma is rubbery and firm. Intraoperative consultation performed on. a frozen by quick section. Representative sections submitted. 1A frozen section. 1B staple line margin. 1C remaining back nodule/node. 1D-1F lung. 2. The specimen is labeled with the patient's name and as ""subcarinal. ST7. Number of gray-tar tissue pieces: 10. Measurements: 0.5 x 0.5 x 0.4 cm to 2.7 x 1.7 x 1 cm. The specimen is submitted in toto. 2A 1 node bisected. 2B one node bisected. 2C 5 nodes. 2D one node bisected. 2E one node quadrisected. 2F one node trisected. 3. The specimen is labeled with the patient's name and as ""interlobar ST. 11"". One piece of gray-tan tissue measuring 3 x 1.7 x 1.1 cm. 3A-3C trisected and submitted in toto. 4. The specimen is labeled with the patient's name and as ""lobar ST12"". Number of gray-black tissue pieces: 4. Measurements: 0.5 x 0.3 x 0.2 cm to 2.2 x 1.5 x 1.2cm. The specimen is submitted in toto. 4A 3 nodes. 4B-4C one node trisected. 5. The specimen is labeled with the patient's name and as ""interlobar. ST11"". One piece of gray-tan tissue measuring 1.3 x 0.6 x 0.6cm. 5A node bisected and submitted in toto. The specimen is labeled with the patient's name and as ""right low. aratracheal ST4R"". One piece of tan black tissue measuring 1.4 x 1.2 x 0.6cm. 6A node bisected and submitted in toto. 7. The specimen is labeled with the patient's name and as ""inferior. pulmonary ligaments ST9"". One piece of tan black tissue measuring 1.8 x 1.3 x 0.6 cm. 7A node bisected and submitted in toto. 8. The specimen is labeled with the patient's name and as ""right lower. lobe"". Resection specimen: right lower lobe lung lobectomy measuring 10.5 x 10. x 6 cm. Pleural surface: intact, smooth cobblestone/shows some surface. adhesions, has an area of puckering measuring 1.7 x 1.2 cm. Tumour. Number of tumours: Measurements: 4.0 x 3.0 x 3.0 cm. Location: peripheral. Distance from resection margins: 2 cm from the bronchial resection. margin; 1.8 cm from the closest stapled parenchymal resection margin. Descriptive characteristics White in colour, specks of black spots;. solid consistency; poorly delineated. Lung parenchyma: Partly congested. Other lesions: No. Lymph Nodes: Multiple peribronchial lymph nodes are identified ranging. from 0.3 to 1.7 x 0.9 x 0.8 cm in greatest dimension. tozen Section: No. issue Banking: Multiple pieces of tumor. 5 of. 6. Representative sections are submitted as follows : 8A bronchial resection margin. 8B staple line margin. 8C-8H tumor. 8I lung parenchyma away from tumor. 8J-8K 1 lobar node bisected in each cassette. 8L 1 segmental node bisected. 8M one lobar node bisected. 8N one lobar node bisected. LA Lymph node with non-necrotizing granulomatous inflammation. Slides received at 10.18 am; reported 10.20 am. 6. of. 6."
BIOCUP_00002,lung,LUAD,TCGA-S2-AA1A,TCGA-S2-AA1A.83A6F838-3F30-411F-9982-B8985C7FA52E,"Female. Admission Date: Discharge Date: Collected Date/Time: Received Date/Time: Final Diagnosis. A. LYMPH NODES, LEVEL VII, LYMPHADENECTOMY: NO TUMOR SEEN IN 3 LYMPH NODES. B. LYMPH NODES, HILAR, LYMPHADENECTOMY: - NO TUMOR SEEN IN ONE LYMPH NODE. C. LYMPH NODES, LEVEL II, LYMPHADENECTOMY: NO TUMOR SEEN IN 6 LYMPH NODES. D. LYMPH NODES, LEVEL IV, LYMPHADENECTOMY: NO TUMOR SEEN IN 2 LYMPH NODES. E. LUNG, RIGHT UPPER LOBE, LOBECTOMY: INVASIVE MUCINOUS ADENOCARCINOMA. NO TUMOR SEEN IN 2 LYMPH NODES. SEE SYNOPTIC REPORT AND NOTE. NOTE: there are multiple foci of invasion with desmoplastic repsonse in a background of a ""lepidic"" involvement of alveolar. spaces, the largest focus measures 5.2 millimiters. (Electronic signature). Verified: Synoptic Report. SPECIMEN: Lobe(s) of lung: right upper. PROCEDURE: Lobectomy. Print Date/Time: Distribute to: Patient Locations: Female. Collected Date/Time: Received Date/Time: SPECIMEN INTEGRITY: Intact. SPECIMEN LATERALITY: Right. TUMOR SITE: Upper lobe. TUMOR SIZE: Greatest dimension: 2.5 cm. Additional dimensions: 1.5 x 1.0 cm. TUMOR FOCALITY: Unifocal. HISTOLOGIC TYPE: Invasive mucinous (former mucinous bronchoalveolar carcinoma). HISTOLOGIC GRADE: G1: Well differentiated. VISCERAL PLEURA INVASION: Not identified. TUMOR EXTENSION: Not applicable. BRONCHIAL MARGIN: Uninvolved by invasive carcinoma. VASCULAR MARGIN: Uninvolved by invasive carcinoma. PARENCHYMAL MARGIN: Uninvolved by invasive carcinoma. PARIETAL PLEURAL MARGIN: Not applicable. CHEST WALL MARGIN: Not applicable. OTHER ATTACHED TISSUE MARGIN: Not applicable. TREATMENT EFFECT: Not applicable. LYMPH-VASCULAR INVASION: Not identified. PRIMARY TUMOR (pT): pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without. bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus). REGIONAL LYMPH NODES (pN): pNO: No regional lymph node metastasis. Number examined: 14. Number involved: 0. DISTANT METASTASIS (pM): Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Print Date/Time: Collected Date/Time: Received Date/Time: Atypical adenomatous hyperplasia. Source of Specimen. A. Lymph Nodes, Level 7. B. Lymph Nodes, Hilar. C. Lymph Nodes, Level 2. D. Lymph Nodes, Level 4. E. Right Uppper Lobe. Clinical Information. PRE-OP DIAGNOSIS: Lung cancer. POST-OP DIAGNOSIS: Same. TYPE OF PROCEDURE:right VATS, lymphadenectomy. Gross Description. Specimen is received in 5 parts: A.The specimen is labeled ""LEVEL VII"" and is received in formalin. It consists of 3 black tan lymph nodes ranging from 0.6 x 0.5 x. 0.3-0.8 x 0.7 x 0.4 cm. Entirely submitted in cassette A1. B. The specimen is labeled ""HILAR LYMPH NODE"" and is received in formalin. It consists of a single black tan lymph node. measuring 1.2 x 0.5 x 0.3 cm. Entirely submitted in cassette B1. C. The specimen is labeled ""LEVEL II"" and is received in formalin. It consists of 6 black tan lymph nodes ranging from 0.5 x 0.5 x. 0.3-1.5 x 0.7 x 0.5 cm. Entirely submitted as follows. C1 = 5 lymph nodes. C2 = largest lymph node, bisected. D. The specimen is labeled ""LEVEL IV"" and is received in formalin. It consists of 2 lymph nodes measuring 0.5 x 0.5 x 0.3-1.0 x 0.5. x 0.3 cm. Entirely submitted in cassette D1. E. The specimen is labeled ""RIGHT UPPER LOBE"" and is received in formalin. It consists of a lobe of the lung measuring 15 x 12 x. 6. cm. and. weighing 270 g. The pleural surface is pink-purple and smooth. The soft tissue margin and bronchial margin of resection are. stapled shut. On section the cut surface shows 2.5 x 1.5 x 1 cm an ill-defined gray-tan mass is noted which is 6 cm away from the. bronchial margin of resection. This mass is located in subpleurally. The pleura overlying this mass is inked black and covered with. smooth surface without any papillary excrescences. A remaining portion of the lung shows dark red congested parenchyma without. other lesions. At the hilum lymph node is not identified. Representative sections are submitted as follows: E1= mass for further study. E2 = bronchial margin and blood vessel margin of resection. E3 = soft tissue margin of resection. E4-E5 = remaining entire mass. E6 = random section of lung. Specimen is in formalin more than 6 hours and less than 48 hours. Print Date/Time: Female. Collected Date/Time: Received Date/Time: Time specimen was removed from the patient: Time specimen was placed in formalin : Ischemic time: 22 minutes. Intra Operative Consultation. E. right upper lobe = adenocarcinoma. Special Stains / Slides. 20 H&E, 1 FS. Tissue Code."
BIOCUP_00003,lung,LUSC,TCGA-22-5474,TCGA-22-5474.e0bf9b86-3d7e-4a37-9545-b74dd999e128,"DIAGNOSIS: Lung, left upper lobe, wedge resection: Grade 3 (of 4) squamous. cell carcinoma forming a 2.0 x 1.8 x 1.8 cm mass arising in the. background of usual interstitial pneurmonia. The tumor invades into. visceral pleura. The tumor is completely excised and extends to. within 1 millimeter from stapled surgical margin. Lymph nodes, superior and inferior mediastinal, excision: Multiple. superior mediastinal (9 right lower paratracheal) , inferior. mediastinal (7 subcarinal) lymph nodes are negative for tumor."
BIOCUP_00004,lung,LUAD,TCGA-55-A48Y,TCGA-55-A48Y.3542521A-EA16-4CD1-A61A-1FB3AE928FC9,"PROCEDURE DATE: RECEIVED DATE: REPORT DATE: Pre-Op Diagnosis. Left lung mass. Post-Op Diagnosis. Same as above. Clinical History. Nothing indicated. Gross Description: Five parts. Container labeled. 1 - level 9 lymph node left lung"". has a 1.8 x 1.0 x 0.5 cm fleshy gray-tan to pink nodule surrounded. by a small amount of yellow adipose tissue. The specimen is bisected. and entirely submitted in a single cassette. Container labeled. 2 - level 10 lymph node left. lung"" has two nodular portions of rubbery gray-tan fleshy tissue. measuring 1.5 x 1.0 x 0.5 cm and 2.0 x 1.0 x 0.5 cm. These are. received along with 1.3 x 1.0 x 0.5 cm of similar fleshy tissue. fragments with associated yellow adipose tissue. The smaller nodule. is bisected and submitted labeled A. The larger nodule is bisected. and submitted labeled B. Remaining tissue fragments are submitted. labeled C. Container labeled. 3 - left lower lobe"" has a 231. gram previously partially inked, partially sectioned portion of. recognizable pulmonary parenchyma grossly consistent with left lower. lobe of lung. The specimen as received on reconstruction is 15.6 x. 9.6 x 5.9 cm and has as the margin of resection the stapled. bifurcation of the tertiary bronchi, as well as several additional. vascular and parenchymal staple lines. Adjacent to the bronchus is a. 1.5 x 1.0 x 0.7 cm lobulated fleshy gray-black nodule. The pleura is. slightly wrinkled gray-tan to pink. On the upper anterolateral. aspect at a point approximately 4.0 cm from the upper portion of the. specimen there is an area of indurated umbilication over an area of. 6.5 cm extending onto the lateral aspect. The anterior extending. to. the lateral aspect of this indurated pleura is overlaid by gray-tan. fibrinous material. The specimen has been previously partially. sectioned within this area to reveal a well defined 5.5 x 5.5 x 5.4. cm lobulated intraparenchymal gritty gray-tan fibrotic lesion. This. extends grossly focally to within 0.2 cm of the pleura. On. sectioning, this has a necrotic gray-tan focally. anthracotic-streaked fibrotic cut surface and grossly appears at its. neareet- peint 1.6 cm from the bronchial margin. A bronchial. connection is grossly identified. On the medial aspect of the. specimen the pleura is taut over the lesion. In the area of the. pleural staple line margins the lesion grossly appears to focally. extend to within 0.2 cm of these staple lines. The lesion grossly. abuts and focally compresses several large vascular structures but. does not grossly appear to extend into them. The specimen is. received after tissue harvest for genomic study. Within the specimen. container are two tissue cassettes labeled. The. remaining parenchyma is spongy, partially collapsed, gray-pink to. red with moderate anthracotic streaking and areas of apparent gross. emphysematous change. Representative sections are submitted labeled. as follows: A - shaved bronchial margin; B - peribronchial nodule,. sectioned; C - lesion with bronchial connection; D - lesion to. fibrinous material on pleura; E-H - lesion and surrounding tissue; I. - random uninvolved parenchyma. Container labeled. 4 - level 6 lymph node left lung"". has a 1.0 x 0.8 x 0.5 cm nodular portion of partially fragmented. gray-brown fleshy tissue with a small amount of associated yellow. adipose tissue. This is received along with a 1.2 x 1.0 x 0.3 cm. portion of yellow adipose tissue with a few adherent fragments of. gray-black fleshy tissue up to 0.3 cm. The nodule is bisected and. the specimen entirely submitted in a single cassette. Container labeled. 5 - level 5 lymph node left lung"". has a 1.6 x 1.2 x 0.4 cm nodular portion of gray-pink fleshy tissue. which is bisected and entirely submitted in a single cassette. Microscopic Description: Reviewed are slides labeled. An elastic stain is performed. (with working control) and supports the following diagnosis. Final Diagnosis. Lymph node, level 9, left lung, biopsy: One lymph node negative for metastatic carcinoma (0/1). Lymph nodes, level 10, left lung, biopsy: Three lymph nodes negative for metastatic carcinoma (0/3). Lung, left lower lobe, lobectomy: Tumor characteristics: Specimen integrity: Intact. Specimen laterality: Left lower lobe. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated (grade II). Tumor site: Left lower lobe. Tumor focality: Unifocal. Tumor size: 5.5 x 5.5 x 5.4 cm. Visceral pleural invasion: Tumor penetrates through elastic layer. into pleura but not to. pleural surface. Lymphovascular space invasion: No unequivocal lymphovascular space. invasion identified. Tumor extension: Confined to lung. Treatment effect: Not identified/not known. Surgical margin status: Tumor distance from bronchial margin: 1.6 cm. Tumor distance from parenchymal margin: 0.2 cm. Tumor distance from pleural surface: 0.2 cm. Lymph node status: Total number of lymph nodes received (with lobectomy specimen. only): One. Total number of lymph nodes containing metastatic carcinoma: Zero. (0/1); seven lymph. nodes received with all specimen parts (0/7). Other: Stage: pT2b NO. Lymph node, level 6, left lung, biopsy: One lymph node negative for metastatic carcinoma (0/1). Lymph node, level 5, left lung, biopsy: One lymph node negative for metastatic carcinoma (0/1). PAS 9. SPC-A. Comments. An elastic stain is performed (with working controls) and supports. the above diagnosis. At the request of the undersigned pathologist, these slides have. been additionally reviewed by Dr. who concurs with the. diagnosis."
BIOCUP_00005,lung,LUAD,TCGA-49-AARE,TCGA-49-AARE.D15D2040-F72D-4913-92FC-54741F573151,"INTERPRETATION AND DIAGNOSIS: 1. LUNG, RIGHT UPPER LOBE (LOBECTOMY) : INFILTRATING POORLY. DIFFERENTIATED ADENOCARCINOMA (2 CM) WITH EXTENSIVE NECROSIS. PLEURAL, BRONCHIAL, VASCULAR AND ALL SURGICAL RESECTION MARGINS ARE. NEGATIVE FOR TUMOR. SURROUNDING LUNG PARENCHYMA SHOWS FOCAL MILD. EMPHYSEMATOUS CHANGES. SEE NOTE. 2. LYMPH NODE, R-10 (EXCISION) : ONE (1) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 3. LYMPH NODE, STATION 7 (EXCISION) : ONE (1) LYMPH NODE AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 4. LYMPH NODE, R-4 (EXCISION) : ONE (1) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 5. PLEURAL NODULES (EXCISION) : DENSE FIBROUS TISSUE WITH FOCAL ACUTE. AND CHRONIC INFLAMMATION, NEGATIVE FOR TUMOR. NOTE: The pathologic stage is pT1 NO MX. This case was shown at the. has seen this case and. concurs. Clinical History: RIGHT LUNG MASS. GROSS DESCRIPTION. PART #1: FS: RIGHT UPPER LOBE, RIGHT LUNG MASS. Resident Pathologist: FROZEN SECTION DIAGNOSIS. FS: RIGHT UPPER LOBE, RIGHT LUNG MASS : INFILTRATING NON-SMALL. CELL CARCINOMA (2.0 CM) WITH EXTENSIVE NECROSIS. The specimen is received fresh, labeled with the patient's name,. and designated right upper lobe. It consists of an. upper Tobe of lung, weighing 160 gm and measuring 14.0 x 11.0 X 2.0. cm. A firm nodule is palpated on the surface opposite the hilum. The. pleura overlying this area is non-puckered and normal appearing. The. remaining pleura is focally hemorrhagic, glistening and with extensive. anthracotic pigmentation. Sectioning in the area of the palpated. mass, shows an ill-defined gray-white and gritty mass, measuring 2.0. cm in greatest dimension. Grossly, this mass is located 0.6 cm from. the pleura surface and does not appear to involve a bronchus. The. mass is well-defined and freely movable from the adjacent lung. parenchyma. The arteries and vessels at the hilum appear grossly. normal. The pleura overlying the tumor is inked black. A. representative frozen section is taken. Hilar lymph nodes are not. present in the specimen. The remaining lung is pink-red with focal. hemorrhage and is crepitant. Representative tumor and normal tissue. are submitted for future studies to tumor bank. The remaining tumor. is submitted in its entirety. SUMMARY OF SECTIONS. 1. FSC. 1. (FROZEN SECTION CONTROL). 1. A. 1 (BRONCHIAL MARGIN). 1. B. 4. (VASCULAR MARGINS). 2. C&D. 1 EACH (TUMOR). 1. E. 1. (NORMAL BRONCHUS). 4. F-I. 1. EACH (NORMAL LUNG). 10 - TOTAL - 13. PART #2: R10, RIGHT LUNG MASS. Resident Pathologist: The specimen is received fresh labeled with the patient's name. and designated R10. It consists of a previously. bisecteu black/pink lymph node measuring 1.0 x 1.0 x 0.6 cm. One. half is submitted for future studies and the remainder is submitted. for routine histology. SUMMARY OF SECTIONS. 1 - A. - 1. 1. - TOTAL - 1. PART #3: STATION 7. Resident Pathologist: The specimen is received fresh labeled with the patient's name. and designated station 7. It consists of one firm. tan/black lymph node measuring 1.2 x 0.6 x 0.4 cm. The specimen is. bisected. One half is submitted for future studies and the remainder. is submitted for permanent histology. SUMMARY OF SECTIONS. 1 - A. - 1. 1. - TOTAL - 1. PART #4: R4. Resident Pathologist : The specimen is received fresh labeled with the patient's name. and designated R4. It consists of one firm, gray to. black lymph node measuring 1.5 x 1.5 x 1.0 cm. One half is submitted. for future studies and the remainder is submitted for permanent. histology. SUMMARY OF SECTIONS. 1 - A. - 1. 1 - TOTAL - 1. PART #5: PLEURAL NODULES. Resident Pathologist: The specimen is received fresh labeled with the patient's name. and designated pleural nodules. It consists of a. lobular, firm, white/tan mass measuring 1.0 x 0.4 x 0.3 cm. The. specimen is submitted in its entirety. SUMMARY OF SECTIONS. 1 - A. - 1. 1. - TOTAL - 1. other Surgical Pathology Specimens known to the computer. printed."
BIOCUP_00006,lung,LUAD,TCGA-50-5051,TCGA-50-5051.ff5f5187-c4da-482c-b6fe-cbde5c820a80,"TCA - -50-5051. FINAL DIAGNOSIS: SUMMARY STATEMENT: The left upper lobectomy demonstrates a moderately differentiated adenocarcinoma, 2.0 cm in diameter, associated with. metastases to the level 5 lymph nodes and accompanied by visceral pleural invasion. All margins free. Pathologic stage;. T2 N2 Mx. PART 1: LUNG, LEFT UPPER LOBE, BRONCHOSCOPIC BIOPSY -. FRAGMENTS OF BRONCHIAL MUCOSA WITH NO SIGNIFICANT ABNORMALITY. PART 2: LYMPH NODE, LEVEL 5 LYMPH NODES, BIOPSY -. TWO OF THREE LYMPH NODE FRAGMENTS WITH METASTATIC ADENOCARCINOMA (2/3). PART 3: LYMPH NODE, LEVEL 12 LYMPH NODE, BIOPSY -. SOLITARY FRAGMENT OF LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA. PART 4: LYMPH NODE, LEVEL 11 LYMPH NODE, BIOPSY -. SOLITARY LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA. PART 5: BONE, ""RIB"", RESECTION -. SPECIMEN UNDERGOING DECALCIFICATION. ADDENDUM REPORT TO FOLLOW. PART 6: LUNG, LEFT UPPER LOBE, LOBECTOMY -. A. MODERATELY DIFFERENTIATED ADENOCARCINOMA WITH CLEAR CELL, SOLID, MUCINOUS AND FETAL. ADENOCARCINOMA-LIKE AREAS ASSOCIATED WITH VISCERAL PLEURAL AND ANGIOLYMPHATIC INVASION,. DIAMETER 2.0 CM. ALL MARGIN FREE. MILD HOST LYMPHOCYTIC RESPONSE. PATHOLOGIC STAGE T2 N2. MX. B. SOLITARY HILAR LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA. C. RESPIRATORY BRONCHIOLITIS WITH EMPHYSEMATOUS CHANGE. D. MULTIFOCAL ATYPICAL ADENOMATOUS HYPERPLASIA. E. PULMONARY ARTERIES WITH MARKED MYOINTIMAL THICKENING."
BIOCUP_00007,lung,LUSC,TCGA-39-5037,TCGA-39-5037.7a100e58-1e99-48b4-9db1-0228aaf4bb71,"Clinical Diagnosis & History: with LLL lesion (+) PET. Specimens Submitted: 1: SPI para-aortic aventitia tissue. 2: SP: Loft lower lobe lung. 3: SP: Left level eleven lymph nodo. 4: SP: Level seven lymph node. 5: SP: Left level ten lymph node. DIAGNOSIS: SOFT TISSUE, PARA-AORTIC-AORTIO ADVENTITIA, EXCISION: - BENION VESSEL WALL. 2). LUNG, LEFT LOWER LOBE, LOBECTOMY. - SQUAMOUS CELL CARCINONA, MODERATELY TO POORLY. DIFYERENTTIAPED/UNDIFPERENTIATED, OF LEFT LOWER LOBE,. - THE TUMOR MEASURES 2.3 x 2.2 x 2.0 CM. - NO VASCULAR INVASION IS IDENTIFIED. - NO PERINEURAL INVASION IS IDENTIFIED. - THE MAINSTEM BRONCHUS xs NOT INVOLVED BY TUMOR. - THE BRONCHIAL MARGIN IS PREE OF TUMOR. - THE PLEURA IS FREE OF TUMOR. - THE LUNG IS UNREMARKABLE. THE NON-NEOPLASTIC LUNG IS UNREMARKABLE. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF. METASTATIC NODES IN RELATION TO THE TOTAL NUMBER OF NODES EXAMINED) 1. PERIBRONCHIAL: 1/2, HILAR: 0/6. 3). LYMPH NODE, LEFT, LRVEL XI, EXCISION: - BENIGN LYMPH NODE. 4). LYMPH NODE, LEVEL VII, EXCISION: - BENIGN LYMPH NODE. 5). LYMPH NODE, LEFT LEVEL x, EXCISION: BENIGN LYMPK NODE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1). The spocimen is received fregh for frozen section consultation, labeled. ""Para aortic avontitia"" and consists of two fragments of soft tissue. measuring 0.4 am and 0.5 em in greatest dimension, which are entirely. submitted for frozen section congultation. Summary of sections: FSC-frozen section control. 2). The specimen is received fresh, labeled, ""left lower lobs lung"". consists of a 16.0 x 13.5 x 4.8 em lung lobe with attached branchus and. blood vessols, which weighs 244 gm. There is no stapled margin, The. attached bronchus measures 1.0 cm in length by 1.1 cm in diameter, Thore. is. a 5.0 x 2.0 em surgical defect on the anterior aspect. The pleural surface. showg multiple areas of fibrous adhesions. The pleural surface is inked. black. Serial sectioning reveals a 2.3 x 2.2 x 2.0 cm white-tan, stellate. tunor. The tumor is ill-defined. The tumor is situated in the mid lung. parenchyma, located 2.2 em from the bronchial margin. The tumor is within. the parenchyma 1.2 em from the pleura. The tumor grossly does not involve. the bronchus without causing bronchial obstruction. The bronchial mucosa is. smooth and glistening. There are no satellite lesions, Peribronchial. anthracotic lymph nodes are identified and submitted. The uninvolved lung. paranchyma is unremarkable. The bronchial margin and a representative. section of tumor were sent for frozen section. Representative sections. including the entire tumor are submitted. TPS is submitted. Photographs are. taken. Summary of sections: FSCA -- frozen section control, bronchial margin. FSCB -- frozen section control, tumor. VM vascular margin. TP tumor with pleura. TB - tumor with bronchus. TV - tumor with adjacent pulmonary parenchyma. RA - random lung parenchyma at loast 3 cm away from main tumor. RC - random lung parenchyma closo to tumor (within 3 cm of main tumor). LN -- lymph nodes. 3). The specimen is received in formalin, labeled left level 11 lymph. node and consiats of an anthracotic lymphoid fragment measuring 0.8 cm in. greatest dimension, which is antirely submitted whole. Summary of sections: U-undesignated. 4). The specimen is raceived in formalin, labeled ""Level 7 lymph node"" and. consists of an anthracotic lymph node measuring 1 cm in greatest dimension,. which is bisected and submitted entirely. Summary of sections: BLN - bisected lymph node. 5). The specimen is received in formalin, laboled ""Left leval 10 lymph. node"" and consists of a 1.2 cm flattened anthracotic lymph node which is. submitted entirely. Summary of aections: U-undesignated. Summary of Sections: Part 1; SP: Para-aortic aventitia tissue. Block. Sect. Site. PCs. 1. fsc. 1. Part 2: SP: Loft lower lobe lung. Block. Sect. site. PCs. 1. fsca. 1. 1. fscb. 2. In. 2. ra. 1. ro. 1. 2. 2. tp. 1. 6. tu. 6. vm. 1. Part 3: SP: Left level eleven lymph node. Block. Sect. Site. PCa. 1. u. Continued on noxt page. Part 4: SP: Level seven lymph node. Block. Sect. site. PCa. 1. bln. 1. Part 51 SP: Left level ten lymph node. Block. Sect. Site. PCs. 1. u. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: PARA-AORTIC AVENT TISSUE. BENIGN. SMOOTH MUSCLE. PERMANENT DIAGNOSIS: SAME. 2A). FROZEN SECTION DIAGNOSIS: LEFT LOWER LOBE LUNG. BENIGN. BRONCHIAL MARGIN. PERMANENT DIAGNOSIS: SAME. 2B). FROZEN SECTION DIAGNOSIS: LEFT LOWER LOBE LUNG. POORLY. SQUAMOUS CELL CARCINOMA. PERMANENT DIAGNOSIS: SAME. Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: PARA-AORTIC AVENT TISSUE. BENIGN. SMOOTH MUSCLE. PERMANENT DIAGNOSIS: SAME. 2A). FROZEN SECTION DIAGNOSIS: LEFT LOWER LOBE LUNG. BENIGN. BRONCHIAL MARGIN,. PERMANENT DIAGNOSIS: SAME. 2B). FROZEN SECTION DIAGNOSIS: LEFT LOWER LOBE LUNG. POORLY. DIFFERETHAITED SQUAMOUS CELL CARCINOMA. PERMANENT DIAGNOSIS: SAME."
BIOCUP_00008,lung,LUSC,TCGA-37-4135,TCGA-37-4135.27fd3de4-a7da-4dc1-a135-637bcb4b7316,Cureline. Clinical. Clinical. Index. Specimen label. Site #. Diagnosis. Lung. 1. Cancer. Lung. Cancer. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. Specificati. Container. Site. Matrix. Format. containers. container. t. on. Lung. Primary. Tumor. Tissue. OCT. block. n/a. Blood. n/a. Normal. Blood. frozen. tube. 1. n/a. Type of. Histological description. Grade. TNM Stage. TNM Stage. TNM Stage. Treatment. Procureme. (Source). (source). (T). (N). (M). type. nt. n/a. Squamous cell carcinoma. 3. 3. 0. 0. none. n/a. blood draw. n/a. n/a. n/a. n/a. n/a. none. Component. of treatment. Tumor cell. (Chemo /. %. Horm Th. Details). n/a. 71. n/a. n/a.
BIOCUP_00009,lung,LUSC,TCGA-33-AASD,TCGA-33-AASD.00E9AF99-0DD2-447D-90F3-7F068E6C3E55,"INTERPRETATION AND DIAGNOSIS: 1. LUNG, RIGHT LOWER LOBE (WEDGE RESECTION) : INFILTRATING SQUAMOUS. CELL CARCINOMA, MODERATELY DIFFERENTIATED (2.5 CM) . THE VISCERAL. PLEURA, BRONCHIAL MARGIN AND VASCULAR MARGIN ARE NEGATIVE FOR TUMOR. SCATTERED NECROTIZING GRANULOMAS. SPECIAL STAINS FOR MYCOBACTERIA. (AFB) AND FUNGUS (GMS) ARE NEGATIVE. 2. LYMPH NODE, STATION 7 (BX.) : ONE LYMPH NODE, NEGATIVE FOR TUMOR. 3. LYMPH NODE LEVEL 9 (BX.) : ONE LYMPH NODE, NEGATIVE FOR TUMOR. NOTE: The pathologic stage is T1 NO MX. Clinical History: YO WITH SQUAMOUS CARCINOMA OF THE LUNG. GROSS DESCRIPTION. SURGICAL. PATHOLOGY. PART #1: RIGHT LOWER LOBE WEDGE. Resident Pathologist: : The specimen is received fresh labeled. and. designated right lower lobe wedge. It consists of an identifiable. wedge of lung weighing 200 gms, and measures 12 x 9 x 4 cm. There is. a palpable nodule present. The margin is stapled close, and there are. grossly identifiable vessels and airways present at the margin. The tumor measures 2.5 cm and is located approximately the central. portion of the specimen. It approaches within 1 cm of the stapled. margin. The tumor is gray/white and firm, well demarcated from the. surrounding low parenchyma. It approaches to within 1 cm of the inked. pleural surface. The uninvolved lung parenchyma shows mucous plugging. focally. The remaining parenchyma is beefy red and otherwise. unremarkable. Representative sections are submitted. SUMMARY OF SECTIONS. 1. A. - 4. (VASCULAR AND BRONCHIAL MARGINS). 1. - B. - 3. (PARENCHYMAL SHAVES AT THE NEAREST. STAPLE MARGIN). 1. - C. - 1. (TUMOR AT CLOSEST VISCERA PLEURA). 2. - D-E - 1 EA. (TUMOR (. 1. - F. 1. (TUMOR AND ADJACENT BRONCHUS). 1. - G. (REPRESENTING TUMOR). 2. - H-I - - 1 EA. (PARENCHYMA REMOTE FROM TUMOR). 9. - TOTAL - 9. PART #2: STATION 7 LYMPH NODE. Resident Pathologist: The specimen is received fresh labeled. and. designated station VII, lymph node. It consists of black tan soft. tissue measuring 2.7 x 1.5 x 0.6 cm. The specimen is bisected and. one half of the lymph node is submitted for tumor bank, and future. studies. The remainder is submitted for permanent sections. SUMMARY OF SECTIONS : 1. - A - 1. 1 - TOTAL -. 1. SURGICAL. PATHOLOGY. PART #3: LYMPH NODE LEVEL 9. Resident Pathologist: The specimen is received fresh labeled. and. designated lymph node level IX. It consists of one piece of black tan. soft tissue measuring 1 x 0.6 x 0.3 cm. The specimen is bisected and. one half is submitted for tumor and future studies. The remaining. half is submitted for permanent sections. SUMMARY OF SECTIONS : - A. - 1. - TOTAL - 1. printed."
BIOCUP_00010,lung,LUAD,TCGA-44-2657,TCGA-44-2657.d31fa48b-949c-48b7-bc78-6954ede98172,"SPECIMEN. Left upper lobe. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung mass. GROSS DESCRIPTION. Received fresh in a container labeled ""left upper lobe"" is. a wedge of lung tissue, spanning an area 10.5 x 4.3 X 3.2. cm. There is a stapled margin. The pleural surface is tan-pink,. smooth, and glistening, with some anthracotic pigment deposition. The specimen is sectioned, revealing a 2.2 X 2.2 X 1.2 cm firm. rubbery nodule, with minimal umbilication of the overlying pleura. The pleural surface is inked black, The lesion comes to within. approximately 0.7 cm from the stapled margin, which is inked blue. The specimen outside the nodule is spongy and tan-pink, without. focal lesion. RS-6. Please note that per the clinical request. tissue is taken for tissue procurement. MICROSCOPIC DESCRIPTION. The following template summarizes the findings in this case : Histologic type Adenocarcinoma, not otherwise characterized. Histologic grade: Moderately differentiated. Primary tumor (pT) : pT2. There is focal visceral pleural invasion. (block #2). Margins of resection: Negative. Direct extension of tumor: Visceral pleural invasion. Vascular invasion: Not definitively identified. Regional lymph nodes (pN) : pNX. Distant metastasis (pM) : pMX. Other findings : Focal fibrosis. MICROSCOPIC DESCRIPTION. 4. DIAGNOSIS. Lung, left upper lobe, wedge resection. - Moderately differentiated adenocarcinoma, with focal visceral. pleural invasion, margins negative for malignancy (see. microscopic. description)."
BIOCUP_00011,lung,LUSC,TCGA-58-A46N,TCGA-58-A46N.95A2F9CB-DFB3-441E-9F24-467D9AB343F9,"Pathology Report-Summary: Material: lung, right, lower lobe: 19.0 X 13.0 X 8.0 cm. tumor: 3.5 X 2.0 X 2.2 cm. Diagnosis: Squamous Cell Carcinoma, basaloid. pT2a, pNO (0/38), pMx, G3."
BIOCUP_00012,lung,LUAD,TCGA-80-5611,TCGA-80-5611.42e15634-a742-4e7c-a795-e5fe6fd7b9aa,"A description for each data field can be found in the 'Data description worksheet (yellow tab). tion Details. Histology and staging. TUMOUR. FF. LUL lung mass. Adenocarcinoma. 0. 11. RESECT. LUL. 3.20. 03. III. T2,NOS. MO."
BIOCUP_00013,lung,LUSC,TCGA-18-3411,TCGA-18-3411.03efa03c-f8f9-43c3-9244-265bc02cbb5c,"SPECIMEN (s) RECEIVED. 1. Pleura: PLEURAL DISEASE - APICAL SEGMENT RIGHT LOWER LOBE. 2. Lymph node : Interlobar ST11. 3. Lung Both bronchial Margin Rt Upper Lobe. Single suture on tracheal. margin, Double suture on Bronchial Margin. 4. Lymph node : Rt low Paratracheal ST4R. Lymph node : Rt TB angle ST1OR. U. Lymph node : Interlobar ST11. 7. Lymph node : Subcarinal ST7. DIAGNOSIS. 1. Apical segment right lower lobe wedg√© biopsy: Subpleural fibrosis and chronic inflammation, negative for malignancy. 2. Interlobar ST11: Negative for tumor, lymph node. 3 . Right upper lobe lung lobectomy with sleeve resection: poorly differentiated squamous cell carcinoma, central, 4.7 cm in. greatest diameter. (pT2). - Peri-tumoral chronic interstitial pneumonia and mucous plugging,. consistent with obstructive pneumonitis. Tumor extensively infiltrates the peribronchial lymph nodes. (See. comment). Bronchial resection margin negative for tumor. - Tracheal resection margin negative for tumor. Remaining lung parenchyma shows moderate to marked centroacinar. emphysematous changes. 4. Right low paratracheal ST4R: Positive for metastatic squamous cell carcinoma. (pN2). Right TB angle ST10R: Positive for metastatic squamous cell carcinoma. Page: 1 of 4. 6. Interlobar ST11: Positive for metastatic squamous cell carcinoma in 1 of 3 lymph nodes. 7. Subcarinal ST7: - Negative for tumor. COMMENT. The peribronchial tissue circumference was painted with Indian ink, and. e bronchus was serially cross-sectioned. One of the sections shows. -ymph node infiltrated by tumor, which also extends to the painted radial. margin of this lymph node. The significance of this finding should be. interpreted in the context of surgical procedure performed. CLINICAL HISTORY. LUNG CANCER. GROSS DESCRIPTION. 1. The specimen container labeled with the patient S name and as ""apical. segment right lower lobe"", contains fragments of tan hemorrhagic tissue. measuring 3.0 x 1.5 x 0.3 cm received fresh. This is examined at. intraoperative consultation by frozen section performed on part of the. specimen. On sectioning there is a white circular lesion in the center. measuring 0.5 x 0.3 cm. The specimen is submitted in toto as follows. 1A - frozen section representative section resubmitted. 1B-1C - remainder of the specimen submitted in toto. 2. The specimen container labeled with the patient' S name and as. ""interlobar ST11"", contains a piece of greyish-brown node measuring 0.6 x. 0.4 x 0. cm received in 10% buffered formalin. 2A - specimen bisected and submitted in toto. The specimen container labeled with the patient' S name and as 11 both. :onchial margin right upper lobe, single suture on tracheal margin,. double suture on bronchial margin"", contains a lobe of lung received. Page: 2 of 4. fresh. This is examined at intraoperative consultation by frozen section. performed on part of the specimen. The lobe of lung measures 14.0 x 10.5. x 6.7 cm. On the hilar area there are two tubular cartilaginous tissue. noted both marked with stitch, one double stitch marking as bronchial. margin and one single stitch marking as the tracheal margin. The. tracheal margin measures 1.5 cm in diameter while the bronchial margin. measures 1. cm in diameter. Surrounding this bronchial and tracheal. area is an area of soft tissue, which is firm and is grey-tan in color. The peripheries of these peri-bronchial and tracheal margins are painted. with India ink. The pleural surface generally is smooth, shiny except. for an area measuring 3.0 x 2.0 cm. This area has some fibrous adhesions. the pleura. On further sectioning underneath this puckered area is a. .11-defined tumor mass measuring 4. 7 x 2.5 x 2.5 cm. The cut surface of. the tumor mass is grey-tan to tan-white in color. On further sectioning. about 1. 8 cm to this tumor is an area of firmness, yellowish-brown to. grey in color or areas of consolidation noted measuring about 2. x 2. 0. cm. The tumor is partly solid and some necrotic areas. The remainder of. the lung tissue appears to be grossly unremarkable with no other discrete. lesion noted. Two pieces of tumor, one piece of bronchial mucosa and one. piece of normal lung tissue were taken for snap freezing. Sections are. submitted as follows: 3A - frozen section, bronchial margin resubmitted. 3B - frozen section tracheal margin resubmitted. (Tracheal margin broke after resection from major specimen). 3C - frozen section tracheal margin representative deeper section from. site of break resubmitted. 3D-3M - bronchial area (bronchus, tracheal) serially sectioned. circumferentially in relation to tumor. 3N-3p - representative section of tumor in relation to the pleura with. fibrous adhesion. 3Q-3R - representative sections of the tumor in relation to normal tissue. 3S -3V - representative sections of adjacent area of the tumor area of. consolidation. 3W - -3X - representative sections of normal lung tissue away from the. tumor. 4. The specimen container labeled with the patient S name and as "" right. ow paratracheal ST4LR"", contains a piece of black-tan node measuring 1.0. 0. 6 x 0.3 cm received in 10% buffered formalin. 4A - submitted in toto. Page: 3 of 4. 5. The specimen container labeled with the patient S name and as II right. TB angle ST10R"", contains a piece of grey-tar node measuring 1.4 x 0.8 x. 0. 6 cm received in 10% buffered formalin. 5A - specimen bisected and submitted in toto. 6. The specimen container labeled with the patient S name and as. ""interlobar ST11"", contains two pieces of greyish-tan nodes measuring 0.9. x 0.6 x 0.5 cm and 1.2 x 0.6 x 0.4 cm received in 10% buffered formalin. 6A - submitted in toto. The specimen container labeled with the patient' S name and as. ""subcarinal ST7"", contains a piece of greyish-brown soft tissue measuring. 1.6 x 1.0 x 0.7 cm received in 10% buffered formalin. 7A - submitted in toto. QUICK SECTION. 1A ""Inflammatory changes identified no malignancy. "". 3A "" Bronchial margin negative for malignancy "". 3B,3C "" Tracheal margin negative for malignancy"". Page: 4 of 4."
BIOCUP_00014,lung,LUSC,TCGA-34-5234,TCGA-34-5234.ecde2410-dc20-4f6d-9215-4bf5452d530c,"FINAL DIAGNOSIS: Summary Statement. The left upper lobe lingulectomy demonstrates a 2.0 cm moderately differentlated squamous cell carcinoma with. angiolymphatic Invasion but without visceral pleural invasion, with all margins free and no Tymph node metastases. Pathologic stage T1, NO, MX. PART 1: BRONCHUS, LEFT SECONDARY CARINA, BIOPSY -. FRAGMENTS OF BRONCHIAL MUCOSA WITH NO SIGNIFICANT ABNORMALITY. PART 2: LYMPH NODE, LEVEL 9 LYMPH NODE, BIOPSY -. SOLITARY LYMPH NODE WITH NO SIGNIFICANT ABNORMALITY. PART 3: LYMPH NODE, LEVEL 10 LYMPH NODE, BIOPSY -. THREE FRAGMENTS OF LYMPH NODE WITH ANTHRACOSILICOTIC NODULES. NO EVIDENCE OF. MALIGNANCY. PART 4: LUNG, LINGULAR SEGMENT OF LEFT UPPER LOBE, SEGMENTECTOMY -. A. MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA WITH PROMINENT LEPIDIC GROWTH. AND FOCAL ANGIOLYMPHATIC INVASION. DIAMETER 2.0 CM. NO EVIDENCE OF VISCERAL PLEURAL. INVASION. ALL MARGINS FREE. MODERATE HOST LYMPHOCYTIC RESPONSE. PATHOLOGIC STAGE T1,. NO, MX. B. RESPIRATORY BRONCHIOLITIS WITH EMPHYSEMATOUS CHANGE,. PART 5: LYMPH NODES, LEVEL 5 LYMPH NODE, BIOPSY -. SEVEN FRAGMENTS OF LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA. PART 6: LYMPH NODES, LEVEL 11 LYMPH NODE, BIOPSY -. TWO FRAGMENTS OF LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA. COMMENT: The squamous cell carcinoma is a moderately differentiated keratinizing squamous carcinoma with a marked. desmoplastic reactlon. Of interest Is the prominent lepidic growth by the neoplastic squamous cells, which is associated. with metaplasia of bronchiolar epithellum and alveolar pneumocytes, with pagetoid spread."
BIOCUP_00015,lung,LUAD,TCGA-62-A472,TCGA-62-A472.1C47AD8C-F1EB-4B7E-9633-3260EF8CEAE4,"Pathology Report-Summary: Material: lung, right, lower lobe: 14.0 X 4.0 X 2.8 cm. tumor 1: 2.5 X 2.2x2.1 cm. tumor 2: 1.5.0 x 1.4 X 1.3 cm. Diagnosis: Both tumors Adenocarcinoma (NOS). Tumor 1 infiltrates and breaks pleura visceralis. pT3, pNo (0/2), pMx, G3."
BIOCUP_00016,lung,LUSC,TCGA-85-8354,TCGA-85-8354.577d1d2a-e784-49eb-8a00-e28ea210db4e,Gross Description. Microscopic Description. Diagnosis Details. Comme. nts. LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 5 X 5 X 5 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 0/4 positive for metastasis. (Regional 0/4). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: Right-lower. Lateralit. y. Right-. lower.
BIOCUP_00017,lung,LUSC,TCGA-56-A4BW,TCGA-56-A4BW.8CC4BF2C-0E0E-4724-BC6C-6E317E0C5C5F,"Result Date: Surgical Pathology Final Repart. - rinal Report. Final Diagnosis (Verified). Left lung, pneumonectomy with frozen section examination: Moderately differentiated squamous cell carcinoma within upper lobe. Overlying pleural surface free of neoplasm. Tumor measures 4.5 cm in maximum gross dimension. Bronchial margins of surgical resection are free. Hilar lymph nodes: Two (2) of six (6) lymph nodes positive for metastatic squamous cell carcinoma. Lymph node dissection: 4L lower paratracheal nodes: One (1) negative node. 7 subcarinal lymph node: Three (3) negative nodes. 8 paraesophageal below carina lymph nodes: Seven (7) negative nodes. 9 pulmonary ligament lymph nodes: Two (2) negative nodes. Comment: This case corresponds to a pathological AJCC stage of T2a,N1. Signature Line. (Electronically signed by). Verified on: Frozen Section Diagnosis (Verified). History: Left lung mass. Specimen A: Left pneumonectomy. Gross A: Pleural surface over tumor inked. Sectioning reveals 4.5 cm white mass. FSA1: Tumor mass: Squamous cell carcinoma. FSA2: Bronchial and vascular margins: No tumor. Clinical Information (Verified). Left lung cancer. Performing Lab (Verified). Testing performed at. Gross Description (Verified). ""A, NFSA."" Received after frozen section is a 349 gram, 18.7 x 12.3 x 5.8 cm left lung. The bronchial and vascular margins have been. previously sampled. There is a 4.5 x 3.2 cm white-tan, firm mass in the upper lobe. The mass grossly appears to come to within 0.3 cm of the. adjacent pleura. The pleura overlying the mass has been previously inked blue. The mass grossly appears to surround the intraparenchymal. portion of the bronchus and comes to within 3.2 cm of the current bronchial margin. The remaining lung parenchyma ranges from pink-tan to. congested. No other masses or lesions are grossly identified in the remainder of the lung. At the hilum of the lobe are 7 possible lymph nodes. ranging from 0.4 to 1.8 cm in greatest dimension. Two portions of the specimen have been submitted for frozen section in cassettes ""FSA1"". and ""FSA2."" ""A1-A3,"" random sections of the mass; ""A4,"" random sections of the mass with adjacent intraparenchymal portion of bronchus;. ""A5,"" random sections remainder of lung; ""A6-A7,"" possible hilar lymph nodes. ""B, 4L lower paratracheal."" Received is a 2.1 x 1.3 x 0.5 cm black to tan lymph node. The lymph node will be bisected and submitted in toto. ""B,"" all. ""C, 7 subcarinal."" Received are 3 lymph nodes ranging from 0.5 to 1.1 cm. The specimen will be submitted in toto. ""C,"" all. ""D, 8 paraesophageal below carina."" Received are 7 possible lymph nodes ranging from 0.3 to 1.1 cm. All the lymph nodes will be submitted. in toto. ""D1,"" smaller lymph nodes; ""D2,"" largest lymph node. ""E, 9 pulmonary ligament."" Received are 3 lymph nodes ranging from 0.7 to 1.2 cm submitted in toto. ""E,"" all. Signature Line. Completed Action List:"
BIOCUP_00018,lung,LUSC,TCGA-39-5034,TCGA-39-5034.8d0c1256-1e5c-4db3-961d-15a4e1329224,"Clinical Diagnosis & History: Pt. had work up for MVA with right upper lobe mass, FNA. ) positive. NSCLC, favor adenooarcinoma. CT chest. ; right upper lobe mass and. right lower lobe nodule. Specimens Submitted: 1; LYMPH NODES; RIOHT LEVEL FOUR MEDIASTINAL; EXCISION. 2. none, PORTION OF SIXTH RIB; EXCISION. 3 r BONE, PORTION OF 3RD RIB; EXCISION. 4: BONE, PORTION OF 2ND RIB; EXCISION. 5: BONE, FINAL POSTERIOR MARGIN OF 3RD RIB; EXCISION. 6: BONE, FINAL POSTERIOR MARGIN OF 2ND RIB; EXCISION. 7: BONE, FINAL ANTERIOR MARGIN OF 2ND RIB; EXCISION. 8: BONE, FINAL ANTERIOR MARGIN OP 3RD RIB; EXCISION. 9: LYMPH NODE, RIGHT LEVEL TWELVE MEDIASTINAL; EXCISION. 10: LYMPH NODE, RIGHT LEVEL TEN MEDIASTINAL; EXCISION. 11: LYMPH NODE, RIGHT LEVEL11 INTERLOBAR; EXCISION. 12: LUNG, RIGHT UPPER LOBE AND PORTIONS OF RIGHT 2ND 3RD RIBS; LOBECTOMY AND. CHEST RESECTION. DIAGNOSIS: 1. LYMPH NODES; RIGHT LEVEL FOUR MEDIASTINAL; EXCISION: - ELEVEN BENIGN LYMPH NODES (0/11). HONE, PORTION OF SIXTH RIB; EXCISION: - BENIGN BONE AND SKELETAL MUSCLE. - NO TUMOR SEEN. BONE, PORTION OF 3RD RIB; EXCISION: BENIGN BONE AND SKELETAL MUSCLE. NO TUMOR SEEN. 4. BONE, PORTION OF 2ND RIB; EXCISION: - BENIGN BONE, FIBROADIPOSE TISSUE, AND SKELETAL MUSCLE. NO TUMOR SEEN. 5. BONE, FINAL POSTERIOR MARGIN OF 3RD RIB; EXCISION: - BENIGN BONE, FIBROADIPOSE TISSUE, AND SKELE/TAL MUSCLE. NO TUMOR SEEN. Fage 2 of 7. 6. DONE, FINAL POSTERIOR MARGIN OF 2ND RIB; EXCISION: - BENIGN BONE, FIBROADIPOSE TISSUE, AND SKELETAL MUSCLE. - NO TUHOR SEEN. BONE, FINAL ANTERIOR MARGIN OF 2ND RIB; EXCISION: - BENIGN BONE, FIHROADIPOSP. TISSUE, AND SKELETAL MUSCLE. - NO TUMOR SEEN. BONE, FINAL ANTERIOR MARGIN OF 3RD RIB; EXCISION: - BENIGN BONE, FIBROADIPOSE TISSUE, AND SKELETAL MUSCLE. - NO TUMOR SEEN. LYMPH NODE, RIGHT LEVEL TWELVE MEDIASTINAL; EXCISION: - ONE BENIGN LYMPH NODE (0/1),. 10. LYMPH NODE, RIGHT LEVEL TEN MEDIASTINAL; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 11. LYMPH NODE, RIGHT LEVEL11 INTERLOBAR; EXCISION: - THREE BENION LYMPH NODE (0/3). 12. LUNG, RIGHT UPPER LOBE AND PORTIONS OF RIGHT 2ND 3RD RIBS;. LOBECTOMY AND CHEST RESECTION: - MODERATELY DIFPERENTIATEn SQUAMOUS CELL CARCINOMA. THE TUMOR MEASURES 3.2 CM IN GREATEST DIMENSION. - THE TUMOR INVOLVES THE CHEST WALL INTOSKELETAL MUSCLE. - VASCULAR INVASION IS PRESENT. - THE BRONCHIAL HARGIN IS FREE OF TUMOR. - THE VASCULAR MARGIN IS FREE OF TUMOR. - THE NON-NEOP√çASIC LUNG SHOWS RESPIRATORY BRONCHIOLITIS AND FOCAL. CHANGES. - TWO BENIGN LYMPH NODES (0/2). - BENIGN BONE AND SKELETAL MUSCLE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTRER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1). The specimen is redeived fresh for frozen section consultation, labeled. Right lovel 4 mediastinal lymph node. It consists of a fragment of yellow. black soft tiggue measuring 3.0 x 1.8 x 1.3 cm. There are multiple lymph. nodes identified and submitted entirely for frozen section consultation. Summary OF sections: FSCA-frozen section control A. PSCB.-frozen section control B. 2). The specimen is received in formalin, labeled ""Portion of right sixth. rib"". It consists of a 3 x 2 x 1.2 cm fragmented gegment of rib. There. is. no discrete abnormality identified. Representative sections are submitted. after decalcification. Summary of sections: U-undesignated. 3). The specimen is received in formalin, labeled ""Portion of right third. rib"". It consists of three pieces of brown tan bony tiesue ranging from 1.5. x 0.8 x 0.4 cm up to 2.0 x 1.4 x 0.5 cm. Representative sections are. submitted after decalcitication. Summary of sections: U-undesignated. 4). The specimen is received in formalin, labeled ""Portion of right second. rib, It consiste of three pieces of brown tan bony tissue measuring 5 x 3. x 0.7 cm in aggregate, There are no discrete abnormalities identified. Rapresentative sections are submitted as decalcification. Summary OF sections: U-undesignated. 5). The specimen is received in formalin laboled ""Right final posterior. margin of third rib"". It consists of a sagment of rib measuring 4 cm in. length and 1.4 cm in diameter. There is attached skeletal muscle measuring. 5.5 x 3 x 1.5 cm. The resected margins of the rib are inked black. On. bivalving the rib it shows unremarkable trabeculated appearance. Cut. section of the skeletal muscle it is grossly unremarkable. Representative. sections are submitted after decaloification. Summary of sections: M-bone with resected margins. U-skeletal muscle. 6). The specimen is received in formalin, laboled Final right posterior. margin of second rib"". It consists OF a fragmented pieces of brown-tan bony. tissue measuring 2.5 x 2 x 1.2 cm. The specimen is sectioned and submitted. entirely aftor decalcifioation. Summary of sections: U-undesignated. Page of 7. 7). The specimon is received in formalin, labalad ""Final right anterior. margin of second rib"", rt consists of a 1.4 x 0.6 x 0.3 cm piece of. brom-tan bone which is entirely submitted after decaloifioation. Summary of sections: U-undesignated. 8). The specimen is received in formalin, labeled ""Final right anterior. margin of third rib"". It consists of two fragmented pieces of brown-tan. bony tissue measuring 2.2 x 2 x 0.6 cm in aggregate. Both are sectioned and. submitted entirely. Summary of sections: U-undusignated. 9). The specimen is received in formalin, labeled Right levol 12. mediastinal lymph node"". It consists of a single anthracotic lymph node. measuring 1.5 x 1.2 x 0.9 cm, which is bisected and submitted entirely,. Surmary of sections: U-undesignated. 10). The specimen is received in formalin, labeled ""Right level 10. mediastinal lymph node and consists of a single anthracotic lymph node. measuring 0.6 x 0.5 x 0.2 cm. The lymph node is entirely submitted. Summary of sections: U-undesignated. 11). The specimen ig received in formalin labeled ""Right levol 11. interlobar lymph node'. It consists of multiple lymph nodes measuring 1.0 x. 0.8 x 0.4 em in aggregate. The lymph nodes are entirely submitted. Summary of sections: U-undesignated. 12), The specimen is received in frosh state, labeled "" right upper lobe. lung with portions of second and third rib and consists of a right upper. lung lobe measuring 16 x 14 x 4.6 em and laterally attached chest wall. measuring 6.5 x 5.5 x 1,2 cm containing a segment of the second rib (4.6 cm. in length 1.2 em in diameter) and a segment of the third rib (6 cm in langth. 1.2 em in diameter). A 15 cm staple line is identified on the modial. aspect. Chest wall resection margin is inked. Sectioning zeveals a 3.2 x. 3.2 x 1.5 cm well-cireumacribed tan firm mass at the periphery in the. lateral aspect of the specimen at 4.3 cm from the bronchial margin. The. tumor firmly adhered to the attached chest wall, and invasion ig strongly. suspected. Rib margins are submitted as separate parts. Multiple. anthracotic peribronchial lymph nodes are identified. Background lung. parenchyma shows diffuse severe emphysematous changes, TPS is previously. taken. Bone is decalcified. The specimen is photographed. Summary of sections: BM -- bronchial margin. VM - vascular margin. SL -- staple line. LN -- lymph node. T -- tumor. TCW -- and chest wall (second rib is included). 2R additional section of second rib. 3R third rib. RC -- background lung parenchyma close to the tumor (less than 3 cm). RA -- background lung parenchyma away from the tumor (more than 3 om). Summary of Sections: Part 1: LYHPK NODES; RIGHT LEVEL FOUR MEDIASTINAL; EXCISION. Block. Sect. Site. PCs. 1. fisca. 1. fach. Part 21 BONE, PORTION OF SIXTK RIB; EXCISION. Block. Seot Site. PCs. 1. u. 1. Part 3: BONE, PORTION OF 3RD RIB; EXCISION. Block. Sect. Site. PCs. u. 1. Part 4: BONE, PORTION OF 2ND RIB; EXCISION. Block. Sect. site. PCs. 1. u. 1. Part 5t BONE, FINAL POSTERIOR MARGIN OF 3RD RIB; EXCISION. Block. Sect. site. PCs. 2. m. 2. 1. u. 1. Part 6: BOUE, FINAL POSTERIOR MARGIN OF 2ND RIB; EXCISION. Block. Sect. Site. PCs. 3. u. 3. Part 7: BONE, FINAL ANTERIOR MARGIN OF 2ND RIB; EXCISION. Block. Sect. Site. PCs. 1. u. 1. Part 8: BONE, FINAL ANTERIOR MARGIN OF 3RD RIB; EXCISION. Block. Sect. Site. PCs. 2. u. 2. Part 9: LYMPH NODE, RIGHT LEVEL TWELVE MEDIASTINAL; EXCISION. Block. Sect, Site. PCs. 1. u. 1. Part 10: LYMPH NODE, RIGHT LEVEL TEN MEDIASTINAL; EXCISION. Block. Sect. Site. PCs. u. 1. Part 11: LYMPH NODE, RIGHT LEVEL11 INTERLOBAR; EXCISION. Block. Sect. Site. PCs. 1. u. Part 12: LUNG, RIGHT UPPER LOBE AND PORTIONS OF RIGHT 2ND 3RD RIBS;. LOBECTONY AND CHEST RESECTION. Block. Sect. Site. PCs. 1. 2r. 1. 1. 1. bm. 1. In. 1. 2. ra. 2. 2. re. 2. 9. gl. 9. 3. 3. tow. 1. vm. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME."
BIOCUP_00019,lung,LUSC,TCGA-77-6842,TCGA-77-6842.4f5574a0-e1d7-427c-8f03-d08cb0b264a4,"LEFT LUNG AND LYMPH NODES. Clinical Notes: L pneumonectomy, number 7 LN, number 5 LN. Three specimens are received: 1: L LUNG. Macroscopy: Specimen consists of a left pneumonectomy specimen measuring 300 x 290 x 58 mm in the. inflated state. There is an area of adhesion between the upper and lower lobes across the. oblique fissure. The pleura otherwise appears normal. Located in the upper lobe 25 mm from. the resection margin is a large well circumscribed firm grey mass measuring 62 mm in. maximal dimension. It appears to extend across the oblique fissure into the lower lobe. It. comes close to the external pleural margin but it appears to be clear of it. The tumour shows. central necrosis and cavitation. Near its most medial aspect of the specimen, several lymph. nodes show some pale discolouration suggestive of direct invasion by tumour. Adjacent lung. tissue shows evidence of mild centri-acinar emphysema. The lung tissue distal to the tumour. in the lower lobe shows yellow discolouration suggestive of lipoid pneumonia. [Bronchial. resection margin with hilar lymph nodes, 1A; further hilar lymph nodes, 1B; tumour where it. appears to cross the oblique fissure, 1C and 1D; tumour with no pleura or margins, 1E; tumour. with pleura, 1F; ? lymph node invasion, 1G; emphysema, 1H; ? lipoid pneumonia, 1I]. Microscopy: Sections show a poorly differentiated carcinoma in which there are some squamous features. The tumour has central necrosis. It invades across the oblique fissure to involve both lobes. Blood vessel invasion is present and there is tumour within an intrapulmonary peribronchial. lymph node. The tumour is clear of the bronchial margin. Centriacinar emphysema is noted. Lung distal to the tumour shows patchy organising pneumonia and endogenous lipid. pneumonia with collections of intra-alveolar foamy macrophages. 2: NUMBER 5 LYMPH NODE. Macroscopy: Specimen consists of two grey pieces of tissue which measure 20 x 10 x 3 mm in aggregate. [BIT, 2A]. Microscopy: The lymph nodes show no evidence of malignancy. The adjacent connective tissue contains. nodules of concentric fibrotic tissue consistent with silicotic nodules. These are probably. within an obliterated node. 3: NUMBER 7 LYMPH NODE. Macroscopy: Specimen consists of three tan coloured pieces of tissue measuring 12 x 12 x 3 mm in. aggregate. [BIT, 3A]. Microscopy: The lymph nodes show no evidence of malignancy. Summary-Specimens 1-3: Left pneumonectomy and mediastinal lymph nodes: 1: Poorly differentiated squamous cell carcinoma of the upper lobe with extension. through the oblique fissure into the lower lobe, 62 mm in maximal dimension. 2: Peribronchial lymph node involvement. 3: Blood vessel and pleural invasion. 4: Clear of bronchial resection margin. 5: Pathological stage T2N1MX. T-28000 M-80703 P1-03000. Copies:"
BIOCUP_00020,lung,LUSC,TCGA-56-A4BX,TCGA-56-A4BX.921CAB89-9289-4C98-9746-4BFB3569E338,"MRN #: Ref Phys. SPECIMEN IN. DIAGNOSIS. DIAGNOSIS: A. Lung, right lower lobe, excision: Tumor Characteristics: 1. Histologic type: Squamous cell carcinoma. 2. Histologic grade: Grade II, moderately differentiated. 3. Tumor site: Right lower lobe. 4. Tumor focality: Unifocal. 5. Tumor size: 6.0 x 5.0 x 3.5 cm. 6. Visceral pleural invasion: Not identified. 7. Lymphovascular space invasion: Not identified. 8. Tumor extension: Tumor confined to lung parenchyma. Surgical Margin Status: 1. Tumor distance from bronchial margin: 4.5 cm. 2. Tumor distance from parenchymal (stapled) margin: 6.0 cm. 3. Tumor distance from pleural surface: 0.1 cm. Lymph Node Status: 1. One peribronchial lymph node negative for malignancy. 2. See parts B, C. Other: 1. pTNM stage: pT2b, NO. B. Level 9 lymph nodes, excision: Four lymph nodes, negative for metastatic disease. C. Level 7 lymph nodes, excision: One lymph node, negative for metastatic disease. COMMENTE. Current. / practice guidelines recommend determination of EGFR and KRAS mutation status in adenocarcinoma of lung to help select patients for. Tyrosine-Kinase Inhibitor (TKI) therapy. EGFR-activating mutations have been show to be significantly associated with response to TKIs and KRAS. mutations are associated with TKI resistance. They are mutually exclusive in. Additionally, recent data show that ALK (Anaplastic Lymphoma. Kinase) gene rearrangements in adenocarcinoma of lung are associated with resistance to TKis and have favorableresponse rates to Crizotinib, the ALK. inhibitor. agent. currentiv. in clinical trials. Mutation analysis for KRAS and EGFR-TK domain and ALK gene rearrangement by FISH is available as the. Testing may be performed on paraffin-embedded tissue from the primary or metastatic tumor or pleural fluid cell block. - nese tests are available on request as a panel or as individual assays. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: year old male with right lower lobe lung cancer. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: specimen. A. Right lower lobe. B. Level 9 lymph node. The specimen consists anthracotic. of a lower The pleural tobe lobectomy surface comes has within been 4.5 cm. C. GROSS Level 7 lymph node and weighs formalin labeled lesion The pleural measuring surface right 6.0 x is lower display 5.0 brown x lobe. 3.5 cystic tan cm shaggy that spaces. is slightly 0.1 cm of the pleural surface tissue area and within one there yellow the is a lesion gray and 5: shave one at the blue,. in 317 grams. The 14.0 x and a yellow cm 6.0 cm surrounding gray of the fibrous stapled lung stringy edge. tissue The is 1.0 red stringy cm. tan Received portions spongy labeled and with congested. the cnariman Within are three ollows: lung and sections peribronchial from the lymph lesion-1 node-8. to tan soft. of. periphery anthracotic labeled the measuring nodule 4.5 cm. The lymph node measuring are vascular submitted margin-7; in cassettes sections level from 9 normal lymph surrounding node. nodes The measuring specimen labeled from consists 1.1 to of 2 a piece and of The brown 6. s follows: largest two lymph. with. sections B. tissue, The 5.0 second trom 2.0 x the container 2.0 The cm. calcified B Sectioning is received node one is reveals in probable decaicified formatin four node \abeled brown and sectioned-2 the tan lymph nodules nodes to consistent 4; the are avel largest entirely 7 lymph lymph submitted node. node in The submitted cassettes specimen in a single after consists cassette decancincation-5 of labeled a brown tan nodule consistent. node probable C. The is calcified. third nodes container each bisected-1 C is received in formalin cm. labeled The lymph node is bisected and entirely submitted. noda."
BIOCUP_00021,lung,LUSC,TCGA-60-2697,TCGA-60-2697.a5d927b3-eb14-4127-a74f-5a53eb3cf536,"GROSS DESCRIPTION: Specimen: FSA subcarinal lymph node. FSB right lung for margin check and distribution. #1 portion of 6th right rib. FS Diagnosis: FSA anthracotic node x2, one 0.3cm. in diameter and the other 0.5cm. in diameter. BxB Specimen consists of a right lung measuring 21x17x8.5cm. The. hilum shows a grossly tumor replaced lymph node measuring 3. 5x2x1.5cm. adjacent to the bronchus which has a resection margin which is grossly. free of tumor. Cross section reveals a tumor mass which occupies. nearly the entire right middle lobe measuring 8x8cm. by approximately. 5. 5cm. The tumor obstructs the bronchi and causes mucus plugs. distally. Mucus plugging is observed in the right middle lobe and. right lower lobe. There are large areas of necrosis, yellow. coloration in addition to grey white coloration and the tumor has. pushing margins overall. It grows against branches of the pulmonary. artery and compresses them. 3cm. from the bronchial resection margin. it grows into the bronchial lumen. Areas of uninvolved lung appear to. be grossly unremarkable with no satellites observed. The main tumor. extends from central to peripheral, grows to the pleura but does not. extend through it grossly. However, there is extensive pleural. reaction with retraction and discoloration with fibrinoid exudate. FSA Two anthracotic lymph nodes with measurements as above. Submitted. in toto. FSB A cross sectional segment of bronchus with attached lymph node. measuring 2.4x1.6x0.3cm. Submitted in toto. BxA An irregular brown and tan segment of soft tissue measuring. 0.7x0.3x0.2cm. Submitted in toto. #1 Portion of 6th rib measuring 5.5x1.5x1.2cm. It shows a smooth. periosteum with attachments of skeletal muscle and fascia with. resection margins unremarkable showing cancellous bone. One section. submitted following decal. SUMMARY: FSA-nodes; FSB-bronchial resection margin; BxA-subcarinal. nodes; BxB1-bronchial resection margin; BxB2 & 3-hilar nodes; BxB4 &. 5-tumor bronchial interface; BxB6-tumor lung interface; BxB7 through. 9-tumor pleural interface; BxB10-non tumor lung. MICROSCOPIC DESCRIPTION: Sections from the lung show an infiltrating halfway differentiated. squamous cell carcinoma. The tumor infiltrates a segmental bronchus,. has penetrated it and ulcerated the mucosa. It is compressing the. segmental artery which is not infiltrated by the tumor. There are 5. para-arterial lymph nodes, one of which shows metastatic tumor. The. lung adjacent to the tumor shows interstitial follicular pneumonia and. early acute supporative pneumonia. The pleura is thick and hemorrahgic. and abutted, but not infiltrated by the tumor. FSA Four small lymph nodes negative for tumr. FSB Bronchus with chronic inflammation. A parabronchial lymph node. with metastatic tumor is present. Another one with no tumor is also. seen. DIAGNOSIS: 1) RIGHT LUNG WITH HALFWAY DIFFERENTIATED SQUAMOUS CELL CARCINOMA. OF MIDDLE LOBE INFILTRATING SEGMENTAL BRONCHUS. 2). METASTATIC SQUAMOUS CELL CARCINOMA TO ONE OUT OF FIVE PARA-. SEGMENTAL PULMONARY ARTERY LYMPH NODES, RIGHT MIDDLE LOBE. 3). BRONCHIAL STUMP WITH NO TUMOR, BUT WITH METASTASIS TO ONE OUT. OF TWO PARABRONCHIAL LYMPH NODES. 4) SUBCARINAL LYMPH NODE WITH NO TUMOR. 5) RIB SECTION ON DECALCIFICATION."
BIOCUP_00022,lung,LUSC,TCGA-22-4593,TCGA-22-4593.d20d26e3-da2c-4456-894d-6f08d62856ea,"TISSUE DESCRIPTION: Right lower lobe lung (330 grams, 17 x 9 x 6.5 cm). Superior. mediastinal (upper paratracheal, lower paratracheal right. tracheobronchial), inferior mediastinal (subcarinal) and N1. (interlobar) lymph nodes. DIAGNOSIS: Lung, right lower lobe, lobectomy: Grade 3 (of 4) invasive squamous. cell carcinoma forming a centrally necrotic mass measuring 6 X 6 X 5 cm. located 1.5 cm from the bronchial resection margin. The tumor involves. the visceral pleura over an area of approximately 3 x 3 cm. The. bronchial margin is negative for tumor. Lymph nodes, superior and inferior mediastinal, N1, excision: Multiple. (1 upper paratracheal, 1 lower paratracheal, 2 right tracheobronchial, 3. subcarinal, 3 interlobar) lymph nodes are negative for tumor."
BIOCUP_00023,lung,LUAD,TCGA-50-5942,TCGA-50-5942.915634e0-d38b-4a37-b96f-b9ac10507179,"PATIENT HISTORY: PRE OP DIAGNOSIS: Right lung cancer. POST. OP DIAGNOSIS: Same. PROCEDURE: Right anteri√≥r thoracotomy, bronchoscopy,. FINAL DIAGNOSIS: PART 1: LUNG, RIGHT UPPER LOBE ANTERIOR SEGMENT, SEGMENTECTOMY -. A. WELL DIFFERENTIATED ADENOCARCINOMA WITH PAPILLARY FEATURES AND LEPIDIC GROWTH, 2.8 CM. B. THE CARCINOMA DOES NOT INVOLVE THE VISCERAL PLEURA (PLO). C. NO DEFINITIVE INGIOLYMPHATIC INVASION. D. NEGATIVE SURGICAL RESECTION.MARGINS. E. MILD CENTRILOBULAR EMPHYSEMA. PART 2: LUNG, RIGHT SECONDARY CARINA, BIOPSY -. SUPERFICIAL FRAGMENTS OF RESPIRATORY EPITHELIUM. PART 3: GASTROINTESTINAL JUNCTION, BIOPSY -. A. SQUAMOUS ESOPHAGEAL AND COLUMNAR GASTRIC-TYPE MUCOSA WITH CHRONIC INFLAMMATION. B. NEGATIVE FOR INTESTINAL METAPLASIA. PART 4: STOMACH, FUNDUS, BIOPSY -. A. UNREMARKABLE FUNDIC/BODY TYPE GASTRIC MUCOSA. B. HELICOBACTER PYLORI ORGANISMS ARE NOT IDENTIFIED. PART 5: RIB, RIGHT THIRD, EXCISION -. BENIGN OSTEOCARTILAGINOUS TISSUE AND BONE MARROW WITH PRESERVED TRILINEAGE MATURATION. PART 6: LYMPH NODE, RIGHT LEVEL 10, EXCISION -. ANTHRACOTIC LYMPH NODE, NEGATIVE-FOR METASTATIC CARCINOMA (0/1). PART 7: LYMPH NODE, RIGHT LEVEL 11, EXCISION -. ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 8: LYMPH NODE, RIGHT LEVEL 4, EXCISION -. ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART: 93 YMPH NODE LEVEL 7. EXCISION. ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). SYNOPTIC DATA - PRIMARY LUNG TUMORS. TUMOR LOCATION: Right Upper Lobe. LUNG SEGMENT(S) INVOLVED: Anterior. PROCEDURE: Segmental. TUMOR SIZE. Maximum dimension: 2.8 cm. Minor dimension: 1.8 cm. GROSS SATELLITES: Number of gross satellite lesions: 0. TUMOR TYPE: Invasive adenocarcinoma. HISTOLOGIC GRADE: G1, Well differentiated. MICROSCOPIC SATELLITES: Number of microscopic satellite lesions: 0. EXTRAPULMONARY PARENCHYMAL. EXTENSION/INVASION OF TUMOR: None identified. ANGIOLYMPHATIC INVASION: TUMOR NECROSIS: < or = to 50%. SURGICAL MARGIN INVOLVEMENT: No. N1 LYMPH NODES: Number of N1 lymph nodes positive: o. Number of N1 lymph nodes examined: 2. N2 LYMPH NODES: Number of N2 lymph nodes positive: 0. Number of N2 lymph nodes examined: 2. UNDERLYING DISEASE(S): Emphysema. T STAGE, PATHOLOGIC: pT1. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ANCILLARY STUDIES: Histochemical stains."
BIOCUP_00024,lung,LUAD,TCGA-49-4514,TCGA-49-4514.1d1c3125-05a9-4939-a296-f98d8f977ab7,"FINAL DIAGNOSIS. LYMPH NODE, STATION 5 (EXCISION) : ONE (1) LYMPH NODE AND. ISSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. :) LYMPH NODE, R11 (EXCISION) : ONE (1) LYMPH NODE AND ASSOCIATED. 'IBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. LYMPH NODE, L8 (EXCISION) : ONE (1) LYMPH NODE AND ASSOCIATED. 'IBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 1) LUNG, LEFT UPPER LOBE (LOBECTOMY) : ;PECIMEN TYPE: obectomy."
BIOCUP_00025,lung,LUAD,TCGA-55-7227,TCGA-55-7227.7910979d-a635-4ef5-ab00-84df0455df66,"FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. LYMPH NODE, DESIGNATED ""N8R"", BIOPSY: - FRAGMENTS OF ANTHRACOTIC LYMPH NODE. - NEGATIVE FOR MALIGNANCY. B. LUNG, RIGHT LOWER LOBE, LOBECTOMY: - INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA OF. THE LUNG, WITH VISCERAL PLEURAL INVASION. - THE TUMOR MEASURES 62 MM IN DIAMETER. - SATELLITE TUMOR NODULES PRESENT ADJACENT TO MAIN MASS. - THE BRONCHIAL MARGIN IS FREE OF TUMOR. THE TUMOR IS PRESENT 50 MM FROM THE BRONCHIAL MARGIN. - LUNG TISSUE WITH EMPHYSEMATOUS CHANGES AND RESPIRATORY. BRONCHIOLITIS. - METASTATIC CARCINOMA IN ONE OF THREE PERIBRONCHIAL LYMPH. NODES (1/3). - BENIGN GLANDULAR EPITHELIAL INCLUSION WITHIN. PERIBRONCHIAL LYMPH NODE. FOCAL NONCASEATING, HYALINIZED GRANULOMATOUS. INFLAMMATION WITHIN PERIBRONCHIAL LYMPH NODE. C. LYMPH NODE, DESIGNATED ""N9R"", BIOPSY: - ANTHRACOTIC LYMPH NODE. - NEGATIVE FOR MALIGNANCY. - SEE SYNOPTIC CANCER STAGING CHECKLIST. COMMENT: Dr. has co-reviewed representative slides from this. case, and concurs with the diagnosis of adenocarcinoma. This report continues. FINAL SURGICAL PATHOLOGY REPORT. Lung Tumor Staging Information. (data derived from current specimen, staging in accordance with or modified from AJCC Cancer Staging. Handbook, 7th Ed, and CAP protocol,. Procedure: Right lower lobectomy, with mediastinal lymph node. biopsies. TUMOR FEATURES: Tumor site: Right lower lobe. Tumor size: 62 mm. Tumor focality: Main tumor mass with at least 3 smaller satellite tumor. nodules. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Lymphovascular invasion: Present. Visceral pleural invasion: Present. LYMPH NODES: Two mediastinal lymph nodes submitted separately,. without evidence of metastatic carcinoma. At least three. peribronchial lymph nodes, one of which is involved by a. small focus of metastatic carcinoma in the subcapsular. sinus. MARGINS: Bronchial margin: Negative (tumor present 50 mm from bronchial. margins). Vascular margin: Negative. PATHOLOGIC TUMOR STAGING: Primary tumor: pT3 (based on presence of separate satellite tumor. nodules in the same lobe of lung). Regional lymph nodes: pN1 (metastasis in ipsilateral peribronchial lymph. nodes). Distant metastasis: pMX (not applicable). Pathologic stage: IIIA. This report continues. FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: A. Lung bx. B. Lung. C. Lung bx. Clinical History/Operative Dx: Malignant neoplasm, right lower lobe. Intraoperative Diagnosis: B. Right lower lobe frozen section diagnosis: ""Bronchial margin free of tumor"". The. intraoperative interpretation(s) was/were performed and rendered at. Gross Description: A. The specimen is labeled N8R and is received in formalin. It consists of two 0.7 cm fragments of red-. brown to anthracotic tissue. The specimens are inked with contrasting colors and each specimen is. bisected. The tissue is entirely submitted in cassette A1. B. The specimen is labeled right lower lobe and is received without fixative. It consists of a lobe of lung. which measures 16.0 X 9.5 X 3.8 cm and weighs 269.0 grams. The pleural surface of the superior portion. of the lobe has a mottled red to dark violet appearance and appears smooth. There is a prominent area. of puckering and distortion of the lateral basilar portion of the lung. Adjacent to this pleural puckering and. distortion are three subpleural firm prominent nodules which vary from 0.7 to 1.2 cm. There is another. subpleural nodule in the lateral apical portion of the lung. At the hilum of the lung a staple line is. dissected from the specimen and the bronchial margin is removed as a thin shave. There are three small. up to 0.6 cm peribronchial lymph nodes. The bronchi are opened and there is no gross evidence of. intraluminal tumor. Sections of the lateral basilar portion of the lung reveal a dull yellow relatively well. circumscribed neoplasm which measures 6.2 X 5.0 X 2.9 cm. This neoplasm is 5,0 cm from the bronchial. resection margin. It abuts and distorts the pleural surface. Representative sections are submitted. Sections summary: B1) bronchial margin from frozen section, B2) vascular margins, B3) peribronchial. nodes, B4-B5) lateral basilar tumor and pleural surface, B6-B7) additional sections of tumor, B8) three. subpleural nodules just adjacent to tumor, B9) subpleural node anterior apical lung, B10) uninvolved. lung. C. The specimen is labeled N9R and is received in formalin. It consists of a single 1.1 X 0.7 X 0.5 cm. fragment of red-brown tissue. It is serially sectioned and entirely submitted in cassette C1. Microscopic Description: A. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. This report continues (FINAL). FINAL SURGICAL PATHOLOGY REPORT. B. Special stain: Elastin stain, performed on blocks B5, B6, and B7, demonstrating visceral pleural. invasion. Immunohistochemical stain: cytokeratin OSCAR, TTF-1, performed on block B3, demonstrating. 1 mm metastatic focus within subcapsular sinus of peribronchial lymph node. The metastatic tumor and. the epithelial inclusion stain positive for cytokeratin OSCAR, where as only the metastatic tumor stains. positive for TTF-1. Appropriate positive and negative controls reviewed. C. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. REPRINT: Orig. printing on."
BIOCUP_00026,lung,LUSC,TCGA-NK-A5CT,TCGA-NK-A5CT.E336C87E-F021-4D95-BE95-ACA979B023CA,"PATHOLOGY SURGICAL. PATHOLOGY RESULT: Clinical Data Repository This report may not match the original report. format. FINAL DIAGNOSIS. A. (Lymph node, level 9; biopsy): Fragments of lymphoid tissue, negative for. malignancy. B. (Lymph node, level 7; biopsy): Fragments of lymphoid tissue, negative for. malignancy. C. (Lymph node, level 7; biopsy): Fragments of lymphoid tissue, negative for. malignancy. D. (Lymph node, level 11; biopsy): Fragments of lymphoid tissue, negative for. malignancy. E. (Lung, left lower lobe; lobectomy): Moderately differentiated squamous. cell carcinoma, measuring 2.8 x 2.7 x 2.1 cm, with associated necrosis. No. convincing lymphovascular invasion noted. Visceral pleura, bronchial margin,. and vascular margin are free of tumor. Eight benign peribronchial lymph nodes. Stage pT1NOMx. See note. F. (Lymph node, level 5; biopsy): Fragments of lymphoid tissue, negative for. malignancy. INTRAOPERATIVE CONSULTATION. E. FROZEN:LEFT LOWER LOBECTOMY FROZEN ON TUMOR: Poorly differentiated. carcinoma. (E91, TP, smear). F. FROZEN:LEVEL 5 LYMPH NODE: Anthracotic lymph node without evidence of. malignancy. (F91, TP, smear). NOTE. E. Lung Cancer Summary. Specimen type: Lobectomy. Tumor location: Left lower lobe. Tumor size: 2.8 X 2.7 X 2.1 cm. Histologic type: Squamous cell carcinoma. Histologic grade: 2. Status of margins: Bronchial: Negative. Vascular: Negative. Parenchymal: Negative. Pleural: Negative. Visceral/Parietal pleural invasion: Absent. Lymphatic vascular invasion: Absent. Lymph node status: Negative. Extension into other structures: Absent. Non-neoplastic pathology: N/A. TNM stage: pT1NOMx. GROSS DESCRIPTION. A. The specimen is labeled ""level 9 node."" Received fresh is a < 1 g. specimen, consisting of a fragment of yellow and black soft tissue (0.9 x 0.5. x 0.3 cm). The entire specimen is wrapped and submitted in cassette A1. DB. B. The specimen is labeled ""level 7 lymph node."" Received fresh is a < 1 g. specimen, consisting of a single fragment of red-black soft tissue (0.6 x 0.3. X 0.3 cm). The entire specimen is wrapped and submitted in cassette B1. DB. C. The specimen is labeled ""level 7 lymph node."" Received fresh is a <1g. specimen, consisting of multiple fragments of red and black soft tissue (1.4: x. 0.4 X 0.3 cm). The entire specimen is wrapped and submitted in cassette C1. D. The specimen is labeled ""level 11L lymph node."" Received fresh is a < 1 g. specimen, consisting of two fragments of red-black soft tissue (1.2 x 1.1 x. 0.7 cm in aggregate). The entire specimen is wrapped and submitted in. cassette D1. E. The specimen is labeled ""left lower lobectomy."" Received fresh for frozen. section is a 192 g specimen, consisting of a lobectomy (22 x 15 X 4.5 cm). The. surface of the specimen is inked red. The specimen is sectioned to show a. well-circumscribed, tan-gray, nodular mass (2.8 x 2.7 x 2.1 cm) located 1.1 cm. from the visceral pleura and > 1 cm from the bronchial margin. The remainder. of the specimen shows a homogenous, red-brown, soft cut surface. No other. lesions or masses are present. Gross pictures are taken. A representative section of the tumor is submitted for frozen section with the. remnant placed in cassette E91. The remainder of the sections are submitted. as follows: E1 bronchial margin; E2 vascular margin; E3 tumor with nearest. visceral pleural margin; E4 through E7 representative sections of the tumor;. E8 lung parenchyma away from the tumor; E9 three peribronchial lymph nodes;. and E10 three peribronchial lymph nodes. F. The specimen is labeled level 5 lymph node. Received fresh for frozen, is. a fragment of yellow-black soft tissue (1.1 x 0.9 x 0.4 cm). One touch prep. and one smear are obtained. The specimen is bisected and submitted in its. entirety for frozen section with a remnant placed in cassette F91. SPECIMEN(S) RECEIVED. A: LEVEL 9 NODE. B: LEVEL 7 LYMPH NODE. C: FRESH ROUTINE - LEVEL 7 LYMPH NODE. D: FRESH ROUTINE - LEVEL 11 L LYMPH NODE. E: FROZEN:LEFT LOWE LOBECTOMY FROZEN ON TUMOR. F: FROZEN:LEVEL 5 LYMPH NODE. The above listed tests (if any) were developed and the performance. characteristics determined b. Department of Pathology. These tests have. not been cleared or approved for commercial use by the U.S. Food and Drug. Administration. The FDA has determined that FDA review is not required for. such in-house assays. (21 CFR 809.30(e)). OPERATIVE INFORMATION. DIAGNOSIS: LUNG CANCER; PROCEDURE: BRONCHOSCOPY FLEXIBLE FIBEROPTIC,. THORACOSCOPY VIDEO ASSISTED. INTRADEPARTMENT CONSULTATION PATHOLOGIST: QA COMMITTEE. ICD-9(s): 162.5. CPT(s): A: 88305. B: 88305. C: 88305. E: 88309, 88331, 88333, 88334. F: 88305, 88331, 88333, 88334. The attending pathologist was physically present when this specimen was. diagnosed, and actively participated in all key decisions. Lab and Collection. PATHOLOGY SURGICAL. Pathology. Procedure Location:"
BIOCUP_00027,lung,LUAD,TCGA-95-7947,TCGA-95-7947.003c68cb-72ea-44c9-80e3-f62224ab3ee2,"Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Anat Path Reports. Document Date: Histology. APRPT (Verified). Acc #: M. Client: Submitting. Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. LUNG, LEFT UPPER LOBE, WEDGE RESECTION, A1FS: ADENOCARCINOMA, MIXED SUBTYPE, WITH ACINAR, PAPILLARY AND MICROPAPILLARY PATTERNS OF. GROWTH. THE CARCINOMA IS MODERATELY DIFFERENTIATED AND MEASURES 1.5 X 1.1 X 0.7 CM. - ANGIOLYMPHATIC INVASION IDENTIFIED. - NO VISCERAL PLEURAL INVASION IS IDENTIFIED. - SURGICAL PARENCHYMAL MARGIN IS NEGATIVE FOR CARCINOMA. - SEE SYNOPTIC REPORT. B. LYMPH NODES, #6, EXCISION, B1FS: - FIVE LYMPH NODE FRGAMENTS, NEGATIVE FOR METASTATIC CARCINOMA (0/5). - PARTIALLY CALCIFIED, FIBROTIC NODULES, NEGATIVE FOR CARCINOMA. C. LYMPH NODES, #7, EXCISION, C1FS: - THREE LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA (0/3). Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. D. LYMPH NODE, #9, EXCISION, D1FS: ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). E. LYMPH NODE, 10L, EXCISION, E1FS: - ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). F. LUNG, LEFT UPPER LOBE, MEDIAL, WEDGE RESECTION: - LUNG WITH BULLOUS EMPHYSEMATOUS CHANGES. - NEGATIVE FOR CARCINOMA. Comment. Immunohistochemical and special stains (all on block A3): CK7. positive. - CK20. negative. - TTF1. positive. - Napsin A. negative. - Pax 8. negative. - Mucicarmine. positive (focal). This staining profile is compatible with a lung primary. Synoptic Worksheet. A. Wedge excision left upper lobe: Specimen: Lung. Procedure: Wedge resection. Specimen Integrity: Intact. Specimen Laterality: Left. Tumor Site: Upper lobe. Tumor Focality: Unifocal. Histologic Type: Adenocarcinoma, mixed subtype. Histologic Grade: G2: Moderately differentiated. Tumor Size: Greatest dimension: 1.5 cm. Additional dimension: 1.1 cm. Additional dimension: 0.7 cm. Visceral Pleura Invasion: Not identified. Tumor Extension: Not applicable. Bronchial Margin: Involvement by invasive carcinoma not applicable. Involvement by squamous cell carcinoma in situ (CIS) not applicable. Vascular Margin: Not applicable. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Parenchymal Margin: Uninvolved by invasive carcinoma. Parietal Pleural Margin: Not applicable. Chest Wall Margin: Not applicable. Other Attached Tissue Margin: Not applicable. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Present. TNM Descriptors: Not applicable. Primary Tumor (pT): pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or. visceral pleura, without bronchoscopic evidence of invasion more proximal. than the lobar bronchus (ie, not in the main bronchus); or Superficial. spreading tumor of any size with its invasive component limited to the. bronchial wall, which may extend proximally to the main bronchus. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Number of nodes examined cannot be determined. Distant Metastasis (pM): Not applicable. Clinical History. Left VATS, upper lobe wedge, lymph node dissection. Laryngeal cancer. Specimen(s) Received. A: Wedge excision left upper lobe. B: #6 Lymph node. C: #7 Lymph node. D: #9 Lymph node. E: 10 L lymph node. F: Medial wedge excision left upper lobe. Gross Description. Specimen A is received fresh for intraoperative consultation, labeled with the patient's name, medical record number and labeled. ""wedge excision, left upper lobe."" It consists of a wedge of lung that weighs 23.8 gram and measures 10.8 x 4.7 x 2.2 cm. There. is a firm, well-defined lesion (that was previously incised) that measures 1.5 x 1.1 x 0.7 cm. The lesion is 0.4 cm from the. parenchymal. margin and puckers the pleura. The remainder of the lung is unremarkable. The pleura is inked blue. Sections are. submitted as follows: Dictated by. A2,A3: Lesion pleura and margin. A4;. Tumor in relation to surrounding lung. A5: Representative sections of uninvolved lung parenchyma. Specimen B is received fresh for intraoperative consultation, labeled with the patient's name, medical record number and as. additionally ""#6 lymph node for frozen.' It consists of multiple pieces of soft tissue measuring in aggregate, 1.8 x 1.7 x 0.9 cm. The tissue is partially calcified. The non-calcified portions are submitted for frozen and the contents of the cryoblock are. submitted in cassette ""B1FS."" The calcified tissue is sectioned and submitted for decal in its entirety in cassette ""B2."" Dictated. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. egarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Specimen C is received fresh for intraoperative consultation, labeled with the patient's name, medical record number and ""#7. lymph node."" It consists of four pieces of soft tissue in aggregate measuring 1.5 x 0.2 x cm The specimen is entirely. submitted for intraoperative consultation and transferred to cassette ""C1FS.' (Dictated by. Specimen D is received fresh for intraoperative consultation, labeled with the patient's name, medical record number and ""#9. lymph node."" It consists of a fatty soft tissue fragment measuring 0.6 X 0.4 x 0.3 cm. The specimen is entirely submitted for. intraoperative consultation and transferred to cassette ""D1FS."" (Dictated by. Specimen E is received fresh for intraoperative consultation, labeled with the patient's name, medical record number and ""10L. lymph node."" It consists of a soft tissue fragment measuring 0.6 x 0.5 x 0.4 cm. The fragment is entirely submitted for. intraoperative consultation and transferred to cassette ""E1FS."" (Dictated by. Specimen F is received in formalin, labeled with the patient's name, medical record number and additionally ""medial wedge. excision, left upper lobe."" It consists of a wedge of lung that measures 8.1 x 2.0 x 2.0 cm and weighs 15 grams. There is a. pleural bleb that measures 2.8 x 1.9 x 1.9 cm. The remainder of the lung is unremarkable. The parenchymal margin is inked. green and the pleura is inked blue. Sections are submitted as follows: Dictated by. F1: Section of bleb and normal lung parenchyma. F2: Normal lung parenchyma. Intraoperative Consult Diagnosis. A1FS: LUNG, LEFT UPPER LOBE (FROZEN SECTION): ADENOCARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. in at. out at. B1FS,B1TP: #6 LYMPH NODE (FROZEN SECTION AND TOUCH PREPARATION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. in at. out at. C1FS: #7 LYMPH NODES (FROZEN SECTION): THREE LYMPH NODES NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. at. and start time. D1FS: #9 LYMPH NODE (FROZEN SECTION): ONE LYMPH NODE NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. at. land start time. E1FS: #10 LYMPH NODE (FROZEN SECTION): ONE LYMPH NODE NEGATIVE FOR CARCINOMA,. Frozen section results were communicated to the surgical team and were repeated back by. on. at. and start time. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Microscopic Description. Microscopic examination performed. ANALYTE SPECIFIC REAGENT (ASR) DISCLAIMER: Some of the above tests may use Class I ASRs. These tests were developed and their performance characteristics determined. They have not been cleared or approved by the Federal Drug Administration (FDA). The FDA. does not require these tests to go through premarket FDA review. These tests are used for clinical purposes, and should not be. regarded as investigational or for research. is certified under the Clinical Laboratory Improvement. Amendments (CLIA) as qualified to perform high complexity clinical laboratory testing."
BIOCUP_00028,lung,LUSC,TCGA-66-2759,TCGA-66-2759.adc593c7-44fc-4059-a161-a80b267db72a,"Material examined: Left lower lobe, among others. Clinical diagnosis and question. Space-occupying lesion left lower lobe S6, (poorly differentiated large-cell, nonkeratinizing squamous cell carcinoma),. status post asbestos exposure. REPORT ON FINDINGS. Macroscopy. 1.) Left lower lobe: inflated, fixed left lower lobe of lung measuring 20 x 15 cm at the base and up to 17 cm in length,. central bronchus resection plane located 0.3 cm proximal to the bifurcation of B6. A 7 cm long branched staple suture. line runs in a ventrocaudal direction from the hilus. In the medioventral region over S6 a cusp-shaped part of the upper. lobe measuring 4 x 1.5 x 1.2 cm is attached, closed by a staple suture line. In the laterodorsal region over S6 and. adjacent sections of S10, part of the parietal pleura, measuring 9.5 x 5.5 cm, is mostly adhesive over an extensive area. and loosely attached in parts at the margin. At the hilus are 3 mobile grayish-black nodes between 0.2 and 0.7 cm in size. Ostium of B6 completely obstructed by endobronchial parts of a central, moderately solid, pale brownish, focally soft. tumor, max. 6 cm in size, located in S6, with unclear demarcation and extending right up to the ventral visceral pleura. over S6 and to within 0.2 cm of the hilar resection surface. Apparent central involvement of some grayish-black. parabronchial nodes up to 1.5 cm in size by the tumor. Macroscopically questionable infiltration of the attached part of. the upper lobe, minimal distance from the resection plane of the pulmonary wedge after removal of the metal staple. line 0.3 cm. Parenchyma peripheral to the tumor in S6 and adjacent sections of S10 right up to the dorsal pleura and to. the pleural adhesion area over S6, with unclear demarcation, shows diffuse induration and a brownish-yellow color. Rest. of parenchyma inconspicuous. Medially in the attached fatty tissue close to the basal margin are 4 grayish-black nodes. between 0.2 and 1.1 cm in size. 2.) Peribronchial tissue left: 0.9 cm flat reddish tissue. 3.) Hilar LN (station 10) left: 1.4 cm grayish-black node or node part with some surrounding tissue. 4.) Pulmonary ligament LN (station 9) left: 2.2 cm grayish-black node with some surrounding tissue, section surfaces. partly indurated and pale grayish-white suggestive of tumor. 5.) Paraesophageal LN (station 8) left: two 2.5 cm specimens of fatty tissue, containing 1 cm node with section surfaces. suggestive of tumor. 6.) Paraaortic LN (station 6):1.2 cm node part with some surrounding tissue. 7.) Subaortic LN (aortopulmonary window) (station 5): two lesioned grayish-black nodes or node parts with. some surrounding tissue, 1.5 and 0.8 cm in size. Examined: 1.) Rapid section remains and resection margins of vessels and hilar nodes, tumor with remaining parenchyma,. endobronchial tumor part in B6, tumor with ventral visceral pleura over S6, 3 sections of hilar resection surface. (color-marked), 2 sections with attached upper lobe part (resection plane after removal of staple suture line. color-marked), brownish-yellow parenchyma and pleural adhesion zone, S10 dorsal, node in basal fatty tissue, 2. further sections with attached upper lobe part (resection plane after removal of staple suture line color-marked),. 2.) Rapid section remains,. 3.), 4.), 6.) + 7.) All material (in 4.) + 6.) nodes halved or multi-segmented, in 7.) nodes isolated),. 5.) Nodes (halved),. 17 blocks, partly Elastica-van Gieson, PAS, diastase-PAS, iron staining. Microscopy. Re 1.) Immediate intraoperative evaluation. bronchus resection margin tumor-free. Re 2.) Immediate intraoperative evaluation (. ): fatty tissue supplied by vessels and nerves shows. scarring, but no evidence of tumor. After paraffin embedding: Description of histological and cytological findings omitted for capacity reasons. EVALUATION. Primary diagnosis/diagnoses: Central to peripheral, histologically poorly differentiate, large-cell, nonkeratinizing squamous cell carcinoma of. the lower lobe of the left lung located in S6. TNM classification according to this picture pT2 pN2 pMX R0, stage IIIA. C 34.3, M 8070/3. Secondary diagnosis/diagnoses: Advanced, active, small foci of colliquating, chronic organizing and focal retention pneumonia accompanied by. fibrous remodeling of the parenchyma peripheral to the tumor associated with a pleural adhesion zone (sample. 1.)). Hilar lymph nodes of the main preparation and lymph nodes of samples 6.) and 7.) with uncharacteristic. reactive lesions, anthracotic pigment deposits and an old, nodular, cicatricially encapsulated area of necrosis. (sample 6.)). Remark/addendum: The tumor has obstructed B6 at its bifurcation, continuously infiltrated parabronchial lymph nodes and extended. focally to within at least 0.2 mm of the hilar resection surface. It has also grown across the pleural fissure. initially and into the co-resected tissue from the upper lobe and has formed further lymph node metastases in. samples 3.) - 5.). The resection lines of the bronchus and vessels, the resection plane of the wedge resection. specimen from the upper lobe and the lymph nodes located at the hilus of the main preparation (sample 1)), the. repeat resection specimen of sample 2.) and the lymph nodes of samples 6.) and 7.) are tumor-free. No asbestos bodies are found in the prepared section planes. However, very much further-reaching investigations, in. particular dust analytical studies, are needed to settle the question of asbestos dust exposure."
BIOCUP_00029,lung,LUSC,TCGA-92-8065,TCGA-92-8065.68423fdb-e1a7-49b8-a531-f27850116a93,"FINAL WITH ADDENDUM. Accessiones. DIAGNOSIS: LUNG. LEFT LOWER LOBE, BIOPSY (FS1). POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA. LYMPH NODE, LEVEL 9. BIOPSY (FS2). - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). LYMPH NODE, LEVEL 10R. BIOPSY. - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). CALCIFIED GRANULOMA. LYMPH NODES, LEVEL 7. BIOPSY. - NO EVIDENCE OF MALIGNANCY IN TWO LYMPH NODES (0/2). - CALCIFIED AND NECROTIZING GRANULOMAS (SEE COMMENT). LUNG, BRONCHIAL MARGIN. BIOPSY (FS3). - NO EVIDENCE OF MALIGNANCY. LUNG. LEFT, PNEUMONECTOMY. - INVASIVE POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA, 9.5 CM. - CARCINOMA INVADES THROUGH PLEURA. - CARCINOMA INVADES HILAR SOFT TISSUE. NO DEFINITE LYMPHVASCULAR INVASION IDENTIFIED. - BRONCHOVASCULAR RESECTION MARGINS FREE OF TUMOR. - PLEURAL ADHESIONS. SEE SYNOPTIC. LYMPH NODES, PERIBRONCHIAL, PNEUMONECTOMY. - NO EVIDENCE OF MALIGNANCY IN FIVE LYMPH NODES (0/5). Page of 4. Intraoperative Consultation: ""Brought to the frozen section area is a specimen labeled 'left lung. consisting of a lung measuring 22.5 x 12 x 7.5 cm. A central mass measuring 9 cm in greatest dimension is identified extending into the upper and lower lobes. The. tumor is sectioned to show a firm, white lesion extending to the pleura and coming within 0.5 cm of the. bronchiat/vascular margin. Tissue taken for research study and for tumor banking. Rest for permanent sections,"" by. FS1: Left lower lobe mass, biopsy. ""Non-small cell carcinoma, favor squamous cell carcinoma,. FS2: Level 9 lymph node, biopsy. - ""No evidence of malignancy,"" by. FS3: Bronchial margin, biopsy. - ""Focal squamous metaplasia in salivary glands; no evidence of malignancy."" by. Microscopic Description and Comment: Microscopic examination substantiates the above cited diagnosis. AFB and GMS stains for acid fast and fungal organisms are pending on a section of granuloma in a level 7 lymph. node. The results will be reported in an addendum. History: The patient is a. .vith a left lung mass. Operative procedure: Left pneumonectomy. Specimen(s) Received: A: LEFT LOWER LOBE MASS. B: LYMPH NODE, LEVEL IX. C: LYMPH NODE. x R. D: LYMPH NODE, VII. E: BRONCHIAL MARGIN. F: LUNG. LEFT. Gross Description;. The specimens are received in six formalin-filled containers. each labeled. The first container is. labeled ""LLL mass, FS1."" It contains a green tissue cassette labeled ""FS1"" that holds two grey-tan pieces of soft tissue. that measure 1.6 x 0.8 0.2 cm, in aggregate. Labeled A (FS1). Jar 0. The second container is labeled ""level 9 node, FS2. It contains an unlabeled green tissue cassette that holds two. portions of grey-tan lymph node tissue that measure 2.3 x 2.2 x 0.4 cm. in aggregate. Labeled B (FS2). Jar 0. The third container is labeled ""level 10R node."" It holds a single grey-tan putative lymph node measuring 1.8 x 1 x 0.5. cm. Bisected to show an unremarkable black-tan interior cut surface. Labeled C, one putative lymph node bisected. Jar 0. The fourth container is labeled ""level 7 lymph node."" It holds two putative lymph nodes that measure 1.1 x 1 x cm. and 0.9 x 0.7 x 0.5 cm, respectively. Bisected to show unremarkable black-tan cut surfaces. Labeled D1 and D2, one. putative lymph node in each cassette, bisected. Jar 0. The fifth container is labeled ""bronchial margin, FS3."" It contains a green tissue cassette labeled ""FS3"" that holds a. C-shaped portion of yellow-tan bronchial margin that measures 1.5 x 0.4 x 0.2 cm. Labeled E (FS3). Jar 0. The sixth container is labeled ""left lung."" It holds a 400 gram left pneumonectomy specimen with two lobes and with. dimensions consistent with the intraoperative non-microscopic consultation. The specimen has been previously. sectioned to expose a 9.5 x 4.5 x 3.8 cm, white-tan, centrally located mass that bridges both the upper and lower. lobes. The pleural surface over this mass at the hilum is stretched and puckered without gross extension of the tumor. onto the pleural surface. However, in the left upper lobe, the tumor appears to extend beyond the pleura as a solid. mass. Also in this vicinity, and on the medial aspect of the lung, there is an 11 cm portion of fibrous tissue comprising. the reflection of the pleura at the mediastinum. The entire pleural surface overlying the tumar is inked blue. The pleura. in the uninvolved portions of the lung is grey-tan, wrinkled with scant fibrous adhesions linking the two lobes. At the. hilum, a few black-tan peribronchial fymph nodes are identified. The vascular margins are closed off with surgical. staples. The staples are removed and the vascular and bronchial resection margins are sampled. The mass is further. sectioned to show a firm, white-tan cut surface that is well-circumscribed but unencapsulated. The lesion abuts the. bronchial margin of resection. Areas of central cavitation/necrosis are present. The uninvolved lung parenchyma is. pink-tan, spongy, and emphysematous. No other localizing lesions are noted. Labeled F1, bronchial and vascular. resection margin; F2, peribronchial lymph nodes; F3. tumor in relation to bronchial resection margin (radial section,. brief acid decalcification); F4 to F6, tumor in relation to overlying pleura: F7, tumor in relation to large proximal blood. vessel, F8 and F9, additional sections of tumor in relation to pleura in left upper lobe (possible extension through. pleura); F10, tumor in relation to lung parenchyma; F11, uninvolved upper lobe; F12, uninvolved lower lobe. Jar 3. SYNOPTIC REPORTING FORM FOR LUNG CARCINOMA. NEOPLASM. A neoplasm is present. HISTOPATHOLOGIC TYPE. The histologic classification of the tumor is squamous cell (epidermoid) carcinoma, keratinizing type. HISTOLOGIC GRADE (G). The grade of the tumor is poorly differentiated (G3). TUMOR SIZE. The maximum dimension of the tumor is 9.5 cm. LYMPHATIC INVASION. Lymphatic invasion by tumor is absent (LO). VENOUS INVASION. Venous invasion by tumor is absent (V0). ARTERIAL INVASION. Arterial invasion by tumor is absent. PLEURAL INVOLVEMENT. Pleural involvement is present; tumor invades through visceral pleura, without involvement of parietal pleura (PL2). SAMPLED SPECIMEN MARGINS. The sampled surgical margins are uninvolved by tumor. NON-NEOPLASTIC TISSUE. focal chronic inflammation and fibrosis. PRIMARY TUMOR (T). Tumor > 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior. sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (<2. cm distal to the carina but without involvement of the carina; or associated atelectasis or obstructive pneumonitis of. the entire lung or separate tumor nodule(s) in the same lobe) (T3). REGIONAL LYMPH NODES (N). No regional lymph node metastasis histologically. no examination for ITC (pNo). The total number of lymph nodes examined is 9. The total number of metastatically-invoived lymph nodes is 0. Extranodal extension by tumor is not applicable; no nodal metastases are present. DISTANT METASTASIS (M). Distant metastasis cannot be assessed (MX). STAGE GROUPING. The overall international stage is pT3/NO/MX (Stage IIB). The pathologic stage assigned here should be regarded as provisional, and may change after integration of clinical. data not provided with this specimen. Addenda/Procedures. Addendum Ordered: Addendum Complete. Addendum Signed O. Addendum Comment. The AFB and GMS stains are negative for acid fast and fungal organisms, respectively. ENO OF REPORT."
BIOCUP_00030,lung,LUAD,TCGA-67-3772,TCGA-67-3772.1b3a5b8e-7469-4fd6-b314-ad1fd7a2b957,"I 22. TISSUES: A. LYMPH NODE. B. LYMPH NODE. C. LUNG-RIGHT UPPER LOBE. D. LYMPH NODE. CODES: P88305 - 88305. p88309 - 88309. P88331 - 88331. D50175 - RESECTION. D50177 - REGIONAL LYMPH. 88305TC - LEVEL IV - GROS. 88309TC - LEVEL VI - GROS. 88331TC - PATHOLOGY CONSU. 88342TC - IMMUNOPEROXIDAS. 1 - SURGICAL SPECIM. T08000 - LYMPH NODE. T28200 - RT UP LOBE LUNG. T282001M81403 - RT UP LOBE LUNG ADENOCARCINOMA,. ICD CODES: 162.9 - MAL NEO BRONCH/LUNG NOS. MARKERS: 88305, 88305TC, 88309, 88309TC, 88331, PATH CONSULT FS, IMMUNOPEROXIDASE, RES, RLN,. CHICATON SDRCIMEN. CLINICAL HISTORY. PERTINENT CLINICAL HISTORY: RT LUNG CA. FINAL DIAGNOSIS. A. RIGHT DIAPHRAGMATIC NODULE, BIOPSY: FIBROADIPOSE TISSUE WITH MESOTHELIAL PROLIFERATION AND CHRONIC. INFLAMMATION. NO MALIGNANCY IS IDENTIFIED. B. LYMPH NODE, RIGHT SUPERIOR HILAR 10R: THREE LYMPH NODES, NEGATIVE FOR TUMOR. C. LUNG, RIGHT UPPER LOBE, LOBECTOMY: MODERATELY DIFFERENTIATED ADENOCARCINOMA WITH FOCAL PAPILLARY. FEATURES, SEE SYNOPTIC REPORT. D. LUNG, RIGHT UPPER NODE: MATTED LYMPH NODE, NEGATIVE FOR TUMOR. E. LYMPH NODE, RIGHT POSTERIOR SUPERIOR HILAR: LYMPH NODE, NEGATIVE FOR TUMOR. GROSS DESCRIPTION. A. The specimen is submitted fresh for frozen section as ""right. diaphramatic nodule"" and consists of five tan tissue fragments ranging. from 0.2 to 0.3 cm in dimension; submitted 5 (1) labeled ""FSP"" for frozen. section. FROZEN SECTION DIAGNOSIS: Focal cluster of atypical cells of uncertain. nature; ? mesothelial cells, dissimilar to. primary lung adenoca in recent aspiration. B. The specimen is submitted fresh for frozen section as ""right superior. hilar node 10R"" and consists of three red black nodes ranging from 0. to. 1.1 cm in dimension. Each is sectioned and the specimen submitted in. toto, 5 (1) labeled ""FSP"" for frozen section. FROZEN SECTION DIAGNOSIS: Negative for tumor. C. The specimen is submitted fresh as ""right upper lobe"" and consists of. a 131 gram (416), 16 x 7 x 3 cm lung lobe. The pleural surface shows a. 2.2 x 2 cm firm puckered indurated area. The pleural surface overlying. this area is inked blue. The pleural surface also shows four ill-defined. tan white firm subpleural nodules measuring 0. to 0.4 cm with the closest. located 6.5 cm from the puckered area. The specimen is received with. multiple stapled margins measuring 3.5 to 7 cm in length along with a. stapled bronchial margin measuring 2.5 cm in diameter and several adjacent. stapled vascular margins measuring 0.2 cm in length x 0.5 cm in diameter. to 0.5 cm in length x 1 cm in diameter. The stapled margins are removed. and the underlying parenchyma inked black. Sectioning reveals a 4.3 x 3 x. 2.2 cm well circumscribed tan yellow to white firm, focally hemorrhagic. mass corresponding to the previous described puckered and indurated area. on the pleural surface grossly appearing to abut the pleural surface. measuring 0. cm from the closest black inked parenchyma underlying the. stapled resection margin and 3 cm from the bronchial margin. The. remaining parenchyma is red to maroon, spongy, homogenous and grossly. unremarkable. No other discrete masses or nodularities are grossly. evident. Also identified at the hilum is a 1 cm in greatest dimension. gray black possible hilar lymph node which is trisected and submitted. entirely. Representative sections are submitted, multiple (7) as follows: Cassette 1: Vasculature and bronchial margins submitted en face. Cassette 2: Subpleural nodules submitted entirely. Cassette 3: Mass with closest pleural surface. Cassette 4: Perpendicular section of mass to the closest stapled. resection margin. GROSS DESCRIPTION. Cassette 5: Additional section of mass with adjacent uninvolved. parenchyma. Cassette 6: Uninvolved parenchyma. Cassette 7: One possible hilar lymph node, trisected. D. The specimen is submitted fresh as ""right upper node"" and consists of. a cluster of multiple gray black to deep red nodules ranging from 0.3 to. 0.7 cm in dimension, the individual nodes separated and the specimen. submitted in toto, multiple (1) -. E. The specimen is submitted fresh as ""right posterior superior hilar. node"" and consists of a single deep red 1. 1 cm nodule, bisected and. submitted in toto, 2 (1). PRIORITY. PRIORITY: FROZEN SEC. SURGICAL PROCEDURES: RESECTION, REGIONAL LYMPH. SYNOPTIC REPORT. SYNOPTIC REPORT: LUNG. (CAP/AJCC/ACS - REQUIRED ELEMENTS). SPECIMEN TYPE: LOBECTOMY. LATERALITY: RIGHT. TUMOR SITE: RIGHT UPPER LOBE. TUMOR SIZE: 4.3 CM. HISTOLOGIC TYPE: ADENOCARCINOMA WITH FOCAL PAPILLARY FEATURES. HISTOLOGIC GRADE: 2 (MODERATELY DIFFERENTIATED). EXTENT OF INVASION: TUMOR INVADES VISCERAL PLEURA. EXTENTION TO PLEURA/OTHER STRUCTURES: NONE IDENTIFIED. MARGINS: BRONCHIAL: UNINVOLVED. PARENCHYMAL: UNINVOLVED. VASCULAR: UNINVOLVED. SYNOPTIC REPORT. DISTANCE TO PERTINENT MARGIN: 3 CM FROM THE BRONCHIAL MARGIN. VENOUS INVASION: ABSENT. ARTERIAL (LARGE VESSEL) INVASION: ABSENT. LYMPH NODE: N1 - # INVOLVED/# EXAMINED: 0/6. N2 - # INVOLVED/#EXAMINED: 0/8. N3 - # INVOLVED/# EXAMINED: 0/0. OTHER PERTINENT FINDINGS: INCIDENTAL PULMONARY MENINOGOTHELIAL-LIKI NODULES/CHEMODECTOMAS (0.3-. 0.4 CM) THESE ARE PR+, CD56+ AND CHROMOGRANIN-. pTNM STAGE: pT2 NO (AJCC 6TH ADDITION). Unless otherwise specified, the performance characteristics of the. immunoperoxidase stains performed here have been confirmed by the St. These tests have not been cleared or. approved by the U.S. Food and Drug Administration, although such approval. is not necessary. Preli. IMMUNOPEROXIDAS. CLINICAL HISTORY. HISTORY: RUL CAVITARY MASS (2 CM) PICKED UP AS AN INCIDENTAL FINDING ON CT SCAN. RENAL MASS - CRYO ABLATION. X-RAY FINDINGS: 2 CM RUL LUNG MASS. GROSS DESCRIPTION. Slide 40 CC Fluid. X Fresh. Fixed. Type Fix. Volume may reflect total of specimen, fixative, and/or collection fluid. APPEARANCE: X Clear. Cloudy. Foamy. Bloody. Clotted. Tissue. Color COLORLESS. PREP : 6 Smear (s). Diff Quick (s). Filter(s). 1 Cell Block (s). Cytospin (s) - 2 Singles (s). Double (s). H&E. Unstained. Comment: FINAL DIAGNOSIS. LUNG, RIGHT UPPER LOBE, NEEDLE ASPIRATION BIOPSY: POSITIVE FOR MALIGNANT CELLS. - ADENOCARCINOMA CONSISTENT WITH LUNG PRIMARY. COMMENT: THE TUMOR SHOWS GLAND FORMATION AND APPEARS MODERATELY. DIFFERENTIATED. A TTF-1 STAIN IS POSITIVE. THE TUMOR MORPHOLOGY IS DISSIMILAR TO THE TUMOR IN THE KIDNEY. SURGICAL PROCEDURES : REGIONAL LYMPH. CLINICAL HISTORY. PERTINENT CLINICAL HISTORY: NON-SMALL CELL LUNG CA, RIGHT. GROSS DESCRIPTION. A. The specimen is submitted fresh as ""4L left lower paratracheal"" and. consists of three pink to red lymph nodes ranging 0.2 cm to 0.8 cm in. dimension. The largest lymph node is bisected. The specimen is submitted. in toto, 4 (1) The largest lymph node is inked with blue dye. B. The specimen is submitted fresh as ""10L left tracheobronchial angle"". and consists of a 0.6 cm grey black lymph node; bisected and submitted,. 2 (1). C. The specimen is submitted fresh as ""2R right upper paratracheal' and. consists of multiple segments of adipose tissue intermixed with pink to. red possible lymph nodes with aggregate dimension 2 x 1.5 x 0.4 cm with. the lymph nodes measuring up to approximately 0. cm. The specimen is. submitted in toto, multiple (1) . D. The specimen is submitted fresh as ""4R right lower paratracheal"" and. consists of multiple segments of yellow adipose tissue intermixed with. pink to purple tan lymph nodes with aggregate dimension 2.3 x 1.6 X 0.4 cm. with the lymph nodes measuring up to 0.5 cm; submitted, multiple (1). E. The specimen is submitted fresh as ""3A lower pretracheal"" and consists. of multiple segments of yellow adipose tissue intermixed with pink lymph. nodes with aggregate dimension 2 x 1.5 x 0.4 cm with the lymph nodes. measuring up to approximately 0.5 cm; submitted, multiple (1). F. The specimen is submitted fresh as ""7 subcarinal"" and consists of. multiple segments of yellow adipose tissue intermixed with pink to red. lymph nodes with aggregate dimension 2 x 2 x 0.3 cm with the lymph nodes. measuring up to approximately 0. cm; submitted, multiple (1) . GROSS DESCRIPTION. G. The specimen is submitted fresh as ""2L left upper paratracheal"" and. consists of a segment of adipose tissue measuring 1.5 X 1 x 0.2 cm with a. single red to pink elongate lymph node measuring 0.8 cm. The lymph node. is bisected and submitted, 2 (1). FINAL DIAGNOSIS. A. 4L LEFT LOWER PARATRACHEAL: THREE LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR TUMOR. (0/3). B. 10L LEFT TRACHEOBRONCHIAL ANGLE: SINGLE LYMPH NODE SHOWING ANTHRACOSIS; NEGATIVE FOR TUMOR (0/1) . C. 2R RIGHT UPPER PARATRACHEAL: MULTIPLE SMALL LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR. TUMOR. D. 4R RIGHT LOWER PARATRACHEAL: MULTIPLE SMALL LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR. TUMOR. E. 3A LOWER PRETRACHEAL: MULTIPLE SMALL LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR. TUMOR. F. 7 SUBCARINAL: MULTIPLE SMALL LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR. TUMOR. G. 2L LEFT UPPER PARATRACHEAL: SINGLE LYMPH NODE AND ADJACENT ADIPOSE TISSUE, NEGATIVE FOR. TUMOR (0/1) ."
BIOCUP_00031,lung,LUSC,TCGA-85-6560,TCGA-85-6560.de1a9413-405b-4f15-ba7f-062ae63ea44b,LUNG TISSUE CHECKLIST. Specimen type: Pneumonectomy. Tumor site: Lung. Tumor size: 3 X 2.5 X 2 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 2/12 positive for metastasis (Hilar. 2/12). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.
BIOCUP_00032,lung,LUAD,TCGA-75-7027,TCGA-75-7027.04803f1d-6cb8-44ec-b4f1-11f1308dc840,"A description for each data field can be found in the 'Data description' worksheet (yellow tab). Sample Collection Details. Type. BUFFY. TUMOUR. Histology and staging. Site of. Year of. Age at. Days to. Days to. Type of. Site of. Preparatio. Tissue. Comments. Procedure. Diagnosis. Procedure. Primary. n. (Histology). (yrs). FF. 0. 16 RESECT. LLL. FF. LLL lung. 0. 16 RESECT. LLL. Tumour. Histology. Grade/. Pathologic Pathologic Clinical M. VALCSG. Histology. Slide URL. Size (cm). Differentiat al T. al N. Stage. Comments. ion. 3.5. 3 III. T2,NOS. M0. 3.5. 3 III. T2,NOS. M0."
BIOCUP_00033,lung,LUAD,TCGA-38-4626,TCGA-38-4626.9ac3c8f7-8399-46b1-9f2c-4e994faf88a3,"agnosis: Lung, left upper lobe, lobectomy. Adenocarcinoma, poorly differentiated, 5.3 cm diameter, bronchial and pleural margins not involved. - Lymph nodes, peribronchial - No metastatic carcinoma identified (0/8) . B: Lymph nodes, station 5, removal. - No metastatic carcinoma identified (0/2). C: Lymph nodes, L10, removal. - No metastatic carcinoma identified (0/2). D: Lymph nodes, station 11, removal. - No metastatic carcinoma identified (0/2). Comment. None. Intraoperative Consultation: Frozen section is requested by Dr. FSA1: Lung, left upper lobe, lobectomy, bronchial margin, biopsy. No tumor seen in bronchial margin. - TWO lymph nodes, no tumor seen (0/2). Clinical History: with adenocarcinoma of the left upper lobe of the lung. Gross Description: Received are four appropriately containers. Container A: Specimen fixation: formalin. Yype of specimen/parts of lung received: left upper lobe lobectomy. Size of specimen: 17.5 x 11.0 x 5.8 cm. Weight of specimen: 340 g. Other attached structures: none. Tumor location: left upper lobe superior segment. Tumor size: 5.3 x 5.0 x 5.0 cm. Sectioning of the tumor reveals a firm, tan, slightly whorled, solid. mass. with pushing of regular borders which is somewhat circumscribed. The specimen almost has a cauliflower. appearance. Relationship of tumor to bronchus: Tumor does not grossly appear to be involving the bronchus. Distance of tumor to bronchial margin: 1.1 cm. Relationship/distance of tumor to pleura: closest distance is 0.4 cm. Distance of tumor to other surgical margins: 1.1 cm from bronchial margin; tumor is 1.4 cm away from stapled. surgical margin. Presence/absence of satellite tumor nodules: absent. Involvement of attached structures by tumor: no attached structures present. Description of nontumorous lung: remaining lung is red/tan and diffusely aerated. There are focal areas which. appear consolidated. Tissue submitted for special studies: yes, next section of bronchial margin, a representative section of tumor. and representative section of normal lung parenchyma. 'ock Summary: JA1 - bronchial margin. A1 - stapled surgical margin. A2 - representative section of tumor at pleura. A3 - representative section of tumor at pleura. A4 - representative section of tumor and adjacent uninvolved lung. A5 - representative section of tumor. A6 - representative section of uninvolved lung, inferior segment. A7 - two lymph node candidates. A8 - one lymph node candidate. A9 - representative section of tumor to distance of bronchus. Container B is additionally labeled ""station 5"". Within the container are two fragments of soft tissue which. measure 1.5 x 1.8 x 0.4 cm in aggregate. The specimens are tan/brown and consistent with lymph nodes. B1 - one lymph node candidate, bisected. B2 - one lymph node candidate, bisected,. Container C is additionally labeled ""L10"". Within the container is a 1.5 x 0.5 x 0.4 cm, single, tan,. irregular. soft tissue fragment consistent with lymph node. C1 - one lymph node candidate, bisected,. Container D is additionally labeled ""station 11"". Within the container is a 0.5 x 0.5 x 0.3 cm, red/tan tissue. fragment consistent with lymph node. The specimen is bisected in D1. Light Microscopy: Light microscopic examination is performed by Dr. The frozen section diagnosis is confirmed. Tumor histologic type (WHO classification) : adenocarcinoma. Tumor histologic grade (WHO classification) : poorly differentiated. Tumor size (greatest dimension) : 5.3 cm. Histologic assessment of surgical margins: not involved. Pleural involvement: not identified. In situ carcinoma: not identified. nvasion: ugiolymphatic - not identified. perineural - not identified. Lymph nodes (by node group) : 0/8 peribronchial 0/2 station 5 0/1 L10 0/1 station 11. Extracapsular extension of tumor in lymph nodes: n/a. Findings in nontumorous lung: hemosiderin-lader macrophages and post-obstructive. changes."
BIOCUP_00034,lung,LUSC,TCGA-66-2785,TCGA-66-2785.92f38512-f7c8-462c-b7f4-018648ad4f56,"Material examined: Left upper lobe, among others. Clinical diagnosis and question. Bronchial carcinoma left central (squamous cell carcinoma (according to pathology in. REPORT ON FINDINGS. Macroscopy. 1.) Upper lobe: inflated, fixed left upper lobe measuring 19 X 17 x 6 cm, central bronchus resection plane. located 0.4 cm proximal to the bifurcation of the bronchus to the apical bronchi. A staple suture line runs from. the hilus in a cranial direction for 6 cm and in a dorsal direction for 6.5 cm. At the hilus two nodes, 1.4 cm and. 2.5 cm in size. Visceral pleura shows partly patchy and partly reticulate blackish pigmentation, in S3 a. paracentral irregularly protruding area of about 5 cm. Under this a moderately firm, pale brown to whitish, in. parts pale yellowish, softened tumor, max. 5.2 cm in size, with an arcuate configuration, almost completely. obstructing B3 with endobronchial growth extending to within 0.1 cm of the bifurcation of B3. The parenchyma. surrounding the tumor is partly vitreous, partly compacted and yellow brownish. Rest of parenchyma relatively. marked patches of blackish pigmentation. 2.) Lobar LN (station 12) lingula: 2.3 cm node. 3.) Interlobar LN (station 11): 1 cm node. 4.) Hilar LN (station 10) left: two nodes, 1.8 and 2 cm in size. 5.) Paraesophageal LN (station 8) left: 1.5 cm node. 6.) Low paratracheal LN (station 4) left: 0.3 cm node with abundant surrounding tissue. 7.) Prevascular and retrotracheal LN (station 3) left: 1.4 cm node with surrounding tissue. 8.) High paratracheal LN (station 2) left: 1,3 cm node with some surrounding tissue. 9.) Subcarinal LN (station 7): 2.5 cm node with some surrounding tissue. 10.) Paraaortic LN (station 6): 1.6 cm node with some surrounding tissue. 11.) Subaortic LN (aortopulmonary window) (station 5): 1 cm node. 12.) Hilar LN (station 10) right: 0.7 cm lesioned node. Examined: 1.) a: Tumor with B3, b: 2 sections of tumor with pleura, c:1 section of parenchyma in the tumor environment,. d: bronchus and vessel resection margins (tangential) and smaller hilar node, e: larger hilar node (lamellated),. 2.) - 8.) All material (in 2.) - 4.) and 7.) lamellated in each case, smaller node in 4a), larger node in 4b)),. 9.) - -1.2.) All material (in 9.) + 10.) lamellated in each case),. 18 blocks, partly Elastica-van Gieson, PAS, diastase-PAS. Microscopy. Description of histological and cytological findings omitted for capacity reasons. EVALUATION. Primary diagnosis/diagnoses: Central to paracentral, peripheral bronchopulmonary, histologically poorly. differentiated, large-cell and polymorphocellular, focal gigantocellular, nonkeratinizing squamous cell. carcinoma of the left lower lobe of the lung with a small differentiated glandular component, focal mucin. inclusions and localization in S3. TNM classification according to this picture pT2 pNO pMX R0, stage IB. C 34.1, M 8070/3,. Secondary diagnosis/diagnoses Active chronic retention pneumonia in the tumor environment (sample 1.)),. lymph nodes with reactive lesions and anthracotic pigment deposits (samples 1.) to 12.)). Remark/addendum: The carcinoma has infiltrated the paracentral visceral pleura enlarged by fibrosis and. extends with endobronchial growth to within the immediate vicinity of the bifurcation of B3. The finding is not. sufficient for the diagnosis of an adenosquamous carcinoma. The resection margin of the bronchus and vessels. and all excised and identified lymph nodes are tumor-free."
BIOCUP_00035,lung,LUAD,TCGA-55-7903,TCGA-55-7903.f044afa0-43c8-4047-a6bf-d46bfb42433c,"PROCEDURE DATE: RECEIVED DATE: REPORT DATE: Pre-Op Diagnosis. Lung mass. Post-Op Diagnosis. Same. Clinical History. Nothing indicated on requisition. Gross Description: Container labeled. - right lower lobe of lung"" is a. 206 gram portion of recognizable pulmonary parenchyma grossly. consistent with right lower lobe of lung. The specimen as received. is 16.1 x 10.5 x 5.0 cm. The margin of resection is a previously. sectioned bronchi with multiple staple lines. The pleura is. wrinkled tan gray to brown and anthracotic streaked with a few. nodular gray tan plaques up to 0.1 cm. Noted in the apparent. lateral aspect in the central portion of the specimen there is a. previously sectioned area of indurated umbilication measuring on. reconstruction approximately 2.4 X 2.0 x 1.8 cm. This has been. previously sectioned to reveal a lobulated gray tan to brown nodular. lesion which grossly appears to extend to but not through the pleura. in this area. This appears at its nearest point approximately 3.6 cm. from the nearest bronchial margin. The remaining parenchyma is. slightly diffusely consolidated mottled gray tan to pink with. anthracotic streaking and focal areas of gross emphysematous change. No other gross lesions are identified. Also received in the same. container are three tissue cassettes each labeled. Representative sections are submitted labeled as. follows: A - shaved apparent bronchial margin, B through E - entire. remaining lesion and surrounding tissue, F - representative pleura. with nodular plaques, G - representative remaining parenchyma. Container labeled. lymph node right lung"". is a 2.0 x 2.0 x 1.0 cm portion of tan yellow fibroadipose tissue. which has an embedded 1.1 cm gray brown fleshy nodule. The nodule. is bisected and entirely submitted in a single cassette. Container labeled. lymph node right lung"". is a 2.3 x 1.5 X 0.6 cm slightly friable nodular portion of focally. shaggy fleshy gray brown to black tissue which on sectioning has a. mottled gray black fleshy cut surface. The bisected nodule is. entirely submitted in two cassettes. Container labeled. lymph node right lung"" are. 2.9 x 2.0 x 1.3 cm aggregate of gray yellow to brown black. fibrofatty tissue fragments with areas of fleshy gray black. discoloration. The specimen is sectioned and entirely submitted in. two cassettes. Container labeled. lymph node right. lung"" are 1.2 x 0.9 x 0.4 cm fleshy gray black tissue fragments. entirely submitted in a single cassette. Container labeled. right lung middle lobe wedge"". is a 17 gram roughly wedge-shaped portion of recognizable pulmonary. parenchyma having an intact staple line at the margin of resection. The specimen overall is 14.4 x 2.5 1.5 cm. The pleura is focally. shaggy mottled gray tan to brown with focal anthracotic streaking. and areas of focal fragmentation. On sectioning the parenchyma is. homogeneous and spongy with a slightly mottled tan brown cut. surface. No gross lesions or cystic structures are identified. Representative sections are submitted in eight cassettes. Microscopic Description: The slides labeled. are examined. See diagnosis. Final Diagnosis. Lung, right lower lobe of lung (lobectomy): Tumor characteristics: Specimen integrity: Intact. Specimen laterality: Right. Tumor site: Lower lobe. Tumor size: 2.4 cm in greatest diameter. Tumor focality: Unifocal. Histologic type: Adenocarcinoma (see comment). Histologic grade: Poorly differentiated. Visceral pleural invasion: Not identified, carcinoma extends up to. but not into pleura. Tumor extension: Not identified. Treatment effect: Not identified. Lymphovascular space invasion: No unequivocal lymphovascular space. invasion identified. Surgical margin status: Bronchial surgical margin: No carcinoma identified. Pleural margin: No carcinoma identified. Distance of tumor from closest margin: Less than 1 mm from the. pleural margin. Lymph node status: One peribronchial lymph node demonstrating no metastatic carcinoma. (0/1). PAS 9. Other: Areas of subpleural fibrosis with interstitial fibrosis,. interstitial chronic inflammation. PAS 4,6. Emphysematous changes. PAS 4. Focal subpleural bone formation. PAS 4. pTN stage: pT1b NO. Level 9 lymph node, right lung (biopsy): Reactive sinus histiocytosis and anthracosilicosis, no metastatic. carcinoma identified within one. lymph node (0/1). PAS 4. Level 7 lymph node, right lung (biopsy): Reactive sinus histiocytosis and anthracosilicosis, no metastatic. carcinoma identified within one. lymph node (0/1). PAS 4. 4R lymph node, right lung (biopsy): Multiple fragments of lymph node demonstrating reactive sinus. histiocytosis and. anthracosilicosis, no metastatic carcinoma identified (see. comment). PAS 4. Level 10 lymph node, right lung (biopsy): Fragments of lymph node demonstrating reactive sinus histiocytosis. and anthracosilicosis, no. metastatic carcinoma identified (see comment). PAS 4. Right lung middle lobe (wedge biopsy): Subpleural fibrosis and foci of interstitial fibrosis. Scattered areas of interstitial chronic inflammation. Emphysematous changes. Intraalveolar macrophages. No carcinoma identified. PAS 4,6 SPC-A. Comments. This is staged as a pT1b lesion based on the size of 2.4 cm in. greatest diameter. The final stage should be performed in. conjunction with the clinical information. Sections of the tumor show a poorly differentiated large cell. carcinoma. A panel of immunohistochemical stains is performed. including CK5/6, p63, TTF1 and CK7 (with appropriate positive and. negative controls). The neoplastic cells are positive for TTF1 and. CK7. The neoplastic cells are negative for CK5/6 and p63. The. overall histologic appearance in conjunction with the. immunohistochemical stains is consistent with a poorly. differentiated adenocarcinoma. In addition, some dense eosinophilic. collagenous scar tissue is present suggesting this may have. represented a so-called scar carcinoma. The carcinoma extends up to. but not into the visceral pleura, being separated from the pleural. margin by less than 1 mm. Clinical correlation and follow up is. recommended. At the request of the undersigned pathologist, these slides have. been additionally reviewed by. who concurs with the. diagnosis. This test has been finalized at the. This test was developed and its performance characteristics. determined by. Laboratory. It has not been. cleared or approved by the U.S. Food and Drug Administration. The. FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded. as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of. as qualified to perform high complexity clinical. laboratory testing."
BIOCUP_00036,lung,LUSC,TCGA-43-2581,TCGA-43-2581.eb835b34-3938-4ace-9c89-11ebefb85da2,"SPECIMEN. A. Right upper lobe. B. Level 11. C. 2R. D. 4R. E. Level 7. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung cancer. GROSS DESCRIPTION. A. Received fresh in a container labeled ""right upper. lobe"" is a 296 gm, 17.8 x 11.8 x 4 cm, lung lobe compatible. with right upper lobe. In the hilar region there is an 0.8 cm long. and 1.5 cm in diameter bronchial stump which is grossly. unremarkable. The vessels at the margin are also grossly. unremarkable. There are some tan-gray lymph nodes up to 1.2 cm in. greatest dimension in the hilar region. The pleural surface is. pink-purple with some anthracotic pigment deposition. There is some. retraction of the pleural surface. The specimen is sectioned, and. there is a 2.6 x 2 x 1.8 Cm rubbery tan-white mass underlying the. area with pleural retraction, with the mass suggestive of invading. the pleura. Approximately 2 cm from this mass is a separate 4 x 3.5. x 3. Cm rubbery tan-white mass. This mass approaches at least near. to the pleural surface. The larger lesion has yellow-orange. discoloration surrounding it, suggestive of surrounding pneumonia. The remainder of the parenchyma is spongy and red-purple without. additional lesions. RS-13, following fixation. BLOCK SUMMARY: A1 - bronchial margin; A2 - vascular margin; A3-A5 -. first lesion described; A6-A9 - larger lesion; A10 - parenchyma. surrounding larger lesion; A11- random lung; A12 - two hilar lymph. nodes; A13 - bisected hilar lymph node. GROSS DESCRIPTION. B. Received fresh in a container labeled ""level 11"" are. two pieces of soft red-gray tissue, 0.7 cm in greatest. aggregate dimension. AS-1, following fixation. C. Received fresh in a container labeled ""2R"" are four. pieces of soft red-gray tissue, 3 cm in greatest aggregate. dimension. AS-2, following fixation. D. Received fresh in a container labeled ""4R"" are multiple. similar fragments of tissue, in aggregate 2.7 x 1 x 0.5 cm. AS-3, following fixation. E. Received fresh in a container labeled ""level 7"" is a. similar portion of tissue, 1.5 cm in greatest dimension. AS-2, following fixation. MICROSCOPIC DESCRIPTION. The following template summarizes the findings in this. case: Histologic type: Both of the mass lesions consist of poorly. differentiated non-small cell carcinoma. There are areas that it is. favored have squamous differentiation, as well as less frequent. foci suggestive of glandular differentiation (adenocarcinoma). Although not entirely identical, the two lesions look similar. Histologic grade: Poorly differentiated. Primary tumor (pT) These two lesions are grossly 2.6 cm and 4 cm. in greatest dimension. The 2.6 cm in diameter lesion has visceral. pleural invasion, with the larger lesion extending very. peripherally but without definite visceral pleural invasion. Although it is difficult to definitely distinguish between. synchronous primaries and the two masses being part of the same. process, given the similarities in appearance, based on the new. guidelines, two nodules of similar histology in the same lobe. MICROSCOPIC DESCRIPTION. would be classified as pT3. Clinical correlation is recommended. Margins of resection: The bronchial and vascular resection margins. are negative. Direct extension of tumor: Visceral pleural extension for the 2. 6. cm in diameter lesion, no direct extension identified for the larger. lesion. Vascular invasion: Not definitively identified. Regional lymph nodes (pN) : pNl. There is metastatic carc√≠noma in. one of three hilar lymph nodes in part A. The separately submitted. lymph nodes in parts B, C, D, and E are negative for malignancy. Distant metastasis (pM) : pMX. Other findings: There are inflammatory changes surrounding the. tumors, with focally prominent pneumonia surrounding the larger. lesion. Note: This case has been reviewed in Intradepartmental Consultation. with all reviewers interpreting the two mass lesions as similar in. appearance. 3,4x3,5. DIAGNOSIS. A. Lung, right upper lobe, excision. - TWO adjacent but separate masses with poorly. differentiated non-small cell carcinoma (see microscopic. description). Metastatic carcinoma in one of three (1/3) hilar lymph. nodes. - Bronchial and vascular resection margins negative for. malignancy,. B-E. Lymph nodes, level 11, 2R, 4R, and level 7, excisions. - Negative for malignancy."
BIOCUP_00037,lung,LUAD,TCGA-67-6216,TCGA-67-6216.9f6ac234-e3d8-44a9-b82d-0552e49224be,"PRIORITY: FROZEN SEC. JURGICAL PROCEDURES: LUNG-LOBECTOMY, REGIONAL LYMPH. CLINICAL HISTORY. PERTINENT CLINICAL HISTORY. RIGHT MEDDLE LOBE MASS. GROSS DESCRIPTION. The specimen is submitted fresh for frozen section as ""right middle. Lobe - please assess resection margins (TCGA) 11 and consists of a wedge. shaped segment of lung measuring 10 x 4.5 x 2.5 cm. The surgical margin. exhibits a line of metallic staples measuring 9 cm. The pleural surface. is pink and smooth. After removal of the staples; there are several. ligated vessels which measure 'up to 0.4 cm in length and 0.3 cm in. diameter. Sectioning of the lung exhibits pink slightly air filled tissue. exhibiting a firm pale white tumor measuring 1.8 X 1.3 x 0.9 cm. The. tumor approaches to within approximately 2 cm from the bronchial margin. Representative sections are submitted in 9 cassettes as follows: Cassette 1: Bronchial margin and vessel margin. Cassettes 2-5: Tumor showing surrounding normal parenchyma and. bronchus. Cassette 6: Remaining small segments of tumor not used for. Cassettes 7 and 8: Normal lung. FSP: Used for frozen section. FROZEN SECTION DIAGNOSIS: Right middle lobe: Adenocarcinomia extending to. within 3-4 mm of the parenchymal margin and. > 2 cm of bronchial margin. B. The specimen is submitted fresh as ""right middle lobar node' and. consists of a gray black lymph node measuring 1 cm in dimension; bisected. and submitted in toto; 2 (1).-. GROSS: DESCRIPTION. C. The specimen is submitted fresh as ""right lower lobar node"" and. consists of a gray black lymph node measuring 1.3 cm in dimension;. bisected and submitted in toto; 2 (1). FINAL DIAGNOSIS. A. RIGHT MIDDLE LOBE (LOBECTOMY SPECIMEN) : MODERATELY DIFFERENTIATED. GLAND FORMING AND PAPILLARY ADENOCARCINOMA WITH FOCAL PSAMMOMA BODY. FORMATION, GRADE II, 1.8 CM MAXIMUM DIAMETER. THE TUMOR IS CONFINED. WITHIN THE LUNG, AND EXTENDS TO WITHIN APPROXIMATELY 4 MM OF THE. PARENCHYMAL MARGIN AT ITS CLOSEST APPROACH AND > 2 CM FROM THE. BRONCHIAL MARGIN. VASCULAR MARGINS AND FOUR HILAR LYMPH NODES ARE. FREE OF DISEASE. RANDOM SECTIONS OF THE REMAINING LUNG ARE. UNREMARKABLE. B. RIGHT MIDDLE LOBAR LYMPH NODE: SINGLE. LYMPH NODE WITH NO EVIDENCE OF. MALIGNANCY. C. RIGHT LOWER LOBAR LYMPH NODE: SINGLE LYMPH NODE WITH NO EVIDENCE OF. MALIGNANCY. SYNOPTIC REPORT. SYNOPTIC REPORT: LUNG. (CAP/AJCC/ACS - REQUIRED ELEMENTS). SPECIMEN TYPE: LOBECTOMY. SPECIMEN INTEGRITY : INTACT. LATERALITY: FRIGHT. TUMOR SITE. MIDDLE LOBE. TUMOR SIZE: 1.8 CM. TUMOR FOCALITY (SPECIFY) : UNIFOCAL. HISTOLOGIC TYPE: ADENOCARCINOMA. HISTOLOGIC GRADE: EXTENT OF INVASION: CONFINED WITHIN LUNG. EXTENTION TO PLEURA/OTHER STRUCTURES (SPECIFY) : NOT IDENTIFIED. ADDITIONAL PERTINENT FINDINGS - ATELECTASIS, PNEUMONIA, ETC: (SEE. NARRATIVE). MARGINS: BRONCHIAL: UNINVOLVED. PARENCHYMAL: UNINVOLVED. VASCULAR: UNINVOLVED. OTHER. MARGINS (PARIETAL PLEURAL/CHEST WALL, ETC. IF APPLICABLE) : N/A. SYNOPTIC. REPORT. DISTANCE TO PERTINENT MARGIN (S) (AS APPLICABLE) : 4. MM FROM STAPLED. PARENCHYMAL MARGIN. NEOADJUVANT TREATMENT EFFECT (IF APPLICABLE) : N/A. VENOUS INVASION: NOT IDENTIFIED. ARTERIAL (LARGE VESSEL) INVASION: NOT IDENTIFIED. LYMPHATIC INVASION:NOT IDENTIFIED. LYMPH NODE (INCLUDING 10:S19905) : N1 - # INVOLVED/# EXAMINED: 0/6. N2 - # INVOLVED/#EXAMINED: 0/4+. N3 - # INVOLVED/# EXAMINED : 0/1+. OTHER PERTINENT FINDINGS: (SEE NARRATIVE). pTNM STAGE: pTla NO MX."
BIOCUP_00038,lung,LUSC,TCGA-56-1622,TCGA-56-1622.8b6c2041-dff4-4ce6-bbd1-683736983803,"SICIAN INFORMATION. SURGICAL. DIAGNOSIS. DIAGNOSIS: A. Lymph node (anterior lobular), lymphadenectomy: Single benign anthracotic lymph node. B. Lung (right lower lobe). lobectomy: Poorly differentiated large cell carcinoma with squamoid features, 3.5 cm in greatest dimension, predominantly endobronchial, but with. pulmonary parenchymal invasion (see comment). Closest inked pleural margin is negative for malignancy. Bronchus and blood vessels at surgical margin negative for malignancy; negative for lymphovascular invasion. Non-neoplastic pulmonary parenchyma shows chest wall adhesions; interstitial fibrosis, patchy. No hilar lymph nodes identified. C. Lymph nodes (subcarinal), lymphadenectomy: Five benign anthracotic lymph nodes. Adjacent soft tissue with dystrophic calcifications. D. Lymph nodes (right hilum), lymphadenectomy: Two benign anthracotic lymph nodes. E. Lymph nodes (right lower peritracheal area), lymphadenectomy: Five benign anthracotic lymph nodes. F. Lung (right middle lobe), wedge biopsy: Benign pulmonary parenchyma with pleural adhesions. COMMENTS: The endobronchial tumor in the right lower lobe (block B2) is stained with a battery of immunohistochemical stains to better categorize the nature of the. tumor. The tumor cells are strongly reactive with high molecular weight cytokeratin (SK) and greater than 70% of the tumor cell nuclei are positive with. p63. CD56. marks about 5-10% of the tumor cell cytoplasm and cytokeratin 5/6 marks approximately 20-30% of the tumor cells. Cytokeratin 7 and thyroid. transcription. factor-1 (TTF-1) are negative. These stains support a diagnosis of poorly differentiated squamous carcinoma. The mildly positive CD56. indicates a small component of a neuroendocrine carcinoma. The positive control slides for CK7. TTF-1, CD56, p63, and SK are appropriate. The. positive control for CK5/6 is assigned to case. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Right lower lobe lung cancer. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Anterior lobar lymph node. B. Right lower lobe. C. Right lung subcarinal node. D. Right lung hilar node. E. Right lower peritracheal node. F. Right middle lobe wedge. SPECIMEN DATA. GROSS DESCRIPTION: A. The first container, A, is labeled with the. and interlobar lymph node. The specimen consists of a brown-tan. anthracotic nodule consistent with a lymph node measuring 1.0 x 0.5 x 0.2 cm. The specimen is entirely submitted in a single cassette labeled. B. The second container, B, is labeled with the patient's name,. on and right lower lobe. The specimen consists of a lobectomy specimen. that measures 15.0 x 15.0 x 4.0 cm and weighs 387 gm. The pleural surface is brown-tan to purple-gray and slightly shaggy. There is a portion of. adhesed fibromembranous tissue measuring 14.0 x 10.0 cm that is yellow to brown-tan and hemorrhagic. The bronchus has been opened to reveal a. gray-tan. to red-tan, hemorrhagic mass measuring 3.5 x 3.0 x 2.5 cm that is 0.3 cm from the inked pleural margin and is 3.2 cm from the bronchial margin. of resection. Sectioning through the surrounding lung tissue reveals a red-tan, spongy cut surface. There is one possible hilar node identified. measuring 0.3 cm. Representative sections were taken for genomic studies and placed in orange cassettes labeled A, B,and C. Also received with the. specimen are two cassettes, one green and one yellow, labeled. Representative sections are submitted in cassettes. as. follows: Sections from mass in blocks 1 through 5; sections from bronchial vascular margin block 6; sections from surrounding lung ussue aspraying the. inked margin of the adhesed fibromembranous tissue in blocks 7 and 8; possible hilar node block 9. C. The third container, C, is labeled with the patient's name. and right lung subcarinal node. The specimen consists of five brown-tan. anthracotic nodules consistent with lymph nodes measuring from 0.5 to 1.5 cm. The largest is bisected and the specimen is entirely submitted in. cassettes. as follows: Two probable nodes block 1; two probable nodes block 2; one lymph node, bisected, block 3. D. The fourth container, D, is labeled with the patient's name,. and right lung hilar node. The specimen consists of two brown-tan. anthracotic nodules consistent with lymph nodes measuring 0.3 and 0.4 cm in greatest dimension. The specimen is entirely submitted in single cassette. E. The fifth container, E, is labeled with the patient's name,. and right lower paratracheal node. The specimen consists of five brown-. tan anthrocotic nodules consistent with lymph nodes measuring from 0.2 to 0.9 cm. The specimen is submitted in two cassettes labeled. (lymph nodes are submitted whole). F. The sixth container, F, is labeled with the patient's name,. and right middle lobe wedge. The specimen consists of a wedge. resection of lung measuring 4.0 x 2.0 x 0.9 cm, weighing 5 gm. The pleural surface is purple-gray with slight adhesion. The 2.0 mm stable edge has. been removed. The subsequent margin has been inked. The specimen is sectioned perpendicular to the inked margin and reveals brown-tan, spongy. cut surface. There are no lesions grossly identified. The specimen is entirely submitted in five cassettes labeled."
BIOCUP_00039,lung,LUAD,TCGA-55-8085,TCGA-55-8085.16f4298e-d5f3-4503-bdad-a15531c3635c,"GROSS AND MICROSCOPIC SURGICAL PANEL. Specimen Information. SURGICAL PANEL: DIAGNOSIS. A) LYMPH NODE, LEVEL 9, LEFT, BIOPSY: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. B) LYMPH NODE, LEVEL 9, LEFT, BIOPSY: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. C) LUNG, LEFT LOWER LOBE, WEDGE RESECTION: 1. Moderately differentiated adenocarcinoma with papillary features. forming a mass measuring 2.5 X 2.2 X 1.6 cm. 2. Stapled parenchymal resection margin and visceral pleura free of. involvement. 3. Two benign peribronchial lymph nodes. 4. Emphysematous changes are present in surrounding non-involved. pulmonary parenchyma. D) LUNG, LEFT UPPER LOBE, WEDGE RESECTION: 1. Severe emphysematous changes with subpleural bullous formation. 2. Apical fibrous scar. 3. No evidence of active inflammation or neoplasia. E) LYMPH NODE, LEVEL 7, LEFT, BIOPSY: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. F) LYMPH NODE, LEVEL 5, LEFT, BIOPSY: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. Final TNM: stage: IA. MACROSCOPIC. SPECIMEN TYPE. Wedge resection. TUMOR SITE. Left Lung-Lower Lobe. TUMOR SIZE. 2.5 X2.2X 1.6 cm. TUMOR FOCALITY. Unifocal. MICROSCOPIC. HISTOLOGIC TYPE. Papillary adenocarcinoma. HISTOLOGICAL GRADE. G2: (moderately differentiated) of G4. VISCERAL PLEURAL INVASION. Not identified. LYMPHATIC VASCULAR INVASION. Absent. TREATMENT EFFECT. Not applicable. TUMOR EXTENSION. Not applicable. MARGINS. Uninvolved by tumor (Parenchymal). Distance of tumor from closest margin is 1.5 cm. PATHOLOGIC STAGING. EXTENT OF INVASION. pT1b. [Tumor greater than 2 cm, but 3 cm or less in greatest. dimension, surrounded by lung or visceral pleura, without bronchoscopic. evidence of invasion more proximal than the lobar bronchus (ie, not in the. main bronchus)]. REGIONAL LYMPH NODES. pNO. (No regional lymph node metastasis). Total nodes: 6. Total positive nodes: 0. N1 nodes: 2. N1 positive nodes: 0. N2 nodes: 4. N2 positive nodes: 0. N2 sites sampled: Station 9: Pulmonary ligament nodes. Station 7: Subcarinal nodes. Station 5: Subaortic nodes (aorto-pulmonary window). DISTANT METASTASIS. pMO. (No distant metastasis). PATHOLOGIC STAGE Summary. Final TNM: 5T1bNOM0. stage: IA. The pathologic stage presumes no distant metastasis. LUNG ANCILLARY TESTING PROTOCOL. HISTOLOGIC TYPE. Papillary adenocarcinoma. STAGE IV STATUS. Stage IV status is undetermined. TISSUE BLOCK AVAILABLE FOR ANCILLARY TESTING. C5. COMMENT. This patient's sample does not meet. criteria for reflex EGFR and ALK testing. No fresh tissue is available. for ancillary testing. The block identified above will be stored in. pathology for 10 years for possible future ancillary testing. Please call. for any ancillary testing requests. EGFR and ALK reflex testing criteria: Stage IV disease (histologically proven or clinically suspicious). Adenocarcinoma or TTF-1 positive adenosquamous cell carcinoma. Attending Pathologist: CLINICAL INFORMATION. Lung cancer. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Lymph node biopsy, level 9, left. The specimen is received labeled ""level 9 lymph node (left),' received in. formalin, is a 0.8 cm red-black partially yellow and fatty thin lymph node. Submitted in toto in one cassette. B) SOURCE: Lymph node biopsy, level 9, left, additional tissue. The specimen is received labeled ""additional level 9 lymph node (left). It. consists of a 1.2 cm gray-black lymph node. Longitudinally bisected and. entirely submitted in one cassette. C) SOURCE: Lung wedge resection -frozen section, left lower lobe. The specimen is received labeled ""wedge resection, left lower lobe.' It. consists of a 48-gram, 9 X 4.5 X 3 cm lung wedge resection with two. partially intersecting staple lines (9.5 X 0.5 cm) in aggregate. The. visceral pleural red-tan surfaces include a minimal amount of subpleural. anthracosis. The stapled margin is trimmed and immediately subjacent tissue. inked black. The intact smooth pleural surfaces are inked green. Cut. surfaces disclose a solid firm gray-tan tumor mass, measuring 2.5 X 2.2 X. 1.6 cm, 1.5 cm from the black-inked stapled resection margin and 0.2 cm. from the green-inked smooth pleural surface. A representative section of the tumor mass is submitted on one block for. frozen microscopy. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Adenocarcinoma,. margin negative. Approximately 2.5 cm tumor, approximately 1.5 cm from. margin."" is rendered by. The remaining lung parenchyma discloses diffuse mild emphysematous change. and a single black peribronchial, 0.3 cm lymph node without evidence of. gross tumor. Note: Fresh tumor is retained for additional possible ancillary studies. Representative sections are submitted in eight cassettes as follows: 1. Frozen section residue. 2-3. Stapled resection margin, perpendicular to black ink. 4-6. Tumor with green-inked pleural surface. 7. Normal lung, at least 1.5 cm away from tumor. 8. One peribronchial lymph node. Note: The specimen is placed in formalin at approximately. on. for a minimum of six hours fixation. This case is accessioned in. D) SOURCE: Left upper lobe wedge resection lung. Labeled ""left upper lobe wedge resection lung"" received in formalin is a. 10.5 X X 4 cm, 55 gram lung wedge. The pleural surface is purple-pink. focally ragged with a staple line present along one edge. The staple line. is removed from underlying tissues inked green. The lung is serially. sectioned revealing a 4 X 3 X 3 cm air pocket surrounded by white-tan dense. tissue. The remaining lung parenchyma is red-tan hemorrhagic and spongy. without masses or lesions identified. Representative sections are submitted. in five cassettes. E) SOURCE: Level 7 lymph node, left. Labeled ""level 7 lymph node, left"" is a 0.8 cm red-brown rubbery lymph. node. The specimen is entirely submitted in one cassette. F) SOURCE: Level 5 lymph node, left. Labeled ""level 5 lymph node, left"" is a 0.6 cm anthracotic lymph node. The. specimen is submitted in toto in one cassette. MICROSCOPIC. A-F) The microscopic appearance substantiates the diagnosis. Dictation by. iscribed by: ACCESSIONED. Lab and Collection. GROSS AND MICROSCOPIC SURGICAL PANEL. - Lab and Collection. Information. Result History. GROSS AND MICROSCOPIC SURGICAL PANEL. Result Date and Time. Provider Status. Lab. Parent Order ID. Child Order ID. Specimen Information,. Specimen Source. Lung. Audit Trail."
BIOCUP_00040,lung,LUAD,TCGA-97-8172,TCGA-97-8172.ef65fdd5-820a-4029-a667-56b5200276a7,"SPECIMENS: 1. LUNG, RIGHT UPPER LOBE. 2. STATION 10 LYMPH NODE. 3. STATION 11 LYMPH NODE. 4. STATION 2 AND 4 LYMPH NODE. 5. STATION 7 LYMPH NODE. SEE ADDENDUM. Reason For Addendum #1: Molecular Studies. Reason For Addendum #2: Molecular Studies. Reason For Addendum #3: Molecular Studies. DIAGNOSIS: 1. LUNG, RIGHT UPPER LOBE: LOBECTOMY. - ADENOCARCINOMA, ACINAR PREDOMINANT (3.5 CM), SEE NOTE. - THE BRONCHIAL AND VASCULAR MARGINS ARE FREE OF TUMOR. SEVEN LYMPH NODES, NEGATIVE FOR CARCINOMA (0/7). Note: The tumor consists of acinar (90%) and lepidic (10%). components and has prominent extracellular mucin. An elastic stain. is indefinite for visceral pleural invasion and a mucin stain is. non-contributory. Results of mutational studies will be reported in. addenda. 2. LYMPH NODE, LEVEL 10: BIOPSY. FIVE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/5). 3. LYMPH NODE, LEVEL 11: BIOPSY. - FIVE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/5). 4. LYMPH NODE, LEVELS 2 AND 4: BIOPSIES. - NINE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/9). 5. LYMPH NODE, LEVEL 7: BIOPSY. - SIX LYMPH NODES, NEGATIVE FOR CARCINOMA (0/6). Specimens: 1: LUNG, RIGHT UPPER LOBE. 2: STATION 10 LYMPH NODE. 3: STATION 11 LYMPH NODE. 4: STATION 2 AND 4 LYMPH NODE. 5: STATION 7 LYMPH NODE. LUNG: Resection. SPECIMEN. Specimen: Lung. Procedure: Lobectomy. Specimen Integrity: Intact. Specimen Laterality: Right. Tumor Site: Upper lobe. Tumor Focality: Unifocal. TUMOR. Histologic Type: Adenocarcinoma. Histologic Grade: G2: Moderately differentiated. EXTENT. Tumor Size: Greatest dimension (cm). 3.5cm. Visceral Pleura Invasion: Not identified. MARGINS. Bronchial Margin. Bronchial Margin Involvement by Invasive Carcinoma: Uninvolved by. invasive carcinoma. Vascular Margin: Uninvolved by invasive carcinoma. ACCESSORY FINDINGS. Lymph-Vascular Invasion: Not identified. STAGE (pTNM). Primary Tumor (pT): pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest. dimension surrounded by lung or visceral pleura without. bronchoscopic evidence of invasion more proximal than the lobar. bronchus (i.e., not in the main bronchus); or Tumor 5 cm or less. in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades. the visceral pleura; associated with atelectasis or obstructive. pneumonitis that extends to the hilar region but does not inolve the. entire lung. Regional Lymph Nodes (pN). pNO: No regional lymph node metastasis. Number Examined. 32. Number Involved. 0. Distant Metastases (pM): Not applicable. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: with hx of breast cancer, now with a RUL adenocarcinoma. MACROSCOPIC DESCRIPTION: The specimen is received in five parts, each labeled with the. patient's name. 1. Part one is labeled 'lung, right upper lobe'. It consists of a. right lobe of lung, measuring 15.5 X 10.5 X 4 cm. The two staple. lines measures 6 cm and 5.5 cm which is shaved and the pleura around. the staple line is inked in black. The bronchial margin at the hilum. area measures 2 cm and the vascular margin measures 1.2 cm. The. pleura are gray pink glistening and mottled moderately with fine. black streaks. There is a puckered area measuring 2.5 cm in greatest. dimension. Beneath the puckered area there is a gray white firm. nodule with ill defined borders measuring 3.5 X 3 X 2 cm, located 3. cm from the bronchial resection margin, and 2 cm from the closest. staple line margin. The remainder of the parenchyma is red and. blotchy. No other nodule grossly identified. Multiple anthracotic. firm lymph nodes ranging from 0.3 cm to 0.6 cm identified from the. hilar and peribronchial area. Representative sections are submitted. 2. Part two is labeled 'station 10 lymph node'. It consists of. multiple soft red-black lymph nodes measuring 2.4 X 2 X 0.5 cm in. aggregate. Entirely submitted in one cassette. 3. Part three is labeled 'station 11 lymph node' It consists of. multiple soft red-black lymph nodes measuring 2 X 1.7 X 0.6 cm in. aggregate. Entirely submitted in one cassette. 4. Part four is labeled 'station 2 and 4 lymph node'. It consists. of multiple soft red-black lymph nodes measuring 0.5 cm to 0.8 cm. Entirely submitted in three cassettes. 5. Part five is labeled 'station 7 lymph node' It consists of. multiple soft red-black lymph nodes measuring 2.4 X 1.5 X 0.5 cm in. aggregate. Entirely submitted in one cassette. SUMMARY OF SECTIONS: 1A-1E nodule. 1F staple line margin. 1G bronchial margin, shaved. 1H vascular margin, shaved. 1I anthracotic lymph node. 1J random section. 2A entirely submitted. 3A entirely submitted. 4A-4C entirely submitted. 5A entirely submitted. SPECIAL PROCEDURES: Elastic. Final Diagnosis performed by. ADDENDUM #1 FOR MOLECULAR TESTS: KRAS, EGFR and ALK were sent on. for patient. The test is to be performed on tissue from case. The case report, slides, and blocks for the cited. accession number were retrieved from archives. The pathologist whose. signature appears below reviewed the original pathology report,. examined candidate H&E slides, and selected block 1B appropriate to. the specifications of the ordered molecular analysis. x1 H&E and x9. unstained slides were prepared and forwarded to. where the. subject molecular test will be performed. An addendum report will be. issued when the results of this molecular test are available. Addendum #1 performed by. ADDENDUM #2: MOLECULAR ONCOLOGY. KRAS MUTATION ANALYSIS. Body Site: Right upper lobe of lung. Specimen Type: Slides. Clinical Data: Adenocarcinoma. RESULTS: Positive for a p.G12V (c.35G>T) mutation in codon 12. of the KRAS gene. INTERPRETATION: Mutations in the KRAS gene are reported to correlate with poor. prognosis and resistance to tyrosine kinase inhibitor therapies in. patients with non-small-cell lung cancer. COMMENT: KRAS mutations occur in 15-30% of non-small-cell lung cancer (NSCLC). patients and are strongly associated with adenocarcinoma and smoking. history. This assay analyzes codons 12 and 13 in exon 2 of the KRAS gene;. based on the current literature, approximately 98% of mutations are. expected to occur in these codons. The analytical sensitivity of. the assay is approximately 10%; thus mutations present in a low. percentage of cells may not be detected. This test is validated for use in identifying KRAS codon 12 and. codon 13 mutations in fresh, frozen, or formalin-fixed paraffin. embedded tissue. In particular the test performance has been. established in samples of colorectal cancer and non-small cell lung. carcinoma which harbor these mutations, although several other. tissues are also known to harbor KRAS mutations (e.g. tumors of. pancreas, bile duct, ovary, appendix, etc.). METHOD/LIMITATIONS: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exon 2 of the KRAS gene. PCR products are subjected to single. nucleotide primer extension to detect mutations at codons 12 and 13;. primer extension products are analyzed using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: This test was developed and its performance characteristics. determined by. The laboratory is regulated under. the Clinical Laboratory Improvement Amendments of. as. qualified to perform high complexity clinical testing. This. particular test is not considered a stand along test and should be. used only in the context of other diagnostic tests or clinical. work-up related to treatment decisions. Addendum #2 performed by. ADDENDUM #3: EGFR Mutation Analysis. Body Site: Right upper lobe of lung. Clinical Data: Adenocarcinoma. RESULTS: No mutation detected. INTERPRETATION: No mutations were identified in the sample provided. for analysis. Fewer than 5% of non-small cell lung carcinoma. patients without identifiable mutations are reported to be. responsive to EGFR tyrosine kinase inhibitor therapies. COMMENT: Forty percent (40%) or more tumor cellularity is optimal. for this mutation analysis. The sample submitted showed 4% tumor. cellularity upon pathologist review. A frequently occurring sequence change 2361G>A (Q787Q) was. identified. This polymorphism is known not to have clinical. significance. Mutations in the tyrosine domain of the epidermal growth factor. receptor (EGFR) gene are reported to be associated with differential. responsiveness or resistance to EGFR tyrosine kinase inhibitor (TKI). therapies. The objective response rate among patients with a. sensitizing mutation ranges from 55 to 82%. This assay analyzes exons 18-21 of the EGFR tyrosine kinase domain;. based on the current literature, most mutations in non-small-cell. lung carcinoma (NSCLC) are expected to occur in these exons. Mutations present in less than 10-20% of extracted DNA may not be. detected by this method. Mutation status in a sample may change. during tumor progression or the course of therapy; therefore, this. result cannot be used to infer the presence or absence of a mutation. in another sample or sub-sample obtained from this tumor. This test is validated for non-small cell lung carcinoma. The. clinical significance and utility of this test in other tumor types. is unknown. METHOD/LIMITATION: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the samples, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exons 18-21 of the EGFR gene. PCR products are analyzed by. bi-directional direct DNA sequencing using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: DISCLAIMER: This test was developed and its performance characteristics. determined by. It has not been cleared or approved by the. US Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. This test is used for. clinical purposes. It should not be regarded as investigation or. for research. The laboratory is regulated under the Clinical. Laboratory Improvement Amendments of. CLIA) as qualified to. perform high complexity clinical testing. This particular test is. not considered a stand alone test and should be used only in the. context of other diagnostic tests or clinical work-up related to. treatment decisions. Addendum #3 performed by. The electronic signature attests that the named Attending. Pathologist has evaluated the specimen referred to in the signed. section of the report and formulated the diagnosis therein. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary."
BIOCUP_00041,lung,LUAD,TCGA-86-7953,TCGA-86-7953.1af715d0-9b4b-444f-b93e-53478cde8e58,Gross Description. Microscopic. Description. Diagnosis Details. Comments. Laterality. LUNG TISSUE CHECKLIST. Left-upper. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 2.5 X 1.5 X 3 cm. Histologic type: Bronchiolo-alveolar adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.
BIOCUP_00042,lung,LUAD,TCGA-78-7539,TCGA-78-7539.686bc9a9-71b6-4c27-a76d-4ca9713fbdbe,"SEE SUPPLEMENTARY REPORT BELOW. HISTORY. Right UL bronchial ca. MACROSCOPIC. Three specimens received. 1: The specimen is labelled 'right upper lobe' and consists of a right upper lobectomy. measuring 145 X 105 X 45 mm. On the medial surface, inferior the hilum is a staple. line measuring 70 mm in length. This is removed (4 mm of tissue) and it, and the. bronchial margin is inked blue. There is extensive puckering of the pleura superiorly. at the apex over a distance of 40mm. This surface has been inked black. Underneath. the puckering is a tan and black nodule with a pushing edge that measures 52 X 51 X. 40 mm. The tumour appears to abut the pleural surface in multiple areas. It is 20 mm. from the bronchial resection margin. No other lesions are identified within the lung. [1A, bronchial margin; 1B, two hilar lymph nodes; 1C-F, RS of tumour including. pleura; 1G, RS of normal lung tissue Note: specimen has been sampled for research]. 2: The specimen is labelled ""number 10 lymph node' and consists of four pieces of tan. and black tissue, the largest piece measuring 15 X 12 X 10 mm. [BIT, 2A]. 3: The specimen is labelled ""number 11 lymph node' and consists of a piece of tan. and black tissue measuring 12 X 9 X 6 mm. [3A, lymph node bisected and BIT]. MICROSCOPIC. 1: Sections show a moderately differentiated adenocarcinoma with 30% lepidic, 30%. acinar, 35% papillary and 5% micropapillary growth. Part of the tumour is composed. of elastotic scarring. The lesion is subpleural and focal visceral pleural invasion is. identified. Blood vessel and probable lymphatic permeation is seen. No perineural. permeation is identified. The lesion is well clear of the bronchial resection margin. No lymph node metastases are seen. Away from the tumour, the lung shows evidence. of mild emphysema and a patchy mild inflammation including interstitial chronic. inflammation, small numbers of airspace and interstitial non-necrotising granulomata. and rare plugs of organising pneumonia. The inflammation is best seen adjacent the. tumour but focally involves the distant lung. 2: Sections of the lymph node fragments show reactive changes only. There is no evidence of. malignancy. Prominent sinus histiocytosis is noted. 3: Sections of the lymph node show reactive changes only. There is no evidence of malignancy. Prominent sinus histiocytosis is noted. SUMMARY. Right upper lobe and No. 10 and 11 lymph nodes: A: Moderately differentiated adenocarcinoma; 52 mm in maximal dimension. B: Blood vessel and probable lymphatic invasion present; no perineural invasion. seen. C: Visceral pleural invasion identified; clear of bronchial margin. D: No lymph node metastases. E: T2bN0Mx. F: Non-neoplastic lung: Mild emphysema and patchy mild inflammatory changes. with some features suggesting extrinsic allergic alveolitis (hypersensitivity. pneumonitis). SUPPLEMENTARY REPORT. 1: Special stains confirm the presence of invasion through the elastin layers of the. visceral pleura. In this section, tumour is not present on the surface. T-28000 M-81403 P1-03000."
BIOCUP_00043,lung,LUSC,TCGA-58-8388,TCGA-58-8388.e7a3f2b5-cc34-47e1-8a36-a552b3150847,"Pathology Report-Summary: Material: Lung, left, upper lobe: 21.5 X 16.5 X 4.5 cm. Tumor: 3.5 X 3.0 X 4.5 cm. Diagnosis: Squamous Cell Carcinoma, mostly basaloid. pT2a, pNO (0/35), pMx, G3. Supplementary examinations: IHC: Tumor positiv for p63, CK5/6, some cells for CK14. Tumor cells negative for: CD56, Chromogranin A, SPA, synaptophysin, TTF1. Proliferation rate: 40 - 60%."
BIOCUP_00044,lung,LUSC,TCGA-66-2790,TCGA-66-2790.7e17dc53-b237-46db-b6d6-86b7eeb51bab,"Material examined: Left lung. Clinical diagnosis and question. Squamous cell carcinoma of left upper lobe (according to histology,. REPORT ON FINDINGS. Macroscopy. 1.) Left lung: inflated, fixed lung measuring 18.5 x 14.5 cm at the base, up to 23 cm high, central bronchus. resection plane located 3 cm proximal to the division into the lobe bronchi. Main bronchus largely skeletonized. At the hilus two nodes, 1.5 cm and 2.2 cm in size. Visceral pleura, especially in the region of the upper lobe,. predominantly patch blackish pigmentation, in the dorsal region over S6 and S10 an area of whitish thickening. measuring about 11 x 4 cm, with an unclear demarcation. Centrally in the upper lobe, a firm tumor, about 4 cm. in size, obstructing or markedly constricting the upper lobe bronchus and its segmental bronchi, distance of. tumor from central bronchus resection line 3 cm. In thee tumor margin area several partly tumor-infiltrated. nodes. Distance of tumor from paracentral visceral pleura focally less than 0.1 cm. Bronchi peripheral to tumor. slightly dilated and filled with mucus. Parenchyma of upper lobe shows small patches of slightly blackish. pigmentation, that of the lower lobe is inconspicuous. 2.) Parietal pleura left: thick-skinned, partly plate-like bone-hard specimen measuring 3 x 2.3 cm and up to 1 cm. thick. 3.) Hilar LN (station 10) left: 2.5 cm specimen with four nodes of max. 1.5 cm and one 0.5 cm node. 4.) Pulmonary ligament LN (station 9) left: 1.2 cm node with surrounding tissue. 5.) Low paratracheal LN (station 4) left: 1 cm node. 6.) Subcarinal LN (station 7): 1.7 cm node part. 7.) Paraaortic LN (station 6): four nodes between 0.6 cm and 1.5 cm,. 8.) Subaortic LN (aortopulmonary window) (station 5): two nodes, 0.5 cm and 0,9 cm. 9.) Hilar LN (station 10) right: 1.5 cm node part. Examined: 1.) a: Tumor with upper and lower lobe bronchus (lower lobe bronchus marked blue). b: two sections of tumor. with pleura. c: one section with dilated mucus-filled bronchi. d: one section each from S6 (smaller specimen) and S10 (larger specimen) dorsal. e: infiltrated nodes in the. tumor margin area (1 section each). f: nodes in the tumor margin area (lamellated). g+h: bronchus and vessel. resection margins as well as smaller hilar node. i. larger hilar node (lamellated). 2.) 2 sections. 3.) - 9.) All material. 17 blocks, partly Elastica-van Gieson, PAS, diastase-PAS and decalcification. Microscopy. Description of histological and cytological findings omitted for capacity reasons. EVALUATION. Primary diagnosis/diagnoses: Central bronchopulimonary, histologically poorly differentiated, nonkeratinizing squamous cell carcinoma of the. left upper lobe of the lung. TNM classification according to this picture pT2 pN1 pMX VIRO, stage IIB. C 3 34.1, M 8070/3. Secondary diagnosis/diagnoses: Bronchiectases peripheral to the tumor in the upper lobe. Respiratory bronchiolitis. Slight centroacinar. pulmonary emphysema. Marked fibrous enlargement and slight chronic inflammation of the visceral pleura over. S6 and 10 (sample 1:)). Partially calcified, hypocellular fibrotic area of parietal pleura (sample 2.)). Lymph. nodes with reactive lesions and anthracotic pigment deposits (samples 3.) to 9.)). Remark/addendum: The carcinoma shows central endobronchial growth with a papillary component. It has produced some central. parabronchial and hilar lymph node metastases in the main preparation. The resection margin of the bronchus. and vessels, the visceral pleura, the lower lobe and the lymph nodes of samples 3.) to 9.) are tumor-free."
BIOCUP_00045,lung,LUSC,TCGA-33-4533,TCGA-33-4533.1791e931-cced-44e6-b530-21bba650cc8c,"E. .AL DIAGNOSIS. LEFT LUNG (RESECTION) : POORLY DIFFERENTIATED. NON-SMALL CELL CARCINOMA OF THE LUNG. THE CARCINOMA SHOWS BOTH. DISTINCTIVE SQUAMOUS AND HIGH-GRADE SPINDLE CELL FEATURES. THE. CARCINOMA INVOLVES THE PLEURAL SURFACE. ALL OTHER SURGICAL MARGINS. OF. RESECTION ARE NEGATIVE FOR TUMOR. ONE (1) HILAR LYMPH NODE AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. THE UNINVOLVED. LUNG PARENCHYMA DEMONSTRATES EMPHYSEMATOUS CHANGE. SEE NOTE. 2. LYMPH NODE, STATION 5 (BX) : ONE (1) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 3. LYMPH NODE, L11 (BX. ) : ONE (1) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR."
BIOCUP_00046,lung,LUSC,TCGA-66-2789,TCGA-66-2789.50601de1-9156-4793-9cdc-b140bb932cc0,"Material examined: Left lower lobe. Clinical diagnosis and question. Unclear space-occupying lesion S9 left, S10 left. Questionable asbestos. REPORT ON FINDINGS. Macroscopy. 1.) Wedge left lower lobe: after removal of the angled, 13 cm long staple suture line, inflated, fixed lung. resection tissue measuring 10 X 2 cm at the base, up to 4.5 cm thick, with pleural margin. Visceral pleura shows. slightly reticulate blackish pigmentation with an eccentric 2 cm area of star-shape retraction. Under this is a. whitish tumor, 1.9 cm in size, with unclear demarcation, at a distance of 0.1 cm from the staple suture line. Rest. of parenchyma shows partial rarefaction with the formation of lacunae max. 0.2 cm in size. 2.) Left lower lobe: inflated, fixed left lower lobe measuring 17 x 7 cm at the base, up to 20.5 cm high. Central. bronchus resection plane located at the level of bifurcation B6. At the hilus two partly lesioned nodes, 0.7 cm. and 3 cm in size. A staple suture line runs from the hilus in a cranial direction for 4 cm, and a staple suture line. runs from the hilus in a caudoventral direction for 5.5 cm. At the laterobasal margin over S8-10 there is a 16 cm. staple suture line demarcating an arcuate defect (status post wedge resection). Visceral pleura, accentuated. lateral partly reticulate and partly patchy blackish pigmentation. Parenchyma in all segments rarefied with. formation of 0.3 cm lacunae. 3.) Parietal pleura: 2.7 cm plate-like tissue up to 0.4 cm thick. 4.) Lobar LN (station 12) left upper lobe: two node parts, 0.4 cm and 1.5 cm. 5.) Interlobar LN (station 11) left: 1.5 cm lesioned node. 6.) Hilar LN (station 10) left: 1.5 cm lesioned node and a small piece of fatty tissue. 7.) Pulmonary ligament LN (station 9) left: two node parts, each 0.8 cm. 8.) Prevascular and retrotracheal LN (station 3) left: 0.8 cm node part with surrounding tissue. 9.) Subcarinal LN (station 7): 2.2 cm lesioned node. 10.) Hilar LN (station 10) right: 1.5 cm node part. 11.) Skin squamous epithelium left thorax: excised skin specimen measuring 2 x 0.6 cm with central button-. like, raised, brown skin lesion of 0.7 cm, distance from the lateral resection margins at least 0.1 cm, at least 0.6. cm from the poles. Examined: 1.) a: Rapid section remains, b+c: tumor (base marked black),. 2.) a: 1 section below the last-named staple suture line, b: S6, c: S10, d: bronchus and vessel resection margins. (tangential) and also smaller hilar node, e: larger hilar node (lamellated),. 3.) - 10.) All material (in 3.), 6.), 9.) and 10.) lamellated in each case). 11.) All material (lamellated). 17 blocks, partly Elastica-van Gieson, PAS, diastase-PAS, iron. Microscopy. Re 1.) Immediate intraoperative evaluation. squamous cell carcinoma. Description of histological and cytological findings omitted for capacity reasons. EVALUATION. Primary diagnosis/diagnoses: Peripheral, bronchopulmonary, histologically poorly differentiated, large-cell nonkeratinizing squamous cell. carcinoma of the left lower lobe of the lung evidently located in S9. TNM classification according to this. picture pT1 pN3 pMX L1 R0, stage III. C 34.3;M 8070/3. Secondary diagnosis/diagnoses: Numerous non-necrotizing epithelioid cell granulomata, largely in paravasal interstitial sites. Slight centroacinar. pulmonary emphysema (samples 1.) and 2.)). Hypocellular fibrosis area of parietal pleura (sample 3.)). Lymph. nodes with large foci of epithelioid cell reaction, nodular, central partly necrotically altered areas of sclerosis. and anthracotic pigment deposits (samples 4.) - 7.) and 9.)). Seborrheic keratosis of the skin of the akanthotic. type (sample 11.)). Remark/addendum: The carcinoma shows lymphangioinvasion at the tumor margin and has produced metastases in the hilar lymph. nodes of sample 2.) and in samples 8.) and 10.). The visceral pleura, the residual lower lobe of the lung,. including its resection margin of bronchus and vessels, and also the lymph nodes of samples 4.) and 7.) - 9.) are. tumor-free. The distribution pattern of epithelioid cell granulomata is primarily consistent with sarcoidosis. No asbestos bodies are found in the prepared section planes. But very much further-reaching investigations,. especially dust analyses, are needed to determine the asbestos exposure of the lung."
BIOCUP_00047,lung,LUAD,TCGA-50-5055,TCGA-50-5055.847a0c64-cd3e-4a99-a6f7-b4ba1636ada1,"FINAL DIAGNOSIS: Summary Statement. The left lower lobe wedge resection demonstrates a 2.5 cm invasive moderately differentiated adenocarcinoma without. visceral pleural invasion and involving one of five N1 lymph nodes. All margins free. Pathologic stage T1, N1, MX. PART 1: LUNG, LEFT LOWER LOBE, SEGMENTAL RESECTION -. A. MODERATELY DIFFERENTIATED ADENOCARCINOMA WITH ACINAR, PAPILLARY AND. BRONCHIOLOALVEOLAR FEATURES. DIAMETER 2.5 CM. FOCAL ANGIOLYMPHATIC INVASION. IDENTIFIED. NO EVIDENCE OF VISCERAL PLEURAL INVASION. MARKED HOST LYMPHOCYTIC. RESPONSE. ALL MARGINS FREE. PATHOLOGIC STAGE T1, N1, MX,. B. EMPHYSEMATOUS CHANGE WITH FOCAL ORGANIZING PNEUMONIA. C. MULTIPLE SMALL CARCINOID TUMORLETS. PART 2: LUNG, INFERIOR LEFT LOWER LOBE NODULE, WEDGE RESECTION -. PULMONARY HAMARTOMA. MARGINS FREE. PART 3: INTERLOBAR LYMPH NODE, BIOPSY -. THREE FRAGMENTS OF LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA. PART 4: LYMPH NODE, POSTERIOR HILAR LYMPH NODE, BIOPSY -. ONE OF TWO LYMPH NODES WITH METASTATIC ADENOCARCINOMA. PART 5: LYMPH NODE, AP WINDOW LYMPH NODE, BIOPSY -. SOLITARY FRAGMENT OF LYMPH NODE WITH NO EVIDENCE OF METASTATIC ADENOCARCINOMA."
BIOCUP_00048,lung,LUAD,TCGA-55-8616,TCGA-55-8616.4506aced-56d2-4297-9a5c-40539f20be87,"GROSS AND MICROSCOPIC SURGICAL PANEL. Specimen Information. DIAGNOSIS. A) LYMPH NODE, RIGHT PARATRACHEAL, RESECTION: One benign lymph node (0/1). B) LYMPH NODES, 4R, PARATRACHEAL, RESECTION: Four benign lymph nodes (0/4). C) LYMPH NODE, LEVEL 7 SUBCARINAL, RESECTION: One benign lymph node (0/1). D) LUNG, RIGHT UPPER LOBE, RIGHT UPPER LOBECTOMY: 1. Moderately-differentiated adenocarcinoma characterized by: a. Size: 4 cm. b. Margins: Negative. 2. No evidence of malignancy in one peribronchial lymph node. 3. Background lung with no additional changes. 4. Please see staging parameters. E) LYMPH NODE, LEVEL 12R, RESECTION: One benign lymph node (0/1). F) LYMPH NODES, LEVEL 9, RESECTION: Three benign lymph nodes (0/3). G) LYMPH NODES, SUBCARINAL, LEVEL 7, RESECTION Four benign lymph nodes. (0/4). H) LYMPH NODE, LEVEL 11R, RESECTION: One benign lymph node (0/1). UNG CANCER STAGING PARAMETERS. Final TNM: pT2aNOMO. tage: IB. MACROSCOPIC. SPECIMEN TYPE. Lobectomy. TUMOR SITE. Right Lung-Upper Lobe. TUMOR SIZE. 4 X 3.5 X 13 cm. TUMOR FOCALITY. Unifocal. MICROSCOPIC. HISTOLOGIC TYPE. Adenocarcinoma. HISTOLOGICAL GRADE. G2: (moderately differentiated) of G4. VISCERAL PLEURAL INVASION. Not identified. LYMPHATIC VASCULAR INVASION. Absent. TREATMENT EFFECT. Not applicable. MARGINS. Uninvolved by tumor (Bronchial, Vascular, Parenchymal). Distance from margins: 1.4 cm from parenchymal staple line, 3.5 cm from bronchial margin. PATHOLOGIC STAGING. EXTENT OF INVASION. pT2a. (Tumor greater than 3 cm, but 5 cm or less in greatest. dimension surrounded by lung or visceral pleura, without bronchoscopic. evidence of invasion more proximal than the lobar bronchus (ie, not in the. main bronchus); or Tumor 5 cm or less in greatest dimension with any of the. following features of extent: involves main bronchus, 2 cm or more distal. to the carina; invades the visceral pleura; associated with atelectasis or. obstructive pneumonitis that extends to the hilar region but does not. involve the entire lung). REGIONAL LYMPH NODES. pNO. (No regional lymph node metastasis). Total nodes: 16. Total positive nodes: 0. N1 nodes: 3. N1 positive nodes: 0. N2 nodes: 13. N2 positive nodes: 0. N2 sites sampled: Station 7: Subcarinal nodes. Station 9: Pulmonary ligament nodes. Station 4: Lower paratracheal nodes. DISTANT METASTASIS. pMO. (No distant metastasis). PATHOLOGIC STAGE Summary. Final TNM: pT2aNOMO. tage: IB. The pathologic stage presumes no distant metastasis. LUNG ANCILLARY TESTING PROTOCOL. HISTOLOGIC TYPE. Adenocarcinoma. STAGE IV STATUS. No stage IV disease pathologically. TISSUE BLOCKS AVAILABLE FOR ANCILLARY TESTING. D 5-10. COMMENT. This patient's sample does not meet. criteria for reflex EGFR and ALK testing. No fresh tissue is available. for ancillary testing. The block identified above will be stored in. pathology for 10 years for possible future ancillary testing. Please call. for any ancillary testing requests. Attending Pathologist: CLINICAL INFORMATION. The patient has a history of adenocarcinoma of the right upper lobe of. lung. The patient undergoes right upper lobectomy and thoracic. lymphadenectomy. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Right paratracheal lymph node. The specimen is received labeled ""right paratracheal lymph node"" and. consists of a 0.3 cm red-black soft lymph nodal tissue, submitted in toto. on one block for frozen microscopy. INTRAOPERATIVE PATHOLOGY CONSULIATION WITH FROZEN SECTION: ""One lymph node,. negative for carcinoma"" is rendered by. B) SOURCE: 4R paratracheal lymph node. The specimen is received labeled ""paratracheal lymph node, 4R"" and consists. of four soft red-black tissues, ranging 0.4-0.7 cm, submitted entirely on. block for frozen microscopy. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Lymph node. tissue, negative for carcinoma"" is rendered by. C) SOURCE: Level 7 subcarinal lymph node. The specimen is received labeled ""subcarinal lymph node level 7"" and. consists of a single 0.4 cm red-black tissue, submitted in toto on one. block for frozen microscopy. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Lymph node. tissue, negative for caricnoma"" is rendered by. D) SOURCE: Right upper lobe, bronchial margin for frozen. Labeled ""right upper lobe, bronchial margin for frozen"" is a 195 g, 20.5 X. 8 X 4 cm lung lobectomy with a continuous parenchymal staple line along 18. cm of the hilar aspect of the specimen. A visceral pleural surface is. puckered apically (inked blue) Cut surfaces disclose a 4 X 3.5 X 3 cm firm. solid gray-tan tumor mass with irregular borders within the superior one. half of the specimen, focally less than 0.1 cm from the puckered serosa and. 3.5 cm from the bronchial resection. The bronchial resection margin is. trimmed (three lumina) en face for frozen microscopy. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Bronchial. margin negative for carcinoma"" is rendered by. The tumor is found 1.4 cm from the nearest parenchymal staple line (inked. blue). The remaining cut surfaces disclose soft red-tan focally crepitant. lung without additional discrete lesions. A single black peribronchial 1.3. cm lymph node is identified. The pulmonary vasculature is thin-walled and. patent. NOTE: Tumor is retained for additional possible ancillary studies. Representative sections are submitted in 12 cassettes as follows: 1. Frozen section residue. 2. Pulmonary vasculature en face margins. 3. One peribronchial bisected lymph node. 4. Parenchymal staple line nearest tumor, perpendicular to blue ink. 5-8. Lung tumor with puckered pleura (inked black. 9-10. Lung tumor and adjacent lung. 11. Normal lung adjacent to tumor. 12. Normal lung inferior half of specimen. Note: Specimen removed from patient at. Specimen placed in. 10% neutral buffered formalin a. Specimen fixed in formalin. for a minimum of 6 hours, and not longer than 48 hours. E) SOURCE: Lymph node resection, level 12R. The specimen is received labeled ""level 12R lymph node."" It consists of a 1. cm anthracotic lymph node. The specimen is entirely submitted in one. cassette. F) SOURCE: Lymph node resection, level 9. The specimen is received labeled ""level 9 lymph node."" It consists of three. anthracotic possible lymph nodes averaging 0.3 cm in greatest dimension. The specimen is submitted in toto in one cassette. G) SOURCE: Lymph node resection, subcarinal, level 7. The specimen is received labeled ""subcarinal lymph node, level 7."" It. consists of four anthracotic pigmented lymph nodes ranging from 0.5 to 1.4. cm in greatest dimension. The specimen is entirely submitted in three. cassettes labeled: G1. Three lymph nodes. 2-3. One node, sectioned. H) SOURCE: Lymph node resection, level 11R. The specimen is received labeled ""level 11R lymph node.' It,consists of a. 1. cm anthracotic lymph node. The specimen is entirely submitted in one. cassette. MICROSCOPIC. A-H) The microscopic appearance substantiates the diagnosis. Dictation by. Lab and Collection. GROSS AND MICROSCOPIC SURGICAL PANEL. on. Lab and Collection. Information. Result History. GROSS AND MICROSCOPIC SURGICAL PANEL. Reviewed bv List."
BIOCUP_00049,lung,LUSC,TCGA-66-2753,TCGA-66-2753.e430d6d9-d03a-437b-9045-18ea0de16574,"Examination report. Macroscopic findings: 1. Parietal pleura: excised material, one with a diameter of max. 5 and one with. a diameter of 4 mm. 2. (a-i) Left inferior pulmonary lobe: resected lobe weighing 277 g and. measuring 180 X 120 x 70 mm with moderate mesh-like anthracosis of the pleura, hilar staple sutures and an. exposed bronchial stump measuring just under 10 mm. Next to this, individual, swollen lymph nodes with. anthracotic pigment but no suspicion of a tumor. In S 6 there is grayish-white tumor infiltration, well-. demarcated around the edge, measuring a good 40 mm, extending up to the outer pleura, with central, post-. necrotic-pseudocystic resorption featuring small lesions, and grayish-yellow, fragile, infiltrated, inflammatory. pulmonary tissue. In B6, no discernible tumor infiltration or destruction in the central branches examined. Immediately next to the tumor there is an inflammatory, adherent section of lung (from the middle pulmonary. lobe?), closed in by the base clip, measuring 15 mm, and without any discernible tumor infiltration. Other than. the tumorous and pneumonic infiltration on laminated sections, no further focal findings. 3. L 12: bipartite, pale lymph node tissue with anthracotic pigment, measuring. just under 10 mm together. 4. (a-b) L 11: segmented lymph adipose tissue with anthracotic pigment,. measuring 25 mm together, also displaying blood coagulation in between (complete embedment). 5. (a-b) L 9: bipartite lymph adipose tissue, measuring just under 20 mm. together. Nodes with anthracotic pigment and unremarkably imposing (complete embedment). 6. L7: bipartite lymph adipose tissue, measuring 10 mm together. 7. L 4: node with anthracotic pigment and adipose tissue, measuring 10 mm. 8. L 3: adipose tissue measuring 10 mm, with an unremarkable node measuring. 5 mm and with anthracotic pigment. Microscopic findings: 1. (HE) In the instantaneous section and the subsequent paraffin embedment,. pleura biopsy with knotty sclerohyalinosis with slit-shaped dehiscences between the thickened, collagen fiber. bundles. Base lymphoid infiltration and slight subpleural adipose connective tissue. 2. (HE, f: PAS, e to h: EvG) The central bronchial amputation border has a. bronchial wall with a regular structure, as does the peribronchial soft tissue. Next to this and further towards the. central and hilar section there are lymph nodes with anthracotic pigment build-up and moderate histiocytosis as. well as slightly lymphatic hyperplasia and small scarred areas. The tumor described comprises mesh-like. infiltrative, growing structures of a pluriform, partly keratinizing, partly severe pleomorphic cell and squamous. cell carcinoma with a clearly misaligned nucleoplasmic ratio, coarsening of the chromatin and prominent. nucleoli and frequent mitosis. Extensive necrosis in the center of the tumor, with pseudocystic transformation,. with concomitant stromadesmoplasia and lymphoid and lymphofollicular infiltrates in the tumor periphery. Extension to the perifocal, reactive, fibrosed pleura with fibrinous exudate which is no longer fresh; the base. membrane of the pleura, with fragmented, elastic membrane here, is, however, not infiltrated. Hemangioinvasion in the tumor center with a formation of obliterative tumor thrombi. Next to the tumor there. are several confluent alveolar cavities with a build-up of granulocytes and foam cell macrophages, fibrinous. exudate and finally confluent, sprouting mesenchyme buds as well as expanded bronchia with mucus permeated. by a large quantity of leucocytes. 3. (HE) Tumor-free lymph node tissue with lymphofollicular hyperplasia, with. activated germinal centers, sinus histiocytosis and marked anthracosis. 4. Similar to 3. 5. Similar to 3. 6. Similar to 3. 7. Similar to 3. 8. Similar to 3. Diagnosis: Resected left inferior lobe 1. to 8. with a centrally postnecrotically-pseudocystically transformed, poorly. differentiated and focal, keratinizing, maturing squamous cell carcinoma, measuring a maximum of 40 mm, and. located in the periphery of S 6. It extends to the still tumor-free, reactive, thickened pleura. The lobe also. displays hemoangioinvasion, and, in the peritumorous section, partly purulent, partly xanthomatous retention. pneumonia, and a tumor-free bronchial resection margin, as well as adjacent and hilar tumor-free lymph nodes. with anthracotic pigment. In samples 3 to 8 there are further tumor-free lymph nodes with anthracotic pigment. and parietal pleura with a small build-up of hyaline plaque. Tumor classification: M-8071/3, G3, pT2, pV 1, pN 0, pMX, stage IB. R 0."
BIOCUP_00050,lung,LUAD,TCGA-97-A4M2,TCGA-97-A4M2.0D5976EC-5D41-44A2-AC0A-CBE90F2A908E,"A total of 50 cells were scored. FINDINGS: FISH was performed on paraffin embedded tissue sections using the. Vysis ALK Break Apart Probe for the ALK gene at 2p23 (. FDA approved). When a rearrangement involving ALK is. present, either inversion or translocation, one of the two fusion. signals separates as one red and one green signal. In this. specimen, separated signals were present in 0% of the nuclei scored. This result is within the normal limits. COMMENTS: Three to four copies of ALK were observed in 26.0% of. cells. This gain of intact ALK fusion hybridization signals. represents an aneuploid population with extra copies of chromosome. 2/2p ALK region. Additional copies of ALK are not uncommon in. NSCLCs, although the significance of extra copies of the ALK gene in. lung carcinoma is unclear at this time (Salido M. et al. J Thorac. Oncol. 2011;6:21-27). References: (1). Soda M, et al. Identification of the transforming. EML4-ALK fusion gene in non-small cell lung cancer. Nature. 2007:448:561-566; (2). Rodrig S, et al. Unique clinicopathologic. features characterize ALK-rearranged lung adenocarcinoma in the. western population. Clin Cancer Res. 2009:15:5216-5223; (3). Shaw. A, et al. Clinical features and outcome of patients with non-small. cell lung cancer who harbor EML4-ALK. J Clin Oncol. 2009:27:4247-4253; (4). Koivunen J, et al. EML4-ALK fusion gene and. efficacy of an ALK kinase Inhibitor in lung cancer. Clin Cancer. Res. 2008:14:4275-4283; (5). Kwak EL. et al. Anaplastic lymphoma. kinase inhibition in non-small cell lung cancer. N Engl J Med. 2010:363(18):1693-1703 (6). The FDA approved Vysis ALK Break Apart. FISH Probe Kit. ISCN RESULTS: nuc ish(ALKx3 4)[59/100]. The Vysis ALK Break Apart Probe FISH test (. 1 is FDA. approved for use in the detection of rearrangements involving the. ALK gene via fluorescence in situ hybridization (FISH) in. formalin-fixed paraffin-embedded (FFPE) non-small cell lung cancer. (NSCLC) tissue specimens. Addendum #4 performed by. The electronic signature attests that the. Pathologist has evaluated the specimen referred to in the signed. section of the report and formulated the diagnosis therein. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary. SPECIMENS: 1. F/S RIGHT MIDDLE LOBE NODULE. 2. STATION 9 LYMPH NODE, RIGHT CHEST. 3. STATION 10 LYMPH NODE, RIGHT CHEST. 4. COMPLETION OF RIGHT MIDDLE LOBECTOMY. 5. STATION 4 LYMPH NODE. 6. STATION 7 LYMPH NODE. SEE ADDENDUM. Reason For Addendum #1: Molecular Studies. Reason For Addendum #2: Molecular Studies. Reason For Addendum #3: Molecular Studies. Reason For Addendum #4: Biomarker Report. DIAGNOSIS: 1. LUNG, RIGHT MIDDLE LOBE: WEDGE RESECTION. - ADENOCARCINOMA, PAPILLARY PREDOMINANT (1.1 CM), SEE NOTE. - THE STAPLE LINE MARGIN IS FREE OF TUMOR. Note: The tumor consists of papillary (70%) and micropapillary. (30%) components. Results of molecular studies will be reported in. addenda. 2. LYMPH NODE, RIGHT LEVEL 9: BIOPSY. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). 3. LYMPH NODE, RIGHT LEVEL 10: BIOPSY. TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). 4. LUNG, RIGHT MIDDLE LOBE: COMPLETION LOBECTOMY. - NO RESIDUAL TUMOR IS SEEN. - THE BRONCHIAL AND VASCULAR MARGINS ARE FREE OF TUMOR. - ONE INTRAPARENCHYMAL LYMPH NODE, NEGATIVE FOR CARCINOMA. (0/1). 5. LYMPH NODE, LEVEL 4: BIOPSY. - THREE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/3). 6. LYMPH NODE, LEVEL 7: BIOPSY. - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). Specimens: 1: F/S RIGHT MIDDLE LOBE NODULE. 2: STATION 9 LYMPH NODE, RIGHT CHEST. 3: STATION 10 LYMPH NODE, RIGHT CHEST. 4: COMPLETION OF RIGHT MIDDLE LOBECTOMY. 5: STATION 4 LYMPH NODE. 6: STATION 7 LYMPH NODE. LUNG: Resection. SPECIMEN. Specimen: Lobe(s) of lung (specify). right middle. Procedure: Lobectomy. Specimen Laterality: Right. Tumor Site: Middle lobe. Tumor Focality: Unifocal. TUMOR. Histologic Type: Adenocarcinoma, mixed subtype. Histologic Grade: G2: Moderately differentiated. EXTENT. Tumor Size: Greatest dimension (cm). 1.1cm. Visceral Pleura Invasion: Not identified. MARGINS. Bronchial Margin. Bronchial Margin Involvement by Invasive Carcinoma: Uninvolved by. invasive carcinoma. Vascular Margin: Uninvolved by invasive carcinoma. ACCESSORY FINDINGS. Lymph-Vascular Invasion: Not identified. STAGE (pTNM). Primary Tumor (pT): pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung. or visceral pleura, without bronchoscopic evidence of invasion more. proximal than the lobar bronchus (i.e., not in the main bronchus);. or Superficial spreading tumor of any size with its invasive. component limited to the bronchial wall, which may extend proximally. to the main bronchus. Regional Lymph Nodes (pN). pNO: No regional lymph node metastasis. Distant Metastases (pM): Not applicable. ADDITIONAL NON-TUMOR. Additional Pathologic Finding(s): Emphysema. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: M smoker (100 pack-years) with hx of prostate cancer (. ) and. COPD, now with a 1.5 cm RML mixed solid and ground-glass nodule and. multiple additional bilateral lung nodules. MACROSCOPIC DESCRIPTION: The specimen is received fresh, in six parts, each labeled with the. patient's name. 1. Part one is labeled 'right middle lobe nodule'. It consists of a. wedge shaped portion of lung measuring 11 x 5 x 2 cm. There is a. staple line identified on the specimen, measuring 10 cm in length. There is a cut identified on the specimen measuring 1.5 cm in. length. On further sectioning there is a gray white ill defined area. measuring 1.1 x 1 cm is identified. This area is 0.3 cm from the. staple line and 0.4 cm from the pleural surface. The staple line is. inked blue. Further sectioning of the lung reveals spongy tan maroon. parenchyma. One portion from the ill defined area is submitted for. frozen section analysis. Representative sections are submitted. 2. Part two is labeled 'station #9 lymph node'. It consists of a. single lymph node measuring 2.4 x 1.5 x 1 cm. The cut surface is. grey-black. Entirely submitted in one cassette. 3. Part three is labeled 'station #10 lymph node'. It consists of. multiple irregular fragments of grey-black lymph nodes measuring 1.5. x 0.8 x 0.5 cm in aggregate. Entirely submitted in one cassette. 4. Part four is labeled 'completion of right middle lobectomy'. It. consists of a lobe of lung measuring 10.5 x 5.5 x 2 cm and weighing. 38 grams. Two staple lines, measuring 8 cm and 6 cm in length are. noted. The bronchial and vascular margins are identified. The. serosal surface is grey-purple and shows a subpleural grey-black. nodule measuring 0.9 x 0.8 cm. Sectioning reveals an unremarkable. red beefy lung parenchyma. The subpleural nodule likely represents. the lymph node. No discrete mass lesions are noted. Representative. sections are submitted. 5. Part five is labeled 'station #4 lymph node'. It consists of. three irregular segments of grey-black lymph nodes ranging from 0.2. to 0.5 cm in greatest dimension. Entirely submitted in one. cassette. 6. Part six is labeled 'station #7 lymph node'. It consists of a. single grey-black lymph node measuring 0.8 x 0.5 x 0.3 cm. Entirely. submitted in one cassette. SUMMARY OF SECTIONS: 1A frozen section control, ill defined area. 1B area adjacent to ill defined area. 1C area adjacent to ill defined area. 1D area adjacent to ill defined area. 1E unremarkable lung parenchyma. 1F stapled line. 2A in toto. 3A in toto. 4A bronchial and vascular margins. 4B entire subpleural nodule. 4C-4E lung, representative. 5A in toto. 6A in toto. SPECIAL PROCEDURES: INTRA - OPERATIVE CONSULTATION: 1. Lung, right middle lobe: wedge resection (FS). - Invasive adenocarcinoma. Intra-Operative Consultation #1 performed by. Final Diagnosis performed by. ADDENDUM #1 FOR MOLECULAR TESTS: KRAS, EGFR and ALK FISH were sent on. The test is to be performed on tissue from case. The case report, slides, and blocks for the cited. accession number were retrieved from archives. The pathologist whose. signature appears below reviewed the original pathology report,. examined candidate H&E slides, and selected block 1A appropriate to. the specifications of the ordered molecular analysis. x1 H&E and x9. unstained slides were prepared and forwarded to. where the subject molecular test will be performed. An. addendum report will be issued when the results of this molecular. test are available. Addendum #1 performed by. ADDENDUM #2: MOLECULAR ONCOLOGY. KRAS MUTATION ANALYSIS. Body Site: Right middle lobe of lung. Specimen Type: Slides. Clinical Data: Adenocarcinoma. RESULTS: Wild-type gene. INTERPRETATION: No mutations were identified at codons 12 and 13 of the KRAS gene. COMMENT: Mutations in the KRAS gene are reported to be associated with poor. prognosis, and resistance to targeted tyrosine kinase inhibitor. therapies in patients with non-small-cell lung cancer (NSCLC). KRAS. mutations occur in 15-30% of NSCLC patients and are strongly. associated with adenocarcinoma and smoking history. This assay analyzes codons 12 and 13 in exon 2 of the KRAS gene;. based on the current literature, approximately 98% of mutations are. expected to occur in these codons. The analytical sensitivity of. the assay is approximately 10%; thus mutations present in a low. percentage of cells may not be detected. This test is validated. for use in identifying KRAS codon 12 and codon 13 mutations in. fresh, frozen, or formalin-fixed paraffin embedded tissue. In. particular the test performance has been established in samples of. colorectal cancer and non-small cell lung carcinoma which harbor. these mutations, although several other tissues are also known to. harbor KRAS mutations (e.g. tumors of pancreas, bile duct, ovary,. appendix, etc.). Analysis of EGFR mutation or gene amplification status may provide. additional information regarding this patient's probability of. response to targeted tyrosine kinase inhibitor therapies, if. clinically indicated. See references. METHOD/LIMITATION: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exon 2 of the KRAS gene. PCR products are subjected to single. nucleotide primer extension to detect mutations at codons 12 and 13;. primer extension products are analyzed using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: NSCLC. Mascaux C, Iannino N, et al. British Journal of Cancer, 2005;. 92:11-139. Pao W, Wang TY, et al. PLoS Medicine, 205; 2(1):57-61. Eberhard DA, Johnson BE, et al. J Clin Oncol, 2005; 23:5900-5909. Han SW, Kim TY, et al. Clin Cancer Res. 2006; 12(8):253888888-2544. CRC. DiFiore C, Blanchard F, et al. Br J Cancer, 20007; 96:1166-1169. Lievre A, Bachet J-B, et al. Cancer Res, 2006; 66:3992-3995,. This test was developed and its performance characteristics. determined by. The laboratory is. regulated under the Clinical Laboratory Improvement Amendments of. 1988 (CLIA) as qualified to perform high complexity clinical. testing. This particular test is not considered a stand along test. and should be used only in the context of other diagnostic tests or. clinical work-up related to treatment decisions. Addendum #2 performed by. ADDENDUM #3: EGFR Mutation Analysis. Body Site: Right middle lobe of lung. Clinical Data: Adenocarcinoma. RESULTS: No mutation detected. INTERPRETATION: No mutations were identified in the sample provided. for analysis. Fewer than 5% of non-small cell lung carcinoma. patients without identifiable mutations are reported to be. responsive to EGFR tyrosine kinase inhibitor therapies. COMMENT: Forty percent (40%) or more tumor cellularity is optimal. for this mutation analysis. The sample submitted showed 70% tumor. cellularity upon pathologist review. A frequently occurring sequence change 2361>GA (Q787Q) was. identified. This polymorphism is known not to have clinical. significance. Mutations in the tyrosine kinase domain of the epidermal growth. factor receptor (EGFR) gene are reported to be associated with. differential responsiveness or resistance to EGFR tyrosine kinase. inhibitor (TKI) therapies. The objective response rate among. patients with a sensitizing mutation ranges from 55 to 82%. This assay analyzes exons 18-21 of the EGFR tyrosine kinase domain;. based on the current literature, most mutations in non-small-cell. lung carcinoma (NSCLC) are expected to occur in these exons. Mutations present in less than 10-20% of extracted DNA may not be. detected by this method. Mutation status in a sample may change. during tumor progression or the course of therapy; therefore, this. result cannot be used to infer the presence or absence of a mutation. in another sample or sub-sample obtained from this tumor. This test is validated for non-small cell lung carcinoma. The. clinical significance and utility of this test in other tumor types. is unknown. METHOD: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exons 18-21 of the EGFR gene. PCR products are analyzed by. bi-directional direct DNA sequencing using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: 1. Azzoli CG, et al. J Clin Oncol. 20095; 27:6251-6266. 2. Jackman DM et al. Clin Carcinoma Res. 2009; 15:5267-5273. 3. Mok TS, et al. N Engl J Med. 1009; 361;947-957. 4. Sharma SV, et al. Nat Rev Carcinoma, 2007; 7:169-181. DISCLAIMER: This test was developed and its performance characteristics. determined by. The laboratory is. regulated under the Clinical Laboratory Improvement Amendments of. 1988 (CLIA) as qualified to perform high complexity clinical. testing. This particular test is not considered a stand alone test. and should be used only in the context of other diagnostic tests or. clinical work-up related to treatment decisions. Addendum #3 performed by. ADDENDUM 4: INTEGRATED ONCOLOGY. Fluorescence In-Situ Hybridization (FISH). Body Site: Right middle lobe of lung. Clinical Data: Adenocarcinoma. INTERPRETATION: Negative for a rearrangement involving the ALK gene. Probe #Nuclei Examined % Positive Nuclei %. Control values. 2p23(ALK) 50 0.0 <15."
BIOCUP_00051,lung,LUAD,TCGA-J2-A4AD,TCGA-J2-A4AD.C7D2CA13-F82C-4B95-9161-E9D8C8D958E0,"COPY ONLY DO NOT FILE. Gource of Specimen. A. ST 7 #1 FS-. B. ST 7 #2 FS-. C. ST 7 #3 FS-. D. 41 #1 In-. E. 41. #2 FS-. F. 11 #3 FS-. G. 4R 41 PS-. H. 1B 42 FS-. I. 4R #3 FS-. J. 4R #4 FS-. K. LECT UPPER LOBE LUNG WEDGE FS-. L. LEET UPPER LOBE LUNG WEDGE. M. STATCON 5 NODE-. N. HILAR NODE #1-. O. HILAR NODE #2-. P. ITILAR NODE #3-. Q. INTERLOBAR NODE-. R. LEFT UPPER LOBE COMPLETION LOBECTOMY-. FINAL DIAGNOSIS: A. 3T 7 $1 FS-. LYMPH NODE, NO TUMOR SEEN. B. 31 i #12 PS-. CYMPH NODE, NO TUMOR SEEN. : SIT 7 #3 PS-. LIMPH NODE, NO TUMOR SEEN. D. 41 #1 85-. TIMPH NODE, NO TOMOR SEEN. Prep. E. 4L #2 FS-. GYMPH NODE, NO TUMOR SEEN. E. 4L #3 ES -. LYMPH NODE, NO TOMOR SEEN. G. 4R #1 PS-. LYMPH NODE, NO TOMOR SEEN. H. 4P. #: FS-. LYMPH NODE, NO TUMOR SEEN. I. 4R #3 FS-. LYMPH NODE, NO TUMOR SEEN. J. 4R #4 FS-. LYMPH NODE, NO TUMOR SEEN. K. LEFT UPPER LOBE LUNG WEDGE FS-. SEE PART L. L. LEFT UPPER LOBE LUNG WEDGE NFS-. INVASIVE CARCINOMA, LIMITED TO LUNG. HISTOLOGIC TYPE: ADENOCARCINOMA. HISTOLOGIC GRADE: 1/4. TUMOR FOCALITY: UNIFOCAL. TUMOR SI3E: 1.8 CM. TUMOR SITE: LEFT UPPER LOBE. VISCERAL PLEURA INVASION: NOT SEEN. NO SIGNIFICANT OBSTRUCTIVE PNEUMONITIS OR ATELECTASIS SEEN. LYMPHATIC (SMALL VESSEL) INVASION: NOT SEEN. LARGE VESSEL INVASION: NOT SEEN. LYMPH NODES INCLUDED IN ALL PARTS: NUMBER INVOLVED : NUMBER EXAMINED: 14. TNM STAGE: pTla, pNo, pMX. SPECIMEN TYPE: WEDGE RESECTION, WITH COMPLETION LOBECTOMY. SPECIMEN SIZE: 9 x 2.5 x 2.0 CM. NO TUMOR SEEN AT RESECTION MARGINS. M. STATION 5 NODE-. LYMPH NODE, NO TUMOR SEEN. N. HILAR NODE #1- ==. FRAGMENT OF FIBROVASCULAR TISSUE, NEGATIVE FOR MALIGNANCY. Prep. O. HILAR NODE #2-. LYMPH NODE, NO TUMOR SEEN. P. HILAR NODE #3-. LYMPH NODE, NO TUMOR SEEN. C. INTERLOBAR NODE-. GYMPH NODE, NO TUMOR SEEN. R. LEFT √úPPER LOBE COMPLETION LOBECTOMY-. SONG WITHOUT STONIFICANT ABNORMALITY. NO CARCINOMA GEEN. Signed Others. Frogen Gection. A. 10 SPECIMENS:: ST7 #1, ST7#2, ST7 #3, 4L #1, 4L #2, 41, #3,. 4R #1, 4R #2, 4R #3, 4R #4. NO TUMOR SEEN. DEFT UPPER LORE WEDGE: ADENOCARCINOMA. Case Clinical Information. LEFT OPPER LOBE LUNG. Gross bescription. A. Received in formalin labeled with the patient's name and ""ST. #1 FS"" are two dark brown tissue fragments measuring 0.5 x 0.2. cm. Filtered, wrapped and submitted in A1. a. Received in formalin labeled with the patient's name and ""ST. & #2 FS"" are two gray-tan tissue fragments; the larger fragment. measures 0.5 cm and the smaller fragment measures 0.2 cm. Wrapped and submitted in B1. C. Received in formalin labeled with the patient's name and ""ST. 7 43 PS"" io a gray-tan frozen section tissue fragment measuring. 0. 1 X 0. 3 cm. Filtered, wrapped and submitted in C1. D. Received in formalin labeled with the patient's name and ""4L. #1 FS"" is a gray-tan frozen section tissue fragment measuring. 0.4 cm. Wrapped and submitted in D1. F. Received in formalin labeled with the patient' name and ""4L. 42 FS"" are three gray-brown tissue fragments measuring 0.5 X 0.2. on. Wrapped and submitted in E1. F. Received in formalin labeled with the patient's name and ""4L. it's FS"" are UWO gray-brown tissue fragments measuring 0.4 x 0. 4. Wrapped and submitted in F1. G. Received in formalin labeled with the patient's name and ""4R. HIL FS"" are two yellow-brown tissue fragments. The larger. fragment measures 1 x 0.5 cm and the smaller fragment measures. 0.5 x 0. cm. Wrapped and submitted in Gl. H. Received in formalin labeled with the patient's name and ""4R. #2 F3"" are chree yellow-brown tissue fragments. The largest. fragment measures 0.5 cm and the smallest fragment measures 0.3. CML. Wrapped and submitted in H1. 1. Received in formalin labeled with the patient's name and ""4R. #3 FS"" are two yellow-tan fibroadipose tissue fragments. measuring 0.5 cm. Wrapped and submitted in Il. J. Received in formalin labeled with the patient's name and ""4R. #4 FS"" are four yellow-tan fibroadipose tissue fragments. The. largest tragment measures 0.9 x 0.5 cm and the smallest fragment. measures 0.5 X 0.4 cm. Wrapped and submitted in J1. K. Received in formalin labeled with the patient's name and. ""left upper lobe lung wedge FS"" is a gray-tan frozen section. tissue tragment measuring 2.2 x 1.5 cm. Wrapped and submitted in. 1. Received in formalin labeled with the patient's name and. ""left upper lobe lung wedge NFS"" is a gray-brown wedge of lung. weighing 26 grams and measures 9 x 2.5 x 2.0 cm. The specimen. cas a staple line at one of the edges which are removed and. inked in black. The specimen has been previously sectioned from. where a Irozen section has been taken showing a gray dark brown. friable firm area and measures 2 x 1.7 cm. The pleura lesion is. inked in blue. The remainder of the parenchyma is serially. sectioned showing a gray dark brown parenchyma. Represented as. follows: the firm area adjacent area from where the frozen. section was taken entirely submitted L1-L7; lung parenchyma. through the black inked resection margin L8-L10. M. Received in formalin labeled with the patient's name and. ""station 5 3ymph node"" is a dark brown tissue fragment measuring. 0. 9 X 0. 5 em. Entirely submitted in M1. N. Received in formalin labeled with the patient's name and. ""hilar node #1"" is a gray-brown tissue fragment measuring 0.5. cm. Wrapped and submitted in N1. c. Received in formalin labeled with the patient's name and. ""hilar node #2"" are two yellow-tan fibroadipose tissue. fragments. The larger fragment measures 0.9 cm and the smaller. tragment measures 0. cm. Wrapped and entirely submitted in 01. P. Received in formalin labeled with the patient's name and. ""hilar node #3"" revealed tan fibroadipose tissue fragments. The. larger Fragment measures 0.5 cm and the smaller fragment. measures 0.0 cm. Wrapped and submitted in P1. 2. Received in formalin labeled with the patient's name and. ""interlobar node"" are three dark brown fibroadipose tissue. tragments. The largest fragment measures 0.8 x 0.5 cm and the. smallest tragment measures 0.4 x 0.4 cm. Wrapped and submitted. i: 01. B. Received in formalin labeled with the patient's name and. ""left upper Lobe, completion lobectony"" is a left upper Tobe. Lung weighing 200 grams measuring 17 x 8 x 4.5 cm. The pleura is. di gray dark brown with moderate anthracotic streaking and has a. staple Line at one of the edges which are removed and inked in. black. The specimon is serially sectioned showing a gray dark. brown, spongy and congested parenchyma. No tumor grossly. identified. The specimen is represented as follows: parenchymal. resection margin ----- R1; lung parenchyma = R2-R4; parenchyma. through the staple inked resection margin = R5-R7. Procedure. A. AA ROUT INE H&E X1 BLOCK. H&E X1. B. AA ROUTINE H&E X1 BLOCK. H&E XI. C. AA ROUTINE H&E X1 BLOCK. H&F 31. D. AA ROUTIME H&E X1 BLOCK. H&E XI. B. AA ROUTINE H&E X1 BLOCK. R&E 31. F. AA ROUTINE H&E X1 BLOCK. HNE X1. G. AA ROUTINE H&E x1 BLOCK. H&E X1. H. AA ROUTINE H&E X1 BLOCK. HAF X1. (. AA ROUTINE HSE X1 BLOCK. 188 X1. J. AA ROUTINE H&E X1 BLOCK. H&E 31. R. AA ROUTTNE H&E X1 BLOCK. II&E X1. L. AA ROUTINE H&E X1 BLOCK. 1. HSE 81. 1. AA ROUTINE H&E X1 BLOCK.2. x1. D. AA BOUTINE H&E X1 BLOCK. 3. H&E X1. is. AA ROUTINE H&E X1 BLOCK. 4. hos X1. 11. AA ROUTINE H&E x1 BLOCK. 5. L. AA ROUPINE 115E X1 BLOCK. 6. H&E X1. L. AA ROUTINE H&E X1 BLOCK. 7. H&E X1. L. AA ROUTINE H&E X1 BLOCK.: 8. 116E X1. L. AA ROUTINE H&E XI BLOCK. 9. H&E X1. G. AA ROUTINE H&E X1 BLOCK. 10. H&E il. M. AA POUTINE H&E X1 BLOCK. H&E XI. N. AA POUTTNE H&E X1 BLOCK. HwB. X1. O. AA ROUTINE HSE X1 BLOCK. H&E X1. P. AA ROUTINE H&E X1 BLOCK. H&E X1. Q. AA ROUTINE HSE X1 BLOCK. H&E x1. R. AA ROUTINE H&E X1 BLOCK.. 1. H&E x1. R. AA ROUTINE H&E X1 BLOCK.2. H&E X1. P. AA ROUTINE H&E X1 BLOCK.3. 168 X1. R. AA ROUTINE H&E x1 BLOCK.4. H&E X1. R. AA ROUTINE H&E X1 BLOCK.5. H&E X1. R. AA ROUTINE HISE X1 BLOCK. 6. H&B X1. R. AA ROOTINE HSE X1 BLOCK. 7. Prepare."
BIOCUP_00052,lung,LUSC,TCGA-33-6737,TCGA-33-6737.d8a5d5d4-48a9-4b5a-bf57-ff32e7302d74,"SURG PATH REPORT. 1st Specimen collected on. FINAL DIAGNOSIS. 1. R4 LYMPH NODE (EXCISION) : METASTATIC CARCINOMA INVOLVING I OF. LYMPH NODE (4 MM FOCUS). 2. HIGH R4 LYMPH NODE (EXCISION) : ONE (1) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 3. R10 LYMPH NODE (EXCISION) : METASTATIC CARCINOMA INVOLVING 1 OF 1. LYMPH NODE (4 MM FOCUS). 4. RIGHT LUNG UPPER LOBE (LOBECTOMY) : SPECIMEN TYPE: Lobectomy. TUMOR SITE: Right, upper lobe. HISTOLOGIC TYPE: Adenosquamous carcinoma. TUMOR SIZE: Greatest dimension: 7.5 cm. LOCATION, SIZE, AND HISTOLOGIC TYPE OR ADDITIONAL SEPARATE TUMOR. NODULES, IF ANY: None identified. HISTOLOGIC GRADE: G3: Poorly differentiated. LYMPH NODES: Metastatic carcinoma in 3 of 9 lymph nodes. (see part 1-6). EXTENT OF INVASION (STAGING). PRIMARY TUMOR: pT2 Tumor which is >3 cm. REGIONAL LYMPH NODES: pN2: Metastasis in ipsilateral mediastinal or subcarinal lymph nodes. DISTANT METASTASIS;. pMx: Cannot be assessed. MARGINS: Margins uninvolved by invasive carcinoma. VENOUS/ARTERIAL (LARGE VESSEL) INVASION: Indeterminate. LYMPHATIC (SMALL VESSEL) INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: None identified. 5. P3 LYMPH NODE (DISSECTION) : TWO (2) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 6. STATION 7 LYMPH NODE (EXCISION) : ONE (1) LYMPH NODE AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. ADDENDUM. EGFR MUTATION ANALYSIS: RESULTS: No mutation detected. K-RAS MUTATION ANALYSIS: RESULTS: No mutations were identified at codons 12 and 13. of the KRAS gene. NOTE: A copy of the complete report is available in. and is on. file in the molecular pathology laboratory. End of Diagnosis. Clinical History: ? LUNG CANCER."
BIOCUP_00053,lung,LUAD,TCGA-35-5375,TCGA-35-5375.a93477c8-5ebe-436b-978a-61b573f65471,"Cureline. Clinical. Clinical. Index. Specimen label. Site #. 1. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. Specificati. Container. Site. Matrix. Format. containers. container. on. Lung, left. Primary. Tumor. Tissue. OCT. block. n/a. n/a. upper lobe. Blood. n/a. Normal. Blood. frozen. tube. 1. n/a. n/a. Component. Type of. of treatment. Histological description. Grade. Procureme. TNM Stage. TNM Stage. TNM Stage. Treatment. (Chemo /. (Source). (source). (T). (N). (M). type. nt. Horm Th. Details). Squamous, non-. 3. 2. 2. 0. none. n/a. keratinizing carcinoma. blood draw. n/a. n/a. n/a. n/a. n/a. none. n/a. Tumor cell. %. 72. n/a."
BIOCUP_00054,lung,LUAD,TCGA-L9-A444,TCGA-L9-A444.7356DDFB-ADA7-4809-85EC-1C6D51D5B32D,"RUN DATE. RUN TIME: specimen Inquiry. RUN USER. Lab Database: LOC: U. AGE/SX: ROOM: REG DR: BED: DIS: TLOC: SPEC #: RECD: PERFORMED AT. COLL: TIME IN FORMALIN: CLINICAL INFORMATION: Pre-Op Diagnosis: Lung CA. Remarks : Specimen (s) : A. Level 7 (frozen section). B. Level 4 (frozen). C. R4. D. Right upper lobe. E. Level 10. A. LEVEL 7 LYMPH NODE: REACTIVE LYMPH NODE. B. LEVEL 4 LYMPH NODE: REACTIVE LYMPH NODE. c. R4 LYMPH NODE: REACTIVE LYMPH NODE. D. RIGHT UPPER LOBE: ADENOCARCINOMA. SEE COMMENT FOR DETAILS. E. LEVEL 10 LYMPH NODE: REACTIVE LYMPH NODE. COMMENT (S). PROTOCOL FOR EXAMINATION OF SPECIMENS WITH PRIMARY NON SMALL CELL CARCINOMA OF THE LUNG. BASED ON AJCC/UICC TNM 7TH EDITION. LUNG: Resection. SPECIMEN: Lobe. PROCEDURE: Lobectomy. SPECIMEN INTEGRITY: Intact. SPECIMEN LATERALITY: Right. TUMOR SITE: Upper lobe. TUMOR SIZE: 1.5 cm. RUN DATE: RUN TIME: Specimen Inquiry. RUN USER: PCI User. Lab Database: SPEC #: COMMENT (s). TUMOR FOCALITY: Unifocal. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G2, moderately differentiated. VISCERAL PLEURAL INVASION: Not identified. TUMOR EXTENSION: Not applicable. MARGINS: : Bronchial Margin: Uninvolved by invasive carcinoma. Vascular Margin: Uninvolved by invasive carcinoma. Parenchymal Margin: Not applicable. Parietal Pleural Margin: Not applicable. Chest Wall Margin: Not applicable. TREATMENT EFFECT: Not applicable. LYMPH-VASCULAR INVASION: Not identified. PATHOLOGIC STAGING: Primary Tumor: pTla. Regional Lymph Node: pNO. Number of lymph nodes examined: 6. Number of lymph nodes involved: o. Distance Metastasis: Not applicable. GROSS DESCRIPTION: A. Received in the unfixed state in the operating room labeled ""level 7 lymph node"". The. specimen consists of multiple tan-red fragments of tissue aggregating to 1.5 x 0.5 x 0.3. cm. One smear imprint is prepared. All the specimen is frozen in one block. B. Labeled ""level 4 lymph node"". The specimen is received in an unfixed state in the. Operating Room, consistent with a single 0.5 cm reddish tan piece of tissue entirely frozen. in one block. C. Part 3 labeled ""R4"". Received in formalin, is a 0.5 x 0.4 x 0.3 cm mildly anthracotic. to pink/tan lymph node. The node is submitted in toto cassette C1. D. Part 4 received fresh for Tissue Banking, labeled with the patient's name, and ""right. upper lobe, is a 224 gram, 16.5 x 8.5 x 4.0 cm upper lobe of lung. This is also received. fresh for frozen section diagnosis. The surgeon changed his mind. The pleura is pink/tan. and spongy to red with anthracotic marbling. The lung is sectioned to have a 1.5 x 1.5 x. 1.0 cm tumor mass. The mass appears circumscribed and possibly within a vessel. The mass. is 2.0 cm from the bronchial margin and does not involve the pleura. The tumor appears to. have an adjacent smaller nodule, which ranges up to 0.5 cm. The lung is sectioned fresh to. have a peripheral pink/tan spongy appearance on the anterior surface in the superior. aspect. The tumor has a central location adjacent to the hilar structures. There is focal. scant mucin filled bronchioles in the area of the tumor. The parenchyma demonstrates mild. congestion inferiorly. No additional masses or lesions are identified. Sections are. sampled as labeled in the following cassettes: D1. frozen section residue of bronchial margin. D2. hilar lymph nodes. D3. vascular margins. RUN DATE. RUN TIME. Specimen Inquiry. RUN USER. PCI User Lab Database: SPEC #: GROSS DESCRIPTION: D4. perpendicular section of bronchus from margin towards tumor. D5-D7-. representative sections of tumor to include separate small nodule of tumor. D8. parenchyma from superior aspect of lobe. D9. parenchyma adjacent to tumor from mid aspect of lobe. D10. inferior sections of parenchyma sampled. The specimen is dissected in an unfixed state for Tumor Banking. Received a call from. the Operating Room just before. stating that. wanted a bronchial. resection margin frozen. The Tumor Banker brought the specimen over but at that time,. 'id not want the bronchial resection margin frozen. E. Part 5 is received in formalin, labeled with the patient's name and ""level 10"" are two. hemorrhagic to focally blackened anthracotic portions of possible lymphoid tissue. The. tissues include a 0.4 cm fragment and a 0.6 cm fragment. The tissues are submitted in toto. cassette E1. INTRAOPERATIVE CONSULTATION: A. FROZEN SECTION AND CYTOLOGY SMEARS, LEVEL 7 LYMPH NODE, BIOPSY: REACTIVE LYMPH NODE. B. FROZEN SECTION, LEVEL 4 LEFT LYMPH NODE, BIOPSY: REACTIVE LYMPH NODE. D. FROZEN SECTION, RIGHT UPPER LOBE: BRONCHIAL RESECTION MARGIN NEGATIVE FOR MALIGNANCY. SPECIMEN DISSECTED FOR TUMOR BANKING. PHOTO. RUN DATE: RUN TIME: Specimen Inquiry. RUN USER: Lab Database: SPEC #: PHOTO DOCURIENTATION. (signature on file)."
BIOCUP_00055,lung,LUAD,TCGA-93-A4JO,TCGA-93-A4JO.54D7BAFD-D766-4EE6-A769-F57A858B5F44,"Cardiothoracic Surgery. Accessioned: DIAGNOSIS: A. LYMPH NODE, LEVEL VII, EXCISION. - EIGHTEEN LYMPH NODES WITH NO EVIDENCE OF MALIGNANCY (18). B. LYMPH NODE, LEVEL X, EXCISION. - ONE LYMPH NODE WITH NO EVIDENCE OF MALIGNANCY (1). C. LYMPH NODE. LEVEL XI. EXCISION. - ONE LYMPH NODE WITH NO EVIDENCE OF MALIGNANCY (1). D. LYMPH NODE, LEVEL XII, EXCISION. - ONE LYMPH NODE WITH NO EVIDENCE OF MALIGNANCY (1). E. LUNG, RIGHT LOWER LOBE, LOBECTOMY. - ADENOCARCINOMA, MIXED TYPE (SOLID - 90%. ACINAR - 10%), POORLY-DIFFERENTIATED (1.5. CM). WITHOUT EVIDENCE OF VISCERAL PLEURA OR LYMPHVASCULAR SPACE INVASION,. RESECTION MARGINS NOT INVOLVED (SEE SYNOPTIC REPORT). - PULMONARY CHONDROID HAMARTOMA (1.3 CM). FOUR LYMPH NODES WITH NO EVIDENCE OF MALIGNANCY (4). - SUBPLEURAL PULMONARY FIBROSIS WITH BRONCHIAL METAPLASIA, METAPLASTIC BONE. FORMATION, AND MUCOUS RETENTION CYST FORMATION. F. LYMPH NODES. LEVEL IV R, EXCISION. - TWO LYMPH NODES WITH NO EVIDENCE OF MALIGNANCY (2). By this signature, - attest that the above diagnosis is based upon my personal. examination of the sides(and/or other material in the degnosis). "". Intraoperative Consultation: ""Brought to frozen is a, 'right lower lobe lung.' consisting of a 191 gram, 12.8 x 7.7 x 3.3 cm lung lobe. Bronchial. Page of 4. margin frozen as FS1. Sectioned to show two distinct masses, one measuring 1.9 x 1.6 x 1.5 cm and is closer to the. base of the lung. The other measures 1.2 x 1.2 x 1.0 cm. Tissue from the larger mass is taken for research. Rest for. permanents,"". FS: Bronchial margin, biopsy. - ""No evidence of malignancy,'. Microscopic Description and Comment: Microscopic examination substantiates the above cited diagnosis. History: The patient is. with two lung nodules. Operative procedure: Right lower lobectomy. Specimen(s) Received: A: LYMPH NODE, LEVEL VII. B: LYMPH NODE, LEVEL x. C: LYMPH NODE, LEVEL XI. D: LYMPH NODE, LEVEL XII. E: LUNG. RIGHT LOWER LOBE. F: LYMPH NODE. LEVEL IVR. Gross Description: The specimens are received in five formalin-filled containers, each labaled. The first container is labeled. ""level VII lymph node."" It contains two fragments of yellow fibroadipose tissue measuring 2.8 x 1.8 x 1.0 cm and 3.5 x. 2.7 x 1.1 cm. multiple putative lymph nodes are identified within the yellow fibroadipose tissue. Labeled A1 to A4 -. multiple putative lymph nodes. Jar 0. The second container is labeled ""level x lymph node."" it contains a single putative lymph node measuring 0.9 x 0.9 x. 0.6 cm. Labeled B1. Jar 0. The third container is labeled ""level XI lymph node."" It contains two fragments of tan-gray tissue measuring 1.1 x 1.0 x. 0.3 cm and 0.9 x 0.7 x 0.3 cm. Labeled C1. Jar 0. The fourth container is labeled ""lymph node level XII. It contains a single putative lymph node measuring 0.8 x 0.7 x. 0.3 cm. Labeled D1. Jar 0. The fifth container is labeled right lower lobe lung."" It contains a 10.5 x 10.0 x 9.7 cm lobe of lung. It has been. previously sectioned to show a 1.5 x 1.1 x 1.4 cm firm white lesion. There is also a separate, 1.3 x 1.2 x 1.0 cm firm. lesion superior to the larger mass. There is no pleural puckering over either mass. The bronchial margin appears. normal. Multiple vascular structures are identified at the resection margin. They are grossly unremarkable. A few. pulative peribronchial lymph nodes are identified. Sections of the uninvolved lung show spongy tan lung parenchyma. with no other focal lesions. Additionally in the container. a green cassette labeled ""FS1,"" that holds multiple fragments. of bronchial tissue measuring 1.5 x 1.2 x 0.2 cm in aggregate. Labeled E1 to E3 - larger mass; E4 and E5 - smaller. more superior mass; E6 - uninvolved lung: E7 . vascular margin; E8 - bronchus; E9 - FS1; E10 and E11 - putative. lymph nodes. The sixth container is labeled ""level IVR. It contains a 3.7 x 2.2 x 1,7 cm pice of yellow fibroadipose tissue. Two. putative lymph nodes are dissected from the fibroadipose tissue, measuring up to 0.7 cm in greatest dimension. Labeled F1 and F2. Jar 1. SYNOPTIC REPORTING FORM FOR LUNG CARCINOMA. NEOPLASM. A neoplasm is present. HISTOPATHOLOGIC TYPE. The histologic classification of the tumor is carcinoma, mixed type Solld-90%, acinar-10%. HISTOLOGIC GRADE (G). The grade of the tumor is paorly differentiated (G3). TUMOR SIZE. The maximum dimension of the tumor is 1.5 cm. LYMPHATIC INVASION. Lymphatic Invasion by tumor is absent (L0). VENOUS INVASION. Venous invasion by tumor is absent (V0). ARTERIAL INVASION. Arterial invasion by tumor Is absent. PLEURAL INVOLVEMENT. Pleural involvement is absent. SAMPLED SPECIMEN MARGINS. The sampled surgical margins are uninvolved by tumor. NON-NEOPLASTIC TISSUE. Subpleural pulmonary fibrosis with bronchial metaplasia, metaplastic bone formation, and mucous retention cyst. formation. PRIMARY TUMOR (T). Tumor <= 2 cm in greatest dimension (T1a). REGIONAL LYMPH NODES (N). No regional lymph node metastasis histologically, no examination for ITC (pNo). The total number of lymph nodes examined is 27. The total number of metastaticaly-involved lymph nodes is 0. DISTANT METASTASIS (M). Distant metastasis cannot be assessed (MX). STAGE GROUPING. The overall international stage is T1a/NO/MO (Stage IA). The pathologic stage assigned here should be regarded as provisional, and may change after integration of clinical. data not provided with this specimen. Surgical Pathology report is available on-line on."
BIOCUP_00056,lung,LUSC,TCGA-37-3789,TCGA-37-3789.9051358f-5b74-4f6c-b7f2-fc83e8f43306,Index. 1. Tissue. Tumor. Specimen. Specimen. Number of Amount/per. Specificati. Container. Matrix. Format. containers. container. on. Primary. Tumor. Tissue. OCT. block. 1. n/a. n/a. Normal. Blood. frozen. tube. 1. n/a. Type of. Histological description. Grade. TNM Stage. TNM Stage. TNM Stage. Treatment. Procureme. (Source). (source). (T). (N). (M). type. nt. n/a. Squamous cell carcinoma. 2. 2. 0. X. none. n/a. blood draw. n/a. n/a. n/a. n/a. n/a. none. Component. of treatment. Tumor cell. (Chemo /. %. Horm Th. Details). n/a. over 50. n/a. n/a.
BIOCUP_00057,lung,LUAD,TCGA-55-8090,TCGA-55-8090.8f75f207-fe12-44ba-86b2-444ab5578d45,"PROCEDURE. Right thoracoscopy. SPECIMEN: Right lower lobe lung mass. Frozen section - check margins. Fyear-old man, hx. of nonsmall cell carcinoma with hip and right. lower lobe nodule. HISTORY. Right lung mass. GROSS. Specimen received in fresh for frozen section labeled as ""right. lower lobe lung mass, consists of a wedge of lung measuring 5 x 4 x. 2.5 cm. By opening, the cut surface reveals a solid tan-white mass. measuring 2.5 x 2 x 2 cm. The sutured margin is negative, 3 mm from. tumor. The serosal surface appears involved by tumor. Representative section is processed for frozen section. The specimen is submitted as follows: 1. Frozen control. 2-3. The tumor, the suture margin. FROZEN SECTION DIAGNOSIS. Adenocarcinoma. is notified for diagnosis at. MICROSCOPIC. Performed. DIAGNOSIS. Right lower lobe of lung, wedgectomy: Adenocarcinoma, moderately differentiated (2.5 cm) . The tumor is. limited in lung, associated with scar of subpleura. Resection margins are negative for tumor. Lymphovascular invasion is present. COMMENT. Compare to left lower lung biopsy at. the. tumor cells of two biopsies are morphologically similar. Dr. reviewed the case and concurs with the diagnosis. M.D. (Electronic Signature). Completed Action List: on. Type: Title:"
BIOCUP_00058,lung,LUAD,TCGA-99-8033,TCGA-99-8033.a7f10fd8-ab32-4adb-94a9-31632e286b11,"Observation Date. Last Edited Date. Diagnosis. Lung, right upper lobe, wedge excision: - Poorly differentiated adenocarcinoma. - Lymphovascular. invasion is present. - Margins negative for malignancy. (Electronically signed by). Verified: Clinical Information. The patient is a. year-old female. Frozen Section Diagnosis. AFS1: Right upper lobe: - Non small cell carcinoma consistent with adenocarcinoma. Gross Description. The specimen is received in a single container labeled with the patient's name, medical record. number, and ""#1 - wedge, right upper lobe."" The specimen received fresh for frozen and now in formalin. consists of a wedge of lung which measures 9.5 X 4.0 X 2.0 cm. There is a staple line margin along the. length of the wedge. Sectioning of the lung reveals a well-defined round tan mass measuring 1.4 cm in. greatest dimension. This mass is separated and is well away from the staple line margin grossly with. the closest margin being approximately 1.0 cm away. Additionally, there is a frozen section in a orange. cassette labeled A1. The remnant measures 2.0 X 1.0 X 0.3 cm and is resubmitted entirely. Block Summary. A1-. Frozen remnant. A2-. Section of mass. A3-. Staple line margin nearest mass. A4-. Representative section of normal appearing lung. A5-. Additional section of tumor. Microscopic Description. A microscopic examination has been performed."
BIOCUP_00059,lung,LUAD,TCGA-44-5644,TCGA-44-5644.041e212a-2fdd-42af-9326-9fb5fef07126,"SPECIMEN. A. R4 lymph node. B. Right lymph node. C. Level 10 lymph node. D. Right lower lobe. E. Level 7 lymph node. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung mass. FROZEN SECTION DIAGNOSIS. R-4 lymph nodes, biopsy: Negative for malignancy. GROSS DESCRIPTION. A. The specimen is received unfixed, labeled ""R4 lymph. nodes"" and consists of multiple pieces of red and black. soft tissue measuring 1.3 cm. in greatest aggregate dimension. The. entire spec. S submitted for frozen section diagnosis as. requested. B. ived in formalin labeled ""R4 lymph node"" and. consists of 4 pieces of white and black soft tissue. varying. from 1.2 to 1.5 cm. in greatest dimension. RS-1. C. Received in formalin labeled ""level 10 lymph node"" and. consists of 5 pieces of white and black soft tissue. measuring up to 1.2 cm. RS-1. D. The specimen is received in formalin but was. apparently. originally received fresh. It consists of a 195 g lung lobe. The. specimen is labeled ""right lower lobe"". The specimen has a pink. and. purple serosal surface and measures 15 X 7 X 5.4 cm. The specimen. has been incised prior to my examination and a portion of the. specimen has been taken for research purposes. The incision is. into. a tumor measuring 3.5 X 3.2 X 3 cm. E. Received in formalin labeled ""level 7 lymph node"" and. consists of four pieces of white and black soft tissue. varying from 0.4 to 2.4 cm. in greatest dimension. RS-2. MICROSCOPIC DESCRIPTION. A. Lymph node pieces are negative for malignancy. B. There is no evidence of malignancy in any of 4 lymph nodes. C. There is no evidence of malignancy in any of 5 lymph nodes. D. Tumor type: : Adenocarcinoma. Tumor grade: : 2 out of 3. Mitotic Index: 26 mitoses/10 HPFs (1 HPF = 0.19 sq mm). Tumor size: 3.5 cm. Pulmonary margin of resection: Negative for malignancy. Pleura: Negative for malignancy. Vascular invasion: Absent. pTNM Stage: T2a NO. Non-tumorous lung: Benign reactive changes. E. There is no evidence of malignancy in any of 4 lymph nodes. 3, 4x4, 14. DIAGNOSIS. A. Lymph node, R4, biopsy: Negative for malignancy. B. Lymph nodes, right biopsy: There is no evidence of malignancy in any of 4 lymph nodes. C. Lymph node, level 10, biopsy: There is no evidence of malignancy in any of 5 lymph nodes. D. Lung, right lower lobe, resection: Moderately differentiated adenocarcinoma. E. Lymph node, level 7, biopsy: There is no evidence of malignancy in any of 4 lymph nodes. End Of Report ---."
BIOCUP_00060,lung,LUAD,TCGA-73-7498,TCGA-73-7498.c60ca2d8-4981-406a-9b8d-8efde4976001,"SPECIMENS: A. 4R RIGHT PARATRACHEAL LYMPH NODE. B. LEVEL 7 LYMPH NODE. C. RIGHT LOWER LOBE WEDGE. D. LEVEL 8 LYMPH NODE. E. LEVEL 9 LYMPH NODE. F. RIGHT LOWER LOBE. SPECIMEN(S): A. 4R RIGHT PARATRACHEAL LYMPH NODE. B. LEVEL 7 LYMPH NODE. C. RIGHT LOWER LOBE WEDGE. D. LEVEL 8 LYMPH NODE. E. LEVEL 9 LYMPH NODE. F. RIGHT LOWER LOBE. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA, Lymph node, 4R right paratracheal, biopsy: Negative for malignancy. FSB, Lymph node, level 7, biopsy: Negative for malignancy. FSC, Lung, right lower lobe, wedge biopsy: Positive for malignancy non-small cell carcinoma, favor. adenocarcinoma, diagnoses called at. and. FSF, lung, right lower, lobectomy: Bronchial margin negative for malignancy, diagnosis called at. DIAGNOSIS: A. LYMPH NODE, RIGHT PARATRACHEAL - 4R, EXCISION: - NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). B. LYMPH NODE, LEVEL 7, EXCISION: - NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). C. LUNG, RIGHT LOWER LOBE, WEDGE RESECTION: ADENOCARCINOMA, MODERATELY DIFFERENTIATED WITH BRONCHIOLOALVEOLAR. FEATURES. - 2.5 CM IN GREATEST DIMENSION. - 1.8 X 1.0 CM IN ADDITIONAL DIMENSIONS. - THE PLEURAL SURFACE IS NEGATIVE FOR TUMOR. - NO ANGIOLYMPHATIC INVASION IDENTIFIED. - MILD EMPHYSEMATOUS CHANGES. D. LYMPH NODE, LEVEL 8, EXCISION: - NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). E. LYMPH NODE, LEVEL 9, EXCISION: - NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). F. LUNG, RIGHT LOWER LOBE, COMPLETION LOBECTOMY: - SEPARATE MICROSCOPIC FOCUS OF ADENOCARCINOMA, BRONCHIOLOALVEOLAR TYPE. - 0.9 CM IN GREATEST DIMENSION (MEASURED MICROSCOPICALLY). - THE PLEURAL SURFACE IS NEGATIVE FOR TUMOR. - THE BRONCHIAL MARGIN IS NEGATIVE FOR TUMOR. - NO ANGIOLYMPHATIC INVASION IDENTIFIED. - PLEURAL PLAQUE. - NO MALIGNANCY IDENTIFIED IN TWO LYMPH NODES (0/2). - MILD EMPHYSEMATOUS CHANGES. COMMENT: Two tumors are identified. The tumor in part C was identified grossly, and the tumor in part. F was only identified microscopically. These tumors are consistent with synchronous primary tumors,. and the tumor in part C will be used for the synoptic report. This case was shown to. and he agrees. SYNOPTIC REPORT - LUNG. Specimens Involved. Specimens: C: RIGHT LOWER LOBE WEDGE. Surgical Procedure: Lobectomy. Laterality: Right. Tumor Site: Lower lobe. Tumor Location: Peripheral. Tumor Size: Greatest diameter: 2.5cm. Additional dimensions: 1.8cm X 1cm. WHO CLASSIFICATION. Adenocarcinoma. Histologic Grade: G2: Moderately differentiated. Angiolymphatic Invasion: Absent. Bronchial Margins: Bronchial margins uninvolved. Visceral Pleural Involvement: Absent. Satellite Tumor(s). Absent. Lymph Node Involvement: N1: Ipsilateral Hilar and/or Peribronchial (levels 10-14). Negative 0/2. N2: Ipsilateral Mediastinal and/or Subcarinal (Levels 1-9). Negative 0/4. N3: Contralateral Mediastinal/Hilar, Scalene or Supraclavicular. N/A. Non-Neoplastic Lung: Emphysematous changes. Additional Pathologic Findings: None identified. Pathological Staging (pTNM): pT 1b. N 0. M X. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. GROSS DESCRIPTION: A. 4R RIGHT PARATRACHEAL LYMPH NODE. Received fresh labeled with the patient's identification and designated ""4R right paratracheal lymph. node"" is a fragment of tan-pink to anthracotic soft tissue measuring 1 X 0.5 and 0.2-cm. Specimen is. bisected. Touch preparation performed. Submitted entirely for frozen section, FSA. B. LEVEL 7 LYMPH NODE. Received fresh labeled with the patient's identification and designated ""level 7 lymph node"" is a. fragment of tan-pink soft tissue measuring 0.7 X 0.5 X 0.2 cm. Specimen is bisected. Touch. preparation performed. Submitted entirely for frozen section, FSB. C. RIGHT LOWER LOBE WEDGE. Received fresh labeled with the patient's identification and designated ""right lower lobe wedge"" is a. stapled wedge of lung tissue weighing 15 g and measuring 6.5 X 3 X 2 cm. The pleural surface inked. black, staple line inked blue. Sectioning shows a firm ill-defined tan mass measuring 2.5 X 1.8 x 1 cm,. located 0.5-cm from the stapled margin. A portion of the specimen is submitted for tissue procurement. The specimen representatively submitted: FSC1: Mass, frozen section sample. C2: Remainder of mass and pleural surface. C3: Uninvolved lung parenchyma. D. LEVEL 8 LYMPH NODE. Received in formalin labeled with the patient's identification and designated ""level 8 lymph node"" is a. fragment of yellow-tan soft tissue measuring 0.6 X 0.3 X 0.2 cm. Entirely submitted, D1. E. LEVEL 9 LYMPH NODE. Received in formalin labeled with the patient's identification and designated ""level 9 lymph node"" is a. fragment of red-tan soft tissue measuring 0.8 X 0.5 X 0.2 cm. Entirely submitted, E1. F. RIGHT LOWER LOBE. Received fresh labeled with the patient's identification and designated ""right lower lobe"" it the resected. lobectomy specimen weighing 182 g and measuring 13.5 X 11 X 3 cm. The pleural surface. demonstrates two 0.3-cm plaque like areas, both located approximately 4-cm from the bronchial margin. Sectioning shows deep red consolidated lung parenchyma. No lesions or nodules are grossly. appreciated. A portion of the specimen is submitted for tissue procurement. The specimen. is. representatively submitted: FSF1: Shaved bronchial margin. F2: Plaque like areas, entirely submitted. F3: Possible peribronchial lymph nodes. F4-F5: Random sections lung parenchyma. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Right lower lobe lung nodule."
BIOCUP_00061,colon,COAD,TCGA-CM-6674,TCGA-CM-6674.c889d318-6874-467a-ae2b-489622f32c7a,"Addendum. Clinical Diagnosis & History: Colonoscopy found nearly obstructing hepatic flexure colon cancer and. sigmoid cancer CT a scan shown mass at hepatic flexure colon previously. polypectomy at sigmoid colon. Hepatic flexure cancer and malignant polyp at. sigmoid. Specimens Submitted: 1: Total abdominal colectomy. 2: Proximal anastomotic ring. 3: Distal anastomotic ring. DIAGNOSIS: 1. Total abdominal colectomy. Tumor Type: Adenocarcinoma with mucinous features (<50% mucinous component). Histologic Grade: Moderately differentiated. Tumor Location: Hepatic flexure. Tumor Size: Length is 4 cm. Width is 5.5 cm. Maximal thickness is 0.4 cm. Tumor Budding: Absent. Increased Tumor Infiltrating Lymphocytes: Present. Precursor Lesions: Tubulovillous adenoma. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Not identified. Large Venous Invasion: Not Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Tattoo pigment is present consistent with the site of prior. procedure. Appendix: Unremarkable. Lymph Nodes: Number with metastasis: 0. Total number examined: 43. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : NO (No regional lymph node metastasis). Note: The results of immunohistochemical stains for mismatch repair proteins. will be reported in an addendum. 2. Ileum, proximal margin; resection: -Segment of small intestine with no pathologic diagnosis. Colon, distal margin; resection: -Segment of colon with no pathologic diagnosis. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. RECUT. Gross Description: 1.) The specimen is received fresh, labeled ""Total abdominal colectomy"" and. consists of a segment of terminal ileum, cecum with attached appendix and. colon. The terminal ileum measures 7 cm in length and 3 cm in circumference. at the proximal resected margin. The remaining colon measures 70 cm in. length with a circumference of 3.5 cm at the distal resected margin. The. attached appendix measures 5 cm in length and averages 0.5 cm in diameter. The appendiceal and intestinal serosa is pink tan and smooth. Focally. hemorrhagic lobulated yellow tan adipose tissue spans the length of the. specimen measuring up to 3 cm in thickness. The specimen is opened to. reveal a mass lesion measuring 4 cm in length and 5.5 cm in width. The mass. is located in the ascending colon, 18 cm from the proximal margin and 50 cm. from the distal margin. Sectioning shows that the tumor invades the. muscularis. The depth of invasion is 0.4 cm grossly. The remaining mucosa. shows numerous diverticula. NO gross lesion is identified in the sigmoid. colon. Two possible tattoo sites are present. One is 26 cm from the. proximal margin and the other is 30 cm from the distal margin. The attached. adipose tissue is thoroughly examined and all identified lymph nodes are. submitted. Representative sections of the specimen are submitted. Summary of sections: P - proximal margin shave. D - distal margin shave. T - tumor. A - appendix representative sections. RS -representative sections. LN - lymph nodes. BLN - bisected lymph nodes. ADD-tattoo sites. 2). The specimen is received in formalin wrapped around anastomotic tan. labeled ""Proximal anastomotic ring.' It consists of a ring of brown-tan. mucosa with attached soft tissue, sutures, and staples measuring 1.7 x 1.5. x. 1.0 cm. The mucosa is trimmed off and submitted entirely. Summary of sections: U - undesignated. 3) The specimen is received in formalin, labeled ""Distal anastomotic ring"". and consists of a ring of pink tan soft tissue measuring 3.0 x 1.8 x 1.7 cm. Multiple sutures and staples are attached. The mucosal surface is pink tan. and focally hemorrhagic. The sutures and staples are removed and the soft. tissue is entirely submitted. Summary of sections: U - undesignated. Summary of Sections: Part 1: Total abdominal colectomy. Block. Sect. Site. PCs. 1. A. 1. 3. ADD. 3. 6. BLN. 12. 1. D. 1. 10. LN. 30. 1. P. 1. 2. RS. 2. 6. T. 6. Part 2: Proximal anastomotic ring. Block. Sect. Site. PCs. 1. u. 1. Part 3: Distal anastomotic ring. Block. Sect. Site. PCs. 1. u. 1. Procedures/Addenda: Addendum. Addendum Diagnosis. Results of immunohistochemical staining for DNA mismatch repair proteins are. as follows: I1:Staining absent in tumor. MSH2:Staining present in tumor. MSH6:Staining present in tumor. PMS2. Staining absent in tumor. Conclusion: Immunohistochemical stains for mismatch repair proteins demonstrate loss of. expression on MLH1 and PMS2. MSH2 and MSH6 expression are preserved. These. results imply an underlying deficiency in DNA mismatch repair function. Clinical correlation is suggested. Addendum Comment."
BIOCUP_00062,colon,COAD,TCGA-AA-A01G,TCGA-AA-A01G.4E27D129-1AC8-4382-B77B-9F8545EFEBE1,"Sample ID #. 1. Diagnosis: Right hemicolectomy preparation with tumor-free resection margins and displaying an. ulcerated, moderately differentiated adenocarcinoma of the cecum, with some sections. showing more relatively marked production of mucus, with infiltration of the perimuscular. fatty tissue and without local lymph node metastases (G2, pT3 L0 V0 R0 pN0 0/22)."
BIOCUP_00063,colon,COAD,TCGA-AA-3854,TCGA-AA-3854.da5ac5a8-184c-4d2f-b0c4-5d2e8e3b7580,"Diagnosis: This is a mucinous adenocarcinoma in I) with infiltration of the muscularis and vessels (G3, pT2,. L1, V1) with free resection margins and free lymph nodes (locally R0, pNo, 0 of 12). in II) a free anastomosis ring. and in III) fragments of a serrated adenoma with focally severe chromatin disorders in the sense. of a high-risk type of."
BIOCUP_00064,colon,COAD,TCGA-AA-3678,TCGA-AA-3678.c37db00c-1ae4-44fb-94c0-6348aec56948,"Diagnosis: 1.: Colon resection material (sigmoid) with tumor-free, oral and aboral resection margins. includes an ulcerated, moderately differentiated adenocarcinoma with infiltration of the lamina. muscularis propria and solitary regional lymph node metastases (G2, pT2 pN1 1/26 L1, V0, RO). 2.: Inflammation-free small intestine or Meckel's diverticulum without evidence of tissue. heterotopy."
BIOCUP_00065,colon,COAD,TCGA-AA-3845,TCGA-AA-3845.afff68af-721b-4271-8c94-1c071bb75321,"Diagnosis: This is a poorly differentiated solid carcinoma in the ascending colon of histopathological. differentiation grade G3, with necrosis, with ulceration of the inner tumor surface, with. peritumorous chronic recurrent secondary inflammation with acute inflammatory activity,. with carcinomatous lymphangitis, with tumor infiltration of the layers of the colon wall. extending to the extramuscular subserous fatty connective tissue,. with tumor-free lymph nodes (0/12) and also. tumor-free overview slices from all other portions of the preparation described. No evidence of serous carcinosis. The tumor spread of the colon carcinoma according to the section preparations available. corresponds to a tumor stage of pT3, pNO (0/12), MX, L1, R0. Tumor classification: ICDO-DA M-8140/3, G3."
BIOCUP_00066,colon,COAD,TCGA-NH-A8F8,TCGA-NH-A8F8.0D65923F-583D-42C2-8CA3-0A209D5F0490,"RUN DATE. RUN TIME. RUN USER. LOC. AGE/SX: M. ROOM: REG DR: BED: DIS: SPEC # : RECD : PERFORMED. COLL: TIME IN FORMALIN: hrs. COLD ISCHEMA TIME: mins. CLINICAL INFORMATION: Pre-Op Diagnosis: Colon CA, R/O metastatic liver involvement. Remarks : Specimen (s) : A. Wedge biopsy liver. B. Right hemicolectomy. C. Wedge biopsy liver #2. MICROSCOPIC DIAGNOSIS. A. WEDGE BIOPSY LIVER #1 : METASTATIC COLONIC ADENOCARCINOMA PRESENT ON PERMANENT SECTION BUT NOT SEEN ON. FROZEN SECTION. B. PORTION RIGHT COLON, PORTION TERMINAL ILEUM AND APPENDIX, RIGHT HEMICOLECTOMY: ADENOCARCINOMA OF ASCENDING COLON. LOW GRADE. TUMOR MEASURES 5 CM AND PENETRATES VISCERAL PERITONEUM. SURGICAL MARGINS FREE OF TUMOR WITH NEAREST MARGIN 8 CM FROM TUMOR, RADIAL AND. PROXIMAL. METASTATIC ADENOCARCINOMA PRESENT IN 15 OF 22 REGIONAL LYMPH NODES WITH. EXTRACAPSULAR EXTENSION. SEE COMMENT FOR SYNOPTIC REPORT. C. WEDGE BIOPSY LIVER #2: METASTATIC COLONIC ADENOCARCINOMA. COMMENT(S). SURGICAL PATHOLOGY CANCER CASE SUMMARY - CAP APPROVED. Specimen: Terminal ileum. cecum. appendix. ascending colon. Procedure: Right hemicolectomy. Tumor Site: Right (ascending) colon. Tumor Size: 5 cm in greatest dimension. Macroscopic Tumor Perforation: Not identified. Histologic Type. Adenocarcinoma. Histologic Grade: Low-grade. Microscopic Tumor Extension. Tumor penetrates to the surface of the visceral. peritoneum (serosa). Margins: Distance of invasive carcinoma from closest margin: 8cm. RUN DATE. RUN TIME. RUN USER. SPEC #: COMMENT (s). Specify Margin: Proximal and radial. Treatment Effect: No prior treatment. Lymph-Vascular Invasion. Present. Perineural Invasion. Not identified. Tumor Deposits: Present. Pathologic Staging: Primary Tumor: pT4a. Regional Lymph Nodes : pN2b. Number examined : 22. Number involved : 15. Distant Metastasis: pM1; liver. GROSS DESCRIPTION: The specimen is received in the fresh state from the operating room in three parts. A. This is a piece of tan tissue measuring 10 x 10 X 2 mm. totally examined by frozen. section as block A1. B. This specimen, received in the fresh state from the operating room for immediate gross. evaluation for evaluation of surgical margins and tumor banking is a right nemicolectomy. specimen. The colon measures 24 cm in length by 6 cm in maximum diameter the terminal. ileum measures 6 cm in length by 2 cm in diameter: the appendix measures 7 x 0. 8 cm. Present in the ascending colon is a circumferential, tan tumor which measures 5 x 5 x 5 cm. located 8 cm from the radial margin, 8 cm from the proximal margin. and 12 cm from the. distal margin. Tissue of the overlying visceral peritoneum is puckered suggestive of. visceral peritoneal penetration. Blue ink is applied to these regions Regional adipose. tissue attached to the specimen measures 15 x 13 x 3 cm. A representative section of the. tumor is submitted for tumor banking. Multiple regional lymph nodes are positive for. metastatic tumor. the largest measuring 1.5 cm in greatest dimension and exhibiting. extracapsular extension of the tumor The following sections are submitted. B1. appendix and proximal margin. B2. distal margin. B3-6 -. colon mass with blue ink on abnormal visceral peritoneum. B7. colon mass. B8,9 -. whole lymph nodes. B10-12-. representative sections of positive lymph nodes. C. This is a wedge biopsy of liver measuring 1 x 1 x 0.5 cm. Portions of the tissue. appear to be replaced by tumor √Ä representative section is examined by frozen section as. block C1. All remaining tissue is submitted as block C2. INTRAOPERATIVE CONSULTATION: A. FROZEN SECTION DIAGNOSIS WEDGE BIOPSY LIVER #1: FIBROSIS. B. IMMEDIATE GROSS EVALUATION RIGHT HEMICOLECTOMY. RUN DATE : RUN TIME : RUN USER. SPEC #. INTRAOPERATIVE CONSULTATION : (Continued). ADENOCARCINOMA. SURGICAL MARGINS FREE OF TUMOR. SPECIMEN PROCESSED FOR TUMOR BANKING. C. FROZEN SECTION DIAGNOSIS WEDGE BIOPSY LIVER #2: METASTATIC ADENOCARCINOMA. PHOTO DOCUMENTATION. Image. Picture Copy Error. Image. Picture Copy Error. Image. Picture Copy Error. Image. Picture Copy Error. Image. Picture Copy Error. (signature on file)."
BIOCUP_00067,colon,COAD,TCGA-CM-6676,TCGA-CM-6676.1d53f325-f6f5-474e-9b52-0b45aef1dff8,"Clinical Diagnosis & History: year old male 5 cm mass seen in descending colon on colonoscopy 45 cm. from anal verge. Specimens Submitted: 1: Sigmoid colon; resection. 2: Distal ring. 3: Proximal ring. DIAGNOSIS: 1. Sigmoid colon; resection: Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Sigmoid colon. Tumor Size: Length is 2.5 cm. Width is 2.0 cm. Maximal thickness is 1.5 cm. Tumor Budding: Focal. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Tubular adenoma. Deepest Tumor Invasion: Muscularis propria. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Not identified. Large Venous Invasion: Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Lymph Nodes: Total number examined: 17. One lymph node contains metastatic carcinoma, consistent with. prostatic origin, see comment. Tumor Staging (AJCC 7th Edition) : pT2 (Tumor invades muscularis propria). Lymph Node Stage (AJCC 7th Edition) : NO (No regional lymph node metastasis). Comment: immunohistochemical stains show that the tumor cells in the. lymph node are positive for PSA, while negative for CK7, CK20, CDX-2, TTF-1,. chromogranin, and synaptophysin, consistent with a prostate origin. 2. Colon, distal ring; excision: -Benign colonic tissue with hyperplastic changes. 3. Colon, proximal ring; excision: -Benign colonic tissue. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. RECUT. Gross Description: 1) The specimen is received fresh and is labeled ""sigmoid colon"". It. consists of an unoriented segment of sigmoid colon that measures 26 x 6 cm. The serosal surface is unremarkable. The radial resection margin is inked. black and the specimen is opened to reveal a polypoid tumor that is located. 2.4 cm from one margin and 21 cm from the opposite margin. The tumor. measures 2.5 cm in length and 2 cm in width. Serial sectioning reveals that. the tumor maximum thickness is 1.5 cm. The remaining mucosa is unremarkable. Pericolic adipose tissue spans the entire length of the specimen with a. maximum thickness of 12 cm. It is submitted for lymph node dissection and. thoroughly examined for lymph nodes, and all possible nodes are submitted. Representative sections are submitted. TPS is submitted. Summary of sections: M1 - margin closer to the tumor. M2 - margin farther from the tumor. T - tumor. U - uninvolved mucosa. LN - lymph nodes. BLN - bisected lymph node. 2) The specimen is received in formalin, labeled ""distal ring"" and consists. of a ring of pink tan soft tissue measuring 2.5 x 1.8 x 1.3 cm. Multiple. sutures and staples are attached. The mucosal surface is pink tan and. focally hemorrhagic. The sutures and staples are removed, and the soft. tissue is entirely submitted. Summary of sections: U - undesignated. 3) The specimen is received in formalin, labeled ""proximal ring"" and. consists of a ring of pink tan soft tissue measuring 2.0 x 1.8 x 1.4 cm. Multiple sutures and staples are attached. The mucosal surface is pink tan. and focally hemorrhagic. The sutures and staples are removed, and the soft. tissue is entirely submitted. Summary of sections: U - undesignated. Summary of Sections: Part 1: Sigmoid colon; resection. Block. Sect. Site. PCs. 6. LN. 16. 1. M1. 1. 1. M2. 2. 4. T. 4. 1. U. 1. Part 2: Distal ring. Block. Sect. Site. PCs. 2. U. 0. Part 3: Proximal ring. Block. Sect. Site. PCs. 2. U. 0."
BIOCUP_00068,colon,COAD,TCGA-AD-6965,TCGA-AD-6965.af7b6e8c-cce1-4d7e-884c-5475d6182eb2,"Pre-Op Diagnosis. Nothing indicated. Post-Op Diagnosis. Nothing indicated. Clinical History. Nothing indicated. Gross Description: Received in a single container labeled. - right colon"". is a previously opened portion of large bowel including cecum, as. well as cm of previously opened portion of terminal ileum. The. specimen is received after formalin fixation and shows the large. bowel to measure 20.6 cm and the ileum to be 9.4 cm. The specimen is. covered by a moderate amount of pericolic and epiploic adipose. tissue in which an 8.0 x 0.6 x 0.6 cm grossly unremarkable vermiform. appendix is identified. The visible serosa is shaggy gray tan to. brown. The wall is up to 0.6 cm edematous and fibrotic. The lumen. is lined by gray-tan mucosa with preservation of intestinal folds. Noted within the cecal pouch extending to the ileocecal valve is a. 4.6 X 3.0 cm centrally ulcerated finely granular tan-gray to pink. lesion with raised rolled borders. This is stated during specimen. opening to be noted at its nearest point 26 cm from the distal. margin and 14 cm from the proximal margin. This has a gritty gray. tan fibrotic cut surface measuring up to 1.9 cm in thickness. This. grossly extends focally through the muscularis into the surrounding. adipose tissue where it is seen at its nearest point 0.7 cm from the. nearest outer margin. In addition, in one area the lesion. umbilicates to the serosa and grossly appears to extend through the. serosa. No other gross lesions are identified. On sectioning, the. surrounding adipose tissue shows several well defined and poorly. defined gray tan nodules measuring up to 1.2 cm in greatest. dimension. The largest nodules have fibrotic necrotic cut surfaces. Also received in the same container are three tissue cassettes each. labeled. Representative sections are submitted. labeled as follows: A - proximal margin; B - distal margin; C-. ileocecal valve; D-G - representative lesion and surrounding tissue;. H - random uninvolved bowel; I - appendix; J-L - representative. sections of grossly positive nodules; M-N - whole smaller pericolic. nodules. Microscopic Description: The slides labeled fare examined. See diagnosis. Final Diagnosis. Distal ileum and right colon (right hemicolectomy): Distal ileum: No pathologic diagnosis. PAS 1. Right colon: Tumor characteristics: Histologic type: Adenocarcinoma. Location of tumor: Cecal pouch. Size: 4.6 X 3.0 cm in greatest dimension. Grade: Moderately differentiated. Lymphovascular space invasion: Yes. Perforation of Visceral peritoneum: Yes (see comment). Presence of mesenteric deposits: No. Depth of invasion: Carcinoma extends through muscularis propria. into subserosal adipose tissue and focally perforates visceral. peritoneum to involve serosal surface focally. Surgical Margin Status: Proximal Margin: No carcinoma identified. Distal Margin: No carcinoma identified. Deep Radial Margin: Carcinoma focally perforated visceral. peritoneum to involve serosal surface focally (see comment). Distance of tumor from closet margin: See above diagnoses. Lymph Node Status: Total number of lymph nodes examined: 17. Total number of lymph nodes with metastatic carcinoma: 11. (11/17) PAS 9. Appendix: Fibrous obliteration of the luminal tip, no carcinoma identified. PAS 4 SPC-A. CPT: 88309. Stage: pT4aN2bVL (see comment). Comments. Grossly in one area, the lesion umbilicated to the serosa and. grossly appears to extend through the serosa. Microscopically,. carcinoma is present focally extending through the visceral. peritoneum to focally involve the serosal surface. Therefore, this. is staged as pT4a. Eleven of 17 lymph nodes demonstrate metastatic. carcinoma. Some of the nodes are completely replaced by carcinoma. with no residual nodal tissue identified. These are counted as lymph. nodes totally replaced by tumor. Therefore, this is staged as a. pN2b. In addition, lymphovascular space invasion is identified and. the additional classifications of VL are therefore used. The final. stage should be performed in conjunction with knowledge of the. clinical stage. At the request of the undersigned pathologist, these slides have. been additionally reviewed by Dr. who concurs with the. diagnosis."
BIOCUP_00069,colon,COAD,TCGA-AA-3530,TCGA-AA-3530.76035d5d-d2bb-4616-a9a2-5794a6f1373d,"Diagnosis/Diagnoses: 1. Sections of a polypoid neoplasm of the colonic mucosa with the structure of a tubular. adenoma with high-grade dysplasia or transition to at least intramucosal adenocarcinoma in situ. (synonym according to WHO: high-grade intra-epithelial neoplasia, according to IUCC: pTis). 2.: Small, or only small portions of, tubular adenomas of the colonic mucosa with slight. dysplasia (synonym: low-grade intra-epithelial neoplasia). 3.: Tubular adenoma of the colonic mucosa with high-grade dysplasia and transition to an. intramucosal adenocarcinoma (synonym according to WHO: high-grade intra-epithelial. neoplasia, according to IUCC: pTis). In 1. and 3., no detectable transition to a manifest, deeper colon carcinoma infiltrating the wall. layers. Complete tumor resection - where not already done - is recommended. Diagnosis/Diagnoses. Right hemicolectomy specimen with an ulcerated colon carcinoma in the area of the cecal pole. measuring 4 cm in the largest diameter and displacing the appendiceal orifice, arising from a. tubulovillous adenoma with severe epithelial dysplasia (synonym: high-grade intra-epithelial. neoplasia). Invasive tumor spread as far as the muscularis propria. Appendix with formation of. an obstructive type of mucocele and with persistent or florid chronic appendicitis and. perityphlitis. Oral and aboral resection margin and greater omentum tumor-free. Twenty-four mesocolic and mesenteric lymph nodes tumor-free and with uncharacteristically. reactive changes. Tumor stage therefore pT2 pNO (0/24) L0 V0; G2."
BIOCUP_00070,colon,READ,TCGA-EI-6882,TCGA-EI-6882.660bcaed-4c60-4a2f-aa60-0f0356fb0cf9,"page 1 / 1. copy No. 1. Examination: Histopathological examination. Material: Multiple organ resection - segment of the large intestine. Expected time of examination: Clinical diagnosis: Cancer of the rectosigmoid junction. Macroscopic description: A 21 cm length of the large intestine with a 3 cm mesorectum tissue. A cauliflower-shaped tumour sized 5.7 X 5.2 x 1 cm found in. the mucosa. The lesion surrounding 90% of the intestine circumference, is removed by 13.5 cm from the proximal line and 2.1 cm. from the distal line. Minimum side margin is 3 cm. Microscopic description: Adenocarcinoma tubulornpillare partim mucinosum (G3). Infiltratio carcinomatosa tunicae muscularispropriac et telae adipos. mesorecti. Incision lines free of neoplastic lesions. Lymplionodulitis reaefi (No XXI). Histopathological diagnosis: Adenocarcinoma tubulopapilare partim mucinosum recti. Tubulopapillar and partially mucinous adenocarcinoma of. the rectum. (G3, Dukes B, Astler-Coller B2, pT3, pNO, RO)."
BIOCUP_00071,colon,COAD,TCGA-AA-3532,TCGA-AA-3532.82516932-0618-4e40-9b7f-bcc09639e261,"Diagnosis / Diagnoses: Resectate of the colon under inclusion of a moderately differentiated adenocarcinoma of. the colorectal type, of maximum 2.5 cm in size, with infiltration of the pericolic fatty. tissue. Tumor-free regional lymph nodes. Tumor-free mesenteric resection margin. Tumor-free large intestinal resection margins. Tumor stage: pT3 pNO (0/35) pMX; G2, L0, V0, locally R0."
BIOCUP_00072,colon,READ,TCGA-CI-6620,TCGA-CI-6620.103605fa-bfbe-49b0-afea-3f8b60a3f2a2,"PATIENT HISTORY. The patient is a. female. Date of Event. PRE-OP DIAGNOSIS: Blood in stool. POST-OP DIAGNOSIS: Rectal mass. PROCEDURE: Not provided. FINAL DIAGNOSIS: RECTUM, MASS, BIOPSY. INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA INVOLVING COLONIC MUCOSA."
BIOCUP_00073,colon,READ,TCGA-DC-6155,TCGA-DC-6155.09a1a795-a160-47ac-bba2-266765cc1184,"Addendum. Clinical Diagnosis & History: with rectosigmoid cancer. Specimens Submitted: 1: SP: Sigmoid and upper rectum open end proximal. 2: SP: Distal ring margin. 3: SP: Proximal ring margin. DIAGNOSIS: 1. SP: Sigmoid and upper rectum open end proximal: Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Rectosigmoid. Tumor Size: Length is 1.5 cm. Width is 1.3 cm. Maximal thickness is 0.2 cm. Tumor Budding: Absent. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Tubulovillous adenoma. Deepest Tumor Invasion: Muscularis propria. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Identified. Large Venous Invasion: Not Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. 4.5cm from distal resection margin. 1.5 cm between deepest tumor portion and deep (radial soft tissue). margin. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Lymph Nodes: Number with metastasis: 3. Total number examined: 31. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC. pT2 (Tumor invades muscularis propria). Lymph Node Stage (AJCC. N1b (Metastasis in 2-3 regional lymph nodes). Comment: The results of immunohistochemical stains for mismatch repair. proteins will be reported in an addendum. 2. RECTUM, DISTAL MARGIN; RESECTION: -SEGMENT OF RECTUM WITH NO PATHOLOGIC DIAGNOSIS. 3. COLON, PROXIMAL MARGIN; RESECTION: -SEGMENT OF COLON WITH NO PATHOLOGIC DIAGNOSIS. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Out. Gross Description: 1. The specimen is received fresh and is labeled ""sigmoid and upper rectum"". It consists of a rectosigmoid colon that measures 15.5 cm in length and. 5.4. cm in circumference. The open end indicates the proximal margin. The serosal. surface is intact and grossly unremarkable. The radial resection margin is. inked black and the specimen is opened to reveal a tumor that is located 9. cm from the proximal margin and 4.5 Cm from the distal margin. The tumor. measures 1.5 Cm in length and 1.3 Cm in width. Serial sectioning reveals. tumor invasion to a depth of 0.2 Cm, which is 1.5 Cm from the closest radial. margin. The remaining mucosa is unremarkable. Pericolic and peri-rectal. adipose tissue is thoroughly examined for lymph nodes, and all possible. nodes are submitted. Representative sections are submitted. TPS is. submitted. Summary of sections: PM - proximal margin. DM - distal margin. RM - radial margin. T - tumor. U - uninvolved mucosa. LN - lymph nodes. BLN - bisected lymph node. 2) The specimen is received in formalin, labeled ""Distal ring margin"" and. consists of a ring of pink tan soft tissue measuring 2.5 x 2.0 x 1.5 cm. Multiple sutures and staples are attached. The mucosal surface is pink tan. and focally hemorrhagic. The sutures and staples are removed and the soft. tissue is entirely submitted. Summary of sections: U - undesignated. 3). The specimen is received in formalin, labeled ""Proximal ring margin"" and. consists of a ring of pink tan soft tissue measuring 1.7 x 1.7 x 1.1 cm. Multiple sutures and staples are attached. The mucosal surface is pink tan. and focally hemorrhagic. The sutures and staples are removed and the soft. tissue is entirely submitted. Summary of sections: U - undesignated. Summary of Sections: Part 1: SP: Sigmoid and upper rectum open end proximal. Block. Sect. Site. PCs. 1. dm. 1. 7. LN. 28. 1. pm. 1. 1. rm. 1. 7. t. 7. 2. u. 2. Part 2: SP: Distal ring margin. Block. Sect. Site. PCs. 1. U. 1. Part 3: SP: Proximal ring margin. Block. Sect. Site. PCs. 1. U. 1. Procedures/Addenda. Addendum. Addendum Diagnosis. Results of immunohistochemical staining for DNA mismatch repair proteins are. as follows: MLH1: Staining present in tumor. MSH2: Staining present in tumor. MSH6: Staining present in tumor. PMS2: Staining present in tumor. Conclusion: Immunohistochemical staining for the tested DNA mismatch repair. proteins is retained in the tumor."
BIOCUP_00074,colon,COAD,TCGA-AY-6386,TCGA-AY-6386.42afbc8e-3c33-4e57-b9ff-68bcaa3efa94,"Diagnosis: Colon, right, colectomy. Tumor Histologic Type: Invasive adenocarcinoma with mucinous features. Histologic Grade: Moderately differentiated. Tumor Location: Cecum with extension into ileocecal valve. Depth of Invasion: Through muscularis propria into the pericolic soft tissue. Lymphovascular Invasion: Not identified. Perineural Invasion: Not identified. Margins: Proximal margin: Negative, 4 cm from tumor. Distal margin: Negative, 8 cm from tumor. Circumferential (radial) margin (rectal tumors only): Not applicable. Mesenteric margin: Negative, 8 cm from tumor. Distance of carcinoma from closest margin (specify): 4 cm to proximal. Regional Lymph Nodes: Total number with metastasis: 1. Total number examined: 19. Additional pathologic findings: Focal abscess formation adjacent to tumor. AJCC PATHOLOGIC TNM STAGE: pT3 pN1a. Note: This pathologic stage assessment is based on information available at the time of this report, and is subject to change pending. clinical review and additional information. Comment: Multiple enlarged lymph nodes without carcinoma were identified. These lymph nodes contained numerous follicles that appeared. reactive. However, due to the large size of the lymph nodes, the number of follicles, and the patient's age, immunostains for BCL2,. CD3 and CD20 were performed to exclude follicular or another low grade lymphoma. These stains reveal a benign reactive pattern. with no evidence of lymphoma. Clinical History: cecal cancer. Gross Description: Specimen fixation: formalin. Parts of bowel received: terminal ileum, cecum and ascending colon with attached fat. Specimen length: The terminal ileum is 4.5 cm in length and the large bowel is 12 cm in length. Orientation: The cecal pouch where the tumor is inked blue. Tumor dimensions: 6.5 X 4.7 X 1.3 cm with a mucinous cut surface. Gross appearance of tumor: Central cratered ulcer with raised rolled borders, broad based configuration. Circumferential growth: n/a; in cecal pouch. Gross depth of invasion: through the muscularis propria and into the subjacent fat of the cecum. Gross evidence of perforation through visceral peritoneum: no. Luminal obstruction: no. Bowel circumference at tumor site: n/a (in cecal pouch). Gross distance of tumor from margins: The tumor is located 4 cm from the proximal margin, 8 cm from the distal margin, 8 cm from. the radial mesenteric margin and focally abuts the deep blue inked serosa. Lymph nodes: submitted as per block summary. Other remarkable findings: The remaining mucosa is velvety tan, and grossly unremarkable. The wall has a uniform thickness of. 0.3 cm. No appendix is grossly identified. The mass focally extends onto the ileocecal valve. Tissue submitted for special investigation: Tumor and normal are given to Tissue Procurement. Digital photograph taken: no. Block Summary: A1 - en face proximal margin. A2 - en face distal margin. A3 - en face radial mesenteric margin. A4 - one lymph node candidate, bisected at radial mesenteric margin. A5-A8 - full thickness sections of tumor to include relationship to inked. serosa and subjacent fat. A9 - tumor spanning ileocecal junction. Lymph node candidates measuring up to 2 cm in greatest dimension are identified. A10 - four lymph node candidates. A11 - three lymph node candidates. A12 - one lymph node candidate, trisected. A13-A14 - one lymph node candidate, sectioned (largest). A15 - two lymph node candidates. A16-A19 - one lymph node candidate, serially sectioned. A20 - six lymph node candidates. A21 - two lymph node candidates. Light Microscopy: Light microscopic examination is performed by Dr. For cases in which immunostains are performed, the following applies: Appropriate internal and/or external positive and negative controls have been evaluated. Some of the immunohistochemical. reagents used in this case may be classified as analyte specific reagents (ASR). These were developed and have performance. characteristics determined by the. These reagents have not. been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research. This. laboratory is certified under the Clinical Laboratory Improvement Amendments of. as qualified to perform high. complexity clinical laboratory testing. Attending Pathologist: I have personally conducted the evaluation of the above specimens and have rendered the above. diagnosis(es)."
BIOCUP_00075,colon,COAD,TCGA-AA-3862,TCGA-AA-3862.422e955e-99a6-42be-9cd9-0d67f6909c11,"Diagnosis: This is a right-sided hemicolectomy preparation with a moderately differentiated. adenocarcinoma (in the ascending colon) of histopathological differentiation grade G2, with. erosions of the inner tumor surface, with carcinomatous lymphangitis, with tumor infiltration of. the colon wall layers into the pericolic fatty connective tissue with peritumorous chronic. recurrent secondary inflammation with an acute inflammatory flare, with focal extracellular. mucus formation in the tumor tissue, with tumor-free lymph nodes (0/16) with a moderate. chronic lymphadenitis and with tumor-free overview slices from all other resection material. portions described. There is also a chronic appendicitis. According to the section preparations available, the tumor spread of the colon carcinoma. corresponds to a tumor stage of pT3, pNO (0/16), MX, L1, R0. Tumor classification: ICDO-DA-M. 8140/3, G2. 11+."
BIOCUP_00076,colon,COAD,TCGA-AU-6004,TCGA-AU-6004.28578993-a474-4afb-93b6-46665b90e1b2,"SURGICAL. OOPHORECTOMY-BI, COLECTOMY-RIGHT. GROSS DESCRTPTTON. A. The specimen is submitted fresh as ""right colon"" and consists of a. segment of large bowel removed in continuity with cecum and terminal. ileum. The proximal and distal margins are joined with a line of. metallic staples. The ileal segment measures 4.5 cm in length and 1.5 am. in diameter at the partially stapled proximal margin. The colonic segment. including cecum measures 13 cm in length and 2 cm in diameter at the. partially stapled distal margin. The serosa is pink with a scant amount. of membranous adhesions and a moderate amount of pericolic fat. There is. puckered 2.5 cm area at the cecal pouch. The vermiform appendix is not. ,rossly identified. The lumen contains a small amount of hemorrhagic. fecal material. The mucosal surfaces are pink tan with the usual folds. and a large nodular 6.5 x 3.5 x 2.5 cm tumor which fills the cecal pouch. The tumor is firmly fixed to the underlying muscularis and corresponds to. the puckering previously described. The radial mesenteric margin measures. 9. cm in length. Sectioning reveals the tumor to infiltrate nearly the. entire thickness of the bowel wall approaching 0.1 cm of the inked (black). serosa. There are two small sessile tan 0.2 cm nodules at a distance of. 11 and 5 cm from the distal margin of resection. Also noted is a 0.6 can. area of submucosal hemorrhage at a distance of 3 cm from the distal. margin. Examination of the attached adipose tissue reveals sixteen. moderately firm to firm pink and pale white nodules ranging 0.3 to 1.5 cm. in greatest dimension. Representative sections are submitted, multiple. (10) labeled as follows: Cassette 1: Margins (proximal margin green dye, distal margin. blue dye). Cassettes 2-5: Tumor (deep margin black). Cassette 6: Sessile polyp. Cassette 7: Submucosal hemorrhage. Cassettes 8-10: Nodules found in the attached pericolic fat. Please note: A portion of tissue is collected for TCGA studies. B. The specimen is submitted fresh as ""right ovary"" and consists of a. segment of fallopian tube with attached ovary. The. fallopian tube includes the fimbria and measures 3 cm in length and 0.3 cm. in diameter. There is a 0.4 cm plastic ligation ring at the proximal. margin. The lumen is patent. The ovary measures 3 x 3 x 3 cm. The. external surface is yellow white and lobulated. Sectioning reveals. multiple serous cysts with a smooth lining ranging 0.3 to 1.5 cm in. greatest dimension and a firm 2 cm pink white whorled nodule. Representative sections are submitted, 9 (6) labeled ""1"" to ""6"". C. The specimen is submitted fresh as ""left ovary"" and consists of a. segment of fallopian tube with attached ovary. The. fallopian tube is stretched across the ovarian surface and includes the. fimbria measuring 6 CIL in length and 0.3 cm in diameter. The ovary. measures 6.5 x 5 x 3.5 cm. The external surface is pink to yellow tan and. lobulated with membranous adhesions. Sectioning reveals a multiloculated. serous cyst with a smooth lining and a small 0.7 cm area of tan papillary. projections. Representative sections are submitted, multiple (6) labeled. ""1"" to ""6"". FINAL DIAGNOSIS. RIGHT COLON (HEMICOLECTOMY) : MODERATELY DIFEERENTIATED ADENOCARCINOMA ARISING IN A TUBULO-. VILLOUS ADENOMA (6.5 CM). TUMOR INVADES INTO BUT NOT ENTIRELY THROUGH MUSCULARIS PROPRIA. WITH EXTENSION TO 0.2 CM FROM ANTIMESENTERIC SEROSAL SURFACE. SEE COMMENT. RADIAL MESENTERIC MARGIN MEASURES 9 CM. SEPARATE TUBULAR ADENOMATA ARE IDENTIFIED AT 5 AND 11 CM FROM. DISTAL MARGIN OF RESECTION (0.2 CM EACH) -. ALL SURGICAL MARGINS AND SIXTEEN REGIONAL LYMPH NODES, NEGATIVE. FOR TUMOR. PATHOLOGIC STAGE: pT2 NO MX. COMMENT: IN REGION OF MAXIMUM TUMOR DEPTH, THE MUSCULARIS PROPRIA IS. DISRUPTED BY FIBROUS TISSUE REACTION. TUMOR DOES NOT EXTEND BEYOND. MUSCULAR PLANE AND DOES NOT INVOLVE PERICOLONIC ADIPOSE TISSUE. INTRADEPARIMENTTAL REVIEW: B. RIGHT OVARY, FALLOPIAN TUBE (SALPINGO-OOPHORECTOMY) : BENIGN CYST-. ADENOFIBROMA (2 CM), NEGATIVE FOR ATYPIA, SURFACE EPITHELIAL. PROLIFERATION, OR FEATURES OF MALIGNANCY. PREVIOUSLY LIGATED. FALLOPIAN TUBE WITH FIBROTIC FIMBRIAE. C. LEFT OVARY, FALLOPIAN TUBE (SALPINGO-OOPHORECTOMY) : BENIGN CYST-. ADENOFIBROMA (6.5 CM), NEGATIVE FOR ATYPIA, SURFACE EPITHELIAL. PROLIFERATION, OR FEATURES OF MALIGNANCY. HISTOLOGICALLY. UNREMARKABIE FALLOPIAN TUBE. SYNOPTIC REPORT. SYNOPTIC REPORT: COLON AND RECTUM. (CAP/AJCC/ACS - REQUIRED ELEMENTS). SPECIMEN TYPE: RIGHT HEMICOLECTOMY. SPECIMEN SIZE: 17.5 CM. TUMOR SITE: CECUM. TUMOR SIZE: 6.5 CM. MACROSCOPIC TUMOR PERFORATION: PRESENT. HISTOLOGIC TYPE: ADENOCARCINOMA. HISTOLOGIC GRADE: MODERATE. EXTENT OF INVASION: INTO BUT NOT THROUGH MUSCULARIS PROPRIA. OTHER ORGANS INVOLVED/VISCERAI PERITONEUM: NONE. PROXIMAL: UNINVOLVED. DISTAL: UNINVOLVED. RADIAL: UNINVOLVEDff. LENGTH OF RADIAL MARGIN: 9 CM. (IF MARGINS UNINVOLVED, DISTANCE TO CLOSEST MARGIN:) 0.2 CM FROM. SEROSAL SURFACE. NEOADJUVANT TREATMENT EFFECT: NOT APPLICABLE. LYMPHATIC INVOLVEMENT: ABSENT. VENOUS (LARGE VESSEL) INVOLVEMENT : ABSENT. PERINEURAL INVASION: ABSENT. TUMOR DEPOSITS (DISCONTINUOUS EXTRAMURAL EXTENSION) : ABSENT. LYMPH NODES: , #INVOLVED/#EXAMINED: 0/16. OTHER PERTINENT FINDINGS: (SEE NARRATIVE). PTNM STAGE: pT2 NO MX."
BIOCUP_00077,colon,COAD,TCGA-AA-3947,TCGA-AA-3947.b9614eb3-7a7f-4737-8e48-c13564ee1a4c,"Diagnosis: Resected ileocolic section with an ulcerated colon carcinoma characterized histologically. as a moderately differentiated, partly mucinous rectal adenocarcinoma, located 3 cm. aborally to Bauhin's valve, encircling the intestinal wall at a length of 12 cm. Invasive. spreadi of the tumor within all intestinal walls up to the bordering subserous connective. tissue and mesocolic fatty tissue. Continuing infiltration to an angular colon section. adhering to the tumor. In addition, colon mucous membrane with five sessile serrated. adenomas. The tumor stage is therefore: pT4 pNO (0/22) L0, V0; G2 R0."
BIOCUP_00078,colon,COAD,TCGA-CK-4947,TCGA-CK-4947.a9e32496-0ecb-4c68-963c-ff8fe4aaa62e,"Report Status: Final. Type: Surgical Pathology. COLON, SEGMENTAL RESECT FOR TUMOR. DIAGNOSIS: SPECIMEN LABELED ""SIGMOID COLON (14.5 cm) "": ADENOCARCINOMA OF THE COLON, moderately differentiated. (4.0 cm in greatest dimension). The tumor invades through the muscularis propria into pericolonic. adipose tissue and is present at the serosal surface. Lymphovascular invasion is not present. Non-neoplastic colonic mucosa with no significant pathologic change. Proximal resection margin is free of carcinoma. METASTATIC CARCINOMA in three (3) of twelve (12) lymph nodes. SPECIMEN LABELED ""DISTAL COLON WITH MARGIN"": Distal resection margin is free of carcinoma. AJCC staging: T4 N1 Mx. CLINICAL DATA: History: Colon CA invading L ureter for palliative resection. Operation: Sigmoid colectomy, left ureterolysis - frozen section. Clinical Diagnosis: Sigmoid colon cancer, left ureteral stricture. TISSUE SUBMITTED: 1. Sigmoid colon - open end is distal. 2. Distal colon with margin. O.R. CONSULTATION: SPECIMEN LABELED ""1) SIGMOID COLON - OPEN END IS DISTAL"" (GROSS ONLY) : Circumferential lesion consistent with adenocarcinoma. The proximal and distal margins are free of carcinoma. GROSS DESCRIPTION: The specimen is received in two separate containers, each labeled with the. patient's name and medical record number. Part one is designated ""sigmoid colon open end is distal"". The specimen. consists of a single segment of colon (14.5 cm length x 3 cm diameter) with. attached fat and mesentery (6.5 cm in maximum diameter) . Distal resection. margin is 2.3 cm. Proximal resection margin is 2.2 cm. There is a. circumferential mass that measures 4 x 3 x 1.8 cm, appears grossly to invade. through full thickness and causes serosal puckering. This mass is present 4.5. cm to distal resection margin and 4 cm to proximal resection margin. Representative sections are taken for tumor bank. Representative sections are. submitted for histologic evaluation. Micro 1-3: tumor at area of deepest invasion, 3 frags,. Micro 4: tumor towards distal margin, 1 frag,. Micro 5: tumor towards proximal resection margin, 1 frag,. Micro 6: proximal resection margin, en face, 2 frags,. Micro 7: distal resection margin, 1 frag,. Micro 8: 3 potential lymph nodes, 3 frags,. Micro 9: 4 potential lymph nodes, 4 frags,. Part two, received designated ""distal colon with margin"". The specimen. consists of a single portion of colon (1 cm length x 3 cm diameter) . Stapled. resection margin measures 4 cm in length. Resection margin is inked in black. Micro 10: stapled resection margin, en face, 2 frags,. Reports to: SPECIMEN TYPE: COLON, SEGMENTAL RESECT FOR TUMOR. ADDITIONAL SPECIMEN TYPE: SURGICAL MARGIN. Page: 1 of I. IT. IT. 1. 2."
BIOCUP_00079,colon,READ,TCGA-DC-4745,TCGA-DC-4745.04b9416d-3de4-48ac-83eb-b18931c3c995,"Addendum. Clinical Diagnosis & History: Rectosigmoid adenocarcinoma,. Specimens Submitted: 1: SP; Sigmoid and upper rectum. 2: SP: Proximal anastomotic ring. 3: SP: Distal anastomotic ring. DIAGNOSIS: 1). SIGNOID AND UPPER RECTUM; PARTIAL COLECTOMY: INVASIVE ADENOCARCINOMA, MODERATELY DIFFERENTIATED. TUMOR LOCATION: RECTOSIGMOID. - TUMOR SIZE, LENGTH IS 3 CM, WIDTH IS 3 CM AND MAXIMAL THICKNESS IS 0.6 CM. - PREEXISTING POLYP (AT THE SITE OF THE CARCINOMA) : NOT IDENTIFIED. - TUMOR INVASION: INVASION INTO SUBSEROSA. - SEROSAL INVOLVEMENT: NOT IDENTIFIED,. - VASCULAR INVASION: NOT IDENTIFIED,. - PERINEURAL INVASION: NOT IDENTIFIED. - SURGICAL MARGINS: FREE OF TUMOR, 3 CM PROM THE DISTAL RESECTION. MARGIN; 3 CM BETWEEN DEEPEST TUMOR PORTION AND DEEP (RADIAL SOFT TISSUE). MARGIN. - POLYPS (AWAY FROM THE CARCINOMA) : NOT IDENTIFIED. - NON-NEOPLASTIC BOWEL: UNREMARKABL. - THE PATHOLOGIC STAGE IS. pT3. LYMPH NODES: NUMBER WITH METASTASES (1), NUMBER EXAMINED (22). - THE PATHOLOGIC STAGE IS. : pN1. - THE RESULTS OF IMMUNOHISTOCHENICAL. STAINS FOR MISMATCH REPAIR. PROTEINS WILL BE REPORTED IN AN ADDENDUM. 2). COLON, ANASTOMOTIC RING, PROXIMAL; EXCISION: - SEGMENT OF COLON WITH NO PATHOLOGIC DIAGNOSIS. 3). RECTUM, ANASTOMOTIC RING, DISTAL; EXCISION: - SEGMENT OF COLON WITH NO PATHOLOGIC DIAGNOSIS. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. 1).The specimen is received fresh and is labeled ""sigmoid and upper rectum,. stitch marks proximal. It consists of. a rectosigmoid colon that measure. 16.0 x 5.0 x 0.6 cm, The sexosal surface is tan-pink, smooth and grossly. unremarkable, The radial resection margin and serosa are inked black. Specimen is opened to reveal a tumor that is located 10.0 em from the. proximal margin and 3,00m from the distal margin. The tumor measures 3.0. en. in length and 3.0 cm in width. Serial Bectioning reveals tumox is 0.6 cm in. depth and is .0cm from the closest radial margin. There is no muscular. invasion grossly. The remaining mugosa is tan-pink and grossly unremarkable. Perioolio and peri-rectal adipose tissue is thoroughly examined for lymph. nodes, and all possible nodes are submitted. Representative sections are. submitted TPS is submitted. Summary of sections;. PM - proximal margin. DM - distal margin. RM - radial margin. T tumor. U - uninvolved mucosa. LN - lymph nodes. 2) The specimen is received in formalin, labeled ""proximal anastomotic. ring"" and consists of a silver metal anastomotic pin measuring 7.5 x 2.8 x. 1.5 cm. At the center of the pin, a ,Sem long blue plastic piece is noted,. A ring of pink tan soft tisque is attached measuring 1.8cm in diameter and. 1. .2cm in length. The mugosal surface is pink tan and focally hemorthagic. and the serosal surface is pink tan and smooth, Several sutures and staples. are noted. The sutures and staples are removed and the representative. section of soft tissue is submitted. Summary of sections: U - undesignated. 3) The specimen is received in formalin, labeled ""distal anastomotic donut"". and consists of a ring of pink tan soft tissue measuring 1.7x1,5x1.0 Cm. Multiple sutures and staples are attached. The mucosal surface is pink tan. and focally hemorrhagic. The sutures and staples are removed and. representative section of soft tissue ig submitted,. Summary of sections: U - undesignated. Summary of Sections: 1: SP: Sigmoid and upper rectum. Sect. site. PCs. Block. 5. {not entered). DM. 1. LN. 18. 6. 1. PM. 1. Part. 2: SP: Proximal anastomotic ring. Block. Seot. site. PCs. 1. Part. 3: SP: Distal anastomotic ring. Sect. site. PCa. Block. 1. 1. Addendum Diagnosis. Results of imenunohistochemical staining for DNA mismatch repair proteins are. as follows: MLH1: (x ) Staining present in tumor. ( ) staining absent in tumor. ) Staining inconclusive. MSH2: (x ) staining present in tumor. ( ) staining abgent in tumor. ) staining inconclusive. MSH6: (X ) staining present in tumor. ( ) Staining absent in tumor. ( ) Staining inconclusive. PMS2: (x) Staining present in tumor. ( ) staining absent in tumor. { ) staining inconclusive. Conclusion: - Inmunohistochemical staining for the tested DNA mismatch repair proteins. is retained in the tumor. Some of the immunohistochemistry and ISH tests were developed and their. performance characteristics were detexmined by the bepartment of Pathology. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research, This laboratory is certified. under the Clinical Laboratory Improvement. as. qualified to perform high complexity clinical laboratory testing,."
BIOCUP_00080,colon,COAD,TCGA-AA-A00E,TCGA-AA-A00E.B999FAB8-FBF9-405F-9E6F-81A6E2204363,"Diagnosis / Diagnoses: Right hemicolectomy specimen with an ulcerated colon carcinoma conforming to the. histological type of a poorly differentiated colorectal adenocarcinoma, located 1.5 cm. aborally from Bauhin's valve and circularly occupying the intestinal wall over a length of. 8 cm. Invasive spread of tumor within all layers of the intestinal wall, extending into the. mesocolic fatty tissue and as far as directly below the serosa. Appendix tumor-free and with post-inflammatory fibrosis of the wall. Oral and aboral resection margins and large omentum tumor-free. 41 regional lymph nodes tumor-free and with uncharacteristic reactive changes. Tumor stage thus pT3 pNO (0/41) L0 V0 R0; G3."
BIOCUP_00081,colon,COAD,TCGA-NH-A5IV,TCGA-NH-A5IV.F7280EE2-0A62-4DE5-8A20-17B6FBB51F41,"RUN DATE : RUN TIME. Spegimen Inquiry. RUN USER : LOC: e. U # : AGE/SX: ROOM: REG DR: BED: DIS: TLOC: SPEC # : PERFORMED AT. TIME IN FORMALIN: 6:25. hrs. CLINICAL INFORMATION: Pre-Op Diagnosis Colon CA. Remarks: Specimen (s): Right colectomy specimen. MICROSCOPIC DIAGNOSIS. RIGHT COLON AND PORTION OF TERMINAL ILEUM, RIGHT COLECTOMY : ADENOCARCINOMA OF TRANSVERSE COLON. LOW GRADE. TUMOR MEASURES 9 CM AND INFILTRATES SUB SEROSA. SURGICAL MARGINS FREE OF TUMOR. NO TUMOR SEEN IN ANY OF 12 REGIONAL LYMPH NODES. SEE COMMENT FOR SYNOPTIC REPORT. COMMENT(S). CAP APPROVED SURGICAL PATHOLOGY CANCER CASE SUMMARY. SPECIMEN: Terminal ileum, cecum, ascending colon, transverse colon. PROCEDURE. Right hemicolectomy. TUMOR SITE: Transverse colon. TUMOR SIZE: Greatest dimension 9 cm. MACROSCOPIC TUMOR PERFORATION. Not identified. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE. Low-grade. MICROSCOPIC TUMOR EXTENSION. Tumor invades through the muscularis propria into the. subserosal adipose tissue or the nonperitonealized. pericolic or perirectal soft tissues, but does not. extend to the serosal surface. MARGINS: Proximal margin : Uninvolved by invasive carcinoma. Distal margin: Uninvolved by invasive carcinoma. Circumferential or Mesenteric Margin: Uninvolved by. invasive carcinoma. LYMPH-VASCULAR INVASION : Not identified. PERINEURAL INVASION: Not identified. TUMOR DPOSITS: Not identified. PATHOLOGIC STAGING: Primary tumor pT3. Regional lymph nodes: pNO. Number of lymph nodes examined 12. Numbers of lymph nodes involved 0. RUN DATE. RUN TIME : Specimen Inquiru. RUN USER. SPEC # : GROSS DESCRIPTION: The. specimen is received in the fresh state from the operating room for immediate gross. evaluation for tumor banking and consists of a right colectomy specimen. The colon. measures 27 cm in length x 10 cm in circumference. Present in the distal portion of the. colon is a fungating. red tumor which measures 9 x 6 x 3 cm. located 6 cm from the distal. margin and 3 cm from the radial margin The terminal ileum measures 14 cm in length x 4 cm. in circumference x 1 cm in wall thickness and appears unremarkable. The appendix appears. to be surgically absent. √Ä representative section of the tumor is removed by aseptic. technique, and the tumor obstructs the lumen. infiltrates the subserosa but does not appear. to penetrate the visceral peritoneum The following sections are submitted: Block 1 - proximal margin. Block 2. distal margin. Blocks 3-6. colon tumor. Blocks 7-9. whole lymph nodes. Block 10. one lymph node trisected. Block 11. one lymph node bisected. Block 12. one lymph node trisected. Regional adipose tissue resected with the specimen measures 30 x 4 x 2 cm. A relatively. small number of lymph nodes is present. These are soft and measure up to 1 cm. INTRAOPERATIVE CONSULTATION: IMMEDIATE GROSS EVALUATION: ADENOCARCINOMA PRESENT IN COLON, PROCESSED FOR TUMOR BANKING. (signature on file)."
BIOCUP_00082,colon,COAD,TCGA-CK-6751,TCGA-CK-6751.c6e7f8d6-a201-4e43-ad3c-7dafdb3301e2,"Report Status: Final. Type: Surgical Pathology,. COLON, SEGMENTAL RESECT FOR TUMOR. BRODSKY,. DIAGNOSIS. SPECIMEN LABELED ""RIGHT COLON"". INVASIVE MUCINOUS ADENOCARCINOMA OF THE COLON, moderately differentiated,. (2.6 cm), arising in association with an adenoma. Tumor focally invades into but not through muscularis propria. No lymphovascular invasion is identified. Eight (8) lymph nodes are negative for tumor. AJCC Stage: T2 NO Mx. CLINICAL DATA: History: None given. Operation: R colectomy. TISSUE SUBMITTED: 1. R colon. GROSS DESCRIPTION: The specimen is received fresh in one part, labeled with the patient's name,. unit number and ""#1 right colon"". The specimen consists of a seggment of. ileocecum. The ileum measures 10 cm in length and 2.3 cm in diameter with a. surgical resection margin (2.2 cm in diameter) The colon measures 20. cm. in. length and 6 cm in diameter with a surgical resection margin (3.5 cm in. diameter) A red/tan mass (2.6 x 1.7 x 0.8 cm) is identified in the cecum. The mass is 12 cm from the ileal resection margin (inked black) and 17 cm from. the colon surgical resection margin (inked black) The mass is 2 cm from. the. ileocecal valve and does not invade through the serosa. The serosal surface. is grossly unremarkable. The serosal surface adjacent to the tumor is inked. black. No appendix is identified. However, a white/tan possible scar. (2 x. 0.5 cm) is present on the serosal surface of the cecum. Micro 1: ileal surgical resection margin en face, 2 frags,. Micro 2: colon resection margin en face, 1 frag,. Micro 3-5: mass and surrounding tissues, 4 frags,. Micro 6: normal appearing ileal tissue, 1 frag,. Micro 7: normal appearing colonic tissue, 1 frag. Micro 8-11: possible lymph nodes, 15 frags,. Micro 12: possible scar tissue, 1 frag,. mjy. Reports to: SPECIMEN TYPE: COLON, SEGMENTAL RESECT FOR TUMOR. Page: 1 of 1."
BIOCUP_00083,colon,READ,TCGA-AG-A025,TCGA-AG-A025.390DADDE-F6CC-4072-B56C-C83EEE9AB337,"Diagnosis: Tubular adenoma of the sigmoid in No. 1 (low-grade intra-epithelial neoplasia). Well-differentiated, invasive adenocarcinoma of the sigmoid in No. 2, arising from a tubular. adenoma with atypia and with infiltration of the submucosa. Tumor classification: M-8210/3, G1. This is chronic appendicitis with obliteration of the lumen by scar tissue, with an acute. inflammatory flare in the outer wall layers with eosinophilia, acute fibrinous granulocytic. serositis (in I.), a rectal resection specimen with a mucosal-submucosal defect in the area marked. with a clip, perifocal, granulating inflammation, polypous hyperplasia of the rectal mucosa in the. area of the margin (block A), wall perforation (block B), acute hemorrhage, necrosis, acute. perifocal inflammation, acute serositis (in II.), moderate reactive lymphadenitis (in II. and IV.),. an anastomosis ring with a diverticulum (in III.) and normally layered plain sections from all. other labeled specimen segments (in II., IV. and V.). No evidence of specificity or malignancy. 15+."
BIOCUP_00084,colon,READ,TCGA-AH-6644,TCGA-AH-6644.d7d2d0d8-c704-4033-897c-167d7bd1bda6,"QC Pathologist: ADDENDUM REPORT. Addendum Final Diagnosis: Two additional lymph nodes are identified in the gross. specimen. No malignancy is identified. Addendum Gross Description: Per the request of the surgeon, the specimen is re-examined. in search for additional lymph nodes. The mesenteric fat. is placed in lymph node Revealing Solution. Upon fixation. there reveals two additional possible lymph nodes that. measure 0.3 and 0.5 cm in greatest dimension. Each of the. lymph nodes have been bisected and submitted in cassette A14. FINAL PATHOLOGIC DIAGNOSIS: A. Rectosigmoid colon, partial colectomy: Tumor Characteristics: 1. Histologic type: Adenocarcinoma. 2. Histologic grade: Well differentiated. 3. Tumor site: Rectosigmoid colon. 4. Tumor size: Circumferential 3.5 X 3,0 cm tumor. 5. Lymphovascular space invasion: No. 6. Microscopic tumor extension: a. Tumor extends through the entire thickness of the. muscularis propria. Surgical Margin Status: 1. Proximal margin: Negative. 2. Circumferential margin: Negative. 3. Distal margin: Negative. 4. Closest tumor margin: 3 cm from the distal margin. Lymph Node Status: 1. Thirteen lymph nodes negative for metastatic carcinoma. Other: 1. pTNM stage: T3. B. Sigmoid colon rings: Colonic mucosa negative for malignancy,. GUMMENIS. CLINICAL HISTORY. Preoperative Diagnosis: Cancer. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Rectosigmoid colon. B. Sigmoid colon rings. PROCEDURAL DEMOGRAPHICS: Accession Date/Tim. GROSS DESCRIPTION: A. The first container A is labeled with the patient's name. The specimen consists of a segment of. rectosigmoid colon measuring 14 cm in total length and up to. 2 cm in diameter. The proximal margin is open. The distal. margin is stapled. The serosal surface of the bowel is gray. to brown-tan with hemorrhage. The attached mesentery is. yellow to brown-tan also displaying hemorrhage. On opening. the bowel the mucosal surface is light tan. There is a. circumferential brown-tan nodular mass, 3.5 x 3.0 cm that is. 3.7 cm from the distal margin and 6.2 cm from the proximal. margin. On sectioning the mass it extends into the. underlying bowel wall, but does not grossly penetrate. through the serosa and is 1.5 cm from the deep resected. margin. The surrounding colon is gray-tan and reveals. normal folds. On sectioning through the mesentery there are. 17 probable lymph nodes that measure from 0.2 up to 0.7 cm. Received with the specimen are two cassettes, one gray and. one yellow labeled. Representative sections are. submitted in cassettes labeled. as follows: proximal margin block 1; distal margin block 2; sections. from mass in blocks 3-7; surrounding uninvolved colon block. 8; lymph nodes submitted in total as follows: six probable. nodes block 9; four probable nodes block 10; one probable. node bisected in block 11; two probable nodes each bisected. in block 12; four probable nodes in block 13. B. The second container B is labeled with the. sigmoid colon rings. The specimen consists of. two circular fragments of bowel measuring 2.0 X 1.5 x 1.0. and 2.0 X 1.5 X 1.5 cm. The mucosal surfaces are brown-tan. with slight hemorrhage. Representative section from each. piece is taken and is submitted in a single cassette labeled."
BIOCUP_00085,colon,COAD,TCGA-G4-6294,TCGA-G4-6294.42cc13ea-0257-453d-8cc0-5af79d8eb6a0,"SPECIMENS: A. RIGHT COLON RESECTION. B. LIVER BX. DIAGNOSIS: RIGHT COLON, RIGHT HEMICOLECTOMY: - EXOPHYTIC ULCERATED INVASIVE MODERATELY DIFFERENTIATED. ADENOCARCINOMA OF CECUM ARISING IN TUBULOVILLOUS ADENOMA. WITH FULL MUSCLE WALL THICKNESS INVASION AND EXTENSION TO. SUBSEROSAL FAT, METASTASIS TO TWO OUT OF TEN PERICOLIC LYMPH. NODES (2/10). - PROXIMAL AND DISTAL MARGINS OF RESECTION, NEGATIVE FOR TUMOR. - SIZE OF TUMOR -4 X 3.7 X 3.5 CM. LIVER, BIOPSY: - METASTATIC ADENOCARCINOMA CONSISTENT WITH METASTASIS FROM. THE ABOVE CECAL ADENOCARCINOMA. COLORECTAL CANCER TEMPLATE. Tumor Size (cm): 4 X 3.7 X 3.5 cm. Histologic Type: Adenocarcinoma. Grade/Differentiation: G2, Moderate. Invasion Depth: Subserosa. Invasion Vasc/Lymphatic: Invasion Perineural: Absent. Extension to Adj. Areas: Margins: Free. Lymph Nodes: N1, Positive (2/10). Stage Pathology: pT3N1. Implants: Absent. Precursor: Present - tubulovillous adenoma. Non-neoplastic areas: Staging: Tis: CIS. T1: Submucosa, Intraepithelial or invasion of lamina propria. T2: Into muscularis propria. T3: Thru muscularis propria. T4: Thru peritoneum or to other areas. Includes invasion of other segments of the colorectum by way of the serosa. Regional Lymph Nodes (N). NO: No lymph node metastasis. N1: 1-3 Lymph nodes positive. N2: ? 4 Lymph nodes positive. 7-14 Lymph nodes should be examined. SPECIMEN(S): A. RIGHT COLON RESECTION B. LIVER BX. CLINICAL HISTORY: with ca. colon. GROSS DESCRIPTION: RIGHT COLON RESECTION. Specimen consists of resected short segment of right colon measuring 15 cm in length. with attached. adherent indurated adipose tissue. Large firm palpable mass occupies mid portion of the specimen. which when the specimen is opened, shows an obstructing circumferential exophytic tumor measuring. 4 X 3.7 X 3.5 cm, involving cecum and extending to ileocecal valve and seen 3 cm from ileal margin and. 6 cm from distal colonic margin of resection. The tumor on sections shows a tan-cream-white surface. and infiltrates entire colonic wall with apparent extension to subjacent adipose tissue. Tumor occludes. cecal lumen. Attached adipose tissue measures 11 X 5 X 2.5 cm. Appendix is not identified. Multiple. sections submitted and labelled as follows. A1-A4: one transverse section of tumor divided into four sections. A5-A7: additional tumor representative. A8: colonic margin. A9: representative of colon. A10: representatives of ileum. A11: distal ileal margin. A12: three lymph nodes, one bisected and inked. A13: three lymph nodes, one inked and bisected. A14: three lymph nodes. A15: one bisected lymph node. LIVER BIOPSY. Received in formalin is a portion of tan brown soft tissue measuring 1.2x0.7x0.5cm. which is previously. partially bisected. The specimen is further sectioned and submitted completely in cassette B."
BIOCUP_00086,colon,READ,TCGA-AG-A026,TCGA-AG-A026.800BF328-7F21-4BF0-95CA-D9092FC6B2D8,"Internal Sample IC. This is vascularized fatty connective tissue with an extensive, chronically granulating and. recurrent inflammation with fibrosis, acute inflammatory activity, hemorrhage and fine foci of. necrosis. No evidence of specificity or malignancy. This is a poorly differentiated adenocarcinoma of the rectum with a degree of pathological. differentiation of G 3, with carcinomatous lymphangiosis, erosions/ulcerations of the inner tumor. surface, accompanying peritumoral, chronic, recurrent inflammation with an acute purulent. abscess-forming inflammatory flare, tumor infiltration of the rectal wall layers into the perirectal. connective tissue (in I.), with similar tumor infiltrates and extensive peritumoral, chronically. granulating and recurrent inflammation in the soft tissue of the sacral cavity (in III.), moderate. chronic lymphadenitis of the tumor-free lymph nodes (0/15), tumor-free resection margins -. aborally and orally - (in I.) and tumor-free plain section from the anastomosis ring (in II.). The tumor spread of the rectal carcinoma, according to the available sections, corresponds to a. tumor stage of p T 4, p N 0, M X, L 1 and at least R 1. No evidence of carcinosis of the blood vessels. The study result was discussed by telephone. 12+."
BIOCUP_00087,colon,COAD,TCGA-AA-A01Z,TCGA-AA-A01Z.E8C798B9-30E0-40B0-93B3-49ABD6E7F29A,"This tumor is a poorly differentiated invasive adenocarcinoma (in this case, ascending. carcinoma, G3), with infiltration of the fatty connective tissue and lymph vessel. invasions, L 1. The resection margins are free resection margins, orally of the ileum. type, distally of the colon type with corresponding three layers of mucosa, submucosa. and muscularis. The ligature consists of fatty connective tissue with vascular components. The lymph nodes are free lymph nodes, pN0 (0 of 12). Tumor classification: ICDO-DA-M 8140/3. G3. pT3, pN0, MX, L1."
BIOCUP_00088,colon,READ,TCGA-AF-3914,TCGA-AF-3914.1D26C175-4FCE-4EDB-B91E-DE7A507DC86A,"Final Surgical Pathology Report. Procedure: Diagnosis. Rectum with J-pouch, attached bladder and prostate, pelvic. exenteration: Recurrent poorly differentiated adenocarcinoma involving rectal. mucosa, submucosa, muscularis propria, perirectal adipose tissue and. extensively infiltrating prostatic parenchyma. Tumor is present at the right pelvic sidewall margins. The prostatic urethral margin is positive or tumor in parenchyma and. lymphatic spaces. The rectal mucosal and deep margins are negative for tumor. Extensive lymphovascular space invasion and perineural space invasion. Microscopic Description: Microscopic examination performed and summarized in the template below: Histologic type: Recurrent adenocarcinoma. Histologic grade: Poorly differentiated. Primary tumor (pT) : Although the tumor with somewhat difficult to. define grossly its microscopic spread was quite extensive with. prominent involvement of the rectum and J-pouch and connective tissue. between the rectum and the prostate and extensive infiltration of the. prostate and prostatic urethra and seminal vesicles. Overall the. recurrent tumor measured greater than 5 cm in greatest dimension. Proximal margin: Proximal rectal margin negative for tumor. Distal margins: Distal rectal margin negative for tumor. Circumferential (radial) margin: Right pelvic sidewall is. microscopically positive for tumor with areas of perineural space. invasion. Also tumor was present at the prostatic urethral margin. Vascular invasion: Present and prominent with both lymphatic and venous. invasion identified. Regional lymph nodes (pN) : 1 residual lymph node was identified and it. is negative for metastatic tumor (0/1). Non-lymph node pericolonic tumor: Present. Distant metastasis (pM) : Not evaluated. Other findings: There is some acute colitis in the rectum that is. nonspecific. There are some nonspecific findings of chronic cystitis. in the bladder. The ureter margins were negative for tumor. However. some tumor was identified attached to the left side of the bladder in. deep nerves attached seminal vesicles. MSI testing was not ordered as this is a recurrent tumor and not a. primary tumor. Specimen. Bladder prostate and rectum. Clinical Information. Recurrent rectal cancer. Recurrence between J-pouch and. prostate/seminal vesicles. Gross Description. Received fresh and subsequently fixed in formalin labeled ""bladder. prostate and rectum"" is a specimen which includes a 4.3 x 3.7 white 3.7. cm prostate, an 8.5 cm portion of rectum with J-pouch, attached bladder. and prostate. The bladder is approximately 6.5 x 5.5 and is 4.0 cm. inflated. There is a catheter in the prostatic urethra and the specimen. is heavily stapled. Orientation of the specimen was reviewed by the. surgeon at time of tissue procurement. No frozen sections were. requested. Proximal end of the rectum is inked blue and the distal end. of the rectum is inked black. The J-pouch of the specimen is. approximately 3 x 2.5 cm and is heavily stapled, located within 2.5 cm. of the distal margin of the rectum. The mucosa of this area is smooth. and glistening showing an average circumference of 7.5 cm in its opened. state. In the J-pouch there is a 1.2 x 0.7 cm ulcer. This comes within. 2.5 cm of the distal rectal margin and 6.5 cm of the proximal rectal. margin. This comes within 1.2 cm of the anastomotic line surface of. this area shows tumor present and a scarred focus. This area of the. J-pouch is adherent to the posterior right side of the prostate. This. area is inked black. The cut surface of this area shows a white tan. scarred irregular focus which is approximately 2.5 x 2.5 x 2.5 cm. The. remainder of the cut surface of the prostate is pink-tan and diffusely. nodular. The remainder of the bladder and prostate are opened in an. anterior Y-shaped incision. Mucosa the bladder is pink-tan smooth. glistening with no other discrete gross lesions identified. The ureters. are propatent an average 4.5 x 0.3 cm. The seminal vesicles cannot be. grossly identified in a variegated and behind the rectum. Vas. deferentia cannot be grossly identified. From minimal fat is gross. identified surrounding the tissue. Possible lymph nodes may be present. Representative sections of the specimen are submitted as follows: 1 -. representative luminal margins of the rectum, 2 - 6 - entire J-pouch. ulceration and to tumor including anastomotic line (inked blue) and. possible seminal vesicle and prostatic tissue, (from proximal to. distal), 7 - left side bladder with ureteral orifice and possible. ureteral margin, 7 - right side bladder with possible ureteral margin. (ureteral orifice cannot be grossly identified) 9 - representative. posterior bladder, 10 - prostatic urethral margin en face, 11 - full. thickness prostate from prostatic urethra to rectum, 12 - 14. representative right sided prostate from apex to base, 13 - 17. representative left prostate from apex to base, 18 - possible lymph. node, 19 - 2 possible lymph nodes, 20 through 22 - additional portions. of perirectal fat."
BIOCUP_00089,colon,COAD,TCGA-AZ-4681,TCGA-AZ-4681.f93f6d03-ddbc-4399-b896-88ad92b285e6,"FINAL DIAGNOSIS: PART 1: RIGHT OVARY AND FALLOPIAN TUBE, RIGHT SALPINGO-OOPHORECTOMY -. A. ATROPHIC OVARY WITH OVARIAN FIBROMA, 1.2 CM. B. FALLOPIAN TUBE WITH MULTIPLE PARATUBAL CYSTS. C. THERE IS NO EVIDENCE OF MALIGNANCY. PART 2: LEFT OVARY AND FALLOPIAN TUBE, LEFT SALPINGO-OOPHORECTOMY -. A. ATROPHIC OVARY WITH OVARIAN FIBROMATA, 2.8 CM AND 2.0 CM. B. FALLOPIAN TUBE WITH PARATUBAL CYSTS. C. THERE IS NO EVIDENCE OF MALIGNANCY. PART 3: RECTUM, PROCTECTOMY -. A. RECTAL ADENOCARCINOMA, MODERATELY DIFFERENTIATED, 2.5 CM IN GREATEST EXTENT. B. TUMOR EXTENDS THROUGH THE FULL THICKNESS OF THE MUSCULARIS PROPRIA INTO PERIRECTAL. ADIPOSE TISSUE. C. THE MARGINS OF RESECTION ARE FREE OF MALIGNANCY. D. EIGHT LYMPH NODES, NO TUMOR SEEN (0/8). E. HISTOPATHOLOGIC STAGE: pTNM = T3 NO MX. F. INCIDENTAL HYPERPLASTIC POLYPS. G. DIVERTICULAR DISEASE. PART 4: RECTUM, MARGINS, RESECTION -. RECTUM, NO TUMOR SEEN. PART 5: COLON, RIGHT, RIGHT HEMICOLECTOMY -. A. COLONIC ADENOCARCINOMA, MODERATELY DIFFERENTIATED, 2.5 CM IN GREATEST EXTENT. B. TUMOR EXTENDS THROUGH THE FULL THICKNESS OF THE MUSCULARIS PROPRIA, INTO PERICOLONIC. ADIPOSE TISSUE. C. THE MARGINS OF RESECTION ARE FREE OF MALIGNANCY. D. FIVE LYMPH NODES, NO TUMOR SEEN (0/5). E. HISTOPATHOLOGIC STAGE: pTNM = T3 NO MX. F. APPENDIX WITH FIBROUS OBLITERATION OF THE TIP. G. DIVERTICULAR DISEASE. PART 6: GALLBLADDER, CHOLECYSTECTOMY -. CHRONIC CHOLECYSTITIS AND CHOLELITHIASIS."
BIOCUP_00090,colon,READ,TCGA-AG-3883,TCGA-AG-3883.3829f7f1-4bc6-4154-84a2-61a1e348ce24,"Diagnosis. This concerns an invasive, moderately differentiated adenocarcinoma of the colon(rectal. carcinoma) with infiltration of the muscularis and the vessels (p T 2, L1, V1) with free. resection margins and free lymph nodes (p N 0). In addition there is a free anastomosis ring. Tumor classification: ICDO-DA M-8140/3. G2. p T 2, L1, V1, p N o - consistent with R 0."
BIOCUP_00091,colon,COAD,TCGA-D5-6923,TCGA-D5-6923.3523f7ac-0a52-44cb-9b99-068955ccb1da,"page 1 / 1. copy No. 2. Examination: Histopathological examination. Cost of diagnostic procedure. Material: Multiple organ resection - segment of the large intestine. Expected time of examination: Clinical diagnosis: Cancer of the sigmoid colon. Macroscopic description: A 12 cm length of the large intestine with fat tissue sized 14 X 6 x 9.5 cm. Tumour sized 4 X 3 X 1.5 cm detected. in the mucosa. The lesion surrounding 50% of the intestine circumference, removed by 5 cm from one of the. incision lines, and 5.3 from the opposite one. The lesion infiltrates macroscopically the muscular membrane. Diverticulum 1 cm in diameter found outside the tumour. Microscopic description: Adenocarcinoma tubulopapillare (G2). Infiltratio carcinomatosa profunda tunicae muscularis propriae . Incision. lines free of neoplastic lesions. Lymphonodulitis reactiva (No XI). Histopathological Diagnosis: Adenocarcinoma tubulopapillare coli. Tubulopapillar adenocarcinoma of the colon. (G2, Dukes B, Astler - Coller Bl, pT2, pNO). CONTACT YOU DOCTOR WITH THIS REPORT!."
BIOCUP_00092,colon,COAD,TCGA-F4-6463,TCGA-F4-6463.a06e1c69-5737-4692-950c-4ef74ced2d03,LARGE INTESTINE TISSUE CHECKLIST. Specimen type: Colectomy. Specimen size: Not specified. Tumor site: Transverse colon. Tumor size: 2.5 X 4 X 3 cm. Tumor features: None specified. Histologic type: Mucinous adenocarcinoma. Histologic grade: Moderately differentiated. Tumor extent: Pericolonic tissues. Lymph nodes: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.
BIOCUP_00093,colon,COAD,TCGA-G4-6322,TCGA-G4-6322.3e8f1c36-63d9-4f6e-8c16-b2e74f8fd138,"SPECIMENS: A. LEFT COLON. SPECIMEN(S): A. LEFT COLON. INTRAOPERATIVE CONSULTATION DIAGNOSIS: A-left colon: Tumor mass is 9 cm away from the distal margin, called by. GROSS DESCRIPTION: A. LEFT COLON. Received fresh labeled with the patient's identification and ""left colon"" is a 24 cm segment of colon with. circumference of 7.5 cm with a suture designating the distal margin. The serosa is unremarkable. The. mesocolon and serosa, subjacent to the mass, is inked black. A 9 X 6.5 X 3cm circumferential, polypoid,. indurated, necrotic mass is present, 9 cm from the distal margin, involving the subserosal fat. Proximal. mucosa has diverticuli and 3 polyps, 0.2 cm, 0.3 cm, and 0.5 cm. A gross assessment is conveyed to O. R., a photograph is taken, and tissue is procured. Representatively submitted: A1: shave of proximal margin. A2: shave of distal margin. A3-A8: mass. A9: possible diverticuli. A10: polyps. A11: normal appearing mucosa extending into flattened mucosa. A12-A13: proximal, 6 possible lymph nodes in each cassette. A14: proximal, 1 lymph node. A15-A16: distal, 6 possible lymph nodes in each cassette. A17: distal, 4 lymph nodes. DIAGNOSIS: COLON, LEFT, RESECTION: - INVASIVE MUCINOUS ADENOCARCINOMA, MODERATELY. DIFFERENTIATED, ARISING IN A TUBULOVILLOUS ADENOMA. - TUMOR MEASURES 9 X 6.5 CM. - TUMOR INVOLVES THE SUBSEROSA. - MARGINS, FREE OF TUMOR. - METASTASTIC CARCINOMA IN TWO OF 26 LYMPH NODES (2/26). - TWO TUBULAR ADENOMAS. - DIVERTICULOSIS. NOTE: On slide A3, mucin with fibrosis and marked inflammation is seen at an inked radial aspect that. is fragmented. Tumor is not definitely identified at the radial margin. Dr. concurs. Clinical-surgical. correlation is recommended. SYNOPTIC REPORT - COLON & RECTUM. Specimen Type: Left hemicolectomy. Tumor Site: Left (descending) colon. Tumor Configuration: Exophytic (polypoid). Infiltrative. Tumor size: 9cm Additional dimensions 6.5cm X 3cm. WHO Classification. Mucinous adenocarcinoma 8480/3. Histologic Grade: G2: Moderately differentiated. Extent of Invasion: Subserosa. Margins: Margin(s) uninvolved by invasive carcinoma (Proximal, Distal, Radial). Venous/Lymphatic Invasion: Present. Perineural Invasion: Absent. Additional Pathologic Findings: Adenoma. Extent of Resection: R0: Complete resection with grossly and microscopically negative margins. Lymph Nodes: Positive 2 /26. Extranodal extension: Absent. Implants: Absent. Pathological Staging (pTNM): pT 3 N 1 MX. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Colon cancer."
BIOCUP_00094,colon,READ,TCGA-AH-6897,TCGA-AH-6897.8beff8a6-b443-4073-9faa-552c57e075d3,"Histopathological Examination. Pre-Op Diagnosis : Sigmoid Colon Cancer. Specimens. : Colon Segment, sigmoid upper rectum. Frozen Diagnosis. : GROSS EXAMINATION: The specimen is received fresh in a container labeled with. the name of the patient and identified as colon segment,. sigmoid, upper rectum. Length: 15 cm. Circumference: Up to 7.3 cm. Margins: Stapled. Serosa: Smooth and glistening. Mesorectum: Incomplete. Mass: Size: 5.3 x 4.2 x 1.4 cm. Type: Infiltrative with raised edges. Region: Distal segment. Distance from distal margin: 4.5 cm. Circumference: Approximately 60%. Depth of Invasion: 0.3 cm. Distance from Radial Margin: 3 cm. Block Summary 1-2, mass with overlying inked serosal edge. (black ink) ; 3-4, additional sections of mass with adjacent. normal bowel wall; 5, radial margin; 6, distal margin; 7,. proximal margin; 8, lymph nodes; 9-12, additional sections. of mesocolon and mesorectum submitted post alcoholic. formalin fixation. DIAGNOSIS BASED ON GROSS AND MICROSCOPIC EXAMINATION: Colon, sigmoid/upper rectum, segmental resection: - Invasive adenocarcinoma, moderately differentiated. extending into muscularis propria (see cancer case summary. checklist) . - Margins are free of tumor. - Benign lymph nodes, negative for metastatic adenocarcinoma. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. (0/14). [T-59300 M-81403 153.9 P3-44090]. COLON AND RECTUM: SPECIMEN: Sigmoid colon and rectum. PROCEDURE: Rectal/rectosigmoid colon (lower anterior. resection) . TUMOR SITE: Rectosigmoid. TUMOR SIZE: 5.3 x 4.2 x 1.4 cm. MACROSCOPIC TUMOR PERFORATION Not identified. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: Low-grade (well differentiated and. moderately differentiated). HISTOLOGIC FEATURES SUGGESTIVE OF MICROSATELLITE. INSTABILITY: Not identified. MICROSCOPIC TUMOR EXTENSION: Tumor invades muscularis propria. MARGINS: Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (radial or mesenteric) margin uninvolved by. invasive carcinoma. Distance of tumor from closest margin: 3 cm, radial margin. TREATMENT EFFECT: No prior treatment. LYMPH-VASCULAR. INVASION: Not identified. PERINEURAL INVASION: Not identified. TUMOR DEPOSITS: Not identified. PATHOLOGIC STAGING (pTNM) : Primary Tumor (pT) : pT2 : Tumor invades muscularis propria. Regional Lymph Nodes (pN) : pNO: No regional lymph node. metastasis. Number examined: 14. Number involved : 0. Distant Metastasis (pM) : N/A. ADDITIONAL PATHOLOGIC FINDINGS: None identified. ANCILLARY STUDIES: None performed. SUMMARY OF PATHOLOGIC STAGING: pT2N0. Comment: The preliminary findings have been discussed with. Intradepartmental. consuitation obtained. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. of 3. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. of 3."
BIOCUP_00095,colon,READ,TCGA-AG-A015,TCGA-AG-A015.FDBE42F3-4A2C-4218-A741-04F23A6689C5,"Diagnosis: Rectosigmoid with a colon and rectal carcinoma of the histological type of a moderately. differentiated colorectal adenocarcinoma, extending a max of 1.5 cm to the aboral resection. margin, and measuring a maximum of 2.5 cm in diameter at the widest point, located at the. base of a tubulovillous adenoma with severe epithelial dysplasia (synonymous: profound. intraepithelial neoplasia). Invasive spread of tumor to the submucosal layer. Oral and aboral resection margin is tumor-free. Eighteen mesocolic and periproctal lymph nodes are tumor-free and display. uncharacteristically reactive changes. Stage of tumor: PT1 pN0 (0/18) L0, V0, G2 R0. N¬∞."
BIOCUP_00096,colon,COAD,TCGA-AA-3684,TCGA-AA-3684.2ff5db80-95db-4eb6-9b72-25c83c492653,"Diagnosis: Right-sided hemicolectomy preparation with locally advanced, poorly differentiated mucinous. adenocarcinoma of the cecum (G3) with invasion of all parietal layers, penetration of the. peritoneum, spreading to a gathered loop of small intestine, multiple regional lymph node. metastases and carcinosis of the peritoneum or omentum (pT4 L1 V0 pN2 9/10 pM1."
BIOCUP_00097,colon,COAD,TCGA-F4-6807,TCGA-F4-6807.f0de4e3e-4bee-4aee-af8c-37a6da374814,LARGE INTESTINE TISSUE. CHECKLIST. Specimen type: Colectomy. Specimen size: Not specified. Tumor site: Colon. Tumor size: 9 X 8 X 2 cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Pericolonic tissues. Lymph nodes: 12/12 positive for. metastasis (Intraabdominal 12/12). Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.
BIOCUP_00098,colon,COAD,TCGA-AA-3949,TCGA-AA-3949.09fa9d57-dd74-4902-a007-ec77402dbd0d,"Diagnosis: Right hemicolectomy preparation with an ulcerated colon carcinoma characterized. histologically as a poorly differentiated, partially mucinous adenocarcinoma of the. colorectal type, located 0.5 cm aborally to Bauhin's valve and encircling the intestinal wall. at a length of 5 cm. Invasive spreading of the tumor within all intestinal wall layers up to. the bordering mesocolic fatty tissue and the level of the subserosa. Oral and aboral resection margins are tumor-free. Three of nineteen lymph nodes display metastasis of the colon carcinoma, not extending. across the capsules. Stage of tumor is therefore: pT3, pN1 (3/19) LO V0; G3 R0."
BIOCUP_00099,colon,COAD,TCGA-F4-6703,TCGA-F4-6703.227ed987-c3d7-420f-9276-2f803646323b,LARGE INTESTINE TISSUE. CHECKLIST. Specimen type: Partial colectomy. Specimen size: Not specified. Tumor site: Ascending colon. Tumor size: 0 X 0 X 8.5 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Subserosa. Lymph nodes: 0/12 positive for. metastasis (Adjacent fatty tissue. 0/12). Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.
BIOCUP_00100,colon,COAD,TCGA-CK-6748,TCGA-CK-6748.d8e78b5e-6e61-413a-b518-a8b77b986e86,"Report Status: Final. Type: Surgical Pathology. Specimen Type: Liver partial resection. Procedure Date: PATIEN. Resident: Pathologi: PATHOLOGIC DIAGNOSIS: A. SPECIMEN DESIGNATED ""LEFT LOBE LIVER WEDGE (104g) "" (including FSA). METASTATIC ADENOCARCINOMA, 5.0 cm, involving liver parenchyma. . Parenchymal resection margin is negative for tumor. Tumor is 1.0 cm from the parenchymal resection margin. Hepatic steatosis, mild. B. SPECIMEN DESIGNATED ""SIGMOID COLON"". ADENOCARCINOMA with mucinous differentiation, high grade, poorly. differentiated (5.0 cm in greatest dimension). Tumor is located in sigmoid colon, forms a fungating mass, is. ulcerative, and has an infiltrating border. Tumor invades through muscularis propria into serosa,. Resection margins are negative for tumor. Invasive tumor is 5.0 cm from the 4.9 cm stapled resection margin,. 7.0 cm from the 3. cm stapled resection margin, 2.6 cm from the. mesenteric resection margin, and <0.1 cm from the serosal surface,. Lymphovascular invasion is not identified. Extramural venous invasion is not identified. Perineural invasion is not identified. Peritumoral lymphoid response (including Crohn's-like infiltrate) is not. present. Residual adenoma is absent. Tattoo. Regional lymph nodes (positive:total) : 2:17. AJCC Classification (6th edition) : pT3c N1 M1. C. SPECIMEN DESIGNATED ""PROXIMAL DONUT"": Portion of colon, negative for tumor. D. SPECIMEN DESIGNATED ""DISTAL DONUT"": Portion of colon, negative for tumor. CLINICAL DATA: History: Colon cancer. Operation: Laparoscopy, wedge resection L lower lobe of liver and low anterior. resection. Operative Findings: Not provided. Clinical Diagnosis: Colon Ca. TISSUE SUBMITTED: A/1) left lobe liver wedge (FS and Tissue Bank). B/2) sigmoid colon - Tissue Bank. C/3) proximal donut. D/4) distal donut. O.R. CONSULTATION: SPECIMEN LABELED ""#1 - LEFT LOBE LIVER WEDGE"" (FSA) : Metastatic adenocarcinoma. Surgical resection margin, negative for tumor. Page: I of 3. The senior physician certifies that he/she personally conducted a gross and/or. microscopic examination of the described specimen (s) and rendered or confirmed. the rapid diagnos (es) related thereto. GROSS DESCRIPTION: The specimen is received fresh, in four parts, each labeled with the patient's. name and unit number. Part A, ""left lobe liver wedge"", consists of a 100.4-g liver wedge resection. (9.0 x 7.2 x 4.2 cm) with a cauterized parenchymal resection margin (9. x 4.2. cm, inked blue) On cut sectioning, there is a white/tan focally. (approximately 10%) necrotic tumor (5.0 x 4.5 x 3.0 cm) that grossly abuts the. liver capsule (inked black) and is located 1.0 cm to the parenchymal resection. margin. A representative section of the parenchymal resection margin is. submitted as FSA. A representative section of tumor and normal liver is. submitted for tissue banking. Representative sections are submitted for. histological examination. Micro A1: FSA remnant, 1 frag,. Micro A2: Tumor, quick fix, 2 frags,. Micro A3: Tumor and capsule and tumor and uninvolved liver parenchyma, 2 frags,. RSS. Micro A4: Uninvolved liver, 1 frag,. Part B, ""sigmoid colon"", consists of an unoriented segment of colon (16.8 x 2.9. cm in diameter) with two stapled resection margins (4.9 cm and 3.6 cm, both. inked black) The specimen is open to reveal a centrally ulcerated mass (5.0. x. 4.0 x 1.2 cm) with raised borders that is 5.0 cm to the 4.9 cm stapled. resection margin, 7.0 cm from the 3. 6 cm stapled resection margin, and 2.6 cm. to the mesenteric resection margin (16.8 x 2.3 cm, inked orange) There. are. two tan/black tattoos (#1 5. x 2.5 cm and #2 4.0 x 3.5 cm). Tattoo #1 is. located 2. 6 cm to the 4.9 cm stapled resection margin and 1.2 cm from the. ulcerated mass. Tattoo #2 is located 4.1 cm to the 3.6 cm stapled resection. margin and 1.2 cm from the centrally ulcerated mass. Tattoos #1 and #2 are. located 7.2 cm from each other and are on opposite sides of the ulcerated mass. Underlying the tattoo #1 is a submucosal firm nodule (0.8 x 0.8 cm) that is. located 0. cm from the 4.9 cm stapled resection margin and 4.0 cm to the. ulcerated mass. Underlying tattoo #2 is a submucosal nodule (1. x 0.8 cm). located 6. cm to the 3.6 cm stapled resection margin and 2.5 cm from the. ulcerated mass, There is an area of serosal puckering immediately deep to the. centrally ulcerated mass (1.5 x 0.5 cm) that is located 4.0 cm from the. mesenteric resection margin, 7.5 cm from the 4.9 cm stapled resection margin,. and 7.0 cm from the 3.6 cm stapled resection margin. Gross photos are taken. and representative sections are submitted for histological examination. Micro B1: 4.9 cm stapled resection margin to include 0.8 cm submucosal nodule;. perpendicular, 1 frag,. Micro B1: 3.6 cm stapled resection margin, perpendicular, 1 frag,. Micro B3: Remainder of 0.8 cm submucosal nodule, 1 frag,. Micro B4: 1.0 cm submucosal nodule, 2 frags,. Micro B5: Mesenteric resection margin, perpendicular, 1 frag,. Micro B6: Tumor and serosa, deepest extent of invasion, perpendicular, 1 frag,. Micro B7: Tumor and adjacent uninvolved mucosa closest to 3.6 cm stapled. resection margin, 1 frag,. Micro B8: Tumor and mucosa closest to 4.9 cm stapled resection margin, 1 frag,. Micro B9: Tumor, 2 frags,. Micro B10; ? matted lymph nodes (1.8 x 1.5 x 0.8 cm), bisected, 1 frag,. Micro B11: 5 lymph node candidates, 5 frags,. Micro B12: 5 lymph node candidates, 5 frags,. Micro B13: 4 lymph node candidates, 4 frags,. Micro B14-B17: Pericolonic adipose tissue, 1 frag each,. Part C, ""proximal donut"", consists of a circular tan/pink soft tissue fragment. (1.1 x 1.6 cm in diameter) that is attached to metallic anvil and contains a. Page: 2 of 3. black stitch. The specimen is entirely submitted for histological examination. Micro C1: Proximal donut, 1 frag,. Part D, ""distal donut"", consists of a tan/yellow soft tissue (1.5 x 1.2 x 0.5. cm) which is entirely submitted. Micro D1: Distal donut, 1 frag,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto. Final Diagnosis by. Page: 3 of 3."
BIOCUP_00101,colon,READ,TCGA-AG-3593,TCGA-AG-3593.85b24198-dc94-497e-989d-4fdf03167ede,"Diagnosis/ diagnoses: 1. Excised soft tissue (abdominal wall) with fibrosis and chronically granulating. inflammation. No sections of the rectal carcinoma described in (2) below. 2. Resected part of colon and rectosigmoid colon shows an ulcerated, rectal carcinoma. characterized histologically as a moderately differentiated colorectal. adenocarcinoma, extending to within 1.3 cm of the aboral resection margin, and. encircling the intestinal wall at a length of 6.5 cm, with necrotic tumor lesion. Invasive tumor spread within all intestinal wall layers, deep into the bordering. periproctic fatty tissue. The minimum distance from the tumor to the soft tissue. resection margin is 2 mm according to microscopy. Tumor-free oral and aboral resection margin as well as the intestine adherent to the. vaginal section and the uterus. Uterus with epidermoid glandular portio ectopy,. slightly chronic cervicitis, cystic atrophy of the corpus endometrium and individual. intramural leiomyomas. Sigmoid colon wall with individual pseudodiverticula and. chronic peridiverticulitis, tending toward scarring. All 38 periproctic and mesocolic lymph nodes are tumor-free, with non-. characteristic reactive lesions. Tumor stage therefore pT3, pNo, (0/38) LO V0; G2."
BIOCUP_00102,colon,COAD,TCGA-CK-4952,TCGA-CK-4952.0086611e-c16d-4934-804e-332f4d0daad1,"Addended Report. Resident: PATHOLOGIC DIAGNOSIS: A. SPECIMEN DESIGNATED ""PERIGASTRIC LYMPH NODES"". Heterotopic pancreas with focal pancreatic intraepithelial neoplasia. type 1 (PanIN1). No lymph node is present. B. SPECIMEN DESIGNATED ""RIGHT COLON, HEMICOLECTOMY"": MUCINOUS ADENOCARCINOMA, low grade, moderately differentiated. (7.0 cm in greatest dimension). The tumor forms a fungating mass and has an infiltrating border. The tumor invades through the subserosa to the serosal surface. The proximal, distal, and radial resection margins are negative. for tumor. Invasive tumor is 152mm from the proximal resection margin, 206mm. from the . distal resection margin, and 21mm from the radial. resection margin. Lymphovascular invasion is not identified. Venous invasion is not identified. Perineural invasion is not identified. Peritumoral lymphoid response (including Crohn's-like infiltrate). is mild. Residual adenoma is present. Regional lymph nodes (positive:total) : 5:31. AJCC Classification. T4 N2 MX. CLINICAL DATA: History: None provided. Operation: Laparoscopic converted to open right hemicolectomy. Operative Findings: None provided. Clinical Diagnosis: Colon cancer. TISSUE SUBMITTED: A/1. Perigastric lymph node. B/2. Right hemicolectomy to FS. GROSS DESCRIPTION: The specimen is received fresh, in two parts, each labeled with the patient's. name and medical record number. Part A, ""#1. Perigastric lymph node"", consists of a red/brown fibroadipose. tissue fragment (2.5 x 1.5 x 1.0 cm) containing a single lymph node. The. specimen is entirely submitted. Micro A1-A2: Lymph node, bisected, 1 frag per cassette,. Part B, ""#2. Right hemicolectomy"", consists of a hemicolectomy specimen (37.5 x. 7.5 cm), including an appendix (7.0 x 0.5 cm) and the distal ileum (3.0 x 2.0. cm), which includes a stapled resection margin (blue, 2. 1 cm) and a distal. stapled resection margin (black, 2.8 cm) There is a fungating tan/red mass. (7.0 x 4.0 x 2.3 cm), which measures 12.6 cm to the ileocecal valve, 15.2 cm to. the proximal stapled resection margin, 20. cm to the distal stapled resection. margin, and 2.1 cm to the radial margin. There is a second tan/yellow polyp. Page: 1 of 2. (0.3 cm in diameter), which measures 4.0 cm to the distal stapled resection. margin and 33.0 cm to the proximal stapled resection margin. No other lesions. are identified. Representative sections of the tumor and normal bowel are. submitted to the tissue bank. Twenty five candidate lymph nodes (largest - 3.2. x 1.9 x 1.6 cm) are identified in the mesentery. Representative sections of. the larger two lymph nodes are submitted. The remaining lymph nodes are. entirely submitted. Micro B1: Proximal stapled resection margin, 1 frag. Micro B2: Distal stapled resection margin, 1 frag,. Micro B3: Radial resection margin, 1 frag,. Micro B4: Tumor with serosal involvement, 1 frag,. Micro B5: Additional tumor, 1 frag,. Micro B6: Tumor with proximal adjacent mucosa, 1 frag,. Micro B7: Tumor with distal adjacent mucosa, 1 frag,. Micro B8: Polyp and normal mucosa, 2 frags,. Micro B9: Appendix, tip and perpendicular distal end, 3 frags,. Micro B10: Appendix, cross sections, 4 frags,. Micro B11: Largest candidate node, 1 frag,. Micro B12: Second largest node, 1 frag,. Micro B13: Third largest node, 2 frags,. Micro B14: Candidate node, 2 frags,. Micro B15-B17: Candidate nodes, 7 frags per cassette,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto. Rinal Diagnosis by. ADDENDUM: Immunostains for MLH1, MSH6, PMS2, and MSH2 reveal intact nuclear staining in. tumor cells. In a very small percentage of tumors, there is an underlying. hereditary genetic defect despite intact nuclear expression in tumor cells. Clinical correlation is required. Addendum #1 by. Page: 2 of."
BIOCUP_00103,colon,COAD,TCGA-AA-3956,TCGA-AA-3956.9bbb5e1a-4bbb-4882-a294-e0f13d82fa4c,"Diagnosis (diagnoses): Resected ileocolic sample with a moderately differentiated adenocarcinoma of the. colorectal type, located in the cecum, max. 4 cm in diameter, with infiltration of the. pericecal fatty tissue. Circumscribed fibrinous serositis in the area of the tumor. Stage of tumor: pT3, pNO (0/36), pMX; G2, L0, V0, R0."
BIOCUP_00104,colon,COAD,TCGA-A6-5659,TCGA-A6-5659.16172149-a834-4f41-a786-5d87a69fc65c,"SPECIMEN. Right colon. CLINICAL NOTES. PRE-OP DIAGNOSIS: Cecal cancer. GROSS DESCRIPTION. Received fresh for tissue procurement labelled ""right. colon"" is a previously unopened 25 cm segment of proximal. right colon with attached 21 cm of distal ileum surfaced by smooth. to slightly scabrous tan-pink serosa with a copious amount of. attached mesocolon, mesentery, and unremarkable omentum. No. appendix is identified grossly. The proximal and distal margins. measure 4.5 and 10.2 cm in circumference respectively. On opening,. there is a moderately well-circumscribed, 5.0 X 4.2 cm rubbery. tan-white-red tumor mass located 3.5 cm distal to the ileocecal. valve. A portion of tumor and a portion of normal mucosa are. submitted for tissue procurement as requested. On sectioning, the. tumor measures up to 0.8 cm in thickness, grossly extending into. muscularis to within 0.15 cm of the inked free radial serosal. surface (see blocks 2-4) Two additional sessile rubbery pale tan. polypoid lesions measuring 0. and 1.0 cm in greatest dimension are. present 8 and 2 cm distal to the aforementioned tumor (see blocks 6. and 7 respectively) . The ileal and remaining uninvolved colonic. mucosa are unremarkable glistening tan-pink with regular folds and. the walls average 0.5 cm in thickness. Multiple soft to slightly. rubbery tan-pink tissues in keeping with lymph nodes measuring up. to. 1.4 cm in greatest dimension are recovered from the attached. mesocolon and mesentery. Representative sections are submitted in. 15 blocks as labelled. RS-15. BLOCK SUMMARY: 1 - proximal and distal margins; 2-4 - tumor. full - thickness to inked free radial serosal surface; 5 - tumor to. normal; 6 - small additional polypoid lesion; 7 - bisected larger. additional polypoid lesion; 8 - random ileum; 9 - ICV; 10 - random. colon; 11-12 - eight whole lymph nodes per cassette; 13 - S whole. lymph nodes; 14-15 - five whole lymph nodes per cassette. MICROSCOPIC DESCRIPTION. Histologic type: Invasive adenocarcinoma, not otherwise specified. Histologic grade Moderately differentiated. Primary tumor (pT) : Tumor invades into muscularis propria, no. invasion into pericolonic fat is identified and the serosal surface. is negative for tumor (pT2). Proximal margin: Negative for tumor. Distal margin: Negative for tumor. Circumferential (radial) margin: Not truly applicable, but the. serosal surface is negative for tumor. Distance of tumor from closest margin: 20 cm from distal margin. Vascular invasion: Not identified. Regional lymph nodes (pN) : Twenty-six lymph nodes are dissected. from the specimen. They are all negative for metastatic tumor. (pNO). Non-lymph node pericolonic tumor: Not identified. Distant metastasis (pM) : Could not evaluate, pMX. Other findings: One tubular adenoma is identified and one serrated. adenoma is identified. Random sections of colon and small. intestine. are unremarkable. 5x1, 3260F. DIAGNOSIS. A. Colon, right, ileocolectomy: Invasive adenocarcinoma, moderately differentiated, invasive. into muscularis propria (pT2). Twenty-six lymph nodes negative for metastatic tumor (pNO) . One tubular adenoma and one serrated adenoma. See Microscopic description. --- End Of Report ---."
BIOCUP_00105,colon,READ,TCGA-DC-6160,TCGA-DC-6160.52adeca8-253e-432d-a349-2eadf318a1aa,"Addendum. Clinical Diagnosis & History: Diagnosed with rectal carcinoma at 15 cm on. rectal carcinoma. Specimens Submitted: 1: SP: Rectum and rectosigmoid. 2: SP: Additional sigmoid. 3: SP: Proximal ring. 4: SP: Distal ring. DIAGNOSIS: 1). COLON, RECTUM AND RECTOSIGMOID, SEGMENTAL RESECTION: - THREE (3) FOCI OF ADENOCARCINOMA, MODERATELY DIFFERENTIATED, OF. SIGMOID AND RECTOSIGMOID. - THE TUMORS MEASURE 2.9 X 1.8 X 0.8 CM, 0.4 x 0.4 x 0.2 CM, AND 0.7 X. 0.5 X 0.2 CM, RESPECTIVELY. - GROSS CONFIGURATIONS ARE POLYPOID. - PREEXISTING TUBULAR ADENOMA IS IDENTIFIED. - TWO SMALLER TUMORS INVADE INTO THE SUBMUCOSA (pT1) . - THE LARGEST TUMOR INVADES INTO MUSCULARIS PROPRIA (pT2). - NO VASCULAR INVASION IS IDENTIFIED. - NO PERINEURAL INVASION IS IDENTIFIED. - SURGICAL MARGINS ARE FREE OF TUMOR. - ADDITIONAL HYPERPLASTIC POLYP IS IDENTIFIED. THE UNINVOLVED COLONIC MUCOSA IS UNREMARKABLE. - LYMPH NODES: NUMBER OF METASTASES:0 NUMBER EXAMINED: 8 (0/8). (ADDITIONAL LYMPH NODES ARE BEING EXAMINED AND AN ADDENDUM REPORT WILL. FOLLOW) . 2). COLON, ADDITIONAL SIGMOID, SEGMENTAL RESECTION: - HYPERPLASTIC POLYP. - UNREMARKABLE COLONIC MUCOSA. - ONE BENIGN LYMPH NODE (0/1). 3). COLON, PROXIMAL RING, EXCISION: - UNREMARKABLE COLONIC MUCOSA. 4. COLON, DISTAL RING, EXCISION: - UNREMARKABLE COLONIC MUCOSA. I. ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1. Gross Description: 1) The specimen is received fresh labeled ""rectum and rectosigmoid"". It. consists of a rectosigmoid colon that measures 12.0 cm in length by 7.0 cm. in circumference at the distal resection margin. The serosal surface is pink. and smooth. The radial resection margin is inked black and the specimen is. opened to reveal a pink-tan papillary tumor measuring 2.9 cm in length by. 1.8 cm in width by 0.4 cm, located 3.5 cm from the distal resection margin. There is a smooth sessile polyp measuring 0.4 x 0.4 x 0.2 cm, located 0.7 cm. from the tumor, and 5.0 cm from the closest (distal) resection margin. There. is a second pink-tan smooth sessile polyp measuring 0.6 x 0.4 x 0.2 cm,. located 1.2 cm from the tumor, and 3.2 cm from the distal resection margin. (arbitrarily designated P2) There is a third pink-tan smooth sessile polyp. measuring 0.7 x 0.5 x 0.2 cm, 1.0 cm distal to the tumor, and 1.8 cm from. the distal resection margin (arbitrarily designated P3) . The three polyps. are blocked out and entirely submitted. The tumor is sectioned to reveal a. well defined pink-white extension to depth of 0.8 cm grossly not involving. the underlying fat, and 1.2 cm from the inked radial resection margin. Representative sections of the tumor are submitted. Remaining mucosa is. otherwise grossly unremarkable. The specimen is submitted for lymph nodes. and possible lymph nodes are submitted. TPS is taken. Representative. sections are submitted. Summary of sections: PM - proximal margin. DM distal margin. RM -- radial margin. T-- tumor. P1, P2, P3polyps submitted from proximal to distal. T tumor. U - undesignated. LN. lymph nodes. RM- radial margin. 2) The specimen is received fresh labeled ""Additional sigmoid"" and consists. of a previously opened portion of bowel measuring 5.6 cm in length by 5.3 cm. in circumference. There is attached pericolic fat extending 6.2 cm in. length. The mucosa reveals a central pink-tar smooth sessile polyp. measuring 0.5 x 0.4 x 0.2 cm, 2.8 cm from the nearest unoriented resection. margin. The polyp is blocked out entirely submitted. The remaining mucosa is. otherwise grossly unremarkable. Representative sections including margins. are. submitted. The specimen is submitted for lymph dissection, and all. identified lymph nodes are submitted. Summary of sections: M1-margin one. M2-opposing margin. P-polyp. U - undesignated. LN - lymph nodes. 3) The specimen is received in formalin, labeled ""proximal ring"" and. consists of a silver metal anastomotic pin measuring 7.5 x 2.8 x 1.5 cm. At. the center of the pin, a plastic piece is noted. A ring of pink tan soft. tissue is attached measuring 2.0 x 1.8 x 0.5 cm. The mucosal surface. is. pink tan and focally hemorrhagic and the serosal surface is pink tan and. smooth. Several sutures and staples are noted. The sutures and staples are. removed and the soft tissue is entirely submitted. Summary of sections: - undesignated. 4) The specimen is received in formalin, labeled ""distal ring"" and consists. of a ring of pink tan soft tissue measuring 1.8 x 1.8 x 0.7 cm. Multiple. sutures and staples are attached. The mucosal surface is pink tan and. focally hemorrhagic. The sutures and staples are removed and the soft tissue. is entirely submitted. Summary of sections: U --undesignated. Summary of Sections: Part 1: SP: Rectum and rectosigmoid. Block. Sect. Site. PCs. 5. ADD. 9. 1. BLN. 2. 2. DM. 2. 6. LN. 12. 1. P1. 1. 1. P2. 1. 1. P3. 1. 2. PM. 2. 1. RM. 1. 3. T. 3. 1. U. 1. Part 2: SP: Additional sigmoid. Block. Sect. Site. PCs. 4. add. 8. 1. LN. 4. 2. M1. 2. 2. M2. 2. 1. U. 1. Part 3: SP: Proximal ring. Block. Sect. Site. PCs. 2. u. 2. Part 4: SP: Distal ring. Block. Sect. Site. PCs. 2. u. 2. Procedures/Addenda: Addendum. Addendum Diagnosis. PART #1 COLON, RECTUM AND RECTOSIGMOID, RESECTION: EIGHT ADDITIONAL LYMPH NODES ARE IDENTIFIED; THE FINAL LYMPH NODE COUNT IS. 0/16, pNO."
BIOCUP_00106,colon,COAD,TCGA-AD-A5EJ,TCGA-AD-A5EJ.7C291BB4-B97B-4EE1-BEB2-3B05FABD24E2,"PROCEDURE DATE: RECEIVED DATE: Pre-Op Diagnosis. Right colon cancer. Post-Op Diagnosis. Same as above. Clinical History. Nothing indicated. Gross Description: Received in a single container labeled. - right colon. and terminal ileum"" is a 23 cm previously opened portion of large. bowel including cecum, as well as 8 cm of attached previously opened. terminal ileum. The specimen is covered by a moderate amount of. pericolic and epiploic adipose tissue in which a 8.4 x 0.8 x 0.8 cm. grossly unremarkable vermiform appendix is identified. The visible. serosa is focally shaggy and tan pink with a few fibrofatty. adhesions. Noted at a point approximately 9 cm from the distal. margin is a 3.3 x 3.2 cm area of indurated umbilication of the. serosa. The specimen has been received after tissue harvest for. genomic study. Within the specimen container are three tissue. cassettes each labeled. The bowel wall is up to. 0.6 cm edematous and fibrotic. The lumen is lined by tan pink mucosa. with preservation of intestinal folds. In the area corresponding to. the umbilication at a point 8.6 cm from the distal margin and 3.8 cm. from the ileocecal valve is a partially sectioned 9.2 x 7.5 cm. plaque like finely granular centrally ulcerated tan pink lesion with. raised rolled borders. This has a gritty gray tan fibrotic cut. surface measuring up to 3.2 cm in thickness. The lesion grossly. extends through the muscularis but is limited by the serosa in the. area away from the pericolic fat. In the area of the pericolic fat. the lesion grossly appears to focally extend through the wall into. the adipose tissue where it is seen at its nearest point. approximately 0.9 cm from the nearest outer surface margin. The. lesion is noted within 0.1 cm of the outer surface in the area of. the serosa. Noted scattered along the length of the bowel are a few. additional tan gray polypoid excrescences up to 0.8 cm which are. unfixed to the underlying muscularis. On sectioning the surrounding. adipose tissue reveals multiple poorly defined fleshy tan pink to. yellow nodules up to 1.5 cm. Representative sections are submitted. labeled as follows: A - proximal margin; B - distal margin; C-G -. representative lesion and surrounding tissue; H - representative. polyps; I - random uninvolved bowel; J - appendix; K-N - individual. pericolic nodules bisected; O-R - whole smaller pericolic nodules. Microscopic Description: The slides labeled. are examined. See diagnosis. Final Diagnosis. Distal ileum, appendix, and right colon (right colectomy): Tumor characteristics: Tumor site: Cecum. Size: 9.2 cm in greatest diameter. Macroscopic tumor perforation: Not identified. Histologic type: Adenocarcinoma. Grade: Moderately differentiated. Microscopic tumor extension: Carcinoma extends through muscularis. propria into subserosal adipose tissue. Margin Status: Proximal margin: No carcinoma identified. Distal margin: No carcinoma identified. Circumferential radial/mesenteric margin: No carcinoma. identified. Distance of tumor from closest margin: 1 mm from the. circumferential radial margin. Treatment effect: Unknown. Lymphovascular space invasion: No unequivocal lymphovascular. space invasion identified. Perineural invasion: Not identified. Presence of mesenteric tumor deposits: Not identified. Lymph Node Status: Total number of lymph nodes examined: 32. Total number of lymph nodes containing metastatic carcinoma: Zero (0/32) PAS 9. Other findings: Scattered foci of lymphoid aggregates. PAS 6. Scattered hyperplastic polyps. PAS 4. Appendix: No carcinoma is identified. PAS 1 SPC-A. Stage: pT3NO. Comments. At the request of the undersigned pathologist, these slides have. been additionally reviewed by Dr. who concurs with the. diagnosis."
BIOCUP_00107,colon,COAD,TCGA-QG-A5YX,TCGA-QG-A5YX.D948972B-8F4F-4C2A-9072-7D4A7E1B58DE,"urgical Pathology: PATHOLOGIC DIAGNOSIS. A. COLON, SIGMOID, SIGMOIDECTOMY: - INVASIVE ADENOCARCINOMA. - TUMOR SITE: SIGMOID COLON. - TUMOR SIZE: - GREATEST DIMENSION: 7.6 CM. - ADDITIONAL DIMENSIONS: 3.2 CM X 2 CM. - HISTOLOGIC GRADE: LOW-GRADE (WELL TO MODERATELY. DIFFERENTIATED). - MICROSCOPIC TUMOR EXTENSION: - TUMOR INVADES THROUGH MUSCULARIS PROPRIA. INTO THE SUBSEROSAL ADIPOSE TISSUE. - MARGINS: - PROXIMAL, DISTAL AND RADIAL MARGINS UNINVOLVED. BY INVASIVE CARCINOMA. - DISTANCE OF INVASIVE CARCINOMA FROM CLOSEST. MARGIN: 2 MM FROM RADIAL MARGIN. - TREATMENT EFFECT: NOT KNOWN. - LYMPHOVASCULAR INVASION: PRESENT. - PERINEURAL INVASION: NOT IDENTIFIED. - TUMOR DEPOSITS: NOT IDENTIFIED. - LYMPH NODES: NO METASTATIC CARCINOMA IDENTIFIED. IN THIRTEEN LYMPH NODES (0/13) (SEE COMMENT). B. COLON, DESCENDING, NEW PROXIMAL MARGIN, EXCISION: - UNREMARKABLE COLONIC MUCOSA AND WALL. C. COLON, DESCENDING, PROXIMAL DONUT, EXCISION: - UNREMARKABLE COLONIC MUCOSA AND WALL. D. RECTUM, DISTAL DONUT, EXCISION: - UNREMARKABLE COLONIC MUCOSA AND WALL. E. SPLEEN, SPLENECTOMY: - BENIGN PARENCHYMA WITH SUBCAPSULAR HEMORRHAGE. PATHOLOGIC STAGING: Primary Tumor (pT): pT3. Regional Lymph Nodes (pN): pNO. Distant Metastasis (pM): Not applicable. Pathologic Staging: IIA. Comment. Please see surgical report. for complete information regarding. microsatellite instability testing, which reveled positive staining by tumor. for MSH-2, MSH-6, PMS-2, and MLH-1. The specimen was examined twice in order to identify a total of thirteen. lymph nodes (0/13). Intraoperative Consultation. Intraoperative Gross Consultation Diagnosis. Part A: Sigmoid colon, sigmoid colectomy: - Tumor grossly located 2.5 cm from proximal margin. - Verbally reported to. Pathology Resident. Pertinent Clinical Information. Pertinent History/Operative Findings: -year-old with history of sigmoid. colon cancer. Tattooed sigmoid mass resected with appropriate margins. (greater than 3 cm). Gross Description. Specimen Material: A- Sigmoid colectomy - stitch distal, B- Descending. colon - new proximal margin- long silk suture, C- Proximal donut from. descending colon, D- Distal donut from rectum, E- Spleen. The case is received in five parts, each labeled with the patient's name. medical record number and given accession number. and it is accompanied by a requisition form labeled with the same. name and accession number. Part A: Received fresh labeled with the patient's name and ""SIGMOID. COLECTOMY GROSS MARGIN, STITCH DISTAL"" is a 26.0 cm long section of sigmoid. colon with an average diameter of 3-4cm. The specimen is received stapled. at both ends, and there is a stitch at the distal end, as oriented by the. surgeon. The radial margin is inked black. The serosal surface is smooth,. yellow, with abundant attached peri-sigmoidal fat. The mucosa is tan with. normal plications. A 7.6 X 3.2 cm tan-brown fungating mass in present. within the lumen, located 2.5 cm from the nearest margin (proximal margin). The mass extends grossly to the serosa with a maximal depth of 2.0 cm, and. is solid, tan, with a central clear mucinoid area. Multiple bright yellow. oval lymph nodes ranging from 0.2 to 1.0 cm are identified. Representative sections are submitted as follows: A1: four presumptive lymph nodes. A2: representative section of proximal margin, en face. A3: representative section of distal margin, en face. A4: uninvolved colon. A5-A7: tumor to greatest depth of invasion. A8-A11: tumor. A12: five lymph nodes. A13: five lymph nodes. A14: five lymph nodes. A15: two lymph nodes. A16: four lymph nodes. A17: two lymph nodes. A18: tumor. Part B: Received in formalin labeled with the patient's name and ""NEW. PROXIMAL MARGIN"" is a 1.6 cm long and 1.7 cm diameter piece of tan-pink. colon. The long stitch identifies the new proximal margin, as oriented by. the surgeon, which is received stapled. The serosa is smooth and pink. The. mucosa is tan, smooth and normally plicated. Cassette Summary: B1: margin, en face. Part C: Received in formalin labeled ""PROXIMAL DONUT FROM DESCENDING COLON"". is a 2 X 2 X 0.5 cm tan-pink mucosal donut with attached blue Prolene. suture. The mucosal surface is tan and edematous with petechial hemorrhage. identified. No discrete masses are found. A representative section is. submitted in C. Part D: Received in formalin labeled ""DISTAL DONUT FROM RECTUM"" is a 1 X. 1. x 0.8 cm tan-pink, mucosal donut. The mucosal surface is edematous and. displays petechial hemorrhage. No discrete masses are identified. A. representative section is submitted in D. Part E: Received in formalin labeled ""SPLEEN"" is a 78 gram, 9.0 x 6.0 x 2.8. cm tan-pink to pink-purple spleen with little attached hilar fat. The. capsular surface displays leathery granularity and is gray-maroon, with a. 3.2 X 2.2 cm focus of subcapsular, dark red-brown blood. The cut surface. displays homogenous tan-red parenchyma without lesions. The cut surface of. the subcapsular lesion shows an organizing subcapsular hematoma. No other. discrete lesions are identified. Representative sections are submitted in cassettes: E1: subcapsular hematoma. E2: parenchyma. Microscopic Description. A-E: Performed. The staff pathologist listed below reviewed this case. Pathology Resident."
BIOCUP_00108,colon,COAD,TCGA-AA-A00N,TCGA-AA-A00N.8A14A987-711E-49C0-AA34-2F035B02CD8A,"Diagnosis: Ileocolonic resectate under inclusion of a poorly differentiated mucinous adenocarcinoma. of the colorectal type, located in the cecum/ascending colon and of max. 7.5 cm in. diameter, with circumscribed penetration of the serosa. Tumor-free regional lymph. nodes. Tumor-free small and large intestinal resection margins. Tumor-free mesenteric. resection margin. Tumor-free omental fat tissue. Tumor stage: pT4 pNO (0/20) pMX; G3; L1, V0, locally R0. A further lymph node is still being decalcified; a follow-up report will be submitted at a. later date. Follow-up report: We now have the histological data on the decalcified lymph node. In this case, there is. also no indication of metastasis from the previously diagnosed carcinoma. Final tumor. stage therefore pT4 pN0 (0/21) pMX; G3; L1, V0, locally R0."
BIOCUP_00109,colon,COAD,TCGA-D5-6540,TCGA-D5-6540.bc47b112-83c6-4192-a914-9c885aeed438,"page 1 / 1. Department OT Cancer Pathology. Examination: Histopathological examination. Material: 1. Total organ resection - colon and caecum. Expected time of examination: Clinical diagnosis: Cancer of the caecum. Macroscopic description: 15 cm length of large intestine with a fragment of mesentery of 20 x 5 x 2 cm and a 10 cm segment of small intestine. and a 7 cm appendix. The mucosa in the caecum tinted green, a defect in the middle part of 2.5 cm in diameter. The defect placed 2 cm from the Baughin valve. Outer surface also tinted green. Some small polyps of up to 0,6 cm in diameter found outside the tumour. Microscopic description: Adenocarcinoma tubulopapillare partim mucinosum (G3). Infiltratio carcinomatosa tunicae muscularis propriae. Minimum side margin is 0.6 cm. Excision lines free of neoplastic lesions. Off tumour: adenoma tubulopapillaria cum dysplasia gradus minoris. Polypus hyperplasticus verticulitis. Sinus histiocytosis et lymphonodorum (No XIII). Histopathology diagnosis: Adenocarcinoma tubulopapillare partim mucinosum coli. Tubulopapillar and partially mucinous adenocarcinoma. of. the colon. (G3, Dukes B, Astler-Coller B1, pT2, pNO)."
BIOCUP_00110,colon,COAD,TCGA-AA-3527,TCGA-AA-3527.401e54d1-5d40-4533-8f5a-939ed4107655,"Diagnosis / Diagnoses: Right hemicolectomy specimen with an ulcerated cecum carcinoma conforming to the. histological type of a moderately differentiated colorectal adenocarcinoma, affecting. Bauhin's valve and with a greatest diameter of 4.5 cm. Invasive spread of tumor within. all layers of the intestinal wall and as far as the neighboring mesocolic fatty tissue and the. subserosa. Remainder of colon mucosal membrane with a hyperplastic polyp. Appendix with apparent post-inflammatory fibrosis of the wall. Oral and aboral resection margins and large omentum tumor-free. Fifteen mesocolic and mesenteric lymph nodes tumor-free with uncharacteristic reactive. changes. Tumor stage thus pT3 pNO (0/15) L0, V0; G2."
BIOCUP_00111,colon,COAD,TCGA-CM-6679,TCGA-CM-6679.59284f77-b8bd-4e43-a940-70c2a80442f2,"Clinical Diagnosis & History: Sigmoid cancer 25cm anterior resection. Specimens Submitted: 1: Sigmoid colon. 2: Proximal ring. 3: Distal ring. DIAGNOSIS: 1. Sigmoid colon: Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Sigmoid colon. Tumor Size: Length is 2.8 cm. Width is 6.5 cm. Maximal thickness is 0.7 cm. Tumor Budding: Focal. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Not identified. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Not identified. Large Venous Invasion: Not Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Lymph Nodes: Number with metastasis: 0. Total number examined: 21. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : NO (No regional lymph node metastasis). 2. Colon, proximal ring excision: - Colonic mucosa with hyperplastic features. - No tumor seen. 3. Colon, distal ring. excision: - Colonic mucosa with hyperplastic features. - No tumor seen. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) The specimen is received fresh and is labeled ""Sigmoid colon"". It. consists of a portion of sigmoid colon that measures 18.5cm in length x 10.0. cm in open circumference at the distal margin. The serosal surface is pink. tan and unremarkable. The radial resection margin is inked black and the. specimen is opened to reveal a tumor that is located 9.0 cm from the. proximal margin and 6.0 cm from the distal margin. The tumor measures 2.8 cm. in length and 6.5 cm in width. Serial sectioning reveals tumor extending to. a. depth of 0.7 cm, through the muscularis and grossly approaching into the. underlying pericolic fat. The tumor is 4.0 cm from the closest radial. margin. The remaining mucosa shows tan-yellow grossly unremarkable mucosal. folds. Pericolic and peri-rectal adipose tissue is thoroughly examined for. lymph nodes, and all possible nodes are submitted. Representative sections. are submitted. TPS is submitted. Summary of sections: PM - proximal margin. DM - distal margin. RM - radial margin. T tumor. RS - uninvolved mucosa. LN - lymph nodes. BLN - bisected lymph node. 2) The specimen is received in formalin, labeled ""Proximal margin"" and. consists of a silver metal anastomotic pin measuring 7.5 X 2.8 X 1.5 cm. At. the center of the pin, a green plastic piece is noted. A ring of pink tan. soft tissue is attached measuring 2.5 x 1.6 x 1.0 cm. The mucosal surface. is pink tan and focally hemorrhagic and the serosal surface is pink tan and. smooth. Several sutures and staples are noted. The sutures and staples are. removed and the soft tissue is entirely submitted. Summary of sections: U - undesignated. 3) The specimen is received in formalin, labeled ""Distal ring"" and consists. of a ring of pink tan soft tissue measuring 2.8 x 1.6 x 1.1 cm. Multiple. sutures and staples are attached. The mucosal surface is pink tan and. focally hemorrhagic. The sutures and staples are removed and the soft tissue. is entirely submitted. Summary of sections: U - undesignated. Summary of Sections: Part 1: Sigmoid colon. Block. Sect. Site. PCs. 6. BLN. 11. 3. DM. 3. 4. LN. 15. 2. PM. 2. 1. RM. 1. 2. RS. 2. 3. T. 3. Part 2: Proximal ring. Block. Sect. Site. PCs. 3. U. 5. Part 3: Distal ring. Block. Sect. Site. PCs. 3. U. 6."
BIOCUP_00112,colon,READ,TCGA-AF-3913,TCGA-AF-3913.df1ab72f-80e5-4f91-ba98-623c4d48b50d,"SPECIMEN. A. Right pelvic lymph nodes grossly suspicious only. B. Left pelvic lymph nodes grossly suspicious only. C. Prostate. D. spleinc flexure colon. E. Recto-sigmoid colon. F. Appendix. CLINICAL NOTES. PRE-OP DIAGNOSIS: Cancer of the rectum and prostate. FROZEN SECTION DIAGNOSIS. FSA) No frozen section done. FSB) No frozen section done. GROSS DESCRIPTION. A. Is submitted fresh for possible frozen, labeled ""right. pelvic lymph nodes"" It consists of a 6 x 4 X 2 cm. portion of lymph node-bearing fat, which contains numerous steel. clips. The section of the fat reveals the presence of five. suspected lymph nodes. The smallest of these is 5 mm. in size, the. largest 3 cm. Bisecting all of the lymph nodes shows them to be. made up of soft fleshy reddish-brown tissue without grossly. suspicious areas of metastasis, therefore no frozen sections are. performed as per request of Dr. BLOCK SUMMARY: Block [09-30] - Quadrisected lymph node, [09-. 30) in each. cassette; blocks 5,6 - bisected lymph node, half in each cassette;. block 7 - two additional lymph nodes. RS-7. B. Is submitted fresh, labeled ""left pelvic nodes"" and. consists of a 3 X 3 x 2 cm. mass of lymph node-bearing. fat. The section of fat reveals a large single lymph node present,. measuring 4 X 2 x 1 cm. Bisecting the node shows it to be soft,. without evidence of any firm or suspicious areas. Therefore, no. GROSS DESCRIPTION. frozen section is done per request of Dr. 1). The single node is. bisected, half submitted in each cassette. RS-2. C. Received fresh, subsequently fixed in formalin,. labeled. ""prostate"" is a 28 gm prostate. This has an inserted catheter and. the prostate, itself, is 4.5 x 3.5 x 3.2 cm. This has attached. bilateral adnexa. The seminal vesicles average 2.2 x 1 x 0.7 cm. and. the vasa deferentia average 2.2 x 0.5 cm. The right side is inked. blue and the left side is inked black. The adnexa is amputated. from. the specimen and the apical and bladder margins are coned from the. specimen. The remainder of the specimen is sectioned from apex to. base to show a pink-tan rubbery and nodular cut surface with no. other discrete gross lesions identified. Representative sections. of. the specimen which include the entire prostate are submitted as. follows Block 1 - apical margin; block 2 - bladder margin; blocks. 3, 4 - slice 1 full thickness composite; blocks 5, 6 - slice 2 full. thickness composite; blocks 7, 8 - slice 3 full thickness. composite;. blocks 9, 10 - slice 4 full thickness composite; blocks 11, 12 -. slice 5 full thickness composite; blocks 13, 14 - slice 6 full. thickness composite; block 15 - last slice, slice 7, bisected full. thickness composite; block 16 - base of adnexa and possible vas. deferential margin. RS-16 (entire prostate submitted). D. Received fresh, subsequently fixed in formalin,. labeled. ""splenic flexure colon. The specimen consists of a 7 cm. long portion of colon which is stapled at both ends. The ends of. the specimen are arbitrarily inked blue and black. The serosa is. pink-tan smooth glistening and the specimen is partially covered. with fat. The specimen is previously opened to show a pink-tan. smooth glistening mucosa, having a circumference of 8.5 cm. There. is a large exophytic mass measuring 4 X 3.2 x 2.2 cm. This is. located equidistant in the specimen. There are two additional. small. polyps grossly identified in the mucosa which are 0.2 cm and 0.3 cm. in greatest dimension. The smaller is located 2 cm from the. nearest. luminal margin (inked black) and the larger is located 1.5 cm from. GROSS DESCRIPTION. the tumor located equidistant between both luminal margins. Lymph. nodes are grossly identified in fat. The cut surface of the tumor. shows minimal invasion into the muscularis propria, not through the. muscularis propria, and comes within 1.5 cm of the deep more radial. margin. Representative sections of the specimen are as follows : BLOCK SUMMARY: Block 1 - Representative luminal margins; block 2 -. small polyp; blocks [11-30] - representative sections of tumor. to normal. and radial margin; block 6 - has two possible lymph nodes. RS-6. E. Received fresh, subsequently fixed in formalin,. labeled. ""rectum and sigmoid. "" The specimen consists of a. rectosigmoid colon which is 13 cm long. The specimen is opened at. one end (inked blue) and at the opposite end is stapled. The. stapled end is inked black. The specimen is partially covered with. pink-tan, smooth glistening serosa and yellow lobular fat. The. retroperitoneal reflection is located 5 cm from the black inked end. The specimen is opened to show a pink-tar smooth glistening mucosa. with an average circumference of 7 cm. There is a large exophytic. mass which is 5.5 x 3.5 X 1.2 cm located 2.5 cm from the distal. margin. There are additional small polyps which range from 0.5 cm. to 1 cm. These are located within 0.5 cm of the blue-inked end to. 5. cm of the black inked end. The cut surface of the small polyps. shows no discrete invasions of muscularis propria. The cut surface. has a large mass and shows invasion through the muscularis propria. and comes within 2.5 cm of the radial margin. Lymph nodes are. grossly identified in the fat. Representative sections of the. specimen are as follows : BLOCK SUMMARY : Block 1 - representative luminal margins which. include small polyp at proximal end; blocks 2, 3 - additional. polyps; blocks [01-01] - tumor to normal and deep; block 7. representative radial margin; blocks 8, 9 - have nine possible. lymph. nodes each; block 10 - has five possible lymph nodes; block 11 -. has. four possible lymph nodes; block 12 - has one possible lymph node. GROSS DESCRIPTION. bisected. RS-12. -. F. Received in formalin labeled ""appendix"" is a grossly. unremarkable appendix, partially covered with yellow. lobular fat and pink-tan smooth glistening serosa. The specimen. is. 6.5 X 0.5 cm. The specimen is sectioned to show an intact wall. with. an average thickness of 0.4 cm. The lumen ranges from pinpoint to. 0.3 cm. No other discrete gross lesions are identified. Representative sections of the specimen are submitted in one. cassette with the proximal end inked. RS-1. MICROSCOPIC DESCRIPTION. A-C: Prostate, seminal vesicles, and bilateral pelvic nodes -. Histologic type: Adenocarcinoma, NOS. Histologic (Gleason) grade 7 (3+4). Primary tumor (pT) : Tumor involves the left lobe of the prostate. gland and exhibits extraprostatic extension (pT3a). Extraprostatic extension: Present. Seminal vesicle invasion: Negative. Margins of resection: Negative. Regional lymph nodes (pN) : Right and left pelvic nodes are. negative. for metastatic carcinoma (pNo). Distant metastasis (pM) : Cannot be assessed (pMx) . Vascular invasion: Negative. Other findings : Perineural invasion by tumor is present. D. Splenic flexure colon -. Histologic type: Adenocarcinoma. Histologic grade: Moderately-differentiated. Primary tumor (pT) : Tumor has invaded into, but not through, the. MICROSCOPIC DESCRIPTION. muscularis propria (pT2). Proximal margin: Negative. Distal margin Negative. Circumferential (radial) margin: Negative. Vascular invasion: Negative. Regional lymph nodes (pN) : Two mesenteric lymph nodes are negative. for metastatic carcinoma (pNo). Non-lymph node pericolonic tumor: Absent. Distant metastasis (pM) : Cannot be assessed (pMx) . Other findings : The tumor has arisen in a tubulovillous adenoma. Hyperplastic polyp. E. Rectosigmoid colon -. Histologic type Adenocarcinoma. Histologic grade: Moderately-differentiated. Primary tumor (pT) : The tumor has extended through the muscularis. propria into the pericolonic fat (pT3) . Proximal margin: Negative. Distal margin: Negative. Circumferential (radial) margin: Negative. Vascular invasion : Negative. Regional lymph nodes (pN) : One of 26 mesenteric lymph nodes. contains metastatic adenocarcinoma (pN1a) . Non-lymph node pericolonic tumor Absent. Distant metastasis (pM) : Cannot be assessed (pMx). Other findings : 6 hyperplastic polyps. 5x3, 4, 3, 1, 13x2. DIAGNOSIS. A. Lymph nodes, right pelvic resection: Four lymph nodes negative for metastatic carcinoma (0/4). DIAGNOSIS. B. Lymph node, left pelvic, resection: Single lymph node negative for metastatic carcinoma (0/1) . C. Prostate and seminal vesicles, resection: Invasive moderate to poorly-differentiated prostatic. adenocarcinoma, Gleason's grade 7 (3+4) involving the left. lobe of the prostate gland. Extraprostatic extension is. present. The apex, bladder neck, and capsular margin of resection are. free of involvement by tumor. Seminal vesicles negative for involvement by tumor. Perineural invasion by tumor is present. D. Colon, splenic flexure, segmental resection. Invasive moderately-differentiated adenocarcinoma arising in. a. tubulovillous adenoma. Carcinoma has extended into, but not through, the muscularis. propria. Proximal, distal and radial margins of resection. free of tumor. Two mesenteric lymph nodes negative for metastatic carcinoma. (0/2) Hyperplastic polyp. E. Colon, rectosigmoid, segmental resection. Invasive moderately-differentiated colonic adenocarcinoma. extending through the wall of the colon into the serosal fat. Proximal, distal and radial margins of resection are free of. tumor. One of 26 mesenteric lymph nodes contains metastatic. adenocarcinoma. Six hyperplastic polyps. DIAGNOSIS. F. Appendix, incidental appendectomy : No significant histopathologic findings. 3. --- End Of Report."
BIOCUP_00113,colon,COAD,TCGA-AZ-5407,TCGA-AZ-5407.6c27f8b9-9e3c-4665-a176-a4679eed1fa9,"PATIENT HISTORY: Colon mass. PRE-OP DIAGNOSIS: Colon mass. POST-OP DIAGNOSIS: Same. PROCEDURE: Laparoscopic colectomy attempted, open right colectomy done. FINAL DIAGNOSIS: SEGMENT OF TERMINAL ILEUM AND RIGHT HEMICOLECTOMY. A. INVASIVE WELL-DIFFERENTIATED COLON ADENOCARCINOMA. a. 0.9 CM INVASIVE TUMOR INTO SUB-MUCOSA. b. INVASIVE CARCINOMA ARISING IN A 2.5 CM GREATEST DIMENSION TUBULOVILLOUS ADENOMA. WITH SERRATED FEATURES. B. ADDITIONAL NON-INVASIVE ADENOMAS: 2 TUBULOVILLOUS ADENOMAS (2.9 CM AND 1.5 CM) AND. 1. TUBULAR ADENOMA (1.0 CM). c. RESECTION MARGINS ARE FREE OF CARCINOMA AND ADENOMA. D. NO ANGIOLYMPHATIC INVASION IS SEEN. E. SIXTEEN BENIGN LYMPH NODES (0/16). F. PATHOLOGIC STAGE; T1 NO MX. G. TERMINAL ILEUM WITH NO SIGNIFICANT PATHOLOGIC CHANGE. H. APPENDIX WITH TUBULAR CARCINOID TUMOR. a. TUBULAR CARCINOID ARISES IN THE APPENDIX TIP. b. TUBULAR CARCINOID MEASURES 3MM. c. (see comment). COMMENT: Immunohistochemical stains were performed on the appendix (slide C). Appendix tumor cells are weakly positive for. glucagon and positive for CDX2, mCEA, pancytokeratin, and synaptophysin. It is negative for estrogen receptor,. progesterone receptor, chromogranin, and p53. These findings are compatible with a tubular carcinoid. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY COLON, RECTAL, APPENDIX TUMORS. SPECIMEN TYPE: Right hemicolectomy. SPECIMEN LENGTH: 22.5 cm. TUMOR SITE: Cecum. TUMOR CONFIGURATION: Arising in a polyp. TUMOR SIZE: Greatest dimension: 0,9 cm. INTACTNESS OF MESORECTUM: Not applicable. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: Low-grade (well to moderately differentiated). PATHOLOGIC STAGING (pTNM): pT1. pNO. Number of nodes examined: 16. Number of nodes involved: 0. pMX. MARGINS: Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (radial) margin - Not applicable. ANGIOLYMPHATIC INVASION: Absent. PERINEURAL INVASION: Absent. TUMOR BORDER CONFIGURATION: Pushing. TUMORAL LYMPHOCYTIC RESPONSE: None. ADDITIONAL PATHOLOGIC FINDINGS: Adenoma(s). Other polyps (type(s)):2 tubulovillous adenomas, 1 tubular adenoma. SPECIAL PROCEDURES: Microdissection Genotyping. Interpretation. Molecular Anatomic Pathology testing for Microsatellite Instability: A. No microsatellite instability detected (Microsatellite stable). B. Immunohistochemistry for the hMLH1, hMSH2 and hMSH6 showed preserved gene expression. Note: The specimen was analyzed by PCR for microsatellite instability because the patient met one or more of the recently. recommended criteria for testing (1). The five recommended dinucleotide and mononucleotide polymorphisms were utilized to. assess for microsatellite instability (MSI). ZERO of five markers showed evidence of microsatellite instability. Additionally, the immunohistochemistry for hMLH1, hMSH2 and hMSH6 demonstrated preserved nuclear staining in the neoplastic. enithelium as compared to the positive lintest."
BIOCUP_00114,colon,COAD,TCGA-AD-6889,TCGA-AD-6889.baf2a936-e132-47d6-831f-675625feaf0b,"Not for Permanent Storage in Medical Records / Not Valid for Signing. Date of Service. Performing Facility. Result Provider. e. PROCEDURE DATE: SPECIMEN DESCRIPTION: Right colon. PRE-OPERATIVE - DIAGNOSIS: Carcinoma, right colon. POST-OPERATIVE DIAGNOSIS: Same. CLINICAL INFORMATION: Same. GROSS DESCRIPTION: The specimen consists of a segment of terminal ileum, cecum, appendix and. ascending colon with attached mesocolon and omentum. Multiple adhesions are. seen on the surface of the specimen. The terminal ileum measures. approximately 7.0 X 3.0 cm. The colonic and cecal segment measures 15.0 X 2.5. cm. An area of induration and puckering is evident on the anterior aspect. just above what appears to be ileocecal valve. Opening the colon reveals a. large fungating ulcerated mass measuring approximately 8.0 X 9.0 cm involving. the full circumference of the colon. It has a central area of ulceration and. raised irregular erythematous edges. The appendix is dilated and measures 4.0. X 1.0 cm. MICROSCOPIC DESCRIPTION: Sections through the tumor demonstrate a variable pattern. In areas, it. consists of atypical glandular structures formed by cells with irregular and. hyperchromatic nuclei. Additionally, areas consist of poorly differentiated. tumor. Here, the cells form solids nests and cords of spindle and polygonal. shaped cells without gland formation. The tumor invades the muscularis from. an ulcerated mucosal surface and extends into serosal tissues where it is. surrounded by a desmoplastic reaction. Sections through sixteen lymph nodes. disclose lymphoid hyperplasia and reactive changes, but no metastatic tumor. The resection margins are free of tumor as well. The serosal surfaces of the. bowel and appendix demonstrate chronic inflammatory changes. ====. FINAL DIAGNOSIS: ASCENDING COLON WITH CONTIGUOUS TERMINAL ILEUM. CECUM AND APPENDIX: ADENOCARCINOMA OF ASCENDING COLON MODERATE TO UNDIFFERENTIATED. SIXTEEN REGIONAL LYMPH NODES FREE OF TUMOR. TUMOR PERMEATES BOWEL WALL AND EXTENDS TO PERICOLIC ADIPOSE TISSUE. Not for Permanent Storage in Medical Records / Not Valid for Signing. Date of Service. Performing Facility. Result Provider. Report Name. CHRONIC SEROSAL INFLAMMATION. TUMOR SIZE - 9.0 CM. TT3, NO. MX. PROXIMAL DISTAL AND RADIAL MARGINS NOT INVOLVED. LYMPHATIC AND VENOUS INVOLVEMENT IS NOT SEEN. CODE 1 6. PATHOLOGIST COMMENT: The histologic grade of this tumor varies from well to undifferentiated."
BIOCUP_00115,colon,READ,TCGA-AG-A036,TCGA-AG-A036.882191BC-6882-4B56-B100-5235ECEB6396,"Internal Sample IC. Diagnosis/Diagnoses: Rectal resection specimen with fully developed diverticulosis in the proximal segment and. aboral, ulcerated, moderately differentiated adenocarcinoma extending into the perirectal fat. (G2). Tumor-free oral and aboral margins. The clinically reported infiltration of the posterior bladder wall is not detectable microscopically. in the available material. Accordingly the neoplasia may be classified histologically as category. pT3. A follow-up report will be issued on the histology of lymph nodes dissected out from the. perirectal fatty tissue after clarification with acetone. Follow-up report: Numerous lymph nodes of up to 1.2 cm in size were dissected out from the pericolic fatty tissue. in the vicinity of the tumor after clarification with acetone. Of 30 lymph nodes embedded as samples, 18 exhibited metastatic infiltrates from the previously. diagnosed adenocarcinoma or colon carcinoma. In conclusion or in summary, therefore, a stage of pT3 pN2 (18/30) is obtained."
BIOCUP_00116,colon,READ,TCGA-CL-5918,TCGA-CL-5918.4c863c92-359e-4d16-ac0b-aa433ddb2a5e,"PATHOLOGIC DIAGNOSIS: A. SPECIMEN DESIGNATED ""RECTUM AND SIGMOID COLON, PARTIAL COLECTOMY"": (22.0 cm) : ADENOCARCINOMA, low grade, moderately differentiated (6.0 cm in. greatest dimension). Tumor is located in rectum, forms a polypoid mass, and has a. pushing. border. Tumor invades into the muscularis propria. Proximal, distal, and radial resection margins are negative for tumor. Invasive tumor is 18.0 cm from proximal resection margin, 3.3 cm from. distal resection margin, and 0.6 cm from radial resection margin. Lymphovascular invasion is not identified. Extramural venous invasion is not identified. Perineural invasion is not identified. Peritumoral lymphoid response (including Crohn?s-like infiltrate) is. mild. Residual adenoma is absent. Diverticulosis. Regional lymph nodes (positive: total) : 0:14. AJCC Classification (6th edition) : T3 NO MX. B. SPECIMEN DESIGNATED ""UMBILICAL HERNIA"": Inflamed mesothelial-line fibroadipose tissue consistent with hernia. sac. C. SPECIMEN DESIGNATED ""ADDITIONAL PROXIMAL COLON, RESECTION"" (12 cm) : Large bowel with diverticulosis. There is no evidence of malignancy. One lymph node, negative for tumor (0:1) . CLINICAL DATA: History: with rectal cancer. Operation: Lower anterior resection + colostomy. Operative Findings: Not provided. Clinical Diagnosis: Rectal cancer. TISSUE SUBMITTED: A. Low anterior resection open + return. B. Umbilical hernia. c. Additional proximal colon. GROSS DESCRIPTION: The specimen is received fresh, in three parts, each labeled with the patient'. name and unit number. Part A, ""low anterior resection"", consists of a segment of colon, consisting of. rectum (22.0 cm in length x 4.9 cm in diameter) and sigmoid (7.5 cm in length x. 4.5 cm in diameter). The distal stapled resection margin (4.3 cm in length) is. inked black and the proximal stapled resection margin (5.5 cm in length) is. inked blue. There is abundant yellow-red mesocolon and the serosa is tan-pink. and smooth. The specimen is opened to exhibit a tan-pink, friable, exophytic. Page: 1 of 2. mass (6.0 x 4.2 x 1.2 cm), which exhibits rolled up borders and is located 3.3. cm from the distal margin and 18.0 cm from the proximal margin. A. representative section of the tumor and of normal colon is allocated to tissue. bank. On cut section, the mass is tan-pink, measures up to 1.9 cm in greatest. thickness and comes to 0. 6 cm from the deep margin (inked orange). The mass. invades muscularis propria. The uninvolved mucosa is tan-pink and exhibits. several uncomplicated diverticula. Multiple tan-pink lymph node candidates' are. identified ranging from 0.3 to 1.3 cm in greatest dimension. Micro A1: Perpendicular proximal and distal margins, 2 frags,. Micro A2: En face radial margin, 1 frag,. Micro A3-A7: Fungating mass to include greatest depth (A3), 1 frag in each,. RSS. Micro A8: Diverticulum, 1 frag,. Micro A9: 1 trisected lymph node candidate, 3 frags,. Micro A10-A11: 5 lymph node candidates in each, 5 frags in each. Micro A12-A13: 4 lymph node candidates in each, 4 frags in each. Micro A14: 5 lymph node candidates, 5 frags,. Part B, ""umbilical hernia"", consists of an irregular tan-pink smooth to focally. ragged fibromembranous saccular soft tissue (3.0 x 2.0 x 1.0 cm), which is. serially sectioned to exhibit a tan-pink surface. No hemorrhage or necrosis is. noted. Micro B1: 2 frags,. Part C, ""#3. Additional proximal colon"", consists of a segment of colon (12.0. cm in length X 2.0 cm in diameter) with an opened resection margin (2.5 cm in. length - inked blue) and a stapled resection margin (3.5 cm in length - inked. black) The attached abundant mesocolon is yellow-red unremarkable. The. serosa is tan-pink, smooth, and glistening. The specimen is opened to exhibit. a tan/pink glistening mucosa with normal fold architecture. Several. uncomplicated diverticula are identified. No masses or lesions are identified. A 0.3 cm tan-pink lymph node candidate is identified. Micro C1: Perpendicular margins, 2 frags. Micro C2-C3: Diverticulum, 3 frags total. Micro C4: 1 lymph node candidate, 1 frag. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis(es). related thereto. Page: 2 of 2."
BIOCUP_00117,colon,COAD,TCGA-G4-6304,TCGA-G4-6304.0e039ee7-40eb-4b0f-9a26-462f68940e85,"SPECIMENS: A. STOMACH, TRANSVERSE COLON, RIGHT COLON, TERMINAL ILLEUM, PORTION OF SMALL. INTEST. B. GASTRIC SUTURE LINE. DIAGNOSIS: A. TERMINAL ILEUM, RIGHT COLON, TRANSVERSE COLON, OMENTUM, MID JEJUNUM,. GREATER CURVATURE OF STOMACH, AND ABDOMINAL WALL, EN BLOC RESECTION: - INVASIVE POORLY DIFFERENTIATED ADENOCARCINOMA INVOLVING PERICOLIC FAT AND. GASTRIC MUSCULARIS PROPRIA AND SPARING GASTRIC MUCOSA. - ADJACENT ACUTE SUPPURATIVE AND CHRONIC INFLAMMATION WITH ABSCESS. FORMATION INVOLVING ADHERED SEGMENT OF SMALL INTESTINE WITH INTESTINAL. PERFORATION, ABDOMINAL WALL SKELETAL MUSCLE, AND SUBCUTANEOUS ADIPOSE. TISSUE (ALL NEGATIVE FOR CARCINOMA). - INVASIVE CARCINOMA SIZE 4.5 X 4.5 CM. - FOCAL SQUAMOUS DIFFERENTIATION PRESENT. - NO TUMOR SEEN IN TWENTY FIVE LYMPH NODES (0/25). - MARGINS NEGATIVE FOR CARCINOMA. - GASTRIC MUCOSA WITH FOCAL CHRONIC GASTRITIS. - ACUTE SEROSITIS. - SEE TEMPLATE. B. GASTRIC SUTURE LINE, EXCISION: - GASTRIC MUCOSA, NO TUMOR SEEN. COLORECTAL CANCER TEMPLATE. SPECIMEN TYPE: En bloc resection of terminal ileum, right colon, transverse colon, mid jejunum,. greater curvature of stomach, and abdominal wall. TUMOR SITE: Transverse colon. TUMOR CONFIGURATION: Infiltrative and ulcerating. TUMOR SIZE: 4.5 X 4.5 cm. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G3. EXTENT OF INVASION: Adjacent structures. MARGINS: Negative for carcinoma (proximal, distal, and radial). LYMPHOVASCULAR INVASION: No definite invasion seen. PERINEURAL INVASION: No definite invasion seen. ADDITIONAL PATHOLOGIC FINDINGS: Abscess formation and dense adhesions. EXTENT OF RESECTION: R0. LYMPH NODES: Negative (0/25). PATHOLOGIC STAGE: pT4 NO Mx. SPECIMEN(S): A. STOMACH, TRANSVERSE COLON, RIGHT COLON, TERMINAL ILLEUM, PORTION OF SMALL. INTEST B. GASTRIC SUTURE LINE. CLINICAL HISTORY: Colon carcinoma. GROSS DESCRIPTION: A. STOMACH, TRANSVERSE COLON, RIGHT COLON, TERMINAL ILEUM, PORTION OF SMALL. INTESTINE. Received fresh is a specimen consisting of segment of terminal ileum (3.0 X 3.0 cm), ascending colon. with transverse colon (27 X 8 cm), a portion of distal stomach (7.0 X 4.5 cm) and a segment of small. bowel (6 X 4 cm) with segment of omentum measuring 22 X 4 cm. The proximal ileal and distal colonic. resection margins measure 3.0 cm and 7.0 cm in circumference. An ellipse of skin measuring 16 X 3.5. cm is also seen. Altogether, the specimen is en bloc resection of transverse colon carcinoma that. invades the gastric wall (the mucosa is grossly negative for tumor) and associated with adjacent cavity. and abscess formation and induration that involves subcutaneous adipose tissue and abdominal wall. muscle, and penetrates the adhered segment of small intestine; the latter has mucosal defect. corresponding to this process. The colonic tumor itself measures 4.5 X 4.5 cm (located 5 cm from distal. margin) and the associated cavity 4.0 X 4.0 cm. Appendix could not be identified. Multiple lymph nodes. are seen (the largest measures 0.7 cm), they are grossly negative for tumor. Representative sections. are submitted in: A1: proximal ileal margin. A2: distal colonic margin. A3: small bowel margin. A4: gastric margin. A5-A8: tumor. A9: stomach with tumor. A10: Small intestine lesion. A11: skin with subcutaneous tissue. A12: cavity with fat. A13: random colonic mucosa. A14-A23: possible lymph nodes (A20 has bisected lymph node). A24-A27: additional sections of the cavity. A28-A33: lymph nodes. B. GASTRIC SUTURE LINE. Received in formalin is a 12.0 X 0.7 cm mucosa tissue with staples. Representative tissue is submitted. in one cassette."
BIOCUP_00118,colon,COAD,TCGA-AA-A01I,TCGA-AA-A01I.51A15A40-E611-49C3-AB69-638871664D86,"Diagnosis: Resected section of colon (left hemicolon) with two colon carcinomas characterized. histologically as colorectal adenocarcinoma of similarly moderate differentiation, one. located at a distance of 3.5 cm from the resection margin, with a diameter of 3.5 cm at the. widest point, and the other located 18 cm from the same resection margin, and measuring. 3.3 cm at the widest point, one at the base of a tubulovillous adenoma with severe epithelial. dysplasia (synonymous: profound intraepithelial neoplasia), and the other clearly at the. base of a tubular adenoma with severe epithelial dysplasia (synonymous: profound. intraepithelial neoplasia). Invasive spread of the tumor to the layers of the muscularis. propria. Mucous membrane of the colon with a tubulovillous adenoma of the colon mucosa with. severe epithelial dysplasia (synonym: profound intraepithelial neoplasia) and two tubular. adenomas of the colon mucosa, with moderate epithelial dysplasia (synonym: mild. intraepithelial neoplasia). Tumor-free oral and aboral resection margin. 36 local lymph nodes are tumor-free with uncharacteristically reactive changes. Stage of tumor of both colon carcinomas: pT2 pNO (0/36) L0 V0; G2 R0."
BIOCUP_00119,colon,READ,TCGA-AG-3893,TCGA-AG-3893.ac9ade90-0865-4b4d-9ecd-a8183ef0e152,"Diagnosis: This is a moderately to poorly differentiated adenocarcinoma of the rectosigmoidal junction of. histopathological differentiation grade G2 to 3, with ulceration of the inner tumor surface, with. peritumorous chronic recurrent secondary inflammation with an acute inflammatory flare, with. carcinomatous lymphangitis, with tumor infiltration of the parietal layers into the subserous fatty. connective tissue, with a regional lymph node metastasis (1/14) and tumor-free overview slices. from all other resection material portions described. According to the section preparations available, the tumor spread of the rectosigmoidal. carcinoma corresponds to a tumor stage of pT3, pN1 (1/14), MX, L1, R0. Tumor classification: ICDO-DA M8140/3, G2 to 3. 8+."
BIOCUP_00120,colon,COAD,TCGA-AA-A02F,TCGA-AA-A02F.F260851E-018C-4F5E-8CB4-7D85F391A41B,"Diagnosis: The material in I is a partial resection of small intestine with reactive lesions,. The material in II is a preparation of the rectosigmoid colon (in clinical terms attributable. to the rectum or the sigmoid colon) with a poorly differentiated carcinoma in the area of the. rectosigmoid junction (G3), with infiltration of blood and lymph vessels (L1, V1) and a. lymph node metastasis (pN1). Locally, the lesion was completely removed. The distance from the mesorectal fascia was at least 1 cm. The overall clinical findings and the topography should serve to determine whether this is a. rectal carcinoma in the narrower sense of the term or a carcinoma of the sigmoid colon."
BIOCUP_00121,breast,BRCA,TCGA-E2-A1LA,TCGA-E2-A1LA.8F401B38-8D91-4F75-ADE5-52521EAA7DFE,"SPECIMENS: A. SENTINEL NODE #1 AND #2. B. RIGHT BREAST. C. RIGHT AXILLARY CONTENTS. SPECIMEN(S): A. SENTINEL NODE #1 AND #2. B. RIGHT BREAST. C. RIGHT AXILLARY CONTENTS. GROSS DESCRIPTION: A. SENTINEL NODE #1 AND #2. Received fresh labeled with the patient's identification and ""sentinel node #1 and #2, right axilla"" is a 1.8. x 1.5 x 0.6 cm portion of adipose tissue, within which, two lymph nodes are identified, 0.4 cm( #2) and. 0.8 cm( #1). A touch preparation is made on each node. The specimen is entirely submitted as follows: A1- lymph node #1. A2-lymph node #2. B. RIGHT BREAST. Received fresh labeled with the patient's identification and designated ""right breast"" is an oriented. (suture in axilla), 358 g, 21 x 17 x 5 cm mastectomy specimen with 7.5 x 5.4 cm beige skin ellipse. showing a 1 cm diameter retracted nipple. Ink code: Posterior-deep, anterior/superior-blue,. anterior/inferior-orange. The specimen is serially sectioned from lateral to medial into 13 slices. revealing two possible lesions. Mass #1, in the upper inner quadrant (two o'clock, slices 9-10), 2 x 1.5 x. 1.4 cm, is located 2.2-cm from the deep margin and 1.4-cm from anterior. Approximately 4.5-cm from. mass #1, a second mass is demonstrated in the upper outer quadrant (slice 8), 2 x 1.5 x 1 cm, located. 2.5-cm from the deep margin and 1 cm from anterior. A portion of the specimen is submitted for tissue. procurement (mass #1). Representatively submitted: B1-B2: Nipple. B3: Skin. B4-B5: Mass #1, two o'clock, UIQ, slice 9. B6-B7: Mass #1, two o'clock, UIQ, slice 9. B8: Deep margin overlying mass #1, slice 9. B9: Firm tissue adjacent to mass #1, slice 9. B10-B12: Mass #2, UOQ, slice 8. B13: Deep margin, mass #2, slice 8. B14: Representative section, LOQ, slice 6. B15-B16: Representative sections, LIQ, slice 12. B17: Possible axillary lymph nodes. C. RIGHT AXILLARY CONTENTS. Received fresh labeled with the patient's identification and "" axillary contents"" is a 10.5 x 10.0 x 2.5 cm. portion of adipose tissue, within which, 34 possible lymph nodes are identified, ranging from 0.1 to 2.5. cm. The cut surfaces of the larger nodes are fatty to soft tan-pink. No evidence of tumor is grossly. noted. The specimen is entirely submitted as follows: C1-six lymph nodes. C2-six lymph nodes. C3-six lymph nodes. C4-six lymph nodes. C5-seven lymph nodes. C6-one lymph node bisected. C7-one lymph node bisected. C8-C9-one lymph node. C10-C14-remaining soft tissue. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1 and #2, RIGHT AXILLA, EXCISION: - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1),. MEASURING 8-MM WITH EXTRANODAL EXTENSION. B. BREAST, RIGHT, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, MEASURING 1.1 CM, PRESENT IN UPPER. INNER QUADRANT. - HIGH NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, SOLID type. - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR. BIOPSY SITE CHANGES WITH FIBROSIS, GRANULATION TISSUE. - usual ductal hyperplasia without atypia. - fibroadenoma (0/.7-CM) AND INTRADUCTAL PAPILLOMA (0.2-CM). SEE SYNOPTIC REPORT. C. LYMPH NODES, RIGHT, AXILLARY DISSECTION: - Thirty-FOUR LYMPH NODES, NEGATIVE FOR METASTASES (0/34). NOTE: Two nodules are grossly identified, one located in the upper inner quadrant and one located in. the upper outer quadrant. Microscopically, the former is invasive ductal carcinoma and the later is. fibroadenoma. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: No. Laterality: Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.1cm. Tumor Site: Upper inner quadrant. Margins: Negative. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node and axillary dissection. Lymph node status: Positive 1 /35 Extranodal extension. Micrometastases: DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 5%. DCIS Type: Solid. DCIS Location: Associated with invasive tumor. Nuclear grade: High. Necrosis: Absent. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT 1c N 1a. CLINICAL HISTORY: year old with right breast cancer, previous biopsy. PRE-OPERATIVE DIAGNOSIS: None given. INTRAOPERATIVE CONSULTATION. TPA: Positive for carcinoma. Called by Dr. to Dr at. Right breast, gross examination: Two possible lesions, mass number one, 1.5-cm located 3.2-cm from. deep margin and 1.4-cm from anterior, mass number two, 2-cm in size located 2.5-cm from deep and. 1cm from anterior. Diagnosis called at. by Dr. ADDENDUM: PathVysion HER-2 DNA Probe Kit. Case oAnalytical Interpretation of Results: HER-2 NOT AMPLIFIED. Clinical Interpretation of results. Amplification of the HER-2 gene was evaluated with interphase fluorescence in-situ. hybridization (FISH) on formalin-fixed paraffin embedded tissue sections using a chromosome. 17 centromeric probe and a HER-2 probe that spans the entire HER-2 gene in the. by Dr.. A majority of tumors cells displayed 2 chromosome 17. signals and 2 HER-2 signals, with a HER-2/CEP 17 Ratio </=2.0, consistent with no. amplification of the HER2/neu gene. Block used B7. Source of case: Tissue fixation. formalin-fixed tissue. Outside Case No: NA. Tissue source. breast Results interpreted: HER2/CEP17 ratio: 1.15. This ratio is derived by dividing the total number of LSI HER-2/neu signals by the total number of. CEP17 signals in at least 20 interphase nuclei with nonoverlapping nuclei in the neoplastic. mammary epithelial cells. Cells with no signals or with signals of only one color are disregarded. Method of ratio enumeration: manual count. Limitations. The Vysis PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is. intended to be used as an adjunct to other prognostic factors currently used to predict disease-free. and overall survival in stage II, node-positive breast cancer patients. In making decisions regarding. adjuvant CAF treatment, all other available clinical information should also be taken into. consideration, such as tumor size, number of involved lymph nodes, and steroid receptor status. treatment decision for stage II, node-positive breast cancer patients should be based on HER-. 2/neu. gene amplification status alone. Overview of this test. FDA APPROVED REAGENT. PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. natients for whom Herceptin therapy is being considered. These tests were performed in the. under the direction. of Dr.. The results of these studies should always be interpreted in the context of the. clinical, morphological, and immunophenotypic diagnosis. Microscopic/Diagnostic Dictation:,. Microscopic/Diagnostic Dictation: Final Review:,. Microscopic/Diagnostic Dictation:, I. Final Review: Pathologist,. Final: Pathologist. Addendum:. Pathologist,. Addendum Final: Pathologist."
BIOCUP_00122,breast,BRCA,TCGA-BH-A0DI,TCGA-BH-A0DI.5B7CE4A4-E1D5-4D0B-B9B4-71B94E32D782,"P.10/33. AGNOSIS: AXILLARY SENTINEL LYMPH NODE #1, RIGHT, BIOPSY -. ONE (1) LYMPH NODE, POSITIVE FOR METASTATIC CARCINOMA MEASURING 3.0 MM (SEE COMMENT). PART 2: AXILLARY SENTINEL LYMPH NODE #2, RIGHT, BIOPSY -. A. ONE (1) LYMPH NODE, POSITIVE FOR METASTATIC CARCINOMA. B. INVASIVE FOCUS MEASURES 4.0 MM IN LARGEST DIMENSION AND WITH VERY FOCAL CAPSULE. INVOLVEMENT. c. LYMPHOVASCULAR INVASION NOTED. PART 3: AXILLARY SENTINEL LYMPH NODE #3 AND #4, RIGHT, BIOPSY -. A. ONE (1) LYMPH NODE, POSITIVE FOR METASTATIC CARCINOMA. B. METASTATIC TUMOR MEASURES 6.0 MM IN LARGEST DIMENSION WITH FOCAL EXTRACAPSULAR. EXTENSION. c. FIBROADIPOSE TISSUE: PART 4: BREAST, LEEL TOTAL MASTECTOMY -. A ATYPICAL LOBULAR HYPERPLASIA INVOLVING SCLEROSING ADENOSIS. B. RADIAL SCAR WITH FLORID DUCTAL EPITHELIAL HYPERPLASIA. C. EXTENSIVE SCLEROSING ADENOSIS. D. FIBROCYSTIC CHANGE WITH DUCTAL EPITHELIAL HYPERPLASIA. E. COLUMNAR CELL CHANGES. r. INTRADUCTAL PAPILLOMAS. G. MICROCALCIFICATIONS WITH ASSOCIATED ABOVE LESION8. H. NIPPLE, SKIN, UNREMARKABLE. PART 5; BREAST RIGHT, MODIFIED RADICAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 2 (TUBULE FORMATION - 3, NUCLEAR ATYPIA - 2. MITOTIC ACTIVITY - 2; TOTAL SCORE: 7/9). B. INVASIVE TUMOR MEASURES 4.0 CM IN LARGEST DIMENSI√ìN (GROSS MEASUREMENT). C. DUCTAL CARCINOMA IN SITU (DCIS), CRIBRIFORM AND SOLID TYPES WITH FOCAL CENTRAL NECROSIS,. NUCLEAR GRADE 2. D. DCIS ACCOUNTS FOR 15% OF THE TOTAL TUMOR VOLUME. ADMIXED WITH INVASIVE COMPONENT. E. LYMPHOVASCULAR INVASION IDENTIFIED. F. RESECTION MARGINS NEGATIVE FOR CARCINOMA (AT LEAST MORE THAN 2.0 CM). G. ATYPICAL DUCTAL HYPERPLASIA. H. ATYPICAL LOBULAR HYPERPLASIA. I. NON-NEOPLASTIC BREAST TISSUE SHOWING RADIAL SCAR, DUCTAL EPITHELIAL HYPERPLASIA,. SCLEROSING ADENOSIS, FIBROCYSTIC CHANGE, COLUMNAR CELL CHANGE, AND INTRADUCTAL. PAPILLOMA. J. INVASIVE CARCINOMA IS MIXED WITH RADIAL SCAR, SCLEROSING ADENOSIS. K. MICROCALCIFICATIONS ASSOCIATED WITH INVASIVE DUCTAL CARCINOMA, DCIS, AND ABOVE BENIGN. LESIONS. L. NIPPLE WITH EPIDERMAL INCLUSION CYST, NEGATIVE FOR CARCINOMA. M. BIOP8Y SITE CHANGE. N. TWENTY-FIVE (25) LYMPH NODE8, NEGATIVE FOR METASTATIC CARCINOMA (0/29). o. INVASIVE TUMOR CELLS ARE POSITIVE FOR ER AND PR AND NEGATIVE FOR HER-2/ncu. CASE SYNOPSIS: LATERALITY: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF RREAST. PROCEDURE: Right. Modified radical mastectomy. SIZE OF TUMOR: Not specified. MUL'TICENTRICITY/MULTIFOCALITY OF Maximum INVASIVE dimension FOCI: Invasive component 4.0 cm. TUMOR TYPE (Invasive component): site : breast, NOS C50.9 3/13/11 for. NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 2. Tubule formiation. 3. Mitolic activity scorc. 2. Total Nottingham Ecore: 7. ANGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 2. DERMAL LYMPHATIC INVASION: Yey. CALCIFICATION: TUMOR TYPE, IN SITU: Yes, malignant zones. Cribriform. Solid. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: LYMPH NODES EXAMINED: 28. METHOD(S) OF LYMPH NODE EXAMINATION: H/F. stain. SENTINEL NODE METASTASIS: T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pT2. pN1a. M STAGE, PATHOLOGIC: ESTROGEN RECEPTORS: pMX. PROGESTERONE RECEPTORS: possitive. HER2/NEU: positive. zero or 1+."
BIOCUP_00123,breast,BRCA,TCGA-PL-A8LZ,TCGA-PL-A8LZ.436F3280-98C7-4FA9-BD6F-1B02CAF1D262,"Sex: Female. Date of Tumour Procurement: 1. GROSS ASSESSMENT: Cut section showed a chalky white tumour. 4x3x2cm,. 2. MICROSCOPIC ASSESSMENT. Microscopic description: Section shows an invasive tumour growing in solid nests and. tubular patterns. It is composed of cells having moderately pleomorphic hyperchromatic. nuclei and amphophilic cytoplasm. The stroma is desmoplastic containing thin-walled. vascular channels, tumour cells and lymphocytes. Focal areas of necrosis noted,. 3. Tumour Type: Malignant. 4. Tumour Site: Left Breast. 5. Distance of invasive carcinoma to closest margin: 5mm. Which margin? Deep resection. 6. HISTOLOGICAL DIAGNOSIS: Invasive ductal carcinoma, NOS. 7. COMMENTS: nil. Dr. Reporting Pathologist Name."
BIOCUP_00124,breast,BRCA,TCGA-AN-A0XN,TCGA-AN-A0XN.4C9C9D24-07E1-47BE-8D34-F94693576BD2,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. - Anatomic Site: Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: OCT. Container: block Type of Procurement: surgery Grade: 2. T Stage: 2 N Stage: 1 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.
BIOCUP_00125,breast,BRCA,TCGA-AO-A0JA,TCGA-AO-A0JA.2E8A1816-E963-4063-B2F0-6289514084A5,"Clinical Diagnosis & History: Right multicentric IDC and ILC presents for bilateral TM, bilateral SLNBx. Specimens Submitted: 1: SP: Sentinel node #1 level 1 left axilla. 2: SP: Sentinel node #2 level 1 left axilla. 3: SP: Sentinel node #1 level 1 right axilla (fs). 4: SP: Sentinel node #2 level 1 right axilla (fs). 5: SP: Right breast and axillary contents level 1, 2, and 3. 6: SP: Left breast. 7: SP: Right rotter's node. 8: SP: Additional level 1 lymph right axilla node 1. 9: SP: Additional right level 2 axillary contents. 10: SP: Level 3 lymph node right axilla. DIAGNOSIS: 1). SENTINEL NODE #1 LEVEL 1 LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 2). SENTINEL NODE #2 LEVEL 1 LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 3). SENTINEL NODE #1 LEVEL 1 RIGHT AXILLA; EXCISION: - METASTATIC CARCINOMA INVOLVING ONE OF ONE LYMPH NODE (1/1). - THE METASTATIC CARCINOMA IS PRESENT AS SUB-CAPSULAR TUMOR CELL. CLUSTERS MEASURING <0 2MM AND COMPOSED OF 30-40 CELLS. THE TUMOR CELLS ARE. SEEN BOTH IN THE HE STAINED AND KERATIN (AE1:AE3) IMIMUNOSTAINED SECTIONS. 4). SENTINEL NODE #2 LEVEL 1 RIGHT AXILLA; EXCISION: - METASTATIC CARCINOMA INVOLVING ONE OF ONE LYMPH NODE (1/1). - THE METASTATIC FOCUS MEASURES 1.2 CM, WITH EXTRANODAL EXTENSION. (>2MM). 5). BREAST, RIGHT; MASTECTOMY: TUMOR #1: - INVASIVE DUCTAL CARCINOMA, WITH FOCAL LOBULAR GROWTH PATTERN,. HISTOLOGIC GRADE II/III (MODERATE TUBULE FORMATION), NUCLEAR GRADE II/III. (MODERATE VARIATION IN SIZE AND SHAPE). MEASURING `3.6 CM IN LARGEST. DIMENSION GROSSLY. - DUCTAL CARCINOMA IN-SITU (DCIS) IS ALSO IDENTIFIED, MICROPAPILLARY TYPE. WITH INTERMEDIATE NUCLEAR GRADE AND MINIMAL NECROSIS. - THE DCIS CONSTITUTES LESS THAN OR EQUAL TO 25% OF THE TOTAL TUMOR MASS,. AND IS PRESENT ADMIXED WITH THE INVASIVE COMPONENT. THE INVASIVE CARCINOMA IS LOCATED IN THE UPPER INNER QUADRANT, AT. 1:00. - THE DCIS IS LOCATED IN THE UPPER INNER QUADRANT. NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA. IS IDENTIFIED. - NO CALCIFICATIONS ARE IDENTIFIED IN EITHER THE INVASIVE OR IN SITU. COMPONENT. - EXTENSIVE VASCULAR INVASION IS PRESENT. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. - INVASIVE CARCINOMA IS 3.3 CM FROM THE DEEP MARGIN GROSSLY. TUMOR #2: - INVASIVE DUCTAL CARCINOMA, NOS TYPE, WITH FOCAL LOBULAR GROWTH. PATTERN, HISTOLOGIC GRADE II/III (MODERATE TUBULE FORMATION) , NUCLEAR GRADE. II/III (MODERATE VARIATION IN SIZE AND SHAPE) . MEASURING 2.5 CM IN LARGEST. DIMENSION GROSSLY. - DUCTAL CARCINOMA IN-SITU (DCIS) IS ALSO IDENTIFIED, SOLID, CRIBRIFORM TYPE. WITH INTERMEDIATE NUCLEAR GRADE AND MODERATE NECROSIS. - LOBULAR INVOLVEMENT BY DCIS IS PRESENT. - THE DCIS CONSTITUTES LESS THAN OR EQUAL TO 25% OF THE TOTAL TUMOR. MASS, AND IS PRESENT ADMIXED WITH THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED IN THE LOWER INNER QUADRANT AT. - THE DCIS IS LOCATED IN THE LOWER INNER QUADRANT. - NO. INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA IS. IDENTIFIED. - CALCIFICATIONS ARE PRESENT IN THE INVASIVE CARCINOMA ONLY. - VASCULAR INVASION IS PRESENT. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. - INVASIVE CARCINOMA IS 4.5 CM FROM THE DEEP MARGIN GROSSLY. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS USUAL DUCTAL HYPERPLASIA,. PAPILLARY APOCRINE HYPERPLASIA, COLUMNAR CELL CHANGE, AND CYSTS. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF POSITIVE. LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES EXAMINED) : 13/17. - THERE IS EXTRANODAL EXTENSION (>2mm) OF CARCINOMA. THE LARGEST. METASTATIC CARCINOMA MEASURES .1CM. - RESULTS OF SPECIAL STAINS (ER, PR, HER2-NEU) ARE AS FOLLOWS: TUMOR 1: ESTROGEN RECEPTOR. 90% nuclear staininy with woderate intensity. PROGESTERONE RECEPTOR. 1: <5% nucle: weak intensity. HER2. Negative ( 1+). (<10% of invasive tumor cells exhibit weak complete membranous staining;. Uniformity of staining: absent;. Homogeneous, dark circumferential pattern: absent). TUMOR 2: ESTROGEN RECEPTOR. 50-60% nuclear staining with moderate intensity. PROGESTERONE RECEPTOR. 10-20% nuclear staining with moderate intensity. Negative ( 1+). (<10% of invasive tumor cells exhibit weak complete membranous staining;. Uniformity of staining: absent;. Homogeneous, dark circumferential pa. absent). Comment: Controls are satisfactory. a PATHWAY anti-HER-2/neu is an. FDA-approved rabbit monoclonal primary antibody (clone 4B5) directed against. the internal domain of the c-erbB-2 oncoprotein (HER2) for. immunohistochemical detection of HER2 protein overexpression in breast. cancer tissue routinely processed for histologic evaluation. The HER2 test. results are reported in accordance with the ASCO/CAP guideline. recommendations for HER2 testing in breast cancer (J Clin Oncol 2007;. 25 (1) :118-145) The ER and PR rabbit monoclonal antibodies are also FDA. approved. 6). LEFT BREAST; MASTECTOMY: - BENIGN BREAST WITH PAPILLARY APOCRINE HYPERPLASIA, USUAL DUCTAL. HYPERPLASIA AND COLUMNAR CELL CHANGE. - BENIGN NIPPLE. 7). RIGHT ROTTER'S NODE; EXCISION: - METASTATIC CARCINOMA LARGELY REPLACING ONE OF ONE LYMPH NODE (1/1). - THE METASTATIC FOCUS MEASURES 0.9 CM, WITH NO EXTRANODAL EXTENSION. 8). ADDITIONAL LEVEL 1 LYMPH RIGHT AXILLA NODE 1; EXCISION: - METASTATIC CARCINOMA INVOLVING THREE OF THREE LYMPH NODES (3/3) . LARGEST METASTATIC CARCINOMA MEASURES .3CM. - EXTRANODAL EXTENSION IS PRESENT. 9). ADDITIONAL RIGHT LEVEL 2 AXILLARY CONTENTS; EXCISION: - METASTATIC CARCINOMA INVOLVING FOUR OF FOUR LYMPH NODES (4/4). LARGEST METASTATIC CARCINOMA MEASURES 0 5CM. - EXTRANODAL EXTENSION IS PRESENT. 10). LEVEL 3 LYMPH NODE RIGHT AXILLA; EXCISION: METASTATIC CARCINOMA LARGELY REPLACING ONE OF ONE LYMPH NODE (1/1) . LARGEST METASTATIC CARCINOMA MEASURES 0.2CM. - EXTRANODAL EXTENSION IS PRESENT. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) . The specimen is received for a canceled a canceled frozen section. consultation, placed in formalin labeled ""Sentinel node number one level. 1. left axilla"" and consists of a 1.4 x 0.5 x 0.5 cm piece of lymphoid fatty. tissue is bisected and entirely submitted. Summary of sections: U - undesignated. 2) The specimen is received for a canceled frozen section consultation,. placed in formalin, labeled ""Sentinel node number two, level one left. axilla"" and consists of 1.3 x 1.3 x 0.5 cm pink-tan lymph node which is. bisected and entirely submitted. Summary of sections: U - undesignated. 3) The specimen is received fresh for frozen section consultation, labeled. "". Sentinel node number one level 1 right axilla"" and consists of a 0.4 x 0.4. x 0.3 cm lymph node which is bisected and entirely submitted for frozen. section. Summary of sections: FSC frozen section control. 4). The specimen is received fresh for frozen section consultation,. labeled ""Sentinel node number two level 1 right axilla"" and consists of a. 1.2 x 1.0 x 1.0 cm lymph node which is bisected and entirely submitted for. frozen section. Summary of sections: FSC -- frozen section control. 5) The specimen is received fresh labeled, ""right breast and axillary. contents level 1,2, and 3"" and consists of a breast with attached axillary. contents. The breast measures 19 x 18 x 6 cm with overlying skin ellipse. measuring 18.5 x 7.5 cm. Situated on the skin surface is a nipple measuring. 1.5 x 1.5 x 0.5 cm and areola measuring 3.5 cm. The skin shows no scar. Axillary contents measures 12 x 7 x 2.5 cm. The posterior surface of the. breast is inked black and the anterior blue. The specimen is serially. sectioned to reveal a mass (mass 1) measuring 3.6 x 3.01 x 2.5 cm, and. located in the UIQ at 1 o' clock and 3.3 cm from the deep margin. A clip. is. identified in the mass 1. Another mass (mass 2) measuring 2.5 x 2.2 x 1.5 cm. LIQ at 5 o' clock located 4.5 cm from the deep margin is identified. The. remaining breast tissue shows fibroglandular tissue. The axillary tissue is. dissected to reveal multiple lymph nodes. Representative sections are. submitted. All dissected lymph nodes are entirely submitted. Summary of sections: N - nipple. NB - nipple base. D1 - deep margin for mass 1. D2 deep margin for mass 2. T1 mass 1. T2 mass 2. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. LN lymph nodes. M.D. 6) The specimen is received fresh labeled, ""left breast"" and consists of. a. breast measuring 25 x 18 x 5cm with overlying skin ellipse measuring 18 x. 8. cm. Situated on the skin surface is a nipple measuring 1.8 x 1.3 x 1cm and. areola measuring 3.5 cm. The skin is unremarkable. A suture demarcates the. axillary aspect. The posterior surface of the breast is inked black and the. axillary aspect is inked yellow. The specimen is serially sectioned to. reveal unremarkable fibroglandular tissue without mass lesion. Sectioning of. the axillary aspect reveals no grossly identifiable lymph nodes. Representative sections are submitted. Summary of sections: N - nipple. NB - nipple base. D - deep margin. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. 7) The specimen is received in formalin, labeled ""Right Rotter' s node"" and. consists of a single pink tan fleshy lymph node measuring 1 x 0.8 x 0.5 cm. The lymph node is entirely submitted. Summary of sections: LN- lymph node. 8) The specimen is received in formalin, labeled ""Additional level 1 lymph. node, right axilla"" and consists of four pink tan firm lymph nodes ranging. from 0.4 to 2.2 cm in greatest dimension. All identified lymph nodes are. submitted. Summary of sections: LN - - lymph nodes. BLN1- - bisected lymph node #1. BLN2' bisected lymph node #2. 9). The specimen is received in formalin, labeled ""Additional right level. two axillary contents"" and consists of a portion of yellow tan adipose. tissue, with four pink tan firm lymph nodes ranging from 0.6 to 1 cm. in. greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN -- lymph nodes. 10) The specimen is received in formalin, labeled ""Level three lymph node,. right axilla"" and consists of a single pink tan fatty lymph node measuring. 0.8 x 0.3 x 0.2 cm. The lymph node is entirely submitted. Summary of sections: LN- lymph node. Summary of Sections: Part 1: SP: Sentinel node #1 level 1 left axilla. Block. Sect. Site. PCs. 1. u. 1. Part 2: SP: Sentinel node #2 level 1 left axilla. Block. Sect. Site. PC's. 1. u. 1. Part 3: SP: Sentinel node #1 level 1 right axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 4: SP: Sentinel node #2 level 1 right axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 5: SP: Right breast and axillary contents level 1, 2, and 3. Block. Sect. Site. PCs. 5. BLN. 10. 1. D1. 1. 1. D2. 1. 1. LIQ. 1. 5. LN. 15. 2. LOQ. 2. 1. N. 1. 1. NB. 1. 3. T1. 3. 3. T2. 3. 1. UIQ. 1. 2. UOO. 2. Part 6: SP: Left breast. Block. Sect. Site. PCs. 1. D. 1. 2. LIQ. 2. 2. LOQ. 2. 1. N. 2. 1. NB. 1. 2. UIQ. 2. 2. UOQ. 2. Part 7: SP: Right rotter's node. Block. Sect. Site. PCs. 1. LN. 1. Part 8: SP: Additional level 1 lymph right axilla node 1. Block. Sect. Site. PCs. 1. bln1. 2. 2. bln2. 2. 1. LN. 2. Part 9: SP: Additional right level 2 axillary contents. Block. Sect. Site. PCs. 1. LN. 4. Part 10: SP: Level 3 lymph node right axilla. Block. Sect. Site. PCs. 1. LN. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 3). FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE #1 LEVEL 1 RIGHT. AXILLA (FS) : BENIGN LYMPH NODE (. PERMANENT DIAGNOSIS: SAME. 4). FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE #2 LEVEL 1 RIGHT. AXILLA (FS) METASTATIC CARCINOMA. PERMANENT DIAGNOSIS: SAME. .e: The diagnoses given in this section pertain only to the tissue sample. amined at the time of the intraoperative consultation. 3). FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE #1 LEVEL 1 RIGHT. AXILLA (FS) : BENIGN LYMPH NODE. PERMANENT DIAGNOSIS: SAME. 4). FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE #2 LEVEL 1 RIGHT. AXILLA (FS) : METASTATIC CARCINOMA. PERMANENT DIAGNOSIS: SAME."
BIOCUP_00126,breast,BRCA,TCGA-BH-A0BT,TCGA-BH-A0BT.18E4043D-34BF-4CD1-9E2D-F906C7C7B019,"FINAL DIAGNOSIS: PART 1: LYMPH NODE, RIGHT SENTINEL #1, EXCISION -. ONE (1) LYMPH NODE, NEGATIVE FOR METASTATIC ADENOCARCINOMA (0/1). PART 2: LYMPH NODE, RIGHT SENTINEL #2, EXCISION -. !. A. ONE (1) LYMPH NODE, POSITIVE FOR MICROMETASTASIS TWO (2) FOCI MEASURING LESS THAN 1.0 MM,. AND ONE (1) ALSO LESS THA 1.0 MM (1/1) (see comment). B. NO EXTRACAPSULAR SPREAD IS SEEN. PART 3: LYMPH NODE, RIGHT SENTINEL #3, EXCISION -. ONE (1) LYMPH NODE, NEGATIVE FOR METASTATIC ADENOCARCINOMA (0/1). PART 4: LYMPH NODE, RIGHT NON-SENTINEL, EXCISION -. ONE (1) LYMPH NODE, NEGATIVE FOR METASTATIC ADENOCARCINOMA (0/1). PART 5: BREASI. RIGHT, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA NOS. B. NOTTINGHAM GRADE 1, SCORE OF 5/9 (TUBULES = 2, NUCLEI = 2, MITOSIS - 1). C. TUMOR MEASURES 2.0 CM ON GROSS EXAMINATION. D. DUCTAL CARCINOMA IN-SITU, CRIBRIFORM TYPE AND WITH COMEDO NECROSIS, NUCLEAR GRADE 2. ADMIXED WITH INVASIVE COMPONENT, COMPRISING APPROXIMATELY LESS THAN 5% OF THE TOTAL. TUMOR VOLUME. E. SURGICAL MARGINS OF RESECTION ARE FREE OF INVASIVE TUMOR. F. CLOSEST POSTERIOR AND SUPERIOR MARGINS OF RESECTION ARE AT 0.6 CM. G. MARGINS OF RESECTION ARE FREE OF DUCTAL CARCINOMA IN-SITU, CLOSEST POSTERIOR MARGIN. AT 1.2 CM. H. ANGIOLYMPHATIC INVASION IS IDENTIFIED. I. ESTROGEN RECEPTOR POSITIVE, PROGESTERONE RECEPTOR POSITIVE, HER-2/NEU NEGATIVE. (SCORE 0), PER PREVIOUS REPORT. J. SKIN WITH NO SIGNIFICANT PATHOLOGIC ABNORMALITY. K. NON-NEOPLASTIC BREAST WITH FIBROCYSTIC CHANGES, DUCTAL EPITHELIAL HYPERPLASIA, AND. FIBROADENOMATOID NODULES. PART 6: BREAST, RIGHT MEDIAL NEW MARGIN, EXCISION -. BREAST TISSUE, NEGATIVE FOR TUMOR. PART 7: BREAST, RIGHT INFERIOR NEW MARGIN, EXCISION -. A. FIBROADIPOSE TISSUE NEGATIVE FOR TUMOR. B. FRAGMENTS OF SKELETAL MUSCLE. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 2.0 cm. MULTICENTRICITYIMULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 2. Mitotic activity score: 1. Total Nottingham score: 5. Nottingham grade (1, 2, 3): 1. ANGIOLYMPHATIO INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: Cribriform. DCIS admixed with invasive carcinoma. Percent of tumor occupied by in situ component: 5 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 6 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 12 mm. LYMPH NODES POSITIVE: 1. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS. ONLY KERATIN POSITIVE CELLS ARE PRESENT: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 1 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pN1mi. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: zero or 1+."
BIOCUP_00127,breast,BRCA,TCGA-B6-A0X5,TCGA-B6-A0X5.29811BAC-AFD1-4951-BDF8-7B859941B634,"Curgical Pathology: Final. CLINICAL HISTORY: Large left breast CA with microcalcification diffusely around invasive tumor. Suggests diffuse intraductal carcinoma. GROSS EXAMINATION: A. ""Left breast mass (Af1)' "". Received is a breast biopsy specimen and frozen. section remnant. The breast tissue measures 5.0 x 4.0 x 3.5 cm. The surgeon. states that the margin is not important, thus the specimen is not inked. Sectioning of the specimen reveals a red-brown nodule measuring 3.0 x 2.5 x. 1.5 cm. Tissue from the nodule has been sent for ER/PR study. A remnant of. frozen section of the red-brown tissue measuring 1.7 x 1.3 x 0.3 cm is. submitted in toto in Block A1, with representative sections of the nodule. submitted in Blocks A2-A4. B. ""Left breast"", fresh. An 18 x 25 x 6 cm breast mastectomy specimen with a. 23 x 14 cm skin ellipse and a 12 x 9.5 cm axillary tail. The skin ellipse is notable for a grossly unremarkable nipple and areola and a. 5.5 cm recently dehised biopsy scar located in the lower medial portion of the. ellipse. The deep surface of the breast specimen is inked in black. Cut sectioning. through the breast reveals a 5 x 4 x 4 cm hollow biopsy cavity in the lower. medial quadrant which is lined by smooth white tissue in its cavity. The. cavity comes to within 0.5 cm of the inked distal surface, 0.8 cm from the. inked posterior surface, and 12 cm from the inked proximal surface. There is. a focal 1.5 x 1.5 x 1 cm firm, finely granular, grey-pink lesion located. adjacent to the lateral tip of the biopsy cavity. This lesion is, at its. closest points, 1.5 cm from the distal inked surface, 4 cm from the posterior. inked surface, 4 cm from the posterior inked surface, 11 cm from the proximal. inked surface, and 2 cm beneath the anterior skin surface. The remainder of. breast specimen is comprised of yellow-white fibrofatty tissue with an. especially prominent white fibrous focus in the upper midportion of breast. parenchyma. BLOCK SUMMARY: B1 representative section of nipple. B2-B5 tissue around biopsy cavity site which includes firm lesion described. above. B6-B7 representative sections from focal white fibrous area in upper. mid-portion of breast. B8-B9 representative sections of upper medial portion of breast. B10-B11 representative sections of lower medial portion of breast. B12-B13 representative sections of upper lateral portion of breast. B14-B15 representative sections of lower lateral portion of breast. B16 three lymph node candidates from intermediate portion of axillary tail. B17 four lymph node candidates from intermediate portion of axillary tail. B18 five lymph node candidates from most lateral portion of axillary tail. B19 four lymph node candidates from most lateral portion of axillary tail. B20 three lymph node candidates from most lateral portion of axillary tail. Dr. INTRA OPERATIVE CONSULTATION: Af1: ""Left breast mass"": Infiltrating carcinoma present. DIAGNOSIS: A. ""LEFT BREAST MASS"": 1 of 2. BREAST WITH INFILTRATING DUCTAL CARCINOMA (3 X 2.5 X 1.5 CM), NUCLEAR. GRADE WELL-DIFFERENTIATED, N.S.A.B.P. HISTOLOGY GRADE 1 OF 3, WITH. CANCERIZATION OF LOBULES AND CRIBRIFORM CARCINOMA IN SITU. B. ""LEFT BREAST"": BREAST WITH RESIDUAL INFILTRATING onconal DUCTAL CARCINOMA (1.5 x 1.5 x 1. CM),. WITH NUCLEAR GRADE WELL-DIFFERENTIATEB AND N.S.A.B.P. HISTOLOGIC GRADE 1. OF 3. THERE IS A COMPONENT OF COLLOID CARCINOMA REPRESENTING LESS THAN. 25% OF THE TOTAL TUMOR VOLUME. THREE OF FOURTEEN (3/14) AXILLARY LYMPH NODES CONTAINING METASTATIC. CARCINOMA. LARGEST METASTATIC FOCUS MEASURES 1.8 x 1.1 CM; NO EXTRANODAL. EXTENSION IDENTIFIED. ALL SURGICAL MARGINS FREE OF TUMOR. SKIN, NIPPLE AND LACTIFEROUS DUCT: NO TUMOR PRESENT. 2 of 2."
BIOCUP_00128,breast,BRCA,TCGA-A8-A06Z,TCGA-A8-A06Z.956F45E5-A8C6-4A4A-9D1F-D31912180584,"Diagnosis: 1. Moderately differentiated invasive ductal carcinoma (tumor diameter: 8 cm). Distance to dorsal resection margin less than 0.1 cm. Concluding tumor classification for the right breast: NOS, G II, pT3LOVORX."
BIOCUP_00129,breast,BRCA,TCGA-JL-A3YX,TCGA-JL-A3YX.25782EF0-8786-446E-ADBA-21F489844237,1. LAB NO. C.P #. CLINICAL INFORMATIONICOMMENTS: FEMALE YEARS Loc. PR. PATIENT CODE 1. CONSULTANT. Histogathology Biopsy Small. Clinical Note: Carcinoma breast left side. Microscopic Features: Section examined reveal breast tissue an infiltrative neoplastic lesion composed of cells. showing moderate pleomorphism with nuclear hyperchromasia and eosinophilic cytoplasm. Few mitotic figures are seen. Almost 100% of the tumor is viable. No areas of necrosis are. seen. Conclusion: Carcinoma left breast :-. Infiltrating Lobular Carcinoma grade II. 100% of tumor is viable. No areas of necrosis are seen. Additional Report. Necrosis. : 0%. Percent of tumor nuclei 90%. Other nuclei. : 10%.
BIOCUP_00130,breast,BRCA,TCGA-BH-A1FB,TCGA-BH-A1FB.C5D116FF-3193-48A0-B69C-D98831D9976A,"Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE of LMP: DATE or LAST DELIVERY: PRE-OP DIAGNOSIS: RT BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: RT SENTINEL LYMPH NODE BIOPSY, RIGHT AXILLARY DISSECTION, RT SEGMENTAL MASTECTOMY,. EXCISION OF LEFT FLANK. CLINICAL HISTORY: MATERIAL SUBMITTED: A) RIGHT SENTINEL LYMPH NODE, PROCUREMENT BY SURGICAL PROCEDURE. (B) RIGHT AXILLARY LYMPH NODE(S), PROCUREMENT BY SURGICAL PROCEDURE. C) RIGHT AXILLARY LYMPH NODE(S), PROCUREMENT BY SURGICAL PROCEDURE. #2. D) RIGHT BREAST BIOPSY/TISSUE, PROCUREMENT BY SURGICAL PROCEDURE. E) RIGHT AXILLA, PROCUREMENT BY SURGICAL PROCEDURE. F) RIGHT NEW MARGIN TISSUE, PROCUREMENT BY SURGICAL PROCEDURE. medial. G) LIPOMA, PROCUREMENT BY SURGICAL PROCEDURE. left flank. INTRAOPERATIVE CONSULTATION: FROZEN SECTION: Sentinel Node #1, one lymph node identified 1.0 x 0.5 x 0.5 cm. Touch Prep Diagnosis: Suspicious. Frozen Section Diagnosis: Positive for Metastatic Carcinoma. Right Breast - history of infiltrating carcinoma, 7.0 x 9.0 x 4.0 cm. Specimen inked and oriented. Tumor. identified 2.2 x 2.4 x 2.4 cm. Tumor closest to the medial margin; all other margins are free of tumor. grossly (less than 1.0 mm). FINAL DIAGNOSIS: FINAL DIAGNOSIS: AGAFS) RIGHT SENTINEL NODE #1: - LYMPH NODE WITH METASTATIC CARCINOMA. - TUMOR DORS NOT EXTEND BEYOND LYMPH NODE CAPSULE. B) RIGHT SENTINEL NODE #2: - LYMPH NODE, NEGATIVE FOR TUMOR. C) RIGHT SENTINEL NODE #3: - LYMPH NODE WITH METASTATIC CARCINOMA. TUMOR DOES NOT EXTEND BRYOND LYMPH NODE CAPSULE. DEF) RIGHT SEGMENTAL MASTECTOMY AND NEW MEDIAL MARGIN: - INFILTRATING AND INTRADUCTAL CARCINOMA, 2.2 BY 2.4 BY 2.4 CM (CROSS REFER. NOTTINGHAM SCORE 4/9. (TUBULES-1, NUCLEI=2, MITOSES-1). - INTRADUCTAL CARCINOMA IS CRIBRIFORM TYPE AND COMPRISES APPROXDIATELY 51 or TUMOR VOLUNE. - TUMOR ASSOCIATED MICROCALCITICATTON IDENTIFIED. - VASCULAR SPACE INVOLVEMENT IS NOT PROMINENT. - SURGICAL NARGINS FREE or TUMOR IN PLANES OF SECTION. - FIBROCYSTIC CHANGES WITH NICROCALCIFICATIONS. E) RIGHT AXILLA: - FIFTEEN LYMPR NODES NEGATIVE FOR TUMOR (0/15). G) MATURE ADIPOSE TISSUE, CONSISTENT WITH LIPONA. NOTE: ER/PR immunoperoxidase assay and Her-2/NEU testing will be performed on block ""D3""."
BIOCUP_00131,breast,BRCA,TCGA-A8-A0A4,TCGA-A8-A0A4.25F8F043-2CD0-4344-9B4A-5BBB691B5BF9,"Diagnosis: 1. Invasive lobular breast carcinoma in the classical differentiation. variant (G II) with extensive infiltration of the skin but no ulceration of the skin (tumor. diameter 3 cm, minimum distance from dorsal resection margin 2.5 cm). Summary tumor classification: invasive lobular breast carcinoma, G II,. pT2pN0(0/10)LOVORO, positive for estrogen and progesterone receptors, negative for. C-erb B-2 oncoprotein. Follow-up finding: three times) A metastatic infiltration and also an influx of. individual cells of the invasive lobular beast carcinoma into the excised axillary lymph. node is definitely excluded. The pNO status is thus confirmed."
BIOCUP_00132,breast,BRCA,TCGA-AR-A24N,TCGA-AR-A24N.AAF32BB7-716A-4C0E-AE7E-04F6A5BF5628,"Final Diagnosis. reast, left, simple mastectomy: Infiltrating ductal carcinoma, Nottingham grade II (of III), forming a 1.9 x 1.2 x 1.0 cm mass in. the superior breast (AJCC pTlc). A minor component of ductal carcinoma in situ, intermediate nuclear grade, is also present. Surgical resection margins are negative for tumor. The nearest (deep) margin is free by 0.2 cm. Lymph nodes, left axillary sentinel, excision: Multiple (3) left axillary sentinel lymph nodes are negative for tumor. Lymph. nodes No.1, and No.2A contain no blue dye, lymph node No.2B contains blue dye. Immunohistochemical cytokeratin stain. was. performed on the paraffin embedded sentinel lymph node tissue and confirms the H&E impression. Lymph node, left axillary, excision: A single left axillary lymph node is negative for tumor (AJCC pN0). Her-2/NEU analysis has been ordered on paraffin embedded tissue."
BIOCUP_00133,breast,BRCA,TCGA-A2-A25E,TCGA-A2-A25E.B81555D4-78D9-4235-AABE-F852CA6F15B5,"Specimen #: (Age: F Race: Physician (s) : AMENDED. SPECIMEN: LEFT BREAST MASTECTOMY AND AXILLARY CONTENTS. FINAL DIAGNOSIS: A. BREAST, LEFT RADICAL MASTECTOMY: - RESIDUAL INVASIVE DUCTAL CARCINOMA, MODERATELY DIFFERENTIATED BY. COMBINED HISTOLOGIC CRITERIA, PRESENT IN THE AREA OF BIOPSY CAVITY. AND LOWER OUTER QUADRANT. ESTIMATED TUMOR SIZE BASED ON PREVIOUS NEEDLE LOCALIZATION. BIOPSIES AT LEAST 3.0 CM. - SEPERATE TUMOR MASS IN THE UPPER OUTER QUADRANT: INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED. TUMOR SIZE: 2.0 CM (GROSS). MARGIN: TUMOR WITHIN 1MM OF SUPERIOR SUPERFICIAL MARGIN. DUCTAL CARCINOMA IN SITU, INTERMEDIATE-GRADE, PREDOMINANTLY SOLID. AND CRIBRIFORM TYPES. DEEP MARGIN: TUMOR (DCIS) EXTENDS WITHIN 1.0 MM OF DEEP SURGICAL. MARGIN IN ONE SECTION (SLIDE A12) . - METASTASIS TO 6/10 AXILLARY LYMPH NODES WITH EXTRA CAPSULAR. EXTENSION. - SKIN AND NIPPLE NEGATIVE FOR CARCINOMA. - FIBROCYSTIC CHANGES. BIOPSY SITE CHANGES. - AJCC STAGE: T2N2MX. COMMENT:The amendment is made to report that there is a seperate tumor. mass in the upper outer quadrant and also the deep margin status. The amendment is made in the absence of the primary pathologist. Specimen #: FINAL DIAGNOSIS (continued) : CLINICAL DIAGNOSIS AND HISTORY: Left breast carcinoma. GROSS DESCRIPTION: Received fresh is a 167 gm modified radical mastectomy specimen with the. following measurements: breast 12.6 x 11.6 x 1.6 cm, overlying ellipse of. nipple-bearing skin 7.2 x 5.5 cm, attached axillary contents 12.5 x 3.5 x. 0.9 cm. Ink code: blue = superior superficial, green = inferior. superficial, black = posterior. The skin is notable for a 2.0 cm well. healed scar near the lateral edge of the ellipse. Examination of the. axilla reveals multiple firm lymph nodes. A seperate mass is present in. the upper outer quadrant measuring 2.0 x 1.4 x 1.4 cm. The breast is then serially sectioned revealing extensive white fibrous. tissue with a 1.2 cm multiloculated biopsy cavity with associated. hemorrhage and fat necrosis in the lower outer quadrant . Sections of the tumor mass and skin and breast samples for. protocol with matching paraffin sections are follows: cassette A1 grossly. normal skin (medial tip). cassettes A2 and A3 2.0 cm tumor mass from upper. outer quadrant, cassette A4 1.7 cm lymph node, high axilla (grossly. positive), cassette A5 1.8 cm grossly normal lymph node, high axilla,. cassette A6 biopsy cavity site, lower outer quadrant, cassette A7 grossly. normal fibrous tissue, lower outer quadrant (approximately 2.0 cm from. biopsy cavity) cassette A8 grossly normal fibrous tissue, upper outer. quadrant, cassette A9 grossly normal fibrous tissue upper inner quadrant,. cassette A10 grossly normal fibrous tissue lower inner quadrant, cassette. A11 representative sections of nipple and scar from skin, cassette A12. biopsy cavity deep margin lateral, cassette A13 biopsy cavity superior. medial, A14 biopsy cavity inferior medial, A15 four additional lymph nodes. from axillary tail, A16 two additional lymph nodes from axillary tail,. cassette A17 one lymph node bisected from axillary tail."
BIOCUP_00134,breast,BRCA,TCGA-A2-A0CL,TCGA-A2-A0CL.17950062-E052-4FC2-A437-A17669B4DD01,"Specimen #: (Age: F Race: BLACK. Physician (s) : SPECIMEN: RIGHT BREAST AND AXILLARY CONTENT. FINAL DIAGNOSIS: BREAST, RIGHT, MASTECTOMY WITH AXILLARY LYMPH NODES : TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. NOTTINGHAM GRADE: POORLY DIFFERENTIATED. NOTTINGHAM SCORE: 9 OF 9. (Tubules= 3, Nuclei= 3, Mitoses= 3). TUMOR SIZE (GREATEST DIMENSION) : 5.6 CM (MEASURED GROSSLY). TUMOR NECROSIS: PRESENT IN INFILTRATING COMPONENT. MICROCALCIFICATIONS: PRESENT IN TUMOR. VENOUS / LYMPHATIC INVASION: PRESENT (EXTENSIVE). MARGINS : DEEP MARGIN IS INVOLVED BY INFILTRATING TUMOR. -DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0 CM, FROM DEEP MARGIN. INTRADUCTAL COMPONENT: PRESENT. LYMPH NODES: 9 OF 12 POSITIVE FOR TUMOR; LARGEST METASTATIC FOCUS IS. 1.5 CM. ESTROGEN RECEPTORS: POSITIVE (20%) (PERFORMED ON. PROGESTERONE RECEPTORS: NEGATIVE (less than 5%) (PERFORMED ON. HER 2 NEU by IHC: NEGATIVE (1%) (PERFORMED ON. PATHOLOGIC STAGE: pT3 N2a M# (AJCC Stage IIIA). CLINICAL DIAGNOSIS AND HISTORY: year old female with right breast cancer. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. Specimen #: GROSS DESCRIPTION: A. Received fresh and consists of 553 gram right mastectomy specimen with. axillary tail. Specimen measures 22 cm medial to lateral, 18 cm superior. to inferior, 3 cm anterior to posterior. Superficial skin ellipse is. darkly pigmented and measures 18 x 7 cm. Centrally everted nipple is. surrounded by nodular areolar. No scar or discharge is noted. Deep. resection margin is inked black. Specimen serially sectioned to reveal. 6. x 3.5 x 1.5 cm poorly circumscribed firm gritty mass within the lateral. outer quadrant. Located 5 cm from this mass at the mid inner aspect at. 3:00 there is a second similar appearing mass measuring 2.5 x 2.5 x 1. o. cm. The surrounding tissue shows marked hemorrhage consistent with. previous biopsy located within lateral inner quadrant is a 1 x 0.8 x 0.5. cm similar mass located 5 cm from 3:00 mass. Also within lateral inner. quadrant is a 1.5 X 0. x 0.5 cm similar mass abutting deep margin. Remainder of breast parenchyma is composed of 40% dense slightly nodular. fibrous tissue. Fatty tissue is unremarkable. Attached axillary tail measures 8 x 5 x 1 cm and contains twelve lymph. nodes ranging from 0. to 2 cm in greatest dimension. Upon sectioning the. cut surfaces are predominantly firm, pink white and appear involved by. lesion. Cassette key: A1: skin. A2: nipple. A3: LOQ mass inferior portion. A4: LOQ mass superior portion. A5: mid inner quadrant 3:00 mas. A6: LIQ mass. A7: LIQ mass at margin. A8: LOQ. A9: LIQ. A10: UIQ. All: UOQ. A12: largest lymph node, low axillary. A13: low axillary lymph node. A14: low axillary lymph node. A15: high axillary lymph node. A15-A18: two lymph nodes bisected in each cassette. A19-A20: one bisected lymph node in each cassette. Matched sections of A1-A6 and A8-A15 placed in. for CBCP protocol."
BIOCUP_00135,breast,BRCA,TCGA-A8-A07E,TCGA-A8-A07E.E20AC0FF-43C4-49EA-9E33-764E553933B7,"Diagnosis: 1. Moderately differentiated invasive ductal carcinoma (tumor diameter: 3.5 cm; distance dorsally 3 cm, other margins remain free). Concluding tumor classification: NOS, G II, pT2N3aLOV0R0."
BIOCUP_00136,breast,BRCA,TCGA-A7-A0CH,TCGA-A7-A0CH.F70DA7E5-2AB3-487F-8B2C-72EEE91E58E0,"SPECIMEN. A. Sentinel node left breast. B. Left breast. C. Left sentinel node. CLINICAL NOTES. PRE-OP DIAGNOSIS: Left breast cancer. FROZEN SECTION DIAGNOSIS. A. Benign on frozen section. C. Benign on frozen section. GROSS DESCRIPTION. A. Received fresh in a container labeled ""A. sentinel. node. left breast"" is a portion of soft to rubbery tissue, 2.6 x. 2 x 0.7 cm. Externally much of the specimen is fatty. On cut. surface, there is some tan-pink lymph node tissue, with prominent. fat replacement. The specimen is entirely submitted for frozen. section in three blocks. B. Received fresh in a container labeled ""left breast"" is. a 33 x 16 x 3.5 cm mastectomy specimen, partially surfaced. by a 20 x 11 cm tan-pink wrinkled skin ellipse, with a 1.6 cm in. diameter everted nipple. There is no gross lesion on the skin. surface. There is an arrow indicating superior. The deep aspect of. the specimen is inked and the specimen is serially sectioned,. revealing a 3.3 x 3.3 x 2 cm tan-white firm indurated mass which is. 1.3 cm from the deep margin. The mass is located centrally but. slightly laterally, with the closest margin the aforementioned deep. margin, with the tumor not grossly near a margin. The specimen. outside the mass lesion consists of yellow adipose tissue with. interspersed tan-white tissue, without additional focal lesion. No. lymph nodes are identified with the breast. RS-10. GROSS DESCRIPTION. BLOCK SUMMARY: B1,B2 - entire nipple, and skin; B3 - deep margin. deep to tumor; B4-B6 - tumor (sections do not include margin) ; B7. inner upper quadrant; B8 - inner lower quadrant; B9 - outer lower. quadrant; B10 - outer upper quadrant. C. Received fresh in a container labeled ""left sentinel. node"" is a portion of soft to rubbery tan-yellow tissue, 2. X 1.5 X 0.7 cm. On cut surface, the specimen is predominantly. fatty,. with some identifiable tan-pink lymph node tissue. It is entirely. submitted for frozen section in two blocks. MICROSCOPIC DESCRIPTION. A,C. The lymph nodes are negative for malignancy. In. addition to examining serial H&E stained sections,. immunostains with antibodies to keratin (AE1/AE3) are examined,. without specific staining, supporting the interpretation that the. lymph nodes are negative for malignancy. B. The following template summarizes the findings in this. part: Invasive carcinoma: Present in the mass lesion in the breast in. part. B. Histologic type: Invasive ductal carcinoma. Histologic grade: Overall grade: 1. Architectural score: 2. Nuclear score: 2. Mitotic score: 1. MICROSCOPIC DESCRIPTION. Greatest dimension (pT) : 3.3 cm (pT2). Specimen margins: Negative for tumor. Vessel invasion: Not identified. Calcification Present focally. Nipple: Negative for tumor. Invasion of skin or chest wall: Not identified. Ductal carcinoma in situ: Present very focally, with the vast. majority of the carcinoma in this specimen invasive carcinoma. Histologic pattern: Cribriform. Nuclear grade: 1-2. Central necrosis: Absent. Specimen margins: Negative. Calcification: Not identified within DCIS. Description of non-tumorous breast: Fibrocystic changes. Prognostic markers: Previously performed on a prior specimen at an. outside institution. 4x3,14x2,15x3,20x5. DIAGNOSIS. A,C. Lymph nodes, left sentinel, excisions -. Negative for malignancy. B. Breast, left, excision -. Invasive ductal carcinoma (see microscopic description). Skin, nipple, and margins negative for malignancy. M.D. (Electronic Signature). --- End Of Report ---."
BIOCUP_00137,breast,BRCA,TCGA-AO-A1KS,TCGA-AO-A1KS.0FB93D92-81F6-4241-9094-4AABF70E6A0F,"Clinical Diagnosis & History: Invasive lobular (questionable duct), carcinoma left breast LOQ for left. wide excision with needle localization, SLNB. Specimens Submitted: 1: SP: Sentinel node #1 level one left axilla. 2: SP: Sentinel node #2 level one left axilla. 3 SP: Non-sentinel tissue left axilla. 4: SP: Sentinel node #3 level one left axilla. 5: SP: Breast, left, 4:00, excision of tumor site. 6: SP: Breast, left, superior margin. 7: SP: Breast, left, medial margin. 8: SP: Breast, left, inferior margin. 9: SP: Breast, left, lateral margin. 10: SP: Breast, left, posterior margin. DIAGNOSIS: 1. SP: Sentinel node #1 level one left axilla: Sentinel Lymph Node Status: No carcinoma present. Number of Sentinel Lymph Nodes Examined: 1. Level of Detection: Initial H&E stained section. Deeper H&E stained sections and cytokeratin AE1:AE3 stains. Extracapsular Extension: Not applicable. 2. SP: Sentinel node #2 level one left axilla: Sentinel Lymph Node Status: No carcinoma present. Number of Sentinel Lymph Nodes Examined: 1. Level of Detection: Initial HEE stained section. Deeper HEE stained sections and cytokeratin AE1:AE3 stains. Extracapsular Extension: Not applicable. 3. SP: Non-sentinel tissue left axilla: Two benign lymph nodes (0/2). 4. SP: Sentinel node #3 level one left axilla: Sentinel Lymph Node Status: No carcinoma present. Number of Sentinel Lymph Nodes Examined: 1. Level of Detection: Initial HAE stained section. Deeper HEE stained sections and cytokeratin AE1:AE3 stains. Extracapsular Extension: Not applicable. 5. SP: Breast lefti 4:00, excision of tumor site: Invasive Carcinoma: Invasive mammary carcincma (see comments). Histologic Grade: III/III: Minimal or no tubule formation 1c 10% of tumor). Nuclear Grade: III/III (marked variation in size and shape). Tumor Size: Gross measurement 26mm. Lobular Neoplasia: Lobular carcinoma in situ (LCIS), classical type. focal. Calcification: Not Identified. Lymphovascular Invasion: Not present. surgical Margins: For Final margin status see seperately submitted margins. Benign Breast Tissue: Biopsy site changes. Estrogen Receptor (6F11 , v. Positive nuclear staining in 99% of tumor cells. Strong intensity. Progesterone Receptor (182; Ventana): Positive nuclear staining in 90% of tumor cells. Strong intensity. Moderate intensity. HER2 (485,. Equivocal (2+) FISH will be performed. Membranous Staining (for Her2 positive and equivocal cases only) : 15% of invasive cells exhibit complete membranous staining. Uniformity of staining is absent. Homogenous, dark circumferential pattern is absent. Comment: This high grade invasive carcinoma has a solid growth pattern. There. is focal associated LCIS. Based on the cytomorphology and the fact. that it is E-Cadherin negative, most likely this is an invasive lobular da. with pleomorphic features. 6. SP: Breast, left, superior margin: Benign breast parenchyma. 7. SP: Breast, left, medial margin: Benign breast parenchyma and skeletal muscle. 8. SP: Breast, left, inferior margin: Benign breast parenchyma. 9. SP: Breast, left, lateral margin: Benign breast parenchyma. 10. SP: Breast, left, posterior margin: Benign breast parenchyma and skeletal muscle. Comment: Controls are satisfactory. Ventana's PATHWAY anti-HER-2/neu in an. FDA-approved rabbit monoclonal primary antibody (clone 485) directed against. the internal domain of the c-erbB-2 oncoprotein (HER2) for. imunohistochemical detection of HER2 protein overexpression in breast. cancer tissue routinely processed for histologic evaluation. Results are. reported in accordance with the ASCO/CAP guideline recommmandations for HER2. testing in breast cancer (3 Clin Oncol 2007; :118-145) ER and PR are. also rabbit monoclonal antibodies which are FDA approved. Some of the immunohistochemiatry and ISH tests were developed and their. performance characteristics were determined by the Department of Pathology. They have not been cleared or approved by the US Food and Prug. Administration. The FDA has determined that such clearance or approval. is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of 1988 (CLIA . 88). as. qualified to perform high complexity clinical laboratory testing. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Report slectronically Signed Out. Gross Description: 1) The specimen is received in formalin, labeled ""Sentinel node #1 level 1. left axilla"" and consists of a gray-tan lymph node measuring 2.2 cm in. greatest dimension. The lymph node is bisected and submitted entirely. Summary of sections: BLN - bisected lymph node. 2) The specimen is received in formalin, labeled ""Sentinel node #2 level 1. left axilla"" and consists of a pink-tan lymph node measuring 1.1 cm in. greatest dimansion, which is bisected and submitted entirely. Summary of sections: U undesignated. 3) The specimen is received in formalin, labeled ""Non-sentinel tissue left. axilla"" and consists of a piece of fatty tissue measuring 4.5 x 4.5 x 0.5 cm. in greatest dimension. A few pink-tan lymphoid nodules are identified. ranging from 0.1 to 0.7 cm in greatest dimension, which are entirely. submitted. Summary of sections: U - undesignated. 4) The specimen is received in formalin, labeled ""Sentinel node #3 level 1. left axilla and consists of a pink-tan lymph node measuring 0.5 cm in. greatest dimension, which is submitted whole. Summary of sections: U undesignated. 5) The specimen is received fresh labeled ""Excision of tumor site at 4. o'clock left breast. It consists of an unoriented segment of yellow-tan. fatty breast tissue measuring 8.5 x 6.5 x 3.4 cm. The specimen is received. on a cardboard grid. There is an accompanying specimen radiograph which. demonstrates a solid tumor mass containing a previous biopsy clip. The outer. surface of the specimen is inked black. In sections reveal a 2.6 x 2.4 x 2.2. cm well circumscribed, stony hard, white-tan tumor with a central previous. biopay site measuring 0.8 x 0.7 x 0.6 cm. A stereotactic biopsy clip is. identified within the biopay site. The tumor abuts the black inked tissue. edge. The remainder of the breast tissue is predominantly yellow tan fatty. and lobulated with focal white-tan fibrous areas. A sample of the tumor is. given to TPS. The remainder of the tumor is blocked out, sequentially. sectioned, and submitted entirely. Summary of sections: TB-sequential section of tumor, bisected. T-tumor. 6) The specimen is received fresh, labeled ""Superior margin left breast and. consists of a piece of fibrofatty breast tissue measuring 4.3 x 3.2 cm, and. 0.9 cm thick. A stitch marks the new margin of excision, which is inked. black. No tumor is grosaly identified. The tissue is serially sectioned and. entirely submitted. Summary of sections: ss - sequential sections. 7) The specimen is received fresh, labeled ""Medial margin left breast and. consists of a piece of fibrofatty breast tissue measuring 3.8 x 3.2, and 1.0. cm thick. A stitch marks the new margin of excision, which is inked black. No tumor is grossly identified. The tissue is serially sectioned and. entirely submitted. Summary of sections: SS - sequential sections. 8) The specimen is received fresh, labeled ""Inferior margin left breast and. consists of a piece of fibrofatty breast tissue measuring 4.0 x 3.9, and 1.5. cm thick. A stitch marks the new margin of excision, which is inked black. No tumor is grossly identified. The tiasue is serially sectioned and. entirely submitted. Summary of sections: ss - sequential sections. 9) The specimen is received fresh, labeled Lateral margin left breast"" and. consists of a piece of fibrofatty breast tissue measuring 4.9 x 3.5cm and. 1.2 cm thick. A stitch marks the new margin of excision, which is inked. black. No tumor is grossly identified. The tissue is serially sectioned and. entirely submitted. Summary of sections: SS - sequential sections. 10) The specimen is received fresh, labeled ""Posterior margin left breast. and consists of a piece of fibrofatty breast tissue measuring 4.7 x 2.5 cm. and 0.5 cm thick. A stitch marks the new margin of excision, which is inked. black. No tumor is grossly identified. The tissue is serially sectioned and. entirely submitted. Summary of sections: ss - sequential sections. Summary of Sections: Part 1: SP: Sentinel node #1 level one left axilla. Block. Sect. Site. PCs. 1. bln. 1. Part 2: SP: Sentinel node #2 level one left axilla. Block. Sect. Site. PCs. 1. bln. 1. Part 3: SP: Non-sentinel tissue left axilla. Block. Sect. Site. PCs. 1. u. Part 4: SP: Sentinel node #3 level one left axilla. Block. Sect. Site. PCs. 1. Part 5: SP: Breast, left, 4:00, excision of tumor site. Block. Sect. Site. PCs. 1. T. 1. 2. TA. 2. 2. TB. 2. 2. TC. 2. Part 6: SP: Breast, left, superior margin. Block. Sect. Site. PCs. 6. as. 6. Part 7: SP: Breast, left, medial margin. Block. Sect. Site. PCs. 5. ss. 5. Part 8: SP: Breast, left, inferior margin. Block. Sect. Site. PCs. 6. ss. 6. Part 9: SP: Breast, left, lateral margin. Block. Sect. Site. PCs. 5. ss. 5. Part 10: SP: Breast, left, posterior margin. Block. Sect. Site. PCs. 5. ss. 5. Procedures/AAdenda: Addendum. Date Complete. Addendum Diagnosis. PART #5: LEFT BREAST. ONCOTYPE TESTING RESULTS RECEIVED ON. :CURRENCE SCORK -23. AVERAGE RATE OF DISTANT RECURRENCE OF 15% (95% CI: 12%-18%). TESTING WAS PERFORMED AT: ONCOTYPE REPORT CAN BE FOUND IN. Specimens Submitted: 1: LEFT BREAST 4:00. Test Performed: FISA for detection of gene amplification. Methodology: Fluorescence in situ Hybridization (FISH) is performed using FDA-approved. ERBB2 (HER2/NEU) PathVysion assay probes and procedure. DIAGNOSTIC INTERPRETATION: HER2/ CEP 17. 1.01 NOT AMPLIFIED. Her-2/neu gene amplification is NOT detected. (cut off ratio: > 2.2 HER2 gene amplified; < 1.8 HER2 gene not amplified;. 1.8 2.2 equivocal). LAB) NOTES: Block # 5 (TA1). Specimen fixative type: Formalin. Adequate number of invasive tumor cells present: Yes. Number of invasive tumor cells counted: 20 + 20. Average number of HER2 probe signals per nucleus: 3.2. Average number of CEP17 chromosome probe signals per nucleus: 3.2. Average HER2/CEP 17 ratio: 1.0. The PathVysion HER2 DNA probe kit (Vysis) is an FDA-approved method. for assessment of HER2 gene amplification in breast cancer specimens. The. HER2 test results are reported in accordance with the ASCO/CAP guideline. reccmmendations for HER2 testing in breast cancer (J Clin Oncol 2007; 25. (1):118-145). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIENED AND APPROVED. THIS REPORT."
BIOCUP_00138,breast,BRCA,TCGA-D8-A1JU,TCGA-D8-A1JU.B5074D1A-C617-414F-B349-6096F59E122D,"page 1 / 1. Examination: Histopathological examination. PESEL: Gender: F. Material: Multiple organ resection - left breast. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the left breast - lesion in the upper outer quadrant. Results of immunohistochemical examination: Estrogen receptors found in 75% of neoplastic cell nuclei. Progesterone receptors found in 75% of neoplastic. cell. nuclei. HER2 protein stained with HercepTest‚Ñ¢ by DAKO. Negative reaction in invasive cancerous cells. (Score = 1+ ). Macroscopic description: Left breast sized 20 x 13 x 2 cm removed without axillary tissues. Skin flap. 20 x 9.5 cm in size. Tumour sized 1.7 x 1.8 x 1.5 cm found on the boundary of outer quadrants, placed 2 cm. from the lower edge, 0.2 cm from the base and 1.0 cm from the skin. Cysts of 0.1 - 0.5 cm in the crass-. section. Microscopic description: Carcinoma ductale invasivum NHG1 (2+2+1 /1 mitosis /10 HPF, vision area diameter 0.57 mm). Additionally, focuses of carcinoma ductale in situ: cribrate type with medium nuclear atopia, no. necrosis, found in the glandular tissue (30% of the tumour cross-section). Glandular tissue showing lesions of the type: mastopathia fibrosa et cystica, adenosis sclerosans,. fiat epithellal atypia ( FEA). fibrocystic changes, sclerosing adenosis. Histopathological diagnosis: (including test No. G-15785/10): Carcinoma ductale invasivum et in situ mammae sinistrae. ( NHG 1, pT1c, pNo/sn/). Invasive and in situ ductal carcinoma of the left breast."
BIOCUP_00139,breast,BRCA,TCGA-AQ-A7U7,TCGA-AQ-A7U7.2B30A85F-7A5F-46E4-BE22-28C902D5DFA3,"Diagnosis: A: Breast, left, total mastectomy. Tumor type: invasive lobular carcinoma. Nottingham combined histologic grade: 2. Tubule formation score: 3. Nuclear pleomorphism score: 2. Mitotic count score: 1. Focality of tumor: single focus. Tumor site: upper outer and lower outer quadrants. Tumor size (greatest dimension) : 4.1 cm (see comment). Lymphovascular invasion: none identified. Ductal carcinoma in situ (DCIS) : none identified. Lobular carcinoma in situ (LCIS) : present. Nipple involvement : not involved. Skin involvement : not involved. Skeletal muscle involvement: not applicable. Margin status: Invasive component : Margins free of carcinoma, closest is black. inked posterior margin at 2 mm. Size of largest metastasis : 4.1 cm. Extracapsular extension: absent. Axillary lymph nodes (from parts B-G) : Total number with metastasis : 2. Total number examined: 7. Size of largest metastatic focus: 0.7 cm. Extracapsular extension: absent. Microcalcifications: associated with benign breast changes. Other pathologic findings: Extensive stromal fibrosis with patchy amyloid deposition. - Fibrocystic changes. - Columnar cell change. - Epidermal inclusion cyst. - Previous biopsy site changes. AJCC PATHOLOGIC TNM STAGE: pT2 pN1a. BREAST STAGE GROUPING: IIB. Note: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. Ancillary studies previously performed on core biopsy case and. reported as : Estrogen receptor: positive, 88%, 3+. Progesterone receptor: positive, 82%, 3+. HER2/neu: negative for overexpression, 0. B: Lymph node, left axillary sentinel lymph node #1, biopsy. - One lymph node positive for metastatic carcinoma (1/1) based. on H & E and cytokeratin stained slides. - Metastatic focus measures 0.5 cm. - No extracapsular extension is identified. - Amyloid present. C: Lymph node, left axillary sentinel lymph node #2, biopsy. - One lymph node negative for metastatic carcinoma (0/1) based. on H & E and cytokeratin stained slides. - Amyloid present. D: Lymph node, left axillary sentinel lymph node #3, biopsy. - One lymph node positive for metastatic carcinoma (1/1) based. on H & E and cytokeratin stained slides. - Metastatic focus measures 0.7 cm. - No extracapsular extension is identified. - Amyloid present. E: Lymph node, left axillary sentinel lymph node #4, biopsy. - Two lymph nodes negative for metastatic carcinoma (0/2) based. on H & E and cytokeratin stained slides. - Amyloid present. F: Lymph node, left axillary sentinel lymph node #5, biopsy. - One lymph node negative for metastatic carcinoma (0/1) based. on H & E and cytokeratin stained slides. - Amyloid present. G: Lymph node, left axillary sentinel lymph node #6, biopsy. - One lymph node negative for metastatic carcinoma (0/1) based. on H & E and cytokeratin stained slides. - Amyloid present. Clinical History: -year-old female with left breast invasive lobular carcinoma. Gross Description: Received are seven appropriately labeled containers. Container A: Specimen fixation: formalin. Time in fixative: 33 hours. Cold ischemic time: 71 mins. Type of mastectomy: left total mastectomy. Weight of specimen: 330 grams. Size of specimen: anterior to posterior, 2.5 cm; superior to. inferior, 19.0 cm; medial to lateral, 20.0 cm. Orientation of specimen: The specimen is oriented with a stitch. in the axillary tail. Inking: anterior=blue, posterior=black, axillary tail=dotted. yellow. Skin ellipse dimensions: 19.0 X 5.8 cm. Nipple/areola 1.4 cm/3.0 cm. Axillary tail: present, minimal tissue. Biopsy site: absent. Discrete Mass (es) : Area of fibrotic, homogeneously firm,. white/tar tissue. Number of discrete masses : one. Size of fibrotic tissue: 7.5 cm from medial to lateral, 6.7 cm. from superior to inferior, and 3.5 cm from anterior to posterior. Location of fibrotic tissue: upper inner quadrant, upper outer. quadrant, lower outer quadrant (includes the area deep to the. nipple/areola). Distance of mass/biopsy site from surgical margin: The fibrotic. tissue abuts the black inked deep margin extensively, it also. abuts the blue inked anterior margin in multiple slices. Gross involvement of skin or fascia/muscle by tumor: The tumor. extends very close to the skin, however, does not appear to. grossly involve the skin. Description of remaining breast : predominantly yellow lobular. adipose tissue. Other remarkable features : none. Tissue submitted for special investigations: Tumor and normal. submitted to Tissue Procurement foundation. Block Summary: A1 - nipple, perpendicular sections, in relation to the tumor. A2 - nipple, perpendicular sections, in relation to the tumor. A3, A4 - perpendicular sections of the areola, in relationship to. the deep tumor. A5, A6 - representative section of the tumor, in relation to the. blue inked inferior margin. A7, A8 - representative section of the tumor, in relation to the. black inked deep margin. A9,A10 - additional representative sections of the mass. A11 - representative section, upper outer quadrant. A12 - representative section, lower outer quadrant. A13 - representative section, upper inner quadrant. A14 - representative section, lower inner quadrant. Additional sections, upper outer quadrant surrounding metallic. clip, lateral to medial: A19 - one section bisected. A20 - one section bisected. A21-A22 - - one section bisected. A23-A24 - one section bisected. A25 - one section. A26 - one section. A27 - one section. A15-A18, A28-A67 additional sections from lateral towards. medial, respectively. Container B is additionally labeled ""lymph node, left axillary. sentinel lymph node #1. Received is a single, unoriented,. yellow lobular adipose tissue fragment, 3.7 X 3.0 X 1.0 cm. A. single lymph node candidate, 2.2 X 1.3 X 0.8 cm is identified. and is sequentially sectioned at 2 mm intervals. The entire. lymph node is submitted in blocks B1 and B2. Adipose tissue. remains in the container. Container C is additionally labeled ""lymph node, left axillary. sentinel lymph node #2. Received is a single, unoriented,. brown/tan fibroadipose tissue fragment, 3.4 X 2.3 X 1.3 cm. A. single, possibly two, lymph node candidates matted together are. identified, 2.3 X 2.3 X 0.8 cm. The lymph node candidate is. serially sectioned at approximately 2 mm intervals and is. entirely submitted in blocks C1-C3. Adipose tissue remains in. the container. Container D is additionally labeled ""lymph node, left axillary. sentinel lymph node #3. "" Received is a single, unoriented,. brown/tan fibroadipose tissue fragment, 1.8 X 1.8 X 1.5 cm. A. single lymph node candidate, 1.2 X 0.8 X 0.8 cm is identified,. is serially sectioned at approximately 2 mm intervals and. entirely submitted in blocks D1 and D2. Adipose tissue remains. in the container. Container E is additionally labeled ""lymph node, left axillary. sentinel lymph node #4. "" Received is a brown/tan, single,. unoriented fibroadipose tissue fragment, 1.5 X 1.0 X 0.9 cm. Two. lymph node candidates, 0.5 and 0.2 cm in diameter are. identified. The larger lymph node is bisected and submitted in. block E1. The smaller lymph node is submitted in block E2. without sectioning. Adipose tissue remains in the container. Container F is additionally labeled ""lymph node, left axillary. lymph node #5. "" Received is a single, unoriented, brown/tan. fibroadipose tissue fragment, 1.2 X 1.2 X 0.6 cm. A single lymph. node candidate, 1.1 X 0.8 X 0.6 cm is identified. The lymph node candidate is serially sectioned at approximately. 2 mm intervals and entirely submitted in block F1. Adipose. tissue remains in the container. Container G is additionally labeled ""lymph node, left axillary. sentinel lymph node #6. Received is a single, gray/tan,. unoriented, 1.0 X 0.9 x 0.6 cm lymph node candidate. The. specimen is serially sectioned, at approximately 2 mm. intervals, and entirely submitted in blocks G1 and G2,."
BIOCUP_00140,breast,BRCA,TCGA-EW-A6SB,TCGA-EW-A6SB.6EEF1F11-603E-4196-91AB-724BBEE20CE7,"X. F. X. X. x. x. x. Pathologic Interpretation: A. LEFT AXILLARY # 1. Negative for carcinoma, four lymph nodes examined (0/4). Keratin immunostain is pending. B. LEFT AXILLARY,. , PALPABLE: Negative for carcinoma, four lymph nodes examined (0/4). Keratin immunostain is pending. C. LEFT SEGMENTAL MASTECTOMY: INVASIVE DUCTAL CARCINOMA, poorly differentiated, Nottingham grade 3 (3+3+3=9), 3.1 cm in greatest. dimension. Immunohistochemical studies performed on previous biopsy showed the following results: Estrogen Receptor: NEGATIVE (< 1%). Progesterone Receptor: NEGATIVE (< 1%). Her2/neu. NEGATIVE (0). Androgen Receptor: NEGATIVE. EGFR: POSITIVE. GCDFP: NEGATIVE. HLA-DR: Immunohistochemistry is pending. Skin is uninvolved by tumor. Resection margins are uninvolved by invasive carcinoma; the tumor is at less than 1 mm from the deep. resection margin. Negative for lymphatic space invasion. SURGICAL PATHOLOGY CANCER CASE SUMMARY. Procedure. Excision without wire-guided localization. Lymph Node. Sentinel lymph node(s). Specimen Laterality. Left. Histologic Type of Invasive Carcinoma. Invasive ductal carcinoma (no special type or not otherwise specified). Tumor Size: Size of Largest Invasive Carcinoma. Greatest dimension of largest focus of invasion >1 mm: 31 mm. Histologic Grade: Nottingham Histologic Score. Glandular (Acinar)/Tubular Differentiation. Score 3: <10% of tumor area forming glandular/tubular structures. Nuclear Pleomorphism. Score 3: Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation in size and. shape, occasionally with very large and bizarre forms. Mitotic Rate. Score 3 (>8 mitoses per mm¬≤) (see Table 1). Overall Grade. Grade 3: scores of 8 or 9. Tumor Focality. Single focus of invasive carcinoma. Ductal Carcinoma In Situ (DCIS). No DCIS is present. Lobular Carcinoma In Situ (LCIS). Not identified. Margins. Invasive Carcinoma. Margins uninvolved by invasive carcinoma. Distance from closest margin: 1 mm. Specify margin: Deep. Lymph Nodes. Number of sentinel lymph nodes examined: 8. Total number of lymph nodes examined (sentinel and nonsentinel): 0. Number of lymph nodes without tumor cells identified: 8. Method of Evaluation of Sentinel Lymph Nodes. Hematoxylin and eosin (H&E), 1 level. Immunohistochemistry. Treatment Effect: Response to Presurgical (Neoadjuvant) Therapy. In the Breast. No known presurgical therapy. In the Lymph Nodes. No known presurgical therapy. Lymph-Vascular Invasion. Not identified. Dermal Lymph-Vascular Invasion. Not identified. Pathologic Staging (based on information available to the pathologist) (pTNM). Primary Tumor (Invasive Carcinoma) (pT). pT2: Tumor >20 mm but <50 mm in greatest dimension. Regional Lymph Nodes (pN). pNO: No regional lymph node metastasis identified histologically. Distant Metastasis (pM). Not applicable. Ancillary Studies. Performed on another specimen. Specify specimen (accession number): xxx. Estrogen Receptor (ER). Results and interpretation: Negative (<1% of tumor cells with nuclear positivity). Progesterone Receptor (PgR). Results and interpretation: Negative (<1% of tumor cells with nuclear positivity). HER2 Immunoperoxidase Studies. Negative (Score 0). AJCC Classification (7th edition): pT2, pNo, pMn/a. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. A. LEFT AXILLARY #1. Keratin immunohistochemistry is negative. B. LEFT AXILLARY,. PALPABLE: Keratin immunohistochemistry is negative. Final AJCC Classification (7th edition): pT2 (sn)NO(i -) Mn/a. Addendum Diagnosis. ADDENDUM C: Immunohistochemistry for HLA-DR is positive in tumoral cells. This neoplasm is consistent with an invasive ductal carcinoma, medullary type. Intraoperative Consultation: A. Left axillary #1,. FS: No malignancy seen. B. Left axillary. palpable, FS1-3: No malignancy seen. x. Clinical History: Patient with palpable breast cancer, please evaluate margins and lymph nodes. Operation Performed: Left segmental mastectomy with sentinel lymph node biopsy, possible axillary node dissection. Pre Operative Diagnosis: Carcinoma left breast. Specimen(s) Received/Processing Information: Fee Codes: A: LEFT AXILLARY # 1. FS Frozen section x 1, FS Perm x 1, Touch Prep. Histology x 1, FSDeep 1 x 1, Cytokeratin Cocktail (KER) x 1, H&E, Initial x 1. A: B: B: LEFT AXILLARY,. , PALPABLE FS Frozen section x 1, FS Perm x 1, Touch. Prep Histology x 1, Cytokeratin Cocktail (KER) x 1, Frozen section x 1, FS Perm x 1,. C: Cytokeratin Cocktail (KER) x 1, Frozen section x 1, FS Perm x 1, Cytokeratin Cocktail (KER) x. 1, H&E, Initial x 1, Cytokeratin Cock. C: LEFT SEGMENTAL MASTECTOMY (1 SUTURE -SUPEIOR, 2 SUTURES - MEDIAL). H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x. 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, HLA-DR (IP) x 1, H&E, Initial x 1, H&E,. Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E,. Gross Description: A.Received fresh labeled ""Left axillary #1,. FS"" is a fragment of adipose tissue that measures 5 x 4 x 2 cm. There are four palpable lymph nodes present. The lymph nodes are bisected and submitted for frozen section. (cassette #1FS). Representative sections of the remaining adipose tissue are submitted in cassette #2. B. .Received fresh labeled ""Left axillary. palpable, FS"" is a fragment of adipose tissue that measures 4 x 4 x. 2 cm. There are four palpable lymph nodes present. The lymph nodes are bisected and submitted for frozen section. in cassettes #1-3FS. The rest of the specimen is submitted in cassettes #4-8. C. Received in formalin labeled ""Left segmental mastectomy (1 suture -superior, 2 sutures -medial)"" is a lumpectomy. specimen weighing 120 grams and measuring 9 x8 x 3.5 cm, with an unremarkable dark skin ellipse measuring. 3.3 x 1.3 cm. The specimen is inked as follows: superior-blue, inferior-green, anterior-yellow, deep-black, medial-. red, lateral-orange. Upon sectioning, there is a 3.1 x 3.0 x 3.0 cm well circumscribed, nodular tumor, white-tan, with. an elastic consistency and central cavity. A metallic clip is identified in the central of the tumor. The tumor is grossly. at less than 0.1 cm from the deep margin, 0.4 cm from the superior margin, 1.0 cm from the lateral margin, 2.0 cm. from the medial margin, 2.5 cm from the anterior and skin margin, 4.0 cm from the inferior margin. The rest of the. specimen has a cut surface, yellow-tan and homogeneous. Cassettes are submitted as follows: Cassette #1. Tumor in relation with deep and superior margins. Cassette #2. Medial margin. Cassette #3. Lateral margin. Cassette #4. Anterior margin (and skin). Cassette #5. Inferior margin. Cassette #6. Area of tumor with clip. Cassettes #7&8. Composite section of the tumor. Cassettes #9-12 Additional sections of the tumor. Cassettes #13-15 Representative sections of the rest of specimen."
BIOCUP_00141,breast,BRCA,TCGA-A2-A4S1,TCGA-A2-A4S1.041580F0-700A-4A47-83A6-207ED267E844,"R√©g. Att. M.D. This report contains corrections; additions or deletions. Any previous versions are stored internally and are available if necessary. Specimen: Req# : Sp type: SURGICAL P. , M.D. PREOPERATIVE DIAGNOSIS. 174-RT BREAST CANCER-INVASIVE. OPERATION PERFORMED. DOCTOR (S) : PROCEDURE: MASTECTOMY PARTIAL LUMPECTOMY, ULTRASONIC NEEDLE LOC BREAST BX. PROCEDURE (CONT) : BX SENTINEL NODE. TISSUE REMOVED. A. RT PARTIAL MASTECTOMY POSSIBLE SARCOMA SHORT STITCH SUPERIOR MEDIAL. SKIN MARGIN LONG STITCH LATERAL SKIN MARGIN @. B. RT BREAST MEDIAL MARGIN AT. C. RT BREAST SUPERIOR MARGIN @. D. RT BREAST LATERAL MARGIN @. E. RT BREAST INFERIOR MARGIN AT. F. RT BREAST POSTERIOR MARGIN @. G. RT BREAST ANTERIOR MARGIN @. H. RT BREAST MEDIAL POSTERIOR MARGIN @. I. RT AXILLARY SENTINEL NODE HOT AND BLUE COUNT 241 @. GROSS DESCRIPTION. RECEIVED IN 9 PARTS. A RECEIVED LABELED. RIGHT BREAST PARTIAL MASTECTOMY. POSSIBLE SARCOMA SHORT SUPERIOR MEDIAL SKIN MARGIN LONG LATERAL SKIN. MARGIN IS A 167 GRAMS PARTIAL MASTECTOMY WITH A 10 X 4.5 CM SKIN. ELLIPSE. ON THE LATERAL PORTION OF THE SPECIMEN THERE ARE SEVERAL. ELEVATED SLIGHTLY DARKENED SKIN LESIONS THE LARGEST 0.5 X 0. CM. ONE. OF THESE IS GROSSLY FOUND TO BE A SUPERIOR LATERAL SKIN MARGIN. THERE. IS A PROMINENT PALPABLE MASS WITHIN THE SPECIMEN. THE MARGINS ARE. MARKED AS FOLLOWS USING SKIN AS THE ANTERIOR MARGIN: LATERAL ORANGE,. MEDIAL RED, INFERIOR BLUE, SUPERIOR GREEN, POSTERIOR BLACK. RED-BROWN. MUSCLE FIBERS ARE NOTED IN THE AREA OF THE MASS ON THE POSTERIOR ASPECT. WHICH OTHERWISE HAS A SMOOTH APPEARANCE. SECTIONING REVEALS A DISCRETE. Specimen. Sp type: SURGICAL P. GROSS DESCRIPTION. FIRM GRAY MASS MEASURING 3.4 x 2.8 x 2.8 CM. CENTRALLY THERE IS RED. DISCOLORATION TO THE NODULE AND ANTERIOR INFERIORLY TO THIS THERE IS A. 1.3 CM IN DIAMETER AREA OF RED-BROWN BLOOD. THE DEEP MEMBRANOUS SURFACE. EASILY SLIDES OVER THIS MASS WHICH IS ONLY COVERED GROSSLY BY THE DEEP. FASCIA AND MUSCLE FIBERS. IT IS OTHERWISE GREATER THAN 1 CM FROM ALL. MARGINS. SECTIONS ARE SUBMITTED AS. EOLLOWS.: Al--RE.PRESENTATIVE. PERPENDICULAR MEDIAL MARGIN, A2--REPRESENTATIVE PERPENDICULAR LATERAL. MARGIN, A3 THROUGH A9--FULL CROSS SECTION OF THE LESION TO INCLUDE THE. DEEP MARGIN (A3) AND THE ADJACENT HEMORRHAGIC AREA (A5), A6--OVERLYING. SKIN TO THIS NODULE, AND REPRESENTATIVE SKIN LESION, A7--REPRESENTATIVE. SUPERIOR MARGIN TO THIS LESION, A8 AND A9--REPRESENTATIVE INFERIOR. MARGIN TO THIS LESION, A10--CROSS SECTION OF LESION TO INCLUDE POSTERIOR. MARGIN, All--THE HEMORRHAGIC AREA ADJACENT TO A10, A12--LATERAL PORTION. OF LESION WITH ADJACENT HEMORRHAGIC TISSUE. NOTE: RANDOM SECTIONS OF THE MASS ARE SUBMITTED PER PROTOCOL AS P1-p5. WITH MIRROR IMAGE SECTION FROZEN OF P1 AND P2 AS WELL AS RANDOM TISSUE. FRESH FROZEN. A PORTION OF SKIN IS ALSO SUBMITTED AS P6 FROM THE AREA. OF SKIN IN A6. B RECEIVED LABELED. BREAST MEDIAL MARGIN IS A 5 x 3.9 x. 1.2 CM FRAGMENT OF YELLOW FATTY TISSUE. PURPLE-BLUE COLORATION IS NOTED. ON ONE SURFACE. THIS SURFACE IS REMARKED WITH BLUE INK WITH A PERIMETER. OF BLACK. THIS IS SECTIONED AND SUBMITTED AS B1-B9. C RECEIVED LABELED. RIGHT BREAST SUPERIOR MARGIN IS A. 3.8 x 2.8 X 1.1 CM FRAGMENT OF YELLOW FATTY TISSUE. BLUE COLORATION IS. SEEN ON ONE SIDE OF THE SPECIMEN. THIS SIDE IS REMARKED WITH BLUE INK. WITH A PERIMETER OF BLACK. THIS IS SECTIONED AND SUBMITTED AS C1-C3. D RECEIVED LABELED. RIGHT BREAST LATERAL MARGIN IS A 2.8. X 1.8 X 0.8 CM FRAGMENT OF YELLOW FATTY TISSUE. PURPLE-BLUE COLORATION. IS SEEN ON ONE SIDE OF THE SPECIMEN. THIS IS REMARKED WITH BLUE INK. WITH A PERIMETER OF BLACK. THIS IS SECTIONED AND SUBMITTED AS D1 AND D2. E RECEIVED LABELED. RIGHT BREAST INFERIOR MARGIN IS A. 4.5 x 2.7 x 1 CM FRAGMENT OF YELLOW FATTY TISSUE. PURPLE-BLUE. COLORATION IS SEEN ON APPROXIMATELY ONE-HALF OF ONE SIDE OF THE. SPECIMEN. THIS SIDE IS ENTIRELY MARKED WITH BLUE INK WITH A PERIMETER. OF BLACK. THIS IS SECTIONED AND SUBMITTED LABELED E1-E3. F RECEIVED LABELED. RIGHT BREAST POSTERIOR MARGIN IS AN. IRREGULAR FRAGMENT OF YELLOW FATTY TISSUE WITH MULTIPLE METAL CLIPS. MEASURING 4.2 X 3.7 x 0.6 CM IN GREATEST DIMENSION. PURPLE-BLUE. Specimen: tatus: Sp type: SURGICAL P. .D. GROSS DESCRIPTION. COLORATION IS SEEN ON ONE SIDE OF THE SPECIMEN WHICH IS THEN REMARKED. WITH BLUE INK WITH A PERIMETER OF BLACK. THIS IS SECTIONED AND. SUBMITTED AS F1-F3. G RECEIVED LABELED. RIGHT BREAST ANTERIOR MARGIN IS AN. IRREGULAR FRAGMENT OF YELLOW FATTY TISSUE MEASURING 5.6. X 3.5 x 1.1 CM. IN GREATEST DIMENSION. PURPLE-BLUE COLORATION IS SEEN ON ONE SIDE OF. THE SPECIMEN WHICH ALSO DEMONSTRATES BLUE DYE WITHIN THE TISSUE. THIS. SIDE IS REMARKED WITH BLUE INK WITH A PERIMETER OF BLACK. THIS IS. SECTIONED AND SUBMITTED LABELED G1-G7. H RECEIVED LABELED. RIGHT BREAST MEDIAL POSTERIOR MARGIN. IS A 4.2 X 3.2 x 0.5 CM FRAGMENT OF YELLOW FATTY TISSUE. BLUE. COLORATION IS SEEN ON ONE SIDE OF THE SPECIMEN. THIS SIDE IS REMARKED. WITH BLUE INK WITH A PERIMETER OF BLACK. THIS IS SECTIONED AND. SUBMITTED LABELED H1-H3. I RECEIVED LABELED. RIGHT AXILLARY SENTINEL NODE HOT AND. BLUE COUNT 241 IS A 5 X 3.5 X 1.5 CM FRAGMENT OF YELLOW FATTY TISSUE. EXAMINATION REVEALS 2 NODAL STRUCTURES. ONE IS 4.0 x 0.8 x 0.4 CM. THIS IS SECTIONED INTO MULTIPLE PIECES AND SUBMITTED AS Il AND 2. THE. 2ND MEASURES 0.6 x 0.4 X 0.2 CM. THIS IS SUBMITTED LABELED I3. COMMENT: THIS CASE IS IN COMPLIANCE WITH CAP. GUIDELINES OF 6-48 HOURS FORMALIN FIXATION TIME. PATH PROCEDURES. PROCEDURES: 88307/9, IMMUNOPEROXIDAS/2, A BLK/12, B BLK/9, C BLK/3, D BLK/2, E BLK/3,. F BLK/3, G BLK/7, H BLK/3, IBX X6/3. FINAL DIAGNOSIS. PART A RIGHT BREAST, PARTIAL MASTECTOMY: 1. POORLY DIFFERENTIATED MALIGNANT NEOPLASM WITH OSTEOSARCOMATOUS. FEATURES WHICH MOST LIKELY REPRESENTS A METAPLASTIC CARCINOMA OF. BREAST NUCLEAR GRADE 3 WITH HIGH MITOTIC INDEX WITH FOCI OF MALIGNANT. OSTEOID FORMATION. - LVI. Specimen: Req# : Sp type: SURGICAL P. M.D. FINAL DIAGNOSIS. 2. ADJACENT BREAST TISSUE WITH FOCI OF INTERMEDIATE TO HIGH GRADE. DUCTAL CARCINOMA IN SITU OF SOLID AND CRIBRIFORM TYPE WITH FOCI OF. INTRADUCTAL NECROSIS AND CALCIFICATION. 3. THE INVASIVE NEOPLASM MEASURES 34 MM IN GREATEST DIMENSION AND IS. PRESENT 2. MM FROM THE POSTERIOR MARGIN AND. 5. MM OR GREATER FROM ALL. OTHER MARGINS. 4. THE LARGEST FOCUS OF DCIS MEASURES 10 MM IN GREATEST DIMENSION. DCIS IS PRESENT 1 MM FROM THE INFERIOR MARGIN, 2 MM FROM THE LATERAL. MARGIN AND 5 MM OR GREATER FROM ALL OTHER MARGINS. 5. LYMPHATIC INVASION IS NOT IDENTIFIED. 6. BIOPSY SITE CHANGE WITH REACTIVE FIBROSIS AND FAT NECROSIS. 7. SEGMENT OF BENIGN SKIN. PART B RIGHT BREAST, MEDIAL MARGIN REEXCISION: FIBROCYSTIC DISEASE. WITH A FOCUS OF ATYPICAL DUCT HYPERPLASIA, DUCT HYPERPLASIA OF THE USUAL. TYPE AND SCLEROSING ADENOSIS. A FEW CALCIFICATIONS ARE PRESENT. THE. NEW INKED MARGIN IS FREE OF NEOPLASM. PART C RIGHT BREAST, SUPERIOR MARGIN REEXCISION: INTERMEDIATE GRADE. DUCTAL CARCINOMA IN SITU WITH EXTENSION INTO TERMINAL LOBULES WITH FOCAL. INTRADUCTAL NECROSIS. DCIS IS PRESENT 3 MM FROM THE NEW INKED MARGIN. RESIDUAL INVASIVE NEOPLASM IS NOT IDENTIFIED. THE AREA INVOLVED BY DCIS. HAS A CALCULATED DIMENSION OF APPROXIMATELY 8 MM. PART D RIGHT BREAST, LATERAL MARGIN REEXCISION: LIPOMATOUS BREAST TISSUE. WITH NO EVIDENCE OF RESIDUAL TUMOR. THE NEW INKED MARGIN IS FREE OF. NEOPLASM. PART E RIGHT BREAST, INFERIOR MARGIN REEXCISION: LOW GRADE DUCTAL. CARCINOMA IN SITU OF CRIBRIFORM TYPE NUCLEAR GRADE 1 WITH LOW MITOTIC. INDEX MEASURING 4 MM IN GREATEST DIMENSION. DCIS IS PRESENT 2 MM FROM. THE NEW INKED MARGIN. RESIDUAL INVASIVE TUMOR IS NOT IDENTIFIED. PART F RIGHT BREAST, POSTERIOR MARGIN REEXCISION: LIPOMATOUS TISSUE. WITH NO EVIDENCE OF RESIDUAL NEOPLASM. THE NEW INKED MARGIN IS FREE OF. NEOPLASM. PART G RIGHT BREAST, ANTERIOR MARGIN REEXCISION: NO EVIDENCE OF. RESIDUAL NEOPLASM. THE NEW INKED MARGIN IS FREE OF NEOPLASM. Specimen: Sp type: SURGICAL P. FINAL DIAGNOSIS. PROLIFERATIVE FIBROCYSTIC DISEASE WITH NUMEROUS CALCIFICATIONS PRESENT. PART H RIGHT BREAST, MEDIAL POSTERIOR MARGIN REEXCISION: LIPOMATOUS. TISSUE AND SKELETAL MUSCLE WITH NO EVIDENCE OF RESIDUAL NEOPLASM. THE. NEW INKED MARGIN IS FREE OF NEOPLASM. PART I RIGHT SENTINEL NODE, BIOPSY: LYMPH NODE (1), NEGATIVE FOR TUMOR. BY STEP SECTION AND CYTOKERATIN STAIN. COMMENT. MULTIPLE BLOCKS OF THE INVASIVE NEOPLASM ARE STAINED WITH CYTOKERATIN. STAIN AND DEMONSTRATE VIRTUALLY NO STAINING OF THE INVASIVE TUMOR. ALTHOUGH FOCI OF ADJACENT DCIS DO DEMONSTRATE STAINING. THIS TUMOR. IS. MOST LIKELY A METAPLASTIC CARCINOMA OF BREAST DUE TO THE ASSOCIATION. WITH DUCTAL CARCINOMA IN SITU. , M.D. yany. Liscrepance."
BIOCUP_00142,breast,BRCA,TCGA-B6-A0IM,TCGA-B6-A0IM.4A86A028-C56D-455E-A5CD-47D8A34B5734,"Putient: CLINICAL HISTORY: Not provided. GROSS EXAMINATION: A. ""Right breast mass #1"", received fresh labeled with the patient's name and. record number for frozen section is a 4 x 2.9 x 2.2 cm specimen with a 2 x 2 x. 1.3 cm tumor. The frozen section remnant is submitted in A1. A2-A4 represent. full cross sections of the tumor and adjacent tissue. B. ""Right breast, long lateral short superior"", received fresh is a right. mastectomy specimen weighing 2040 grams. The skin ellipse measures 34.5 x. 17.5 cm, has a 4 cm areola and a 0.9 cm nipple. A suture marks the lateral. aspect of the specimen. The breast measures 35 x 23 x 6 cm with an 8 x 6.5 x. 1 cm axillary tail. In the upper outer quadrant is a recent sutured surgical. incision 7 cm. The soft tissue margins are inked blue. Sectioning shows a. recent biopsy cavity approximately 5 cm in diameter deep to the suture. On. the medial aspect of this biopsy cavity, another tumor is identified. While. contiguous with the cavity, the bulk of the tumor is more medial. This is felt. to represent a single ""dumbell"" shaped tumor rather than two separate tumors. Maximal dimensions of this tumor are 5 x 3.5 x 3 cm. This tumor is also. located in the upper lateral quadrant and is 2 cm from the deep resection. margin. Further firm tissue suspicious for tumor is identified in the lateral. aspect of the biopsy cavity and measures 2 cm. Again this is 2 cm from the. deep resection margin. Measuring from the medially located tumor to the. lesion present at the lateral aspect of the biopsy cavity the maximum tumor. diameter is 7 cm. The axilla is sampled from medial to lateral. BLOCK SUMMARY: B1 - lateral aspect of biopsy cavity. B2 - medial aspect of the biopsy cavity. B3&B4 - tumor in upper outer quadrant. B5 - tissue from lower lateral quadrant. B6 - tissue, upper inner quadrant. B7 - tissue, lower inner quadrant. B8&B9 - nipple. B10&B11 - deep margin. B12 - one lymph node, serially sectioned. B13 - two lymph nodes, one inked red. B14 - three node candidates. B15 - one lymph node. B16 - highest node (near suture). INTRA OPERATIVE CONSULTATION: A. ""Right breast mass (AF1) "" - infiltrating ductal carcinoma present. (Dr. REVISED DIAGNOSIS. This report is being revised to correct the specimen ""B"" site from ""left"" to. ""right"" breast. The remainder of the diagnosis is unchanged. A. ""RIGHT BREAST MASS"", (INCISIONAL BIOPSY) : INFILTRATE DUCTAL CARCINOMA WITH PROMINENT CRIBRIFORM PATTERN. TUMOR SIZE; 2 CM. B. ""RIGHT BREAST"", (MASTECTOMY) : sult for: 1 of 2. INFILTRATING CARCINOMA, PRESENT. HISTOLOGIC TYPE, DUCTAL WITH A PROMINENT. CRIBRIFORM COMPONENT. N.S.A.B.P. HISTOLOGIC GRADE 1 OF 3. N.S.A.B.P. NUCLEAR GRADE 2 OF 3. GROSS TUMOR SIZE; 7 CM. SEE COMMENT. INVASION TUMOR SIZE, 7 CM. SEE COMMENT. LOCATION, UPPER OUTER QUADRANT. MULTIFOCAL TUMOR, NO. IN-SITU CARCINOMA, ABSENT. STATUS OF NON-NEOPLASTIC BREAST TISSUE; SCLEROSING ADENOSIS WITH. MICROCALCIFICATIONS. LYMPHATIC/VASCULAR INVASION ABSENT. SURGICAL MARGIN STATUS, NEGATIVE. NIPPLE STATUS; PAGET'S DISEASE ABSENT. SKIN STATUS; FREE OF TUMOR. MUSCLE STATUS; NOT SAMPLED. LYMPH NODES STATUS; 9 LYMPH NODES, NO CARCINOMA IDENTIFIED (0/9). ESTROGEN/PROGESTERONE AND CELL CYCLE ANALYSIS PENDING, YES. METHODOLOGY, FRESH TISSUE. RESULTS WILL BE ISSUED IN AN ADDENDUM. COMMENT: The tumor size in the mastectomy specimen is 7 cm in greatest. dimension and the size of the tumor in the incisional biopsy is 2 cm. The. overall tumor size is mostly likely 9 cm in greatest dimension. The results of this revision has been discussed withr=. on. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . Darte. ADDENDUM 1: Tissue was sent to the. for assay of the estrogen. and progesterone receptors. The estrogen receptor activity was judged to be. positive with an estimated FMOL value of 113. The progesterone receptor. activity was judged as borderline with an estimated FMOL of value of 14. Please refer to. for a complete report. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). 2 of 2."
BIOCUP_00143,breast,BRCA,TCGA-E2-A56Z,TCGA-E2-A56Z.83AAF7BF-131D-4044-AD3B-670B838A23D6,"METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by. following the manufacturer S instructions. This. assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Breast Core Needle Biopsy. Block Number: Interpretation: EQUIVOCAL. Intensity: 2+. % Tumor Staining: 10%. Fish Ordered: METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analysis was performed using the FDA approved. HercepTest (TM) test kit. using rabbit anti-human HER2. This assay was not modified. External kit-slides. provided by the manufacturer (cell lines with high, low and negative HER2 protein expression) and in-. house known HER2 amplified control tissue were evaluated along with the test tissue. Adequate, well. preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2. immunohistochemical stain is guided by published results in the medical literature, information provided. by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the. joint recommendations and guidelines from. ASCO and CAP and from the NCCN HER2 testing in Breast Cancer Task Force. The. Pathology Department takes full responsibility for this test's performance. FISH/ISH ANALYSIS REPORT 3. Specimens Involved. Specimens: B: RIGHT BREAST SUBAREOLAR CORE BIOPSY. HER2/NEU RESULTS. ANALYTICAL INTERPRETATION OF RESULTS. INDETERMINATE (EQUIVOCAL) FOR HER-2 AMPLIFICATION. Clinical interpretation of the results. A majority of tumors cells displayed 2 to CEP17 signals and 4 to 5 HER-2 signals, with a HER-2/CEP. 17 Ratio of 2. A HER-2/CEP 17 Ratio of >2.2 is generally considered amplification, while a ratio of 1.8. to <2.2 is generally considered indeterminate. This specimen is a biopsy and recommendation is to. repeat HER2 FISH test on resection specimen. Probes identification. .SI Her-2/neu 17q11.2-12, spectrumorange. CEP 17, 17 p11.1-q11.1 alpha satellite DNA, spectrumgreen. Image analysis method - Manual. Results interpreted. Number of invasive tumor cells counted. 100. Number of observers. 1. Number of Her2 signals/nucleus. 4.0. Number of CEP 17 signals/nucleus. 2.0. Her2/CEP 17 ratio. 2.0. TEST CHARACTERISTICS: PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. patients for whom Herceptin therapy is being considered. These tests were performed in the Pathology. Core Facility, Department of Pathology,. under the direction of Dr.. The. results of these studies should always be interpreted in the context of the clinical, morphological, and. immunophenotypic diagnosis. The. PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is intended. to be used as an adjunct to other prognostic factors currently used to predict disease-free and overall. survival in stage II, node-positive breast cancer patients. In making decisions regarding adjuvant CAF. treatment, all other available clinical information should also be taken into consideration, such as tumor. size, number of involved lymph nodes, and steroid receptor status. No treatment decision for stage II,. node-positive breast cancer patients should be based on HER-2/neu gene amplification status alone. Specimen information. Block number used. Comment: Controls: The FISH study was performed with appropriately stained positive and negative controls. SPECIMEN(S): A. SLN #1 RIGHT AXILLA. B. LEFT BREAST TISSUE BIOPSY WITH NEEDLE LOCALIZATION. C. RIGHT BREAST TISSUE BIOPSY WITH NEEDLE LOCALIZATION. D. ADDITIONAL MEDIAL SUPERIOR MARGIN RIGHT BREAST. E. RIGHT AXILLARY CONTENTS. CLINICAL HISTORY: None Given. PRE-OPERATIVE DIAGNOSIS: Right breast cancer- left breast atypia. INTRAOPERATIVE CONSULTATION: TPA: SLN #1 right axilla- Positive for carcinoma. Diagnosis called to Dr. at by Dr. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, RIGHT AXILLA, EXCISION: - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1),. MEASURING 0.3-CM WITH NO EXTRANODAL EXTENSION. B. BREAST, LEFT, WIDE LOCAL EXCISION: - FOCAL FIBROADENOMATOID CHANGES WITH COARSE. CALCIFICATIONS. - BIOPSY SITE CHANGES WITH FIBROSIS, GRANULATION TISSUE,. FOREIGN BODY GIANT CELL REACTION AND FAT NECROSIS, NO. TUMOR SEEN. C. BREAST, RIGHT, WIDE LOCAL EXCISION: - INVASIVE DUCTAL CARCINOMA WITH PAPILLARY AND FOCAL. MUCINOUS FEATURES, SBR GRADE 2, MEASURING 3-CM. - HIGH NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, SOLID,. MICROPAPILLARY, PAPILLARY AND CRIBRIFORM TYPES WITH. CENTRAL NECROSIS AND MICROCALCIFICATIONS. - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR. - BIOPSY SITE CHANGES WITH FIBROSIS, GRANULATION TISSUE,. FOREIGN BODY GIANT CELL REACTION AND FAT NECROSIS. - SEE SYNOPTIC REPORT AND SEE NOTE. D. BREAST, RIGHT, ADDITIONAL MEDIAL SUPERIOR MARGIN, EXCISION: - BREAST TISSUE NO TUMOR SEEN. E. LYMPH NODES, RIGHT, AXILLARY DISSECTION: - FIFTEEN LYMPH NODES, NEGATIVE FOR METASTASES (0/15). NOTE: Invasive ductal carcinoma is identified in 5 consecutive slices from lateral to. medial, measuring about 3.0 CM. HER-2/neu test by FISH is ordered, since the core needle biopsy results were equivocal. SUMMARY OF IMMUNOHISTOCHEMISTRYISPECIAL STAINS. Material: Block A1. Population: Lymph Node. Stain/Marker: Comment: CYTOKERATIN AE1/3. Positive. CYTOKERATIN 7. Negative. S-100. Negative. ESTROGEN RECEPTOR. Positive. Material: Block C7. Population: Tumor Cells. Stain/Marker: Comment: CYTOKERATIN AE1/3. Positive. CYTOKERATIN 7. Negative. S-100. Negative. ESTROGEN RECEPTOR. Positive. Material: Block C12. Population: Tumor Cells. Stain/Marker: Comment: P63. Negative. CALP. Negative. SMOOTH MUSCLE. Negative. MYOSIN. The interpretation of the above immunohistochemistry stain or stains is guided by published results in the medical literature, provided. package information from the manufacturer and by internal review of staining performance and assay validation within the. Immunohistochemistry Laboratory of the. The use of one or more reagents in the above tests is. regulated as an analyte specific reagent (ASR). These tests were developed and their performance characteristic determined by the. Department of Pathology Laboratory at. `hey have not been cleared or approved by the U.S. Food and. Drug Administration. The FDA has determined that such clearance or approval is not necessary. Special stains and/or immunohistochemical stains were performed with appropriately stained positive and/or negative. controls. SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: A: SLN #1 RIGHT AXILLA. C: RIGHT BREAST TISSUE BIOPSY WITH NEEDLE LOCALIZATION. D: ADDITIONAL MEDIAL SUPERIOR MARGIN RIGHT BREAST. E: RIGHT AXILLARY CONTENTS. Specimen Type: Excision. Needle Localization: Laterality: Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3cm. Margins: Negative. Distance from closest margin: 0.4cm. anterior. Tubular Score: 2. Nuclear Grade: 3. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node. Axillary dissection. Lymph node status: Positive 1 / 16. Micrometastases: DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 10%. DCIS Type: Cribriform. Micropapillary. Papillary. DCIS Location: Associated with invasive tumor. Nuclear grade: High. Necrosis: Present. Location of CA++: DCIS. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Pending by FISH. Performed on Case: ER/PR. on case. HER2 by FISH pending on the current case. Pathological staging (pTN): pT 2 N la. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. GROSS DESCRIPTION: A. SLN #1 RIGHT AXILLA. Received fresh labeled with the patient's identification and 'SLN #1 right axilla' is a tan. pink lymph node 1.7 X 0.9 X 0.7cm. The specimen is serially sectioned. A touch prep is. taken. Toto A1. B. LEFT BREAST TISSUE BIOPSY WITH NEEDLE LOCALIZATION. Received in formalin labeled with the patient's identification and 'left breast tissue. biopsy with needle localization' are two oriented, previously inked lumpectomy. specimens 59g and 53g each - when placed back together by the surgeon, measuring 11.5. x 8 x 4.5cm. Ink code- anterior-yellow, posterior-black, superior-blue, inferior-orange,. medial-green, lateral-red. Specimen is serially sectioned in to 15 slices revealing a 0.6 x. 0.5 x 0.5cm previous biopsy site with surrounding necrosis, at the anterior margin in. slices 4-5-6. The specimen is radiographed and areas of concern are marked by the. radiologist. A biopsy clip is identified in slice 5. Representatively submitted: B1-B2: medial margin slice 1. B3: anterior margin slice 2. B4: anterior margin slice 3. B5: bx site with anterior margin slice 4. B6: inferior margin slice 4. B7: bx site with anterior margin and clip ID slice 5. B8: superior margin slice 5. B9: posterior margin slice 5. B10: inferior margin slice 5. B11: bx site with anterior margin slice 6. B12: superior-posterior margin marked by the radiologist slice 14. B13-B14: inferior margin slice 14. B15: lateral margin marked by the radiologist slice 15. C. RIGHT BREAST TISSUE BIOPSY WITH NEEDLE LOCALIZATION. Received in formalin labeled with the patient's identification and 'right breast tissue. biopsy with needle localization' is an oriented, previously inked 201g, 15.2 x 11 x 3.4cm. needle localized lumpectomy with two radiographs. Ink code- anterior-yellow, posterior-. black, superior-blue, inferior-orange, medial-green, lateral-red. Specimen is serially. sectioned in to 11 slices revealing a tan white gelatinous lobulated mass 5.3 x 4 x 2.8cm,. 0. 1cm from the closest anterior and posterior margins in slices 2-3-4-5-6-7 and 8. A. portion of the specimen is submitted for tissue procurement. Representatively submitted: C1: lateral margin slice 1. C2: mass with anterior margin slice 2. C3: mass with anterior margin slice 3. C4-C5: mass with anterior margin slice 4. C6-C8: mass with anterior margin slice 5. C9: superior margin slice 5. C10-C11: mass with posterior margin slice 6. C12: mass with posterior margin slice 7. C13: anterior - inferior margins slice 7. C14: mass slice 8. C15: inferior margin slice 9. C16: posterior margin slice 10. C17: medial margin slice 11. D. ADDITIONAL MEDIAL SUPERIOR MARGIN RIGHT BREAST. Received in formalin labeled with the patient's identification and ""additional medial. superior margin right breast' is an oriented 37g, 7 x 7 x 3cm fibrofatty tissue. Final. margin inked blue. Serial sectioning reveals unremarkable parenchyma. Representatively. submitted in D1-D6. E. RIGHT AXILLARY CONTENTS. Received in formalin labeled with the patient's identification and ""right axillary contents'. are multiple tan pink fragments of fibrofatty tissue aggregating to 15 x 8 x 3.5cm. Dissection reveals sixteen lymph nodes ranging from 3.5 x 2.4 x 1.6cm to 0.2 x 0.2 x. 0.2cm. E1: five lymph nodes. E2: five lymph nodes. E3: two lymph nodes. E4: one lymph node. E5-E6: one lymph node. E7-E8: one lymph node. E9-E10: one lymph node. ADDENDUM: FISH/ISH ANALYSIS REPORT 3. Specimens Involved. Specimens: C: RIGHT BREAST TISSUE BIOPSY WITH NEEDLE LOCALIZATION. HER2/NEU RESULTS. ANALYTICAL INTERPRETATION OF RESULTS. HER-2 NOT AMPLIFIED. Clinical interpretation of the results. A majority of tumors cells displayed moderate polysomy 17 with 2 to 3 chromosome 17. centromere signals and 2 to 4 HER2 signals, with a HER2/CEP 17 Ratio 1.5, consistent with. no amplification of the HER2/neu gene. Probes identification. LSI Her-2/neu 17q11.2-12, spectrumorange. CEP 17, 17 p11.1-q11.1 alpha satellite DNA, spectrumgreen. Image analysis method - Manual. Results interpreted. ISCN. nuc ish: (CEP17x2),(HER2x3)[200]. Number of invasive tumor cells counted. 200. Number of observers. 1. Number of Her2 signals/nucleus. 3.2. Number of CEP 17 signals/nucleus. 2.2. Her2/CEP 17 ratio. 1.5. TEST CHARACTERISTICS: HER-2 DNA Probe Kit is FDA approved for. selection of patients for whom Herceptin therapy is being considered. These tests were. performed in the Pathology Core Facility, Department of Pathology,. under the direction of Dr.. The results of these studies should always be. interpreted in the context of the clinical, morphological, and immunophenotypic diagnosis. The. Kit is not intended for use to screen for or diagnose breast cancer. It. is intended to be used as an adjunct to other prognostic factors currently used to predict. disease-free and overall survival in stage II, node-positive breast cancer patients. In. making decisions regarding adjuvant CAF treatment, all other available clinical. information should also be taken into consideration, such as tumor size, number of. involved lymph nodes, and steroid receptor status. No treatment decision for stage II,. node-positive breast cancer patients should be based on HER-2/neu gene amplification. status alone. Specimen information. RPCI surgical pathology/cytology case number. Source of case. RPCI. Block number used C7. Specimen site. Breast. Female breast right. Specimen type. Complete excision (less total mastectomy). Specimen fixative type. Formalin. Duration of fixation (hrs). 6 48 hrs. Comment: Controls: The FISH study was performed with appropriately stained positive and negative. controls. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 27. CLINICAL EXPERIENCE: Patients with a recurrence score of: 27 in the clinical validation. study had an average rate of Distant Recurrence at 10 years of 18%. ER Score: 12 Positive. PR Score: 6.7 Positive. Her2 Score: 9.1 Negative. Interpretation: ER. Negative < 6.5 Positive >= 6.5. PR. Negative < 5.5 Positive >= 5.5. Her2 Negative <10.7 Positive >= 11.5 Equivocal = 10.7 - 11.4. See separate. report for further information. left breast bx. SPECIMENS: A. LEFT BREAST CENTRAL CORE BIOPSY. B. RIGHT BREAST SUBAREOLAR CORE BIOPSY. SPECIMEN(S): A. LEFT BREAST CENTRAL CORE BIOPSY. B. RIGHT BREAST SUBAREOLAR CORE BIOPSY. DIAGNOSIS: A. BREAST, LEFT, CENTRAL, BIOPSY: - MINUTE FRAGMENTS OF ATYPICAL CELLS WITH NECROSIS. - STROMAL CALCIFICATIONS, SEE NOTE. NOTE: Scattered minute fragments of crushed cells with necrosis are identified. They may represent. contents of DCIS. Multiple levels are examined. Excisional biopsy is recommended. B. BREAST, RIGHT, SUBAREOLAR, BIOPSY: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, SEE NOTE. NOTE: Maximum invasive tumor size measures 0.8-cm. This measurement may not reflect the actual. size of the tumor. Breast biomarkers are ordered. GROSS DESCRIPTION: A. LEFT BREAST CENTRAL CORE BIOPSY. Received in formalin labeled with the patient's identification and 'left breast central core biopsy' are. multiple tan vellow cores of tissue ranging from 4.3 x 0.2cm to 0.5 x 0.2cm. Toto A1-A2. Time placed in. formalin-. B. RIGHT BREAST SUBAREOLAR CORE BIOPSY. Received in formalin labeled with the patient's identification and 'right breast subareolar core biopsy' are. four tan yellow cores of tissue ranging from 1.1 x 0.1cm to 0.5 x 0.1cm. Toto B1. Time placed in. formalin-. CLINICAL HISTORY: A) Suspicious calcification in central left breast. B) New mass - highly suspicious for cancer. PRE-OPERATIVE DIAGNOSIS: A) Rule out DCIS. ADDENDUM: SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Breast Core Needle Biopsy. Block Number: ER: Positive. Allred Score: 8 = Proportion Score 5 + Intensity Score 3. PR: Positive Allred Score: 5 = Proportion Score 2 + Intensity Score 3. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2."
BIOCUP_00144,breast,BRCA,TCGA-3C-AAAU,TCGA-3C-AAAU.0CD23E1B-3FA3-4A43-AE6E-C8E7B51252F8,"Path No.: Date Obtained: (Age: Date Received: F. See Addendum/Procedure. SPECIMEN: A:Lymph node, left axilla sentinel, biopsy. B:Breast, left, modified radical mastectomy. DIAGNOSIS(ES): A. Lymph node, left axilla sentinel, biopsy: Metastatic carcinoma, following carcinoma of breast. B. Breast, left, modified radical mastectomy: 1. Carcinoma, invasive lobular, poorly differentiated, multifocal, with extensive lymphatic permeation. and extension into nipple. 2. Lobular neoplasia, multifocal. 3. Fibrocystic disease, proliferative, with atypia. 4. Metastatic carcinoma in 3 of 12 axillary lymph nodes. Date Dictated: CLINICAL INFORMATION: None. GROSS DESCRIPTION: The specimen is received in two parts. Part A is received unfixed in a container labeled with the patient's name and ""sentinel node #1"". It consists of one piece. of well circumscribed gritty tan tissue with attached fat measuring 1.2x1.0x0.6cm. It is bisected and a portion of it is. submitted as AFS. The rest is submitted in one cassette labeled A1. Part B is received unfixed in a container labeled with the patient's name and ""left breast mastectomy tissue"" consists of. a left radical modified mastectomy specimen measuring 21x17x3 cm. The skin measures 9.5x5x0.1 cm and has a. circumareolar scar which measures 4 cm in length. The nipple is mobile and everted. A firm area is palpable. underneath the scar. The deep (fascial) margin is inked black, the remaining margins are inked yellow. The axillary. tissue measures 9x5x1.2 √ßm. Several lymph nodes are palpable within it. One lymph node has been previously. bisected by the surgeon. The lymph nodes range in size from 2.5 to 0.5 cm. They are dissected, proceeding from the. axilla towards the breast. The specimen is serially sectioned at closely spaced intervals. Beneath the previously. described scar is an ill-defined white, firm area which measures approximately 3.8x3.1x3 cm; it abuts the skin and is 3. cm from the deep margin. A second ill-defined white, firm area is present in the outer, lower quadrant approximately 1. cm from the central lesion; it measures approximately 2.5x2.3x1.8 cm and is located 0,5 cm from the deep margin and. 1 cm from the superficial margin. At its center is a 1 cm firm area with a gelatinous appearance. The rest of the. specimen is composed of 40% breast tissue, and 60% yellow fatty tissue. Representative sections are submitted in 40. cassettes labeled B1-B40. Legend: B1-B3=nipple. B4-B13=white, firm area under scar with superficial/skin margin. B14-B15=deep margin under white, firm area below scar. B16-B17=white, firm area under scar with superficial margin. B18-B20=outer, lower quadrant white, firm area with superficial margin. B21-B25=outer, lower quadrant white, firm area with deep margin. B26=section from center of outer, lower quadrant white, firm area with small gelatinous area. B27=deep margin under white, firm area below scar (additional). B28=inner, upper quadrant with deep margin. B29=inner, upper quadrant with superficial margin. B30=inner, lower quadrant with superficial margin. B31=inner, lower quadrant with deep margin. B32=outer, upper quadrant with deep margin. B33=outer, upper quadrant with superficial margin. B34=one LN from distal part of axillary tail bisected (level 3). B35=three other LNs from distal part of axillary tail (level 3). B36=one LN (the one previously cut by surgeon) in middle part of axillary tail (level 2). B37-B38=one large LN from middle part of axillary tail (level 2). B39-B40=LNs from proximal part of axillary tail (level 1). INTRAOPERATIVE CONSULTATION: AFS: metastatic carcinoma in lymph node. Performed by: Resident: Interpreted by: Attending: MICROSCOPIC DESCRIPTION: I. TYPE OF SPECIMEN: Left modified radical mastectomy. II. LOCATION OF THE TUMOR: Lower outer quadrant. II. LOCATION OF THE TUMOR: Central. III. TYPE OF NEOPLASM: Carcinoma, invasive lobular - pleomorphic, nuclear grade 3. Lobular neoplasia, type B (pleomorphic) widespread. IV. GROSS/MICRO FINAL INVASIVE TUMOR SIZE INTERPRETATION: 1.2 cm in greatest dimension, at least. V. BORDERS OF INVASIVE NEOPLASM: III-defined. VI. VASCULAR SPACE INVASION: Present in lymphatics. VII. CALCIFICATION: Present in benign areas. VIII. NIPPLE: Stroma involved by cancer. Lymphatics involved by cancer. Ducts involved by cancer. IX. SKIN: Uninvolved by cancer. X. ADJACENT BREAST TISSUE: Cystic disease, proliferative with atypia. XI. SURGICAL MARGIN: No carcinoma is identified on surgical margins. XII. AXILLARY LYMPH NODES: TOTAL: 13. LEVEL I: 4. LEVEL II: 2. LEVEL III: 6. SENTINEL NODE: 1. XIII. POSITIVE LYMPH NODES: TOTAL: 4 of 13. LEVEL I: 2 of 4. LEVEL II: 1 of 2. LEVEL III:0 of 6. SENTINEL NODE: 1 of 1. DEGREE OF INVOLVEMENT: Extensive replacement. EXTRANODAL EXTENSION: Absent. XIV. PECTORAL MUSCLE: No pectoral muscle identified. ADDITIONAL COMMENTS: Invasive carcinoma appears to arise multifocally. A definite second focus is identified in. the lower outer quadrant (B26). Below the nipple, the fibrous scar tissue contains multiple separate foci of invasive. lobular carcinoma. Extensive lymphatic permeation is noted. This report has been reviewed electronically and signed on. Interpreted by: Attending: Case Resident: The diagnosis was rendered by the attending pathologist. Receptor Expression Analysis. INTERPRETATION. Test Performed on: Left breast. Specimen part: B. Slide#: B26. More than 50% of the invasive carcinoma cell nuclei stain with an immunohistochemical stain utilizing an anti-estrogen. receptor antibody. Therefore, this tumor is considered strongly positive for estrogen receptor expression. More than 50% of the invasive carcinoma cell nuclei stain with an immunohistochemical stain utilizing an. anti-progesterone receptor antibody. Therefore, this tumor is considered strongly positive for progesterone receptor expression. Her-2/neu expression has been evaluated using the. HercepTest HercepTest score : 0. No Her-2/neu overexpression is identified in the invasive carcinoma cells. This procedure/addenda has been electronically reviewed and signed on. Interpreted by: Attending: Addendum. ADDENDUM. Molecular Analysis has been ordered on this case, the blocks and slides have been retrieved from the archival files, the. slides and pathology report were re-reviewed for tumor cellularity by the pathologist, and the appropriate block was. selected for testing. This procedure/addenda has been electronically reviewed and signed on. Interpreted by: Attending: Note: Immunochemistry testing performed at. was developed and its performance characteristics determined by the. These tests were interpreted in conjunction with external positive and internal negative controls, unless. FDA. This test is used for clinical purposes only. It should not be regarded as investigational or for research."
BIOCUP_00145,breast,BRCA,TCGA-AR-A1AP,TCGA-AR-A1AP.0BFF09DE-6F36-4F68-AC13-8BC16AA0DCBE,"B1961 Final Diagnosis. Breast, left, wide local excision: Infiltrating ductal carcinoma with mucinous features,. Nottingham grade III (of III), forming a mass (1.9 x 1.0 x 0.9 cm) [AJCC pTlc]. Ductal. carcinoma in situ, high nuclear grade, comprises approximately 5-25% of the tumor volume and. extends beyond the main mass. Angiolymphatic invasion is absent. The non-neoplastic breast. parenchyma shows proliferative fibrocystic changes. The medial margin, after multiple (3). separately submitted re-excisions, is positive for ductal carcinoma in situ. Breast, left, simple mastectomy: Microscopic residual ductal carcinoma in situ is identified in the. region of the prior biopsy site in the upper inner quadrant. No residual invasive neoplasm. identified. The skin, nipple, and deep surgical margin are free of neoplasm. Sentinel lymph node, left axillary, sentinel biopsy: A single left axillary sentinel lymph node. with blue dye is negative for metastatic carcinoma [AJCC pNO (i-) (sn)]. Immunohistochemical. cytokeratin stain was performed on the paraffin embedded sentinel lymph node tissue and. confirms the H&E impression. Her-2/NEU has been ordered on paraffin-embedded tissue."
BIOCUP_00146,breast,BRCA,TCGA-E9-A247,TCGA-E9-A247.61E73960-32B0-413E-AF1D-2EF4582293B3,"OC#: 3/3/2011 Laterality:Left, upper inner quadrant. Path Report:BREAST TISSUE CHECKLIST. Specimen type: Lumpectomy. Specimen size: Not specified. Tumor site: Upper inner quadrant. Tumor size: 1.3 x 0 X 1.5 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 0/10 positive for metastasis (Axillary 0/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None. Revies his / 4/25/11."
BIOCUP_00147,breast,BRCA,TCGA-A2-A4RW,TCGA-A2-A4RW.C1D4D6BB-AF86-4208-A729-C61365941217,"34. Unit#: : Specimen: Spec Type: SURGICAL P. PREOPERATIVE DIAGNOSIS. RIGHT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR. PROCEDURE: MASTECTOMY MODIFIED RADICAL. TISSUE REMOVED. A. RT BREAST MASTECTOMY. B. RT AXILLARY NODE DISSECTION. GROSS DESCRIPTION. RECEIVED IN 2 PARTS. A RECEIVED LABELED. RIGHT BREAST STITCH 12 O'CLOCK IS A. 650 GRAM SIMPLE MASTECTOMY SPECIMEN MEASURING 23.5 X 21.5 x 3.7 CM. THE. NIPPLE IS UNREMARKABLE WITHIN A SKIN ELLIPSE MEASURING 23.5 x 12.5 CM. A SUTURE DENOTES 12 O'CLOCK. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE. INK, THE DEEP WITH BLACK. SECTIONING REVEALS A CENTRAL PORTION OF THE. BREAST TO BE A MIXTURE OF TAN FIBROUS TISSUE AND YELLOW FAT. THE. PERIMETER CONSISTS OF BLAND YELLOW FATTY TISSUE. IN THE 10 O'CLOCK AREA. OF THE BREAST IS A FIRM MASS MEASURING 4 CM FROM MEDIAL TO LATERAL BY. 3.5 CM FROM SUPERIOR TO INFERIOR AND 2.1 CM FROM ANTERIOR TO POSTERIOR. THERE IS A SMALL RIM OF FATTY TISSUE DEEP TO THE LESION. GROSSLY THERE. IS AT LEAST 0.5 CM OF TISSUE. THIS DOES NOT INVOLVE THE SKIN GROSSLY. SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE, A2 AND 3--LESION IN DEEP. MARGIN, A4--FAR LATERAL ASPECT OF LESION WITH SKIN, A5--GROSS MEDIAL. ASPECT OF LESION 4 CM FROM A4, AND A10 IS THE TISSUE SUPERFICIAL TO A8. SUPERFICIAL TO DEEP MEASUREMENT. SECTIONS OF THE LESION ARE ALSO. SUBMITTED PER PROTOCOL. A BOWTIE-SHAPED CLIP IS IDENTIFIED WITHIN THE. LESION, A11--TUMOR, A12--UPPER INNER QUADRANT, A13--UPPER OUTER QUADRANT. LATERAL TO LESION, A14--LOWER OUTER QUADRANT, A15--LOWER INNER QUADRANT. B RECEIVED LABELED. RIGHT AXILLARY NODE DISSECTION ARE 2. IRREGULAR PORTIONS OF YELLOW-RED FATTY TISSUE TOGETHER MEASURING 9 X 7 x. 2.5 CM. THIS TISSUE IS EXAMINED FOR LYMPH NODES. THE LARGEST NODE. WHICH IS 2.5 CM IN DIAMETER DEMONSTRATES A ROD-SHAPED METAL CLIP. IT. HAS ILL-DEFINED BORDERS. ONE-HALF IS SUBMITTED IN B1. THE REMAINDER IS. Specimen: q#. Spec Type: GROSS DESCRIPTION. TAKEN PER PROTOCOL. ADDITIONAL NODES ARE ALSO IDENTIFIED AND SUBMITTED. AS. FOLLOWS. THERE IS A 2ND 2.5 CM LYMPH NODE WHICH IS GROSSLY. UNREMARKABLE. ONE-HALF IS SUBMITTED AS B2. THE REMAINDER IS TAKEN PER. PROTOCOL. A 1.7 CM LYMPH NODE IS BISECTED, ONE-HALF SUBMITTED IN B3,. THE REMAINDER SUBMITTED PER PROTOCOL. ADDITIONAL NODES ARE THEN. SUBMITTED AS FOLLOWS: B4--2 NODES EACH BISECTED, B5--3 NODES EACH. BISECTED, B6--3 NODES EACH BISECTED, B7--1 NODE TOTAL, B8--5 NODES,. B9~-4 NODES, B10-4 NODES. FORMALIN FIXATION TIME IS 6 HOURS AND 10 MINUTES. PATH PROCEDURES. PROCEDURES: 88309, A BLK/15, B BLK/10. FINAL DIAGNOSIS. PART A RIGHT BREAST, SIMPLE MASTECTOMY: 1. INTRALOBULAR AND INFILTRATING LOBULAR CARCINOMA OF THE PLEOMORPHIC. TYPE. THE INVASIVE COMPONENT SHOWS NUCLEAR GRADE 2/3, LOW MITOTIC. INDEX AND TUBULE FORMATION 3 FOR A TOTAL NOTTINGHAM SCORE OF. LCIS. WITH RARE FOCI OF LUMINAL NECROSIS COMPRISES APPROXIMATELY 30% OF THE. TUMOR. 2. THE TUMOR HAS A MAXIMUM GROSS DIMENSION OF 4 CM ALTHOUGH RARE IN. SITU AND INVASIVE FOCI ARE IDENTIFIED IN A RANDOM SECTION FROM THE. LOWER OUTER QUADRANT. 3. INVASIVE TUMOR IS FOCALLY IDENTIFIED 4 MM FROM THE NEAREST INKED. SUPERFICIAL MARGIN (A2) AND 4 MM FROM THE SKIN SURFACE (A4) . 4. THE BIOPSY SITE. ) AND A BOWTIE-SHAPED CLIP ARE IDENTIFIED. 5. ALTHOUGH LYMPHOVASCULAR INVASION IS NOT IDENTIFIED, PERINEURAL. INVASION IS PRESENT. PART B RIGHT AXILLA,. IS IDENTIFIED IN ALL. OF LYMPH THE NODE 27 LYMPH DISSECTION: NODES EXAMINED. METASTATIC FOCAL BREAST EXTRANODAL CARCINOMA 27/27/20. EXTENSION INTO THE PERINODAL FAT IS PRESENT. A BIOPSY SITE INCLUDING A. Specimen: Spec Type: 1, D.O. FINAL DIAGNOSIS. ROD-SHAPED METAL CLIP IS ALSO PRESENT. :, M.D."
BIOCUP_00148,breast,BRCA,TCGA-BH-A18U,TCGA-BH-A18U.2616F70D-3E15-45BA-8907-65694595F726,"PATIENT HISTORY: The patient is a year-old female. Date of last menstrual period: Not given. PRE OP DIAGNOSIS: Ca left breast. POST OP DIAGNOSIS: Same. PROCEDURE: Sentinel node biopsy, total mastectomy. ADDENDA: Addendum. ESTROGEN/PROGESTERONE AND HER-2/NEU REPORT. Using appropriate positive and negative controls, the test for the presence of these hormone receptor proteins is. performed by the immunoperoxidase method, and reported according to the NIH consensus statement on adjuvant. therapy for breast cancer, of. A positive ER or PR tumor shows any nuclear immunostaining, and is. semiquantitated as indicated below. Semiquantitative Statement. ER positive. Percent cells staining as: (0 20%; 1+ 30%, 2+ 30%, 3+ 20%). PR positive. Percent cells staining as: (0 70%, 1+ 10%, 2+ 10%, 3+ 10%). HER-2/NEU DAKO HERCEPTEST: A STRONG COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE THAN 10% OF. THE TUMOR CELLS. HER-2/NEU IS INTERPRETED AS STRONGLY POSITIVE (SCORE 3+). FINAL DIAGNOSIS: PART 1: LEFT BREAST, TOTAL MASTECTOMY -. A. INFILTRATING DUCT CARCINOMA, TWO LESIONS, 2.6 X 1.7 X 1.5 CM IN THE LOWER OUTER QUADRANT. AND 3.0 x 2.8 X 2.5 CM IN THE UPPER OUTER QUADRANT NOTTINGHAM SCORE 9 OUT OF 9 (TUBULES 3,. NUCLEI 3, MITOSIS 3). B. LYMPHOVASCULAR INVASION IDENTIFIED. C. DUCTAL CARCINOMA IN-SITU, SOLID TYPE, NUCLEAR GRADE 3 WITH COMEDO-TYPE NECROSIS,. COMPRISING LESS THAN 5% OF TUMOR. D. SURGICAL MARGINS NEGATIVE FOR INFILTRATING DUCT CARCINOMA AND DUCTAL CARCINOMA IN-. SITU. E. INFILTRATING DUCT CARCINOMA FOCALLY APPROACHES VERY CLOSELY MARGIN OF EXCISION IN. THE LOWER OUTER QUADRANT (WITHIN 0.2 CM). F. NIPPLE NEGATIVE FOR TUMOR. G. CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSY SITE. H. TWO LYMPH NODES, POSITIVE FOR METASTATIC CARCINOMA (2 OUT OF 2). PART 2: LEFT BREAST, NEW ANTERIOR-INFERIOR MARGIN, EXCISION -. SKIN AND SUBCUTANEOUS TISSUE, NEGATIVE FOR TUMOR. PART 3: LEFT SENTINEL LYMPH NODE #1, BIOPSY -. ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1 OUT OF 1). PART 4: LEFT SENTINEL LYMPH NODE #2, BIOPSY -. ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0 OUT OF 1). PART 5: LEFT SENTINEL LYMPH NODE #3, BIOPSY -. ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1 OUT OF 1). PART 6: LEFT AXILLARY CONTENTS, EXCISION -. FIVE OF ELEVEN LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA, THREE WITH EXTRACAPSULAR. EXTENSION. PART 7: RIGHT BREAST TISSUE, EXCISION (396 GRAMS) -. A. FOCAL ATYPICAL DUCTAL HYPERPLASIA ASSOCIATED WITH MICROCALCIFICATIONS. B. CALCIFIED FIBROADENOMA. C. FIBROCYSTIC CHANGES WITH MICROCALCIFICATIONS. D. SCLEROSING ADENOSIS. E. SCLEROSING INTRADUCTAL PAPILLOMA. F. UNREMARKABLE SKIN. COMMENT: Estrogen receptor, progesterone receptor and HER-2/neu immunostains will be ordered and subsequently reported in an. addendum. Immunostaining for e-cadherin and myosin heavy chain confirm the interpretation of changes in the right. breast tissue."
BIOCUP_00149,breast,BRCA,TCGA-A2-A0CR,TCGA-A2-A0CR.A3167E2D-3588-41D4-99AA-6DCB660D55A4,"Specimen #: F. Race: WHITE. Physician (s) : SPECIMEN: LEFT BREAST MASTECTOMY. FINAL DIAGNOSIS: BREAST, LEFT, MASTECTOMY: INFILTRATING LOBULAR CARCINOMA. - ELL-DIFFERENTIATED BY COMBINED HISTOLOGIC CRITERIA. - SIZE: 9 CM. - ANGIOLYMPHATIC INVASION IDENTIFIED (A12) . - FOCAL DERMAL LYMPHATIC INVOLVEMENT (NIPPLE, SLIDE A8). - TUMOR WITHIN 1 MM OF DEEP MARGIN (A9, A10). - 16 LYMPH NODES IDENTIFIED, ALL NEGATIVE FOR MALIGNANCY. - AJCC STAGE IIB (T3 NO MX). - FOCAL LOBULAR CARCNOMA IN SITU (A5) . - INTRADUCTAL HYPERPLASIA, FLORID. - FIBROCYTSTIC CHANGES. COMMENT: Hormone receptor and HER2 studies previously reported. CLINICAL DIAGNOSIS AND HISTORY: -year-old female with breast carcinoma, left. GROSS DESCRIPTION: LEFT BRFAST MASTECTOMY received fresh, labeled with the patient's name,. designated ""LEFT BREAST AND AXILLARY CONTENTS"" consists. of a 1,044.0 gram modified radical mastectomy specimen. It measures 20.5. cm medial to lateral, 20.0 cm superior to inferior, 4.5 cm anterior to. posterior, with an attached axillary tail, 11.0 x 7.0 x 3.7 cm, and an. overlying ellipse of nipple bearing skin, measuring 18. x 9.5 cm. The. nipple is inverted and the skin is otherwise unremarkable. Ink code: Blue=superior superficial, green=inferior superficial, black=deep. Sectioning reveals a poorly defined, indurated mass in the upper inner. quadrant focally abutting the deep margin. Continuous with this lesion and. extending laterally to the outer portion of the breast is a broad area of. Specimen # : GROSS DESCRIPTION (continued). variably indurated fibrous tissue (overall maximum dimension of mass plus. indurated fibrous tissue = 9.0 cm) . Multiple sections are harvested for. the. protocol with matching paraffin sections as follows : A1: Skin (medial tip). A2: Lymph node, 1.8 cm, mid/upper axillary tail. A3: Tumor, upper inner quadrant. A4: Indurated fibrous tissue (5.0 cm from medial extent of tumor). central. A5: Indurated fibrous tissue (7.0 cm from medial extent of tumor) ,. central. A6: Indurated fibrous tissue (9.0 cm from medial extent of tumor) ,. mid center. A7: Grossly normal fibrofatty tissue, lower outer quadrant. Sectioning through the axillary tail reveals 14 possible lymph nodes. ranging in size from 0.2 cm to 3.0 cm in greatest dimension. Additional. representative sections are submitted in cassettes A8 through A22, as. follows: A8: Nipple. A9-A11: Mass upper inner quadrant . A12: Centralized fibrous area. Al3: Upper inner quadrant. A14: Lower inner quadrant. A15: Lower outer quadrant. A16: Upper outer quadrant. A17: Five possible lymph nodes. A18: Five possible lymph nodes. A19: Two possible lymph nodes, largest lymph node bisected and submitted. in its entirety. A20: One lymph node bisected and submitted in its entirety. A21-A22: One lymph node bisected and submitted in its entirety in two. cassettes. 22CF."
BIOCUP_00150,breast,BRCA,TCGA-A2-A0EM,TCGA-A2-A0EM.454CB5E9-3778-4666-9CED-913E08CB3615,"Specimen #: F. Race : WHITE. Physician (s) : AMENDED. SPECIMEN: A: SENTINEL LYMPH NODE B: RIGHT BREAST TISSUE. C: SUPERIOR MEDIAL BORDER. FINAL DIAGNOSIS: A. SENTINEL LYMPH NODE, BIOPSY : - 1 LYMPH NODES NEGATIVE FOR TUMOR BY H&E. - NEGATIVE FOR CITOKERATIN BY IMMUNOHISTOCHEMISTRY. B. BREAST, RIGHT, LUMPECTOMY: - INFLITRATIVE DUCTAL CARCINOMA WITH CRIBRIFORM PATTERN, WELL. DIFFERENTIATED. - SIZE: 1 CM. - MARGINS NEGATIVE. NEAREST MARGIN, SUPERIOR, 2.0 MM. - NO LYMPHVASCULAR SPACE INVASION IDENTIFIED. - FIBROCYSTIC CHANGES. TO. INCLUDE FIBROSIS, CYSTS, AND APOCRINE METAPLASIA. - MICROCALCIFICATIONS ASSOCIATED WITH BENIGN AND MALIGNANT BREAST. TISSUE. - AJCC T1bNOMx. C. SUPERIOR MEDIAL BORDER TISSUE, EXCISION: - BENIGN FIBROFATTY CONNECTIVE TISSUE. CLINICAL DIAGNOSIS AND HISTORY: -year-old - white female with right breast cancer. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. √©age. Specimen #: GROSS DESCRIPTION: A. SENTINEL LYMPH NODE received fresh and consists of multiple irregular. fragments of tan/yellow soft tissue measuring 3.0 x 2.0 x 0.5 cm in. aggregate. The specimen is submitted in its entirety in two cassettes. B. RIGHT BREAST TISSUE received fresh and consists of a 9.0 x 6.5 x 2.3 cm. piece of fatty tissue oriented with sutures (one=medial, two=superior,. three=anterior) Ink code: Red=medial and lateral, blue=superior,. green=inferior, yellow=anterior, black=posterior. Sectioning reveals a 0.6. cm white/tan, ovoid mass with gritty cut surface, on sectioning-3.0 mm. from superior/posterior margin. The remaining tissue is mostly fatty with. admixed patches of white fibrous tissue. One section of each tumor and. grossly normal fibrous tissue harvested for CBCP protocol; mirror images. for Histology in cassettes B1 and B3 respectively. B2 tissue adjacent to. tumor in the same plane. Additional representative sections are. submitted in sequential order in 15 cassettes, the following pairs of. cassettes representing one section in multiple cassettes: B4-B5, B7-B8,. B9-B11. B7 and B8, and B9-B11 are tissue on either side of tumor. C. SUPERIOR MEDIAL BORDER received in formalin and consists of one. irregular shaped fragment of tan/yellow, lobular, fibrofatty adipose. tissue measuring 3.0 x 2.4 x 1.5 cm. Orientation is not provided. The. specimen is inked and serially section to reveal a yellow, lobular,. glistening cut surface with no well-defined lesions or nodules identified. The specimen is submitted in its entirety in sequential order in three. cassettes."
BIOCUP_00151,breast,BRCA,TCGA-AC-A2B8,TCGA-AC-A2B8.3D878253-22B3-4A53-AE54-C0D95E085DB1,"Sex: Female. SPECIMEN INFORMA TION. Acct/Reg: DIAGNOSIS. DIAGNOSIS: A. Right axillary sentinel lymph node: One lymph node, no evidence of metastatic carcinoma. Confirms frozen section diagnosis and confirmed by negative staining for pancytokeratin. a. Right breeal. Recidual invasive lobular carcinome. Size: 8 cm. Architectural score: 3 of 3. Nuclear score: 2 of 3. Mitotic score: 1 of 3. Total score: 6 of 9 = grade 2. Carcinoma involves portions of the nipple. No evidence of involvement of the overlying epidermis. Deep margin of excision is free of carcinoma. PTNM classification: T3pNO (|-) MX. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Right modified radical mastectomy with sentinel node mapping with frozen section. Invasive lobular carcinoma. ER positive, PR. positive, Ki-67 (MIB1) high - 28%. Postoperative Diagnosie: Symptoms/Radiologic Findings: SPECIMENS: A. Right axiliary sentinel node #1300 with frozen section. B. Right breast. SPLCIMEN DAIA. GROSS DESCRIPTION: The specimen is received in two containers, labeled with the patient's name,. Container A is additionally labeled ""right axiliary sentinel node,"" and contains a 2.0 cm, yellow-tan, firm. fatty nodule. It is bisected and entirely submitted. for frozen section. The residual is entirely resubmitted for permanent section in cassette A, labeleti. Container B is received with formalin, additionally labeled ""right breast,"" and contains an 685.4 gm, 19.0 x 13.5 x 7.5 cm, simple mastectomy specimen,. partially surfaced by a 17.0 x 8.0 cm ellipse of pink-tan wrinkled skin, bearing a central 0.9 x 0.9 x 0.5 cm inverted nipple. The deep margin is Inked and. the specimen is serially sectioned to reveal a 8.0 x 4.0 x 2.5 cm, ill-defined, gray-white gritty mass that resides 2.0 cm from the deep margin and 2.5 cm. below the skin surface. The remainder of the cut surface is comprised of yellow-tan adipose tissue admixed with moderate amounte ""f interenered. gray-white flbrous tissue. Additional masses are not identified. Representative sections are submitted in cassettes B1-11, labeled. ./. designated as follows: 1 - nipple; 2 - inked deep margin, perpendicular; 3-8 -- mass; 9-11 -- sections from the three uninvolved quadrants. Additionally a yellow and green cassette are submitted for genomics research, each labeled. INTRA-OPERATIVE CONSULTATION: A. FROZEN SECTION DIAGNOSIS: ""Negative for tumor,"" per Dr. inclusions. The sentinel node contains two small microscopic glands in the outer layer of the fibrous capsule of the node. I think they are benign glandular. They stain with cytokeratin but they do not look like the invasive lobular carcinoma cells."
BIOCUP_00152,breast,BRCA,TCGA-AC-A5XS,TCGA-AC-A5XS.C4F259BA-7C00-4326-ACB2-924C4AE33E87,"PROCEDURE. Bilateral simple breast mastectomy with sentinel node biopsy left. breast. A. Right breast. B. Left breast with attached sentinel nodes. HISTORY. Left breast cancer. GROSS. A. Received in formalin in a container labeled ""right breast"" is a. mastectomy (22 x 18 x 5 cm). Orientation of the specimen is not. provided. The skin ellipse (20 x 15 cm) has a central unremarkable. nipple and areola. The posterior margin is composed of thin fascia. without attached skeletal muscle. The margins are marked with black. ink. The specimen is serially sectioned. The parenchyma has discrete and. ill-defined areas of soft white fibrous tissue. A suspicious lesion. is not palpated. 1. Nipple and areola. 1NS. 2. Subareolar parenchyma. 2SS. 3-6. Representative sections from four quadrants. B. Received fresh in a container labeled ""left breast"" is a. mastectomy (23 x 17 x 5 cm) with a 7 cm axillary tail. The skin. ellipse (20 x 12 cm) has a central unremarkable nipple and areola. The parenchyma is serially sectioned. The medial hemisphere has a. 2.6 cm in greatest dimension hard gray-white sclerotic neoplasm with. an ill-defined radially infiltrating border measuring approximately. 1 cm from the posterior margin, 2.2 cm from the skin surface and 1. cm from the nearest (inferomedial) radial margin. A representative. portion of the tumor along with normal parenchyma away from the. neoplasm is submitted for TCGA/. The remaining. parenchyma has scattered areas of ill-defined fibrous tissue without. a palpable mass. The axillary tail has numerous fatty lymph nodes. up to 2.5 cm in greatest dimension. 1. Small lymph node. 2-7. Bisected lymph nodes (1 lymph node per cassette). 8-10. Large lymph node. 11. Nipple and areola. 12. Skin and posterior margin nearest neoplasm. 13. Inferomedial quadrant nearest neoplasm. 14-16. Neoplasm. 17. Superolateral quadrant. 18. Inferolateral quadrant. MICROSCOPIC. A-B. Performed. DIAGNOSIS. A. Right simple mastectomy: Nonproliferative breast parenchyma with acellular dense. stromal fibrosis and rare microcalcification. Nipple, free of lesion. CPT 88307. B. Left mastectomy with attached sentinel nodes: Invasive lobular carcinoma, Nottingham grade 1 (previously. diagnosed,. Nipple and skin of posterior margin (nearest neoplasm), free. of lesion. Eight of eight sentinel lymph nodes, free of metastatic. carcinoma. CPT 88309. BREAST CARCINOMA SUMMARY: SPECIMEN: Left breast. PROCEDURE: Left breast with attached sentinel lymph nodes. SPECIMEN INTEGRITY: Intact. SPECIMEN LATERALITY: Left. SPECIMEN SIZE: 23 x 17 x 5 cm. LYMPH NODE SAMPLING: SENTINEL LYMPH NODES: 8 of 8, negative for metastatic. carcinoma. TUMOR SIZE: 2.6 cm. TUMOR FOCALITY: Single focus. SKIN INVOLVEMENT: Negative for cancer. NIPPLE INVOLVEMENT: Negative for cancer. SKELETAL MUSCLE INVOLVEMENT: N/A. DUCTAL CARCINOMA IN SITU (DCIS) : Not present. LOBULAR CARCINOMA IN SITU (LCIS) : N/A. HISTOLOGIC TYPE: Lobular carcinoma. GRADING (NOTTINGHAM) : Tubular Formation Score: 3. Nuclear Pleomorphism Score: 1. Mitotic Rate Score: 1. COMBINED GRADE (NOTTINGHAM) : 1. LYMPHOVASCULAR INVASION: Not seen. MARGIN OF EXCISION: Negative for carcinoma. LYMPH NODES: See above. MICROCALCIFICATION: Not seen. OTHER FINDINGS: N/A. HORMONE RECEPTORS: ER positive. PR positive. HER2: Negative (1+) . PATHOLOGIC. (AJCC Seventh Edition) : pT2 pNO. (Electronic Signature). Completed Action List: on. Type: Sura Path Final Report. Title: Contributor system: SP 1st Addendum Report. SP 1ST ADDENDUM REPORT. ADDENDUM REPORT. E-cadherin immunostain is performed on block B15 to confirm the. lobular nature of the infiltrating mammary carcinoma. The stain is. negative, supporting the diagnosis of invasive LOBULAR carcinoma. Positive and negative tissue controls perform as expected. 88342. (Electronic Signature). Completed Action List: Type: SP 1st Addend. Title: SP 1ST ADDENDUM REPORT. Contributor system:"
BIOCUP_00153,breast,BRCA,TCGA-BH-A0DX,TCGA-BH-A0DX.EBAB36DE-A97F-4F8B-806C-EF182519933A,"P.20/33. FINAL DIAGNOSIS: PART 1: LEFT SENTINEL LYMPH NODE #1, BIOPSY -. ONE (1) LYMPH NODE. NEGATIVE FOR TUMOR (0/1). PART 2: LEFT SENTINEL LYMPH NODE #2, BIOPSY -. ELEVEN LYMPH NODES, NEGATIVE FOR TUMOR (0/11). PART 3: LEFT BREAST, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCT CARCINOMA, 0.8 X 0.7 X 0.6 CM. B. NOTTINGHAM SCORE: 7/9 (TUBULES - 2, NUCLEI - 2, MITOSES - 3). C. NO LYMPHOVASCULAR INVASION IDENTIFIED. D. DUCTAL CARCINOMA IN SITU, CRIBRIFORM TYPE. NUCLEAR GRADE 2, PRESENT IN THE SURROUNDING. BREAST TISSUE AND ASSOCIATED WITH MICROCALCIFICATIONS. E. SURGICAL MARGINS NEGATIVE FOR INFILTRATING DUCT CARCINOMA AND DUCTAL CARCINOMA IN. SITU. F. CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSY SITE. G. TUMOR IS ESTROGEN RECEPTOR POSITIVE, PROGESTERONE RECEPTOR FOCALLY AND WEAKLY. POSITIVE AND HER-2/neu IS NEGATIVE, SCORE: 0. H. FIBROCYSTIC CHANGES. I. THERMAL EFFECT. PART 4: LEFT BREAST, NEW POSTERIOR MARGIN, EXCISION -. A. NEGATIVE FOR TUMOR. B. FIBROCYSTIC CHANGES. BYNOPTIC -PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive componenti 0.8 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 2. Mitolic activity score: 3. Total Nottingham score: 7. Nottingham grade (1, 2. 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 11. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: M STAGE, PATHOLOGIC: pMx. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HCR2/NEU: zero or 1+."
BIOCUP_00154,breast,BRCA,TCGA-B6-A3ZX,TCGA-B6-A3ZX.B3CFFF02-89AA-43AE-B19B-BEE6817AA997,"AP Surgical Pathology: Additional info d. CLINICAL HISTORY: Rule out malignancy of left breast. Palpable left breast mass within large. axillary node. If invasive carcinoma, please obtain ER, PR, EGFR, HER2/Neu by. immunohistochemistry; for all 2+ IHC results please do FISH analysis. GROSS EXAMINATION: A. ""USNCB left breast, number of cores 4, 11:00 site 1"", received in formalin. is a 1 x 0.6 x 0.2 cm aggregate of yellow-tan fibrofatty tissue which is. submitted entirely in a mesh bag in block A1. B. ""USNCB left breast, number of cores 4, axilla site 2"", received in formalin. is a 0.9 x 0.6 x 0.2 cm aggregate of yellow-tan fibrofatty tissue which is. submitted entirely in a mesh bag in block B1. MICROSCOPIC EXAMINATION: Microscopic examination is performed. DIAGNOSIS: A. ""LEFT BREAST, 11:00, SITE ONE"" (ULTRASOUND GUIDED NEEDLE CORE BIOPSY). INVASIVE ADENOCARCINOMA OF THE BREAST. HISTOLOGIC TYPE: DUCTAL, WITH LOBULAR FEATURES. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 3 OF 3. TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 3. MITOTIC RATE SCORE: 2. IN-SITU CARCINOMA: PRESENT. TYPE OF IN-SITU CARCINOMA: SOLID. NUCLEAR GRADE OF IN-SITU CARCINOMA: 3 OF 3. ESTROGEN/PROGESTERONE RECEPTOR, HER2/NEU, AND EGFR ANALYSIS: PENDING. PARAFFIN BLOCK NUMBER: A1. RESULTS WILL BE ISSUED IN A SEPARATE REPORT FROM THE IMAGE CYTOMETRY. LAB. B. ""LEFT BREAST, AXILLA, SITE TWO"" (ULTRASOUND GUIDED NEEDLE CORE BIOPSY) : LYMPH NODE WITH METASTATIC DUCTAL ADENOCARCINOMA. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). - - ADDENDUM 1: Please see. for results of supplementary. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es)."
BIOCUP_00155,breast,BRCA,TCGA-E2-A1LH,TCGA-E2-A1LH.DAB174BB-862D-49BE-9BA4-9C11C4489305,"SPECIMENS: A. SENTINEL LYMPH NODE BX #1 RIGHT AXILLA. B. SENTINEL LYMPH NODE BX #2 RIGHT AXILLA. C. WIDE EXCISION RIGHT BREAST. D. RIGHT BREAST CYST. E. RE-EXCISION INFERIOR LATERAL MARGIN-RIGHT BREAST. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, RIGHT AXILLA, EXCISION: ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). B. LYMPH NODE, SENTINEL #2, RIGHT AXILLA, EXCISION: ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). C. BREAST, RIGHT, WIDE EXCISION: -INVASIVE POORLY DIFFERENTIATED DUCTAL CARCINOMA WITH LOBULAR EXTENSION OF. RIGHT BREAST (SBR GRADE 3). -SIZE OF TUMOR: 1.5x1.5x1.2cm. -MARGINS OF RESECTION: FREE OF TUMOR. -BLUNT DUCT ADENOSIS AND FOCAL SCLEROSING ADENOSIS. -FOCAL DUCT ECTASIA. D. RIGHT BREAST CYST, EXCISION: -CONISITENT WITH RUPTURED APOCRINE RETENTION CYST WITH REACTIVE ATYPIA; AND. PERIDUCTAL FIBROSIS WITH GRANULATION TISSUE. -CYSTIC AND PAPILLARY APOCRINE CHANGE. -FOCAL BLUNT DUCT ADENOSIS. -FOCAL PERIDUCTAL DUCT ECTASIA (NEGATIVE FOR TUMOR). E. RIGHT BREAST, RE-EXCISION-INFERIOR LATERAL MARGIN: -DUCTAL CARCINOMA IN SITU WITH LOBULAR EXTENSION (SOLID. PATTERN) ,HIGH NUCLEAR GRADE see note. STROMAL FIBROSIS FOCAL PERIDUCTAL MASTITIS. -CYSTIC APOCRINE CHANGE WITH MICRO AND COARSE CALCIFIACTION. Note: Slide#E1-represents section from new margin that shows extension of DCIS involving. 3 lobular acini. There is no stromal invasion. Slide#E6-focus of DCIS measures 8x5 mm, and in#E4-6x4 mm. Invasive Breast Cancer Template. INVASIVE TUMOR: Histologic type: ductal. Tumor Size (cm): 1.5x1.5x1.2cm. Size of Invasive Focus: 1.5x1.5x1.2cm. Grade, Histologic: 3. Grade, Nuclear: 3. Mitoses (Olympus 40x): 3. Scarff Bloom Richardson grade: III. Necrosis: absent. Invasion Vasc/Lymphatic: absent. DCIS component. DCIS Quantity: <25%. DCIS Type: solid. DCIS Location: inside and outside main mass. Nuclear grade: high. Necrosis: present. Margins: see note. Lymph nodes: negative (0/2) sentinel lymph nodes. Stage, Pathology : pT1c. Non-neoplastic areas: Hormone receptor status (by IHC): ER: pending. PR: pending. HERCEPTEST (by IHC): pending. ADDENDUM. The ER/PR/HER2 status of the invasive breast carcinoma was determined by immunohistochemistry. and quantitated via ACIS (image analysis). Results are as follows: ER. 0%. PR. 0%. HER2. 0.0%. A separate ACIS report has been generated. NOTE: FISH analysis for HER2 gene amplification has not been ordered. SPECIMEN(S): A. SENTINEL LYMPH NODE BX #1 RIGHT AXILLA B. SENTINEL LYMPH NODE BX #2 RIGHT. AXILLA C. WIDE EXCISION RIGHT BREAST D. RIGHT BREAST CYST E. RE-EXCISION INFERIOR. LATERAL MARGIN-RIGHT BREAST. CLINICAL HISTORY: Right breast ca. FROZEN SECTION DIAGNOSIS: A. SENTINEL LYMPH NODE #1 RIGHT AXILLA. Touch prep: No tumor seen on touch prep. B. SENTINEL LYMPH NODE BIOPSY #2 RIGHT AXILLA. Touch prep: No tumor seen on touch prep, reported to Dr. by Dr. a. C. WIDE EXCISION RIGHT BREAST. Gross only: Tumor about 0.8cm. from anterior margin, reported to Dr. by Dr. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE BIOPSY #1 RIGHT AXILLA. Received fresh in a single container labelled and designated ""sentinel lymph node bx #1 right axilla"". and consists of a single 1.5x1.1x0.4cm. lymph node with tan cut surfaces and associated unremarkable. adipose tissue. A touch preparation is made from the lymph node. The entire specimen is submitted in. a single cassette labelled A1. B. SENTINEL LYMPH NODE BIOPSY #2 RIGHT AXILLA. Received fresh in a single container labelled and designated ""sentinel lymph node bx #2 right axilla"". and consists of a single 1.3x1.3x0.4cm. lymph node with tan cut surfaces and associated unremarkable. adipose tissue. Touch preparations are made from the lymph node. The entire specimen is submitted. in a single cassette labelled B1. C. WIDE EXCISION RIGHT BREAST. Received fresh in a single container labelled and designated ""wide excision right breast cancer with. needle localization"" and consists of a single 8.5x7.5x3.0cm. resected portion of breast tissue. A single. stitch of suture indicates the anterior aspect and a double stitch indicates the lateral aspect. A. localization wire is present within the specimen. A radiograph is also received with the specimen and. shows a radiographic density in the region of the tip of the wire. The margins of resection is inked as. follows: inferior orange, superior red, lateral yellow, anterior blue, medial green, posterior black. The. specimen is serially sectioned from superior to inferior and a 1.5x1.5x1.2cm. tan grey well. circumscribed tumor is identified. The tumor does not approach any of the margins grossly. However,. it is within approximately 0.8cm. of the anterior (blue) margin. The tumor is at least 1.5cm. away from. all the other margins. A small portion of tumor is submitted for tissue procurement as well as a portion. of uninvolved breast parenchyma. The remainder of the cut surfaces are remarkable only for multiple. small cystic nodules all 0.3cm. in diameter or less. Multiple sections including approximately 95% of the. tumor are submitted and labelled as follows:,. Code of sections: C1-C2: tumor approaching anterior margin. C3: tumor. C4-C5: tissue adjacent to medial margin. C6-C9: breast with cystic nodules. D. RIGHT BREAST CYST,excision. Received in formalin in a single container labelled and designated ""right breast cyst"" and consists of a. single portion of firm tan yellow fibrofatty tissue measuring 3.7x2.7x2.2cm. No orientation is given. The. resection margin is inked. The specimen is serially sectioned and located centrally is a 1.2cm. diameter. cyst. The inner lining is smooth and tan. The remainder of the cut surfaces are composed of. unremarkable adipose tissue with streaks of breast parenchyma. All of the cyst is submitted in. cassettes D1 through D6. E. RE-EXCISION INFERIOR LATERAL MARGIN RIGHT BREAST. Received in formalin in a single container labelled and designated ""re-excision inferior lateral margin. right breast"" and consists of a portion of tissue measuring 2.0x1.7x1.5cm. A short stitch of suture. indicates the inferior aspect of the specimen and a long stitch indicates the lateral aspect which is the. new margin. The new margin submitted in a single cassette labelled E1 en face. The remainder of the. specimen is serially sectioned and the cut surfaces show unremarkable adipose tissue and breast. parenchyma.Remainder of specimen submitted and labelled E2-E9. Microscopic/Diagnostic Dictation: Pathologist, 1. Final Review: Pathologis. Final: Pathologist,. Addendum: Pathologist,. Addendum Review: Pathologist,. Addendum Final: Pathologis."
BIOCUP_00156,breast,BRCA,TCGA-BH-A28O,TCGA-BH-A28O.12A869FC-7578-4506-BB23-7C25597834EA,"PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/ POST-OP DIAGNOSIS: Right breast lobar carcinoma in situ. LMP DATE: Stopped. Seasonique. PROCEDURE: Right axillary sentinel lymph node biopsy, bilateral total mastectomy, free fiap. SPECIFIC CLINICAL QUESTION: Not provided. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY: No. OTHER DISEASES: No. FINAL DIAGNOSIS: PART 1: SENTINEL LYMPH NODE #1, RIGHT AXILLARY, BIOPSY -. A. METASTATIC CARCINOMA INVOLVES ONE LYMPH NODE (1/1). B. EXTRACAPSULAR EXTENSION IS NOT IDENTIFIED. PART 2: NON-SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY -. A. METASTATIC CARCINOMA INVOLVES ONE LYMPH NODE (1/1). B. EXTRACAPSULAR EXTENSION IS NOT IDENTIFIED. PART 3: SENTINEL LYMPH NODE #2, RIGHT AXILLA, BIOPSY -. ICD-0-3 - -. A. METASTATIC CARCINOMA INVOLVES ONE LYMPH NODE (1/1). B. EXTRACAPSULAR EXTENSION IS NOT IDENTIFIED. PART 4: SENTINEL LYMPH NODE #3, RIGHT AXILLA, BIOPSY -. A. METASTATIC CARCINOMA INVOLVES ONE LYMPH NODE (1/1). B. EXTRACAPSULAR EXTENSION IS NOT IDENTIFIED. PART 5: BREAST, RIGHT, RETROAREOLAR BIOPSY -. BENIGN BREAST PARENCHYMA AND LACTIFEROUS DUCTS. PART 6: BREAST LEFT, NIPPLE AREOLAR SPARING MASTECTOMY-. A. FLAT EPITHELIAL ATYPIA. B. COLUMNAR CELL CHANGES AND HYPERPLASIA. C. FIBROICYSTIC CHANGES. D. MICROSCOLIC RADILA SCAR. PART 7: BREAST, RIGHT, NIPPLE AREOLAR SPARING MASTECTOMY -. A. MULTIFOCAL MULTICENTRIC INVASIVE LOBULAR CARCINOMA, NOTTINGHAM GRADE 1 (COMBINED. NOTTINGHAM SCORE 5; TUBULE FORMATION 3/3, NUCLEAR ATYPIA 1/3, MITOTIC ACTIVITY 1/3). B. TUMOR PREDOMINANTLY LOCATED IN THE UPPER/OUTER AND UPPER/INNER QUADRANTS AND. MEASURES 6.0 CM IN GREATEST DIMENSION (GROSS) WITH MULTIPLE MICROSCOPIC FOCI IN. ADDITIONAL REPRESENTATIVE SECTIONS FROM ALL FOUR QUADRANTS, MEASURING UP TO 2 MM IN. GREATEST DIAMETER. c. LYMPHOVASCULAR INVASION IS NOT IDENTIFIED. D. TUMOR WITHIN 0.1 CM FROM ANTERIOR AND 0.1 CM FROM POSTERIOR MARGINS. E. FIBROCYSTIC CHANGES. F. COLUMNAR CELL CHANGES. G. BIOPSY SITE CHANGES. H. PATHOLOGIC STAGE: T3 N3 MX. PART 8: BREAST, RIGHT, TOTAL MASTECTOMY UPPER QUADRANT -. PREDOMINANTLY ADIPOSE BREAST PARENCHYMA, NEGATIVE FOR TUMOR. PART 9: RIGHT RETROAREOLAR AREA, EXCISION -. BENIGN BREAST PARENCHYMA. PART 10: AXILLARY CONTENTS, RIGHT, DISSECTION -. A. METASTATIC CARCINOMA INVOLVES TEN LYMPH NODES (10/10). 8. EXTRACAPSULAR EXTENSIONS IS NOT IDENTIFIED (see comment). COMMENT: Please note that the majority of the tumor in the breast has nuclear grade 1; however, the metastatic carcinoma in the. lymph nodes varies from nuclear grade 1 to nuclear grade 2 with minor higher grade component, nuclear grade. 3. (pleomorphic lobular). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Simple mastectomy. Upper outer quadrant. Upper inner quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 60 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Infiltrating lobular carcinoma. NOTTINGHAM SCORE: Nuclear grade: 1. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 5. Nottingham grade (1,2, 3): 1. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: LYMPH NODES POSITIVE: 14. LYMPH NODES EXAMINED: 14. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: T STAGE, PATHOLOGIC: pT3."
BIOCUP_00157,breast,BRCA,TCGA-E2-A1IU,TCGA-E2-A1IU.ACE20EC5-2822-4F50-949E-E194C59F0FCD,"SPECIMENS: A. SENTINEL LYMPH NODE #1 RIGHT AXILLA. B. RIGHT BREAST. SPECIMEN(S): A. SENTINEL LYMPH NODE #1 RIGHT AXILLA. B. RIGHT BREAST. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1 RIGHT AXILLA. Received fresh labeled with the patient's name and designated ""sentinel LN #1 right axilla"" is a 2.2 x 1.5. x 0.6 cm lymph node. Touch preps are prepared. Lymph node and fibroadipose tissue are entirely. submitted. A1: one lymph node. A2: fibroadipose tissue with additional possible lymph nodes. B. RIGHT BREAST. Received fresh labeled with the patient's name and ""right breast"" is an oriented (stitch in axillary tail),. 1544g, 35.5 x 26 x 6.2 cm mastectomy with 24 x 14 cm skin ellipse and 1.1 cm everted nipple. Ink code: anterior superior-blue, anterior inferior-orange, posterior-black. The specimen is serially sectioned into. 16 slices from medial to lateral with nipple in slice 5 revealing a 4 x 2.2 x 0.7 cm tan, firm, spiculated. mass, in the upper outer quadrant, slices 6-8, 4.4 cm from the deep margin. The axillary tail is sectioned. to reveal multiple pink-tan lymph nodes. Tissue is procured. Representatively submitted: B1-B2: slice 5, nipple. B3: slice 7, mass. B4: slice 7, mass (adjacent tissue to section in B3). B5: slice 8, mass with skin. B6: slice 7, deep margin overlying mass. B7: slice 8, anterior inferior margin adjacent to mass. B8: slice 9, upper outer quadrant with deep margin. B9: slice 9, lower outer quadrant. B10: slice 4, upper inner quadrant. B11: slice 5, central. B12: slice 2, lower inner quadrant. B13: one lymph node, bisected. B14: one lymph node. B15: six possible lymph nodes. B16: four possible lymph nodes. B17: four possible lymph nodes. B18: one lymph node, bisected. B19: four possible lymph nodes. DIAGNOSIS: A. SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY: TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). B. BREAST, RIGHT, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 1. - 2 CM IN SIZE. - MARGINS, FREE OF CARCINOMA. - DUCTAL CARCINOMA IN SITU (DCIS), CRIBRIFORM TYPE,. NUCLEAR GRADE 1, WITH MICROCALCIFICATIONS. - NIPPLE, NO TUMOR SEEN. - NINE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/9). SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2cm. Tumor Site: Upper outer quadrant. Margins: Negative. Tubular Score: 2. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 1. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node. Axillary dissection. Lymph node status: Negative 0/11. Non-neoplastic areas: radial scars. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 15%. DCIS Type: Cribriform. DCIS Location: Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Absent. Location of CA++: DCIS. Benign epithelium. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT 1c N 0. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. CLINICAL HISTORY: mammogram 8/13-nodular parenchymal enhancement of right breast. PRE-OPERATIVE DIAGNOSIS: Invasive ductal cancer right breast. INTRA-OPERATIVE CONSULTATION DIAGNOSIS: TPA: Sentinel node #1, right axilla - Negative for carcinoma. Microscopic/Diagnostic Dictation: M.D. Final Review:, M.D., Pathologist. Final Review:, M.D., Pathologist,. Final:, M.D., Pathologist,."
BIOCUP_00158,breast,BRCA,TCGA-BH-A0EI,TCGA-BH-A0EI.DFB21194-30C7-430E-A53C-C38345209B1F,"FINAL DIAGNOSIS: PART 1: BREAST, RIGHT, NEEDLE LOCALIZED SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, 2.0 CM (GROSS), NOTTINGHAM GRADE 1 (COMBINED NOTTINGHAM. SCORE 4/9: TUBULE FORMATION 1/3, NUCLEAR PLEOMORPHISM 2/3, MITOTIC ACTIVITY 1/3). B. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 2, CRIBRIFORM TYPE, CONSTITUTES. APPROXIMATELY 5% OF THE TUMOR VOLUME AND IS ADMIXED WITH THE INVASIVE COMPONENT. C. LYMPHOVASCULAR SPACE INVASION IS NOT IDENTIFIED. D. MARGINS FREE, CLOSEST ANTERIOR/SUPERIOR WITHIN 0.6 CM. E. DUCTAL EPITHELIAL HYPERPLASIA. F. FIBROCYSTIC CHANGES. G. SCLEROSING ADENOSIS. H. COLUMNAR CELL CHANGE. I. FIBROADENOMATOID NODULES. J. SKIN IS NEGATIVE FOR TUMOR. K. BIOPSY SITE CHANGES. PART 2: LYMPH NOVES, KIGNI, SENUINEL. A. METASTATIC CARCINOMA (0.4 CM.) INVOLVES ONE OF TWO LYMPH NODES (1/2) (see comment). B. EXTRACAPSULAR EXTENSION IS IDENTIFIED, 0.1 CM X 0.07 CM. PART 3: LYMPH NODE, RIGHT, SENTINEL #2, BIOPSY -. A. METASTATIC CARCINOMA INVOLVES ONE LYMPH NODE (1/1) (see comment). B. EXTRACAPSULAR EXTENSION IS NOT IDENTIFIED. PART 4: LYMPH NODE, KIGNT, SENTINEL #3, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1) (see comment). PART 5: BREAST, RIGHT, NEW LATERAL MARGIN, EXCISION -. A. RADIAL SCAR. B. FIBROCYSTIC CHANGES. C. SCLEROSING ADENOSIS. D. DUCTAL EPITHELIAL HYPERPLASIA. E. COLUMNAR CELL CHANGE WITH ASSOCIATED CALCIFICATIONS. F. FAT NECROSIS. UNUE INOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 2 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 2.5 cm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 1. Mitotic activity score: 1. Total Nottingham score: 4. Nottingham grade (1, 2, 3): 1. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, benign zones. Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. DCIS admixed with invasive carcinoma. Percent of tumor occupied by in situ component: 5 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 2. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain, Keratin stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 4 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pN1. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU:"
BIOCUP_00159,breast,BRCA,TCGA-BH-A18I,TCGA-BH-A18I.01E8D241-C303-47FA-B484-B800D580B34C,"PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/POST-OP DIAGNOSIS: Invasive ductal carcin√≥ma in the left breast at 10 o'clock. Calcifications. and atypia at 12 o'clock. LMP DATE: Not listed. PROCEDURE: Left segmental mastectomy, sentinel lymph node biopsy, excisional biopsy. SPECIFIC CLINICAL QUESTION: Not listed. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY: No. OTHER DISEASES: No. FINAL DIAGNOSIS: PART 1: LEFT BREAST, 40 O'CLOCK, SEGMENTAL MASTECTOMY -. A. TWO FOCI OF INVASIVE DUCTAL CARCINOMA, NO SPECIAL TYPE. B. NOTTINGHAM GRADE 2 (TUBULE FORMATION: 2, NUCLEAR PLEOMORPHISM: 3, MITOTIC ACTIVITY: TOTAL SCORE: 7/9). 2;. C. THE DOMINANT MASS OF INVASIVE CARCINOMA MEASURES 1.9 CM IN LARGEST DIMENSION. D. THE SATELLITE FOCUS MEASURES 0.6 CM AND IS PRESENT 0.5 CM AWAY FROM THE MAIN MASS. E. DUCTAL CARCINOMA IN-SITU (DCIS), NUCLEAR GRADE 2, CRIBRIFORM TYPE. F. THE DCIS CONSTITUTES 10% OF THE TOTAL TUMOR VOLUME AND IS ADMIXED WITH INVASIVE. COMPONENT. G. NO LYMPHOVASCULAR SPACE INVASION IS NOTED. H. THE INVASIVE CARCINOMA (DOMINANT MASS) FOCALLY EXTENDS TO THE SUPERIOR MARGIN AND IS. <0.1 CM TO THE POSTERO-INFERIOR MARGIN. I. THE SATELLITE FOCUS OF INVASIVE CARCINOMA IS 0.15 CM FROM THE POSTERIOR MARGIN. J. FLAT EPITHELIAL ATYPIA. K. CALCIFICATIONS ARE ASSOCIATED WITH INVASIVE CARCINOMA AND BENIGN BREAST PARENCHYMA. L. THE NON-NEOPLASTIC BREAST SHOWS FLORID DUCTAL HYPERPLASIA, COLUMNAR CELL CHANGE AND. FIBROCYSTIC CHANGES. M. PREVIOUS BIOPSY SITE CHANGES. N. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN RECEPTOR (H- score 240) AND POSITIVE. FOR PROGESTERONE RECEPTOR (H-score 240) AND NEGATIVE FOR HER-2, AS PER PREVIOUS. PART 2: LEFT BREAST, 12 O'CLOCK, BIOPSY -. A. FLORID DUCTAL HYPERPLASIA. B. COLUMNAR CELL CHANGES AND HYPERPLASIA. C. RADIAL SCAR. D. FIBROADENOMATOID AND FIBROCYSTIC CHANGES. E. NO RESIDUAL ATYPIA SEEN. F. PREVIOUS BIOPSY SITE. PART 3: LEFT SENTINEL LYMPH NODE #1, BIOPSY -. A. ONE LYMPH NODE, POSITIVE FOR METASTATIC TUMOR (1/1). B. THE METASTATIC FOCUS MEASURES 0.6 CM IN LARGEST DIMENSION. C. FOCAL EXTRACAPSULAR EXTENSION (<0.1 CM) IS IDENTIFIED. PART 4: LEFT SENTINEL LYMPH NODE #2, BIOPSY -. TWO LYMPH NODES, NEGATIVE FOR METASTATIC TUMOR (0/2). COMMENT: The invasive tumor nuclear grade is variable and ranges-from nuclear grade 2 to nuclear grade 3. The highest grade is. taken into account for Nottingham scoring and grading. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. Antibody/Antigen. E-cadherin. Membranous reactivity in invasive tumor cells. P120. Membranous reactivity in invasive tumor cells. Utilizing formalin-fixed (8-96 hour range), paraffin embedded tissue, immunohistology is. performed with the following selected antibodies and designated antibody clone (s) directed. against the following antigenic target (s) with adequate positive and negative internal and. external controls. Antibodies are optimized appropriate for fixation times. ANTIBODY. CLONE. TARGET ANTIGEN. VENDOR. E-cadherin. 36. Ductal Carcinoma. P120. 98. Lobular carcinoma. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Clock position: 10.00. SIZE OF TUMOR: Maximum dimension invasive component: 19 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 2.5 mm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 2. Mitotic activity score: 2. Total Nottingham score: 7. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, benign zones. Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. DCIS admixed with invasive carcinoma. Percent of tumor occupied by in situ component: 10 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Yes, focal. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 1. LYMPH NODES EXAMINED: 3. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 6 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Yes, Maximum size is:0.75mm. NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE MODIFIER: (sn). N STAGE, PATHOLOGIC: pNX. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, H-score: 240. PROGESTERONE RECEPTORS: positive, H-score: 240. HER2/NEU: 1+. Comment: The tumor pN stage is at least pN1. Since the sentinel node is positive, a final N. stage will be assigned after complete lymph node dissection."
BIOCUP_00160,breast,BRCA,TCGA-BH-A0DH,TCGA-BH-A0DH.79B22278-2BA1-4904-BCA6-2B1368C77475,"To: P.9/33. OIAGNOSIS: f: AXILLARY CONTENTS. LEFT. RESECTION -. A. METASTATIC ADENOCARCINOMA (1H, 1Q-1R and 13-1T) INVOLVING THREE OF TWENTY-EIGHT LYMPH. NODES (3/28), UP TO 1.5 CM (1R). WITH EXTRACAPSULAR EXTENSION (0.2 CM). B. CHANGES CONSISTENT WITH PREVIOUS FINE NEEDLE ASPIRATION SITE, SEE PRIOR. PART 2: BREAST. LEFT. SEGMENTAL MASTECTOMY -. A. INFILTRATING OUCIAL CARCINOMA (ZA thru 21, 2M thru 20 and 2S), WITH ASSOCIATED. MICROCALCIFICATIONS. THE INVASIVE TUMOR INVOLVES THE POSTERIOR RESECTION MARGIN (2A),. THE INFERIOR RESECTION MARGIN (2F, 2N and 20), AND COMES TO WITHIN 0.2 CM FROM THE ANTERIOR. RESECTION MARGIN (2H). B. THE TUMOR SIZE IS 3.5 2.5 x 1.7 CM. C. NOTTINGHAM SCORE 6/9 (TUBULES 3. NUCLFI 2, MITOSIS 1). D. LYMPHOVASCULAR INVASION IS PRESENT. E. DUCTAL CARCINOMA IN SITU, SOUD AND CRIBRIFORM TYPES, NUCLEAR GRADE 2, WITH. COMEDONECROSIS, ASSUCIATED MICROCALCIFICATIONS AND RETROGRADE CANCERIZATION OF. LOBULES, REPRESENTING ABOUT 2% OF TUMOR VOLUME. F. DUCTAL CARCINOMA IN SITU IS PRESENT ADMIXED WITH INVASIVE TUMOR. G. ALL OTHER MARGINS OF RESECTION ARE FREE OF TUMOR. H. ATYPICAL DUCTAL HYPERPLASIA. I. DUCTAL PAPILLOMAS. J. RADIAL SCARS WITH DUCTAL EPITHELIAL HYPERPLASIA AND COLUMNAR CELL CHANGES,. K. PROLIFERATIVE FIBROCYSTIC CHANGES WITH DUCTAL EPITHELIAL HYPERPLASIA, COLUMNAR CELL. CHANGE8 AND MULTIFOCAL SCLEROSING ADENOSIS WITH ASSOCIATED MICROCALCIFICATIONS. L. CHANGES CONSISTENT WITH PREVIOUS BIOPSY SITE, SEE PRIOR. M. IMMUNOHISTOCHEMICAL STAINING FOR ESTROGEN RECEPTOD D. ICRUME RECEPTOR AND HER. 2/NEU WERE PREVIOUSLY PERFORMED ON CORE BIOPSY. AND WERG REPORTED AS. FOLLOWS: ESTROGEN RECEPTOR - POSITIVE, PROGESTERONE RECEPTOR - POSITIVE AND HER-2/NEU. NEGATIVE (SCORE 0). PART 3: BREAST, LEFT, NEW POSTERIOR-LATERAL MARGINS, EXCISION -. A. MICROSCOPIC FOCUS OF INVASIVE DUCTAL CARCINOMA (3E), COMING TO WITHIN 0.3 CM FROM THE. NEW INKED RESECTION MARGIN (9ce comment). B. ATYPICAL DUCTAL MYPERPLASIA. c. DUCTAL PAPILLOMA. D. RADIAL SCARS WITH DUCTAL EPITHELIAL HYPERPLASIA AND ASSOCIATED MICROCALCIFICATIONS. E. PROLIFERATIVE FIBROCYSTIC CHANGES. CHANGES AND EXTENSIVE SCLEROSING ADENOSIS WITH ASSOCIATED MULTIFOCAL. MICROCALCIFICATIONS. F. MEDIAL CALCIFICATIONS OF BLOOD VESSEL. G. NEW RESECTION MARGINS ARE FREE OF TUMOR. CASE SYNOPSIS: SYNOPTIC PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmentel. SIZE OF TUMOR: Not specified. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasivo component: 3.5 cm. TUMOR TYPE (Invanive componant): Ductal adenocarcinoine. NOS. NOTTINGHAM SCORE: Nuclcar grade: 2. Tubule formation: 3. Mitotic activity scoie: 1. Total Nottingham score: A. ANGIOLYMPHATIC INVASION: Nollingham grede (1. 2, 3). 2. DERMAL LYMPHATIC INVASION: Not applicable. Yes, benign zones. TUMOR TYPE. IN SITU: Yes. malignent zones. Cribriform. Solld. DCIS admixod with invasivo cancinoma. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Percent of tumor occupied by In situ component: 2 %. Yes, diffuse. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPM NODES POSITIVE: 3. LYMPH NODES EXAMINED: 28. METHOD(S) OF LYMPM NODE EXAMINATION;. H/E stuin. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of targuet lymph node metastaus: 15 min. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: T STAGE, PATHOLOGIC: NON-NEOPLASTIC BREAST TISSUE: ADH, Redial scar, Papillonn, FCU. pT2. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTOR9: positive. HER2/NEU: zoro or 1+."
BIOCUP_00161,breast,BRCA,TCGA-A8-A096,TCGA-A8-A096.91BFC77A-E56F-49F0-A294-A5EE9F266FB6,"Diagnosis: 1. Moderately differentiated invasive ductal carcinoma (tumor diameter 4.0 cm). In conjunction with the preliminary finding, this gives rise to the following tumor. classification: NOS, G II, pT2NOi+(sn)LOVORO."
BIOCUP_00162,breast,BRCA,TCGA-E2-A14X,TCGA-E2-A14X.734305A3-5EC4-4DE4-B263-91A49082F146,"SPECIMENS: A. RIGHT BREAST WLE NEEDLE LOCALIZATION. B. ADDITIONAL ANTERIOR INFERIOR MARGIN. C. ADDITIONAL SUPERIOR MARGIN. D. SENTINEL LYMPH NODE #1. E. SENTINEL LYMPH NODE #2. F. RIGHT AXILLARY CONTENTS LEVELS 1 & 2. SPECIMEN(S): A. RIGHT BREAST WLE NEEDLE LOCALIZATION. B. ADDITIONAL ANTERIOR INFERIOR MARGIN. C. ADDITIONAL SUPERIOR MARGIN. D. SENTINEL LYMPH NODE #1. E. SENTINEL LYMPH NODE #2. F. RIGHT AXILLARY CONTENTS LEVELS 1 & 2. GROSS DESCRIPTION: A. RIGHT BREAST WLE NEEDLE LOCALIZATION. Received fresh labeled with the patients identification and ""Right Breast WLE needle localization"" is an oriented. (Single-Anterior, Double-Lateral, Triple-Superior and Quadruple-Inferior) 59g, 8.5 x 8.5 x 2 1.5cm needle localized. lumpectomy with 2 radiographs. Ink code: Anterior-Yellow, Posterior-Black, Superior-Blue, Inferior-Orange, Medial-. Green, Lateral-Yellow. Specimen serially sectioned from medial to lateral into 7 slices revealing a 2.5 x 1.5 x 1.5cm. tan white firm well circumscribed mass abutting the anterior and posterior margins in slices 3-5. A portion of the. specimen is submitted for tissue procurement. Representative sections are submitted. A1-A3: medial margin slice 1. A4: superior margin slice 2. A5-A6: anterior margin slice 3. A7-A8: deep margin slice 3. A9-A11: anterior margin slice 3. A12-A14: deep margin with mass in A13 slice 3. A15: superior margin slice 4. A16: mass with anterior/deep margin slice 4. A17-A18: mass with anterior margin slice 4. A19-A20: mass with deep margin slice 4. A21: superior margin slice 5. A22-A23: mass with anterior/deep margin slice 5. A24: inferior margin slice 5. A25: area next to mass with anterior/deep margin slice 6. A26: lateral margin slice 7. B. ADDITIONAL ANTERIOR INFERIOR MARGIN. Received fresh labeled with the patient's identification and ""Additional Anterior/Inferior margin"" is an oriented (Single-. Anterior, Double-Inferior) 19g, 5 x 5 x 2.5cm fragment of fibrofatty tissue. Final Anterior margin is inked Yellow and. the final Inferior margin is inked Orange. Serial sectioning reveals no discrete lesions. Toto B1-B14. C. ADDITIONAL SUPERIOR MARGIN. Received fresh labeled with the patient's identification and ""Additional Superior margin"" is an oriented (Single-. Anterior, Double-Inferior) 10g, 3 x 3 x 2cm fragment of fibrofatty tissue. Final margin is inked Black. Serial sectioning. reveals no discrete lesions. Toto C1-C7. D. SENTINEL LYMPH NODE #1. Received fresh labeled with the patient's identification and ""SLN #1"" are two possible lymph nodes 0.8 x 0.8 x 0.5cm. and 0.5 x 0.3 x 0.2cm. A touch prep is taken and the larger lymph node is submitted in FSD. The smaller possible. lymph node is submitted in D2. E. SENTINEL LYMPH NODE #2 (CLUMP OF FREE NODES). Received fresh labeled with the patient's identification and ""SLN #2"" are 3 tan pink lymph nodes ranging from 1.4 x. 0.9 x 0.8cm to 1.4 x 0.8 x 0.6cm. Toto FSE1, FSE2 and FSE3. F. RIGHT AXILLARY CONTENTS LEVELS 1 & 2. Received in formalin are multiple tan pink soft tissue fragments aggregating to 10 x 10 x 4cm. Dissection reveals. multiple lymph nodes. Entirely submitted: F1: 5 lymph nodes. F2: 5 lymph nodes. F3: 1 lymph node. F4: 1 lymph node. F5: 1 lymph node. F6: 1 lymph node. F7-F8: 1 lymph node. F9-F10: 1 lymph node. F11-F12: 1 lymph node. F13-F20: axillary tissue. SUMMARY OF IMMUNOHISTOCHEMISTRY/SPECIAL STAINS. Material: Block A1. Population: Tissue. Stain/Marker: Result: Comment: CALP. Positive. In DCIS. Material: Block A12. Population: Tissue. Stain/Marker: Result: Comment: CD31. Positive. Material: Block A24. Population: Tissue. Stain/Marker: Result: Comment: CD31. Positive. Material: Block B7. Population: Tissue. Stain/Marker: Result: Comment: ESTROGEN RECEPTOR. Positive Heterogeneous staining consistent with UDH. The interpretation of the above immunohistochemistry stain or stains is guided by published results in the medical. literature, provided package information from the manufacturer and by internal review of staining performance and. assay validation within the Immunohistochemistry Laboratory. The use of one or more reagents in the above tests is. regulated as an analyte specific reagent (ASR). These tests were developed and their performance characteristic. determined by the Department of Pathology Laboratory. They have not been cleared or approved by the U.S. Food. and Drug Administration The FDA has determined that such clearance or approval is not necessary. Special stains and/or immunohistochemical stains were performed with appropriately stained positive and negative. controls. DIAGNOSIS: A. BREAST, RIGHT, NEEDLE LOCALIZATION WIDE LOCAL EXCISION: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 3, WITH MICROPAPILLARY. FEATURES (SEE NOTE). INVASIVE CARCINOMA MEASURES 2.5 CM. - INVASIVE CARCINOMA IS PRESENT AT THE ANTERIOR MARGIN. AND IS 0.3 CM FROM THE POSTERIOR MARGIN. - EXTENSIVE LYMPHVASCULAR INVASION IS PRESENT. DUCTAL CARCINOMA IN SITU (DCIS), SOLID TYPE, NUCLEAR GRADE. 3,. WITH NECROSIS, MINOR COMPONENT. - DCIS IS FOCALLY WITHIN 0.4 CM OF THE MEDIAL MARGIN. - PREVIOUS BIOPSY SITE CHANGES PRESENT. NOTE: The additional anterior inferior margin (specimen B) is free of invasive carcinoma. Surgical correlation is. recommended. CD31 stains show positive staining around tumor foci near. superior and posterior margins consistent with tumor in lymphvascular channels. B. BREAST, RIGHT, ADDITIONAL ANTERIOR INFERIOR MARGIN, EXCISION: - FOCAL ATYPICAL DUCTAL HYPERPLASIA (ADH) AND USUAL DUCTAL. HYPERPLASIA (UDH). C. BREAST, RIGHT, ADDITIONAL SUPERIOR MARGIN, EXCISION: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 3. - TUMOR MEASURES 0.6 CM. - TUMOR IS WITHIN 0.2 CM OF THE NEW MARGIN. - LYMPHVASCULAR INVASION IS PRESENT. - DCIS, SOLID TYPE, NUCLEAR GRADE 3, WITH NECROSIS, MINOR. COMPONENT. D. SENTINEL LYMPH NODE #1, RIGHT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). E. SENTINEL LYMPH NODE #2, RIGHT AXILLA, BIOPSY: - METASTATIC CARCINOMA TO TWO OF THREE LYMPH NODES, LARGEST. METASTASIS IS 0.7 CM, WITH NO EXTRANODAL EXTENSION (2/3). F. AXILLARY CONTENTS, RIGHT, LEVELS 1 AND 2, DISSECTION: - METASTATIC CARCINOMA TO 3 OF 17 LYMPH NODES, LARGEST. METASTASIS IS 1.5 CM WITH EXTRANODAL EXTENSION (3/17). SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Yes For mass. Laterality: Right. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.5cm. Tumor Site: Upper outer quadrant. Margins: Negative. Distance from closest margin: Less than 0.2cm. superior. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: Present. Extent: extensive. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node and axillary dissection. Lymph node status: Positive 5 / 21 Extranodal extension. Non-neoplastic areas: fibroadenoma. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 5%. DCIS Type: Solid. DCIS Location: :Associated with invasive tumor. Nuclear grade: High. Necrosis: Present. ER/PR/HER2 Results. ER: Negative. PR: Negative. HER2: Negative by IHC. Pathological staging (pTN): pT 2 N 2. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: A22 and F12 (lymph node). ER: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score. 0. PR: Negative Allred Score: 0. = Proportion Score 0 + Intensity Score 0. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the proportion score. (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of cells staining, 4 = 31-60% of. cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak intensity of staining, 2 = intermediate. intensity of staining, 3 = strong intensity of staining), with a scoring range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score of less than. or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistrv was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR 136, 1:100). provided by Dako. following the manufacturer S instructions. This assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published results in the medical literature,. information provided by the reagent manufacturer and by internal review of staining performance. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: F12 (lymph node). Interpretation: NEGATIVE. Intensity: 1+. % Tumor Staining: 5%. Fish Ordered: No. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analysis. was performed using the FDA approved Dako HercepTes (TM) test kit. using rabbit anti-. human HER2. This assay was not modified. External kit-slides provided by the manufacturer (cell lines with. high,. low and negative HER2 protein expression) and in-house known HER2 amplified control tissue were evaluated along. with the test tissue. Adequate, well preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2 immunohistochemical stain is guided by published results in the medical literature,. information provided by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the 2007 joint recommendations and guidelines from ASCO and CAP. and from the NCCN HER2 testing in Breast Cancer Task Force. The Pathology Department takes full responsibility. for this test's performance. CLINICAL HISTORY: year old female with Abnormal MMG- Bx Right Breast at 9-10 o'clock IDC ER-. MRI showed additional. abnormality 2.6cm posterior to this. PRE-OPERATIVE DIAGNOSIS: Right Breast Cancer. INTRAOPERATIVE CONSULTATION: FSD-TPD: One lymph node negative for tumor. FSE1-FSE2-FSE3: Positive for metastatic Adenocarcinoma. Diagnoses called to Dr. at . (D) and. I (E) by Dr. Microscopic/Diagnostic Dictation: Pathologist,. Final Review: Pathologist,. Final Review: Pathologist,. Final: Pathologist,."
BIOCUP_00163,breast,BRCA,TCGA-A2-A0T6,TCGA-A2-A0T6.377F7050-F900-4345-A326-568F00050BC3,"/F. Acct# : Unit# : Specimen: Spec Type: SURGICAL P. LEFT BREAST CANCER INVASIVE. DOCTOR (s) : PROCEDURE: BILATERAL SIMPLE MASTECTOMY-SENTINEL NODE BX. A. LT SENTINEL NODE #2 - FS. B. LT SENTINEL NODE #1. C. LT SIMPLE MASTECTOMY. D. RT SIMPLE MASTECTOMY. E. RT SENTINEL NODE #10/1. F. RT SENTINEL NODE #2 0/1. 4. POSSIBLE LT SENTINEL NODE. LT SENTINEL NODE # $91. A. BENIGN. and. PART A RECEIVED FRESH LABELED. LEFT SECOND SENTINEL NODE. PALPABLE, CONSISTS OF AN IRREGULAR PORTION OF YELLOW-RED FATTY TISSUE. MEASURING 2.5 X 1.0 X 1.0 CM. SECTIONING REVEALS 2 LYMPH NODES, THE. LARGER 0.9 CM IN DIAMETER DEMONSTRATES A RIBBON CLIP THE SECOND IS 0.5. CM. SECTION OF THE LARGER IS SUBMITTED AS FSA. THE REMAINDER OF THE. SPECIMEN IS SUBMITTED LABELED A. PART B RECEIVED FRESH LABELED. LEFT FIRST SENTINEL NODE. HOT AND BLUE, IS A PORTION OF YELLOW-RED FATTY TISSUE MEASURING 2.2 X 1.5. x 1.0 CM. SECTIONING REVEALS GROSSLY UNREMARKABLE NODAL TISSUE WITH. FOCAL BLUE DYE. ONE HALF IS SUBMITTED PER PROTOCOL, THE REMAINDER IS. SUBMITTED LABELED B. PART C RECEIVED FRESH LABELED. LEFT SIMPLE MASTECTOMY. STITCH AT 12 O'CLOCK, IS A MASTECTOMY SPECIMEN WITH OVERALL DIMENSIONS OF. 23.5 X 20.5 X 4.5 CM. THE NIPPLE IS UNREMARKABLE AND IS WITHIN AN. IRREGULAR SHAPED SKIN EXCISION MEASURING 8.0 x 4.3 CM IN GREATEST. 1. √†. Specimen. Spec Type: SURGICAL P. GROSS. DIMENSIONS. A SUTURE DENOTES 12 O'CLOCK AND BLUE DISCOLORATION IS NOTED. IN THE UPPER INNER QUADRANT. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE. INK, THE DEEP MARGIN IN BLACK INK. SECTIONING REVEALS DENSE PINK-TAN. FIBROUS NODULE IN THE MIDPORTION OF THE SPECIMEN WHICH IS CENTRAL AND IN. THE SUPERIOR ONE-HALF OF THE SPECIMEN TO INCLUDE BOTH THE OUTER AND INNER. QUADRANTS. IT HAS AN IRREGULAR SHAPE WITH NO PERCEPTIBLE DIFFERENTIATION. BETWEEN THE LOBULATED ARMS CREATING A 7.0 CM SPAN FROM MEDIAL TO LATERAL. 3.5 CM FROM SUPERIOR TO INFERIOR AND UP TO 2.5 CM FROM ANTERIOR TO. POSTERIOR. THIS EXTENDS TO WITHIN 0.7 CM OF THE DEEP MARGIN. THERE ARE. SMALL PALPABLE NODULES SURROUNDING THIS. ONE OF THESE IN THE UPPER INNER. QUADRANT MEASURES 0.5 CM AND IS 1.3 CM FROM THE DEEP MARGIN. GROSSLY. THIS IS NOT IN CONTINUATION WITH THE LESION AND SEPARATED BY 1 CM. THE. PERIMETER TISSUE IS BLAND YELLOW FATTY TISSUE. SECTIONS ARE SUBMITTED AS. FOLLOWS: C1 --NIPPLE AND SKIN (MIRROR IMAGE TO PROTOCOL), C2--THE - FAR. MEDIAL PORTION OF THE LARGE LESION IN THE UPPER INNER QUADRANT, C3 - - THE. SMALL NODULE IN THE UPPER INNER QUADRANT, C4--TISSUE FROM LOWER INNER. QUADRANT 2 CM INFERIOR TO C2, C5 THROUGH C7--A SUPERIOR TO INFERIOR. CROSS-SECTION OF THE LESION IMMEDIATELY SUBAREOLAR, C8--LESION AND DEEP. MARGIN (MIRROR IMAGE TO PROTOCOL SECTION). C9 AND C10--SECTIONS OF. PALPABLE LESION FAR LATERAL, SUPERIOR, AND INFERIOR, C11--LESION AND. SUPERFICIAL MARGIN, --THE SUPERFICIAL PORTION OF THE LESION AND SKIN. CORRESPONDING TO C8, C13--LOWER OUTER QUADRANT 3 CM FROM TUMOR,. C14--UPPER OUTER QUADRANT 3 CM FROM TUMOR, C15--TUMOR (MIRROR IMAGE TO. PROTOCOL), C16--TISSUE 6 'CLOCK. PART D RECEIVED FRESH LABELED. RIGHT SIMPLE MASTECTOMY. STITCH AT 12 O'CLOCK, IS A SIMPLE MASTECTOMY SPECIMEN MEASURING 16.0 x. 15.5 x 4.0 CM. THE NIPPLE IS UNREMARKABLE WITHIN A 7.2 X 4.3 CM SKIN. ELLIPSE. A SUTURE DENOTES 12 O'CLOCK. THE SUPERFICIAL ASPECT IS MARKED. WITH BLUE INK, THE DEEP WITH BLACK. SECTIONING REVEALS A CENTRAL PORTION. OF THE BREAST TO CONSIST OF PINK-TAN FIBROUS TISSUE WITH MULTIPLE. FLUID-FILLED CYSTS. THIS IS SURROUNDED BY A PERIMETER OF BLAND YELLOW. FATTY TISSUE WITH FINE FIBROUS BANDS. THE FIBROUS COMPONENT IS 50% OF. THE SPECIMEN. ONE CYST IN THE 9 O'CLOCK AREA CONTAINS TAN PUTTY-LIKE. MATERIAL (D3) THE SPECIMENS ARE SUBMITTED AS FOLLOWS D1--NIPPLE,. D2--9 O' 'CLOCK AREA (MIRROR IMAGE TO PROTOCOL BLOCK), D3-CYST IN 9. 'CLOCK AREA, D4 - LOWER OUTER QUADRANT, D5 --UPPER OUTER QUADRANT,. D6--CENTRAL DEEP MARGIN, D7 AND 08--LOWER INNER QUADRANT, D9 AND. 010--UPPER INNER QUADRANT. PART E RECEIVED FRESH LABELED. RIGHT SENTINEL NODE BLUE. NOT HOT, IS FATTY TISSUE MEASURING 2.8 X 2.5X 1.0 CM. SECTIONING. REVEALS A 0.8 CM IN DIAMETER RED-TAN NODE. HALF IS SUBMITTED FOR. PROTOCOL, THE REMAINDER IS SUBMITTED LABELED E. PART F RECEIVED FRESH LABELED. SECOND RIGHT SENTINEL NODE. Specimen: Req# : Spec Type: SURGICAL P. GROSS OMSCRIPTION. HOT BLUE, IS AN OVOID PORTION OF RED-TAN TISSUE MEASURING 2.5 x 1.3 x 1.0. CM, IS A 1.2 CM LYMPH NODE SHOWING BLUE DISCOLORATION. ONE-HALF IS. SUBMITTED PER PROTOCOL, THE REMAINDER IS SUBMITTED LABELED F. PART G RECEIVED FRESH LABELED. LEFT FOURTH SENTINEL. NODE_ HOT ONLY, IS YELLOW FATTY TISSUE MEASURING 2.3 X 1.5 X 0.8 CM. IT. REVEALED A 1 CM GROSSLY UNREMARKABLE LYMPH NODE. ONE HALF IS SUBMITTED. PER PROTOCOL, THE REMAINDER IS SUBMITTED LABELED G. PART H RECEIVED FRESH LABELED. POSSIBLE LEFT SENTINEL. NODE HOT NOT BLUE, YELLOW-FATTY TISSUE. THIS NODAL TISSUE IS IDENTIFIED. AND THE SPECIMEN IS SUBMITTED ENTIRELY LABELED H. PROCEDURES: 88307/8, IMMUNOPEROXIDAS/6, PATH FS , ABX X6, BBX X6, C BLK/16, D BLK/10,. EBX X6, FBX X6, FROZ.SEC. A, GBX X6, HBX X6. PARTS A AND B LEFT SECOND AND FIRST AXILLARY SENTINEL LYMPH NODE. BIOPSIES: LYMPH NODES WITH NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED. BY NEGATIVE CYTOKERATIN IMMUNOHISTOCHEMICAL STAINING. PART C LEFT SIMPLE MASTECTOMY: MULTICENTRIC IN SITU AND INFILTRATING. LOBULAR CARCINOMA. THE TUMOR IS NUCLEAR GRADE II/III WITH A LOW MITOTIC. INDEX. INVASIVE CARCINOMA SPANNED A GROSS DISTANCE OF 7.0 CM FROM MEDIAL. TO LATERAL IN THE SUPERIOR CENTRAL PORTION OF THE SPECIMEN, SPANNING THE. OUTER AND INNER QUADRANTS, WITH A DISTINCT AND SEPARATE 1 0-CM NODULE. INVASIVE LOBULAR CARCINOMA IN THE UPPER OUTER QUADRANT OF THE BREAST. THE SUPERFICIAL AND DEEP MARGINS ARE FREE OF TUMOR BY AT LEAST 1 CM. PART D RIGHT SIMPLE MASTECTOMY FIBROCYSTIC CHANGES WITH FOCALLY MARKED. NON-ATYPICAL INTRADUCTAL EPITHELIAL HYPERPLASIA PRESENT. NO EVIDENCE OF. MALIGNANCY. PARTS E AND F RIGHT FIRST AND SECOND AXILLARY SENTINEL LYMPH NODE. BIOPSIES: LYMPH NODES WITH NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED. BY NEGATIVE CYTOKERATIN IMMUNOHISTOCHEMISTRY. PART G LEFT FOURTH AXILLARY SENTINEL LYMPH NODE, BIOPSY: LYMPH NODE. WITH NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED BY NEGATIVE CYTOKERATIN. IMMUNOHISTOCHEMICAL STAINING. Speciment. Spec Type: SURGICAL P. PART H POSSIBLE LEFT AXILLARY LYMPH NODE, BIOPSY ADIPOSE TISSUE WITH p. NO LYMPH NODE PRESENT. (signature on file)."
BIOCUP_00164,breast,BRCA,TCGA-EW-A1J1,TCGA-EW-A1J1.E8B860F6-F3FD-4FDF-B467-8988646C2F00,"F. Pathologic Interpretation: A. Sentinel node #1 Count #. FS: Metastatic carcinoma to lymph node (1/1) with extracapsular extension. B. Sentinel node #2 count. - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. C. Sentinel node #3 count. - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. D. Sentinel node #4 count. FS: - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. E. Sentinel node #5 count. FS: - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. F. Sentinel node #6 count. FS: - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. G. Axiliary fat (perm): - No malignancy seen in one lymph node (0/1). H. Skin right breast: - Skin with no specific pathologic change. I. Right breast lumpectomy (short stitch superior, long lateral ) fresh: - Invasive poorly differentiated ductal carcinoma, Nottingham grade 3 (3 + 3 + 3), 3.5 cm. Lymphovascular space invasion is not identified. - Specimen margins are negative for tumor. J. Additional deep margin (perm): - No malignancy seen. K. Right axiliary contents (perm): No malignancy seen in ten lymph nodes (0/10). L. Left breast tissue (perm): No malignancy seen. Surgical Pathology Tumor Summary. Specimen: partial breast. Procedure: Excision without wire-guided localization. Lymph node sampling: Sentinel lymph nodes, axillary dissection (partial or complete dissection). Specimen Integrity: Single intact specimen. Specimen Size: Greatest dimension: 9.5 cm. Additional dimensions: 8 x 5.5 cm. Specimen Laterality: Right. Tumor Size: Greatest dimension of largest focus of invasion over 0.1 cm: 3.5 cm. Additional dimensions: 3 x 3 cm. Skin: Invasive carcinoma does not invade into the dermis or epidermis. Skeletal Muscle: No skeletal muscle present. SURGICAL PATHOL Report. Histologic type of invasion: Invasive ductal carcinoma. Glandular (Acinar)/tubular Differentiation: Score 3: <10% of tumor are forming glandular/tubular structures. Nuclear Pleomorphism: Score 3: Vesicular nuclei, often with prominent nucleoli exhibiting marked variation in size and shape,. occasionally with very large and bizarre forms. Mitotic Count: Score 3. Overall Grade: Grade 3: scores of 8 or 9. Margins uninvolved by invasive carcinoma. Lymph-vascular invasion: Not identified. Number of lymph nodes examined: 6. Total number of lymph nodes examined (sentinel and non-sentinel): 17. Number of lymph nodes with macrometastasis (>0.2 cm): 1. Extranodal extension: Present. Method of evaluation of sentinel lymph nodes: Hematoxylin and eosin (H & E ) one level, immunohistochemistry. PT2: Tumor >20 mm but <50 mm in greatest dimension. PN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mm. Distant metastasis: not applicable. Estrogen Receptor: Performed on another specimen. 1. immunoreactive tumor cells present (>1%). Progesterone Receptor. Performed on another specimen. immunoreactive tumor cells present (>1%). Immunoperoxidase studies: Performed on another specimen. negative (score 0). NOTE: Some immunohistochemical antibodies are analyte specific reagents (ASRs) validated by our laboratory (Her 2. Parvo, H. pytori, HBcore). These ASRs are clinically indicators that do. not require FDA approval. These clones are used: 105=ER, PgR 636=PR, A485=HER2, H-11=EGFR, CCH2/DDG9=CMV, F39.4. 1=AR and HPV by ISH. AI immunohiatochernich/ stains are used. with formalin or molecular fixed, parafin embedded tissue. Detection is by LSAB. The results are read by a pathologist as positive or negative. As the attending pathologiet, I attest that I: (I) Examined the relevant. preparation(s) for the specimen(s); and (d) Rendered the diegnosis(es). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. B. Immunohistochemistry for Keratin stain is negative for metastatic carcinoma to the lymph node. C. Immunohistochemistry for Keratin stain is negative for metastatic carcinoma to the lymph node. D. Immunohistochemistry for Keratin stain is negative for metastatic carcinoma to the lymph node. E. Immunohistochemistry for Keratin stain is negative for metastatic carcinoma to the lymph node. Intraoperative Consultation. AFS. Sentinel node #1 Count #. FS: One lymph node with metastatic carcinoma. BFS. Sentinel node #2 count. FS: SURGICAL PATHOL Report. One lymph node, no carcinoma seen. CFS. Sentinel node #3 count. Adipose tissue only. No lymph node identified grossly. DFS. Seninel node #4 count. FS: One lymph node, no carcinoma seen. EFS. Sentinel node #5 count. FS: One lymph node, no carcinoma seen. FFS. Sentinel node #6 count. FS: One lymph node, no carcinoma seen. Clinical History: Patient is a. female with right breast cancer. Pre Operative Diagnosis: Right breast cancer. Specimen(s) Received: A: Sentinel node #1 Count #. FS. B: Sentinel node #2 count. FS. C: Sentinel node #3 count. 1. D: Seninel node #4 count i. FS. E: Sentinel node #5 count. FS. F: Sentinel node #6 count. FS. G: Axillary fat (perm). H: Skin right breast. I: Right breast lumpectomy (short stitch superior, long lateral ) fresh. J: Additional deep margin (perm). K: Right axillary contents (perm). L: Left breast tissue (perm). Gross Description: A. Received fresh and labeled ""sentinel node #1 count #. FS"" consists of pale yellow soft tissue measuring 1 x 0.3 x. 0.2 cm. The cassettes are submitted as follows: 1. Submitted for frozen section. 2. Remainder of the tissue. B. Received fresh and labeled ""sentinel node #2 count. FS"" consists of light brown fragments -49-count. measuring 1. x 0.2 x 0.3 cm in aggregate. The cassettes are submitted as follows: 1. Submitted for frozen section. 2. Remainder of the tissue. C. Received fresh and labeled ""sentinel node #3 count. consists of light brown soft tissue measuring 2 x 1 x 1 cm. The. specimen submitted in toto in two cassettes. D. Received fresh and labeled ""seninel node #4 count. FS"" consists of pale white tissue measuring 1 x 0.8 x 0.2 cm. Specimen as follows: 1. Submitted for frozen section. 2. Remainder of tissue. E. Received fresh and labeled ""sentinel node #5 count. FS"" consists of sift white fragment measuring 1 x. The specimen is submitted as follows: 1. Submitted for frozen section. SURGICAL PATHOL Report. 2. Remainder of tissue. F. Received fresh and labeled ""sentinel node #6 count. FS"" consists of light brown fragment measuring 0.5 x 0.3 x. 0.2. cm. The specimen is submitted as follows: 1. Submitted for frozen section. 2. Remainder of tissue. G. Received in formalin and labeled ""axiliary fat (perm)"" consists of yellow brown soft tissue measuring 4 x 2x3ccm in. aggregate. The entire specimen is submitted in toto in eight cassettes. H. Received in formalin and labeled ""skin right breast"" consists of skin tag measuring 5 x 0.5 x 0.1 cm. A representative. section of the skin tag is submitted in one cassette. I. Received in formalin and labeled ""right breast lumpectomy (short stitch superior, long lateral ) fresh"" consists of breast. tissue mass measuring 186 grams and measures 9.5 cm medial to lateral, 5.5 cm inferior superior and 8 cm anterior to. posterior. It is round to oval in shape. It is yellow in color and soft in consistency. The specimen has sutures for. orientation. The specimen is inked as follows: anterior yellow; superior blue; posterior black; inferior green; lateral orange. and medial red. Serial sectioning of the specimen reveals a well defined round to oval mass measuring 3 x 3 x 3.5 cm. It. is hard in consistency. It occupies 20% of the entire specimen. The nearest margin is at the superior margin which is 1.5. cm from the mass. Remaining margins are away from the mass. There is an area of fibrosis which is situated anterior to. the mass; it is 1 cm away from the mass. The area of fibrosis measures 1 x 1 cm. The breast parenchyma i√© between. the mass and the fibrosis is normal. The remaining breast parenchyma consists of the fat to stroma ratio 90: 10. The. cassettes are submitted as follows: 1. Superior margin. 2. inferior margin. 3. Anterior margin. 4. Posterior margin. 5. Medial margin. 6. Lateral margin. 7-10. Representative sections of the tumor. 11. Area of fibrosis. 12. Breast parenchyma between the tumor and fibrosis. J. Received in formalin and labeled ""additional deep margin (perm)"" consists of two yellow fragments soft in consistency. measuring 1 x 0.3 x 0.3 cm in aggregate. The entire specimen is submitted in toto in two cassettes. K. Received In formalin and labeled 'right axillary contents (perm)"" consists of a yellow brown soft tissue measuring 9 x 7 x 2. cm. Ten possible lymph nodes are extracted from the specimen and submitted in six cassettes. One lymph hode. which. measures 1 x 0.5 x 0.3 cm, bisected and submitted in cassette 1. 2. One lymph node bisected. 3. Two lymph nodes. 4&5. Three lymph nodes. 6. One lymph node. L. Received in formalin and labeled ""left breast tissue (perm)"" consists of a breast mass measuring 465 grams and. measures 8 x 5 x 2 cm in greatest dimension. It has a skin ellipse which measures 4 x 1.5 cm. The. entire. specimen. other. than skin is inked black. Serial sectioning of the mass it reveals fibrofatty tissue with fat to stoma ratio 70:30. No gross. lesions are identified. 1-5. Representative section of the fibrofatty tissue. 6. Skin tag. ICD-9(s): 174.8 196.3."
BIOCUP_00165,breast,BRCA,TCGA-BH-A0B0,TCGA-BH-A0B0.EB09D890-879C-4874-AE3F-47E41C2C66FE,"FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEFT BREAST, #1 SENTINEL, EXCISION -. NO EVIDENCE OF METASTATIC MAMMARY CARCINOMA IN ONE LYMPH NODE (0/1). PART 2: LYMPH NODE, LEFT BREAST, #2 SENTINEL, EXCISION -. NO EVIDENCE OF METASTATIC MAMMARY CARCINOMA IN ONE LYMPH NODE (0/1). PART 3: BREAST, LEFT, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCIAL CARCINOMA. B. NOTTINGHAM GRADE (TUBULE FORMATION: 2, NUCLEAR PLEOMORPHISM: 2, MITOTIC ACTIVITY: 1;. TOTAL SCORE 5/9). C. INVASIVE TUMOR MEASURES 1.8 CM IN LARGEST DIMENSION. D. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. E. INVASIVE CARCINOMA IS 0.8 CM FROM THE NEAREST ANTERIOR MARGIN. SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.8 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 2. Mitotic activity score: 1. Total Nottingham score: 5. Nottingham grade (1, 2, 3): 1. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 8 mm. PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 2. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNo. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: zero or 1+."
BIOCUP_00166,breast,BRCA,TCGA-A2-A0T7,TCGA-A2-A0T7.383EC600-FBF3-4F91-8FAC-41E3DDE6589E,"Specimen: (. spec Type: SURGICAL P. RIGHT BREAST CANCER INVASIVE. DATE: 1. DOCTOR (s) : BITATERAL SIMPLE MASTECTOMY - SENTINEL NODE BX. A. LT BREAST MASTECTOMY. B. RT BREAST SENTINEL NODE #1. C. RT BREAST SENTINEL NODE #2. D. RT BREAST MASTECTOMY. RECEIVED IN FOUR PARTS. PART A: RECEIVED FRESH LABELED LEFT BREAST MASTECTOMY, STITCH AT 1200 IS A. SIMPLE MASTECTOMY SPECIMEN MEASURING 15 X 14.5 x 4 CM IN GREASTEST. DIMENSIONS. THE NIPPLE IS UNREMARKABLE WITHIN A 6.3 x 3.6 CM SKIN. ELLIPSE. THE SUPERFICIAL MARGIN IS MARKED BLUE WHILE THE DEEP ASPECT IS. MARKED WITH BLACK INK. SECTIONING REVEALS CENTRAL FIBROSIS WITH MULTIPLE. CYSTIC AREAS CONTAINING GREY MUCINOUS FLUID. THIS AREA IS MEASURES 10.5. x. 9 x 3 CM AND IS SURROUNDED BY GROSSLY UNREMARKABLE YELLOW FATTY TISSUE. REPRESENTATIVE SECTIONS ARE SUBMITTED AS FOLLOWS: A1-NIPPLE; A2-CENTRAL. DEEP MARGIN; A3- UPPER OUTER QUADRANT; A5-6 UPPER INNER QUADRANT; A7-8. LOWER INNER QUADRANT AND A9-10-LOWER OUTER QUADRANT. PART B: RECEIVED FRESH LABELED SENTINEL NODE #1 HOT AND BLUE IS AN OVOID. FRAGMENT OF BLUE COLORED TISSUE AND SURROUNDING YELLOW FAT MEASURING 2 x 1. x 1 CM. SECTIONING REVEALS A GROSSLY UNREMARKABLE BLUE DYED NODE MEASURING. 1.7 CM IN GREATEST DIMENSION. A PORTION IS TAKEN PER PROTOCOL AND THE. REMAINDER IS SUBMITTED LABELED B. PART C: RECEIVED FRESH LABELED SENTINEL NODE #2 HOT IS AN OVOID PORTION OF. YELLOW FATTY TISSUE MEASURING 2 x 1 x 1 CM. SECTIONING REVEALS. UNREMARKABLE NODAL TISSUE SUBMITTED ENTIRELY LABELED C. PART D: RECEIVED FRESH LABELED. RIGHT BREAST MASTECTOMY,. STITCH AT 12 O'CLOCK IS A SIMPLE MASTECTOMY SPECIMEN MEASURING 17 x 15 x. 5.0 CM. THE NIPPLE IS GROSSLY UNREMARKABLE WITHIN A 6 x 3 CM SKIN ELLIPSE. THE SUPERFICIAL ASPECT IS MARKED IN BLUE INK. THE DEEP MARGIN IS MARKED. IN BLACK INK. SECTIONING REVEALS A FIRM FIBROUS NODULE IN THE UPPER INNER. QUADRANT MEASURING 2.5 x 1.5 x 1.5 CM. THE LESION GROSSLY EXTENDS TO. WITHIN 0.8 CM OF THE MOST MEDIAL MARGIN AND IS 0.7 CM FROM BOTH THE. SUPERFICIAL AND DEEP MARGINS. THE CENTRAL PORTION OF THE BREAST CONSISTS. OF DENSE FIBROUS TISSUE WITH NUMEROUS CYSTIC AREAS AND THIS SURROUNDED BY. BLAND YELLOW FATTY TISSUE. THE CENTRAL AREA MEASURES 13 x 10.5 x 3.0 CM. (Costinsed). Specimen: atus: : Spec Type: SURGICAL P. ADDITIONALLY LOOSE WITHIN THE CONTAINER ARE TWO FRAGMENTS OF GROSSLY. UNREMARKABLE FATTY TISSUE TOGETHER MEASURING 7.5 x 5.7 x 2.0 CM. NO. SECTIONS ARE SUBMITTED. D1--NIPPLE AND ADJACENT SKIN (MIRROR IMAGE TO. RESEARCH), D2-3--FULL CROSS SECTION OF LESIONAL AREA, D4-5--FULL CROSS. SECTION TO LESIONAL AREA. NOTE D2 THROUGH D5 MIRROR IMAGE TO TISSUE. PROTOCOL, D5--SECTION - OF LESION AND MOST MEDIAL MARGIN, D7--TUMOR (MIRROR. IMAGE TO PROTOCOL), D8--UPPER INNER QUADRANT IMMEDIATELY ADJACENT TO. TUMOR; D9--UPPER OUTER QUADRANT 7 CM FROM TUMOR, D10--LOWER OUTER QUADRANT. 7 CM FROM TUMOR, D11--LOWER INNER QUADRANT 4 CM FROM TUMOR. PROCEDURES. 88307/4, IMMUNOPEROXIDAS/2, A BLK/10, BBX X6, CBX X6, D BLK/11. PART A LEFT BREAST, SIMPLE MASTECTOMY: DIFFUSE FIBROCYSTIC CHANGES WITH FCC. ADENOSIS AND FOCALLY MARKED NON-ATYPICAL INTRADUCTAL EPITHELIAL. HYPERPLASIA PRESENT. NO EVIDENCE OF MALIGNANCY. PART B RIGHT AXILLARY SENTINEL LYMPH NODE #1: REACTIVE LYMPH NODE WITH. NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED BY NEGATIVE CYTOKERATIN. IMMUNOHISTOCHEMICAL STAINING. PART C RIGHT AXILLARY SENTINEL LYMPH NODE #2: ISOLATED TUMOR CELL. CLUSTER, 0.1 MM, IDENTIFIED IN A CAPSULAR LYMPHATIC SPACE. THE LESION IS. 1. VISIBLE ON ROUTINE H&E STAINING, CONFIRMED BY POSITIVE CYTOKERATIN. IMMUNOHISTOCHEMICAL STAINING. THE FOCUS DISAPPEARS ON DEEPER SECTIONING. INTO THE TISSUE BLOCK. PART D RIGHT SIMPLE MASTECTOMY: MODERATELY DIFFERENTIATED INFILTRATING. DUCTAL CARCINOMA, NUCLEAR GRADE III/III WITH A HIGH MITOTIC INDEX WITH. INVASIVE CARCINOMA SPANNING A MICROSCOPIC DISTANCE OF 2.6 CM. MINOR FOCI. OF MICROPAPILLARY-TYPE DUCTAL CARCINOMA IN SITU ARE PRESENT, BUT OVER 90%. OF THE TUMOR IS INVASIVE. THE TUMOR IS LOCATED IN THE UPPER INNER. QUADRANT OF THE BREAST (2 O'CLOCK POSITION) WITH A MICROSCOPIC TENDRIL OF. TUMOR EXTENDING TO THE SUPERFICIAL MARGIN (SLIDE D3) . THE MEDIAL MARGIN. IS FREE OF TUMOR BY A DISTANCE OF 5 MM AND THE DEEP MARGIN BY. APPROXIMATELY 1 CM. REPRESENTATIVE SECTIONS OF BREAST TISSUE AWAY FROM. THE PRIMARY TUMOR SITE SHOW PROLIFERATIVE FIBROCYSTIC CHANGES WITH AREAS. OF MARKED INTRADUCTAL EPITHELIAL HYPERPLASIA PRESENT, BUT NO ADDITIONAL. AREAS OF MALIGNANCY. Specimen: Spec Type: SURGICAL p. 1. (prelim.). (signature on file)."
BIOCUP_00167,breast,BRCA,TCGA-AO-A0JM,TCGA-AO-A0JM.3023C34B-CF59-43EA-9241-33B738D19B05,"Clinical Diagnosis & History: y/o female with right lower inner quadrant carcinoma IDC/DCIS with. microcalcifications, Right 3:00 => IDC poorly differentiated; DCIS with. microcalcification. Specimens Submitted: 1: SP: Senitnle node #1, level one, right axilla (fp). 2: SP: Sentinel node #2, level one, right axilla (fi. 3: SP: Sentinel node #3, level two, right axilla (fs. 4: SP: Right breast and axillary contents levels 1, 2 and 3. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1 LEVEL I RIGHT AXILLA; BIOPSY: METASTATIC CARCINOMA IN ONE OUT OF SIX LYMPH NODES (1/6). - THERE IS NO EXTRANODAL EXTENSION OF CARCINOMA. 2). LYMPH NODE, SENTINEL #2 LEVEL I RIGHT AXILLA; BIOPSY: - METASTATIC CARCINOMA IN ONE OF ONE LYMPH NODE (1/1) (SEE NOTE). - NO EXTRANODAL EXTENSION SEEN. NOTE: THE METASTASIS IS PRESENT ON DEEPER LEVEL PERMANENT SECTION ONLY. 3). LYMPH NODE, SENTINEL #3 LEVEL II RIGHT AXILLA; BIOPSY: - TWO BENIGN LYMPH NODES (0/2). 4). BREAST AND AXILLARY CONTENTS, RIGHT LEVELS I, II, AND III;. MASTECTOMY: - MULTIPLE FOCI OF INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC. GRADE III/III (SLIGHT OR NO TUBULE FORMATION) NUCLEAR GRADE III/III (MARKED. VARIATION IN SIZE AND SHAPE), RANGING IN SIZE FROM 0.1 CM UP TO 3 CM. - DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID, CRIBRIFORM, AND. MICROPAPILLARY TYPES WITH HIGH NUCLEAR GRADE AND MODERATE NECROSIS. - LOBULAR INVOLVEMENT BY DCIS IS PRESENT. - THE DCIS CONSTITUTES >= 25% OF THE TOTAL TUMOR MASS, AND IS PRESENT. ADMIXED WITH AND AWAY FROM THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED IN THE LOWER OUTER QUADRANT AND LOWER. INNER QUADRANT. - THE DCIS IS LOCATED IN THE LOWER OUTER QUADRANT AND LOWER INNER QUADRANT. - DCIS INVOLVES THE LARGE LACTIFEROUS DUCTS. - CALCIFICATIONS ARE PRESENT IN BOTH THE IN SITU AND INVASIVE CARCINOMA. - VASCULAR INVASION IS PRESENT. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY INVASIVE CARCINOMA IS. IDENTIFIED. - RARE FOCI OF DCIS/IN SITU CARCINOMA ARE CLOSE (1 MM) TO THE FOLLOWING. SURGICAL MARGIN: DEEP. - NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE ATTACHED SKELETAL MUSCLE IS NEGATIVE FOR TUMOR. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF POSITIVE. LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES EXAMINED) : LEVEL. I: 0/13; LEVEL II: 0/9; AND LEVEL III: 0/2. RESULTS OF SPECIAL STAINS (ER, PR, HER2-NEU) WILL BE REPORTED AS AN. ADDENDUM. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. El .conically Signed Out. Special Studies: Special Stain. Comment. ER-C. PR-C. HER2-C. IMM RECUT. NEG CONT. Gross. MD. 1). The specimen is received fresh for frozen section consultation,. labeled ""Sentinel node number one, level 1, right axilla"" and consists of 7. lymph nodes and measure 3.5 x 2.6 x 1.0 cm in aggregate. One lymph node is. blue and has been bisected, and the lymph nodes are entirely submitted in. two cassettes. Summary of sections: FSCA- frozen section control A. FSCB--frozen section control B. 2) The specimen is received fresh for frozen section consultation,. labeled ""Sentinel node number two, level 1, left axilla"" and consists of a. soft lymph node measuring 0.6 x 0.5 x 0.5 cm, bisected and entirely. submitted for frozen section. Summary of sections: FSC-frozen section control. PA. 3). The specimen is received fresh for frozen section consultation,. labeled ""Sentinel node number three, level 2, right axilla"" and consists of. two soft tan lymph nodes totaling 2.0 x 1.2 x 0.6 cm, entirely submitted for. frozen section. Summary of sections: FSC-frozen section control. MD. 4). The specimen is received fresh in a container, labeled ""Right breast and. axillary contents levels 1, 2 and 3 with tags attached"". The specimen. consists of a mastectomy measuring 30 x 19 x 3 cm. That axillary tail. measures 13 x 8 x 2 cm. The overlying ellipse of skin measures 10 x 3 cm. No scar can be identified on the skin. The nipple measures 1 x 1 cm and it. is grossly unremarkable. The deep resection margin is inked blue. The. specimen is serially sectioned revealing a pinkish red, relatively. well-circumscribed and firm lesion measuring 3 x 1.5 x 1 cm which closely. abuts the inked resection margin. The lesion is 2 cm away from the skin. The lesion is located in the lower inner quadrant. Surrounding the lesion,. are areas of fibrosis which show punctate areas of cheesy necrosis. Away. from this lesion, in the lower outer quadrant is a vaguely defined area of. fibrosis and nodularity. Approximate measurements of this area are 10 x 6. cm. The upper inner and outer quadrants show mainly fatty tissue. An. axillary dissection is performed revealing 3 level one lymph nodes, 4 level. two lymph nodes and 2 level three lymph nodes. Summary of sections: TRM-tumor in relation to inked resection margin. TRS-tumor in relation to skin. LIQ-lower inner quadrant. LOQ-lower outer quadrant. UOQ-upper outer quadrant. UIQ-upper inner quadrant. N-nipple. L1-level one lymph nodes. L2-level two lymph nodes. L3-level three lymph nodes. Summary of Sections: Part 1: SP: Senitnle node #1, level one, right axilla (fa). Block. Sect. Site. PCs. 1. {not entered}. 1. 1. fsc. 1. Part 2: SP: Sentinel node #2, level one, right axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Sentinel node #3, level two, right axilla (fs). Block. Sect. Site. PCs. 1. fsc. Part 4: SP: Right breast and axillary contents levels 1, 2 and 3. Block. Sect. Site. PCs. 1. 11. 1. 1. 12. 1. 1. 13. 1. 11. lig. 11. 15. log. 15. 1. n. 1. 3. trm. 3. 1. trs. 1. 1. uiq. 1. 1. uoq. 1. Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. ADDENDUM. SITE; RIGHT BREAST. PART #4. ER: 90% OF NUCLEAR STAINING WITH MODERATE INTENSITY. PR: 1% OF NUCLEAR STAINING WITH MODERATE TO WEAK INTENSITY. HER2/NEU (HERCEPTEST) : POSITIVE (STAINING INTENSITY OF 3+). MD. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. Page 5 of. 5. 1). FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOMA (SLIDE B) . PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: NEGATIVE LYMPH NODE. PERMANENT DIAGNOSIS: SEE FINAL DIAGNOSIS. 3). FROZEN SECTION DIAGNOSIS: NEGATIVE LYMPH NODE. PERMANENT DIAGNOSIS: SAME."
BIOCUP_00168,breast,BRCA,TCGA-E2-A15T,TCGA-E2-A15T.8FEBDA40-59FF-4E76-A9B1-F46BAB7C3E4A,"SPECIMENS: A. SENTINEL LYMPH NODE #1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. LEFT BREAST. D. LEFT BREAST SKIN. E. RIGHT BREAST TISSUE. SPECIMEN(S): A. SENTINEL LYMPH NODE #1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. LEFT BREAST. D. LEFT BREAST SKIN. E. RIGHT BREAST TISSUE. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA/TPB-SLN #1, #2: Negative for carcinoma. Diagnosis called by Dr. to Dr. at. (A,B). GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1 LEFT AXILLA. Received fresh labeled with the patient's identification and ""sentinel LN #1"" is a fragment of yellow fibroadipose. tissue, 5 x 3 x 1 cm containing a lymph node measuring 2 x 1 x 0.9 cm. The lymph node is sectioned and a touch. prep performed; lymph node submitted entirely in A1. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. Received fresh labeled with the patient's identification and ""sentinel LN #2"" is a fragment of yellow fibroadipose. tissue measuring 2.5 x 1.5 x 1 cm containing a 1.5 x 1 x 0.9 cm lymph node. It is sectioned, a touch prep is. performed, and lymph node is submitted entirely in B1. C. LEFT BREAST. Received fresh labeled with the patient's identification and ""left breast"" is an oriented 1408 g, 28 x 20 x 4 cm. mastectomy with 17 x 7 cm skin ellipse and a 0.9 cm everted nipple. Ink code: Anterior/superior-blue,. anterior/inferior-orange, posterior-black. Specimen is serially sectioned into 12 slices from lateral to medial with. nipple in slice 7 revealing a 7.2 x 5.8 x 3.2 cm ill-defined infiltrating mass extending from the 12 to 3 o'clock positions. in the upper outer quadrant in slices 3-7 that is closest to the anterior margin at 1.2 cm. In the axillary region is a. possible lymph node, 2.3 x 1.5 x 0.6 cm. Representatively submitted: C1: slice 2, UOQ lateral to lesion. C2-C3: slice 3, UOQ lesion (bisected). C4: slice 4, UOQ superior portion of lesion. C5-C6: slice 4, UOQ lesion (bisected). C7: slice 4, LOQ inferior lesion. C8: slice 5, UOQ superior to lesion. C9: slice 5, posterior margin (grossly closest deep margin). C10: slice 6, mid section including lesion. C11: slice 7, mid section. C12: slice 8, medial to lesion. C13: slice 9, UIQ. C14: slice 11, LIQ. C15: slice 2, LOQ. C16: slice 1, UOQ. C17: possible lymph node. C18-C19: skin and nipple (bisected perpendicular sections). D. LEFT BREAST SKIN. Received in formalin labeled with the patient's identification and ""left breast skin"" is an unoriented tan pink skin. excision 32 x 1cm excised to a depth ranging from 0.4cm to 1.8cm. The skin surface is grossly unremarkable. Representatively submitted in D1-D2. E. RIGHT BREAST TISSUE. Received in formalin labeled with the patient's identification and ""right breast tissue"" is a 236g, 27 x 12 x 5.4cm. aggregate of fibrofatty tissue with attached unremarkable tan pink skin 10.5 x 4.3cm. The specimen is serially. sectioned to reveal unremarkable breast parenchyma. Representatively submitted in B1-B2. DIAGNOSIS: A. SENTINEL LYMPH NODE 1, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). B. SENTINEL LYMPH NODE 2, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). C. BREAST, LEFT SIMPLE MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, WITH MUCINOUS. FEATURES. - INVASIVE CARCINOMA MEASURES AT LEAST 3 CM. - MARGINS, FREE OF TUMOR. - DUCTAL CARCINOMA IN SITU (DCIS), MICROPAPILLARY, PAPILLARY,. CRIBRIFORM, AND SOLID TYPES, NUCLEAR GRADE 2, WITH NECROSIS. - SKIN, NIPPLE, AND SKELETAL MUSCLE, NO TUMOR SEEN. NOTE: The tumor involves the upper outer quadrant and consists of multiple foci of invasive carcinoma admixed with. DCIS. On a single. slide, the largest focus of invasive carcinoma measures at least 3 cm. Invasive carcinoma spans. an area - 7 cm. D. SKIN, LEFT BREAST, EXCISION: - SKIN, NO TUMOR SEEN. E. BREAST, RIGHT, EXCISION: - APOCRINE METAPLASIA AND STROMAL FIBROSIS. - BENIGN SKIN. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3cm. Tumor Site: Upper outer quadrant. Margins: Negative. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node. Lymph node status: Negative 0/2. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 35%. DCIS Type: Solid. Cribriform. Micropapillary. Papiliary. DCIS Location:Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT2N0. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. CLINICAL HISTORY;. Multicentric cancer left breast; two areas were core biopsy showed invasive cancer. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 21. CLINICAL EXPERIENCE: Patients with a recurrence score of: 21 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 14%. ER Score: 12.1 Positive. PR Score: 5.5 Positive. Her2 Score: 10.3 Negative. Interpretation: ER. Negative < 6.5. Positive >= 6.5. PR. Negative < 5.5. Positive >= 5.5. Her2 Negative <10.7 Positive >=11.5 Equivocal = 10.7 - 11.4. See separate. report for further information. Final Review: Pathologist, (. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologis."
BIOCUP_00169,breast,BRCA,TCGA-BH-A6R8,TCGA-BH-A6R8.BF07FF13-D7EE-40E1-9729-8F9CCBD1534F,"FINAL DIAGNOSIS: PART 1: LEFT BREAST AT 2 O'CLOCK, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 3 (NUCLEAR GRADE - 3, TUBULE SCORE - 3,. MITOTIC ACTIVITY SCORE - 2; TOTAL SCORE: 8/9). B. CARCINOMA MEASURES 4.0 CM. C. NO DIAGNOSTIC LYMPHOVASCULAR SPACE INVASION (ABUNDANT RETRACTION ARTIFACT IS SEEN). D. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 2, SOLID AND CRIBRIFORM TYPES WITH. CALCIFICATIONS AND COMEDO NECROSIS. E. MARGINS ARE NEGATIVE; MICROSCOPICALLY TUMOR IS CLOSEST TO THE SUPERIOR MARGIN (0.4 CM). F. FIBROSIS, SUGGESTIVE OF PRIOR BIOPSY. G. FIBROCYSTIC CHANGES. H. TUMOR PREVIOUSLY REPORTED TO BE POSITIVE FOR ER AND PR, AND NEGATIVE FOR HER-2 BY FISH. I. PATHOLOGIC STAGE: pT2 pNO pMX. PART 2: LEFT AXILLARY NON-SENTINEL LYMPH NODE, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR MALIGNANCY (0/1). PART 3: LEFT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR MALIGNANCY (0/1). PART 4: LEFT AXILLARY SENTINEL LYMPH NODE #2, BIOPSY -. TWO LYMPH NODES, NEGATIVE FOR MALIGNANCY (0/2). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Clock position:2 oclock. SIZE OF TUMOR: Maximum dimension invasive component: 40 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 2. Total Nottingham score: 8. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. Solid. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 4 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pNO. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, previously performed, H-score: 255. PROGESTERONE RECEPTORS: positive, previously performed, H-score: 265. HER2/NEU: 2+. HER2/NEU (FISH): Not amplified."
BIOCUP_00170,breast,BRCA,TCGA-AR-A251,TCGA-AR-A251.F5B17108-8904-48E7-9B3D-182F0EA388B7,"Final Diagnosis. Yeast, left/wide local excision: Infiltrating ductal carcinoma, Nottingham grade III (of III), forming a 2.7 x 2.4 x 2.0 cm bilobed. mass. [AJCC pT2]. Extensive ductal carcinoma in situ, high nuclear grade, present within (>25%) and outside the invasive. component. Angiolymphatic invasion is present. The non-neoplastic breast parenchyma shows proliferative fibrocystic changes. Calcifications present in malignant ducts. Biopsy site changes present. The tumor does not involve overlying skin. The. medial/inferior margin is positive for ductal carcinoma in-situ. Left breast, new inferomedial margin, re-excision: Focally positive for ductal carcinoma in- situ. Left breast, new deep margin, re-excision: Negative for tumor. Lymph nodes, left axillary, dissection: Multiple (3 of 7) left axillary lymph nodes are positive for metastatic carcinoma. The. largest metastatic focus measures 2.2 x 1.9 x 1.5 cm. Extranodal extension is present. Lymph nodes, additional left axillary, excision: A single (of 3) left axillary lymph node is positive for metastatic carcinoma. [Total 4 positive lymph nodes; AJCCpN2]. Breast, left, total mastectomy: No residual carcinoma identified. Biopsy site changes are present in the outer quadrant. The. adjacent breast parenchyma shows proliferative fibrocystic changes. Surgical margins are negative for tumor. The nipple is. without diagnostic abnormality."
BIOCUP_00171,breast,BRCA,TCGA-A8-A09Q,TCGA-A8-A09Q.46C0AB7B-82FC-4D06-9F26-22AEC8BEEDA7,"Diagnosis: 1. Poorly differentiated ductal breast carcinoma (maximum diameter 4.5 cm, malignancy. grade III) with widespread tumor infiltration of the skin also with ulceration of the skin, along. with invasion of the lymph vessels and infiltration of the neural sheaths. Remainder of. glandular body fibrolipomatous and in advanced involution, also with cystic duct ectasia. No. calcification. No evidence of DCIS. At the site of the nodular formation already macroscopically documented in the region of the. cranial resection line (skin) cutaneous/subcutaneous tumor infiltrates, also with invasion of. the lymph vessels here. Other safety margins free of atypia. Tumor classification: pT4b pN2 (at least, see conglomerate tumors), MX, R1 (see cranial. resection line, axillary soft tissue!), G3 (L1, V0)."
BIOCUP_00172,breast,BRCA,TCGA-A8-A07J,TCGA-A8-A07J.2243F29C-191C-4D33-8483-09BB3AD36598,"Diagnosis: 1. Breast segment with a bifocal invasive ductal carcinoma (G II; tumor diameter: 3. cm and 0.8 cm) with focal intraductal components. Tumor classification: NOS, G II, pT2(m) pN1a(1/18)LOV0R0."
BIOCUP_00173,breast,BRCA,TCGA-BH-A28Q,TCGA-BH-A28Q.9D040C65-C225-4D41-BA4C-6BB21EC1CD32,"PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/POST-OP DIAGNOSIS: invasive ductal carcinoma right breast, positive fymph nodes, left. preventative mastectomy. LMP DATE: PROCEDURE: right modified radicat mestectomy, left total mastectomy. SPECIFIC CLINICAL QUESTION: Not provided. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY: No. OTHER DISEASES: No. FINAL DIAGNOSIS: PART 1: BREAST, RIGHT, MASTECTOMY -. A. INVASIVE LOBULAR CARCINOMA, CLASSICAL TYPE. B. NOTTINGHAM GRADE 2 (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM: 2, MITOTIC ACTIVITY: 1;. TOTAL SCORE: 6/9). C. THE INVASIVE TUMOR MEASURES 4.0 CM IN LARGEST DIMENSION. D. LOBULAR CARCINOMA IN SITU (LCIS) is ALSO IDENTIFIED. E. LYMPHOVASCULAR SPACE INVASION is IDENTIFIED. F. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. G. INVASIVE CARCINOMA is 1.0 CM FROM THE NEAREST (POSTERIOR) MARGIN. H. THE INVASIVE CARCINOMA IS LOCATED AT THE JUNCTION OF. UPPER OUTER QUADRANT AND LOWER. OUTER QUADRANT. I. NIPPLE IS NEGATIVE FOR TUMOR. J. SKIN is NEGATIVE FOR TUMOR. K. NON-NEOPLASTIC BREAST SHOWS SCLEROSING ADENOSIS, FIBROADENOMA, FIBROCYSTIC CHANGES,. COLUMNAR CELL CHANGES AND PSEUDOANGIOMIATOUS STROMAL HYPERPLASIA. PREVIOUS BIOPSY SITE CHANGES. M. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN RECEPTOR (H-ecore 270), POSITIVE FOR. PROGESTERONE RECEPTOR (H-ecore 270) ANO NEGATIVE FOR HER-2, AS PER THE PREVIOUS. PART 2: BREAST, LEFT, TOTAL MASTECTOMY . A. FIBROADENOMA. B. COLUMNAR CELL CHANGES. c. FIBROCYSTIC CHANGES. D. PSEUDOANGIOMATOUS STROMAL HYPERPLASIA. E. PRIOR BIOPSY SITE CHANGES. F. UNREMARKABLE NIPPLE AND SKIN. PART 3: LYMPH NODES, RIGHT AXILLA, DISSECTION- -. A. METASTATIC CARCINOMA INVOLVES TWO OF EIGHTEEN LYMPH NODES (2/18). B. THE LARGEST METASTATIC FOCUS MEASURES 1.6 CM. c. NO EXTRACAPSULAR EXTENSION is IDENTIFIED. CASE SYNOPSIS: SYNOPTIC PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Upper outer quadrant. Lower outer quadrant. SIZE OF TUMOR: Maximum dimension invesive component: 40 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): infiltrating lobular carcinoma. HISTOLOGIC TYPE: Classical. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: LCIS. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 10 mm. PAGETS DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 2. LYMPH NODES EXANINED: 18. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 16 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: Fibroadenoma, FCD. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pN1a. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, H-score: 270. PROGESTERONE RECEPTORS: positive, H-score: 270. HER2/NEU;. 1+."
BIOCUP_00174,breast,BRCA,TCGA-A8-A086,TCGA-A8-A086.D4E86E20-B75E-4CDA-83F2-22C481D4B9E8,"Diagnosis: 1. Moderately differentiated invasive ductal carcinoma (tumor diameter: 1.9 cm) with. focal intraductal components. Together with the preliminary finding, this gives rise to the following tumor. classification: NOS, G II, pT1cN1aL1V0R0."
BIOCUP_00175,breast,BRCA,TCGA-E2-A14P,TCGA-E2-A14P.FD8CDFD9-6DCF-4CE1-9BB1-A7FF568EE53C,"SPECIMENS: A. RIGHT AXILLARY CONTENTS. B. RIGHT BREAST LUMPECTOMY. C. RIGHT BREAST SUPERIOR MARGIN. SPECIMEN(S): A. RIGHT AXILLARY CONTENTS. B. RIGHT BREAST LUMPECTOMY. C. RIGHT BREAST SUPERIOR MARGIN. INTRAOPERATIVE CONSULTATION DIAGNOSIS: B. Right breast, lumpectomy (Gross examination only): 3.0 cm firm tumor, 1.5 cm from deep margin. Satellite tumor. 1 cm from main tumor, 1 cm in diameter (1.0 cm from antero medial margin). By Dr. called to Dr. at. GROSS DESCRIPTION: A. RIGHT AXILLARY CONTENTS. Received in formalin in a container labeled with the patient name designated ""a. right axillary contents"" is a portion of. red-yellow firm adipose tissue measuring 10.1 x 8.5 x 3.7 cm. Multiple firm enlarged lymph nodes are identified,. ranging in size from 0.3 x 0.2 x 0.2 up to 3.5 x 2.5 x 2.0 cm. Cassettes are submitted as follows: A1-A2: representative sections, 1 lymph node. A3-A5: 1 lymph node. A6-A8: 1 lymph node. A9-A10: 1 bisected lymph node. A11: 1 bisected lymph node. A12: 4 lymph nodes. A13: 3 lymph nodes. A14: 3 lymph nodes. A15: 2 lymph nodes. A16: 3 lymph nodes. A17: 3 lymph nodes. A18-A20: additional possible lymph nodes. B. RIGHT BREAST LUMPECTOMY. Received fresh is an oriented 226 gm lumpectomy specimen, 15 x 10 x 4 cm. The specimen is partially surfaced. with a tan-pink ellipse of skin, 11.5 x 5.5 cm. The skin surface is grossly unremarkable. The specimen is inked as. follows: anterior-blue, posterior-black, superior-red, inferior-orange, medial-green, lateral-yellow. Specimen is. serially sectioned from superior to inferior into 6 slices; slice 1 being most superior, slice 6 being most inferior to. reveal a gray-white firm well circumscribed mass, 3.0 x 2.5 x 1.7 cm located in slice 2 and 3. Mass #1 measures 1.5. cm from the closest deep margin and 2.0 cm from the anterior margin. A 2nd possible satellite nodule is identified,. 0.8 x 0.7 x 0.6 cm, 0.6 cm medial to mass #1 located in slice 2. The 2nd mass measures <1.0 cm from all margins. The 2nd mass measures 0.6 cm from the medial margin. Mass #2 measures 0.6 cm from mass #1. The remaining. cut surface reveal predominantly yellow lobulated adipose tissue inter dispersed with gray-white fibrous tissue. A. portion of the specimen is submitted for tissue procurement and representative sections are submitted as follows: B1: area immediately adjacent to mass #1 slice 1. B2: perpendicular sections of the superior margin slice 1. B3: lateral margin slice 2. B4: posterior margin slice 2. B5: mass #1 slice 2. B6-B7: mass #1, bisected slice 2. B8-B9: #2, bisected slice 2. B10: medial margin slice 2. B11: skin slice 2. B12: lateral margin slice 3. B13-B14: mass #2 slice 3. B15: area immediately adjacent to mass #2 slice 3. B16: medial margin slice 3. B17: skin slice 3. B18: posterior margin slice 3. B19: area immediately adjacent to mass #1 slice 4. B20: medial margin slice 4. B21: medial and posterior margin slice 5. B22: lateral margin slice 5. B23: perpendicular section taken of the inferior margin slice 6 as per attached diagram. B24: posterior margin. B25: superior margin. C. RIGHT BREAST SUPERIOR MARGIN. Received in formalin is a 12 gm oriented fragment of fibrofatty tissue, 9.0 x 3.0 x 1.5 cm. The new true margin is. inked blue and the specimen is serially sectioned to reveal grossly unremarkable breast parenchyma. Entirely. submitted in cassettes C1-C10. DIAGNOSIS: A. AXILLARY CONTENTS, RIGHT, DISSECTION: - METASTATIC CARCINOMA TO 10 OF 24 LYMPH NODES WITH. EXTRANODAL EXTENSION, LARGEST METASTASIS IS 3.5 CM (10/24). B. BREAST, RIGHT, LUMPECTOMY: - INVASIVE DUCTAL CARCINOMA WITH SATELLITE NODULE. - SBR GRADE 3. - TUMOR MEASURES 3 CM AND 1.1 CM. - MARGINS, NEGATIVE FOR CARCINOMA. - LYMPHOVASCULAR INVASION IS PRESENT. - DUCTAL CARCINOMA IN SITU (DCIS), SOLID AND CRIBRIFORM TYPES,. NUCLEAR GRADE 3, WITH COMEDO NECROSIS, MINOR COMPONENT. - SKIN, NEGATIVE FOR CARCINOMA. C. BREAST, RIGHT, SUPERIOR MARGIN, EXCISION: - BREAST TISSUE, NEGATIVE FOR CARCINOMA. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Right. Invasive tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3cm. Tumor site: Upper outer quadrant. Margins: Negative. Distance from closest margin: Greater than 1cm. all margins. Tubular score: 3. Nuclear grade: 3. Mitotic score: 2. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: Present. Lobular neoplasia: None. Lymph nodes: Axillary dissection. Lymph node status: Positive 10 /24 Extranodal extension. DCIS present. Margins uninvolved by DCIS: 0.4 cm from medial margin, focal. DCIS Quantity: Estimate 10%. DCIS type: Solid. Cribriform. DCIS location: Both associated and separate from invasive tumor mass. Nuclear grade: High. Necrosis: Present. ER/PR/HER2 Results. Performed on Case: ER: Negative. PR: Negative. HER2: Positive by IHC. Pathological staging (pTN): pT 2N3. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: B14. ER: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score. 0. PR: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score 0. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the proportion score (0. = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of cells staining, 4 = 31-60% of. cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak intensity of staining, 2 = intermediate. intensity of staining, 3 = strong intensity of staining), with a scoring range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score of less than or. equal to 2. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin. -) for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Mouse anti-human ER and. PR,. Comment: This assay Car; be used to select invasive breast cancer patients for hormone therapy (1). ER and PR analysis was performed on this case by immunohistochemistry utilizing the ER (ER 1D5, 1:100) and PR. (PGR 136, 1:100) antibody provided by Dako, following the manufacturer's instructions listed in the package insert. This assay was not modified, and adherence to all instruction and guidelines were strictly followed. Interpretation of. the ER/PR immunohistochemical staining characteristics is guided by published results in the medical literature (1),. information provided by the reagent manufacturer and by internal review of staining performance within the. Pathology Department. 1. Harvey JM, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for. predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 17:1474-1481, 1999. SYNOPTIC REPORT - BREAST HER-2 RESULTS. HER2 Status Results, Immunohistochemistry Evaluation. Specimen: Surgical Excision. Block Number: B14. Interpretation: POSITIVE. Intensity: 3+. % Tumor Staining: 100%. Fish Ordered: No. METHODOLOGY. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin. for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Rabbit anti-human HER2,. HerceptestTM (FDA-approved test kit),. ). Control Slides Examined: External kit-slides. provided by manufacturer (cell lines with mign, low and regative HER2 protein expression), and in-house known. HER2 amplified control tissue were evaluated along with the test tissue. These control slides run along side of this. patient's sample showed appropriate staining. Adequacy of Specimen: Adequate, well preserved, clear-cut invasive. carcinoma identified for HER2 evaluation. Scoring Criterion and Scoring System: IHC Level of Expression(Score) /Tumor Cell Membrane Staining Pattern. Negative (0)/Absence of Staining. Negative (1+)/Faint Incomplete membrane Staining, >10% of Cells. Equivocal (2+)/Weak complete membrane Staining, >10% of Cells. Positive (3+)/Strong complete membrane Staining, >10% of Cells. Equivocal Category for HER2 IHC results: A HER2, 2+ staining result that is interpreted as equivocal may not. indicate gene amplification. A FISH test for HER2 gene amplification will be ordered for all HER2 IHC 2+ results. COMMENT. This assay can be used to select invasive breast cancer patients for Trastuzumab (Hereptin) therapy (1,2). Clinical. Trials have shown that Trastuzumab substantially increases the likelihood for an objective response and overall. survival for patients with metastatic HER2-positive breast cancer, regardless of whether HER2 tumor status was. determined as IHC 3+ or FISH positive. Trastuzumab added to adjuvant chemotherapy substantially increase. disease-free survival and decreases the risk of disease recurrence by about 50% for patients with early-stage HER2. protein over-expressed or gene amplified invasive breast cancer (3). HER2 analysis was performed on this case by immunohistochemistry utilizing the FDA approved Dako HercepTest. (TM) test kit following the manufacturer's instructions listed in the package insert. This assay was not modified, and. adherence to all instruction and guidelines were strictly followed. Interpretation of the HER2 immunohistochemical. staining characteristics is guided by published results in the medical literature (4), information provided by the. reagent manufacturer and by internal review of staining performance within the Pathology Department. HER2 TEST VALIDATION. This HER2 immunohistochemical assay has been validated according to the recently revised recommendations and. guidelines from the NCCN HER2 testing in Breast Cancer Task Force, and the jointly issued recommendations and. guidelines from ASCO and the CAP (5). 80 randomly selected breast cancer samples were tested for HER2 by IHC. as outline above and interpreted as, negative (score 0/1+) equivocal (score 2+) and positive (score 3+) without. knowledge of the previous reported results. These cases were also blindly read using two different FISH assay as amplified or non-amplified and. the. HER2/CEP17 ratios were recorded. After analyzing these results, there was 100% concordance between the IHC. and FISH results for cases that were interpreted as either positive or negative by IHC. 9 of the 80 cases were. interpreted as equivocal by IHC and of these 3/9 (33%) were non-amplified by FISH and 6/9 (66%) were found to be. amplified. The Pathology Department Immunohistochemistry laboratory takes full responsibility for this tests performance. and has programs in place to regularly monitor the proficiency and the interpretation of HER2 assays. The. laboratory also participates in external quality assurance HER2 programs including the CAP proficiency testing. program. REFERENCE. 1. Carlson RW, Anderson BO, Burstein HJ, et al., NCCN breast cancer clinical practice guidelines in oncology. J. Natl Compr Canc Netw. 2005;3:238-289. 2. Carlson RW, Brown E, Burstein HJ, et al., NCCN Task Force Report: adjuvant therapy for breast cancer. J Nati. Compr Canc Netw. 2006;4:S1-S26. 3. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive. breast cancer. N Eng J Med 2005;353(16):1673-84. 4. Leong ASY, Formby M, Haffajee Z, et al. Refinement of immunohistologic parameters for Her2/neu scoring. validation by FISH and CISH. Appl Immunohistochem Mol Morphol. 2006;14:384-389. 5. Wolff AC, Hammond EH, Schwartz JN, et al., American Society of Clinical Oncology/College of American. Pathologists Guideline Recommendations for Human Epidermal Growth Factor Recepto 2 Testing in Breast Cancer. Arch of Path and Lab Med 2007; 131:18-43. CLINICAL HISTORY: year old female with large right breast mass and satellite lesion (1 cm) anterior to main tumor. Now for. lumpectomy. PRE-OPERATIVE DIAGNOSIS: None given. Microscopia/Diagnostic Dictation: Pathologist,. Microscopic/Diagnostic Dictation: Pathologisi. Final Review: Pathologist,. Final: Pathologist,."
BIOCUP_00176,breast,BRCA,TCGA-A2-A04V,TCGA-A2-A04V.7D84A145-19AF-48D0-A5D9-F5724068CB26,"Specimen #: Race: WHITE. SPECIMEN: A: RIGHT BREAST B : ADDITIONAL RIGHT BREAST TISSUE. C: MUSCLE, LEFT BREAST, DEEP D: LEFT BREAST. E: ADDITIONAL LEFT BREAST TISSUE. F: RIGHT AXILLARY SENTINEL LYMPH NODE. G: RIGHT AXILLARY SENTINEL LYMPH NODE. H: ADDITIONAL LEFT BREAST TISSUE, INFRAMAMMARY CREASE. I: LEFT AXILLARY SENTINEL LYMPH NODE. J: LEFT AXILLARY SENTINEL LYMPH NODE #2. FINAL DIAGNOSIS: A. BREAST, RIGHT, MASTECTOMY: - INFILTRATING DUCTAL CARCINOMA, GRADE II (3 FOR TUBULE FORMATION, 2. FOR PLEOMORPHISM, 1 FOR MITOSES = 6). - TUMOR MEASURES 2.2 X 2.0 X 1.5 CM (GROSS). - MARGINS NEGATIVE FOR TUMOR (APPROACHES 2.0 CM FROM DEEP MARGIN). - NO DUCTAL CARCINOMA IN SITU IDENTIFIED. - NO LYMPHVASCULAR INVASION IDENTIFIED. - USUAL DUCTAL HYPERPLASIA (A11). - BIOPSY SITE CHANGES. - UNREMARKABLE SKIN AND NIPPLE. - AJCC STAGE pT2NOMX. B. BREAST, RIGHT, EXCISION: - UNREMARKABLE FIBROADIPOSE TISSUE. - NO EVIDENCE OF MALIGNANCY. C. SOFT TISSUE, DEEP LEFT BREAST, EXCISION: - UNREMARKABLE SKELETAL MUSCLE AND MATURE ADIPOSE TISSUE. - NO EVIDENCE OF MALIGNANCY. D. BREAST, LEFT, MASTECTOMY: - INFILTRATING DUCTAL CARCINOMA, GRADE II (3 FOR TUBULE FORMATION, 2. FOR PLEOMORPHISM, 1 FOR MITOSES = 6) WITH ASSOCIATED NECROSIS. - TUMOR MEASURES 2.2 x 1.8 x 1.8 CM (GROSS) . - TUMOR ABUTS THE DEEP MARGIN WITHOUT DEFINITIVE INVOLVEMENT (D4). - FOCAL ASSOCIATED DUCTAL CARCINOMA IN SITU, SOLID TYPE (D6 AND D7). - FOCAL VASCULAR INVASION (D6). - BIOPSY SITE CHANGES. specimen #: FINAL DIAGNOSIS (continued) : - UNREMARKABLE SKIN AND NIPPLE. - AJCC STAGE pT2NOMX. E. BREAST, LEFT, EXCISION: - UNREMARKABLE FIBROADIPOSE TISSUE. F. LYMPH NODE, RIGHT AXILLARY, EXCISION: - NO EVIDENCE OF MALIGNANCY BY HEMATOXYLIN AND EOSIN AND IMMUNO- -. HISTOCHEMICAL STAINS (0/1). G. LYMPH NODE, RIGHT AXILLARY, EXCISION: - NO EVIDENCE OF MALIGNANCY BY HEMATOXYLIN AND EOSIN AND IMMUNO-. HISTOCHEMICAL STAINS (0/5). H. SOFT TISSUE, LEFT INFRAMAMMARY CREASE, EXCISION: - BENIGN BREAST TISSUE. I. LYMPH NODE, LEFT AXILLA, EXCISION: - NO EVIDENCE OF MALIGNANCY BY HEMATOXYLIN AND EOSIN AND IMMUNO-. HISTOCHEMICAL STAINS (0/2). J. LYMPH NODE, LEFT AXILLA, EXCISION: - NO EVIDENCE OF MALIGNANCY BY HEMATOXYLIN AND EOSIN AND IMMUNO- -. HISTOCHEMICAL STAINS (0/1). CLINICAL DIAGNOSIS AND HISTORY: white female with synchronous bilateral infiltrating. breast carcinoma. FROZEN SECTION DIAGNOSIS: C. SPECIMEN TYPE: CHEST WALL. REPORTED TO: DR. REPORTED BY: DR. # BLOCKS : 2. Specimen #: FROZEN SECTION DIAGNOSIS (continued) : # SCRAPE PREPS 0. FROZEN SECTION DIAGNOSIS: - -NEGATIVE FOR TUMOR BASED ON TISSUE SUBMITTED. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated ""RIGHT BREAST"" is a 980 gram simple mastectomy specimen. measuring 23.5 cm superior to inferior, 18.0 cm medial to lateral, and 5.1. cm anterior to posterior. The overyling ellipse of nipple bearing skin. measures 7.4 x 3.8 cm, and is without gross abnormalities. Ink code. blue=superior/anterior, green=inferior/anterior, and black=posterior. Sectioning reveals a 2.2 x 2.0 x 1.5 cm stellate tumor with a tan, gritty,. and focally hemorrhagic cut surface in the lower outer quadrant, 2.0 cm. from the deep margin, and 2.5 cm from the inferior/anterior margin. The. remaining tissue is mostly fatty with interspersed lengths of soft, white,. parenchyma. Multiple tissue sections are submitted for CBCP protocol. with. matching paraffin sections in cassette A1, A2, A3, and A7. Slide key: A1: Skin. A2: Tumor. A3: Tumor. A4-A6: Margins nearest tumor. A7: Fibrosis (central). A8: Nipple. A9: Upper inner quadrant. A10: Lower inner quadrant. All: Lower outer quadrant. A12: Upper outer quadrant. 12CF. B. Received in formalin, labeled with the patient's name,. designated 'ADDITIONAL RIGHT BREAST TISSUE"" are two fragments of. can-yellow, fibrofatty, non-oriented, soft tissue. The larger measures. 11.0 x 9.5 x 3.5 cm. The smaller measures 7.5 x 7.0 x 3.8 cm. The outer. portion of both specimens is inked entirely in black. Sectioning reveals. a uniform, glistening, yellow, lobular cut surface admixed with a scant. portion of white, fibrous appearing connective tissue. Representative. sections are submitted. Specimen #: GROSS DESCRIPTION (continued) : Slide key : B1-B6: - Random sections of larger fragment. B7-B10 Random sections of smaller fragment. 10CF. C. Received fresh for intraoperative consultation, labeled with the. patient's I designated ""ADDITIONAL CHEST WALL DEEP AT. SITE OF TUMOR, LEFT BREAST SHORT SUPERIOR, LONG LATERAL DOUBLE DEEP"" is a. 7.5 x 3.5 x 0.8 cm fragment of red-brown, soft tissue. The surface. appears to be muscle grossly. Sectioning reveals a white, fibrous. appearing band 0.3 cm thick, running the length of the center of the. specimen parallel to the deep margin. The specimen is inked deep in. black, superior in yellow, and inferior in green. The specimen is. entirely submitted lateral to medial. Slide key. C1: Inferior portion of section 1.0 cm from the lateral margin contiguous. with C5. C2: Inferior portion of section submitted for frozen contiguous with C10. 14CF. D. Received fresh, labeled with the patient's name,. designated ""LEFT BREAST"" is a 984 gram simple mastectomy specimen. The. specimen measures 26.0 cm superior to inferior, 18.0 cm medial to lateral,. and 5.8 cm anterior to posterior. The overlying ellipse of nipple bearing. skin measures 7.2 x 3.5 cm, and is notable for an inverted nipple. Ink. code: blue=superior/anterior, green=inferior/anterior, and. black=posterior. Sectioning reveals a 2.2 x 1.8 x 1.8 cm tumor with. stellate margins, and tan, gritty, hemorrhagic cut surface in the lower. outer quadrant abutting the deep margin. The remaining tissue is mostly. fatty with interspersed widths of soft, white parenchyma. Multiple tissue. sections are submitted for CBCP protocol with matching paraffin sections. in cassettes D1, D4, and D5. Slide key: D1: Skin (medial tip) . D2-D4: Tumor with margin. D5: : Fibrous, upper outer quadrant, 5.0 cm from tumor. D6-D8: Remaining lateral portion of tumor including deep black inked. margin. D9: Two sections of nipple. Specimen #: GROSS DESCRIPTION (continued) : D10: Upper outer quadrant. D11: Lower outer quadrant. D12: Lower inner quadrant. D13: Upper inner quadrant. 13CF. E. Received in formalin, labeled with the patient's name,. designated ""ADDITIONAL LEFT BREAST TISSUE"" is an unoriented,. yellow-tan,. fibrofatty fragment measuring 8.3 x 6.5 x 3.5 cm. The entire outer. portion of the specimen is inked in black. Sectioning reveals a uniform,. can-yellow, glistening, lobular, cut surface admixed with widths of soft,. white, parenchyma. Representative sections are submitted. 4C6. F. Received fresh, labeled with the patient's name,. designated ""RIGHT AXILLARY SENTINEL LYMPH NODE"" is a 1.9 x 1.4 x 1.2 cm. lymph node with adherent fat. Half of the node is submitted for the CBCP. protocol. The remaining half is submitted for paraffin sections. 1C1. G. Received fresh, labeled with the patient's name,. designated ""RIGHT AXILLARY SENTINEL LYMPH NODE #2"" is a 1.4 x 1.3 x 0.8 cm. lymph node with adherent fat. Half of the node is submitted for the CBCP. protocol. The remaining half is submitted for paraffin section in G1. The remaining fatty tissue is bisected, and entirely submitted in. cassettes G2 and G3. 3CF. H. Received in formalin, labeled with the patient's name,. designated ""ADDITIONAL LEFT BREAST TISSUE, INFRAMAMMARY CREASE"" is a 9.5 x. 7. x 4.5 cm fragment of tan-yellow, glistening, fibrofatty, lobulated,. soft tissue. The specimen arrives unoriented. The entire outer portion. is inked in black. Sectioning reveals a smooth, glistening, lobulated,. fibrofatty, yellow-tan, cut surface admixed with widths of soft, white. parenchyma. Representative sections are submitted. 8CF. I. Received fresh, labeled with the patient's name,. designated ""LEFT AXILLARY SENTINEL LYMPH NODE"" are two lymph nodes with. adherent fat measuring 2.2 and 2.0 cm in greatest dimension. Half of the. larger node is submitted for the CBCP protocol. The remaining half is. submitted for paraffin section in cassette Il. The smaller node is in. cassette I2. The remaining fatty tissue is submitted in cassettes I3. through I6. 6CF. J. Received in formalin, labeled with the patient's name,. designated ""LEFT AXILLARY SENTINEL LYMPH NODE #2"" is a 3.2 x 2.0 x 1.2 cm. Specimen #: GROSS DESCRIPTION (continued) : yellow-tan fragment of fibrofatty, soft tissue. Within the soft tissue. there is a single identifiable lymph node measuring 0.9 cm in greatest. dimension. The node is submitted in J1. The remainder of fibrofatty,. soft tissue is submitted in J2. 2C2."
BIOCUP_00177,breast,BRCA,TCGA-BH-A0H3,TCGA-BH-A0H3.6D3F79A6-C55C-497F-9CCD-1C6D3ACE7492,"FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEFT AXILLA, SENTINEL NUMBER 1 -. ONE LYMPH NODE, FREE OF METASTATIC CARCINOMA (0/1). PART 2: LYMPH NODE, LEFT AXILLA, SENTINEL NUMBER 2 -. ONE LYMPH NODE, FREE OF METASTATIC CARCINOMA (0/1). PART 3: BREAST. LEFL, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA WITH TUBULAR AND INVASIVE CRIBRIFORM FEATURES. B. NOTTINGHAM GRADEY (TUBULE FORMATION 1, NUCLEAR PLEOMORPHISM 2, MITOTIC ACTIVITY 1,. TOTAL SCORE 4/9). C. THE INVASIVE TUMOR MEASURES 1.6 CM IN GREATEST DIMENSION. D. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 2, CRIBRIFORM AND MICROPAPILLARY TYPES. DCIS CONSTITUTES 20% OF THE TOTAL TUMOR MASS AND IS PRESENT ADMIXED AND ADJACENT TO. THE INVASIVE COMPONENT. E. NO LYMPHOVASCULAR SPACE INVASION IS NOTED. F. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. G. INVASIVE DUCTAL CARCINOMA IS PRESENT 3.0 MM FROM THE POSTERIOR (CLOSEST) MARGIN; ALL. OTHER MARGINS ARE GREATER THAN 0.5 CM AWAY FROM INVASIVE CARCINOMA. H. DUCTAL CARCINOMA IN SITU IS PRESENT 4.0 MM FROM THE POSTERIOR (CLOSEST) MARGIN; ALL. OTHER MARGINS ARE GREATER THAN 0.5 CM AWAY FROM IN SITU CARCINOMA. I. ATYPICAL DUCTAL HYPERPLASIA. J. SCLEROSING ADENOSIS AND FIBROCYSTIC CHANGES. K. PREVIOUS BIOPSY SITE CHANGES. L. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN RECEPTOR AND PROGESTERONE. RECEPTOR AND NEGATIVE FOR HER-2/NEU (FISH NONAMPLIFIED) AS PER PREVIOUS PATHOLOGY. CASE STNUPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.6 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Other Type(s): IDC with tubular and cribriform features. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 1. Mitotic activity score: 1. Total Nottingham score: 4. Nottingham grade (1, 2, 3): 1. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. Micropapillary. Percent of tumor occupied by in situ component: 20 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 3 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 2. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. NON-NEOPLASTIC BREAST TISSUE: ADH, FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+."
BIOCUP_00178,breast,BRCA,TCGA-E2-A156,TCGA-E2-A156.EF28484E-82C7-4988-A6E0-DDDA555652EA,"SPECIMENS: A. SENTINEL LYMPH NODE #1, LEFT AXILLA. B. SENTINEL LYMPH NODE #2, LEFT AXILLA. C. NON-SENTINEL LYMPH NODE LEFT AXILLA. D. WIDE EXCISION LEFT BREAST MASS. E. ADDITIONAL NEW MARGIN SUPERIOR LATERAL. F. SKIN AT ANTERIOR MARGIN. SPECIMEN(S): A. SENTINEL LYMPH NODE #1, LEFT AXILLA. B. SENTINEL LYMPH NODE #2, LEFT AXILLA. C. NON-SENTINEL LYMPH NODE LEFT AXILLA. D. WIDE EXCISION LEFT BREAST MASS. E. ADDITIONAL NEW MARGIN SUPERIOR LATERAL. F. SKIN AT ANTERIOR MARGIN. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA, Sentinel lymph node #1, left axilla, excision: Negative for carcinoma. TPB, Sentinel lymph node #2, left axilla, excision: Negative for carcinoma. Part D, Left breast, excisional biopsy, gross examination: Tumor approximately 0.3-cm from the posterior margin. Diagnoses called at. f and B) and. (D) by Dr. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1, LEFT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node number one left axilla"". is. a fragment of red-tan possible lymphoid tissue measuring 1 x 0.5 x 0.3-cm. Touch preparation is performed. The. entire specimen is submitted, A1. B. SENTINEL LYMPH NODE #2, LEFT AXILLA. Received fresh labeled with the patient identification and designated ""sentinel lymph node number two left axilla"" is. fragment of red-tan possible lymphoid tissue measuring 1.3 x 0.5 x 0.2 cm. Touch preparation is performed. The. entire specimen is submitted, B1. C. NON-SENTINEL LYMPH NODE LEFT AXILLA. Received in formalin labeled with the patient's identification and designated ""Non-sentinel lymph node left axilla"" is a. fragment of adipose tissue, 2.5 x 2.4 x 0.5 cm, consisting of one possible lymph node measuring 1 x 0.5 x 0.4 cm. The lymph node is submitted, C1. D. WIDE EXCISION LEFT BREAST MASS. Received fresh labeled with the patient's identification and designated ""wide excision left breast"" is a previously. inked, oriented, 89-g, 9 x 8.4 x 2.5 cm lumpectomy specimen. The single clip designates superior, double-lateral,. triple-anterior. ink code: Anterior-yellow, posterior-black, superior-blue, inferior-orange, medial- green, lateral-red. The specimen is serially sectioned from medial to lateral into 7 slices revealing an irregular friable soft tan mass, 3 x. 2.4 x 0.9 cm, located 0.3-cm from the nearest posterior margin (Slices 3-5). A previous hemorrhagic biopsy cavity is. identified 0.6-cm from the mass (lateral), measuring 1.4 x 0.8 x 0.7 cm. A portion of the specimen is submitted for. tissue procurement. Representatively submitted: D1-D2: Representative perpendicular sections, medial margin. D3: Slice 2, posterior. D4: Slice 2, superior. D5-D11: Slice 3, entirely submitted, D8 and D10 demonstrating tumor. D12-D15: Slice 4, posterior/superior/anterior/superior, tumor. D16-D19: Slice 5, D16-D18 demonstrating biopsy cavity. D20-D21: Slice 6, superior, remainder of biopsy cavity. D22-D25: Perpendicular sections lateral margin, entirely submitted. E. ADDITIONAL NEW MARGIN SUPERIOR LATERAL. Received in formalin labeled with the patient's identification and designated ""additional new margin superior lateral"". is a previously inked, 6-g, 5.2 x 3 x 0.8 cm fragment of fibroadipose tissue. Ink code: Superior-blue, lateral-red. Sectioning shows no obvious gross abnormalities. The entire specimen is submitted, E1-E2 (superior), E3-E4. (lateral). F. SKIN AT ANTERIOR MARGIN. Received in formalin labeled with the patient's identification and designated ""skin at anterior margin"" is a slender. fragment of unoriented light beige skin measuring 2.1 x 0.6 x 0.2 cm. the entire specimen is submitted, F1. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, left AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). B. LYMPH NODE, SENTINEL #2, left AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). C. LYMPH NODE, non-SENTINEL, left AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). D. BREAST, LEFT, WIDE LOCAL EXCISION: INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, MEASURING 1.8-CM. - INTERMEDIATE NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPE WITH. CENTRAL NECROSIS AND MICROCALCIFICATIONS WITH A COMPONENT OF INTRACYSTIC PAPILLARY. CARCINOMA. - SURGICAL RESECTION MARGINS NEGATIVE FOR INVASIVE TUMOR. - MICROSCOPIC FOCUS OF LOW GRADE DUCTAL CARCINOMA IN SITU AT INFERIOR SURGICAL. RESECTION MARGIN. - BIOPSY SITE CHANGES WITH FIBROSIS AND GRANULATION TISSUE. - SEE SYNOPTIC REPORT AND SEE NOTE. e. breast, left, additional superior lateral margin, excision: - fibroadipose tissue, NO TUMOR SEEN. f. skin, anterior margin, excision: - SKIN tissue, NO TUMOR SEEN. NOTE: Ductal carcinoma is identified in 5 consecutive slices. The tumor is composed of 3 components, invasive, in. situ and intracystic. The gross measurement of the tumor is a 3-cm. The largest confluent invasive tumor measures. 1.8-cm. A microscopic focus of low-grade DCIS is identified at the inferior surgical resection margin. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.8cm. Tumor Site: Not specified. Margins: Negative. Distance from closest margin: 0.3cm. deep. Tubular Score: 2. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/3. DCIS present. Margins involved by DCIS: inferior. DCIS Quantity: Estimate 20%. DCIS Type: Solid. Cribriform. intracystic. DCIS Location:Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Present. Location of CA++: DCIS. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by IHC. Performed on Case: Pathological staging (pTN): pT 1c N 0. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Left breast mass. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 0. CLINICAL EXPERIENCE: Patients with a recurrence score of: 0 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 3%. ER Score: 11.8 Positive. PR Score: 10 Positive. Her2 Score: 9.8 Negative. Interpretation: ER Negative < 6.5 Positive >= 6.5. PR. Negative < 5.5 Positive >= 5.5. Her2 Negative <10.7 Positive >=11.5 Equivocal = 10.7 - 11.4. See separate. 1 report for further information. Microscopic/Diagnostic Dictation: Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,."
BIOCUP_00179,breast,BRCA,TCGA-A8-A08S,TCGA-A8-A08S.0D293DF8-374D-4681-9B2A-ACC98601AA25,"Diagnosis: 1. Poorly differentiated invasive ductal carcinoma (tumor diameter: 1.8 cm). Tumor classification: NOS, G III, pT1Nla(sn)LOVORO."
BIOCUP_00180,breast,BRCA,TCGA-D8-A1XK,TCGA-D8-A1XK.B3DB4F9E-C91B-4913-93E8-F18FF22CBA7C,"page 1 / 1. copy No. Examination: Histopathological examination. Gender: F. Material: 1. Multiple organ resection - left breast""with axillary tissues. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the left breast. Macroscopic description: Left breast sized 16.8 x 15.3 x 5.2 cm removed along with axillary tissues sized 10 x 6 x 5 cm and a 16.2 x 9.8 cm skin flap and a. fragment of the muscle sized 4 x 3 cm. Weight 620 g. Tumour sized 3.5 x 3 x 3 cm found in the inner upper quadrant, 1 cm from the inner boundary, 0.2 cm from the base and 0.8 cm. from the skin. Microscopic description: Carcinoma ductale invasivum - NHG3 (3+3+3/36 mitoses/10 HPF - visual area: 0.55mm'. Mamilla sine laesionibus. Glandular tissue with lesions of the type mastopathia fibrosa and cystica. Invasive lesions 0.1 cm away from the base. Axillary lymph nodes: Metastases carcinomatosae in lymphonodis (No III/XVIII). Histopathological diagnosis: Carcinoma invasivum mammae sinistrae. Invasive ductal carcinoma of the left breast. Metastases carcinomatosae in lymphonodis axillae (NHG3, pT2, pN1a). Cancer metastases in axillary lymph nodes. Compliance validated b. Results of immunohistochemical examination: No estrogen receptors found in neoplastic cell nuclei. No progesterone receptors found in neoplastic cell nuclei. HER2 protein stained with HercepTest‚Ñ¢M by DAKO. Negative reaction in invasive carcinoma cells ( Score = 0)."
BIOCUP_00181,prostate,PRAD,TCGA-CH-5764,TCGA-CH-5764.e7f4fceb-1960-44f0-8e0b-fde2337011ce,"Diagnosis. 1. Poorly differentiated bilateral adenocarcinoma of the prostate across the organ, mainly in. the peripheral zone (Gleason 4+3=7, tertiary grade 5). Gleason 4: 5%, Gleason 5: <5%. Max. tumor diameter 31 mm. Tumor infiltration of rectolateral periprostatic fatty tissue on. both sides in three successive steps (infiltration depth up to 1.5 mm, infiltration width up to. 6 mm). Bilateral infiltration of seminal vesicles. Extensive tumor involvement of perineural. sheaths. Tumor-free surgical preparation margins. Additional foci of a prostatic intraepithelial neoplasia (HGPIN) and signs of. myoglandular prostatic hyperplasia. Urothelium of prostatic urethra without dysplasia. 2. Five tumor-free lymph nodes on the right (0/5). 3. Three tumor-free lymph nodes on the left (0/3). Tumor classification. pT3b, max. tumor diameter 31 mm. Gleason 4+3=7, tertiary grade 5 (Gleason 4: 70%,. Gleason 5: <5%), R0, pNO (0/8). Remark. No further carcinoma was detected in the prior frozen section analysis. Carcinoma tissue was detected in the punch biopsies. Here, too, a Gleason 4 pattern was. predominant. Gleason 5 patterns were not observed. Follow-up report. Immunohistology: D2-40, CD31 (BR1, BR2). Additional immunohistological investigations were carried out to establish whether there was. vessel invasion. No evidence of either lymph or blood vessel invasion was detected. Final tumor classification: pT3b, maximum tumor diameter 31.0 mm, Gleason 4+3=7 tertiary grade 5 (Gleason 4: 70%,. Gleason 5: < 5%), L0, V0, R0, pN0 (0/8)."
BIOCUP_00182,prostate,PRAD,TCGA-XK-AAIR,TCGA-XK-AAIR.72784D06-D1DA-4E0C-B378-771030D57046,"!. Clinic Number: Procedure Date: Date of Birth: (Age: Gender: M. Report Signed: Final Diagnosis: A. Right external iliac lymph nodes, lymph node dissection: Four (4) benign reactive lymph nodes, negative for malignancy. B. Right obturator and internal iliac lymph nodes, lymph node dissection: Site Prostate NOS C61.9. Two (2) benign reactive lymph nodes, negative for malignancy. C. Left external iliac lymph node dissection: Two (2) benign reactive lymph nodes, negative for malignancy. D. Left obturator and internal iliac lymph node, lymph node dissection: Two (2) benign reactive lymph nodes, negative for malignancy. E. Prostate, radical prostatectomy: Prostatic adenocarcinoma, Gleason score 4+4=8. See synoptic report. Procedure: Radical prostatectomy. Histologic type: Prostatic adenocarcinoma, acinar type. Histologic grade: Primary pattern: 4, Secondary pattern: 4. Total Gleason Score: 8. Tumor quantitation and location: Tumor is present bilaterally in the apex and midprostate, and involves. approximately 35% of the sampled prostate tissue by volume. Extraprostatic extension: Not identified. Margins: Negative for carcinoma. Lymph-vascular invasion: Not identified. Perineural invasion: Present. Seminal vesicle invasion: Not identified. Treatment effect on carcinoma: Not identified. Lymph nodes: Ten (10) total lymph nodes (specimens A through D), all negative for carcinoma. Additional pathologic findings: None. Ancillary studies: Available upon request. Pathologic staging: pT2c, NO (AJCC 7th Edition). Biorepository sample (if applicable): Block E17 containing 70% tumor (Gleason 4+4=8). Block(s) containing malignancy suitable for additional testing: E8, E10. Interpreted by: Clinical Information: Prostate cancer. Specimen(s): A: :Right external iliac lymph nodes. B:Right obturator and internal iliac lymph nodes. C:Left external iliac lymph node. D:Left obturator and internal iliac lymph node. E:Prostate. Gross Description: Pathologist's Assistant. A1A2BIB2CIC2DID2E1E2E3E4ESE6E7E8E9E10E11E12E13E14E15E16E17. A. Received fresh labeled "". and ""right external iliac pelvic nodes"" is a 5.2-cm piece of fibrofatty. tissue. Within the fatty tissue are four possible lymph nodes, the largest is up to 2 cm in maximum dimension. All of. the lymph nodes are submitted in two cassettes labeled. A1) three lymph nodes; A2) one lymph node. B. Received fresh labeled. and ""right obturator and internal iliac lymph node."" Within the adipose. tissue are two lymph nodes, the largest is up to 2 cm. in maxi mun dimension. All of the lymph nodes are submitted in. cassettes labeled. B1) one lymph node, bisected; B2) one lymph node, bisected. C. Received fresh labeled "". and ""left external iliac lymph nodes"" are two pieces of adipose tissue. aggregating to 3.5 x 3 x 0.8 cm. Within the adipose tissue are two possible fatty lymph nodes. All of the tissue is. submitted in cassettes labeled. C1) one possible lymph node and fat; C2) one possible lymph node and fat. D. Received fresh labeled. and ""left obturator and internal iliac lymph nodes"" are two pieces of. adipose tissue aggregating to 3.5 x 2.5 x 1 cm. Within the adipose tissue are two lymph nodes, the largest is up to 2.2. cm. in maxi mun dimension. All of the lymph nodes are submitted in two cassettes labeled. D1) one lymph. node, bisected; D2) larger lymph node, bisected. E. Received fresh labeled. and ""prostate"". Procedure: Radical prostatectomy. Prostate size: Weight: 53 grams; Dimensions: 5 x 5 x 4.8 cm; Seminal vesicles: 1.7 x 1.5 x 0.8 cm. Gross notes: Grossly evident tumor: Yes, 0.8 x 0.8 x 0.5 cm, right mid-base. Symmetry: Asymmetrical. The right is slightly larger than the left. Gross nodular hyperplasia: Moderate. Gross capsular bulge/defect: None. Inking: left-black, right-blue. Biorepository sample collected: Yes. See block key summary. Lymph nodes: No lymph nodes present. Block key for specimen E: 1) proximal urethral margin. 2) distal urethral margin. 3) left apical margin, perpendicular. 4) right apical margin, perpendicular. 5) left bladder neck margin, perpendicular. 6) right bladder neck margin, perpendicular. 7) left apical prostate. 8) right apical prostate. 9) left mid prostate. 10) right mid prostate. 11) left mid prostate. 12) right mid prostate. 13) left base of prostate. 14) right base of prostate. 15) left seminal vesicle. 16) right seminal vesicle. Additional sections: 17) mirror image of tissue corresponding to research. Support for the diagnosis in this case may have included the use of immunohistochemisty tests that were developed and whose performance characteristics were determined by. They have not been cleared or approved by the U. S. Food and Drug Administration (FDA). The IDA has determined that such clearance or approval is. not necessary. These tests should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Impovement Amendinents of 1988 (CLIA') as. qualified to perform high complexity dinical laboratory lesting."
BIOCUP_00183,prostate,PRAD,TCGA-EJ-5502,TCGA-EJ-5502.173e45e9-e2ab-4a1d-8bcc-15374f1ae511,"PATIENT HISTORY: The patient is a. with a history of PSA value of 5.3. The patient also has a history of biopsy. this biopsy reveals: Moderately differentiated adenocarcinoma, Gleason score 3+3 = 6 in the left and right sides of. the prostate. with prostate cancer. PRE-OP DIAGNOSIS: Prostate cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Radical prostatectomy. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN THREE (3) LYMPH NODES EXAMINED. PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN EIGHT (8) LYMPH NODES EXAMINED. PART 3: PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL PROSTATECTOMY -. A. INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA, GLEASON SCORE 3 + 4 = 7. B. THE CARCINOMA INVOLVES BOTH THE RIGHT AND LEFT LOBES AND HAS A GREATEST NODULAR. DIAMETER OF 1.4 CM. C. THE CARCINOMA INVOLVES 10% OF THE EXAMINED PROSTATE VOLUME. D. THE CARCINOMA IS ORGAN CONFINED AND SHOWS NO EVIDENCE OF EXTRACAPSULAR EXTENSION. E. BILATERAL SEMINAL VESICLES ARE FREE OF CARCINOMA. F. ALL EXAMINED SURGICAL RESECTION MARGINS ARE FREE OF CARCINOMA. G. PERINEURAL INVASION IS IDENTIFIED. H. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. I. HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA IS IDENTIFIED. J. PATHOLOGIC TNM STAGE: pT2c NO MX. K. TNM HISTOLOGIC GRADE = G3. L. BENIGN PROSTATIC HYPERTROPHY AND CHRONIC MODERATELY ACTIVE PROSTATITIS ARE NOTED. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 5.3. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 3. SECONDARY GLEASON GRADE: 4. GLEASON SUM SCORE: 7. GLEASON 4/5 PERCENTAGE: 10%. WEIGHT OF PROSTATE: 41.70gm. TUMOR SIZE: Maximum dimension: 1.4 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: 5 25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes NOS. EXTRAPROSTATIC EXTENSION: PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. LYMPH NODES EXAMINED: 3. LYMPH NODES POSITIVE: 8. T STAGE, PATHOLOGIC: pT2c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated."
BIOCUP_00184,prostate,PRAD,TCGA-J4-AATZ,TCGA-J4-AATZ.369F71EC-186A-41DA-91F7-B0FD209BEC8F,"M. Date Of Birth. COPY ONLY DO NOT FILE. Source of Specimen. A. LEFT PELVIC NODE FS-. B. LEFT PELVIC NODE NFS-. C. RIGHT PELVIC NODE FS-. D. RIGHT PELVIC NODE NFS-. E. BLADDER NECK FS-. F. PROSTATE, VAS & SEMINAL VESICLES-NFS-. FINAL DIAGNOSIS: A. LEFT PELVIC NODE FS-. TWO LYMPH NODES, NO TUMOR SEEN. B. LEFT PELVIC NODE NFS-. MULTIPLE LYMPH NODE FRAGMENTS, NO TUMOR SEEN. C. RIGHT PELVIC NODE FS-. TWO LYMPH NODES, NO TUMOR SEEN. D. RIGHT PELVIC NODE NFS-. MULTIPLE LYMPH NODE FRAGMENTS, NO TUMOR SEEN. E. BLADDER NECK FS-. NO TUMOR SEEN. F. PROSTATE, VAS & SEMINAL VESICLES-NFS-. ADENOCARCINOMA OF PROSTATE WITH UNILATERAL EXTENSION INTO. EXTRAPROSTATIC SOFT TISSUE. TUMOR SITE: RIGHT APEX, RIGHT AND LEFT PERIPHERAL ZONES,. PREDOMINANTLY RIGHT-SIDED. SPECIMEN TYPE: RADICAL PROSTATECTOMY. WEIGHT: 50 GRAMS. SIZE: 4.5 x 4 x 3 CM. Prepared for. GLEASON SCORE (PRIMARY + SECONDARY PATTERN) : 4 + 5 = 9/10. TERTIARY PATTERN: NOT PRESENT. SEVERITY IN EXTENT OF TUMOR: 4 /s. (1: <5%; 2: 5-15%; 3: 15-30%; 4: 30-50%; 5: > 50% tissue. involvement). DOMINANT NODULE (AT LEAST 1 CM IN SIZE) : NOT PRESENT. TREATMENT EFFECT ON CARCINOMA: NOT IDENTIFIED. LYMPH NODE (S) INCLUDED IN ALL PARTS: NUMBER INVOLVED : 0. NUMBER EXAMINED: 4. TNM STAGE: pT3a, pNo, pMX. (Extraprostatic extension or microscopic invasion of bladder. neck). (NO: negative node; N1: positive regional node). LYMPHATIC (SMALL VESSEL) INVASION: NOT SEEN. PERINEURAL INVASION: IS PRESENT. NO TUMOR SEEN IN SEMINAL VESICLES. NO TUMOR SEEN AT MARGINS OF URETHRA AND BLADDER NECK. TUMOR IS SEEN AT INKED APICAL MARGIN, RIGHT SIDE. (Case signed. Signed Others. Frozen Section. A. LEFT PELVIC LYMPH NODES: 2 LYMPH NODES; REPRESENTATIVE. SECTIONS: NTS (0/2) . RIGHT PELVIC LYMPH NODES: 2 LYMPH NODES; REPRESENTATIVE. SECTIONS: NTS (0/2) <. BLADDER NECK: NTS. FS performed by. Prepared for. (Frozen Section Signed. Case Clinical Information. PROSTATE CA. Gross Description. A. Received in formalin labeled with the patient's name and. left pelvic node FS consists of two gray-tan FS tissue. fragments. The larger measures 2.2 x 0.7 cm and the smaller. measures 1 x 0.7 cm. Submitted complete in A1. B. Received in formalin labeled with the patient's name and. ""left pelvic node NFS"" is an aggregate of yellow, fibrofatty. tissue fragments measuring 3.5 x 3 cm. The fat is trimmed and. two probable lymph nodes are grossly identified. The larger. measures 1 x 0.5 cm. The smaller measures 0.5 x 0.5 cm. The. remainder of the specimen is submitted complete in B2-B5. C. Received in formalin labeled with the patient's name and. ""right pelvic nodes FS"" are two gray-tan FS tissue fragments. The larger measures 2 x 0.7 cm. The smaller measures 1.5 x 0.2. cm. Submitted complete in C1. D. Received in formalin labeled with the patient's name and. ""right pelvic node NFS"" is an aggregate of yellow, fibrofatty. tissue fragments measuring 3 x 3 cm. The fat is trimmed, and. five probable lymph nodes are grossly identified. The largest. measures 2 x 0.7 cm. The smallest measures 0.3 x 0.2 cm. Submitted complete in D1 and D2. E. Received in formalin labeled with the patient's name and. ""bladder neck FS"" is a gray-tan FS tissue fragment measuring 1.5. x 1 cm. Submitted complete in E1. F. Received in formalin labeled with the patient's name and. ""prostate, vas & seminal vesicles NFS is a radical. prostatectomy specimen which includes a 50-gram prostate gland. with attached seminal vesicles and vas deferens. The prostate. gland measures 4.5 x 4 x 3 cm and has a shaggy capsule that is. disrupted at the bladder resection margin and has been. previously inked black on the left and blue on the right. The. right seminal vesicle measures 1.5 x 1.5 cm, and the right vas. deferens measures 1 x 0.5 cm. The left seminal vesicle measures. 2.5 x 1 cm, and the left vas deferens measures 1 x 0.5 cm. Also, there is a portion of tissue between the bladder resection. margin, which measures 1 x 1 x 1 cm. The inferior prostate is. sectioned transversely, removed from the rest of the specimen,. and sectioned from anterior to posterior parallel to the plane. of the urethra. The remaining gland is serially sectioned. transversely and shows a firm, focally nodular parenchyma. The. seminal vesicles and vasa deferentia show no abnormalities. Representative sections submitted as follows: inferior prostate. Prepared for. on. to demonstrate apical margin submitted entirely anterior to. posterior in F1-F6; bladder resection margin is shaved, serially. sectioned, and submitted in F7-F8; complete section of the mid. gland anterior F9-F10; posterior F11-F12; complete section of. upper third of gland, anterior F13-F14; posterior F15-F16;. posterior gland submitted in F17-F22; right seminal vesicle and. vas deferens F23; left seminal vesicle and vas deferens F24;. tissue from between the bladder resection margin submitted in. F25. Procedure. A. AA ROUTINE H&E X1 BLOCK. H&E X1. B. AA ROUTINE H&E X1 BLOCK. 1. H&E X1. B. AA ROUTINE H&E X1 BLOCK.: 2. H&E X1. B. AA ROUTINE H&E X1 BLOCK.3. H&E X1. B. AA ROUTINE H&E X1 BLOCK.4. H&E X1. B. AA ROUTINE H&E X1 BLOCK.5. H&E X1. C. AA ROUTINE H&E X1 BLOCK. H&E X1. D. AA ROUTINE H&E X1 BLOCK. 1. H&E X1. D. AA ROUTINE H&E X1 BLOCK. 2. H&E X1. E. AA ROUTINE H&E X1 BLOCK. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 1. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 2. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 3. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 4. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 5. H&E x1. F. AA ROUTINE H&E X1 BLOCK.6. H&E X1. F. AA ROUTINE H&E X1 BLOCK.7. H&E X1. Prepared for. F. AA ROUTINE H&E X1 BLOCK. 8. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 9. H&E X1. F. AA ROUTINE H&E x1 BLOCK.10. H&E X1. F . AA ROUTINE H&E X1 BLOCK.: 11. H&E X1. F. AA ROUTINE H&E X1 BLOCK.12. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 13. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 14. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 15. H&E X1. F. AA ROUTINE H&E x1 BLOCK.: 16. H&E X1. F. AA ROUTINE H&E X1 BLOCK.17. H&E X1. F. AA ROUTINE H&E X1 BLOCK, 18. H&E X1. F. AA ROUTINE H&E x1 BLOCK. 19. H&E x1. F. AA ROUTINE H&E X1 BLOCK. 20. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 21. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 22. H&E X1. F. AA ROUTINE H&E X1 BLOCK.23. H&E X1. F. AA ROUTINE H&E x1 BLOCK. 24. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 25. H&E X1. Prepared for."
BIOCUP_00185,prostate,PRAD,TCGA-XJ-A83H,TCGA-XJ-A83H.B4E981CF-B54B-422D-9FD4-E867FAB1FAA8,"SURG PATH #: SPECIMEN CLASS: ALT ID #: SEX: M. DATE RECEIVED: DATE OF PRINTING: Material Received: A: Bladder neck (margin). B: Prostate. History: year old male with a clinical history of prostate cancer. Final Diagnosis: A. Bladder neck (margin): There is no evidence of malignancy. B. Prostate, prostatectomy: Adenocarcinoma, moderately differentiated, Gleason score 3+4=7 ( see comment). Comment: Prostate. Procedure: Prostatectomy. Histologic Type: Adenocarcinoma. Histologic Grade: Moderately well differentiated. Gleason Pattern. Primary Pattern: 3. Secondary Pattern: 4. Total Gleason Score (Primary + Secondary): 4+3. Proportion (percent) of prostate involved by tumor: 10. Tumor Multicentricity: Yes, both lobes. Extraprostatic Extension: No. Seminal Vesicle Invasion: Not involved. Margins: Margins are clear. Perineural Invasion : No. Vascular Invasion : No. Additional Pathologic Findings: Lymph Nodes: N/A. Gross Picture Taken: N/A. Pathologic Staging: pT2cNXMX. Primary Tumor (pT). Not identified. pT2: Organ confined. Date of Printing: SURG PATH #: ALT ID #: pT2a: Unilateral, involving one-half of 1 side (""lobe"") or less. pT2b: Unilateral, involving more than one-half of 1 side (""lobe"") but not both sides (""lobes""). pT2c: Bilateral disease. The pathologic stage assigned here should be regarded as provisional, as it reflects only current pathologic data and does not. incorporate full knowledge of the patient's clinical status and/or prior pathology. Attestation: By this signature, I attest that I have personally formulated the final interpretation expressed in this report and that the above diagnosis is based. upon my examination of the slides and/or other material indicated in this report. Interpreted by: MD, Attending Physician. M.D. Fellow. Gross Description: A. Received fresh labeled ""posterior bladder neck"". The specimen is submitted in cassette A1FS. B. Received in formalin labeled ""prostate"" is a prostate weighing 33grams and measuring 5 cm from superior to inferior margin,. 5.5cm from left to right margin and 3.3cm from anterior to posterior margin. The left side of prostate is inked in blue and the right. side inked black. The specimen is bisected to separate the anterior and the posterior portion and each portion is serially sectioned. from apex to the base to reveal a tan cut surface. The specimen is submitted as follow: Cassette B1: Right bladder neck margin (serially sectioned). Cassette B2: Left bladder neck margin (serially sectioned). Cassette B3: Right distal urethral margin (serially sectioned). Cassette B4: Left distal urethral margin (serially sectioned). Cassette B5: Right seminal vesicle margin. Cassette B6: Left seminal vesicle margin. Cassette B7: Representative section from right middle anterior prostate. Cassette B8: Representative section from left middle anterior prostate. Cassette B9 through B16: Entire posterior right lobe from apex to base. Cassette B17 through B24: Entire posterior left lobe from apex to base. Intraoperative Consultation: A1FS: Prostate, ""bladder neck margin"": No evidence of malignancy. MD, Attending Physician. Date of Printing:"
BIOCUP_00186,prostate,PRAD,TCGA-KK-A7AY,TCGA-KK-A7AY.BA64AA42-00AD-4DAD-ABE7-BDDC253B9B45,"(152. 1cm 69.2kg BSA: 1. .71m¬≤. MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) LEFT PELVIC LYMPH NODES: Five lymph nodes, no tumor present. (0/5). (B) RIGHT PELVIC LYMPH NODES: Three lymph nodes, no tumor present. (0/3). (C) ANTERIOR BLADDER NECK: Smooth muscle and adipose tissue consistent with bladder neck tissue, no tumor or prostatic glands present. (D) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) LEFT PELVIC LYMPH NODE - Received is adipose tissue with lymph nodes measuring 6.5 x 5 x 1.5 cm. SECTION CODE: A1, two possible lymph nodes; A2, A3, each containing one possible bisected lymph node; A4, one. possible lymph node. (B) RIGHT PELVIC LYMPH NODES - Received is adipose tissue with possible lymph nodes measuring 4.5 x 3.5 x 1.2 cm. SECTION CODE: B1, B2, each containing one possible lymph node; B3, one possible lymph node. (C). ANTERIOR BLADDER NECK TISSUE - Received are two pieces of pale-tan soft tissue measuring 2.5 x 1.7 x 0.7 cm. The. specimen is submitted into cassette C. Supplemental report to follow. (D) PROSTATE AND SEMINAL VESICLES - Supplemental report to follow. CLINICAL HISTORY. None given. SNOMED CODES. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drua Administration."". Entire report and diagnosis completed by: Start of ADDENDUM. Page: 2. (152.1cm 69.2kg BSA: 1.71m¬≤. ADDENDUM. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (D) PROSTATE AND SEMINAL VESICLES: PROSTATIC ADENOCARCINOMA, GLEASON SCORE 7 (4+3). (SEE COMMENT). TUMOR CONFINED TO THE PROSTATE. MARGINS OF RESECTION FREE OF TUMOR. Right and left seminal vesicles, no tumor present. Segments of right and left vasa deferentia, no tumor present. PERINEURAL INVASION PRESENT. No vascular/lymphatic invasion identified. PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN), HIGH-GRADE. COMMENT. The prostate gland contains a single focus of prostatic adenocarcinoma. The tumor is located in the right posterolateral, right. posterior, mid posterior, and left posterior peripheral zone. The tumor focus measures 2.5 x 0.9 cm in the largest cross-sectional. dimension, and it is present in the three cross sections of the prostate, extensively in the apex and focally in the base region. The. tumor is confined to the prostate. The margins of resection are free of tumor. GROSS DESCRIPTION. (D). PROSTATE AND SEMINAL VESICLES - A specimen consisting of a prostate, attached right and left seminal vesicles and. attached segments of right and left vasa deferentia. The. prostate gland (5.2 x 2.5 x 3.8 cm, 36 grams, post-fixation) has the usual shape. The soft tissue present along the. posterolateral aspect of the prostate is abundant and more extensive along the right side. An area of firmness is noted on the. midline. posterior surface of the prostate. Serial cross sections after fixation demonstrate an area of tumor in the mid posterior. region of the two cross sections of the prostate. The seminal vesicles and segments of vasa deferentia are grossly free of tumor. SECTION CODE: D1-D3, right seminal vesicle and segment of right vas deferens from the base towards the tip; D4, D5,. left seminal vesicle and segment of left vas deferens from the base towards the tip; D6, prostatic base right border; D7-D9,. prostatic. base. right posterior border; D10-D12, prostatic base central portion; D13, D14, prostatic base left border; D15, D16,. prostatic base left posterior border; D17, D18, apex anterior; D19, D20, apex left; D21, D22, apex posterior; D23, D24, apex right;. D25-D36, sections of the three cross sections of the prostate according to specimen radiograph. The anterior aspect of the prostate is inked in green, left surface in red, right surface in yellow and posterior surface in. black. Blue ink (D7, 8, 10-12, 19-24, 27, 28, 32 and 36) and orange ink (D31) denote surfaces that do not represent a true margin. of resection. Two blocks (D25 and 29) submitted for decalcification. SNOMED CODES. Page: 3. (152.1cm . 69.2kg BSA: 1.71m¬≤ . Entire report and diagnosis completed by: END OF REPORT-."
BIOCUP_00187,prostate,PRAD,TCGA-CH-5739,TCGA-CH-5739.6db82b14-85e4-40c4-9827-a588c4a25ce8,"Diagnosis. 1. Tumor-free preprostatic fatty tissue. 2. Six tumor-free lymph nodes on the right. 3. Two tumor-free lymph nodes on the left. 4. Predominantly moderately differentiated adenocarcinoma of the prostate with spread in the. left prostate lobe and infiltration of the left-sided perivesicular fatty tissue. Predominance in the. left rectolateral peripheral zone. Maximum tumor diameter 1.2 cm. Focal perineural tumor. spread. Tumor-free seminal vesicles and preparation margins. Remark. Tumor classification: pT3a pN0 (0/8); L0, V0, Gleason 3+4 = 7 (Gleason 4: 10%), complete local. resection."
BIOCUP_00188,prostate,PRAD,TCGA-HC-7820,TCGA-HC-7820.750c91eb-1732-4ca3-8c71-f1309a90e4f5,"FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: PROSTATE, RADICAL PROSTATECTOMY: - PROSTATE ADENOCARCINOMA, GLEASON SCORE 3+4=7. - MULTIFOCAL, LARGEST FOCUS 1.3 CM. - INVOLVES RIGHT AND LEFT PROSTATE LOBES. - NO EXTRAPROSTATIC EXTENSION IDENTIFIED. - SURGICAL MARGINS FREE OF TUMOR. PATHOLOGIC TUMOR STAGING SYNOPSIS: Type and grade: Prostatic adenocarcinoma, Gleason score 3+4=7. Primary tumor: pT2c. Regional lymph node: pNX. Distant metastasis: pMX. Pathologic stage: IIB. Perineural invasion: Not identified. Lymphovascular invasion: Not identified. Surgical margins: R0, negative. FINAL SURGICAL PATHOLOGY REPORT. Prostate (data derived from current specimen, staging in accordance with or modified from AJCC Cancer Staging. Tumor Staging Information. Handbook, 7th Ed, and CAP protocol. Radical prostatectomy. Procedure: Prostate. Specimen type: 42 grams, 5.1 X 3.4 X 3.2 cm. Prostate site/weight: TUMOR FEATURES: Right and left prostate. Tumor site: Multifocal, largest focus 1.3 cm. Tumor size: 5% of prostate. Tumor quantification: Prostatic adenocarcinoma. Histologic type: Histologic grade (Gleason pattern): 3. Primary pattern: 4. Secondary pattern: N/A. Tertiary pattern: 7. Total Gleason score: Not identified. Lymphovascular invasion: Not identified. Perineural invasion: Not identified. Extraprostatic extension: Not identified. Seminal vesicle invasion: N/A. Treatment effect: N/A. LYMPH NODES: MARGIN EVALUATION: 0.1 cm from left apex and posterior margin. Distance to closest margin: 0.2 cm from right apex. Other margins: PATHOLOGIC TUMOR STAGING DESCRIPTORS: pT2c. Primary tumor: pNX. Regional lymph node: pMX. Distant metastasis: R0, negative. Margin status: IIB. Pathologic stage: High grade prostatic intraepithelial neoplasia. Additional findings: N/A. Comment: FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: Prostatectomy. Gross Description: Specimen is designated as prostate. Initially received in the fresh state for tumor bank study is a 42 gram. radical prostatectomy, 5.1 cm apex to base, 3.4 cm across and 3.2 cm posterior-anterior. The attached. right seminal vesicle extends up to 2.7 X 1.4 X 0.5 cm, adjacent vas 1.4 X 0.4 cm: the left seminal vesicle. extends up to 3.0 X 1.4 x 0.5 cm and corresponding vas 1.9 X 0.4 cm. The prostate margin has a shaggy,. pink and tan appearance and the margins are now differentially inked as follows: posterior - black, right. body prostate - blue and remaining left body prostate green. Sectioning through the bilateral seminal. vesicles demonstrate rubbery honeycomb, pink and tan cut surface without gross tumor involvement. The. prostate is serially sectioned, apex to base, demonstrating a variegated rubbery, mildly congested, pink. and yellow-tan cut surface with circumscribed nodularity predominating the anterior half of the specimen. against the urethral tract. A suspicious focus of glistening deep yellow change is appreciated near the left. apical and posterior margins upwards of 1.0 X 0.9 X 0.8 cm. Representative portion of this suspicious. lesion is submitted for tumor bank. Further examination of the cut sections of prostate demonstrate. additional foci of suspicious yellow-orange change posterior to the urethral tract near the base, upwards of. 0.5 cm, and the origin of the right seminal vesicles demonstrates an additional 0.5 cm focus of suspicion. for malignancy. Tissue included within the container are two oriented tubular fragments of apparent vas. deferens, 2.3 X 0.5 cm and 2.5 X 0.4 cm each. Representative sections are submitted for microscopic. evaluation. Cassette summary: A1) unoriented vas deferens segments represented, A2) right and left vas margins and. seminal vesicles represented, A3-A4) right and left apex sections submitted, respectively, A5-A6) right and. left base sections submitted, respectively, A7-A11) representation of right body of prostate, apex towards. base, A12-A18) representation left body of prostate, apex towards base. Microscopic Description: Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered."
BIOCUP_00189,prostate,PRAD,TCGA-EJ-A7NF,TCGA-EJ-A7NF.1487F0B2-58BB-41C3-B23F-F51676796AA7,"FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, LYMPHADENECTOMY -. SIXTEEN LYMPH NODES, NO EVIDENCE OF METASTATIC CARCINOMA (0/16). PART 2: LYMPH NODES, LEFT PELVIC, LYMPHADENECTOMY -. THIRTEEN LYMPH NODES, NO EVIDENCE OF METASTATIC CARCINOMA (0/13). PART 3: PROSTATE, RADICAL PROSTATECTOMY -. A. INVASIVE PROSTATIC ADENOCARCINOMA, GLEASON SCORE 3 + 4 = 7. B. THE TUMOR INVOLVES\BOTH THE RIGHT AND THE LEFT LOBES-QF THE PROSTATE AND CONSTITUTES. APPROXIMATELLY 5% OF THE TOTAL TISSUE EVALUATED. C. MAXIMAL NODULAR DIMENSION OF THE CARCINOMA IS 1.0.CM. D. THE CARCINOMA IS CONFINED WITHIN THE CAPSULE OF PROSTATE. E. ALL INKED MARGINS OF RESECTION ARE FREE OF CARCINOMA. F. BILATERAL SEMINAL VESICLES, NO EVIDENCE OF CARCINOMA SEEN. G. PERINEURAL INVASION BY THE CARCINOMA IS IDENTIFIED. H. MULTIFOCAL HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) IS SEEN. I. TNM STAGE: T2c NO MX. J. HISTOLOGIC GRADE: G3 (POORLY DIFFERENTIATED). CASE SYNOPSIS: SYNOPTIC DATA . PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 4.6. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 3. SECONDARY GLEASON GRADE: 4. GLEASON SUM SCORE: 7. GLEASON 4/5 PERCENTAGE: 25%. WEIGHT OF PROSTATE: 51.8gm. TUMOR SIZE: Maximum dimension: 1.0 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: 5 -25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes - multifocal. EXTRAPROSTATIC EXTENSION: PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. RESIDUAL TUMOR: R0. LYMPH NODES EXAMINED: 29. LYMPH NODES POSITIVE: 0. T STAGE, PATHOLOGIC: pT2c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated."
BIOCUP_00190,prostate,PRAD,TCGA-EJ-5524,TCGA-EJ-5524.1f767c93-41f5-45d1-917f-3f1fc5330fb9,"The patient is a. with a history of prostatic adenocarcinoma with Gleason Score 4 + 4 = 8 on. the left side. PSA 3.76 ng/ml. Clinical TMN stage= cT2b. PRE-OP DIAGNOSIS: Prostate cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Radical retropubic prostatectomy. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN EIGHT LYMPH NODES (0/8). PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN NINE LYMPH NODES (0/9). PART 3: PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL PROSTATECTOMY -. A. INVASIVE PROSTATIC ADENOCARCINOMA, ACINAR TYPE, GLEASON SCORE 4+5=9 WITH. TERTIARY GLEASON PATTERN 3 COMPONENT. B. THE CARCINOMA INVOLVES BOTH THE RIGHT AND LEFT LOBES AND HAS A GREATEST NODULAR. DIAMETER OF 2 cm (slide 3EE). C. THE CARCINOMA INVOLVES APPROXIMATELY 15% OF THE EXAMINED PROSTATE VOLUME. D. THE CARCINOMA SHOWS EVIDENCE OF ESTABLISHED EXTRACAPSULAR EXTENSION IN THE. RIGHT POSTERIOR BASE (slide 3U). E. BILATERAL SEMINAL VESICLES AND VASA DEFERENTIA ARE FREE OF CARCINOMA. F. ALL EXAMINED SURGICAL MARGINS ARE FREE OF CARCINOMA. G. MULTIFOCAL PERINEURAL INVASION IS IDENTIFIED. H. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. I. HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA AND INTRADUCTAL EXTENSION OF. CARCINOMA ARE IDENTIFIED. J. PATHOLOGIC TNM STAGE: pT3a NO MX. K. NON NEOPLASTIC PROSTATE WITH FOCAL NODULAR HYPERPLASIA, GLANDULAR ATROPHY,. AND CHRONIC INFLAMMATION ARE NOTED (see synoptic). CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 3.76. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 4. SECONDARY GLEASON GRADE: 5. GLEASON SUM SCORE: 9. GLEASON 4/5 PERCENTAGE: 80%. WEIGHT OF PROSTATE: 43.04gm. TUMOR SIZE: Maximum dimension: 2.0 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: 5 25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes - multifocal. EXTRAPROSTATIC EXTENSION: Yes - Established (> 0.8mm). PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. LYMPH NODES EXAMINED: 17. LYMPH NODES POSITIVE: 0. T STAGE, PATHOLOGIC: pT3a. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated. Comment: Gleason score 4+5=9 with tertiary 3. Extracapsular extension in Rt posterior base (slide 3U)."
BIOCUP_00191,prostate,PRAD,TCGA-G9-6366,TCGA-G9-6366.6ef07861-a4db-4aa2-ba73-4cd43e10d72f,"SPECIMENS: A. PROSTATE. SPECIMEN(S): A. PROSTATE. GROSS DESCRIPTION: A. PROSTATE. Received fresh labeled with the patient's identification and designated ""prostate"" is an intact resected. prostate gland weighing 92 g and measuring 7-cm from right to left, 5-cm from anterior to posterior,. and. 4-cm from apex to base. The capsule is smooth and red. Ink code: Apex - red, anterior-orange,. posterior-black, base- blue, right-green, left-yellow. The apex and base are removed from the. specimen. to yield a new weight of 57 g. The specimen is serially sectioned from apex to base revealing tan. fibrous bulging parenchyma and focal brown calcified concretions. The right and left seminal vesicle, 3. X 1.5 X 0.5 cm and 3.2 X 1.7 X 0.4 cm, respectively, are bisected to show beige tan cystic tissue. The. right and left vas deferens, 3 x 0.5 cm and 1.5 X 0,5 cm, respectively, are sectioned to show firm tan. tube structure. A portion of the specimen is submitted for tissue procurement, the remainder entirely. submitted: A1-A4: Right apex. A5-A8: Left Apex. A9: Level 1 right anterior. A10: Level 1 right mid. A11: Level 1 right posterior. A12: Level 1 left anterior. A13: Level 1 left mid. A14: Level 1 left posterior. A15: Level 2 capsule right side. A16-A17: Level 2 capsule left side. A18: Level 3 capsule right side. A19-A20: Level 3 capsule left side. A21-A23: Right lateral base. A24-A27: Right base. A28: Right base and proximal urethral margin. A29: Left base and proximal urethral margin. A30: Left base. A31-A33: Left lateral base. A34: Right seminal vesicle, right vas deferens. A35: Left seminal vesicle, left vas deferens. DIAGNOSIS: A. PROSTATE, RADICAL PROSTATECTOMY: PROSTATIC ADENOCARCINOMA, GLEASON SCORE 4+3=7 (7/10). INVOLVING APPROXIMATELY 4% OF EXAMINED GLAND AND EXTENDING. INTO THE LEFT SEMINAL VESICLE WALL. - LEFT POSTERIOR MARGIN FOCALLY INVOLVED. - FOCAL EXTRAPROSTATIC EXTENSION IDENTIFIED. SYNOPTIC REPORT - PROSTATE GLAND. Specimens Involved. Specimens: A: PROSTATE. Left. Posterior lateral. Apical. Basal. Anterior. WHO CLASSIFICATION. Epithelial tumors. Adenocarcinoma 8140/3. Multicentricity: Gland Involvement: 4%. Gleason Grade/Sum:: Grade 4 + 3, Sum 7. High Grade PIN Present: Perineural Invasion: Yes. Vascular/Lymphatic Invasion: Seminal Vesicle Invasion: Left. Muscular Wall Invasion: Lumen Invasion: Periprostatic Fat Involved: Details: left posterior. Bladder Neck Involved: Margins Involvement: No. Frozen Performed: Post Hormonal Therapy Change: Lymph Nodes: No lymph nodes sampled. Other Pathologic Findings: None identified. Pathological Staging (pTNM): T 3b. N X. M: X. Comment(s): The single focus of positive margin is in block A17 and measures 0.6 mm. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Prostate carcinoma."
BIOCUP_00192,prostate,PRAD,TCGA-YL-A8HL,TCGA-YL-A8HL.0C91388C-CCC6-4BBD-B13A-E543A8FC2E5F,PROSTATE AND PELVIC/OBTURATOR LYMPH NODES; RADICAL PROSTATECTOMY: HISTOLOGIC TYPE. ACINAR ADENOCARCINOMA. HISTOLOGIC GRADE (PRIMARY PATTERN+SECONDARY PATTERN = GLEASON SCORE): 4 + 5 = 9. TERTIARY PATTERN NOT PRESENT. PERCENTAGE OF DIFFERENT GLEASON PATTERNS. Not described. TUMOR LOCATION. APEX. MID. BASE. ANTERIOR. RIGHT. LEFT. POSTERIOR. RIGHT. LEFT. EXTRA-PROSTATIC EXTENSION. PRESENT. NON-FOCAL. SITE OF EXTRA-PROSTATIC EXTENSION. MID. POSTERIOR. RIGHT. SEMINAL VESICAL INVASION. PRESENT. RIGHT. SURGICAL MARGINS. INVOLVED BY INVASIVE CARCINOMA. APEX. MID. BASE. BLADDER NECK. ANTERIOR. RIGHT. POSTERIOR. RIGHT. NATURE OF POSITIVE MARGINS. INDETERMINATE. EXTENT OF POSITIVE MARGINS. MULTIFOCAL. GLEASON GRADE OF CARCINOMA PRESENT AT THE POSITIVE MARGINS. Not described. LYMPHOVASCULAR INVASION. Not described. PERINEURAL INVASION. PRESENT. TUMOR VOLUME. PROPORTION OF PROSTATE INVOLVED BY CARCINOMA: _75__%. TREATMENT EFFECT ON CARCINOMA. NOT APPLICABLE. LYMPH NODES. RIGHT PELVIC. NUMBER OF NODES INDENTIFIED: 2. NUMBER OF NODES INVOLVED BY METASTASIS: 0_. LEFT PELVIC. NUMBER OF NODES INDENTIFIED: 3. NUMBER OF NODES INVOLVED BY. NUMBER OF NODES IDENTIFIED: 3. NUMBER OF NODES INVOLVED BY METASTASIS: _1__. DIAMETER OF LARGEST LYMPH NODE METASTASIS: 30_MM. PATHOLOGICAL STAGING. pT3b. pN1. pMX. COMMENT(S).
BIOCUP_00193,prostate,PRAD,TCGA-KK-A8I9,TCGA-KK-A8I9.D086A0A1-E06A-4B7E-B158-A5D04BCE06E1,"MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. (B) RIGHT PELVIC LYMPH NODES: Thirteen lymph nodes, no tumor present (0/13). (C) LEFT PELVIC LYMPH NODES: One lymph node, no tumor present (0/1). GROSS DESCRIPTION. (A) PROSTATE AND SEMINAL VESICLES - Supplemental report to follow. (B) RIGHT PELVIC LYMPH NODES - A pad of adipose tissue (6.0 x 3.4 x 1.0 cm) with eight possible lymph nodes (0.4 x 0.4 cm. to 3.8 x 1.0 cm). The specimen is entirely submitted. SECTION CODE: B1, one possible lymph node; B2, B3, one possible lymph node, sectioned; B4, one possible lymph. node sectioned; B5-B10, largest lymph node sectioned; B11, two possible lymph nodes; B12, two possible lymph nodes; B13-B17,. remainder of adipose tissue. (C) LEFT PELVIC LYMPH NODES - A pad of adipose tissue (3.0 x 1.9 x 1.3 cm) with one possible lymph node. The specimen is. entirely submitted. SECTION CODE: C1-C5, one lymph node, sectioned; C6, remainder of adipose tissue. CLINICAL HISTORY. Prostate cancer. SNOMED CODES. T-C4600, M-00110. ""Some tests reported here may have been developed and performance characteristics determined by. . These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: Start of ADDENDUM. Page: 2. ADDENDUM. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (A) PROSTATE AND SEMINAL VESICLES: PROSTATIC ADENOCARCINOMA, GLEASON SCORE 8 (4+4). (SEE COMMENT). EXTRAPROSTATIC EXTENSION PRESENT. FOCAL EXTENSION OF TUMOR TO THE CAUTERIZED MARGIN OF RESECTION CANNOT BE UNEQUIVOCALLY. EXCLUDED. Right and left seminal vesicles, no tumor present. Segments of right and left vasa deferentia, no tumor present. PERINEURAL AND LYMPHOVASCULAR INVASION PRESENT. COMMENT. The prostate gland contains two foci of prostatic adenocarcinoma, one in the peripheral zone and one in the transition zone. The. dominant tumor focus is located in the right lateral, right posterolateral, right posterior, mid posterior and left posterior peripheral. zone. This tumor focus measures 2.5 x 2.0 cm in the largest cross-sectional dimension and it is present in the single cross. section. of. the. prostate and extensively in the apex and base. The tumor exhibits extensive extraprostatic extension in the right. posterolateral surface of the prostate and right superior neurovascular bundle region. The added length of extraprostatic extension. is 18.5 mm. On the right base, focal extension of tumor to the cauterized margin cannot be unequivocally excluded. The second. tumor focus is located in the left transition zone. This tumor focus measures 0.8 x 0.3 cm in the largest cross-sectional dimension. and it is present in the single cross section of the prostate, focally in the apex and extensively in the base. This tumor focus is of. lower histologic grade and confined to the prostate with negative margins. GROSS DESCRIPTION. (A) PROSTATE AND SEMINAL VESICLES - A specimen consisting of a prostate, attached right and left seminal vesicles and. attached segments of right and left vasa deferentia. The prostate gland (5.1 x 3.1 x 3.9 cm, 28.0 grams, post-fixation) has the usual shape. The soft tissue present along the. posterolateral aspects of the prostate is abundant and symmetrical. A nodule is palpated on the right side of the prostate. Serial. cross-sections. after fixation demonstrate an area consistent with tumor in the right side of the single cross-section of the prostate. The seminal vesicles and segments of vasa deferentia are grossly free of tumor. SECTION CODE: A1-A4, right seminal vesicle and segment of right vas deferens from the base towards the tip; A5-A7,. left seminal vesicle and segment of left vas deferens from the base towards the tip; A8, prostatic base, right border; A9-A12,. prostatic base, right posterior border; A13-A20, prostatic base, central portion; A21, prostatic base, left border; A22-A24. prostatic base, left posterior border; A25-A26, apex anterior; A27-A28, apex left; A29-A31, apex posterior; A32-A33, apex right;. A34-A37, sections of the single cross-section of the prostate according to the specimen radiograph. The anterior aspect of the prostate is inked in green, left surface in red, right surface in yellow and posterior surface in. Page: 3. black. SNOMED CODES. T-92000, M-Y1973. Entire report and diagnosis completed by: END OF REPORT-."
BIOCUP_00194,prostate,PRAD,TCGA-Y6-A9XI,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED,"Surgical Pathology Report (Order. Value. Surgical. ACCESSION NO. Final Diagnosis (es) : (A) Bladder neck margin, biopsy: Normal prostate glands. present. (B). Prostate with seminal vesicles, radical prostatectomy : 1) Bilateral prostate adenocarcinoma, Gleason sum score. 4+4 = 8/10 (see Synoptic report, below) . 2) Largest nodule: 4.5 x 3.0 x 2.0 cm = 36 cc. 3). Lymphovascular and perineural invasion present. 4). Extensive bilateral capsular penetration. Right side - slides B2, B13, B17, B21, B25, B29. Left side - slides B5, B14, B22, B26, B30. 5). Positive right posterior lateral margin (slides B2,. B9,. B13) . 6) Pathologic stage: pT3aNOMX. (C). Bilateral pelvic lymph nodes, excision: Four lymph nodes. negative for malignancy (0/4) . Synoptic Report: Diagnosis: Prostate adenocarcinoma, bilateral. Procedure: Radical prostatectomy. Specimen Size: 4.5 x 3.8 x 3.6 cm. Specimen Weight: 40.1 gm. Lymph Node Sampling: Pelvic lymph node dissection. Histologic Type: Adenocarcinoma, acinar type. Histologic Grade (Gleason pattern). Primary Pattern: Grade. 4. Secondary Pattern: Grade 4. Total Gleason Score: 4+4 = 8/10. Percent of Prostate Involved: 36 CC. Size of Dominant Nodule. Greatest dimension: 14.5 mm. Additional dimensions: 13. x. 13. mm. Extraprostatic Extension: Nonfocal. Seminal Vesicle Invasion: Left: Negative. Right: Negative. Lymphvascular Invasion: Positive. Margins : Posterolateral: Positive. Nodes: Node Group: Bilateral pelvic nodes. Total: 4. Positive: 0. Pathologic Stage: pT3aNOMX. Specimen (s) Received: A: Posterior bladder neck margin. B: Prostate with seminal vesicles. C: Bilateral pelvic LN. Clinical History: Prostate cancer. (B) Tumor Bank. Intraoperative Consultation: FSA1: Posterior bladder neck margin: Benign fibromuscular. tissue with three glands at one end (1 block) . Gross Description: (A) (posterior bladder neck margin) Received fresh for. frozen. section analysis is a fragment of firm white-tan tissue. measuring 0.3 x 0.2 cm submitted in cassette FSA1. (B) (prostate with seminal vesicles) Received in formalin. following Tumor Bank sampling, inking and orientation is a. radical prostatectomy with the bilateral seminal vesicles. removed and weighs 40.1 gm and is 4.5 cm right to left, 3.6 cm. superior to inferior and 3.8 cm anterior to posterior. Right. half is inked red, the left half is inked green and the. posterior midline is inked black. The capsule appears intact. Serial oblique sections are made and show focal tan solid. nodules within both the right and left halves of the specimen. This nodularity comprises roughly 10% of the total volume of. the. specimen. There is a large nodule measuring 0.5 x 0.6 cm that. is abutting the capsule on the right side of the specimen at. approximately levels 5-7. The remaining volume consists of. pale. tan rubbery trabeculated tissue. The right seminal vesicle. is. 5.0 x 1.8 x 0.6 cm and the vas deferens is 4.6 cm long x 0.7. cm. in diameter. The left seminal vesicle is 3.9 x 1.5 x 0.9 cm. and. the left vas deferens is 4.5 cm long x 0.7 cm in diameter. A. diagram is provided to facilitate orientation. The entire. specimen is submitted as follows: B1-B7 - apex submitted right to left. B8-B39 - prostate submitted entirely. B40-856 - bilateral seminal vesicles submitted entirely. (C) (bilateral pelvic lymph nodes) Received in formalin are. multiple fragments of lobular yellow adipose tissue with firm. lymph nodes measuring 5.5 x 4.0 x 1.0 cm. The specimen is. palpated for nodes and submitted as follows: C1 - one lymph node, sectioned. C2 - one lymph node, sectioned. C3 - one node. Microscopic Description: Complete microscopic evaluation has been performed. Appropriately reacting controls have been performed and. evaluated for all stains on this case as required. Histopathology has a list of IH antibodies that are regulated. as. analyte specific reagents (ASR's) These assays were. developed. and their performance characteristics determined by the. Histopathology Laboratory in the Department of Pathology. at. They. have not been cleared by the US Food and Drug Administration. The FDA has determined that such clearance or approval is not. necessary for the ASR's. These tests are not investigational. and are used in standard clinical care. In cases where. Immunohistochemistry testing is performed, the following. antibodies and their respective clones may be used to. determine. therapy for the patient: EFGR(3c6), ER (SP1), PR (1E2). Her2neu (4B5), CD117(Poly), CD20 (L26) Ki67 (30-9) . Unless otherwise stated in the report, all tissue tested for. ERPR by IHC, Her2 by IHC and/or HER2 by FISH have been fixed. as. per C.A.P. requirements for a minimum of 6 hours and a maximum. of 48 hours. ER, PR, Ki-67, p53 are reported as a semi-quantitative. percentage of positively stained nuclei. Her-2/neu and EGFR. are. scored as follows: No staining at all is scored as (0), weak,. incomplete membrane staining in any proportion of cells is. scored as (1+), less than strong but complete staining in any. proportion of cells or complete strong staining in less than. 30%. of cells is scored as (2+), and strong complete staining in. more. that 30% of cells is scored as (3+). All studies are."
BIOCUP_00195,prostate,PRAD,TCGA-QU-A6IP,TCGA-QU-A6IP.D1E73097-6F07-4B1E-8914-074FA037CB85,"Pathology Examination. Birthdate. Pathology. #. Male. Report to: Gross Description by: SPECIMEN SUBMITTED: PROSTATE,LEFT/RIGHT LYMPH NODE (RT. & LT. PELVIC LYMPH. NODES). Procedure date. Tissue received. Report Date. Diagnosed by. Previous biopsies: Consult slides referred to. DIAGNOSIS: 1. Left lymph node (A): Single lymph node, no malignancy identified. 2. Right lymph node (B): Single lymph node, no malignancy identified. 3. Prostate and seminal vesicles (C-O): Adenocarcinoma involving right lobe; see synopsis report. Prostate Gland: Radical prostatectomy Synopsis. MICROSCOPIC. Histologic Type: Adenocarcinoma. Histologic Grade -- Gleason Pattern. Primary pattern: Grade 3. Secondary pattern: Grade 3. Total Gleason Score: 6. Tumor quantitation. Proportion (percent) of prostate involved by tumor: 5%. # Positive Slides Total Slides. Left. 0. 3. Left apex. 0. 2. Right. 1. 3. Right apex. 0. 2. EXTENT OF INVASION. Primary Tumor: pT2a: Unilateral, involving one-half of 1 side (""lobe ) or less. Regional Lymph Nodes: pNO: No regional lymph node metastasis. Lymph Nodes. Number examined: 2. Number involved: 0. Margins: Margins uninvolved by invasive carcinoma. Extraprostatic extension: Absent. Seminal vesicle invasion (invasion of muscular wall required): Absent. Perineural invasion: Present. Comments: Small focus of probable carcinoma in right mid (H) as well. Clinical: Prostate cancer. Gross: The specimen is received fresh in three parts all labeled. Part 1 is labeled ""left pelvic lymph node pocket"" and consists of a piece of adipose tissue. measuring 3.5 x 3 x 1.5 cm. The specimen is examined for lymph nodes. One lymph node. measuring 0.2 cm is identified. The lymph node is entirely submitted in cassette A. Part 2 is labeled ""right pelvic lymph node pocket"" and consists of fragments of adipose tissue. measuring 4.5 x 3.5 x 1.5 cm in aggregate. The specimen is examined for lymph node. One lymph. node is identified measuring 1.5 cm. The lymph node is entirely submitted in cassette B. Part 3 is labeled ""prostate and seminal vesicles"" and consists of a prostatectomy specimen. weighing 51 grams and measuring 5.5 X 5 x 3.5 cm. The right seminal vesicle measures 2.5 x 1.5 x. 0.5 cm. The right vas deferens measures 0.5 cm in length and 0.5 cm in diameter. The left seminal. vesicle measures 2.5 x 1.5 x 0.5 cm. The left vas deferens measures 1 cm in length and 0.5 cm in. diameter. Prostatic capsule is grossly unremarkable. The specimen is inked as follows: right =. black, left = blue. The urethral (apical) and the lateral margins are shaved up and the specimen is. serially sectioned to reveal a nodular pattern of the prostatic parenchyma. No discrete lesions are. grossly identified. The specimen is represented as follows: C-D = right apical resection margin,. coned and serially sectioned, E-F = left apical resection margin, coned and serially sectioned. G-I =. right apex, mid and base respectively, J-L = left apex, mid and base, respectively., M = bladder. resection margin shave, N = right seminal vesicle, O = left seminal vesicle. By his/her signature above, the senior physician certifies that he/she personally conducted a gross and/or microscopic examination of the described. specimens(s) and rendered or confirmed the diagnosis(es) related thereto. Immunohistochemistry test(s), If applicable, were developed and their performance characteristics were determined by. They have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined. that such clearance or approval is not necessary. 1 nese tests are used for clinical purposes. They should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA - 88) as qualified to perform high complexity clinical. laboratory testing."
BIOCUP_00196,prostate,PRAD,TCGA-KK-A7AU,TCGA-KK-A7AU.4BA7AC63-6B00-44E3-9545-6A4836912B1E,"(180.0cm 106.6kg BSA: 2.31m¬≤. MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) PROSATE AND SEMINAL VESICLES - TO BE REPORTED. (B) PELVIC LYMPH NODES, LEFT, EXCISION: TWO OF FIVE LYMPH NODES POSITIVE FOR METASTATIC ADENOCARCINOMA, CONSISTENT WITH PROSTATIC. ORIGIN (2/5). SIZE OF LARGEST METASTATIC FOCUS IS 10.0 MM; NEGATIVE FOR PERINODAL EXTENSION. (C) PELVIC LYMPH NODES, RIGHT, EXCISION: ONE OF SIX LYMPH NODES POSITIVE FOR METASTATIC ADENOCARCINOMA, CONSISTENT WITH PROSTATIC. ORIGIN (1/6). SIZE OF METASTATIC FOCUS IS 4.0 MM; NEGATIVE FOR PERINODAL EXTENSION. GROSS DESCRIPTION. (A) PROSATE AND SEMINAL VESICLES - TO BE REPORTED. (B) LEFT PELVIC LYMPH NODE - Received is a 5.5 X 4.0 X 2.0 cm portion of fibroadipose tissue which yields multiple possible. lymph nodes ranging from 1.0 to 3.5 cm in greatest dimension. Lymph nodes are submitted entirely. SECTION CODE: B1, two lymph nodes; B2, one lymph node bisected; B3, B4, one lymph node serially sectioned; B5, B6,. one lymph node serially sectioned. (C) RIGHT PELVIC LYMPH NODES - Received is a 5.0 x 3.5 x 1.5 cm portion of fibroadipose tissue which yields multiple. possible lymph nodes ranging from 0.6 to 3.0 cm in greatest dimension. The lymph nodes are submitted entirely. SECTION CODE: C1, two lymph nodes; C2, two lymph nodes; C3, one lymph node trisected; C4-C6, one lymph node. serially sectioned. CLINICAL HISTORY. None given. SNOMED CODES. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: Start of ADDENDUM #1. GA-KK-A7AU-01A-PR. Page: 2. (180.0cm 106.6kg BSA: 2.31m¬≤. ADDENDUM. This modified report is being issued to report. Addendum completed by. COMMENT. Immunohistochemistry on block B shows neoplastic cells to stain positively for PSA and prostein thereby confirming a prostatic. origin. The original diagnosis remains unchanged. Entire report and diagnosis completed by: Start of ADDENDUM #2. Page: 3. (180.0cm . 106.6kg BSA: 2.31m¬≤. ADDENDUM #2. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (A) PROSTATE AND SEMINAL VESICLES: PROSTATIC ADENOCARCINOMA, GLEASON SCORE 9 (4+5) (SEE COMMENT). MULTIFOCAL EXTENSIVE EXTRAPROSTATIC EXTENSION PRESENT. CARCINOMA INVADING RIGHT AND LEFT SEMINAL VESICLES AND PERIVESICULAR SOFT TISSUE. CARCINOMA EXTENDING TO THE MARGIN OF RESECTION. PERINEURAL INVASION PRESENT. NO UNEQUIVOCAL VASCULAR/LYMPHATIC INVASION IDENTIFIED. PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN), HIGH GRADE. SEE PREVIOUS REPORT FOR DIAGNOSIS OF PELVIC LYMPH NODES. COMMENT. The prostate gland contains a single focus of prostatic adenocarcinoma. The tumor is located in the right lateral, right. posterolateral, right posterior, mid posterior, left posterior, left posterolateral and left lateral peripheral zone. The tumor focus. measures 3.0 x 1.4 cm in the largest cross-sectional dimension, and it is present in the two cross sections of the prostate and. extensively in the apex and base regions. The tumor exhibits extensive, multifocal extraprostatic extension. Areas of. extraprostatic extension include the right and left posterolateral surface of the prostate, right and left posterior surface of the. prostate, right and posterior apex, base region anterior to the left seminal vesicle and left superior neurovascular bundle. On the. left superior neurovascular bundle, at the site of extraprostatic extension, tumor is present at the inked margin of resection. The. extent of marginal involvement in this region is less than 1.0 mm. In other regions, carcinoma is present at less than 0.1 mm from. the inked margin of resection (posterior apex and bladder neck region). The tumor invades both seminal vesicles including. extraprostatic portion of the right and left seminal vesicles, and intraprostatic portion of the left seminal vesicle. Involvement. of. perivesicular soft tissue is also present. Please refer to the previous report for the diagnosis of the pelvic lymph nodes. GROSS DESCRIPTION. (A) PROSTATE AND SEMINAL VESICLES - A specimen consisting of a prostate, attached right and left seminal vesicles and. attached segments of right and left vasa deferentia. The prostate gland (4.1 x 3.4 X 3.0 cm, 24 grams, post-fixation) has the usual shape. The soft tissue present along the left. posterolateral aspect of the prostate is scant, but slightly more abundant than along the right side. A nodule is palpated in the left. apex and right side of the prostate. Serial cross sections after fixation demonstrate areas suspicious for tumor in the right side of. the two cross sections of the prostate. Page: 4. (180.0cm 106. 6kg BSA: 2.31m¬≤. The seminal vesicles and segments of vasa deferentia are grossly free of tumor. SECTION CODE: A1, A2, base of right seminal vesicle and right vas deferens; A3, A4, base of left seminal vesicle and. left vas deferens; A5, A6, prostatic base, right border; A7, A8, prostatic base, right posterior border; A9-A12, prostatic base, central. portion; A13, A14, prostatic base, left border; A15, A16, prostatic base, left posterior border; A17, A18, apex anterior; A19, A20,. apex left; A21, A22, apex posterior; A23, A24, apex right; A25-A32, sections of the two cross sections of the prostate according to. the specimen radiograph. A33-A35 reminder of seminal vesicles. The anterior aspect of the prostate is inked in green, left surface in red, right surface in yellow and posterior surface in. black. Blue ink (A25, 26, 29 and 30) denotes surfaces that do not represent the true margin of resection. SNOMED CODES. Entire report and diagnosis completed by: END OF REPORT-."
BIOCUP_00197,prostate,PRAD,TCGA-HC-7747,TCGA-HC-7747.cd814697-95e2-46d6-8f80-4467d7bedf01,"DIAGNOSIS. DIAGNOSIS: A. Right and left pelvic lymph nodes, regional resection: Four lymph nodes negative for metastatic tumor (0/4). B. Prostate, radical prostatectomy: Infiltrating prostatic adenocarcinoma. Tumor Characteristics: 1. Histologic type: Adenocarcinoma. 2. Prostate size: 4.5 x 3.0x2.8 cm. 3. Tumor quantitation: Tumor involves approximately 25% of the gland. 4. Gleason grade: a. Primary pattern: 3/5. b. Secondary pattern: 4/5. C. Total Gleason score: 7/10. 5. Extraprostatic extension: Not identified. 6. Seminal vesicle involvement: Tumor closely abuts the junction between the prostate and the seminal vesicles, but there is no evidence of. involvement of the seminal vesicles proper. 7. Perineural invasion: Present. 8. High grade PIN: Present. Surgical Margin Status: 1. Multiple inked surgical margins of resection are positive for tumor, including the apex, right anterior, and right posterior. Lymph Node Status: Four lymph nodes negative for tumor - see part A above. Other: 1. pTNM stage: T2cNOM0 IIB. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Right and left pelvic lymph node. B. Prostate. SPECIMEN DATA. GROSS DESCRIPTION: The specimen is received in two formalin filled containers labeled with the patients name. A. Container A is additionally labeled ""right and left pelvic nodes' and contains a 6.0 x 4,0 X 2.0 cm aggregate of yellow-tan fibrofatty soft tissue. On. palpation four firm fatty possible lymph nodes are identified ranging from 1.5 up to 3.5 cm in greatest dimension. They are entirely submitted in. cassettes A1-3 labeled. designated as follows: 1 -- two whole possible lymph nodes; 2&3 -- one whole possible bisected lymph node. in each cassette. B. Container B is additionally labeled 'prostate' and contains a 23.9 gram, 4,5 x 3,0 x 2.8 cm prostate received with attached bilateral adnexa which has. overall dimensions of 4.0 X 2.2 x 1.0 cm. The capsule is pink-tan and shaggy. Specimen is inked as follows: red side blue and left side black. The. base and apical margins are coned and serially sectioned. The remainder of the gland is serially sectioned from apex to base to reveal a pink-tan focally. cystic cut surface with periurethral nodularity. No calculi or masses are identified. Representative sections are submitted in B1-18 labeled. inated as follows: 1 - right prostate/seminal vesicle junction; 2 -- left prostate/ seminal vesicle junction; 3 & - apical margin. perpendicular: 5& 6 -- base margin, perpendicular, 7-9 - right anterior. apex to base; 10-12 -- right posterior apex to base: 13-15 -- left anterior, apex to. hase: 16-18 -- left posterior, apex to base. Additionally, a yellow and green cassette are submitted for Genomics research each labeled."
BIOCUP_00198,prostate,PRAD,TCGA-KK-A59V,TCGA-KK-A59V.0A977EFF-C276-46CB-9187-92F504C7B535,"MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) LEFT OBTURATOR LYMPH NODE: Four lymph nodes, no tumor present. (B) RIGHT EXTERNAL ILIAC LYMPH NODE: Two lymph nodes, no tumor present. (C) RIGHT OBTURATOR LYMPH NODES: Three lymph nodes, no tumor present. (D) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. (E) BLADDER NECK, 7 O'CLOCK: Fibromuscular tissue, no prostatic tissue identified, no tumor present. (F) BLADDER NECK, 5 O'CLOCK: Fibromuscular tissue, no prostatic tissue identified, no tumor present. (G) PUBIC BONE: Supplemental report to follow. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) LEFT OBTURATOR LYMPH NODE - An irregular fragment of fibroadipose tissue (5.6 x 4.5 x 1.3 cm) which contains four. lymph nodes (3.0 X 1.3 x 1.0 cm, 1.7 x 1.0 x 0.8 cm - two of them, and 0.9 x 0.8 x 0.4 cm). The lymph nodes are serially. sectioned; no tumor is grossly identified. SECTION CODE: A1-A3, largest lymph node, serially sectioned for frozen section; A4, A5, one bisected lymph node, for. frozen section; A6, A7, one bisected lymph node for frozen section; A8, one bisected lymph node for frozen section. FS/DX: FOUR LYMPH NODES, NO TUMOR PRESENT (0/4). (B) RIGHT EXTERNAL ILIAC LYMPH NODE - Two irregular fragments of fibroadipose tissue (4.7 x 2.2 x 1.7 cm in aggregate),. which contains two lymph nodes (2.2 x 1.4 X 0.9 cm and 1.9 x 0.8 x 0.7 cm). The lymph nodes are bisected; no tumor is grossly. identified. SECTION CODE: B1, B2, largest lymph node bisected, for frozen section; B3, B4, one lymph node bisected for frozen. section. FS/DX: TWO LYMPH NODES, NO TUMOR PRESENT (0/2). (C) RIGHT OBTURATOR LYMPH NODES - Three lymph nodes ranging from 0.8 x 0.5 x 0.2 to 4.0 x 1.5 X 0.8 cm. SECTION CODE: C1-C3, one lymph node serially sectioned; C4, one lymph node bisected; C5, one lymph node. (D) PROSTATE AND SEMINAL VESICLES - Supplemental report to follow. (E) BLADDER NECK, 7 O'CLOCK - A 1.0 x 0.5 x 0.4 cm pink-purple soft tissue fragment has been previously inked in the OR,. re-inked blue, perpendicularly sectioned and submitted for frozen section in E. FS/DX: FIBROMUSCULAR TISSUE, NO PROSTATIC TISSUE IDENTIFIED. (F) BLADDER NECK, 5 O'CLOCK - A 0.7 x 0.5 x 0.3 cm segment of purple-pink soft tissue has been previously inked in the OR,. re-inked blue, and perpendicularly sectioned, and submitted for frozen section in F. FS/DX; FIBROMUSCULAR TISSUE, NO PROSTATIC TISSUE IDENTIFIED. (G) PUBIC BONE - Multiple tan-pink irregular fragments of pubic bone (8.0 x 4.5 x 0.8 cm). The specimen is entirely sent to the. Page: 2. bone lab for further processing. CLINICAL HISTORY. Prostate cancer. SNOMED CODES. These tests have not been. ""Some tests reported here may have been developed and performance characteristics determined by. specifically cleared or approved by the U.S. Food and Drug Administration."". Start of ADDENDUM. Page: 3. ADDENDUM. DIAGNOSIS. (D) PROSTATE AND SEMINAL VESICLES: PROSTATIC ADENOCARCINOMA, GLEASON'S SCORE 9 (4+5). (SEE COMMENT). TUMOR EXTENDING INTO EXTRAPROSTATIC TISSUE. TUMOR INVADING LEFT SEMINAL VESICLE (INTRAPROSTATIC PORTION). TUMOR EXTENDING FOCALLY TO LESS THAN 0.1 MM FROM THE APICAL MARGIN OF RESECTION. Immunoperoxidase studies and recuts pending. TUMOR INVADING LOOSE CONNECTIVE TISSUE SURROUNDING EJACULATORY DUCTS (SO-CALLED. INVAGINATED EXTRAPROSTATIC SPACE). PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN), HIGH GRADE. Right and left seminal vesicles and segments of vasa deferentia, no tumor present. One periprostatic lymph node (left superior neurovascular bundle region), no tumor present. (G) PUBIC BONE: Fragments of bone, no tumor present. COMMENT. The prostate gland contains two separate foci of prostatic adenocarcinoma, one in the transition zone and. one. in. the. peripheral. zone. The largest tumor focus although not the one of the highest histologic grade (Gleason score 5/3+2) located in the right and. left transition zone. This tumor focus measures 2.7 x 1.3 cm in the largest cross sectional dimension and it is present. in. four. cross. sections and focally in the apical region. This tumor focus is confined to the prostate and the margins of resection are free. of. tumor. The second tumor focus is located in the left lateral, left posterolateral, left posterior, mid posterior and right posterior. peripheral zone. This tumor focus measures 2.2 x 1.5 cm in the largest cross sectional dimension and it is present in three cross. sections, extensively in the apex and focally in the base region. This tumor focus is a high grade carcinoma (Gleason score 4+5). and. is. associated with an increased lymphocytic infiltrate. The tumor focus exhibits extraprostatic extension in the left apex and left. posterolateral aspect of the prostate. Extraprostatic extension is present in two separate sections and the added length of. extraprostatic tumor is 9.0 mm. At the site of extraprostatic extension the margins of resection are free of tumor. This tumor focus. focally extends to less than 0.1 mm from the margin of resection in the apex. This tumor focus invades the intraprostatic portion of. the left seminal vesicle. Due to the presence of distortion in areas of the tumor close to the margins of resection in the apex and the presence of a marked. lymphocytic infiltrate, immunoperoxidase studies for keratin, lymphocyte marker and neuroendocrine differentiation markers were. performed. Cytokeratin highlights tumor which is seen focally approaching but not at the margins of resection. The lymphocytic. infiltrate is a mixture of both CD20 positive B lymphocytes and CD5 positive T lymphocytes with a predominance of the latter. The. tumor is negative for synaptophysin but a few scattered neoplastic cells are positive for chromogranir supporting the presence of. focal minimal neuroendocrine differentiation. Page: 4. (D) PROSTATE AND SEMINAL VESICLES - A specimen consisting of a prostate, attached right and left seminal vesicles and. attached segments of right and left vasa deferentia. The prostate gland (4.5 x 2.5 x 4.5 cm, 40 grams, post-fixation) has the usual shape. The soft tissue present along the. right and left posterolateral aspects of the prostate appears symmetrical. A nodule is palpated on the left posterolateral aspect of. the prostate include the left apex and left mid region. Serial cross sections after fixation demonstrate firm area consistent with. tumor in the left peripheral zone extending from the first to the third cross sections of the prostate. The seminal vesicles and segments of vasa deferentia are grossly free of tumor. SECTION CODE: D1-D3, right seminal vesicle and segment of right vas deferens from the base towards the tip; D4-D6,. left seminal vesicle and segment of left vas deferens from the base towards the tip; D7, prostatic base right border; D8, D9,. prostatic base right posterior border; D10-D15, prostatic base central portion; D16, prostatic base left border; D17, D18, prostatic. base left posterior border; D19, apex anterior; D20-D22, apex left; D23-D25, apex posterior; D26, D27, apex right; D28-D43,. sections of four cross sections of the prostate according to specimen radiograph. The anterior aspect of the prostate is inked in green, left surface in red, right surface in yellow and posterior surface in. black. Blue ink (D20-22, D28 and D32) denote surfaces which do not represent the true margins of resection. SNOMED CODES. END OF REPORT-."
BIOCUP_00199,prostate,PRAD,TCGA-HC-7232,TCGA-HC-7232.d5b6e727-43d6-4d27-a7ae-d89c046ef4eb,"FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: PROSTATE GLAND, RADICAL PROSTATECTOMY: = PROSTATIC ADENOCARCINOIA. - Gleason score 4+5=9,. - Multifocal, involving both lobes. - Dominant nodule, 2.5 cm in maximum dimension. - MARGIN STATUS: NEGATIVE. es Closet margin, right apex, 0.07 cm. - LYMPHOVASCULAR INVASION: NOT IDENTIFIED. - PERINEURAL INVASION: PRESENT. - EXTRAPROSTATIC EXTENSION: PRESENT. - SEMINAL VESICLE INVASION: PRESENT. PATHOLOGIC TUMOR STAGING SUMMARY: - Primary tumor: pT3b (tumor invades seminal vesicle). - Regional lymph nodes: pNX. - Distant metastasis: pMX. - Pathologic stage: III. . Margin status: R0 (closest, right apex at 0.07 cm). FINAL SURGICAL PATHOLOGY REPORT. Prostate (data derived Tumor from current Staging specimen, Information staging in accordance with or modified from AJCC Cancer Staging. Handbook, 7th Ed, and CAP protocol,. Radical prostatectomy. Procedure: Prostate gland. Specimen type: 5.2 X 3.2 X 3,5 cm, 62 grams. Prostate size/weight: TUMOR FEATURES: Multifocal, Involving both lobes. Tumor site: Dominant nodule 2.5 cm in greatest dimension; tumor. Tumor quantification: Involves approximately 70% of the prostate gland. Adenocarcinoma. Histologic type: Histologic grade: 4. Primary pattern: 5. Secondary pattern: Not applicable. Tertlary pattern: 9. Total Gleason score: Not identified. Lymphovascular invasion: Present. Perineural invasion: Present. Extraprostatic extension: Present. Seminal vesicle invasion: Not applicable. Treatment effect: None submitted for evaluation. Lymph nodes: Margin evaluation: Right apex, at 0.07 cm. Distance to closest margin: Uninvolved by invasive carcinoma. Other margins: PATHOLOGIO TUMOR STAGING SUMMARY: pT3b (tumor invades seminal vesicle). Primary tumor: pNX. Regional lymph nodes: pMX. Distant metastasis: III. Pathologic stage: R0 (closest margin, right apex at 0.07 cm). Margin status: High grade prostatic intraepithellal neoplasia. Additional findings: FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: Prostatectomy. Clinical History/Operative Dx: Prostate cancer. Gross Description: The specimen is labeled prostate and Is received without fixative. It consists of a prostatectomy specimen. which welghs 62 grams. The prostate gland measures 5.2 X 3,2 X 3,5 cm and Includes a 4 x 1.5 X 0.8 cm. right seminal vesicle, a 2 cm segment of right vas deferens, a 1.7 cm segment of left vas deferens, and a. 3.8 X 1.5 X 1 cm left seminal vesicle. The right anterior surface of the prostate is inked blue, the left. anterior surface is Inked green, and the posterior surface is inked black, The prostatic apex, bladder neck,. and seminal vesicles/vasa are trimmed. The prostate is serially sectioned from apex to bladder neck. The. prostatic gland parenchyma shows bright yellow discoloration In the apical portion of the right prostate. and bright yellow discoloration extends throughout most of the posterior gland bilaterally. There is. bulging yellow nodularity in the periurethral region. Representative prostatic tissue is obtained for. research purposes. Also in the speclmen container are three additional tubular portlons of pink-tan tissue. suggestive of portions of vasa varying from 0.5-2,5 cm In length and up to 0.7 cm in diameter. Representative sections are submitted. Section summary: A1-A2) apical margin right prostate, A3-A4). apical margin left prostate, A5) right bladder neck, A6) left bladder neck, A7) surgical margin right vas. deferens, right seminal vesicle, A8) surgical margin left vas deferens, left seminal vesicle, A9-A22). prostate, apex-bladder neck, A23) separate tissue,. Microscopic Description: Microscopic sections have been examined. The microscoplo findings are reflected in the diagnosis. rendered."
BIOCUP_00200,prostate,PRAD,TCGA-EJ-5507,TCGA-EJ-5507.153de441-fbe9-4c8b-9a84-9cdf9c5edcf2,"PATIENT HISTORY. The patient is a. vith a history of PSA value of 8.85. The patient also has a history of biopsy on. his biopsy reveals: poorly-differentiated prostatic adenocarcinoma, Gleason score 4+3 = 7 in the left apex, teit. base, right rapex, right mid and right base of the prostate and poorly-differentiated prostatic adenocarcinoma, Gleason score- 3+4. =. 7 in the left mid of the prostate. The patient also has a history of a. PRE-OP DIAGNOSIS: Prostate cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Radical prostatectomy. ADDENDA: Addendum. Specimen labeled ""right pedicle margin"" has been evaluated with multiple levels and PSA, racemase, CK903 and p63. iimmunohistochemical stains. The immunohistochemical stains show PSA expression in the glands, confirming prostatic origin. Immunohistochemical. stains show expression of racemase in these glands. Presence of basal cells is confirmed by CK903 and p63. immunohistochemical stains. This immunohistochemical profile suggests these glands represent high grade prostatic intraepithellal neoplasia. No. evidence of invasive carcinoma is seen. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. A. METASTATIC CARCINOMA IN 1 OF 13 LYMPH NODES (1/13). B. EXTRANODAL EXTENSION IS PRESENT. PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. METASTATIC CARCINOMA IN 1 OF 8 LYMPH NODES (1/8). PART 3: PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL PROSTATECTOMY. A. PROSTATE ADENOCARCINOMA, GLEASON SCORE 4 + 5 = 9. B. THE CARCINOMA INVOLVES BOTH THE RIGHT AND LEFT LOBES AND HAS A GREATEST NODULAR DIAMETER OF. 2 CM IN ONE HISTOLOGIC SECTION (SLIDE 3U). C. THE CARCINOMA INVOLVES 35% OF THE EXAMINED PROSTATE VOLUME. D. EXTENSIVE EXTRAPROSTATIC EXTENSION IS PRESENT. E. BILATERAL SEMINAL VESICLES ARE INVOLVED BY CARCINOMA,. F. THE INKED MARGINS OF RESECTION ARE FREE OF CARCINOMA. G. EXTENSIVE PERINEURAL INVASION IS IDENTIFIED. H. HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA IS IDENTIFIED. 1. PATHOLOGIC TNM STAGE: pT3b N1 MX. J. BACKGROUND PROSTATE TISSUE WITH NODULAR HYPERPLASIA AND CHRONIC INFLAMMATION. PART 4: RIGHT PEDICLE MARGIN, BIOPSY-. A. FIBROVASCULAR TISSUE, WITH PROMINENT CRUSH ARTIFACT, AND FOCAL ATYPICAL AREAS. B. IMMUNOHISTOCHEMICAL STAINS PENDING, REPORT TO FOLLOW IN AN ADDENDUM. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 8.85. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE;. 4. SECONDARY GLEASON GRADE: 5. GLEASON SUM SCORE: 9. GLEASON 4/5 PERCENTAGE: 95%. WEIGHT OF PROSTATE: 41.11gm. TUMOR SIZE: Maximum dimension: 2 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: > 25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes multifocal. EXTRAPROSTATIC EXTENSION: Yes - Established (> 0.8mm). PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: Unknown. SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. RESIDUAL TUMOR: LYMPH NODES EXAMINED: 21. LYMPH NODES POSITIVE: 2. EXTRANODAL EXTENSION: SIZE OF NODAL METASTASIS: 1.5mm. T STAGE, PATHOLOGIC: pT3b. N STAGE, PATHOLOGIC: pN1. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated."
BIOCUP_00201,prostate,PRAD,TCGA-YL-A8HK,TCGA-YL-A8HK.AB7217AC-ABF7-4704-9413-9298DDE688EE,PROSTATE AND PELVIC/OBTURATOR LYMPH NODES; RADICAL PROSTATECTOMY: HISTOLOGIC TYPE. ACINAR ADENOCARCINOMA. HISTOLOGIC GRADE (PRIMARY PATTERN+SECONDARY PATTERN = GLEASON SCORE): 4 + 5 = 9. TERTIARY PATTERN NOT PRESENT. PERCENTAGE OF DIFFERENT GLEASON PATTERNS. Not determined. TUMOR LOCATION. APEX. MID. BASE. BLADDER NECK. ANTERIOR. RIGHT. LEFT. LATERAL. RIGHT. LEFT. POSTERIOR. RIGHT. LEFT. EXTRA-PROSTATIC EXTENSION. PRESENT NON-FOCAL. SITE OF EXTRA-PROSTATIC EXTENSION. LATERAL. RIGHT. POSTERIOR. RIGHT. SEMINAL VESICAL INVASION. PRESENT. BOTH. SURGICAL MARGINS. INVOLVED BY INVASIVE CARCINOMA. BASE. POSTERIOR. RIGHT. LEFT. NATURE OF POSITIVE MARGINS. IN AREAS OF EXTRA-PROSTATIC EXTENSION. EXTENT OF POSITIVE MARGINS. MULTIFOCAL. MILLIMETRIC EXTENT OF POSITIVE MARGINS: not determined. GLEASON GRADE OF CARCINOMA PRESENT AT THE POSITIVE MARGINS. Not described. LYMPHOVASCULAR INVASION. PRESENT. PERINEURAL INVASION. PRESENT. TUMOR VOLUME/ SIZE OF LARGEST TUMOR NODULE. 3.5X3.5X1.44=5.05CC. TREATMENT EFFECT ON CARCINOMA. NOT APPLICABLE. LYMPH NODES. LEFT PELVIC. NUMBER OF NODES INDENTIFIED: 1. NUMBER OF NODES INVOLVED BY METASTASIS: 0. ADDITIONAL PATHOLOGIC FINDINGS. LN: Hyperplasia histiocitaria sinusal. OTHERS: IHC anti-cytokeratin negative. PATHOLOGICAL STAGING. pT3b. pNO. pMX. COMMENT(S).
BIOCUP_00202,prostate,PRAD,TCGA-CH-5761,TCGA-CH-5761.205f9f59-486c-4211-aa60-0a5b4f746a74,"Diagnosis. 1. Poorly differentiated adenocarcinoma of the prostate in the left rectolateral and basal. peripheral zone. Maximum tumor spread 2.6 cm. Extensive perineural infiltration and. extraprostatic tumor growth in the left rectolateral and basal region. Infiltration of the left seminal. vesicle. Infiltration of the surgical margins in the left rectolateral and basal resection. 2. Tumor-free fatty connective tissue with vessels and nerves. 3. Fatty tissue with two tumor-free lymph nodes. 4. Fatty tissue with three tumor-free lymph nodes. Remark. The tumor classification to date is as follows: pT3b; Gleason 5+4 = 9 with small tertiary Gleason 3 portion (approx. 95% Gleason 5/4). In the left lateral and basal region, carcinoma cells extend in a multifocal and elongated pattern. the preparation margin (blue labeling, contact surface max. 8 mm and about 17 mm wide. altogether). To be on the safe side, additional immunohistological studies will follow to establish whether. there is any invasion of the vessels and any lymph node metastases that could not yet be. detected. The results will be presented in a follow-up report. Follow-up report. Diagnosis already reported. Poorly differentiated adenocarcinoma of the prostate. Immunohistology (CD31) also showed no evidence for invasion of the vessels. In the. submitted lymph nodes mentioned under 3. and 4., immunohistology also showed no. metastases and no disseminated tumor cells. Concluding tumor classification. pT3b, pN0 (0/3), L0, V0; Gleason 5+4=9. At the request of the clinician, an additional immunohistological investigation will be carried. out to settle the question of chromatin expression. The results will be presented in a follow-. up report."
BIOCUP_00203,prostate,PRAD,TCGA-V1-A8WN,TCGA-V1-A8WN.F25C1C00-CDFE-4ABD-A920-857AFEA691A5,"FINAL PATHOLOGIC DIAGNOSIS. A. Soft tissue, peri-prostatic fat, biopsy: Benign fibroadipose tissue, no prostatic. epithelium or carcinoma. B. Right anterior apex margin, biopsy: Benign prostatic tissue, no carcinoma present. C. Right posterior apex margin, biopsy: Fibromuscular tissue, no prostatic epithelium. or carcinoma. D. Prostate gland, bilateral seminal vesicles, radical prostatectomy: - Prostate gland: Prostatic adenocarcinoma, Gleason score 3+4=7, confined to. prostate, excised; see comment. - Right and left seminal vesicles: No tumor identified. COMMENT: Synoptic Comment for Prostate Tumors. - Type of tumor: Small acinar adenocarcinoma. - Location of tumor: Posterior bilateral, apex-base (~ 2 cc; slides D3, D5, D6, D9-D12). Left anterior. mid gland, slides D4, D6 (~0.1cc). - Estimated volume of tumor: N2 cc. - Gleason score: 3+4=7. - Estimated volume > Gleason pattern 3: ~10%. - Involvement of capsule: None. - Extraprostatic extension: None. - Margin status for tumor: Negative. - Margin status for benign prostate glands: Present at inked right base margin (~1 mm). - High-grade prostatic intraepithelial neoplasia (HGPIN): None. - Tumor involvement of seminal vesicle: None. - Perineural infiltration: None. - Lymph node status: None present. - AJCC/UICC stage: pT2cNO. Specimen(s) Received. A:Peri-prostatic fat (perm). B:Rght anterior apex margin (perm). C:Right posterior apex margin (perm). D:Prostate and seminal vesicles (Perm). Clinical History. OR Room and Phone # (frozen specimen : interoperative consults only): Relevant History:prostate cancer. Pre-op Diagnosis: Gross Description. The specimen is received in four parts, each labeled with the patient's name and medical record. number. Parts A-C are received in formalin. Part D is received fresh. Part A, additionally labeled ""periprostatic fat,"" consists of one irregular fragment of rubbery, deep-yellow. to red, lobulated soft tissue (3.9 x 1.8 x 0.3 cm). No lymph nodes are identified. The specimen is. entirely submitted in cassettes A1 and A2. Part B, additionally labeled ""right anterior apex margin (perm),"" consists of one unoriented, irregular. fragment of rubbery, deep-brown soft tissue (0.3 x 0.2 x 0.1 cm), entirely submitted in cassette B1. Part C, additionally labeled ""right posterior apex margin (perm),"" consists of one unoriented, irregular. fragment of rubbery, deep-brown soft tissue (0.4 x 0.2 x 0.1 cm), entirely submitted in cassette C1. Part D, additionally labeled ""prostate and seminal vesicles,"" consists of a prostate with attached seminal. vesicles (37 gm; 3 cm from apex to base x 3.5 cm in width x 3 cm from anterior to posterior). The. seminal vesicle/vas deferens bundles (right 4.5 x 2.5 x 1 cm; left 4 x 2 x 0.5 cm) have tan-pink,. lobulated cut surfaces. GROSS ABNORMALITIES: No lesion is identified. The parenchyma is tan-pink and spongy with few. rubbery, well-circumscribed, tan periurethral nodules (0.2-0.4 cm in greatest dimension). The anterior. fibrous stroma is open. The remaining capsule Is ripped and sutured closed. ORIENTED BY: Anatomic landmarks (seminal vesicles, urethra). INKING: Anterior right green, anterior left blue, posterior black. POTENTIAL STUDIES: Snap frozen. TOTAL NUMBER OF SLICES: (Not including apex and base margin slices): 5. AVERAGE SLICE THICKNESS: 0.4 cm (for slices 1-4). CASSETTES: Representative sections are submitted as follows: Apical margins, entirely submitted in perpendicular sections. D1: Right apex. D2: Left apex. Slice 1. D3: Right. D4: Left. Silce 2. D5: Right. D6: Left. Right anterior quadrant. D7: Slice 3. D8: Slice 4. Right posterior quadrant. D9: Slice 3. D10: Slice 4. Left posterior quadrant. D11: Slice 3. D12: Slice 4. Left anterior quadrant. D13: Slice 3. D14: Slice 4. Bladder margins, entirely submitted in perpendicular sections. D15: Right. D16: Left. Prostatic/seminal vesicle junction and cross-section of vas deferens. D17: Right. D18: Left. For properly consented patients, sections of the prostate not required by Pathology for diagnosis, and. not submitted as described above, have been submitted to the. for processing. and can also be made available. Diagnosis based on gross and microscopic examinations. Final diagnosis made by attending pathologist following review of all. pathology slides. The attending pathologist has reviewed all dictations, including prosector work, and preliminary interpretations. performed by any resident involved in the case and performed all necessary edits before signing the final report. /Pathology Resident. /Pathologist."
BIOCUP_00204,prostate,PRAD,TCGA-EJ-7788,TCGA-EJ-7788.b66a0868-e91c-4ebf-be9c-ba55e94552fd,"PATIENT HISTORY: with a history of PSA value of 26.6 ng/ml. The patient had a biopsy on. prostatic adenocarcinoma Gleason score 4+3 = 7 in the right mid aspect. PRE-OP DIAGNOSIS: Prostate cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Radical prostatectomy with bilateral lymphadenectomy. FINAL DIAGNOSIS: PART 1: LYMPH NODE, RIGHT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN ONE LYMPH NODE (0/1). PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN FIVE LYMPH NODES (0/5). PART 3: PROSTATE AND BILATERAL SEMINAL VESICLES AND VASA DEFERENTIA, RADICAL PROSTATECTOMY -. A. PROSTATIC ADENOCARCINOMA, ACINAR TYPE, MULTIFOCAL, GLEASON SCORE 3 + 4 = 7 WITH TERTIARY. GLEASON PATTERN 5, AND A TOTAL GLEASON 4/5 PERCENTAGE OF 30%. B. THE CARCINOMA INVOLVES BOTH THE RIGHT AND LEFT LOBES AND HAS A GREATEST NODULAR DIAMETER OF. 3.0 CM IN ONE HISTOLOGIC SECTION (SLIDE 3NN). C. THE CARCINOMA INVOLVES APPROXIMATELY 60% OF THE EXAMINED PROSTATE VOLUME. D. THE CARCINOMA SHOWS MULTIFOCAL, ESTABLISHED EXTRACAPSULAR EXTENSION IN THE REGIONS OF THE. RIGHT AND LEFT SEMINAL VESICLES (SLIDES 3A & 3C), ANTERIOR RIGHT AND LEFT BASE (SLIDES 3P & 3V),. POSTERIOR RIGHT AND LEFT BASE (SLIDES 3Y, 3BB, 3NN, 3QQ AND 3RR) AND POSTERIOR LEFT MID (SLIDE. 3AA). E. THE CARCINOMA EXTENSIVELY INVOLVES THE RIGHT SEMINAL VESICLE AND FOCALLY INVOLVES THE LEFT. SEMINAL VESICLE. F. PARTIALLY CAUTERIZED CARCINOMA EXTENSIVELY INVOLVES PROXIMAL URETHRAL/ BASILAR (SLIDES 3F &. 3H) AND DISTAL URETHRAL / APICAL RESECTION MARGINS (SLIDE 3J). LINEAR EXTENT OF MARGIN POSITIVITY. is GREATER THAN 1.7 CM (SLIDE 3H). G. MULTIFOCAL PERINEURAL INVASION IS IDENTIFIED. H. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. I. HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA IS IDENTIFIED. J. PATHOLOGIC TNM STAGE: pT3b NO MX (See synoptic). K. HISTOLOGIC GRADE G3-4. L. BACKGROUND PROSTATE TISSUE WITH NODULAR HYPERPLASIA AND CHRONIC INFLAMMATION. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 26.6. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 3. SECONDARY GLEASON GRADE: 4. GLEASON SUM SCORE: 7. GLEASON 4/5 PERCENTAGE: 30%. WEIGHT OF PROSTATE: 57.61gm. TUMOR SIZE: Maximum dimension: 3.0 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: > 25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes - multifocal. EXTRAPROSTATIC EXTENSION: Yes - Multifocal. PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: Widespread tumor involvement at margin. LYMPH NODES EXAMINED: 6. LYMPH NODES POSITIVE: 0. T STAGE, PATHOLOGIC: pT3b. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated."
BIOCUP_00205,prostate,PRAD,TCGA-EJ-A65M,TCGA-EJ-A65M.E0FB271C-8BC6-43FB-BE90-85A28009D962,"FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN THIRTEEN (13) LYMPH NODES EXAMINED. PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN SEVENTEEN (17) LYMPH NODES EXAMINED. PART 3: PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL PROSTATECTOMY- -. A. INVASIVE # DIFFERENTIATED ADENOCARCINOMA, GLEASON SCORE 3 + 3 = 6 WITH TERTIARY GLEASON. PATTERN 4. B. THE CARCINOMA INVOLVES BOTH THE RIGHT AND LEFT LOBES AND HAS A GREATEST NODULAR. DIAMETER OF 1.7 CM. C. THE CARCINOMA INVOLVES APPROXIMATELY 10% OF THE EXAMINED PROSTATE VOLUME. D. THE CARCINOMA IS ORGAN CONFINED AND SHOWS NO EVIDENCE OF EXTRACAPSULAR EXTENSION. E. BILATERAL SEMINAL VESICLES ARE FREE OF CARCINOMA. F. ALL EXAMINED SURGICAL RESECTION MARGINS ARE FREE OF CARCINOMA. G. PERINEURAL INVASION IS IDENTIFIED. H. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. I. HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA IS IDENTIFIED. J. PATHOLOGIC TNM STAGE: pT2c NO MX. K. TNM HISTOLOGIC GRADE = G3. L. BENIGN PROSTATIC HYPERTROPHY AND CHRONIC MODERATELY ACTIVE PROSTATITIS ARE NOTED. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 6.9. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 3. SECONDARY GLEASON GRADE: 3. GLEASON SUM SCORE: 6. GLEASON 4/5 PERCENTAGE: 10%. WEIGHT OF PROSTATE: 58.45gm. TUMOR SIZE: Maximum dimension: 1.7 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: 5 25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes NOS. EXTRAPROSTATIC EXTENSION: PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. LYMPH NODES EXAMINED: 30. LYMPH NODES POSITIVE: 0. T STAGE, PATHOLOGIC: pT2c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G2, Moderately differentiated. PATIENT HISTORY: The patient is. a -year-old black male with a history of PSA value of 6.9. The patient also has a history of biopsy on. this biopsy reveals: Poorly-differentiated prostatic adenocarcinoma, Gleason score 3+4 = 7 in the right side of the. prostate and moderately-differentiated prostatic adenocarcinama, Gleason score 3+3 = 6 in the left side of the prostate. The. patient also has a history of a benign right breast mass with recurrence and a right femur fracture. PRE-OP DIAGNOSIS: Prostate cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Radical prostatectomy."
BIOCUP_00206,prostate,PRAD,TCGA-J4-A67T,TCGA-J4-A67T.8E3BAF97-3B7F-4B3A-BC88-BACB5A716DFD,"M. Date Of Birth. Encounter Number. COPY ONLY DO NOT FILE. Correction to results. Correction. Source of specimen. A. TISSUE OVER PROSTATE-. B. RIGHT EXTENED PELVIC LYMPH NODE DISSECTION-. C. PROSTATE GLAND SEMINAL VESICLES / VAS DEFERENS-. FINAL DIAGNOSIS: A. TISSUE OVER PROSTATE-. FATTY TISSUE, NO TUMOR SEEN. B. RIGHT EXTENED PELVIC LYMPH NODE DISSECTION-. EIGHT LYMPH NODES, NEGATIVE FOR TUMOR. C. PROSTATE GLAND SEMINAL VESICLES / VAS DEFERENS-. ADENOCARCINOMA OF PROSTATE. TUMOR SITE: LEFT AND RIGHT PROSTATE, MOSTLY IN PERIPHERAL ZONE. SPECIMEN TYPE: RADICAL PROSTATECTOMY. WEIGHT: 47 GRAMS. SIZE: 3.5 x 3.5 x 3 CM. GLEASON SCORE (PRIMARY + SECONDARY PATTERN) : 3 + 4 = 7/10. TERTIARY PATTERN: NOT SEEN. SEVERITY IN EXTENT OF TUMOR: 3/5. (1: <5%; 2: 5-15%; 3: 15-30%; 4: 30-50%; 5: > 50% tissue. involvement). DOMINANT NODULE (AT LEAST 1 CM IN SIZE) : IS PRESENT, 1.1 CM IN. SIZE. Prepared for. TREATMENT EFFECT ON CARCINOMA: NOT IDENTIFIED. TNM STAGE: AT LEAST pT2c, pNO, pMX. LYMPHATIC (SMALL VESSEL) INVASION: NOT SEEN. PERINEURAL INVASION: PRESENT. NO TUMOR SEEN IN SEMINAL VESICLES. MARGIN STATUS: POSITIVE INKED MARGINS: RIGHT POSTERIOR PROSTATE, SEE NOTE. OTHER MARGINS ARE CLEAR. NOTE: THE CAPSILE OF THE POSITIVE MARGIN APPEARS TO BE DISRUPTED. BY AN IATROGENIC INCISION. THERE IS NO EXTRAPROSTATIC INVASION. SEEN ELSEWHERE. FURTHER CLINICAL CORRELATION IS NEEDED. Case Clinical Information. PROSTATE CANCER. Gross Description. A. Received in formalin labeled with the patient's name and. ""tissue over prostate"" is a yellow, fibrofatty tissue fragment. measuring 3 x 2 cm. No lymph node is grossly identified. The. specimen is submitted complete in A1-A3. B. Received in formalin labeled with the patient's name and. ""right extended pelvic lymph node"" is a yellow fibrofatty tissue. fragment measuring 7 x 7 x 1 cm. The fat is trimmed and eight. probable lymph nodes are grossly identified. The largest. measures 1 x 0.5 cm and the smallest measures 0.5 x 0.5 cm. The. specimen is submitted complete in B1-B2. C. Received in formalin labeled with the patient's name and. ""prostate gland seminal vesicle and vas deferens"" is a radical. prostatectomy specimen which includes a 47 gram prostate gland. with attached seminal vesicle and vas deferens. The prostate. gland measures 3.5 x 3.5 x 3.0 cm and has a shaggy capsule that. is disrupted at the bladder resection margin and has been. previously inked black on the left and blue on the right. The. right seminal vesicle measures 3 x 1 cm. The right vas measures. 5 x 0.6 cm. The left seminal vesicle measures 3.5 x 1.5 cm. The. left vas deferens measures 4.5 x 0.5 cm. The inferior prostate. Prepared for. is sectioned transversely, removed from the rest of the. specimen, and sectioned from anterior to posterior parallel to. the plane of the urethra. The remaining gland is serially. sectioned transversely and shows a firm, focally nodular. parenchyma. The seminal vesicles and vasa deferentia show no. abnormalities. Representative sections submitted as follows: inferior prostate demonstrating apical margin submitted entirely. anterior to posterior in C1-C6; bladder resection margin C7-C8;. complete section of mid gland anterior C9-C10; posterior. C11-C12; complete section of upper third of gland, anterior. C13-C14; posterior C15-C16; remainder of the posterior gland. submitted in C17-C24; right seminal vesicle and vas deferens. C25; left seminal vesicle and vas deferens C26. Also, there are. two additional cassettes for research, labeled ""tumor"" and. ""normal"". Signed Supplemental. C. The case was reviewed along with. After review, it is concluded that the tumor focally penetrates. through the capsule of the right posterior prostate. Surrounding the tumor at this site, a single-cell layer of. fibrous tissue is appreciable at the margin. This tumor is best. regarded as being completely excised. The TNM stage of the tumor is revised as: TNM stage: pT3a, pNo, pMX. Procedure. A. AA ROUTINE H&E X1 BLOCK. 1. H&E X1. A. AA ROUTINE H&E X1 BLOCK. 2. H&E X1. A. AA ROUTINE H&E X1 BLOCK. 3. H&E X1. B. AA ROUTINE H&E X1 BLOCK. 1. H&E X1. B. AA ROUTINE H&E X1 BLOCK. 2. Prepared for. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 1. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 2. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 3. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 4. H&E X1. C. AA ROUTINE H&E X1 BLOCK.5. H&E X1. C. AA ROUTINE H&E X1 BLOCK.6. H&E X1. C. AA ROUTINE H&E X1 BLOCK.7. H&E X1. C. AA ROUTINE H&E X1 BLOCK.8. H&E X1. C. AA ROUTINE H&E X1 BLOCK.9. H&E X1. C. AA ROUTINE H&E X1 BLOCK.10. H&E X1. C. AA ROUTINE H&E X1 BLOCK.11. H&E X1. C. AA ROUTINE H&E X1 BLOCK.12. H&E X1. C. AA ROUTINE H&E X1 BLOCK.13. H&E X1. C. AA ROUTINE H&E X1 BLOCK.14. H&E X1. C. AA ROUTINE H&E X1 BLOCK.15. H&E X1. C. AA ROUTINE H&E X1 BLOCK.16. H&E X1. C. AA ROUTINE H&E X1 BLOCK.17. H&E X1. C. AA ROUTINE H&E X1 BLOCK.18. H&E X1. C. AA ROUTINE H&E X1 BLOCK.: 19. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 20. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 21. H&E X1. C. AA ROUTINE H&E X1 BLOCK.22. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 23. H&E X1 A RECUTS. C. AA ROUTINE H&E X1 BLOCK.24. H&E X1. Prepared for. C. AA ROUTINE H&E X1 BLOCK. 25. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 26. H&E X1. Prepared for."
BIOCUP_00207,prostate,PRAD,TCGA-KK-A8IC,TCGA-KK-A8IC.D11CB264-3D9E-49ED-85AA-57E4A26A5ED1,"MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) RIGHT PELVIC LYMPH NODES: Twenty one lymph nodes, no tumor present. (B) LEFT PELVIC LYMPH NODES: Seventeen lymph nodes, no tumor present. (C) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) RIGHT PELVIC LYMPH NODES - Multiple fragments of tan-red soft tissue and fat, measuring 3.0 x 3.0 x 1.5 cm. Lymph. nodes are separated and submitted. SECTION CODE: A1, A2, one lymph node (bisected); A3, A4, one lymph node each; A5, four possible lymph nodes; A6,. seven possible lymph nodes; A7, seven possible lymph nodes. (B) LEFT PELVIC LYMPH NODES - Multiple fragments of tan-red soft tissue, measuring 3.0 x 3.0 x 1.0 cm in aggregate. Lymph. nodes are separated and submitted. SECTION CODE: B1, B2, one lymph node; B3, B4, one lymph node each; B5, five possible lymph node; B6, three. possible lymph nodes. (C) PROSTATE AND SEMINAL VESICLES - Supplemental report to follow. CLINICAL HISTORY. Prostate cancer. SNOMED CODES. T-C4600, M-00110. ""Some tests reported here may have been developed and performance characteristics determined by. . These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: Start of ADDENDUM. Page: 2. ADDENDUM. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (C) PROSTATE AND SEMINAL VESICLES: PROSTATIC ADENOCARCINOMA, GLEASON SCORE 9 (4 + 5). (SEE COMMENT). TUMOR EXTENDING INTO EXTRAPROSTATIC TISSUE. TUMOR INVADING RIGHT SEMINAL VESICLE. MARGINS OF RESECTION, FREE OF TUMOR. PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN), HIGH GRADE. LYMPHATIC/VASCULAR INVASION PRESENT. Left seminal vesicle and segment of vasa deferentia, no tumor present. One periprostatic lymph node, no tumor present. COMMENT. The prostate gland contains a single focus of prostatic adenocarcinoma. The tumor is located in the right lateral, right. posterolateral, right posterior, mid posterior, left posterior and left posterolateral peripheral zone. The tumor focus measures 3.0 x. 1.5 cm in the largest cross-sectional dimension, and it is present in two cross sections and extensively in the apex and base. regions. The tumor exhibits extraprostatic extension in the right superior neurovascular bundle region. Extraprostatic extension is. present in three sections and the added length of extraprostatic tumor is 8.0 mm. The margins of resection are free of tumor. The. tumor invades in the intraprostatic portion of the right seminal vesicle. The margins of resection are free of tumor. GROSS DESCRIPTION. (C). PROSTATE. AND SEMINAL VESICLES - A specimen consisting of a prostate, attached right and left seminal vesicles and. attached segments of right and left vasa deferentia. The. prostate gland (5.6 x 3.0 x 3.7 cm, 46 grams, post fixation) has the usual shape. The soft tissue present along the. right and left posterolateral aspects of the prostate appears symmetrical. A palpable nodule is present in the right base region. Serial cross sections after fixation demonstrate a firm area consistent with tumor in the right peripheral zone of the two cross. sections of the prostate. There is a portion of extraprostatic tissue attached to the left side of the prostate. The surface of the. fragment which does not represent the true margin is inked blue. Similarly, blue ink is applied to the surface of the prostate in. areas under sutures. The seminal vesicles and segments of vasa deferentia are grossly free of tumor. SECTION CODE: C1-C3, extraprostatic tissue attached to left side of prostate; C4-C6, right seminal vesicles and. segment. of. right vas deferens from the base towards the tip; C7-C11, left seminal vesicle and segment of left vas deferens from. the base towards the tip; C12, prostatic base, right border; C13-C17, prostatic base, right posterior border; C18-C25, prostatic. base,. central. portion; C26, prostatic base, left border; C27-C31, prostatic base, left posterior border; C32-C36, apex anterior; C37,. C38, apex left; C39-C42, apex posterior; C43-C46, apex right; C47-C48, detached portions of margin of resection according to. Page: 3. specimen radiograph; C49-C57, sections of the two cross sections of the prostate according to specimen radiograph. The anterior aspect of the prostate is inked in green, left surface in red, right surface in yellow and posterior surface in. black. Blue ink (C2, C10, C11, C39-C42) and orange ink (C50-C53, C56 and C57) denote surfaces and do not represent the true. margin of resection. SNOMED CODES. T-92000, M-Y1973. Entire report and diagnosis completed by:"
BIOCUP_00208,prostate,PRAD,TCGA-EJ-7115,TCGA-EJ-7115.1638ac15-f8d6-4c88-b91e-e21033ae09db,"FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN FIVE (0/5) LYMPH NODES EXAMINED. PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN SIXTEEN (0/16) LYMPH NODES EXAMINED. PART 3: PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL PROSTATECTOMY -. A. INVASIVE POORLY DIFFERENTIATED ADENOCARCINOMA, GLEASON SCORE 4 + 3 = 7. B. THE CARCINOMA INVOLVES BOTH THE RIGHT AND LEFT LOBES AND HAS A GREATEST NODULAR DIAMETER. OF 0.5 cm. C. THE CARCINOMA INVOLVES LESS THAN 5% OF THE EXAMINED PROSTATE VOLUME. D. THE CARCINOMA SHOWS ESTABLISHED EXTRACAPSULAR EXTENSION. E. THE EXTRACAPSULAR EXTENSION IS SEEN IN THE RIGHT POSTERIOR REGION CLOSE TO THE RIGHT SEMINAL. VESICLE (SLIDE 3A). F. BILATERAL SEMINAL VESICLES ARE FREE OF CARCINOMA. G. ALL EXAMINED SURGICAL RESECTION MARGINS ARE FREE OF CARCINOMA. H. EXTENSIVE PERINEURAL INVASION is IDENTIFIED. I. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. J. EXTENSIVE HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA IS IDENTIFIED. K. PATHOLOGIC TNM STAGE: pT3a NO Mx. L. TNM HISTOLOGIC GRADE = G3-4. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 3.6. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 4. SECONDARY GLEASON GRADE: 3. GLEASON SUM SCORE: 7. GLEASON 4/5 PERCENTAGE: 60%. WEIGHT OF PROSTATE: 70.82gm. TUMOR SIZE: Maximum dimension: 0.5 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: < 5% of specimen involved by invasive tumor. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes - multifocal. EXTRAPROSTATIC EXTENSION: Yes - Established (> 0.8mm). PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. LYMPH NODES EXAMINED: 21. LYMPH NODES POSITIVE: 0. T STAGE, PATHOLOGIC: pT3a. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G2, Moderately differentiated."
BIOCUP_00209,prostate,PRAD,TCGA-KK-A8IL,TCGA-KK-A8IL.9F54DC02-35C0-4D0E-A1D8-63F820CF72C4,"MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. (B) RIGHT PELVIC LYMPH NODES: Four lymph nodes, no tumor present. (0/4). (C) LEFT PELVIC LYMPH NODES: METASTATIC ADENOCARCINOMA IN ONE OUT OF FOUR LYMPH NODES (1/4), CONSISTENT WITH A. PROSTATIC PRIMARY. SIZE OF METASTASIS: 0.3 CM. GROSS DESCRIPTION. (A) PROSTATE AND SEMINAL VESICLES - Supplemental report to follow. (B). RIGHT. PELVIC LYMPH NODE - Received is a portion of fibroadipose tissue (9 x 5 x 0.8 cm). Dissection reveals multiple. possible lymph nodes, ranging in size from 0.5 to 2.8 cm. All lymph nodes are submitted as follows: B1, B2, largest lymph node,. serially sectioned; B3, one lymph node, bisected; B4, two possible lymph nodes, intact. (C) LEFT PELVIC LYMPH NODE - A portion of fibroadipose tissue (10 x 4 x 1 cm), containing multiple possible lymph nodes. ranging in size from 0.3 to 2 cm in greatest dimension. All lymph nodes are submitted as follows: C1, two possible lymph. nodes,. intact; C2, one lymph node, bisected; C3, one lymph node, bisected. CLINICAL HISTORY. None given. SNOMED CODES. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: Start of ADDENDUM. Page: 2. ADDENDUM. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (A) PROSTATE AND SEMINAL VESICLES: PROSTATIC ADENOCARCINOMA GLEASON SCORE 9 (4+5). (SEE COMMENT). EXTRAPROSTATIC EXTENSION PRESENT. TUMOR INVADING RIGHT AND LEFT SEMINAL VESICLES AND PERIVESICULAR SOFT TISSUE. TUMOR EXTENDING FOCALLY TO THE MARGIN OF RESECTION. PROSTATIC INTRAEPITHELIAL NEOPLASIA, HIGH-GRADE. SEE PREVIOUS REPORT FOR DIAGNOSIS OF PELVIC LYMPH NODES. COMMENT. The prostate gland contains a single focus of prostatic adenocarcinoma. The tumor is located in the left anterolateral, left lateral,. left posterolateral, left posterior, mid posterior and right posterior peripheral zone. The tumor focus measures 2.3 x 1.5 cm in base the. largest cross-sectional dimension and it is present in the four cross sections of the prostate and extensively in the apex and. regions. The tumor exhibits extraprostatic extension in the left posterolateral surface of the prostate and left superior. neurovascular bundle region. The extent of extraprostatic extension is 3.5 mm. The tumor extensively invades both right and left. seminal vesicles including intra and extraprostatic portions. Extension into perivesicular soft tissue is also present. Tumor extends. focally to the margin of resection in the left posterolateral surface and left superior neurovascular bundle region. The extent of. marginal involvement is approximately 1.0 mm. Please refer to the previous report for the diagnosis of the pelvic lymph nodes. GROSS DESCRIPTION. (A) PROSTATE AND SEMINAL VESICLES - A prostate, attached right and left seminal vesicles and attached segments of right. and left vasa deferentia. The prostate gland (4.2 X 3.7 x 3.3 cm, 29 gm, postfixation) has the usual shape. The soft tissue present along the right. and left posterolateral aspects of the prostate appears symmetrical. A nodule is palpated on the left side of the prostate. Serial four. cross sections after demonstrate a firm area of possible tumor in the left posterolateral peripheral zone of the first two of the. cross sections of the prostate. The seminal vesicles and segments of vasa deferentia are grossly free of tumor. SECTION CODE: A1, A2, base of right seminal vesicle and right vas deferens; A3, A4, base of left seminal vesicle and. left vas deferens; A5, prostatic base right border; A6, A7, prostatic base right posterior border; A8-A11, prostatic base central. portion; A12, prostatic base left border; A13, A14, prostatic base left posterior border; A15, apex anterior; A16, A17, apex left; A18,. Page: 3. A19, apex posterior; A20, A21, apex right; A22, detached portions of margin of resection according to specimen radiograph;. A23-A38, sections of the four cross sections of the prostate according to specimen radiograph. The anterior aspect of the prostate is inked in green, left surface in red, right surface in yellow and posterior surface. in. black. Orange ink (A29, 30, 33, 34 and 38) denotes surfaces that do not represent the true margin of resection. SNOMED CODES. Entire report and diagnosis completed by: END OF REPORT-."
BIOCUP_00210,prostate,PRAD,TCGA-TP-A8TV,TCGA-TP-A8TV.5B38DF20-A6AF-4CD7-9322-36D4823C7A3E,"FINAL DIAGNOSIS: (A) Lymph node, left pelvic; excision: Small single benign lymph node. (B) Lymph nodes, right pelvic; excision: Three benign lymph nodes. (C) Prostate; radical prostatectomy: Adenocarcinoma of the prostate. pTNM classification (based on available surgical material): pT2c, pN0. Histologic type: Adenocarcinoma. Gleason grade: 4 + 3 = 7/10 (please see comment). Percent Gleason grades 4 and 5: 75% and <5%, respectively. Tumor location: All four quadrants involved by tumor (comprising approximately 15%). Maximal tumor diameter: Approximately 2.0 cm. Vascular invasion: Not definitively seen. Extraprostatic extension: Absent. Resection margins: Positive for malignancy in the right anterior base region (spanning an area of. 3 mm). Seminal vesicles: Negative for malignancy. Third Gleason pattern: Present (pattern 5, comprising <5%). Tumor multicentricity: Present. Premalignant changes: High-grade PIN. Non-neoplastic changes: Nodular hyperplasia. Acute prostatitis. Lymph nodes: Please see separate specimens above (0/4). Representative tumor blocks: C6-10. Other findings or comments: A dominant tumor nodule is present in the right anterior region,. showing predominantly 4+4 Gleason pattern with focal tertiary Gleason 5. (D) Bladder neck margin; excision: Negative for malignancy. CLINICAL HISTORY: Malignant neoplasm of prostate. GROSS DESCRIPTION: (A) The specimen is received unfixed labeled. L pelvic node and is a piece of soft, fatty. tissue measuring 1.0 x 1.0 x 0.4 cm. The entire specimen is submitted. (B) The specimen is received unfixed labeled. and rt. Pelvic lymph nodes and are three. lymph nodes ranging in size fro 0.5 to 0.7 cm. (C)) The specimen is received unfixed labeled. and prostate. It is a prostate gland with. attached seminal vesicles. It weighs 32 grams and measures 4.0 x 3.8 x 3.8 cm. The right seminal vesicle. measures 2.5 x 0.7 x 0.4 cm. The left seminal vesicle measures 2.6 x 0.8 x 0.4 cm. The right anterior. prostate is marked with orange ink, right posterior prostate marked with blue ink, left anterior prostate. marked with black ink, left posterior prostate marked with green ink. Sectioning shows a right-sided. poorly defined mass measuring 2.0 x 1.6 X 1.6 cm. Sections are submitted as follows: 1. Right seminal vesicle;. 2. Left seminal vesicle;. 3+4. Apex, coned;. 5. Proximal margin, coned;. 6-10. Right anterior prostate, apex to base;. 11-15. Right posterior prostate, apex to base;. 16-20. Left anterior prostate, apex to base;. 21-25. Left posterior prostate, apex to base. 25 cassettes). (D) The specimen is received in formalin. and bladder neck margin. The specimen consists. of a 0.5 cm pink-tan tissue fragment. 1 (1 cassette)."
BIOCUP_00211,prostate,PRAD,TCGA-VP-AA1N,TCGA-VP-AA1N.B76B30C1-F87D-494B-A95A-3F9E511ED3B1,"Hospital #. Accessioned. DIAGNOSIS: PROSTATE, RADICAL PROSTATECTOMY: ADENOCARCINOMA, GLEASON GRADE 5 + 4 = SCORE OF 9 (SEE SYNOPSIS). 30% OF THE PROSTATE GLAND IS INVOLVED BY CARCINOMA. - CARCINOMA INVOLVES LEFT APEX, RIGHT APEX, ANDLEFT BASE. RIGHT BASE IS FREE OF TUMOR. EXTRAPROSTATIC EXTENSION IDENTIFIED AT LEFT APEX ANDLEFT BASE, AND INTO BLADDER. NECK (SEE COMMENT). CARCINOMA FOCALLY EXTENDS TO RIGHT DISTAL APICAL RESECTION MARGIN; ALL OTHER. MARGINS, INCLUDING BLADDER NECK AND PERIPHERAL MARGINS ARE FREE OF TUMOR. SEMINAL VESICLES, BILATERAL, RADICAL PROSTATECTOMY. - NO EMDENCE OF MALIGNANCY. LYMPH NODES, BILATERAL PELVIC, EXOSION: - FIVE LYMPH NODES WITH NO EVIDENCE OF MALIGNANCY (0/5). Intraoperative Consultation: ""Brought to frozen, 'prostate, consisting of a 34.6 gram prostate (4x 4x 3.8 cm) with bilateral seminal vesicles. Tissue. taken for tumor bank. Rest for permanents,"". Microscopic Description and Comment: Sections show adenocarcinoma of the prostate, Gleason grade 5 + 4 = score of 9, involving 30% of the prostate gland. Page of 3. Page: 1 of 3. Printed from. as determined by a grid morphometric technique. There is established extraprostatic extension by carcinoma at the left. apex and left base. There is also extension into bladder neck (slide B7), which is formally pT4 according to the 2002. TNM scheme, but follow-up data from several studies indicate that this bladder neck involvement is more appropriately. designated pT3. History: The patient is a. with a history of prostate cancer. Operative procedure: Robotic assisted laparoscopic. prostatectomy. Specimen(s) Received: A: LYMPH NODE, BILATERAL PELVIC. B: PROSTATE. Gross Description;. The specimens are received in twoformalin-filled containers, each labeled. The first container is. labeled ""bilateral pelvic lymph nodes."" Five lymph nodes are identified. Labeled A1, one lymph node bisected; A2, four. lymph nodes. Jar 1. The second container is labeled ""prostate.' It holds the previously described, 34.6 gram prostate measuring 4 x 4 x 3.8. cm. The bilateral seminal vesicles are attached. The right seminal vesicle measures 2.9 cm in length. The left seminal. vesicle measures 3 cm in length. The prostate has been previously inked blue. The prostatic urethra is probe patent. Labeled B1, bladder neck margin; B2, left apex margin; B3, right apex margin; B4 and B5, left apex; B6 and B7, left. base; B8 and B9, right apex; B10 and B11, right base; B12, left seminal vesicle; B13, right seminal vesicle. Jar 1. SYNOPTIC WORKSHEET - PROSTATE CARCINOMA. NEOPLASM. A neoplasm is present. HISTOPATHOLOGICTYPE. The tumor type is adenocarcinoma, acinar type. INTRAGLANDULAR TUMOR EXTENT. The intraglandular tumor extent (reported as percent of prostate gland involved by carcinoma) = 30%, as determined. by a grid morphometric technique. GLEASON'S GRADE. The Gleason's Grade is 5+4=9. Page: 2 of 3. Printed from. /. TUMOR LOCATION. The location of the tumor involves the. right apex. left base. left apex. PERINEURAL INVASION. Perineural Invasion is identified. VASCULAR INVASION. Vascular Invesion is not identified. EXTRAPROSTATICEXTENSION. Extraprostatic (extracapsular) extension is established. The tumor extends into the periprostatic soft tissues (specify site): left base and left apex. SEMINAL VESICLES. Seminal vesicles are free of tumor. SAMPLED SPECIMEN MARGINS. Tumor is present at sampled distal apical (urethral) margin of resection. with 1 mm of involvement. NON-NEOPLASTIC PROSTATE. The non-neoplastic prostate shows PIN, high grade, focal. MET ASTATIC LYMPH NODES. The lymph nodes are as follows (expressed as the number of metastatic nodes in relation to the total number of nodes. examined). Bilateral pelvic: 0/5. PRIMARY TUMOR (T). Extracapsular extension (unilateral or bilateral) (T3a). REGIONAL LYMPH NODES (N). No regional lymph node metastasis (NO). DISTANT METASTASIS. No distant metastasis (M0). STAGE GROUPING. Based on this information, the overall AJCC/UICC stage of the tumor is T3/N0/M0/Gleason score 5 + 4 = 9 (Stage III). The pathologic stage assigned here should be regarded as provisional, and may change after integration of clinical. data not provided with this specimen. Surgical Pathology report is available. Page: 3 of 3. Printed from."
BIOCUP_00212,prostate,PRAD,TCGA-HI-7169,TCGA-HI-7169.ed386bc1-82a8-489e-81e0-53a93325a48e,"Sex: M. Source of Specimen(s): 1: left posterior lateral margin. 2: Prostate and Seminal Vessicles. 3: right pelvic lymph nodes. 4: left pelvic lymph nodes. Gross Description: Received in four parts. Source of Tissue: 1. Labeled # 1, ""left posterior lateral margin"". Gross Description: Received fresh in a container labeled,. left posterior lateral margin"". It consists of two fragments. of dark red fibrofatty tissue measuring 0.7 and 0.9 cm. They are. unremarkable and submitted in toto. in 1A. Source of Tissue: 2. Labeled # 2, ""prostate and seminal vesicles"". Gross Description: Received fresh in a container labeled "", ,. , prostate and seminal vesicles"". It consists of a radical. prostate resection weighing 35-grams and measuring 3.5 X 4.0 x 3.4 cm. The capsule is intact and a probe inserts easily through the prostatic. urethra. The right side is inked black and left side blue. Sections. disclose a yellowish tan periphery and centrally the parenchyma is firm. and white, suspicious for lesion. There is a small amount of prostatic. concretions noted. The right seminal vesicle measures 2.0 X 1.2 x 0.7 cm. and left measures 3.0 X 1.5 x 1.0 cm. Both are unremarkable. The right. and left vas deferens stumps measure 2.5 X 0.6 cm. Representative. sections are submitted in 2A-N. Designation of Sections: 2A-2B- apex, 2C-2D- base, 2E-2H- right side of. prostate gland [E- anterior, F- mid, G&H- superior posterior], 2I-2L-. left side of prostate gland [I- anterior, J- mid, K&L- superior. posterior], 2M-right vas deferens and seminal vesicle, 2N- left vas. deferens and seminal vesicle. Source of Tissue: 3. Labeled # 3, ""right pelvic lymph nodes"". Gross Description: Received fresh in a container labeled,. right pelvic lymph nodes"". It consists of multiple fragments. of fibroadipose tissue measuring collectively 4.5 x 3.5 x 2.0 cm. The. tissue is dissected to disclose two potential lymph nodes measuring. respectively 0.9 x 0.5 x 0.5 and 2.0 X 1.0 x 1.0 cm. Both nodes are. fatty. All of the nodal tissue is submitted in 3A and the rest of the fat. in 3B. Source of Tissue: 4. Labeled # 4, ""left pelvic lymph nodes"". Gross Description: Received fresh in a container labeled,. left pelvic lymph nodes"". It consists of some fibroadipose. tissue measuring collectively 4.0 x 3.0 x 1.5 cm. The tissue is dissected. disclosing two firm tan lymph nodes measuring 1.0 and 1.4 cm respectively. All of the nodal tissue is submitted in 4A and the remaining fat in 4B. Final Diagnosis: 1. Left posterior lateral margin, excision: - No tumor seen. No prostatic tissue seen. 2. Prostate and seminal vesicles, radical prostatectomy: - Prostatic adenocarcinoma, Gleason's score 7 (3+4), involving both right. and left lobes (right>left); extraprostatic extension is seen (the right. mid on slide 2F and the right apex on slide 2B); see note. - Tumor is present at the inked right apex margin. - The base and other radial margins with no tumor seen. - The seminal vesicles with no tumor seen. Note: The tumor is seen on most of the sections of the right side of the. prostate (including the right apex). 3. Right pelvic lymph nodes, excision: - No tumor seen in two lymph nodes (0/2). 4. Left pelvic lymph nodes, excision: - No tumor seen in two lymph nodes (0/2)."
BIOCUP_00213,prostate,PRAD,TCGA-M7-A725,TCGA-M7-A725.5885079D-F3C7-44DB-9BA1-60DCA1C9919C,"Diagnosis: A: Lymph nodes, right pelvic, dissection. - No tumor identified in four lymph nodes (0/4). B: Lymph nodes, left pelvic, dissection. - No tumor identified in seven lymph nodes (0/7). C: Prostate, radical prostatectomy. Tumor histologic type: prostatic adenocarcinoma, acinar. Tumor grade (Gleason system) : 7 (4+3) with tertiary Gleason. pattern 5 (5% of tumor volume). Approximate percentage of prostate involved by tumor: overall. 40%; right 15%, left 65%. Extent of tumor: Location of tumor involvement in prostate: bilateral involvement. from apex to near base. Confinement/non-confinement of tumor within the prostatic. capsule: non-confinement of tumor. Location of extracapsular tumor involvement: left mid. (C15, C17). Type of extracapsular tissue involved within tumor: adipose. tissue. Lymphovascular space invasion: present. Seminal vesicles (invasion of muscular wall required) : right. extraprostatic seminal vesicle involved by tumor (C11), left. seminal vesicle negative for tumor. Histologic assessment of surgical margins: positive soft tissue. margins in left mid linear extent <1 mm in each focus, involving. non-contiguous sections (C16, C18). Other significant findings high grade prostatic intraepithelial. neoplasia, extensive perineural involvement. Lymph nodes: no tumor identified in 11 lymph nodes (0/11). Size and location of largest tumor metastasis: not applicable. Extracapsular extension of tumor in lymph nodes: not applicable. AJCC Staging: : pT3b. pNO. This staging information is based on this pathologic specimen. and may be incomplete. A comprehensive review of all available. information is recommended to determine final staging. Clinical History: +year-old male with prostate cancer. Gross Description: Received are three appropriately labeled containers. Container A is additionally labeled ""right pelvic lymph nodes. "". It holds fragments of yellow/tan fibroadipose tissue that in. aggregate measure 5.5 X 5.5 x 1.0 cm. Multiple candidate lymph. nodes are palpated, with the largest measuring 3.1 X 1. 4 X 0.9. cm. The candidate lymph nodes are submitted per block summary. Adipose tissue remains in formalin. Block Summary. A1 - one candidate lymph node, sectioned. A2-A3 - one candidate lymph node, sectioned. A4-A5 - largest candidate lymph node, sectioned. A6-A9 - multiple candidate lymph nodes. Container B is additionally labeled ""left pelvic lymph nodes. "". It holds multiple fragments of yellow/tan fibroadipose tissue. that in aggregate measure 5.0 X 4.5 X 0.9 cm. Block summary: B1-B3 - - largest candidate lymph node, sectioned. B4 - one candidate lymph node, sectioned. B5 - multiple candidate lymph nodes. B6 - multiple candidate 1 ymph nodes. Container C: Specimen fixation: formalin. Type of specimen (s) received: robot assisted laparoscopic. Size of specimen: 4.4 cm medial to lateral, 4.4 cm superior to. inferior, 3.6 cm anterior to posterior. Weight of specimen: 40.0 grams. Orientation: Inking: right=blue, left=black, apex=yellow,. base/bladder neck=red. Size and description of other organs or structures: The prostate. is received with bilateral seminal vesicles and vas deferents. intact. Gross description of prostate Prostatic tissue demonstrates. grossly evidence of mild prostatic hyperplasia by. examination. No gross carcinoma or areas of necrosis or. hemorrhage are identified. Digital photograph taken: not taken. Block summary. C1 - right apex, perpendicular sections. C2-C10 - right prostate, apex to base, respectively, entire. posterior lobe. C11 - right seminal vesicle tissue and right vas deferens. margin, en face. C12 - right bladder neck margin, perpendicular sections. C13 - left apex, perpendicular sections. C14-C22 left prostate, apex to base, respectively, entire. posterior lobe. C23 - left seminal vesicle tissue and left vas deferens margin,. en face. C24 - left bladder neck margin, perpendicular sections."
BIOCUP_00214,prostate,PRAD,TCGA-VP-A87B,TCGA-VP-A87B.C92C198A-660D-4007-AFC2-EA9FE193C3A4,"Gender: M. MRN : Physician (s) : Other Related Clinical Data: DIAGNOSIS: A. PROSTATE, RADICAL PROSTATECTOMY. - ACINAR ADENOCARCINOMA OF THE PROSTATE, GLEASON GRADE 4+4 = 8 WITH. TERTIARY PATTERN OF 3 (SEE SYNOPTIC). - FOCAL LYMPHVASCULAR SPACE INVASION IDENTIFIED. - NO EXTRAPROSTATIC EXTENSION IDENTIFIED. - ALL SAMPLED SURGICAL RESECTION MARGINS, INCLUDING BLADDER NECK AND PROSTATE. APICAL MARGINS FREE OF CARCINOMA. SEMINAL VESICLES, BILATERAL, RADICAL PROSTATECTOMY. - NO EVIDENCE OF MALIGNANCY. B. LYMPH NODES, BILATERAL PELVIC, DISSECTION. - TWO (2) LYMPH NODES, NEGATIVE FOR TUMOR (0/2). By this signature, I attest that the above diagnosis is. based upon my personal. examination of the slides (and/or other material indicated in the. diagnosis). Intraoperative Consultation: An intraoperative non-microscopic consultation was obtained and interpreted as: ""Called to pick up 'prostate, consisting of a 37 gram prostate with attached. bilateral seminal vesicles. The prostate measures 4.5 x 4.5 x 2 cm. Inked. Tissue taken for tumor bank. Rest for permanents, by. Microscopic Description and Comment: Microscopic examination substantiates the above cited diagnosis. History: The patient is a. year old man with localized prostate carcinoma. Operative. procedure: Laparoscopic radical prostatectomy with bilateral pelvic lymph node. dissection. Specimen (s) Received: A: LYMPH NODES, BILATERAL PELVIC. B: PROSTATE. Gross Description. The specimens are received in two formalin-filler containers, each labeled. The first container is labeled ""prostate. It contains a. previously sectioned and inked 37-gram prostate with attached bilateral seminal. vesicles. The prostate measures 4.5 x 4.5 x 2 cm. The right seminal vesicle. measures 1.5 x 1 x 0.3 cm; the left, 1 x 1 x 0.5 cm. The prostate shows. elliptical defects measuring 2.5 cm on either side, representing tissue taken. for tumor bank. Sectioned to show a 0.7 cm tan-white nodule in the right base,. within 0.1 cm of the inked margin. Sectioning the area of the right apex also. shows a well-defined, tan-white nodule measuring 1 cm, abutting the inked. margin and suspicious for carcinoma. Sectioning the left lobe shows a tan-white. to tan-yellow cut surface. Sectioning the bilateral seminal vesicles shows. tan-yellow cut surfaces. Labeled A1, A2 - right apex; A3, A4 - right base; A5,. A6 - left apex; A7, A8 - left base; A9 - left apical margin (perpendicular) i A10. - right apical margin (perpendicular); A11 - bladder neck margin (shave) i A12 -. left seminal vesicle; A13 - right seminal vesicle. Jar 1. The second container is labeled ""bilateral pelvic lymph node."" It contains. two. fragments of tan-yellow fibroadipose tissue, the larger measuring 4.5 x 2.5 x. 0.7 cm; the smaller, 4 x 2 x 0.5 cm. Sectioned to show two fat-infiltrative. lymph nodes with tan-yellow cut surfaces. Labeled B1, B2 - one node; B3 to B6 -. one node. Jar 1. B. PROSTATE: SYNOPTIC WORKSHEET - PROSTATE CARCINOMA. NEOPLASM. A neoplasm is present. HISTOPATHOLOGIC TYPE. The tumor type is adenocarcinoma, acinar type. INTRAGLANDULAR TUMOR EXTENT. The intraglandular tumor extent (reported as percent of prostate gland involved. by carcinoma) is 10-15%. GLEASON'S GRADE. The Gleason's Grade is 4+ 4 = 8 with tertiary pattern of 3. TUMOR LOCATION. The location of the tumor involves the. right base. right apex. PERINEURAL INVASION. Perineural Invasion is identified. VASCULAR INVASION. Focal lymphvascular space invasion identified (seen on slide A4). EXTRAPROSTATIC EXTENSION. Extraprostatic (extracapsular) extension is absent. SEMINAL VESICLES. Seminal vesicles are free of tumor. SAMPLED SPECIMEN MARGINS. All sampled surgical margins are free of tumor. METASTATIC LYMPH NODES. The lymph nodes are as follows (expressed as the number of metastatic nodes in. relation to the total number of nodes examined). Bilateral pelvic: 0/2. PRIMARY TUMOR (T). Tumor involves more than one-half of one lobe but not both lobes (T2b). REGIONAL LYMPH NODES (N). No regional lymph node metastasis (NO). DISTANT METASTASIS. Distant metastasis cannot be assessed (not evaluated by any modality) (MX). STAGE GROUPING. Based on this information, the overall AJCC/UICC stage of the tumor is. T2/NO/MO/Gleason score 4+4 =8 with tertiary pattern of 3 (Stage II). The pathologic stage assigned here should be regarded as provisional, and may. change after integration of clinical data not provided with this specimen. The performance characteristics of some immunohistochemical stains, fluorescence. in-situ hybridization tests and immunophenotyping by flow cytometry cited in. this report (if anv) were determined by the. part of an ongoing quality assurance program and in. compliance with federally mandated regulations drawn from the Clinical. Laboratory Improvement Act of 1988 (CLIA '88) Some of these tests rely on the. use of ""analyte specific reagents"" and are subject to specific labeling. requirements by the US Food and Drug Administration. Such diagnostic tests may. only be performed in a facility that is certified by the Department of Health. and Human Services as a high complexity laboratory under CLIA '88. The FDA has. determined that such clearance or approval is not necessary. This test is used. for clinical purposes. It should not be regarded as investigational or for. research. Nevertheless, federal rules concerning the medical use of analyte. specific reagents require that the following disclaimer be attached to the. This test was develoned and its performance characteristics determined by. the. It has not been. cleared or approved by the U. S. Food and Drug Administration."
BIOCUP_00215,prostate,PRAD,TCGA-H9-A6BY,TCGA-H9-A6BY.87EDA3C6-8BAC-49FD-8592-1D38812660E6,"Operative Procedure: Prostatectomy, pelvic lymph node dissection. Pre-Operative Diagnosis: Not provided. Post-Operative Diagnosis: Not provided. A: Prostate and seminal vesicles. B: Right pelvic lymph nodes. C: Left pelvic lymph nodes. Final Pathologic Diagnosis: A. Prostate and seminal vesicles, prostatectomy: Histologic type: Prostatic adenocarcinoma. Variant histology present: Prostate size: 33 X 54 X 38 mm; weight: 42 g. Gleason score (primary + secondary): 3 + 4 = 7. Primary pattern (%): 3, 80 %. Secondary pattern (%): 4, 20 %. Tertiary pattern (%): Not applicable. Tumor quantitation: Largest tumor focus: 32 mm (greatest dimension). Additional dimensions: 27 x 15 mm. Right posterior extending into anterior. Multifocality: Second largest focus: 21 mm (greatest dimension). Left posterior extending into right posterior. Extraprostatic extension: Focal or non-focal: Focal. Location(s). Right posterior. Seminal vesicle invasion: Cancer at surgical margin: Closest distance with location: <1 mm, left and right posterior. and right anterior. Incised specimen: Apex involvement: Bladder neck involvement: Yes, but not at the margin. Lymph-vascular invasion: Perineural invasion: Present. Treatment effect on carcinoma: Other histologic findings: High-grade prostatic intraepithelial. neoplasia. Lymph nodes submitted: 0 positive / 19 submitted. Ancillary studies: None. Pathologic stage (2010). pT3a pNO pM-not applicable. B. Lymph nodes (10), right pelvic, regional resection: Ten lymph nodes with no pathologic change (0/10). C. Lymph nodes (9), left pelvic, regional resection: Nine lymph nodes with no pathologic change (0/9). The examination of this case material and the preparation of this report were. Gross Description: Received are three formalin filled containers all labeled with the patient's. Part A is received additionally labeled ""prostate and seminal vesicles."" The. specimen consists of a prostate gland with attached bilateral seminal vesicles. and segments of vas deferens. The specimen is inked in the following manner: right side yellow, left side black, posterior aspect over-inked in red. The. remaining gland has a weight of 42 g, and a length of 3.3 cm with additional. dimensions of 5.4 x 3.8 cm. The apex and base prostatic margins of surgical. resection are coned and submitted in cassettes A1-2, respectively. The remaining. gland is step-sectioned in an apex to base manner with sections submitted as. follows: A3-11. right posterior prostate gland apex to base manner;. A12-20. left posterior prostate gland apex to base manner;. A21. right anterior prostate gland level 2;. A22. left anterior prostate gland level 3;. A23. right anterior prostate gland level 4;. A24. left anterior prostate gland level 6;. A25. right anterior prostate gland level 6;. A26. left anterior prostate gland level 7;. A27. right anterior prostate gland level 8;. A28-29 right and left prostate gland approaching interface with seminal. vesicles, respectively;. A30-32. right seminal vesicle and segment of vas in a base, mid to apex. manner;. A33-35. left seminal vesicle and vas in a base, mid to apex manner. Part B is received additionally labeled ""right pelvic nodes"" and consists of. yellow, lobulated, fibrofatty tissues having aggregate dimensions of 5.5 X 3.5. cm by up to 1 cm. These tissues are placed in a ""clearing agent"" and a. subsequent search reveals six probable lymph nodes that range from 0.5 to 3.5 cm. in greatest dimension. The lymph node candidates are submitted as follows: B1. four whole probable lymph nodes;. B2. one whole lymph node bisected;. B3-4. one whole lymph node quadrisected, one-half in each cassette. Part C is received additionally labeled ""left pelvic nodes"" and consists of. yellow, lobulated, fibrofatty tissues having aggregate dimensions of 7 X 5.5 X 1. cm. These tissues are placed in a ""clearing agent' and a subsequent search. reveals six probable lymph nodes that range from 0.5 to 3 cm in greatest. dimension. These lymph node candidates are submitted as follows: C1. two whole probable lymph nodes;. C2. two whole probable lymph nodes;. C3. one whole probable lymph node;. C4-5 one whole lymph node bisected, one-half in each cassette. Microscopic Description: The final diagnosis of each specimen incorporates the microscopic examination. findings. Gender: M."
BIOCUP_00216,prostate,PRAD,TCGA-J4-A67S,TCGA-J4-A67S.D5BC3AA7-D957-4291-8A6B-D148AA7CA909,"M. Date Of Birth. Encounter Number. COPY ONLY DO NOT FILE. Finar. Source of Specimen. A. LEFT PELVIC LYMPH NODES FS-. B. LEFT PELVIC LYMPH NODES NFS-. C. PROSTATE SEMINAL VESICLES AND VAS DEFERENS-. FINAL DIAGNOSIS: A. LEFT PELVIC LYMPH NODES FS-. LYMPH NODE, NO TUMOR SEEN. B. LEFT PELVIC LYMPH NODES NFS-. TWO LYMPH NODE FRAGMENTS, NO TUMOR SEEN. C. PROSTATE SEMINAL VESICLES AND VAS DEFERENS-. ADENOCARCINOMA OF PROSTATE WITH UNI- LATERAL EXTENSION INTO. EXTRAPROSTATIC SOFT TISSUE. TUMOR SITE: RIGHT AND LEFT, MOSTLY IN LEFT PERIPHERAL ZONE. SPECIMEN TYPE: RADICAL PROSTATECTOMY. WEIGHT: 40 GRAMS. SIZE: 4 x 3.5 x 3 CM. GLEASON SCORE (PRIMARY + SECONDARY PATTERN) : 3 + 4 = 7/10. TERTIARY PATTERN: NOT PRESENT. SEVERITY IN EXTENT OF TUMOR: 4 /5. (1: <5% 2: 5-15%; 3: 15-30%; 4: 30-508; 5: > 50% tissue. involvement). Prepared for. DOMINANT NODULE (AT LEAST 1 CM IN SIZE) : NOT PRESENT. TREATMENT EFFECT ON CARCINOMA: NOT IDENTIFIED. TNM STAGE: pT3a, pNo, pMX. (NO: negative node; N1: positive regional node). LYMPHATIC (SMALL VESSEL) INVASION: NOT SEEN. PERINEURAL INVASION: NOT PRESENT. NO TUMOR SEEN IN SEMINAL VESICLES. MARGIN STATUS: POSITIVE INKED MARGINS: LEFT PROSTATE. OTHER MARGINS ARE CLEAR. signed others. Frozen Section. A. LEFT PELVIC LYMPH NODE: NO TUMOR SEEN 10 OF 1) . FS performed by. Case Clinical Information. ADENOCARCINOMA OF PROSTATE. Gross Description. A. Received in formalin labeled with the patient's name and. 'left pelvic lymph nodes FS"" is a gray-tan FS tissue fragment. measuring 1.3 x 0.6 cm. Submitted in A1. B. Received in formalin labeled with the patient's name and. ""left pelvic lymph nodes NFS"" is a yellow fibrofatty tissue. fragment measuring 3.0 x 2.5 x 0.5 cm. The fat is trimmed and. two probable lymph nodes are grossly identified. The larger. measures 0.7 x 0.4 cm and the smaller measures 0.5 x 0.2 cm. Submitted in B1. C. Received in formalin labeled with the patient's name and. ""prostate seminal vesicles and vas deferens"" is a radical. Prepared for. prostatectomy specimen weighs 40 gram prostate gland with. attached seminal vesicle and vas deferens. The prostate gland. measures 4.0 x 3.5 x 3.0 cm and has a shaggy capsule that is. disrupted at the bladder resection margin and has been. previously inked black on the left and blue on the right. The. right seminal vesicle measures 3.5 x 1.5 cm. The right vas. measures 1.5 x 0.5 cm. The left seminal vesicle measures 3.0 x. 1.0 cm. The left vas measures 1.0 x 0.5 cm. The inferior. prostate is sectioned transversely, removed from the rest of the. specimen and sectioned from anterior to posterior following the. plane of the urethra. The remaining gland is serially sectioned. transversely and shows a firm, focally nodular parenchyma. The. seminal vesicles and vasa deferentia show no abnormalities. Representative sections submitted as follows: inferior prostate. demonstrating apical margin submitted entirely anterior to. posterior in C1-C6 ; bladder resection margin in C7-C8; complete. section of mid gland anterior C9-C10; posterior C11-C12;. complete section of upper third of gland, anterior C13-C14;. posterior C15-C16; remainder of the posterior gland submitted in. C17-C22; right seminal vesicle and vas deferens C23; left. seminal vesicle and vas deferens C24. Also there are two. additional cassettes for research labeled ""normal"" and. ""tumor"". Procedure. A. AA ROUTINE H&E X1 BLOCK. H&E X1. B. AA ROUTINE H&E X1 BLOCK. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 1. H&E X1. C. AA ROUTINE H&E X1 BLOCK.: 2. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 3. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 4. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 5. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 6. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 7. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 8. Prepared for. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 9. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 10. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 11. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 12. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 13. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 14. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 15. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 16. H&E X1. C. AA ROUTINE H&E X1 BLOCK.: 17. H&E X1. C. AA ROUTINE H&E X1 BLOCK.18. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 19. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 20. H&E X1. C. AA ROUTINE H&E X1 BLOCK.21. H&E X1. C. AA ROUTINE H&E X1 BLOCK.22. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 23. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 24. H&E x1. Prepared for."
BIOCUP_00217,prostate,PRAD,TCGA-V1-A8MU,TCGA-V1-A8MU.8E072738-2D8E-4254-B1DE-A8008C614B7F,"Service Date: Male. Soc. Sec. #: Client: FINAL PATHOLOGIC DIAGNOSIS. A. Prostate, right posterior base, biopsy: Vascular fibroadipose tissue, smooth muscle. and nerve. No tumor. B. Prostate, left posterior apex margin, biopsy: Prostatic adenocarcinoma; see. comment. C. Lymph nodes, right external iliac, dissection: No tumor in two lymph nodes (0/2). D. Lymph nodes, right obturator, dissection: Metastatic adenocarcinoma in one of. three lymph nodes (1/3). E. Lymph nodes, left external iliac, dissection: No tumor in five lymph nodes (0/5). F. Lymph nodes, left obturator, dissection: No tumor in ten lymph nodes (0/10). G. Prostate, anterior apical margin, biopsy: Fibromuscular tissue and nerve, no. tumor. H. Prostate, posterior apex margin, biopsy: Vascular fibromuscular tissue and nerve,. no tumor. I. Soft tissue, preprostatic, excision: Vascular fibroadipose tissue, no tumor. J. Prostate and seminal vesicles, radical prostatectomy: 1. Prostatic adenocarcinoma, Gleason pattern 3+4=7, involving bilateral prostate with. limited extracapsular extension; see comment. 2. Seminal vesicles with no tumor. COMMENT: The left posterior apical margin specimen submitted for frozen section (part B) contains a focus of. glandular epithelium with complex architecture, but without an infiltrative appearance. Immunohistochemical stains for p63 and HMWK were obtained on this specimen and the focus in. question is negative for basal cells. These results support our interpretation that this focus represents. prostatic adenocarcinoma. In addition, cauterized glands highly suspicious for adenocarcinoma are present at the inked, cauterized. apical margin of the main specimen (slides J1 and J2). Immunohistochemical stains for p63 and HMWK. were obtained on block J2 in order to evaluate these glands. The glands in question are negative for. basal cells, supporting the interpretation of these foci as adenocarcinoma and our interpretation that. this represents tumor at the inked, cauterized margin. Of note, the separately submitted anterior apical. margin (part G) and posterior apical margin (part H) are negative for carcinoma. Correlation with. operative findings is required in order to determine the final margin status. Synoptic Comment for Prostate Tumors. - Type of tumor: Small acinar adenocarcinoma. - Location of tumor: Left posterior apex, slides J2 and J9; mid gland, slide J10; base, slide J11; left. anterior apex, slides J2 and J12; mid gland, slide J13; base, slide J19; right posterior apex, slides J1. and J6; mid gland, slide J7; base, slide 08; right anterior apex, slides J1 and J3; mid gland, slide J4;. base, slide J18. - Estimated volume of tumor: 7.35 cm¬≥. - Gleason score: 3+4; primary pattern 3, secondary pattern 4. - Estimated volume > Gleason pattern 3: 40%. - Involvement of capsule: Tumor invades capsule (slide J7 - right posterior mid gland, slide J8 - right. posterior base). Extraprostatic extension: Present, limited in extent (slide J18 - right posterior base). has reviewed this section and agrees with the interpretation of limited extraprostatic extension. - Margin status for tumor: - Positive (slide J1 - right apex, slide J2 - left apex); location and length of largest positive. margin: Left apex, slide J2, 1 mm in length. Gleason pattern at largest positive margin: 3 + 4. The separately submitted anterior apical and posterior apical margins (parts G and H) are. negative for tumor. In addition, tumor is present immediately adjacent to the inked margin at the right posterior mid gland. (slide J7) and adjacent to the right seminal vesicle (slide J18). - Margin status for benign prostate glands: - No benign glands present at inked excision margins. - High-grade prostatic intraepithelial neoplasia (HGPIN): Present, focally. - Tumor involvement of seminal vesicle: None. - Perineural infiltration: Present. - Lymph node status: - Positive;. - Total number of positive nodes: 1. - Total number of nodes examined: 20. - Size of largest metastasis in node: 0.3 mm. - Extranodal extension: None. - AJCC/UICC stage: pT3aN1. Specimen(s) Received. A:Right posterior base (FS). B:Left posterior apex margin (FS). C:Right external illac LN. D:Right obturator lymph nodes. E:Left external iliac LN. F:Left obturator LN. G:Anterior apical margin. H:Posterior apex margin. I:Pre-prostate fat. J:Prostate & seminal vesicles (fresh). Intraoperative Diagnosis. FS1 (A) Right posterior base, biopsy: Benign vascular fibroadipose tissue, smooth muscle, and nerve,. no epithelium, no tumor. FS2 (B) Left posterior apex margin, biopsy: Glands with smooth muscle, highly suspicious for. carcinoma, but cannot entirely rule out benign prostate or peri-urethral glands. Clinical Historv. The patient is al. man. Review of electronic medical records. indicates. that the patient has biopsy-proven prostatic adenocarcinoma, Gleason grade 3+4 in the right. mid-gland, right base, left apex, left mid-gland and left base. The patient now. undergoes a robotic assisted laparoscopic radical prostatectomy. Gross Description. The specimen is received in ten parts, each labeled with the patient's name and medical record number. Parts A, B, and J are received fresh. The remainder of the parts are received in formalin. Part A, additionally labeled ""right posterior base - frozen section,"" consists of an irregular, unoriented,. red-tan soft tissue fragment (1 x 0.3 x 0.2 cm). The entire specimen is frozen for frozen section. diagnosis 1, and subsequently submitted in cassette A1. 1. Part B, additionally labeled ""left posterior apex margin - FS,"" consists of a piece of irregular, unoriented,. red-tan soft tissue (0.8 x 0.6 x 0.2 cm). The entire specimen is frozen for frozen section diagnosis 2,. and subsequently submitted in cassette B1. Part C, additionally labeled ""right external iliac lymph nodes,"" consists of a single irregular, unoriented,. yellow-tan fibrofatty tissue fragment (4.5 x 2.5 x 0.7 cm). Examination reveals two ovoid, firm,. light-tan lymph node candidates (both approximately 1.3 cm) which are bisected and entirely submitted. in cassette C1. Part D, additionally labeled ""right obturator lymph nodes,"" consists of multiple soft to firm, irregular,. yellow-tan, fibrofatty tissue fragments (4 x 3 x 1 cm in aggregate). Examination reveals three firm,. irregular, light-tan lymph node candidates (1.3 cm - 1.7 cm) which are submitted as follows: D1: One lymph node candidate, bisected. D2: One lymph node candidate, bisected. D3: One lymph node candidate, bisected. Part E, additionally labeled ""left external iliac lymph node,"" consists of multiple soft to firm, irregular,. yellow-tan fibrofatty tissue fragments (3.5 x 3 x 1 cm in aggregate). Examination reveals four firm,. light-tan lymph node candidates (0.5 cm - 1.7 cm), which are submitted as follows: E1: One lymph node candidate, bisected. E2: One lymph node candidate, bisected. E3: Two lymph node candidates, intact. Part F, additionally labeled ""left obturator lymph nodes,"" consists of multiple soft to firm, irregular,. yellow-tan fibrofatty tissue fragments (4 x 4 x 1 cm in aggregate). Careful examination reveals eight. irregular, firm, tan, unoriented lymph node candidates (0.4 cm - 1.7 cm), which are submitted as. follows: F1: One lymph node candidate, bisected. F2: One lymph node candidate, bisected. F3: One lymph node candidate, intact. F4: Two lymph node candidates, intact. F5: Three lymph node candidates, intact. Part G, additionally labeled ""anterior apical margin,"" consists of a single, irregularly shaped, unoriented,. white-tan, heavily cauterized tissue fragment (0.5 x 0.2 x 0.2 cm). The specimen is inked black and. entirely submitted in cassette G1. Part H, additionally labeled ""posterior apex margin,"" consists of three irregular, unoriented, white-tan,. cauterized tissue fragments (1 x 0.3 x 0.2 cm in aggregate). The fragments are inked black and. entirely submitted in cassette H1. Part 1, additionally labeled ""preprostatic fat,"" consists of a single irregular segment of soft, yellow-tan. fibrofatty tissue (3 x 2 x 0.5 cm). Examination reveals no lymph node candidates. The entire specimen. is submitted in cassette I1. Part J, additionally labeled ""prostate and bilateral seminal vesicles,"" consists of a single intact radical. prostatectomy specimen with attached seminal vesicle/vas deferens bundles (53.5 gm; 3.8 cm from. apex to base x 4.5 cm in width x 3.6 cm from anterior to posterior. GROSS PATHOLOGIC FINDINGS: There is a large, irregular, poorly defined, lobular, white-tan mass (2. x 1.5 x 0.8 cm) in the right posterior mid gland through base (slices S-7, cassettes J7 and J8). A. second solld, white, well-circumscribed, ovoid nodule (0.7 x 0,7 x 0.7 cm) is noted in the left posterior. apex through mid gland (slices 3-5, cassettes J9 and J10). The remaining parenchyma is light-tan and. unremarkable. The central-transitional zone is of normal size and composed predominantly of striated,. fibrous tissue. No other discrete masses or lesions are noted. The anterior fibrous stroma is open, and. the remaining capsule is intact. The seminal vesicle/vas deferens bundles (both measure approximately. 5 x 3 x 1 cm) are soft, red-tan, whorled without discrete lesion or mass. ORIENTED BY: Anatomic landmarks. INKING: - Right anterior: Green. - Left anterior: Blue. - Posterior: Black. POTENTIAL STUDIES: Fresh tissue is snap frozen for research purposes. GROSS PHOTOGRAPHS: Yes. NUMBER OF SLICES: 9 (inclusive of apical margin) with average slice thickness being 0.42 cm. CASSETTES: Representative sections are submitted as follows: Apical margin, entirely submitted in perpendicular sections. J1: Right apex. J2: Left apex. Right anterior quadrant. J3: Serial slice 3. J4: Serial slice 5. J5: Serial slice 7. Right posterior quadrant. J6: Serial slice 3. J7: Serial slice 5. J8: Serial slice 7. Left posterior quadrant. J9: Serial slice 3. J10: Serial slice 5. J11: Serial slice 7. Left anterior quadrant. J12: Serial slice 3. J13: Serial slice 5. J14: Serial slice 7. Bladder margin, entirely submitted in perpendicular sections. J15-J17: Sequentially submitted from right to left. Prostatic/seminal vesicle junction and cross-section of vas deferens. J18: Right. J19: Left. The immunoperoxidase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. S. Food and Drug Administration. The FDA has determined that Such clearance or approval is not necessary. These tests are used for clinical purposes. They. should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (""CLIA"") as qualified to perform high-complexity clinical testing. Diagnosis based on gross and microscopic examinations. Final diagnosis made by attending pathologist. following review of all pathology slides."
BIOCUP_00218,prostate,PRAD,TCGA-YL-A8HO,TCGA-YL-A8HO.3C690B20-F9EC-456D-B397-928E39B3FFE2,"SPECIMEN. PROSTATE, RESECTION. RIGHT PELVIC NODES. LEFT PELVIC NODES. GROSS DESCRIPTION. Specimen is received fresh in one container labeled with patient's name and ""prostate + seminal vesicles"". The. specimen consists of a radical prostatectomy weighing 94.42 grams. The prostate measures 6.0 cm. x 5.0 cm x. 4.5 cm. The left vas deferens measures 3.0 cm. x 0,5 cm. The anterior aspect of the prostate is inked red, and. the posterior aspect is inked black. Specimen is sectioned as per protocol and submitted as per summary of. sections. Please note that some tissue is tissue banked. SUMMARY OF SECTIONS. A1 = LEFT VAS DEFERENS;. A2 = BLADDER NECK, SHAVE D MARGIN;. A3 = RIGHT ANTERIOR APEX;. A4-A8 = RIGHT ANTERIOR QUADRANT, APEX TO BASE;. A9 = RIGHT ANTERIOR MARGINS;. A10 = RIGHT ANTERIOR BASE;. All =RIGHT ANTERIOR BASE. A12 = RIGHT POSTERIOR APEX;. A13-A15 = RIGHT POSTERIOR QUADRANT, APEX TO BASE;. A16 = RIGHT POSTERIOR MARGINS;. A17 = RIGHT POSTERIOR BASE;. A18 = LEFT ANTERIOR APEX;. A19 AND A20 = LEFT ANTERIOR QUADRANT, APEX TO BASE;. A21 = LEFT ANTERIOR MARGINS;. A22 = LEFT ANTERIOR BASE;. A23 = LEFT ANTERIOR BASE;. A24 = LEFT POSTERIOR APEX;. A25-A27 = LEFT POSTERIOR QUADRANT, APEX TO BASE;. A28 = LEFT POSTERIOR MARGINS;. A29 = LEFT POSTERIOR BASE;. A30 = LEFT POSTERIOR BASE. DIAGNOSIS. PROSTATE GLAND, RADICAL PROSTATECTOMY WITH RIGHT AND LEFT PELVIC LYMPHADENECTOMY: PRIMARY TUMOR DIAGNOSIS : ADENOCARCINOMA (ACINAR, NOT OTHERWISE SPECIFIED). GLEASON SCORE 4 + 3 = 7 /10. WITH A TERTIARY COMPONENT 5. LOCATION OF TUMOR : - TUMOR INVOLVES BOTH LOBES, (RIGHT ANTERIOR, RIGHT POSTERIOR, LEFT ANTERIOR. LEFT POSTERIOR QUADRANTS). EXTENT OF TUMOR : TUMOR DEMONSTRATES EXTRA-PROSTATIC EXTENSION, UNILATERAL (LEFT SIDE). - TUMOR DOES NOT INVADE THE MUSCULAR WALL OF THE SEMINAL VESICLE. MARGIN OF EXCISION : - TUMOR is PRESENT AT THE BLADDER BASE MARGIN. LYMPH NODES, RIGHT PELVIC : &-BENIGN LYMPH NODES (0/8). LYMPH NODES, LEFT PELVIC : - 10 BENIGN LYMPH NODES (0/10). ADDITIONAL TUMOR FEATURES : - TUMOR INVOLVES APPROXIMATELY 15 TO 20% OF THE PROSTATE GLAND. VASCULAR INVASION IS NOT IDENTIFIED. PERINEURAL INVASION IS IDENTIFIED. EXTENT OF EXTRA-PROSTATIC SPREAD : FOCAL. EXTENT OF MARGIN POSITIVITY : FOCAL. ADDITIONAL FINDINGS AND COMMENTS : - PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN), HIGH GRADE. - BASAL CELL HYPERPLASIA. - ATROPHY. TNM : pT3a (R1: residual microscopic disease), NO, Mx. ""es. ,iteria. hagne sis Discrepancy. rimary Tamer Site Diser spance. IPA A Discreading. not Malignence. rua'. (circle). QUALINE /. initi. Date Rewewed: 1513."
BIOCUP_00219,prostate,PRAD,TCGA-HC-7750,TCGA-HC-7750.f05d95fd-391d-49ab-8a2f-039110a654bd,"DIAGNOSIS. DIAGNOSIS: A. Prostate, vas deferens and seminal vesicles, prostatectomy: Tumor Characteristics: 1. Histologic type: Adenocarcinoma. 2. Prostate size: 4.5x4.0x3.5cm. 3. Tumor quantitation: Tumor occupies roughly 10 to 15% of prostate volume. 4. Gleason grade: a. Primary pattern: 3/5. b. Secondary pattern: 4/5. C. Total Gleason score: 7/10. 5. Extraprostatic extension: Not identified. 6. Seminal vesicle involvement: Not identified. 7. Lymphovascular space invasion: Not identified. 8. High grade PIN: Not identified. Surgical Margin Status: 1. Inked margins negative for tumor. 2. Apex and bladder base margins negative. Lymph Node Status: 1. No lymph nodes present. Other: 1. pTNM stage: pT2cNX. B. Left lateral margin, biopsy: Negative for malignancy. C. Urethral margin, biopsy: Extensive cautery artifact without definitive malignancy identified. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: year old maie with prostate cancer. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Prostate, vas deferens, seminal vesicle. B. Left lateral margin. C. Urethral margin. SPECIMENDATA. GROSS DESCRIPTION: The specimen is received in three formalin filled containers labeled with the patient's nan. Container A is additionally labeled ""prostate, vas deferens, seminal vesicle"" and contains a 41.4 gm, 4.5 x 4.0 X 3.5 am prostate received with attached. bilateral adnexa having overall dimensions of 4.0 x 3.8 x 1.0 cm. The capsule is pink-tan and shaggy. It is inked as follows: right side blue and left side. black. The base and apical margins are coned and serially sectioned. The remainder of the gland is serially sections from apex to base to reveal a pink-. tan focally cystic cut surface with diffuse periurethral nodularity. A 0.5 cm, ill defined, yellow-tan lesion is present within the left posterior quadrant near. the apex. This nodule approaches to within 0,4 cm of the inked capsule. No additional lesions are identified. Also received in the same container. is. 4.0 cm in length by 0.4 cm in diameter, pink-tan. cvlindrical soft tissue consistent with vas deferen. A1-18 labele. Lesignated as follows: 1 right prostate/seminal vesicle junction; 2 left prostate/seminal vesicle junction; 3-4 apical. margin, perpendicular; 5-6 base margin, perpendicular; 7-9 right anterior, apex to base; 10-12 right posterior, apex to base; 13-15 left anterior, apex to. base; 16-18 left posterior, apex to base. Additionally, a yellow and green cassette are submitted for genomics research, each labeled. Container B is additionally labeled ""left lateral margin"" and contains two pink-tan, rubbery, irregular soft tissues, each measuring 1.5 cm in greatest. dimension. One tissue features a white clip at one edge. No designation is given to the clip. The clip is removed and the specimen is entirely. submitted. in cassette B labele. Container C is additionally labeled ""urethral margin"" and contains a 1.3 x 0.5 x 0.4 cm, pink-tan, diffusely cauterized, rubbery soft tissue. Entirely. submitted in cassette C labeled."
BIOCUP_00220,prostate,PRAD,TCGA-J4-A83M,TCGA-J4-A83M.8AA3EBE4-49E8-4D0A-A3A4-B51E41B3AA4F,"Date Of Birth. Encounter Number. COPY ONLY DO NOT FILE. Source of Specimen. A. LEFT PELVIC LYMPH NODES-. B. RIGHT PELVIC LYMPH NODES-. C. PROSTATE, SEMINAL VESICLES AND VASA DEFERENTIA-. FINAL DIAGNOSIS: A. LEFT PELVIC LYMPH NODES-. TWO LYMPH NODES (0/2), NO TUMOR SEEN. B. RIGHT PELVIC LYMPH NODES-. TWO LYMPH NODES (0/2), NO TUMOR SEEN. c. PROSTATE, SEMINAL VESICLES AND VASA DEFERENTIA-. ADENOCARCINOMA OF PROSTATE. TUMOR SITE: BILATERAL, MOSTLY IN PERIPHERAL ZONE. SPECIMEN TYPE: RADICAL PROSTATECTOMY. WEIGHT: 29 GRAMS. SIZE: 4.0 x 3.0 x 3.0 CM. GLEASON SCORE (PRIMARY + SECONDARY PATTERN) : 4 + 3 = 7/10. TERTIARY PATTERN: IS NOT PRESENT. SEVERITY IN EXTENT OF TUMOR: 5/5. (1: <5%; 2: 5-15%; 3: 15-30%; 4: 30-50; 5: > 50% tissue. involvement). DOMINANT NODULE (AT LEAST 1 CM IN SIZE) : IS PRESENT, 1.0 CM IS. SIZE. TREATMENT EFFECT ON CARCINOMA: N/A. TNM STAGE: AT LEAST pT2c (SEE COMMENT), pNo, pMX. LYMPHATIC (SMALL VESSEL) INVASION: IS NOT SEEN. PERINEURAL INVASION: IS PRESENT. NO TUMOR SEEN IN SEMINAL VESICLES. MARGIN STATUS: POSITIVE INKED MARGINS: LEFT ANTERIOR PROSTATE (C11) AND. RIGHT POSTERIOR (C14), SEE COMMENT. OTHER MARGINS ARE CLEAR. COMMENT: THERE IS NO EXTRAPROSTATIC SOFT TISSUE IDENTIFIED AT. THE POSITIVE MARGINS. THE PERIPROSTATIC SOFT TISSUE IDENTIFIED. IN REMAINING SECTIONS, IS NOT INVOLVED BY TUMOR. Signed Others. Frozen Section. A. RIGHT PELVIC LYMPH NODES, GROSS EXAM: 1.7 x 1 X 1 CM. FRAGMENT OF LOBULATED ADIPOSE TISSUE. NO LYMPH NODES PALPATED. OR SEEN. DEFERRED FOR PERMANENTS. LEFT PELVIC LYMPH NODES, GROSS EXAM: 4.2 X 0.9 x 0.5 CM. ELONGATED FRAGMENT OF LOBULATED ADIPOSE TISSUE. NO LYMPH NODES. PALPATED OR SEEN. DEFERRED FOR PERMANENTS. FS performed by. Case Clinical Information. PROSTATE CANCER. Gross Description. A. Received in formalin labeled with the patient's name and. ""left pelvic lymph nodes"" is a single elongated nodule with. attached fat and an attached suture with no definitive. orientation to the suture on the container or the requisition. The specimen measures 4 x 1 x 0.3 cm thick. The suture is. removed. The entire specimen is bisected and submitted in A1. B. Received in formalin labeled with the patient's name and. ""right pelvic lymph nodes"" is a single elongated nodule of tan,. fatty tissue measuring 3 x 1 x 0.3 cm in maximal thickness. The. specimen is bisected and entirely submitted in B1. C. Received in formalin labeled ""prostate, seminal vesicles and. vasa deferentia"" is a radical prostatectomy specimen which. includes a 29 gram prostate gland with attached seminal vesicles. and vasa deferentia. The prostate gland measures 4 x 3 x 3 cm. and has a shaggy capsule that is disrupted at the bladder. resection margin and has been previously inked black on the left. and blue on the right. The right seminal vesicle measures 3 x 1. x 1 cm. The right vas measures 2 cm in length. The left seminal. vesicle measures 2.8 x 1 x 1 cm. The left vas measures 2.5 cm. in. length. The inferior prostate is sectioned transversely,. removed from the rest of the specimen and sectioned from. anterior to posterior following the plane of the urethra. The. remaining gland is serially sectioned transversely and shows a. firm, focally nodular parenchyma. The seminal vesicles and vasa. deferentia show no gross abnormalities. Representative sections. submitted as follows: inferior prostate demonstrating apical. margin submitted entirely anterior to posterior in C1-C7;. bladder resection margin in C8-C10; complete section of mid. gland anterior in C11, C12; posterior in C13, C14; complete. section of upper third of gland, anterior in C15, C16; posterior. in C17, C18; remainder of the posterior gland entirely submitted. in C19-C21; right seminal vesicle and vas deferens in C22; and. left seminal vesicle and vas deferens in C23. Procedure. A. AA ROUTINE H&E X1 BLOCK. H&E X1. B. AA ROUTINE H&E X1 BLOCK. H&E X1. c. AA ROUTINE H&E X1 BLOCK. 1. H&E X1 A RECUTS. c. AA ROUTINE H&E X1 BLOCK.: 2. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 3. H&E X1. C. AA ROUTINE H&E X1 BLOCK. H&E X1. c. AA ROUTINE H&E X1 BLOCK.5. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 6. H&E X1. c. AA ROUTINE H&E X1 BLOCK. 7. H&E X1. C. AA ROUTINE H&E X1 BLOCK. H&E X1. c. AA ROUTINE H&E X1 BLOCK. 9. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 10. H&E X1. c. AA ROUTINE H&E X1 BLOCK. 11. H&E X1 A RECUTS. c. AA ROUTINE H&E X1 BLOCK.12. H&E X1. c. AA ROUTINE H&E X1 BLOCK. 13. H&E X1. C. AA ROUTINE H&E X1 BLOCK. 14. H&E X1 A RECUTS. C. AA ROUTINE H&E X1 BLOCK.15. H&E X1. C. AA ROUTINE H&E X1 BLOCK.16. H&E X1. c. AA ROUTINE H&E X1 BLOCK.17. H&E X1. c. AA ROUTINE H&E X1 BLOCK. 18. H&E X1 A RECUTS. C. AA ROUTINE H&E X1 BLOCK.19. H&E X1. c. AA ROUTINE H&E X1 BLOCK.20. H&E X1. c. AA ROUTINE H&E X1 BLOCK.21. H&E X1 A RECUTS. c. AA ROUTINE H&E X1 BLOCK. 22. H&E X1. c. AA ROUTINE H&E X1 BLOCK. 23. H&E X1."
BIOCUP_00221,prostate,PRAD,TCGA-EJ-5495,TCGA-EJ-5495.5c549c39-b223-49eb-aa93-0298cdf33370,"The patient is a. He underwent a prostate needle biopsy. demonstrating prostatic. adenocarcinoma, with a maximal Gleason score 4 + 4 = 8. PRE-OP DIAGNOSIS: Prostate cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Radical retropubic prostatectomy and bilateral pelvic lymph node dissection. FINAL DIAGNOSIS: PART 1: RIGHT PELVIC LYMPH NODES, EXCISION -. A. MICROSCOPIC FOCUS OF METASTATIC PROSTATIC ADENOCARCINOMA LARGELY REPLACING ONE OF. NINE (1/9) LYMPH NODES (SLIDE 1C). B. METASTATIC FOCUS MEASURES 0.15 CM. C. NO EXTRACAPSULAR EXTENSION IS IDENTIFIED (See comment). PART 2: LEFT PELVIC LYMPH NODES, EXCISION -. NINE BENIGN LYMPH NODES (0/9). NO EVIDENCE OF MALIGNANCY. PART 3: PROSTATE, BILATERAL SEMINAL VESICLES, AND BILATERAL DISTAL VASA DEFERENTIA (RADICAL. PROSTATECTOMY). A. PROSTATIC ADENOCARCINOMA, ACINAR TYPE WITH FOCAL ONCOCYTIC AND FOCAL SIGNET RING CELL. FEATURES, GLEASON SCORE 5 + 3 = 8 WITH A TERTIARY GLEASON PATTERN 4 CARCINOMA. COMPONENT. GLEASON PATTERNS 4 AND 5 COMPONENTS COMPRISE APPROXIMATELY 75% OF THE. EXAMINED TUMOR VOLUME. CARCINOMA EXTENSIVELY INVOLVES BOTH RIGHT AND LEFT LOBES OF. THE PROSTATE GLAND. B. MAXIMAL TUMOR DIAMETER IS 2.3 CM IN A HISTOLOGIC SECTION. C. CARCINOMA COMPRISES APPROXIMATELY 40% OF THE EXAMINED PROSTATE GLAND VOLUME. D. MULTIFOCAL ESTABLISHED EXTRACAPSULAR EXTENSION IS PRESENT IN THE FOLLOWING REGIONS: BILATERAL POSTERIOR BASE / PERISEMINAL VESICLE SOFT TISSUE (SECTIONS 3A, 3C, 3AA),. BILATERAL ANTERIOR MID PROSTATE (SECTIONS 3N AND 3S), AND LEFT ANTERIOR BASE (SECTION 3T). E. EXTENSIVE CARCINOMATOUS PERINEURAL INVASION IS IDENTIFIED. F. SEVERAL MICROSCOPIC ANGIOLYMPHATIC TUMOR EMBOLI ARE IDENTIFIED (SECTIONS 3Q, 3T, 3RR,. AND 3YY). G. CARCINOMA EXTENSIVELY INFILTRATES BILATERAL SEMINAL VESICLES (SECTIONS 3A AND 3C) AND. RIGHT VAS DEFERENS (SECTION 3B). H. CARCINOMA IS PRESENT AT THE RIGHT VAS DEFERENS RESECTION MARGIN. MAXIMAL LINEAR EXTENT. OF MARGIN POSITIVITY IS 0.3 CM. ALL OTHER SURGICAL RESECTION MARGINS SAMPLED ARE. MICROSCOPICALLY FREE OF NEOPLASIA. I. MULTIFOCAL HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA. J. NON-NEOPLASTIC PROSTATE WITH FOCAL GLANDULAR ATROPHY. K. TNM PATHOLOGIC STAGE: T3b, N1, MX. L. HISTOLOGIC GRADE: G3-4 (SEE COMMENT AND SYNOPTIC). COMMENT: Parts 1 and 3: One small lymph node is largely replaced by metastatic carcinoma (slide 1C), visible on the H&E stained. section. The diagnosis of metastatic prostatic adenocarcinoma is supported to an immunohistochemical panel of stains,. demonstrating that the metastatic carcinoma cells are immunoreactive for pankeratin, prostate specific antigen, and. androgen receptor, and are negative for leukocyte common antigen and CD68. Cytokeratin immunostains performed on. the. other two right pelvic lymph nodes sections (sildes 1A, 1B) are also performed, and show no occult metastatic foci in. these lymph nodes. The overall pathologic N stage is N1,. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 10.84. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. Signet ring adenocarcinoma. PRIMARY GLEASON GRADE: 5. SECONDARY GLEASON GRADE: 3. GLEASON SUM SCORE: 8. GLEASON 4/5 PERCENTAGE: 75%. WEIGHT OF PROSTATE: 67 1.8gm. TUMOR SIZE: Maximum dimension: 2.3 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: > 25%. MULTIFOCAL DISEASE: HIGH GRADE, PIN: Yes multifocal. EXTRAPROSTATIC EXTENSION: Yes Multifocal. PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: Focal tumor involvment at margin. LYMPH NODES EXAMINED: 18. LYMPH NODES POSITIVE: 1. EXTRANODAL EXTENSION: SIZE OF NODAL METASTASIS: 1.5mm. T STAGE, PATHOLOGIC: pT3b. N STAGE, PATHOLOGIC: pN1. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated. Comment: Tertiary Gleason pattern 4 carcinoma component is present. Carcinoma involves the right vas deferens resection margin."
BIOCUP_00222,prostate,PRAD,TCGA-HC-7210,TCGA-HC-7210.8398444a-bfad-41d6-94a6-ab85ddf159aa,"Ref Phyoma. SPECIMENTINFORMATION. Acct / Reg #: DIAGNOSIS. DIAGNOSIS: A. Deep bilateral pelvic lymph node dissections: Seven benign hyperplastic regional lymph nodes (0/7). B. Radical prostatectomy: Carcinoma. Tumor Characteristics: 1. Histologic type: Adenocarcinoma, conventional type. 2. Prostate size: 50 grams; 5.0 x 4.5 x 4.0 cm.. 3. Tumor quantitation: Approximately 5% of gland volume. 4. Gleason grade: a. Primary pattern: 3/5. b. Secondary pattern: 4/5. c, Total Gleason score: 7/10. 5. Tumor involves: Right tobe only. 6. Extracapsular tumor extension: No. 7. Seminal vesicle involvement: No. 8. Lymphovascular space invasion: No. 9. Perineural space invasion: No. 10. High grade PIN. Present. 11. Treatment effect: Not identified. Surgical Margin Status: 1. Bladder neck: Negative. 2. Apical (inferior): Negative, however tumor is within 0.1 cm of inked apical margin. 3. Inked prostatic margin: Negative. Lymph Node Status (utilizing specimen A): 1. Total number of lymph nodes received: 7. 2. Total number of lymph nodes containing metastatic carcinoma: None (0/7). 3. Frozen section correlation statement: None. Other: 1. Other significant findings: Benign prostatic hyperplasia. 2. PTNM stage: pT2a, NO. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Deep pelvic lymph nodes right and left. B. Prostate. SPECIMEN DATA. GROSS DESCRIPTION: The specimen is received in two formalin filled containers labeled with the patient's name : A. Container A is additionally labeled deep pelvic lymph nodes, right and left and contains a 4.8 x 4.8 x 1.8 cm. aggregate of yellow-tan fibrofatty soft. tissue. On palpation, seven firm fatty possible lymph nodes areidentified rangingfrom 0.5 up to 3.0 cm. in greatest dimension. They are entirely. submitted in cassettes A1-3 labeled. designated as follows: A1-five whole possible lymph nodes; A2tand 3--one whole possible bisected. lymph node in each cassette. B. Container B is additionally labeled prostate and contains a 50.5 gram, 5.0 x 4.5 x 4.0 cm. prosiate received with attached bilateral adnexa having. overall dimensions of 4.5 x 3.5 x 1.0 cm. The capsule is pink-tan and shaggy. The specimen is inked as follows: right side blue and left side black. The. base and apical margins are coned, serially sectioned. The remainder of the gland is serially sectioned from apex to base to reveal a 1.5 x 1.0 x 0.7. cm. ill defined tan orange lesion located in the right posterior quadrant. This lesion approaches to within 0.3 cm. of the inked capsule. The remainder of the. cut surface is pink-tan and focally cystic with diffuse periurethral nodularity. No additional lesions are identified. Representative sections are submitted in cassettes B1 through 18-labeled. designated as follows: 1--right prostate/seminal vesical. junction; 2-left prostate/seminal vesical junction; 3 and 4-apical margin, perpendicular, 5 and 6-base margin, perpendicular; 7 through 9--right anterior,. apex to base; 10 through 12-right posterior, apex to base; 13 through 15-left anterior, apex to base: 16 through 18-left posterior, apex to base. Additionally, a yellow blue and green cassette are submitted for."
BIOCUP_00223,prostate,PRAD,TCGA-EJ-5516,TCGA-EJ-5516.b15c052e-04f9-49d7-bca9-dddf59a7e9da,"PATIENT HISTORY: PSA of 10.9 Left mid has Gleason of 4 + 3. The left apex Gleason of 3 + 4. Right mid Gleason of 4 + 4. The right apex Gleason of. PRE-OP DIAGNOSIS: Prostate cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Prostatectomy. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN 3 LYMPH NODES. PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN 3 LYMPH NODES. PART 3: PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL PROSTATECTOMY -. A. INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA, GLEASON SCORE 3+4=7 WITH TERTIARY. PATTRN 5. B. THE CARCINOMA INVOLVES BOTH THE RIGHT AND LEFT LOBES AND HAS A GREATEST NODULAR DIAMETER. OF 1.4 cm. C. THE CARCINOMA INVOLVES 15% OF THE EXAMINED PROSTATE VOLUME. D. THE CARCINOMA SHOWS 2 FOCI OF EXTRACAPSULAR EXTENSION IN THE LEFT POSTERIOR BASE (SLIDES. 3C AND 3Y, 0.3 CM). E. ALL EXAMINED SURGICAL RESECTION MARGINS ARE FREE OF CARCINOMA. F. BILATERAL SEMINAL VESICLES ARE FREE OF CARCINOMA. G. PERINEURAL INVASION IS IDENTIFIED. H. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. I. HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA IS IDENTIFIED. J. PATHOLOGIC TNM STAGE: pT3a NO MX. K. TNM HISTOLOGIC GRADE = G3-4. L. BENIGN PROSTATIC HYPERPLASIA AND CHRONIC INFLAMMATION ARE NOTED. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 10.9. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 3. SECONDARY GLEASON GRADE: 4. GLEASON SUM SCORE: 7. GLEASON 4/5 PERCENTAGE: 30%. WEIGHT OF PROSTATE: 50.38gm. TUMOR SIZE: Maximum dimension: 1.4 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: 5 25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes - multifocal. EXTRAPROSTATIC EXTENSION: Yes - Multifocal. PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. LYMPH NODES EXAMINED: 6. LYMPH NODES POSITIVE: 0. T STAGE, PATHOLOGIC: pT3a. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated."
BIOCUP_00224,prostate,PRAD,TCGA-YL-A9WK,TCGA-YL-A9WK.B963A02D-0AE8-494C-A522-376AFABA374A,PROSTATE AND PELVIC/OBTURATOR LYMPH NODES; RADICAL PROSTATECTOMY: TUMOR PROCUREMENT: HISTOLOGIC TYPE. ACINAR ADENOCARCINOMA. HISTOLOGIC GRADE (PRIMARY ATTERN+SECONDARY PATTERN = GLEASON SCORE): 4+5=9. TERTIARY PATTERN NOT PRESENT. PERCENTAGE OF DIFFERENT GLEASON PATTERNS. NOT REPORTED. TUMOR LOCATION. ANTERIOR. RIGHT. LEFT. POSTERIOR. RIGHT. LEFT. EXTRA-PROSTATIO EXTENSION. PRESENT. NON-FOCAL. SITE OF EXTRA-PROSTATIC EXTENSION. POSTERIOR. RIGHT. LEFT. SEMINAL VESICAL INVASION. PRESENT. BOTH. SURGICAL MARGINS. INVOLVED BY INVASIVE CARCINOMA. POSTERIOR. RIGHT. LEFT. NATURE OF POSITIVE MARGINS. NOT REPORTED. EXTENT OF POSITIVE MARGINS. MULTIFOCAL. MILLIMETRIC EXTENT OF POSITIVE MARGINS: NOT REPORTED. GLEASON GRADE OF CARCINOMA PRESENT AT THE POSITIVE MARGINS. NOT REPORTED. LYMPHOVASCULAR INVASION. ABSENT. PERINEURAL INVASION. PRESENT. TUMOR VOLUME. PROPORTION OF PROSTATE INVOLVED BY CARCINOMA: 30%. TREATMENT EFFECT ON CARCINOMA. NOT APPLICABLE. LYMPH NODES. LEFT PELVIC. NUMBER OF NODES INDENTIFIED: 1. NUMBER OF NODES INVOLVED BY METASTASIS: 0. ADDITIONAL PATHOLOGIC FINDINGS. HIGH-GRADE PROSTATIC INTRA-EPITHELIAL NEOPLASIA. BASAL CELL HYPERPLASIA. ATROPHY. PATHOLOGICAL STAGING. pT3b. pNO. pMX.
BIOCUP_00225,prostate,PRAD,TCGA-XJ-A9DI,TCGA-XJ-A9DI.8D5547ED-4864-4CE1-87D0-2FE7621B9B7C,"SURG PATH #: SPECIMEN CLASS: ALT ID #: SEX: M. DATE RECEIVED: DATE OF PRINTING: Material Received: A: left pelvic lymph node. B: right pelvic lymph node. C: prostate. D: Hernia sac. Historv: -year-old male with prostate cancer. Final Diagnosis: A. Lymph nodes (4), ""left pelvic lymph node"", biopsy: There is no evidence of malignancy (0/4). B. Lymph node (1), ""right pelvic lymph node"", biopsy: There is no evidence of malignancy (0/1). C. Prostate, ""prostate"", prostatectomy: Prostatic adenocarcinoma, poorly differentiated, Gleason grade 5 + 4 (score 9), with invasion of seminal vesicles,. extraprostatic extension, and bilateral involvement of 60% of the tissue submitted. See comment. D. Mesothelial lined fibrous tissue, ""hernia sac"", excision: Hernia sac. Comment: Prostate. Procedure: Robotic-assisted laparoscopic prostatectomy. Histologic Type: Adenocarcinoma. Histologic Grade: Poorly differentiated. Gleason Pattern. Primary Pattern: 5. Secondary Pattern: 4. Tertiary Pattern (if higher than primary and secondary): n/a. Total Gleason Score (Primary + Secondary): 9. Proportion (percent) of prostate involved by tumor: 60%. Tumor Multicentricity: No. Extraprostatic Extension: Yes, near base of left posterior lobe. Seminal Vesicle Invasion: Yes, bilateral. Margins: Not involved by tumor. Date of Printing: SURG PATH #: ALT ID #: Perineural Invasion: Yes. Vascular Invasion: Present. Additional Pathologic Findings: None. Lymph Nodes: Number Examined: 5. Number Involved: 0. Gross Picture Taken: No. Pathologic Staging: pT3b NO Mx. The pathologic stage assigned here should be regarded as provisional, as it reflects only current pathologic data and does not incorporate full. knowledge of the patient's clinical status and/or prior pathology. Pursuant to the Quality Assurance Program at. this case has been concurrently reviewed by the following. pathologist: Dr. tho agrees with the above diagnosis. Attestation: By this signature, I attest that I have personally formulated the final interpretation expressed in this report and that the above diagnosis is based. upon my examination of the slides and/or other material indicated in this report. Interpreted by: Gross Description: A. Received fresh labeled with the patient's name and ""left pelvic lymph node"" are four palpable lymph nodes ranging in size from. 2.5 x 1.5 x 0.6 cm to 0.9 x 0.5 x 0.2 cm. The specimen is submitted as follows: A1FS, one lymph (trisected). A2FS, one lymph, one lymph node inked black and one lymph node inked green. The specimen is submitted entirely in A1FS and A2FS. B. Received fresh labeled with the patient's name and ""right pelvic lymph node"" is one matted lymph node measuring 5.5 x 1.2 x. 0.6 cm. The specimen is sectioned into four pieces and submitted entirely in cassettes B1FS and B2FS. C. Received in formalin labeled with the patient's name and ""prostate-cancer study"" is a 39 gram prostate measuring 4.3 cm from. right to left, 3.0 cm from anterior to posterior and 4.0 cm from superior to inferior. The right seminal vesicle measures 1.4 x 1 x 0.5. cm. The right vas deferens measures 1.5 cm in length and 0.7 cmin diameter. The left vas deferens measures 1.8 cm in length. and 0.7 cm in diameter and the leftseminal vesiclemeasures 1.3cm x 0.8 cm x 0.5 cm. There is a polypoid protrusion from the. otherwise oval prostate located at the bladder neck margin. The protruding tissue measures 1.5 x 1.3 x 1.2 cm. Two core biopsies. with a diameter of 0.5 cm have been removed from the right and left posterior lobes of the prostate and submitted for the tissue bank. study. The right side of the prostate is inked black and the left side is inked blue. The specimen is serially sectioned to reveal an. enlarged left anterior and left posterior lobe of the prostate with a tan-yellow multinodular appearance with nodules ranging in size. from 0.8 X 0.7 to 1.0 x 0.7 cm. The remainder of the cut surface is unremarkable. The specimen is submitted as follows: C1-C2. Right bladder neck margin. C3-C4. Left bladder neck margin. C5. Right distal urethral margin. C6 -. Left distal urethral margin. C7. Right seminal vesicle margin. C8. Left seminal vesicle margin. C9. Right mid anterior lobe (representative section). C10. Left mid anterior lobe (representative section). C11-C20-. Right posterior lobe (entirely submitted). C21-C30 -. Left posterior lobe (entirely submitted). D. Received in formalin labeled with the patient's name and ""hernia sac"" is a 1.5 x 1.0 x 0.7 cm oval piece of tan-pink soft tissue. The specimen is trisected and submitted entirely in D1. Date of Printing: SURG PATH #: ALT ID#: Intraoperative Consultation: A1FS, lymph node (4), ""left pelvic lymph node"", biopsy: Negative for malignancy. B1FS and B2FS, lymph node (1), ""right pelvic lymph node"", biopsy: Negative for malignancy. MD, Attending Physician. Date of Printing:"
BIOCUP_00226,prostate,PRAD,TCGA-G9-6351,TCGA-G9-6351.7942304b-0a3d-492c-bbb2-65695f1958e4,"SPECIMENS: A. PROSTATE. SPECIMEN(S): A. PROSTATE. GROSS DESCRIPTION: A. PROSTATE. Received fresh labeled with the patient identification and designated as ""Part A, Prostate"" is a 34g. resected 4.5cm from right to left, 4.0cm from anterior to posterior, and 3.2cm from apex to base,. with. attached right and left seminal vesicles and vas deferens. The capsule is tan pink smooth and intact. The specimen is inked as follows: Anterior-Orange, Posterior-Black, Apex-Red, Base-Blue, Right-. Green, Left-Yellow. After removal of the apex and base, the remaining prostate weight is 15g. The. specimen is serially sectioned from apex to base to reveal firm tan fibrous parenchyma. No obvious. lesions or nodules are grossly identified. The attached right and left seminal vesicles are 3.0 x 1.0 X. 1.0cm and 4.5 x 1.0 X 1.0cm, respectively, are sectioned to beige tan cystic tissue with no gross. evidence of tumor involvement. The attached right and left segments of vas deferens are 0,6 x 0.5cm. and 4.0 x 0.6cm, respectively, are sectioned to reveal firm tan tubular structure with no gross evidence. of tumor involvement. A portion of the specimen is submitted for tissue procurement (Levels 1 and III). The remainder of the specimen is submitted as follows: A1: right apex. A2: left apex. A3: Level I right anterior capsule. A4: Level I right posterior capsule. A5: Level I left anterior capsule. A6: Level 1 left posterior capsule. A7: Level Il right anterior. A8-A9: Level Il right posterior. A10: Level Il left anterior. A11-A12: Level Il left posterior. A13: Level III right anterior capsule. A14: Level III right posterior capsule. A15: Level III left anterior capsule. A16: Level III left posterior capsule. A17: right base with periurethral margin. A18: left base with periurethral margin. A19: right lateral base. A20: left lateral base. A21: right base. A22: left base. A23: right seminal vesicle and vas deferens. A24: left seminal vesicle and vas deferens. DIAGNOSIS: A. PROSTATE, PROSTATECTOMY: -PROSTATIC ADENOCARCINOMA, GLEASON SCORE 3+4 (7/10) INVOLVING BOTH LEFT AND. RIGHT LOBES OF PROSTATE AND AN ESTIMATED 10 TO 15% OF PROSTATIC GLAND. ADENOCARCINOMA FOCALLY PRESENT AT LEFT POSTERIOR CAPUSLE. -PERINEURAL INVASION IDENTIFIED. -NO EXTRAPROSTATIC EXTENSION IDENTIFIED. -BILATERAL SEMINAL VESICLE, NEGATIVE FOR TUMOR. SYNOPTIC REPORT - PROSTATE GLAND. Specimens Involved. Specimens: A: PROSTATE. Left. Right. WHO CLASSIFICATION. Epithelial tumors. Adenocarcinoma. Multicentricity: Gland Involvement: 10%. Gleason Grade/Sum:: Grade 3 + 4, Sum 7. High Grade PIN Present: Perineural Invasion: Yes. Vascular/Lymphatic Invasion: Seminal Vesicle Invasion: Periprostatic Fat Involved: Bladder Neck Involved: Margins Involvement: Yes. left posterior capsule just proximal to the apex. Linear Distance: Focal (1-10mm). Frozen Performed: Post Hormonal Therapy Change: Lymph Nodes: No lymph nodes sampled. Other Pathologic Findings: BPH. Pathological Staging (pTNM): 2 2c. N X. M X. CLINICAL HISTORY: None provided. PRE-OPERATIVE DIAGNOSIS: Prostate cancer. ADDENDUM: The positive margin in this case (slide A6) was reviewed with Dr. and correlated with the gross. examination and operative report. During the operative procedure there was a surgical violation of the. prostatic capsule in two places that were marked by surgical sutures for gross examination. One of. these areas was at the site of the positive margin and comparing this information to the histological. section it is likely that inked drained through this surgically created cleft. In summary, it is likely that the. tumor present at the inked surface in this slide is not a true positive margin."
BIOCUP_00227,prostate,PRAD,TCGA-V1-A9OT,TCGA-V1-A9OT.40B928AE-1977-4077-9F44-282E85273EF2,"FINAL PATHOLOGIC DIAGNOSIS. A. Anterior prostatic fat, biopsy: Benign fibrofatty tissue, no carcinoma. B. Prostate and seminal vesicles, total prostatectomy: 1. Prostatic adenocarcinoma, Gleason score 3+3 = 6, involving right and left. lobes; see comment. 2. Seminal vesicles with no significant pathologic abnormality. COMMENT: Synoptic Comment for Prostate Tumors. - Type of tumor: Small acinar adenocarcinoma. - Location of tumor: Left posterior mid gland (slides B6, B16, B17 and B18), right posterior mid gland. (slides B11-B14 and B25). - Estimated volume of tumor: 4.2 cc. Gleason score: 3+3; primary pattern 3, secondary pattern 3. - Estimated volume > Gleason pattern 3: <1%. - Involvement of capsule: Tumor invades capsule (B11, B12, B13, B14). - Extraprostatic extension: None. - Margin status for tumor: - Positive (slide B14); length of positive margin 0.3 cm at black inked posterior margin on slide. B14. Gleason pattern at largest positive margin is 3+3=6. - Margin status for benign prostate glands: - No benign glands present at inked excision margins. - High-grade prostatic intraepithelial neoplasia (HGPIN): Present, focally. - Tumor involvement of seminal vesicle: None. - Perineural infiltration: Present. - Lymph node status: None present. - AJCC/UICC stage: pT2cNx. Level sections on blocks B12, B13, B17 and B18 were evaluated and confirm the diagnosis. Specimen(s) Received. A:Anterior prostatic fat. B: Prostate gland + seminal vesicles (fresh). Clinical History. The patient is a. year-old man who, per review of the electronic medical record. was. diagnosed with Gleason score 3 +3 = 6 prostatic adenocarcinoma of the right mid-gland and base with. perineural invasion. He now undergoes a robot-assisted radical prostatectomy. Gross Description. The specimen is received in two parts, each labeled with the patient's name and medical record number. Part A is received in formalin. Part B is received fresh. Part A, labeled ""anterior prostatic fat,"" consists of multiple soft, irregular pieces of yellow, fibrofatty. tissue (4.4 x 2.9 x 1.2 cm in aggregate). No masses or candidate lymph nodes are found. The. specimen is entirely submitted in cassette A1. Part B, labeled ""prostate gland and seminal vesicles,"" consists of a radical prostatectomy specimen (76. gm; 4 cm from apex to base x 5 cm in width x 4 cm from anterior to posterior). GROSS PATHOLOGIC FINDINGS: There are two nodules. Nodule 1 (1.5 x 1.2 x 0.6 cm) is ill defined,. rubbery and yellow. It is located in the right posterior gland (slices 4-10) and abuts the posterior. margin. Nodule 2 (0.8 x 0.4 x 0.3 cm) is ill defined, rubbery and yellow. It is located in the left. posterior gland (slices 5-7) and is 0.3 cm from the posterior margin. The anterior fibrous stroma is red,. roughened and is open. The remaining capsule is intact. The remaining prostatic parenchyma is tan. The seminal vesicle/vas deferens bundles (right 3 x 2.5 x 0.5 cm; left 3 x 2 x 0.5 cm) are soft, lobulated. and without obvious lesion or mass. Some of the prostate is taken by the. ORIENTED BY: Anatomic landmarks. INKING: - Right anterior: Green. - Left anterior: Blue. - Posterior: Black. GROSS PHOTOGRAPHS: Yes. TOTAL NUMBER OF SLICES: 9; not including apex and base margin slices. AVERAGE SLICE THICKNESS: 0.4 cm. CASSETTES: Representative sections are submitted as follows: Apical margins, entirely submitted in perpendicular sections. B1: Right apex. B2: Left apex. Additional tissue. B3: Right half, slice 1. 84: Left half, slice 1. B5: Right half, slice 2. B6: Left half, slice 2. Right anterior quadrant. 87: Slice 4. B8: Slice 5. 89: Slice 6. B10: Slice 7. Right posterior quadrant. B11: Slice 4 (suspicious nodule 1). B12: Slice 5 (suspicious nodule 1). B13: Slice 6 (suspicious nodule 1). B14: Slice 7 (suspicious nodule 1). Left posterior quadrant. B15: Slice 4. 816: Slice 5 (suspicious nodule 2). B17: Slice 6 (suspicious nodule 2). B18: Slice 7 (suspicious nodule 2). Left anterior quadrant. B19: Slice 4. B20: Slice 5. B21: Slice 6. B22: Slice 7. Bladder margins, entirely submitted in perpendicular sections. B23: Right. B24: Left. Prostatic/seminal vesicle junction and cross-section of vas deferens. B25: Right. B26: Left. Diagnosis based on gross and microscopic examinations. Final diagnosis made by attending pathologist following review of all. pathology slides. The attending pathologist has reviewed all dictations, including prosector work, and preliminary interpretations. performed by any resident involved in the case and performed all necessary edits before signing the final report."
BIOCUP_00228,prostate,PRAD,TCGA-G9-6347,TCGA-G9-6347.2ED4FCE8-5DCF-4529-95E5-C454529D7971,"SPECIMENS: A. PROSTATE. SPECIMEN(S): A. PROSTATE. GROSS DESCRIPTION: A. PROSTATE. Received fresh is a 59g resected prostate 4.0cm from apex to base, 4.5cm from anterior to posterior. and 5.5cm from right to left with attached right and left seminal vesicle and vas deferens. The capsule is. tan pink smooth and intact. The specimen is inked as follows: Apex-Red, Anterior-Orange, Right. Lateral-Green, Left Lateral-Yellow, Base-Blue, Posterior-Black. After removal of the apex and base, the. remaining prostate weight is 32g. The specimen is serially sectioned from apex to base to reveal beige. tan spongy tissue. The attached right and left seminal vesicles are 5.0 x 1.5 x 1.0cm and 3.5 x 2.0 x. 1.0cm respectively, are sectioned to reveal beige tan cystic structure with no gross evidence of tumor. involvement. The attached right and left vas deferens are 3.0 x 0.6cm and 3.5 x 0.5cm respectively, are. sectioned to reveal beige tan tubular structure with no gross evidence of tumor involvement. A portion of. the specimen is submitted for tissue procurement (Levels Il and IV). The remainder of the specimen is. submitted as follows: A1-A2: right apex. A3-A4: left apex. A5: Level I right anterior. A6: Level 1 right posterior. A7: Level I left anterior. A8-A9: Level I left posterior. A10: Level Il right anterior capsule. A11: Level Il right posterior capsule. A12: Level Il left anterior capsule. A13: Level Il left posterior capsule. A14: Level III right anterior. A15: Level III right posterior. A16: Level III left anterior. A17: Level III left posterior. A18: Level IV right anterior capsule. A19: Level IV right posterior capsule. A20: Level IV left anterior capsule. A21: Level IV left posterior capsule. A22-A23: right base with periurethral margin. A24-A25: left base with periurethral margin. A26: right lateral base. A27: left lateral base. A28: right base. A29: left base. A30: right seminal vesicle and vas deferens. A31: left seminal vesicle and vas deferens. DIAGNOSIS: A. PROSTATE, PROSTATECTOMY: - PROSTATIC ADENOCARCINOMA, GLEASON SCORE PRESENT IN. BILATERAL PROSTATE FROM APEX TO MID. - CARCINOMA INVOLVING APPROXIMATELY 25% OF PROSTATIC GLAND. - SURGICAL RESECTION MARGINS, NEGATIVE FOR TUMOR. - NO EXTRAPROSTATIC EXTENSION IDENTIFIED. - BILATERAL SEMINAL VESICLE, NEGATIVE FOR TUMOR. - SEE TEMPLATE. SYNOPTIC REPORT - PROSTATE GLAND. Location: Bilateral from apex to mid, peripheral zones. WHO CLASSIFICATION. Epithelial tumors. Adenocarcinoma 8140/3. Multicentricity: Gland Involvement: 25%. Gleason Grade/Sum:: Grade 3 + 3, Sum 6. High Grade PIN Present: Perineural Invasion: Yes. Vascular/Lymphatic Invasion: Seminal Vesicle Invasion: Periprostatic Fat Involved: Bladder Neck Involved: Margins Involvement: No. Frozen Performed: Post Hormonal Therapy Change: Lymph Nodes: No lymph nodes sampled. Other Pathologic Findings: BPH. Pathological Staging (pTNM): p. T 2c. N x. Mx. CLINICAL HISTORY: None provided. PRE-OPERATIVE DIAGNOSIS: Prostate Cancer."
BIOCUP_00229,prostate,PRAD,TCGA-HC-A632,TCGA-HC-A632.9EF1E09B-C468-4A42-917E-365F88055077,"Hosnital #. M. ACCESSION NO. Final Diagnosis(es): (A) Prostate with seminal vesicles, excision: 1) Prostatic adenocarcinoma, Gleason grade 4+5. 2) Perineural invasion present. 3) Extracapsular penetration on right (Slide A1, A10, A11, A24, and A41). 4) Total tumor volume approximately 4.5 x 2.0 X 3.0 cm = 27 CC. 5). Pathologic stage: pT3aNOMX. 6). All surgical margins negative (see synoptic report). (B). Bilateral pelvic lymph nodes, excision: Five lymph nodes, negative for metastasis. Synoptic Report: Diagnosis: Prostatic adenocarcinoma. Procedure: Radical prostatectomy. Specimen Size: 5.0 x 6.5 x 5.0 cm. Specimen Weight: 78.1 gm. Lymph Node Sampling: Pelvic lymph node dissection. Histologic Type: Adenocarcinoma, acinar type. Histologic Grade (Gleason pattern). Primary Pattern: Grade 4. Secondary Pattern: Grade 5. Total Gleason Score: 9. Percent of Prostate Involved: 25%. Size of Dominant Nodule. Greatest dimension: 45 mm. Additional dimensions: 30 mm. Extraprostatic Extension: Nonfocal. Seminal Vesicle Invasion: Left: Not identified. Right: Not identified. Lymphvascular Invasion: Present. Perineural Invasion: Present. Periprostatic Fat Invasion: Present. Margins: Apical: Negative. Printed: Bladder neck: Negative. Anterior: Negative. Lateral: Negative. Posterolateral: Negative. Posterior: Negative. Nodes: Node Group: Bilateral pelvic nodes. Total: 5. Positive: 0. Pathologic Stage: pT3apN0pMX. Specimen(s) Received: A: prostate with seminal vesicles. B: bilateral pelvic lymph nodes. Clinical History: Prostate cancer. Tumor Bank. Gross Description: (A) (prostate with seminal vesicles) Received in formalin is a 78.1 gm, previously incised and inked. prostate measuring 5.0 cm from base to apex, 6.5 cm right to left, and 5.0 cm superior to inferior. Attached seminal vesicles measure 6.0 cm in length, 4.0 cm right to left, and 1.5 cm in maximum thickness. Sectioning of the prostate reveals multiple cystic spaces ranging in diameter from 0.3 to 0.6 cm which. could be native or introduced by tumor banking. Firm nodularity is centered in the right apex region, but. vague nodularity persists throughout the sectioned prostate. Near the right base there is a 1.4 cm circular,. dark black, gray, firm nodule. The apex most slice is removed and is serially longitudinally sectioned and. submitted from right to left in cassettes A1-A9. The remaining body of the prostate is sectioned and. submitted according to the University protocol in its entirely in cassettes A10-A52. The right seminal. vesicle is serially sectioned and submitted sequentially in casettes A53-A60. The left seminal vesicle is. similarly sectioned and submitted serially from A61-A68. (B). (bilateral pelvic lymph nodes) Received in formalin is a mass of adipose tissue with embedded. candidate lymph nodes measuring 11.0 x 7.0 X 3.0 cm. Dissection reveals one large node that is. submitted entirely in cassette B1. One large node is bisected and submitted in cassette B2. One large. lymph node is serially sectioned and submitted in cassettes B3 and B4. One lymph node is bisected and. submitted in cassette B5. One large lymph node is serially sectioned and submitted entirely in cassette B6. Printed: Microscopic Description: Complete microscopic evaluation has been performed. Appropriately reacting controls have been performed and evaluated for all stains on this case as required. Histopathology has a list of IH antibodies that are regulated as analute specific reagents (ASR'a) These assays were developed and their performance characteristics determined by the. Histopathology Laboratory in the Department of Pathology. They have not been cleared by the US Food and Drug Administration. The FDA has determined that such clearance or approval for the moso tosts are not are used in standard. clinical. care,. In. cases. where. Immunohistochemistry testing is performed, the following antibodies and their respective clones may be used to determine therapy for the patient: EGFR(3C6), ER(SP1), PR(1E2), Her2neu(4B5),. CD117(Poly), CD20(L26), Ki67(30-9). Unless otherwise stated in the report, all tissue tested for HER2 by IHC and/or HER2 by FISH have been fixed as per C.A.P. requirements for a minimum of 6 hours and a maximum of 48 hours. ER, PR, KI-67, p53 are reported as a semi-quantitative percentage of positively stained nuclei. Her-2/neu and EGFR are scored as follows: No staining at all is scored as (0), weak, incomplete. membrane staining in any proportion of cells is scored as (1+), less than strong but complete staining in any proportion of cells or complete strong staining in less than 30% of cells is scored as. (2+), and strong complete staining in more that 30% of ceils is scored as (3+). All studies are performed on tissue fixed in 10% neutral buffered formalin and embedded in paraffin unless otherwise. stated in the report. Printed:"
BIOCUP_00230,prostate,PRAD,TCGA-G9-6377,TCGA-G9-6377.520abbf9-817a-45db-aecc-22c4fc80ddae,"SPECIMENS: A. LEFT PELVIC LYMPH NODES. B. RIGHT PELVIC LYMPH NODES. C. PROSTATE. SPECIMEN(S): A. LEFT PELVIC LYMPH NODES. B. RIGHT PELVIC LYMPH NODES. C. PROSTATE. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA1-FSA3/FSB1-FSB2: Left and right pelvic lymph nodes: No tumor seen. Diagnoses called by Dr. to Dr. GROSS DESCRIPTION: A. LEFT PELVIC LYMPH NODE. Received fresh labeled with the patient's identification and ""left pelvic lymph node"" are multiple pieces of. fatty tissue in aggregate, 5.8 x 4.5 X 0.8 cm containing two lymph nodes, 0.5 x 0.3 x 0.2 cm(1) and 3.5 X. 1 X 0.3 cm(2); touch preps are performed and the lymph nodes are submitted entirely for frozen section. diagnosis: FSA1: lymph node 1. FSA2-FSA3: lymph node 2. B. RIGHT PELVIC LYMPH NODES. Received fresh labeled with the patient's identification and ""right pelvic lymph nodes"" are multiple pieces. of fatty tissue in aggregate, 5.5 x 3.6 x 1 cm. Six possible lymph nodes are identified ranging from 0,5. to 2.5 cm. Lymph nodes are submitted entirely for frozen section diagnosis: FSB1: largest lymph node. FSB2: 5 possible smaller lymph nodes. C. PROSTATE. Received fresh labeled with the patient's identification and ""prostate"" is a 39-g resected prostate gland. measuring 4.2 cm from left lateral to right lateral, 3.8 cm from anterior to posterior, and 3,5 cm from. apex to base. The capsule is smooth, red, and intact. Ink code: Anterior-orange, apex-red, base-blue,. right lateral-green, left lateral-yellow, posterior-black. After removal of apex to base, the prostate. weighs 21 g; it has a nodular tan parenchyma. The right seminal vesicle is 3.5 X 2.6 x 0.9 cm and the. left is 4 x 1.2 x 0,7 cm; they consist of cystic tan tissue. The right vas deferens is 2.7 X 0,5 cm and the. left is 1,9 X 0.6 cm; they consist of tubular tan tissue. Tissue is procured (10g). Submitted entirely: C1: right apex, perpendicular sections. C2: left apex, perpendicular sections. C3: level 1, anterior and right lateral capsule. C4: level 1, posterior and left lateral capsule. C5: level 2, right anterior. C6: level 2, right posterior. C7: level 2, left anterior. C8: level 2, left posterior. C9: level 3, anterior and right lateral capsule. C10-C11: level 3, posterior and left lateral capsule. C12-C13: right mid base, perpendicular sections. C14-C15: left mid base, perpendicular sections. C16-C17: right lateral base, perpendicular sections. C18-C19: left lateral base, perpendicular sections. C20: base with root of right seminal vesicle and vas deferens. C21: base with root of left seminal vesicle and vas deferens. C22: right seminal vesicle and vas deferens. C23: left seminal vesicle and vas deferens. DIAGNOSIS: A. LEFT PELVIC LYMPH NODES, EXCISION: TWO (2) LYMPH NODES AND ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. B. RIGHT PELVIC LYMPH NODES, EXCISION: FOUR (4) LYMPH NODES AND THE ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR. TUMOR. C. PROSTATE, SEMINAL VESICLES, AND VASA DEFERENTIA (RADICAL PROSTATECTOMY): - PROSTATIC ADENOCARCINOMA, GLEASON SCORE 3 + 4 = 7 INVOLVING THE LEFT AND. RIGHT PROSTATE LOBES, LIMITED TO THE PROSTATE. - TUMOR INVOLVES LESS THAN 10% OF PROSTATE TISSUE. - PERINEURAL INVASION IDENTIFIED. - NO ANGIOLYMPHATIC INVASION IDENTIFIED. - NO EXTRAPROSTATIC EXTENSION IDENTIFIED. LEFT AND RIGHT SEMINAL VESICLES AND VAS DEFERENS, NEGATIVE FOR TUMOR. - SEE SYNOPTIC REPORT. SYNOPTIC REPORT - PROSTATE GLAND. Specimens Involved. Specimens: A: LEFT PELVIC LYMPH NODES. B: RIGHT PELVIC LYMPH NODES. C: PROSTATE. Left. Right. Posterior lateral. Apical. Basal. Anterior. WHO CLASSIFICATION. Epithelial tumors. Adenocarcinoma 8140/3. Multicentricity: Gland Involvement: 10%. Gleason Grade/Sum:: Grade 3 + 4, Sum 7. High Grade PIN Present: Perineural Invasion: Yes. Vascular/Lymphatic Invasion: Seminal Vesicle Invasion: Periprostatic Fat Involved: Bladder Neck Involved: Margins Involvement: No. Frozen Performed: Lymph Nodes: Negative Right 0/4 Left 0 / 2. Other Pathologic Findings: BPH. Pathological Staging (pTNM): T 2c. N 0. M x. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. pT2c: Tumor involves both lobes. pMX: Cannot be assessed. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Prostate cancer."
BIOCUP_00231,prostate,PRAD,TCGA-KC-A4BL,TCGA-KC-A4BL.EEF5303A-D63A-4D2F-A8B6-A78437A583FF,"A: Right neurovascular margin (frozen section). B: Prostate and seminal vesicles. C: Bilateral lymph nodes. CLINICAL INFORMATION: Prostate cancer. Specimen submitted: A. Right neurovascular margin (frozen. section). i B. Prostate and seminal vesicles; C. Bilateral lymph. nodes. FROZEN SECTION DIAGNOSIS: A. Frozen Section Diagnosis: Fibroadipose tissue with. nerve. Negative for carcinoma or prostatic glands. Reported to. GROSS DESCRIPTION: A. Received fresh, the specimen is labeled ""right neurovascular. margin (f.s.), and consists of a 0.3 x 0.2 x 0.1 cm piece of red. soft tissue frozen in its entirety for frozen section diagnosis. Summary of sections: AFSC-frozen section control. B. Received fresh, the specimen is labeled ""prostate and seminal. vesicles"", and consists of a 21 gram radical prostatectomy. specimen including a 3.0 x 2.5 x 2.5 cm prostate, a 2.5 x 1.2 x. 0.5 cm left seminal vesicle, a 2.0 x 0.5 x 0.4 cm left vas. deferens, a 2.0 x 1.0 x 0.5 cm right seminal vesicle and a 2.0 x. 0.5 x 0.4 cm right vas deferens. The right side of the specimen. is inked green and the left side is inked black. The seminal. vesicle base, bladder neck and apical margins are shaved and. submitted. The prostate is serially sectioned from the apex to. base with sections designated from A to F respectively. On. sectioning, multiple nodular and cystic areas are seen. The. prostate is submitted in its entirety. Summary of sections: B1-right seminal vesicle and vas deferens; B2-left seminal. vesicle and vas deferens; B3-right bladder neck margin; B4-left. bladder neck margin; B5-right apical margin; B6-left apical. margin; B7-level A margin; B8-level B margin; B9- ; B10-. B11-. B12-. B13-. B14-. B15-. B16-. B17-. B18-. B19-. B20- ; B21- ; B22- B23-. : B24-. Note: (R=Right; L=Left; A=Anterior; P=posterior). C. Received fresh, the specimen is labeled ""bilateral lymph. nodes,"" and consists of a 3.0 x 1.5 x 0.8 cm piece of fatty. tissue and lymph nodes. 100% submitted. Summary of sections: C1-C2. DIAGNOSIS: A. Right neurovascular margin (biopsy) : Fibromuscular tissue and nerve. No prostatic glands or carcinoma seen. B. Prostate and seminal vesicles (radical prostatectomy) : Adenocarcinoma of the prostate, Gleason score 7 (3+4),. with focal areas of Gleason grade 5. The tumor is present in both lobes and. located primarily in the peripheral zone. The tumor involves approximately 20-30% of. the submitted tissue. Extraprostatic extension is not identified. The seminal vesicles, bladder neck and. apical margins, as well as all inked peripheral surgical margins. are free of tumor. Prominent perineural invasion is identified. No angiolymphatic invasion is identified. C. Bilateral lymph nodes (excision) : Four lymph nodes, negative for metastatic carcinoma (0/4). Result Narrative."
BIOCUP_00232,prostate,PRAD,TCGA-EJ-5510,TCGA-EJ-5510.9f549743-cbb3-46bb-9356-40f80e961b4d,"PATIENT HISTORY: The patient is a. In. addition, he has an elevated serum PSA level of 15.3 ng/ml. A previous prostate needle biopsy performed in. reveals bilateral prostatic adenocarcinoma (3+3=6 in the left, 3+4 = 7 in the right). PRE-OP DIAGNOSIS: Prostate cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Radical retropubic prostatectomy and bilateral pelvic lymph node dissection. FINAL DIAGNOSIS: PART 1: RIGHT PELVIC LYMPH NODES, EXCISION -. FIVE (5) BENIGN LYMPH NODES (0/5). NO EVIDENCE OF MALIGNANCY. PART 2: LEFT PELVIC LYMPH NODES, EXCISION -. TWELVE (12) BENIGN LYMPH NODES (0/12). NO EVIDENCE OF MALIGNANCY. PART 3: PROSTATE, SEMINAL VESICLES, AND DISTAL VASA DEFERENTIA, RADICAL PROSTATECTOMY -. A. PROSTATIC ADENOCARCINOMA, ACINAR TYPE, GLEASON SCORE 4+3=7, INVOLVING BOTH RIGHT AND. LEFT LOBES OF THE PROSTATE GLAND (SLIDES 3Y-3DD, 3JJ, 3NN, 3PP). GLEASON PATTERN 4. COMPONENT COMPRISES 50-60% OF THE SAMPLED TUMOR VOLUME. B. MAXIMAL TUMOR DIAMETER IS 2.0 CM IN A HISTOLOGIC SECTION (SLIDE 3DD). C. CARCINOMA COMPRISES 10-15% OF THE SAMPLED PROSTATE GLAND VOLUME. D. MULTIFOCAL CARCINOMATOUS PERINEURAL INVASION IS IDENTIFIED (SLIDES 3Z-3DD). E. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. F. BENIGN SEMINAL VESICLES AND DISTAL VASA DEFERENTIA. G. ALL SURGICAL RESECTION MARGINS ARE FREE OF NEOPLASIA. H. FOCAL HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA. I. TNM PATHOLOGIC STAGE: T2c, NO, MX. J. HISTOLOGIC GRADE: G3-4. K. NON-NEOPLASTIC PROSTATE WITH NODULAR HYPERPLASIA AND FOCAL GLANDULAR ATROPHY (See. Synoptic). CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 15.3. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 4. SECONDARY GLEASON GRADE: 3. GLEASON SUM SCORE: 7. GLEASON 4/5 PERCENTAGE: 60%. WEIGHT OF PROSTATE: 52.61gm. TUMOR SIZE: Maximum dimension: 2.0 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: 5 25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes - 1 or 2 foci away from tumor. EXTRAPROSTATIC EXTENSION: PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. LYMPH NODES EXAMINED: 17. LYMPH NODES POSITIVE: 0. T STAGE, PATHOLOGIC: pT2c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G3-4, Poorly differentiated/undifferentiated."
BIOCUP_00233,prostate,PRAD,TCGA-YL-A8HM,TCGA-YL-A8HM.4CDB8D1D-D1F1-4A78-A0C0-CA56CBC0689C,PROSTATE AND PELVIC/OBTURATOR LYMPH NODES; RADICAL PROSTATECTOMY: HISTOLOGIC TYPE. ACINAR ADENOCARCINOMA. HISTOLOGIC GRADE (PRIMARY PATTERN+SECONDARY PATTERN = GLEASON SCORE): 4 + 5 = 9. TERTIARY PATTERN NOT PRESENT. TUMOR LOCATION. APEX. MID. BASE. LATERAL. RIGHT. LEFT. POSTERIOR. LEFT. EXTRA-PROSTATIC EXTENSION. PRESENT. NON-FOCAL. SITE OF EXTRA-PROSTATIC EXTENSION. POSTERIOR. RIGHT. SEMINAL VESICAL INVASION. PRESENT. RIGHT. SURGICAL MARGINS. FREE OF INVASIVE CARCINOMA. LYMPHOVASCULAR INVASION. PRESENT. PERINEURAL INVASION. PRESENT. TUMOR VOLUME/ size of the largest nodule. 1.9x0.9x0.4cm=0.84cc. REATMENT EFFECT ON CARCINOMA. NOT APPLICABLE. LYMPH NODES. RIGHT OBTURATOR. NUMBER OF NODES INDENTIFIED: 4. NUMBER OF NODES INVOLVED BY METASTASIS: 0. LEFT OBTURATOR. NUMBER OF NODES IDENTIFIED: 5. NUMBER OF NODES INVOLVED BY METASTASIS: _0_. OTHERS (SPECIFY): Left Peri-vesical. NUMBER OF NODES IDENTIFIED: 1. NUMBER OF NODES INVOLVED BY METASTASIS: _0. PATHOLOGICAL STAGING. pT3b. pNO. pMX. COMMENT(S).
BIOCUP_00234,prostate,PRAD,TCGA-HC-7212,TCGA-HC-7212.b401d78b-78c2-4e6e-86db-c93997da85a4,"SPECIMEN INFORMATION. Acct/Reg #: DIAGNOSIS. DIAGNOSIS: A. Prostatectomy: Tumor Characteristics;. 1. Histologic type: Adenocarcinoma. 2. Prostate size: 5.0 x 5.0 X 4.0 cm; 47 g. 3. Tumor quantitation: Neoplasm involves approximately 5% of the prostatic tissue examined. It is confined to the right lobe of the prostate gland. 4. Gleason grade: a. Primary pattern: 3/5. b. Secondary pattern: 4/5. c. Total Gleason score: 7/10. 5. Extraprostatic extension: No. 6. Seminal vesicle involvement: No. 7. Lymphovascular space invasion: No definitive intraluminal neoplasm is identified. Extensive perineural invasion is present. 8. High grade PIN: Present,. Surgical Margin Status: 1. The apical margin demonstrates no histologic evidence of malignancy. 2. The neoplasm extends to the Inked prostatic margin in the right posterior section. 3. All other resection margins are free of malignancy. Lymph Node Status: 1. Total number of lymph nodes received: See specimen C below. Other: 1. Fibromuscular and fibrogiandular hypertrophy (BPH) with extensive glandular atrophy. 2. pTNM stage: pT2a NO MX. B. Right urethral margin: No histologic evidence of malignancy identified. C. Bilateral pelvic lymph nodes: Total number of lymph nodes examined: 4. Total number of lymph nodes containing metastatic carcinoma: 0. COMMENTS: The neoplasm demonstrates an extensive cribriform pattern in addition to the usua. 3/4 pattern. All sections of neoplasm are identified in. the right lobe of the prostate, but additional tissue is submitted from the left lobe for examination. Review of these additional slides demonstrate no. histologic evidence of malignancy. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Malignant neoplasm prostate. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Prostate. B. Right urethral margin. C. Bilateral pelvic lymph nodes. GROSS DESCRIPTION: A. The first container A is labeled. ostate. The specimen consists of an intact prostate gland with attached bilateral seminal. vesicles. and. vas. deferens. The prostate measures 5.0x5.0 x 4.0 cm and weighs 47 grams. The surface of the prostate is gray to brown tan with slight. hemorrhage. and. adhesions. The seminal vesicles measure in average 3.0 cm in length and 1.5 cm in diameter and the vas deferens measure 4.5 cm in. length. and. 0.3. cm. in. diameter and are likewise unremarkable. The right half of the prostate has been inked blue and the left half has been inked black. The. specimen. is. serially. sectioned from apex to base. The cut surface is gray tan nodular. A definitive lesion is not identified grossly. Received with the. specimen ~re two two cassettes, one green and one yellow, labeled. Representative sections are submitted in cassettes 12956A. S follows: right seminal vesicle and vas-1; left seminal vesicle and vas-2; perpendicular sections taken from the margins from apex--3;. base-4; prostate submitted from apex to base as follows: level 1 left anterior-5; left posterior-6; right posterior-7; right anterior-8; level 2 left anterior-. 9; left posterior-10; right posterior-11; right anterior-12; level 3 left anterior-13; left posterior-14 right posterior-15; right anterior-16. This is an additional tissue request from. no would like six additional sections from the left side of the prostate in part A. Additional sections. of the left half of the prostate are submitted in cassettes A17-A22 labeled. B. The second container B is labelet. ate, right urethral margin. The specimen consists of a piece of brown tan soft tissue measuring. 0.7 x 0.5 x 0,2 cm. The specimen is entirely submitted in a single cassetti. C. The third container C is labelt. bilateral pelvic lymph nodes. The specimen consists of a portion of fibroadipose fissue. measuring 5,0 x 4.0 X 1 nam. Environcy wour propable lymph nodes measuring from 0.3 to 2.5 cm. The lymph nodes are entirely submitted in. cassettes. follows: one probable node bisected-1; one probable node-2; one probable node bisected--3; one probable node. trisected- to o."
BIOCUP_00235,prostate,PRAD,TCGA-HC-7078,TCGA-HC-7078.fb3865df-5e90-4a2f-b684-063d41369bfc,"Accessic. Acct / Reg #: DIAGNOSIS: A. Bilateral pelvic lymph node dissection: Three benign hyperplastic lymph nodes. B. Radical prostatectomy: Tumor Characteristics: 1. Histologic type: Adenocarcinoma, conventional type. 2. Gleason Grade: a. Primary pattern: 3/5. b. Secondary pattern: 4/5. C.A. Score: 7/10. ‚Ç¨. 3. Tumor involves: Both lobes. 4. Tumor quantitation: Tumor Involves approximately 20% of gland volume. 5. Seminal vesicle involvement: Not identified. 6. Extra-capsular tumor extension: Yes, focal in left posterior region. 7. Lympho-vascular space invasion: Not identified. 8. Perineural space invasion: Absent. 9. High grade PIN: Present. Surgical Margin Status: 1. Bladder Neck: Negative. 2. Apical (inferior): Negative. 3. Inked prostatic margin: Negative. Lymph Node Status: 1. Total number of lymph nodes examined: 3. 2. Number of lymph nodes containing metastatic carcinoma: None. Other significant findings: 1. Frozen section correlation statement: None. 2. Other findings: Benign prostatic hyperplasia. 3. PTNM stage: pT3aN0, MX. CLINICAL HISTORY: Preoperative Diagnosis: Malignant neoplasm of prostate. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Bilateral pelvic lymph nodes. B. Prostate. GROSS DESCRIPTION: A. Received in a single container labeled. bilateral pelvic nodes are two pieces of yellow-brown fibroadipose tissue measuring in aggregate 5. x 3 x 1.5 cm. Sectioning reveals three probable lymph nodes measuring from 0.3 up to 2.2 cm. The fymph nodes are entirely submitted in cassettes. is follows: one probable node in block 1; one probablenode bisected in blocks 2-3;one probablenode sectioned in blocks 4-6. B. Received in a single container labeled. prostate is a prostate gland with attached seminal vesicals. The prostate measures 5 x 6 x 3 cm. and. weighing. 51. grams. The attached seminal vesicals measure in average 2.5 cm. in length and 1 cm. in diameter and are grossly unremarkable. The. seminal vesicals also measure 2.5 cm. in length and 0.2 cm. in average diameter and likewise are grossly unremarkable. The specimen has been. received previously Inked, the right half is inked yellow and the left half has been inked black. The cut surface of the prostate is yellow to gray-tan and. multinodular. There is no definite mass lesion grossly identified. Received with the specimen are two cassettes, one green, one yellow and labeled. Representative sections are submitted in cassettes. las follows: right seminal vesical and vas block 1; left seminal vesical and. vas block 2; sections taken from apical margin in block 3; base mangut in block 4; prostate section from base to apex are submitted as follows: level I left. posterior. block. 5;. left. anterior block 6; right anterior block 7; right posterior block 8; level Il left posterior block 9; left anterior block 10; right anterior block. 11; right posterior block 12; level III left posterior block 13; left anterior block 14; right anterior block 15; right posterior block 16."
BIOCUP_00236,prostate,PRAD,TCGA-HC-A6AN,TCGA-HC-A6AN.D5C8CC7E-BADE-457C-AC31-CC138C8C794C,"TEST: Surgical Pathology. Collected Date & Time: Result Name. Reference Range. SURGICAL P. (Age: Gender : M. Taken Received. Physician (s) : Specimen (s) Received. A: Right iliac and obturator lymph nodes. B: Prostate. Pathologic Diagnosis. A. Right iliac and obturator lymph nodes: One benign lymph node (0/1). B. Prostate, prostatectomy: Prostatic adenocarcinoma, Gleason grade 4 + 3 (sum = 7) . There is extensive involvement of gland bilaterally with. approximately 20% of the gland showing involvement by tumor. Focal extraprostatic extension is identified at the right. apex and right anterior prostate. This consists of two small foci. of tumor within fat, each measuring approximately 1-2 mm. Tumor is identified at the surgical margin at the right. anterior prostate (1 mm) and posteriorly on both the right and. left sides as a few foci all < 1mm. Benign seminal vesicles. SYNOPTIC REPORT: PROSTATE GLAND, RADICAL PROSTATECTOMY. Procedure: Radical prostatectomy. Prostate Size: Weight: 29 g. Size: 4.0 x 3.8 x 3.0 cm. Lymph Node Sampling: Pelvic lymph node dissection. Histologic Type: Adenocarcinoma. Histologic Grade/Gleason Pattern: Primary Pattern: 4. Secondary Pattern: 3. Tertiary Pattern: Not applicable. Total Gleason Score: 7. Tumor Quantitation: Proportion of prostate involved by tumor: 20%. Extraprostatic Extension: Present, focal, right apex. Seminal Vesicle Invasion: Not identified. Margins: Involved by invasive carcinoma, focal anterior and. posterior. Treatment Effect on Carcinoma: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Present. PATHOLOGIC STAGE: pT3a NO MX. NOTE: Information on pathology stage and the operative procedure. is transmitted to this Institution's Cancer Registry as required. for accreditation by the Commission on Cancer. Pathology stage. is based solely upon the current tissue specimen being evaluated. and does not incorporate other relevant data. Pathology stage is. only a component to be considered in determining the clinical. stage and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's. operative report. Primary Pathologist: lectronically Signed Out by: Clinical History. Prostate cancer. Intraoperative Consultation. A. Right iliac and obturator lymph nodes: One benign lymph node. (microscopic evaluation). Gross Description. A. Received fresh for frozen section labeled ""right iliac and. obturator lymph nodes"" is a single lymph node measuring 3.2 cm in. greatest dimension. The specimen is inked yellow and entirely. submitted in cassette A1FS. B. Received in formalin labeled ""prostate"" is a 29 gram, 4.0 cm. from left to right, 3.8 cm from anterior to posterior, 3.0 cm. from apex to bladder neck margin prostatectomy specimen with. attached right seminal vesicle (3.0 x 1.3 x 0.5 cm) right vas. deferens (2.8 x 0.7 x 0.4 cm), left seminal vesicle (3.0 x 1.5 x. 1.0 cm), left vas deferens (3.0 x 0.8 x 0.5 cm). The prostate is. inked as follows: the right prostate is inked blue, the left. prostate is inked black and bladder neck margin is inked yellow. The prostate is serially sectioned from apex to bladder neck. margin to reveal a 2.0 cm in greatest dimension firm, white-tan. lesion located in the right posterior and anterior prostate. The. lesion does not grossly cross the midline into the left posterior. prostate. The lesion grossly abuts the blue-inked margin. There. are other discrete nodules or masses grossly identified and the. remaining prostate parenchyma is pink-tan. Ninety percent (90%). of the specimen is submitted in cassettes B1-B20. Sections are submitted as follows: B1-B2 - right apex, perpendicularly cut;. B3-B4 - left apex, perpendicularly cut;. B5-B6 - right bladder neck margin, perpendicularly cut;. B7-B8 - left bladder neck margin, perpendicularly cut;. 89 - right seminal vesicle insertion point and cross section. through right seminal vesicle and vas deferens;. B10 - left seminal vesicle insertion point and cross section. through right seminal vesicle and vas deferens;. B11 - right anterior prostate;. B12-B15 - right posterior prostate, from apex to bladder neck. margin;. B16 - left anterior prostate;. B17-B20 - left posterior prostate, from apex to bladder neck. margin. Microscopic Description. Microscopic examination has been performed on all slides. The. pathologic diagnosis encompasses the essential microscopic. findings of this case. Interpretation performed at. If immunohistochemistry or in situ hybridization was used the. following applies: This test was developed and its performance. characteristic determined by. It. has not been cleared or approved by the U. S.Food and Drug. Administration (FDA) The FDA does not require this test to go. through premarket FDA review. This test is used for clinical. purposes. It should not be regarded as investigational or for. research. This laboratory is certified under the Clinical. Laboratory Improvement Amendments (CLIA) as qualified to perform. high complexity clinical laboratory testing. All special stains. used have adequate controls."
BIOCUP_00237,prostate,PRAD,TCGA-V1-A9ZI,TCGA-V1-A9ZI.7C3EC6A6-C005-4877-A6C8-C3174709A3FF,"FINAL PATHOLOGIC DIAGNOSIS. A. Lymph nodes, right pelvic, dissection: Seven lymph nodes negative for carcinoma. (0/7). B. Lymph nodes, left pelvic, dissection: Three lymph nodes negative for carcinoma. (0/3). C. Prostate and bilateral seminal vesicles, radical prostatectomy: Prostatic. adenocarcinoma, Gleason grade 5+4, score=9, with bilateral involvement,. extraprostatic extension and invasion into right seminal vesicle, negative margins; see. comment. COMMENT: Synoptic Comment for Prostate Tumors. - Type of tumor: Small acinar adenocarcinoma. - Location of tumor: Left posterior midgland - slide C10, right posterior midgland - slides C6 and C7;. right posterior base - slide C8; right anterior midgland - slides C3 and C4; right anterior base - slides C5. and C17. - Estimated volume of tumor: 5.7 cubic centimeter. - Gleason score: 5+4; primary pattern 5, secondary pattern 4. - Estimated volume > Gleason pattern 3: 100%. Involvement of capsule: Tumor invades capsule (Right anterior midgland - slides C3 and C4; right. posterior midgland - slide C7; right posterior base - slides C8 and C17. - Extraprostatic extension: Present, limited in extent (right posterior midgland - slide C7; right. posterior base - slides C8 and C17). - Margin status for tumor: Negative (tumor is <0.1 mm from margin, slide C8). - Margin status for benign prostate glands: No benign glands present at inked excision margins. - High-grade prostatic intraepithelial neoplasia (HGPIN): None. - Tumor involvement of seminal vesicle: Present: Right side. - Lymphovascular invasion: Present (slide C7). - Perineural infiltration: Present. - Lymph node status: Negative, total number of nodes examined: 10. - AJCC/UICC stage: pT3bNO. Dr. reviewed slide C7 and concurs with the diagnosis of prostatic adenocarcinoma, Gleason grade. 5+4. Specimen(s) Received. A:Right pelvic lymph nodes. B:Left pelvic lymph nodes. C:Prostate & bilateral seminal vesicles (fresh). Clinical History. The patient is a -year-old man with prostatic adenocarcinoma in the right apex, right mid, right base,. and right nodule, with Gleason grade 4+5=9 The patient now undergoes robot-assisted. radical prostatectomy and bilateral pelvic lymph node dissections. Gross Description. The specimen is received in three parts, each labeled with the patient's name and medical record. number. Parts A and B are received in formalin. Part C is received fresh. Part A, additionally labeled ""right pelvic lymph nodes,"" consists of a piece of irregular, unoriented,. yellow-tan fibrofatty tissue (4.5 x 3 x 0.8 cm) that contains five uniformly pink-tan soft/firm lymph node. candidates (2 cm-0.5 cm). The entire specimen is submitted as follows: Cassette A1: Intact largest lymph node candidate. Cassette A2: Four intact smaller lymph node candidates. Cassette A3: Fibrofatty tissue. Part B, additionally labeled ""left pelvic lymph nodes,"" consists of a piece of irregular, unoriented,. yellow-tan fibrofatty tissue (4 x 2.7 x 1 cm) that contains three uniformly pink-tan soft/firm lymph. nodes (3 cm, 0.5 cm, and 0.4 cm). The cut surface of the largest lymph node appears homogenous. white-pink. The entire specimen is submitted as follows: Cassettes B1-B2: Largest lymph node, serially sectioned. Cassette B3: Two intact smaller lymph nodes. Cassette B4: Fibrofatty tissue. Part C is labeled ""prostate and bilateral seminal vesicles,"" and consists of a radical prostatectomy. specimen (53 gm; 4 cm from apex to base x 5 cm in width x 3.5 cm from anterior to posterior). GROSS PATHOLOGIC FINDINGS: There are multiple, tan, rubbery nodules (largest 1.3 x 1 x 1 cm). located centrally. In slices 1-8, there is a white-tan firm mass (3.2 x 2.5 x 1.2 cm) with an irregular. border in the peripheral aspect of the right lobe that does not extend across the midline. The mass. abuts the right lateral and right posterior margins. The anterior fibrous stroma is red-tan, roughened, and open; the remaining capsule is intact. The. remaining prostatic parenchyma is tan. The seminal vesicle/vas deferens bundles (right 2.5 x 2.5 x 0.7. cm; left 2.5 x 2 x 0.7 cm) are soft, lobulated, and red-tan, without obvious mass. Some of the fresh. prostate tissue is taken by the. The non-sectioned slices are embedded for research. purposes. ORIENTED BY: Anatomic landmarks; seminal vesicles, urethra. INKING: Right anterior in green, left anterior in blue, posterior in black. POTENTIAL STUDIES: Snap-frozen. GROSS PHOTOGRAPHS: Yes. CASSETTES: Representative sections are submitted as follows: Apical margins, entirely submitted in perpendicular sections. C1: Right apex. C2: Left apex. Right anterior quadrant. C3: Slice 2, with white-tan firm mass. C4: Slice 4, with white-tan firm mass and portion of the largest nodule located centrally. C5: Slice 7. Right posterior quadrant. C6: Slice 2, with white-tan firm mass. C7: Slice 4, with white-tan firm mass and portion of the largest nodule located centrally. C8: Slice 7, with white-tan firm mass. Left posterior quadrant. C9: Slice 2. C10: Slice 4. C11: Slice 7. Left anterior quadrant. C12: Slice 2. C13: Slice 4. C14: Slice 7. Bladder margins, entirely submitted in perpendicular sections. C15: Right. C16: Left. Prostatic/seminal vesicle junction and cross-section of vas deferens. C17: Right. C18: Left. Diagnosis based on gross and microscopic examinations. Final diagnosis made by attending pathologist. following review of all pathology slides."
BIOCUP_00238,prostate,PRAD,TCGA-CH-5792,TCGA-CH-5792.72de5993-cad1-4ba0-9ea5-c545799a2f6e,"Diagnosis. Multifocal, acinar adenocarcinoma of the prostate with carcinoma foci on both sides, both in. the apical and in the basal zone of the organ. In the region of the largest carcinoma focus is a. left dorsoperipheral spread across the organ with infiltration of the periprostatic tissue. The. outer areas of the resected material are tumor-free in the parts that can be visualized. Tumor volume overall about 7 cm. The follow-up resection material, the pelvic lymph nodes and seminal vesicles are tumor-free. Tumor stage pT3a pNO, Gleason score 4+5."
BIOCUP_00239,prostate,PRAD,TCGA-KK-A59X,TCGA-KK-A59X.64BB13A6-1071-4C2A-937C-17ACC07ADF75,"MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) RIGHT PELVIC LYMPH NODES: Eight lymph nodes, no tumor present (0/8). (B) LEFT PELVIC LYMPH NODES: METASTATIC PROSTATE ADENOCARCINOMA IN TWO OF SIX LYMPH NODES (2/6) WITH EXTRANODAL. EXTENSION. THE LARGEST FOCUS MEASURES 3.0 MM. (C) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. (A) RIGHT PELVIC LYMPH NODES - Received is a single fragment of fatty tissue measuring 7.5 x 4.0 x 2.0 cm. Dissection. reveals. multiple possible lymph nodes ranging from 0.5 up to 2.0 cm in greatest dimension. Possible lymph nodes are entirely. submitted. SECTION CODE: A1, five possible lymph nodes; A2, two possible lymph nodes; A3, A4, one sectioned possible lymph. node. (B) LEFT PELVIC LYMPH NODES - Received is a single fragment of fatty tissue measuring 7.5 x 4.0 X 2.0 cm. Dissection. reveals three possible lymph nodes ranging from 0.7 up to 3.0 cm in greatest dimension. Possible lymph nodes and the rest of the. fatty tissue are submitted. SECTION CODE: B1, one possible lymph node; B2, one sectioned possible lymph node; B3, B4, one sectioned possible. lymph node; B5-B10, rest of fatty tissue for all possible lymph nodes. (C) PROSTATE AND SEMINAL VESICLES - Supplemental report to follow. CLINICAL HISTORY. Prostate cancer. SNOMED CODES. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Start of ADDENDUM. Page: 2. ADDENDUM. This modified report is being issued to provide additional information/results. DIAGNOSIS. (C) PROSTATE AND SEMINAL VESICLES: PROSTATIC ADENOCARCINOMA, GLEASON SCORE 9 (5+4) (SEE COMMENT). MULTIFOCAL EXTRAPROSTATIC EXTENSION PRESENT. TUMOR INVADING RIGHT AND LEFT SEMINAL VESICLES AND PERIVESICULAR SOFT TISSUE. TUMOR EXTENDING IN MULTIPLE AREAS TO THE MARGIN OF RESECTION. SEE PREVIOUS REPORT FOR DIAGNOSIS OF PELVIC LYMPH NODES. COMMENT. Approximately 90% of the prostate gland is involved by prostatic adenocarcinoma. There are two tumor foci, one of peripheral. zone and one of transition zone origin. The dominant tumor focus is located in the right anterolateral, right lateral, right. posterolateral, right posterior, mid posterior, left posterior, left posterolateral, left lateral and left anterolateral peripheral zone with. extension into the transition zone. This tumor focus measures 4.0 x 3.0 cm in the largest cross-sectional dimension and it is. present in three cross sections and extensively in the apex and base regions. This tumor focus exhibits multifocal extraprostatic. extension and multifocal extension to the margin of resection. This tumor focus extensively invades both seminal vesicles. including intra and extraprostatic portions and perivesicular soft tissue. The second tumor focus is located in the right and left. transition zone. This tumor focus measures 2.0 x 1.0 cm in the largest cross-sectional dimension and it is present in three cross. sections, extensively in the apex and focally in the base region. This tumor focus is of lower histologic grade (Gleason score. 6/3+3) and it is confined to the prostate. Please refer to the previous report for the diagnosis of the pelvic lymph nodes. GROSS DESCRIPTION. (C) PROSTATE, SEMINAL VESICLES - A prostate, attached right and left seminal vesicles and attached segments of right and. left vasa deferentia. The. prostate gland (5.3 x 3.5 x 3.6 cm, 56 gm, postfixation) has the usual shape. A nodule is palpated in the right mid and. right base regions. Serial cross sections after fixation demonstrate a firm area consistent with tumor in the right peripheral zone. involving the three cross sections of the prostate. The seminal vesicles and segments of vasa deferentia are grossly free of tumor. SECTION CODE; C1-C4, right seminal vesicle and segment of right vas deferens from the base towards the tip; C5-C7,. left. seminal vesicle and segment of left vas deferens from the base towards the tip; C8, C9, prostatic base right border; C10-C13,. prostatic base right posterior border; C14-C21, prostatic base central portion; C22, prostatic base left border; C23-C26, prostatic. Page: 3. base left posterior border; C27, C28, apex anterior; C29-C32 apex left; C33-C36, apex posterior; C37, apex right; C38, detached. portions of margins of resection according to specimen radiograph; C39-C53, sections of the three cross sections of the prostate. according to specimen radiograph. The anterior aspect of the prostate is inked in green, left surface in red, right surface in yellow and posterior surface in. black. Orange (C41, 42, 49-51) denotes surfaces that do not represent a true margin of resection. SNOMED CODES. END OF REPORT-."
BIOCUP_00240,prostate,PRAD,TCGA-KK-A6E8,TCGA-KK-A6E8.3716A52E-E0B7-4FE0-AC2B-07F2F3A0D6AD,"MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) PERIPROSTATIC LYMPH NODE: Adipose tissue, no tumor present. No lymph nodes present. (B) ANTERIOR APEX: Prostatic tissue, no tumor present. Normal glands present focally at the inked surface. (C) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. (D) LEFT PELVIC LYMPH NODES: Seven lymph nodes, no tumor present. (E) RIGHT PELVIC LYMPH NODES: Seven lymph nodes, no tumor present. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A). PERIPROSTATIC. LYMPH NODE - Received is a portion of yellow-tan fibrofatty adipose tissue that is focally hemorrhagic. measuring 2.5 X 2.0 x 0.6 cm. Tissue is dissected revealing no definite lymph node tissue. Tissue is submitted entirely. in. cassettes A1-A4. (B). ANTERIOR APEX - A fragment of tan grey tissue (0.5 x 0.4 x 0.2 cm). The surface previously inked is reinked. Submitted in. toto for frozen section. FS/DX: PROSTATIC GLANDS AT THE MARGIN. TUMOR NOT IDENTIFIED. (C) PROSTATE AND SEMINAL VESICLES - Supplemental report to follow. (D). LEFT PELVIC LYMPH NODE - Received is a portion of yellow-tan fibrofatty adipose tissue measuring 5.8 x 3.8 x 1.0 cm. Tissue is dissected revealing seven possible lymph nodes that range from 0.5 x 0.4 x 0.3 cm up to 2.0 x 0.8 x 0.5 cm. Possible. lymph nodes are submitted in cassettes D1-D7. SECTION CODE: D1, three possible lymph nodes; D2, single possible lymph node, bisected; D3, single possible lymph. node, trisected; D4, single possible lymph node, bisected; D5-D7, single possible lymph node, sectioned. (E) RIGHT PELVIC LYMPH NODE - Received is a portion of yellow-tan fibrofatty adipose tissue measuring 6.5 x 3.5 x 0.8 cm. Tissue is dissected revealing seven possible lymph nodes that range from 0.3 x 0.3 X 0.2 cm up to 1.2 x 0.5 X 0.4 cm. Possible. lymph nodes are submitted in cassettes E1-E3. SECTION CODE: E1, four possible lymph nodes; E2, two possible lymph nodes; E3, single possible lymph node. sectioned. CLINICAL HISTORY. Prostate cancer. CONSULTANT(S). SNOMED CODES. Page: 2. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Released by: Start of ADDENDUM. Page: 3. ADDENDUM. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (C) PROSTATE AND SEMINAL VESICLES: PROSTATIC ADENOCARCINOMA, GLEASON SCORE 9 (4 + 5), (SEE COMMENT). FOCAL EXTENSION OF TUMOR TO THE LEFT APICAL MARGIN OF RESECTION CANNOT BE EXCLUDED. No extraprostatic extension present. PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN), HIGH GRADE. Right and left seminal vesicles, no tumor present. Segments of right and left vasa deferentia, no tumor present. Entire report and diagnosis completed by. COMMENT. The prostate gland contains a single focus of prostatic adenocarcinoma. The tumor is located in the transition zone and occupies. practically the entire anterior half of the prostate. The tumor focus measures 3.5 x 1.5 cm in the largest cross-sectional dimension,. and it is present in the two cross sections of the prostate, extensively in the apex and focally in the base region. Focal extension of. tumor (less than 1.0 mm) to the left apical margin cannot be excluded. GROSS DESCRIPTION. (C) PROSTATE AND SEMINAL VESICLES - A specimen consisting of a prostate, attached right and left seminal vesicles and. attached segments of right and left vasa deferentia. The prostate gland (4.5 x 4.5 X 3.9 cm, 42 grams, post fixation) has the usual shape. The soft tissue present along the. right. and. left posterolateral aspects of the prostate appears symmetrical. A nodule is palpated on the left anterior surface of the. prostate. Serial cross sections after fixation demonstrate a firm area consistent with tumor in the anterior portion of the prostate. of. both cross sections. The seminal vesicles and segments of vasa deferentia are grossly free of tumor. SECTION CODE: C1-C3, right seminal vesicle and segment of right vas deferens; C4-C6, left seminal vesicle and. segment of left vas deferens; C7, C8, prostatic base, right border; C9, C10, prostatic base, right posterior border; C11-C18,. prostatic. base,. central portion; C19, prostatic base, left border; C20, prostatic base, left posterior border; C21, C22, apex anterior;. C23-C25, apex left; C26-C29, apex posterior; C30, C31, apex right; C32-C41, sections of the two cross sections of the prostate. according to specimen radiograph. The anterior aspect of the prostate is inked in green, left surface in red, right surface in yellow and posterior surface in. black. Blue ink (C21 and C22) denotes surfaces that do not representative the true margin of resection. SNOMED CODES. Page: 4. Released by: END OF REPORT-."
BIOCUP_00241,ovary,OV,TCGA-36-2542,TCGA-36-2542.f901accb-a3be-461f-b145-39b83c201293,"Receive Date: PHN: Final Diagnosis: A. Omentum: metastatic high-grade serous carcinoma. B. Cul-de-sac mass: high-grade serous carcinoma (see comment). C. Pelvic tumour: high-grade serous carcinoma (see comment). D. Uterus, tubes, and ovaries: 1. high-grade serous carcinoma involving both ovaries and uterine. serosa; the largest mass replaces the left ovary, which is the. likely primary site. 2. inactive endometrium, submucosal leiomyoma, adenomyosis. 3. endometriosis of cul-de-sac. 4. unremarkable cervix. E. Pelvic tumour: high-grade serous carcinoma (see comment). F. Peritoneal washings. positive for serous carcinoma. Comment: It is difficult to determine from histological examination if the tumour in. specimens B, C, and E are metastatic from the main tumour in the left ovary or became. detached from it pre- or intraoperatively. Clinical History as Provided by. See. with ascites complex pelvic mass. A. Omentum. B. Cul-de-sac mass. C. Pelvic tumor. D. Uterus, cervix, tubes and ovaries. E. Pelvic tumor. Specimens Received: A: omentum. B: cul de sac. C: pelvic tumour. D: uterus,cervix,tubes + ovaries. E: pelvic tumour. Gross Description: The specimen is received in five containers each labelled with the patient's name. Container A is labelled OMENTUM and consists of a piece of omental tissue measuring. 28 X 5 X 1 cm. There are multiple, small, solid nodules present on the surface of the. omentum, the largest measuring 1.4 cm in greatest dimension. Representative sections. are submitted in cassettes A1-A4. Container B is labelled CUL-DE-SAC MASS and consists of a 375 g tumor mass that. measures 10 X 8 X 7 cm. The surface is variegated with smooth and roughened areas. Serial sectioning of the tumor reveals a mostly solid mass with light-tan/creamy-. coloured cut surface. No obvious necrosis or hemorrhage is noted. Focal small cystic. areas contain gelatinous material. Several roughened surface areas are inked black,. and the representative sections are submitted in cassette B1-B10. Container C is labelled PELVIC TUMOR and consists of multiple fragments of tumor. mass measuring 9 X 8 X 2 cm in aggregate. The largest fragment measures 6 X 3 X 0.8. cm. Representative sections are submitted in cassettes C1-C4. Container D is labelled UTERUS, CERVIX, TUBES AND OVARIES and consists of a. total hysterectomy and a bilateral salpingo-oophorectomy specimen. The specimen. weighs 135 g. The uterus measures 4 cm (cornu to cornu) X 8.5 cm (fundus to. ectocervix) X 3.5 cm (anterior to posterior). There are multiple small nodules present on. the uterine serosal surface. The largest nodule measures 2.5 cm in greatest dimension. and is present on the anterior serosal surface. The ectocervix is covered by smooth. mucosa. Opening of the uterus reveals a patent endocervical canal and a firm, well-. circumscribed nodule protruding subserosally measuring 1.5 cm in diameter. This. nodule is lined by smooth endometrial surface. The rest of the endometrium and. myometrium is unremarkable. The myometrium measures up to 1.4 cm in thickness. Representative sections are submitted as follows: D1 -anterior cervix. D2 -posterior cervix. D3 - -cul-de-sac. D4-D5 -anterior endometrium with subserosal nodule. D6-D7 -posterior endometrium. D8 -anterior serosal surface nodule. The left adnexal area has a large tumor mass measuring up to 5 cm in greatest. dimension. This tumor has a roughened surface in some areas. The normal ovary is not. grossly identified within the left adnexa. A segment of fallopian tube, mostly the distal. portion, is present. This segment measures 4.5 cm in length and up to 0.4 cm in. diameter. A fimbriated end is present at the distal end. Serial sectioning of the tumor. mass reveals mostly white, solid, cut surface. Representative sections of the left adnexa. are submitted as follows: D9-D13 -tumor mass. D14 -tumor mass with fallopian tube. D15-D16 -fallopian tube. The right fallopian tube measures 6 cm in length and up to 0.4 cm in diameter and has a. roughened, dark-brown surface in some areas. Otherwise the fallopian tube is grossly. normal. The right ovary measures 2.5 X 1 X 0.8 cm with two nodules present on the. ovarian surface, the larger one measures up to 1.5 cm in greatest dimension, and the. small one measures 0.6 cm in greatest dimension. The larger one appears roughened. on the surface. Representative sections are submitted as follows: D17-D18 -ovary and the ovarian surface nodule. D19-D20 -right fallopian tube. Container E is labelled PELVIC TUMOR and consists of a 5 x 4 X 3 cm tumor mass with. a roughened surface. Serial sectioning of the tumor mass reveals mostly solid cut. surface. Representative sections are submitted in cassettes E1-E4."
BIOCUP_00242,ovary,OV,TCGA-09-2055,TCGA-09-2055.4cff882a-1ce5-4586-a808-a7f00e319743,"FINAL PATHOLOGIC DIAGNOSIS. A. Left ovary and fallopian tube, salpingo-oophorectomy: -Left ovary: 1. High-grade serous carcinoma, oxyphilic variant, 16.5 cm; see. comment. 2. Benign follicle cysts. - Left fallopian tube: No significant pathologic abnormality, no tumor. identified. B. Lymph nodes, left pelvic, excision: No tumor identified in six lymph nodes. (0/6). C. Lymph nodes, left pelvic, excision: No tumor identified in eleven lymph. nodes (0/11). D. Lymph nodes, right pelvic, excision: No tumor identified in seventeen. lymph nodes (0/17). E. Lymph nodes, right peri-aortic, excision: No tumor identified in three. lymph nodes (0/3). F. Omentum, omentectomy: Reactive mesothelial hyperplasia, no tumor. identified. G. Appendix, appendectomy: No significant pathologic abnormality, no tumor. identified. H. Lymph nodes, left peri-aortic, excision: No tumor identified in nineteen. lymph nodes (0/19). COMMENT: The tumor shows complex papillary architecture with a multilayered syncytial-appearing epithelium. with abundant budding. The tumor cells are pleomorphic with relatively abundant eosinophilic. cytoplasm, a very high N:C ratio, and coarse vesicular chromatin with prominent eosinophilic. nucleoli. Abundant mitotic figures and apoptotic cells are seen. The findings are most likely those of. a high-grade serous carcinoma, and the large cell size with eosinophilic cytoplasm suggests the. oxyphilic variant thereof. However, the differential diagnosis can include oxyphilic variants of clear. cell carcinoma or a high-grade endometrioid adenocarcinoma. The absence of extra-ovarian tumor. given the size of the primary is also rather unusual for serous carcinoma. Serous carcinoma is. nonetheless favored as the overall growth pattern is most consistent with this diagnosis, and areas. with well-developed features of either clear cell or endometrioid adenocarcinoma are not seen. Additional stains were necessary to properly assess this case, and these were performed and. evaluated with the following results: -WT1: Positive. -p53: Positive, variable intensity. -ER: Negative. -PR: Focal, patchy positive. -CA125: Positive. The expression of WT1 is most consistent with an ovarian serous carcinoma, which is also supported. by the diffuse expression of p53 and CA125, and low-level or absent expression of PR and ER. respectively. Although p53 staining is diffuse, the intensity varies more than is typical of serous. carcinoma. Nonetheless, the diagnosis is not excluded by this pattern. In contrast, expression of. NT1 and diffuse p53 argues against clear cell carcinoma, and while some PAS-positive material is. resent, this is diastase-resistant and therefore not compatible with glycogen. At least some of the. material is mucin and stains with mucicarmine. The expression of WT1 and poor expression of ER. and PR also argue against endometrioid adenocarcinoma. Ovarian Tumor Synoptic Comment. 1. Type of tumor: Serous carcinoma. 2. Grade of tumor: High-grade. 3. Location of tumor: Left ovary. 4. Diameter of tumor: 16.5 cm. 5. Appearance of surface of ovary: Smooth, intact. 6. Condition of capsule: Unruptured. 7. Appearance of cut surface: Solid, soft, gray-white. 8. Color of solid areas: Gray-white. 9. Necrosis: Present. 10. Lymphatic/vascular invasion: None seen. 11. Sites of metastases in pelvis: None identified. 12. Pelvic lymph nodes: No tumor in 17 left pelvic, and 17 right pelvic lymph nodes (0/34). 13. Sites of metastases in abdomen: None. 14. Para-aortic lymph nodes: No tumor in 19 left and 3 right peri-aortic lymph nodes (0/22). 15. Peritoneal cytology: Malignant. Cytology accession number: 16. Other significant findings: None. 17. FIGO stage: IC-due to microscopic tumor growth to inked surface of ovary. 18. TNM stage: pT1c NO MX. Specimen(s) Received. A:Left ovary and tube. B:Left peri-aortic lymph nodes. C:Left pelvic node. D:Right pelvic lymph node. E:Right peri-aortic nodes. F:Omentum. G:Appendix. H:Left peri-aortic lymph nodes. Intraoperative Diagnosis. ES1 (A) Left ovary and tube, salpingo-oophorectomy: Poorly differentiated carcinoma. FS2 (B) Lymph node, left periaortic, biopsy: Negative for carcinoma. Tissue section and cytologic. preparation. (L. Clinical Histor. The patient is a. No other clinical history is provided. Per the electronic medical. record, the serum CA125 level on. was 3151 U/ml (<35 U/ml). Gross Description. The specimen is received in eight parts, each labeled with the patient's name and medical record. number. Parts A and B are received fresh. Parts C through H are received in formalin. Part A is additionally labeled ""left ovary and tube."" It consists of a single unoriented, intact, red. salpingo-oophorectomy specimen, weighing a total of 908 gm and measuring 16.8 X 11.5 X 9.5 cm,. including an attached fallopian tube, measuring 7.5 X 1.2 X 1 cm. The external surface of the ovary. and tube is predominantly smooth, except for a vague, ill-defined, approximately 3 cm area on the. ovarian surface which is slightly irregular in texture. This area is inked in blue, and the remaining. surface is inked in black. Although irregular, no overt papillary excrescences are seen. In addition,. the fallopian tube resection margin is inked in green. The fallopian tube appears unremarkable, and. no discrete lesions are seen or palpated, and the fimbriae are lush. The ovary is sectioned to reveal. a soft, fleshy, gray-white, almost-solid interior with an irregular, up-to-6 cm apparently necrotic. cavity in the middle. The tumor is soft and has a grossly discernible papillary appearance. There is. also a single smooth-walled, 4 cm, unilocular cyst filled with a clear, yellow-brown fluid as well as an. adjacent 2.4 cm, unilocular, hemorrhagic cyst. This latter cyst directly underlies the blue-inked area. and contains multiple small papillary excrescences along the wall as well as a 1.5 cm, solid area with. a consistency similar to the rest of the bulk tumor. The fallopian tube is sectioned and appears. grossly unremarkable. A representative section of the tumor is submitted for frozen section diagnosis. as FS1, with the frozen section remnant submitted in cassette A1. In addition, approximately 150 gm. of the tumor is submitted for tissue banking. Additional representative sections are submitted as. follows: Cassette A2: Fallopian tube plus tumor. Cassette A3: Additional sections of tube and fimbriae. Cassette A4: Representative sections of blue-inked area. Cassettes A5-A8: Additional representative sections of tumor, multiple sections per cassette. Part B is additionally labeled ""left pelvic node."" It consists of a single unoriented fragment of pink. soft tissue, measuring 5 X 1.5 X 0.5 cm. A representative section is submitted for frozen section. diagnosis as FS2 and a touch prep, with the frozen section remnant submitted in cassette B1. Palpation through the remaining tissue reveals five additional candidate lymph nodes, ranging in size. from 0,2 cm to 0.5 cm. The entire remainder of the specimen is submitted in cassette B2. Part C is additionally labeled ""left pelvic node."" It consists of multiple fragments of yellow-tan and. soft tissue, measuring 3.5 X 3 X 2 cm in aggregate. Multiple lymph node candidates are identified. within the fatty, lobular tissue. Sections are submitted as follows: Cassette C1: Two whole lymph nodes and one lymph node inked and bisected. Cassette C2: One whole lymph node inked and bisected. Cassettes C3-C4: Remainder of fatty tissue. Part D is additionally labeled ""right pelvic lymph node."" It consists of multiple unoriented fragments. of yellow-tan, fatty, lobular soft tissue, measuring 4.1 X 2.5 X 2.1 cm in aggregate. Multiple lymph. node candidates are identified within the fatty, lobular tissue. Sections are submitted as follows: Cassette D1: Three whole lymph nodes. Cassette D2: Four whole lymph nodes. Cassette D3: Multiple small lymph node candidates. Cassettes D4-D5: Remainder of fatty tissue. Part E is additionally labeled ""right periaortic node."" It consists of a single fragment of gray-tan and. yellow-tan soft tissue, measuring 1.5 x 1.2 X 1.2 cm. The specimen is inked black, trisected, and. entirely submitted in cassettes E1 and E2. Part F is additionally labeled ""omentum."" It consists of an irregular, unoriented fragment of adipose. tissue, measuring 56 X 18 X 0.5 cm and weighing 418 gm. Serial sectioning of the specimen reveals. homogeneous yellow-tan, fatty, lobular tissue with no lesions or masses noted. Multiple. representative sections are submitted in cassettes F1 through F3. Part G is additionally labeled ""appendix."" It consists of a single vermiform appendix, measuring 5.7. cm in length and 0.4 cm in average diameter. The serosal surface is pink-tan, smooth, and. unremarkable in appearance. Serial sectioning reveals an unremarkable internal mucosa in the. lumen, with a wall thickness of 0.2 cm. The specimen is entirely submitted in cassettes G1 through. G4. Part H is additionally labeled ""left periaortic lymph nodes."" It consists of multiple fragments of. yellow-tan and gray-tan soft tissue, measuring 3.5 X 3.3 X 1,5 cm in aggregate. Multiple lymph node. candidates are identified within the yellow-tan, fatty, lobular tissue. Sections are submitted as. follows: Cassette H1: Three whole lymph nodes and one lymph node inked and bisected. Cassette H2: One lymph node inked and bisected and one lymph node uninked and. bisected. Cassette H3: Multiple whole lymph node candidates. ""assettes H4-H5: Remainder of fatty, fibrous tissue. viagnosis based on gross and microscopic examinations. Final diagnosis made by attending. pathologist following review of all pathology slides."
BIOCUP_00243,ovary,OV,TCGA-29-2428,TCGA-29-2428.45a6c74c-045b-4fdd-a93d-9e1a8d36e4cb,"CLINICAL HISTORY: Abdominal/pelvic swelling. History- high grade endometrium carcinoma (from. Pap), left adnexal mass (retrograde endometrial carcinoma ?). GROSS EXAMINATION: A. ""Left tube and ovary (AF1)"" Received fresh is a 10.5 x 8.9 x 8.5 cm. multicystic, serous fluid filled and hemorrhagic ovary filled with tumor that. is nodular and exudative. The serosa is intact. A 3.0 x 3.5 x 2.0 cm ovarian. remnant is identified adjacent to it. The 6.0 x 0.7 x 0.5 cm fallopian tube in. which the distal end is obscured by a 4.0 x 3.0 x 2.5 cm tan-white, homogenous. tumor (AF1 Frozen section; remnant in A1, additional blocks A). BLOCK SUMMARY: A1- AF1 remnant. A2- tube and tumor (longitudinal section). A3- tube (cross sections, surgical margin inked black) . A4- residual ovary and mass. A5- hemorrhagic cyst and mass. A6-A7- mass with fibrinous exudate. B. ""Uterus, left tube and ovary (gross consult) "". Received fresh and placed in. formalin is a 48.9 gram, 7.3 x 6.7 x 2.5 cm uterus, a 2.5 x 0.7 x 0. 6 cm. segment of fallopian tube (fimbria not identified) and a 2.5 X 1.8 x 0.8 cm. tan-white ovary. The ovary, fallopian tube, and uterus are all grossly. unremarkable: Nabothian cysts are identified in the endocervix. BLOCK SUMMARY: B1- fallopian tube and ovary. B2- anterior endomyometrium. B3- anterior cervix. B4- posterior endomyometrium. B5- posterior cervix. C. ""Left periaortic node (CF1) "". Received fresh and placed in formalin is a. 3.0 X 1.5 x 1.0 cm lymph node of which part consists for frozen section CF1. The remaining fragment are submitted in blocks C2-C4. D. ""Perirectal mass"". Received fresh and placed in formalin. A 3.3 x 3.0. x. 2.3 cm aggregate of fibrofatty tissue and peritoneum, which on cut section. demonstrates a 2.7 x 2.2 x 1.5 cmitan-white, nodular mass, which measures 0.2. cm from the blue-inked outer surface. Representative in D1-4. E. ""Left pelvic mass"". Received fresh and placed in formalin. Two tan-white. tissue fragments, which measure in aggregate 2.5 x 2.5 x 1.1 cm. The outer. surface is inked blue. The larger fragment (2.5 x 1.6 x 1.0 cm) demonstrates. a tan-white homogenous cut surface that extends to the blue inked outer. surface. Representative in E1-2. F. ""Left external iliac node"". Received fresh and placed in formalin. A 4.3. x 2.5 x 1.2 cm aggregate of fibrofatty tissue, which is dissected for lymph. node candidates. One lymph node candidate is identified and submitted. entirely in F1. G. ""Left obturator nodes"". Received fresh and placed in formalin. A 5.7 x. 2.5 x 2.4 cm aggregate of fibrofatty, which is dissected for lymph node. candidates. Two lymph node candidates are identified. The largest lymph node. candidate measures 4.3 x 2.0 x 0.7 cm. The smaller lymph node candidate. represents a mat of two apparent lymph nodes. BLOCK SUMMARY: G1-3- one lymph node candidate. G4-5- one lymph node candidate. H. ""Right external node"" Received fresh and placed in formalin. A 3.5 x 3.0. x 1.0 cm aggregate of fibrofatty tissue which dissected for lymph node. candidates. The largest lymph node candidate measures 1.8 x 1.4 x 0.5 cm. BLOCK SUMMARY: H1- four lymph node candidates. H2- one lymph node candidate. H3- two lymph node candidates. I. ""Right obturator nodes"". Received fresh and placed in formalin. A 5.5 x. 2.5 x 1.0 cm aggregate of fibrofatty tissue, which is dissected for lymph node. candidates. The largest lymph node candidate measures 5.0 x 1.4 x 0.5 cm. BLOCK SUMMARY: I1-2- one lymph node candidate. I3- three lymph node candidates (one inked blue and bisected). J. ""Omentum"". Received fresh and placed in formalin. A 22.0 x 18.0 x 4.0 cm. aggregate of omentum no masses or lesions are identified. INTRA OPERATIVE CONSULTATION: A. ""Left tube and ovary"" AF1- papillary serous adenocarcinoma. B. ""Uterus, left tube, ovary"" BF1- grossly benign. C. ""Left periaortic node"": CF1 metastatic serous adenocarcinoma. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: HYSTERECTOMY, OOPHORECTOMY & LYMPH NODES. PATHOLOGIC STAGE. pT3C pN1 pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to. this. required for. accreditation by th. stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. ""LEFT OVARY"": TYPE: SEROUS ADENOCARCINOMA. FIGO GRADE: 3. TUMOR SIZE: 10.5 X 8.9 X 8.. CM. WEIGHT: N.A. SEROSA: INVOLVED. ADDITIONAL FINDINGS: NONE. SPECIMENS WITH METASTATIC/IMPLANTED TUMOR. A. LEFT FALLOPIAN TUBE, 4.0 CM NODULE AT TERMINUS. B. UTERUS: 50 GRAMS. ENDOMETRIUM: TUMOR SITE: LOWER POLYP IN THE LOWER UTERINE SEGMENT INTO THE CERVIX. HISTOLOGIC TYPE: SEROUS ADENOCARCINOMA. FIGO GRADE: 3. TUMOR SIZE: 4 MM. MAXIMUM DEPTH OF MYOMETRIAL INVASION: 0 CM, IN A 1.2 CM THICK WALL. LYMPHATIC/VASCULAR INVASION: NEGATIVE. ADJACENT NON-NEOPLASTIC ENDOMETRIUM: ATROPHIC. REMAINING MYOMETRIUM: NEGATIVE. CERVIX: NEGATIVE. SEROSA: NO PATHOLOGIC DIAGNOSIS. C. LEFT PERIAORTIC LYMPH NODE: ONE OF ONE NODE POSITIVE (3 CM). D. PERIRECTAL MASS: METASTATIC TUMOR, 2.7 CM. E. LEFT PELVIC MASS: 0.5 CM TUMOR NODULE. F. LEFT EXTERNAL ILIAC LYMPH NODE: ONE OF ONE NODE, POSITIVE (0/1). THE FOLLOWING SPECIMENS ARE FREE OF TUMOR: G. RIGHT OBTURATOR LYMPH NODE: NO TUMOR IN 10 LYMPH NODES (0/10). H. RIGHT EXTERNAL ILIAC NODE: NO TUMOR IN 7 LYMPH NODES (0/7). I. RIGHT OBTURATOR: NO TUMOR IN 8 LYMPH NODES (0/8) . J. OMENTUM. NOTE: The origin of the tumor, a serous adenocarcinoma, is most likely of. ovarian origin, although there is some. degree of uncertainty. Key features. are (1) large size of the ovarian tumor and (2) WT-1 reactivity which is. usually positive in ovarian serous primaries, but usually negative in. endometrial serous primaries. While there was a past history of endometrial. tumor detected by pap smear, it is possible this is from cells shed by the. ovarian tumor that have passed through the reproductive canal. The tumor also. occupies half of the endometrial polyp, including its interior, which is not. typical for a metastasis, but certainly can be expected if present for some. period of time, The polyp arises in the lower uterine segment and has. prolapsed into the cervix. I certify that I personally conducted the diagnostic evaluation of the aboye. specimen (s) and have rendered the above diagnosis (es). ADDENDUM 1: The tumor is reactive for P53 and WT1. The former was omitted accidentally. from the report. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es)."
BIOCUP_00244,ovary,OV,TCGA-29-1778,TCGA-29-1778.439a81dd-dc54-49e5-942c-4aa8d0be8701,"rage 1 or 4. CLINICAL HISTORY: Abdominal swelling, per E-browser ovarian mass. GROSS EXAMINATION: A. ""Right ovary and tube (AF1). received fresh for frozen section is a 352 gm,. 13 x 6.9 x 6.5 cm right ovary with attached 8.9 x 2 x 1.9 cm fallopian tube. The ovary has an intact smooth tan-pink capsule, and upon section the ovarian. parenchyma is completely obliterated by a brown-tan bulging mildly friable. mass, and no normal ovarian parenchyma is identified. Adjacent to the ovary. is a purple-tan fallopian tube with a 0.1 cm diameter lumen with tan-white. mucosa. The fimbriated ends of the fallopian tube is distended by a 4 x 3 x. 2. cm smooth encapsulated mass with a cut surface resembling the ovarian mass. (tan-white mildly friable and bulging) and notable for hemorrhage. A section. of the ovarian tumor is frozen as AF1. No mass lesions are identified, and. representative sections are submitted as follows: A1-. AF1-representative ovarian mass. A2-A4 representative ovarian mass. A5-. fallopian tube. A6-A7 fallopian tube mass. B. ""Right round ligament"", received fresh and placed in formalin is a 2.3 x. 1.7 x 0.8 cm fragment of purple-pink fibroadipose tissue. Sections. demonstrate pink-tan cut surface with central hemorrhage, and representative. sections are submitted in block B1. :. ""Left tube and ovary"", received fresh and placed in formalin is a 6.5 gm. fixed weight), 2.5 x 1 x 0.8 cm purple-pink smooth cerebriformed ovary with. adjacent 4 cm long x 0.5 cm diameter fimbriated fallopian tube. The ovarian. cut surface is slightly hemorrhagic and grossly unremarkable. The fallopian. tube serosa is purple-pink smooth glistening, and the cut surface reveals a. pinpoint lumen and tan-white mucosa. There are two paratubal cysts with. greatest dimensions of 0. cm and 0.4 cm. NO mass lesions are identified, a. representative section of ovary submitted in block C1, and fallopian tube with. cysts in block C2. D. ""Cervix and uterus and posterior vaginal perineum"", received fresh and. placed in formalin is a 105 gm, 9 x 5 x 3.5 cm hysterectomy specimen which is. opened on the left side per surgeon. On right side adjacent to the. endocervical canal is a 2.5 x 2.5 x 2 cm mass. The cut surface is mass is. tan-white firm and focally hemorrhagic with infiltrating borders which extend. through the serosa to involve the outer one third of myometrium. The mass is. 0.6 cm from the vaginal cuff, 2.5 cm from the cervical, and 1.3 cm from the. endocervical canal. The serosa is smooth pink and glistening with a 0.4 cm subserosal nodule on. the anterior aspect. The cervix is 3.5 cm in diameter, which has an. erythematous anterior aspect, surrounded by a 0.5 cm thick vaginal cuff, and. has a 0.2 cm diameter probe patent cervical os leading into a 3 cm long. endocervical canal. The 4.5 X 1.5 cm endometrial cavity is lined by a 0.2 cm. thick endometrium overlying a 1.4 cm thick myometrium which contains several. intramural nodules ranging in size from 0.3 cm to 0.9 cm in greatest. dimension. These nodules all have a white whorled bulging cut surface with no. necrosis or hemorrhage. No other mass lesions are identified, and. representative sections are submitted as follows: mass with respect to vaginal cuff and exocervix. mass with respect to endocervical canal. rage 4 014. mass with respect to cervix. D4-. representative mass. D5-. anterior cervix. !D6-. left posterior cervix. D7-. anterior myometrium, full-thickness. D8-. posterior myometrium, full-thickness. D9-. subserosal nodules. D10-D11 intramural nodules. E. ""Posterior vaginal peritoneum"", received fresh and placed in formalin is a. 1.1 x 1 x 0.3 cm fragment of red-brown soft tissue which is grossly and. unremarkable and submitted in toto in block E1. F. ""Right IP ligament"", received fresh and placed in formalin is a 2.5 x 1.8 x. 0.9 cm fragment of pink-yellow fibroadipose tissue. Sections demonstrate an. unremarkable fatty cut surface, and representative sections are submitted in. block F1. G. ""Right pelvic lymph node"", received fresh and placed in formalin is a 6 x. 5.5 x 2 cm aggregate of pink-yellow fibroadipose tissue, which is dissected. for lymph node candidates. Six lymph node candidates are identified ranging. from 0.8 to 1.9 cm in greatest dimension. Two lymph node candidates submitted. in block G1, two candidates in block G2, and one candidate each in blocks G3. and G4. H. ""Right gutter peritoneum"", received fresh and placed in formalin is a 3.5 x. 3 x 0.3 cm fragment of red-yellow fibroadipose tissue. The tissue is. sectioned to reveal an unremarkable cut surface, and representative sections. are submitted in block H1. I. ""Omentum"", received fresh and placed in formalin is a 33 x 17 x 1 cm sheet. of yellow-pink adipose tissue. The tissue appears grossly unremarkable, and. no mass lesions are identified. A representative section is submitted in. block I1. i. ""Right common iliac lymph node"", received fresh and placed in formalin is a. 1.9 x 1.8 x 0.6 cm aggregate of multiple fragments of tan-yellow fibroadipose. tissue. The tissue is dissected for lymph node candidates, and one candidate. 1.2 x 0.4 x 0.4 cm is identified and submitted in toto in block J1. K. ""Para-aortic lymph node"", received fresh and placed in formalin is a 3.5 X. 2.8 x 1.5 cm fragment of tan-pink fibroadipose tissue, which is dissected for. lymph node candidates three lymph node candidates are identified ranging in. size from 1.5 to 2.4 cm in greatest dimension. The two smaller candidates are. submitted in block K1, and the largest candidate is bisected and submitted in. block K2. L. ""Nodule of mesentery sigmoid colon"", received fresh and placed in formalin. is a 0. x 0.5 x 0.3 cm fragment of pink-tan soft tissue which is submitted in. toto in block L1. M. ""Nodule mesentery appendix"", received fresh and placed in formalin is a 1.2. x 1 x 0.3 cm aggregate of three similarly sized tan-white fragments of soft. tissue which are submitted in toto in block M1. A. INTRA OPERATIVE CONSULTATION: A. ""Right ovary and tube"": AF1 (representative) - high-grade carcinoma, favor. serous papillary. MICROSCOPIC EXAMINATION: Microscopic examination is performed. ATHOLOGIC STAGE: PROCEDURE: Hysterosalpingo-oophorectomy and node dissection. PATHOLOGIC STAGE (AJCC 6th Edition) : pT3a pNO pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by the. stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. ""RIGHT OVARY AND TUBE (AF1) "". RIGHT OVARY: TYPE: PAPILLARY SEROUS ADENOCARCINOMA. FIGO GRADE: 3. TUMOR SIZE: 13 X 6.9 X 6.5 CM. WEIGHT: 352 GRAMS. SEROSA: POSITIVE FOR TUMOR. RIGHT FALLOPIAN TUBE: POSITIVE FOR SEROUS ADENOCARCINOMA. B. ""RIGHT ROUND LIGAMENT"": REACTIVE MESOTHELIUM, HEMORRHAGE, AND INFLAMMATION. NEGATIVE FOR CARCINOMA. C. ""LEFT TUBE AND OVARY"": FALLOPIAN TUBE AND OVARY, NEGATIVE FOR CARCINOMA. D. ""CERVIX AND UTERUS AND POSTERIOR VAGINAL PERINEUM"": UTERUS, 105 GRAMS. ENDOMETRIUM: INACTIVE. MYOMETRIUM: ADENOMYOSIS AND LEIOMYOMATA. CERVIX: MUCOSA NEGATIVE FOR TUMOR, WITH ADVENTITIAL SEROUS. ADENOCARCINOMA, SEE COMMENT. SEROSA: POSITIVE FOR SEROUS ADENOCARCINOMA (LOWER UTERINE SEGMENT,. ENDOCERVIX, AND ECTOCERVICAL PORTION OF UTERUS). SPECIMEN MARGINS: NEGATIVE FOR TUMOR. E. ""POSTERIOR VAGINAL PERITONEUM"". POSITIVE FOR SEROUS ADENOCARCINOMA, MAXIMUM TUMOR SIZE 6 MM. F. ""RIGHT IP LIGAMENT"": NEGATIVE FOR CARCINOMA. G. ""RIGHT PELVIC LYMPH NODE"" (DISSECTION) : SIX LYMPH NODES, NEGATIVE FOR CARCINOMA (0/6). H. ""RIGHT GUTTER PERITONEUM"": REACTIVE MESOTHELIUM, HEMORRHAGE, AND INFLAMMATION. NEGATIVE FOR CARCINOMA. I. ""OMENTUM"" (PARTIAL RESECTION) : NEGATIVE FOR CARCINOMA. J. ""RIGHT COMMON ILIAC LYMPH NODE"": ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1) . K. ""PARAAORTIC LYMPH NODE"": THREE LYMPH NODES NEGATIVE FOR CARCINOMA (0/3) . L. ""NODULE OF MESENTERY SIGMOID COLON"": POSITIVE FOR SEROUS ADENOCARCINOMA. MAXIMUM TUMOR SIZE 8 MM. M. ""NODULE OF MESENTERY APPENDIX"": POSITIVE FOR SEROUS ADENOCARCINOMA. MAXIMUM TUMOR SIZE 1.2 CM. COMMENT: Immunostains of the tumor in part A are positive for CK7, Berep4,. and WT1, are focally positive for CA125, and are negative for CK20, CDX2, and. calretinin. As described above, in the hysterectomy specimen, adjacent to the. endocervical canal is a externally based 2.5 cm area of serous. adenocarcinoma. This involves the external portions of cervix, endocervix and. lower uterine segment, but cervical and vaginal epithelial margins are. legative for tumor. In summary, the above findings are most consistent with a primary serous. adenocarcinoma of the right ovary. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es)."
BIOCUP_00245,ovary,OV,TCGA-29-1699,TCGA-29-1699.9e2cf2f9-c45c-4702-8b6f-565c59730036,"CLINICAL HISTORY: Malignant neoplasm ovary. GROSS EXAMINATION: A. ""Omentum"". Received fresh for frozen section is a 25 x 9 x 2.5 cm portion. of omentum that is caked with tan-white tumor nodules. The frozen section. remnant AF1 is submitted as A1 and additional representative section is. submitted as block A2. B. ""Left tube and ovary"". Received is a 159 gram, 8.5 x 7.5 x 4.5 cm cystic. ovarian remnant with tan-white tumor mass. Sectioning the mass shows multiple. blood and fluid filled cysts and large areas of necrosis. An ovarian remnant. is hard to appreciate grossly. The 7.5 x 0.8 cm segment of fimbriated. fallopian tube is studded with tumor. BLOCK SUMMARY: B1-2- ovary and tumor. B3-. solid area of edge of cyst. B4-. representative of fallopian tube. C. ""Right tube and ovary"". Received in formalin is a 144.8 gram, 8 x 6 x 5.5. cm multicystic ovary with a 5.5 x 4.5 x 2.5 cm tan-white necrotic tumor mass. emerging from its external surface. Cross section of the ovary and mass shows. mostly solid and white necrotic tumor with multiple large and clear fluid. filled cystic spaces. Ovarian remnant is difficult to grossly identify,. however, an 8 cm length of fallopian tube studded with tumor is identified. BLOCK SUMMARY: C1-2- tumor in its relation to external surface of specimen. C3-. representative of tumor. C4-. fallopian tube. D. ""Tumor"". Received is a 10 x 7.5 x 6.9 cm mass of tan-white tumor that. includes a thin walled cyst reminiscent of cystic ovary. Sectioning of the. main tumor mass shows a fibrotic white whorled cut surface on the edge of the. tumor measuring 3 x 1.5 x 0.6 cm, reminiscent of ovarian tissue. BLOCK SUMMARY: D1- representative of cyst. D2-3- representative of fibrotic tumor mass. D4- potential ovarian remnant. E. ""Uterus"". Received is a 286 gram, 9 x 7 x 6.5 cm uterus that shows a. roughened serosal surface suspicious for tumor studding. Within the uterus. the endometrium is distended by a 5.5 x 4.5 x 4.0 cm leiomyoma. The cervix is. not present in this specimen. BLOCK SUMMARY: E1-2- leiomyoma. E3-. representatives of roughened serosal surface. E4-. representative of endomyometrium. F. ""Bladder peritoneum"". Received is an 11 x 5 x 1.9 cm segment of fibrofatty. tissue studded with multiple tumor nodules. A representative section is. placed in F1. G. ""Cecum and ileum"". Received is a 24 x 7 cm length of bowel that includes a. 6 cm length of colon. No appendix is grossly identified. The mucosal surface. is grossly unremarkable. The serosal surface, however, shows numerous tumor. nodules on the surface. BLOCK SUMMARY: G1-. proximal margin (ileum). G2- distal margin (large bowel). G3-. representative of serosal tumor nodules. H. ""Rectosigmoid and cervix"". Received is an 18 x 4 x 1.5 cm segment of. rectosigmoid that shows a 2.5 cm long stricture. Overlying the stricture is. a 2.5 x 1.2 x 1.0 cm tumor nodule involving the serosa. Otherwise the mucosa. of the rectosigmoid is grossly unremarkable. Also attached to this specimen is. a 3.3 x 3.0 x 2.0 cm cervix that is grossly unremarkable. BLOCK SUMMARY: H1- distal margin of rectosigmoid. H2- proximal margin of rectosigmoid. H3- stricture and tumor. H4- representative of cervix. I. ""Right external iliac node"". Received is a 4.2 x 3.0 x 1.6 cm aggregate of. three grossly positive lymph nodes. Representative sections of two nodes are. submitted in block Il and I2 and the third lymph node is submitted entirely as. block I3. J. ""Rectal margin"". Received is a 7 cm in diameter mushroom shaped steel. surgical device with 3 x 0. x 0.2 cm segment of mucosa is removed from the. surgical device and submitted as J1. INTRA OPERATIVE CONSULTATION: A. ""Omentum"": AF1-poorly differentiated carcinoma. MICROSCOPIC EXAMINATION: Microscopic examination is performed. DIAGNOSIS: A. ""OMENTUM"" (OMENTECTOMY) : METASTATIC PAPILLARY SEROUS CARCINOMA (>2 CM). B. ""LEFT FALLOPIAN TUBE AND OVARY"" (SALPINGO-OOPHORECTOMY) : OVARY WITH POORLY DIFFERENTIATED PAPILLARY SEROUS CARCINOMA. FIGO GRADE: 3 OF 3. TUMOR SIZE: 8.5 x 7.5 X 4.5 CM. SURFACE INVOLVEMENT: PRESENT. FALLOPIAN TUBE: POSITIVE FOR CARCINOMA. C. ""RIGHT TUBE AND OVARY"" (SALPINGO-OOPHORECTOMY): OVARY WITH POORLY DIFFERENTIATED PAPILLARY SEROUS CARCINOMA. FIGO GRADE: 3 OF 3. TUMOR SIZE: 8 X 6 X 5.5 CM. SURFACE INVOLVEMENT: PRESENT. FALLOPIAN TUBE: POSITIVE FOR CARCINOMA. l age J 01 3. D. ""TUMOR"" (EXCISION) : PAPILLARY SEROUS CARCINOMA, AND PORTION OF FIBROMA. E. ""UTERUS"" (HYSTERECTOMY) : UTERUS, 286 GRAMS: SEROSA: METASTATIC SEROUS CARCINOMA. ENDOMETRIUM: PROLIFERATIVE, WITH ENDOMETRIAL POLYP. MYOMETRIUM: LEIOMYOMA (5.5 CM). CERVIX: SUBMITTED SEPARATELY. F. ""BLADDER PERITONEUM"": METASTATIC PAPILLARY SEROUS CARCINOMA. G. ""CECUM AND ILEUM"" (RESECTION) : COLON AND SMALL BOWEL WITH MULTIPLE METASTASES OF PAPILLARY SEROUS. CARCINOMA. H. ""RECTOSIGMOID COLON, AND CERVIX"" (EXCISION) : SEGMENT OF COLON WITH MULTIPLE METASTASES OF PAPILLARY SEROUS CARCINOMA,. WITH STRICTURE OF COLON. CERVIX IS FREE OF TUMOR. I. ""RIGHT EXTERNAL ILIAC NODE"": THREE LYMPH NODES WITH METASTATIC PAPILLARY SEROUS CARCINOMA (3/3). J. ""RECTAL MARGIN"" (BIOPSY) : SEGMENT OF COLON, FREE OF TUMOR. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es)."
BIOCUP_00246,ovary,OV,TCGA-24-2290,TCGA-24-2290.71036f77-0d99-427a-883c-75624453890d,"T. Hosp No. : DIAGNOSIS. OMENTUM, OMENTECTOMY - PAPILLARY SEROUS ADENOCARCINOMA. UTERUS, CERVIX, ABDOMINAL HYSTERECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. UTERUS, ENDOMETRIUM, ABDOMINAL HYSTERECTOMY. - ENDOMETRIAL POLYPS. UTERUS, MYOMETRIUM, ABDOMINAL HYSTERECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. UTERUS, SEROSA, ABDOMINAL HYSTERECTOMY. PAPILLARY SEROUS ADEINOCARCINOMA. OVARY, LEFT, SALPINGO-OOPHORECTOMY -. - PAPILLARY SEROUS ADENOCAARCINOMA. OVARY, RIGHT, SALPINGO-OOPHORECTOMY. - PAPILLARY SEROUS ADENOCARCINOMA. FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY -. - PAPILLARY SEROUS ADENOCARCINOMA. INVOLVING PERITUBAL SOFT TISSUE. FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOMY -. PAPILLARY SEROUS ADENOCARCINOMA. INVOLVING PERITUBAL SOFT TISSUE. SOFT TISSUE, CUL-DE-snc, NODULE, EXCISTON (FS1). PAPILLARY SEROUS ADENOCARCINOMA. SOFT TISSUE, CUL-DE-SAC, NODULE, EXCISION. - PAPILLARY SEROUS ADEINOCARCINOMA. APPENDIX, APPENDECTOMY - PAPILLARY SEROUS ADENOCARCTNOMA. By this signature, I attest that the. above diagnosis ie based upon my. --1--. DIAGNOSIS (continued). personal examination of the slides. (and/or other material indicated in. the diagnosis), and that I have. reviewed and approved this report. SPECIMEN (8) SUBMITTED. Part 1: FS1-CUL - DE SAC NODULE. Part 2: UTERUS, OVARIES, CERVIX, TUBES. Part 3 : CUL DE SAC NODULE. Part 1: APPENDIX. Part 5: OMENTUM. HISTORY. The patient is a. with ovarian carcinoma. Operative procedure: Examination under anesthesia, adhesiolysis,. tumor debulking, TAH/BSO and appendectomy. An intraoperative non-microscopic consultation was obtained and. interpreted as: ""Received freah in OR is a uterus attached to an. ovary. Opened laterally to show a generally soft, smooth. endometrial surface with a 1.5 am sessile polyp on the posterior. Burface. Tienue donated for GOG. Fixed in formalin. "". FROZEN. F9: Cul-de-sac nodule and biopsy. ""Adenocarati.noma, poorly differentiated. favor mullerian primary. "". GROSS. The specimens are received in 5 containers of formalin, each. labeled with the patient's name. The first container ia labeled. - -2--. /. Thuss (continued). cul-de-sac - nodule"" and contains two fragments of tan-yellow,. soft tissue with black ink, measuring 1.7 x 1.0 x 0.2 cm. Labeled. FS1. The gecond container is labeled ""uterus, ovaries, cervix and. tubes"" and contains a previously opened uterus with attached. bilateral adnexa weighing 88. gm. The uterus measures 6.5 cm. superior to inferior by 4 am anterior to posterior by 3.5 om. cornu-to-cornu The gervix measures 2.7 x 2.7 x 2.7 am and the OB. measures 0.5 cm in diameter. The mucosa of the posterior. endocervical canal, measuring 2.2 x 0.5 x 0.2 cm, and a portion of. anterior endometrium meamuring 1.! x 0.7 x 0. cm, has been. removed prior to receipl:. The cervix and endogervical canal are. otherwise grossly unremarkable. The endometrium shows a white,. firm, sessile polyp measuring 1.5 x 1.3 am on the posterior wall. In addition, there is a pedunculated polyp measuring 0.7 x 0.! x. 0.3 cm at the anterior right: auperior aspect of the endometrium. The remainder of the endometrium meanujes 0.1 am in thickness. The myometrium ie grosely unremarkable and measures 1.4 cm in. thickness. The anterior seromal. aurface of the uterus is. diffusely involved by firm, whi.ce tumor that focally appears to. invade the serosal surface of the myometrium. The anterior. serosal ourface showe focal. hemorrhage but no gross tumor. The right fallopian tube measures 5.5 am in length and 0.6 cm in. di eter. A nodule of tan-white tumor is present in the paratubal. soft tissue in the proximal third of the fallopian tube. It. measures 1.1 cm in maximum diameter. The right ovary measures 2.7. x 1.1 x 1.4 am. Sections ohow a tan-white nodule measuring 0.7 cm. in diameter that i.s grossly suspicious for tumor. The left. fallopian tube measures 5.8 am in length and 0.6 cm in. polypoid nodule in. fallopian tube that measures 0.8 x 0.3 x 0.3 am. The. left. ovary. measures 3.0 x 2.0 x 1.5 cm. The gerosal surfage is irregular and. grossly suspicious for involvement by tumor. Sections ghow gross. involvement by tan-white tumor extending to the surface. The. ovaries are submitted in their entirety. Labeled: CX1 - posterior. cervix; CX2 - anterior cervix; EM1 and EM2 - posterior endometrium. with sessile polyp; EM3 and EM4 - anterior endometrium with. serogal tumors (EM4 also with pedunculated polyp) . CX1. and EM1,. as well as CX2 and EM3 represent continuous gections. LT - left. fallopian tube; RT - right fallopian tube; LO and L02 - left. ovary; RO, RO2, RO3, RO4, RO5 - right ovary. --3-- -. GROSS (continued). The third container i.e labeled ""cul-de-aac nodule"" and contains. multiple fragments of tan-white, friable tissue, measuring 3.0 x. 2.0 x 0.5 cm in aggregate. The fourth container is labeled ""appendix"" and contains an. appendix measuring 7 am in length and 0.6 cm in proximal diameter. The distal tip of the appendix is expanded by tan-white tumor,. measuring 2.5 x 2.4 x 2.8 cm. The mid portion of the appendix. shows fibrous obliteration and a diameter of 0.2 cm over. approximately 1 cm of its length. The fifth container is labeled ""omentum"" and contains a portion of. omentum measuring 23 x 8 x 4.5 cm. Tumor grossly involves the. great majority of the fibroadipose tisnue with multiple nodules as. well as diffuse infiltration of fak. Much of the surface of the. omentum appears hemorrhagic. COMMENT. The omentum is diffusely replaced by poorly differentiated. papillary serous adenocarcinoma. Adenocarainoma with identica). histologic features is also present on the serosal surface of the. uterus, in peritubal soft tissue, in the cul-de-sac - nodule, and. around the appendix. Histologically identical adenocarainoma also. extensively involves the surfaces of the entirely submitted. ovaries. Carc√≠noma focally extends into the superficial cortex of. the ovaries and a single, 3 mm nodule of adenocarcinoma is present. within the parenchyma of one ovary. Because none of the. non-surface ovarian involvement measures more than 5 mm, according. to. criteria, this case should be considered a primary. peritoneal carcinoma. rid of Report). -4--."
BIOCUP_00247,ovary,OV,TCGA-61-1722,TCGA-61-1722.059421f4-442e-4e81-a726-7a8486c74cdc,"FINAL DIAGNOSIS: PART 1: OMENTUM, BIOPSY -. BENIGN OMENTAL ADIPOSE TISSUE. PART 2: ADNEXA, LEFT, LEFT SALPINGO-OOPHORECTOMY -. A. HIGH GRADE PAPILLARY SEROUS OVARIAN ADENOCARCINOMA, NUCLEAR GRADE 3. B. NO EVIDENCE OF CAPSULAR INVASION. C. BENIGN LEFT FALLOPIAN TUBE. PART 3: ADNEXA, RIGHT, SALPINGO-OOPHORECTOMY -. A. HIGH GRADE PAPILLARY SEROUS OVARIAN ADENOCARCINOMA, NUCLEAR GRADE 3. B. NO EVIDENCE OF CAPSULAR INVASION. C. RIGHT FALLOPIAN TUBE WITH TUBAL INTRAEPITHELIAL CARCINOMA AND SUBMOCOSAL INVASIVE. ADENOCARCINOMA (SLIDE 3F). COMMENT: Strong immunohistochemical staining with P53 in atypical tubal epithelium and adjacent invasive adenocarcinoma. supports presence of tubal intraepithelial carcinoma in slide 3F from the right fallopian tube and raises the possibility. of a tubal origin for high grade serous adenocarcinoma present In both ovaries. Diffuse strong WT1 nuclear staining in. the adenocarcinoma in 2A and 3C supports the diagnosis of serous adenocarcinoma. CASE SYNOPSIS: SYNOPTIC - PRIMARY OVARIAN TUMORS INCLUDING BORDERLINE TUMORS. TUMOR LOCATION: Bilateral. PROCEDURE: TUMOR SIZE: Bilateral Salpingo-oophorectomy. Maximum dimension: 3.5 cm. TUMOR TYPE: Papillary serous carcinoma. HISTOLOGIC SILVERBERG GRADE: ARCHITECTURAL PATTERN: Poorly differentiated (8-9 pts). Solid (3). CYTOLOGIC ATYPIA: Marked (3). MITOTIC COUNTS / 10hpf: VASCULAR INVASION: > or = 25 (3). TUMOR CAPSULE: Intact. SURFACE IMPLANTS: Not present. MALIGNANT CELLS IN ASCITES OR. PERITONEAL WASHING: LYMPH NODES EXAMINED: T STAGE, PATHOLOGIC: Total number of lymph nodes examined: 0. pT1b. N STAGE, PATHOLOGIC: pNX. M STAGE, PATHOLOGIC: pMX. FIGO STAGE:"
BIOCUP_00248,ovary,OV,TCGA-31-1956,TCGA-31-1956.3646c24b-c4b7-400b-bc93-7ef485c6892c,"Consent: Specimen Type: 1: Omentum. 2: LT OVARY. 3: PERITONEAL DEPOSIT. Clinical Details: Ovarian Tumour. Macroscopic Description: 1) Omentum. This is a piece of omental fat measuring 12.5 X 6 X 1.5cm, with multiple solid firm areas. BLOCK. A to C - 1pc each,. 2) Left Ovary. This is an irregular soft firm specimen weighing 30grams and measures 5 X 4.5 X 3cm, with. few membranous fragments adherent to it. BLOCK. A to D - 1pc each, representative slices. 3) Biopsy from Peritoneal Surface of abdominal wall. This is a soft firm irregular piece of tan to brown tissue, measuring 2 X 1.3 X 0.5cm. Bisected. BLOCK: 1, 2pcs. Microscopic Description: CASE SHOWN AT. MEETING. All three specimens contain similar adenocarcinoma, which is all viable, poorly differentiated. and has a predominant solid sheet-like pattern. In the ovary, there are slit-like spaces and some bizarre giant cells indicating serous. differentiation. The tumour is extracapsular, and present within the adherent ovarian. ligaments. In the omentum, the tumour is destructive, with the largest single area (formed of contiguous. modules of tumour) being 16 millimetres across, but nowhere quite reaching a single solid. mass greater than two centimetres across. Lymphatic but no vascular invasion is present. here. In the nodule from the peritoneal surface of the abdominal wall, the tumour is all viable and. measures 11 millimetres across, surrounded by fibrotic tissue within which no definite muscle. is identifiable. Final Diagnosis: 1. OMENTUM: METASTATIC POORLY DIFFERENTIATED SEROUS. ADENOCARCINOMA, FIGO GRADE 3, STAGE 3B, VIABLE. 2. LT OVARY: POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA REACHING. CAPSULE AND INTO OVARIAN LIGAMENT. 3. PERITONEAL DEPOSIT: POORLY DIFFERENTIATED VIABLE METASTATIC. ADENOCARCINOMA 11 MM ACROSS. Additional Pathologist(s)/BMS(s)."
BIOCUP_00249,ovary,OV,TCGA-24-1104,TCGA-24-1104.4991D5F7-0259-430F-AFF7-1307DF563E41,"DOE. Hospical. Physician (s) : Other Related Clinical Data: DIAGNOSIS: OVARY, LEFT, OOPHORECTOMY. - POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. - TUMOR INVOLVES THE OVARIAN SURFACE. - VASCULAR LYMPHATIC INVASION IS IDENTIFIED. FALLOPIAN TUBE, LEFT, SALPINGECTOMY. - METASTATIC SEROUS ADENOCARCINOMA. OVARY, RIGHT, OOPHORECTOMY. - NO EVIDENCE OF ADENOCARCINOMA IN THE OVARY. - SURFACE FIBROVASCULAR ADHESIONS. - METASTATIC SEROUS ADENOCARCINOMA PRESENT IN MESOVARIAN TISSUE. FALLOPIAN TUBE, RIGHT, SALPINGECTOMY. - NEGATIVE FOR ADENOCARCINOMA. SOFT TISSUE , LEFT PELVIC SIDE WALL, BIOPSY. - METASTATIC SEROUS ADENOCARCINOMA. OMENTUM, BIOPSY. - METASTATIC SEROUS ADENOCARCINOMA. SMALL INTESTINE, RESECTION. - METASTATIC SEROUS ADENOCARCINOMA INVOLVING ENTIRE THICKNESS OF INTESTINAL WALL. - RESECTION MARGINS FREE OF TUMOR. - METASTATIC SEROUS ADENOCARCINOMA IN THREE OF THREE LYMPH NODES (3/3). LYMPH NODES, SPLENIC FLEXURE, EXCISION. - METASTATIC SEROUS ADENOCARCINOMA IN TWO OF TWO LYMPH NODES (2/2). Printed from. on. By this signature, I attest that the above diagnosis is based upon my. personal. examination of the slides (and/or other material indicated in the diagnosis). Intraoperative Consultation. An intraoperative non-microscopic consultation was obtained and interpreted as: ""Cailed to. pick up specimen labeled 'left adnexa, consisting of a partially cystic ovary, 13.5 x 9.5. x. 6 cm, weighing 430 grams. Serially sectioned to reveal a tan to tan-yellow cut surface. Representative frozen (FS1) submitted for tumor bank and. Rest for permanents, by. FS1: Adnexa, left, biopsy. - ""Carcinoma,"" by. Microscopic Description and Comment: Microscopic examination substantiates the above cited diagnosis. History: The patient is a. year old woman with enlarged left adnexa and pelvic nodule, supraclavicle. lymph node biopsy showed non-small cell carcinoma. Specimen (s) Received: A: LEFT OVARY AND TUBE. B: RIGHT OVARY AND TUBE. C: LEFT PELVIC SIDE WALL. D: OMENTUM, ROUTINE. E: SMALL BOWELL. F: SPLENIC FLEXURE. Gross Description. The specimens are received in six formalin-fillec containers, each labeled with the patient's. name. The first container is labeled ""left adnexa.' It contains a tan, lobulated mass,. weighing 430 grams. The outer surface is tan to hemorrhagic and irregular with possible. tumor present. The specimen was previously sliced. The surface is inked. Sectioning shows. the cut surface is tan to yellow-tan slightly lobulated, with cystic areas. Some areas. show a light yellow, edematous, trabeculated consistency. Focal hemorrhage is noticed. A. structure resembling fallopian tube is identified attaching to the tumor. In the container. there is a cassette labeled ""FS1"" which holds the frozen section remnant. Labeled A1 to A4 -. tumor (A1 and A3 tumor with possible fallopian tube) ; A5, A6 - white-tan to yellow area; A7,. A8 - solid area; A9, A10 - cystic areas; A11, A12 - yellow spongy area; A13 - large cystic. areas; A14 - frozen remnant. Jar 2. The second container is labeled ""right adnexa. It contains a 6 x 2.7 x 0.1 cm, yellow. to. tan to hemorrhagic irregular soft tissue fragment. A possible ovary is identified which. measures 2.7 x 2 x 0. cm. The outer surface is pink-tan and smooth. Sectioning shows. the cut surface is white-gray and smooth. A fallopian tube measures 2 cm in length, 0. 4. cm in diameter, with an unremarkable appearance. In the adipose tissue, a firm nodule is. identified measuring 1 x 0.7 x 0.3 cm. Labeled B1 to B3 - ovary and fallopian tube; 34 -. bisected firm nodule. Jar 1. Printed from. The third container is labeled ""left pelvic side wall. "" It contains two tan to hemorrhagic,. irregular soft tissue fragments measuring 2 x 1 x 0.7 cm and 3 x 2.5 x 0.5 cm. On. examination, two firm nodules are identified, 1.5 cm and 1.9 cm in greatest dimension. Sectioning shows the nodule has a white-tan, smooth cut surface. Labeled C1. Jar 1. The fourth container is labeled ""omentum."" It contains two fragments of yellow adipose. tissue consistent with omentum measuring 15 x 11.5 x 1.5 cm and 5.5 x 4 x 1 cm. On. examination, four firm nodules are identified, measuring 0.3 to 1.1 cm in greatest. dimension. Sectioning shows they have a well circumscribed, white-gray, firm cut surface. Labeled D1, D2. Jar 2. The fifth container is labeled ""small intestine."" It contains a 35 cm in length, 4.3 cm. in circumference segment of small bowel with attached mesentery measuring 14 x 3 x 1 cm. The serosa is pink-tan with extensive adhesions to adhere the small bowel to each other. Multiple white-gray small nodules are present on the surface of the serosa. There is a. sutured area. Sectioning shows this area has a submucosal white-gray nodule with hemorrhage. Opening of the remaining small bowel shows the mucosa is pink-tan with prominent intestinal. folds. No polyps or other abnormalities are identified. The bowel wall measures 0.2 cm. in thickness. In the mesentery there is a 2 x 1.5 x 0.8 cm, white-gray, firm area noted. Labeled E1, E2 - serosal nodules; E3 - sutured area; E4 - mesentery solid area; E5 -. resection margin. Jar 2. The sixth container is labeled ""splenic flexure. It contains a 7 x 5.5 x 2 cm yellow,. lobulated adipose tissue. On examination, two white-gray, firm nodules are identified. measuring 0.6 x 0.3 x 0.3 cm and 2.5 x 1.8 x 1.6 cm. Labeled F1, F2. Jar 2. Printed from."
BIOCUP_00250,ovary,OV,TCGA-23-1122,TCGA-23-1122.9507d553-b1c7-4b71-90c1-064fd8ef15ba,"SURGICAL PATH. Hospital No. : Date of Birth. Soc. Sec. No. Attending MD: Copies To: DIAGNOSIS: 1: UTERUS, TOTAL ABDOMINAL HYSTERECTOMY: -Cervix: -Chronic endocervicitis. -Nabothian cysts. -Negative for malignancy. - -Endometrium: -Non-phasic atrophic endometrium. -Endometrial polyp with complex hyperplasia and focal high. grade and anaplastic mullerian-derived adenocarcinoma (see. Comment). -Focal metastatic nodules on the posterior serosal aspect. -Myometrium: -Adenomyosis. -Leiomyoma. 2: OVARY AND FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY: -High grade mullerian-derived adenocarcinoma involving the ovary. and fallopian tube. 3: OVARY AND FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOMY: -High grade mullerian-derived adenocarcinoma, (see Microscopic. Description and Comment) involving the ovary and fallopian tube. 4: OMENTUM, NUMBER 1, PARTIAL OMENTECTOMY: -Metastatic mullerian-derived adenocarcinoma. 5: LYMPH NODE, PELVIC, LEFT, EXCISION: -Five (5) lymph nodes with reactive follicular hyperplasia, sinus. histiocytosis and focal calcifications. -Negative for malignancy. 6: LYMPH NODE, RIGHT EXTERNAL ILIAC, EXCISION: -One (1) lymph node with reactive follicular hyperplasia. -Negative for malignancy. 7: OMENTUM, NUMBER 2, PARTIAL OMENTECTOMY: -Metastatic mullerian-derived adenocarcinoma. HISTORY: MICROSCOPIC: The tumor shows features of a high grade mullerian-derived. adenocarcinoma, papillary serous type. The possibilities that this. represents primary uterine papillary serous adenocarcinoma with. metastases, or multifocal papillary serous adenocarcinoma with. involvement of the bilateral ovaries, endometrium, and right. fallopian tube should be considered. The latter scenario is. favored. Selected slides were reviewed by. concurs with the interpretation. GROSS: 1: UTERUS. Labeled ""uterus"" and received in formalin is a 410 gram enlarged. uterus without attached bilateral adnexa. The uterus is 9.0 cm fundus. to cervix, 6.0 cm cornu to cornu, and 4.5 cm anterior to posterior. The serosa is diffusely congested with numerous dark red fibrous. adhesions. The cervix is 3.5 x 3.0 cm with a small attached vaginal. cuff ranging from 0.5 cm posteriorly to 1.0 cm anteriorly. The mucosa. is smooth focally hyperemic and surrounds a patent 0.1 cm os. The. squamo-columnar junction is 111-defined. The endocervical canal is. 2.5 cm in length, tan and rugose with numerous nabothian cysts. measuring up to 0.6 cm in greatest dimension. The endometrial cavity. is 4.0 cm superior to inferior, and 3.0 cm laterally. The endometrium. is tan, smooth up to 0.1 cm in thickness with two, pink-tan friable. polypoid lesions on the left lateral aspect of both the anterior and. posterior walls which are 0.5 and 1.0 cm in greatest dimensions. respectively. There is a also a firm 1.0 x 0.5 cm sessile polypoid. lesion on the fundus. The coarsely trabecular pink-tan myometrium is. up to 1.7 cm in thickness. There is a single 1.3 cm in diameter. subserosal leiomyoma which has a typical grey-white whorled. appearance. Representative sections are submitted. A. Anterior cervix - 1. B. Posterior cervix - 1. C. Anterior uterine corpus, full thickness including serosal. adhesions - 1. D. Posterior uterine corpus, including serosal adhesions - 1. E. Anterior uterine fundus with polypoid lesion - 1. F. Posterior uterine fundus with polypoid lesion - 1. G. Fundic endometrium nodule - 1. H. Fundic subserosal nodule and adhesions - 3. 2: LEFT TUBE AND OVARY. Labeled ""left tube and ovary"", received fresh in the Operating Room. and subsequently fixed in formalin is an enlarged 8.5 cm long. fimbriated fallopian tube with a maximum diameter of 3.0 cm. The. serosa is red-tan with numerous fibrous adhesions. Upon sectioning,. the lumen is filled with tan, friable lobulated tumor. The fimbriated. end is tan-red and is also involved by tumor. There is an underlying. 5.5 x 3.5 x 3. cm disrupted friable tumor mass which has numerous. fibrous adhesions. Upon sectioning in this region, the mass is. predominantly solid, homogeneous and lobulated with a few cystic. spaces measuring up to 1.7 cm in greatest dimension. The cysts are. thin and smooth and predominantly thin walled with a 0.6 cm. excrescence and contain a small amount of bloody fluid. There is no. grossly identifiable residual ovarian parenchyma remaining. Representative sections are submitted. I,J. Fallopian tube with tumor - 1 each. K. Underlying mass with cystic spaces - 2. L. 1. 3: RIGHT OVARY. Labeled ""right ovary"" and received in formalin is a 480 gram, 13.0 x. 10.5 x 8.0 cm fluctuant bosselated ovary. The external surface is. covered by numerous red-tan tumor implants and fibrous adhesions as. well as a 6.5 x 1.0 cm convoluted fimbriated fallopian tube. The. external surface of the fallopian tube also is covered by tan-red. tumor. There is an adjacent 2.0 cm smooth thin walled paratubal cyst. Upon sectioning, the fallopian tube has a stellate patent lumen. The cut surface consists of approximately 70% solid tan lobulated. tumor with multifocal areas of hemorrhage and necrosis and 308 is. cystic. The cysts are filled with a red tinged serous fluid. There. is also a small amount of gelatinous matrix in both the solid and. cystic components. Representative sections are submitted. M. Fallopian tube with paratubal cyst and tumor - 2. N,O. Solid and cystic component - 2 each. P,Q. Solid and cystic component in relation with external tumor. nodules - 2 each. 4: OMENTUM NO.1. Labeled ""omentum no. 1"" and received in formalin is a 3.5 x 3.5 x 1.0. cm aggregate of tan-yellow lobulated fat. Upon sectioning, the cut. surfaces are tan-yellow lobulated and fatty with a single 0.4 cm. segment of firm tan-grey tumor. Representative sections are submitted. R. Multiple. 5: LEFT PELVIC LYMPH NODE. Labeled ""left pelvic lymph node and received in formalin is a 3.0 x. 2.0 x 0.5 cm aggregate of tan-yellow lobulated fat containing four,. firm, tan-red lymph nodes ranging from 1.0 to 1.5 cm in greatest. dimension. The lymph nodes are entirely submitted. S. 5. 6: RIGHT EXTERNAL ILIAC NODE. Labeled ""right external iliac node"" and received in formalin is a 2.0. x. 1.7 x 1.0 cm aggregate of tan-yellow lobulated fat containing a. single 1.5 x 0.7 x 0.6 cm congested lymph node. All embedded. T. 1. 7: OMENTUM NO.2. Labeled 'omentum no. 2"" and received in formalin is a 15.0 x 12.0. x. 2.0 cm aggregate of multiple fragments of omentum. Upon sectioning,. the cut surface is tan-yellow, lobulated and fatty with five, firm,. tan tumor nodules ranging from 0.5 to 2.0 cm in greatest dimension. which involve approximately 10% of the cut surface. Representative sections are submitted. U. 4. Gross dictated by. OPERATIVE CONSULT (GROSS) : Bilateral ovarian, left ovarian tumor. Mullerian-derived."
BIOCUP_00251,ovary,OV,TCGA-61-2094,TCGA-61-2094.205b0520-854c-480e-881d-89bc8cbcff75,"FINAL DIAGNOSIS: PART 1: LEFT ADNEXA, LEFT SALPINGO OOPHORECTOMY -. A. HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY CARCINOMA OF LEFT OVARY. B, PARATUBAL CYST. C. LEFT FALLOPIAN TUBE, UNREMARKABLE. PART 2: RIGHT ADNEXA, RIGHT SALPINGO OOPHORECTOMY -. A. HIGH GRADE POORLY DIFFERENTIATED SEROUS PAPILLARY CARCINOMA OF RIGHT OVARY, WITH. FOCAL SURFACE INVOLVEMENT, ARISING IN SEROUS TUMOR OF LOW MALIGNANT POTENTIAL. B. RIGHT FALLOPIAN TUBE UNREMARKABLE. PART 3: UTERUS WITHOUT BILATERAL ADNEXA (60 GM), TOTAL ABDOMINAL HYSTERECTOMY -. A. CHRONIC CERVICITIS, FOCAL SQUAMOUS METAPLASIA, ENDOCERVICAL POLYP AND NABOTHIAN. CYSTS. B. INACTIVE ENDOMETRIUM WITH FOCAL COMPLEX ATYPICAL HYPERPLASIA. C. ADENOMYOSIS. D. LEIOMYOMAS, UP TO 2.0 CM. PART 4; SIGMOID, BIOPSY -. METASTATIC SEROUS PAPILLARY CARCINOMA. PART 5: POSTERIOR CUL DE SAC, BIOPSY -. METASTATIC SEROUS PAPILLARY CARCINOMA. PART 6: LEFT COMMON ILIAC LYMPH NODES, DISSECTION -. ONE REACTIVE LYMPH NODE FREE OF TUMOR (0/1). PART 7: LEFT INTERNAL AND EXTERNAL ILIAC LYMPH NODES, DISSECTION -. SEVEN LYMPH NODES FREE OF TUMOR (0/7). PART 8: LEFT OBTURATOR LYMPH NODES, DISSECTION -. TWO LYMPH NODES FREE OF TUMOR (0/3). PART 9: RIGHT COMMON LYMPH NODES, DISSECTION -. TWO LYMPH NODES FREE OF TUMOR (0/2). PART 10: RIGHT INTERNAL AND EXTERNAL ILIAC LYMPH NODES, DISSECTION -. THREE LYMPH NODES FREE OF TUMOR (0/3). PART 11: RIGHT OBTURATOR LYMPH NODES, DISSECTION -. TWO LYMPH NODES FREE OF TUMOR (0/3. PART 12: ANTERIOR CUL DE SAC, BIOPSY -. BENIGN FIBROADIPOSE TISSUE. PART 13: RIGHT PELVIC, BIOPSY -. BENIGN FIBROADIPOSE TISSUE. PART 14: LEFT CUL DE SAC, BIOPSY -. BENIGN FIBROADIPOSE TISSUE,. PART 15: LEFT GUTTER, BIOPSY -. BENIGN FIBROADIPOSE TISSUE. PART 16: APPENDIX, APPENDECTOMY -. APPENDIX WITH FIBROUS OBLITERATION AND BENIGN EPITHELIAL INCLUSION. PART 17: RIGHT PERIAORTIC LYMPH NODES, DISSECTION -. THREE LYMPH NODES FREE OF TUMOR (0/3). PART 18: LEFT PERIAORTIC LYMPH NODES, DISSECTION -. FIVE LYMPH NODES FREE OF TUMOR (0/5). PART 19: OMENTUM, EXCISION -. BENIGN ADIPOSE TISSUE. PART 20: SIGMOID NODULE, EXCISION -. METASTATIO."
BIOCUP_00252,ovary,OV,TCGA-23-2072,TCGA-23-2072.b0475cc1-edd5-451c-8f26-ec3594811f2e,"SURGICI. A/S: Rec: Col: Attending MD: Copies To: DIAGNOSIS: 1. OMENTUM, BIOPSY: - -Infiltrating serous papillary adenocarcinoma. -High grade. 2. RIGHT TUBE AND OVARY: -Serous papillary adenocarcinoma, ovary. -High grade. -Psammoma bodies. -Unremarkable fallopian tube. LEFT TUBE AND OVARY: -Serous papillary adenocarcinoma, ovary. -High grade. -Tumor invades fallopian tube from serosa up to the outer. portions of mucosa. - -Psammoma bodies. 4. UTERUS AND CERVIX: -Serous papillary adenocarcinoma invading uterine wall serosa. and outer portions of myometrium. -Psammoma bodies. -Adenomyomatous polyp, endometrial/endocervical polyp. -Leiomyoma, subserosal, minute. -Benign endocervical mucosa with focal squamous metaplasia,. nabothian cyst and mild chronic non-specific inflammation. 5. PELVIC MASS: -Serous papillary adenocarcinoma. -High grade. 6. SIGMOID MASS: -Serous papillary adenocarcinoma. -High grade. 7. ANTERIOR LIVER TUMOR: -Serous papillary adenocarcinoma, metastatic. 8. POSTERIOR LIVER TUMOR: -Serous papillary adenocarcinoma, metastatic. 9. RIGHT RETROPERITONEAL TUMOR: -Serous papillary adenocarcinoma. 10. OMENTUM TUMOR: -Serous papillary adenocarcinoma. -Psammoma bodies. 11. ABDOMINAL TUMOR: -Serous papillary adenocarcinoma, metastatic. -Psammoma bodies. HISTORY: Pelvic mass; ovarian carcinoma. MICROSCOPIC: See Diagnosis. GROSS: 1: OMENTUM. Labeled ""omentum"" and received in formalin is a 5.5 x 3.5 x 2.5 cm. firm, yellow, nodular adipose tissue with red-brown discoloration. Cut surface is yellow-tan, firm and remarkable for two white. circular nodules measuring 0.6 and 0.5 cm in diameter. A. Representative sections - 3. 2: RIGHT TUBE AND OVARY. Labeled ""right tube and ovary"" and received in formalin is a 7.0 cm. in length, 0.5 cm in diameter segment of fallopian tube with. fimbriated end. The serosa is pink-tan and focally hyperemic. Cut. surface reveals a 0.1 cm wall with a patent pinpoint lumen. Attached. is a 3.5 x 2.0 x 2.0 cm ovary with a pink-tan, focally hyperemic,. firm, nodular cortical surface. The cut surface is remarkable for. pink-tan, friable tissue; a 1.7 x 1.0 x 1.0 cm subcortical, smooth-. walled cyst; a 2.0 x 1.0 x 0.6 cm firm, white, homogeneous nodule and. a. scant amount of normal variegated, pink-tan ovarian parenchyma with. two corpora albicantia. The mesovarium is markedly hemorrhagic. Representative sections submitted. B. cross section of ovary including friable tissue, firm white. tissue, cyst, normal ovarian parenchyma with corpus albicans - 1. C. Cross section of ovary with fallopian tube - 2. 3: LEFT TUBE AND OVARY. Labeled left tube and ovary"" and received in formalin is a 60 gram,. 7.0 x 5.0 x 4.5 cm ovary with a pink-tan distended cortical surface. with numerous (greater than ten) pink-tan, friable tumor studs. ranging from 0.5 x 0.3 x 0.3 cm up to 3.0 x 2.8 x 2.0 cm. The cut. surface is remarkable for both solid and cystic areas. The largest. cyst measures 4.0 x 4.0 x 4.0 cm and is remarkable for 30 CC of amber. serous fluid and multiple yellow-pink papillary excrescences. extending from the inner lining of the cyst wall. Attached is a. 3.0 cm in length, 0.4 cm in average diameter segment of fallopian. tube with pink-tan focally hyperemic serosa. Fimbriated end is. present. Cut surface reveals a 0.1 cm wall with patent pinpoint. lumen. Also present is a moderate amount of pink-tan, moderately. hemorrhagic mesovarium tissue. Representative sections submitted. D. Cross section of cystic and solid area of tumor, fallopian. tube - 2. E. Cross section of cystic and solid tumor and fallopian tube - 3. 4: UTERUS AND CERVIX. Labeled ""uterus and cervix"" and received in formalin is a 75 gram. symmetric uterus with cervix and without bilateral adnexa, measuring. 4.0 cm cornu to cornu, 7.0 cm superior to inferior and 4.0 cm. anterior to posterior. The serosa is pink-tan and focally disrupted. by a 4.0 x 3.0 cm area of hemorrhage on the anterior surface,. multiple cysts ranging from 0.2 up to 0.7 cm in diameter and patchy. areas of grey-tan fibrinous exudate. There is a 0.5 x 0,5 x 0.4 cm. tan-white subserosal spherical nodule on the posterior corpus which. on cut section has a tan-white, homogeneous, whorled surface without. hemorrhage, calcification or necrosis. The cervix measures 3.3. x. 2.8 cm in area with a 0.7 cm in width anterior vaginal cuff and. 1.5 cm in width posterior vaginal cuff. The ectocervical mucosa is. tan-pink and moderately hyperemic. The os measures 1.5 x 1.0 cm, is. round and has a pink-tan, firm, nodular polyp extending 2.0 cm from. the opening. The specimen is bivalved to reveal a 2.5 cm in length,. 1.0 cm in width endocervical canal with a tan-pink, smooth mucosa. The endometrial cavity measures 3.7 cm in length, 1.7 cm in width. The endometrial lining measures 0.1 cm in thickness and is tan-pink. and lush. The lining is significant for a 6.5 x 2.2 x 1.5 cm polyp. which extends from the anterior lower uterine segment through the. endocervical canal with multiple foci of adhesions and then continues. out through the cervical os, extending 2.0 cm from the opening. Also. present is a 0.5 x 0.2 x 0.2 cm white endometrial polyp extending. from the posterior lower uterine segment. The myometrium measures. 1.6 cm in maximum thickness and is tan-pink. No lesions are grossly. identified. Representative sections submitted. F. Anterior ectocervix - 1. G. Anterior lower uterine segment including base of large polyp. and area of disruption on serosa of hemorrhage and fibrinous. adhesions - 1. H. Continuation of large polyp -. I. Full thickness myometrium of anterior corpus - 1. J. Posterior ectocervix and vaginal cuff - 1. K. Posterior lower uterine segment with small polyp - 1. L. Full thickness myometrium, posterior corpus - 1. M. Subserosal nodule - 1. N. Cross section of serosa at anterior corpus in area of. hemorrhage and fibrous adhesions - 1. 5: PELVIC MASS. Labeled ""pelvic mass"" and received in formalin is a 1.0 x 0.7 x. 0.7 cm pink-tan, friable, papillary fragment of tissue with foci of. hemorrhage and yellow fibrinous adhesions. o. All embedded - 1. 6: SIGMOID MASS. Labeled ""sigmoid mass"", received fresh in the Operating Room for. intraoperative frozen section diagnosis and subsequently fixed in. formalin, are two soft, pink-tan 2.0 x 1.1 x 0.3 cm and 1.0 x 1.5 x. 0.9 cm fragments of tissue. Representative sections submitted. P. Frozen section remnant -. Q. Cross sections of fragments - 2. 7: ANTERIOR LIVER TUMOR. Labeled anterior liver tumor"" and received in formalin is a 7.0 x. 7.0 x 4.0 cm tan-pink, focally hemorrhagic, friable aggregate of. papillary tissue and blood clot. R. Representative sections - 2. POSTERIOR LIVER TUMOR. Labeled posterior liver tumor"" and received in formalin is a 4.0 x. 3.0 x 2.5 cm aggregate of pink-tan friable papillary tissue. S. Representative sections - 2. 9: RIGHT RETROPERITONEAL TUMOR. Labeled ""right peritoneal tumor"" and received in formalin is a 7.0 x. 6.0 x 2.5 cm aggregate of tan-pink friable papillary tissue fragments. and blood clot. T. Representative sections - 2. 10: OMENTUM TUMOR. Labeled ""omentum tumor"" and received in formalin is an 8.0 x 5.0 x. 3.5 cm aggregate of pink-tan friable nodular adipose tissue with red-. brown discoloration and adherent blood clot. Cross section reveals a. 5.0 x 2.5 x 2.0 cm yellow-white, firm nodular mass surrounded by the."
BIOCUP_00253,ovary,OV,TCGA-24-1843,TCGA-24-1843.d2625c77-0f03-42ea-b5ea-df45769f0fbb,"DIAGNOSIS: OVARY, RIGHT, BILATERAL SALPINGO-OOPHORECTOMY (INCLUDING FS1A). - HIGH GRADE SEROUS ADENOCARCINOMA. - SURFACE INVOLVEMENT BY ADENOCARCINOMA IS PRESENT. - LYMPHVASCULAR SPACE INVASION IDENTIFIED. - SEE SYNOPTIC. FALLOPIAN TUBE, RIGHT, BILATERAL SALPINGO-OOPHORECTOMY. METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA IN THE PERITUBAL SOFT TISSUE WITH. EXTENSION INTO THE FALLOPIAN TUBE. SOFT TISSUE, PELVIC SIDEWALL, BIOPSY (FS1B). - METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA. SOFT TISSUE, BLADDER PERITONEUM, EXCISION. - METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA. SOFT TISSUE, LEFT PELVIC SIDEWALL, EXCISION. - METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA. OVARY, LEFT, BILATERAL SALPINGO-OOPHORECTOMY. - METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA, PRESENT WITHIN PERIOVARIAN SOFT. TISSUE AND OVARIAN PARENCHYMA. FALLOPIAN TUBE, LEFT, BILATERAL SALPINGO-OOPHORECTOMY. - METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA PRESENT IN PERITUBAL SOFT TISSUE. SMALL INTESTINE, ""SMALL BOWEL TUMOR,"" PARTIAL EXCISION. - METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA WITH INVASION INTO THE MUSCULARIS. PROPRIA AND SUBMUCOSA WITH NECROSIS OF THE OVERLYING MUCOSA. - SURGICAL MARGINS FREE OF CARCINOMA. - SEROSAL ADHESIONS. APPENDIX, APPENDECTOMY. - METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA INVOLVING THE SEROSA AND. COMPLETELY REPLACING THE LUMEN. SOFT TISSUE, ""SMALL BOWEL NODULE,"" EXCISION. Page: 1 of 5. - METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA. SOFT TISSUE, ""CECAL NODULE,"" EXCISION. - METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA. SOFT TISSUE, LARGE BOWEL TUMOR,"" EXCISION. - METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA. SOFT TISSUE, OMENTUM, EXCISION. - METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA. SOFT TISSUE, COLON NODULE,"" EXCISION. - METASTATIC HIGH GRADE SEROUS ADENOCARCINOMA. SOFT TISSUE, ANTERIOR ABDOMINAL WALL MASS,"" EXCISION. - PERSISTENT URACHUS WITH MARKED ACUTE AND CHRONIC INFLAMMATION. - CARCINOMA NOT IDENTIFIED. By this signature, I attest that the above diagnosis is based upon my personal. examination of the slides(and/or other material indicated in the diagnosis). Intraoperative Consultation: An intraoperative non microscopic consultation was obtained and interpreted as: Brought to frozen 'right tube and. ovary, pelvic sidewall' consisting of a 77-gram, 7 x 4.5 x 3,2 cm ovary and fallopian tube. The ovary is replaced by a 7. cm tan-white mass with tumor on the surface. The fallopian tube is draped over the ovarian mass and appears normal. Sections of the ovary show a solid lobulated mass. A portion is frozen as FS1A (surface inked for orientation). Also in. the container is an irregular 2.8 x 2 X 1.5 cm tan-white mass. A portion is frozen as FS1B. Aportion of the ovarian. mass and normal fallopian tube is taken for. Rest for permanents.'. FS1A: Ovary, right, biopsy. Poorly differentiated carcinoma consistent with Mullerian origin"" by. FS1B: Soft tissue, pelvic sidewall, biopsy. ""Poorly differentiated carcinoma consistent with Mullerian origin"" by. Microscopic Description and Comment: Microscopic examination substantiates the above cited diagnosis. History: The patient is. with an ovarian tumor and a CA125 of 223. Operative procedure: Total abdominal. hysterectomy and bilateral salpingo-oophorectomy. Specimen(s) Received: A: ANTERIOR ABDOMEN WALL MASS. Page: 2 of 5. B: RIGHT TUBE AND OVARY AND PELVIC SIDE WALL. C: BLADDER PERITONEUM. D: LEFT PELVIC SIDE WALL. E: LEFT TUBE AND OVARY. F: SMALL BOWEL TUMOR. G: APPENDIX. H: SMALL BOWEL NODULE. I: CECAL NODULE. J: LARGE BOWEL TUMOR. K: OMENTUM. L: COLON TUMOR. Gross Description;. The specimens are received in 12 formalin-filled containers, each labeled. The first is additionally. labeled ""anterior abdominal wall mass."" It holds a solid piece of tan-white, firm, fibrous tissue measuring 3 x 1.5. cm. Sectioned to show a yellow-brown solid cut surface with a central 0.2 cm cystic space. The second container is labeled ""pelvic sidewall, right tube and ovary, FS1A/1B/X.¬∞ It holds two white tissue cassettes. The first, labeled FS1A, holds a previously sectioned piece of tan tissue measuring 2 x 1 x 0.1 cm. Labeled B1 (FS1A). The second white tissue cassette, labeled FS1B, holds a previously sectioned piece of tan fibroadipose tissue. measuring 2.2 x 0.5 x 0.1 cm. Labeled B2 (FS1B). Also in the container is a previously sectioned right fallopian tube. and ovary specimen as described above the intraoperative consultation. The specimen measures 7 x 4.5 x 3.2 cm and. has a focal area of black ink designating tumor on the ovarian surface. The cut surface is solid with a vaguely tobular. pattern separated by fibrous bands. The 5 x 0.5 cm fallopian tube is diffusely adhesed to the ovary and, on cut. surface, has an unremarkable 0.1 cm Jumen. Also in the container is a previously sampled piece of tan tissue. designated as tumor from the pelvic sidewall measuring 1,5 x 1.5 X 0.3 cm. Labeled B3 and B4 - section of tumor. in. area of surface ink; B5 and B6 - additional sections of tumor; B7 - tumor in relationship to fallopian tube; B8 - remainder. of pelvic side wall tumor. The third container is labeled ""bladder peritoneum."" It holds multiple fragments of firm tan-white tissue measuring 4.5 x. 4.5 x 0,5cm Many of these fragments show firm white nodules consistent with involvement by metastatic tumor. The fourth container is labeled ""left pelvic sidewall."" It holds multiple pieces of tan firm tissue consistent with. involvement by metastatic disease. These fragments measure 4 x 3 x 1.5 cm in aggregate. The fifth container is labeled ""left tube and ovary. It holds a 21-gram left ovary and fallopian tube specimen. The. ovary measures 3.5 x 1.5 x 0.5 cm. The periovarian and peritubal soft tissue is matted with a firm white nodule. opposite the fallopian tube fimbria and measures 3 x 2 x 1.5 cm. The remainder of the 4,2 x 0.5 cm fallopian tube. is. unremarkable with the exception of multiple paratubal cysts. Labeled E1 - mass in relationship to fallopian tube;. E2. mass in relationship to ovary; E3 - ovary; E4 - additional sections of fallopian tube. The sixth container is labeled ""small bowel tumor. It holds an unoriented piece of adhesed small bowel measuring 15. cm in length with a uniform diameter of 2.5 cm. Centrally located is a serosal-based firm white mass measuring. approximately 4 cm in greatest dimension causing extensive bowel adhesions. On sectioning, the mass has a solid. white cut surface with focal areas of central degeneration and encroaches onto the bowel lumen with gross evidence of. extension into the muscularis but not the mucosa. On opening, the small bowel mucosa has a normal folding pattern. with no mucosal-based lesions or masses. Labeled F1 and F2 - margins; F3 to F5 - mass in relationship to bowel wall. The. seventh container is labeled ""appendix."" It holds an 8.1 cm long appendix with attached mesoappendix measuring. 1.5 cm in greatest depth. The appendiceal serosa is studded with multiple white nodules, the largest located 1.5 cm. from the appendiceal tip and measures 1.2 cm in greatest dimension. The appendiceal diameter ranges from 0.6 in. the uninvolved areas to 1.2 cm in the involved areas. No appendiceal perforations or serosal exudates are noted. Sectioned to show an obliterated appendiceal lumen. Multiple firm densities are present in the mesoappendix. consistent with involvement by metastatic disease. The eighth container is labeled ""small bowel nodule. It holds multiple tan-white nodules grossly consistent with the. tumor seen at previous sites, measuring 2 x 1.5 X 0.3 cm. Wrapped. The ninth container is labeled ""cecal nodule. It holds a single tan-white firm tissue fragment measuring 1.2 x 0.9 x 0.2. cm. Page: 3 of 5. The tenth container is labeled ""large bowel tumor."" It holds multiple pieces of fibroadipose tissue studded with firm. white nodules grossly consistent with metastatic tumor. These tissue fragments measure 4 x 3.5 x 0.3 cm in. aggregate. The 11th container is labeled ""omentum."" It holds a single piece of fibroadipose tissue grossly consistent with. omentum, measuring 15 x 12 x 2 cm. Multiple tumor deposits are present, the largest measuring 5.5 cm in greatest. dimension. On cut surface, these tumor deposits are solid and white. The 12th container is labeled ""colon nodule."" It holds multiple pieces of firm white tissue grossly consistent with tumor. identified elsewhere. These fragments measure 2.5 x 2 x 0.3 cm in aggregate. SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS. HISTOPATHOLOGIO TYPE. The histologic diagnosis is serous adenocarcinoma. TUMOR LOCATION. The location of the primary tumor is the right ovary only. HISTOLOGIC GRADE. The histologic grade is poorly differentiated (G3). TUMOR INVASION. Tumor is identified on the ovarian surface(s). TUMOR INVOLVEMENT. Tumor involvement of the pelvic peritoneum/soft tissue is present. Metastatic involvement of the extrapelvic peritoneum is present. Metastatic involvement of the omentum is present. TUMOR SIZE. The maximum dimension of tumor Implants outside the true pelvis is greater than or equal to 2 cm. PRIMARY TUMOR (T). Based on the above information, the primary tumor is classified as macroscopic peritoneal metastasis beyond pelvis. more than 2 cm in greatest dimension or regional lymph node metastasis (T3c/IIIC). REGIONAL LYMPH NODES (N). The regional lymph nodes cannot be assessed (NX). DISTANT METASTASIS (M). The status of distant tumor site cannot be assessed (MX). STAGE GROUPING. The Final AJCC/UICC/FIGO stage is T3c/NX/MX. The pathologic stage assigned here should be regarded as provisional, and may change after integration of clinical. data not provided with this specimen. Page: 4 of 5."
BIOCUP_00254,ovary,OV,TCGA-13-0893,TCGA-13-0893.0648E74B-766C-4AB7-BEEE-D45895413E5E,"V3.00 110614. Instructions: The TCGA Missing Pathology Report Form should be completed for cases for which a pathology report is not. available. General Pathology Report Information. #. Data Element. Entry Alternatives. Working Instructions. Provide the tumor type of the case. 1. Tumor type: Indicate to which BCR location the case was originally sent. BCR specimen originally sent. NCH. 2. to: IGC. Biospecimen Core Resource (BCR). 3. Date specimen received at. BCR: ICD-0-3 Histology Code: Provide the histology code for the sample from the Case. Quality Control Form (CQCF) and the overall case (patient. For Specimen: (CQCF). diagnosis, if different). 4. For Case: (patient. diagnosis, if available. elsewhere). ICD-0-3 Site Code: Provide the site code for the sample from the Case Quality. Control Form (CQCF) and the overall case (patient diagnosis, if. different). For Specimen: (CQCF). 5. For Case: (patient. diagnosis, if available. elsewhere)."
BIOCUP_00255,ovary,OV,TCGA-30-1853,TCGA-30-1853.ded9ba4c-8d3d-450b-a345-772a3e3ae288,"Apcession Number: Report Status Final. Type: Surgical Pathology. SOFT TISSUE TUMOR EXTENSIVE RESECTION. DIAGNOSIS: SPECIMEN LABELED ""OMENTAL TUMOR"": METASTATIC PAPILLARY SEROUS CARCINOMA. SPECIMEN LABELED ""RIGHT ADNEXA"": PAPILLARY SEROUS ADENOCARCINOMA of the ovary, poorly differentiated, with. surface involvement and extension into mesosalpinx. Endometriosis involving mesosalpinx. SPECIMEN LABELED ""LEFT ADNEXA"": PAPILLARY SEROUS ADENOCARCINOMA of the ovary, poorly differentiated, with. surface involvement. The tumor is associated with an adenof√≠broma and does not involve the. fallopian tube. SPECIMEN LABELED ""UTERUS AND CERVIX"": Atrophic endometrium. Leiomyoma. CLINICAL DATA: History: with ovarian masses and cysts. Clinical Diagnosis: ? ovarian cancer. TISSUE SUBMITTED: 1. Omentum tumor. 2. Right adnexa. 3. Left adnexa. 4. Uterus and cervix. O.R. CONSULTATION: SPECIMEN LABELLED ""#1 OMENTAL TUMOR"" (FSA) : Papillary carcinoma, favor serous type. SPECIMEN LABELLED ""#2 RIGHT ADNEXA"" (FSB) : Papillary carcinoma, favor serous type. SPECIMEN LABELLED ""#3 LEFT ADNEXA"" (FSC) : Papillary carcinoma, favor serous type. CYTOLOGY : PERITONEAL FLUID. CELL BLOCK AND CYTOLOGY. <. SUSPICIOUS CELLS PRESENT. Few clusters of atypical epithelial cells, suspicious for adenocarcinoma. (Best seen on cytology preparations). The specimen, labeled ""peritoneal fluid"", consists of. of orange/red fluid. The fluid is centrifuged, and the remaining cell. pellet, measuring 1.0 cm, is submitted in formalin for cell block sections. Micro CB: peritoneal fluid, multi frags, 1 cass,. GROSS DESCRIPTION: The specimen is received fresh, in four parts, labelled with the patient's. name and unit number. Part one, ""omental tumor"", consists of an irregular fragment of fibrofatty. tissue measuring 21 x 12 x 6.5 cm. The external surface of the specimen is. irregular, bosselated, focally hemorrhagic. The cut surface of the specimen. shows a 12.5 x 11 x 7 cm yellow/tan soft, extensively hemorrhagic and necrotic. tumor mass. The central portion of the lesion shows a glistening area of. possible degeneration. The tumor mass is surrounded by a rim of mature adipose. tissue. A representative section of the tumor mass is submitted for. Micro 1-3 : tumor mass, 3 E,. Micro 4: fibroadipose tissue, 1 ¬£,. Micro 16: remnant FSA, 1 ¬£,. Page: 1 of 2. Part two, ""right adnexa"", consists of a fragmented irregular ovary measuring. 8.5 x 8 x 2.5 cm with attached non-fimbriated fallopian tube measuring 8 cm in. length and ranging in diameter from 2.5 cm to 0.5 cm. The external surface. of the fallopian tube is red/tan, focally hemorrhagic. The distal portion of. the fallopian shows a 3 x 2.5 x 2 cm firm nodule. The cut surface of the. nodule is yellow/tan, focally hemorrhagic and necrotic. The mid-portion of the. fallopian tube is dilated up to 1.5 cm in diameter. The area of dilatation. is filled with hemorrhagic fluid. The external surface of the the ovary is. irregular, focally hemorrhagic. Multiple yellow/tan, raised soft nodules are. identified, the largest of which measures 3.5 x 3 x 2 cm. The cut surface of. the ovary (previously opened) shows few cavities. The internal surface of one. of the cavities identified shows a 1.2 x 1 x 0.2 cm area of yellow/tan soft. papillary projections. The internal surface of the other cavities is. predominantly smooth and glistening with focal areas of hemorrhage. Received. also is a 5.5 x 3.5 x 3.2 cm irregular nodule of yellow/tan soft tissue,. detached from the rest of the specimen. The cut surface of the nodules is. pink/grey, fleshy with focal areas of hemorrhage. A representative section of. one of the ovarian is submitted for. Micro 5-6: tubal nodule, 2 f,. Micro 7: fallopian tube with area of cystic dilatation, 2. Micro 8-12: solid nodules on the ovarian surface, mult frags,. Micro 13: area with papillary projections, 2 ¬£,. Micro 14: nodules received separated from the rest of the specimen,. 1 f,. Micro 15: remnant of FSB, 1 ¬£,. Part three, ""left adnexa"", consists of a 6 x 4 x 3 cm fragment of tissue with. an irregular surface. A fallopian tube with a fimbriated end is identified and. measures 4.5 cm in length x 0.8 cm in largest diameter. The attached adnexal. mass consists mostly of a nodule with a papillary/irregular surface and a cyst. containing both cystic and solid elements. Both the solid nodule and the. cystic nodules have been cut. The solid nodule measures 3.2 x 2.5 x 2.8 cm and. the cystic mass measures 2.5 cm in the largest diameter. Micro 17: FSCR, 1 ¬£,. Micro 18: sections of fallopian tube, 3 ¬£,. Micro 19-20: sections of solid nodules, 2 ¬£,. Micro 21-22: sections of cystic mass, 2 ¬£,. Part four, ""uterus with cervix"", consists of a 50 gm hysterectomy. The uterus. and cervix measures 7 x 5 x 3 cm in overall dimensions having a smooth,. glistening and focally hemorrhagic serosal surface. The tan, smooth and. glistening exocervix (3.3 cm in diameter) has a slit-like os (1.5 cm in. diameter) The specimen is inked prior to processing. The endocervix (2.1. cm. in length x 1.4 cm in width) has a smooth and glistening surface with a 0.6 cm. fluid filled cyst. The endometrium (2.1 cm from cornu to cornu x 3.8 cm in. length x 0.1 cm in thickness) is smooth and glistening with focal mucosal. hemorrhages. The myometrium (1. cm in maximal thickness) contains a single. small intramural white nodule measuring 0.3 cm in diameter. Micro 23: anterior cervix, 1 ¬£,. Micro 24: posterior cervix, 1 f,. Micro 25: posterior lus, 1 ¬£,. Micro 26-27: anterior endometrium and serosa, 2. Micro 28-29: posterior endometrium and serosa,. 1. Micro 30: section of myometrial nodule, 1 f,. ports to: SPECIMEN TYPE: SOFT TISSUE TUMOR EXTENSIVE RESECTION. ADDITIONAL SPECIMEN TYPE: UTERUS WITH OR WITHOUT TUBES & OVARIES, , NEOPLASTIC. ADDITIONAL SPECIMEN TYPE: CELL BLOCK (ANY SOURCE)."
BIOCUP_00256,ovary,OV,TCGA-24-1563,TCGA-24-1563.6fdeb714-439d-49d7-aae0-99166a3e8eba,"Other Related Clinical Data: DIAGNOSIS: OVARY, LEFT, SALPINGO-OOPHORECTOMY. POORLY DIFFERENTIATED ADENOCARCINOMA, MIXED EPITHELIAL TYPE (SEE COMMENT). FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY. - METASTATIC ADENOCARCINOMA. OVARY, RIGHT, SALPINGO-OOPHORECTOMY. - METASTATIC ADENOCARCINOMA INVOLVING MESOVARIUM. - PARAOVARIAN ADHESIONS. FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. UTERUS, CERVIX, TOTAL ABDOMINAL HYSTERECTOMY. - METASTATIC ADENOCARCINOMA INVOLVING DEEP CERVICAL SOFT TISSUE. - MILD CHRONIC INFLAMMATION. UTERUS, ENDOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - CYSTIC ATROPHY. UTERUS, MYOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - METASTATIC ADENOCARCINOMA BY DIRECT EXTENSION FROM SEROSAL IMPLANT. - MULTIPLE LEIOMYOMAS, INTRAMURAL AND SUBMUCOSAL. UTERUS, SEROSA, TOTAL ABDOMINAL HYSTERECTOMY. - EXTENSIVE METASTATIC ADENOCARCINOMA. - ADHESIONS. PERITONEUM, CUL-DE-SAC, BIOPSY. - METASTATIC ADENOCARCINOMA. OMENTUM, OMENTECTOMY. - METASTATIC ADENOCARCINOMA. PELVIS, TUMOR, EXCISION. - METASTATIC ADENOCARCINOMA. MESENTERY, NODULE, EXCISION. - METASTATIC ADENOCARCINOMA. APPENDIX, APPENDECTOMY. - METASTATIC ADENOCARCINOMA INVOLVING SEROSAL ASPECT. LARGE INTESTINE, SIGMOID,TUMOR, EXCISION. - METASTATIC ADENOCARCINOMA. LARGE INTESTINE, SIGMOID, PARTIAL EXCISION. CINOMA INVOLVING ONE RESECTION MARGIN. By this signature, I attest that the above diagnosis is based upon my. personal examination of the slides(and/or other material indicated in the diagnosis). eport Electronically Reviewed and Signed Out By. Microscopic Description and Comment: Histologic sections from the left ovarian mass show. a poorly differentiated Mullerian adenocarcinoma. The majority of the tumor is present. in solid sheets and nests. Some of the tumor, however, exhibits definite glandular. differentiation with occasional areas of back to back glands diagnostic of endometrioid. differentiation. Other areas exhibit intraluminal complexity in the form of papilla with. markedly pleomorphic nuclei and numerous atypical mitotic figures consistent with serous. differentiation. Metastatic adenocarcinoma is present in and around the left fallopian tube,. in a small nodule in the right mesovarium, extensively involving the serosal aspect of the. uterus and deep paracervical tissue with superficial invasion of overlying myometrium, in. the omentum, on the serosal aspect of the appendix, in a mesenteric nodule, in a sigmoid. nodule, and in the pelvis. A segment of the sigmoid colon has been resected. This segment is. unoriented but one resection margin exhibits metastatic adenocarcinoma. History: The patient is. ith a pelvic mass. now undergoes evaluation. under anesthesia, exploratory laparotomy, total abdominal hysterectomy, with bilateral. salpingo-oophorectomy, omentectomy, appendectomy, sigmoid resection with re-anastomosis, and. optimal tumor debulking. Specimen (s) Received. A: CUL-DE-SAC TUMOR. B: UTERUS, CERVIX, BSO. C: SIGMOID TUMOR. D: SIGMOID COLON. E: PELVIC TUMOR. F: MESENTERY NODULE. G: APPENDIX. H: OMENTUM. Gross Description Received are eight containers, each labeled with the patient's name. The. first is further designated ""cul de sac tumor. It contains a 1 x 1 x 1 cm aggregate of. friable tan tissue. The second container is further designated ""uterus, cervix, BSO. It contains a 200. gram uterine corpus with attached adnexae and attached cervix. The left adnexa is largely. replaced by a 7 x 4 x 4 cm friable tan tumor mass. The tumor has a finely papillary. appearance. Attached to the tumor is a 3 cm in diameter smooth-lined cyst. Grossly, the. tumor appears to be adhesed and possibly invading the serosal surface of the left uterine. corpus. The fallopian tube, which measures 3 cm in length and 1 cm in diameter appears to. be uninvolved, although it is adherent to the tumor mass. The right adnexa consists of. a. 2 x 1.5 x 0.8 cm firm white and tan ovary with multiple corpora albicans and a 4 cm in. length and 0.8 cm in diameter fallopian tube. There does not appear to be any evidence. of tumor in the fallopian tube or the ovary; however, in the mesovarium, there is a 0.5. cm firm white nodule. The uterine corpus which measures 4.5 cm superior-inferior, 4 cm. cornu-cornu, and 4.5 cm anterior-posterior is adhesed to the left ovarian mass. Furthermore,. there are multiple nodules of tumor studding the serosal surface. The endometrial cavity. measures 2.5 x 2 cm with an endometrial thickness of 0.2 cm. The endometrium sounds to a. depth of 8 cm. The endometrial lining is remarkable for a 2 x 2 X 1 cm polyp protruding into. the endometrial cavity. Sectioning of the polyp reveals a central core with a firm white. lobulated appearance, measuring 2 x 1.2 x 0.5 cm. The core of this polyp appears to arise. from the underlying myometrium and is consistent with a submucosal leiomyoma protruding. into the lumen of the cavity with an intact endometrial lining overlying the leiomyoma. There are also other intramural and subserosal unremarkable leiomyomas present, ranging. from 1 cm in greatest dimension to 1.6 cm in greatest dimension. The myometrium is 2. cm. in thickness anteriorly and 1.4 cm in thickness posteriorly. The cervix, which measures. 3 cm in length and 3 cm in diameter with a round os measuring 0.5 cm in diameter, appears. to be unremarkable without evidence of papillary formations, masses or nodules. Labeled B1. - soft tissue in area of right parametrium; B2 - soft tissue in area of left parametrium;. B3 - left ovarian tumor; B4 and B5 - ovarian tumor in relation to cyst; B6 - additional. cyst; B7 - left fallopian tube; B8 - extension of tumor to anterior uterine serosa; B9 -. extension of tumor to posterior uterine serosa; B10 - extension of tumor into myometrium;. B11 and B12 - tumor invading myometrium and base of endometrial polyp/leiomyoma; B13 and. B14 - rest of polyp/leiomyoma; B15 - anterior cervix; B16 - anterior lower uterine segment;. B17 - additional anterior endometrium; B18 - posterior cervix; B19 - posterior lower. uterine. segment; B20. - additional posterior endometrium; B21 - additional serosal nodules; B22 - right ovary and. fallopian tube; B23 - right mesovarian nodule; B24 - additional left cyst. The third container is further designated ""sigmoid tumor.' It contains a 4 x 4 x 4 cm. aggregate of friable tan tumor. The fourth container is further designated ""sigmoid colon. It contains an unoriented. segment of bowel measuring 9 cm in length and 2 cm in diameter with a serosal surface that. is extensively involved by friable tan tumor. The tumor appears to extend very close to. the resection margin. The mucosal surface appears to be unremarkable. Labeled: D1 - one. resection margin; D2 - other margin; D3 - random section with tumor. The fifth container is further designated ""pelvic tumor. It contains a 1 x 1 x 0.5. cm. aggregate of friable tan tumor. The sixth container is further designated ""mesentery nodule. It contains two portions of. 1. cm in diameter tissue covered with a glistening membrane. The seventh container is further designated ""appendix."" It contains an 8 cm in length and. 0.5 cm in diameter portion of appendix grossly involved by tumor at the serosa of the tip. Labeled G1, appendix including resection margin. The eighth container is further designated ""omentum. , It contains a 29 x 8 x 0.5 cm portion. of omentum grossly involved by multiple nodules of tumor ranging from 0.5 to 2.5 cm in. greatest dimension. Synopsis SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS 1. A neoplasm is. PRESENT. 2. The HISTOLOGIC DIAGNOSIS is: Other (Mixed epithelial type: endometrioid and serous). 3. The LOCATION(S) OF THE PRIMARY TUMOR (S) is/are: Left ovary only - but also in mesovarium. of right ovary. 5. The NUCLEAR (BRODERS') GRADE of the tumor is: G3. Poorly-differentiated). 6. Tumor IS identified on the ovarian surface (s). 7. Tumor DOES invade the mesovarium. 8. Tumor DOES NOT invade the adjacent fallopian tube. 9. Tumor DOES invade the pelvic soft tissue. 10. Tumor involvement of the pelvic peritoneum is PRESENT. 11. Metastatic involvement of the EXTRAPELVIC PERITONEUM is PRESENT. 12. Metastatic involvement of the omentum is PRESENT. 13. The maximum dimension of tumor implants outside the true pelvis is: 2.5 cm. 14. Metastatic involvement of the uterine serosa is PRESENT. 15. Metastatic involvement of the endometrium is ABSENT. 16. Regional lymph node metastases CANNOT BE EVALUATED. 17. The total number of regional lymph nodes examined is: 0. 18. The total number of metastatically-involved regional lymph nodes is: 0. 19. DETAILED STAGING INFORMATION: Based on the above information, the PRIMARY TUMOR is classified as: TNM Scheme. FIGO Scheme. Definition. IIIC. Macroscopic. peritoneal metastasis beyond true pelvis measuring > 2 cm in greatest dimension. THE REGIONAL LYMPH NODES are classified as : NX (Nodal status cannot be assessed). THE STATUS OF DISTANT TUMOR SITES is classified as: (Status cannot be assessed). 20. The FINAL AJCC/UICC/FIGO STAGE IS: AJCC/UICC/FIGO. X. Insufficient data to assign stage. The pathologic stage assigned here should be regarded as provisional, and may change after. integration of clinical data not provided with this specimen."
BIOCUP_00257,ovary,OV,TCGA-29-1761,TCGA-29-1761.63defa27-e729-4514-bdd2-d887c4100854,"CLINICAL HISTORY: Pelvic organ prolapse, bilateral adnexal masses. GROSS EXAMINATION: A. ""Omentum"", received fresh. A 25 x 17 x 7 cm aggregate of firm, matted. adipose and fibrous tissue with scabrous yellow tan cut surfaces. Representative sections are submitted as Blocks A1-A2. B. ""Right tube and ovary"", received fresh. A 59.4 gram, 8.5 x 5.2 x 3.5 cm. friable tan-pink mass with an identifiable 6.5 cm length of tube and focally. adherent fat. One nodule is adjacent to the fimbriated end of the tube,. Sectioning reveals predominantly compact yellow gray cut surfaces and. peripheral cyst like formation lined by granular friable surfaces (B3). Representative sections to include fallopian tubes are submitted as Blocks. B1-B3. c. ""Left tube and ovary and uterus"", received fresh. A 62.2 gram portion of. tissue composed of 5.4 x 4.5 x 3.5 cm uterine body with attached 6.5 cm length. of fallopian tube and adjacent 3.5 x 2.5 x 1.0 cm ovary. No cervix is. identified. The serosa is markedly nodule with a friable tan-gray mass. extending onto the fallopian tube and ovarian serosa. The endometrium is. granular tan-pink and less than 0.1 cm in thickness. The myometrium is 1.5 cm. in thickness and contains a 1.9 cm circumscribed firm yellow intramural nodule. and a focally calcified 1.5 cm diameter subserosal nodule. Sectioning the. ovary reveals a compact whorled cut surface adjacent to the friable external. nodules. BLOCK SUMMARY: C1- posterior endomyometrium toward lower uterine segment. C2- anterior lower uterine segment. C3- anterior endomyometrium with intramural fibroids and serosal nodules. C4- left fallopian tube. C5- left ovary. D. ""Sigmoid colon"", received fresh. An 8 cm segment of unoriented bowel with. two stapled ends and multiple adherent friable red-tan nodules and matted. adipose. The bowel segment is opened to reveal a tan velvety mucosa with no. lesions identified. Sectioning reveals the friable external mass to encase the. segment of bowel. Representative sections are submitted as Blocks D1-D2. DIAGNOSIS: A. ""OMENTUM"" (BIOPSY) : METASTATIC ADENOCARCINOMA INVOLVING OMENTAL TISSUE. B. ""RIGHT TUBE AND OVARY"" (SALPINGO-OOPHORECTOMY) : 1. ORLY-DIFFERENTIATED SEROUS ADENOCARCINOMA OF OVARY. - TUMOR SIZE 8. .CM;. - TUMOR INVOLVES OVARIAN SURFACE. TUMOR IMPLANTS EXTENSIVELY INVOLVE FALLOPIAN TUBE. C. ""LEFT TUBE AND OVARY AND UTERUS"" (HYSTERECTOMY AND SALPINGO-OOPHORECTOMY) : 1. POORLY-DIFFERENTIATED SEROUS ADENOCARCINOMA INVOLVING OVARIAN HILUM. AND UTERINE SEROSA. 2. ENDOMETRIUM WITH CYSTIC ATROPHY. 3. MYOMETRIUM WITH LEIOMYOMA (1.3 CM). 4. NO CERVIX IDENTIFIED. 5. FALLOPIAN TUBE, NEGATIVE FOR CARCINOMA. D. ""SIGMOID COLON"" (SEGMENTAL RESECTION) : SEGMENT OF COLON (8 CM), WITH SEROSAL IMPLANT OF METASTATIC. ADENOCARCINOMA. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es)."
BIOCUP_00258,ovary,OV,TCGA-61-1910,TCGA-61-1910.32905714-6e41-4df8-91dd-6d3068475b40,"FINAL DIAGNOSIS: PART 1: OVARY AND FALLOPIAN TUBE, LEFT SALPINGOOOPHORECTOMY -. A. OVARY WITH POORLY DIFFERENTIATED SEROUS PAPILLARY ADENOCARCINOMA (GRADE 3), INVOLVING. OVARIAN STROMA AND SEROSA, WITH EPITHELIAL INCLUSIONS (ENDOSALPINGIOSIS) AND. CALCIFICATION. (see comment). B. FALLOPIAN TUBE WITH LUMINAL SEROUS PAPILLARY ADENOCARCINOMA. (see comment). PART 2: UTERUS WITH RIGHT OVARY AND FALLOPIAN TUBE, TOTAL ABDOMINAL HYSTERECTOMY AND RIGHT. SALPINGOOOPHORECTOMY (90 GRAMS) -. A. CHRONIC CERVICITIS. B. BASAL ENDOMETRIUM. C. MULTIPLE LEIOMYOMAS UP TO 3.5 CM WITH HYALINIZATION AND CALCIFICATIONS. D. RIGHT OVARY WITH SEROUS PAPILLARY ADENOCARCINOMA FOCALLY INVOLVING SEROSA (2G), WITH. EPITHELIAL INCLUSIONS (ENDOSALPINGIOSIS) AND CALCIFICATION (see comment). E. RIGHT FALLOPIAN TUBE WITH PARATUBAL CYST, NO TUMOR SEEN. PART 3: SOFT TISSUE, LEFT BROAD LIGAMENT, BIOPSY -. SEROUS PAPILLARY ADENOCARCINOMA WITH LYMPHO-VASCULAR PERMEATION. PART 4: LYMPH NODES, RIGHT PELVIC, BIOPSY -. TWELVE LYMPH NODES, FREE OF TUMOR (0/12). PART 5: LYMPH NODE, RIGHT PERI-AORTIC, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 6: LYMPH NODES, LEFT PERI-AORTIC, BIOPSY -. TWO (2) LYMPH NODE, FREE OF TUMOR (0/2). PART 7: LYMPH NODES, LEFT PELVIC, BIOPSY -. TWO LYMPH NODES, FREE OF TUMOR (0/2). PART 8: SOFT TISSUE, RIGHT PELVIC SIDEWALL, BIOPSY -. FIBROADIPOSE TISSUE, NO TUMOR SEEN. PART 9: SOFT TISSUE, LEFT PELVIC SIDEWALL, BIOPSY -. PART 10: OMENTUM, OMENTECTOMY -. OMENTUM, NO TUMOR SEEN. PART 11: SOFT TISSUE, RIGHT PERICOLIC GUTTER, BIOPSY -. FIBROVASCULAR TISSUE, NO TUMOR SEEN. PART 12: SOFT TISSUE, LEFT PERICOLIC GUTTER, BIOPSY -. FIBROADIPOSE TISSUE AND SKELETAL MUSCLE, NO TUMOR SEEN. MICROSCOPIC: SYNOPTIC - PRIMARY OVARIAN TUMORS INCLUDING BORDERLINE TUMORS. TUMOR LOCATION: Bilateral. PROCEDURE: TAH with salpingo-oophorectomy. TUMOR SIZE: Maximum dimension: 6 cm. TUMOR TYPE: Papillary serous carcinoma. HISTOLOGIC SILVERBERG GRADE: Poorly differentiated (8-9 pts). ARCHITECTURAL PATTERN: Solid (3). CYTOLOGIC ATYPIA: Marked (3). MITOTIC COUNTS / 10hpf: 10-24 (2). VASCULAR INVASION: TUMOR CAPSULE: Ruptured. SURFACE IMPLANTS: Invasive. SURFACE IMPLANT SITE: Fallopian Tubes. SURFACE IMPLANT SIZE: > 2 cm. ASSOCIATED OTHER LESION: Surface epithelial inclusion. MALIGNANT CELLS IN ASCITES OR. PERITONEAL WASHING: LYMPH NODES EXAMINED: Total number of lymph nodes examined: 17. LYMPH NODES POSITIVE: Number of positive lymph nodes, Right: 0. Number of positive lymph nodes, Left: 0. T STAGE, PATHOLOGIC: pT2c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. FIGO STAGE: IIC."
BIOCUP_00259,ovary,OV,TCGA-20-0996,TCGA-20-0996.B9EF21BB-4075-4A29-8023-1874FD090BA5,"Sex: F. Clinical History/Diagnosis: Not entered. Source of Specimen(s): A: CYTOLOGY. B: OMENTUM. C: ADDITIONAL SUPRACOLIC OMENTUM. D: RT TUBE OVARY. E: ADDITIONAL TUMOR FROM GREATER CURVATURE OF ST. F: BLADDER PERITONEUM TUMOR. G: UTERUS,LT TUBE OVARY RECTUM. H: TUMOR @ SPLENIC FLEXURE. I: EEA HEAD WITH DISTAL PORTION. J: TUMOR FROM LT COLON. K: RT PARACOLIC NODULE. Clinical History/Diagnosis: PELVIC MASS; (+) BX FOR ADENOCA. Specimen(s): 1. CYTOLOGY. 2. OMENTUM. 3. ADDITIONAL SUPRACOLIC OMENTUM. 4. R TUBE AND OVARY. 5. ADDITIONAL TUMOR FROM GREATER CURVATURE OF STOMACH. BLADDER PERITONEUM TUMOR. 7. UTERUS, L TUBE AND OVARY, AND RECTUM. 8. TUMOR AT SPLENIC FLEXURE. 9. EEA HEAD WITH DISTAL PORTION. 10. TUMOR FROM L COLON. 11. R PARACOLIC NODULE. Gross Description: GROSS DESCRIPTION: Received in eleven parts. SOURCE OF TISSUE: 1. CYTOLOGY. SOURCE OF TISSUE: 2. Labeled #2, ""omentum"". FROZEN SECTION DIAGNOSIS: 2FS - PAPILLARY SEROUS CARCINOMA. GROSS DESCRIPTION: Received fresh for frozen section evaluation is a 32.0. X 15.0 X 6.5 cm portion of caked omental fat. It is sectioned to reveal. multiple clear fluid-filled cysts, 1.0 to 3.5 cm in greatest dimension. The remaining cut surfaces are tan, firm and sponge-like. Two representative. sections are submitted for frozen section evaluation and the frozen section. residue is submitted in one block. Additional representative sections are. submitted in four blocks. DESIGNATION OF SECTIONS: 2FS, 2A-2D. SUMMARY OF SECTIONS: FS, A-D - multiple. SOURCE OF TISSUE: 3. Labeled #3, ""additional supracolic omentum"". GROSS DESCRIPTION: Received fresh are 11.0 x 5.0 x 3.5 cm of caked. Omental fragments. They are sectioned to reveal multiple clear fluid-filled. cysts, 1.5 cm in greatest dimension. The remaining cut surfaces are tan, soft. and sponge-like. Representative sections are submitted in three blocks. DESIGNATION OF SECTIONS: 3A-3C. SUMMARY OF SECTIONS: each block has one piece. SOURCE OF TISSUE: 4. Labeled #4, ""right tube and ovary"". GROSS DESCRIPTION: Received fresh are two tan to red-purple irregular. Soft tissue fragments, 4.0 x 2.5 x 2.0 cm and 4.5 x 4.0 X 2.0 cm in greatest. dimension. They are sectioned to reveal tan soft to friable cut surfaces. The fallopian tube is not readily identified. Representative sections are. submitted in four blocks. DESIGNATION OF SECTIONS: 4A - ? fallopian tube, 4B-4D - representative. sections, tissue fragments. SUMMARY OF SECTIONS: A-D - multiple. SOURCE OF TISSUE: 5. Labeled #5, ""additional tumor from greater. Curvature of stomach"". GROSS DESCRIPTION: Received fresh is a 7.5 x 2.5 x 2.0 cm yellow-tan. fragment of omental fat. It is sectioned to reveal tan glistening cut. surfaces containing multiple tan-pink tumor nodules, 1.5 cm in greatest. dimension. Representative sections are submitted in two blocks. DESIGNATION OF SECTIONS: 5A-5B. SUMMARY OF SECTIONS: A-B - multiple. SOURCE OF TISSUE: 6. Labeled #6, ""bladder peritoneum tumor"". GROSS DESCRIPTION: Received fresh is a 5.0 x 2.0 x .5 cm tan fragment of. tumor which is sectioned to reveal soft firm to friable cut surfaces. Representative sections are submitted in two blocks. DESIGNATION OF SECTIONS: 6A-6B. SUMMARY OF SECTIONS: A-2,B-2. SOURCE OF TISSUE: 7. Labeled #7, ""uterus, left tube and ovary and. rectum"". GROSS DESCRIPTION: Received fresh is a 28.0 cm in length fragment of. large. bowel and rectum having a tan-pink serosa with an abundant amount of. attached adipose tissue. The bowel is adhesed upon itself and on. sectioning. through the attached adipose tissue there are multiple tan tumor nodules,. 3.0 cm in greatest dimension. 5.0 cm from the proximal margin of. resection. there is an attached uterus with cervix and left adnexa. The uterine body. is 3.5 x 3.0 x 2.5 cm in greatest dimension having a tan-pink shaggy. serosa. The attached cervix is 3.0 X 2.5 x 2.0 cm in greatest dimension having a. tan-pink exocervix with a 0.3 cm patulous os. The specimen is bivalved to. reveal a tan glistening endocervix with a minimal amount of mucus. The. myometrium is tan-pink, 1.0 cm in greatest thickness. The uterine cavity. is lined by a tan glistening endometrium, 0.3 cm in greatest thickness. The attached left ovary is approximately 3.5 X 2.5 x 2.0 cm in greatest. dimension, which is sectioned to reveal tan, friable tumor. It is covered. in part by a 3.5 x 0.6 cm tan-pink fallopian tube having a pin point lumen. and one fimbriated end. The ovary/tumor is firmly adherent to the large. bowel. On opening the bowel ranges from 3.0 to 5.5 cm in greatest. circumference with the wall averaging 0.5 cm in thickness. The mucosa is. tan, glistening, slightly edematous, with the usual folds. In the mid. portion of the bowel there is a 1.0 cm in greatest dimension tan. pedunculated polyp. No additional mucosal lesions are grossly identified. Representative sections are submitted in fifteen blocks. DESIGNATION OF SECTIONS: 7A - proximal margin, 7B - distal margin, 7C-7D. random sections bowel, 7E - pedunculated polyp, 7F - random sections tumor. nodules in attached adipose tissue, 7G - anterior cervix, 7H - posterior. cervix, 7I-7J - anterior endometrium/myornetrium, 7K-7L - postrior. endometrium/myornetrum, 7M - fallopian tube, 7N-70 - area of ovary/tumor. with attached bowel wall. SUMMARY OF SECTIONS: A-O - multiple. SOURCE OF TISSUE: 8. Labeled #8, ""tumor at splenic flexure"". GROSS DESCRIPTION: Received fresh is an 11.5 x 8.0 x 3.5 cm tan to. pink-red. firm fragment of tissue. It is sectioned to reveal multiple clear fluid F. filled cysts, 2.0 cm in greatest dimension. The remaining cut surfaces. are. light tan and sponge like. Representative sections are submitted in three. blocks. DESIGNATION OF SECTIONS: 8A-8C. SUMMARY OF SECTIONS: each block has one piece. SOURCE OF TISSUE: 9. Labeled #9, ""EEA head with distal portion"". GROSS DESCRIPTION: Received fresh on a stapler spike are two tan-pink. annular fragments of mucosa, 2.0 cm in greatest dimension. The fragments. are not specifically designated. Each contains multiple staples, these. removed, and the remaining soft tissue is entirely submitted in four. blocks. DESIGNATION OF SECTIONS: 9A-9B - rounded end, 9C-9D - pointed end. SUMMARY OF SECTIONS: A-D - multiple. SOURCE OF TISSUE: 10. Labeled #10, ""tumor from left colon"". GROSS DESCRIPTION: Received fresh is a 6.0 x 3.5 x 2.0 cm tan to pink-red. fragment of soft tissue. It is sectioned to reveal cut surfaces. infiltrated. by tan turnor. There are multiple clear fluid-filled cysts, 1.0 cm in. greatest dimension. Representative sections are submitted in two blocks. DESIGNATION OF SECTIONS: 10A-10B. SUMMARY OF SECTIONS: A-1,B-1. SOURCE OF TISSUE: 11. Labeled #11, ""right paracolic nodule"". GROSS DESCRIPTION: Received fresh is a 9.5 x 5.0 x 2.5 cm yellow-tan. fragment of fibroadipose tissue. It is sectioned to reveal cut surfaces. which are infiltrated by tan tumor. Also present are several clear fluid-. filled cysts, 1.0 cm in greatest dimension. Representative sections are. submitted in two blocks. DESIGNATION OF SECTIONS:11A-11E. SUMMARY OF SECTIONS: A-B - multiple. Final Diagnosis: DIAGNOSIS: 1. CYTOLOGY. 2. OMENTUM, OMENTECTOMY: - METASTATIC SEROUS PAPILLARY CARCINOMA. 3. OMENTUM, SUPRACOLIC, ADDITIONAL, EXCISION: - METASTATIC SEROUS PAPILLARY CARCINOMA. 4. RIGHT OVARY AND FALLOPIAN TUBE, SALPINGO-OOPHORECTOMY: - SEROUS PAPILLARY CARCINOMA WITH SUPERFICIAL INVASION OF OVARY. 5. STOMACH, GREATER CURVATURE, EXCISION: - METASTATIC SEROUS PAPILLARY CARCINOMA. 6. BLADDER PERITONEUM, EXCISION: - METASTATIC SEROUS PAPILLARY CARCINOMA. TWO SMALL LYMPH NODES BOTH NEGATIVE FOR TUMOR (0/2). 7. UTERUS, LEFT OVARY AND FALLOPIAN TUBE AND RECTUM, RESECTION: SEROUS PAPILLARY CARCINOMA, INTERMEDIATE GRADE EFFACING THE LEFT OVARY. AND INVADING THE LEFT FALLOPIAN TUBE. - TUMOR INVADES OUTER RECTAL WALL AND UTERINE AND CERVICAL SEROSA WITH. SUPERFICIAL INVASION. - UTERUS WITH BENIGN ATROPHIC ENDOMETRIUM AND BENIGN ECTO AND. ENDOCERVIX. - TUBUALR ADENOMA OF RECTUM. - PROXIMAL AND DISTAL MARGINS OF THE BOWEL NEGATIVE. 8. TUMOR AT SPLENIC FLEXURE, EXCISION: - METASTATIC SEROUS PAPILLARY CARCINOMA. 9. EEA HEAD WITH DISTAL PORTION: - NO TUMOR SEEN. 10. LEFT COLON, TUMOR, EXCISION: - METASTATIC SEROUS PAPILLARY CARCINOMA. 11. RIGHT PARACOLIC NODULE, EXCISION: - METASTATIC SEROUS PAPILLARY CARCINOMA."
BIOCUP_00260,ovary,OV,TCGA-24-2280,TCGA-24-2280.deb1a0d1-92a0-4c10-b491-a6a1ca5e3192,"RG. Taken : . Physician (s) : Other Related Clinical Data: DIAGNOSIS: OVARY, LEFT, OOPHORECTOMY (FS1). - PAPILLARY SEROUS CARCINOMA, MODERATELY DIFFERENTIATED INVOLVING. PARA-OVARIAN SOFT TISSUE AND OVARIAN SURFACE. FALLOPIAN TUBE, LEFT, SALPINGECTOMY. - PAPILLARY SEROUS CARCINOMA INVOLVING PARATUBAL SOFT TISSUE. - PARATUBAL CYSTS. OVARY, RIGHT, OOPHORECTOMY. - PAPILLARY SEROUS CARCINOMA INVOLVING PARA-OVARIAN SOFT TISSUE. FALLOPIAN TUBE, RIGHT, SALPINGECTOMY. - PAPILLARY SEROUS CARCINOMA INVOLVING PARATUBAL SOFT TISSUE. - SIMPLE CYST. OMENTUM, OMENTECTOMY. - PAPILLARY SEROUS CARCINOMA, INVASIVE (SEE COMMENT). LYMPH NODE, LEFT PELVIC, EXCISION. - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (1/1). - RARE NON-NECROTIZING GRANULOMATA. By this signature, I attest that the above diagnosis is. based upon my personal. examination of the slides(and/or other material indicated in the. diagnosis). Intraoperative Consultation. An intraoperative non-microscopic consultation was obtained and interpreted as: ""Called to pick-up 'left tube and ovary' consisting of a 6 x 3 x 1.5 cm adnexal. specimen with a few separate fragments of red-tan tissue. The ovary and. fallopian tube show adhesions with nodularity. Representative tissue frozen as. FS1. Remainder for permanents,. FS1: Ovary, left, biopsy - ""Carcinoma, favor Mullerian,. Microscopic Description and Comment: Sections show a poorly differentiated serous adenocarcinoma consistent with a. primary peritoneal serous carc√≠noma as the omental mass appears dominant and the. ovaries are atrophic with only surface implants. The tumor is distinctly. different than the patient's breast carcinoma. History: The patient is a. with a history of breast cancer. Cytologic. evaluation of abdominal ascites showed adenocarcinoma. Operative procedure and. findings Examination under anesthesia, exploratory laparotomy, bilateral. salpingo-oophorectomy, omentectomy, left ureterolysis, tumor debulking, left. cervical lymph node aspiration, lymph node sampling (pelvic). Specimen (s) Received: A: OVARY AND TUBE, LEFT. B: OVARY AND TUBE, RIGHT. C: OMENTUM. D: LYMPH NODE, LEFT PELVIC. Gross Description. Received are four formalin-filled containers, each labeled. The first container is additionally labeled left tube and ovary. It contains. a segment of fallopian tube which is adhesed to an atrophic ovary and the. adjacent soft tissue. The fallopian tube measures 5 cm in length and 0.5 cm in. diameter. The adjacent atrophic ovary measures 2.1 x 0. 8 x 0.5 cm. Covering. the external surface of the fallopian tube, paratubal soft tissue, and ovary are. numerous tan-grey granular nodules which measure up to 0.4 cm in greatest. dimension. The fallopian tube is serially sectioned; the lumen is patent with. no focal lesions. The atrophic ovary is bisected; the cut surface is tan-grey. with no focal lesions. The frozen section specimen is submitted in A1 (FS1). Additional sections of fallopian tube and ovary are submitted in A2 to A4. Jar. 1. The second container is labeled ""right tube and ovary. It contains a fallopian. tube with adjacent atrophic ovary. The fallopian tube measures 5 cm in length. and up to 0.4 cm in diameter. Multiple simple cysts are identified at the. fimbriated end. Sections of the tube disclose a patent lumen with no focal. lesions. The adjacent atrophic ovary measures 1.5 x 0.5 x 0.6 cm. The surface. is tan-white and smooth. The ovary is bisected; the cut surface shows tan-grey. parenchyma with no focal lesions. Fallopian tube and ovary labeled B1 and B2. Jar 1. The third container is labeled ""omentum. It contains a single segment. of. yellow lobular adipose tissue which measures 25 x 11 x 2.5 cm. The omentum. is. diffusely replaced by a tan-white mass. The fourth container is additionally labeled 'left pelvic lymph node.'. contains a single lymph node surrounded by yellow lobular adipose tissue. The. lymph node measures 2.2 cm in greatest dimension. It is bisected to show. tan-white tissue with no focal gross lesions. The lymph node is submitted. entirely."
BIOCUP_00261,ovary,OV,TCGA-30-1855,TCGA-30-1855.cba111de-b005-4460-b4d1-d8b24126d1d3,"Report Status: Final. Type: Surgical Pathology. OMENTUM BIOPSY. WELCH,. DIAGNOSIS: SPECIMEN LABELED ""OMENTAL BIOPSY' (including FSA) : POORLY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA, present. fibroadipose tissue. SPECIMEN LABELED ""TRANSVERSE COLON AND OMENTUM"": POORLY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA diffusely. involving omentum and focally invading bowel muscularis propria. and submucosa. SPECIMEN LABELED ""RIGHT ADNEXA"": POORLY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA extensively. involving adnexa. No residual ovary and tube identified. SPECIMEN LABELED ""TUMOR FROM SMALL BOWEL"": POORLY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA present in. fibroadipose tissue. SPECIMEN LABELED ""PELVIC PERITONEAL MASS"": POORLY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA present in. fibroadipose tissue. SPECIMEN LABELED ""PORTION OF SIGMOID AND LEFT ADNEXA"": POORLY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA involving. adnexa, mesocolon and bowel serosa. Lymphovascular invasion is present. SPECIMEN LABELED ""RECTAL MASS"": POORLY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA involving. mesocolon, perirectal adipose tissue and bowel serosa. SPECIMEN LABELED ""BLADDER AND OMENTUM"": POORLY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA present in. fibroadipose tissue. SPECIMEN LABELED ""CUL-DE-SAC MASS"": POORLY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA present in. fibroadipose tissue. SPECIMEN LABELED ""SPLEEN AND TUMOR"": POORLY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA involving. omentum and splenic capsule, with focal invasion of splenic. parenchyma. CLINICAL DATA: History: with ascites, pelvic mass, CA125 = 5000. Clinical Diagnosis: Pelvic mass. TISSUE SUBMITTED: 1. Omental biopsy. 2. Transverse colon and omentum. 3. Right adnexa. 4. Tumor from small bowel. 5. Pelvic peritoneal mass. 6. Portion of sigmoid and left adnexa. 7. Rectal mass. 8. Bladder and omentum. 9. Cul-de-sac mass. 10. Spleen and tumor. O.R. CONSULTATION: SPECIMEN LABELED ""OMENTUM"" (FSA) : Poorly differentiated adenocarcinoma consistent with ovarian or. Mullerian origin. GROSS DESCRIPTION: Page: 1 of 3. The specimen is received fresh, in 10 parts, each labeled with the patient's. name and unit number. Part 1, ""omental biopsy"", consists of a single fragment of tan/yellow soft. tissue (2.5 x 1.0 x 0.5 cm) with a firm, papillary/polypoid surface. A. representative section is submitted as ""FSA"". Micro 1. - FSA remnant, 1 f,. Micro 2. - additional representative sections of specimen, 1 f,. Part 2, ""transverse colon and omentum"", consists of an unoriented fragment of. colon (20 cm in length by 4 cm in diameter) with two stapled resection margins. (3.0 and 3.4 cm) Attached to the colon is peritoneal adipose tissue (20 x 13. x 4 cm overall). which is very firm secondary to diffuse infiltration by a. solid, tan tumor mass. The tumor grossly abutts on the outer wall of the. bowel, but the bowel mucosa is free of any lesions. The specimen is. photographed. Also received is a separate segment of omentum (14.5 x 10 x 3.0. cm) diffusely involved by the same tumor process. Micro 3-4 - bowel resection margins, 2. Micro 5. - tumor at nearest approach to bowel wall, 1 ¬£,. Micro 6. tumor involving peritoneal adipose tissue, 2. Micro 7. - separate segment of omentum involved by tumor, 1 f,. Part 3, ""right adnexa"", consists of four fragments of pink/yellow soft tissue,. diffusely involved by a solid, tan tumor mass with a papillary/polypoid. surface. The specimen measures 9.0 x 8.0 x 2.0 cm in aggregate. Sectioning. does not reveal a grossly identifiable ovary or fallopian tube, although these. structures may be replaced by the diffuse tumor process. The largest tissue. fragment contains a membranous structure, consistent with the remnant of a cyst. wall, both surfaces of which are involved by tumor. Micro 8-9 - membranous tissue involved by tumor, 2 f,. Micro 10. - additional representative sections of tissue diffusely involved. by tumor, 1 ¬£,. Part 4, ""tumor from small bowel"", consists of a single fragment of yellow/pink. fibroadipose tissue (4.0 X 3.4 x 1.5 cm) diffusely involved by a solid, tan. tumor mass with a papillary/polypoid surface. Micro 11 - representative sections of specimen, 1 f,. Part 5, ""pelvic peritoneal mass"", consists of a single fragment of yellow/pink. fibroadipose tissue (6.0 x 5.0 x 3.0 cm overall), diffusely involved by. multiple nodules of firm, tan tumor. Micro 12 - tissue involved by tumor, 1 f,. Part 6, ""portion of sigmoid and left adnexa"", measures 11.0 x 10.0 x 5.0 cm. overall and consists of a segment of colon (6.5 cm in length by 3.0 cm in. diameter). with a stapled resection margin (4.0 cm) and an open resection margin. (1.5 cm) The colonic mucosa is free of any grossly identifiable lesions. The attached soft tissue is encased/diffusely infiltrated by multiple. nodules of firm, tan tumor. Sectioning of the soft tissue component reveals a. multilobulated, partly solid, partly cystic structure. No ovary or tube can be. identified grossly, though these structures may be largely replaced by tumor. The tumor abutts on, but does not appear to grossly invade the bowel wall. The. specimen is photographed. Micro 13. bowel stapled resection margin, 1. Micro 14. - bowel open resection margin, 1 f,. Micro 15. - tumor at nearest approach to bowel wall, 1 f. Micro. 16-18 - representative sections of adnexa involved by tumor, 4. f. Part 7, ""rectal mass"", measures 13.0 x 9.5 x 4.5 cm overall and consists of a. segment of colon (10.0 cm in length by 3.5 cm in diameter) with a stapled. resection margin (3.5 cm) and an open resection margin (2.0 cm) The attached. pericolonic adipose tissue is firm, secondary to diffuse infiltration by a. Page: 2 of 3. multinodular, tan tumor mass. The tumor abutts on, but does not frankly invade. the bowel wall. The bowel mucosa contains a single 0.3 cm polyp located 2.7 cm. from the open resection margin, but is otherwise unremarkable. Micro 19. colonic stapled resection margin, 3. Micro 20. colonic open resection margin, 2 ¬£,. Micro 21. colonic polyp, 1 f, ESS. Micro 22. - tumor at nearest approach to bowel wall, 1 ¬£,. Micro 23. - representative soft tissue involved by tumor,. Part 8, ""bladder tumor"", consists of multiple fragments of tan/yellow. fibroadipose tissue (11 x 10.5 x 1 cm in aggregate) One surface of each. fragment has a tan/grey surface which is extensively involved by numerous firm,. tan tumor nodules (up to 2.5 cm in size), and an opposite surface comprised of. yellow adipose tissue. Micro 24-25 - tissue involved by tumor, 4 f,. Part 9, ""cul-de-sac mass"", consists of a 6.5 x 5.5 x 4.5 cm cystic mass, which. has an outer wall that is predominantly smooth with occasional firm, tan. nodules (up to 1.3 cm) and an inner wall diffusely involved by numerous firm,. tan, papillary projections. Micro 26 - representative sections of cyst wall, 3. f. Part 10, ""spleen and tumor"", consists of a spleen (12.5 x 7.0 x 2.0 cm) and. attached peritoneal adipose tissue (14 x 12 x 6 cm) The adipose tissue is. diffusely infiltrated by a multinodular, firm, tan tumor mass. The splenic. capsule is also studded by multiple tumor nodules (up to 2.0 cm in largest. dimension) The tumor focally invades the splenic parenchyma, both from the. free capsular surface and from the hilum. The specimen is photographed. Micro 27. - tumor invading splenic parenchyma from free capsule, 1 f,. Micro 28. tumor invading splenic parenchyma from hilum, 1 f. Micro 29. representative grossly uninvolved spleen, 1 f,. Micro 30. - tumor involving peritoneal adipose tissue, 1 f,. Reports to: SPECIMEN TYPE: OMENTUM BIOPSY. ADDITIONAL SPECIMEN TYPE: COLON, SEGMENTAL RESECT FOR TUMOR. ADDITIONAL SPECIMEN TYPE: OVARY WITH OR WITHOUT FALLOPIAN TUBE- NON-NEOPLAS. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE BIOPSY. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE MASS OR SIMPLE EXCISION. ADDITIONAL SPECIMEN TYPE: COLON, SEGMENTAL RESECT FOR TUMOR. ADDITIONAL SPECIMEN TYPE: COLON, SEGMENTAL RESECT FOR TUMOR. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE MASS OR SIMPLE EXCISION. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE MASS OR SIMPLE EXCISION. ADDITIONAL SPECIMEN TYPE: SPLEEN. Page: 3 of 3."
BIOCUP_00262,ovary,OV,TCGA-29-1764,TCGA-29-1764.3bae7a57-63d7-4770-a960-cd8f0749ca17,"CLINICAL HISTORY: Malignant neoplasm, ovary. with CA125=903. GROSS EXAMINATION: A. ""Right adnexa (AF1)"". received fresh for frozen section. In the container. is a 40 gram specimen consisting of a 6.5 x 1.5 cm fallopian tube, 4 X 3 x 1. 4. cm ovary and 4.7 x 3.7 x 1.0 detached aggregate of tan hemorrhagic papillary. fragments of tissue. The surface of the ovary and fallopian tube are covered. in hemorrhagic fibrous adhesions. In addition, sectioning of the ovary. demonstrates a 0.7 x 0.6 x 0.5 cm white firm mass immediately beneath the. surface epithelium with overlying surface excrescences. Representatives. of. ovary and detached tissue were frozen as AF1. BLOCK SUMMARY: A1-. frozen remnant. A2-3- ovary with t'umor. A4-. fallopian tube with fibrous adhesions. A5-. additional representative of detached tissue. B. ""Left tube and ovary"", received fresh and placed in formalin. A 16.29 gram. adnexa consists of a 3 x 2.5 x 1.0 cm ovary and 5.0 cm long, 1.0 cm in. diameter fimbriated fallopian tube. The surface of the ovary and fallopian. tube are covered in hemorrhagic fibrous adhesions. In addition, numerous tan. friable tumor nodule are identified on the surface of the ovary and between. the ovary and fallopian tube. Sectioning of the ovary demonstrates a 0.7. x. 0.5 x 0.5 cm firm white nodule immediately beneath the surface. BLOCK SUMMARY: B1- ovary with excrescences. B2- ovary with mass. B3- fallopian tube with exrescences. C. ""Omental tumor"", received fresh and placed in formalin. A 15 x 11 x 3 cm. aggregate of fibroadipose tissue is received encased entirely in a friable. tan-white papillary tumor. Representative in C1 and C2. D. ""Uterus"", received fresh and placed in formalin. A 70 gram, 6.5 x 5.5. x. 5.0 cm uterus with a 0.2 cm external os opening contains numerous tumor. implants and hemorrhagic fibrous adhesions on the serosa. Sectioning. demonstrates a 1.5 x 0.7 x 0.2 cm pedunculated tan endometrial polyp. anteriorly. The 2.0 cm long endocervical canal is grossly unremarkable. The. squamocolumnar junction is distinct. The ectocervix demonstrates patchy. petechial hemorrhages. Tumor extends from the serosa 1.2 cm into the 1.5 cm. thick posterior myometrium. In addition seven intramural and submucosal. leiomyomata from 0.3 to 2.5 cm in diameter are identified. BLOCK SUMMARY: D1- endometrial polyp. D2-3- posterior endomyometrium with tumor and leiomyoma. D4-. posterior cervix. D5- anterior endomyometrium. D6-. anterior cervix. / slides to. INTRA OPERATIVE CONSULTATION: A. ""Right adnexa"": AF1-carcinoma present. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: TOTAL ABDOMINAL HYSTERECTOMY AND BILATERAL SALPINGO-OOPHORECTOMY,. OMENTECTOMY. PATHOLOGIC STAGE:pT3cNXMX (peritoneal primary). NOTE: Information on pathology stage and the operative procedure is transmitted to. this. as required for accreditation purposes by. the. stage is based solely upon the current. tissue opecimen being evaluated, and does not incorporate information on any. specimens submitted separately to our Cytology section, past pathology. information, imaging studies, or clinical or operative findings. Pathology. stage is only a component to be considered in determining the clinical stage,. and should not be confused with nor substituted for it. The exact operative. procedure is available in the surgeon's operative report. DIAGNOSIS: A. ""RIGHT ADNEXA"" (SALPINGO-OOPHORECTOMY) : OVARY AND FALLOPIAN TUBE WITH SEROSAL IMPLANTS OF SEROUS PAPILLARY. ADENOCARCINOMA, SEE COMMENT. B. ""LEFT TUBE AND OVARY"" (SALPINGO-OOPHORECTOMY) : OVARY AND FALLOPIAN TUBE WITH SEROSAL IMPLANTS OF SEROUS PAPILLARY. ADENOCARCINOMA, SEE COMMENT. c. ""OMENTAL TUMOR"": SEROUS PAPILLARY ADENOCARCINOMA OF THE PERITONEUM, SEE COMMENT. HISTOLOGIC GRADE: MODERATELY DIFFERENTIATED (GRADE 2). TUMOR SIZE: 15 CM. D. ""UTERUS"" (HYSTERECTOMY) : UTERUS (70 GRAMS) : ENDOMETRIUM: INACTIVE, ENDOMETRIAL POLYP: MYOMETRIUM: LEIOMYOMATA (LARGEST 2.5 CM). CERVIX: FREE OF TUMOR. SEROSA: EXTENSIVE IMPLANTS OF ADENOCARCINOMA. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). COMMENT: The ovaries show primarily surface involvement by tumor, with less than 5 mm. of parenchymal involvement. This meets the. criteria for a diagnosis of primary peritoneal carcinoma."
BIOCUP_00263,ovary,OV,TCGA-09-1674,TCGA-09-1674.d8e0ddd2-304d-4f5e-9225-2cd88ae9984e,"FINAL PATHOLOGIC DIAGNOSIS. A. Right adnexa, salpingo-oophorectomy: -Ovary: Serous carcinoma; see comment. -Fallopian tube: Serosal involvement by serous carcinoma. B. Left adnexa, salpingo-oophorectomy: -Ovary: Serous carcinoma; see comment. -Fallopian tube: No significant pathologic abnormality. C. Omentum, omentectomy: Serous carcinoma. D. Omentum, omentectomy: Serous carcinoma. COMMENT: The tumor distribution favors a primary origin in bilateral ovaries. The volume of. tumor is greater in. the right compared to the left. Ovarian Tumor Synoptic Comment. - Location of tumor: Bilateral. - Type of tumor: Serous carcinoma. - Grade of tumor: 3. - Size of tumor: Right ovary: 2.5 cm; left ovary: microscopic. - Condition of capsule: Ruptured. - Cut surface: Solid. - Necrosis: Focal. - Lymphatic/vascular invasion: None. - Sites of metastases in pelvis: None. - Pelvic lymph nodes: None sampled. - Sites of metastases in abdomen: Omentum. - Size of largest abdominal metastasis: Diffuse/confluent sub-centimeter nodules. of tumor. involving the omentum. - Para-aortic lymph nodes: None sampled. - Peritoneal cytology: Not sampled. - Other findings: None. - FIGO stage: IIIC. - AJCC stage: pT3cNXMX. Specimen(s) Received. A:Right tube and ovary (FS). B:Left tube and ovary (fresh for oncotech). C:Omentum #1 (fresh). D:Omentum #2. Intraoperative Diagnosis. FS1 (A) Right ovary and tube, salpingo-oophorectomy: Adenocarcinoma. (Dr. Clinical History. The patient is a. woman with an adnexal mass and carcinomatosis. The specimen is received in four parts, each labeled with the patient's name and. medical record. number. Parts A is received fresh. Part A is additionally labeled ""right tube and ovary."" The specimen consists of. a. single segment of. tan-yellow soft tissue that weighs 10 grams and measures 4.2 x 2.5 X 1.8 cm. In the. soft tissue,. there is a firm, white, papillary lesion that involves the center of the specimen,. extends to the. surface and measures 2.5 cm. No normal ovary is identified grossly. Two segments. of fallopian tube. are identified grossly that have been disrupted and are discontinuous and adherent. to the. surrounding soft tissue. These segments measures 2.2 X 0.5 and 0.8 X 0.5 cm,. respectively. A. portion of the papillary lesion is submitted for frozen section diagnosis, with the. frozen section. remnant submitted in cassette A1. The remainder of the specimen is entirely. submitted in cassettes. A2-A8. Part B is additionally labeled ""left tube and ovary."" The specimen consists of a. previously opened. circular structure that has been disrupted prior to receipt in Pathology. It measures 9. X 8 X 3.9 cm. and weighs 84 grams. The cyst wall of the specimen measures from 0.1 cm in. thickness to 0.6 cm in. thickness. No papillary or large solid areas of growth are identified. No fallopian tube. is identified. grossly. A portion of the specimen is sent for Oncotech. Representative sections are. submitted in. cassettes B1-B8. Part C is additionally labeled ""omentum."" The specimen consists of a single segment. of unoriented,. tan-yellow, adipose tissue that measures 23 X 10 X 4 cm. The specimen is serially. sectioned and is. most remarkable for innumerable tan-white, firm nodules that litter the entire. segment of the. omentum and involve both the surface and center of the omentum. The nodules. measure from 0.1 to. 0.5 cm in dimension. Representative sections are submitted in cassettes C1-C5. Part D is received in formalin labeled ""omentum #2,"" and consists of two sheets of. soft-to-firm,. irregular, bloody, yellow, fatty tissue measuring 17 X 12 X 2.5 cm in aggregate. After. initial palpation. and initial examination, multiple firm nodules are found scattered about the. specimen. The specimen. is serially sectioned at 1-cm intervals. Cut sections reveal scattered areas of firm,. white-tan tissue. The scattered firm areas range between 1 to 3 cm in maximum dimension. Representative sections. are submitted in cassettes D1-D4. Diagnosis based on gross and microscopic examinations. Final diagnosis made by. attending. pathologist following review of all pathology slides."
BIOCUP_00264,ovary,OV,TCGA-24-2262,TCGA-24-2262.d58b58ac-365c-43d0-a893-0becfb6e9fff,"Hosp. No. : MR No. : surgeons: DIAGNOSIS. OVARY, - AND BILATERAL. LEFT FALLOPIAN TUBE AND OVARY, POORLY TOTAL DIFFERENTIATED HYSTERECTOMY. UTERUS. CERVIX, BILATERAL ADENOCARCINOHA - (SEE COMMENT). AND. PERITONEUM, ANTERIDR, BIOPSY - - SUTURE NO EVIDENCE GRANULOMA OF MALIGNANCY. PERITONEUM, SIDEWALL. BIOPSY - POORLY ADENOCARCINOM√Ä DIFFERENTINTE COMMENT) METASTATIC. (SEE. PELVIS, LYMPH NODE, RIGHT - ONE OF ONE LYMPH ADENOCARCINOM NODE PRESENT SHOW. - SOFT TISSUE INVOLVEMENT WITH. HETASTATIC. ADENOCARCINOMA. PELVIS, LYMPH NODE(, RIGHT - METASTATIC TISSUES ADENOCARCINOMA IN SOFT. - NO LYMPH NODES IDENTIFIED. LIVER, BIOPSY - METASTATIC ADENOCARCINOMA. OMENTUM - NO HISTOPATHOLOGIC ABNORMALITY. PELVIS, LYMPH NODE, LEFT - METASTATIC TISSUE SOFT. ADENOCARCINOMA IN. √©. - NO LYMPH NODE IDENTIFIED. SPECIMEN (s) SUBMITTED. Part OVARY. 1: ANTERIOR PERITONEAL BIOPSY. Part 2: 3: SIDEWALL PERITONEAL BIOPSY. Part 4: 5 : RIGHT PELVIC LYMPH NODE SEPARATE. Part RIGHT PELVIC LYMPH NODE. Part Part 6: TRU-CUT LIVER BIOPSY. - -1--. SPECIMEN (s) SUBMITTED. Part 7: OMENTUM. Part 8 : LEFT PELVIC LYMPH NODE. Part 9: FS1 OVARY RIGHT OOPHARECTOMY. Part 10: X1 OVARY. HISTORY. The patient is. G5, P1, SAB4, white. with. diagnosis: complex Same as above. Operative procedure: EUA, exploratory. pelvic mass, adenocarcinoma and ascites. cinfical. laparotomy, TAM/BSO, omentectomy, various biopsies,. FROZEN. F 5 : ovary, right, oophorectomy. - ""Poorly difnerentiated carcinoma consistent with ovarian. primary"" by. GROSS. The specimens are received in nine containers, each labelled with. the patient' # name. The first specimen is received fresh, labeled. with the patient's name and ""frozen section. 11 The specimen. consists of two rectangular fragments of tissue measuring, the. larger 1.3 x 0.6 cm. Multiple small white nodules are present in. the fragments of tissuo. The specimen is entirely submitted in. one cassette. The second container is labeled "" anterior peritomeal biopsy. The. specimen consists of a white, fibrous fragment of tissue with two. small purple nodules. The fragment of tissue measures 0.5 x 0.2. cm, The spacimen is entirely submitted in one cassette. Labeled. The third specimen is received in formalin and labeled ""right. ovary. The specimen consists of an ovary measuring 10 x 4 x 3. cm. The lesion appears cystic and after opening, uniloculated. cyst containing clear fluid 1 8 present. The wall is rubbery and. range in thicknems from 0.1 to 0.3 cm. Multiple papillary areas. that in some areas are very prominent are identified. One of the. areas in the lesion is markedly solid measuring 0.9 x 0.3 cm with. areas of congestion and multiple small white nodules diffusely. present around all of these solid areas, Some of the nodules. present in the interior of the cyst extend to the external aspect. of the ovary. Representative sections are submitted in eight. --2--. Name : 1. GROSS (continued). casettes from 3A to 2H. The third specimen is received in formalin and labeled. ""uterus and cervix, and left ovary. The specimen consists of a. uterus neasuring 10 x 7 x 2 CE and weighing 210 grams. The lett. fallopian tube and left ovary is attached to the attached to the. specimen. The right adnexa were amputated previously. Intraoperatively. Externally, the uterus is globoid in shape and. multiple pink-yellow, firm nodules are present in the serosa of. the uterus, covering the anterior and posterior aspect of the. uterus. Also, externally, a firm yellow-white mass with grossly. areas of necrosis is present surrounding the area of the right. parametrium. The cervix measures 3 x 2 cm and the ectocervix is. grossly unremarkable. Aftor opening, the endometrial cavity. measures 7 cm in Length and is covered by a alightly irregular. pink-yellow endometrium. After sectioning, the myometrial wall. measures up to 6 da and multiple yellow-white, poorly. circumsribed nodules are present, ranging in size from 0. to 0.8. cm. The endometrial cavity is symmetrical in shape. The Left. fallopian tube neasures 6.5 em externally torturous with two small. pink-yellow nodules present in the serosa. After sectioning, the. lumen appears pinpoint and unremarkable. The left ovary measures. 3. x 2 x 1.2 CM and externally is unremarkable. After sectioning,. a gray-white irregular stroma in identified. The right. fallopian tube is not present in this specimen. Representative. sections are subsitted in eleven cassettes. Labeled A. cervix,. anterior; 8, cervix posterior; C and D, anterior endometrium;. E. and r, posterior endometrium i G and H, right parametrium; I,. ovary; 3, fallopian tube; K, serous aspect of the endometrium,. All of these cassettes are labeled part 3,. The fourth specimen i s received in formalin, labeled ""Bide wall,. peritoneal biopsy. - The specimen consists of a fragment of soft. tissue measuring 3 x 1 x 0.2 cm. The tissue appears fibrotic and. markedly congested with small white-gray nodules. The specimen is. entirely submitted in two cassettes. The fifth specimen is received in formalin, labeled ""right pelvic. lymph node. The specimen consists of a fragment of adipose. tissue measuring 6 x 2 CM and weighing 11 grams. Some areas of. the specimen appear congested and after resection, firm elongated. lymph node measuring 0.2 x 0. cm is identified. Representative. sections are submitted in two cassettes. the sixth specimen is received in formalin and labeled ""right. pelvis, lymph nodes. The specimen consists of four fragments of. tissue, throe of them are gray and rubbery, and range in size from. The specimen is entirely submitted in two cassettes. 0.3 to 0.5 cm. (continued) Also, a clot measuring 0.5 x 0.2 cm is present. specimen is received in formalin and thin labeled fragment ""Tru-cut of. The seventh biopsy. The specimen consists of a very appears brown. liver tissue in color moasuring and the rest 1.5 x is 0. white. cm. Half The of specimen the specimen 13 entirely. submitted in one cassette. The specimen is received in formalin and measuring labeled ""omentum. 16 x 6 cm. The eighth specimen consists of a segment specimen of omentum consists of soft adipose. and weighs and 48 grams. The No nodules are. identified. tissue Representativo sections are submitted. that grossly appears unremarkable in tho. cassettes. The pelvic ninth lymph node. The n.1 specimen cm. The consists specimen of is a entirely submitted lymph. specimen is received in formalin and labeled brown-gray ""left. node measuring 0.2 V. in one cassette. widespread including poorly solid, glandular; and <serous feel 15. differentiated adenocarcinoma with a papillary mixture of. patterns Because of the size and histological There features, is extension we. present. that and metastasis the tumor originated to the uterine parametrium in the serosa, right left myometrium/ ovary. ovary, cervix, endometrium, multiple. both fallopian tubes, pelvic lymph node. Metastatic adenocarcinoma is 4. biopsies is also present and right 1a the liver biopsy. The grade of the tumor. (End of Report}."
BIOCUP_00265,ovary,OV,TCGA-29-2432,TCGA-29-2432.9de0ca7f-0603-46a9-9c69-7e2196cbfb6f,"CLINICAL HISTORY: Ascites, increased CA 125, pelvic mass (9 cm, complex) . GROSS EXAMINATION: A. ""Omentum (AF1)"" received fresh for frozen section consultation is a 7.5 x. 6.5 x 1.5 cm aggregate of tan, firm, rubbery tumor and associated fibroadipose. tissue. A representative section of mass is frozen as AF1. The frozen. section remnant is submitted in block A1. Additional representative sections. are submitted in blocks A2-3. B. ""Right tube and ovary"", received fresh and placed in formalin is a 23 gram. adnexal specimen remarkable for a 4.5 x 4.3 x 2.9 cm ovary blanketed with. pink-tan, friable tumor involves the ovarian cortex. The remaining ovary. demonstrates multiple corpora albicantia (0.4 cm in greatest dimension),. a hemorrhagic corpus luteum 0.8 cm in greatest dimension), as well as a serous. fluid-filled cyst (0.5 cm in greatest dimension) The fallopian tube (5.5 cm. long x 0.5 cm diameter) has serosal surface deposits of the aforementioned. ovarian tumor and an unremarkable pinpoint lumen. BLOCK SUMMARY: B1-2- representative ovary with tumor. B3- fallopian tube. C. ""Omentum #2"", received fresh and placed in formalin is a 6.5 x 6 x 2 cm. aggregate of pink-tan tissue that consists of firm, rubbery, tan tumor and. associated fibroadipose tissue. Representative sections of the tumor are. submitted in blocks C1-2. D. ""Left tube and ovary"", received fresh and placed in formalin is a 29 gram. adnexal specimen remarkable for a 4.5 x 3.2 x 2.5 cm ovary blanketed with. friable, pink-tan tumor that grossly involves underlying ovarian cortex. The. uninvolved ovary has a 1.2 x 1 x 0.8 cm firm, yellow, fibrous mass at the. lateral pole. The attached fallopian tube (5.6 cm long x 0.5 cm diameter) has. a serosal surface involved by the aforementioned friable tumor an an. unremarkable pinpoint lumen. BLOCK SUMMARY: D1- tumor with invasion into ovary. D2- firm, yellow, ovarian nodule and fallopian tube. D3- additional ovary and fallopian tube. INTRA OPERATIVE CONSULTATION: A. ""Omentum"": AF1- poorly differentiated adenocarcinoma, compatible with. an ovarian primary. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: Bilateral salpingo-oophorectomy and omentectomy. PATHOLOGIC STAGE (AJCC 6th Edition) : pT3c pNX pMX. NOTE: Information on pathology stage and the operative procedure is. Page 2 oil. transmitted to this. required for. accreditation by th. Istage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for. it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. ""OMENTUM"" (OMENTECTOMY) : METASTATIC SEROUS ADENOCARCINOMA, 7.5 CM. B. ""OVARY AND FALLOPIAN TUBE, RIGHT"" (SALPINGO-OOPHORECTOMY). ""RIGHT OVARY"": TYPE: SEROUS ADENOCARCINOMA. FIGO GRADE: 3. TUMOR SIZE: 4.5 X 4.3 X 2.9 CM. WEIGHT: 23 GRAMS. SEROSA: INVOLVED. FALLOPIAN TUBE: METASTATIC SEROUS ADENOCARCINOMA. C. ""OMENTUM, #2"" (OMENTECTOMY) : METASTATIC SEROUS ADENOCARCINOMA, 6.5 CM. D. ""OVARY AND FALLOPIAN TUBE, LEFT"" (SALPINGO-OOPHORECTOMY) : ""LEFT OVARY"": TYPE: SEROUS ADENOCARCINOMA. FIGO GRADE: 3. TUMOR SIZE: 4.5 X 3.2 x 2.5 CM. WEIGHT: 29 GRAMS. SEROSA: INVOLVED. ADDITIONAL FINDINGS: BENIGN FIBROMA, 1.2 CM. FALLOPIAN TUBE: METASTATIC SEROUS ADENOCARCINOMA. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es)."
BIOCUP_00266,ovary,OV,TCGA-36-1568,TCGA-36-1568.dad4bbdc-0156-48c2-a975-27ccfb9152a3,"Final Diagnosis: A,B. Bilateral ovaries and tubes: 1) Invasive high-grade carcinoma ovarian consistent with serous. carcinoma with small foci of clear cell change. 2) Silverberg grade 3/3 (Nuclear score 3; mitotic score 2;. architecture score 3). 3) Extraovarian pelvic spread present-6 cm deposit attached to the. left fallopian tube. 4) No definite lymphatic invasion identified. C. Uterus and cervix: 1) Inactive endometrium. 2) Lejomyoma. 3) Benign endometrial and endocervical polyp. 4) Benign cervical tissue. D. pelvic wash shows reactive mesothelial cells,. inflammatory cells; no malignant cells seen. E. TMN stage: pT2a, Nx, Mx. F. Specimens Received: A: left ovary + tube. B: right tube + ovary. C: uterus + cervix. Gross Description: Specimen is received in three containers each labelled with the patient's name. Container ""A"" is labelled ""left ovary and tube"" and consists of two lesions connected together by fallopian tube-like structure. It weighs 92 g. The maximum. tumour ovtanction of and of the locions le 6 cm and the other is 1.cm. The fallopian tube measures 5.5x. 7 cm. Intraoperative diagnosis done by. On cut section, the first lesion (6 cm) is composed mainly of a solid yellowish nodular. lesion. me secono one is composed or cysts and a 2 em yellowish nodular solid area. The cyst is filled with serous clear fluid. Representative sections are submitted as follows: ""A1"" -frozen section. ""A2"" -representative from the first lesion with the fallopian. tube attachment. ""A3-A4"" -representative from the rest of the first lesion. ""A5"" -representative from the fallopian tube with the second. fesion. ""A6-A8"" -representative from the second lesion. ""A9"" -representative from the fallopian tube,. Container ""B"" is labelled ""right tube and ovary"" and consists of a 4.5 x .7 cm fallopian tube-like structure attached to a yellowish nodular lesion. This tesion. measures 7 x 4 x 2.5 cm. On cut section, it shows multifoculated cysts, some filled by clear serous fluid and others by mucoid material, and a 3.5 cm solid. whitish nodular lesion. Representative sections are submitted as follows: ""B1"" -from the fallopian tube. ""B2-B8"" -representative from the ovarian mass. A part of the tumour of specimen B is submitted for tumour bank. Container ""C"" is labelled ""uterus and cervix"". The uterus weighs 91 g and measures 5.5 cm from the superior to inferior, 6 cm from anterior to posterior,. and. 5. cm from side to side. The anterior serosal surface shows a 3.5 cm subserosal nodule, otherwise unremarkable. The cervix measures. 4 x 4 cm which is unremarkable. The anterior myometrial wall shows a whitish whorled lesion, which measures 3x 2.5x2 cm. The. anterior. endometrium. appears unremarkable. The posterior myometrial wall shows a. .8 cm whitish whorled lesion, otherwise unremarkable. Two posterior lower uterine segment polyps are identified which measure .7 and 1.5 cm respectively. The rest of the posterior endometrium appears unremarkable. Representative sections are submitted as follows: ""C1-C2"" -from the anterior and posterior cervix respectively. ""C3-C4"" -representative from the anterior uterine wall. ""C5-C6"" -representative from the anterior myometrium lesion. ""C7-C8"" -representative from the posterior uterine wall. ""C9-C10"" -representative from the posterior endometrial polyps. ""C11"" -representative from the posterior myometrium lesion. ""C12"" -representative from the cul-de-sac. Intraoperative Consultation: FSA/1. Gross Description: 1. Max. 6 cm. 2. 4 cm."
BIOCUP_00267,ovary,OV,TCGA-61-2614,TCGA-61-2614.d0ffe1e5-5b41-4dfb-b82d-da937b5b345b,"PART 1: OMENTUM, OMENTECTOMY -. HIGH GRADE POORLY DIFFERENTIATED CARCINOMA. PART 2: ADDITIONAL OMENTUM, EXCISION -. A. FOCAL HIGH GRADE POORLY DIFFERENTIATED CARCINOMA. B. THREE LYMPH NODES, NEGATIVE FOR TUMOR (0 OUT OF 3). PART 3. AND 4: LEFT AND RIGHT PELVIC SIDEWALL, BIOPSY -. HIGH GRADE POORLY DIFFERENTIATED CARCINOMA. PART 5: UTERUS, CERVIX, BILATERAL ADNEXA, RECTOSIGMOID COLON AND APPENDIX, TOTAL ABDOMINAL. HYSTERECTOMY, BILATERAL SALPINGOOOPHORECTOMY, RECTOSIGMOIDECTOMY AND APPENDECTOMY -. A. HIGH GRADE POORLY DIFFERENTIATED CARCINOMA INVOLVING RIGHT AND LEFT OVARY, EXTENDING. TO RIGHT PARATUBAL TISSUE, INFILTRATING APPENDICEAL WALL AND MESOAPPENDIX AND INVADING. FULL THICKNESS OF RECTOSIGMOID COLON. B. SEROSA OF PROXIMAL RECTOSIGMOID MARGIN POSITIVE FOR TUMOR. C. MYOMETRIUM AND UTERINE SEROSA WITH METASTATIC HIGH GRADE POORLY DIFFERENTIATED. CARCINOMA WITH LYMPHOVASCULAR INVASION. D. BENIGN ENDOCERVIX. E. ATROPHIC ENDOMETRIUM. PART 6: RECTOSIGMOID MESENTERY, EXCISION -. HIGH GRADE POORLY DIFFERENTIATED CARCINOMA. PART 7: BLADDER PERITONEUM, EXCISION -. HIGH GRADE POORLY DIFFERENTIATED CARCINOMA. PART 8: LEFT IP LIGAMENT, EXCISION -. HIGH GRADE POORLY DIFFERENTIATED CARCINOMA. PART 9: RIGHT PERIAORTIC LYMPH NODES, DISSECTION -. THREE LYMPH NODES POSITIVE FOR TUMOR (0/3). PART 10: ANASTOMOTIC RING, EXCISION -. BOWEL WALL WITH MILD CHRONIC INFLAMMATION AND EDEMA. CASE SYNUPSIS: SYNOPTIC - PRIMARY OVARIAN TUMORS INCLUDING BORDERLINE TUMORS. TUMOR LOCATION: Bilateral. PROCEDURE: TUMOR SIZE: Other: appendectomy, rectosigmoidectomy, omentectomy. Maximum dimension: 5.0 cm. TUMOR TYPE: Papillary serous carcinoma. HISTOLOGIC SILVERBERG GRADE: Poorly differentiated (8-9 pts). ARCHITECTURAL PATTERN: Solid (3). CYTOLOGIC ATYPIA: Marked (3). MITOTIC COUNTS / 10hpf: > or = 25 (3). VASCULAR INVASION: TUMOR CAPSULE: Ruptured. SURFACE IMPLANTS: Invasive. SURFACE IMPLANT SITE: SURFACE IMPLANT SIZE: Uterus, Fallopian Tubes, Omentum, Peritoneal metastasis bevond the pelvis. > 2 cm. MALIGNANT CELLS IN ASCITES OR. PERITONEAL WASHING: LYMPH NODES EXAMINED: LYMPH NODES POSITIVE: Total number of lymph nodes examined: 6. Number of positive lymph nodes, Right: 3. T STAGE, PATHOLOGIC: Number of positive lymph nodes, Left: 0. N STAGE, PATHOLOGIC: pT3. pN1. M STAGE, PATHOLOGIC: FIGO STAGE: pMX. IIIC."
BIOCUP_00268,ovary,OV,TCGA-24-1470,TCGA-24-1470.f47eefcf-f15d-42cb-8bd2-d0c252ecafb3,"MRN : Accessioned: DIAGNOSIS: OVARIES, RIGHT AND LEFT, BILATERAL SALPINGO-OOPHORECTOMY. - ADENOCARCINOMA, MIXED EPITHELIAL TYPE, SEROUS (60%) AND TRANSITIONAL (40%). PARAOVARIAN ADHESIONS WITH ASSOCIATED CARCINOMA. FALLOPIAN TUBE, SIDE NOT SPECIFIED, SALPINGECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. OMENTUM, OMENTECTOMY. - METASTATIC ADENOCARCINOMA. RIGHT GUTTER, EXCISION. - METASTATIC ADENOCARCINOMA. RIGHT PELVIS, EXCISION. - METASTATIC ADENOCARCINOMA. Rep. Intraoperative Consultation: An intraoperative non-microscopic consultation was obtained and interpreted as: ""Called to pick up 'left adnexa and. right adnexa' consisting of bilateral unmarked ovaries. One ovary weighs 142 gm and measures 11 x 8 x 4.5 cm. The. surface is disrupted and carpeted with tan papillary excrescences. Opened to show a solid, tan-brown, friable mass. with no identifiable fallopian tube. The second ovary weighs 134 gm and measures 8 x 6.3 X 4 cm with a mostly. smooth surface with focal papillary surface lesions. Opened to show a mostly solid, tan-yellow tumor with no residual. ovarian parenchyma. Fimbriated end of the fallopian tube is identified and measures 2.5 x 0,3 cm. Portion of the first. opened ovary frozen as 'FS1.'. Ovary, right and left, excision. - ""Poorly differentiated adenocarcinoma, favor Mullerian origin,"" by. Page: 1 of 3. Microscopic Description and Comment: Microscopic examination substantiates the above cited diagnosis. History: The patient is a. with a history of breast cancer and a pelvic mass. The patient also has a CA-125. of 947. Operative procedure: Bilateral satpingo-oophorectomy and omentectomy. Specimen(s) Received: A: LEFT ADNEXAL, RIGHT ADNEXAL. B: OMENTUM. C: RIGHT GUTTER. D: RIGHT PELVIC. Gross Description;. The specimens are received in four formalin-filled containers each labeled. The first container is. labeled ""left adnexal and right adnexal. It contains a white cassette labeled 'FS1"" that holds two pieces of tan-white. tissue measuring 1.6 X 1.8 x 0.2 cm and 1.7 x 1.1 x 0.3 cm. Additionally in the container are two previously sectioned. ovaries, the larger ovary measures approximately 9.5 x 8.0 x 3.5 cm. It has been previously sectioned to show a. tan-brown friable mass as described in the intraoperative consult. There is no identifiable fallopian tube attached. The. smaller ovary measures approximately 7.8 x 4.7 x 4.8 cm and has been previously sectioned to show a friable tan. mass conceivably replacing the ovary as described in the intraoperative consultation. A small portion of attached. fallopian tube is identified measuring 2.5 x 0.8 x 0.4 cm. Labeled A2 to A6 - larger ovary; A7 to A11 - smaller ovary;. A12 - fallopian tube. The second container is labeled ""omentum."" It contains a 26.5 x 18.x 1.0 cm piece of yellow-tan omentum. Sections. show no focal lesions. The third container is labeled ""right gutter."" It contains multiple fragments of tan tissue measuring 3.1 x 2.2 x 0.6 cm in. aggregate. The fourth container is labeled ""right pelvis."" It contains a 2.2 x 1.8 x 0.8 cm piece of yellow-brown tissue. Sections. show firm tan and white tissue. SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS. HISTOPATHOLOGIC TYPE. The histologic diagnosis is mixed serous (60%) and transitional (40%). TUMOR LOCATION. The locations of the primary tumor(s) are the right and left ovary (synchronous primary tumors). HISTOLOGIC GRADE. The histologic grade is poorly differentiated. TUMOR INVASION. Tumor is identified on the ovarian surface(s). Tumor does not invade the adjacent fallopian tube/peritubal soft tissue. Page: 2 of 3. TUMOR INVOLVEMENT. Tumor involvement of the pelvic peritoneum/soft tissue is present. Metastatic involvement of the omentum is present. TUMOR SIZE. The maximum dimension of tumor implants outside the true pelvis is microscopic. PRIMARY TUMOR (T). Based on the above information, the primary tumor is classified as microscopic peritoneal metastasis beyond pelvis. (T3a/IlIA). REGIONAL LYMPH NODES (N). The regional lymph nodes cannot be assessed. DISTANT METASTASIS (M). The status of distant tumor site cannot be assessed. STAGE GROUPING. The Final AJCC/UICC/FIGO stage is T3a/NO/MO (Stage IIIA). The pathologic stage assigned here should be regarded as provisional, and may change after integration of clinical. data not provided with this specimen. Page: 3 of 3."
BIOCUP_00269,ovary,OV,TCGA-61-2018,TCGA-61-2018.2aec8abd-7bdc-4ca3-a404-7dce57aea7c7,"FINAL DIAGNOSIS: PART 1: DIAPHRAGM, BIOPSY -. FIBROMUSCULAR AND ADIPOSE TISSUE WITH MESOTHELIAL LINING, NEGATIVE FOR TUMOR. PART 2: RIGHT ADNEXA, RIGHT SALPINGO-OOPHORECTOMY -. A. POORLY DIFFERENTIATED ADENOCARCINOMA WITH ENDOMETRIOID, SEROUS AND TRANSITIONAL. FEATURES, 11.5 CM. B. RIGHT FALLOPIAN TUBE WITH PARATUBAL CYSTS, NEGATIVE FOR TUMOR. PART 3: LEFT ADNEXA, LEFT ALPINGO-OOPHORECTOMY -. A. MODERATELY DIFFERENTIATED ADENOCARCINOMA WITH SEROUS AND ENDOMETRIOID FEATURES, 5.8. CM. C. LEFT FALLOPIAN TUBE, NEGATIVE FOR TUMOR. PART 4: UTERUS, TOTAL ABDOMINAL HYSTERECTOMY (106 GRAMS) -. A. FOCAL CERVICAL INTRAEPITHELIAL NEOPLASIA 1 (CIN 1). B. ECTOCERVICAL MARGINS NEGATIVE. C. INACTIVE ENDOMETRIUM. D. LEIOMYOMAS, UP TO 0.8 CM. E. FOCAL ADENOMYOSIS. PART 5: ADDITIONAL VAGINAL MARGIN, EXCISION -. SQUAMOUS MUCOSA WITH ACUTE AND CHRONIC INFLAMMATION AND REACTIVE ATYPIA, NEGATIVE FOR. TUMOR. PART 6: BLADDER FLAP #1, BIOPSY -. FIBROADIPOSE TISSUE AND DETACHED FRAGMENT OF BENIGN SQUAMOUS EPITHELIUM, NEGATIVE FOR. TUMOR. PART 7: BLADDER FLAP #2, BIOPSY -. FIBROADIPOSE TISSUE LINED BY MESOTHELIUM, NEGATIVE FOR TUMOR. PART 8: CUL-DE-SAC #1, BIOPSY -. FIBROADIPOSE TISSUE WITH ACUTE INFLAMMATION, NEGATIVE FOR TUMOR. PART 9: CUL-DE-SAC #2, BIOPSY. FIBROADIPOSE TISSUE WITH REACTIVE MESOTHELIAL LINING, NEGATIVE FOR TUMOR. PART 10: CUL-DE-SAC #3, BIOPSY -. FIBROMUSCULAR AND ADIPOSE TISSUE WITH ACUTE INFLAMMATION, NEGATIVE FOR TUMOR. PART 11: LEFT PELVIC SIDEWALL, BIOPSY -. FIBROMUSCULAR AND ADIPOSE TISSUE, NEGATIVE FOR TUMOR. PART 12: RIGHT PELVIC SIDEWALL, BIOPSY -. FIBROMUSCULAR TISSUE WITH ACUTE INFLAMMATION, NEGATIVE FOR TUMOR. PART 13: LEFT PELVIC LYMPH NODES, EXCISION -. THREE BENIGN LYMPH NODES, NEGATIVE FOR TUMOR (0/3). PART 14: RIGHT PELVIC LYMPH NODES, EXCISION -. FIVE BENIGN LYMPH NODES, NEGATIVE FOR TUMOR (0/5). PART 15: LEFT COMMON AND PERIAORTIC LYMPH NODES, EXCISION -. TWO BENIGN LYMPH NODES, NEGATIVE FOR TUMOR (0/2). PART 16: RIGHT COMMON AND PERIAORTIC LYMPH NODES, EXCISION -. FOUR BENIGN LYMPH NODES, NEGATIVE FOR TUMOR (0/4). PART 17: APPENDIX, APPENDECTOMY -. VERMIFORM APPENDIX, NEGATIVE FOR TUMOR. PART 18: LEFT PERICOLIC GUTTER, BIOPSY -. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. PART 19: RIGHT PERICOLIC GUTTER, BIOPSY -. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. PART 20: OMENTUM, OMENTECTOMY -. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR."
BIOCUP_00270,ovary,OV,TCGA-23-1031,TCGA-23-1031.6D440E0F-B290-48CB-8445-C268B444ADE1,"DIAGNOSIS: 1: OMENTUM, PARTIAL OMENTECTONY: -Metastatic serous carcinoma (see comment). 2: FALLOPIAN TUBE AND OVARY, LEFT, SALPINGO-OOPHORECTOMY: -Serous adenocarcinoma, grade 3. -Tumor subtotally replaces ovary. -There is also extensive serosal surface ovarian involvement. by carcinoma. -Carcinoma also involves paraovarian and paratubal soft. tissues. -Serosal surface of fallopian tube is involved by carcinoma. -Free-floating aggregates of carcincma cells are present. within the lumen of the fallopian tube. -other findings include: -Paratubal cystic Walthard rest. -Tiny benign paraovarian adenofibroma. -Atrophic changes and cystic epithelial inclusions of ovary. 3: FALLOPIAN TUBE AND OVARY, RIGHT, SALPINGO-OOPHORECTOMY: -Serous adenocarcinoma, grade 3 (see comment). -Ovary is nearly totally replaced by invasive carcinoma. -There is also extensive serosal surface involvement of the. ovary by tumor. -Tumor is present in paraovarian and paratubal adnexal soft. tissues. -Nodular aggregates of carcinoma are adherent to the. fimbriated end of fallopian tube. -Tiny free-floating aggregates of carcinoma are present within. lumen of fallopian tube. -Mild acute and chronic inflammation of serosa/subserosa of. fallopian tube. -Lymphovascular ectasia and stromal edema of fallopian tube. 4: LARGE INTESTINE, RECTOSIGMOID TUMOR, EXCISION: -Metastatic serous carcinoma (see comment). 5: LARGE INTESTINE, CECAL TUMOR, EXCISION: -Metastatic serous carcinoma (see comment). 6: UTERUS, TOTAL ABDOMINAL HYSTERECTOMY: -Metastatic serous carcinoma involving: -Serosal surface, subserosa, and external muscular wall. (myometrium) of uterus. -Parametrial soft tissues. -Cervix and vaginal cuff are free of tumor. -Inactive (atrophic to focally weakly proliferative) endometrium,. some cystically dilated glands, foci of ciliated epithelial. metaplasia, and reactive stromal lymphoid aggregates. -Microscopic (less than 1.5 nun in diameter) epithelioid. leiomyoma, plexiform type (plexiform tumorlet). apparently arising from smooth muscle in the wall of an. intrauterine vein (slides 0 and 0 da-1). -Microscopic cellular leiomyoma (about 1 mm in diameter) and. small cellular uterine leiomyoma (about 5 mn in diameter). -Two small uterine leiomyomas, larger is partially hyalinized. -Adencmyosis. -Uterine serosal adhesions. -Chronic and mild acute cervicitis with reserve cell hyperplasia,. squamous metaplasia, reactive epithelial changes, and. endocervical nabothian cysts. -Small benign endocervical polyp. -Vaginal cuff mucosa with chronic and mild acute inflammation. 7: MESENTERY OF SMALL INTESTINE, BIOPSY: -Netastatic serous carcinoma involving fragments of lymph nodes. and mesenteric fat/fibroadipose tissue (see comment). 8: [SOFT TISSUE], RIGHT ADNEXAL, EXCISION: -Serous adenocarcinoma (see comment). 9: LIVER, BIOPSY: -Netastatic serous carcinoma involving capsular surface and. invading liver parenchyma (see comment). -Liver also shows macrovesicular steatosis, mild pleomorphism. of hepatocytes, chronic inflammation in portal triads and. adjacent to tumor and focal portal fibrosis. 10: SOFT TISSUE, CUL DE SAC, TUMOR, EXCISION: -Ketastatic serous carcinoma (see comment). COMMENT: The right ovary is massively involved and is nearly totally. replaced by adenocarcinoma. Tumor in the right ovary appears to be. primary at that site. The left ovarian neoplasm probably represents. a second (synchronous) primary neoplasm. Carcinoma in all of. the involved sites exhibits predominantly serous features, albeit. with focal ""undifferentiated'/anaplastic components and pseudo-. transitional appearance in some areas. In a few of the involved. sites, the tumor exhibits hobnail and/or clear cell features. The. carcinoma exhibits papillary, glandular and solid patterns of. growth. Tumor-associated psammoma bodies are prominent in most of. the involved sites. Tumor necrosis, secondary acute and chronic. inflammatory changes, fibrosing stromal reaction to tumor, and. adhesions are noted in many of the involved sites. Lymphovascular. invasion by carcinoma is present virtually in most of the involved. sites. Preliminary pathologic tindings were reported to the office. of. HISTORY: Ovarian papillary carcinoma. MICROSCOPIC: See Diagnosis. GROSS: 1: OMENTUM WITH FROZEN SECTION NO. 1. Labeled omentum with frozen section #1¬∞ and received fresh in the. Operating Room for intraoperative frozen section is a 20 x 11.5 x 1.5. cm indurated portion of tan-yellow cmental fat that is subtotally. replaced by nodular and plaque-like aggregates of firm white. metastatic tumor. A representative fresh sterile portion of the. Page 3 ot 5. tumor is placed in. and submitted to. for clonogenic assays. Another representative portion of tumor is. frozen and sectioned for intraoperative diagnosis. Interpretation of. the frozen section was rendered by Dr. The remaining. frozen tissue and the rest of the specimen are subsequently fixed in. formalin. Representative sections. A. Remnant of frozen section #1 - 1. B. Unfrozen omental tumor - 1. 2: LEFT TUBE AND OVARY. Labeled left tube and ovary' and received in formalin is a salpingo-. oophorectomy specimen. The ovary is 3.6 x 1.8 x 1.6 cm. The serosal. surface of the ovary shows extensive involvement by papillated and. nodular tan tumor. Cut sections of the ovary reveal nearly total. replacement by firm, white-yellow invasive tumor. Nodular and. plaque-like aggregates of tumor are also present in the paraovarian. and paratubal soft tissues. The fallopian tube has fimbria at one. end, is about 2.8 can long and up to 0.6 cm in diameter. There is a. plaque-like aggregate of firm, yellow-tan tumor focally involving the. serosal surface of the fallopian tube. The latter measures about 0.5. cm in diameter. Cross sections of the fallopian tube reveal a. pinpoint patent lumen, about 0.1 cm in diameter, and no invasive. tumor in the muscular wall of the fallopian tube. Representative sections. c. Fallopian tube and paratubal tumor - 2. D,2 Ovarian tumor - 1 each. F. Ovary and adnexal soft tissues with tumor - 1. RIGHT TUBE AND OVARY. Labeled ""right tube and ovary' and received in formalin is a. salpingo-oophorectomy specimen. The ovary is massively enlarged,. about 8.6 x 7.4 x 6.2 cm. The ovary is focally ruptured and. partially fragmented. The serosal surface of the ovary shows. extensive involvement by papillated and nodular plaque-like. aggregates of semi-firm to firm tan-white tumor. Cut sections of the. ovary reveal nearly total replacement by mostly firm, yellow-tan. tumor with areas of cystic degeneration, focal hemorrhages, and. necrosis noted. No residual non-neoplastic ovarian tissue is grossly. evident. The fallopian tube has fimbria at one end, is 4.1 cm long. and up to 0.7 cm in diameter. Attached to the fimbriated end of the. fallopian tube, there are several firm, yellow-tan tumor nodules, the. largest of which measures about 1.2 cm in diameter. The serosal. surface of the fallopian tube is pink-tan and relatively smooth. elsewhere. Cross sections of the fallopian tube reveal a stellate. patent lumen, up to about 0.2 cm in diameter and an edematous wall. No invasive tumor is seen in the fallopian tube. Representative sections. G. Fallopian tube and tumor nodule attached to fimbriated end - 2. H-L. Ovarian tumor - 1 each. 4: SIGMOID RECTAL TUMOR. Labeled ""sigmoid rectal tumor"" and received in formalin is a 2.6 x. 1.4 x 1.2 cm aggregate of firm, focally hemorrhagic red-brown to. white tumor fragments, some of which are semi-soft and friable and. others of which are firm. Representative section. M. Tumor - 1. 5: CECAL TUMOR. Labeled 'cecal tumor' and received in formalin is a 1.5 x 1.0 x 0.6. cm aggregate of semi-soft, friable and firmer tan tumor. Representative section. N. Tumor - 1. UTERUS AND CERVIX. Labeled ""uterus and cervix and received in formalin is a 70 gram. total hysterectomy specimen. The uterus is symmetric. The uterus. measures about 7.7 cm from the fundus to the ectocervix, 3.6 cm from. cornu to cornu, and a maximum of 3.4 cm from the anterior surface to. the posterior surface. The uterine serosa is red-tan and shaggy. showing adhesions and nodular and plaque-like aggregates of semi-firm. tan tumor anteriorly and posteriorly. Nodular aggregates of firm tan. metastatic tumor are also present in the parametrial soft tissues. The cervix is about 3.1 cm long and up to 2.2 cm in diameter. The. ectocervical mucosa is pale tan and smooth. The external cervical os. is slit-shaped, 1.1 cm in diameter, and patent. The uterus is. incised on both sides. The cervical transformation zone is distinct. The endocervical canal is about 2.4 cm long and lined by tan, focally. rugose mucosa. Cut sections of the cervix reveal several mucus-. filled cysts, ranging from less than 0.1 to 0.3 Cm in diameter. The. endometrial cavity is about 4 em long and up to 1.2 cm in width. The. endometrium is tan, smooth, and about 0.1 cm in maximum thickness. No primary gross pathologic lesions of the endometrium are seen. The. muscular uterine wall has a maximum thickness of about 1.7 cm. Within the uterus, there are three sharply circunscribed intramural. leiomyomas, about 0.5, 0.6 and 1.7 cm in diameter. The smallest. and second smallest have firm solid tan whorled cut surfaces. The larger leiomyoma has a tan-white whorled cut surface with areas. of hyalinization. No areas of necrosis or hemorrhages are seen in. either leiomyoma. The outermost aspect of the muscular uterine wall. is focally involved by tumor in the anterior and posterior uterine. corpus. Representative sections. o. Anterior uterine corpus with smaller leiomyoma - 1. P. Anterior cervix - 1. Q. Posterior uterine corpus - 1. R. Posterior cervix - 1. s. Larger leiomyoma - 1. T. Serosa and paranetria with adhesions and tumor nodules - Multiple. SMALL BOWEL KESENTERY. Labeled 'small bowel mesentery' and received in formalin is a 2.5 x. 1.2 x 0.6 cm aggregate of yellow fatty tissue within which there are. multiple irregular firm nodular aggregates of white-tan tumor, the. largest of which measures about 0.5 cm in diameter. Representative sections. U. Tumor - Multiple. 8: RIGHT ADNEXA. Labeled ""right adnexa' and received in formalin is a 1.2 x 0.8 x 0.5. cm firm nodular portion of tan-white tumor. Representative section. V. Tumor - 1. 9: LIVER BIOPSY. Labeled ""liver biopsy' and received in formalin is a 2.0 x 1.5 x 0.5. cm aggregate of tan-brown liver tissue which shows extensive cautery. artifacts and nodular to irregular aggregates of firm, tan-white. tumor. Representative sections. W. Liver with tumor - 2. 10: CUL DE SAC TUMOR. Labeled 'cul de sac tumor' and received in formalin is a 5.0 x 3.5 x. 2.0 cm aggregate of multiple fragments of semi-soft friable and. firmer tan-white tumor. Representative section. x. Tumor - 1. Gross dictated by. OPERATIVE CONSULT (PROZEN) : 1. Omentum: -Metastatic adenocarcinoma with some papillations and. calcifications, favor mullerian origin. -Tumor taken for clonogenic assay. Special Studies: Frozen Section. ; H&E-stained step sections. See Also: None. I,. the pathologist of record, have. personally examined the specimen, interpreted the. results, reviewed this report and signed it electronically. Date Finalled:"
BIOCUP_00271,ovary,OV,TCGA-29-1691,TCGA-29-1691.74e45220-b3ac-4404-8bb6-811f3d4ba611,"CLINICAL HISTORY : Ovarian cancer. Additional history: Left ovary, history of bilateral breast cancer in the. ? mets. ? ovarian cancer. GROSS EXAMINATION: A. ""Left ovary"", in formalin. Received is a large brown and tan mass which. measures 12.5 x 9 x 7 cm. The surface has a diffuse, finely papillary growth. with numerous larger nodules. On cut sections, the majority of the tumor is. solid but has a variegated appearance with areas which are white and yellow. and other areas which appear hemorrhagic. The papillary growth is present. diffusely throughout. Block Summary: A1 - Frozen section remnant AF1. A2-A4 Tumor. B. ""Umbilical hernia sac"", in formalin. Received is a portion of. fibroadipose tissue which measures 5.5 x 4 x 2 cm. It contains a firm white. and tan finely nodular area which measures 3 x 1.7 x 0.5 cm consistent with. tumor. Representative sections are submitted in Block B1. C. ""Small bowel nodule"", in formalin. Several pieces of tan-white tissue. with a finely papillary surface consistent with tumor. Representative. sections submitted in Block C1. The specimen measures in toto 3.5 x 2 x 1 cm. D. ""Right diaphragm"", in formalin. A white papillary nodule which measures. 1.5 x 0.6 x 0.6 cm. Submitted in toto in Block D1. E. ""Omentum"", in formalin. A large portion of fibroadipose tissue consistent. with omentum which measures 26 x 20 x 4 cm. The specimen is serially. sectioned revealing numerous firm white nodules and cystic areas. Representative sections are submitted in Block E1,. F. ""Right ovary"", in formalin. Received are several fragments of hemorrhagic. and white solid tumor with a finely papillary surface. The specimen measures. in aggregate 15 x 14 x 5.5 cm. There are also several clear cysts which. express clear yellow fluid. On cut section, the tumor is mainly solid with. many areas of hemorrhage and necrosis. No clear residual ovary is identified. Representative sections are submitted in. G. ""Bladder flap"", in formalin. Several pieces of fibroadipose tissue. containing a solid white papillary lesion. The specimen measures in aggregate. 6.4 x 3.4 x 2.5 cm. Representative sections are submitted in Block G1. H. ""Anterior cul-de-sac"", in formalin. A portion of fibroadipose tissue with. a papillary white nodular growth. The specimen measures 4.5 x 2 x 0.5 cm and. representative sections are submitted in Block H1. I. ""Posterior cul-de-sac"", in formalin. Several pieces of firm, white tissue. with a finely nodular papillary surface which measures in aggregate 7.5 x 5.5. x. 4.5 cm. Representative sections are submitted in Block I1. J. ""Sigmoid colon"", in formalin. Received are several portions of. fibroadipose tissue containing firm, white nodules. The specimen measures in. aggregate 10 x 7 x 4 cm. Representative sections submitted in Block J1. K. ""Right sidewall"", in formalin. Several portions of fibroadipose tissue. which measure in aggregate 2 x 1 x 1.5 cm. A representative section is. submitted in Block K1. A firm white nodule is present. L. ""Right gutter"", in formalin. A portion of fibroadipose tissue which. measures 9.5 x 4.5 x 0.7 cm which contains several firm, white nodules. Representative sections are submitted in Block L1. M. ""Ventral hernia sac"", in formalin. A portion of fibroadipose tissue which. measures 4.2 x 2.5 x 1.5 cm. The specimen is sectioned revealing white. fibrous tissue, but no tumor nodules are identified. Representative sections. are submitted in Block M1. N. ""Anterior abdominal peritoneal wall"", in formalin. A portion of. fibroadipose tissue which measures 9 x 4.8 x 0.7 cm. There is a firm white. nodule which measures 2 x 0.9 x 0.4 cm and a second attached piece which. contains papillary white nodular growths. Representative sections are. submitted in Block N1. INTRA OPERATIVE CONSULTATION: AF1 - ""Left ovary"": Adenocarcinoma with some papillary differentiation -. favor ovarian primary. DIAGNOSIS: LEFT (A) & RIGHT (F) OVARIES (A) : SEROUS ADENOCARCINOMA, FIGO GRADE 2, WITH. METASTASES TO: B. UMBILICAL HERNIA SAC. C. SMALL BOWEL NODULE. D. RIGHT DIAPHRAGM. E. OMENTUM. F. RIGHT OVARY. G. BLADDER FLAP. H. ANTERIOR CUL-DE-SAC. I. POSTERIOR CUL-DE-SAC. J. SIGMOID COLON. K. RIGHT SIDE WALL. L. RIGHT GUTTER. N. ANTERIOR ABDOMINAL PERITONEAL WALL. THE FOLLOWING SPECIMEN IS FREE OF TUMOR: M. VENTRAL HERNIA SAC. NOTE: While many areas in the tumor are solid (estimated 308), the tumor is. classified as grade 2 since less than 50% is solid. ADDENDUM 1: This addendum is issued to report the results for immunostaining for HER2/neu. oncoprotein. The test is performed at the request of. Immunostaining for HER2/neu (c-erbB-2) oncoprotein is performed on recut. sections of block A2 (""left ovary"") . The immunostaining is done using DAKO. rabbit anti-human c-erbB-2 oncoprotein which is an affinity-isolated antibody. (DAKO product number A0485) The immunostaining is performed after antigen. retrieval by heating the unstained sections at 95 degrees centigrade for 20. minutes in 10 mM citrate buffer, pH 6.0 The primary antibody is used at a. dilution of 1:1500 (manual staining) or 1:2000 (autostainer), with an. incubation for one hour at 37 degrees centigrade. The Histostain Plus kit. (Zymed Laboratories) is used as the detection system. The histological. section consists predominantly of serous adenocarcinoma with areas of. papillary differentiation. The tumor has a variable immunostaining profile. The majority of the tumor has negligible staining of the cytoplasm or cell. membrane (score = 0) . There is a minority population of the tumor cells that. u1. has trace staining of the cytoplasm with mildly to moderately intense. circumferential staining of the cell membrane. These cells with. circumferential cell membrane staining are present as multiple foci scattered. throughout the tumor. This makes it difficult to estimate the overall tumor. population with the staining pattern indicative of weak overexpression of. HER2/neu oncoprotein, but I estimate that such cells account for approximately. 5% of the tumor cells. In summary, the serous adenocarcinoma present in the left ovary has a. subpopulation of tumor cells (approximately 5% of the total population) with. an immunostaining profile indicative of mild overexpression of HER2/neu. oncoprotein. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es)."
BIOCUP_00272,ovary,OV,TCGA-29-1762,TCGA-29-1762.f94712a1-78da-4341-9ac9-6ea41c11610e,"CLINICAL HISTORY: with ovarian carcinoma, malignant effusion and ascites. GROSS EXAMINATION: A. ""Right ovary (AF1)"". received fresh. A 162 gram, 12.2 x 9.5 x 3.8 cm. aggregate of lobulated, friable, gray-tan tissue with focally adherent blood. clot. Representative tissue is frozen as AF1. The remnant is submitted as. A1. Additional sections submitted as A2-3. B. ""Uterus"" (gross consult), received fresh. A 75.4 gram, 7.5 x 4.5 x 3.8 cm. uterus with an attached 3.5 x 2.4 cm cervix and attached 5.8 x 0.6 cm right. fallopian tube. The serosa is markedly roughened with multiple fibrous. adhesions and focally discolored green, tan. The ectocervix is smooth,. gray-white and glistening with a central patent 1.4 cm os extending into a. trabecular yellow endocervical canal. The endometrium is granular, gray-tan. and less than 0.1 cm in uniform thickness. The myometrium is 1.4 cm in. thickness and contains two intramural white circumscribed nodules each 0.8 cm. in diameter. Sectioning of the fallopian tube reveals a patent lumen and. abundant hemorrhage in the adjacent peritubular soft tissue. Block Summary: B1-2 Anterior and posterior cervix, respectively. B3-4 Anterior and posterior endomyometrium respectively,. B5. Right fallopian tube. Also received is a 5:9 x 4.5 x 2.6 cm aggregate of granular gray-tan tissue. from which representative sections are submitted as B6. c. ""Omentum"", received fresh. Four fragments of finely lobulated yellow-pink. adipose aggregating 14.5 x 11.5 x 0.6 cm. No discrete lesions or nodules are. noted. Representative sections are submitted as C1 and C2. Each fragment is sampled. D. ""Left tube and ovary"", received fresh. A 16.7 gram aggregate of tissue. composed of a 4.5 x 0.5 cm segment of fallopian tube adjacent to a nodular and. slightly distorted 3.7 x 1.8 x 1.5 cm ovary. The serosa is markedly granular. and studded with small friable nodules. Sectioning the tube reveals a patent. lumen. Sectioning of the ovary reveals a yellow-white fibrous cut surface. Representative sections from the ovary are submitted as D1 and from the tube. as D2. E. ""Bladder flap tumor"", received fresh. A 7.5 x 4.4 x 2.2 cm aggregate of. soft, friable, pink-tan tissue from representative sections are submitted as. E1 and E2. INTRA OPERATIVE CONSULTATION: A. ""Right ovary"": AF1- - adenocarcinoma. B. ""Uterns"" (gross consult) - no evidence of endometrial carcinoma. DIAGNOSIS: A. ""RIGHT OVARY"" (OOPHORECTOMY) : SEROUS CARCINOMA OF OVARY, MODERATELY DIFFERENTIATED (GRADE 2 OF 3) . TUMOR SIZE: 12.2 CM (AGGREGATE MEASUREMENT) . B. ""UTERUS"" (HYSTERECTOMY AND RIGHT SALPINGECTOMY) : UTERUS (75. 4 GM) WITH: METASTATIC SEROUS CARCINOMA TO SEROSA. CERVIX, NO PATHOLOGIC DIAGNOSIS. ENDOMETRIUM, INACTIVE. MYOMETRIUM, WITH TWO LEIOMYOMAS (GREATEST SINGLE DIMENSION 0.8 CM). RIGHT FALLOPIAN TUBE WITH METASTATIC SEROUS CARCINOMA. c. ""OMENTUM"" (BIOPSY) : OMENTUM WITH METASTATIC SEROUS CARCINOMA. D. ""LEFT TUBE AND OVARY"" (SALPINGO-OOPHORECTOMY): LEFT OVARY AND FALLOPIAN TUBE WITH METASTATIC SEROUS CARCINOMA. E. ""BLADDER FLAP TUMOR"": METASTATIC SEROUS CARCINOMA. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) ."
BIOCUP_00273,ovary,OV,TCGA-61-2088,TCGA-61-2088.62624308-45b6-46f3-85a0-5a4639b44bf3,"FINAL DIAGNOSIS: PART 1: OMENTAL MASS, EXCISION -. METASTATIC CARCINOMA (4 CM) WITH PSAMMOMA BODY FORMATION. PART 2: ANTERIOR PERITONEAL TUMOR EXCISION -. FRAGMENTS OF METASTATIC CARCINOMA. PART 3: RIGHT ADNEXA, SALPINGO-OOPHORECTOMY -. A. HIGH GRADE SEROUS PAPILLARY CARCINOMA (7 CM). B. TUMOR INVOLVES THE EXTERIOR SURFACE OF THE OVARY. C. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. D. RESIDUAL OVARIAN TISSUE WITH SEROUS CYST (2 CM). E. FALLOPIAN TUBE WITH MICROSCOPIC FOCI OF SEROSAL TUMOR. PART 4: LEFT ADNEXA, SALPINGO-OOPHORECTOMY -. A. HIGH GRADE SEROUS PAPILLARY CARCINOMA (8.0 CM). B. TUMOR INVOLVES EXTERIOR SURFACE OF OVARY. C. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. D. RESIDUAL OVARIAN TISSUE WITH SEROUS CYST (6.0 CM). E. FALLOPIAN TUBE WITH FOCAL EPITHELIAL ATYPIA IN FIMBRIATED END; NO DEFINITIVE INVOLVEMENT. BY TUMOR. PART 5: ANTERIOR CUL-DE-SAC TUMOR, EXCISION -. FRAGMENTS OF METASTATIC CARCINOMA. PART 6: UTERUS AND CERVIX, TOTAL ABDOMINAL HYSTERECTOMY (128.0 GRAMS) -. A. SEROSAL ADHESIONS WITH MICROSCOPIC DEPOSITS OF METASTATIC CARCINOMA. B. CERVIX WITH FOCAL MICROGLANDULAR HYPERPLASIA. C. ENDOMETRIUM WITH FOCAL COMPLEX HYPERPLASIA WITHOUT ATYPIA,. PART 7: LEFT PELVIC LYMPH NODE, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR NEOPLASM (0/1). PART 8: DIAPHRAGM TUMOR, EXCISION -. METASTATIC CARCINOMA. PART 9: FALCIFORM LIGAMENT, EXCISION -. METASTATIC CARCINOMA. PART 10: OMENTUM, OMENTECTOMY -. A. OMENTUM WITH MULTIPLE FOCI OF TUMOR MEASURING UP TO APPROXIMATELY 2.0 CM. B. NO DEFINITE LYMPHOVASCULAR INVASION IS IDENTIFIED. PART 11: APPENDIX, APPENDECTOMY -. APPENDIX WITH FIBRO-INTIMAL ABLATION AND SEROSAL ADHESIONS, NEGATIVE FOR TUMOR. SYNOPTIC - PRIMARY OVARIAN TUMORS INCLUDING BORDERLINE TUMORS. TUMOR LOCATION: Bilateral. PROCEDURE: TAH with salpingo-oophorectomy. TUMOR SIZE: Maximum dimension: 8.0 cm. TUMOR TYPE: Papillary serous carcinoma. HISTOLOGIC GRADE (serous tumors): High grade. VASCULAR INVASION: TUMOR CAPSULE: Ruptured. MALIGNANT CELLS IN ASCITES OR. PERITONEAL WASHING: LYMPH NODES EXAMINED: Total number of lymph nodes examined: 1. LYMPH NODES POSITIVE: Number of positive lymph nodes, Right: 0. Number of positive lymph nodes, Left: 0. T STAGE, PATHOLOGIC: T STAGE, PATHOLOGIC. T STAGE, PATHOLOGIC continued. pT3c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. FIGO STAGE: IIIC."
BIOCUP_00274,ovary,OV,TCGA-09-1673,TCGA-09-1673.d4f7aa96-11e8-4d66-a1be-595ec22de450,"FINAL PATHOLOGIC DIAGNOSIS. A. Omentum, omentectomy: Metastatic high-grade serous carcinoma. B. Ovary and fallopian tube, left, excision: Ovary and fallopian tube. completely. replaced by high-grade serous carcinoma; see comment. C. Ovary and fallopian tube, right, excision: 1. Ovary and fallopian tube with high-grade serous carcinoma; see. comment. 2. Leiomyoma in soft tissue adjacent to ovary, uninvolved by ovarian. tumor. D. Mesentery, mass, biopsy: Metastatic high-grade serous carcinoma. E. Residual omentum, excision: Metastatic high-grade serous. carcinoma. F. Skin, subcutaneous nodule, excision: Skin and subcutaneous tissue. with metastatic. high-grade serous carcinoma, extends to margin of resection. COMMENT: Focal areas with clear cell changes and sarcomatoid cell morphology are noted,. which can be seen in. this type of tumor. The percentage of these areas is <5% of the total tumor. Ovarian Tumor Synoptic Comment. - Location of tumor: Bilateral. - Type of tumor: Serous. - Grade of tumor: 3. - Size of tumor: Left ovary and fallopian tube: 10 cm. Right ovary and fallopian tube: 8.5 cm. - Surface of ovary: Tumor on surface. - Condition of capsule: Ruptured. - Cut surface: Solid (minor cystic areas). - Necrosis: Focal. - Lymphatic/vascular invasion: Present (best seen in slide B2). - Sites of metastases in pelvis: Fallopian tube, other (omentum and mesentery). - Size of largest pelvic metastasis is entire omentum: >2 cm (see gross. description). - Pelvic lymph nodes: None present. - Sites of metastases in abdomen: Omentum and serosa of bowel. - Size of largest abdominal metastasis is entire omentum: > 2cm (see gross. description). - Para-aortic lymph nodes: None sampled. - Peritoneal cytology: Positive. (Cytology accession number: - Other findings: None. - FIGO stage: 4. - AJCC stage: pT3cNXM1. las reviewed the case and agrees with the above diagnoses. Specimen(s) Received. A:Omentum (Oncotech). tube and ovary (iresti). C:Right tube and ovary (fresh). D:Mesenteric mass. E:Residual omentum. F:Subcutaneous nodule. Clinical History. The patient is a. with advanced stage ovarian cancer. She now. undergoes. exploratory laparotomy, bilateral salpingo-oophorectomy, omentectomy and tumor. reductive surgery. Gross Description. The specimen is received in six parts, each labeled with the patient's name and. medical record. number. Parts A-C are received fresh. Parts D-F are received in formalin. Part A is received fresh and additionally labeled ""omentum."" It consists of one firm,. bink-white/yellow-brown, irregular, unoriented, multinodular tissue fragment that. measures 37 X. 21.5 x 6 cm and weighing 1368 grams. The specimen is approximately 100%. nodular. A. representative section is submitted to Oncotech. A representative section is. submitted for ovarian. tissue banking. Representative sections are submitted in cassettes A1-A4. Part A has. been grossly. reviewed by. The remaining tissue is. returned to the. container. Part B is additionally labeled ""left tube and ovary,"" and consists of a morcellated. yellow-tan, irregular. soft tissue specimen measuring 10 x 8.5 X 2.5 cm in aggregate and weighing 86. grams in toto. There. are several dilated cysts or ducts filled with yellow-tan, mucoid substance, the. largest measuring 1.1. cm in greatest diameter. In addition, there is a white, firm tissue fragment with ill-. defined borders. measuring 2.5 x 1.2 X 1 cm. The remaining parts of the specimen are tan, rough and. studded with. numerous white nodules up to 1 cm. Tissue samples are taken for ovarian tumor. banking, and. photos are taken. Representative sections are submitted in cassettes B1-B5. Part C is additionally labeled ""right tube and ovary,"" and consists of a single irregular. adnexa. resection. The specimen is received measuring 8.5 x 5.5 X 3 cm and weighing 58. grams. There is a. disrupted candidate fallopian tube and ovary present that is partially encased in. white-tan-yellow. irregular mass. The candidate ovary measures 2.2 X 1.5 X 1.5 cm, with a white-tan,. whorled interior. The candidate fallopian tube measures 0.5 cm in average diameter. The surrounding. mass is. white-tan-yellow and firm. Sections are submitted as follows: Cassette C1: Candidate ovary and adjacent soft tissue. Cassette C2: Candidate fallopian tube and mass. Cassettes C3-C5: Mass, representative. Part D, additionally labeled ""mesenteric mass,"" consists of multiple white-tan/brown,. irregular,. unoriented, firm tissue fragments that are 7 X 4.5 X 1.5 cm and 21.6 grams in. aggregate. Representative sections are submitted in cassettes D1-D3 at a rate of one section. per centimeter. The remaining tissue is returned to the container. This specimen was grossly. reviewed by. Part E, additionally labeled ""5 - residual omentum,"" consists of one white-yellow,. irregular,. unoriented, firm tissue fragment that is 95% nodular. It is 5.6 x 3.1 X 2 cm. Representative sections. are submitted in cassettes E1-E3. The remaining tissue is returned to the container. Part F, additionally labeled ""6 - subcutaneous nodule,"" consists of one pink-tan,. irregular, unoriented,. elliptical skin fragment with a central defect. The specimen is 4 X 1 x 2.5 cm. The. defect is 0.6 x 0.1. cm. The defect is 1.4 cm from a tip, 2 cm from the opposite tip, 0.5 cm from the. side, and 0.3 cm. from the opposite side. The resection margin is inked blue. The specimen is serially. sectioned. parallel to the long axis revealing yellow subcutaneous tissue, with white, diffuse,. firm tissue. subjacent to the skin. The firm area abuts the resection margin. Representative. sections are. submitted in cassettes F1-F3 as follows: Cassette F1: Tips. Cassettes F2-F3: Full-thickness central defect showing area of white, diffuse tissue. The remaining tissue is returned to the container. Part F has been reviewed by Dr. Diagnosis based on gross and microscopic examinations. Final diagnosis made by. attending. pathologist following review of all pathology slides."
BIOCUP_00275,ovary,OV,TCGA-59-2372,TCGA-59-2372.4411c3e9-2751-45eb-bc8f-e64ca2940a09,"Addendum. SPECIMEN(S): A. LEFT OVARIAN MASS. B. RIGHT OVARIAN MASS. C. LEFT PELVIC NODES. D. RIGHT PELVIC NODES. E. PARA AORTIC NODES. F. OMENTUM. G. PORTION FREATER CURVATURE STOMACH. CLINICAL HISTORY: PRE-OPERATIVE DIAGNOSIS: Ascites and pelvic mass. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA: Left ovarian mass, FSB: Right ovarian mass: Papillary serous cystadenocarcinoma. called. GROSS DESCRIPTION: A. LEFT OVARIAN MASS. Received fresh for frozen section and labeled ""left ovarian mass"" is an enlarged ovary mass. measuring 1.0x8.5x4.0cm and weighing 141gm. The surface of the ovary is a papillary. appearance with friable granules on the surface. Dissections reveal tan brown solid stalk. attached to a thin fibrous capsule. At one end of the ovary shows multiple loculated cysts. containing clear fluid. The wall is approximately 0.1cm in thickness at this area, where the. surface of the lining is smooth and gray white. Inside the cyst, focally shows the same kind of. tan brown tumor mass, Representative sections are submitted in 9 cassettes. Cassette 1: frozen section. Cassette 2-8: sections from the papillary tumor mass. Cassette 9: sections from loculated cysts. B. RIGHT OVARIAN MASS. Received fresh for frozen section and labeled ""right ovarian mass"" is a distorted ovarian mass. weighing 109gm, measuring 10x7x3.5cm. There is a thin cyst in one end of the specimen. measuring 4cm in greatest dimension with a gray white smooth surface lining in both inner and. exterior. However, at the opposite end, the polypoid tumor mass attached on to with fine. granular and friable appearance. Sections reveal solid tan yellow appearance. Representative. sections are submitted in 9 cassettes. Cassette 1: frozen section. Cassette 2-9: random sections. C. LEFT PELVIC NODES. Received fresh and labeled ""left pelvic lymph nodes"" are 2 fragments of fatty tissue aggregating. 5.0x1.5x0.5cm. Dissections reveal multiple lymph nodes ranging from 0.5 to 5.0cm in greatest. dimension. Lymph nodes are entirely submitted in 3 cassettes. Cassette 1: multiple lymph nodes. Cassette 2-3: 1 bisected large lymph node. D. RIGHT PELVIC NODES. Received fresh and labeled ""right pelvic lymph nodes"" are multiple fragments of fatty tissue. aggregating 3.0x2.0x0.5cm. Dissections reveal multiple lymph nodes ranging from 0,6 to 1.0cm. Lymph nodes are entirely submitted in 2 cassettes. E. PARA-AORTIC NODES. Received fresh and labeled ""para-aortic nodes"" are 2 lymph nodes, each measures 2.0cm. One of. the lymph nodes shows tumor involvement. Lymph nodes are entirely submitted in 2 cassettes. Cassette 1: 1 lymph node. Cassette 2: 1 bisected lymph node, tumor involved. F. OMENTUM. Received fresh and labeled ""omentum"" is a fragment of omentum measuring 27x5x1cm. Serial. sections reveal multiple areas involved by the gray white solid tumor mass ranging from 1. .1cm to. 5.0cm. Representative sections are submitted in 2 cassettes. G. PORTION GREATER CURVATURE STOMACH. Received fresh and labeled ""portion greater curvature stomach"" is a ring shaped mucosa tissue. measuring Icm in length, 3cm in outer ring diameter and 1cm in inner ring diameter. Entirely. submitted in 2 cassettes. DIAGNOSIS: A. OVARY, LEFT MASS, OOPHORECTOMY: -SEROUS PAPILLARY CYSTADENOCARCINOMA WITH PSAMMOMA BODIES.,. MEASURING 11 X 8 CM, ARISING FROM BORDERLINE SEROUS PAPILLARY. CYSTADENOMA. B. OVARY, RIGHT MASS, OOPHORECTOMY: -SEROUS PAPILLARY CYSTADENOCARCINOMA MEASURING 10X 7 CM. C. LYMPH NODE, LEFT PELVIC, EXCISION: -ONE LYMPH NODE WITH METASTASIS AND CAPSULAR EFFRACTION (1/1). D. LYMPH NODE, RIGHT PELVIC, EXCISION: -LYMPH NODES WITH METASTASIS (2/6). E. LYMPH NODE, PARA-AORTIC, EXCISION: -LYMPH NODES WITH METASTASIS (3/5). F. OMENTUM: -ADIPOSE TISSUE WITH METASTATIC SEROUS PAPILLARY. CYSTADENOCARCINOMA OF THE OVARY. G. PORTION GREATER CURVATURE STOMACH, EXCISION: -GASTRIC MUCOSA WITH NO DIAGNOSTIC ABNORMALITIES. -NO METASTASIS. A&B: See template. OVARIAN NEOPLASM TEMPLATE. Specimen type: oophorectomy, right and left. Tumor site and size: right 11cm, left 10cm. Specimen integrity: intact. Gross Surface Involvement: yes. Cut Surface: unilocular cystic with multilocular. Gross Necrosis: no. Histologic Type: epithelial, serous. Histologic Grade: well differentiated. Summary of organs/tissues microscopically involved by tumor: both ovaries and omentum. Venous/Lymphatic Invasion: absent. Implants (only applies to borderline tumors): Lymph Node Dissection: Right pelvic 2/6. Left pelvic 1/4. Para-aortic 3/5. Additional Pathologic Findings: Peritoneal Cytology if Tumor Limited to Ovary: pending. NY ESO-1:Negative. Pathologic Stage: pT2 N1 Mx. ADDENDUM: This report is issued to correct the typographical error as it appeared in the template. Left pelvic. lymph should read 1/1 instead of 1/4. Thank you to take notice."
BIOCUP_00276,ovary,OV,TCGA-10-0938,TCGA-10-0938.faa8920a-3b4a-4767-bdb1-5d086e51fe92,"(A) RIGHT OVARY AND PORTION OF FALLOPIAN TUBE: OVARY, HIGH-GRADE PAPILLARY SEROUS CARCINOMA. THE TUMOR INVOLVES THE FALLOPIAN TUBE. (B) UTERUS, CERVIX, LEFT FALLOPIAN TUBE AND OVARY: MINUTE FOCI OF PAPILLARY SEROUS CARCINOMA INVOLVING THE OVARY, PERIADNEXAL SOFT TISSUE AND. FALLOPIAN TUBE LUMEN. Hyperplastic endometrial polyp. Simple endometrial hyperplasia without atypia and focal mucinous metaplasia. Adenomyosis. Uterine cervix, Nabothian cysts. (C) OMENTUM: METASTATIC HIGH-GRADE PAPILLARY SEROUS CARCINOMA. (D) ANTERIOR ABDOMINAL WALL: METASTATIC HIGH-GRADE PAPILLARY SEROUS CARCINOMA. GROSS DESCRIPTION. (A) RIGHT OVARY AND PORTION OF TUBE - An ovarian mass measuring 8.0 x 7.0 X 6.0 cm, fallopian tube measuring 5.0 X. 1.0 cm and paraovarian soft tissue. The tumor replaces the entire ovary and demonstrates papillary areas (occupying approximately 40%), solid tan-yellow. areas (occupying 30%) and a cystic area with blood clot and smooth lining (30%). The tumor does not extend into the fallopian. tube. No normal ovary is identified. Fallopian tube on serial sectioning is unremarkable. SECTION CODE: A1, A2, section of ovary and tumor for frozen section; A3-A7, sections from the papillary areas; A8-A12,. sections from the solid area; A13-A15, sections from the cyst with blood clot; A16, fallopian tube. FSDX: HIGH GRADE PAPILLARY SEROUS CARCINOMA. (B) UTERUS, CERVIX, LEFT TUBE AND OVARY - A 9.0 x 5.0 X 5.0 cm uterus with attached unremarkable left ovary 1.5 x 0.8 x. 0.5 cm, and a portion of fallopian tube 2.5 cm in length X 0.5 cm in diameter. Located within the fundus is a 2.5 X 1.5 x 1.0 cm, well-circumscribed, soft, friable, polypoid mass that involves the anterior. and posterior endometrium. The polyp is cystic and very friable. The lesion is superficial and there is no identifiable extension to. the myometrium. The polyp focally extends to the posterior lower uterine segment. The adjacent normal endometrium has a. maximum thickness of 0.1 cm. The myometrium is thin and unremarkable. The left ovary is sclerotic with a white-tan cut surface. Multiple, small, paratubal cysts ranging in size from 0.2 to 0.3 cm. are present attached to the surface of the tube. The fallopian tube is otherwise unremarkable. INK CODE: Black-uterine serosa. SECTION CODE: B1, cervix at 3 o'clock; B2, cervix at 9 o'clock; B3, anterior cervix; B4, B5, anterior lower uterine. segment; B6-B13, endometrial polyp attached to the anterior endometrium and adjacent myometrium; B14-B15, polyp attached to. the posterior endometrium; B16, B17 and B18, lower posterior uterine segment: 819-B22 representative sections of the. endometrium; B23, B24, ovary; B25, paratubal cysts and left fallopian tube,. (C) OMENTUM - A portion of omentum, 0 X 12.0 X 3.5 cm. The omentum is diffuse placed by white-tan tumor tissue. SECTION CODE: C1-C10, repre. tative sections of omentum. (D) ANTERIOR ABDOMINAL WALL - Portions of pink-tan soft tissue 4.0 x 3,0 X 0.5 cm and 2.5 X 1.7 X 0.5 cm. An ill-defined. white-tan tumor is present in the larger portion of the specimen 1.0 X 0.7 X 0.7 cm. The cut surface of the second fragment is light. tan. SECTION CODE: D1, D2, nodule on large fragment; D3, representative sections of the small fragment. CLINICAL HISTORY. History of ovarian carcinoma. Start of ADDENDUM."
BIOCUP_00277,ovary,OV,TCGA-24-1474,TCGA-24-1474.c4d49a95-0478-4399-a5eb-224ca6d16cd7,"Other Related Clinical Data: DIAGNOSIS: OVARY, LEFT, EXCISION. - POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA (FIGO GRADE III/III) (SEE SYNOPTIC). - NO RESIDUAL OVARY IDENTIFIED. ""FALLOPIAN TUBE, "" LEFT, EXCISION. - NO FALLOPIAN TUBE IDENTIFIED. OVARY, RIGHT, SALPINGO-OOPHORECTOMY. - METASTATIC SEROUS ADENOCARCINOMA ON OVARIAN SURFACE. - DETACHED FRAGMENT OF METASTATIC SEROUS ADENOCARCINOMA. FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOMY. - PORTION OF FALLOPIAN TUBE (FIMBRIA) IDENTIFIED. - NO EVIDENCE OF MALIGNANCY. PERITONEUM, RIGHT UPPER QUADRANT NODULE (INCLUDING FS1), BIOPSY. - METASTATIC SEROUS ADENOCARCINOMA. MESENTERY, SMALL INTESTINE, BIOPSY. - METASTATIC SEROUS ADENOCARCINOMA. OMENTUM, EXCISION. - SINGLE MICROSCOPIC FOCUS OF METASTATIC SEROUS ADENOCARCINOMA WITHIN INFLAMMATORY AND. HEMORRHAGIC EXUDATE ON SURFACE OF OMENTUM. - MATURE ADIPOSE TISSUE WITH MESOTHELIAL HYPERPLASIA AND CHRONIC INFLAMMATION. By this signature, I attest that the above diagnosis is based upon my. personal examination of the slides (and/or other material indicated in the diagnosis). Synopsis SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS 1. A neoplasm is PRESENT. 2. The HISTOLOGIC DIAGNOSIS is: Serous adenocarcinoma. 3. The LOCATION (S) OF THE PRIMARY TUMOR (S) is/are: Left ovary only. 4. The FIGO GRADE of the tumor is: III (Tumor composed of >50% solid cellular nests). 5. The NUCLEAR (BRODERS') GRADE of the tumor is: GRADE 2. 6. Tumor IS identified on both ovarian surfaces. 7. The presence of tumor invasion of the mesovarium CANNOT BE EVALUATED. 8. Invasion of adjacent fallopian tube CANNOT BE EVALUATED (Fallopian tube is not. identified). 9. Tumor invasion of pelvic soft tissue CANNOT BE EVALUATED. 10. Tumor involvement of the pelvic peritoneum CANNOT BE EVALUATED. 11. Metastatic involvement of the EXTRAPELVIC PERITONEUM is PRESENT. 12. Metastatic involvement of the omentum is PRESENT. 13. The maximum dimension of tumor implants outside the true pelvis is 5 cm. 14. Metastatic involvement of the uterine serosa CANNOT BE EVALUATED. 15. Metastatic involvement of the endometrium CANNOT BE EVALUATED. 16. Regional lymph node metastases CANNOT BE EVALUATED. 17. The total number of regional lymph nodes examined is 0. 18. The total number of metastatically-involved regional lymph nodes is not applicable. 19. DETAILED STAGING INFORMATION: Based on the above information, the PRIMARY TUMOR is classified as : TNM Scheme. FIGO Scheme. Definition. T3c. IIIC. Macroscopic. peritoneal metastasis beyond true pelvis measuring > 2 cm in maximum dimension. THE REGIONAL LYMPH NODES are classified as: NX. (Nodal status cannot be assessed). THE STATUS OF DISTANT TUMOR SITES is classified as: MX (Status cannot be assessed). 20. The FINAL AJCC/UICC/FIGO STAGE IS: AJCC/UICC/FIGO. at least IIIC. The pathologic stage assigned here should be regarded as provisional, and may change after. integration of clinical data not provided with this specimen."
BIOCUP_00278,ovary,OV,TCGA-36-1571,TCGA-36-1571.cee6fb75-8fcc-4347-824e-b00b96e6e481,"Anatomical Pathology. Final Diagnosis: A. Omentectomy specimen showing: 1. Nodule of metastatic high-grade (3/3) papillary serous adenocarcinoma. 2. Abundant adipose tissue. B. Left salpingo-oophorectomy specimen showing: 1. Large high-grade (3/3) papillary serous adenocarcinoma of the ovary,. with extension to ovarian surface and focal intramucosal involvement. of fallopian tube,. 2. The carcinoma has solid, tubular/glandular and papillary patterns,. and there is an area of cyst formation. 3. No lymphatic or vascular invasion found. 4. Uninvolved fallopian tube mucosa, unremarkable. 5. Tubo-ovarian adhesions. C. Right salpingo-oophorectomy specimen showing: 1. Surface ovarian implant of high-grade (3/3) serous adenocarcinoma, within adhesions. 2. Abundant tubo-ovarian adhesions. 3. Fallopian tube not involved by tumor. 4. Ovarian parenchyma, not involved by tumor, cystic follicles and. corpus luteum present. 5. No lymphatic or vascular invasion. D. Specimen labelled ""right pelvic sidewall tymph node"": One benign lymph. node, with abundant surrounding fibrofatty tissue. E. Peritoneal washings, cytology specimen (VC07-463); positive for. high-grade papillary serous adenocarcinoma (numerous clumps of carcinoma. cells present). Final Diagnosis Comment: in my opinion, the overall findings are most in keeping with a primary serous adenocarcinoma of the left ovary, with metastatic spread. Clinical History as Provided by. Research/Tissue Harvesting. Cytology Report. with hx renal cell ca. Now with complex pelvic mass. Ovarian mass. A. Omentum -stitch on nodule (for frozen section). B. Left ovary (for frozen section). C. Right fallopian tube and right ovary. D. Right pelvic sidewall lymph node. Specimens Received: A: omentum. B: left ovary. C: right fallopian tube + right ovary. D: ight pelvic side wall lymph node. Gross Description: Specimen is received in four containers each labelled with the patient's name. Container ""A"" Is labelled ""omentum; stitch on nodule"" and consists of fatly tissue fragments which measure 22 x 14 x 1 cm. A nodule marked by suture is. identified which measures 1 cm in maximum dimension. The rest of the fatty tissue appears unremarkable. Representative sections are submitted as follows: ""A1"" -from the nodule. ""A3-A4"" -representative from the rest of the fatty tissue. Container ""B"" is labelled ""left ovary"" and consists of a cystic and solid mass which measures 10 cm in maximum dimension. The outer surface shows. attached fallopian tobe which measures 9 cm in length and .7 cm in diameter. The rest of the outer surface shows a 4 cm tumour area which is not. covered by the ovarian capsule (?artificial rupture). On cul sectioning, the lesion is composed of solid and cystic parts. The solid nodule measures 6 x 4. x 3 cm. Intraoperative diagnosis done by. as consistent with papillary serous ovarian carcinoma. Representative sections are submitted as follows: ""B1-B2"" -frozen section. ""B3"" -representative from the fallopian tube. ""B4"" -representative from the ?rupture area. ""B5"" -representative from the solid area. ""B6"" -representative from the cystic area. Container ""C"" is labelled ""right fallopian tube and ovary"". The ovary measures 3.5 x 2 x 1 cm, while the fallopian tube measures 2 x .6 cm. The outer. surface of the ovary is irregular. The cut surface shows multiple cysts, the largest one with a diameter measuring 1 cm. The specimen is submitted in toto. in six cassettes labelled as ""C1-C6"" with fallopian tube in ""C6"". Container ""D"" is labelted ""right pelvic sidewall lymph node"" and consists of a single fibrofatty tissue fragment which measures 1.5 x 1x.3 cm. The. specimen is submitted in toto in one cassette labelled as ""D1"". Intraoperative Consultation: FSA/1. Gross Description: 9 x 6 x 3 cm solid nodule with cystic component. Two sections taken for frozen section. Provisional Diagnosis: Consistent with papillary serous ovarian carcinoma. Copies to:"
BIOCUP_00279,ovary,OV,TCGA-24-1436,TCGA-24-1436.621d3f29-b555-4767-83dd-a6989af0be12,"Other Related Clinical Data: DIAGNOSIS: OVARY, RIGHT, OOPHORECTOMY. -MODERATELY TO POORLY DIFFERENTIATED SEROUS PAPILLARY ADENOCARCINOMA (4. 5 CM IN GREATEST. DIMENSION) (SEE SYNOPTIC). -LYMPHVASCULAR INVASION BY CARCINOMA IS IDENTIFIED. FALLOPIAN TUBE, RIGHT SALPINGECTOMY. -SEROUS PAPILLARY ADENOCARCINOMA INVOLVING SEROSA. UTERUS, CERVIX, HYSTERECTOMY. -CHRONIC INFLAMMATION. UTERUS, ENDOMETRIUM, HYSTERECTOMY. -INACTIVE ENDOMETRIUM. UTERUS, MYOMETRIUM, HYSTERECTOMY. -LEIOMYOMAS. -FOCAL EXTENSION OF CARCINOMA INTO OUTER THIRD OF MYOMETRIUM. UTERUS, SEROSA, HYSTERECTOMY. -SEROUS PAPILLARY ADENOCARCINOMA. OMENTUM, EXCISION. -SEROUS PAPILLARY ADENOCARCINOMA. APPENDIX, EXCISION. SEROUS PAPILLARY ADENOCARCINOMA INVOLVING THE MUSCULARIS AND SEROSA. Synopsis SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS 1. A neoplasm is. PRESENT. 2. The HISTOLOGIC DIAGNOSIS is: Serous adenocarcinoma. 3. The LOCATION (S) OF THE PRIMARY TUMOR (S) is/are: Right ovary only. 5. The NUCLEAR (BRODERS') GRADE of the tumor is: G3 (Poorly-differentiated). 6. Tumor IS identified on the ovarian surface (s) . Tumor DOES invade the mesovarium. 8. Tumor DOES NOT invade the adjacent fallopian tube. 9. Tumor invasion of pelvic soft tissue CANNOT BE EVALUATED. 10. Tumor involvement of the pelvic peritoneum CANNOT BE EVALUATED. 11. Metastatic involvement of the EXTRAPELVIC PERITONEUM is PRESENT. 12. Metastatic involvement of the omentum is PRESENT. 13. The maximum dimension of tumor implants outside the true pelvis is: 7.0 cm. 14. Metastatic involvement of the uterine serosa is PRESENT. 15. Metastatic involvement of the endometrium is ABSENT. 16. Regional lymph node metastases CANNOT BE EVALUATED. 17. The total number of regional lymph nodes examined is: 0. 19. DETAILED STAGING INFORMATION: Based on the above information, the PRIMARY TUMOR is classified as: TNM Scheme. FIGO Scheme. Definition. T3c. IIIC. Macroscopic. peritoneal metastasis beyond true pelvis measuring > 2 cm in greatest dimension, OR Regional. lymph node metastasis OR Metastasis to capsule of liver. 20. The FINAL AJCC/UICC/FIGO STAGE IS: AJCC/UICC/FIGO. IIIC. The pathologic stage assigned here should be regarded as provisional, and may change after. integration of clinical data not provided with this specimen."
BIOCUP_00280,ovary,OV,TCGA-24-1562,TCGA-24-1562.0ce36daf-9512-4860-a5a3-b2ff7f487c5a,"Other Related Clinical Data: DIAGNOSIS: OVARY, RIGHT, SALPINGO-OOPHORECTOMY. - PAPILLARY SEROUS ADENOCARCINOMA. - CYS'TADENOFIBROMA. OVARY, LEFT, SALPINGO-OOPHORECTOMY. - PAPILLARY SEROUS ADENOCARCINOMA. - PARAOVARIAN ADHESIONS WITH METASTATIC ADENOCARCINOMA. FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOMY. - METASTATIC PAPILLARY SEROUS ADENOCARCINOMA INVOLVING PARATUBAL SOFT TISSUE. FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY. - METASTATIC PAPILLARY SEROUS ADENOCARCINOMA INVOLVING PARATUBAL SOFT TISSUE. UTERUS, CERVIX, TOTAL ABDOMINAL HYSTERECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. UTERUS, ENDOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - INACTIVE ENDOMETRIUM. UTERUS, MYOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - LEIOMYOMA. OMENTUM, OMENTECTOMY. - METASTATIC PAPILLARY SEROUS ADENOCARCINOMA. BLADDER, FLAP, BIOPSY. - METASTATIC PAPILLARY SEROUS ADENOCARCINOMA. CUL-DE-SAC, TUMOR, BIOPSY. - METASTATIC PAPILLARY SEROUS ADENOCARCINOM. UMBILICUS, NODULE, EXCISION. - METASTATIC PAPILLARY SEROUS ADENOCARCINOMA. By this signature, I attest that the above diagnosis is based upon my. personal examination of the slides (and/or other material indicated in the diagnosis) -. Microscopic Description and Comment: Papillary serous adenocarcinoma is present in the right. and left ovaries. In the left ovary, the tumor predominantly involves paraovarian adhesions. In the right ovary, benign serous cystadenofibroma is present adjacent to invasive papillary. serous carcinoma. Extensive metastatic papillary serous adenocarcinoma is present in right. and left paratubal soft tissues, the omentum and in the snecimens labeled ""bladder flap,. cul-de-sac tumor, "" and ""umbilical nodule."". History: The patient is a. with a right ovarian mass on. ultrasound and an elevated CA143. operative procedure: Exploratory laparotomy, omentectomy,. total abdominal hysterectomy, bilateral salpingo-oophorectomy and optimal tumor debulking. Specimen (s) Received: A: OMENTUM. B: BLADDER FLAP. C: CUL DE SAC TUMOR. D: HYSTERECTOMY, BSO. E: UMBILICAL NODULE. Gross Description The specimens are received in five containers of formalin, each labeled. with the patient's name. The first container is additionally labeled ""omentum. It. consists of a 40 x 15 x 5 cm omental cake extensively involved by a solid, tan-yellow tumor. mass. Labeled A1 - A3. The second container is labeled ""bladder flap. It consists of irregular grey-tan,. tumor-like tissue measuring 3.5 x 2.5 x 2 cm in aggregate. The third container is labeled ""cul-de-sac tumor. "" It consists of a 2.5 x 1 x 0.8 cm. grey-tan nodule, compatible with tumor. The fourth container is labeled ""uterus, cervix, BSO. It consists of a 92 gram, 7.5 x. 4 x 3 cm uterus with attached bilateral adnexae. The serosa of the uterus, except for the. presence of a subserosal leiomyoma, is smooth and unremarkable. The ectocervix measures. 3.5 cm in greatest diameter and is covered by a grey-tan, slightly hemorrhagic mucosa. The endocervix is 2.5 cm in length and has a slightly mucoid, yellow, mucosa that is free. of tumor. The endometrial cavity measures 2.5 x 1.5 cm and has an unremarkable tan-yellow. mucosa. The myometrium is composed of a coarsely trabeculated musculature, that, except for. the presence of a circumscribed, white, whorled, 7 mm leiomyoma is grossly unremarkable. The right ovary has previously been opened. It measures approximately 3 x 2 x 2 cm and. is apparently largely replaced by a unilocular cyst. The cyst contains a single solid. tan-yellow papillary area measuring 1.0 cm in greatest dimension and covering less than. 10% of the total cyst surface area. The remaining surface area is smooth, glistening and. unremarkable. The right fallopian tube measures 4.5 cm in length and has fimbria at the. distal end. There are three small tumor nodules in the paratubal soft tissues that measure. up to 8 mm in greatest dimension. The tube, appears grossly free of tumor. The left adnexal. structures are ill-defined grossly, due to the presence of numerous hemorrhagic adhesions. There appears to be a portion of ovary that measures 2 x 1 x 0.4 cm. There are nodular. excrescences on the surface but these appear to represent hemorrhagic exudate. Sectioning of. the ovary shows a normal-appearing grey-white stroma, without gross evidence of tumor. There. is also a distorted portion of fallopian tube that has fimbria distally and appears grossly. uninvolved by tumor. Labeled D1, anterior cervix; D2, anterior endomyometrium; D3, posterior. cervix; D4, posterior endomyometrium; D5, subserosal leiomyoma; D6 - D12, completely. embedded right adnexal tissue; D13 - D20 completely embedded left adnexal tissues. The fifth container is labeled ""umbilical nodule. It consists of an irregular 3 x 3 x 2 cm. fragment of fibrosis tisue. The sectioned tissue shows specimen replacement of the adipose. tissue by tumor. Synopsis SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS 1. A neoplasm is. PRESENT. 2. The HISTOLOGIC DIAGNOSIS is: Serous adenocarcinoma. 3. The LOCATION(S) OF THE PRIMARY TUMOR (s) is/are: Right and left ovary (synchronous primary. tumors). 5. The NUCLEAR (BRODERS') GRADE of the tumor is: G3 (Poorly-differentiated). 6. Tumor IS identified on the ovarian surface (s) . 7. Tumor DOES invade the mesovarium. 8. Tumor DOES invade the adjacent paratubal soft tissue. 9. Tumor DOES invade the pelvic soft tissue. 10. Tumor involvement of the pelvic peritoneum is PRESENT. 11. Metastatic involvement of the EXTRAPELVIC PERITONEUM is PRESENT. 12. Metastatic involvement of the omentum is PRESENT. 13. The maximum dimension of tumor implants outside the true pelvis is: >2.0 cm. 14. Metastatic involvement of the uterine serosa is ABSENT. 15. Metastatic involvement of the endometrium is ABSENT. 16. Regional lymph node metastases CANNOT BE EVALUATED. 17. The total number of regional lymph nodes examined is: 0. 19. DETAILED STAGING INFORMATION: Based on the above information, the PRIMARY TUMOR is classified as: TNM Scheme. FIGO Scheme. Definition. T3c. IIIC. Macroscopic peritoneal metastasis beyond true pelvis measuring > 2 cm in greatest. dimension,. OR Regional lymph node metastasis OR Metastasis to capsule of liver. THE REGIONAL LYMPH NODES are classified as: NX (Nodal status cannot be assessed). THE STATUS OF DISTANT TUMOR SITES is classified as : MX. (Status cannot be assessed). 20. The FINAL AJCC/UICC/FIGO STAGE IS: AJCC/UICC/FIGO. X. Insufficient data to assign stage. The pathologic stage assigned here should be regarded as provisional, and may change after. integration of clinical data not provided with this specimen."
BIOCUP_00281,ovary,OV,TCGA-24-1464,TCGA-24-1464.242047B0-E0E3-4BA3-A0DF-95887392602E,"Accession # : Gender: F. Patient Typ. Physician (s) : Other Related Clinical Data: DIAGNOSIS: OVARY, LEFT, SALPINGO-OOPHORECTOMY. - POORLY DIFFERENTIATED ADENOCARCINOMA (SEE COMMENT). OVARY, RIGHT, SALPINGO-OOPHORECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOMY. - PERITUBAL SIMPLE CYST. SPECIMEN LABELED ""HERNIA SAC AND NODULE, "" EXCISION. - POORLY DIFFERENTIATED ADENOCARCINOMA. UTERUS, CERVIX, TOTAL ABDOMINAL HYSTERECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. UTERUS, ENDOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - DISORDERED PROLIFERATIVE ENDOMETRIUM. - ENDOMETRIAL POLYP. UTERUS, MYOMETRIUM, ABDOMINAL HYSTERECTOMY. - EXTENSIVE INVOLVEMENT OF LYMPHATIC SPACES BY METASTATIC ADENOCARCINOMA. LYMPH NODE, RIGHT COMMON, EXCISION. - NO CARCINOMA IDENTIFIED IN ONE LYMPH NODE (0/1). Printed from. LYMPH NODES, RIGHT EXTERNAL ILIAC, EXCISION. - METASTATIC ADENOCARCINOMA INVOLVING TWO OF TWO LYMPH NODES (2/2). LYMPH NODES, RIGHT OBTURATOR, EXCISION. - METASTATIC ADENOCARCINOMA INVOLVING TWO OF TWO LYMPH NODES (2/2). LYMPH NODES, LEFT EXTERNAL ILIAC, EXCISION. - METASTATIC ADENOCARCINOMA INVOLVING ONE OF TWO LYMPH NODES (1/2). LYMPH NODES, LEFT OBTURATOR, EXCISION. - METASTATIC ADENOCARCINOMA INVOLVING TWO OF SIX LYMPH NODES (2/6). LYMPH NODES, RIGHT PERI-AORTIC, EXCISION. - METASTATIC ADENOCARCINOMA INVOLVING TWO OF TWO LYMPH NODES (2/2). LYMPH NODE, LEFT PERI-AORTIC, EXCISION. METASTATIC ADENOCARCINOMA INVOLVING ONE LYMPH NODE (1/1). OMENTUM, OMENTECTOMY. - NO CARCINOMA IDENTIFIED. APPENDIX, APPENDECTOMY. - METASTATIC ADENOCARCINOMA INVOLVING PERIAPPENDICEAL SOFT TISSUE. - MUCOCELE. SMALL INTESTINE, MESENTERIC MASS, EXCISION. - METASTATIC ADENOCARCINOMA (SEE COMMENT). By this signature, I attest that the above diagnosis is based upon my. personal examination of the slides (and/or other material indicated in the diagnosis) . Intraoperative Consultation: #2, section of umbilical hernia ""nodule"", resection - pick up. only. FS1 - Left ovary mass. - ""Adenocarcinoma"" by. Microscopic Description and Comment: Histologic sections from the left ovarian mass show. a poorly differentiated adenocarcinoma. The tumor is present predominantly in sheets of. cells with large vesicular nuclei and occasional tumor giant cells. In some areas the. tumor is present in thin single file cords invading a desmoplastic stroma. Other areas show. rhabdoid features with perinuclear eosinophilic cytoplasm. A significant minority of the. tumor forms well-defined endometrioid-type glands. These glands appear to be present in. an adenofibromatous stroma. Metastatic adenocarcinoma extensively involves the lymphatics. of the myometrium but no serosal implants are present. The endometrium has been entirely. submitted and exhibits a disordered proliferative pattern but no carcinoma is identified. The right ovary (enitrely submitted) and both fallopian tubes are free of carcinoma. Metastatic adenocarcinoma is present in periappendiceal soft tissue. The appendix also. contains a focal mucocele but no carcinoma involving epithelium is present. Metastatic. adenocarcinoma is present in 2 of 2 right external iliac lymph nodes, 2 of 2 right obturator. lymph nodes, lof 2 left external iliac lymph nodes, 2 of 6 left obturator lymph nodes, 2 of. 2 right peri-aortic lymph nodes, and 1 of 1 left peri-aortic lymph nodes. One right common. iliac lymph node is free of carcinoma. Poorly differentiated adenocarcinoma is present in. Printed from. the specimen labeled ""umbilical hernia and nodule. The single submitted section from the. specimen labeled ""small bowel mesenteric mass"" appears to represent near total replacement. of a large lymph node The omentum is free of carcinoma. Given the somewhat unusual morphologic features immunostains were performed. The tumor is. negative for gross cystic disease fluid protein an antibody that stains approximately 60 to. 80% of breast carcinomas. The tumor is focally positive for S-100 and is strongly positive. for CA-125 in the better differentiated endometrioid areas. Although the morphologic. features and tumor distribution are somewhat unusual, in the absence of another primary. tumor these features are consistent with a mullerian (ovarian) primary. has reviewed selected slides and concurs with this interpretation. (D: History: The patient is a. year old woman with an abdominal mass. Operative procedure : Hysterectomy, removal of abdominal mass, multiple node samplings. Specimen (s) Received: A: MASS, LEFT OVARY. B: UMBILICAL HERNIA IT\ NODULE. C: UTERUS CERVIX RIGHT OVARY RIGHT TUBE. D: RIGHT COMMON NODES. E: RIGHT EXTERNAL NODES. F: RIGHT OBTURATOR NODES. G: OMENTUM. H: EXTERNAL NODES, LEFT. I: LEFT OBTURATOR NODES. J: RIGHT PERI AORTIC NODES. K: LEFT PERI AORTIC NODES. L: APPENDIX. M: SMALL BOWEL MESSENTARY MASS. Gross Description Thirteen formalin-filled containers are received, each labeled with the. patient's name. The first container is labeled ""uterus, left ovary and tube.' It contains a. white cassette labeled FS1. It contains a section of white-tan mass, measuring 1.5 x 1.8 x. 0.2 cm. Labeled Al - FS. Also present in the container is a large irregularly shaped mass,. measuring 18 x 15 x 14 cm and weighing 1100 grams after fixation. The surface is covered. by a glistening membrane, is irregular, nodular and partially hemorrhagic. No tumor is. evident outside the capsule. There is a thin walled cyst present, measuring 4 x 3.5 x 6 cm. A fragment of the left fallopian tube is present on the surface of the mass, measuring 4.5. cm in length and 0.3 cm in diameter. The fimbriae are not evident. On sectioning, the tumor. mass is mostly solid, firm, tan-brown with areas of hemorrhage and necrosis. Only minute. cystic areas are present except the previously described cyst. No normal ovarian parenchyma. is identified. No uterus is present in the container. Labeled: A2 - left fallopian tube; A3. to All - sections of the tumor. Jar 5. The second container is labeled ""section of umbilical hernia and nodule."" It contains. an elliptical excision of skin including the umbilicus, measuring 4.5 x 1.2 cm on the. skin surface and 5 cm from skin surface to deep resection margin. The skin surface. is unremarkable. The deep resection margin is inked black. Sections show a tan-pink,. circumscribed nodule, measuring 3 x 2 x 1.5 cm. The mass does not reach the inked margin. Labeled B1. Jar 1. The third container is labeled ""uterus, cervix, right ovary, right tube."" It contains. the uterus with attached right fallopian tube and ovary, weighing 86 grams and measuring 5. Printed from. cm from cornu to cornu, 9.8 cm from cornu to cervix, and 3.0 cm anterior-posteriorly. The. cervix measures 3.5 x 2 cm, scant ectocervix is present. The endocervix measures 3.8 cm in. length and 1.5 cm in diameter, and is unremarkable. The endometrial cavity measures 5.5 x. 3.0. cm. The endometrium is 0.1 cm thick, slightly nodular and hemorrhagic. There is a 0.: x 0.5 cm endometrial polyp present in the left cornu. The myometrium is 1.5 cm thick and. unremarkable. The serosa is unremarkable. The right fallopian tube measures 5 cm in length. and 0.3 cm in diameter. The attached right ovary measures 2.8 x 1. x 0.6 cm. Sections are. unremarkable. Labeled: C1 - anterior cervix; C2 - anterior endomyometrium; C3 - anterior. endomyometrium with endometrial polyp; C4 - posterior cervix; C5 - posterior endomyometrium;. C6 - right fallopian tube; C7 - right ovary, C8 -remainder of the right ovary, EM9-EM20. remainder of endometrium. Jar 2. The fourth container is labeled ""R common node. It contains two fragments of fibrofatty. tissue,. measuring 1 x 0.8 x 0.3, and 1. 8 x 0.5 x 0.5 cm. No lymph node is grossly identified. in the fat. Labeled D1. Jar 0. The fifth container is labeled ""R external node.' It contains multiple fragments of. fibrofatty tissue, measuring 5.5 x 3 x 1 cm in aggregate. Two lymph nodes are dissected. from the fat, measuring 0.3 x 0.2 x 0.2 and 2 x 1.5 x 1 cm. The larger lymph node is grossly. suspicious for metastasis. Labeled E1. Jar 1. The sixth container is labeled ""Rt obturator node.' It contains several fragments of. fibrofatty tissue, measuring 1.5 x 3 x 1.5 cm in aggregate. Two lymph nodes are dissected. from the fat, measuring 3 x 0.5 x 0.5 and 2 x 1 x 1 cm. Labeled F1. Jar 1. The seventh container is labeled ""omentum."" It contains the omentum, measuring 44. x. 15. x. 1.5 cm. It is yellow, soft and fatty. Sections show no identifiable lesion. Labeled. G1. to. G5. Jar 2. The eighth container is labeled ""L external node.' It contains several fragments of. fibrofatty tissue, measuring 4.5 x 3 x 1.5 cm in aggregate. Several lymph. nodes. are. dissected from the fat. Labeled H1. Jar 1. The ninth container is labeled ""L obturator L node.' It contains several fragments of. fibrofatty tissue, measuring 4 x 2.5 x 2 cm in aggregate. Several lymph nodes are dissected. from the fat, two of them show replacement of their parenchyma by white, firm tumor tissue. Labeled Il and I2. Jar 1. The tenth container is labeled ""right periaortic node.' It contains three fragments of soft. tissue, measuring 1 x 0.2 x 0.2, 2 x 0.5 x 0.2, and 2.5 x 0.8 x 0.5. The smallest fragment. contains a surgical staple. Several lymph nodes are dissected from the fat. Labeled J1. Jar. 1. The eleventh container is labeled ""left periaortic node.' It contains a single fragment. of. soft tissue with two surgical staples, measuring 1.5 x 1.5 x 0.5 cm. Sections show one lymph. node. Labeled K1. Jar 1. The twelfth container is labeled ""appendix."" It contains an appendix, measuring 6.5 x 0.5. x 0.5 cm. The serosa is unremarkable, except an attached lymph node at the tip. The wall. measures 0.1 cm in thickness. The lumen is not identifiable. Labeled L1-L4. Jar 1. The thirteenth container is labeled ""small bowel mesenteric mass.' It contains eight. fragments of partially serosa-covered, tan-white, irregularly shaped nodules. They range. in size from 1 to 4.5 cm in largest diameter. Sections show firm, tan-white, partially. hemorrhagic and necrotic tumor. Labeled M1. Jar 1. Printed from. Synopsis SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS 1. A neoplasm is. PRESENT 2. The HISTOLOGIC DIAGNOSIS is: Adenocarcinoma. 3. The LOCATION (S) OF THE PRIMARY TUMOR (S) is/are: Left ovary only. 4. The FIGO GRADE of the tumor is: III (Tumor composed of >50% solid cellular nests). 5. The NUCLEAR (BRODERS') GRADE of the tumor is: G3. (Poorly-differentiated). Tumor IS NOT identified on the ovarian surface (s) . 7. Tumor DOES invade the mesovarium. 8. Tumor DOES NOT invade the adjacent fallopian tube. 9. Invasion of pelvic soft tissue cannot be assessed. 10. Tumor involvement of the pelvic peritoneum CANNOT BE EVALUATED. 11. Metastatic involvement of the EXTRAPELVIC PERITONEUM is PRESENT. 12. Metastatic involvement of the omentum is ABSENT. 13. The maximum dimension of tumor implants outside the true pelvis is 3.0. cm. 14. Metastatic involvement of the uterine serosa is ABSENT. 15. Metastatic involvement of the endometrium is ABSENT. 16. Regional lymph node metastases are PRESENT. 17. The total number of regional lymph nodes examined is: 16. 18. The total number of metastatically-involved regional lymph nodes is: 10. Extranodal extension by tumor metastases is ABSENT. 19. DETAILED STAGING INFORMATION: Based on the above information, the PRIMARY TUMOR is classified as : TNM Scheme. FIGO Scheme. Definition. T3c. IIIc. regional. lymph node metastases. THE REGIONAL LYMPH NODES are classified as: N1 (Nodes contain metastatic tumor). THE STATUS OF DISTANT TUMOR SITES is classified as: MX 20. The FINAL AJCC/FIGO STAGE IS: AJCC Scheme. FIGO Scheme. x insufficient data to assign stage The pathologic stage assigned here should be regarded. as provisional, and may change after integration of clinical data not provided with this. specimen. Printed from."
BIOCUP_00282,ovary,OV,TCGA-24-2019,TCGA-24-2019.15a77e5d-acfb-4013-81de-ef9d2f6398d1,"DIAGNOSIS: OVARY, RIGHT, BILATERAL SALPINGO-OOPHORECTOMY(INCLUDING FS1). - POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. - ADENOCARCINOMA INVOLVES THE OVARIAN SURFACE. - SEE COMMENT AND SYNOPTIC. FALLOPIAN TUBE, RIGHT, BILATERAL SALPINGO-OOPHORECTOMY. - METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA IN PERITUBAL SOFT TISSUE. - ENDOMETRIOSIS. - FOCAL TUBAL INTRAEPITHELIAL NEOPLASIA. OVARY, LEFT, BILATERAL SALPINGO-OOPHORECTOMY. - POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. - ADENOCARCINOMA INVOLVES THE OVARIAN SURFACE. FALLOPIAN TUBE, LEFT, BILATERAL SALPINGO-OOPHORECTOMY. - METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA IN PERITUBAL SOFT TISSUE. - ENDOMETRIOSIS. - FOCAL TUBAL INTRAEPITHELIAL NEOPLASIA. UTERUS, CERVIX, TOTAL ABDOMINAL HYSTERECTOMY. - CHRONIC INFLAMMATION WITH FOLLICULAR CERVICITIS. UTERUS, ENDOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - LATE SECRETORY PATTERN. UTERUS, MYOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - ADENOMYOSIS. UTERUS, SEROSAL SURFACE, TOTAL ABDOMINAL HYSTERECTOMY. - METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. SOFT TISSUE, ANTERIOR CUL-DE-SAC, EXCISION. - METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. SOFT TISSUE, LABELED ""LEFT PELVIC LYMPH NODE,"" EXCISION. - METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. - SEE COMMENT. Page: 1 of 5. SOFT TISSUE, SIGMOID COLON TUMOR, EXCISION. - METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. SOFT TISSUE, LABELED ""ANTERIOR ABDOMINAL WALL NODULE,"" EXCISION. - METASTATIC ADENOCARCINOMA IN TWO OF TWO LYMPH NODES (2/2). SOFT TISSUE, RECTAL NODULE, EXCISION (FS2). - METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. SOFT TISSUE, OMENTUM, OMENTECTOMY. - METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. - NO EVIDENCE OF MALIGNANCY IN ONE INCIDENTAL LYMPH NODE. SOFT-TISSUE; LABELED ""RIGHT DIAPHRAGM TUMOR,"" EXCISION. - METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. SOFT TISSUE, ILEAL NODULE, EXCISION. - METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. SMALL INTESTINE, TERMINAL ILEUM, ILEOCOLECTOMY. - SEROSAL IMPLANTS OF METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. - SEROSAL ADHESIONS. LARGE INTESTINE, CECUM, ILEOCOLECTOMY. - SEROSAL IMPLANTS OF METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. SEROSAL ENDOMETRIOSIS WITH ASSOCIATED DENSE FIBROSIS AND ADHESIONS. LYMPH NODES, MESENTERIC, EXCISION. - METASTATIC ADENOCARCINOMA IN ONE OF FIVE LYMPH NODES (1/5). SOFT TISSUE, RIGHT PELVIC NODULE, EXCISION. METASTATIC POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. SKIN AND SOFT TISSUE, UMBILICUS, EXCISION. - NO EVIDENCE OF MALIGNANCY. By this signature, I attest that the above diagnosis is based upon my personal. examination of the slides(and/or other material indicated in the diagnosis). Intraoperative Consultation: An Intraoperative non-microscopic consultation was obtained and interpreted as: ""Brought to frozen is a 'right tube and. ovary,' consisting of an 80 gram, 9.5 x 3 X 8.2 cm multicystic and solid mass. Numerous excrescenses are present on. the surface of the ovary. Sectioned to show a complex, multicystic mass without identifiable residual normal ovarian. parenchyma. Portion frozen as 'FS1.' Rest for permanents,"" by. ""Called to pick up 'left tube and ovary,' consisting of a 60 gram ovary reportedly in formalin for a few minutes. A. tan-brown, heterogeneous tumor is sampled for. Rest for permanents,"". FS1; Ovary, right, biopsy. ""Poorly differentiated adenocarcinoma. favor Mullerian,"" by. FS2: Soft tissue, rectal nodule, blopsy. Page: 2 of 5. Microscopic Description and Comment: Histologic evaluation of the ovarian mass shows poorly differentiated serous adenocarcinoma. While the majority of. the tumor shows typical serous features, focal areas have cytologic features reminiscent of neuroendocrine. differentiation including nuclear molding and a lack of prominent nucleoli; these areas also show immunoreactivity for. the neuroendocrine markers chromogranin and synaptophysin (immunoreactivity with pan-cytokeratin is also noted). Focal expression of neuroendocrine markers in serous adenocarcinoma has been described in the literature, however,. Examination of the specimen labeled ""left pelvic lymph node,"" which was entirely submitted for histologic examination,. shows metastatic poorly differentlated serous adenocarcinoma. Fragments of lymphoid tissue are present, but there is. no definitive lymph node architecture. The findings could represent a lymph node that has been effaced by metastatic. disease, or a soft tissue tumor deposit of adenocarcinoma with a lymphocytic response. Clinical correlation is required. History: The patient is a. with an ovarian mass. Operative procedure: Exploratory laparotomy, total. abdominal hysterectomy, bilateral salpingo-oophorectomy and tumor debulking. Specimen(s) Received: A: RIGHT OVARY AND TUBE. B: ANTERIOR CULDESAC. C: LEFT PELVIC LYMPH NODE. D: LEFT OVARY AND TUBE. E: UTERUS AND CERVIX. F: SIGMOID COLON TUMOR. G: ANTERIOR ABDOMINAL WALL NODULE. H: RECTAL NODULE. I: OMENTUM. J: RIGHT DIAPHRAGM. K: ILEO NODULE. L: ILEUM AND CECUM. M: RIGHT PELVIC NODULE. N: UMBILICUS. Gross Description;. The specimens are received in fourteen formalin-filled containers each labeled. The first container is. labeled ""right tube and ovary/ FS1/X."" It holds a white tissue cassette labeled ""ST that contains a frozen section. remnant measuring 2 x 1.5 x 0,2 cm. Labeled A1 (FS1). Also in the container is a previously sectioned, 9.5 x 3 x 8.2. cm ovary. The serosal surface is studded with multiple, tan-white, papillary excrescences. The ovary has been. sectioned to show a multicystic mass with no grossly identifiable normal ovarian parenchyma. On cut surface, the. mass has papillary features and is solid in many areas. Along one surface is a 4.5 x 0.5 cm portion of fallopian tube. Paratubal adhesions with tumor are noted at the fimbriated end. Labeled A2 to A5 - additional sections of mass; A6 -. fallopian tube with paratubal adhesions. The second container is labeled ""anterior cul de sac."" It holds multiple tan tissue fragments, measuring 2.5 x 2 x 0.2. cm in aggregate. Many of the fragments have a slightly papillary architecture, consistent with invoivement by. metastatic disease. The third container is labeled ""left pelvic lymph node. It holds a tan-brown tissue fragment, measuring 2x2x0.2 cm. No definitive lymphoid tissue is identified. Dane. 2 of F. The fourth container is labeled ""left tube and ovary."" It holds a 67 gram specimen measuring 8 x 8 X up to 5 cm. The. majority of the ovarian surface is involved by a tan papillary tumor. The ovary is sectioned to show extensive tumor. involvement. Multiple hemorrhagic cysts are also present. Along one surface is a 3.5 x 0.5 cm portion of fallopian tube. with no definitive serosal nodules. Labeled D1 - intraparenchymal and serosal involvement by tumor; D2, D3 -. additional sections of tumor; D4 - fallopian tube. The fifth container is labeled ""uterus and cervix."" It holds a 140 gram uterus measuring 9 cm in length, 8 cm cornu to. cornu, and 4 cm anterior to posterior. The bilateral adnexa are absent. The 3 X 3.5 cm tan ectocervix has multiple. pinpoint areas of mucosal dark red congestion. The serosal surface has multiple serosal densities (0.1 to 0.2 cm),. present primarily over the posterior aspect. The 2,8 cm long endocervical canal is lined by unremarkable mucosa. Scattered Nabothian cysts are present. The 4 x 2.2 cm endometrial cavity is unremarkable. The endometrium. measures 0,2 cm thick with a myometrial thickness of 1.5 cm. Labeled E1 - anterior ectocervix; E2 - posterior. ectocervix; E3 - anterior endomyometrium; E4 - posterior endomyometrium; E5 - posterior serosal nodules. The sixth container is labeled ""sigmold colon tumor."" It holds multiple pieces of fibroadipose tissue measuring 2 x 1 x. 0.3 cm in aggregate. Many of the tissue fragments are consistent with involvement by metastatic disease. Filtered and. wrapped. The seventh container is labeled ""anterior abdominal wall nodule."" It holds two pieces of fibroadipose tissue measuring. 1.5 x x and 1 x nex 0.2 cm. Both pieces have firm white densities, consistent with involvement by metastatic. disease. The eighth container is labeled ""rectal nodule/FS2."" It holds a frozen section remnant measuring 1 X 0.3 x 0.2 cm. Labeled H1 (FS2). The ninth container is labeled ""omentum."" It holds a piece of fibroadipose tissue measuring 20 x 10 x 3 cm. The. specimen is studded with innumerable white firm nodules, the largest measuring 4,5 cm in greatest dimension. The tenth container is labeled ""right diaphragm tumor. It holds tan, clear, thin tissue fragment measuring 0.5 x 0.5 x. 0.1 cm. Filtered. Wrapped. The eleventh container is labeled ""ileal nodule."" it holds multiple tan-brown tissue fragments, measuring 0.7 x 0,5 x 0.2. cm, in aggregate. Filtered. Wrapped. The twelfth container is labeled ""ileum and cecum."" It holds an ileocolectomy specimen consisting of terminal ileum. (8.5 x 2 cm) and cecum (10 x 3 cm). The serosal surface and the mesenteric fat of both the terminal ileum and cecum. are involved by tan friable tumor nodules that range from 0.1 cm to 3 cm in maximal dimension. The pericecal soft. tissue is sectioned to show multiple lymph nodes. No appendix is identified. Labeled L1 - terminal ileum margin; L2. terminal ileal serosal nodule; L3 - cecal margin; L4 - additional section of cecum with serosal irregularity; L5 - pericecal. mass; L6 - lymph nodes. The thirteenth container is labeled ""right pelvic nodule."" It holds a slightly firm tan piece of fibrous tissue, measuring 1. x 0.5 x 0.2 cm. Wrapped. The fourteenth container is labeled ""umbilicus."" It holds a umbilicus specimen with a 4 X 1,5 cm tan, hairbearing skin. ellipse with a central umbilicus measuring 1.5 X 0.1 cm. The subcutaneous tissue is tan-yellow and measures a depth. of 3 cm. No definitive lesions or masses are noted. SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS. HISTOPATHOLOGIC TYPE. The histologic diagnosis is serous adenocarcinoma. TUMOR LOCATION. Page: 4 of 5. The locations of the primary tumor(s) are the right and left ovary (synchronous primary tumors). HISTOLOGIC GRADE. The histologic grade is poorly differentiated (G3). TUMOR INVASION. Tumor is identified on the ovarian surface(s). Tumor does invade the adjacent fallopian tube/peritubal soft tissue. TUMOR INVOLVEMENT. Tumor involvement of the pelvic peritoneum/soft tissue is present. Metastatic involvement of the extrapelvic peritoneum is present. Metastatic involvement of the omentum is present. TUMOR-SIZE. The maximum dimension of tumor implants outside the true pelvis is greater than or equal to 2 cm. PRIMARY TUMOR (T). Based on the above information, the primary tumor is classified as macroscopic peritoneal metastasis beyond pelvis. more than 2 cm in greatest dimension or regional lymph node metastasis (T3c/IIIC). REGIONAL LYMPH NODES (N). The regional lymph nodes are classified as regional lymph node metastasis (N1). The total number of regional lymph nodes examined is 8. The total number of metastatically-involved lymph nodes is 3. DISTANT METASTASIS (M). The status of distant tumor site cannot be assessed (MX). STAGE GROUPING. The Final AJCC/UICC/FIGO stage is T3c/N1/MX (Stage X). The pathologic stage assigned here should be regarded as provisional, and may change after integration of clinical. data not provided with this specimen."
BIOCUP_00283,ovary,OV,TCGA-10-0937,TCGA-10-0937.2a86dcb5-1af7-447d-b20f-eef4972048a0,"(A) OMENTUM: HIGH-GRADE SEROUS CARCINOMA. (B) RIGHT FALLOPIAN TUBE AND OVARY: OVARY, HIGH-GRADE SEROUS CARCINOMA. (SEE COMMENT). FALLOPIAN TUBE, MESOSALPINGEAL INVOLVEMENT BY HIGH-GRADE SEROUS CARCINOMA. (C) LEFT FALLOPIAN TUBE AND OVARY;. OVARY, HIGH-GRADE SEROUS CARCINOMA. Fallopian tube, no tumor present. (D) UTERUS AND CERVIX: HIGH-GRADE SEROUS CARCINOMA INVOLVING UTERINE SEROSA. Proliferative endometrium with adjacent benign endometrial polyp. Myometrial teiomyoma. Cervix, squamous metaplasia. (E) CUL-DE-SAC TUMOR: HIGH-GRADE SEROUS CARCINOMA. (F) SIGMOID COLON: HIGH-GRADE SEROUS CARCINOMA INVOLVING SEROSA AND PERICOLIC ADIPOSE TISSUE. Colon resection margins free of tumor. GROSS DESCRIPTION. (A). OMENTUM - A piece of omentum infiltrated by tumor. The overall specimen dimensions are 14.5 x 8.5 X 1.5 cm. Tumor. comprises approximately 40-50% of the specimen volume. The areas of tumor have a solid pale-gray to white cut surface and are. interspersed within fat lobules, imparting a firm consistency to the specimen. SECTION CODE: A1-A3, representative frozen section; A4-A8, additional representative sections of tumor. FS/DX: SEROUS CARCINOMA, MOST LIKELY HIGH GRADE. (B). RIGHT. TUBE, RIGHT OVARY - A tumor distorted right ovary, 4.0 X 4.5x2.5 cm and a fallopian tube which is 6.2 cm long with. a diameter of 1.5 cm. The fallopian tube has a surface nodule measuring 0.9 X 0.8 x 0.3 cm. Otherwise, the fallopian tube surface. is purple-gray and smooth. The ovary is approximately 40% replaced by a solid tan, fleshy tumor with a friable consistency. The remainder of the. ovarian parenchyma is pink-tan with a hemorrhagic 1.3 cm corpus luteum cyst identified. There is a 0.1 to 0.2 cm thick rim of. white ovarian cortical tissue around the uninvolved ovar√≠an parenchyma. SECTION CODE: B1, ovary with corpus luteum cyst; B2, ovary with corpus luteum cyst; B3, B4, ovary with tumor; B5, B6,. representative sections of fallopian tube. (C) LEFT TUBE AND OVARY - The specimen consists of left adnexal tissue. There is a 5.5 cm long fallopian tube with a. diameter of 0.9 cm. The left ovary meast 3.5 x 2.5 X 1.6 cm and has a tan to white. lated external surface. There is a 1.5 X. 1.0 X 1.2 cm white solid nodule with a friaure cut surface arising adjacent to (possibly within) the ovarian parenchyma. This nodule. appears circumscribed. The outer surface of the ovary is covered by a white to tan layer of tumor, 0.1 to 0.2 cm in thickness. The. ovarian parenchyma is pink-tan with a 1.2 cm fluid-filled cyst identified, as well as a 0.7 cm corpus luteum cyst. No lesions are. grossly identified on the fallopian tube surface. A representative portion of the solid nodule is submitted to the tumor bank. SECTION CODE: C1, ovary; C2, ovarian nodule; C3 is ovary and representative section of nodule; C4 is ovary; C5,. fallopian tube; C6, ovarian cyst. (D) UTERUS, CERVIX - A hysterectomy specimen (10.2 X 7.2 X 5.9 cm). The serosa has a tumor nodule at the posterior. peritoneal reflection measuring 2.5 x 2.5 X 1.2 cm. The anterior serosa has a large irregular plaque-like area measuring 5,5 X 5.5. cm up to 0.3 cm in thickness. The endometrium is 0.3 cm in thickness. On the posterior wall of the uterus is a 0,4 X 0.3 X 0.3 cm endometrial polyp. The myometrium is tan and unremarkable except for four white whorled nodules ranging from 0.5 to 2.0 cm in greatest dimension. The largest is calcified and does not permit sectioning with the scalpel blade. The second largest measures 1.5 cm in greatest. dimension and has a rubbery pink-tan cut surface. The exocervix is smooth, tan glistening and unremarkable. SECTION CODE: D1, posterior endometrial polyp and posterior endometrium; D2, posterior cervix; D3, lower uterine. segment and serosal tumor, posterior; D4, tumor at posterior peritoneal reflection; D5, posterior endometrium; D6, anterior cervix;. D7, anterior endometrium; D8, anterior serosa; D9, anterior lower uterine segment; D10, anterior serosa. (E). CUL-DE-SAC TUMOR - Multiple tan-white irregular fragments of tissue (7.0 X 5.0 X 2.0 cm) in aggregate. Representative. sections in cassettes E1-E3,. (F) SIGMOID COLON - A segment of sigmoid colon measures 11.0 cm in length with attached pericolonic adipose tissue. Multiple irregular lesions were identified on the surface of the colon invading the submucosa of colon. Colonic mucosa is. unremarkable. Tumor nodule is abutting to one resection soft tissue margin. Multiple lesions measure ranging from 1.0: X 1.0 x 0.5. cm up to 6.0 X 5.0 X 3.0 cm. Multiple lymph nodes were identified in the pericolonic adipose tissue measures ranging from 0.2 X. 0.2 x 0.2 cm up to 1.0 X 0.7 x 0.5 cm. Representative sections are submitted. INK CODE: Black - surface of the specimen. SECTION CODE: F1, entire shaved section from one of the resection margins; F2-F3, entirely shaved section from the. other resection margin; F4-F7, representative section from the largest lesion; F8-F13, representative section from other different. nodules; F14-F23, six possible lymph nodes for each; F24, four possible lymph nodes. CLINICAL HISTORY. None given."
BIOCUP_00284,ovary,OV,TCGA-24-1426,TCGA-24-1426.72914511-b2f7-484f-a7ab-3f4f1868f2cb,"Accessioned. DIAGNOSIS: OVARIES, LEFT, PROCEDURE NOT STATED (INCLUDING FS1). HIGH GRADE SEROUS CARCINOMA WITH EXTENSIVE SURFACE INVOLVEMENT. SEE SYNOPSIS. FALLOPIAN TUBE, LEFT, PROCEDURE NOT STATED. - HIGH GRADE SEROUS CARCINOMA INVOLVING FALLOPIAN TUBE LUMEN. OVARIES, RIGHT, PROCEDURE NOT STATED (INCLUDING FS1). - HIGH GRADE SEROUS CARCINOMA WITH EXTENSIVE SURFACE INVOLVEMENT. FALLOPIAN TUBES, BILATERAL, PROCEDURE NOT STATED. - HIGH GRADE SEROUS CARCINOMA INVOLVING FIMBRIA, LYMPHOVASCULAR SPACES AND. FALLOPIAN TUBE LUMEN. UTERUS AND CERVIX, PROCEDURE NOT STATED. - HIGH GRADE SEROUS CARCINOMA INVOLVING UTERINE SEROSA AND OUTER MYOMETRIUM. ADENOMYOSIS WITH TUBAL METAPLASIA AND STROMAL CALCIFICATION. - PROLIFERATIVE ENDOMETRIUM. - LEIOMYOMA. - CERVIX WITH MILD CHRONIC INFLAMMATION. LARGE INTESTINE, ""RECTAL TUMOR,"" BIOPSY. - HIGH GRADE SEROUS CARCINOMA. SOFT TISSUE, FALCIFORM LIGAMENT, BIOPSY. HIGH GRADE SEROUS CARCINOMA. SOFT TISSUE, GASTRIC FOLIC OMENTUM, BIOPSY. - HIGH GRADE SEROUS CARCINOMA. SOFT TISSUE, LESSER CURVATURE OF STOMACH, BIOPSY. - HIGH GRADE SEROUS CARCINOMA. By this signature, F attest that the above diagnosis is based upon my personal. examination of the slides(and/or other matorial Indicated in the diagnosis). Page of 4. Page: 1 of 4. luteum left along with a single cystic space that measures 1.6 cm in greatest dimension. Labeled B1, B2 - anterior and. posterior cervix; B3, B4 - anterior and posterior endocervical canal; B5 to B8 - anterlor and posterior endomyometrlum;. B9 to B12 - tumor; B13 - falloplan tube. Labeled B14 - B24 additional sections. Jar 3. The third container Is liabeled ""rectal tumor."" It consists of multiple fragments of tan-brown and brown-black soft tissue. that measure -3 x3x0.5 cm in aggregate. Labeled C1. Jar 1. The tourth container is labeled ""falciform ligament."" II contains two fragments of lan-yollow and tan-white fibroadipose. tissue that measure 11 x 6 x 3 cm in aggregate. The surface of the fibroadipose tissue is covered with multiple, small,. tan-white nodules that appear granular, consistent with the above described ovarian tumors. The greatest collection. measures 3 cm in greatest dimension. Labeled D1 - representative sections of tumor deposits. Jar 1. The fifth container Is labeled ""gastric follo omentum."" It contains a single plece of omentum that measures 57 x 18 x 3. cm in greatest dimension. The entire omentum is involved by metastatic tumor (omental caking). Labeled E1. Jar 4. The sixth container is labeled ""lesser curvature of stomach."" It contains multiple pieces of fibroadipose tissue that also. appear to be involved by tumor, and measure 6 x 5 x 2.5 cm in aggregate. Labeled F1. Jar 1. SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS. HISTOPATHOLOGIC TYPE. The histologic diagnosis is high grade serous carcinoma. TUMOR LOCATION. The locations of the primary tumor(s) are the right and left ovary. HISTOLOGIC GRADE. The histologic grade is poorly differontiated (G3). TUMOR INVASION. Tumor Is identified on the ovarian surface(s). Tumor does Invade the adjacent fallopian tube/peritubal soft tissue. TUMOR INVOLVEMENT. Tumor involvement of the pelvic peritoneum/soft tissue is present. Tumor involvement of the extrapelvic peritoneum is present. Tumor Involvement of the omentum is present. TUMOR SIZE. The maximum dimension of tumor implants outside the true pelvis is greater than or equal to 2 cm. PRIMARY TUMOR (T). Based on the above information, the primary tumor is classified as macroscopic peritoneal motastasis beyond pelvis. more than 2 cm in greatest dimension or regional lymph node motastasis (T3c/IIIC). REGIONAL LYMPH NODES (N). The regional lymph nodes cannot be assessed (NX). DISTANT METASTASIS (M). The status of distant tumor site is not known (MX). STAGE GROUPING. The Final AJCC/UICC/FIGO stage Is T3c,Nx,Mx (Stage IIIC). The pathologic stage assigned here should be regarded as provisional, and may change after integration of clinical. data not provided with this specimen. Pago 3 of 4. Page: 3 of 4. DOE. Page: 4 of 4."
BIOCUP_00285,ovary,OV,TCGA-61-2087,TCGA-61-2087.fadb191f-2726-4afe-a146-1d912ff4b5b8,"FINAL DIAGNOSIS: PART 1: OVARY, LEFT, RUPTURED TUMOR, EXCISION -. POORLY DIFFERENTIATED OVARIAN SEROUS ADENOCARCINOMA. PART 2: OVARY AND FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY -. A, POORLY DIFFERENTIATED OVARIAN SEROUS ADENOCARCINOMA. B. CAPSULAR RUPTURE. C. BENIGN FALLOPIAN TUBE. PART 3: INTER-PHRENIC MARGIN, LEFT DISTAL, EXCISION -. BENIGN FIBROFATTY AND FIBROMUSCULAR STROMA. PART 4: OVARY AND FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOMY -. A. BENIGN OVARY WITH M√úLLERIAN GLANDULAR INCLUSIONS. B. BENIGN FALLOPIAN TUBE. PART 5: UTERUS AND CERVIX, TOTAL ABDOMINAL HYSTERECTOMY -. A. CHRONIC CERVICITIS WITH REACTIVE SQUAMOUS METAPLASIA AND BENIGN ENDOCERVICAL. GLANDULAR EPITHELIUM. B. HYPERPLASTIC ENDOMETRIAL POLYP. C. LEIOMYOMA. PART 6: LYMPH NODES, RIGHT PELVIC, LYMPH NODE DISSECTION -. NO METASTATIC CARCINOMA IDENTIFIED IN THREE LYMPH NODES (0/3). PART 7: LYMPH NODE, RIGHT COMMON ILIAC, LYMPH NODE DISSECTION -. NO METASTATIC CARCINOMA IDENTIFIED IN ONE LYMPH NODE (0/1). PART 8: LYMPH NODE, RIGHT PERIAORTIC, LYMPH NODE DISSECTION -. NO METASTATIC CARCINOMA IDENTIFIED IN ONE LYMPH NODE (0/1). PART 9: LYMPH NODES, LEFT PELVIC, LYMPH NODE DISSECTION -. NO METASTATIC CARCINOMA IDENTIFIED IN SEVEN LYMPH NODES (0/7). PART 10: LYMPH NODES, LEFT COMMON ILIAC, LYMPH NODE DISSECTION -. NO METASTATIC CARCINOMA IDENTIFIED IN ONE LYMPH NODE (0/1). PART 11: LYMPH NODES, LEFT PERIAORTIC, LYMPH NODE DISSECTION -. NO METASTATIC CARCINOMA IDENTIFIED IN TWO LYMPH NODES (0/2). PART 12: CUL-DE-SAC, POSTERIOR, TUMOR, EXCISION -. REACTIVE FIBROMUSCULAR STROMA WITH RECENT AND OLD HEMORRHAGE AND INFLAMMATION. PART 13: CUL-DE-SAC, ANTERIOR, BIOPSY -. REACTIVE FIBROVASCULAR STROMA WITH INFLAMMATION. PART 14: PERICOLIC GUTTER, LEFT, BIOPSY -. BENIGN SOFT TISSUE,. PART 15: PERICOLIC GUTTER, RIGHT, BIOPSY -. BENIGN SOFT TISSUE. PART 16: OMENTUM, OMENTECTOMY -. BENIGN ADIPOSE TISSUE WITH CHRONIC INFLAMMATION AND REACTIVE MESOTHELIAL. HYPERPLASIA. PART 17: DIAPHRAGM, BIOPSY -. BENIGN MUSCULAR TISSUE. SYNOPTIC - PRIMARY OVARIAN TUMORS INCLUDING BORDERLINE TUMORS. TUMOR LOCATION: Left. PROCEDURE: TAH with salpingo-oophorectomy. TUMOR SIZE: Maximum dimension: 13 cm. TUMOR TYPE: Papillary serous carcinoma. HISTOLOGIC SILVERBERG GRADE: Poorly differentiated (8-9 pts). ARCHITECTURAL PATTERN: Solid (3). CYTOLOGIC ATYPIA: Marked (3). MITOTIC COUNTS / 10hpf: 10-24 (2). HISTOLOGIC GRADE (serous tumors): High grade. VASCULAR INVASION: TUMOR CAPSULE: Ruptured. SURFACE IMPLANTS: Not present. ASSOCIATED OTHER LESION: Surface epithelial inclusion. MALIGNANT CELLS IN ASCITES OR. PERITONEAL WASHING: LYMPH NODES EXAMINED: Total number of lymph nodes examined: 14. LYMPH NODES POSITIVE: Number of positive lymph nodes, Right: 0. Number of positive lymph nodes, Left:0. T STAGE, PATHOLOGIC: pT1c. T STAGE, PATHOLOGIC. T STAGE, PATHOLOGIC continued. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. FIGO STAGE: IC."
BIOCUP_00286,ovary,OV,TCGA-23-2084,TCGA-23-2084.00fd3d04-b48e-434e-8d25-0f0949e796cc,"A/S: Rec: Col: Attending MD: Copies To: DIAGNOSIS: 1-5: ""RIGHT IP NODE"", EXCISION, OMENTUM, PARTIAL OMENTECTOMY,. OMENTUM, BIOPSY, ROUND LIGAMENT, BIOPSY, CUL DE SAC TUMOR"",. EXCISION: -Metastatic high-grade serous carcinoma extensively involving. soft tissues and lymphovascular spaces (regional lymphatics). in all five involved sites. FALLOPIAN TUBE AND OVARY, RIGHT, SALPINGO-OOPHORECTOMY: -Right ovarian serous carcinoma, grade III (see comment). -Ovary (ovarian parenchyma) is nearly totally replaced by. carcinoma. -Serosal surface of ovary is involved by tumor. -Lymphovascular space invasion by tumor in ovary is. extensive. -Fallopian tube with secondary involvement of serosa, wall. and lymphatics, including mucosal lymphatics by serous. carcinoma. -Adnexal soft tissues/ligaments and regional (adnexal). lymphovascular spaces are also extensive involved by. serous carc√≠noma. -Ovary also shows follicular cyst. 7. FALLOPIAN TUBE AND OVARY, LEFT SALPINGO-OOPHORECTOMY: -Left ovary with serous carcinoma, grade III (see comment). -Ovary (ovarian parenchyma) is subtotally replaced by. carc√≠noma. -Serosal surface of ovary is involved by tumor. -Lymphovascular space invasion by tumor within ovary is. extensive. - -Fallopian tube with intramucosal/intraepithelial high-grade. serous carcinoma, serous carcinoma within tubal lymphatics,. and involving serosal surface of fallopian tube. -Serous carc√≠noma also involves adnexal soft tissue/ligament. and lymphovascular spaces within adnexal soft tissues. -Ovary also shows a luteinized follicular cyst, a mesothelial. cyst and stromal edema. 8. [MESENTERY] 'SIGMOID TUMOR"", EXCISION: -Metastatic serous carcinoma virtually replacing soft tissues. and extensively involving regional lymphovascular spaces. 9. LYMPH NODE, LEFT PELVIC, EXCISION: -One lymph node showing near total replacement by metastatic. serous carcinoma (1/1). -Metastatic serous carcinoma is also present in regional. lymphatic and perinodal fat. 10. MESENTERY. -Metastatic serous carc√≠noma extensive involving mesenteric fat. and regional lymphovascular spaces. 11. [MESENTERY/SEROSA), JEJUNUM ""TUMOR EXCISION: -Metastatic serous carcinoma extensively involving soft tissues. (mesenteric fat) and regional lymphovascular spaces. 12. UTERUS, TOTAL ABDOMINAL HYSTERECTOMY: -Serous carcinoma, high-grade (see comment) involving: -Lymphovascular spaces (regional lymphatics) within. endometrial mucosa, uterine wall, including deep aspect of. wall, and subserosal lymphatics of uterus. -Areas of endometrial mucosal involvement by serous. carcinoma, favor metastatic, with intramucosal extension. from involved lymphatics. -Patchy foci of myometrial invasion by serous carcinoma,. including in deep aspect of uterine wall, probably via. extension from involved lymphatics. -Cervix (ectocervix and endocervix) with extensive. lymphovascular space invasion by serous carcinoma. including lymphatics deep within wall, intramucosal. lymphatics and lymphatics near external surface. -Lymphovascular space invasion by serous carcinoma within. cervix extends very close to (within less than 1 mm of the. surgical margin). -other findings include: -Disordered proliferative to focally minimally hyperplastic. endometrium (latter simple type without significant atypia). with focal superimposed secretory-like changes and foci of. ciliated epithelial metaplasia. -Reactive lymphoid aggregates within endometrial mucosa. -Four small uterine leiomyomas, one of which exhibits focal. 'epithelioid features. -Adenomyosis. -Uterine serosal adhesions. -Microglandular endocervical hyperplasia and foci of mild. macroglandular endocervical hyperplasia without significant. cellular atypia. -Foci of ciliated metaplasia of endocervical epithelium. -Endocervical nabothian cysts. -Cervix with minimal (focal) superficial mucosal erosions,. acute and chronic inflammation, reserve cell hyperplasia,. squamous metaplasia, and reactive epithelial changes. -Focal parakeratosis of ectocervical squamous epithelium. 13. ILEUM (TERMINAL), RIGHT COLON, MESENTERY, AND REGIONAL LYMPH. NODES, SEGMENTAL RESECTION: -Metastatic serous carcinoma, multifocal, involving. -A 4 cm diameter area of the decum; tumor involvement of. cecum involves the serosa, subserosa, full thickness of. muscular wall, submucosa and focally the mucosa. -Second 4.5 cm tumor mass involving distal right colon;. involvement of distal right colon is also transmural with. with involvement of serosa, subserosa, full thickness of. muscular wall, submucosa and focally the mucosa. -Regional lymphovascular spaces invasion by tumor in. vicinity of cecal and distal right colon masses, as well. as elsewhere in colon and mesentery/pericolic fat is. extensive. -Multiple other nodular and plaque like deposits of. metastatic tumor ranging from microscopic to about 1 cm. in maximum dimension are present within other segments of. the right colon, the small intestine, and pericolic/. mesenteric fat. -Metastatic carcinoma is present about 1 cm from the. proximal (ileal) margin of resection. -Bulk tumor (nodular aggregate of carcinoma) is present. about 2 cm from the distal (colonic) margin of resection. -Metastatic carcinoma within lymphatics is present about 3. mm from the distal surgical margin. -Four of four mesenteric/pericolic/small intestinal lymph. nodes are positive for metastatic carcinoma (4/4) i the. involved lymph nodes are subtotally replaced by tumor. -Tumor is also present in perinodal lymphatic and perinodal. fat. COMMENT: This high-grade primary ovarian (bilateral ovarian) serous carcinoma. exhibits predominantly solid growth (with a ""undifferentiated""-like. appearance), and also exhibits papillary growth and focal glandular. growth. both fallopian tubes exhibit secondary involvement by. serous carcinoma. In addition, the left fallopian tube shows and. area of intraepithelial/intramucosal carcinoma, which may be primary. to that site. Intraluminal aggregates of serous carc√≠noma are also. present in the left fallopian tube. There is extensive lympho--. vascular space invasion by carcinoma in all involved sites,. including the uterus and cervix. Within the uterus, the endometrial. mucosal involvement by serous carcinoma is predominantly within. lymphatic spaces. There are, however, a few small foci of mucosal. involvement extrinsic to lymphatics. While the latter might. represent primary uterine papillary serous carcinoma, the alternate. possibility that the endometrial deposits of tumor within the. uterus represent secondary extension into the mucosa from involued. lymphatic spaces is favored. Ill all addicional routinely stained sections have been. incorporated in the final diagnosis. HISTORY: Ovarian carcinoma. MICROSCOPIC: See Diagnosis. GROSS: 1. RIGHT I P NODE. Labeled with the patient's name, designated right IP node"" and. received in formalin is an irregular 1.9 x 1.6 x 1.2 cm firm, white-. tan nodular aggregate of tumor. Representative section. A: Tumor - 1. 2. OMENTUM. Labeled with the patient's name, designated ""omentum"", received fresh. in the Operating Room for intraoperative frozen section diagnosis is. a 23 x 12 x 1.3 cm portion of lobulated yellow omental fat which is. extensively involved by nodular and plaque like aggregates of firm,. tan-white tumor, some of the tumor aggregates are confluent. The. largest individual tumor aggregate measures about 3 cm in greatest. dimension. Two representative sections of omental tumor are frozen. and sectioned for intraoperative diagnosis. The remaining frozen. tissue and the rest of the specimen are then fixed in formalin. Representative sections. B: Remnant of frozen section (omental tumor) -. 2. C: Omental tumor - 1. 3. OMENTUM BIOPSY. Labeled with the patient's name, designated ""omentum biopsy"" and. received in formalin is an irregular 4 x 4 x 0.7 cm portion of yellow. omental fat, which is partially replaced by nodular and plaque like. aggregates of firm, tan-white tumor, measuring up to 1.2 cm in. greatest dimensions. Representative sections. D: Omentum with tumor - 1. 4. ROUND LIGAMENT. Labeled with the patient's name, designated ""round ligament"" and. received in formalin are two irregular aggregates of firm, tan-white. tumor each with a small amount of attached uninvolved yellow-tar. focally hemorrhagic fibroadipose tissue. Representative sections. E: Tumor - 2. 5. CUL-DE-SAC TUMOR. Labeled with the patient's name, designated ""cul de sac tumor"" and. received in formalin is a 2.7 x 2.2 x 1 cm aggregate of multiple. irregularly shaped fragments of firm, tan-white tumor, some of which. have a small amount of attached uninvolved hemorrhagic red-tan soft. tissue. Representative sections. F: Tumor - 2. 6. RIGHT TUBE AND OVARY. Labeled with the patient's name, designated right tube and ovary"",. received fresh in the Operating Room and subsequently fixed in. formalin, is a salpingo-oophorectomy specimen including an entire. ovary, and adjacent fallopian tube, and adjacent/intervening adnexal. soft tissues. The ovary is 3.3 x 2.9 x 2.6 cm and has a lobulated. yellow-tan focally nodular external surface with small nodular and. plaque like aggregates of serosal tumor. Cut surfaces of the ovary. reveal near total replacement by firm, variegated tan-white-yellow. tumor. There is minimal residual uninvolved ovarian parenchyma, a. small 0.3 cm diameter fluid-filled cyst is also noted in the ovary,. The fallopian tube, complete with fimbriae at one end is about 6.2 cm. long and has an average cross sectional diameter of about 0.7 cm. The serosal surface of the fallopian tube, particularly near the. fimbriated end is distorted by firm, small nodular and plaque like. aggregates of white-tan tumor. The adnexal soft tissues also are. involved by similar-appearing firm, tan-white tumor aggregate,. measuring up to about 1 cm in diameter. Cross sections of the. fallopian tube reveal a central patent lumen, about 0.3 cm in. diameter, and a 0.2 cm average wall thickness. Representative sections. G: Fallopian tube and mesosalpinx - 2. H-K: Ovary - 1. 7. LEFT TUBE AND OVARY. Labeled with the patient's name, designated left tube and ovary"" and. received in formalin is a salpingo-oophorectomy specimen including. the entire ovary, fallopian tube, and ligamentous adnexal soft. tissues. The ovary is 3.9 x 2.9 x 1.7 cm and has a lobulated tan. external surface. The serosal surface of the ovary is distorted by. nodular and plaque-like aggregates of firm, tan-white tumor,. measuring up to about 0.8 cm in diameter. Cut sections of the ovary. reveal subtotal replacement by firm, tan-white tumor. There is a. small amount of intervening edematous appearing uninvolved ovarian. parenchyma and an amber 1.2 cm diameter cyst with a smooth lining and. a 0.1 cm wall thickness. The fallopian tube, complete with fimbria. at one is 6.3 cm long and has an average cross sectional diameter of. about 0.5 cm. The serosal surface of the fallopian tube is pink-tan. and shows tiny foci, up to about 0.3 cm in diameter of nodular to. plaque like aggregates of firm, tan-white tumor. Cross sections of. the fallopian tube reveal a central patent lumen, about 0.2 cm in. diameter and a 0.1 cm average wall thickness. The adjacent. ligamentous paratubal and paraovarian soft tissues are also partially. replaced by nodular to plaque like aggregates of similar-appearing. firm, tan-white tumor, measuring up to about 0.5 cm in diameter. Representative sections. L: Fallopian tube and mesosalpinx - 2. M-O: Ovary with tumor - 1 each. P: Ovary with tumor and cyst - 2. 8. SIGMOID TUMOR. Labeled with the patient's name, designated ""sigmoid tumor and. received in formalin is a 2.5 x 1.5 x 0.5 cm aggregate of several. irregularly shaped fragments of firm, tan-white tumor, ranging from. about 0.3 to 1.2 cm in greatest dimension. Representative sections. Q: Tumor - 4. 9. LEFT PELVIC NODE. Labeled with the patient's name, designated ""left pelvic node"" and. received in formalin is a 2.5 x 1.4 x 0.8 cm lymph node with scant. attached yellow fat. Cut sections of the lymph node reveal near. total replacement by firm, white-tan metastatic tumor. There is total replacement of lymphoid parenchyma by white firm. Representative section. R: One lymph node - 1. 10. MESENTERIC TUMOR. Labeled with the patient's name, designated ""mesenteric tumor and. received in formalin is a 2 x 1.5 x 0.3 cm aggregate of several. fragments of yellow-tan fibroadipose tissue which are subtotally to. near totally replaced by firm, tan-white tumor. Entirely submitted. S: Mesenteric tumor - multiple. 11. JEJUNUM TUMOR. Labeled with the patient's name, designated ""jejunum tumor"" and. received in formalin are several irregular to nodular aggregates of. firm, tan-white tumor, some of which have a small amount of attached. uninvolved yellow adipose tissue. The individual tumor nodules range. from about 0.5 to 1.5 cm in greatest dimensions. Representative sections. T: Jejunal tumor - multiple. 12. UTERUS. Labeled with the patient's name, designated ""uterus"" and received in. formalin is a 190 gram total hysterectomy specimen. The uterine. corpus is symmetric, measuring 5.8 cm superior to inferior, 5.6 cm. cornu to cornu, and 4.9 cm anterior to posterior. The serosa is. tan-red and roughened with abundant tumor studding. The cervix has. a length of 4.2 cm and a diameter of 4.4 cm There is a 1.1 cm slit-. like patent os. The ectocervical mucosa is pink-white and smooth,. without obvious lesions. The transformation zone is distinct. The. endocervical canal is 2.1 cm in length and is is tan and rugose. The endometrial cavity is 4.5 cm in length, 3.5 cm in width, and. is. lined by a soft red-tan, smooth endometrium with a thickness of 0.3. cm. The endometrium is grossly unremarkable. The myometrium is 3.2. cm in maximum thickness. There are two subserosal and two. intramural sharply circumscribed, firm, whorled, tan-white spherical. leiomyomas, ranging from 0.3 to 2.5 cm in greatest dimension. On. sectioning the cut surfaces are firm, tan-white and whorled without. areas of hemorrhage, necrosis, or calcifications. The myometrium is. otherwise grossly unremarkable. Representative sections. U: Leiomyomas - 4. V: Serosal tumor deposits - 3. W: Anterior uterine corpus - 1. X: Posterior uterine corpus - 1. Y: Anterior cervix-1. Z: Posterior cervix-1. ADDITIONAL REPRESENTATIVE SECTIONS. G2: Uterine fundus - 1. H2: Anterior uterine corpus - 1. I2: Anterior lower uterine segment - 1. J2: Posterior uterine corpus - 1. KK: Posterior lower uterine corpus and lower uterine segment - 1. 13. TERMINAL ILEUM AND RIGHT COLON. Labeled with the patient's name, designated ""terminal ileum and. right colon"" received in the fresh state in the Operating Room for. intra-operative gross consultation and subsequently fixed in. formalin is a segment of right colon, 20.3 cm long and 6.5 cm in. average circumference, with 27.7 cm of attached small bowel that is. 4.9 cm in average circumference. There is moderate pericolic fat. and mesenteric fat. Within the adipose tissue are multiple tumor. nodules. No appendix is identified grossly. The serosa is tan-red. and dull with multiple areas of serosal tumor studding On opening. the bowel contains minimal fecal material. There are two areas of. mucosal protrusion, one is 4.0 cm in greatest dimension in the. cecum, and the other it is 4.5 cm in greatest dimension and is 2.5. cm from the distal margin. These masses are extending in word from. the mesentery and secondarily invade the bowel wall. Representative sections. A2: Proximal margin-1. B2: Distal margin-1. C2: Cecal mass-1. D2: Distal mass-1. E2-F2: Mesenteric nodules/lymph nodes?-2 each. OPERATIVE CONSULT (FROZEN) : OMENTUM, PARTIAL OMENTECTOMY. Poorly differentiated/undifferentiated carcinoma, favor. mullerian-derived. OPERATIVE CONSULT (GROSS) : TERMINAL ILEUM AND RIGHT COLON: - Portion of tumor within mesentery, submitted for clonogenic. assays. Special Studies: Clonogenic assay; inhibin (P), additional H&E-. stained section (L). See Also. the pathologist of record, have. personally the specimen, interpreted the. results, reviewed this report and signed it electronically."
BIOCUP_00287,ovary,OV,TCGA-24-2027,TCGA-24-2027.8a4d0373-9d57-4cf7-ac78-d8b558d43df6,"Name : {. =. Location: (. MR No. : Hosp. No. : DIGnos. OVARY, LEFT, SALPINGO-OOPHORECTOMY: - POORLY DIFFEREN'TIATED PAPILLARY SEROUS ADENOCARCINOMA. - SEROSAL INVOLVEMENT PRESENT. OVARY, RIGHT, SALPINGO-OOPHORECTOMY: - POORLY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA. - SEROSAL INVOLVEMENT PRESENT. FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY. - METASTATIC SEROUS ADENOCARCINOMA. - HYDROSALPINX. FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOHY: - NO EVIDENCE OF MALIGNANCY. UTERUS, HYSTERECTOMY. - SEROSAL INVOLVEMENT BY SEROUS ADENOCARCINOMA. - PROLIFERATIVE PHASE ENDOMETRIUM. - FOCAL ADENOMYOSIS. SOFT TISSUE, OMENTUM, EXCISION: - METASTATIC PAPILLARY SEROUS ADENOCARCINOMA. - LARGEST METASTATIC FOCUS MEASURES 1.0 CM. LYMPH NODES, RIGHT EXTERNAL ILIAC, EXCISION: - METASTATIC SEROUS ADENOCARCINOMA (11/12 NODES). - EXTRACAPSULAR EXTENSION BY TUMOR PRESENT. LYMPH NODES, PARA-AORTIC, EXCISION: - METASTATIC SEROUS ADENOCARCINOMA (7/8 NODES). LYMPH NODES, LEFT EXTERNAL ILIAC, EXCISION: - NO EVIDENCE OF MALIGNANCY 1017 NODES). --1--. a. SPECIMEN (s) SUBMITTED. Part 1i FSI - OVARY, LEFT, EXCISION. Part 2: X1- OVARY, LEFT, EXCISION. Part 3: RIGHT OVARY. Part. 4: UTERUS CERVIX. Part 5: RIGHT EXTERNAL ILIAC LYMPH NODE. Part 6: PARAORTIC LYMPH NODE. Part 7: LEFT EXTERNAL ILIAC LYMPH NODE. Part 8: OMENTUM. HISTORY. The patient is a. who presents with. increasing abdom: CT scall showed a 12 x 6 x 6 cm. mass. Operative procedure: TAH/BSO, lymph node dissection, omentectomy,. ascites evacuation. Clinical diagnosis: Stage III-C ovarian. carcinoma. An intraoperative non-microscopio consultation was obtained and. interpreted as: ""ovary, left - multiple fragments of polypoid. tissue, the largest measuring 14 x 9 x 6 cm. and bearing a. recognizable serosal surface between polypoid projections of. variable (size. 'l'. FROZEN. FS: ovary, left, excision - ""Serous carcinoma. "" by. GROSS. The specimens are received in eight containers of formalin, each. labelled with the patient's name. The first conthiner is. additionally labelled ""FS1 - left ovary"" and consists of a flat. irregular fragment of -soft; tan-white tissue measuring 1.8 x 1.2. x. 0.3 cm., and represents the remnant of the frozen section. Labelled FS. The second container is labelled ""X - left ovary"" and consists of. numerous polypoid fragments of light tan tissue, several which. appear to be partially invested by a thin translucent serosa,. ranging in size from 1.0 cm. in greatest dimension up to 9.0 x 6.0. x. 6. cm. The largest fragment shows obvious serosal involvement. by nodular, focally papillary excrescences. An area that may. representi a portion of distended fallopian tube is identified,. covered by papillary excrescences and numerous firm, tan-white. --2--. surg. Path. GROSS (continued). adherent nodules. The fimbriae are not identified grossly. Serial. sectioning through this region demonstrates a cystically dilated. lumen, and a focal bright yellow focus that may represent a corpus. luteum. Representative sections of the nodular masses labelled XA. through XF, and sections through the distended fallopian tube. segment and adjacent tissue labelled XG and XH,. The third container is labelled ""right ovary"" and consists of. numerous polypoid tissue fragments, some partially invested by. serosa, ranging from 1.0 cm. in greatest dimension up to 9, x 7.5. x. 5.5 cm. In areas where there is recognizable serosa, numerous. polypoid and papillary excrescences are noted on the serosal. surface. Pross=sectioning demonstrates partially solid and cystic. areas of light tan, focally hemorrhagic and necrotic tumor. one. fragment shows a segment of fallopian tube that includes the. fimbriated end, measuring 4.5 cm. in length and up to 0.5 cm. in. diameter. The serosa of the fallopian tube appears smooth and. uninvolved by tumor. However, the attached tissue that may. represent a partially cystic ovary that has been previously opened. is present, again showing numerous papillary excrescences on the. surface, and measures 5.0 x 2.0 x 1.5.cm. The cut section of what. may represent the ovary shows numerous papillary growths both. within and outside of the ovary, Blocks submitted: A1 through A3. - right ovary and fallopian tube; A4 through A8 - representative. remaining nodules. The fourth container is labelled ""uterus and cervix"" and consists. of an 81 gram uterus that measures 8.5 x 5.9 x 4.0 cm. The. uterine serosa is predominantly smooth with a few scattered,. contracted, scar-like nodular areas noted on the anterior surface. The cervix measures 3.3 x 3.0 cm with a transverse os that. measures 0.6 cm. The cervical mucosa is smooth and gray-pink with. scattered petechiae. Attached to the uterus is a portion of the. left adnexal soft-ti-ssue-th-at-measurea 3.5 x 1.0 cm. A. fallopian tube segment or ovary is not identified grossly. The. uterus is bivalved to reveal a roughly triangular endometrial. cavity that measures 3.5 x 1.5 cm lined by a focally hemorrhagic,. flat endometrium that measures less than 0. 1 cm in thickness. The. endocervical canal is grossly unremarkable. Serial sectioning. through the myometrium shows a uniformly trabeculated, pink-tan. myometrium that measures 1.5 cm. in thickness. Blocks submitted. B1 - anterior cervix; B2 - posterior cervix; B3 and B4 - anterior. and posterior endomyometrium; B5 - thickened uterine serosa; .B6. representative leit adnexal tissue. Jar 2. The fifth container is labelled ""right external iliac lymph node"". GROSS (continued). and consists of multiple firm to rubbery fragments of nodular. tissue admixed with adipose tissue measuring in aggregate, 9.5 x. 6.0 x 3.0 cm. The individual nodules grossly appear to be lymph. nodes replaced by tumor and range from 0.9 x 0.5 x 0. cm. up to. groups of enlarged, matted lymph nodes that measure 5.0 x 4.0. x. cm. A representative section of each nodule submitted. labelled C1 through C7 (C6 and C7 represent a section of one lymph. node). The sixth container is labelled 'para-aortic lymph node"" and. consists of multiple irregular, nodular fragments of pink-tan -. tissue measuring in aggregate, 5.5 x 5. x 3:0 cm. The largest. fragment appears to -representmultiple matted nodules and measures. 5.0 x 3.0 x 2.5 cm. Sectioning demonstrates numerous matted. nodules that are grossly replaced by tumor. Blocks submitted: D1. and D2 - largest nodule; D3 - representative section or smaller. nodule. The seventh container is labelled ""left external iliac lymph node"". and consists of multiple sort, irregular fragments of yellow-tan. fibrofatty tissue measuring 5,0 x 3.0 x 1.0 cm. in aggregate. Multiple light tan nodules are dissected from the adipose tissue,. ranging from 0 . 3 cm. in greatest dimension up to 2.5 x 1.0 x 0,3. cm. The eighth container is labelled ""omentum"" and consists of a flat,. irregular sheet of soft, yellow omental adipose tissue that. measures 35 x 11 x 1 cm. A focal firm area is palpable, and. sectioning in this region demonstrates a tan-yellow nodule that. measures 1.5 cm. in greatest dimension. Sectioning through the. remainder of the omentum shows no grossly visible nodules, The. palpable nodule is labelled F1 and representative remaining tissue. is labelled F2 and F 3 . COMMENT. Both the right and left ovaries are replaced by a poorly. differentiated papillary serous adenocarcinoma. The tumor shows a. predominant papillary and cribriform architecture but also shows. significant areas of solid proliferation Cystic areas lined by. flautened layers of tumor cells are also present. The tumor cells. are large with marked cellular and nuclear pleomorphism, and. moderate amounts of granular eosinophilic cytoplasm. Mitotic. figures are numerous and ioci of necrosis are easily identified. Focal areas also show clear cell differentiation. --4--. COMMENT (continued). The tumor grossly and microscopically involved the surfaces of the. ovaries, the mesovarium, and microscopically also involved the. left fallopian tube. The thickened areas on the uterine serosa. noted grossly represented foci of metastatic tumor. Many of the. regional lymph nodes were replaced by tumor, and some of the. nodules showed no identifiable residual lymph node tissue, and may. represent soft tissue metastases. SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS. 1a. A neoplasm is PRESENT. 2. The HISTOLOGIC DIAGNOSIS, is: Serous adenocarcinoma. 3. The LOCATIONS OF THE PRIMARY TUMORS are: Right and left ovary (synchronous primary tumors). 4. The FIGO GRADE of the tumor is: II ( Tumor composed of 5-50% solid cellular nests). 5. The NUCLEAR (BRODERS' ) GRADE of the tumor is: G3 ( Poorly-differentiated. 6, Tumor IS identified on the ovarian surfaces. 7. Tumor DOES invade the mesovarium. 8., Tumor DOES invade the adjacent fallopian tube. 9. Tumor invasion of the pelvic soft tissue CANNOT BE EVALUATED. 10. Tumor involvement of the pelvic peritoneum IS PRESENT. 11. Metastatic involvement of the EXTRAPELVIC peritoneum is. PRESENT. 12. Metastatic involvement of the omentum is PRESENT. 13. The maximum dimension of tumor implants outside the true. pelvis is 1. 0 cm. 14. Metastatic involvement of the uterine serosa is PRESENT. 15, Metastatic involvement of the endometrium is ABSENT. 16. Regional lymph node metastases are PRESENT. Extracapsular extention of tumor is PRESENT. 17. The total number of regional lymph nodes examined is 2%. 18. The total number or metastatically-involved regional lymph. nodes-1s-18: 19, DETAILED STAGING INFORMATION: Based on the above information, the PRIMARY TUMOR is. classified as: TNM SCHEME. FIGO SCHEME. DEFINITION. IIIC. Macroscopic peritoneal. metastasis beyond true pelvis. measuring greater than 2 em in. greatest dimension, OR. Regional lymph node metastasis. OR Metastasis to capsule of. - - 5. COMMENT (continued). liver,. THE REGIONAL LYMPH NODES are classified as: N1. ( Nodes contain metastatic tumor). THE STATUS OF DISTANT TUMOR SITES is classified as : MX ( Status cannot be assessed). 20. The FINAL AJCC/FIGO STAGE IS AT LEAST: AJCC SCHEME. FIGO SCHEME. 3c. (T3C/ NO / MO) OR. IIIC. (Any T / N1/ MO). The pathologic stage assigned here should be regarded as. provisional, and may change after integration of clinical. data not provided with this specimen. 100."
BIOCUP_00288,ovary,OV,TCGA-09-1664,TCGA-09-1664.1e80516c-0cc5-4a3b-abae-054c57ca7b3c,"Speciment (s) Received. A: R adenexa (FS). TICL, rust X 1, TICL, X 1, First X 1, H&E, First X 1, H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E,. First x 1,. H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E, First x 1. B: Sigmoid implant (FS). H&E, First x 1. C: Uterus +/- tubes/ovaries, neoplastic. H&E, First x 1, H&E, First x 1, H&E, First x1,H&E,Firstx1,H&E,Firstx1,H&E, First x 1, H&E, First x 1, H&E,. First x 1,. H&E, First x 1, H&E, First X 1, H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E, First X 1, H&E, First x 1. D: Pelvic lymph node (perm). H&E, First x 1. E: Bladder implant. H&E, First x 1. F: R common iliac lymph node. H&E, First X 1. G' R paraaortic lymph node. H&E, First x 1. H: L pelvic lymph node. H&E, First x 1. I: L common iliac. H&E, First x 1. 1: periaortic. X I. K: Diaphragm tumor. H&E, First x 1. L: Appendix. incidental. H&E, First X 1. M: Sigmoid implant. H&E, First x 1. N: Omentum. H&E, First x 1. Final Pathologic Diagnosis: A. Right adnexa, salpingo-oophorectomy: Papillary serous cystadenocarcinoma. extensively involving ovary with serosal metastasis to fallopian tube. B. Soft tissue, ""sigmoid implant,"" biopsy: Metastatic papillary serous. cystadenocarcinoma. C. Uterus and left adnexa, total abdominal hysterectomy and left. salpingo-oophorectomy: - Cervix: Endocervical and squamous mucosa with no significant pathologic. abnormality; no dysplasia or carcinoma identified. - Endometrium: Proliferative pattern, no hyperplasia or carcinoma identified. - Myometrium: No significant pathologic abnormality. - Serosa: Metastatic papillary serous cystadenocarcinoma. - Bilateral parametrial soft tissue: Metastatic papillary serous. cystadenocarcinoma. - Left ovary: Extensively involved by papillary serous cystadenocarcinoma. - Left fallopian tube: Metastatic papillary serous cystadenocarcinoma. D. Lymph node, pelvic, biopsy: Three lymph nodes with no tumor identified (0/3). E. Soft tissue, ""bladder implant,"" biopsy: Metastatic papillary cystadenocarcinoma. F. Lymph node, right common iliac, dissection: Four lymph nodes with no tumor. identified (0/4). G. Lymph node, right para-aortic, dissection: Five lymph nodes with no tumor. identified (0/5). H. Lymph node, left pelvic, dissection: Papillary serous cystadenocarcinoma. metastatic to one of eleven lymph nodes (1/11). I. Lymph node, left common iliac, dissection: Three lymph nodes with no tumor. identified (0/3). J. Lymph node, left para-aortic, dissection Five lymph nodes with no tumor. identified (0/5). K. Soft tissue, ""diaphragm tumor,"" biopsy: Metastatic papillary serous. cystadenocarcinoma. L. Appendix, appendectomy: Serosal fibrosis and chronic inflammation, no tumor. identified. M. Soft tissue, ""sigmoid implant,' biopsy: Metastatic papillary serous. cystadenocarcinoma. N. Soft tissue, omentum, biopsy: Metastatic papillary serous cystadenocarcinoma. Note: Ovarian Tumor Synoptic Comment. 1. Type of tumor: Papillary serous cystadenocarcinoma. 2. Grade of tumor: Grade 1. 3. Location of tumor: Bilateral. 4. Diameter of tumor: 15.0 cm right, 10.5 cm left. 5. Appearance of surface of ovary: Tumor on surface bilaterally. 6. Condition of capsule: Intact bilaterally. 7. Appearance of cut surface: Multilocular cysts bilaterally. 8. Color of solid areas: Tan. 9. Necrosis: None present. 10. Lymphatic/vascular invasion: Not present. 11. Sites of metastases in pelvis: Bilateral parametria, bladder serosa, one left pelvic lymph node,. bilateral. fallopian tubes. 12. Sites of metastases in abdomen: Omentum, sigmoid colon serosa, diaphragm. 13. tymph noues. Tell tympn nodes WILT TTO tamor. 14. Peritoneal cytology: Pending processing. Cytology accession number: 15. Other significant findings: A total of thirty one lymph nodes are identified, including metastasis. to one. left pelvic lymph node (1/31). 16. FIGO stage: IIIC. 17. TNM stage: pT3cN1M0. Intraoperative Consult Diagnosis. FS1 (A) Right adnexal mass, excision: Micropapillary borderline tumor versus low-grade serous. carcinoma. FS2 (A) Right adnexal mass. excision: Micropapillary borderline tumor versus low-grade serous. carcinoma. FS3 (B) ""Sigmold implant #3, biopsy: Tumor implant, invasiveness not determined. Clinical History. The patient is a. G2 P1, with an 18.0-cm complex pelvic mass and omental cake with a. CA125 of. 1,746. She undergoes exploratory laparotomy, total abdominal hysterectomy, bilateral. salpingo-oophorectomy, PLND, PALND, radical pelvic dissection, omentectomy, appendectomy,. peritoneal. stripping, and tumor debulking. Gross Description. The specimen is received fresh in fourteen parts, each labeled with the patient's name and medical. record. number. Part A is additionally labeled. and consists of a right ovary and fallopian tube,. weighing. 570 gm and measuring 15.0 X 14.0 X 6.0 cm. The tube portion of the specimen measures 6.7 cm in. length. X 1.0 cm in average diameter. the ovary is massively enlarged and multicystic with diffuse tan to. dark red,. friable, sessile lesions studding the outside of the mass. The specimen is opened to reveal roughly. 300 CC of. viscous, cloudy, yellow fluid. The cut surface of the specimen is multicystic with some areas being. relatively smooth-walled and others being apparently filled with tan, somewhat friable tumor. Two. areas of. the tumor are inked overlying the shaggy, hemorrhagic-appearing external portion, and sections. through. these are taken and submitted for frozen sections 1 and 2. The frozen section remnants are. submitted in. cassettes. respectively. Fourteen representative sections of solid, cystic, and papillary. areas of. tumor are submitted in cassettes. Multiple representative sections of tube are submitted in. cassette. Part B is additionally labeled ""3 - sigmoid implant #3 (FS),"" and consists of a single irregular,. unoriented. piece of pink-red, soft tissue measuring 1.0 X 0,8 X 0.5 cm. The specimen is entirely frozen to. perform. frozen section diagnosis 3, and the remnant is submitted in cassette. Part C is received fresh, not additionally labeled, and consists of a uterus and left ovary and. fallopian tube,. weighing 435 gm. The uterine portion of the specimen measures 7.5 X 7.2 X 5.2 cm. The left ovary. measures 10.5 x 7.0 X 5.8 cm. The left tube measures 9.2 cm in length x 1.2-2.2 cm in diameter. The left. ovary is covered almost entirely by large, tan-pink to red, papillary, frond-like excrescences. The. underlying. ovary is soft and multicystic. There is a large paratubal cyst measuring 3.0 X 2.7 x 2.1 cm. The. serosal. surface of the uterus is studded with similar papillary excrescences as the ovary, although they are. much. smaller and more sessile. The cervix is slightly rough, but tan and otherwise unremarkable. The. uterus is. opened to reveal the endometrial cavity to be 3.2 cm in length X 1.2 cm in width, and grossly. unremarkable. Likewise, the myometrium appears unremarkable. Tissue is submitted in cassettes as follows: Representative section of anterior cervix. Representative section of posterior cervix. Representative section through the posterior lower uterine segment. Two representative sections through anterior endometrium. Two representative sections through posterior myometrium. Two representative sections of serosa through areas of apparent involvement with. tumor. Multiple representative sections of right parametrium. Multiple representative sections of left parametrium. Multiple representative sections of left fallopian tube. Cassettes. Multiple representative sections of left ovary tumor (including papillary. excrescences. and necrotic-appearing areas). Part D is received fresh, additionally labeled ""4 - R pelvic lymph node perm. OR 12,"" and. consists. of multiple irregular fragments of yellow, fibrofatty-appearing tissue measuring 4.4 X 3.0 X 1.2 cm. in. aggregate. Three candidate lymph nodes are identified, and the fatty remnants are removed and. returned. to the container. The candidate lymph nodes are submitted in cassette. 1. Part E is received fresh, additionally labeled ""13 - bladder implant,"" and consists of a single. unoriented,. irregular fragment of tan-pink to yellow, soft and friable-appearing tissue measuring 2.3 X 0.5 x 0.3. cm in. aggregate. The specimen is entirely submitted in cassette. Part F is additionally labeled ""5 - R common iliac lymph node (perm),' and consists of multiple. irregular,. unoriented, soft pieces of yellow and fibrofatty-appearing tissue measuring 3.2 X 2.3 X 0.5 cm in. aggregate. Multiple candidate lymph nodes are identified, and the fatty remnants are trimmed and returned to. the. container. The candidate lymph nodes are wrapped in tissue paper and submitted in cassette. Part G is received fresh, additionally labeled ""6 - right peri-aortic lymph node (perm),' and consists. of. multiple irregular, unoriented fragments of tan-pink, soft to rubbery tissue measuring 2.3 X 1.7 X. aggregate. Multiple candidate lymph nodes are identified and submitted in cassette. a The. fibrofatty. remnants are returned to the container. Part H is additionally labeled ""7 - left pelvic lymph node,"" and consists of multiple irregular. fragments of. soft, fatty-appearing tissue measuring 4.4 x 4.0 X 1.0 cm in aggregate. Multiple candidate lymph. nodes are. identified and are submitted in cassette. Part I is additionally labeled ""8 - L common iliac (perm),"" and consists of multiple fatty-appearing. fragments. of tissue measuring 2.3 x 1.5 X 0.5 cm in aggregate. Multiple candidate lymph nodes are identified. and. submitted in cassette I1. The fatty remnants are returned to the container. Part J is received fresh, additionally labeled ""9 - L peri-aortic (perm),' and consists of multiple. irregular,. unoriented fragments of soft, tan to yellow and fibrofatty tissue measuring 2.8 X 1.8 x 0.5 cm in. aggregate. Five candidate lymph nodes are identified and submitted in cassette J1, wrapped in tissue paper. The fatty. remnants are returned to the container. Part K is additionally labeled ""11 - diaphragm tumor,"" and consists of multiple irregular, soft, tan. fragments. measuring 0.9 X 0.5 X 0.2 cm in aggregate. The specimen is wrapped in tissue paper and entirely. submitted in cassette. Part L is additionally labeled ""12 - appendix,"" and consists of a vermiform appendix measuring 3.9. cm in. length X 0.8 cm in average diameter. The gross appearance is unremarkable with no obvious serosal. lesions. Representative sections are submitted in cassette. Part M is additionally labeled ""13 - sigmoid implant,"" and consists of multiple irregular, soft, tan-. pink to red. pieces of tissue measuring 4.5 X 1.7 X 0.5 cm in aggregate. The specimen is entirely submitted in. cassette. Part N is additionally labeled ""10 - omentum,"" and consists of a portion of omentum measuring 32.0. cm in. length x 7.0 cm in width x 1.2 cm in depth. There are multiple firm to hard nodules studding the. omentum nubmitted in cassette. Other Specimens. Specimen(s) Received: Vaginal, Thin Prep. Final Diagnosis. Vaginal, Thin Prep. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Hyperkeratosis. SPECIMEN ADEQUACY: Satisfactory for evaluation. Specimen(s Received: Peritoneal Washing. Final Diagnosis. Peritoneal Washing. ADENOCARCINOMA, METASTATIC. Acute inflammation."
BIOCUP_00289,ovary,OV,TCGA-36-1580,TCGA-36-1580.a647e4da-8579-4848-b545-bc857db85d98,"Receive Date: PHN: Final Diagnosis: 1. Omentum: Omental cake showing high grade papillary serous carcinoma, compatible with peritoneal, ovarian, or tubal origin, FIGO. tumor grade 3/3 (both specimens). 2. Abdominal ascitic fluid. I: Positive for numerous cell clusters of high grade papillary serous carcinoma. Clinical History as Provided by. A. Umentum-trozen. B. Omentum. Specimens Received: A: omentum. B: omentum. Gross Description: Specimen is received in two containers both labelled with the patient's name. Container ""A"" is labelled ""omentum"" and consists of a fragment of fatty tissue measuring 1.0 cm in diameter. Provisional diagnosis: Poorly differentiated papillary serous carcinoma. Submitted in toto as ""A1"", frozen section block, ""A2"" rest of the specimen. Container ""B"" is labelled ""omentum"" and consists of a greater omentum measuring 13.0 x 8.5 x 3,0 cm weighing 140 grams. Specimen. consists of firm nodule predominantly occupying omentum. Cross section of the nodule shows tan white fibrous structure with focal. hemorrhage and necrosis. Representative section submitted as ""B1""-""B4"". Intraoperative Consultation: FSA1: GROSS: Fragments of greyish white friable tissue, 1.0 cm in diameter. PROVISIONAL DIAGNOSIS: Poorly differentiated papillary serous carcinoma."
BIOCUP_00290,ovary,OV,TCGA-36-1578,TCGA-36-1578.6BD44F43-7D75-4DF3-891D-7E08291F020C,"Receive Date: F. Final Diagnosis: A. Right fallopian tube and ovary showing: 1) Invasive serous adenocarcinoma involving predominantly the tube (with. maximum dimension of 3.5 cm) and ovary (with maximum dimension of 3. cm)- please see comment. 2) FIGO tumor grade 3/3 (nuclear score 3; mitotic score 2;. architecture score 3). 2) The ovarian portion of the tumor is predominantly surface. involvement. 4) No vascular invasion seen. B. Specimen labelled ""omentum"" showing multiple foci of metastatic serous. adenocarcinoma; the largest one is 10 cm. C. Peritoneal washing showing malignant cells consistent. with serous carcinoma. D. TNM: pT3c, Nx, Mx; FIGO stage Illc. Final Diagnosis Comment: The fallopian tumor involvement is greater than the ovarian involvement with focal carcinoma in situ, which is suggestive of fallopian tube origin. Clinical History as Provided by. /.O. female with 16 cm pelvic mass + omental disease. Suspect ovarian cancer vs primary peritoneal cancer. A. Right tube + ovary. B. Omentum. Specimens Received: A: right tube + ovary. B: omentum. Gross Description: The specimen is received in two containers; each labelled with the patient's name. Container ""A"" is labelled ""right tube and ovary"". The specimen consists of two lesions connected together by a tubular structure. The tubular structure. between the two lesions measures 2.0 cm in length and 0.8 cm in diameter. The two lesions measure 3.0 x 2.5 x 1.5 cm and 3.5 x 1.5: 1.8 cm,. respectively. The outer surface of both lesions is irregular and nodular. One of these lesions contains a 2.0 x 1.0 cm ovarian-like tissue. (the smallest lesion). Representative sections are submitted as follows: ""A1""&""A2"" -the ovary with the lesion. ""A3""-""A5"" -from the other lesion. ""A6"" -representative section from the tubular structure. Container ""B"" is labelled ""omentum"". The specimen consists of fibrofatty tissue, which weighs 272 gm and measures 23.0 x 9.0 x 4.0 cm. Multiple. whitish nodular lesions are seen. The largest one measures 10.0 cm in maximum dimension. A sample from this tumor is taken for the Tumor Bank. Representative sections are submitted in six cassettes labelled as. B1""-""B6"". Copies to:"
BIOCUP_00291,ovary,OV,TCGA-09-2053,TCGA-09-2053.0d28e549-3ed0-4a22-bac7-9cbe24e44f53,"FINAL PATHOLOGIC DIAGNOSIS. A. Left ovary, salpingo-oophorectomy: Ovarian serous carcinoma with. direct extension. to fallopian tube; see comment. B. Uterus, right adnexa, hysterectomy and salpingo -oophorectomy: -Serosa: No significant pathologic abnormality. -Myometrium: No significant pathologic abnormality. -Endometrium: Atrophy. -Cervix: No significant pathologic abnormality. -Right ovary: Surface adhesions and epithelial inclusions. -Right Fallopian tube: Paratubal cysts. -Separate fragment of serous carcinoma; see comment. C. Diaphragm, biopsy: Serous carcinoma. D. Periureteral soft tissue, biopsy: Serous carcinoma. E. Recto-sigmoid colon, segmental resection: 1. Serous carcinoma involving serosa with direct invasion of. muscularis. 2. Metastatic carcinoma in two lymph nodes (2/9). F. Omentum, omentectomy: Serous carcinoma. G. Diaphragm, biopsy: Serous carcinoma. H. Right periaortic lymph nodes, dissection: No tumor (0/9). I. Left periaortic lymph nodes, dissection: No tumor (0/12). J. Right pelvic lymph nodes, dissection: No tumor (0/12). K. Left pelvic lymph nodes, dissection: No tumor (0/12). L. Mesentery, biopsy: Serous carcinoma. M. Colon, resection margins, excision: No tumor. N. Abdominal wall, biopsy: Cauterized atypical cells, suspicious for serous carcinoma. COMMENT: Ovarian Tumor Synoptic Comment. 1. Type of tumor: Serous carcinoma. 2. Grade of tumor: High grade. 3. Location of tumor: Left ovary. 4. Diameter of tumor: 7.0cm. 5. Appearance of surface of ovary: Smooth. 6. Condition of capsule: Intact. 7. Appearance of cut surface: Solid and cystic, mainly cystic. 8. Color of solid areas: Tan-yellow. 9. Necrosis: Focally present. 10. Lymphatic/vascular invasion: Not identified. 11. Sites of metastases in pelvis: Ipsilateral fallopian tube lumen; serosal. involvement of recto-sigmoid. colon. 12. Pelvic lymph nodes: Metastatic carcinoma present in two lymph nodes (2/33). 13. Sites of metastases in abdomen: Omentum, diaphragm, mesentery. 14. Para-aortic lymph nodes: No carcinoma identified in twenty-one lymph nodes. (0/21). 15. Peritoneal cytology: Benign. Cytology accession number: 16. Other significant findings: None. 17. FIGO stage: IIIC. 18. TNM stage: pT3cN1MX. In the hysterectomy specimen (Part B), a separate tissue fragment was present in. the specimen container. Microscopic evaluation demonstrated serous carcinoma. This fragment likely. represents a detached. fragment of the left ovary. Specimen(s) Received. A:Left ovary (FS). B:Uterus, right ovary and cervix. C:Diaghragm nodule (FS). D:Ureteral implant. E:Rectus sigmoid colon. F:Omentum. G:Diaphram nodule. H:Right periaortic lymph node. I:Left periaortic lymph node. J:Right pelvic lymph node. K:Left pelvic lymph node. L:Mesentaric lymph node. M:Donut. N:Abdominal wall nodule. Intraoperative Diagnosis. FS1 (A) Left ovary and tube, salpingo-oophorectomy: Poorly differentiated. carcinoma. FS2 (C) Diaphragm nodule, biopsy: Poorly differentiated carcinoma. (Dr. Clinical History. The patient is a. with a complex left adnexal mass suspicious for. ovarian carcinoma. undergoes exploratory laparotomy, total abdominal hysterectomy- bilateral. saipingo-oophorectomy. partial colectomy, lymph node dissection and staging biopsies. Gross Description. The specimen is received from the Operating Room in 14 parts, each labeled with the. patient's name and. medical record number. Parts A through C are received fresh, and Parts D through N. are received in. formalin. Part A is additionally labeled ""left ovary -. "". and consists of a left ovary and. Fallopian tube. The. ovary weighs 36 grams and measures 7.0 X 4.5 X 2.5 cm. The serosal surface is. smooth and gray-white. with an intact capsule. Sectioning reveals a unilocular cyst measuring 7.0 x 4.3 X 2.4. cm that contains. serosanguinous fluid. The cyst wall demonstrates multiple tan-yellow solid areas that. vary from plaque-like. to complex exophytic friable masses that fill approximately 40% of the cyst volume. No normal ovarian. parenchyma is grossly identified. The fallopian tube measures 5 cm in length and 1.0. cm in average. diameter. Its serosal surface is tan-red and smooth. On sectioning, the lumen is. filled and mildly. distended by grossly adherent friable tan-yellow material. A portion of the cyst wall. is sent to. further studies. An additional section of the cyst wall is frozen for intraoperative. consultation and the. remnant is submitted in cassette A1. Gross photographs are taken and additional. representative sections. are submitted as follows: Cassette A1: Frozen section remnant. Cassettes A2-A3: Ovary. Cassette A4: Ovary and Fallopian tube. Cassette A5: Fallopian tube. Cassette A6: Ovary. Part B is additionally labeled ""uterus, right ovary and cervix - fresh,' and consists of. a uterus with attached. cervix and left adnexa weighing 70 grams. The uterus measures 9 cm from fundus to. cervix, 3.5 cm from. cornu to cornu and 2.7 cm from anterior to posterior, and is oriented by the. relationship of the round. ligament to the fallopian tubes and the peritoneal reflections. The serosa is smooth. and unremarkable. The uterine cavity sounds to 6.2 cm. The transition zone and endocervical canal are. unremarkable. The. endometrium is tan, measures 0.1cm, and contains no polyps. The myometrium. measures 1.2 cm in. thickness; no leiomyomata are present. The right fallopian tube measures 7.1 cm in. length and 0.6 cm in. average diameter. The serosal surface is smooth and tan-gray. The fimbria are lush. On cut section,. multiple paratubal cysts are identified. The tubal lumen is patent and grossly. unremarkable. The left right. measures 2.8 X 1.0 X 0.6 cm. The surface is smooth. The cut surface is. unremarkable. Representative. sections are submitted as follows: Cassette B1: Anterior cervix. Cassette B2; Posterior cervix. Cassette B3: Anterior endomyometrium. Cassette B4: Posterior endomyometrium. Cassette B5: Right ovary. Cassette B6: Distal fallopian tube including paratubal cyst. Cassette B7: Fallopian tube and ligaments adjacent to uterus. Cassettes B8-B9: Posterior cul de sac fat. Also present in the specimen container is a single separate unoriented fragment of. yellow-tan friable soft. tissue measuring 2.5 X 1.4 X 0.7cm. It is bisected and entirely submitted in cassette. B10. Part C is additionally labeled ""diaphragm nodule frozen section,"" consists of a single. firm, irregular,. unoriented piece of pink-tan tissue measuring 0.6 X 0.5 x 0.1 cm. The entire. specimen is frozen for frozen. section 3, with the remnant submitted in cassette C1. Part D is additionally labeled ""ureteral implant.' It consists of multiple irregular and. extensively fragmented. pieces of soft, pink-brown tissue, measuring 2.4 x 2.0 x 0.4 cm in aggregate. The. specimen is entirely. submitted in cassettes D1 and D2. Part E is additionally labeled ""rectosigmoid."" It consists of an unoriented segment of. large bowel,. measuring 27.1 cm in length and 3.7 cm in average diameter. One margin of the. specimen has been. stapled shut (inked blue), and the other end is open (inked black). The attached. omentum demonstrates a. friable, fungating, gray-brown mass, measuring 10.8 x 4.7 X 3.6 cm; this extends to. within 6.5 cm of the. black-inked margin and appears to have been grossly transected at the radial. margin. In addition, two. additional masses are identified on the antimesenteric serosal surface of the colon;. the first of these. measures 1.8 x 1.5 X 1.5 cm and is present 1.8 cm from the black-inked margin, and. the second of these. measures 1.2 X 0.8 x 0,5 cm and is present 8.6 cm from the blue-inked surgical. margin. The colonic. mucosa is gray-tan and contains the normal mucosal folds. No mucosal masses or. nodules are grossly. apparent. The previously identified serosal nodules do not appear to erode through. to the mucosal surface. The radial surgical margin is inked black. Representative sections are submitted as. follows: Cassette E1: Lateral margin. Cassettes E2-E4: Mesenteric mass. Cassette E5: Serosal mass #1. Cassette E6: Serosal mass #2. Cassettes E7-E8; Candidate lymph nodes, entirely submitted. Part F is additionally labeled ""omentum."" It consists of a single roughly rectangular. piece of firm,. yellow-tan fatty tissue, measuring 44.0 X 9.0 X 2.5 cm and weighing 285 gm. Multiple firm, irregular. nodules are found scattered and embedded throughout the specimen; they range in. size from 0.5 cm to 4.0. cm in greatest dimension. Representative sections of various lesions and omentum. are submitted in. cassettes F1 through F5,. Part G is additionally labeled ""diaphragm nodule."" It consists of a single irregular. piece of firm, yellow-tan. tissue, measuring 2.2 x 1.7 X 1.5 cm. On one surface is a round nodule, measuring. 1.0 X 0.9 X 0.6 cm. The specimen is serially sectioned and entirely submitted in cassettes G1 and G2. Part H is additionally labeled ""right periaortic lymph node."" It consists of a single. irregular piece of soft,. yellow-brown fatty tissue, measuring 5.0 X 3.2 X 1.5 cm. The specimen is examined. for candidate lymph. nodes, and multiple candidate lymph nodes are found, ranging from 0.5 cm to 1.2. cm in greatest. dimension. Candidate lymph nodes are submitted as follows: Cassette H1: One node, bisected. Cassette H2: One node, bisected. Cassette H3: Two whole nodes. Cassette H4: Two nodes, each bisected. Cassette H5: One node, bisected. Cassette H6: Three whole nodes. The remaining tissue is returned to the container. Part I is additionally labeled ""left periaortic lymph node."" It consists of a single. irregular piece of soft,. yellow-brown fatty tissue, measuring 6.5 X 3.4 X 2.2 cm. The specimen is examined. for candidate lymph. nodes, and multiple candidate nodes are found, ranging from 0.3 cm to 1.9 cm in. greatest dimension. Candidate lymph nodes are submitted as follows: Cassette I1: Multiple whole nodes. Cassettes I2-I3: One node, trisected. Cassettes I4-I5: One node, trisected. Cassette 16: One node, bisected. Cassette 17: One node, bisected. Cassette I8: Two nodes, each bisected. Cassette I9: Two nodes, each bisected. Cassette I10: Two nodes, one bisected. The remaining tissue is returned to the container. Part J is additionally labeled ""right pelvic lymph node."" It consists of multiple. irregular pieces of soft,. yellow-brown fatty tissue, measuring 8.0 x 5.0 X 2.0 cm in aggregate. The specimen. is examined for. candidate lymph nodes, and multiple candidate nodes are found, ranging from 0.2. cm to 2.2 cm in greatest. dimension. Candidate lymph nodes are submitted as follows: Cassette J1: Multiple whole nodes. Cassettes J2-J3: One node, serially sectioned. Cassette 04: Two nodes, each bisected. Cassette J5: Two nodes, each bisected. Cassettes J6-J7: One node, trisected. Cassette J8: One node, bisected. Cassette J9: One node, bisected. Cassette 010: Two whole nodes. Cassettes J11-J12: One node, serially sectioned. The remaining tissue is returned to the container. Part K is additionally labeled ""left pelvic lymph node.' It consists of multiple irregular. pieces of soft,. yellow-brown fatty tissue, measuring 6.4 X 5.3 X 2.0 cm in aggregate. The specimen. is examined for. candidate lymph nodes, and multiple candidate nodes are found, ranging from 0.3. cm to 2.7 cm in greatest. dimension. Candidate lymph nodes are submitted as follows: Cassette K1: One node, bisected. Cassette K2: Multiple whole nodes. Cassette K3: Two whole nodes. Cassette K4: One node, bisected. Cassette K5: One node, bisected. Cassette K6: One node, bisected. Cassette K7: One node, bisected. Cassette K8: Two whole nodes. Part L is additionally labeled ""mesenteric lymph node."" It consists of a single ovoid. piece of firm, white-tan. tissue, measuring 1.5 x 1.1 x 0.8 cm. The specimen is trisected and entirely. submitted in cassette L1. Part M is additionally labeled ""donuts."" It consists of a single hard, roughly umbrella-. shaped, silver-gray,. synthetic bowel ring rod, measuring 7.3 x 2.8 X 2.0 cm. Sutured onto the rod are. two ring-shaped pieces of. soft, pink-tan intestinal tissue, measuring 2.0 X 1.6 x 0.7 cm and 1.9 X 1.5 x 1.0 cm. The intestinal rings. are unoriented. Each has a smooth, tan mucosa. Each bowel ring is removed from. the rod. The margin of. the smaller ring is inked blue, and the margin of the larger ring is inked green. Each. ring is radially. sectioned, and no lesions are found. A blue suture runs through each ring. Representative radial sections. of the smaller bowel ring are submitted in cassette M1. Representative radial. sections of the larger bowel. ring are submitted in cassette M2. Part N is additionally labeled ""abdominal wall nodule."" It consists of a single irregular. piece of firm,. red-tan/white tissue, measuring 1.2 x 0.8 X 0.6 cm. The specimen is bisected and. entirely submitted in. cassette N1. Diagnosis based on gross and microscopic examinations. Final diagnosis made by. attending. pathologist following review of all nathology clidac."
BIOCUP_00292,ovary,OV,TCGA-24-2260,TCGA-24-2260.920817f6-bd04-4e9a-8f41-ba28be22cbc8,"Name : '. KR No. . 1. Hosp. No. . : surgeons: OVARY, LEFT, EXCISION - PAPILLARY. SEROUS ADENOCARCINOMA,. MODERATELY-TO-POORLY DIFFERENTIATEID. OVARY, RIGHT, EXCISION - PAPILLARY SEROUS ADENOCARCINOMA,. MODERATELY-TO-POORLY DIFFERENTIATED. FALLOPIAN TUBES, LEFT AND RIGHT, EXCISION - METASTATIC PAPILLARY. ADENOCARCINOMA. LARGE INTESTINE, TRANSVERSE COLON, PARTIAL EXCISION -. - METASTATIC PAPILLARY ADENOCARCINOMA ( SEROSAL. AND MESENTERIC). LARGE INTESTINE, SIGMOID COLON, EXCISION - METASTATIC PAPILLARY. ADENOCARCINOMA. LARGE INTESTINE, BIOPSIES #1 AND 2, PARTIAL EXCISIONS -. - METASTATIC PAPILLARY ADENOCARCINOMF. ( INVOLVING PERICOLIC FAT ONLY). SOFT TISSUE, OMENTUM, EXCISION - METASTATIC PAPILLARY. ADENOCARCINOMA. SPECIMEN (s) SUBMITTED. Part 1: OMENTAL CAKE. Part 2 : TRANSVERSE COLON. Part 3: BOWEL BIOPSY #1. Part 4: BOWEL BIOPSY #2. Part 5: LEFT TUBE & OVARY. Part 6: RIGHT TUBE AND OVARY. Part 7: SIGMOID COLON. HISTORY. The patient ia. 02, P2 with last menetrual period. in. , status port vaginal hysterectomy who now has a new pelvic. mass. Clinical diagnosis: Unstated. Operative procedure: Examination under anesthesia; exploratory laparotomy; bilateral. alpingo-oophoreotomy. GROSS. The specimen is received in formalin in seven containers each. labelled with the patient's name. The first is labelled. omental cake. . It consista of an indurated, focally hemorrhagic. piece of fatty tissue consistent with omentum that measures 18 x 9. x 4 CM. Transverse sections show homogenization of the fat with. hemorrhage, necrosis, and formation of cysta. The second container is labelled ""transverse colon. u. It consists. of a segment of bowel measuring 14 cm in length by 3.5 cm in. diameter. Both ends are stapled shut and the serosal surface in. areas where it is visible is pink-tar and amooth. The nesentery. is firm and appears occupied by an infiltrative process. There. are hemorrhagio adhesions on the antimesenteria borders midway. along the specimen. Also along the antimesenterio border is a. collection of fatty tiasue measuring 8.5 cm in greatest dimension. that is consistent with omentum. There is a 0.3 cm mucosal. erosion, but the mucosa appears otherwise tan and normally folded. with no intralumenal lesions. There is no evidence of. obstruction. Labelled B1, mucosa with possible erosion; B2,. adhesion; 83, mesentery. The third container is labelled ""#3, bowel (colon) biopsy #1,"". consista of two fragments of Dowel, each containing multiple. staples. The fragments in aggregate measure 3 x 3 x 1.5 cm. One. fragment has an adherent piece of fat consistent with an appendix. epiploicus. The second fragment also has a small of. adherent soft fatty tissue. The fourth container is 14, bowel (colon) biopsy #2. "". It consista of a fragment of bowel measuring 2.5 cm x 1.0 x 1.0. cm. It includes a stapled margin and a small amount of adherent. fatty tissue. A second fragment of fatty tissue is present in the. container measuring 1.4 cm in greatest dimension. Labelled D. The fifth. lied ""#5, left tube and ovary."" It. consists. brted ovary measuring 4.5 x 2,5 x 2.5. - 2--. Name ? 1. GROSS (continued). cm. The mesovarium is studded with a coarse papillary gray-tan. growth which also appears to involve the serosa of the ovary. The. fimbria of the Fallopian tube are adhesed to the surface of the. ovary. Also present in the container ia a segment of Fallopian. tube measuring 5 ca in length and ranging from 1.0 to 1.5 am in. diameter. There is a 1.5 cm cystically dilated region at the. center of the tube which contains brown fluid. Labelled E1,. cystically dilated area; E2, ovary; E3, tube/mesovarium. The mixth container is labelled ""#6, right tube and ovary.' M It. consists of an ovary that measures 4.3 x 1.5 x 1.1 on which has a. relatively smooth gray-white cortical surface. The Fallopian tube. is adjacent to and adhesed to the ovary, measures 7 cm-in length x. 0.t en in diameter, and contains, within the connective timsue,. between the tube and ovary, a moderately firm yellow-white nodule. There is also a piece of fat measuring 2.5 om in greatest. dimension adherent to the fimbriated end of the tube. Labelled. F1, ovary; F2, tube, including adhesions. The seventh container is labelled ""#7, sigmoid colon. . It. consista of a segment of intestine measuring 12 cm in length. The. diameter of the fragment, including dense adjacent mesenteric fat,. ranges from 4 to 7 on. While the surrounding fat is focally. hemorrhagic and indurated, the nucosa appears unrenarkable, with. intralumenal lesions. Labelled G1. unremarkable bowel, G2,. inflamed diverticulum. Jar 2. COMMENT. Microscopic examination aubatantiates the above cited diagnosis. {End of Report}."
BIOCUP_00293,ovary,OV,TCGA-24-1422,TCGA-24-1422.8bcb6cf4-84ea-41a1-9113-061a7523c19f,"MAN : Accessioned: DIAGNOSIS: OVARY, RIGHT, SALPINGO-OOPHORECTOMY. - PARAOVARIAN SEROUS CYSTADENOMA. - SEROUS ADENOCARCINOMA, HIGH GRADE (SEE COMMENT). - STROMA LUTEINIZATION. FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOMY. - SEROUS ADENOCARCINOMA, HIGH GRADE, INVOLVING SEROSAL SURFACE. OVARY, LEFT SALPINGO-OOPHORECTOMY. - SEROUS ADENOCARCINOMA, HIGH GRADE. - STROMAL LUTEINIZATION. FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY. - SEROUS ADENOCARCINOMA, HIGH GRADE, INVOLVING SEROSAL SURFACE. UTERUS, CERVIX, TOTAL ABDOMINAL HYSTERECTOMY. - FOLLICULAR CERVICITIS. UTERUS, ENDOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. CYSTIC ATROPHY. UTERUS, MYOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - LEIOMYOMATA, LARGEST 1 CM GREATEST DIMENSION. UTERUS, SEROSA, TOTAL ABDOMINAL HYSTERECTOMY. - SEROUS ADENOCARCINOMA, HIGH GRADE. OMENTUM, OMENTECTOMY. - SEROUS ADENOCARCINOMA, HIGH GRADE (SEE COMMENT). Intraoperative Consultation: An intraoperative non-microscopic consultation was obtained and interpreted as: ""Brought to frozen area is a 'right tube. and ovary,"" consisting of a multicystic ovary measuring 7.3 x 4.7 x 4.5 cm and a fallopian tube measuring 6.3 cm in. length and 0.7 cm in diameter, weighing 85 grams total. The serosal surface of both ovary and fallopian tube are. studded with nodules, ranging from 0.1 x 0.1 x 0.1 cm to 0.5 x 0.3 x 0,2 cm. On the surface of the ovary is a 0.6 x 0.4. x. 0,3 cm nodule, somewhat different in character. Sections show a firm and tan-white cut surface. The outer surface is. inked black. The ovary is sectioned to reveal multiple cysts with smooth inner linings and trabeculations, measuring up. to 4.0 x 2.5 x 2,5 cm. A section was taken of a serosal nodule, and frozen as 'FS1.' Rest for permanents,"". FS1: Ovary and fallopian tube. right aaloingo-oopborectomv. Microscopic Description and Comment: Histologic sections from the right ovary show a large cyst that appears to be paraovarian. It is lined by benign ciliated. epithelium is most consistent with a benign serous cyst adenoma. On the surface of this cyst, however, are small. nodules of metastatic high grade serous adenocarcinoma. The bulk of the malignant tumor in this case is located in. the omentum with small implants on both fallopian tubes, left ovary, and on the serosal surface of the uterus. These. findings are most consistent with a primary peritoneal carcinoma. History: with ascites and a pelvic mass. Operative procedure: Examination under. anesthesia, exploratory laparotomy, Total abdominal hysterectomy, bilateral salpingo-oophorectomy, infracolic. omentectomy, and optimal tumor debulking. Specimen(s) Received: A: RIGHT TUBE AND OVARY. B: UTERUS, CERVIX, LEFT TUBE AND OVARY. C: OMENTUM. Gross Description;. The specimens are received in three formalin-filled containers, each labeled. The first container is. labeled right tube and ovary."" It contains a tissue cassette labeled ""FS1"" that holds a 2.5 x 1.5 x 0,3 cm piece of. yellow-tan tissue. Also in the container is a previously inked and sectioned right adnexa, consisting of a 7.3 x 4.7 x 4.5. cm multicystic ovary, and a 6.3 x 0.7 cm fallopian tube. There is a 0.6 x 0,4 x 0.4 cm white-tan, firm nodule on the. surface of the ovary. In addition, the serosal surface of the ovary and fallopian tube are studded with nodules ranging. from 0.1 x 0.1 cm to 0.5 x 0.3 cm, as described in the intraoperative non-microscopic consultation. The ovary is. sectioned to show a 4 x 2.5 x 2.5 cm multiloculated cystic mass with a white-tan, smooth inner lining. There are no. solid areas within the cystic mass. The uninvolved ovary is sectioned to show yellow-tan, unremarkable ovarian. parenchyma. The fallopian tube is sectioned to show white-tan mucosa with a patent lumen. Labeled A2 to A7 - ovary. with cystic mass (A4 - serosal nodule); A8 - fallopian tube. The second container is labeled ""uterus, cervix, left tube and ovary."" It contains a 43 gram uterus with attached cervix. The uterus measures 7 cm from superior to inferior, 4 cm from cornu to cornu, and 3 cm from anterior to posterior. The. serosal surface of the uterus shows fibrous adhesions anteriorly. However, it is smooth and shiny posteriorly. The 2 x. 2 cm tan ectocervix has multiple areas of red-brown pinpoint hemormhages with a 0.6 cm external os. The 1.7 cm long. endocervical canal is lined by pink-tan mucosa and has scattered Nabothian cysts, the largest measuring 0,4 cm. The. Page: 2 of 3. 3.5 x 1.2 cm endometrial cavity is pink-tan and unremarkable. The endometrium is 0.2 cm thick; the myometrium is 0.8. cm thick. The myometrium contains three well circumscribed, tan-white, firm lesions with whorled cut surfaces, free of. hemorrhage and necrosis, measuring 1 cm, 0.6 cm, and 0.5 cm in greatest dimension, consistent with leiomyomas. The largest lelomyoma shows focal calcification. There is also a 0.5 x 0.3 cm subserosal leiomyoma anteriorly. Also in. the container is a detached, 10 gram left adnexa including a 2.5 x 2,2 x 1 cm ovary and a 4 x 0.6 cm attached fallopian. tube. The surface of the ovary and fallopian tube shows extensive fibrous adhesions. There are multiple paratubal. cysts, the largest measuring 1.2 cm in greatest dimension. The ovary is sectioned to show yellow-tan unremarkable. ovarian parenchyma. The fallopian tube is sectioned to show white-tan mucosa with a patent lumen. There are no. discrete lesions. Labeled Bland B2 - anterior and posterior ectocervix; B3 and B4 - anterior and posterior lower. uterine segment; B5 and B6 - anterior and posterior endomyometrium; B7 - leiomyoma; B8 - left ovary; B9 - left ovary. with paratubal cyst; B10 - left fallopian tube. Jar 1. The third container is labeled ""omentum."" It contains an 18 x 10 x 1.5 cm piece of yellow-tan fibroadipose tissue. Sectioned to show multiple white-tan, firm tumor implants, the largest measuring 2.5 cm in greatest dimension. Labeled C1and C2."
BIOCUP_00294,ovary,OV,TCGA-30-1857,TCGA-30-1857.e3d84909-0149-4691-a398-1a6b272dde60,"Report Status. Type : Surgical Pathology. OMENTUM BIOPSY. DIAGNOSIS: SPECIMEN LABELED ""OMENTUM, BIOPSY"" (including FSA) : METASTATIC PAPILLARY SEROUS CARCINOMA involving omentum. SPECIMEN LABELED ""OMENTUM, RESECTION"": METASTATIC PAPILLARY SEROUS CARCINOMA involving omentum. SPECIMEN LABELED ""STOMACH MASS, BIOPSY"": METASTATIC PAPILLARY SEROUS CARCINOMA involving a lymph node and adipose. tissue. SPECIMEN LABELED ""ADDITIONAL OMENTAL TUMOR"", BIOPSY: METASTATIC PAPILLARY SEROUS CARCINOMA involving omentum. SPECIMEN LABELED ""LEFT ADNEXA: PAPILLARY SEROUS ADENOCARCINOMA grade 3 (of 3) involving ovary. and surrounding the fallopian tube. SPECIMEN LABELED ""SMALL BOWEL, SEGMENTAL RESECTION"": METASTATIC PAPILLARY SEROUS CARCINOMA involving the serosal surface of. the small bowel. The margins of resection are free of tumor. CLINICAL DATA: History. with ascites (positive adenocarcinoma) . Operation: Small bowel resection, radical cytoreductive. exploratory lap. Clinical Diagnosis: Ascites/pelvic mass. TISSUE SUBMITTED: 1. Omental biopsy. 2. Omental tumor. 3. Tumor from stomach. 4. Additional omental tumor. 5. Left adnexa. 6. Small bowel section. O.R. CONSULTATION: SPECIMEN LABELED ""#1 OMENTAL BIOPSY"". Metastatic papillary serous carcinoma consistent with. ovarian origin. GROSS DESCRIPTION: The specimen is received fresh in six parts, each labeled with the patient's. name and unit number. Part one, ""omental biopsy"", consists of a single fragment of tan/red soft. tissue (6 x 5 x 2 cm) that is diffusely firm and polypoid. Representative. sections are submitted as frozen section A. Representative sections are. submitted. Micro sections: Micro 1: frozen section A remnant, 1 frag,. Micro 2-3: representative sections of omental biopsy, 6 frags. Part two, ""omental tumor"", consists of a segment of omentum (13 x 8 x 2.5 cm). that is diffusely infiltrated by a tan firm nodular tumor. Representative. sections are submitted. Micro 4-5: omental tumor, 7 frags,. Part three, ""tumor from stomach"", consists of a fragment of tan/pink soft. tissue (5 x 3 x 1.2 cm). Micro 6-7: tumor from stomach, 3 frags,. Page: 1 of 2. Part four, ""additional omental tumor"", consists of tan/pink firm tissue (7 x. 4. 1.5 cm) from which representative sections are submitted. Micro 8-9: additional omental tumor, 4 frags,. Part five, ""left adnexa"", consists of a fragment of tan firm tissue (4 x 33x2. cm) with a clear cystic area and possible tan exudate at its surface. Representative sections are submitted. Micro 10-11: left adnexa, 4 frags,. Part six, ""small bowel section"". consists of unoriented segment of bowel (1 cm. in length by 3.5 cm in diameter), with stapled resection margins (3 cm and 2.6. cm) On along the surface of the bowel there are multiple implants firm tan. tissue measuring up to 1 cm in greatest dimension. Representative sections are. submitted. Small implants do not appear to penetrate through the mucosal. surface. Micro 12: unoriented margins, 2 frags. Micro 13: surface implant, 3 frags,. Micro 14: sections of bowel and tumor, 3 frags. Micro 15: representative section of uninvolved valve, I fra. Reports to: SPECIMEN TYPE: OMENTUM BIOPSY. ADDITIONAL SPECIMEN TYPE: OMENTUM BIOPSY. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE BIOPSY. ADDITIONAL SPECIMEN TYPE: OMENTUM BIOPSY. ADDITIONAL SPECIMEN TYPE: OVARY WITH OR WITHOUT FALLOPIAN TUBE- NEOPLASTIC. ADDITIONAL SPECIMEN TYPE: SMALL INTESTINE RESECTION OTHER THAN FOR TUMOR. Page: 2 of 2."
BIOCUP_00295,ovary,OV,TCGA-61-1743,TCGA-61-1743.190b258b-d756-4872-b5f4-53c2d10e86b1,"FINAL DIAGNOSIS: PART 1: ADNEXA, RIGHT. A. MODERATELY DIFFERENTIATED MICROPAPILLARY SEROUS ADENOCARCINOMA OF THE OVARY (SEE. COMMENT). B. UNREMARKABLE FALLOPIAN TUBE (SEE COMMENT). PART 2: ADNEXA, LEFT -. A. MODERATELY DIFFERENTIATED MICROPAPILLARY SEROUS ADENOCARCINOMA OF THE OVARY (SEE. COMMENT). B. UNREMARKABLE FALLOPIAN TUBE (SEE COMMENT). PART 3: UTERUS WITHOUT ADNEXA, 130-GRAMS -. A. CHRONIC CYSTIC CERVICITIS. B. PROLIFERATIVE ENDOMETRIUM. C. LEIOMYOMA UTERI. PART 4: CUL-DE-SAC, POSTERIOR, #1 -. CONNECTIVE TISSUE, NEGATIVE FOR TUMOR. PART 5: CUL-DE-SAC, POSTERIOR, #2 -. CONNECTIVE TISSUE, NEGATIVE FOR TUMOR. PART 6: BLADDER PERITONIUM, BIOPSY. CONNECTIVE TISSUE, NEGATIVE FOR TUMOR (SEE COMMENT). PART 7: PELVIC, RIGHT, BIOPSY-. CONNECTIVE TISSUE, NEGATIVE FOR TUMOR. PART 8: PELVIC, LEFT, SIDEWALL -. CONNECTIVE TISSUE, NEGATIVE FOR TUMOR. PART 9: LYMPH NODES, RIGHT, PELVIC -. THREE LYMPH NODES, NEGATIVE FOR TUMOR (0/3). PART 10: LYMPH NODES, OBTURATOR, RIGHT -. THREE LYMPH NODES, NEGATIVE FOR TUMOR (0/3). PART 11: LYMPH NODES, PELVIC, LEFT -. FOUR LYMPH NODES, NEGATIVE FOR TUMOR (0/4). PART 12: LYMPH NODES, LEFT, OBTURATOR -. THREE LYMPH NODES, NEGATIVE FOR TUMOR (0/3). PART 13: LYMPH NODES, PERIAORTIC, LEFT -. LYMPH NODE, NEGATIVE FOR TUMOR (0/1). PART 14: LYMPH NODES, PERIAORTIC, RIGHT -. TWO LYMPH NODES, NEGATIVE FOR TUMOR (0/2). PART 15: RIGHT GUTTER -. CONNECTIVE TISSUE, NEGATIVE FOR TUMOR (SEE COMMENT). PART 16: GUTTER, LEFT -. CONNECTIVE TISSUE, NEGATIVE FOR TUMOR. PART 17: DIAPHRAGM, BIOPSY -. CONNECTIVE TISSUE, NEGATIVE FOR TUMOR. PART 18: VERMIFORM APPENDIX -. MUCOCELE WITH MUCINOUS CYSTADENOMA (SEE COMMENT). PART 19: OMENTUM -. MATURE ADIPOSE TISSUE, NEGATIVE FOR TUMOR."
BIOCUP_00296,ovary,OV,TCGA-30-1869,TCGA-30-1869.8d42d1a4-dff9-47a9-b95b-2eb27747308c,"Report Status: Final. Type: Surgical Pathology. OMENTUM BIOPSY. DIAGNOSIS: SPECIMEN LABELED ""OMENTAL BIOPSY"" (including FSA) : METASTATIC PAPILLARY SEROUS CARCINOMA present in fibroadipose tissue. SPECIMEN LABELED ""RECTUS MUSCLE"": The entire specimem is submitted for research. SPECIMEN LABELED ""RIGHT ADNEXA"". PAPILLARY SEROUS CARCINOMA of the ovary, grade 3 (of 3) . Tumor is present on the surface of the ovary. Tumor is present in the lumen and on the serosa of the fallopian tube. SPECIMEN LABELED ""LEFT ADNEXA"": PAPILLARY SEROUS CARCINOMA of the ovary, grade 3 (of 3) . Tumor is present on the surface of the ovary. Fallopian tube not identified. METASTIC PAPILLARY SEROUS CARCINOMA present in one (1) lymph node. SPECIMEN LABELED ""UTERUS AND CERVIX"". METASTATIC PAPILLARY SEROUS CARCINOMA. Tumor involves the serosa, myometrium and cervical stroma. Tumor is present in lymphatics of the cervix and myometrium. Proliferative endometrium with endometrial polyp. Leiomyomata (1.5 to 3.0 cm). SPECIMEN LABELED ""LEFT EXTERNAL ILIAC NODE"". METASTATIC PAPILLARY SEROUS CARCINOMA present in one (1) lymph node. SPECIMEN LABELED ""SIGMOID COLON"": METASTATIC PAPILLARY SEROUS CARCINOMA to the colonic serosa with. extension into the muscularis propria and present in the pericolonic. adipose tissue at the resection margins. SPECIMEN LABELED ""TUMOR ADJACENT TO RIGHT URETER"": METASTATIC PAPILLARY SEROUS CARCINOMA. SPECIMEN LABELED ""TUMOR AT SURFACE OF BLADDER"": METASTATIC PAPILLARY SEROUS CARCINOMA. SPECIMEN LABELED ""OMENTUM"": METASTATIC PAPILLARY SEROUS CARCINOMA. SPECIMEN LABELED ""SPLEEN"". METASTATIC PAPILLARY SEROUS CARCINOMA present in the hilum of the spleen. with extension into splenic parenchyma and the perisplenic soft tissue. SPECIMEN LABELED ""TUMOR FROM MESENTERY TRANSVERSE COLON"": METASTATIC PAPILLARY SEROUS CARCINOMA. One (1) lymph node with no tumor present. SPECIMEN LABELED ""DIAPHRAGMATIC TUMOR"": METASTATIC PAPILLARY SEROUS CARCINOMA,. SPECIMEN LABELED ""SIGMOID COLON"": METASTATIC PAPILLARY SEROUS CARCINOMA present in the pericolonic adipose. tissue and focally extending to a resection margin. SPECIMEN LABELED ""DISTAL AND PROXIMAL ENDS OF ANASTOMOSIS"": Segments of colon with no tumor present. Page: 1 of 4. CLINICAL DATA-. History: with pelvic/omental mass, increase CA 125. Clinical Diagnosis: Ovarian cancer. TISSUE SUBMITTED: 1. Omental biopsy (FS). CCAA-30-1869 -. 2. Rectus muscle (given to pathologist). 3. Right adnexa. 4. Left adnexa. 5. Uterus & cervix. 6. Left external iliac node. 7. Sigmoid colon. 8. Tumor adjacent to right ureter. 9. Tumor at surface of bladder. 10. Omentum. 11. Spleen. 12. Tumor from mesentery transverse colon. 13. Diaphramatic tumor. 14. Sigmoid colon. 15. Distal and proximal ends of anastamosis. O.R. CONSULTATION: SPECIMEN DESIGNATED ""OMENTUM"": Papillary serous carcinoma. GROSS DESCRIPTION: The specimen is received fresh in firteen parts, each labeled with the. patient's name and unit number. Part one, ""omental biopsy"", and consists of a single fragment of omentum (8.2 x. 2.9 x 1.7 cm) which contains multiple nodules of white/tan fibrotic tissue. A representative section is submitted for frozen section A. Representative. sections are submitted for histologic evaluation. Micro sections: Micro 1: frozen section A remnant,. Micro 2-3: representative fragments, 4 frags,. Part two, ""rectus muscle"", consists of a single fragment of muscle (1.2 x 0.8 x. 0.3 cm) which is grossly unremarkable and entirely submitted to. Part three, ""right adnexa"", a single knotted brown/tan mass (5.5 x 5 x 2 cm). with attached fallopian tube (7 cm in length by 1 cm in greatest diameter). The mass is fragmented and granular with a small focus of smooth ovarian. surface. The fallopian tube is grossly uninvolved by the tumor. There is a. paratubal cyst filled with a serous fluid (1 cm) Scant identifiable residual. ovary is present and the majority is diffusely replaced by tumor. Representative sections are submitted for histologic evaluation. Micro 4-8: representative sections of ovary, multiple frags,. Micro 9: fallopian tube, 4 frags,. Part four, ""left adnexa"", consists of a tan/brown/blue matted mass (7 x 5.5 x. 4. cm) which is extensively fragmented. No identifiable ovary is present nor. fallopian tube, The mass consists of various of white/tan firm nodules,. necrosis and hemorrhage. A 4.5 cm unilocular smooth walled cyst is identified. within the mass. The tumor is grossly present at all margins. Representative. sections are submitted for histologic evaluation. Micro 10-14: 5 frags,. Part five, ""uterus with cervix"", consists of a 105 gm hysterectomy specimen. including a uterus (6.5 x 6 x 5 cm), and exocervix (2.5 x 2 cm) with a. slit-like os (2 cm) The serosal surface is studded with multiple nodules of. brown/tan firm tissue and areas of necrosis. An anterior and posterior. endometrium cannot be identified. The endocervical canal (2 cm in length) is. covered by a tan herringbone mucosa. The endometrial cavity (1 cm from cornu. to cornu and 3 cm in length) has a tan/pink hemorrhagic endometrium (0.3 cm in. maximum thickness) The myometrium (2.5 cm in maximum thickness) contains. multiple leiomyomata (1.5 cm up to 3 cm) The serosal surface is completely. Page: 2 of 4. involved by tumor (up to 1 cm in maximum thickness) . Representative sections. are submitted for histologic evaluation. Micro 15-16: cervix, 2 frags,. Micro 17: LUS, 1 frag,. Micro 18: endoemtrium, 2 frags,. Micro 19-20: leiomyomas, 2 frags,. Micro 21-22: serosa, 2 frags,. Part six, ""left external iliac nodes"", consists of a single fragment of. fibroadipose tissue (3 x 1.5 x 3 cm) which contains a single lymph node. The. entire lymph node is submitted for histologic evaluation. Micro 23: 1 lymph node, 2 frags,. Part seven, ""sigmoid colon"", is a single segment of colon (33 cm in length by. 3. cm in diameter) with an opened resection margin (3 cm in diameter) and opposing. staple resection margin (2.5 cm in length). The serosal surface is diffusely. studded with white/tan hemorrhagic tumor nodules (up to 5 cm in greatest. dimension) The tumor is grossly present in the pericolonic adipose tissue and. either margin. The colonic mucosa is smooth, glistening with no direct. involvement by the serosally tumor. The colonic resection margins are. unremarkable. Representative sections are submitted for histologic evaluation. Micro 24: opened resection margin, 3 frags,. Micro 25: pericolonic adipose tissue present at the opened resection margin,. multiple frags,. Micro 26: staple resection margin en face, 2 frags,. Micro 27: pericolonic adipose tissue, present at staple resection margin, 2. frags,. Micro 28-30: fibrous tumor in relation to overlying mucosa, 4 frags. Part eight, ""tumor adjacent to right ureter"", consists of multiple fragments of. firm, yellow/tan soft tissue (5 x 4 x 1 cm) which are grossly consistent with. tumor. No identifiable ureter is present. Representative sections are. submitted for histologic evaluation. Micro 31: 3 frags,. Part nine, ""tumor at surface of bladder"", consists of multiple fragments of. tan/yellow soft tissue (4 x 4 x 0.5 cm in aggregate) which are grossly. consistent with tumor. No identifiable bladder mucosa is present. Representative sections are submitted for histologic evaluation. Micro 32: multiple frags,. Part ten, ""omentum"", consists of multiple fragments of yellow/tan fibroadipose. tissue (12 x 7 x 11 cm) which is grossly studded with tumor nodules ranging up. to 4 cm in greatest dimension. The nodules are firm, white/tan with areas of. necrosis. Representative sections are submitted for histologic evaluation. Micro 33-34: 2 frags. Part eleven, ""spleen"", consists of a 150 gm splenectomy specimen including a. spleen (10.5 x 6.5 x 5 cm) and soft tissue (7 x 7 x 3 cm) The splenic. soft tissue contains multiple white/tan nodules consistent with tumor. measuring up to 1.5 cm in greatest dimension and focally infiltrating the. splenic parenchyma. The splenic capsule contains focal areas of thickening. consistent with { ] tumor. The uninvolved splenic parenchyma is beefy red and. unremarkable. No splenic lymph nodes are identified. Representative sections. are submitted for histologic evaluation. Micro 35: spleen with capsule of thickening, 1 frag,. Micro 36: tumor nodule infiltrating speen, 1 frag,. Micro 37: tumor within splenic soft tissue, 2 frags,. Micro 38: tumor adjacent to spleen, 1 frag,. Part twelve, ""tumor from mesentery transverse colon"", consists of multiple. Page: 3 of 4. fragments of tan/pink soft tissue (3 x 3 x 2 cm) . Representative sections are. submitted for histologic evaluation. Micro 39: 2 frags,. Part thirteen, ""diaphramatic tumor"", consists of multiple fragments of. white/tan soft tissue (10 x 9 x 2 cm in aggregate), which are grossly. consistent with multiple tumor nodules. No identifiable skeletal muscle 15. present. Representative sections are submitted for histologic evaluation. Micro 40: 2 frags,. Part fourteen, ""sigmoid colon"", consists of a single fragment of colon (6 cm in. length by 2.5 cm in diameter) which is unoriented and has two opened. resection margins. The mucosa is smooth and glistening with no evidence of. masses or lesions. The serosa contains pericolonic adipose tissue with no. evidence of masses or lesions. No lymph nodes are identified. Representative. sections are submitted for histologic evaluation. Micro 41-42: margins of resection, en face, multiple frags,. Micro 43: representative cross section, 1 frag,. Part fifteen, ""distal and proximal ends of anastamosis"", consists of two. colonic donuts (2 x 1.5 x 1 cm, 1 x 1 x 0.5 cm) Representative sections are. submitted for histologic evaluation. Micro 44: 4 frags,. SPECIMEN TYPE: OMENTUM BIOPSY. ADDITIONAL SPECIMEN TYPE: TISSUE FOR SPECIAL STUDIES ONLY. ADDITIONAL SPECIMEN TYPE: UTERUS WITH OR WITHOUT TUBES & OVARIES, NEOPLASTIC. ADDITIONAL SPECIMEN TYPE: LYMPH NODE BIOPSY. ADDITIONAL SPECIMEN TYPE: COLON, SEGMENTAL RESECTION OTHER THAN FOR TUMOR. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE BIOPSY. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE BIOPSY. ADDITIONAL SPECIMEN TYPE: OMENTUM BIOPSY. ADDITIONAL SPECIMEN TYPE: SPLEEN. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE BIOPSY. ADDITIONAL SPECIMEN TYPE: SOFT TISSUE MASS OR SIMPLE EXCISION. ADDITIONAL SPECIMEN TYPE: COLON, SEGMENTAL RESECTION OTHER THAN FOR TUMOR. ADDITIONAL SPECIMEN TYPE: SURGICAL MARGIN. Page: 4 of 4."
BIOCUP_00297,ovary,OV,TCGA-24-2038,TCGA-24-2038.82958234-9de0-429f-8e63-3e8891f1df81,"CCA-24-2038 - -. MRN : Other Related Clinical Data: DIAGNOSIS: OVARY, LEFT, SALPINGO-OOPHORECTOMY (INCLUDING FS1). - SEROUS PAPILLARY NEOPLASM OF LOW MALIGNANT POTENTIAL (SEROUS BORDERLINE TUMOR). MEASURING 14.5 CM. - CO-EXISTENT MUCINOUS CYSTADENOMA, MEASURING 1.2 CM. FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. OVARY, RIGHT, SALPINGO-OOPHORECTOMY. - SEROUS PAPILLARY CYSTADENOMA OF LOW MALIGNANT POTENTIAL (SEROUS BORDERLINE TUMOR) ,. MEASURING 5.0 CM. FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. UTERUS, CERVIX, TOTAL ABDOMINAL HYSTERECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. UTERUS, ENDOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - CYSTIC ATROPHY. UTERUS, MYOMETRIUM, TOTAL ABDOMINAL HYSTERECTOMY. - NO HISTOPATHOLOGIC ABNORMALITY. SOFT TISSUE, ""RECTO-SIGMOID, "" BIOPSY. - NO EVIDENCE OF MALIGNANCY. SOFT TISSUE, ANTERIOR CUL-DE-SAC, BIOPSY. - NO EVIDENCE OF MALIGNANCY. SOFT TISSUE, LEFT PELVIC SIDEWALL, BIOPSY. - NO EVIDENCE OF MALIGNANCY. SOFT TISSUE, LEFT GUTTER, BIOPSY. - NO EVIDENCE OF MALIGNANCY. SOFT TISSUE, POSTERIOR CUL-DE-SAC, BIOPSY. - NO EVIDENCE OF MALIGNANCY. SOFT TISSUE, RIGHT PELVIO SIDEWALL, BIOPSY. - NO EVIDENCE OF MALIGNANCY. SOFT TISSUE, RIGHT GUTTER, BIOPSY. - NO EVIDENCE OF MALIGNANCY. LYMPH NODES, RIGHT PELVIC, EXCISION. SIX LYMPH NODES WITH NO EVIDENCE OF MALIGNANCY (0/6). LYMPH NODES, LEFT. PELVIC, EXCISION. - EIGHT LYMPH NODES WITH NO EVIDENCE OF MALIGNANCY (0/8). LYMPH NODES, RIGHT PERIAORTIC EXCISION. - SIX LYMPH NODES WITH NO EVIDENCE OF MALIGNANCY (0/6). LYMPH NODES, LEFT PERIAORTIC, EXCISION. - TWO LYMPH NODES WITH NO EVIDENCE OF MALIGNANCY (0/2). OMENTUM, EXCISION. - NON-INVASIVE DESMOPLASTIC BORDERLINE SEROUS TUMOR IMPLANTS, MULTIPLE. By this signature, I attest that the above diagnosis is based upon my. personal. examination of the slides (and/or other material indicated in the diagnosis) . Intraoperative Consultation: An. intraoperative. non-microscopic consultation was obtained and interpreted as: ""Called. to O.R. to pickup fresh LSO' - 690-gram ovary measuring 14.5 x 11 x 7 cm with surface. excrescences over ~10% of the surface. Opened to show straw-colored fluid and multilocular. cysts. Solid papillary tan area measures 5 x 5 x 5 cm. Frozen as FS1. Remainder for. permanents,. FS1: Ovary, left, biopsy. ""Serous tumor of low malignant potential at least,"" by. Microscopic Description and Comment: Histologic sections of the left ovary show a serous papillary neoplasm of low malignant. potential (serous borderline tumor) that involves the ovarian surface and ovarian. parenchyma. An incidental mucinous cystadenoma is identified as well. Sections of the. fallopian tube show no hilstopathologic abnormality. Histologic sections of the separately. submitted right ovary show a serous papillary neoplasm of low malignant potential (serous. borderline tumor) involving the ovarian surface and parenchyma. Sections of the right. fallopian tube show no histopathologic abnormality. There is cystic atrophy of the. endometrium. No cervical or myometrial histopathologic abnormalities. are identified. Sections of the separately submitted staging biopsies and lymph node. dissections show no. evidence of metastatic tumor. Routine sections of the omentum show scattered. desmoplastic implants of serous borderline tumor, with psammoma bodies. History: The patient is a. with a complex left ovarian mass, Operative procedure: Examination under anesthesia, laparotomy, total abdominal hysterectomy bilateral. salpingo-oophorectomy, and staging with pelvic lymph node dissection,. specimen (s) Received: A: OVARY, TUMOR. B: HYSTERECTOMY, RSO UTERUS AND CERVIX. C: RECTAL/SIGMOISD COLON. D: ANTERIOR CUL DE SAC. E: LEFT PELVIC SIDEWALL. F: LEFT GUTTER. G: POSTERIOR CUL DE SAC. H: RIGHT PELVIC SIDEWALL. I: RIGHT GUTTER. J: RIGHT PELVIC LYMPH NODES. K: LEFT PELVIC LYMPH NODES. L: RIGHT PERI-AORTIC LYMPH NODES. M: LEFT PERI-AORTIC LYMPH NODES. N: OMENTUM, ROUTINE. Gross Description. The specimens are received in fourteen formalin-filled containers, each labeled with the. patient's name. The first container is labeled ""LSO, FS1/X"" and contains a 690-gram ovary. measuring 14.5 x 11.0 x 7.0 cm. There are multiple tan-white papillary excrescences on the. ovarian surface covering ~10% of the surface, and measuring 4.0 x 2. 5 cm in greatest area. The ovary has been previously opened to reveal a multiloculated cyst with multiple tan-white. papillations on the cyst walls. A solid area is present on one side measuring 5.0 x 5.0 x. 5.0 cm. Sections show no gross evidence of invasive tumor. A fallopian tube measuring 4.0. cm in length, ranging in diameter from 0.3 to 0.5 cm is present as well. Sections. show. discrete tumors. Labeled A1 - tissue previously frozen as FS1; A2 to A14 - sections of cyst. including solid areas; A15 to A18 - sections of cyst including external. papillary. surface. excrescences; A19 - fallopian tube. The second container is labeled ""uterus, cervix, RSO"" and contains a 16-gram uterus. without. adnexa, and a separate ovary and attached fallopian tube. The ovary measures. 5.0. x. 4.0. x 2.5 cm in greatest dimension and weighs 44 grams. The ovarian surface is covered. multiple tan-white papillary excrescences covering >90% of the ovarian surface. Sections. show tan-white papillary structures emanating from the surface of the ovary with no gross. evidence of invasion of the underlying ovary. The underlying ovary contains. multiple. small. uniloculated cysts ranging in size from 0.1 to 0.3 cm, filled with clear serous fluid. The. remainder of the ovarian parenchyma is firm tan-white. The attached fallopian tube measures. 4.0 cm in length and ranges in diameter from 0.4 to 0.7 cm. The serosal surface is smooth. and glistening. Sections show no discrete tumors. The serosal surface is tan-brown with. focal areas of serosal thickening identified. The uterus measures 7 dm in length x 4.5. cm. from. cornu. to. cornu. x 2.0 cm. The ectocervix is white-tan and smooth. Portions of the. ectocervix. are not present with the specimen. The area of ectocervix identified measures. 1.0 x 0.8 x 0.5 cm and is smooth-white with no discrete lesions identified. The external. os measures 0. cm in greatest dimension. The endocervical canal measures 2.0 cm in length x. 0.4 cm in greatest diameter. The endocervical mucosa is tan with no discrete lesions grossly. identified. The endometria cavity measures 3.3 cm in length x 0.5 cm in greatest width. The endometrial mucosa. ils tan with no discrete mucosal lesions identified. Sections show. no discrete endom√©trial tumors. Sections through the myometrium show tan myometrium with no. discrete tumors identified Labeled B1 to B6 - right ovary; B7 - right fallopian tube; B8. - anterior cervix; B9. - posterior cervix; B10 - anterior endometrium and myometrium; B11 -. posterior endometrium and myometrium; B12 - areas of serosal thickening. The third container is labeled ""recto-sigmoid biopsy"" and contains a single piece of. tan-brown soft tissue measuring 3.0 x 2.0 x 0.1 cm. Sections show no discrete lesions. The fourth container is labeled ""anterior cul-de-sac biopsy"" and contains a single piece of. firm tan-white tissue measuring 0.5 x 0.3 x 0.2 cm. The fifth container is labeled ""left pelvic sidewall biopsy"" and contains a single piece of. tan-brown soft tissue measuring 1.0 x 0.3 x 0.2 cm. The sixth container is labeled ""left gutter biopsy"" and contains a single piece of tan-yellow. soft tissue measuring 1. 0 X 0.3 x 0.1 cm. The seventh container is labeled ""posterior cul-de-sac biopsy"" and contains a single piece of. grey-red soft tissue measuring 0.3 x 0.2 x 0.1 cm. The eighth container is labeled ""right pelvic sidewall"" and contains a single piece of. tan-brown soft tissue measuring 0.5 x 0.3 x 0.2 cm. The ninth container is labeled ""right gutter biopsy"" and contains a single piece of tan-brown. tissue measuring 0.8 X 0.2 x 0.2 cm. The tenth. container is labeled ""right pelvic lymph node"" and contains a single piece of soft. lobulated yellow fibroadipose tissue measuring 4.0 x 2.5 x 2.0 cm in greatest dimension. Multiple lymph- nodes are dissected from the fibroadipose tissue ranging in size from 0.3 x. 0.2 x 0.3 cm to 1.0 x 0. 5 x 0.5 cm. Sections of the lymph nodes are homogeneous tan-white. lymphoid tissue with no discrete lesions grossly identified,. The eleventh container is labeled ""left pelvic lymph nodes"" and contains multiple fragments. of soft yellow lobulated fibroadipose tissue ranging in size from 1. 4 'x 0.5 x 0.3 cm to. 3.0 x 2.5 x 2.0 cm. Multiple lymph nodes are dissected from the fibroadipose tissue ranging. in size from 0.3 x 0.4 x 0.3 cm to 1.5 x 0.8 x 0.4 cm. Sections of the lymph nodes show. homogeneous tan-grey lymphoid tissue with no discrete lesions grossly identified. Labeled K1. and K2. The twelfth container is labeled ""right periaortic lymph nodes"" and contains a single piece. of soft lobulated tan-yellow fibroadipose tissue measuring 3.0 x 1.8 x 0.9 cm in greatest. dimension. Multiple lymph nodes are dissected from the fibroadipose tissue ranging in size. from 0.3 x 0.3 X 0.3 cm to 1.1 x 0.4 X 0.5 cm. The thirteenth container is labeled ""left periaortic lymph node"" and contains a single piece. of tan-yellow lobulated fibroadipose tissue measuring 1.5 x 0.5 x 0.8 cm. Two lymph nodes. are dissected from the fibroadipose tissue measuring 0.7 X 0.5 x 0.4 cm and 1.0 x 0.5 x 0.4. cm. Sections of both lymph nodes show homogeneous grey-tan lymphoid tissue and no discrete. lesions grossly identified. The fourteenth container is labeled ""omentum"" and contains a single portion of omentum. measuring 15.5 x 8.0 x 2.0 cm in greatest dimension. The external surface is soft, yellow. and lobulated. No discrete lesions identified. Sections show lobulated soft yellow adipose. tissue and no discrete lesions or tumor. synopsis. SYNOPTIC REPORTING FORM FOR MALIGNANT OVARIAN NEOPLASMS. 1. A neoplasm is PRESENT. 2. The HISTOLOGIC DIAGNOSIS is: Borderline serous tumor (serous tumor of low grade malignant potential). 3. The LOCATION (S) OF THE PRIMARY TUMOR (s) is/are: Right and left ovary (synchronous primary tumors). 4. The FIGO GRADE of the tumor is: 0. (BORDERLINE TUMOR). 5. The NUCLEAR (BRODERS' GRADE of the tumor is: G1. (WELL DIFFERENTIATED). 6. Tumor IS identified on the ovarian surface (s) . 7. Tumor DOES NOT invade the mesovarium. 8. Tumor DOES NOT invade the adjacent fallopian tube. 9. Tumor DOES NOT invade the pelvic soft tissue. 10. Tumor involvement of the Pelvic peritoneum is ABSENT. 11. Metastaic involvement of the extra-pelvic peritoneum is: ABSENT. 12. Metastaic involvement of the OMENTUM is: PRESENT; NON-INVASIVE DESMOPLASTIC IMPLANTS. 13. The maximum dimension of tumor implants outside the true pelvis is 0.1cm (enter ""0"" if no. implants). 14. Metastatic involvement of the uterine serosa is ABSENT. 15. Metastatic involvement of the endometrium is ABSENT. 16. Regional lymph node metastases are ABSENT. 17. The total number of regional lymph nodes examined is 22. 18. Extranodal extension by tumor is NOT APPLICABLE; no nodal metastases are. present. 19. DETAILED STAGING INFORMATION: Based on the above information, the PRIMARY TUMOR is classified as: TNM Scheme. FIGO Scheme. Definition. T3a. IIIA. Microscopic peritoneal. implant beyond true pelvis. THE REGIONAL LYMPH NODES are classified as: NO (Nodes are free of metastases). THE STATUS OF DISTANT TUMOR SITES is classified as: MO. (Distant met'astases are reportedly absent). 20. The FINAL AJCC/UICC/FIGO STAGE IS: AJCC/UICC/FIGO. IIIA. (T3a/NO/M0). The pathologic stage assigned here should be regarded as provisional, and may change. after integration of clinical data not provided with this specimen."
BIOCUP_00298,ovary,OV,TCGA-24-2261,TCGA-24-2261.6145afd6-e7d7-47bc-a659-ac84c3434e86,"sury. Path Ho: : HR No. : 8. OVARY, LEFT, EXCISION - ADENOCARCINOMA, POORLY DIFFERENTIATED. (SEE COMMENT). - EXTENSIVE INVASION INTO SURROUNDING SOFT. TISSUES. - EXTENSIVE LYMPHATIC INVASION IDENTIFIED. OVARY, RIGHT, EXCISION. - METASTATIC POORLY DIFFERENTIATED ADENOCARCINOMA. SALPINX, RIGHT, EXCISION - METASTATIC POORLY DIFFERENTIATED. ADENOCARCINOMA IN LYMPHATICS. COLON, SIGMOID, PARTIAL EXCISION. - METASTATIC POORLY. ADENOCARCINOMA IN LYMPHATICS. - STENOSIS, 98%. - SCAR TISSUE AND FOREION BODY , GRANULOMAS. - IVERTICULOSIE. OMENTUM, BIOPSY. EXTENSIVE METASTATIC POORLY DIFFERENTIATED. SPECIMEN(S) SUBMITTED Purt 1: OMENTUM Bropsy. 1' Part 2 : SIGMOID COLON /LEFT OVARY. Part 3 : FS1 OMENTUM BIOPSY. Part 4 s x1 OMENTUM BIOPSY. Part 6 RICHT OVARY AND TUBE. HISTORY. The patient is a. mulliparous with complex. pelvic mass that WICH lort ovary and rectrosiumoid. Operative procedure : 850, omentectomy debulking, rectrosigoid. resection with bowul An intraoperalive. the. nonwaicrosopic wus obtained and interpreted as: ""1.1). Quentum, biopsy - Omentum nearly completely replaced by hard,. HISTORY (continued). gray-white metastatic tumor mass with multiple individual smaller. tumor nodilles. 15. 0 x 10.0 x 8.0 em portion of tumor to. sigmoid colon und left ovary, excision - Multiple. tumor hodules wtudding bowel verosa and mesentery. In agen. ""djucent to the left ovary tumor wurrounds bowni with 95% stenomia. of lumen, No mucosal lesion identified : Tumor, also involves lert. overy. Portions of left ovary, metastasis and colonic mucoua Lo. FROZEN. Quentum, biopsy - poorly differentiated carcinoma. GROSS. Received are 100r containers lubelled with the patient's name,. number and specimen type. The first specimen, labelled ""omentum,. small piece, "" is received unfixed und consists of a 1.8 x 1.5 x. 0.4 cut piece of lirm gray-white tinsue. The second_ container, labelled ""omentum, "" is received unfixed It. consists of a 25.0 x 18.0 x 5.0 cui pisce of carentum that is nearly. complutely replaced the of firm tan-white nodules. The third contaiuer, labelled ""sigmoid colon and left ovary, "" is. received unfixed. It conalsts of "" 25.8 CM length of colon with. attached soft tissues. The specimen is opened to reveal an. unremurkable nucona. The soft tiwsues adjacent to the bowel. contain matted masses of firm gray-white tumor nodulew. There is. un ovary 6.2 from one bowni margin, measuring 3.2 x 2.1 1.4. cm. Multiple gray-white ""tumor nodules exteud from the √≥vary and. invade wurrounding soft tissuem. The main tumor mass measures up. to 10.0 cm. in greatest dimension. Sections through other portione. of the colonic mucosa show multiple diverticuli. No perforations. or inflammatory reactions are identified. Labelled: B1 and B2 -. colonic bargins of resection; B3, Bd - stenotic ules of colon; #5,. 86 - random sections though baricnlonic goit tissues; L01 to LO3. sections through left ovary,. The. fourth container, labelled ""right ovary and tube, "" contains an. ovary measurlag 3. 1 x 1.5 x 1.0 cm. The external surfaces are. tan-white und lobular. There are several sanall (<0.2 cin in. gremtent dimension) firm tun-white - nodules studding the surface of. the ovary. The tube 6.2 em in length and up 10. surg. Path No. : GROSS (continued). 0.7 CMB in diameter. The fimbria are thin and delicate. The. paraovarian soft tissues contain matted masses OE firm gray-white. tumor nodules. Labelled: ROT - right tube and overy; C1 - right. paraovarian soft tissue. COMMENT. Sections through the left ovary show a poorly differentiated. malignant neoplasm composed by a high pleomorphic population of. cells with a large, irregular nuclei. Numerous mitotic figures. including atypical mitosis are seen. The cells have variable. amounts of amphophilic cytoplasm. The majority of the specimen. shows the tumor growing in solld sheets. There are a few foci, of. yland-like configuratioms and in one section from the omentum. there i's a papillary growth pattern. Metestatic deposits of tumor. are seen extensively throughout the soft tissues surrounding the. sigmoid colon. Tumor is also Identified in sections of the right. ovary. There is extensive lymphatic invasion in sections from the. right adnexa including lymphatics of the fallopian tube. There is. also extensive lymphatic invasion throughout the bowel wall. No. tumor is identified at the margins of resection of the bowel. In. Lhe central portion of the bowel at the site of the stricture,. there is scarring in the bowel wall and a foreign body type. granuloma is seen. The main tumor mass is that of a poorly differentiated. adenocercinoma. Th√© histologic appearance and pattern of spread. is consistent with a primary in the left ovary."
BIOCUP_00299,ovary,OV,TCGA-57-1584,TCGA-57-1584.3e4b484e-4727-444f-b2bc-c32d5d1ad815,"DIAGNOSIS: Uterus, cervix, bilateral tubes and ovaries, hysterectomy: Tumor Characteristics: 1. Histologic type: Serous papiliary adenocarcinoma. 2. Grade: 3. 3. Location: Ovary. a. Ovary involved: Bilateral. b. Amount/degree of Involvement of each ovary: Tumor involves all parts of both ovaries. 4. Lymphovascular space invasion: Yes. 5. Right fallopian tube: Normal. 6. Left falloplan tube: Normal. 7. Omentum. involvement by tumor: Yes, grossly and microscopically largely nodule measures 0.5 cm following fixation and processing. 8. Other peritoneal biopsies: B. Left pelvic sidewall, biopsy: Metastatic adenocarc√≠noma. F. Colon implant, biopsy. Metastatic adenocarcinoma. Lymph Node Status: C. Left pelvic lymph nodes, excision: Number of lymph nodes examined: 2. Number of lymph nodes containing metastatic carcinoma: 0 (0/2). D. Left aortic lymph nodes, excision: Number of lymph nodes examined: 7. Number of fymph nodes containing metastatic carcinoma: o (0/7). E. Right pelvic lymph nodes, excision: Number of lymph nodes examined: 3. NUMBER OF LYMPH NODES CONTAINING METAST√ÅTIC CARCINOMA 2 (2/3). Microscopic subcapsular metastasis identified in 2 nodes. G. Right aortic lymph nodes, excision: Number of lymph nodes examined: 3. Number of lymph nodes containing metastatic carcinoma: o (0/3). Other: 1. Cervix: No significant histopathologic findings. 2. Endocervix: Negative for tumor involvement. 3. Endometrium: Proliferative endometrium. 4. Myometrium: Superficial adenomyosis. 5. Uterine serosa: Serosal adhesions without evidence of metastatic carcinoma. 6. Other organs or biopsies: Vermiform appendix demonstrating no significant histopathologic changes. 7. pTNM stage: T2bN1MX. COMMENTS: This case has been reviewed in intradepartmental consultation and as part of the Department's Quality Review Program by. who is in. agreement with the diagnosis. CLINICAL HISTORY: Preoperative Diagnosis: Malignant neoplasm ovary. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Uterus, cervix, bilateral tubes and ovaries (tissue study). B. Left pelvic sidewall. C. Left pelvic lymph nodes. D. Left aortic nodes. E. Right pelvic lymph nodes. F. Colon implant. G. Right aortic nodes. H. Appendix. I. Omentum. SPESMENDATI. GROSS DESCRIPTION: A. Part A received in formalin labele. Band #1 uterus, cervix, bilateral tubes and ovaries is a 114 gram hysterectomy specimen,. consisting of a 6.8 x 4.3 x 3.2 cm uterine body and a 3.2 x 2.5 x 2.3 cm cervix, with attached bilateral adnexa. The serosa is smooth and tan pink. Th. exocervix is smooth and gray white with a 0.6 cm slit-like os. The endocervical canal is tan and 2.1 cm in length. The endometrial cavity is 1.4 cm from. comu. to. comu. and. 4.8. cm. in. length. The endometrium is glistening tan, focally hemormhagic, and averages 0.3 cm in thickness. The myometrium is. trabeculated, tan pink, and averages 1.8 cm in thickness. The 9.2 x 6.7 x 3.6 cm left ovary has an attached 6.4 x 0.2 cm fimbriated left fallopian tube. The outer surface of the ovary is smooth to lobulated and. tan pink to purple. The cut surface consists of focally cystic gray white soft tissue. There are focal areas of yellow lined corpora luteal cysts. The. fallopian tube has a tan pink serosa and a pinpoint lumen. The 11.8x7.1 x 3.7 cm right ovary has a minimal amount of attached possible fallopian tube. The outer surface is smooth to lobulated and tan p√Ænk. The cut surface consists of focally cystic gray white soft tissue with a minimal amount of. yellow. lined corporal luteal cysts. The fallopian tube has a tan pink serosa and a pinpoint lumen. The specimen is serially sectioned and representative sections are submitted as labeled: 1-anterior cervix, posterior cervix-2; 3--anterior. endomyometrium with serosa; 4-posterior endomvometrium with serosa; 5-left fallopian tube; 6 to 9-left ovary; 10-right ovary and fallopian. tube;. 11. to. 13-right ovary. The blocks are labeled. Also received in the same container is a green and yellow cassette labeled. for genomic research study. B. Part B received in formalin labelel. #2 left pelvic sidewall is a 1.7 x 1.1 x 0.3 cm irregular, shaggy tan red soft tissue, which is. serially sectioned and submitted in its entirety in one cassette labeled. C. Part C received in formalin labeled. and #3 left pelvic lymph nodes is a 4.8 x 2.6 x 0.6 cm irregular fibroadipose tissue, bearing two. irregular tan yellow firm tissues, consistent with probable lymph nodes, measuring 0.6 x 0.2 x 0.1 cm and 3.8 x 0.7 x 0,4 cm. The specimen is sectioned. and representative sections are submitted, to include the nodes in their entirety, as labeled: 1-one whole probable lymph node, 2 and 3-one. lymph node, serfally sectioned. The blocks are labelec. D. Part D received in formalin labeled. and #4 left aortic nodes is a 4.3 x 2.1 x 0,8 cm aggregate of fibroadipose tissue, bearing multiple. irregular tan yellow firm tissues, consistent with probable lymph nodes, ranging from 0.4 x 0.2 x 0.1 cm to 1.6 x 0.4 x 0.2 cn). The specimen is sectioned. and representative sections are submitted, to include the lymph nodes in their entirety, as labeled: 1-three whole probable tymph nodes; 2-two. whole. probable lymph nodes; 3 and 4-one lymph node, bisected in each. The blocks are labeled. E. Part E received in formalin labeled. and #5 right pelvic lymph nodes is a 3.7 x 2.6 x 0.7 cm aggregate of fibroadipose tissue, bearing. three irregular tan yellow firm tissues, consistent with probable lymph nodes, ranging from 0.7 x 0.6 x 0.5 cm to 2.3 x 1.3 x 0.4 cm. The specimen is. sectioned and representative sections are submitted, to include the lymph nodes in their entirety, as labeled: 1 to 3-one lymph node, bisected in each. The blocks are labeled. F. Part F received in formalin labeled. and #6 colon implant is a 2.6 x 2.3 x 0.7 cm aggregate of fibroadipose tissue. The cut surface. consists of focal gray white areas. The specimen is serially sectioned and representative sections are submitted in three cassettes labeled. G. Part G received in formalin labeled. and #7 right aortic nodes is a 2.8 x 1.4 x 0.4 cm irregular fibroadipose tissue, bearing three. irregular tan pink soft tissues, consistent with probable lymph nodes, ranging from 0.6 x 0.5 x 0.2 cm to 1.7: x 1.2x 0.4 cm. The specimen is sectioned. and representative sections are submitted, to include the lymph nodes in their entirety, as labeled: 1-two whole probable lymph nodes; 2-one lymph. node, bisected. The blocks are labeled. H. Part H received in formalin labeled. and #8 appendix is a 6.5 x 0.5 x 0.4 cm appendix, with attached adpose tissue. The serosa is. smooth and Ian pinkwithgray whitenodules near the distal tip.Themucosais smooth and tan. The Jumen averages 0.1 cm and contains a green. substance. The wall thickness averages 0.1 cm. The specimen is serially sectioned, the proximal margin is inked, and reptesentative sections are. submitted in one cassette labeled. I. Part I received in formalin labeled. and #9 omentum is a 50.6 x 12.8 x 0.8 cm irregular fibroadipose tissue, consistent with omentum. The cut surface consists of predominantly yellow lobulated adipose tissue with a minimal amount of gray white fibrous tissue. There are small focal gray. white nodules on the cut surface. The specimen is serially sectioned and representative sections are submitted in one cassette labeled."
BIOCUP_00300,ovary,OV,TCGA-09-0367,TCGA-09-0367.8a24fe8a-9f7f-4fbf-86c7-704427ccaf89,"Specimen(s) Received. H&E, First X 1, H&E, First X 1, Frozen section, first X 1. B: Right ovary and tube (FS). H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E,. First x 1,. H&E, First x 1. C: Uterus. cervix. left ovary and tube, rectosigmoid colon. H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E,. First x 1,. H8F First 1, H&E, First x 1, H&E, First x 1, H&E, First x 1, H&E, First x 1. H&E, First X 1, H&E, First X 1, H&E, First X 1, H&E, First X I. F. Transverse colon tumor. H&E, First x 1. F: Small bowel mesentery. H&E, First x 1. G: Bladder peritoneum. H&E, First x 1. Final Pathologic Diagnosis: A. Omentum, omentectomy: Papillary serous carcinoma, high grade. B. Right ovary and fallopian tube, right oophorectomy and salpingectomy: Papillary. serous carcinoma, high grade. C. Uterus, cervix, left ovary and fallopian tube, rectosigmoid colon: left. salpingo-oophorectomy, total abdominal hysterectomy and rectosigmoidectomy: - Cervix: No significant pathologic abnormality. - Endometrium: Inactive pattern. Myometrium: Extensive papillary serous carcinoma, high grade, present on. serosal surface with extensive lymphovascular invasio. Left ovary: Ovarian parenchyma essentially replaced by papillary serous. carcinoma, high grade. - Fallopian tube: Extensive serosal involvement by papillary serous carcinoma,. high grade, unremarkable fallopian mucosa. - Rectosigmoid colon: Extensive serosal involvement by papillary serous. carcinoma, high grade, with extension into muscularis propria,. unremarkable colonic mucosa. D. Rectum, proctectomy: Papillary serous carcinoma, high grade, present as a 3.0 cm. mass extending to inked radial margin. Primary surgery. 1 of 4. E. Transverse colon, ""tumor,"" biopsy: Papillary serous carcinoma, high grade, in. fibroadipose tissue. F. Small bowel mesentery, biopsy: Papillary serous carcinoma, high grade. G. Bladder peritoneum, biopsy: Papillary serous carcinoma, high grade, in fibrous. tissue. Note: Ovarian Tumor Synoptic Comment. 1. Type of tumor: Papillary serous carcinoma. 2. Grade of tumor: III. 3. Location of tumor: Bilateral ovaries, omentum, with extensive serosal and lymphovascular invasion. of. myometrium. 4. Diameter of tumor: Present as multiple large masses, ranging up to 11.0 cm in the right ovary. 5. Appearance of surface of ovary: Bilateral ovaries essentially replaced by tumor, right greater than. left. 6. Condition of capsule: Disrupted. 7. Appearance of cut surface: Numerous whorls of tan-white tumor. 8. Color of solid areas: Tan-white. 9. Necrosis: Absent. 10. Lymphatic/vascular invasion: Extensive. 11. Sites of metastases in pelvis: Ovary, uterus, bilateral fallopian tubes, rectum, urinary bladder,. peritoneum. 12. Pelvic lymph nodes: None sampled. 13. Sites of metastases in abdomen: Omentum and large bowel. 14. Para-aortic lymph nodes: None sampled. 15. Peritoneal cytology: None submitted. 16. Other significant findings: None. 17. FIGO stage: IIIC. 18. TNM stage: pT3cNXM0. Intraoperative Consult Diagnosis. FS1 (B) Ovary,_right, oophorectomy: Carcinoma, consistent with ovarian primary, probably serous. (Dr. Clinical History. This is a. , G3 P3, with ascites, omental caking and a complex right ovarian mass,. positive peritoneal cytology and an elevated CA125 (2802) who undergoes right oophorectomy and. tumor. debulking with rectosigmoid resection, endo-colostomy and Hartmann's pouch/omentectomy,. exploratory. laparotomy, TAH/BSO and radical pelvic dissection. Gross Description. The specimen is received in seven parts, labeled with the patient's name and medical record number. Parts. A and B are received fresh. Parts C-F are received in formalin. Primary surgery. 2 of 4. Part A, additionally labeled ""omentum,"" consists of a section of red-tan, fibrofatty and firm tissue. measuring. 13.0 x 13.0 x 2.0 cm. The specimen is studded with multiple yellow-tan to yellow-white nodules. ranging in. size from 0.2 cm up to 2.5 cm in greatest dimension. A 1.0 x 1.0 x 1.0 cm portion of the specimen is. taken for tumor banking, and representative sections are submitted in cassettes A1-A2. Part B, additionally labeled ""right ovary plus tube,"" consists of a partially cystic, partially solid structure. with no identifiable ovary and attached fallopian tube, which measures 11.0 x 9.0 x 4.0 cm and weighs. 238.2 gm. The cystic portion measures 4.0 cm in greatest dimension and has a cyst wall that ranges. between 0.1 and 0.2 cm in greatest dimension, and has two exophytic papillary-like structures on the. external surface, which measure 2.0 and 0.8 cm in greatest dimension, respectively. Deep to these, the. specimen is solid and has a fleshy, yellow-tan, irregular parenchyma. The solid portion measures 4.0 x 3.0. x. 2.0 cm. The attached fallopian tube measures 3,5 cm in length x 0.4 cm in average diameter, is smooth,. pink-tan, and otherwise unremarkable. The external surface of the specimen is inked in black. A. representative section of the solid portion is submitted as frozen section 1 with the remnant in cassette B1. The remainder of the specimen is submitted as follows: Cassette B2: Representative sections of fallopian tube. Cassette B3: Representative sections of larger mass on exterior surface of cyst. Cassette B4: Representative sections of smaller exophytic mass on external surface of cyst. Cassettes B5-B6; Additional representative sections of cyst. Cassettes B7-B10: Representative sections of solid portion of cyst. Part C, labeled ""uterus, cervix, left ovary and tube and rectosigmoid colon,"" consists of a uterus, attached. cervix, fallopian tube and attached soft tissue tumor mass, and attached short segment of sigmoid colon. The uterine specimen measures 7.5 cm from superior to inferior, 5.5 cm from cornu to cornu and 4.0 cm. from anterior to posterior. The cervix measures 3,5 cm from side to side, 3.0 cm from anterior to posterior. and approximately 2.0 cm in length. The serosal surface of the uterus is tan-brown, smooth and glistening,. with areas of subserosal hemorrhage scattered throughout. The cervical mucosa is tan-white, smooth and. glistening, again with small areas of punctate mucosal and submucosal hemorrhage. The specimen probes. to 6.5 cm and is opened along the lateral surfaces. The endocervical mucosa is pale tan and measures 1.0. mm in thickness. The endometrium is also pale tan, and free of polyps and masses. The endometrium. measures 2.0 mm in thickness. The myometrium is serially sectioned, revealing no mural lesions. The. myometrium averages 1.3 cm in thickness. Two nodular masses of tissue are attached to the left surface of. the uterus. The serosal surfaces of both are similar, each with a very nodular contour, covered by a. tan-brown serosa, and grossly obvious tumor nodules. Grossly, it is difficult to ascertain which of these. two masses contains the ovary, however one does appear to be attached to the uterus by a tubular. structure, likely the fallopian tube. This portion of tissue measures 7.5 x 4.5 x 4.0 cm and the adjacent. tubular structure measures 2.5 cm in length, with an average diameter of 1.0 cm. Serial sections through. the mass reveal no grossly obvious ovarian tissue, though a lumen filled with necrotic tissue is identified in. the previously-described tubular structure. The adjacent mass of tissue has a similar gross appearance. and measures 5.5 x 4.5 x 3.5 cm. One portion of the specimen contains a thin-walled cyst filled with. translucent fluid, measuring 3.0 cm in greatest diameter. On cut section, the specimen is composed of. multiple nodules of tan-white, firm tissue ranging in size between 0,5 and 2.0 cm. Adherent to the uterus. and ovary is a segment of large bowel measuring 14.0 cm in length with an average diameter of 4.0 cm. The serosal surface is diffusely caked with tumor nodules ranging in size between 0.2 and 0.5 cm, though. with confluence of tumor in other areas. What is thought to be the proximal margin is received stapled. shut, with the distal margin remaining open. Upon opening, a scant, tan-brown mucoid material is. identified. The mucosa is pale tan, and unremarkable. Sections are submitted as follows: Cassette C1: Anterior cervix. Cassette C2: Posterior cervix. Cassette C3: Anterior endomyometrium. Cassette C4: Posterior endomyometrium. Cassettes C5-C6; Sections of putative ovary. Primary surgery. 3 of 4. Cassette C7: Putative fallopian tube. Cassettes C8-C9; Mass adjacent to ovary. Cassette C10: Proximal bowel margin. Cassette C11: Distal bowel margin. Cassette C12: Sections through unremarkable bowel mucosa. Cassette C13: Representative sections of small bowel serosa. Part D, labeled rectum, staples proximal,"" consists of a single, short segment of rectum measuring 6.5 cm. in length with an average diameter of 2.5 cm. Attached to the specimen is a large amount of very irregular. and fragmented brown-tan, fibrous connective tissue measuring 8.5 cm in width x 4.0 x 2.5 cm. The. surrounding soft tissue is inked prior to opening of the staple surface at the proximal margin. The. specimen is opened to reveal pale tan-brown, glistening mucosa with no grossly identifiable masses or. lesions. A section of the proximal margin is submitted in cassette D1. A section of the distal margin is. submitted in cassette D2. A random section is submitted in cassette D3. The attached fibrous connective. tissue is serially sectioned, revealing a pericolonic mass of tan-white tumor measuring 3.0 x 2.5 x 2.0 cm. The tumor mass approaches the proximal margin of resection within 1.0-2.0 mm, and the lateral margin of. resection within 3.0 mm. A representative section is submitted in cassette D4. Part E, labeled ""transverse colon tumor,"" consists of an irregular and fragmentary tan-brown, polypoid. mass measuring 3.4 x 2.0 x 1.5 cm. The specimen is serially sectioned, and representative sections are. submitted in cassette E1. Part F, labeled ""small bowel mesentery,"" consists of a single ovoid nodule of yellow-tan, soft tissue. measuring 0.6 x 0.5 x 0.2 cm. The specimen is entirely submitted in cassette F1. Part G, labeled ""bladder peritoneum,"" consists of an irregular and fragmentary tan-brown, polypoid mass. measuring 3.4 x 1.8 x 1.0 cm. The specimen is serially sectioned, and representative sections are. submitted in cassette G1. Fee Codes: I. Primary surgery. 4 of 4."
BIOCUP_00301,pancreas,PAAD,TCGA-IB-AAUS,TCGA-IB-AAUS.FCA3763B-0CCE-4EFF-ACAA-FD05281A87D7,"CONFIDENTIAL. Demographics (for. verification purposes). Sex: F. Surgical Pathology Renor+. Collected Date/Time. Received Date/Time. Specimen Description. A. Lymph node number 12 at. B. Gallbladder at. c. Lymph node number 8 at. D. Bile duct margin at. E. Whipple's specimen at. F. Pancreatic margin at. Clinical Information. Pancreatic Ca. Infectious patient: No. Diagnosis. A. Lymph Node, Number 12, Excision: - One lymph node negative for carcinoma (0/1). B. Gallbladder, Cholecystectomy: - Chronic cholecystitis. - One reactive lymph node. - Negative for malignancy. Lymph Node, Number 8, Excision: One lymph node negative for carcinoma (0/1). D. Bile Duct Margin, Excision: - Negative for malignancy. E. Pancreas, Distal Stomach, Proximal Duodenum, Whipple's Procedure: - Adenocarcinoma, see synoptic report and comment. F. Pancreatic Margin, Excision: - Adenocarcinoma is present at the margin, see comment. Verified: Synoptic Report. SPECIMEN: Head of pancreas. Body of pancreas. Duodenum. Stomach. Common bile duct. Gallbladder. PROCEDURE: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. TUMOR SITE: Pancreatic head. Uncinate process. Pancreatic body. TUMOR SIZE: Greatest dimension: 4.0 cm. Additional dimensions: 4.0 x 3.0. cm. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades ampulla of Vater or sphincter of Oddi. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy) : No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3 : Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN) : pN1 Regional lymph node metastasis. Number examined: 14. Number involved: 2. ANCILLARY STUDIES: Gross Description. Received are specimen containers A to F. All requisitions and specimen containers are. labelled with the patient'e name,. The cassettes and. identifiers. are labelled with the Surgical Numbe. A. The specimen is received fresh and is subsequently placed into formalin. The. container is designated ""A: Lymph node number 12"". Specimen consists of a possible lymph. node measuring 2.5 x 2.2 x 0.4 cm. Specimen is bisected. Cut surface is tan, brown, and. variegated. Specimen is bisected and submitted in toto in two cassettes. B. The specimen is received fresh and is subsequently placed into formalin. The. container is designated ""B: Gallbladder"". Specimen consists of a grey green, intact. gallbladder, measuring 10.0 x 3.5 x 1.5 cm. Serosal surface is tan and smooth. Cystic. duct lymph node is identified, measuring 1.8 x 1.0 x 0.7 cm. Cystic duct is patent. Lumen. contains thick dark green mucus bile. Mucosa is green and velvety. The gallbladder wall. averages 0.4 cm in thickness and appears somewhat edematous. Sections are submitted as. follows: B1. cystic duct lymph node bisected and submitted in toto. B2. representative section. c. The specimen is received fresh and is subsequently placed into formalin. The. container is designated ""C: Lymph node number 8"". Specimen consists of tan possible lymph. node, measuring 2.2 x 0.8 x 0.3 cm. Specimen is bisected and submitted in toto in one. cassette. D. The specimen consists of tan tissue measuring 1.5 x 0.5 x 0.2 cm. Submitted for quick. section. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""D: Bile duct margin"". E. The specimen is received fresh and is subsequently placed into formalin. The. container is designated ""E: Whipple specimen"". Specimen consists of a whipple's resection. including distal stomach, measuring 4.0 cm along the lesser curvature, 5.0 cm along the. greater curvature and ranging in circumference from 4.0 cm of the pylorus to 7.5 cm of. the proximal margin, which was received stapled. There is a portion of pancreas,. measuring 5.5 x 4.0 x 2.0 cm. The duodenum measures 22.5 cm in length and averages 4.0 cm. in circumference. Attached peripancreatic soft tissue, extends to a maximum depth of 4.0. cm. Proximal margin of stomach and distal margin and received stapled. Specimen is inked. as follows: vessel bed margin- green, pancreatic body- blue, uncinate process- black,. anterior soft tissue surface- orange, and the posterior soft tissue surface- yellow. The. common bile duct measures 5.5 cm in length and averages 1.3 cm in circumference. There is an ill defined, firm tan mass identified within the pancreas, 4.0 x 4.0 x 3.0 cm. and comes within 1.0 cm to the body margin, 0.3 cm to the uncinate margin, 1.0 cm to the. anterior surface, 0.2 cm to the posterior surface, grossly extends to the vessel bed. margin, 16.0 cm to the distal margin, 5.5 cm to the proximal margin and 2.5 cm to the. common bile duct margin. The mass appears to involve the ampulla and pancreatic duct. There is a submucosal soft yellow nodule, located in the duodenum. The serosal surfaces. of the stomach and duodenum are tan, smooth and appear grossly unremarkable. Sections are. submitted as follows: E1. common bile duct margin. E2 to 4. proximal margin trisected. E5/6. distal margin bisected. E7/8. mass in relation to the ampulla. E9 to 11. mass in relation to the vessel bed margin. E12. mass in relation to the anterior surface with E11, E12 being a contiguous. section bisected. E13 to 15. mass in relation to the body margin. E16/17. mass in relation to the uncinate margin and anterior surface. E18/19. mass in relation to the posterior surface. E20. representative section of the submucosal nodule from duodenum and the. duodenum. E21. transition from pylorus to duodenum. E22 to 25. eight possible peripancreatic lymph nodes, ranging in size from 0.5 to 1.5. cm in. maximum dimension with E22 containing four possible lymph nodes, E23 two. possible. lymph nodes, and E24/25 each containing one possible lymph node bisected. F. The specimen consists of a 2.5 x 2.0 x 0.5 cm friable tissue in toto for quick. section. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""F: Pancreatic margin"". Sample and Test Request Deficiency. D. Bile Duct Margin: Negative for carcinoma. F. Pancreatic Margin: Negative for carcinoma. Pathologist Comment. Sections demonstrate carcinoma at the pancreatic margin in part F. Multiple foci are. better visualized in the permanent sections. In part E, the Body margin is negative. The. vascular bed margin is close (0.1 cm) The anterior and posterior soft tissue surfaces. are also close (<0.1 cm) The remaining margins are negative. Fourteen lymph nodes were examined in total, from parts A. C, and E. The following slides were shown in consultation to Dr. E7, E9-E11, E13-E17. Encounter Number. Patient Location."
BIOCUP_00302,pancreas,PAAD,TCGA-US-A77G,TCGA-US-A77G.FB498A85-B151-4963-BA96-A5BF955310C0,"CLINICAL NOTES: Pancreatic head mass ? pancreatic cancer. SPECIMEN: WHIPPLE'S. MACROSCOPIC -. The posterior portal vein margin has been inked blue. Neck margin is inked black. Around the distal. part of the common bile duct is tumour measuring up to 15mm and present at 20mm from the ampulla. of Vater and 20mm from the common bile duct margin. 1. SPECIMEN TYPE: The specimen comprises a partial pancreatectomy (Whipple's resection). 2. SPECIMEN DIMENSIONS: Length of duodenum: 110mm. Length of lesser curve of stomach: 70mm. Length of greater curve of stomach: 70mm. Size of gallbladder: 60 x 60 x 120mm. Wall thickness of gallbladder: 3mm. Calculi in gallbladder: present. Size of and weight of spleen: N/A. Length of bile duct: 80mm. Maximum diameter of bile duct: 10mm. Size of pancreas: 100mm from medial to lateral, 80mm from superior to inferior and 50mm from. anterior to posterior. Location of stent: Present - plastic in the distal common duct and protruding out into the duodenum. 3. TUMOUR LOCATION: Pancreatic body/pancreatic head. 4. TUMOUR: Configuration: infiltrative. Description: pale, firm with an ill defined margin. 5. TUMOUR SIZE: Greatest dimension: 15mm. Additional dimensions: 15 x 15mm. REVIEWING DOCTOR'S SIGNATURE: 6. (MACROSCOPIC) DISTANCE OF TUMOUR TO MARGINS: Pancreatic neck: 10mm. Periuncinate soft tissue: 40mm. Posterior retroperitoneal: 2-3mm. Portal vein bed: 2-3mm. Anterior pancreatic capsule: 10mm. Common bile duct: possibly involved. Proximal intestinal/gastric: 85mm. Distal intestinal margin: 180mm. Proximal pancreatic margin (applicable to distal pancreatectomies only): N/A. 7. ADDITIONAL GROSS PATHOLOGIC FINDINGS: Chronic pancreatitis: present. Chronic cholecystitis and cholelithiasis: present. Acute pancreatitis: negative. Pancreatic calculi: negative. Stomach: nil significant. Intestine: nil significant. Common bile duct obstruction: a stent is in situ. Pancreatic duct obstruction: present with dilatation. BLOCK KEY: 1 ex frozen of the pancreatic margin. 2=ex frozen of the pancreatic lesion. 3,4,5+6=Specimen serially sectioned and submitted in entirety transverse sections through mid. common bile duct within head of pancreas from distal to proximal with surrounding tumour and. adjacent portal vein margin and distal cystic duct. -10=representative transverse sections adjacent. common bile duct and neck margins. 11+12=representative from anterior body of pancreas with. pancreatitis. 13+14=longitudinal section through ampulla of Vater. 15=representative posterior. uncinate process adjacent to tumour. 16=representative from uninvolved body of pancreas without. macroscopic pancreatitis. 17=proximal common bile duct margin, also included a single cystic duct. node. 18=neck of gallbladder representative. 19=body of gallbladder including scarred area. 20=fundus of gallbladder representative. 21=proximal gastric margin. 22=pylorus. 23=representative. distal small bowel margin. 24=multiple nodes from lesser curve. 25=representative from greater. curve. 26=single anterior pancreatic node. 27=multiple nodes from posterior peripancreatic fat. INTRA-OPERATIVE FROZEN SECTION REPORT: ""I. Neck Margin: No Evidence of malignancy. 2 Tumour:Moderately differentiated adenocarcinoma > 75% plus vessel. MICROSCOPIC-. Sections of the tumour confirm a well to moderately differentiated ductal carcinoma arising in the. posterior body/neck adjacent to the mid to distal common bile duct (CBD). The overall tumour. dimensions are 20 x 20 x 20mm. The tumour spreads alongside the mid common bile duct (with a. common bile duct margin of 10mm). Tumour shows a gland and ductal architecture with marked. desmoplasia and extensive perineural infiltration. There is extensive perineural invasion and spread. into the peripancreatic tissue. Tumour invades the wall of the portal vein (Block 3) but does not reach. the lumen or involve the peripheral venous resection margin. The tumour comes to within 1mm of the. posterior soft tissue margin at the neck of pancreas (blocks 4 and 7) Lymphovascular space invasion. is. noted (Blocks 4) with extension into a peripancreatic node(Block 8) with a micrometastis in a. peripancreatic node (Block 4) and periuncinate node (block 15). Adjacent to the tumour high grade. PanIN is identified (block 8). REVIEWING DOCTOR'S SIGNATURE: Sections from the pancreatic neck resection margin show chronic pancreatitis. No high grade PanIN is. identified. Sections from the proximal common bile duct margin show no evidence of malignancy and. uninvolved cystic duct node. Representative sections from the ampulla of Vater show reactive changes within the common bile duct. epithelium along with some epithelial hyperplasia. Representative sections from the pancreas. elsewhere show normal morphology of ducts without PanIN. Fatty infiltration of the pancreas is seen in. Blocks 11 & 12 with associated fat necrosis. Representative sections from the gallbladder show. Rokitansky-Aschoff sinus formation with fibrosis of the gallbladder wall and a mixed inflammatory. cell infiltrate. The gallbladder mucosa is attenuated and shows underlying haemorrhage. Cholesterolosis is not identified. Representative sections from the proximal gastric margin are within. normal limits. Representative sections from the pylorus are within normal limits. Representative. sections from the distal small bowel margin are also within normal limits. Three out of eight peripancreatic nodes contain tumour (including the one seen in Block 4 and. including the one seen in Block 8 and block 15). No lesser curve nodes are identified. Only one single. lymphoid aggregate is noted from the greater curve. There are two cystic duct nodes. This gives a total. of three out of eleven nodes involved. CONCLUSION: 8. TUMOUR LOCATION: BODY/NECK OF PANCREAS. 9. HISTOLOGIC TYPE: DUCTAL CARCINOMA. 10. HISTOLOGIC GRADE: MODERATELY DIFFERENTIATED. 11. TUMOUR SIZE: 20 X 20 1 X 20. 12. EXTENSION OUT OF PANCREAS: POSTERIORLY. 13. SMALL VESSEL (CAPILLARY/LYMPHATIC) INVASION: PRESENT. 14,. LARGE VESSEL (VEIN/ARTERY) INVASION: PRESENT BUT NOT INTO LUMEN. 15. PERINEURAL INVASION: PRESENT AND EXTENSIVE. 16. (MICROSCOPIC) DISTANCE OF INVASIVE TUMOUR FROM RESECTION. MARGINS: Pancreatic neck: 5mm. Periuncinate soft tissue: Greater than 10mm. Posterior retroperitoneal: 1mm. Portal vein bed: 1mm. Common bile duct: 10mm. 17. LYMPH NODES FROM MAIN RESECTION SPECIMEN: Separately received lymph nodes: ELEVEN. 18. Pan-IN: Highest grade of Pan-In present: High grade. Grade of Pan-In at pancreatic neck resection margin: Not applicable. REVIEWING DOCTOR'S SIGNATURE: 19. PATHOLOGIC STAGING (PTNM, AJCC 6th edition 2002). Staged as: Pancreatic ductal carcinoma. pT: 3. pN: 1. pM: X. Overall stage: STAGE IIB. Additional pathologic comments and findings in other resected organs: GPECIFIC OTHER FINDINGS. Immunohistochemistry (ampullary and periampullary tumours only). CK7: not applicable. CK20: not applicable. CDX2: not applicable. SUMMARY -. Tumour type: DUCTAL ADENOCARCINOMA. Tumour grade: MODERATELY DIFFERENTIATED. Tumour location: BODY NECK OF PANCREAS. Tumour size: 20 x 20 x 20MM. Lymph nodes: 3 OUT OF 11. Involved or close margins (includes tumour less than 1mm from margin): POSTERIOR SOFT. TISSUE AND PORTAL VEIN. OFFICE USE ONLY. CHARGE: CLASS: SUMMARY: DUCTAL ADENOCARCINOMA, LYMPH NODE METS. REPORTER: CUTUP. TYPIST: T3 pNI MX, ATLEAST STAGE IIB. REVIEWING DOCTOR'S SIGNATURE:"
BIOCUP_00303,pancreas,PAAD,TCGA-HZ-A77O,TCGA-HZ-A77O.426F2D0F-C2A1-40FC-A001-83B737C0511C,"Provider Group : Date of Service: Date Received: A copy of this report will be printed for: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. - F.) HEAD OF PANCREAS, DISTAL STOMACH, DUODENUM, GALLBLADDER,. APPENDIX, PANCREATICODUODENECTOMY (WHIPPLE PROCEDURE,. PARTIAL PANCREATECTOMY), CHOLECYSTECTOMY, APPENDECTOMY: INVASIVE MODERATELY DIFFERENTIATED DUCTAL ADENOCARCINOMA. - 2.8 cm in maximum dimension. - Confined to the pancreas. - MARGINS: NEGATIVE FOR INVASIVE CARCINOMA. - Mild dysplasia is present at the common bile duct margin. - PERINEURAL INVASION: PRESENT. - LYMPH-VASCULAR INVASION: PRESENT. - FOUR OF TWENTY-SIX LYMPH NODES, POSITIVE FOR METASTASIS (4/26). - PANCREATIC INTRAEPITHELIAL NEOPLASIA, GRADE3 (PanIN-3). - ACUTE AND CHRONIC PANCREATITIS. - CHRONIC CHOLECYSTITIS. - UNREMARKABLE VERMIFORM APPENDIX. - SEE TUMOR STAGING SUMMARY BELOW. PATHOLOGIC TUMOR STAGING SUMMARY: Type and grade: Ductal adenocarcinoma, moderately differentiated. Primary tumor: pT2 (2.8 cm in greatest dimension, limited to the pancreas). Regional lymph nodes: pN1 (four of twenty-six lymph nodes, positive for. metastasis). Distant metastasis: Not applicable. Lymphovascular invasion: Present. Pathologic stage: IIB. Margins: R0. Exocrine Pancreas Tumor Staging Information. (AJCC Cancer Staging Handbook, 7th Ed, and CAP protocol, June 2012). Printed: This report continues (FINAL). - Page 1/5. .ge 1. FINAL SURGICAL PATHOLOGY REPORT. Head of pancreas, distal stomach,. Specimen: duodenum, gallbladder, common appendix. bile. duct,. Whipple procedure (partial. Procedure: pancreatectomy), cholecystectomy,. appendectomy. Head of pancreas. Tumor site: 2.8 cm in greatest dimension. Tumor size: Ductal adenocarcinoma. Histologic type: Moderately differentiated, (G2). Histologic grade: Limited to the pancreas. Microscopic tumor extension: Negative for invasive carcinoma. Margins: Not applicable. Treatment effect: Present. Lymph-vascular invasion: Present. Perineural invasion: Four of twenty-six lymph nodes,. Lymph nodes: positive for metastasis (4/26). Pathologic Staging: pT2 (2.8 cm in greatest dimension,. Primary tumor. limited to the pancreas). pN1 (4/26 positive for metastasis). Regional lymph nodes. Not applicable. Distant metastasis. IIB. Pathologic stage. PanIN-3. Additional pathologic findings: Acute and chronic pancreatitis. Islet cell hyperplasia. Source of Specimen: A. Appendix. B. Gallbladder. This report continues. Printed: - Page 2/5. FINAL SURGICAL PATHOLOGY REPORT. C. Lymph node;Portal. D. Whipple. E. Final bile duct margin. F. Bile duct new margin. Clinical History/Operative Dx: Pancreatic cancer. Intraoperative Diagnosis: C. Portal lymph node: Negative for metastasis: D. Whipple procedure: Pancreatic margin negative. E. (FSE) Final bile duct margin: Atypia suspicious for dysplasia. F. (FSF) New bile duct margin: Low grade dysplasia. The intraoperative interpretation(s) was/were performed and rendered at. Gross Description: A. The specimen is labeled appendix and is received in formalin. It consists of a very slightly curved. vermiform appendix which is 4.8 cm in length and has a maximum diameter of 0.6 cm. The serosal. surface is tan smooth and shiny. The appendiceal wall is intact. The mesoappendix is unremarkable. Representative sections are submitted in cassette A1 (proximal margin inked). B. The specimen is labeled gallbladder and is received in formalin. It consists of a deflated but intact. gallbladder which is 11 cm in length and up to 3.8 cm in diameter. The free serosal surface is red-violet. and smooth. The cystic duct is patent and there are two firm pale tan cystic duct nodes which are up to 0.6. cm in maximum dimension. The gallbladder wall is generally 0.5 cm in thickness. The mucosa varies from. yellow-tan to pale red and is finally granular throughout. There is partial septation of the gallbladder neck. as well as an area of septation at the fundus. No calculi are present. There are no palpable nodules within. the gastric wall. Representative sections re submitted. Section summary: B1) cystic duct margin, cystic duct. nodes, gallbladder neck, B2) gallbladder body and fundus. C. The specimen is labeled portal lymph node and consists of a 2x 1.9 x 0.8 cm fragment of yellow-tan to. paie red tissue. On sectioning there is a single lymph node measuring approximately1.: cm in maximum. dimension. The node is sectioned and touch imprints are obtained. The specimen is entirely submitted in. cassette C1. D. The specimen is labeled Whipple procedure and is received without fixative. It consists of a composite. resection of tissue which includes a 5 x 3 X 1.8 cm wedge resection of distal gastric tissue including pylorus. and a 27 cm segment of duodenum. There is a firm portion of pancreatic head which measures 6.3 x 4.7. x. 5 cm. The anterior-superior surface of the pancreas is inked blue, the anterior-inferior surface is inked. green, and the posterior surface is inked black. The free serosal surface of the gastric resection is pale red and smooth. There is a moderate amount of. Printed: This report continues. - Page 3/5. 'age 3. FINAL SURGICAL PATHOLOGY REPORT. adherent perigastric adipose tissue along what appears to be the greater curvature. The free serosal. surface of the distal duodenum is tan with some slight surgical disruption but there are no areas of. perforation. The specimen is opened to reveal the gastric mucosa is flat, tan to pale red, slightly granular. There is some slight irregularity of the mucosa at the pylorus but no true ulceration. The circumference at. the proximal duodenum is 6 cm. The ampulla is located 10 cm distal to the pylorus (11.5 cm from. proximal margin and 17 cm from the distal margin). A wire stent protrudes from the ampulla. Sectioning. of. the pancreas along the common bile duct reveals gritty tan-white, firm, poorly delineated neoplastic tissue. in the head of the pancreas measuring 2.8 cm in maximum dimension. This neoplastic process grossly. appears to be 1.8 cm from the ampulla. The pancreatic resection margin and the bile duct are marked. with sutures. Sectioning reveals that the neoplasm is grossly 1.3 cm from the pancreatic resection margin. The neoplasm is in close proximity to the anterior-superior surface as well as the anterior-inferior surface. It. is grossly 0.3 cm from the closest posterior pancreatic surface. Further sectioning of the pancreas reveals a. prominent diverticulum-like out-pouching of the duodenum 2 cm proximal to the ampulla. This. diverticular out pouching grossly extends into the head of the pancreas but does not appear to have. neoplastic involvement. The pancreas tissue away from the neoplasm is firm and yellowish. There are. scattered peripancreatic nodes which are up to 2.5 cm. The peripancreatic tissue is dissected for further. nodes. Just distal to the ampulla, the circumference of the duodenum is 7 cm and at the distal duodenal margin. circumference is 5.5 cm. The duodenal mucosa is yellow-tan with normal appearing mucosal folds and no. palpable areas of nodularity are present within the duodenal wall. There is very little duodenal adipose. tissue present. The pancreatic resection margin is removed as a thin shave and submitted for frozen. section as FSD1. Section summary: D1) pancreatic resection margin from frozen section,. D2) proximal gastric resection margin,. D3) representative distal gastric tissue,. D4) sections of pylorus,. D5-D6) sections of ampulla (stent dissected free),. D7-D8) diverticulum-like structure of duodenum extending into head of pancreas,. D9-D12) anterior superior pancreas in vicinity of tumor,. D13-D15) anterior inferior pancreas in vicinity of neoplasm. D16-D18) posterior pancreas with closest approach of neoplasm,. D19-D20) additional sections of distal common bile duct and neoplasm,. D21) additional sections of body of pancreas adjacent to pancreatic resection margin,. D22) distal duodenal margin,. D23) possible nodes from perigastric adipose tissue,. D24) one larger peripancreatic node, bivalved, two smaller nodes intact,. D25) one large peripancreatic node, bivalved,. D26) single prominent peripancreatic node, serially sectioned,. D27) larger peripancreatic node, bivalved,. D28) large peripancreatic node, bivalved,. D29) four possible peripancreatic nodes, intact,. D30) single peripancreatic node, bivalved,. Printed: This report continues. - Page 4/5. FINAL SURGICAL PATHOLOGY REPORT. D31) four smaller possible peripancreatic nodes. E. The specimen is labeled final bile duct margin and is received without fixative. It consists of a roughly. cylindrical portion of tan to yellow-green tissue measuring 2 x 1.5 x 1 cm. A suture marks the true margin. The margin is removed as a thin shave and submitted for frozen section as FSE1. The tissue remaining. from frozen section is submitted for permanent section in cassette E1. F. The specimen is labeled new bile duct margin and is received without fixative. It consists of a. cylindrical portion of pale green tissue measuring 3.5 x 1.5 x 1.2 cm. A suture marks the true margin. The. true margin is removed as a thin shave and submitted for frozen section as FSF1. The tissue remaining. from frozen section is submitted for permanent section in cassette F1. Microscopic Description: A. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. B. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Two lymph nodes are present, and are negative for metastatic carcinoma. C. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Sections demonstrate a single lymph node, negative for metastasis. D. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Venous invasion is present. A total of twenty-three lymph nodes are present, four of which are. positive for metastatic carcinoma. E. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Histologic sections demonstrate a segment of common bile duct, with mild to moderate. dysplasia. Invasive carcinoma is not identified. F. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Histologic sections demonstrate a segment of common bile duct, with mild dysplasia. Invasive. carcinoma is not identified. Printed: END OF REPORT (FINAL). - Page 5/5. ige 5."
BIOCUP_00304,pancreas,PAAD,TCGA-3A-A9IV,TCGA-3A-A9IV.A0D8875D-EBF7-4D76-945F-3CDFB6B9A351,"Final Diagnosis. A. LYMPH NODE, HEPATIC ARTERY, EXCISION: One lymph node, negative for metastatic carcinoma (0/1). B. PANCREAS AND SPLEEN, SUBTOTAL PANCREATECTOMY AND SPLENECTOMY: Pancreatic endocrine neoplasm, grade 2. Tumor size: 3 x 2.5: cm. Surgical margins: Free of tumor. Necrosis: present. Mitotic rate: 7/10 HPFs. Fifteen regional lymph nodes with no evidence of metastasis. Unremarkable spleen. See Key Pathological Findings. C. ACCESSORY SPLEEN, ""SPLENULE"", EXCISION: Unremarkable splenic parenchyma. D. GALLBLADDER, CHOLECYSTECTOMY: Chronic cholecystitis and cholesterolosis. No evidence of dysplasia or malignancy. I,. the attending pathologiat, personally reviewed all. aliues and / or materials and rendered the final diagnosis. Electronically. Key Pathological Findings. B: Pancreas Endocrine. SPECIMEN: Tail of pancreas. Spleen. SPECIMEN: Splenectomy. TUMOR SITE: Pancreatic fail. TUMOR SIZE: Greatest dimension: 3.0 cm. Additional dimensions: 2.5x2.0 cm. TUMOR FOCALITY: Unifocal. HISTOLOGIC TYPE: Well-differentiated neuroendocrine tumor. WORLD HEALTH ORGANIZATION CLASSIFICATION: Well-differentiated endocrine tumor, uncertain behavior. FUNCTIONAL TYPE: Cannot be assessed. MITOTIC ACTIVITY: Greater than or equal to 2 mitoses/10 HPF to 10 mitoses/10 HPF; number of mitoses per 10. HPF: 7 mitoses / 10 high power fields. Ki67 LABELING INDEX: 3%-20% Ki67-positive cells. TUMOR NECROSIS: Present. MICROSCOPIC TUMOR EXTENSION: Tumor is confined to pancreas. MARGINS: Margina uninvolved by tumor. Distance of tumor from closest margin: 0.2 mm. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT): pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. REGIONAL LYMPH NODES (pN): pNO: No regional fymph node metastasis. Number examined: 16. Number involved: 0. DISTANT METASTASIS. ADDITIONAL PATHOLOGIC FINDINGS: PANIN lla. ANCILLARY STUDIES: The neoplastic cells are positive for synaptophysin, focally positive for chromogranin by. immunohistochemistry. The Ki-67 immunostain is positive in approximately 15% of the. neoplastic cells. COMMENT(S). B2-7 adequate for molecular studies. Specimen(s) Received. A. HEPATIC ARTERY LYMPH NODE. B. SUBTOTAL PANCREATECTOMY AND SPLENECTOMY FS. C. SPLENULE. D. GALLBLADDER GROSSLY CHECK FOR POLYP. Clinical History. Y/O FEMALE MORBID OBESITY, HM-ASTHMA. Preoperative Diagnosis. PANCREATIC NEUROENDOCRINE TUMOR. Intraoperative Consultation. FSB1 SUBTOTAL PANCREATECTOMY AND SPLENECTOMY: Pancreatic margin, no evidence of malignancy. GROSS EXAMINATION. D. GALLBLADDER GROSSLY CHECK FOR POLYP: Partially calcified mucosal polyps, measuring 3 mm to 5 mm. FSD1 GALLBLADDER GROSSLY CHECK FOR POLYP: Largest polyp no evidence of malignancy. Intradepartmental Consultation: The case was also reviewed by. MD, who concurs. with the above interpretation (FSD1). Comment: These frozen section diagnoses/results were communicated to and acknowledged by Dr. I.D., have performed the intraoperative consultations and issued the above. diagnosis. Gross Description. A. Specimen A is received fresh labeled ""hepatic artery lymph node."" The specimen consists of. a 2.0 x 1.5 x 1.0, moderately firm gray tan irregular lymph node which is serially sectioned and entirely. submitted as A1-A2. B. Specimen B is received fresh for frozen section analysis labeled ""subtotal pancreatectomy and. spienectomy."" The specimen consists of a subtotal pancreatectomy (8.0 x 4.0 x 2.5 cm) attached to a. grossly unremarkable spleen (14.0 x 8.0 x 6.0 cm). Both specimens are adherent to a moderate. amount of fat. The pancreatic margin of resection is stapled. The staples are removed and the. underlying tissue is removed tangentially and entirely submitted on frozen section as FSB1. The. pancreatic duct is markedly dilated but is probe-patent for approximately 2 cm where it is filled with. a. soft brown tan protruding tissue (possible tumor). The end of the pancreas which attaches to the. spleen is markedly indurated and exhibits a gray white smooth ill-defined mass (3.0 x 2.5 x 2.0 cm). abutting the soft tissue margin of resection and is approximately 4 cm from the pancreatic margin of. resection. The mass at this point totally occludes the pancreatic duct. The mass occupies. approximately 75% of the pancreas. The random pancreatic parenchyma is lobulated gray tan grossly. unremarkable. The capsule of the spleen is brown tan and intact. The cut surface exhibits a soft red brown tissue. with grossly unremarkable parenchyma. Sectioning of the adipose tissue isolates no definitive fymph. nodes. A representative section of the tumor is submitted to Tissue Procurement Laboratory. Representative sections are submitted as: B2: Mirror image of tumor submitted to Tissue Bank. B3-B6: Sections of tumor showing relationship to soft tissue margin of resection. B7-B8: Sections of tumor showing relationship to pancreatic duct. B9: Grossly unremarkable pancreatic parenchyma. B10: Grossly unremarkable spleen. B11-B26: Representative sections of adipose tissue. c. Specimen C is received fresh labeled ""splenule."" The specimen consists of what grossly. appears to be a lobule of spienic tissue partially covered by adipose tissue (2.5 x 2.0 x 2.0 cm). The. overlying adipose tissue is marked with black ink. The specimen is serially sectioned and reveals a. red brown grossly unremarkable splenic parenchyma. Representative sections submitted as C1. D. Specimen D is received fresh for frozen section analysis labeled ""gallbladder grossly check for. polyps. The specimen consists of a club-shaped gallbladder (8.0 x 3.0 x 1.5 cm). Te external surface. is green yellow, wrinkled with a small amount of attached fibroadipose tissue. The lumen is filled with. a. green vicile bile. No calculi grossly appreciated. There are several adherent soft lesions (possible. polyps) ranging from 0.2 cm to 0.5 cm in greatest dimension. A representative section of these. lesions is submitted for frozen section as FSD1. The remainder of the mucosal surface is. green-yellow, velvet-like and grossly unremarkable. Permanent representative sections are submitted. as D2-D3."
BIOCUP_00305,pancreas,PAAD,TCGA-F2-7273,TCGA-F2-7273.9517F018-4ECE-459D-B850-E57C26990865,"Diagnosis : FSA: Liver, biopsy. - Cholestasis, mesothelial lined cyst, no metastatic carcinoma. identified. FSB : Common bile duct margin, excision. - No carcinoma identified. FSC : Pancreatic duct margin, excision. - No carcinoma identified. D: Portal lymph nodes, dissection. - No metastatic carcinoma identified (0/9). E: Hepatic artery lymph nodes, dissection. No metastatic carcinoma identified (0/12 lymph nodes and lymph. node fragments). F: Gallbladder, cholecystectomy. - Chronic cholecystitis, no stones identified. G: Pancreaticoduodenectomy Whipple procedure. Tumor Histologic Type invasive ductal adenocarcinoma. Histologic grade: moderate to poorly differentiated. Tumor size: 4.2 cm. Extent of invasion: Peripancreatic soft tissues: involved (G9). Duodenum involved (G14). Ampulla : involved (G7). Lymphatic Invasion: present (G12). Venous Invasion: not identified. Perineural Invasion: present. Surgical Margins : Pancreatic neck: not involved. Bile duct: not involved. Posterior pancreatic surface (deep radial margin) : positive at. site of SMA (G9) and site of portal vein (G11). Peripancreatic soft tissues: involved posteriorly, see above. Proximal (gastric) : not involved. Distal (duodenal) : not involved. Regional lymph nodes: Total number with metastasis: 3. Total number examined: 32. Additional pathologic findings : none. AJCC Stage: pT3 pN1 pMx. Note: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. Intraoperative Consult Diagnosis: A frozen section consultation was requested by. at. FSA1: Liver, biopsy. - Liver with bile stasis, mild inflammation and detached. peritoneum versus mesothelial cyst. No malignancy identified. FSB1 : Bile duct margin, excision. - No carcinoma identified. FSC1: Pancreatic duct margin, excision. - Chronic pancreatitis with fibrosis; no carcinoma identified. Drs. at. Drs. at. Frozen Section Pathologist : M.D., Ph.D. Clinical History : year-old male with a mass in the pancreatic head and. obstructive jaundice. The mass was not previously biopsied. Gross Description: Received are seven appropriately labeled containers. Container A is additionally labeled ""liver biopsy. The. container holds three beige/tan soft tissue fragments measuring. in aggregate 1.5 X 1.0 X 0.7 cm frozen and totally submitted as. FSA1,. Container B is additionally labeled ""common bile duct margin. The container holds a 1.5 x 0.2 X 0.2 cm red/beige/tan soft. tissue fragment frozen and totally submitted as FSB1,. Container C is additionally labeled ""pancreatic duct margin. The container holds a 0.9 X 0.2 X 0.2 cm red/beige/tan soft. tissue fragment frozen and totally submitted as FSC1,. Container D is additionally labeled ""portal lymph nodes. The. container holds a 3.5 X 1.5 X 0.2 cm tan fibroadipose soft. tissue fragment with several small lymph node candidates. palpated within ranging in size from 0.2 to 0.6 cm. The. specimen is totally submitted in blocks D1 and D2,. Container E is additionally labeled ""hepatic artery lymph. nodes. "" The container holds an aggregate of tan fibroadipose. soft tissue fragments loosely measuring 3 X 2 X 0.7 cm. Several. firm lymph node fragments are palpated within the specimen. The. specimen is totally submitted in blocks E1 and E2,. Container F is additionally labeled ""gallbladder. "" The container. holds a cholecystectomy specimen measuring 8 X 3.5 X 2.5 cm. The. serosal surface is pink/tan and smooth with a rough liver bed. resection surface. The mucosa is hemorrhagic, velvety and finely. trabeculated. The wall is uniform 0.2 to 0. cm in thickness. There are no stones. There are scant hemorrhagic luminal. contents. No mucosal or mural lesions are noted. Block summary : F1 - resection margin with cystic duct and artery and. representative section from fundus. F2 - representative sections from mid body and neck. Container G is additionally labeled ""pancreaticoduodenectomy. with short stitch at uncinate, long stitch at SMA. "" The. container holds a standard Whipple specimen with the following. measurements: distal stomach 7.5 X 5 cm; portion of greater. omentum attached to stomach 11 X 4.5 X 1.5 cm; duodenum 24 cm in. length X 2.5 cm in average diameter (after fixation) ; pancreatic. head and neck 6 X 4.5 X 4.5 cm. A long stitch marks the. pancreatic margin at the SMA and a short stitch marks the. uncinate process margin. Inking common bile duct=yellow,. resection margin at pancreatic neck=blue, uncinate. process=black, peripancreatic soft tissue=green. The serosal surface of the stomach and duodenum is tan and. smooth. The pancreatic head is very firm. Opening the duodenum. reveals erythematous coarse and thickened mucosa at the ampulla. The remainder of the stomach and duodenal mucosa is beige/tan,. unremarkable, and appropriately folded. The pancreas is. sectioned revealing a 4.2 X 4.0 X 4.0 cm white/tan/yellow solid. firm mass occupying most of the pancreatic parenchyma in the. specimen. The mass has areas of necrotic cystic change along the. dorsal pancreatic surface. The tumor constricts the common bile. duct to lumen diameter of 1-2 mm. It comes up into the ampulla. and undermines the duodenal mucosa. The tumor infiltrates into. the duodenal wall proximal to the ampulla as well, extending up. to and possibly into the submucosa. The tumor does not involve. the pylorus. There is relatively poor demarcation between the. mass and the pancreatic neck. To assess distance to pancreatic. neck margin the resection surface of the neck is inked blue and. sections are taken perpendicular to this surface (true surgical. margin at the neck is superseded by the en face G2 section) . The. mass extends to the inked uncinate margin at short stitch and. the margin at the SMA at long stitch. It also abuts. peripancreatic soft tissue. Distance to mucosal margins: stomach. margin 16 cm, duodenal margin 13 cm, common bile duct margin 1.5. cm. A number of firm lymph nodes are identified in the. peripancreatic soft tissue ranging in size from 0.2 to 0.6 cm,. submitted per block summary. Tumor was collected by Tissue. Block Summary : G1 - common bile duct margin, en face. G2 - pancreatic neck margin, en face. G3 - gastric mucosal margin, en face. G4 - duodenal mucosal margin, en face. G5 - lymph node candidate at the common bile duct, bisected. G6 - perpendicular sections to the pancreatic neck (inked blue). G7 - ampulla section. G8 - perpendicular margin at uncinate at the surgeon' S short. stitch (black ink). G9 - perpendicular section at the SMA margin at long stitch. (green ink). G10-G11 representative sections to green inked pancreatic. surface, G10 near common bile duct, G11. near the portal vein groove. G12 - ulcerated duodenal mucosa at ampulla. G13 - tumor in relation to the common bile duct, two sections. G14 - tumor undermining duodenal wall. G15 - pylorus, representative section. G16 - representative sections of stomach and duodenum. G17 - multiple peripancreatic lymph node candidates. G18 - multiple peripancreatic lymph node candidates at base of. common bile duct. G19 - multiple peripancreatic lymph node candidates. G20-G22 - multiple perigastric lymph nodes candidates, each. cassette, greater omentum. Light Microscopy: Light microscopic examination is performed by. The frozen. section diagnoses are confirmed. Permanent sections show invasive ductal adenocarcinoma with mucinous. features within pancreatic head, extending into peripancreatic fat,. extending through the duodenal wall to undermine the mucosa, and. extending posteriorly to the pancreatic posterior soft tissue margin. at the site of the SMA and the portal vein. Definite nodal metastasis. is identified in block G18. Two soft tissue nodules in block G17 are. interpreted as most consistent with complete effacement by metastatic. carcinoma."
BIOCUP_00306,pancreas,PAAD,TCGA-3A-A9IO,TCGA-3A-A9IO.4151276B-536F-47F2-9B97-92E79722AB68,"Final Diagnosis. A. SPLEEN AND PANCREAS, RESECTION: Pancreatic endocrine neoplasm, well differentiated. Tumor size: 3 cm. Mitotic count: about 1 per 10 HPF. No necrosis is present. Pancreatic margin of resection is free of tumor. A focus of PanIN 1-2 present at the pancreatic resection margin. Uninvolved pancreatic parenchyma with focal fibrosis, atrophy and PanIN-3. Spleen with no significant pathologic findings. I,. the attending pathologist, personally reviewed the. entire case and rendered the final diagnosis. Electronically Signed Out by. Comment. This case (slide FSA2) was reviewed prospectively at the. slide review conference. Ancillary Studies. Immunohistochemistry stain, performed with proper control, revealed the tumor cells to be positive for. Synaptophysin and chromogranin and CD56. Ki-67 immunostain, performed with the proper control on block A4, showed proliferation index. approximately less than 1% (manual count). Specimen(s) Received. A. SPLEEN AND PANCREAS 3 FS. Clinical History. PANCREATIC NEUROENDOCRINE TUMOR. Preoperative Diagnosis. NONE GIVEN. Frozen Section Diagnosis. FSA1-FSA2. PANCREATIC MARGIN: No invasive tumor present. In 4/16/14. FSA3. Carcinoma with endocrine features. These frozen section diagnoses/results were communicated to and acknowledged by. I,. M.D., have performed the intraoperative consultation and issued the above diagnosis. Gross Description. A. The specimen is received fresh for OR consult labeled ""spleen and pancreas (check margin),. frozen section"". The specimen consists of a resected portion of the pancreas with adjacent spleen. (14.5 x 9.0 x 7.0 cm). The pancreas measures 6.5 x 4.0 x 2.5 cm). A palpable mass is grossly. appreciated. The overlying tissue is marked with blue ink. Serial sections reveal a partially calcified. brown-tan ill-defined mass (3.0 x 2.0 x 2.0). The mass is located 4.0 cm from the pancreatic surgical. margin of resection abutting the overlying soft tissue. A portion of the tumor is taken and submitted for. frozen section as FSA3. The pancreatic margin is removed tangentially and entirely submitted for. frozen sections FSA1 and FSA2. The pancreatic duct is propatent and grossly free of tumor. The. remaining pancreatic parenchyma is grossly unremarkable. The attached spleen measures 11.5 x 6.5. x 5.5 cm. The capsule is red brown and intact. Cut surface exhibits a grossly unremarkable spleen. parenchyma. Adjacent to the tissue is a moderate amount of fat (25.0 x 9.0 x 2.0 cm). A. representative section of the tumor is submitted to the Tissue Procurement Laboratory. Permanent. representative sections are submitted following decalcification as: A4: Mirror image of tumor submitted to Tissue Procurement Laboratory. A5-A9: Random representative sections of calcified mass. A10: Grossly unremarkable pancreas. A11: Grossly unremarkable spleen. A12: Pancreas showing relationship to spleen. A13-A17: Adipose tissue adjacent to lesion. A18-A22: Additional sections from pancreas."
BIOCUP_00307,pancreas,PAAD,TCGA-FB-AAPS,TCGA-FB-AAPS.0369BABC-3B58-4386-9CF6-71889B1F651B,"Gross Description: D: Whipple (paired silk prior pancreatic margin, long single silk portal. vein, long single blue SMA margin, looped blue suture deep radial margin): Received is a Whipple specimen that comprises a pancreas, duodenum, and. gallbladder. The specimen is oriented by the surgeon with a paired silk. suture designated as prior pancreatic margin, a long single silk suture. designated as portal vein, a long single blue suture designated as superior. mesenteric artery margin, and a looped blue suture designated as deep. radial margin. The pancreas measures 5.5 x 5.5 X 4 cm. The neck margin is inked blue and. the radial margin is inked black. The pancreas is sectioned to reveal an. ill-defined, indurated, white-yellow mass that measures. 3 x 3 X 2.7 cm that abuts and possibly invades the common bile duct, is. less than 0.1 cm to the superior mesenteric artery margin, and less than. 0.1 cm to the deep radial margin, less than 0.4 cm to the portal vein. margin, and greater than 2 cm from the pancreatic neck margin. The common. bile duct and pancreatic duct are both probe patent. The remaining. pancreatic parenchyma is tan-yellow with normal lobular architecture. The duodenum measures 19.5 cm in length X 3.3 cm in diameter and has. smooth, red-purple serosa. Both ends are stapled shut. The staples are. inked and opened to reveal a tan-brown mucosal surface with normal. appearing longitudinal folds. The distal 6.5 cm of duodenum is dark brown. and focally hemorrhagic with a slightly dusky appearance. There is an. ill-defined, erythematous lesion at the opening of the pancreatic duct in. the duodenum that measures approximately 2 X 1 cm in circumference. The. remaining duodenal mucosa is unremarkable. No other masses or lesions are. identified. The gallbladder measures 10.2 X 4.2 X 1.6 cm and has a smooth-to-roughened,. red-tan serosal surface. The gallbladder is opened and is filled with. viscous, red-black bile fluid. A cystic duct remnant is identified and. measures 1.5 cm in length X 0.4 cm in diameter. The serosal surface is. bile-stained and grossly unremarkable. In addition, there is a. crystallized calculus, 1.5 cm in greatest dimension, identified. No masses. or lesions are identified. The pancreatic duct and common bile duct enter the duodenum at different. locations approximately. 1.5 cm apart from each other. Sectioning through the fat closely reveals five possible lymph nodes. The. largest measures. 1.5 cm in greatest dimension. Representative sections are submitted. Microscopic Description: Diagnosis Details: SOURCE OF SPECIMEN:A Common bile duct - FS. SOURCE OF SPECIMEN:B Gastroduodenal lymph node. SOURCE OF SPECIMEN:C Pancreatic neck margin - FS. SOURCE OF SPECIMEN:D Whipple. Final Pathologic Diagnosis: A: Common bile duct, biopsy: - Bile duct, negative for malignancy. B: Gastroduodenal lymph node, biopsy: - Two lymph nodes, negative for malignancy (0/2). C: Pancreatic neck margin, biopsy: - Pancreas, negative for malignancy. D: Pancreas, duodenum, and gallbladder, Whipple procedure: - Ductal adenocarcinoma of the head of. pancreas, moderately differentiated. Comments: Formatted Path Reports: PANCREAS TISSUE CHECKLIST. Specimen type: Pancreatoduodenectomy. Tumor site: Head. Tumor size: 3 X 3 x 2.7 cm. Histologic type: Adenocarcinoma, ductal type. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 1/7 positive for metastasis (Regional 1/7). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None."
BIOCUP_00308,pancreas,PAAD,TCGA-HZ-8005,TCGA-HZ-8005.866af8ee-52c6-48f2-a385-e3cad487c401,"Diagnosis: A. - E.) PANCREAS, DUODENUM, DISTAL STOMACH, GALLBLADDER, APPENDIX,. CELIAC LYMPH NODE, PANCREATICODUODENECTOMY (WHIPPLE RESECTION),. TOTAL PANCREATECTOMY, DISTAL GASTRECTOMY, CHOLECYSTECTOMY. APPENDECTOMY AND REGIONAL LYMPH NODE DISSECTION: . POORLY DIFFERENTIATED ADENOCARCINOMA. - 4.5 cm in greatest dimension. - Involves pancreatic head and portion of pancreatic body. - Invades ampulla of Vater, duodenal wall, duodenal mucosa, and invades. peripancreatic soft tissue. - MARGIN STATUS: POSITIVE. - Tumor focally extends to the inferior anterior margin. - All other margins negative for tumor. - PERINEURAL INVASION: PRESENT. - EIGHT OF TWENTY-FOUR TOTAL LYMPH NODES, POSITIVE FOR. METASTATIO CARCINOMA (8/24). - CHRONIC CHOLECYSTITIS. - FIBROUS LUMINAL OBLITERATION OF APPENDICEAL TIP. - SEE TUMOR STAGING SUMMARY BELOW. PATHOLOGIC TUMOR STAGING SUMMARY: Type and grade: Ductal adenocarcinoma, poorly differentiated. Primary tumor: pT3 (tumor invades ampulla of Vater, duodenal wall,. duodenal mucosa and peripancreatic soft tissue). Regional lymph nodes: pN1 (twenty-four lymph nodes; eight positive for. metastasis). Distant metastasis: Not applicable. Pathologic stage: IIB. Lymphovascular invasion: Not identified. Margin status: R1 (tumor focally extends to inferior anterior margin). FINAL SURGICAL PATHOLOGY REPORT. Tumor Staging Information. Data derived from.current specimen. Staging in accordance with or modified from AJCC Cancer Staging. Handbook. and CAP protocol. Speciment. Head. body. and tail of pancieas quodenum dista-. stomach. gallbladder and appendax. Procedure: Pancreaticoduodenectomy resector: pancreatectomy. partial gastrectomy. chotecystectomy. and appendectomy. TUMOR FEATURES: Tumor site: Pancreatic head and body. Tumor size: Greatest dimension: 4.5 cm. Additional dimensions 4 x25cm. Histologic type: Ductal adenocarcinoma. Histologic grade. Poorty differentiated. Lymphovascular invasion: Not identified. Perineural invasion: Present. Tumor extension: Tumoi invades ampulla of Vater duodenal wall, and. extends into duodenal mucosa and peripancreatic soft. tissue. Treatment effect: Not applicable. LYMPH NODES: Eight of twenty-four lymph nodes. positive for metastatic. carcinoma (8/24). MARGIN EVALUATION. POSITIVE (R1). Distance to closest margin. Tumor tocally extends 10 antenor margit: Other margins: Uninvolved by invasive carcinoma. PATHOLOGIC TUMOR STAGING DESCRIPTORS: Primary tumor: pT3 (lumor involes ampulla of Vater. duodenal wall. duodenal mucosa, and peripancreatic soft lissue). Regional lymph nodes: pN1 (8/24 lymph nodes). Distant metastasis. Not applicable. Margin status. R1 (tumor focally involves infenor-antenor - marigin). Pathologic stage: IIB. Additional pathologic findings: Acute and chronic pancreatitis. Pancreatic intraepthelial neoplasia (Panim grade. FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: A Gallbladder. B. Appendix. C. Lymph node;Celiac. D. Whipple. E. Body and tail of pancreas. Clinical History/Operative Dx: Pancreatic lesion. Intraoperative Diagnosis: D. FSD1: Whipple procedure: Pancreatic margin positive. FSD2: Bile duct and portion of pancreatic margin Bile duct negative. Gross Description: A. The specimen is labeled gallbladder and is received in formalin. It consists of an intact gallbladder. which is 10.7 cm in length and has a maximum diameter of 4.8 em at the fundus. The free serosal surface. is pate violet, smooth and shiny. The cystic duct is slightly angulated and slightly thick-walled but the. cystic duct is patent. There is a 0.7 cm firm cystic duct node. The gallbladder wall is 0.3 cm in thickness. The mucosa is tan to pate green and velvety to finely nodular. There are no calculi present. Representative sections are submitted in cassette A1. B. The specimen is labeled appendix and is received in formalin It consist of a C-shaped appendix which. is 4 5 cm in length and has a maximum diameter centrally of 0 7 cm The serosal surface is :an smooth. and shiny. The appendiceal wall is intact. The mesoappendix is unternarkable The proximal margin. is. inked. Sections are unremarkable. Representative sections are submitted in cassette B1. C. The specimen is labeled celiac lymph node and is received in formalin It consists of a roughly ovoid. fragment of fibrofatty tissue which is 2 cm in maximum dimension. Il appears to contain lour discrete. lymph nodes, the largest of which measures 1.6 x 0 7 x 0.4 cm and the smallest node IS 0.4 cm in. maximum dimension. The two largest nodes are inked with contrasting colors. They are serially sectioned. and submitted in cassette C1. The two smaller nodes are inked with contrasting colors. They are sectioned. and submitted in cassette C2. FINAL SURGICAL PATHOLOGY REPORT. D The specimen is labeled Whipple procedure and is received without fixative It consists of a composite. resection which includes a 12.5 x 6 X 2.5 cm portion of gastric tissue and a 21 cm segment of duodenum. The proximal and distal margins are stapled. The free serosal surface of the gastric portion is. reddish-violet and smooth with a small amount of perigastric adipose tissue. A prominent lymph node is. adherent to the pyloric portion of the resection Just distal to the pylorus there is a hard 6 x 4 8 X em. portion of pancreatic tissue There are several posteriorly located peripancreatic lymph nodes which are. up to 1.5 CITI in maximum dimension Along the postenor-superior edge of the pancreatic lissut them is it. 3.8 cm segment of markedly dilated bile duct which is up to 1.3 cm in diameter The bile duct margin and. the distal pancreatic margin are removed and submitted for frozen section The bile duct is opened to. reveal a braided metallic stent within the lumen of the bile duct The anterior-superior surface of the. pancreas is inked blue, the anterior-inferior and uncinate portion of the pancreas is inked green. and the. posterior surface is inked black The free serosal surface of the duodenum is reddish-violet with stringing. fibrous adhesions but the duodenal wall appears intact. The specimen is opened to reveal the gastric. mucosa has small irregular rugal folds and is dark red and hyperemic throughout. The pylorus is 3 5 cm lll. diameter and shows similar dark red hemorrhagic discoloration Hemorrhagic discoloration extends 25 cm. distal 10 the pylorus in the proximal duodenal mucosa. The ampulla of Vatei is located 7.5 ens distal of. the pylorus and a braided metallic stent is present at the ampulla The underlying pancreato. ussue . prominently firm and on sectioning. the head of the pancreas IS nearly compietely replaced Dy is. pale tan to pale yellow neoplasm which is focally centrally necrotic This neoplasm overali measures 4 5. 4 x 2.5 cm. The neoplasm appears to encircle the ampulla but does not grossly appear to extend into the. duodenal mucosa surrounding the ampulla. The neoplasm is 9 5 cm from the distai margin and 14 un: from the proximal margin. The neoplasm abuts the anterior and posterior surfaces of the pancreas and. appears present at the distal pancreatic resection margin grossly The distal duodenal mucosa IS pale red. but shows normal appearing mucosal folds and there is a submucosal pale yellow. 0.4 cm nodule located. 3 cm distal to the ampulla. No other mucosal lesions are identified within the duodenum There is very. little adherent peripancreatic fat Following fixation, representative sections are submitted. Section. summary: D1) distal pancreatic margin from frozen section. D2) bile duct margin and portion of pancreatic. margin from frozen section, D3-D4) proximal gastric margin. D5) representative gastric tissue from fundus. D6) representative pylorus, D7) proximal duodenal mucosa just distal to pylorus. 08-D9) sections of. ampulla and peri-ampullary mucosa (stent has been dislodged). D12 D13) it. pancreas, D14) posterior surface of pancreas D15-D16) representative pancreatic tumor on D18, ,intions. of pancreatic tumor and bile duct as il enters the pancreas D19) small duodenal submucosal lesion distal. 10 ampulla, D20) distal duodenal margin. D21) lymph node al pylorus. D22) largest penpancieatio note. and adjacent pancreatic tumor. D23) additional posterior peripancreatic lymph node, D24) additional. postenor peripancreatic lymph node. D25-D26) additional possible peripancreatic nodes. E. The specimen is labeled body and tail of pancreas and is received in formalin It consists of a roughly. elliptical portion of pancreatic tissue which weighs 11 grams. Black sutures are present at one end of the. specimen and mark the body of the pancreas. The external surface varies from smooth to slightly distupted. near the tail of the pancreas The entire external surface is inked The specimen is senally sectioned. perpendicular to the long axis to reveal il IS composed of moderately firm pale yeilow tissas with a uptri. hemorrhagic appearing tubular structure which courses nearly through the entre. Well-delineated tumor is not appreciated grossly The specimen is sequentially and entirely submited JS. summarized below. Section summary E1) head of pancreas as en face section E2-E8) sections. progressing toward tail. E9) tail as perpendicular sections. P. FINAL SURGICAL PATHOLOGY REPORT. Microscopic Description: A. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. B. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. C. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. D. Microscopic sections have been examined The microscopic findings are reflected in the diagnosis. rendered. E. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered."
BIOCUP_00309,pancreas,PAAD,TCGA-2J-AABE,TCGA-2J-AABE.16730789-69FC-4C59-9411-4472A4130F81,"Surgery date: DIAGNOSIS: A. Soft tissue, falciform ligament, excision: Benign elastotic. nodule. B. Pancreatic body and tail and spleen, partial pancreatectomy and. splenectomy: Invasive moderately differentiated ductal. adenocarcinoma is identified forming a mass (5.8 x 3.6 X 3.3 cm). located in the pancreatic body. The tumor extends beyond the. pancreas to involve the peripancreatic soft tissue. Perineural. invasion is present. Tumor necrosis is absent. All surgical. resection margins are negative for tumor (minimum tumor free margin,. 2.1 cm, proximal pancreatic margin). The adjacent non-neoplastic. pancreatic parenchyma contains PanIN 1A. Multiple (23) regional. lymph nodes are negative for tumor. C. Lymph node, peripancreatic, excision: A single (1) lymph node. is negative for tumor. With available surgical material, [AJCC pT3N0] (7th edition, 2010). This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s). Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. GROSS DESCRIPTION: A. Received fresh labeled ""falciform ligament"" is a 0.4 x 0.4 x 0.2. cm fragment of tan soft tissue. All submitted. Grossed by. B. Received fresh labeled ""spleen, distal pancreas"" is a distal. pancreatectomy specimen consisting of 10.8 x 5.3 x 2.0 cm portion of. pancreas and a 170.0 gram, 11.5 x 8.8 x 2.5 cm partially morcellated. spleen. A 5.8 X 3.6 x 3.3 cm tan-white, solid, and cystic, firm. mass is present within the pancreas, 2.1 cm from the proximal. pancreatic margin. The mass does not appear to be confined to the. pancreas, grossly. The peripancreatic soft tissue is inked. Peripancreatic lymph nodes and splenic hilar lymph nodes are. identified. The spleen is grossly unremarkable. Representative. sections are submitted. Grossed by. C. Received fresh labeled ""peripancreatic lymph nodes"" is a 2.6 x. 1.1 x 0.8 cm aggregate of adipose tissue, lymphatic tissue not. identified grossly. All submitted. Grossed by. BLOCK SUMMARY: Part A: Falciform ligament. 1 Falciform ligament. Part B: Distal pancreas and spleen. 1 Proximal pancreatic margin. 2 Mass-1. 3 Mass-2. 4 Mass-3. 5 Spleen. 6 Mass to splenic artery. 7 Splenic LNs-1(B7). 8 Splenic LNs-1(B8). 9 Splenic LNs-5(B9). 10 Peripancreatic LNs-5(B1). 11 Peripancreatic LNs-3(B2). 12 Peripancreatic LNs-4(B3). 13 Peripancreatic LNs-3(B4). 14 Peripancreatic LNs-3(B5). 15 Peripancreatic LNs-1(B6). Part C: Peri pancreactic lymph node. 1 Peripancreatic tissue."
BIOCUP_00310,pancreas,PAAD,TCGA-FB-A7DR,TCGA-FB-A7DR.DEBA9632-E0F3-4D6C-836B-543E07B42612,"Gross Description: Tumor is located in head, tumor is invasive of duodenum to form a mass and solid,. with 3x2.5x2.2cm in size, firm and white-gray surface. Microscopic Description: Tumor is composed of papillary glands or dilated glands containing mucin. Glands are variability in shape and size. Tumor cells are invasion of fat tissue or duodenum mucosa or. pancreatic tissue. Mitotic index is present. Nuclei are hyperchromatic and very irregularly enlarged and. prominent nucleoli. Cytoplasm are moderate and eosinophilic. Stroma is desmoplastic and invasion of. lymphocytes. Diagnosis Details: Mucinous non-cyst adenocarcinoma, moderately-differentiated, infiltrating fat tissue. Comments: Formatted Path Reports: PANCREAS TISSUE CHECKLIST. Specimen type: Surgical resection. Tumor site: Head. Tumor size: 3 X 2.5 X 2.2 cm. Histologic type: Mucin-producing adenocarcinoma. Histologic grade: Moderately differentiated. Tumor extent: Other - Duodenum. Lymph nodes: Not specified. Lymphatic invasion: Present. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None. in 8/21/13 Yes."
BIOCUP_00311,pancreas,PAAD,TCGA-2J-AAB4,TCGA-2J-AAB4.A59BDECC-6076-4035-A359-EED94BBF3C95,"Surgery date: REVISED REPORT (Revised information underlined). DIAGNOSIS: A. Liver, left lobe nodule, biopsy: Bile duct hemartoma. B. Lymph node, hepatic artery, biopsy: A single (1) lymph node is. negative for tumor. C. Pancreas, neck margin, excision: Negative for tumor. D. Body and tail of pancreas, spleen, and portion omentum; distal. pancreatectomy: Invasive, well-differentiated (grade 2 of 4). adenocarcinoma involving an area measuring 6.8 x 4.0 x 2.6 cm. The. tumor is confined to the pancreas. Extensive perineural invasion is. present. Lymphovascular invasion is not identified. The adjacent. non-neoplastic pancreatic parenchyma shows chronic pancreatitis. The spleen is uninvolved. A single (of 33) regional. lymph node is positive for metastatic adenocarcinoma. All surgical resection margins are negative for tumor. With available surgical material, [AJCC pT2 N1. (7th edition, 2010). Frozen section histologic interpretation of nodule left lobe liver,. hepatic artery lymph node, and neck of pancreas margin performed by: This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s). Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. AMENDMENTS: (Previous Signout Date: Revision Description: A lymph node was found to be positve for. metastatic adenocarcinoma. Diagnosis is changed accordingly. Original Diagnosis. A. Liver, left lobe nodule, biopsy: Bile duct hemartoma. B. Lymph node, hepatic artery, biopsy: A single (1) lymph node is. negative for tumor. C. Pancreas, neck margin, excision: Negative for tumor. D. Body and tail of pancreas, spleen, and portion omentum; distal. pancreatectomy: Invasive, well-differentiated (grade 2 of 4). adenocarcinoma involving an area measuring 6.8 X 4.0 x 2.6 cm. The. tumor is confined to the pancreas. Extensive perineural invasion is. present. Lymphovascular invasion is not identified. The adjacent. non-neoplastic pancreatic parenchyma shows chronic pancreatitis. The spleen is uninvolved. Multiple (33) regional lymph nodes are. negative for tumor. All surgical resection margins are negative for. tumor. With available surgical material, [AJCC pT2N0] (7th edition, 2010). Frozen section histologic interpretation of nodule left lobe liver,. hepatic artery lymph node, and neck of pancreas margin performed by: This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s). Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. GROSS DESCRIPTION: A. Received fresh labeled ""nodule left lobe liver"" is a 0.6 X 0.3 x. 0.2 cm aggregate of pale tan soft tissue with a 0.1 x 0.1 x 0,1 cm. white plaque within it. All submitted. Grossed by. B. Received fresh labeled ""hepatic artery lymph node"" is a 1.8 x 1.6. x 0.9 cm lymph node. All submitted. Grossed by. C. Received fresh labeled ""neck of pancreas margin up"" is a 2.8 X. 1.7 X 0.8 cm portion of neck of pancreas with orientation. Margin. submitted. Grossed by. D. Received fresh labeled ""body and tail of pancreas, spleen,. portion of omentum"" is a distal pancreatectomy specimen consisting. of 7.2 X 4.1 x 3.8 cm portion of pancreas and a 165.0 gram, 10.8 X. 7.7 x 5.2 cm spleen and a 14.8 x 11.4 X 2.6 cm portion of omentum. A 6.8 X 4.0 X 2.9 cm firm white fibrous mass is present within the. pancreas, 1.1 cm from the proximal pancreatic margin. The mass does. not appear to be confined to the pancreas, grossly. The. peripancreatic soft tissue is inked. Peripancreatic lymph nodes and. splenic hilar lymph nodes are identified. The spleen is grossly. unremarkable. Representative sections are submitted. Grossed by. BLOCK SUMMARY: Part A: Nodule left lobe liver. 1 Nodule Lt lobe liver. Part B: Hepatic artery lymph node. 1 Hepatic artery LN lof2 (B1). 2 Hepatic artery LN 2of2 (B1). Part C: Neck of pancreas margin. 1 Pancreatic neck margin 1. 2 Pancreatic neck margin 2. Part D: Body and tail of pancreas, spleen, portion omentum. 1 Proximal pancreas. 2 Pancreas mass splenic artery. 3 Dist pancreatic mass. 4 Pancreas w/post soft tissue. 5 Dist pancreatic mass 2. 6 Spleen. 7 Peripancreatic LN 3(D1). 8 Peripancreatic LN 5(D2). 9 Peripancreatic LN 5(D3). 10 Peripancreatic LN 5(D4). 11 Peripancreatic LN 5(D5). 12 Peripancreatic LN 4(D6). 13 Peripancreatic LN 1(D7). 14 Peripancreatic LN 1(D8). 15 Peripancreatic LN 2(D9)."
BIOCUP_00312,pancreas,PAAD,TCGA-HV-A7OP,TCGA-HV-A7OP.9CF238DA-57D1-4DDF-9ECB-23BC9F887056,"M/. CLINICAL DIAGNOSIS : Pancreatic Cancer. FROZEN DIAGNOSIS : Fro 1) R/O liver mass, biopsy: Mesothelial cell hyperplasia. Fro 2) R/O peritoneal seeding #1, biopsy: Negative. Fro 3) R/O peritoneal seeding #2, biopsy: Atypical glands. Fro 4) R/O peritoneal seeding #3, biopsy: No tumor present. Fro 5) R/O peritoneal seeding #4. biopsy: No tumor present. Fro 6) Omental seeding, biopsy: No tumor present in lymph node. Fro 7) Pancreatic resection margin, biopsy: Negative. DIAGNOSIS: Pancreas, duodenum and common bile duct, pancreatico-duodenectomy: Intraductal tubulopapillary neoplasm, invasive, pancreas head. 1) Size of tumor: 6.5x5.0x5.0cm. 2) Extent of invasion: invasion to duodenum and ampulla of Vater. 5) Blood vessel invasion: absent. 6) Lymphatic invasions: present. 7) Perineural invasion: present. 8) Surgical margins: free (safety margin: 6.5cm from common bile duct margin,. 0. 1cm from retroperitoneal margin,. 3.5cm from duodenum proximal margin. 5.0cm from pancreas resection margin). 9) Lymph node: metastasis in 7 out of 28 lymph nodes. (mesenteric LN: 1/7, pericholedochal LN: 0/2, inferior head LN: 1/2, LN: 0/0,. LN #8: 0/6. LN #12: 0/0, LN #13: 1/1, LN #16: 0/5, LN #17: 4/5, omentum: 0/0). 10) Pathologic stage: pT3N1. 11) Related slide: 12) Associated findings: Pan IN 3 in remaining pancreatic parenchyma. Tissue labeled ""R/O liver mass"", biopsy: Mesothelial cell hyperplasia. Tissue labeled ""R/O peritoneal seeding #2"", biopsy: Atypical glands. Tissue labeled ""R/O peritoneal seeding #1. #3, #4"", biopsy: No tumor present. Tissue labeled ""omental seeding"". biopsy: No tumor present. Gallbladder, cholecystectomy: Chronic cholecystitis. Soft tissue, omentum, omentectomy: No tumor present."
BIOCUP_00313,pancreas,PAAD,TCGA-IB-A5SS,TCGA-IB-A5SS.9A82F47C-BD4B-4773-A6CF-885CE56D491E,"Note: If you do not see ""END OF PRINTED REPORT"" at the bottom of the. the report YOU DO NOT HAVE THE ENTIRE REPORT. Please try printir. CONFIDENTIAL. Time Reporte. Relevant. Information. Demographics. (for verification. Date of Birth. purposes). Sex: F. Collected Date/Time. Received Date/Time. Specimen Description. A: #8 lymph node. B: Distal pancreas and spleen . Clinical Information. History pancreatic cancer (adjacent to aorta). Diagnosis. A. #8 Lymph Node, Excision: - One lymph node, negative for malignancy (0/1). 3. Distal Pancreas and Spleen, Resection: - Poorly differentiated pancreatic ductal adenocarcinoma. - Tumor measures 4.5 cm in maximum dimension and extends into the. peripancreatic adipose tissue (pT3). - The cancer extends to the anterior and posterior edges of the pancreas. - The pancreatic surgical margin is negative for in situ and invasive. carcinoma. - Positive for perineural and lymphvascular space invasion. - Six lymph nodes are identified, five of the six are positive for metastatic. carcinoma (5/6), pN1. - Adenocarcinoma in situ is associated with the invasive tumor. - Intraductal papillary mucinous neoplasm is present in the pancreatic tail. See Synoptic Report and Microscopic Description. - The spleen is unremarkable. Rlectronically signed by: Synoptic Report. B: Pancreas (Exocrine), Macroscopic. SPECIMEN: Tail of pancreas. Spleen. PROCEDURE: Partial pancreatectomy (pancreatic tail) and splenectomy. TUMOR SITE: Pancreatic body. Pancreatic tail. TUMOR SIZE: Greatest dimension: 4.5 cm. Additional dimensions: 2.4 x 1.6. cm. B: Pancreas (Exocrine), Microscopic. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G3: Poorly differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades peripancreatic soft tissues. Tumor invades other peripancreatic soft tissue: Tumor nodules are present in fat on the posterior surface. This may represent replacement. of a lymph node. Tumor invades other adjacent organs or structures: Tumor invades the wall of the splenic artery and tumor embolus is present within the. lumen of the splenic artery. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 8. mm. Specified margin: Pancreatic margin. Margins uninvolved by carcinoma in situ. Invasive carcinoma involves posterior retroperitoneal surface of pancreas. TREATMENT EFFECT (applicable to carcinomas treated with necadjuvant therapy) : No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN) : pN1: Regional lymph node metastasis. Number examined: 6. Number involved: 5. DISTANT METASTASIS (pM) : Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN 3 ). Chronic pancreatitis. Intraductal papillary mucinous neoplasm present in the tail of the pancreas. CLINICAL HISTORY: Not specified. Gross Description. Received are specimens n and R All requisitions and specimen containers are labelled with. the patient's name. The cassettes and AP identifiers are labelled with. the Surgical Number. A: The specimen consists of a single lymph node with a small amount of fatty tissue. The. lymph node measures 2 x 1 x 0.5 cm. The lymph node is bisected and the cut surface is. tan and grossly unremarkable. The two halves of the lymph node are submitted in toto in. A1. The fatty tissue is submitted in A2. B: The specimen consists of the spleen along with a portion of pancreas. The spleen. measures 15 x 8 x 3.5 cm and the portion of pancreas measures 9 x 5.5 x 2.5 cm. The. pancreas has been painted as follows: anterior surface blue, stapled medial resection. margin orange, and the posterior surface black. Sectioning through the pancreas reveals. a relatively well circumscribed tan slightly whorled appearing mass which measures 4.5 x. 2.4 x 1.6 cm. The mass appears to encase the splenic vein and abuts the splenic artery. The tumor is less than 1 mm from the posterior pancreatic surface. The staples are. carefully removed from the pancreatic resection margin. Minimal pancreatic tissue is. removed with the staples. The mass is located 0.8 cm from the pancreatic resection. margin and 1 cm from the spleen. Sectioning through the tail of the pancreas reveals that. there are several small cystic structures present at the distal edge of the tumor. Sections are submitted as follows: B1-7. perpendicular sections through the pancreatic resection margin. Margin. submitted in toto. and shows the relationship of the margin to the tumor mass. B8-13. representative sections perpendicular through the tumor showing the. relationship of the. tumor to the anterior and posterior surgical plane. B14-19. sagittal sections taken through the tail of the pancreas showing the cystic. areas. B20-22. sections of the spleen where the tail of the pancreas intersects with the. splenic hilum. Microscopic Description. Sections show a poorly differentiated ductal adenocarcinoma arising in the tail of the. pancreas. Pancreatic adenocarcinoma in situ (PanIN 3) is identified at the edge of the. invasive tumor. This area is located 1.1 cm from the pancreatic resection margin. Low. grade pancreatic intraepithelial neoplasia is present at the pancreatic resection margin. The cytomorphology of the lesion is consistent PanIN 2. The invasive component replaces. the tail of the pancreas and extends out into the peripancreatic soft tissue. Invasive. carcinoma is identified at the inked anterior and posterior surfaces of the pancreas. Within the tail of the pancreas there is also an intraductal papillary mucinous neoplasm. (IPMN) identified. Invasive ductal adenocarcinoma is seen surrounding the IPMN. The. invasive component also invades into the wall of the splenic artery and tumor embolus is. present within the lumen of the splenic artery. Six lymph nodes are identified in the. peripancreatic fatty tissue of the tail. Five of the six lymph nodes are positive for. metastatic ductal adenocarcinoma. Number. Encounter. Number. Patient Location. - END OF PRINTED REPORT -."
BIOCUP_00314,pancreas,PAAD,TCGA-3A-A9IU,TCGA-3A-A9IU.49937937-79B1-4723-9E00-9EDD2F8707BC,"Corrected Report Comment. The reason for the corrected report is to change the lymph node count from 1 to 24 to 2 to 25, and. also the synoptic report will have to be corrected. Final Diagnosis. A. HEAD OF PANCREAS, PORTION OF DUODENUM, PORTION OF STOMACH AND. GALLBLADDER, PANCREATICODUODENECTOMY AND CHOLECYSTECTOMY: Pancreatic ductal adenocarcinoma, poorty-differentiated, with focal clear cell. differentiation. Carcinoma extends into the posterior retroperitoneal soft tissue. The common bile duct, duodenal, gastric, superior mesenteric artery margin, portal. groove, and posterior surface are all free of carcinoma. Metastatic carcinoma to 2 of 25 lymph nodes (2/25). Chronic cholecystitis and cholelithiasis. See synoptic report. B. PANCREAS, FINAL MARGIN, RESECTION: Pancreatic parenchyma, negative for carcinoma and intraepithelial neoplasia. I,. the attending pathologist, personally reviewed all. alides and / or materials and rendered the final diagnosis. Electronically. Key Pathological Findings. A: Pancreas Exocrine. SPECIMEN: Head of pancreas. Quodenum. Stomach. Common bile duct. Gallbladder. PROCEDURE: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Greatest dimension of solid component: 4.0 cm. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G3: Poorly differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades peripancreatic soft tissues. Tumor invades retroperitoneal soft tissue. MARGINS: Margins uninvolved by invasive carcinoma. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy): No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. TNM DESCRIPTORS: Not applicable. PRIMARY TUMOR (pT): pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesentenc artery. HISTOLOGIC PATTERNS: Clear cell. REGIONAL LYMPH NODES (pN): pN1: Regional lymph node metastasis. Number examined: 25. Number involved: 2. DISTANT METASTASIS (pM): Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PaniN 2). Squamous metaplasia. CLINICAL HISTORY: Not specified. Specimen(s) Received. A. WHIPPLE FS. B. PANCREATIC MARGIN FS. Clinical History. PANCREATIC CA. Preoperative Diagnosis. Pancreatic cancer. Intraoperative Consultation. FSA1. WHIPPLE: Bile duct margin, no evidence of malignancy. FSB1. PANCREATIC MARGIN: No evidence of malignancy. Comment: This frozen section diagnosis/result was communicated to and acknowledged by Dr. I,. M.D., have performed the intraoperative consultation and issued the above. diagnosis. Gross Description. A. Specimen A is received fresh for frozen section analysis labeled ""stomach, pancreas, bile. duct,. duodenum, gallbladder. The specimen consists of a resected head of pancreas (5.0 x 3.0 x 1.5. cm), portion of stomach (3.0 cm on the lesser curvature and 6.5 cm on the greater curvature),. duodenum (11.0 cm in length and 5.0 cm in circumference), and gallbladder (8.5 x 4.0: x 3.5 cm). The pancreatic margin of resection is removed and submitted tangentially. The portal vein groove is. marked with yellow ink, removed and entirely submitted perpendicularly. The superior mesenteric. artery margin of resection is marked with black ink, totally removed and entirely submitted. perpendicularly. The retroperitoneal surface is marked with blue ink and is entirely submitted. perpendicularly. A palpable pancreatic mass is appreciated. The pancreatic duct is probe patent for. approximately 5 mm and is totally obstructed due to the presence of a firm, gray yellow, ill-defined. pancreatic mass (4.0 x 3.0 x 2.0 cm). The mass is approximately 5 mm from the pancreatic margin of. resection and grossly abuts the portal vein groove and the superior mesenteric artery margin of. resection. Grossly the mass appears to involve the wall of the common bile duct but does not appear. to. involve the Ampulla of Vater or duodenum. The remainder of the pancreatic parenchyma is grossly. unremarkable. The duodenum and gastric mucosa exhibits normal mucosal folds with no gross. evidence of nodularity or pofypoid lesions. A catheter is inserted in the common bile duct. The. gallbladder is filled with a small amount of green viscous bile. There is 1 green-yellow calculi present. measuring 1.5 x 1.0 x 1.0 cm. The mucosal surface is green yellow and velvet-like. The wall of the. gallbladder ranges from 0.1 cm to 0.3 cm in thickness. On gross examination, the galibladder is free. of tumor. A section of the adjacent adipose tissue isolates 2 gray-tan, irregular lymph nodes. measuring 1.5 cm in greatest dimension. The lymph nodes are isolated at the pancreas. A. representative frozen section is taken and submitted as FSA1 and submitted as bile duct. Permanent. sections are submitted as: A2: Mirror image of tumor submitted to tissue bank. A3: Tangential pancreatic margin of resection. A4: Perpendicular portal vein groove. AS-A6: Perpendicular superior mesenteric artery margin of resection. A7-A8: Perpendicular retroperitoneal surface. A9: Tangential gastric margin of resection. A10: Tangential duodenal margin of resection. A11: Tumor showing its relationship to the pancreatic duct. A12-A13: Tumor showing its relationship to the common bile duct. A14: Ampulla of Vater. A15: Tumor showing its relationship to the duodenum. A16-A17: Additional sections of tumor showing its relationship to adjacent tumor. A18: Grossly unremarkable pancreatic parenchyma. A19: Grossly unremarkable gastric mucosa. A20: Grossly unremarkable duodenal mucosa. A21: Grossly unremarkable gallbladder. A22: Two lymph nodes, peripancreatic. A23: Entire adipose tissue adjacent to pancreas. A24-A27: Entire adipose tissue attached to lesser curvature. A28-A35: Entire adipose tissue attached to greater curvature. B. Specimen B is received fresh for frozen section analysis labeled ""pancreatic margin."" The. specimen consists of a 2.5 x 1.5 x 0.5 cm, moderately-firm, brown-tan, irregular fragment of tissue. which is entirely submitted tangentially for frozen section as FSB1."
BIOCUP_00315,pancreas,PAAD,TCGA-3A-A9I7,TCGA-3A-A9I7.6D8DBB3D-111F-4A77-9611-7F5A85A5F11A,"Final Diagnosis. A. GALLBLADDER, CHOLECYSTECTOMY: Gallbladder with chronic cholecystitis. B. LYMPH NODE, HEPATIC ARTERY, BIOPSY: One lymph node with metastatic adenocarcinoma (1/1). C. BILIARY STENT, REMOVAL: Biliary stent, gross diagnosis only. D. HEAD OF PANCREAS, PORTION OF DUODENUM AND DISTAL STOMACH, STANDARD. PANCREATODUODENECTOMY: Adenocarcinoma, moderately differentiated, pancreatic ductal origin. Perineural.targe-vessel and lymphatic invasion identified. Carcinoma invades the duodenum, common bile duct, Ampulla and peripancreatic tissue. Adjacent pancreatic parenchyma with panIN 3. Adenocarcinoma involves 1 of 27 lymph nodes (1/27). the attending pathologist, personally reviewed all. alides and / CL materials and rendered the final diagnosia. Electronically. Comment. The carcinoma appears to be of pancreatic origin, based on the presence of extensive pancreatic. intraepithelial neoplasia, and the lack of Ampullary precursors. The bulk of the invasive carcinoma. is. within the pancreas and secondarily involves the Ampulla and duodenum. Deeper sections examined of lymph node blocks D31-D32, D41 and D43. Key Pathological Findings. Specimen type: D: Pancreas-Exocrine Synoptic Data. SPECIMEN TYPE: Pancreaticoduodenectomy (Whipple resection), partial. pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Invasive: 1.5 cm. OTHER ORGANS RESECTED: OTHER ORGANS RESECTED: Gallbladder. Duodenum. Distal Stomach. Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. Duodenum. Bile duct. PRIMARY TUMOR (pT): pT3: Tumor extends beyond the pancreas but without. involvement of the celiac axis or the superior mesenteric artery. REGIONAL LYMPH NODES (pN): pN1a: Metastasis in single regional lymph node. Number examined: 28. Number involved: 2. DISTANT METASTASIS (pM): pMX: Cannot be assessed. MARGINS: Margins free of tumor. VENOUS (LARGE VESSEL) INVASION (V): Present. LYMPHATIC (SMALL VESSEL) INVASION (L): Present. PERINEURAL INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN 3). COMMENT(S). Lymph node count includes the hepatic artery lymph node. Specimen(s) Received. A. GALLBLADDER. B. HEPATIC ARTERY NODE. C. BILIARY STENT ( GROSS ONLY. D. WHIPPLE 4FS. Clinical History. AMPULLARY CANCER. Preoperative Diagnosis. Ampullary cancer. Intraoperative Consultation. FSD1. PANCREATIC MARGIN: Negative. FSD2: COMMON BILE DUCT MARGIN: Negative. FSD3, FSD4: RETROPERITONEAL MARGIN (PERPENDICULAR): Negative. Comment: This frozen section diagnosis/result was communicated to and acknowledged by Dr. in. I,. M.D., have performed the intraoperative consultation (s) and issued the above. diagnosis. Gross Description. A. The specimen was received fresh in 4 containers. Specimen A is labeled gallbladder"". The. specimen consists of a gallbladder which measures 8 x 4x3 cm. The serosa covering the gallbladder. is pink-tan to dusky purple, smooth and glistening. No transformal perforations are grossly identified. The galibladder's contents consist of a moderate amount of dark green, viscous bile. The mucosa. of. the gallbladder is elevated and grossly unremarkable. The cystic duct is patent to the flow of bile and. has a 0.3 cm in diameter fumen. No lymph nodes are grossly identified attached to the gallbladder. neck. The gallbladder's wall is mildly edematous, averaging 0.3 cm in thickness, No tissue was. submitted to the Tissue Procurement Laboratory. Representative sections of the specimen are. submitted in 2 cassettes, A1 and A2. B. Specimen B is labeled ""hepatic artery node"". The specimen consists of a single, roughly. ovoid, rubbery potential lymph node measuring up to 1.4 cm in greatest dimension. No tissue was. submitted to the Tissue Procurement Laboratory. The lymph node is serially sectioned and is. submitted entirely in 2 cassettes, B1 and 82. C. Specimen C is labeled biliary stent, gross only. The specimen consists of a blue plastic tube. which measures 13.0 cm in length and 0.2 cm in diameter. The ends of the tube reveal a patent. lumen which measures up to 0,2 cm in diameter. No sticky material is identified on the surface of the. tube. The specimen is received for gross analysis only. D. Specimen D is labeled ""Whipple, frozen section on retroperitoneal margin, pancreatic margin,. bile duct"", The specimen consists of a pancreatic head (7 x x 2.5 cm) with attached duodenum. (16.0 cm in length and up to 4.5 cm in circumference at the level of distal resection margin) and distal. portion of stomach (4.5 cm in length and up to 10.0 cm in circumference at the level of stapled gastric. resection margin). The serosa of the stomach is pink-tan, smooth and glistening, while the outer. surface of the duodenum is shaggy with a small amount of fibroadipose tissue attached. There is. also. a small amount of omental adipose tissue attached to the gastric wall. The peripheral aspects of the. pancreatic head are composed of a small amount of adipose tissue which is ranging from 0.1 to 0.3. cm in thickness. Prior to sectioning, the specimen is inked as follows: Anterior aspect of the pancreatic head: Green. Medial aspect (groove): Red. Stapled retroperitoneal margin: Orange. The remainder of the posterior aspect of the pancreatic head: Black. Parenchymal resection margin: Black. Common bile duct margin: Blue. On opening. the duodenum reveais an irregular, ill defined, sessile, focal hemormagic tumor (1.5 x 1. cm) which involves ampulla of Vater On sectioning, the tumor measures up to 0,5 cm in depth and. appears to involve adjacent portion of pancreatic head. The tumor also appears to involve the distal. portion of common bile duct and main pancreatic duct, A 1.0 distal cm of the common bile duct, and. the area of junction between main pancreatic duct and common bile duct are partially obstructed by. the tumor. The portion of the common bile duct and the main pancreatic ducti are located distal to the. obstructed area, dilated up to 1.8 cm in circumference. The dilated portion of the common bile duct. is 0,5 cm from the closest retroperitoneal resection margin. The remaining parenchyma of the. pancreatic head is pale yellow, lobulated, rubbery to firm with some areas of intralobular fibrosis within. parenchyma surrounding dilated portion of common bile duct. The portion of pancreatic parenchyma. adjacent to the parenchymal resection margin is grossly unremarkable. Several potential lymph nodes. are grossly identified within fibroadipose tissue surrounding pancreatic head. The remaining mucosa. of the duodenum and stomach are grossly unremarkable. Representative sections of the specimen. are submitted to the Tissue Procurement Laboratory. Representative sections of the specimen are. submitted for frozen section analysis and frozen section remnants are submitted in 4 cassettes as. follows: FSD1: Pancreatic resection margin, tangential section. FSD2: Common bile duct margin, tangential section. FSD3, FSD4: Retroperitoneal margin (perpendicular cross sections) closest to the tumor. Additional sections of the specimen are submitted in 39 cassettes, D5-D43 as follows: D5-D6: Gastric resection margin, tangential section. D7: Duodenal resection margin, tangential section. D8: Ampulla of Vater with adjacent area of junction between main pancreatic duct. and common bile duct. D9-D12: The remainder of the tumor involving ampulla of Vater with adjacent distal. portion of common bile duct. D13-D15: Additional sections of the retroperitoneal margin in relation to the main. pancreatic duct. D16-D19: Additional sections of the indurated parenchyma of the pancreatic head. adjacent to the common bile duct and the main pancreatic duct. D20: Dilated portion of the common bile duct. D21: Additional section of the duodenum adjacent to the ampulla of Vater. D22-D24: Additional sections of the pancreatic head adjacent to the common bile duct. and the main pancreatic duct. D25-D27: The remainder of the fibroadipose tissue, anterior aspect of the pancreatic. head. D28: The remainder of the fibroadipose tissue attached to the medial aspect of the. pancreatic head. D29-D30: The remainder of the fibroadipose tissue, superior aspect of the pancreatic. head. D31-D34: The remainder of the adipose tissue of of the retroperitoneal aspect with. potential lymph nodes. D35-D36: A portion of less omental adipose tissue in it's entirety. D37-D43: A portion of greater omentum with potential lymph nodes."
BIOCUP_00316,pancreas,PAAD,TCGA-3A-A9J0,TCGA-3A-A9J0.0FEC454A-9BE2-4538-A74B-4BE531410B6D,"Final Diagnosis. A. LYMPH NODE, HEPATIC ARTERY, BIOPSY: One lymph node, negative for metastatic carcinoma (0/1). B. PORTION OF HEAD OF PANCREAS, PORTION OF DUODENUM, DISTAL STOMACH,. PORTION OF COMMON BILE DUCT, AND GALLBLADDER, STANDARD. PANCREATODUODENECTOMY: Pancreatic ductal adenocarcinoma, moderately differentiated, measuring 4.0 cm, extending. into Ampulla, duodenum and peripancreatic tissue. Carcinoma approaches to 0.75 mm of the posterior surface. Portal vein groove and superior mesenteric artery are negative for carcinoma. The common bile duct margin is negative for dysplasia and carcinoma. Gallbladder with chronic cholecystitis. Adjacent pancreatic parenchyma with PanIN-3, see comment. Metastatic carcinoma to 5 of 14 peripancreatic lymph nodes (5/14). Perineural, lymphovascular and large vessel invasion identified. C. PANCREAS, NEW PANCREATIC MARGIN, RESECTION: Low-grade dysplasia identified. Negative for carcinoma. the attending pathologist, personally reviewed all. slides and / or materials and rendered the final diagnosis. Electronically. Comment. Sections through the Ampulla show apancreatic ductal adenocarcinoma secondarily involving the. Ampulla and common bile duct. A precursor lesion for the carcinoma is not identified in the Ampulla,. duodenum or bile duct. The carcinoma, however, is centered on the main pancreatic duct. The. adjancet pancreatic parenchyma hsows PanIN 3. These findings support the interpretation of this as a. pancreatic ductal primary, rather than an Ampullary or common bile duct primary. Ancillary Testing. Immunohistochemical stains with appropriate controls were performed on block B9. These results. show strong and diffuse expression for MUC-1, and no expression for MUC-2 and CDX2. These. results are consistent with a pancreatobiliary phenotype. Key Pathological Findings. SPECIMEN: Head of pancreas. Duodenum. Stomach. Common bile duct. Gallbladder. PROCEDURE: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Greatest dimension of solid component: 4.0 cm. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades ampulla of Vater or sphincter of Oddi. Tumor invades duodenal wall. Tumor invades peripancreatic soft tissues. Tumor invades retroperitoneal soft tissue. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 0.75 mm. Specified margin: posterior surface. Margins uninvolved by carcinoma in situ. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy): No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. TNM DESCRIPTORS: Not applicable. PRIMARY TUMOR (pT): pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN): pN1: Regional lymph node metastasis. Number examined: 15. Number involved: 5. DISTANT METASTASIS (pM): pM0: No Distant metatstasis. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN 3). ANCILLARY STUDIES. Specimen(s) Received. A. HEPATIC ARTERY LYMPH NODES FS. B. WHIPPLE SPECIMEN FS. C. NEW PANCREATIC MARGIN FS. Clinical History. NOT GIVEN. Preoperative Diagnosis. AMPULLARY CA. Intraoperative Consultation. FSA1. HEPATIC ARTERY LYMPH NODE FROZEN SECTION: Negative for carcinoma. FSB1. WHIPPLE, COMMON BILE DUCT MARGIN: Negative. FSC1. NEW PANCREATIC MARGIN: Negative. Comment: These frozen section diagnoses/results were communicated to and acknowledged by Dr. I,. have performed the intraoperative consultations and issued the. above diagnosis. Gross Description. A. Specimen A is received fresh for frozen section analysis labeled ""hepatic artery lymph node."". The specimen consists of a 2.0 x 1.5 x 0.5-cm, firm gray-brown irregular lymph node which is bisected. and entirely submitted for frozen section as FSA1. B. Specimen B is received fresh for frozen section analysis labeled ""bile duct, gallbladder portion. of pancreas duodenum and distal stomach."" The specimen consists of a portion of the pancreas (4.5. x 3.0 x 2.0 cm), duodenum (8.0 cm in length), gallbladder (10.0 x 3.0 x 3.0 cm). No distal stomach is. grossly appreciated. The portal vein groove is marked with blue ink, superior mesenteric artery. margin yellow ink, and retroperitoneal surface exterior green ink. The pancreatic duct is probe-patent. for approximately 2.0 cm and is grossly occluded by firm indurated gray-tan mass (4.0 x 3.0 x 2.0 cm). Grossly the mass appears to be directly subjacent to the common bile duct and grossly involving the. Ampulla. The remaining pancreatic parenchyma consists of a yellow lobulated grossly unremarkable. tissue. The common bile duct is probe-patent but does grossly appear to be somewhat dilated. The. remainder of the duodenal mucosa exhibits normal intestinal folds. No other nodules or polyps are. grossly appreciated. The serosa of the gallbladder is green-yellow and smooth. On opening, there is. a moderate amount of green viscous bile. No calculi grossly appreciated. The mucosal surface of the. gallbladder is green-yellow and velvet-like. No stomach is grossly appreciated. A representative. section of the tumor is submitted to Tissue Procurement Laboratory. A representative frozen section. is taken and submitted as: FSB1: Tangential common bile duct margin of resection. Permanent representative sections are submitted as: B2: Portal vein groove perpendicularly sectioned. B3: Superior mesenteric artery tangentially removed and perpendicularly. sectioned. B4: Retroperitoneal surface perpendicularly sectioned. B5: Tangential pancreatic margin of resection. B6: Proximal duodenum/distal stomach. B7: Distal duodenum. B8-B9: Tumor showing its relationship to pancreas, Ampulla of Vater, and duodenum. B10: Cross section of common bile duct showing relationship to tumor. B11-B13: Random representative sections of tumor showing relationship to adjacent. tissue. B14: Longitudinal section pancreatic duct. B15: Cross section pancreatic duct and adjacent lymph node. B16: Grossly unremarkable duodenal mucosa. B17: Gallbladder. B18-B19: Unsectioned lymph nodes isolated at pancreas. B20-B21: Entire adipose tissue. B22-B25: Remainder of Ampulla. C. Specimen C is received fresh for frozen section analysis labeled ""new pancreatic margin, new. margin up."" The specimen consists of a 3.0 x 1.5 x 0.3-cm, firm yellow-tan lobulated fragment of. pancreas. The margin of resection is removed tangentially and entirely submitted on frozen section as. FSC1."
BIOCUP_00317,pancreas,PAAD,TCGA-3A-A9IH,TCGA-3A-A9IH.A9D376FF-9D71-4B4F-AB05-77CD42E2EB11,"GA-3A-A9IH-01A-PR. Final Diagnosis. A. OMENTUM, NODULE, EXCISION: Benign mesothelial cysts. There is no evidence of malignancy. B. LYMPH NODE, HEPATIC ARTERY, EXCISION: Lymph node with reactive changes and no evidence of malignancy (0/1). C. PANCREAS AND SPLEEN, SUBTOTAL PANCREATECTOMY AND SPLENECTOMY: Invasive pancreatic ductal adenocarcinoma, well to moderately differentiated. See Key Pathological Findings. Spleen with no significant pathologic changes and free of carcinoma. Five regional tymph nodes with reactive changes and no evidence of malignancy (D/5). D. LYMPH NODE, HEPATIC ARTERY #2, EXCISION: Lymph node with reactive changes and no evidence of malignancy (D/1). E. LYMPH NODE GASTRIC NODE, EXCISION: Lymph node with reactive changes and no evidence of malignancy (0/1). GALLBLADDER, CHOLECYSTECTOMY: Chronic cholecystitis and cholelithiasis. There is no evidence of malignancy. the attendir.g pathologist, personally reviewed all. alides and / or materiala and rendered the final diagnosis. Electronically. Key Pathological Findings. C: Pancreas Exocrine. SPECIMEN: Body of pancreas. Tail of pancreas. Gallbladder. Spleen. PROCEDURE: Spenectomy. TUMOR SITE: Pancreatic body. Pancreatic tail. TUMOR SIZE: Greatest dimension of solid component: 2 cm. Greatest dimension of cystic component: 0.5 cm. Additional dimensions: 2 cm. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC TYPE - NON INVASIVE OTHER NEOPLASMS: Introductal papillary mucinous neoplasm. Low grade dysplasia. Moderate dysplasia. High grade dysplasia. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor is confined to pancreas. MARGINS: Margins uninvolved by invasive carcinoma. Margins uninvolved by carcinoma in situ. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy): No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT): pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension. REGIONAL LYMPH NODES (pN): pNO: No regional lymph node metastasis. Number examined: 8. Number involved: 0. DISTANT METASTASIS (pM): pMO: No Distant metatstasis. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN PanIN 1B at the. pancreatic margin ). Chronic pancreatitis. Spleen with no significant pathologic changes. Specimen(s) Received. A. OMENTUM NODULE FS. B. HEPATIC ARTERY LYMPH NODE. C. SUBTOTAL PANCREATECTOMY AND SPLENECTOMY FS. D. HEPATIC ARTERY NODE #2. E. GASTRIC NODE. F. GALLBLADDER. Clinical History. PANCREATIC CANCER. Preoperative Diagnosis. Pancreatic cancer. Intraoperative Consultation. FSA: OMENTUM NODULE: Negative. Suggestive of mesothelial cysts. FSC1-FSC2: SUBTOTAL PANCREATECTOMY AND SPLENECTOMY: Pancreatic margin negative for carcinoma. Focal IPMN present. Comment: This frozen section diagnosis/result was communicated to and acknowledged by Dr. I. MD, have performed the intraoperative consultations and issued the above. diagnosis. Gross Description. A. The specimen is received fresh for frozen section and labeled ""omentum nodule."" The. specimen is received fresh and consists of 2 cysts measuring 1.0 x 1.5 cm in greatest dimension. Representative sections are submitted as FSA1. The remaining tissue is submitted for permanence. as A2. B. The specimen is labeled ""hepatic artery lymph node."" The specimen is received fresh and. consists of 1,5 x 0.5 x 0.5 cm tan-pink, irregular lymph node which is serially sectioned and entirely. submitted as B1. C. The specimen is received fresh for frozen section analysis labeled subtotal pancreatectomy. and splenectomy, frozen section. The specimen consists of a subtotal pancreatectomy (10.0 x 4.5 x. 2.0 cm), and splenectomy (13.0 x 7.5. 1.5 cm). The pancreas is marked with green ink on the. anterior aspect, orange ink on retroperitoneal surface, and blue ink on the inferior. The margin. of. resection is stapled. The staples are removed and the underlying tissue is submitted for frozen. section as FSC1-FSC2. The pancreatic duct is probe patent and grossly appears free of tumor. An. ill-defined, gray-white indurated focus is isolated in the pancreas towards the distal end of the. specimen adjacent to the spleen (2.0 x 2.0 x 1.0 cm) grossly abutting the anterior margin of resection. The left is approximately 3.5 cm from staple margin of resection. The remainder of the pancreatic. parenchyma is tan-yellow, tobulated, and grossly unremarkable. The capsule of adjacent spleen is. red-brown and intact. Cut surface exhibits a bright red, grossly unremarkable tissue. Upon additional. sectioning of the pancreatic tumor, the cut surface also reveals multiple cystic structures ranging from. 0.1 cm to 0.5 cm in greatest dimension. Sectioning of the adjacent adipose tissue isolates no. definitive lymph nodes. A section of the tumor is submitted to Tissue Procurement Laboratory. Permanent representative sections are submitted 38: C3: Mirror image of tumor submitted to tissue bank. C4-C11: Representative sections of pancreatic tumor shown in relationship to. adjacent tissue. C12: Pancreatic duct. C13: Grossly unremarkable pancreatic parenchyma. C14: Grossly unremarkable splenic parenchyma. C15: Adipose tissue adjacent to pancreatic tumor. D. The specimen is labeled ""hepatic artery node No. 2."" The specimen is received fresh and. consists of a 1.5 x 1.0 x 0.5 cm, moderately firm, tan-pink, irregular lymph node which is serially. sectioned and entirely submitted as D1. E. The specimen is labeled ""gastric nodule."" The specimen is received fresh and consists of a. 0.5 x 0.5 x 0.2 cm, tan-pink, irregular nodule which is submitted in toto as E1. F. The specimen is labeled ""gallbladder."" The specimen is received fresh and consists of a. club-shaped, tan-pink, galibladder (8.0 x 3.0 x 3.2 cm). Cystic duct is identified measuring 0.5 cm in. length. Upon opening, the galibladder contains multiple green-yellow calculi ranging from 0.2 cm to. 0.8 cm in greatest dimension. The mucosal surface reveais a small polypoid lesion measuring 0.1 cm. in greatest dimension. The remainder of mucosa is green-yellow, velvet-like and grossly. unremarkable. The wall of the gallbladder measures up to 3 mm in thickness. No tissue is submitted to Tissue Procurement Laboratory. Representative sections are submitted as: F1: Gallbladder. F2: Mucosal lesion."
BIOCUP_00318,pancreas,PAAD,TCGA-IB-7893,TCGA-IB-7893.52e9b7dd-75da-49c0-b8ce-b2cd33f01887,"ORIGINAL REPORT. SPECIMEN: A. Distal pancreas to stitch marks neok of pancreas. B. Gallbladder. CLINICAL BISTORY: Pancreatic mass - body of the pancreas. DIAGNOSIS: A, DISTAL PANCREAS; RESECTION: - INVASIVE POORLY DIFFERENTIATION DUCTAL ADENOCARCINOMA (7.0 cau). FAT, PERINEURAL INVASION PRESENT, RADIAL RESECTION MARGIN POSITIVE FOR. INFILTRATING PANCREATIC PARENCHYMA AND EXTENDING INTO PERIPANCREATIC. MALIGNANCY, PROXINAL AND DISTAL RESECTION MARGINS UNINVOLVED. III). HIGH GRADE PANCREATIC INTRAEPITHELIAL NEOPLASIA (PanIN. - - EIGHT PERIPANCREATIC LYMPK NODES NEGATIVE FOR MALIGNANCY. B. GALLBLADDER; CEOLECYSTECTOMY: - CHOLEEITHIASIS, CHRONIC CHOLECYSTITIS, NEGATIVE FOR MALIGNANCY. QROSS DESCRIPTION: A. The specimen consista of diatal panoreas which measures 12.0 x 4.5 x 3.0. with silver nitrate, The body of the pancreas is almost completely occupied. cm. The proximal margin is marked by a long suture, The specimen is painted. by a firm oylindrical tumor which measures 7.0 x 2,3 x 2.0 cm. The tumor. appears to be confined within the pancreatic parenchyma and is 0.2 cm from The the. radial margin, The tumor is 2. 0 cm from the proximal resection margin. out surfaces of the tumor are fairly circumacribed, yellow-white,. predominantly solid with few small cystic areas near the periphery. The. measures 0.7 em in diameter at the distal end of the pancreas, The proximal. pancreatic duct appears to be intact in the tumor and is dilated, The duct. resection margin is painted with India ink,. 201. HISTOPATHOLOGY REPORT. pivision Head: GROSS DESCRIPTION: sections;. A1,. proximal resection margin. A2-9. tumor. A10,. distal resection margin (enface). A11. tumor. A12. one lymph node. A13,. two lymph nodes. A14. additional section of the proximal margin. A15-A16. tumor and radial margin. A17. dilated duct. B, The specimen consists of, a gallbladder which measures 10.5 x 2.3 x 2.0. cm. The outer surtace is unremarkable. The wall. measures less than 0.1 cm in. thickness and the lumen contains numerous yellow-green stones admixed with. dark areen muginous material, Sectione are submitted in one cassette. Co:"
BIOCUP_00319,pancreas,PAAD,TCGA-S4-A8RO,TCGA-S4-A8RO.5E00B061-17CC-4BF0-A5FA-9DE01160DAD5,"Gender: Female. Race: White. FINAL PATHOLOGIC DIAGNOSIS. Biopsy; jejunal mesenteric mass: - No tumor in one lymph node (0/1). Cholecystectomy; gallbladder: - Gallbladder without diagnostic abnormality. Excision; portion of gastric staple line: - Portion of gastric antrum with antral gastritis. - No evidence of tumor. Whipple procedure; pancreas, duodenum, stomach: - Invasive moderately differentiated pancreatic ductal adenocarcinoma. - See Synoptic Report (below). Excision; gastric staple line: - Portion of stomach with antral gastritis. - No evidence of tumor. PANCREAS (EXOCRINE): Resection. Tumor Size: 4.0 x 2.7 x 2.7 cm. Histologic Type: Ductal adenocarcinoma. Histologic Grade: G2 (moderately differentiated). Margins: Margins involved by invasive tumor (uncinate & posterior. retroperitoneal surface). Treatment Effect: No prior treatment. Lymph-Vascular Invasion: Present. Perineural Invasion: Present. Pathologic Staging (pTNM) - pT3, N1, R1. Primary Tumor (pT): pT3 (tumor extends beyond the pancreas). Regional Lymph Nodes (pN): pN1 (regional lymph node metastasis). Number examined: Seventeen. Number involved: One (1/17). Distant Metastasis (pM): Not applicable. Effective January 1, 2010 this Checklist utilizes the 7th edition TNM staging. system for pancreas exocrine of the American Joint Committee on Cancer (AJCC). and the International Union Against Cancer (UICC). , M.D. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow, , MD. M.D. Clinical History: The patient is a. -year-old female with pancreatic adenocarcinoma, undergoing a. staging Whipple procedure. Specimens Received: A: Jejunal mesenteric mass. B: Gallbladder. C: Portion of gastric staple line. D: Pancreas, duodenum, stomach. E: Gastric staple line. Gross Description: The specimens are received in five containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""jejunal mesenteric. mass"". Received fresh for intraoperative diagnosis is a 1.5 x 0.7 X 0.3 cm piece. of yellow soft tissue which is entirely frozen and diagnosed as ""benign lymph. node"" by Dr. The entire remaining frozen section is submitted in Al FS. B. The second container is additionally identified as, ""gallbladder"". Received. fresh and placed in formalin is a 7.5 X 3.9 x 2.7 cm gallbladder with green,. glistening serosa and one cauterized aspect. The cystic duct margin is patent. measuring 0.5 cm in diameter. The specimen is opened revealing black-green. velvety mucosa with approximately 5 mL of black, viscus bile. No stones are. present. Wall thickness measures 0.2 cm. Representative sections including the. cystic duct margin are submitted in B1. C. The third container is additionally identified as, ""portion of gastric. staple line"". Received fresh and placed in formalin is an unoriented tan. glistening piece of tissue measuring 4.1 x 1.2 X 0.6 cm closed by 2 staple lines. measuring 3.9 and 3.5 cm. The staple lines are and the underlying margin is. inked blue. The specimen is entirely submitted, with the exception of the tissue. within the staples, in C1-2. D. The fourth container is additionally identified as, ""stomach pancreas. duodenum"". Received fresh and placed in formalin is a Whipple specimen that. consists of a 15.5 cm long segment of duodenum with an internal circumference of. 7.0 cm, a 10.5 X 5.0 x 3.0 cm segment of distal stomach, and a 5.2 x 5.0 x 3.6. cm portion of pancreas. The pancreatic neck margin is inked blue, the uncinate. margin is inked black, and the posterior retroperioneal (portal vein groove). margin is inked red. The margins are trimmed, serially sectioned and submitted. The common bile duct is patent, with a diameter of 0.9 cm at the resection. margin. Serial sectioning of the pancreas reveals a 4.0 x 2.7 X 2.7 cm firm,. tan, poorly circumscribed mass. The mass 3extends to within 1.2 cm of the. pancreatic neck margin and grossly abuts the uncinate and portal vein groove. margins. The mass abuts the the duodenal serosa, but there is no gross invasion. into the duodenal wall. The remaining pancreatic parenchyma is yellow-tan,. rubbery and lobulated. The stomach and duodenum reveal grossly unremarkable, tan. mucosa with a uniform 0.4 cm wall thickness. The peripancreatic adipose tissue. is dissected to reveal multiple pink-gray fibrofatty lymph nodes measuring up to. 1.4 cm in greatest dimension. Block summary: D1: Portal vein. D2: Common bile duct margin. D3: Posterior (portal vein groove) margin, serially sectioned. D4: Uncinate margin, serially sectioned. D5: Neck margin, serially sectioned. D6: Duodenal resection margin. D7: Gastric margin. D8: Mass in relationship to the common bile duct and main pancreatic. duct. D9: Mass and ampulla of Vater. D10: Mass and duodenum. D11-12: Mass and unremarkable pancreas. D13: Uninvolved stomach and duodenum. D14-15: One lymph node bisected, each cassette. D16-21: Multiple peripancreatic lymph nodes. E. The fifth container is additionally identified as, ""gastric staple line"". Received fresh and placed in formalin is a portion of tan-purple gastric wall. measuring 3.9 X 1.0 x 0.7 cm with a 3.9 cm staple line. The staple line is. removed and the entire remaining tissue is submitted in E1. M.D. Intraoperative Consult Diagnosis: Al FS: ""Benign lymph node"" by Dr. on."
BIOCUP_00320,pancreas,PAAD,TCGA-XN-A8T3,TCGA-XN-A8T3.4B77F18C-2A61-42E5-BF41-05FB9959EB3F,"NATURE OF MATERIAL : PANCREAS. BIOPSY : MACROSCOPY. - bottle 1 : specimen made of pancreatic head and segment of duodenum . The pancreas. measures 6.0 X 4,5x 4,5 cm. The duodenum measuring 15.5 cm in length and diameter 2.5 cm. nlt was noted a head injury in pancreas, measuring 2.4 x 2,2 cm. bottle 2 : gallbladder measured 12.2 cm length for 2.5 cm in diameter greater. - bottle 3 : 4 lymph nodes measuring between 0.2 and 1.0 cm cm in major axes. MICROSCOPIC. Product of pancreaticoduodenectomy: invasive ductal adenocarcinoma localized in cephalic portion of pancreas, moderately. differentiated, measuring 2.4 cm. - foci of intraepithelial pancreatic neoplasms associated with high degree dysplasia / dcis. - presence of neoplasm infiltration and perineural associated with angiolymphatic embolization. - lack of infiltration neoplasm duodenal papilla. - surgical margin committed by pancreatic neoplasms. No metastasis in lymph nodes examined 15 (0/15 ) . - Stage: pT2 pNO."
BIOCUP_00321,pancreas,PAAD,TCGA-IB-8126,TCGA-IB-8126.165130cb-6c48-4016-9519-f86c563bba30,"Chart ID: PHN: ACB: Telephone: Encounter: Suraical Pathology Report. Collected Date: Received Date/Time: 7). Specimen Description. A. Gallbladder at. B. Common bile duct Ivmph node at. C. Tissue from SMA. D. Whipple's specimen. Clinical Information. Pancreatic cancer. Infectious patient: No. Immunocompromised: No. History of neoplasm: N/A. Diagnosis. A: Gallbladder: Chronic cholecystitis. Negative for malignancy or dysplasia. B: Common Bile Duct Lymph Node: One reactive lymph node, negative for malignancy. C: Tissue from SMA: Extensive metastatic adenocarcinoma. D: Pancreas and Duodenum, Whipple Specimen: Chart Request ID: Print Date/Time: Pathology: Provider - Permanent. PHN: ACB: Collected Date: Received Date/Time: Pancreatic invasive well-differentiated ductal adenocarcinoma. (~ 3.5 cm), involving common bile duct, peripancreatic fat and tissue. around superior mesentery vein. Multifocal PanIN (1-3). Extensive perineural invasion. No lymph-vascular invasion identified. Pancreatic distal resection margin involved by carcinoma. Resection margin of peripancreatic fat is < 0.1 cm from tumor. Posterior (uncinate) margin of pancreas free of tumor: at least. 1.2 cm away, and 0.6 cm distant from PanIN. Common bile duct resection margin free of tumor: - 1.3 cm away. Ampulla of Vater and duodenal mucosa not involved by tumor. Five of ten (5/10) peripancreatic lymph nodes positive for metastatic. carcinoma with extranodal extension. AJCC Staging: pT4N1Mx. See Synoptic Report. Verified: Synoptic Report. D: Pancreas (Exocrine), Macroscopic. SPECIMEN: Head of pancreas. Duodenum. Stomach. Common bile duct. Gallbladder. Superior mesenteric vein. Chart Request ID: Pathology: Provider - Permanent. Print Date/Time: PHN: ACB: Collected Date: Received Date/Time: PROCEDURE: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Greatest dimension: 3.5 cm. Additional dimensions: 2.8 X 2.5 cm. D: Pancreas (Exocrine), Microscopic. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G1: Well differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades peripancreatic soft tissues. Tumor invades retroperitoneal soft tissue. Tumor invades mesenteric adipose tissue. MARGINS: Margin(s) involved by invasive carcinoma. Distal pancreatic margin. Invasive carcinoma involves posterior retroperitoneal surface of pancreas. LYMPH-VASCULAR INVASION: Not identified. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT): pT4: Tumor involves the celiac axis or the superior mesenteric artery. REGIONAL LYMPH NODES (pN): pN1: Regional lymph node metastasis. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN PanIN 1-3 ). CLINICAL HISTORY: Not specified. Gross Description. Received are specimens A to D. All requisitions and specimen containers are labelled with the patient's name. The cassettes and AP identifiers are labelled with the Surgical Number. Chart Request ID: Print Date/Time: Pathology: Provider - Permanent. PHN: ACB: Suraical Pathology Report. Collected Date: Received Date/Time: A. The specimen consists of an intact cholecystectomy specimen measuring 8.5 x 4.0 X 3.5 cm. The serosal surface. appears smooth. The cystic duct is patent. Upon opening, no gallstones are identified. The mucosa appears velvety and. unremarkable. The cystic wall measures 0.3 cm in maximum thickness. No evidence of tumor is identified. Representative sections are submitted in one cassette. B. The. specimen consists of one pre-bisected lymph node measuring 2.2 cm in greatest dimension. Attached to the node. is a piece of membranous fibrous tissue. The specimen Is serially sectioned longitudinally and submitted in toto in. four. cassette. C. The specimen consists of a small nodule which is submitted in toto for QS. The entire remnant of the frozen section block is submitted in CQS1. D. The specimen consists of a segment of duodenum and portion of gastric pylorus, measuring 19.0 cm long and 6.0 cm. in circumference. Attached to the duodenum is a portion of pancreas measuring 4.0 cm in length and 4.5 cm in width,. and. 2.5 cm in thickness. A minimal amount of fatly tissue is present. The ampulla region of the duodenal mucosa appears. prominent but without ulceration or obvious mass. The peripancreatic tissue appears unremarkable. A portion of distal. common. bile. duct is attached, 2.5 cm in length, and 2.0 cm in greatest diameter. The pancreatic resection margin is inked. blue. and the posterior margin is inked orange. Serial cross-sections through the pancreas reveal an ill-defined whitish. solitary mass measuring 3.5 x 2.8 X 2.5 cm. The pancreatic resection margin seems to be involved. Representative sections are submitted in cassettes labeled as follows: D1 - shave margin of common bile duct. D2 and D3 - longitudinal section through common bile duct and adjacent pancreatic tumor. D4 - cross-section through tumor and pancreatic duct. D5 - cross-section through tumor and pancreatic duct. D6 and D7 - longitudinal section through pancreatic duct and ampulla. D8 and D9 - pancreatic tumor with overlying duodenum. D10 - additional longitudinal section through ampulla. D11 and D12 - single cross-section of pancreatic tumor. D13 - additional cross-section of pancreatic tumor with surrounding tissue. D14 and D15 - tumor with pancreatic resection margin. D16 and D17 - pancreas with posterior margin. D18 - distal margin of duodenum. D19 - perpendicular margin of proximal duodenum and gastric pylorus. D20 - two peripancreatic lymph nodes with one bisected. D21 and D22 - more putative lymph nodes. Chart Request ID: Print Date/Time: Pathology: Provider - Permanent. PHN: ACB: Collected Date: Received Date/Time: D23 - cross-section of SMV and SMA with pancreas. Frozen Section Diagnosis. C. Tissue from SMA: Metastatic adenocarcinoma. (Conf # 17). Ce: Chart Request ID: Pathology: Provider - Permanent. Print Date/Time:"
BIOCUP_00322,pancreas,PAAD,TCGA-YH-A8SY,TCGA-YH-A8SY.F26B8F86-CC18-4B90-BD82-CC010A144681,"Sex: F. Results: SURGICAL PROCEDURE (Orde'. Status: Edited. Result Narrative. THIS IS AN AMENDED REPORT. Accession No: SPECIMEN SUBMITTED: A. GALLBLADDER. B. WHIPPLE SPECIMEN. Amendment Note: An amendment is issued to correct the TNM staining. (pT3) . The diagnosis is otherwise unchanged. The changes are. italicized. CLINICAL HISTORY: Per prior biopsy adenocarcinoma in the pancreas. OPERATION: Pylorus preserving pancreaticoduodenectomy. CLINICAL DIAGNOSIS: Pancreatic mass. GROSS DESCRIPTION: Two specimens are received labeled with the. patient's name and medical record number. The first specimen labeled ""gallbladder"" is received in formalin and. consists of a single piece of tan, soft tissue measuring 8.1 x 3.0 x. 2.2 cm representing a gallbladder. Grossly, a 1.8 cm greatest. dimension green gallstone is identified. Representative sections. are submitted in cassette A1. The second specimen labeled ""Whipple specimen"" is received fresh. from the OR and consists of a piece of small bowel with attached. pancreas measuring 32 x 7 x 5 cm. The uncinate margin is inked in. blue, the vascular growth is inked in black and the pancreatic. resection margin is inked in green. The common bile duct and. pancreatic duct are probed. The specimen is incised on the anterior. aspect and a palpable firm, tan, well circumscribed mass is revealed. measuring 4. 1 x 3.5 x 3.1 cm. Sections are submitted as follows: B1. distal duodenal margin, B2 proximal duodenal margin, B3 bile duct. margin, B4-5 pancreatic resection margin, amputated and submitted on. edge, B6-7 uncinate margin, amputated and submitted on edge, B8 full. cross section of tumor from green ink to the duodenum, B9. cross-section of tumor to black ink, B10 tumor surrounding common. bile duct to black ink, B11 representative section of tumor, B12. normal appearing pancreas, B13-21 peripancreatic fat for lymph. nodes. COMMENT: Histological sections show pancreatic adenocarcinoma. centered around the pancreatic duct. Sections of the residual. pancreatic parenchyma show fat necrosis and chronic pancreatitis. PANCREAS CARCINOMA SUMMARY. Site Pancreas head. Specimen Type Whipple specimen. Tumor Type. Adenocarcinoma. Size (cm) 4.1. Grade. Moderately differentiated. Associated Lesions Including PanIN Not identified. Common Bile Duct Margin Negative. Distal Pancreatic Margin Positive. Posterior Margin. Negative. Retroperitoneal/Uncinate Process Margin Negative, greater than 0.5. cm. Perineural Invasion Present. Lymphovascular Invasion Present. Lymph Node Status. Sixteen out of twenty-seven lymph nodes positive. for carcinoma (16/27). Largest Metastatic Focus 1.0 cm. Extracapsular Extension Present. Distant Metastasis N/A. TNM (AJCC, 7th Edition) pT3 pN1. DIAGNOSIS: Gallbladder, resection. chronic cholecystitis and cholelithiasis. Pancreas, PANCREATICODUODENECTOMY. INVASIVE ADENOCARCINOMA, MODERATELY DIFFERENTIATED, SIZE 4.1. CM, EXTENDING INTO THE PERIPANCREATIC FAT, INVOLVING DISTAL. PANCREATIC RESECTION MARGIN (SEE SUMMARY TABLE AND COMMENT). CARCINOMA IN SIXTEEN OUT OF TWENTYSEVEN LYMPH NODES (16/27). I have reviewed the specimen and agree with the interpretation. above. Amendment #1. Result History. SURGICAL PROCEDURE (Order #. on. Components. information. SURGICAL PROCEDURE (Order 1. on. Authorizing Drnvidor. Incoming Clinical Results. Parent Order ID. Child Order ID. Lab IDs. Specimen #. Patient Release Status: This result is not viewable by the patient. Additional Information. Specimen ID. Bill Type. Client ID. Additional Information. Specimen Date. Specimen Time. Specimen. Specimen. Result Date. Result Time. Sex: F. SURGICAL PROCEDURE. (Order. Patient Information. Female. Room. Bed. Authorizing Provider. Results,. Incoming Clinical. Admitting Provider. Frequency. Priority. ONCE. Routine. Normal. Physician Start Date/Time. Account Information. Collected By: Collect Time:"
BIOCUP_00323,pancreas,PAAD,TCGA-XD-AAUH,TCGA-XD-AAUH.7547A833-EA2B-48ED-B779-D632A6869FA0,"Clinical Information. Obstruction of bile duct. Acute pancreatitis. Diagnosis. A. LIVER CORE BIOPSY: - Liver tissue with features consistent with bile outflow obstruction. - No evidence of malignancy. B. LIVER, WEDGE BIOPSY: - Hyalinized nodule and features of bile outflow obstruction. - No evidence of malignancy. C. COMMON HEPATIC ARTERY LYMPH NODE, BIOPSY: - Three lymph nodes with no evidence of malignancy (0/3). D. PARTIAL PANCREATICODUODENECTOMY: - Invasive moderately to poorly differentiated ductal adenocarcinoma, size: 2.8 cm in maximum. diameter, invading into peripancreatic tissue and wall of small bowel, please see staging summary. - Seven of twenty-two lymph nodes positive for metastatic carcinoma (7/22). - Perineural invasion identified. - Common bile duct, pancreatic duct margin and SMA margin negative for malignancy. - Proximal duodenal margin positive for subserosal ductal adenocarcinoma, distal duodenal margin. negative. E. LYMPH NODE FROM AORTOCAVAL GROOVE, BIOPSY: - Four lymph nodes with no evidence of malignancy (0/5). Pathology Synoptic. Specimen type: Partial pancreaticoduodenectomy. Tumor location: Head of pancreas. Histologic type: Ductal adenocarcinoma. Histologic grade: G2-3. Tumor size and invasion of: Tumor extends beyond the pancreas, but without involvement of. celiac axis or SMA: Yes. Tumor involves celiac axis or SMA: No. Lymphatic invasion: Identified. Large vessel invasion: Not identified. Margins: Common bile duct: Negative. Proximal duodenal: Positive. Distal duodenal margin: Negative. Proximal or distal pancreatic margin: Negative. Peripancreatic soft tissue margin (including retroperitoneal and posterior. pancreatic margin): Negative. Total regional lymph nodes: 30 Number positive: 7. AJCC Pathologic Stage: pT3 N1 (AJCC 7th edition, 2010). Dictated and authenticated by: Performing Location: Gross Description. A. CORE LIVER BIOPSY. Received fresh labeled with the patient name. Description: The specimen consists of two cylinders of tan-brown tissue having lengths of 0.7 and 1.2. cm and diameters of less than 0.1 cm. The specimen is entirely embedded for a frozen section. diagnosis. FROZEN SECTION DIAGNOSIS PERFORMED AT. No evidence. of malignancy. SECTIONS: A1. Frozen section control. B. WEDGE LIVER BIOPSY. Received fresh labeled with the patient name. Description: The specimen consists of three pieces of tan-brown tissue ranging from 0.5-1.0 cm in. greatest dimension, each of which reveals a white-tan nodule measuring up to 0.1 cm in greatest. specimen. The specimen is entirely embedded for a frozen section diagnosis. FROZEN SECTION DIAGNOSIS PERFORMED AT. No evidence. of malignancy. SECTIONS: B1. Frozen section control. C. COMMON HEPATIC ARTERY LYMPH NODE. Received in formalin labeled with the patient name. Description: The specimen consists of an irregular piece of yellow-brown tissue measuring 3.1 cm in. greatest dimension, from which are retrieved three lymph nodes which are submitted in their entirety. SECTIONS: C1. One longitudinally bisected lymph node. C2. One intact lymph node and one inked and longitudinally bisected lymph node. D. PRODUCT OF PARTIAL PANCREATICODUODENECTOMY: Received fresh labeled with the patient name. Specimen received: Product of a partial pancreaticoduodenectomy. Orientation given: Two medium length sutures, one long suture and two long sutures identify the bile. duct, pancreatic neck and SMA margin respectively, per the intraoperative consultation form. Integrity: The pancreatic component is intact; the duodenum is unopened. Size of pancreas: 6.5 X 6.0 x 3.5 cm. Length of duodenum: 19.0 cm. Ducts: Probe patency cannot be demonstrated between the common bile duct and the ampulla. Ampulla: The ampulla is easily probed from the pancreatic duct. Inking scheme: The anterior and posterior surfaces of the pancreas are inked blue and black. respectively. The margins of the common bile duct and the pancreas are inked purple and green. respectively, after the true pancreatic margin is embedded for a frozen section diagnosis. The concavity. created by the portal vein is inked yellow and the SMA margin is inked orange. Tumor site: Within the head of the pancreas. Tumor size: Tumor is estimated to measure 2.8 cm in greatest dimension. Tumor description: White-tan, waxy, poorly circumscribed. Invasion of: The tumor surrounds the common bile duct, compressing it to a diameter of less than 0.1. cm, having a diameter of 1.7 cm at its margin of resection. Distance from margins: The tumor appears to most closely approximate the pancreatic margin of. resection by 0.5 cm, the bile duct margin by 3.0 cm, the anterior blue ink aspect of the pancreas by. apparently less than 0.1 cm, the posterior pancreas by 1.0 cm, the concavity created by the portal vein. by 0.5 cm and the SMA margin by 1.0 cm. Remaining specimen: The small intestinal component has stapled margins of resection, scant serosal. adhesions, an average wall thickness of 0.3 cm and an unremarkable mucosa. Peripheral to the tumor. the pancreas reveals unremarkable cut surfaces, excepting for a 1.1 cm smooth-walled cyst. Lymph nodes: The lymph nodes retrieved from the specimen are submitted in their entirety. Representative sections are submitted with the pancreatic component being submitted proceeding from. the margin towards head. FROZEN SECTION DIAGNOSIS PERFORMED AT. Indicated. margins: All negative for carcinoma. SECTIONS: D1. Frozen section control of common bile duct margin. D2. Frozen section control of pancreatic margin. D3. Frozen section control of SMA margin. D4-5. En face proximal and distal duodenal margins, respectively. D6-7. Longitudinally bisected ampulla. D8-9. Transverse of common bile duct proceeding from margin towards head with adjacent pancreatic. tissue (green ink does not represent a true surgical margin). D10. Approximation of tumor to blue inked anterior pancreatic surface, duodenal wall and green inked. cut surface of pancreas. D11. Approximation of tumor to concavity created by portal vein including pancreatic cyst and. beginning of stricture of common bile duct. D12. Pancreatic cyst, SMA margin and the posterior surface of pancreas. D13. Compressed bile duct and posterior surface of pancreas. D14. Tumor and anterior surface of pancreas. D15. Pancreas, SMA margin, posterior surface and one bisected lymph node. D16. Pancreatic tissue and adjacent duodenal wall, posterior surface of pancreas and compressed. common bile duct. D17. Tumor, anterior surface of pancreas and pancreatic duct. D18. Two inked and longitudinally bisected lymph nodes retrieved from anterior surface of pancreas. D19-20. Eight intact lymph nodes retrieved from inferior aspect of pancreas with four in each cassette. D21. Three intact lymph nodes retrieved from inferior aspect of pancreas. D22. Two longitudinally bisected lymph nodes retrieved from inferior pancreas with one inked orange. D23. One trisected lymph node retrieved from inferior aspect of pancreas. D24-26. One sectioned lymph node retrieved from anterior pancreas adjacent to common bile duct. E. LYMPH NODE FROM AORTOCAVAL GROOVE. Received in formalin labeled with the patient name. Description: The specimen consists of an ovoid piece of tan tissue having a diameter of 2.5 cm from. which are retrieved multiple suspected lymph nodes which are submitted in their entirety. SECTIONS: E1. Four intact suspected lymph nodes. E2-3. One longitudinally trisected lymph node. Microscopic Description. A. CORE LIVER BIOPSY: Microscopic examination is performed and supports the diagnosis above. B. WEDGE LIVER BIOPSY: Microscopic examination is performed and supports the diagnosis above. C. COMMON HEPATIC ARTERY LYMPH NODE: Microscopic examination is performed and supports the. diagnosis above. D. PRODUCT OF PARTIAL PANCREATICODUODENECTOMY: Microscopic examination is performed and. supports the diagnosis above. E. LYMPH NODE FROM AORTOCAVAL GROOVE: Microscopic examination is performed and supports. the diagnosis above. Surg Path Non-Chartable Comment. Diagnosis given directly to surgeon over telephone/speaker phone. (parts Aand B). Tumor QC block on part D.;."
BIOCUP_00324,pancreas,PAAD,TCGA-2J-AABP,TCGA-2J-AABP.1AB545A6-DC90-47E9-8112-DD094F6BCD02,"Surgery date: DIAGNOSIS: A. Pancreas, body, margin, excision: Negative for tumor. B. Pancreas and spleen, partial pancreatectomy and splenectomy: Undifferentiated carcinoma with a sarcomatoid component is. identified forming a solid 7.2 x 6.0 X 5.4 cm mass located in the. pancreatic tail. The tumor extends beyond the pancreas involving. the peripancreatic soft tissue. Angiolymphatic invasion is absent. Perineural invasion is absent. Tumor necrosis is present. All. surgical resection margins are negative for tumor (minimum tumor. free margin, 2.6 cm, pancreatic body margin). The patient has had. no prior treatment. The adjacent non-neoplastic pancreatic. parenchyma shows focal atrophy. The spleen is unremarkable. A. single (1 of 22) regional lymph node is positive for metastatic. carcinoma. Immunoperoxidase studies were performed on paraffin sections of the. pancreatic tail mass using antibodies directed against the following. antigens: Keratin AE1/AE3, S100, CD45, SMA, desmin, CD30, ALK1. The. neoplastic cells are focally positive for keratin AE1/AE3, OSCAR. keratin, and smooth muscle actin while being negative for S100,. desmin, CD30, ALK-1 and CD45. This immunophenotype supports above. diagnosis. AJCC stage (with available surgical material): pT3N1 (7th edition). Participated in interpretation: PRELIMINARY FROZEN SECTION CONSULTATION: A. Pancreas, body, margin, excision: Negative for tumor. B. Pancreas and spleen, partial pancreatectomy and splenectomy: Poorly differentiated malignant neoplasm forming a 7.2 X 6.0 x 5.4. cm mass. The surgical margin is free by 2.6 cm. A single (1 of 22). regional lymph node is positive for metastatic carcinoma. Hold over. for immunostains and classification. Frozen section histologic interpretation performed by: GROSS DESCRIPTION: A. Received fresh labeled ""pancreatic body margin"" is a 2.6 x 1.3 x. 0.7 cm portion of lobulated tan soft tissue without orientation. Margin submitted en face. Grossed by. B. Received fresh labeled ""distal pancreas, spleen"" is a distal. pancreatectomy specimen consisting of 9.2 x 7.5 x 5.5 cm portion of. pancreas and 190.0 gram, 12.0 x 6.8 X 4.3 cm spleen. A 7.2 X 6.0. x5.4 cm solid tan-yellow mass is present within the pancreas, 2.6 cm. from the proximal pancreatic margin. The mass does not appear to be. confined to the pancreas, grossly. Peripancreatic lymph nodes and. splenic hilar lymph nodes are identified. The spleen is grossly. unremarkable. Representative sections are submitted. Research. tissue collected,. BLOCK SUMMARY: Part A: Pancreatic body margin. 1 Pancreatic body margin 1. 2 Pancreatic body margin 2. Part B: Distal pancreas and spleen. 1 Pancreatic mass 1. 2 Pancreatic mass 1. 3 Pancreatic mass 2. 4 Pancreatic mass 3. 5 Pancreatic mass 4. 6 Pancreatic mass 5. 7 Pancreatic mass 6. 8 Pancreatic mass 7. 9 Spleen. 10 Spleen. 11 Peripancreatic LN 4(B1). 12 Peripancreatic LN 1(B2). 13 Peripancreatic LN 4(B3). 14 Peripancreatic LN 3(B4). 15 Peripancreatic LN 3(B5). 16 Peripancreatic LN 3(B6). 17 Peripancreatic LN 5(B7). 18 Peripancreatic LN 2(B8). 19 Peripancreatic LN 2(B9)."
BIOCUP_00325,pancreas,PAAD,TCGA-3A-A9IC,TCGA-3A-A9IC.74597CF2-71A6-4F3A-91E5-F22FD31D4417,"Final Diagnosis. A. BILE DUCT, PANCREAS, DUODENUM, WHIPPLE PROCEDURE: Invasive pancreatic ductal adenocarcinoma, moderately differentiated. See Key Pathological Findings. B. ADDITIONAL PANCREATIC MARGIN, EXCISION: Pancreatic intraepithelial neoplasia low grade. There is no evidence of carcinoma and/or high grade dysplasia. the attending pathologist, personally reviewed all. alides and / ar materials and rendered the final diagnosis. Electronically. Key Pathological Findings. A: Pancreas-Exocrine Synoptic Data. SPECIMEN TYPE: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Invasive: 4 x 3.5 x 2.5 cm. OTHER ORGANS RESECTED: Duodenum. Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. EXTENT OF INVASION - PRIMARY TUMOR: Tumor invades adjacent structures/organs. Duodenum. PRIMARY TUMOR (pT): pT3: Tumor extends beyond the pancreas but without involvement of the. celiac axis or the superior mesenteric artery. REGIONAL LYMPH NODES (pN): pN1b: Metastasis in multiple regional lymph nodes. Number examined: 21. Number involved: 4. DISTANT METASTASIS (pM): pMX: Cannot be assessed. MARGINS: Margins free of tumor. Distance of invasive carcinoma from closest margin: 1. mm. Specify margin (if possible): retroperitoneal margin. PANCREATIC RESECTION MARGIN, INVOLVED BY:: PanINIb. VENOUS (LARGE VESSEL) INVASION (V): Absent. LYMPHATIC (SMALL VESSEL) INVASION (L): Present. PERINEURAL INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Acute pancreatitis. Chronic pancreatitis. Specimen(s) Received. A. BILE DUCT, PANCREAS, DUODENUM FS. B. ADDITIONAL PANCREATIC MARGIN FS. Clinical History. Not given. Preoperative Diagnosis. Pancreatic adenocarcinoma. Intraoperative Consultation. FSA. BILE DUCT, PANCREAS, DUODENUM: Common bile duct margin free of invasive carcinoma, focal intraductal papiliary mucinous. neoplasia (IPMN) present (obscuring cavity artifact present). intradepartmental Consultation: The case was also reviewed by. MD, who concurs. with the above interpretation. FSB. ADDITIONAL PANCREATIC MARGIN: No evidence of malignancy. Comment: This frozen section diagnosis/result was communicated to and acknowledged by Dr. in frozen section room at. MD and. MD, have performed the intraoperative consultations and. issued the above diagnosis. Gross Description. A. The specimen is received fresh for frozen section analysis labeled bile duct, pancreas,. duodenum."" The specimen consists of a resected portion of the pancreatic head (4.5 x 4 x 3 cm) and. attached duodenum (12 cm in length and 6 cm in greatest circumference). The serosal surface of the. duodenum is brown-tan and smooth. Upon opening, the tumen contains a moderate amount of. viscous bile. The mucosal surface of the duodenum exhibits normal folds with no gross evidence of. polyps or nodularity. The pancreatic margin resection is marked with black ink, the portal vein groove is marked with blue. ink and the retroperitoneal surface is marked with green ink. There is no stapled line grossly present. that would indicate the superior mesentery artery. A palpable pancreatic mass is identified. The. pancreatic duct is not probe patent and is totally occluded by the presence of the tumor. Serial. sectioning into the pancreas reveals a firm, yellow-gray, ill-defined mass. (4 x 3.5 x 2.5 cm), which abuts the retroperitoneal surface/uncinate process. Grossly the mass does. appear to involve the common bite duct, which is probe patent and somewhat dilated with an inserted. catheter. Grossly the mass does appear to involve the duodenal wall extending to the mucosal. surface and grossly involving the ampulla of Vater. There is a minimal amount of grossly uninvolved. pancreatic tissue. A section of the minimal amount of attached adipose tissue isolates 2 moderately. firm, round, tan, irregular lymph nodes, which measure 1.5 cm in greatest dimension. The lymph. nodes are isolated adjacent to the pancreas. A representative frozen section is taken and submitted. as FSA1. Permanent sections are submitted as: A2: Mirror image of tumor submitted to Tissue Bank. A3: Tangential pancreatic margin attached to specimen. A4: Perpendicular portal vein groove. AS: Tangential proximal duodenal margin of resection. A6: Tangential distal duodenal margin of resection. A7-A8: Sections of tumor showing relationship to retroperitoneal surface (green. ink). 49-A10:Tumor showing its relationship to common bile duct and ampulla of. Vater. A11: Tumor showing its relationship to duodenum. A12: Grossly unremarkable pancreas. A13: Grossly unremarkable duodenal mucosa. A14: One bisected lymph node. A15: One bisected lymph node. A16-A18: Entire remaining adipose tissue. A representative section of the tumor is submitted to the Tissue Procurement Laboratory. B. The specimen is received fresh for frozen section analysis labeled ""additional pancreatic. margin."" The specimen consists of a 3 x 1.5 x 0.5 cm, firm, gray-yellow, irregular fragment of tissue. The margin is entirely submitted tangentially for frozen section as FSB1."
BIOCUP_00326,pancreas,PAAD,TCGA-LB-A8F3,TCGA-LB-A8F3.44BA040E-C349-4D92-AB2B-A271769B466C,"):44BA040E-C349-4092-AB2B-A271769B466C. RUN DATE : RUN TIME. RUN USER. LOC: AGE/SX: ROOM. REG DR: BED: SPEC #: RECD. PERFORMED AT. COLL. TIME IN FORMALIN: hrs. COLD ISCHEMA TIME: 0:00. mins. CLINICAL INFORMATION: Pre-Op Diagnosis: Pancreatic mass. Remarks: Speciment (s). √Ä. Common bile duct margin. B. Pancreatic duct margin. C. Gallbladder. D. Whipple resection. MICROSCOPIC DIAGNOSIS. A. COMMON BILE DUCT MARGIN: NO TUMOR SEEN. B. PANCREATIC DUCT MARGIN: NO TUMOR SEEN. C. HEAD OF PANCREAS. PORTION DUODENUM. PORTION DISTAL STOMACH, PORTION DISTAL BILE DUCT,. WHIPPLE RESECTION. ADENOCARCINOMA OF HEAD OF PANCREAS, LOW GRADE. TUMOR MEASURES 5 CM AND INFILTRATES DUODENAL WALL AND PERIPANCREATIC SOFT TISSUE. SURGICAL MARGINS FREE OF TUMOR WITH NEAREST MARGIN 2 MM FROM TUMOR,. PERIPANCREATIC UNCINATE PROCESS. NO TUMOR SEEN IN ANY OF 10 REGIONAL LYMPH NODES. SEE COMMENT FOR SYNOPTIC REPORT. D. GALLBLADDER, CHOLECYSTECTOMY: CHRONIC CHOLECYSTITIS. NO TUMOR SEEN. COMMENT(S). SURGICAL PATHOLOGY CANCER CASE SUMMARY - CAP APPROVED. Specimen : Head of pancreas duodenum, stomach, common bile duct,. gallbladder. Procedure : Pancreaticoduodenectomy (whipple resection). partial. pancreatectomy. Tumor Site: Pancreatic head. Tumor Size: 5 cm in greatest dimension. RUN DATE: RUN TIME : RUN USER. SPEC #: COMMENT (S). Histologic Type: Ductal adenocarcinoma. Histologic Grade: G1. Microscopic Tumor Extension : Tumor invades duodenal wall, tumor invades. peripancreatic soft tissue. Margins: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin 2. mm: uncinate process peripancreatic. Treatment Effect: No prior treatment. Pathologic Staging: Primary Tumor : pT3. Regional Lymph Nodes: pNO. Number of lymph nodes : 10. Number involved : 0. Distant Metastasis: Not applicable. GROSS DESCRIPTION: The specimen is received in multiple parts. A. The specimen in the fresh state is a portion of dilated duct wall which measures 2 x 1. x 0.3 cm, totally examined by frozen section as block A1. B. This is a section of pancreas which measures 2 x 1.3 x 0.5 cm. The surgeon has placed. a. suture on the margin side. Tangential sections through the surgical margin are examined. by frozen section as block B1. C. This specimen in formalin is a dilated gallbladder which measures 11 x 3.5 x 3 cm. The. attached cystic duct measures 2 x 1 cm. The serosal surface is smooth and green Within. the lumen is gritty. green sludge The wall measures 5 mm in thickness Representative. sections are submitted in block C2. D. This is a whipple resection which measures 15 x 6 x 6 cm and includes: head of. pancreas segment of duodenum, distal portion of stomach. distal portion of dilated. common. bile duct. The duodenum measures 9 cm in length by 4 cm in diameter. The stomach measures. 8 cm in length by 5 cm proximal diameter. Proximal and distal margins are stapled closed. The pancreatic head measures 7 x 4 x 4 cm and contains a firm, relatively circumscribed. yellow tumor which measures 5 x 4 x 4 cm. Peripheral margins appear free of tumor. The. surgeon has tagged the retroperitoneal margin and I have applied black ink to this margin. I have applied blue ink to the margin of the uncinate process. The common bile duct is. dilated and measures 4 x 2 cm. Representative sections of the tumor are submitted for. tumor banking. The tumor invades the duodenum wall in the region of the ampulla. The following sections are submitted. D1. proximal gastric margin. D2. distal duodenal margin. D3. pancreatic duct margin. D4-6 -. pancreatic tumor with blue ink on uncinate process margin. D7,8 -. pancreatic tumor invading duodenal wall. RUN DATE. RUN TIME. RUN USER: SPEC # : GROSS DESCRIPTION: (Continued). D9. representative pancreatic tumor. D10. retroperitoneal margin black ink on margin. D11. distal pyloric lymph node candidates. D12. retroperitoneal lymph node candidates. largest lymph node bisected. D13 -. distal bile duct lymph nodes, largest bisected. D14. distal bile duct lymph node, bisected. INTRAOPERATIVE CONSULTATION: A. FROZEN SECTION DIAGNOSIS, COMMON BILE DUCT MARGIN: NO TUMOR SEEN. B. FROZEN SECTION DIAGNOSIS, DISTAL PANCREATIC DUCT MARGIN: NO TUMOR SEEN. D. IMMEDIATE GROSS EVALUATION, WHIPPLE RESECTION. TUMOR PRESENT IN HEAD OF PANCREAS. PROCESSED FOR TUMOR BANKING. PERIPHERAL MARGINS GROSSLY FREE OF TUMOR. PHOTO DOCUMENTATION. Image. Picture Copy Error. Image. Picture Copy Error. (signature on file)."
BIOCUP_00327,pancreas,PAAD,TCGA-HV-A5A5,TCGA-HV-A5A5.CB59EF73-6734-4BE4-8BBB-C24359E66FEF,"CLINICAL DIAGNOSIS: Pancreatic head cancer. Specimen : CBD, Pancreatic head(LN). GROSS: Specimen status: Fresh. Operation: Pylorus preserving pancreaticoduodenectomy. Cholecystectomy. Organs: Small intestine (25.5 cm in length and 2.5 cm in diameter),. pancreas, partial (7.5 x 5.4 x 3.5 cm),. and common bile duct (5.5 cm in length and 1.0 cm in diameter) in contintuity. Gallbladder (8.5 cm in length, 3.4 cm in diameter). [Pancreas]. Lesion: An ill-defined ovoid mass in pancreatic head to ampullary area. Size: 2.5 x 1.8 x 1.5 cm. Cut surface: Pale tan and firm mass. Extent: Extend to duodenal wall. Resection margins: Distal pancreatic resection margin: Free of tumor (safety margin: 2.3 cm). Radial pancreatic margin: Very close to tumor (safety margin: 0.1 cm). Common bile duct resection margin: Free of tumor. Remaining pancreas: Fibrotic change. [Common bile duct]. Eroded and no mass-like lesion. [Duodenum]. Unremarkable. [Gallbladder]. Mucosa: Dark red to mahogany and velvety. Serosa: Pale pink and smooth. Wall: 0.6 cm in thickness. Frozen section diagnosis. FS1-2, proximal bile duct resection margin: No tumor present. FS3, distal pancreatic resection margin: No tumor present. Gross photo: Present. Blocks. T1-8, pancreatic mass X 8. BD, common bile duct x 1. LN1-2, periduodenal lymph nodes x 2. LN3, No. 12 lymph nodes x 1. LN4, No. 13 lymph nodes X 1. FS1-3, frozen permanent x 3. P and D, duodenal resection margin x 2. GB, gallbladder x 1. Microscopic: Tumor type: Ductal adenocarcinoma. Tumor location: Pancreas. Histologic grade: Moderately differentiated. In situ carcinoma: Not identified. Tumor size: 2.5 x 1.8 x 1.5 cm. Direct extension: Tumor extends beyond the pancreas to duodenum and peripancreatic tissue. Lymphovascular invasion: Present. Perineurial invasion: Present. Surgical margins: Radial margin: Close to tumor (safety margin: 0.1 cm). Distal pancreatic resection margin: Free of tumor. Proximal bile duct resection margin: Free of tumor. DIAGNOSIS: Pancreas, head, pylorus preserving pancreaticoduodenectomy: Ductal adenocarcinoma, moderately differentiated, infiltrating. Common bile duct, pylorus preserving pancreaticoduodenectomy: No tumor present. Small intestine, duodenum, pylorus preserving pancreaticoduodenectomy: Direct tumor extension. Gallbladder, cholecystectomy: Chronic cholecystitis. Lymph node, regional, pylorus preserving pancreaticoduodenectomy: Peripancreatic: Direct tumor extension (2/4). Periduodenal: No tumor present (0/9). Lymph node, regional, biopsy: No. 12: No tumor present (0/3). No. 13: No tumor present (0/3). di."
BIOCUP_00328,pancreas,PAAD,TCGA-IB-AAUV,TCGA-IB-AAUV.3B060A4A-5A3D-4167-81B5-60C09D1769A8,"CONFIDENTIAL. Nami. Demographics (for. verification purposes). Date of birur: Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. A. Lymph nodes group A at. B. Gallbladder at. C. Whipple's specimen at. D. Portal lymph node at. E. Branch of superior mesenteric vein at. F. Retroperitoneal margin at. G. Mesocolon lymph nodes at. Clinical Information. Pancreatic cancer pancreatic head mass. Infectious patient: No. Inmunocompromised: No. History of neoplasm: No. Diagnosis. A. Lymph Nodes, Group A, Resection: Five lymph nodes negative for carcinoma (0/5). B. Gallbladder, Cholecystectomy: Mild non-specific acute inflammation with marked eosinophilia. C. Duodenum and Pancreas, Pancreaticoduodenectomy (Whipple's) : Head and uncinate process of the pancreas and common bile duct: Pancreatic moderately differentiated invasive ductal. adenocarcinoma with mucinous features (see Comment) . POSITIVE for perineural invasion. POSITIVE for lymph-vascular invasion. Foci of pancreatic intraepithelial neoplasia, grade 3 (PanIN 3) . Common bile duct mucosa focally involved by carcinoma (i.e.,. cancerization). Vascular bed margin POSITIVE for carcinoma. Pancreatic resection margin negative for carcinoma, at least. 0.6 cm away. Posterior resection margin negative for carcinoma, at least 0.15. cm away. Common bile duct resection margin negative for carcinoma. Three of fifteen peripancreatic lymph node POSITIVE for. metastatic carcinoma (3/15). pT3N1Mx. Duodenum and distal stomach. Ampullary region (submucosa, muscularis mucosa, and base of. mucosa) involved by invasive carcinoma;. Distal duodenum ischemic changes, most likely related to the. Distal and proximal resection margins free of tumor. D. Portal lymph node, resection: Two lymph nodes negative for carcinoma (0/2). E. Branch of superior mesenteric vein, resection: Negative for carcinoma. F. Retroperitoneal margin, biopsy: Fragment of fibrous tissue and skeletal muscle, negative for. carcinoma. One lymph node negative for carcinoma (0/1). G. Mesocolon lymph nodes, resection: One of two lymph nodes POSITIVE for metastatic carcinoma. (1/2) with extranodal extension. Verified: Responsible Resident: Synoptic Report. SPECIMEN: Head of pancreas. Duodenum. Common bile duct. Gallbladder. PROCEDURE: Pancreaticoduodenectomy (Whipple resection) , partial pancreatectomy. TUMOR SITE: Pancreatic head. Uncinate process. TUMOR SIZE: Greatest dimension: 4.8. cm. Additional dimensions: 3.6 x 2.2 cm cm. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Carcinoma in situ. Tumor invades ampulla of Vater or sphincter of Oddi. Tumor invades duodenal wall. Tumor invades peripancreatic soft tissues. Tumor invades retroperitoneal soft tissue. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1.5. mm. Specified margin: retroperitoneal. Margin(s) involved by invasive carcinoma. vascular bed margin. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy) : Not known. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN) : pN1: Regional lymph node metastasis. Number examined: 15. Number involved: 3. Gross Description. Received are specimen containers A to G. All requisitions and specimen containers are. labelled with the patient's name,. ne cassettes and identifiers. are labelled with the Surgical Numbe: A. The specimen is received fresh and designated as ""A - lymph node group A"". The. specimen consists of a single irregular piece of tan-yellow fibrofatty tissue (3.2 x 2.5. x 0.3 cm) . Five possible lymph nodes are identified and range in size from 0.7 cm to 1.5. cm. in greatest dimension. Cassettes submitted as follows: A1. largest lymph node bisected. A2-3. two possible lymph nodes bisected, one inked blue. B. The specimen is received fresh and designated as ""B - gallbladder at. The. specimen consists of dusky grey, intact gallbladder (8.1 x 3.5 x 1.0 cm) The serosal. surface is smooth and glistening. No identifiable nodules or abnormalities present. cystic lymph nodes identified. On opening the gallbladder surface is light green and. velvety with no identifiable calculi. There is a scant amount of thin green bile. Average wall thickness is 0.3 cm. Representative sections of the body, fundus, and. cystic duct margin are submitted in cassette B1. c. The specimen, is received fresh and designated as ""C - whipple's specimen at. The specimen consists of a whipple's procedure including proximal and distal duodenum,. pancreatic head, and pancreatic uncinate process. No pyloric sphincter or gastric. mucosa. identified. Duodenum measures 21.2 cm in length and 6.5 cm in circumference. The distal. 14.0 cm of duodenum is dusky and dark brown in color with sharp demarcation consistent. with ischemia. The proximal portion is light tan-brown with regular plicae circulares. extending from proximal to distal end. The bile duct extending to the ampulla of Vater. is bisected and opened prior to fixation. The area surrounding ampulla of Vater is. distinct from the surrounding duodenal mucosa. It is firm multinodular, dark-brown with. irregular border extending roughly 3.1 x 2.2 cm with some contraction distorting the. surrounding mucosal surface. Broad based nodules measure in size range from 0.2 to 0.5 cm. in greatest diameter. The full length of common bile duct to the ampulla of Vater is 4.8. cm with an average diameter of 0.3 cm. Please note, the margins are inked as follows: Blue pancreatic resection margin, orange uncinate process, black vessel bed margin. The. pancreatic resection margin measures 2.3 x 1.8 cm with central pancreatic duct (0.2 cm in. diameter) The pancreatic duct can be probed only distally to a length of ..ccm. Proximal. portion was not identified. Combined the pancreas measures 5.6 x 4.8 x 2.7 cm. The cut. surface of the common bile duct shows heterogenous light yellow, firm, irregular lesion. extending 3.0 cm from the ampulla of Vater into the common bile duct involving the. ampulla and duodenal submucosa. On cross sectioning, the tumor is solid, light-yellow,. firm, with no obvious areas of necrosis or hemorrhage. The tumor seems to occupy the. majority of uncinate process, head of the pancreas and grossly extends within 0.6 cm. of. the pancreatic resection margin and fully involves the common bile duct closest to the. ampulla of Vater. The tumor itself, is poorly demarcated with a diffuse infiltrating. border into the normal pancreatic parenchyma. Grossly, the tumor measures 4.8 x 3.6 x. 2.2 cm. The specimen was photographed. The representative sections are submitted as. follows: C1. bile duct resection margin. C2-5. duodenum and ampulla of Vater, adjacent section taken in a longitudinal. direction along the long axis of the common bile duct. C6. duodenum and common bile duct, adjacent to the ampulla of Vater, transverse. cross. section to the direction of the common bile duct. C7. cross section through duodenum, tumor, and common bile duct, transverse. cross section to the direction of the common bile duct. C8. transverse cross section at the ampulla of Vater immediately includes. duodenum and. common bile duct immediately contiguous with cassette C6. C9. transverse cross section through duodenum, tumor, and the common bile duct,. 0.5. cm away from C8 and is immediately contiguous with a section of C7. C10. duodenum, tumor, and common bile duct transverse cross section approximately. 0.5 cm. away from cassette C9 and C7. C11. transverse cross section through common bile duct 0.5 cm distal from. cassette C10,. includes vascular bed resection margin. C12. representative cross section of duodenum and tumor immediately adjacent to. C10-11. C13. representative transverse section through retroperitoneal resection margin. including. uncinate process in orange. C14-15. representative sections of the retroperitoneal resection margins, transverse. including. uncinate process inked in orange, sections contiguous. C16. additional sections of the uncinate process immediately continuous with C13. C17. additional transverse cross section through uncinate process, immediately. continuous. with C14 and C15. C18-20. pancreatic resection margin inked blue adjacent perpendicular cross sections. C21. proximal resection margin. C22. representative section of proximal normal duodenum. C23. representative section of normal distal duodenum. C24. distal resection margin. C25. representative section of grossly normal pancreatic parenchyma. C26. four anterior peripancreatic possible lymph nodes. C27. three anterior peripancreatic possible lymph nodes. C28. two possible anterior peripancreatic lymph nodes bisected, one inked blue. C29. two possible inferior lymph nodes. C30. one possible superior lymph node. Additional cassettes designated as follows: C31 to 33. additional vascular bed margins. C34. additional section of vascular bed margin. D. The specimen is received fresh and designated as ""D - portal lymph node at. The specimen consists of two pieces of dark grey to brown irregular piece of firm soft. tissue. The larger fragment measures 1.5 x 1.6 x 0.5 cm. The smaller fragment measures. 1.2 x 0.7 x 0.2 cm. The possible resection surface is present revealing the presence of. a possible lymph node. The specimen is bisected and submitted in toto in cassettes D1. and D2. E. The specimen is received fresh and designated as ""E - branch of superior mesenteric. vein at. The specimen consists of a single small fragment of tan-white firm tissue. with no grossly identifiable features measuring 0.2 x 0.2 x 0.1 cm. Specimen is. submitted in toto in cassette E1. F. Single piece, irregular soft fibrous tissue, extensive cautery edge, red-pink. One. suture present (cut away) 1.5 x 0.9 x 0.4 cm. Submitted in toto for. G. The specimen is received fresh and designated as ""G - mesocolon lymph node"". The. specimen consists of a single irregular piece of tan grey to brown fibrofatty tissue (3.6. x 2.0 x 0.5 cm) Within the fibrofatty tissue are two possible lymph nodes with the. largest measuring 2.0 cm and the second measuring 1.1 cm in greatest dimension. Both. lymph nodes are bisected and the first large lymph node is bisected and submitted in G1. The smaller lymph node is bisected and submitted in G2. Frozen Section Diagnosis. F. Retroperitoneal Margin: Negative for carcinoma. Conf #. Pathologist Comment. Invasive moderately differentiated ductal carcinoma of the pancreas arising in the. background of PanIN3. Large cells with pleomorphic nuclei forming incomplete glands with. mucinous features (<50%) . Atypical mitoses present and extensive desmoplastic response. Adenocarcinoma involves duodenal muscularis mucosae, ampulla of Vater, and common bile. duct with focal epithelial cancerization. Cancer invades within 0.6 cm of the pancreatic. resection margin, 0.15 cm of the posterior resection margin, and is present at the. vascular bed resection margin. Distal common bile duct is denuded of epithelium likely. due to instrumentation (stent placement) -. Encounter Number. Patient Location."
BIOCUP_00329,pancreas,PAAD,TCGA-HZ-A49H,TCGA-HZ-A49H.6F534DEF-868A-4F2C-8A57-E4F738B285DF,"F. I. Path Report. ACCESSION NO. : Final Diagnosis(es): (A) Bile duct margin, biopsy: Negative for malignancy. (B) Pancreas margin, biopsy: Negative for malignancy. (C) Stomach, gallbladder, head of pancreas, bile duct,. duodenum, small bowel, Whipple' S procedure: 1) Pancreatic adenocarcinoma, moderately differentiated. 2) Tumor measures 2.8 cm in greatest dimension. 3) Tumor extends through the duodenal wall. 4) pT3 N1. 5) 1 of 44 lymph nodes positive for metastatic carcinoma. (2 mm in maximum dimension). 6) Perineural and lymphvascular invasion identified. 7) See Synoptic report, below. (D) Lymph node, superior pancreatic, excision: Negative for. metastatic carcinoma. (E) Lymph node, hepatic duodenal, excision: Negative for. metastatic carcinoma. (F) Lymph node, celiac, excision: Negative for metastatic. Synoptic Report: Specimens: Head of pancreas, duodenum, stomach, common bile. duct and gallbladder. Procedure: Pancreaticoduodenectomy (Whipple resection), partial. pancreatectomy. Tumor Site: Pancreatic head. Tumor Size: 2.8 cm in greatest dimension. Histologic Type: Ductal adenocarcinoma. Histologic Grade: G2: Moderately differentiated. Microscopic Tumor Extension: Tumor invades duodenal wall. Margins: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 3 mm. from posterior pancreatic soft tissue. Treatment Effect: Not known. Lymphvascular Invasion: Present. Perineural Invasion: Present. Pathologic Staging: Primary Tumor: pT3: Tumor extends beyond the pancreas but. without involvement of the celiac. axis or. the superior mesenteric artery. Regional Lymph Nodes: pN1: Regional lymph node. metastasis. Number of Lymph Nodes Examined: 47. Number of Lymph Nodes Involved: 1 (2 mm in maximum. dimension). Additional Pathologic Findings: Chronic pancreatitis. Printed from: Default. Page: I of 5. F. /. MD (Fellow). Specimen(s) Received: A: Bile duct margin. B: Pancreas margin. C: Stomach, gallbladder, head of pancreas, bile duct, duodenum,. small bowel. D: Superior pancreatic LN. E: Hepatic dudoenal LN. F: Celiac LN. Clinical History: Pancreatic cancer. (A) Stitch marks margin of interest. (B) Stitch marks margin of interest. (C) Tumor Bank. Intraoperative Consultation: FSA1: Bile duct margin: Negative for malignancy (1 block). FSB1: Pancreas margin: Negative for malignancy (1 block). M.D. Resident). Gross Description: (A) (bile duct margin) Received fresh for frozen section. evaluation with a stitch that marks the margin of interest is an. annular segment of gray-pink rubbery tissue that is 1.6 cm in. diameter x 0.4 cm long and 0.3 cm thick, having scant tan. inspissated material within the lumen. The specimen is entirely. submitted fresh for frozen section evaluation in cassette FSA1. (B) (pancreas margin - the stitch marks the margin of interest). Received fresh for frozen section evaluation is a 2.6 x 1.1 x. 0.4 cm thick portion of tan-pink lobulated pancreatic parenchyma. with an eccentrically located patent lumen 0.3 cm in diameter. consistent with a ductule. The specimen is entirely submitted. en face, fresh for frozen section evaluation in cassette FSB1. (C) (stomach, gallbladder, head of pancreas, bile duct,. duodenum, small bowel). Specimen components and dimensions: Received fresh for Tumor. Bank sampling is a head of pancreas that measures anterior to. posterior 5.5 cm, superior to inferior 3.8 cm and medial to. lateral. 3.4 cm. The portion of distal stomach measures. 10.5 cm along the greater curvature, 5.8 cm along the lesser. curvature, 5.8 cm along the lesser curvature and 2.0 cm from. anterior to posterior. The portion of proximal duodenum. measures 21.0 cm in length and 2.8 cm in diameter. The. gallbladder is attached and measures 8.5 x 4.6 x 4.0 cm. The. common bile duct is stented. The margins are inked as follows: Printed from: Default. Page: 2 of 5. F. Pancreatic head anterior margin yellow, main pancreatic duct. red, uncinate margin green, vascular notch margin indigo, common. bile duct margin blue, posterior pancreatic margin black, and. the mucosa of the common bile duct orange. Size, appearance, and location of tumor: The tumor is located. within the head of the pancreas. Its site of origin appears to. be adjacent to the ampulla of Vater within the parenchyma of the. pancreas itself and measures 1.9 cm anterior to posterior, 2.8. cm superior to inferior. The tumor appears to efface the normal. morphology of the normal yellow lobulated pancreas and is. replaced by a vague dull gray pale tan appearance with. ill-defined and vague borders. Gross impression of invasive growth: The tumor does not appear. to grossly involve the bile duct or the pancreatic ducts and. appears limited to within the pancreatic parenchyma showing no. gross involvement with the duodenal mucosa and appears to abut. the ampulla. Closest resection margins and distance: The ampulla, within 0.3. cm, the anterior margin within 0,3 cm. Other findings: the tumor is free of the uncinate, vascular and. main pancreatic duct margin and shows no gross involvement with. the common bile duct margin. Uninvolved tissues: Soft to rubbery, yellow lobulated pancreas. with normal caliber ducts throughout the pancreas. The. gallbladder is red-brown, heavily congested with a smooth. serosa, 0.3 to 0.6 cm thick walls and bile-stained green,. velvety mucosal surfaces filled with green mucoid and viscous. bile showing no calculi. The cystic duct 0.2 cm in diameter and. showing no gross evidence of tumor, The stomach shows heavily. denuded mucosal surfaces corresponding with gastritis and the. duodenum is of normal tan-brown tightly folded mucosa showing no. focal lesion. Lymph nodes attached: There are three within the pericommon. bile duct region, five within the posterior peripancreatic soft. tissue, nine within the anterior peripancreatic soft tissue and. four within the gastro-omental soft tissue of the greater. curvature with the lymph nodes ranging from 0.3 to 2.2 cm in. greatest dimension, the largest near the pericommon bile duct. region. Blocks submitted: C1 - tumor to ampulla, common bile duct duodenum and pancreatic. parenchyma. C2-C3 - tumor to distal common bile duct divided. C4 - additional sections of tumor to ampulla. C5 - central section of tumor. C6 - representative section of tumor to anterior and posterior. margins. C7 - main pancreatic duct margin. C8 - common bile duct margin. C9-C10 - vascular notch margin serially sectioned sequentially. Printed from: Default. Page: 3 of 5. F. I. from posterior to anterior. C11-C12 - uncinate margin sequentially from posterior to. anterior. C13-C15 - posterior/retroperitoneal margin submitted. sequentially from superior to inferior. C16-C17 - proximal gastric margin. C18 - representative sections of stomach. C19 - representative sections of gallbladder. C20 - representative sections of duodenum. C21 - representative sections of distal duodenal margin. C22 - two pericommon bile duct lymph nodes intact. C23 - six lymph nodes intact from the anterior peripancreatic. region. C24 - three lymph nodes intact from the anterior peripancreatic. region. C25 - four lymph nodes from the gastro-omental region (the four. lymph nodes from the posterior peripancreatic region are. submitted as part of the posterior margin en face sections). (D) (superior pancreatic lymph node) Received in formalin is a. tan-pink rubbery lymph node that is 1.2 cm in greatest. dimension. It is trisected and submitted entirely in cassette. D1. (E) (hepatic duodenal lymph node) Received in formalin is a. 3.2 x 2.9 x 1.0 cm tan to red-brown rubbery tissue. It is. serially sectioned and submitted entirely in cassettes E1 and. E2. (F) (celiac lymph node) Received in formalin is a tan-pink to. yellow, soft to rubbery tissue fragment that has a smooth. glistening external surface and measures 2.7 x 1.5 x 0.4 cm. It. is serially sectioned and submitted entirely in cassette F1. Microscopic Description: Complete microscopic evaluation has been performed. Appropriately reacting controls have been performed and. evaluated for all stains on this case as required. Histopathology has a list of IH antibodies that are regulated as. analyte specific reagents (ASR's). These assays were developed. and their performance characteristics determined by the. Histopathology Laboratory in the Department of Pathology at The. They. have not been cleared by the US Food and Drug Administration. The FDA has determined that such clearance or approval is not. necessary for the ASR's. These tests are not investigational. and are used in standard clinical care. In cases where. Immunohistochemistry testing is performed, the following. antibodies and their respective clones may be used to determine. therapy for the patient: EFGR(31G7), ER(SP1), PR(1E2),. Her2neu(4B5), CD117(Poly), CD20(L26). Unless otherwise stated in the report, all tissue tested for. Printed from: Default. Page: + of 5. F. ERPR by IHC, Her2 by IHC and/or HER2 by FISH have been fixed as. per ANP.22998 for a minimum of 6 hours and a maximum of 48. hours. ER, PR, Ki-67, p53 are reported as a semi-quantitative. percentage of positively stained nuclei. Her-2/neu and EGFR are. scored as follows: No staining at all is scored as (0), weak,. incomplete membrane staining in any proportion of cells is. scored as (1+), less than strong but complete staining in any. proportion of cells or complete strong staining in less than 30%. of cells is scored as (2+), and strong complete staining in more. that 30% of cells is scored as (3+). All studies are performed. on tissue fixed in 10% neutral buffered formalin and embedded in. paraffin unless otherwise stated in the report. Printed from: Default. Page: 5 of 5."
BIOCUP_00330,pancreas,PAAD,TCGA-IB-AAUQ,TCGA-IB-AAUQ.B2B5526A-ADC6-4F65-B5B2-6B0E895968FF,"CONFIDENTIAL. Demographics (for. verification purposes). Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. A. Liver biopsy at. B. Liver biopsy number 2 at. C. Liver biopsy number 3 at. D. Body and tail of pancreas at. Clinical Information. Pancreatitis. Possible pancreatic cancer. Diagnosis. A. Liver, Biopsy: Bile duct hamartoma. Negative for malignancy. B. Liver, Biopsy #2: Benign liver tissue. Negative for malignancy. C. Liver, Biopsy #3: Benign liver tissue. Negative for malignancy. D. Pancreas, Body and Tail, Distal Pancreatectomy: Invasive ductal adenocarcinoma, moderately differentiated with. focal foamy gland pattern, 4.5 x 3.5 x 3.5 cm. Prominent perineural, lymphatic, and venous invasion present. Invasive adenocarcinoma involves retroperitoneal margin and. pancreatic body margin. Thirteen of twenty-one peripancreatic lymph nodes involved by. metastatic adenocarcinoma (13/21) extranodal extension present;. largest tumor deposit 1.2 cm. Please see comment and synontin report. Verified: Synoptic Report. SPECIMEN: Body of pancreas. Tail of pancreas. PROCEDURE: Partial pancreatectomy, pancreatic tail. TUMOR SITE: Pancreatic tail. TUMOR SIZE: Greatest dimension: 4.5. cm. Additional dimensions: 3.5 x 3.5. cm. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades peripancreatic soft tissues. Tumor invades retroperitoneal soft tissue. Tumor invades other adjacent organs or structures. tumor invades wall of splenic vein. MARGINS: Margin(s) involved by invasive carcinoma. Proximal pancreatic margin. Invasive carcinoma involves posterior retroperitoneal surface of pancreas. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy). No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN) : pN1: Regional lymph node metastasis. Number examined: 21. Number involved: 13. DISTANT METASTASIS (pM) : Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN 2. Chronic pancreatitis. Gross Description. Received are specimen containers A to D. A11 requisitions and specimen containers are. labelled with the patient's name,. The cassettes and identifiers are. labelled with the Surgical Number. A. The specimen consists of liver tissue, measuring 0.3 cm. Submitted in toto in one. cassette. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""A: Liver biopsy at. The previously frozen tissue is entirely. resubmitted for permanent sections in cassette AQS1. B. The specimen consists of liver tissue, measuring 0.2 cm. Submitted in toto in one. cassette. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""B: Liver biopsy number 2 at. The previously frozen tissue is. entirely resubmitted for permanent sections in cassette BQS1. C. The specimen consists of liver tissue, measuring 0.8 cm. Submitted in toto in one. cassette. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""C: Liver biopsy number 3 at. The previously frozen tissue is. entirely submitted for permanent sections in cassette CQS1. D. The specimen is received fresh and is subsequently placed into formalin. The. container is designated ""D: Body and tail of pancreas at. and contains a 12.0 x 6.0. x 3.5 cm portion of pancreatic body and tail. The pancreatic body margin is inked blue,. the distal margin is inked orange, and the radial margin is inked black. The specimen is. bisected longitudinally and is fixed in formalin overnight. Sectioning reveals an ill-. defined, firm, yellow-tan, 4.5 x 3.5 x 3.5 cm mass with a few punctate hemorrhagic areas. The mass is located in the anterior half of the specimen and grossly extends to the. anterior serosa, to within 1.0 cm of the blue-inked pancreatic body resection margin, and. very close (1-2 mm) to the posterior/retroperitoneal margin. The rim of pancreatic. tissue proximal to the mass is soft and tan-colored with a normal lobular configuration. The pancreatic tail tissue distal to the mass (3.5 x 1.0 cm) is attenuated, faintly. nodular, and atrophic-appearing. The pancreatic duct passes through the central. posterior aspect of the mass, and shows no obvious dilation, stricture, or intraductal. mass. Within the peripancreatic fat superior, inferior and posterior to the mass, there. are multiple vell-circumscribed ovoid, firm, white nodules, consistent with lymph nodes,. many of which appear grossly suspicious for metastatic tumor. Representative sections. are submitted as follows: D1. representative perpendicular section of pancreatic body margin closest to. tumor. D2/3. remainder of pancreatic body margin, shaved and submitted en face. D4. single grossly suspicious lymph node, superior to pancreatic mass, sectioned. D5. additional superior margin with possible lymph nodes. D6. single grossly suspicious lymph node located superior to mass, bisected. D7 to 9. additional representative sections of superior portion of tumor with. adjacent grossly. positive lymph nodes. D10 to 12. representative sections of tumor with retroperitoneal margin and grossly. suspicious. retroperitoneal lymph nodes. D13. representative section of atrophic pancreatic tail near retroperitoneum. D14. representative portion of central tumor with large vessel. D15/16. tumor with inferior margin. D17. representative portion of atrophic distal pancreatic tail with distal margin. D18. distal portion of tumor with adjacent possible lymph node. D19. tumor with adjacent anterior serosa. D20. distal peripancreatic fat with three possible lymph nodes (bisected). D21. two additional possible lymph nodes. Frozen Section Diagnosis. A. Liver Biopsy: No evidence of carcinoma. B. Liver Biopsy Number 2: Negative for malignancy. C. Liver Biopsy Number 3: Negative for carcinoma. Pathologist Comment. In case ancillary studies are desired, tumor block information is listed below: Best tumor block: D4. Best normal block: D17. Encounter Number. Patient Location."
BIOCUP_00331,pancreas,PAAD,TCGA-RB-A7B8,TCGA-RB-A7B8.F63EAC42-1415-4F1F-B647-C9D61A2EB8C3,"Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Anat Path Reports. Document Date: Histology. Acc #: (Age: F. Client: Submitting. Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. BILE DUCT MARGIN, EXCISION (A1FS): - NEGATIVE FOR CARCINOMA. B. PANCREATIC NECK MARGIN, EXCISION (B1FS): - NEGATIVE FOR CARCINOMA. C. RETROPERITONEAL MARGIN, EXCISION (C1FS): - NEGATIVE FOR CARCINOMA. D. LYMPH NODE, HEPATIC ARTERY, EXCISION: - ONE LYMPH NODE WITH CAUTERY ARTIFACT, NEGATIVE FOR METASTATIC CARCINOMA (0/1). E. PANCREAS AND DUODENUM, PANCREATICODUODENECTOMY: INVASIVE ADENOCARCINOMA, MODERATELY DIFFERENTIATED, PANCREATOBILIARY TYPE WITH FOCAL. MICROPAPILLARY COMPONENT, (2.3 X 2.2 X 2.0 CM). -Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. - CARCINOMA INVOLVES THE PERIPANCREATIC SOFT TISSUE. - PERINEURAL INVASION IS PRESENT. - LYMPHOVASCULAR INVASION IS NOT IDENTIFIED. - CARCINOMA EXTENDS TO THE RETROPERITONEAL EDGE; REFER TO SPECIMEN 'C' FOR STATUS OF. RETROPERITONEAL MARGIN. - COMMON BILE DUCT EDGE AND PANCREATIC NECK EDGE ARE NEGATIVE FOR CARCINOMA; REFER TO PARTS. 'A' AND 'B' FOR STATUS OF BILE DUCT AND PANCREATIC NECK MARGINS, RESPECTIVELY. - PROXIMAL AND DISTAL DUODENAL MARGINS ARE NEGATIVE FOR CARCINOMA. EIGHT OF TWENTY-THREE LYMPH NODES ARE POSITIVE FOR METASTATIC CARCINOMA (8/23). - SEE SYNOPTIC REPORT AND COMMENT. Comment. There is a cystic component to the tumor (approximately 20% grossly) which is not clearly an intraductal papillary mucinous. neoplasm (IPMN). The differential diagnosis includes colonization of a retention cyst or large duct by carcinoma versus IPMN. replaced by carcinoma. Some of the positive lymph nodes appear to be positive by direct extension of the tumor. The micropapillary component accounts for approximately 10% of the tumor. Selected slides from this case have been reviewed at our daily. with. concurring with the diagnosis. Synoptic Worksheet. E. Whipple: Specimen: Head of pancreas. Duodenum. Common bile duct. Procedure: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. Tumor Site: Pancreatic head. Tumor Size: Greatest dimension: 2.3 cm. Additional dimension: 2.2 cm. Additional dimension: 2.0 cm. Histologic Type: Ductal adenocarcinoma. Histologic Grade: G2: Moderately differentiated. Microscopic Tumor Extension: Tumor invades peripancreatic soft tissues. Margins: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1 mm. Confidential Document. This information is subject to all Federal and State laws regarding contidentiality and privacy and to the policies and procedures of. regarding. patient information Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Margin: Retroperitoneal. Margins uninvolved by carcinoma in situ. Treatment Effect: No prior treatment. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Present. TNM Descriptors: Not applicable. Primary Tumor (pT): pT3: Tumor extends beyond the pancreas but without involvement of the celiac. axis or the superior mesenteric artery. Regional Lymph Nodes (pN): pN1: Regional lymph node metastasis. Number of lymph nodes examined: 8. Number of lymph nodes involved: 24. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: None identified. Clinical History. Pancreatic head mass. Whipple. Specimen(s) Received. A: Bile duct margin. B: Pancreatic neck margin. C: Retroperitoneal margin. D: Hepatic artery node. E: Whipple. Gross Description. Five specimens are received, each labeled with the patient's name and medical record number. Specimen A is received fresh for intraoperative consultation, identified with the patient's name and medical record number and. designated as ""bile duct margin."" The specimen consists of luminal soft tissue measuring 0.8 x 0.5 x 0.2 cm. The entire. specimen is submitted for frozen section diagnosis and the contents of the cryoblock are transferred to cassette ""A1FS."". Specimen B is received fresh for intraoperative consultation, identified with the patient's name and medical record number and. designated as ""pancreatic neck margin."" The specimen consists of a fragment of soft tissue measuring 0.5 x 0.3 x 0.1 cm. The. entire specimen is submitted for frozen section diagnosis and the contents of the cryoblock are transferred to cassette ""B1FS.'. Specimen C is received fresh for intraoperative consultation, identified with the patient's name and medical record number and. designated as ""retroperitoneal margin."" The specimen consists of a fragment of soft tissue measuring 1.5 x 1.1 x 0.1 cm. The. entire specimen is submitted for frozen section diagnosis and the contents of the cryoblock are transferred to cassette ""C1FS."". Specimen D is received in formalin and is labeled ""hepatic artery node."" It consists of two fragments of soft tissue measuring in. -Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. egarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. aggregate cm. The specimen is submitted entirely, wrapped in lens paper in cassette ""D1."" Dictated by. Specimen E is received fresh and is labeled ""Whipple."" It consists of a pancreaticoduodenectomy specimen with duodenum. measuring 19.5 cm in length and 5.5 cm in circumference and pancreatic head measuring 4.5 cm anterior/posterior, 5.4 cm. superior-to-inferior. and. 5.0 cm from duodenal edge to neck edge. The stomach and gallbladder are not present. The common. bile duct is dilated and measures 2.9 cm in length and 0.6 cm in diameter. The pancreatic duct measures 3.0 cm in length and up. to 0.2 cm in diameter. The two ducts open to different ampullae through separate orifices. The accessory ampulla measures 0.5. x 0.4 cm, does not communicate with the common bile duct nor the cystic duct, and is 1.0 cm from the proximal duodenal margin. There is a mass located predominantly in the pancreatic head that has both solid (80%) and cystic components (20%). The mass. is tan-white with well-defined borders and measures 2.3 x 2.2 x 2.0 cm. Areas of necrosis are not identified. There are no. polypoid or soft friable papillary areas. The mass does not involve the ampulla. The mass abuts the common bile duct and. invasion cannot be grossly ruled out. The mass grossly involves the pancreatic duct causing constriction at 1.0 cm from the. ductal edge. The mass does not involve the duodenum and is grossly confined to the pancreatic head. The mass is located 1.0. cm. from the pancreatic neck edge and abuts and possibly involves the retroperitoneal edge and vascular bed. The mass abuts. the free posterior lateral surface and is 0.8 cm from the free anterior surface. The accessory ampulla is uninvolved by the mass. A representative section of the mass as well as uninvolved duodenum is submitted to. The. specimen is inked as follows: vascular bed-blue, retroperitoneal edge-black, accessory ampulla-green, serosal surface-blue. Representative sections are submitted as stated below. CASSETTE SUMMARY: E1: Common bile duct edge, shaved and en face. E2: Pancreatic neck edge, shaved and en face. E3: Representative vascular bed, perpendicular. E4, E5: Retroperitoneal edge, perpendicular. E6: Common bile duct lymph node. E7: Superior head lymph nodes. E8, E9: Anterior pancreaticoduodenal lymph nodes. E10, E11: Anterior pancreatic lymph nodes. E12: Inferior pancreatic head lymph nodes. E13: Posterior pancreaticoduodenal lymph nodes. E14, E15: Posterior pancreatic lymph nodes. E16: Proximal duodenal margin, shaved. E17: Distal duodenal margin, shaved. E18: Accessory ampulla, shaved. E19: Pancreatic duct, common bile duct, ampulla and mass (anterior). E20: Mass to pancreatic duct, common bile duct, duodenum and normal pancreas. E21: Cystic area within mass to common bile duct and possibly pancreatic duct with invasion (anterior). E22: Mass center (anterior half). E23: Mass and common bile duct (posterior half). E24: Tumor to normal (anterior half). E25: Normal pancreas (anterior half). E26, E27: Additional mass (posterior half). E28: Duodenum, representative. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Intraoperative Consult Diagnosis. A1FS: BILE DUCT MARGIN (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. in. at. out at. B1FS: PANCREATIC NECK MARGIN (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. in. at. out at. C1FS: RETROPERITONEAL MARGIN (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. in. at. out at. Microscopic Description. Microscopic examination performed."
BIOCUP_00332,pancreas,PAAD,TCGA-IB-7644,TCGA-IB-7644.edbd392f-eaca-4329-8abb-94a1315db088,"Lab Patient Demographice. (for vertfication purponee). surgical Pathology Report. Collected Date/Time. Received Date/Time. Specimen Description. A. Gallbladder at. B. Pancreatic duct margin. c. Bile duct margin. D. Whipple's. E. Aortic cable node. Clinical information. Obstructive haundice - ERCP - atricture distal bile duos - plastic stent inserted; CT. reveala biliary dilatation involving intrahepatic and extratepatic bile. ducts and pancreatic duct markadly dilated and lesion in liver (thought to be aysts) and. lymphadenopathy involving iliac region. Diagnosia. A. Cholecystectomy. Acute cholecystitis. B. Pancreatic Duct Margin: Negative for carcinoma. c. Bile Duct Margin: Negative for carcinoma. D. Pancreaticoduodenectomy (WHipple Resection), partia pancreas resection: Ductal adenocarcinoma of pancreatic head/uncinate process. (please 480 synoptic)."
BIOCUP_00333,pancreas,PAAD,TCGA-YY-A8LH,TCGA-YY-A8LH.B1D3B194-868B-468E-9EED-37E24FA91D60,"SPECIMENS: A. EPIGASTRIC HERNIA. B. DISTAL PANCREAS AND SPLEEN. C. RETROPERITONEAL MARGIN. SPECIMEN(S): A. EPIGASTRIC HERNIA. B. DISTAL PANCREAS AND SPLEEN. C. RETROPERITONEAL MARGIN. DIAGNOSIS: A. EPIGASTRIC HERNIA, EXCISION: - PORTION OF ADIPOSE TISSUE CONTAINING LYMPHOID TISSUE, NEGATIVE. FOR. TUMOR. B. DISTAL PANCREAS AND SPLEEN, PANCREATECTOMY AND SPLENECTOMY: - PANCREATIC DUCTAL ADENOCARCINOMA IN PANCREATIC TAIL,. MODERATELY. TO POORLY DIFFERENTIATED, TUMOR SIZE 4.2 X 3.1 CM. - CARCINOMA INVADING THROUGH PANCREAS INTO PERIPANCREATIC. ADIPOSE. TISSUE. - CARCINOMA INVADING INTO VASCULAR WALL OF SPLENIC VEIN. - PERINEURAL INVASION AND ANGIOLYMPHATIC INVASION IDENTIFIED. - METASTATIC CARCINOMA PRESENT IN ONE TWO OUT OF SEVENTEEN. PERIPANCREATIC LYMPH NODES (2/17). - PROXIMAL PANCREATIC MARGIN, NEGATIVE FOR TUMOR. - RETROPERITONEAL MARGIN, NEGATIVE FOR TUMOR. - SEE TEMPLATE. C. RETROPERITONEAL MARGIN: - PORTION OF FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. SYNOPTIC REPORT - PANCREAS (EXOCRINE). Specimen Type: Partial pancreatectomy, pancreatic tail and splenectomy. Tumor Site: Pancreatic tail. Tumor Configuration: Infiltrative. Tumor size greatest dimension:4 2cm. Tumor size additional dimensions: 3.1cm x 2.4cm. WHO CLASSIFICATION. Ductal adenocarcinoma 8500/3. Histologic Grade: G3: Poorly differentiated. Extent of Invasion: Invades through the pancreatic capsule but spares adjacent structures. Carcinoma invade into vascular wall of splenic vein, but negative for tumor thrombus. Margins/Carcinoma in situ: Carcinoma in situ absent at ductal margins. Margins / Invasive Carcinoma: Margin uninvolved by invasive carcinoma. Venous/Lymphatic (Large/Small Vessel) Invasion (V/L): Present. Perineural Invasion: Present. Additional Pathologic Findings: Pancreatic intraepithelial neoplasia. Highest grade: PanIN:2. Extent of Resection: R0: Complete resection with grossly and microscopically negative margins. Lymph Nodes: Positive /17. Extranodal extension Yes. Pathologic Staging (pTNM): pT3N1bMX. GROSS DESCRIPTION: A. EPIGASTRIC HERNIA. Received in formalin is an irregularly shaped piece of fibroadipose soft tissue measuring 4.2 x 2.7 x 2.4. cm. Serial sectioning reveals no mass or nodularity. Representative sections are submitted in one. cassette labeled A. B. DISTAL PANCREAS AND SPLEEN. Received fresh and subsequently fixed in formalin in a single matching container is a distal. pancreatectomy/splenectomy specimen weighing 168 grams overall. The spleen measures 11.0. x. 6.5. x. 4.0 cm and the pancreatic portion measures 11.0 x 5.5. x 3.8 cm. There is a stapled margin at the. proximal aspect of the pancreas measuring 3.5 cm in length. The entire anterior aspect of the pancreas. and spleen are inked blue. The posterior aspect of both pancreas and spleen is inked black. On serial. sectioning is a firm, tan-white mass present within the pancreatic parenchyma that measures 4.2 x 3.1 x. 2.4 cm. Tissue is procured from the mass. Grossly the mass extends to within 0.1 cm of the anterior. retroperitoneal margin. Grossly the pancreatic duct cannot definitively be identified. The mass also. extends to within 0.1 cm of the posterior retroperitoneal margin. The splenic surface has a coarsely. granular texture. Serial sectioning reveals no focal lesions. The pancreatic mass is located 1.2 cm. from the splenic hilum. The spleen is uninvolved by the mass. Representative sections are submitted. as follows: B1: proximal pancreatic margin (stapled margin). B2-B5: mass with anterior and posterior retroperitoneal margins. B6-B7: mass with margins and adjacent grossly uninvolved pancreas. B8-B9: spleen. B10: spleen-pancreas interface. B11: vasculature. B12-B13: spleen artery and vein. B14: four possible lymph nodes. B15-B23: additional possible lymph nodes. C. RETROPERITONEAL MARGIN. Received in formalin is a single irregularly shaped fragment of tan-brown soft tissue measuring 1.5 x 0.5. x 0.3 cm. The specimen is submitted entirely as is in one cassette labeled C. CLINICAL HISTORY: None provided. PRE-OPERATIVE DIAGNOSIS: Pancreatic cyst. Microscopic/Diagnostic Dictation:., Pathologist,. Final Review:., Pathologist. Final Review: Pathologist,. Final: Pathologist,."
BIOCUP_00334,pancreas,PAAD,TCGA-2J-AABV,TCGA-2J-AABV.D506891E-7B4D-449C-8BA9-2F8FE36C94DC,"Surgery date: DIAGNOSIS: A. Lymph nodes, common hepatic artery, biopsy: Multiple (3) lymph. nodes are negative for tumor. B. Pancreas, neck margin, excision: Low-grade pancreatic. intraepithelial neoplasia (PanIN) is present. Negative for. malignancy. C. Common hepatic duct, margin, excision: Negative for tumor. D. Lymph node, hepatic hilar, biopsy: A single (1) lymph node is. negative for tumor. E. Head of pancreas, duodenum, portion of jejunum and gallbladder,. common bile duct, Whipple resection: Invasive grade 3 (of 4) ductal. adenocarcinoma, is identified forming a solid mass (3.3 x 3.2 X 2.6. cm) located in the pancreatic head. The tumor extends beyond the. pancreas involving the peripancreatic soft tissue and duodenal. submucosa. Gallbladder shows mild chronic cholecystitis. Angiolymphatic invasion is present. Perineural invasion is present. Tumor necrosis is absent. All surgical resection margins are. negative for tumor (minimum free margin, 1.2 cm, uncinate margin). Carcinoma in situ (low-grade PanIN) is present at the pancreatic. margin. The adjacent non-neoplastic pancreatic parenchyma contains. low-grade PanIN. Multiple (2 of 24) regional lymph nodes are. positive for metastatic adenocarcinoma. With available surgical material, [AJCC pT3N1] (7th edition, 2010). Frozen section histologic interpretation of common hepatic artery. lymph nodes performed by: This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s). Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. GROSS DESCRIPTION: A. Received fresh labeled ""common hepatic artery lymph nodes"" is a. 3.0 X 2.2 x 0.8 cm aggregate of adipose and lymphatic tissue. Lymph. nodes submitted. Grossed by. B. Received fresh labeled ""pancreatic neck margin"" is a 2.9 X 1.9 x. 0.7 cm portion of pancreatic parenchyma with orientation. All. submitted. Grossed by. C. Received fresh labeled ""common hepatic duct margin"" is a 1.0 x. 0.8 x 0.5 cm portion of tan-red tubular tissue with orientation. Margin submitted. Grossed by. D. Received fresh labeled ""hepatic hilar lymph nodes"" is a 2.5 X 1.7. x 1.1 cm aggregate of adipose and lymphatic tissue. Lymph nodes. submitted. Grossed by. E. Received fresh labeled ""head of pancreas, duodenum, portion. jejunum, common bile duct, gallbladder"" is a Whipple specimen. consisting of 35.0 cm in length portion of duodenum, 6.1 X 4.2 x 4.0. cm portion of pancreas, 10.1 x 4.3 x 1.1 cm gallbladder. The. pancreatic uncinate margin is inked yellow and shaved, the portal. vein groove margin is inked black and submitted perpendicularly. There is a 3.3 x 3.2 x 2.6 cm diffusely infiltrative mass within the. head of the pancreas, 1.2 cm from the uncinate margin. The mass. grossly extends into the small bowel wall over an area of 8.5 cm,. involving the ampulla, and into the surrounding soft tissue. A. stent is present within the main pancreatic duct. The gallbladder. contains no choleliths. Peripancreatic lymph nodes and periduodenal. lymph nodes are identified. Representative sections are submitted. BLOCK SUMMARY: Part A: Common hepatic artery lymph nodes. 1 Com hepatic artery LN2(A1). 2 Com hepatic artery LN1(A2). Part B: Pancreatic neck margin. 1 Pancreatic neck margin1. 2 Pancreatic neck margin2. Part C: Common hepatic duct margin. 1 Comm hepatic duct margin. Part D: Hepatic hilar lymph node. 1 Hepatic hilar LN (D1). Part E: Head of pancreas, doudenum, portion jejunum, common bile. duct, gallbladder. 1 Uncinate margin 1. 2 Uncinate margin 1. 3 Uncinate margin 2. 4 Uncinate margin 2. '5 Uncinate margin 3. 6 Uncinate margin 3. 7 Mass to bowel. 8 Ampulla. 9 Mass to bile duct. 10 PVG margin. 11 Mass to surrounding St. 12 Mass 1. 13 Gallbladder. 14 Peripancreatic LN2(E1). 15 Peripancreatic LN5(E2). 16 Peripancreatic LN3(E3). 17 Peripancreatic LN1 (E4). 18 Peripancreatic LN1/2(E4). 19 Peripancreatic LN2/2(E4). 20 Peripancreatic LN 3 (E6). 21 Peripancreatic LN 2 (E7). 22 Peripancreatic LN 3 (E8). 23 Periduodenal LN 5 (E9)."
BIOCUP_00335,pancreas,PAAD,TCGA-2J-AAB6,TCGA-2J-AAB6.1FE3683C-294A-4FC5-A3F7-7DE1EFEFF11A,"Surgery date: REVISED REPORT (Addendum/Procedure included). DIAGNOSIS: A. Lymph nodes, common hepatic artery, biopsy: Multiple (2). lymph nodes are negative for tumor. B. Soft tissue, celiac axis stump, biopsy: Fragment of nerve. trunk and adjacent soft tissue. No evidence of malignancy. C. Celiac artery, margin, biopsy: Fragment of arterial wall. Negative for tumor. D. Pancreatic neck, margin, biopsy: Negative for tumor. E. Pancreatic body/tail, spleen, and celiac axis, partial. pancreatectomy and splenectomy: Invasive moderately differentiated. ductal adenocarcinoma is identified forming a solid mass (5.0 cm). located in the pancreatic body. The tumor extends beyond pancreas. involves peripancreatic soft tissue. Angiolymphatic invasion is. absent. Perineural invasion is absent. Tumor necrosis is absent. All surgical resection margins are negative for tumor (minimum tumor. free margin, 2.5 cm, pancreatic neck margin). The adjacent. non-neoplastic pancreatic parenchyma contains PanIN (1B). Multiple. (16) regional lymph nodes are negative for metastatic tumor. With available surgical material [AJCC pT3 NO] (7th edition, 2010). This final pathology report is based on the gross/macroscopic. examination and frozen section histologic evaluation of the. specimen(s). Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. Interpreted by: ADDENDUM: Spleen is unremarkable and negative for tumor. GROSS DESCRIPTION: A. Received fresh labeled ""common hepatic artery lymph nodes"" is. a 1.3 x 1.3 x 0.5 cm portion of tan-red fibroadipose tissue. A 0.8. x 0.4 x 0.3 cm lymph node is present. All submitted. Grossed by. B. Received fresh labeled ""celiac axis stump tissue"" is a 0.8 x. 0.3 x 0.3 cm fragment of red-tan soft tissue. All submitted. C. Received fresh labeled ""celiac artery margin, margin up"" is a. 1.0 x 0.5 X 0.3 cm fragment of tan, ring-shaped soft tissue. All. submitted. Grossed by. D. Received fresh labeled ""pancreatic neck margin, margin up"" is. a 2.5 X 1.5 x 0.4 cm portion of bloody pancreatic tissue. All. submitted. Grossed by. E. Received fresh labeled ""distal pancreas, spleen, and celiac. axis"" is a distal pancreatectomy specimen consisting of 17.0 x 9.0 x. 4.0 cm portion of pancreas and a 295 gram, 13.0 x 9.0 X 4.0 cm. spleen. A 5.0 x 3.5 x 3.0 cm mass is present within the pancreas. 2.5 cm from the proximal pancreatic margin. The mass does not. appear to be confined to the pancreas, grossly, and appears to. extend into peripancreatic soft tissue. Peripancreatic lymph nodes. and splenic hilar lymph nodes are identified. The spleen is grossly. unremarkable. Representative sections submitted. Grossed by. BLOCK SUMMARY: Part A: Common hepatic artery lymph nodes. 1 Common hepatic artery. 2 Common hepatic arteryLN1(A1). Part B: Celiac axis stump tissue. 1 Celiac axis stump tissue. Part C: Celiac artery margin. 1 Celiac artery margin. Part D: Pancreatic neck margin. 1 Pancreatic neck margin. Part E: Distal pancreas, spleen and celiac axis. 1 Pancreas tumor. 2 Tumor/soft tissue. 3 Peripancreatic Ln 2(E1). 4 Peripancreatic Ln 2(E2). 5 Peripancreatic Ln 1(E3). 6 Peripancreatic LN 4(E4). 7 Peripancreatic Ln 3 (E5). 8 Peripancreatic Ln 1 (E6). 9 Peripancreatic Ln 2(E7). 10 Spleen."
BIOCUP_00336,pancreas,PAAD,TCGA-FB-AAPY,TCGA-FB-AAPY.BE077658-3286-455B-A84E-87CEA81BEF59,"Gross Description: Pancreas and duodenum, pancreaticoduodenectomy: - Pancreatic ductal adenocarcinoma, moderately differentiated, 3.5 cm in greatest dimension, limited to. pancreas (see worksheet). - Perineural invasion identified. - Resection margins negative for malignancy. - Metastatic carcinoma in two of nine lymph nodes (2/9). Microscopic Description: Diagnosis Details: Comments: Tumor Site (check all that apply): Pancreatic head. Tumor Size: Tumor size greatest dimension: 3.5cm. Histologic Type: Ductal adenocarcinoma. Histologic Grade: G2: Moderately differentiated. AJCC Stage (pTNM). Primary Tumor (pT): pT2. Regional Lymph Nodes (pN): N1b. Number of regional lymph nodes involved: 2. Number of regional lymph nodes examined: 9. Distant Metastasis (pM): pMX. Margin(s) negative for invasive carcinoma. Angiolymphatic Invasion (V/L): Absent. Perineural Invasion: Present. Formatted Path Reports: PANCREAS TISSUE CHECKLIST. Specimen type: Whipple resection. Tumor site: Head. Tumor size: 3.5 cm. Histologic type: Adenocarcinoma, ductal type. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 2/9 positive for metastasis (Regional 2/9). Lymphatic invasion: Absent. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None."
BIOCUP_00337,pancreas,PAAD,TCGA-M8-A5N4,TCGA-M8-A5N4.DA73BF07-6A4B-472E-8164-486504B8A516,Sample Type TUMOUR. Diagnosis. ductal adenocarcinoma. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). pancreas. Tumour Size (cm). 3.3999999999999999. Histology. ductal adenocarcinoma. Grade/Differentiation. II. Pathological T. T3. Pathological N. Clinical M. M0. Histology Comments. pancreatic head. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.
BIOCUP_00338,pancreas,PAAD,TCGA-IB-7649,TCGA-IB-7649.fc689c64-8c88-492c-ac93-866ad0c243dd,"ORIGINAL REPORT. SPECIMEN: A. Gallbladder. B. Node of importance. c. Bile duct margin - fs. D. Duodenum, pancreatic margin (long stitch), uncinate margin (short stitch). CLINICAL HISTORY: ERCP shows common bile duot and pancreatic duct stricture - brushings show. high grade epithelial neoplasia. DIAGNOSIS: A. GALLBLADDER, CHOLECYSTECTOMY: ACUTE CHOLECYSTITIS AND CROLELITHASIS. NEGATIVE FOR DYSPLASIA OR MALIGNANCY. B. NODE OF IMPORTANCE, EXCISION: ONE LYMPH NODE, NEGATIVE FOR MALIGNANCY. LYMPH NODE WITH LIPID GRANULOMAS. c. BILE DUCT MARGIN, EXCISION: NEGATIVE FOR MALIGNANCY. MIXED ACUTE AND CHRONIC INFLAMMATION. D. DUODENUM AND PORTION OF PANCREAS, PANCREATODUODEINECTOMY (WHIPPLE. PROCEDURE) : INVASIVE MODERATELY DIFFERETIATED ADENOCARCINOMA OF PANCREATIC HEAD. (SEE COMMENT). TOMOR SIZEt 3.0 X 4.0 X 2.5 CM. INFILTRATING TNTO DUODENAL WALL AND COMMON BILE DUCT. LYMPHOVASCOLAR INVASION PRESENT. PERINEURAL INVASION PRESENT. TUMOR IS PRESENT AT THE TRIMMED UNCINATE MARGIN. DUODENAL MARGINS, PANCREATIC MARGIN, AND COMMON BILE DUCT MARGIN FREE. OF TUMOR. FIVE OF THIRTEEN (5/13) LYMPH NODES POSTTIVE FOR METASTASIS. F INAL. DIAGNOSIS: GROSS DESCRIPTION: A. Received fresh ie a 10 x 3.5 x 2 cm gallbladder. The serosal surface is. smooth and shiny, A roughened area is corresponding to area attached to the. liver. On opening, the gallbladder ie filled with multiple dark brown stones,. measuring from 0.5 to 1.5 cm in size and 5 x 3 x 1.5 cm in aggregate. The. mucosal surface is trabecular and appears flattened. The wall thickness. measures 0.4 cm. Two representative sections are aubmitted in one. cassette. B. Received in formalin is a 1.5 x 1 x 0.5 cm lymph node. The node is. bisected and entirely submitted in one cassette. C. Ixregular fragment of soft tigsue measuring 0.6 x 0.3 x 0.2 cm, submitted. in toto for FS. The tissue used for frozen section is resubmitted in cassette CQS. D. Received in fresh state is a Whipple resection containing a portion of. duodenum, common bile duct and portion of pancreas. The long stitch labels the. pancreatic margin and the short stitch labels the uncinate margin,. The. duodenum measures 24 am in length and 5.7 em in circumference. The. portion. of. pancreas measures 2.5 em in length and 6 x 4.5 cm on cut surface. There. a. mesh stent in the common bile duct. The common bile duct measures 6 am in. length with a diameter of 1.3 cm. Cross sections of the pancreatic tissue. reveal; a 3 x 4 x 2.5 am tan-yellow firm mass which is grosely invading into. the duodenal wall and common bile ductal wall. Representative sections are. submitted as follows: D1. - proximal duodenal margin. D2. - distal duodenal margin. D3. - pancreatic margin. D4. - uncinate margin. D5. - common bile duct margin. - dommon bile duot with underlying pancreatic tumor. - common bile duct, duodenum and underlying tumor. D10. common bile duct. Division Hoad: Inquiry. GROSS DESCRIPTION: D11,012. - one tumor cut section including adjacent normal pancreatic tissue. D13. another tumor section. Please note the pancreatic margin and uncinate margin are trimmed and the. common bile duat margin is also a trimmed margin. Also attached to the. specimen is a 5 x 4 x 2 cm piece of adipose tissue, There are several white. tan lymph nodes identified and entirely submitted in casgette D14. FROZEN SECTION DIAGNOSIS. C. BILE DUCT MARGIN: - NEGATIVE FOR MALIGNANCY. COMNENT's. The main tumor mass is in the pancreatic head. However, the duodenal wall and. common bile duct are also infiltrated. Morphologically the tumor is either. from pancreatic duct or from bile duct. The pathological stage is IIb (pT3,N1)."
BIOCUP_00339,pancreas,PAAD,TCGA-OE-A75W,TCGA-OE-A75W.D0E49643-BAB9-42A7-86AE-46BE5EF4BD0C,"1st Addendum Report. 1ST ADDENDUM REPORT. ADDENDUM REPORT. A, B: PANCREAS CANCER PROFILE. SPECIMEN TYPE: DISTAL PANCREATECTOMY WITH SPLENECTOMY. CLINICAL/WORKING STAGE: N/A. TISSUE COLD ISCHEMIA TIME: TISSUE DURATION IN 10 PERCENT NEUTRAL BUFFERED FORMALIN: 27.25. HOURS. TUMOR SITE: PANCREAS TAIL. TUMOR SIZE: 4.5 x 2.6 x 2.7 CM. HISTOLOGIC TYPE AND GRADE: DUCTAL ADENOCARCINOMA,. WELL-DIFFERENTIATED (GRADE I) . Note: The tumor displays a cystic component, evidence of possible. origin. within a mucinous cystadenocarcinoma. EXTENT OF INVASION: THE TUMOR SHOWS LIMITED, FOCAL EXTENSION INTO. PERIPANCREATIC FAT. 1st Addendum Report. LYMPH-VASCULAR INVASION: NOT IDENTIFIED. PERINEURAL INVASION: NOT IDENTIFIED. MARGINS: MARGINS FREE OF TUMOR. TUMOR MEASURES 1.5 CM FROM THE PROXIMAL SURGICAL PANCREATIC MARGIN. TUMOR MEASURES LESS THAN 1 MILLIMETER FROM THE POSTERIOR. (RETROPERITONEAL). MARGIN. REGIONAL LYMPH NODES: TWO PERIPANCREATIC LYMPH NODES ARE NEGATIVE. FOR TUMOR. THE ADDITIONAL FAT-CLEARED LYMPH NODE DISSECTION SHOWS 20 OF 20. LYMPH NODES NEGATIVE FOR METASTATIC TUMOR. FAT-CLEARED LYMPH NODE SUMMARY: ZONE 1, 12; 2, 3; 3, 1; 4, 4. ADDITIONAL PATHOLOGIC FINDINGS: BENIGN SPLEEN. UNINVOLVED PANCREAS SHOWS NO SIGNIFICANT. PATHOLOGIC CHANGE. THE MESENTERIC NODULE (PART B) CONSISTS OF. ADIPOSE STROMA WITH FAT NECROSIS. DISTANT METASTASIS: NOT APPLICABLE. CANCER STAGE: pT3, pNO. Note: This addendum is issued to report the results of the. fat-cleared lymph. node dissection. (Electronic Signature)."
BIOCUP_00340,pancreas,PAAD,TCGA-HZ-A49G,TCGA-HZ-A49G.B4B072E1-3592-4EBA-A4A4-F8AA591A2FFE,"Provider Cenain . Date of Service: Date Received: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. & C.) WHIPPLE CONTENTS AND NEW PANCREATIC MARGIN, WHIPPLE RESECTION. AND RE-EXCISION OF PANCREATIC MARGIN: - INVASIVE MODERATELY DIFFERENTIATED DUCTAL ADENOCARCINOMA. INVOLVING THE HEAD OF THE PANCREAS, 3 CM IN GREATEST DIMENSION. - TUMOR FOCALLY INVOLVES UNCINATE MARGIN. - REMAINING MARGINS (COMMON BILE DUCT MARGIN, FINAL PANCREATIC. RESECTION MARGIN, GASTRIC AND DUODENAL MARGINS) ARE NEGATIVE. FOR TUMOR. - NO DEFINITIVE LYMPHOVASCULAR INVASION IDENTIFIED. - FOCAL PERINEURAL INVASION IDENTIFIED. - METASTATIC CARCINOMA IDENTIFIED IN THREE OF EIGHTEEN LYMPH NODES. (3/18). - NO EXTRANODAL EXTENSION IDENTIFIED. - FEW ATYPICAL CELLS IDENTIFIED IN THREE ADDITIONAL NODES, INDEFINITE. FOR TUMOR CELLS. - PANCREATIC INTRAEPITHELIAL NEOPLASIA (PanIN-2) IDENTIFIED. - BENIGN PORTION OF STOMACH AND DUODENUM. B. GALLBLADDER, CHOLECYSTECTOMY: - CHRONIC CHOLECYSTITIS AND CHOLELITHIASIS. - ONE UNREMARKABLE ISOLATED LYMPH NODE. - NEGATIVE FOR DYSPLASIA. PATHOLOGIC TUMOR STAGING SYNOPSIS: Type and grade (invasive): Pancreatic ductal adenocarcinoma, moderately. differentiated. Primary tumor: pT2. Regional lymph nodes: pN1. Distant metastasis: N/A. Stage: IIB. Tumor Staging Information. This report continues (FINAL). Pathology Report - Page 1/5. Job. Page 1 Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. Data derived from current specimen. Staging in accordance with or modified from AJCC Cancer Staging. Handbook, 7th Ed, and CAP protocol,. Specimen: Whipple contents. Procedure: Whipple resection. TUMOR FEATURES: Tumor site: Head of pancreas. Tumor size: 3 x 2.3 x 1.8 cm. Histologic type: Ductal adenocarcinoma. Histologic grade: Moderately differentiated. Microscopic tumor extension: Tumor focally involves uncinate margin. MARGINS: Tumor focally involves uncinate margin. Final. pancreatic resection margin, bile duct margin, and. gastric and duodenal margins are negative for tumor. Treatment effect: N/A. Lymphovascular invasion: Not identified. Perineural invasion: Not identified. LYMPH NODES: Metastatitic carcinoma in 3 of 18 regional lymph nodes. PATHOLOGIC TUMOR STAGING: Primary tumor: pT2. Regional lymph nodes: pN1. Distant metastasis: N/A. Pathologic stage: IIB. Printed: This report continues (FINAL). MR No. -. Acct No. Pathology Report - Page 2/5. Job. FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: A. Whipple. B. Gallbladder. C. Pancreatic new margin. Clinical History/Operative Dx: Pancreatic mass. The specimen is labeled as pancreatic new margin; suture marks new margin. Initially received in the. fresh state for frozen section analysis is a portion of pancreas, 2.0 cm in length and 2.0 x 3.4 cm. A suture. marks the new margin which is additionally marked blue. The new margin is trimmed and submitted en. face for frozen section analysis with residual frozen tissue submitted in C1 for permanent sections. The. pancreatic duct is 0.3 cm in diameter and probe patent. Sectioning demonstrates yellow-gray glandular. parenchyma with mild hemorrhagic congestion and without grossly residual tumor. The remainder of the. pancreas is submitted in a sequential fashion, proximal (old margin) to distal (new margin) in C2-C5. A. scant amount of peripancreatic fat is examined and is suspicious for discrete lymph node content,. sectioned and submitted in C6. Intraoperative Diagnosis: A. Whipple contents: Pancreatic margin positive for adenocarcinoma, bile duct margin is negative for. carcinoma. C. New pancreatic margin: Negative for carcinoma,. intraoperative interpretation(s). was/were performed and rendered at. Gross Description: A. The specimen is labeled Whipple contents. Received in formalin, is a generous portion of tissue. consistent with a Whipple procedure specimen: a distal resection of stomach, 5.7 cm lesser, 11.0 cm. greater, a 25.5 cm length of duodenum averaging 3.3 cm in diameter, and the pancreas includes the. head measuring 2.4 cm in length, 4.6 cm superior-inferior. and 4.6 cm anterior-posterior/ uncinate margin. The gastric and small bowel segment demonstrates a semi-congested, light pink to deep red appearance. The pancreas is palpably soft to dense towards the superior-posterior periphery. The margins of the. pancreas are now differentially inked as follows: Anterior surface: Yellow,. Inferior surface: Green,. Superior margin: Blue,. Posterior margin/uncinate: Black,. Printed: This report continues. Acct No. Pathology Report - Page 3/5. Page 3 Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. Pancreatic notch surface: Red. The common bile duct extends 1.3 and 0.9 cm in diameter, with a probe patent lumen into the smail. bowel segment. The pancreatic duct is unable to probe for patency with the CBD or small bowel lumen. The distal pancreatic margin is trimmed and submitted en face for frozen section analysis on one chuck. with the residual frozen tissue submitted in A1 for permanent sections; the common bile duct margin is. trimmed and submitted en face for frozen section analysis on a second chuck with the residual frozen. tissue submitted in A2 for permanent sections. The gastric and small bowel segments are now opened; the luminal contents are cleared revealing. semi-congested, light pink to proximally deep red, gastric mucosa without discrete lesion. The small bowel. segment demonstrates prominent, light pink and tan, circular plica that is increasingly softened and. congested toward the distal margin of resection. The ampulla of Vater is oriented 5.3 cm distal to the. pylorus and greater than 18.0 cm from the distal small bowel margin of resection. The ampulla. demonstrates slightly raised and granular appearance. Initial sectioning through the pancreas reveals an. ill-defined, dense, grossly fibrotic, light gray and pink, mass lesion, measuring upwards of 3.0 x 2.3 x 1.8. cm, and predominantly positioned in the superior-posterior aspect of the pancreas, within 0.1 cm of the. superior, 0.3 cm of the posterior, 0.7 cm of the anterior margins, and within 0.1 cm of the surface of the. pancreatic notch. The mass lesion appears to abut the common bile duct, however, the mucosa is. glistening to wrinkled, light gray and deep red, without gross involvement. The lesion is grossly within 0.1. cm of the distal pancreatic margin, formally removed for frozen section analysis. The pancreatic duct. narrows to 0.1 cm towards the small bowel length and is possibly obliterated by tumor. The grossly. uninvolved pancreas demonstrates a pronounced, lobular-glandular, pink-yellow gross architecture, that. becomes increasingly fatty towards the inferior anterior periphery. Initial examination of the peripancreatic fat reveais twelve lymph node candidates ranging from 0.15 cm. to 1.5 cm, rubbery, light gray to deep red. Initial examination of the perigastric fat does not reveal. additional lymph node candidacy. Representative sections are submitted for microscopic evaluation. Cassette summary: A1) distal pancreatic margin, FS,. A2) common bile duct margin, FS,. A3-A4) ampulla of Vater - pancreas, superior margin included,. A5-A6) superior pancreas, tumor, edge of anterior margin,. A7) additional anterior pancreas,. A8-A9) pancreas - tumor - mesenteric groove/pancreatic notch surface,. A10-A11) inferior pancreas,. A12-A13) posterior/uncinate pancreas and tumor,. A14) gastric tissue represented, two pieces,. A15) small bowel length represented including additional representation of small bowel adjacent to. ampulla of Vater,. A18) proximal gastric margin of resection, represented,. A17) distal small bowel margin of resection, trimmed and submitted,. A18) five lymph node candidates,. A19) three lymph node candidates,. Printed: This report continues. (FINAL). MR No. -. Acct No. -. Pathology Report - Page 4/5. FINAL SURGICAL PATHOLOGY REPORT. A20) single lymph node candidate, bisected,. A21) peripancreatic lymph node candidate, trisected,. A22) peripancreatic lymph node candidate, serially sectioned,. A23) peripancreatic lymph node candidate, serially sectioned. B. The specimen is labeled gallbladder. Received in formalin is a previously disrupted, partially deflated. gallbladder, 12.1 x 3.8 x 1.8 cm. The serosa is glistening, semi-congested and fatty, tan. The cystic duct. margin demonstrates an obvious patent 5 mm lumen. A discrete cystic duct lymph node candidate is 2.5. mm. The wall is 0.1-0.3 cm with the submucosa appearing partially erythematous. The lumen contains. residual dark green viscous bile without calculi. The mucosa is velvety, tan-green without grossly unusual. areas of change suggestive of neoplasia. Representative sections are submitted to include submission. of. the lymph node candidate, cystic duct margin, and representation of the dome and mid fundus of the. gallbladder in B1. Microscopic Description: A. - C. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. B. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Intradepartmental consultation: reviewed selected slides and concurs. Printed: END OF REPORT (FINAL). Acct No. -. Pathology Report - Page 5/5."
BIOCUP_00341,pancreas,PAAD,TCGA-IB-7646,TCGA-IB-7646.ce071fe4-67c4-4c5b-9829-433597e36067,"ORIGINAL REPORT. B PECIMEN. A: pancreas. B. Galdbladder. a. Bilesduat margin. D. R. Portal vein. F. Pancreas duodenum; and be junum. Panozeal 18 margin. H. Pexd pancreas. COTNICAL. RF panareas and duodenum. DIAGNOSTS: AG. BODY OF PANOREAS; BIOPSY1. SHALL FRACHENTE of DENSE FIBRODS TISSUE. NO NORMAL PANCREATIC TISSUE. PRESENT. Bf. GALTELADOER CHOTECYSTECTONY: UNREMARKABLE GALLELADERE. INEGATIVE FOR MALIGNANCY. c). BILE DUCT MARGIN; BIOPSY: NEGATIVE FOR MALIGNANCY. Di. FANCREATIC MARGIN; BIOPSY;. POSTILIVE FOR ADENOCARCINOMA. Ei PORTAL BIOPSYi. NEGATIVE FOR- MALIGNANCY. Fn PANCREAB AND DEJUNUM, PARTIAL REGECTION: MODERATELY INVASIVE ADENOCARCINOMA, $.5 ax. IN FANCREATIC AND FOCALLY INVOLVING THE PANCREAT. RESECHION. EVIDENCE on FAT INVASION. EVTORNCE or PERINEURAL AND VASCULAR INVASION. 9IX VODES ARE ALL POSTTIVE FOR METASTATIO. ADENOCARCEENOMA NITH EXTRANODAL EXTENSION. TUMOR INVADING MUSCULAR WALL OF DUODENUM AND COMMON BILE DUCT. HISTOPATHOLOGY REPORT. GROSS DESCRIPTION. 053 em All Eiseue de submitted for in E. The Arozen neation cassette is resubmitted. R. The apecimen of a pancreat; head (7.0 x 5.0 x 2.0 am), common. bile of em in length and 215 com in circumEerence), part of the distal. atomach 3100 en on length and 8,10. sm in circunference) , and duodenum and small. borrel (22) D an ength and 6.0. cm in circunference. The pancreatic. resection margin is painted black Serial sections through the pancreatic. head reveale an and defined tem mase lesion located within the pancreatic. bead Fesion measures about, 4 5 cm in greatest dimension, The lesion. appealls nto be present at the inked pancreatic and resection margin and appears. to dinvade the common bile duct grossly. The mucosa of the distal stomach and. dubdienum 8.8. well as the emall bowel axe unremarkable. sect ons are submi tted as followei. common bile duat resection margin,. TA Chrough T5 representative sections of the pancreatic head mass lesion. pancreatio resection margin. E:6 and epresentative sections of the mess lesion with adjacent common. F8. dection of the. to. perpendioular section of gastric resection margin. RID. parpendicular section of dietal emall bowel resection margin,. and F12 mone bisected peripencreatic lymph node. F13 and four possible peripancreatic lymph nodes (2 each). 215 representatiye section of the mage lesion with adjacent duodenal mucosa. prepent to heicontainer is a degment of omentum measuring 25.0 x 10.0. x. and There de no obviouo nodular lesion present. TWO representative. henorhhag le areas are submitted in F16. The repecimen ata of a piece of soft tissue. All tissue submitted for. Q8 in one blook. The frozen section. cassette is resubmitted. FINAT. HISTOPATHOLOGY REPORT. GROSE. the DESCRIPTION lets or A fragment of hodular white soft tissue measuring and. opeciment dons The specimen ie bisected and submitted in toto in H1. 1. H2. DICROSCOPIC). G. inflamitatory reactive Changen present. Features consistent with chronic pancreatitis. FROKEN. A. BOPX DE PANCREASH. TISSUE INCLUDING A LARGE DUCT. NEGATIVE FOR MALIGNANCK. NO PANCREATIC PARENCHYMA INCLUDED IN THE SPECIMEN. to. DUST MARGIN'. NEGATIVE FOR MALIGNANCY. Di. PANCREAS MARGTING. POSITIVE FOR CARCINOMA. En. PORTAL VEIN. FOR MALIGNANCY. GI. BANCREATIC MARGING. NEGATIVE FOR MALTGNANCY."
BIOCUP_00342,pancreas,PAAD,TCGA-FZ-5923,TCGA-FZ-5923.c21958e8-38cc-4d5f-a1a3-a1e068fde5d9,"FINAL DIAGNOSIS: PART 1: PANCREAS, UNCINATE, BIOPSY -. ADENOCARCINOMA (see comment). PART 2: GALLBLADDER, CHOLECYSTECTOMY -. CHRONIC CHOLECYSTITIS. PART 3: GASTRODUODENAL LYMPH NODE, EXCISION -. ONE (1) BENIGN LYMPH NODE. PART 4: PANCREAS, HEAD, BIOPSY -. ADENOCARCINOMA (see comment). PART 5: STOMACH, DUODENUM, PANCREAS, BILE DUCT, WHIPPLE RESECTION -. A. INVASIVE WELL DIFFERENTIATED ADENOCARCINOMA OF THE HEAD OF THE PANCREAS (3.8 CM). B. THE CARCINOMA INVADES BEYOND THE PANCREAS TO INVOLVE THE PERIPANCREATIC SOFT TISSUE AND. DUODENUM. C. METASTATIC ADENOCARCINOMAI IS PRESENT IN ONE OF THIRTEEN (1/13) PERIPANCREATIC LYMPH NODES. D. PROXIMAL GASTRIC, DISTAL DUODENAL, BILE DUCT, PANCREATIC, RETROPERITONEAL AND VASCULAR. GROOVE MARGINS ARE NEGATIVE FOR TUMOR. E. PANCREATIC INTRAEPITHELIAL NEOPLASIA, GRADE 3 (PANIN-3). F. PATHOLOGIC STAGE; pT3, N1, M1 (SEE,PART 6). PART 6: TRANSVERSE MESOCOLON, EXCISION -. A. METASTATIC ADENOCARCINOMA INVOLVING FIBROADIPOSE TISSUE. B. ONE (1) BENIGN LYMPH NODE. PART 7: TRANSVERSE MESOCOLON, LYMPH NODE, EXCISION -. ONE (1) BENIGN LYMPH NODE. COMMENT: The biopsies of the pancreas are diagnostic of adenocarcinoma in comparison to the main resection specimen which. shows a well-differentiated adenocarcinoma with features similar to those seen in the biopsies. SYNOPTIC DATA - PRIMARY PANCREAS(EXOCRINE) TUMORS. MACROSCOPIC. SPECIMEN TYPE: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Greatest dimension: 3.8 cm. Additional dimensions: 3.2 x 2.5 cm. OTHER ORGANS RESECTED: Gallbladder. MICROSCOPIC. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G1. PATHOLOGIC STAGING (pTNM): pN1a. Number of lymph nodes examined: 13. Number of lymph nodes involved: 1. pM1. Site(s): transverse mesocolon (part 6). MARGINS: Common bile duct margin uninvolved. Pancreatic parenchymal margin uninvolved. Uncinate process/retroperitoneal margin uninvolved. SMV/portal vein notch margin uninvolved. Proximal duodenal/gastric margin uninvolved. Distal duodenal margin uninvolved. Distance of invasive carcinoma from closest margin: 2 mm. Margin: vascular groove. VENOUSILYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Present. PERINEURAL INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN 3)."
BIOCUP_00343,pancreas,PAAD,TCGA-3A-A9IX,TCGA-3A-A9IX.4B708CCE-6C54-4A4B-8E27-519461D5A1C2,"Final Diagnosis. A. LIVER, NODULE, BIOPSY: Benign hepatic parenchyma. B. HEAD OF PANCREAS, DISTAL STOMACH AND DUODENUM, STANDARD. PANCREATODUODENECTOMY: Adenocarcinoma, moderately differentiated, confined to the pancreas. Pancreatic neck margin with panIN 1A and 1B. Adjacent pancreatic parenchyma with panIN 3. Thirty-five lymph nodes are free of metastases (0/35). Proximal gastric and distal duodenal margins are free of dysplasia and carcinoma. Superior mesenteric artery and posterior surface are free of carcinoma. Common bile duct with surface epithelial erosions and reactive changes, negative for high. grade dysplasia and carcinoma. See synoptic report. the attending pathologist, personally reviewed all. slides and / or materials and rendered the final diagnosis. Electronically. Key Pathological Findings. B: Pancreas Exocrine. SPECIMEN: Head of pancreas. Duodenum. Stomach. Common bile duct. PROCEDURE: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Greatest dimension of solid component: 2.0 cm. HISTOLOGIC TYPE: Ductat adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor is confined to pancreas. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 5 mm. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy): No prior treatment. LYMPH-VASCULAR INVASION: Not identified. PERINEURAL INVASION: Present. TNM DESCRIPTORS: Not applicable. PRIMARY TUMOR (pT): pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension. REGIONAL LYMPH NODES (pN): pNO: No regional lymph node metastasis. Number examined: 35. Number involved: 0. DISTANT METASTASIS (pM): Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN 3). CLINICAL HISTORY: Not specified. Specimen(s) Received. A. LIVER NODULE FS. B. WHIPPLE. Clinical History. PANCREATIC HEAD CANCER. Preoperative Diagnosis. Pancreatic head cancer. Intraoperative Consultation. FSA1. LIVER NODULE: Benign. B. WHIPPLE: FSB1. Common bile duct; focal mild dysplasia. FSB2. Pancreas margin; focal PanIN-1, negative for carcinoma. Comment: This frozen section diagnosis/result was communicated to and acknowledged by Dr. I,. have performed the intraoperative consultations and issued the above diagnosis. Gross Description. A. The specimen is received fresh for frozen section analysis, labeled ""liver nodule."" The. specimen consists of a 1.0 x 0.5 x 0.1 cm, soft, tan-pink irregular fragment of liver, which is entirely. submitted for frozen section as FSA1. B. The specimen is received fresh for frozen section analysis labeled ""Whipple; specimen is. gallbladder, head of pancreas, distal stomach, and duodenum."" The specimen consists of a resected. portion of head of the pancreas (4.0 x 3.0 x 2.5 cm), the duodenum (12 cm in length and 2 cm in its. greatest diameter), distal stomach (3 cm along the lesser curvature and 6.5 cm along the greater. curvature), and attached gallbladder (7.0 X 3.0 x 2.5 cm). The landmarks of the specimen are inked. as follows; superior mesenteric artery stapled margin of resection yellow, portal vein groove blue, and. retroperitoneal surface black. The pancreatic duct is probed-patent up to about 2 cm, at which point it appears to be obstructed by. an ill-defined, indurated pancreatic mass (2.0 x 2.0 x 0.3 cm), grossly coming to within 2 cm of the. pancreatic margin of resection, and 0.5 cm of the radial soft tissue margin. Grossly the mass does. appear to involve the common bile duct, ampulla of Vater, or duodenum. The remainder of the. pancreatic parenchyma is grossly unremarkable. The gastric and the duodenal mucosa are grossly. unremarkable. On opening the attached gallbladder a moderate amount of red-brown, viscous bile is. expelled. No calculi are grossly appreciated. The wall of the gallbladder measures up to 3 mm in. thickness. The internal surface is red-brown and veivet-like. Dissection of the attached adipose tissue. isolates no definitive lymph nodes. The adipose tissue is submitted in its entirety. Two representative frozen sections are taken and submitted as FSB1 and FSB2. A representative. section of the tumor is submitted to the Tissue Procurement Laboratory. Permanent representative. sections are submitted as: B3: Mirror image of tumor submitted to Tissue Bank. B4-B5: Tangential superior mesenteric artery margin of resection. B6-B7: Perpendicular pulmonary vein groove. B8-B9: Retroperitoneal surface. B10-B11: Tangential gastric margin of resection. B12: Tangential duodenal margin of resection. B13: Tumor showing its relationship to pancreatic duct. B14: Tumor showing its relationship to duodenum. B15-B16: Tumor showing its relationship to duodenum, common bile duct,. and ampulla of Vater. B17: Additional section of tumor. B18: Tumor showing its relationship to nearest radial margin of. resection. B19: Grossly unremarkable gastric mucosa. B20: Grossly unremarkable duodenum. B21: Gallbladder. B22-B24: Entire adipose tissue with attached pancreas. B25-B30: Entire adipose tissue attached at lesser curvature. B31-854: Entire adipose tissue attached to lesser curvature."
BIOCUP_00344,pancreas,PAAD,TCGA-IB-7645,TCGA-IB-7645.8a7e8a98-1835-4cc1-8c30-aa6bbbb1dcbc,"ORIGINAL REPORT. SPECIMEN: A. Periportal lymph node,. B. Gallbladder. c. Bile duct margin,. D. Pancreas margin. E. Superior mesenteric lymph nodes (fresh). F. Pancreas (Whipple's spec√≠men). G. Omentum. CLINICAL HISTORY?. Pancreatic cancer. DIAGNOSIS: A: #PERTPORTAL"" LYMPH NODE: REACTIVE LYMPH NODE WITH NO EVIDENCE OF MALIGNANCY. B: GALLBLADDER (CHOLECYSTEICTOMY) : NO EVIDENCE OF MALIGNANCY. C: BILE DUCT MARGIN: NO EVIDENCE OF MALIGNANCY OR DYSPLASIA. D: PANCREAS MARGIN: CHRONTO PANCREATITIS WITH EXTENSIVE FIBROSIS, NO EVIDENCE OF. MALIGNANCY. E: ""SUPERIOR MESENTERIC"" LYMPH NODE: REACTIVE LYMPH NODE. WITH NO BYIDENCE OF MALIGNANCY. F'= PANCREAS (WHIPPLE' SPECIMEN) : RANCREATIC ADENOCARCINO (PLEASE SEE PROGNOSTIC INDICES BELOW). G: OMENTUM (OMENTECTOMY): NO EVIDENCE OF MALIGNANCY. PROGNOSTIC INDICES. TUMOR. SITE: Head of pancreas/common bile duot. TOMOR TYPE: Ademocaroinoma. GRADE: Well pifferentiated. MAXIMUM SIZE: 4.6 CH. INVOLVEMENT OF ADJACENT STRUCTURES: Sima, 11 bowel wall, Ampulla of Vater,. periampullary tissues, peripancreatia address. Page 1 CONTINUED. Division Head: Inquiry Mumbera: DIAGNOSIS: LYMPEVASCULAR INVASION: Prezent. PERINTURAL INVASION: Present. SURGICAL RESECTION MARGINS: STOMACH: Negative. DUODENUM: Negative. PANCIREATIC: Negative. BIZE DUCT: Wegative. LYMPH NODES: # POSITIVE: 5. # EXAMINED. OTHER FINDINGS. Severe churonic panoreatitis, pataby dyaplasia along. pancreatio/common bile duct. GROSS DESCRIPTION: The specimen comes in in seven separate containers labelled with the patient's. A. The specimen is labelled periportal lymph node"", The specimen consists. of one piece of large tan firm lymphoid tissue which measures 8 em in largest. dimension. The specimen is submitted in toto in A. The specimen is labelled ""gallbladder"", consists of a gallbladder which. measures 12.0 x 5.0 cm. The gallbladder contains about 15 ml of dark green. bile with no stones identified. The serosal aurface of the gallbladder is. smooth. The gallbladder wall is slightly thickened and the mucoma is grossly. unremarkable. Representative sections of the gallbladder neck and the body is. submitted in B. C. The specimen consiste of one piece of tissue 3.0 cm in maximum dimension. Submitted in toto for Q8. The specimen is labelled ""duct margin"" and submitted for frozen section. Division Head: GROSE DESCRIPTION: D. The specimen consists of piece of tissue, 2.5 x 2.0 x 0.5 cm. Submitted in toto for QS. The specimen is submitted in toto for frozen section. E. The specimen is labelled ""superior mesenteric lymph node"" and consists of. one piece of lymphoid tissue which measures 1.0 cm in largest dimension. The. specimen is submitted in toto in K. B. The specimen is labeled ""pancreas, (Whipple's specimen) "". The specimen is. composed of the head of the pancreas, which measures 6.0 x 5.0 x 2.5 em with. attached lower segment of stomach, which measures 7.0 x 5.0 cm and duodenal. tiasue which measures 24.5 am in length and 4.5 cm in circumference. A tumor. mass measures 4.5 x 2.0 x 2.5 em is identified in the pancreas surrounding the. conmon bile duct. The tumor mase is poorly circumscribed and yellow/white in. color. There are areas of cystic formation and no area of hemorrhage or. neczosis in the tumor. The common bile duct is patent and the tumor has been. previously cut along the common bile duct. The tumor is in contact with. the. ampulla grossly, and is about 3.7 cm away from the bile duct resection. margin. The stomach and the upper segment of the duodenal mucoga is grossly. unremarkable. The mucosal surface of the lower 8.5 cru of the duodenum is. hemorrhagic in color. Representative sections of the specimen are submitted as follows: F1. is the enface pancreatic resection margin. F2, F3. tissue from uncinate pancreas. F4. bile duet resection margin. F5. stomach resection margin. F6. duodenal resaction margin. F7 to F9. serial section of the ampulla region. F10 to F19. perial section of the tumor along the common bile duct. (from close to ampulla to far from ampulla. tumor and small bowel. F21 and F22. tumor extending close to the serosal surface of pancreas. F23. random sections of the duodenum. F24 and F25. lymphoid tissue. F26. three lymph nodes. F27. one lymph node."
BIOCUP_00345,pancreas,PAAD,TCGA-Z5-AAPL,TCGA-Z5-AAPL.10A49855-26E8-47AB-B7A8-941737E26C1A,"Female. Clinical diagnosis: Pancreatic cancer. Gross description: Pancreas (body and tail) 3.5x 2x1.5 cm. Discovered tumor. mass in pancreas. Section reveals dense, grayish-white surface. Tumor infiltrated. pancreatic capsule and adjacent adipose tissue. Adjacent adipose tissue contains. 9 lymphatic nodes 2cm - 1cm in diameter. Soft, pink-gray appearance. Microscopic description: 1) Histology consistent with poorly differentiated ductal adenocarcinoma (G1),. infiltrating pancreas, adjacent adipose tissue with multiple nests of intra- and. extra-pancreatic invasion. 2) All 9 lymph nodes are negative. 3) Pancreas shows signs of chronic inflammation. Final diagnosis: Low grade pancreatic adenocarcinoma, ductal type, grade 1. Confidential."
BIOCUP_00346,pancreas,PAAD,TCGA-2J-AABO,TCGA-2J-AABO.947FC080-A75D-4D6B-9585-D5204266EF3F,"Surgery date: REVISED REPORT (Addendum/Procedure included). DIAGNOSIS: Site Pancreas head C25.0. A. Liver, right lobe, biopsy: Scant liver parenchyma with capsular. fibrosis. Rare cluster of atypical cells of uncertain significance. B. Lymph node, common hepatic, biopsy: Involved by metastatic. adenocarcinoma. C. Common hepatic duct, margin, excision: Negative for tumor. D. Pancreatic body, margin, excision: Intraductal papillary. mucinous neoplasm with high-grade dysplasia, present in the. pancreatic duct. No invasive carcinoma. E. Portal vein, adventitia, biopsy: Negative for tumor. F. Head pancreas, gallbladder, duodenum, common bile duct, portion. jejunum, Whipple resection: Invasive moderately differentiated. ductal adenocarcinoma on a background of extensive intraductal. papillary mucinous neoplasm with high-grade dysplasia, forming a. solid 4.6 x 2.3 x 2.0 cm mass located in the pancreatic head. The. tumor extends beyond pancreas to involve the peripancreatic soft. tissue. Perineural invasion is present. The uncinate margin tissue. shows metastic adenocarcinoma to a lymph node with soft tissue. extension. The tumor is 0.1 cm from the portal vein groove. The. patient has had no prior treatment. Multiple (7 of 15) regional. lymph nodes are involved by metastatic metastatic adenocarcinoma. The gallbladder shows mild chronic cholecystitis. G. Pancreatic body, new margin, excision: Negative for invasive. adenocarcinoma. Intraductal papillary mucinous neoplasm with. low-grade dysplasia. AJCC stage (with available surgical material): pT3N1 (7th edition). This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s). A revised report will be issued to document the final. interpretation after review of the Hematoxylin and Eosin (H&E). permanent sections. Interpreted by: ADDENDUM: Frozen section interpretation has been confirmed by Hematoxylin and. Eosin (H&E) permanent section review. GROSS DESCRIPTION: A. Received fresh labeled ""right lobe liver biopsy"" is a 1.2 X 0.3 X. 0.3 cm aggregate of tan-pink tissue. All submitted. Grossed by. B. Received fresh labeled ""common hepatic lymph node"" is a 1.7 x 1.2. x 0.3 cm lymph node. All submitted. Grossed by. C. Received fresh labeled ""common hepatic duct margin"" is a 1.5 x. 0.5 x 0.3 cm fragment of pink-tan soft tissue with orientation. Margin submitted. Grossed by. D. Received fresh labeled ""pancreatic body margin"" is a 3.0 x 2.0 x. 0.5 cm portion of pink-tan soft tissue with orientation. Margin. submitted. Grossed by. E. Received fresh labeled ""adventitia tissue portal vein"" is a 0.3 x. 0.1 x 0.1 cm fragment of pink tissue. All submitted. Grossed by. F. Received fresh labeled ""head pancreas, gallbladder, duodenum,. common bile duct, portion jejunum"" is a Whipple specimen consisting. of 34.0 cm in length portion of duodenum, 6.0 x 5.0 X 3.0 cm portion. of pancreas, 9.3 x 4.2 x 2.6 cm gallbladder. The pancreatic. uncinate margin is inked yellow and shaved, the portal vein groove. is inked black and submitted perpendicularly. There is a 4.6 X 2.3 x. 2.0 cm diffusely infiltrative mass within the pancreas, 0.1 cm from. the portal vein groove margin. The mass is confined to the. pancreas. The gallbladder contains no choleliths. Peripancreatic. lymph nodes and periduodenal lymph nodes are identified. Representative sections are submitted. Research tissue collected,. G. Received fresh labeled ""new pancreatic body margin"" is a 3.1 x. 2.0 x 0.7 cm portion of pancreatic tissue with orientation. All. submitted. Grossed by. BLOCK SUMMARY: Part A: Right lobe liver biopsy. 1 Rt lobe liver bx. Part B: Common hepatic lymph node. 1 Comm hepatic LN 1(B1). Part C: Common hepatic duct margin. 1 Comm hepatic duct margin. Part D: Pancreatic body margin. 1 Pancreatic body margin 1. 2 Pancreatic body margin 2. Part E: Adventitia tissue portal vein. 1 Advenitia tissue portal vein. Part F: Head pancrea, gallbladder, duodenum, common bile duct,. portion jejunum. 1 Uncinate margin 1. 2 Uncinate margin 1. 3 Uncinate margin 2. 4 Uncinate margin 2. 5 Ampulla. 6 Mass at uncinate. 7 Mass at pancreatic head. 8 Area between masses. 9 Gallbladder. 10 Peripancreatic LNs 6 (F1). 11 Peripancreatic LNs 4 (F2). 12 Peripancreatic LNs 3 (F3). 13 Peripancreatic LNs 2 (F4). 14 Peripancreatic LNs 2 (F5). 15 Peripancreatic LN 1 (F6). 16 Periduodenal LN 1 (F7). Part G: New pancreatic body margin. 1 New pancreatic margin 1. 2 New pancreatic margin 2."
BIOCUP_00347,pancreas,PAAD,TCGA-IB-7885,TCGA-IB-7885.29bb1247-7507-4c0d-984d-10956563c3e4,"Collected Date: Received Date/Time: Specimen Description. A. Gallbladder. B, Node of Importance. C. Whipple's specimen. Clinical Information. Cancer in the head of the pancreas with malignant-appearing structure of the common bile duct ns well as a double duot. sign. Diagnonie. A. Cholecystectomy: Chronic cholecystitis. B. Node Of. Importance: One-lymph node negative for carcinama (0/1). C. Pancreaticoduodertectomy (Whipple resection), Partial Pancreatectomy: Ductal adenocarc√≠noma-. Site: pancreatic head. Size: 2.4 cm. Grade 2. Tumor invades retropancreatic soft tissue. Margins uninvolved by Invasive carcinoma. Distance of invasive carcinoma from closest margin: 0.5 mm. (nonperitonealized retropanereaticluncinate margin). Lymph-vascular invasion Identified. annual Datholony Renart. Collected Date: Qaraived Date/Time: Pathologiat: Perineural invasion identified. Three out of 12 lymph nodes directly Invaded by tumor (3/12). Pancreatic intraepithelial neoplasia (PanIN-2). Chronic pancreatitis. Gross Description. Received are specimens A to C. All requisitions and specimen containers are tabelled with the patient's name. The cassettes and AP idantifiers are labelled with the Surgical Number. A. Gallbladden meesuring 9.5 x 4.5 x 1.6 cm. The cystic duct is short. The gallbladder is closed. After opaning, It Is filled. with green bile and no calculus. The wall thickness Is 3 mm. The mucosa is smooth with yellow surfece. The serocal. surface is smooth. There is bilar lymph node Identified, Representativa sections submitted In A1,. B. Node of importance. Ohe lymph node 2.6 cm In diameter, bisected in B1 and B2. C, Devitalization time starts at. The specimen consists of a duodenum. measuring 19.0 cm In length and 5.0 to 6,0 cm in circumierence, There is a portion of gastric tissue 2,5 em in tength. The. common bile duct measures 5,3 cm In length and 1.6 cm In clrcumference. At 1.7 cm distal from the ampulla of Vater,. there Is stenosis of the common bile duct. The pancreas measures 5.0 x 2,5 x 2,0 cm, The nonperitonealized uncinate. inked margin is inked in blue, There is a second minor duadenal papilla in addition to the major duodenal papilla. within. the head of the pancreas, there Is a not well-demarcated tumor measuring 2.4 x 2,0 cm, The tumor shows some cystic. areas toward-the minor duodenal papilla, and is otherwise solid yellow/white and seems to approach the retropancreatic. margin grosslyiquite closaly. 01 common bile duct margin. C2 proximal gastric margin. AWD. Chenical Patholoay Report. Collected Date: Received Date/Time: C3 distal intestinal margin. C4 minor duodenal papilla. C6-C10 ampulia of Vater perpendicular sections. C11 en-face transverse section below C6-C10. C12-013 tumor in relation to conmon bile duct. 014C17 tumor in relation to nonpertonealized uncinate Inked margin. 018 pancreatic parenchyma margin. 018 lymph nodes. C20 one lymph node bisected. 021 further pancreatic parenchyma from the head. C:22 further ? lymph node. MKO/ct. Due to an unexplained technical problem. no synoptic report could be assessed."
BIOCUP_00348,pancreas,PAAD,TCGA-S4-A8RM,TCGA-S4-A8RM.4D1E4F48-60FC-4982-AF71-81859F14ABB4,"Gender: Male. Race: White. FINAL PATHOLOGIC DIAGNOSIS. Pancreaticoduodenectomy and splenectomy;. A. Liver segment: - Hyalinized granuloma, no tumor. B. Duodenal mass: - Benign mesothelial cyst. C. Gallbladder: - Gallbladder without diagnostic abnormality. D. Bile duct stent: - Surgical hardware, consistent with stent. E. Pancreatectomy: - Invasive ductal adenocarcinoma (foamy gland type), arising from a. brand-duct intraductal papillary mucinous neoplasm (BD-IPMN). See pathologic. parameters. - One of nine lymph nodes positive for metastatic carcinoma (1/9). F. Splenectomy: - Spleen without diagnostic abnormality. G. Gastric staple line: - Portion of stomach, no tumor. H. Omentum: - Vascularized fibroadipose tissue, no tumor. PANCREAS (EXOCRINE): Resection. Tumor Size. Greatest dimension: 6 cm. Additional dimensions: 3 x 2.7 cm. Histologic Type (select all that apply). Ductal adenocarcinoma. Intraductal papillary-mucinous carcinoma (BD-IPMN). Invasive. Histologic Grade (ductal carcinoma only). G3: Poorly differentiated. Margins (select all that apply). Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1 mm. Specify margin (if possible): Uncinate. Treatment Effect (applicable to carcinomas treated with neoadjuvant therapy). (select all that apply). No prior treatment. Lymph-Vascular Invasion. Present. Perineural Invasion. Present. Pathologic Staging (pTNM): pT3, N1, MX. Primary Tumor (pT). pT3: Tumor extends beyond the pancreas but without involvement of the. celiac axis or. the superior mesenteric artery. Regional Lymph Nodes (pN). pN1: Regional lymph node metastasis. Specify: Number examined: 9. Number involved: 1. Distant Metastasis (pM). Not applicable. Effective January I, 2010 this Checklist utilizes the 7th edition TNM staging. system for pancreas exocrine of the American Joint Committee on Cancer (AJCC). and the International Union Against Cancer (UICC). Comment. The tumor invades into the duodenal wall, the serosal side of the adhesed. gastric wall. A cystic lesion (slide E15) exhibits features of a branch duct-. intraductal papillary mucinous neoplasm. Therefore, the invasive carcinoma is. interpreted as arising from the IPMN. , M.D. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow, , MD. M.D. Clinical History: The patient is a. -year-old male with pancreatic cancer who undergoes Whipple. procedure. Specimens Received: A: Liver segment. B: Duodenal mass. C: Gallbladder. D: Bile duct stent. E: Pancreatectomy. F: Spleenectomy. G: Gastric staple line. H: Omentum. Gross Description: The specimens are received in eight containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""1. Liver segment"". Received fresh for intraoperative diagnosis is a red black irregular soft tissue. fragment measuring 0.9 X 0.7 x 0.1 cm which is entirely frozen. The diagnosis is. ""scar, no tumor"" as read by Dr. . The entire specimen is submitted ir A1 FS. B. The second container is additionally identified as, ""2. Duodenal mass"". Received fresh for intraoperative diagnosis is a tan-yellow soft tissue fragment. measuring 0.4 x 0.2 x 0.1 cm which is entirely frozen. The diagnosis is ""cyst,. benign"" as read by Dr. . The entire specimen is submitted as B1 FS. C. The third container is additionally identified as, ""3. Gallbladder"". Received fresh in a laparoscopic bag is a 7.5 x 3.8 X 2.8 cm gallbladder. The. serosa is tan-pink, glistening and cauterized along the hepatic attachment. The. specimen is opened adjacent to the bile duct revealing green-tan, velvety mucosa. with diffuse gold speckling. The mucosal wall thickness is 0.2 cm. The opened. specimen reveals multiple yellow, friable stones measuring from 0.3-0.5 cm in. greatest dimension. Grossly, the stones do not obstruct the bile duct. There is. 3 ml of viscous brown bile. Representative sections of the fundus, body, and. bile duct margin are submitted in cassetie C1. D. The fourth container is additionally identified as, ""4. Bile duct stent"". Received is a 6.5 cm in length by 0.8 cm in diameter gray wire metal stent which. is intact. A photograph is taken. This is a gross description only. E. The fifth container is additionally identified as, ""5. Pancreaticoduodenectomy including total pancreatectomy"". Received fresh and. placed in formalin is a Whipple specimen that consists of a 14 cm in length. segment of duodenum with an internal circumference of 7 cm, 7.5 x 5.5 x 1.5 cm. segment of distal stomach, and 13 x 4.5 by 4 cm portion of pancreas. The. uncinate margin is inked black, the portal vein groove margin is inked blue, and. the posterior margin is inked red. The margins are trimmed, serially sectioned. and submitted. The common bile duct is dilated at the resection margin with a. diameter of 0.7 cm. Serial sectioning of the pancreas reveals a 6 x 3 X 2.7 cm. firm, white, well-circumscribed mass with focally cystic areas and is located in. the tail of the pancreas. The mass is almost entirely replaces the pancreas. The. mass is less than 0.1 cm from the uncinate margin, less than 0.1 cm to the. portal vein groove margin, and 0.3 cm from the posterior margin. The mass. entirely obliterates the pancreatic duct and encases the common bile duct,. extending to involve the ampulla of Vater. The mass does not grossly invade the. duodenum and stomach wall. The remaining pancreatic parenchyma is yellow-tan,. rubbery and lobulated. In the pancreatic tail, the mass encases the splenic vein. and artery. The stomach and duodenum reveal grossly unremarkable, tan mucosa. with a uniform 0.4 cm wall thickness. The peripancreatic adipose tissue is. extensively dissected to reveal one pink-gray fibrofatty lymph node measuring up. to 2.3 cm in greatest dimension. Block summary: E1: Bile duct margin. E2: Portal vein groove margin. E3-E4: Uncinate margin. E5-E7: Posterior margin. E8: Stomach margin. E9: Duodenal margin. E10: Mass in relation to ampulla of Vater. E11: Mass in relation to common bile duct. E12: Mass in relation to stomach. E13: Mass in relation to duodenum. E14: Mass, pancreatic tail, encasing splenic artery and vein. E15-17: Mass, pancreatic tail, cystic areas. E18: Mass in relation to stomach and uninvolved pancreas. E19-21: Additional sections of mass. E22: One lymph node, bisected. E23-E30: Peripancreatic adipose tissue. F. The sixth container is additionally identified as, ""6. Splenectomy"". Received fresh is a 408.8 gm spleen measuring 14.5 x 9.5 X 5.5 cm with attached. yellow lobulated adipose tissue measuring 12.5 x 12 X 3 cm. The outer capsule is. smooth, purple-gray and glistening. The spleen is serially sectioned to reveal. soft, red-brown, homogenous cut surface with no masses or lesions. The. fibroadipose tissue is extensively dissected for lymph nodes; none are found. No. nodules are lesions are present in the fibroadipose tissue. Representative. sections are submitted as follows: F1-F2: Spleen. F3-F4: Fibroadipose tissue. G. The seventh container is additionally identified as, ""7. Gastric staple. line"". Received fresh and placed in formalin is a fragment of tan soft tissue. measuring 5.5 x 0.8 x 0.8 cm. A staple line is present measuring 5 cm. The. staple line is removed and the remaining soft tissue is submitted in cassette. G1-G2. H. The eighth container is additionally identified as, ""8. Omentum"". Received. fresh in place in formalin are multiple fragments of yellow, lobulated. fibroadipose tissue weighing 546.7 g. The specimen is extensively dissected; no. nodules, lesions, or lymph nodes are identified. A representative section of the. specimen is submitted in cassette H1. , M.D."
BIOCUP_00349,pancreas,PAAD,TCGA-RL-AAAS,TCGA-RL-AAAS.60731A10-B15C-49EC-96D5-05B0E023C053,"ADDENDUM MICROSCOPIC DESCRIPTION: Deeper levels and additional histologic sections are reviewed. As stated in the original. report, this pancreas is involved by ductal adenocarcinoma. The neoplasm shows. discontiuous spread and appears to arise from a background of high grade pancreatic. ductal dysplasia, with tumor surrounding dilated ductal elements (4H and 41). There is. periampullary involvement (4F). The lack of continuity between foci makes evaluation. of tumor size difficult, but it appears greater than 2 cm overall. Perineural tumor is. present. There are multiple peripheral foci consistent with atrophic change, some. associated with inflammation. The designated surgical margins (1-3) are negative for. diagnostic dysplasia or malignancy. The permanent sections of the bile duct (4G),. taken from the Whipple specimen, show foci of glandular dysplasia in a background of. inflammation (particularly in the deeper levels). There is no involvement by carcinoma,. however. The true margin was submitted at the time of surgery (specimen #1) and is. negative. All examined lymph nodes are negative for diagnostic metastatic disease. ADDENDUM DIAGNOSIS: 1. Bile duct margin, biopsy: - Negative for diagnostic high grade dysplasia or malignancy. 2. Pancreatic neck margin, biopsy: - Negative for diagnostic high grade dysplasia or malignancy. 3. Pancreatic uncinate margin, biopsy: - Negative for diagnostic high grade dysplasia or malignancy; atrophy. 4. Pancreas, distal stomach and proximal small bowel, Whipple resection: Ductal adenocarcinoma of pancreas, moderately differentiated. - Resection margins negative (see above discussion). - Seventeen (17) peripancreatic lymph nodes, NEGATIVE for metastatic. carcinoma. 5. Stent (gross only): - Plastic tubing, consistent with stent. 6. Lymph nodes, celiac, regional resection: Two (2) lymph nodes, NEGATIVE for metastatic carcinoma. 7. Lymph node, portal, biopsy: - One (1) lymph node, NEGATIVE for metastatic carcinoma. Carcinoma of Pancreas Summary. Specimen: Head of pancreas, distal stomach, proximal small bowel,. common bile duct. Procedure: Pancreaticoduodenectomy (Whipple resection), partial. pancreatectomy. Tumor site: Pancreatic head. Tumor size: Cannot be determined, greater than 2 cm by gross. examination. Histologic type: Ductal adenocarcinoma. Histologic grade: Moderately differentiated, grade 2. Microscopic tumor extension: Tumor within pancreas (prominent. around pancreatic duct) and involves. periampullary region. Margins: Margins uninvolved by invasive carcinoma (see discussion. of bile duct above). Treatment effect: N/A. Lymphovascular invasion: Not identified. Lymph nodes: Twenty (20) lymph nodes, negative for metastatic. malignancy - see above. Perineural invasion: Present. Pathologic staging: pT2, pNO (AJCC/UICC TNM 7th edition). Additional pathologic findings: Pancreatic intraepithelial neoplasia,. PanIN-3. Clinical Information. Pre-op diagnosis: Pancreatic mass. Procedure: Whipple. Post-op diagnosis: Pancreatic mass. Clinical History: Pancreatic mass. Specimen Submitted. 1. Bile duct margin. 2. Pancreatic neck margin. 3. Uncinate margin. 4. Whipple. 5. Stent. 6. Celiac lymph node. 7. Portal lymph nodes. Gross Description. 1. Received fresh for frozen section, labeled with the patient's name and ""bile duct. margin"", is an irregular and unoriented portion of tan-pink soft tissue measure 1.2 X 1.0. X 0.5 cm. The entire specimen is frozen as F1A. Frozen section diagnosis: Negative for malignancy. The tissue block is subsequently submitted for permanent sectioning. 2. Received fresh for frozen section, labeled with the patient's name and ""pancreatic. neck margin"", is an irregular and unoriented portion of tan-pink soft tissue measuring. 1.0 X 0.5 X 0.4 cm. The entire specimen is frozen as F2A. Frozen section diagnosis: Margin negative. The tissue block is subsequently submitted for permanent sectioning. 3. Received fresh for frozen section, labeled with the patient's name and ""uncinate. margin"", is an irregular and unoriented portion of tan-pink soft tissue measuring 1.0 X. 1.0 X 0.5 cm. The entire specimen is frozen as F3A. Frozen section diagnosis: Negative for neoplasm. The tissue block is subsequently submitted for permanent sectioning. 4. Received in formalin, labeled with the patient's name and ""Whipple"", is a Whipple. resection specimen including distal stomach, duodenum, pancreas and common bile. duct stump. The distal stomach measures 6.0 cm in length, 4.5 cm in greatest diameter. and 0.6 cm in wall thickness. The small bowel measures 103 cm in length, 3.5 cm in. greatest diameter and 0.4 cm in wall thickness. The pancreas measures 7.0 X 6.5 X 4.5. cm. The common bile duct stump measures 2.5 cm in length and 0.6 cm in diameter at. the margin. The distal pancreatic margin is inked blue, the posterior peri-pancreatic soft. tissue is inked black and the anterior peri-pancreatic soft tissue is inked green. The. gastric and duodenal mucosa shows a tan-pink and velvety mucosa with appropriate. folds. Sectioning the pancreas demonstrates an ill-defined fibrotic area with an irregular. tan-white to yellow cut surface surrounding the pancreatic duct measuring 2.3 X 1.5 X. 1.5 cm. The uninvolved pancreas is firm and lobular. Multiple lymph nodes are. identified in the peripancreatic soft tissue, ranging in greatest dimension from 0.3-1.2. cm. Representative sections are submitted as follows: 4A) Distal pancreatic resection margin. 4B) Retroperitoneal pancreatic margin. 4C) Proximal gastric margin. 4D) Distal duodenal margin. 4E-F) Ampulla of Vater. 4G) Common bile duct margin. 4H-L) Pancreatic mass. 4M) Uninvolved pancreas. 4N-O) Anterior peripancreatic soft tissue and lymph nodes. 4P-R) Posterior peripancreatic soft tissue and lymph nodes. 4S) Additional pancreatic mass. 4T) Additional posterior peripancreatic soft tissue and lymph nodes. 4U) Additional anterior peripancreatic soft tissue and lymph nodes. 5. Received fresh, labeled with the patient's name and ""stent, gross only"", is a segment. of fenestrated blue plastic tubing with a length of 9.0 cm and a diameter of 0.3 cm. There are no identifying marks on the specimen. The specimen is submitted for gross. diagnosis only. 6. Received in formalin, labeled with the patient's name and ""celiac lymph nodes"", are. multiple irregular fragments of tan-pink to yellow fibrofatty soft tissue, aggregating to 3.0. X 2.7 X 1.0 cm. Two possible lymph nodes are identified, ranging in greatest dimension. from 1.3-2.0 cm. The entire specimen is submitted as follows: 6A) Single bisected lymph node. 6B) Single lymph node. 6C) Fibrofatty soft tissue. 7. Received in formalin, labeled with the patient's name and ""portal lymph nodes"", is an. irregular portion of tan-pink soft tissue measuring 1.5 X 1.2 X 0.7 cm. Bisecting the. specimen reveals this to be a single lymph node. The entire bisected lymph node is. submitted in cassette 7A. Microscopic Description. 1. Sections of bile duct demonstrate a bland mucosal lining. No diagnostic dysplasia or. malignancy is identified. 2. Sections of pancreas are negative for malignancy. 3. Sections of pancreas demonstrate a lobular architecture with focal fibrosis/atrophy. and chronic inflammation. There is no diagnostic dysplasia or malignancy. 4. Section of the pancreas demonstrate a well-differentiated ductal adenocarcinoma. surrounding a dilated duct. The neoplastic glands are angulated and lined by cells with. nuclei that are enlarged and bear prominent nuclei. Scattered mitotic figures are seen. No lymphovascular invasion is noted. The tumor focally encroaches upon nerve. bundles (deeper levels pending). There are foci of background chronic. pancreatitis/atrophy. Seventeen (17) peripancreatic lymph nodes are negative for. metastatic carcinoma. There are zones of fibroblastic elements/reactive change,. consistent with prior biopsy site. Additional sections of the ampullary region, as well as. deeper levels of tumor, are pending. 5. Gross diagnosis only. 6. Sections demonstrate two lymph nodes, which are negative for metastatic. carcinoma. 7. Sections demonstrate a single lymph node, which is negative for metastatic. carcinoma. DIAGNOSIS. (Provisional). 1. Bile duct margin, biopsy: - Negative for diagnostic dysplasia or malignancy. 2. Pancreatic neck margin, biopsy: - Negative for diagnostic dysplasia or malignancy. 3. Pancreatic uncinate margin, biopsy: - Negative for diagnostic dysplasia or malignancy. 4. Pancreas, distal stomach and proximal small bowel, Whipple resection: - Ductal adenocarcinoma of pancreas, well to moderately differentiated. - Resection margins negative. - Seventeen (17) peripancreatic lymph nodes, NEGATIVE for metastatic. carcinoma. Pending additional studies. 5. Stent (gross only): - Plastic tubing, consistent with stent. 6. Lymph nodes, celiac, regional resection: - Two (2) lymph nodes, NEGATIVE for metastatic carcinoma. 7. Lymph node, portal, biopsy: - One (1) lymph node, NEGATIVE for metastatic carcinoma."
BIOCUP_00350,pancreas,PAAD,TCGA-HZ-A77P,TCGA-HZ-A77P.71CF594D-2A24-4B98-AF3F-1D97DF421433,"Gender: M. Provider Group : Date of Service: Date Received: A copy of this report will be faxed to: FINAL SURGICAL PATHOLOGY REPORT Adenoracinone) NOS. Diagnosis: A. GALLBLADDER, CHOLECYSTECTOMY: - MILD CHRONIC CHOLECYSTITIS,. - ONE REACTIVE LYMPH NODE, NO TUMOR SEEN (0/1). B. LYMPH NODE, BILE DUCT, EXCISION: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). C. STOMACH, DUODENUM, PANCREAS, WHIPPLE PROCEDURE: - ADENOCARCINOMA, WELL DIFFERENTIATED. - TUMOR SIZE 3.1 CM. TUMOR INVADES TO PERIPANCREATIC SOFT TISSUE AND INTO. MUSCULARIS PROPRIA OF DUODENUM. - SURGICAL MARGINS NEGATIVE. ONE OF TWENTY LYMPH NODES POSITIVE FOR METASTATIC. CARCINOMA (1/20). - LYMPHOVASCULAR INVASION PRESENT. PATHOLOGIC TUMOR STAGING SYNOPSIS (PANCREAS): Type and grade: Adenocarcinoma, well differentiated. Primary tumor: pT3. Regional lymph node: pN1. Distant metastasis: N/A. Pathologic stage: IIB. Lymphovascular invasion: Present. Margin status: R0, negative. Tumor Staging Information. Data derived from current specimen. Staging in accordance with or modified from AJCC Cancer Staging. FINAL SURGICAL PATHOLOGY REPORT. Handbook, 7th Ed, and CAP protocol, June 2012. Specimen: Stomach, duodenum, pancreas. Procedure: Whipple excision. Tumor site: Head of pancreas. Tumor size: 3.1 cm. Histologic type: Adenocarcinoma,. Histologic grade: G1, well differentiated. Microscopic tumor extension: Tumor extends to peripancreatic soft ussue and. muscularis propria of duodenum. MARGINS: R0, negative, closest margin deep at 0,5 cm, common. bile duct and pancreatic margin >2 cm. Treatment effect: N/A. Lymphovascular invasion: Present. Perineural invasion: Not identified. LYMPH NODES;. One of twenty lymph nodes positive for carcinoma. (1/20). PATHOLOGIC TUMOR STAGING: Primary tumor: Regiona lymph node: pN1. Distant metastasis: N/A. Pathologic stage: IIB. Source of Specimen: A. Gallbladder. B. Lymph node;Common bile duct lymph node. C. Whipple. Clinical History/Operative Dx: Malignant neoplasm of pancreas. Intraoperative Diagnosis: Pancreatic margin - no tumor seen; bile duct - no bile duct tissue identified in frozen. section. The intraoperative interpretation(s) was/were performed and rendered at. Gross Description: A. Part A designated gallbladder. Received in formalin is a previously disrupted, deflated gallbladder, 7.8. x 3.2x 1.2 cm. The serosa is glistening, fatty pink and tan. There are two paracystic duct lymph node. candidates are 0.3 and 0.4 cm each. The cystic duct margin demonstrates a narrow 1 mm lumen, difficult. to probe for patency, however, upon sectioning does not appear obstructed. The lumen contains a. residual amount of viscous dark green bile without calculi; no calcull are present within the container. The. mucosa is velvety, dark green with few raised yellow flecks without grossly unusual areas of change. suggestive of neoplasia. Representative sections are submitted for microscopic evaluation, including. representation of the cystic duct margin (orange), lymph node, mid fundus and dome of fundus in A1. B. Part 8 designated common bile duct lymph node. Received In formalin is a rubbery pink and tan lymph. node candidate measuring 1.1 x 0.6 x 0,5 cm. The lymph node and surrounding fat is now bisected and. submitted together in B1. This report continues (FINAL). Printed: C. Part C designated Whipple procedure. Initially received in a fresh state for frozen section analysis is a. generous portion of tissue, consistent with a Whipple procedure specimen. Il consists of a distal portion of. the antrum of the stomach, 12.0 cm along the greater curvature and 7.8 cm on the lesser, and up to 7.0. cm in diameter at the proximal surgical margin of resection; the small bowel is 21.0 cm in length with an. average diameter of 2.5 cm and up to 3.1 cm at the proximity of the pancreatic head; the pancreas. includes the head and portion of the body 5.7 cm in length, 5.0 cm Inferior-superlor, 4.2 cm. anterior-posterior. The common bile duct is obscurred by peripancreatic fat, and extends out to 1.8 cm, is. markedly narrow, 0.35 cm diameter. The CBD probe patent to a depth of 2.5 cm. FINAL SURGICAL PATHOLOGY REPORT. The gastric and small bowel is now opened, and examination of the small bowel demonstrates prominent,. semi-congested pink and tan circular plica, with the apparent ampulla of Vater oriented 6,4 cm distal to. the pylorus, and Is obscured by a ralsed, dusky red lesion measuring 1.3 x 0.8 cm. The AV through the. pancreatic duct is probe patent. Several attempts to probe the AV with the common bile duct is. unsuccessful. The CBD and distal pancreatic margin are submitted for frozen section analysis, the residual. frozen tissue submilled en face for permanent sections. The pancreas is initially bisected through the. ampulla of Vater. towards the distal margin, revealing a poorly demarcated, dense, pink-gray tumor mass. measuring upwards of 3.1 x 3.0 x 2.2 cm, and grossly approaching within 2.8 cm of the distal margin of. the pancreas, and 2.8 cm from the common bile duct margin and grossly approaching within 0.5 cm of the. pancreatic notch/adventitlal margin. The length of the common bile duct is opened, revealing a light pink. and tan mucosa that is roughly kinked within the head of the pancreas, and routes parallel to the. pancreatic duct and inserts 0.3 cm from the pancreatic duct into the ""ampulia of Vater"". The tumor mass. approaches wilhin 0.5 cm of the edge of the CBD. The tumor is primarily oriented within the head of the. pancreas with discrete contiguous relationship with the ampulla of Vater. In addition, 2.0 cm proximal to the ampulla of Vater, the small bowel demonstrates a distincily raised,. granular area of density, that upon sectioning reveals evidence of an accessory duct with associated. firmness suspicious for tumor (C7-C8). The area appears to grossly approach within 0.5 cm of the superior. edge of the radial surface. 1.0 cm of the posterior surface. 0.3 cm of the Inferior surface, and 0.7 cm of the. anterior surface. The surrounding pancreatic parenchyma is admixed fatly and glandular, pink and tan. No additional tesions are appreciated along the small bowel length, however, the pyloric ridge. demonstrates raised granular changes. The gastric mucosa is wrinkled, erythematous light pink and tan,. however, abruptly transitions to severely congested, deep red-brown throughout the proximal two-thirds of. the gastric antrum. No additional lesions appreciated. Initial examination of the peripancreatic fat reveals twenty additional lymph nodes ranging from 0.2 cm. 1.4 x 0.8 x 0.8 cm each. Examination of the lesser and greater gastric fat does not reveal gross lymph. node content. The lymph nodes are entirely submitted for microscopic evaluation, with the specimen. retained in. solution to enhance future lymph node, identification if Indicated. Cassette summary: C1) distal pancreatic surgical margin, FS,. C2) CBD margin, FS,. C3) additional CBD distal end,. C4) CBD and adjacent tumor relationship,. C5-C8) AV lesion. parallel CBD and pancreatic duct insertion relationship,. C7-C8) duodenal lesion, possible fused accessory duct - head of pancreas,. C9) tumor and pancreatic notch/adventitial margin relationship, possible lymph node,. C10) additional pancreatic notch margin, two pieces,. C11) pancreatic tumor, superior edge,. C12) tumor, posterior edge, including two lymph nodes,. C13) anterior pancreas, lengthwise sectloned, including distal edge of pancreatic duct, former margin. shaved for frozen section,. Printed: This report continues. FINAL SURGICAL PATHOLOGY REPORT. C14) inferior pancreas,. C15) most distal uncinate,. C16) proximal gastric margin of resection, anterior and posterior,. C17) distal smail bowel margin of resection, trimmed and submitted,. C18) gastric tissue, including pylorus,. C19) pylorus and distal length of smail bowel,. C20) small lymph nodes,. C21) six lymph nodes,. C22) single lymph node,. C23) two lymph nodes bisected, one marked orange,. C24) two lymph nodes bisected, one marked green,. C25) single lymph node bisected,. C26) single lymph node bisected,. C27) single lymph node trisected,. C28) largest lymph node trisected,. C29) peripancreatic fat possible lymph node or tumor content, adjacent ink surfaces, four pleces. Microscopic Description: A. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. B. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. C. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. An intradepartmental consultation with. was obtained. - Page 4. 1."
BIOCUP_00351,pancreas,PAAD,TCGA-HZ-7918,TCGA-HZ-7918.66cc897f-570a-4f7d-b134-71ad8066d40e,"GROSS AND MICROSCOPIC SURGICAL PANEL. Specimen Information. SURGICAL PANEL: LAB: DIAGNOSIS. A) LEFT HEPATIC LIGAMENT, BIOPSY: 1. Benign simple cyst. 2. Background hepatic parenchyma is benign. 3. Negative for malignancy. B) LYMPH NODE, HEPATIC ARTERY, BIOPSY: 1. One (1) benign lymph node is identified. 2. Negative for malignancy. C) GALLBLADDER, CHOLECYSTECTOMY: 1. Unremarkable gallbladder. 2. Negative for malignancy. 3. A single (1) cystic duct lymph node is identified and is negative or. malignancy. D) PANCREAS, PROXIMAL PARTIAL PANCREATECTOMY WITH TOTAL DUODENECTOMY AND. ANASTOMOSIS (STANDARD WHIPPLE RESECTION): 1. Poorly differentiated adenocarcinoma, characterized by: a. Tumor size: 5.5 X 5 X 3.2 cm. b. Tumor location: Pancreatic head. C. Tumor extent: Extensive infiltration of the pancreatic parenchyma. with extension into the peripancreatic adipose tissue. 2. Extensive angiolymphatic space invasion and perineural invasion. identified. 3. Adenocarcinoma extends to involve the portal vein groove and portal. vein margin (small fragment identified); remaining margins are. negative- though the tumor comes to within 0.1 cm on the uncinate. margin. 4. Metastatic adenocarcinoma is identified in multiple (11 of 21). peripancreatic lymph nodes. a. Extracapsular extension is identified. b. The largest metastatic focus is 1.5 cm in greatest dimension. 5. See staging summary. E) PORTAL VEIN, SEGMENTAL RE-EXCISION: 1. Portion of portal vein identified. 2. Negative for malignancy. PANCREATIC CANCER STAGING PARAMETERS. Final TNM: p T3N1M0. stage: IIB. MACROSCOPIC. SPECIMEN TYPE. Whipple, Standard. TUMOR SITE. Pancreatic head. TUMOR SIZE. 5.5 X5X3.2cm. MICROSCOPIC. HISTOLOGIC TYPE. Ductal Adenocarcinoma. HISTOLOGIC GRADE. G3: (poorly differentiated) of G4. MARGINS - PANCREATICODUODECTOMY. Negative for invasive carcinoma, following re-excision of portal. vein segment (specimen E). Location(s): Portal vein groove and portal vein (from main. specimen, part D). Margin(s) evaluated: Bile duct, Distal pancreatic, Pancreatic. retroperitoneal (uncinate). LYMPHATIC/VASCULAR INVASION. Present: Lymph-vascular invasion present/Identified. PERINEURAL INVASION. Present. PATHOLOGIC STAGING. EXTENT OF INVASION. pT3. (Tumor extends beyond the pancreas but without involvement of. the celiac axis or the superior mesenteric artery). REGIONAL LYMPH NODES. pN1. (Regional lymph node metastasis). Total nodes: 21. Total positive nodes: 11. DISTANT METASTASIS. pM0. (No distant metastasis). PATHOLOGIC STAGE SUMMARY. Final TNM: pT3N1M0. stage: IIB. The pathologic stage presumes no distant metastasis. Attending Pathologist: CLINICAL INFORMATION. A. vear-old male patient with pancreatic adenocarcinoma. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Left hepatic ligament. Received fresh labeled ""left hepatic ligament"" is a 0.8 X 0.6 X 0.4 cm. clear fluid-filled, smooth-walled translucent cyst. The cyst is bisected. and entirely submitted on one chuck for frozen section diagnosis. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Benign cyst"" is. rendered by. B) SOURCE: Hepatic artery lymph node. The specimen is received fresh labeled ""hepatic artery lymph node."". It. consists of a 2.3 x 2 X 1.1 cm tan-red lymph node. It is serially sectioned. and has a tan-red cut surface. It is entirely submitted for frozen on three. blocks. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""One (1) benign. lymph node (0/1)"" is rendered by. C) SOURCE: Gallbladder. Labeled ""gallbladder"" is a purple-tan smooth surfaced 11 X 4 X 4 cm. gallbladder. The serosal surface is smooth and glistening. The cystic duct. is identified with a 0.3 cm luminal diameter. A 0.5 cm cystic duct lymph. node is also seen. The specimen is opened revealing approximately 20 ml of. thin green-brown bile. There are no calculi grossly identified. The mucosa. is. orange-green and velvety. The average wall thickness is 0.2 cm. Multiple. representative sections of gallbladder wall, en face cystic duct margin and. cystic duct lymph node are submitted in a single cassette. D) SOURCE: Whipple. Received fresh labeled ""Whipple"" is a Whipple specimen which includes a 12. X 7 X 2.5 cm portion of stomach, 28 cm in length and averaging 3 cm in. diameter segment of duodenum and a 9 X 6 X 4.5 cm portion of pancreas. The. specimen is received inked in the usual fashion. The common bile duct is. identified, displaying it to be dilated to 1.5 cm. It is taken en face and. submitted on chuck #1. The distal pancreatic margin is taken en face and. submitted on chuck #2. At the portal vein bed is an area of orange ink. indicated by the surgeon as being an area of portal vein. This area is. taken perpendicular and submitted on chuck #3. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Common bile. duct margin negative for carcinoma. Distal pancreas en face margin. negative. Portal vein groove and veins show involvement hv poorly. differentiated adenocarcinoma"" is rendered by. The common bile duct has a pigtail stent in place and is probe patent. It. is opened revealing it to be slightly granular and focally stenosed to 0.5. cm. The pancreatic duct cannot be probed. The specimen is sectioned. revealing a firm white tumor mass encompassing the majority of the pancreas. measuring 5.5 X 5 X 3.2 cm. It extends to the portal vein bed, 0.1 cm from. the distal pancreatic margin, 0.5 cm from the uncinate margin, 0.5 cm from. the retroperitoneal margin. The tumor mass pushes the mucosa of the. duodenum but does not extend through it. It has obliterated the pancreatic. duct. There is a small area of normal-appearing pancreatic parenchyma in. the proximal portion of the specimen. The ampulla is granular but. otherwise unremarkable. The stomach and duodenum mucosa are unremarkable and display no lesions. Note: Tissue is taken for possible ancillary studies. Photographs are taken. The pancreatic fat is searched revealing 13 tan-pink lymph nodes, some of. which are found in the parenchyma. They range from 0.5-2.6 cm in greatest. dimension. The gastric fat is searched revealing no lymph nodes. Sections of the p√°ncreas are submitted from distal to proximal. Representative sections are submitted in 27 cassettes labeled: DFS1. Frozen section, common bile duct. DFS2. Frozen section, distal pancreatic margin. DFS3. Frozen section, portal vein bed with portal vein. 4. Proximal gastric margin. 5. Distal duodenal margin. 6. Random normal gastric and duodenal mucosa, unremarkable. 7,8. Uncinate with retroperitoneum and portal vein bed margin. 9. Distal tumor with adjacent lymph node. 10-14. Representative tumor with common bile duct from distal to. proximal with adjacent normal pancreas. 15. Deep tumor serosa and possible lymph node. 16. Three pancreatic lymph nodes, one bisected, inked blue. 17. One lymph node. 18. Two lymph nodes. 19. One lymph node. 20. Two lymph nodes, each bisected, one inked blue. 21-23. Remainder of pancreatic fat. 24,25. Representative gastric fat. 26. Largest pancreatic lymph node, greatest dimension of tumor,. representative. 27. One pancreatic lymph node bisected. E) SOURCE: Vein segment, portal. Labeled ""portal vein stitch on area of importance"" consists of a wrinkled. unoriented segment of apparent vasculature that has been previously opened. There are sutures on the outer aspect. The outer aspect with suture of area. of importance is inked orange. The specimen is sectioned transversely and. entirely submitted in a single cassette. This case is accessioned in. MICROSCOPIC. A-E) The microscopic appearance substantiates the diagnosis. Dictation by: Interpreted at. ACCESSIONED. Lab and Collection. Result History. Result Date and Time. Provider Status."
BIOCUP_00352,pancreas,PAAD,TCGA-IB-A6UG,TCGA-IB-A6UG.E1FA7F32-07A8-435B-BA17-133EFD0295D9,"CONFIDENTIAL. Demographics (for. verification purposes). Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. A. Gallbladder. B. Whipple specimen. Clinical Information. Pancreatic ca. Infectious patient:No. Immunocompromised: No. History of neoplasm: N/A. Diagnosis. A. Gallbladder, Cholecystectomy: Chronic cholecystitis. Cystic duct lymph node with areas of hyalinization, negative for. malignancy. B. Head of Pancreas (Whipple's Resection) : Invasive moderate to poorly differentiated duct adenocarcinoma of. the pancreas. Carcinoma invades through muscularis propria of duodenum and. erodes mucosa of the ampulla of Vater. Focal extension to inferior margin and margin in the groove of the. superior mesenteric vessels. Metastatic carcinoma in 16 of 19 dissected lymph nodes. Verified: B: pancreas (Exocrine) Macroscopic. SPECIMEN: Head of pancreas. Duodenum. PROCEDURE: Pancreaticoduodenectomy (Whipple resection) . partial pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Greatest dimension: 3.0 cm. Additional dimensions : 2.5 x 2.0 cm. B: Pancreas (Exocrine), Microscopic. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G3: Poorly differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades peripancreatic soft tissues. Tumor invades retroperitoneal soft tissue. MARGINS: Margin(s) involved by invasive carcinoma. Uncinate process (retroperitoneal) margin (nonperitonealized surface of the uncinate. process). TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy) : Not known. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3 Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN) : pNl: Regional lymph node metastasis. Number examined: 19. Number involved: 16. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN. II ). Gross Description. Received are specimen containers A to B. All requisitions and specimen containers are. labelled with the patient's na. cassettes and. are. labelled with the. A. Specimen is received fresh and subsequently fixed in formalin. The container is. designated ""gallbladder"". The specimen consists of a collapsed gallbladder with abundant. fatty tissue around the gallbladder. The gallbladder measures 7.0 cm in length and up to. 2.5 cm in transverse diameter. On opening the gallbladder it contains a small amount of. mucoid bile as well as small fragments of calculus material ranging from 0.2 cm up to 0.8. cm. The mucosal surface is green and velvety. The gallbladder wall measures up to 0.2. cm in thickness. A cystic duct lymph node is visible at the proximal resection margin. The proximal resection margin and cystic duct lymph node are submitted in A1. Representative sections from the body and fundus are submitted in A2. B. Specimen is received fresh and subsequently fixed in formalin. The container is. designated ""Whipple's specimen"". The specimen consists of a pancreatic duodenectomy. specimen. The duodenal portion measures 32.0 cm in length with a short segment of distal. antrum, 2.0 cm in length. The head of pancreas measures 6.0 cm from superior to. inferior, 3.5 cm from medial to lateral and approximately 3.5 cm in thickness from. anterior surface to retroperitoneal resection margin. The superior mesenteric vessel. groove is painted green and the protruding uncinate process is painted orange. The. retroperitoneal soft tissue margin is painted black. The resection margin at the neck. of. the pancreas is painted blue. The ampulla of Vater is somewhat protuberant, measuring. 1.5 cm across with mucosal congestion. The gallbladder is layed open to reveal a firm. tumorous mass encircling the common bile duct starting 0.8 cm from the opening of the. ampulla and extending out the common bile duct for a distance of 2.0 cm. The remaining. proximal common bile duct is 2.5 cm from the proximal extent of the mass. There is. a. bifurcation, likely representing a low insertion of the cystic duct. The bifurcation. lies 1.5 cm from the proximal common bile duct margin. An incision from the uncinate. process aspect at the head of pancreas shows a hard tumorous mass that occupies. approximately 50% of the head of pancreas measuring 3.0 cm from superior to inferior,. approximately 2.0 cm from the wall of the common bile duct in a medial-lateral. orientation and approximately 2.5 cm in thickness in AP orientation. The tumor appears. to lie closest to the retroperitoneal resection margin although soft friable fatty tissue. is present at the surface. The section of the soft tissue around the head of the. pancreas yields a distinct node at the proximal end of the common bile duct, two lymph. nodes along the superior edge of the head of pancreas, approximately four enlarged firm. areas, possibly nodes, in the adipose tissue attached to the distal stomach,. approximately four lymph nodes in the gastroduodenal zone and approximately three lymph. nodes in the fatty tissue at the inferior aspect at the head of pancreas. Sections are taken as follows: B1 - proximal common bile duct resection margin. B2 - resection margin at neck of pancreas. B3 - inferior edge at head of pancreas, perpendicular. B4 through B7 - transverse sections of posterior aspect of pancreatic head from inferior. to superior. B8 through B13 - transverse sections of anterior half of head of pancreas from inferior. to superior. B14 - lymph node at proximal end of cammon bile duct. B15 - lymph nodes at superior edge of head of pancreas. B16 and B17 - lymph nodes on lesser curve of stomach. B18 and B19 - gastroduodenal lymph nodes. B20 - lymph nodes at inferior edge at head of pancreas. B21 - representative section of proximal resection margin, perpendicular. B22 - distal resection margin, perpendicular. Microscopic Description. A. Sections show gallbladder tissue with chronic cholecystitis, but no cytologic atypia. in the mucosa of the gallbladder. The cystic duct lymph node shows accumulation of. macrophages with areas of hyalinization, but without significant mineral oil. lipogranulomatosis. No sign of malignancy is present. B. Sections of the head of pancreas shows an invasive moderate to poorly differentiated. pancreatic duct adenocarcinoma that invades along the distal common bile duct, extends. through the wall adjacent duodenum and involves the orifice of the ampulla of Vater. The. bulk of the cancer, however, lies in the inferior part of the head of the pancreas. focally extiending to a cauterized inferior margin and focally to a cauterized edge in the. groove of the superior mesenteric vessels. There is also areas of lymphovascular. invasion and perineural invasion. Focal residual ducts on the periphery of the cancer. shows changes of PANIN grade II. The pancreatic neck resection margin is clear and no. clear involvement of the main pancreatic duct can be seen. Also, the secondary. pancreatic papilla is visualized with no direct invasion by cancer. The proximal. resection of the common bile duct is clear of tumor. Multiple lymph nodes included in. the sections of the head of the pancreas shows metastatic carc√≠noma and together with. additional lymph nodes dissected separately, there appears to be up to 19 lymph nodes,. including the nodes in the distal perigastric tissue. Sixteen of these show either. metastatic deposits of pancreatic carcinoma. te. mucosa. and. The sections of the proximal margin the show distal unremarkable resection distal margin gastric is clear antral with unremarkable. unremarkable. duodenal. mucoga,. and. duodenal mucosa. Accession Numbe. Encounter Number. Patient Location."
BIOCUP_00353,pancreas,PAAD,TCGA-H8-A6C1,TCGA-H8-A6C1.719BE4BC-2FEB-4AB4-8F9E-D1BBD7085975,"Clinical Information: Pancreatic cancer. Operative Procedure: Laparoscopic Whipple. Pre-Operative Diagnosis: Pancreatic cancer. A: whipple specimen - ( short black - panc. neck , long black - uncinate blue. - bile duct ) (FS). B: Gallbladder. C: portal lymph node. D: SMA tissue. Final Pathologic Diagnosis: A. Pancreas, Whipple resection: Specimen: Head of pancreas; Duodenum; Gallbladder. Procedure: Pancreaticoduodenectomy (Whipple resection);. Cholecystectomy. Tumor site: Pancreatic head. Tumor size: 3.1 X 2.1 X 1.1 cm (greatest dimensions). Tumor focality: Unifocal. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated (G2). Microscopic tumor extension: Tumor invades peripancreatic soft tissue and. duodenal wall. Margins. Margins uninvolved by tumor. Distance of tumor from closest margin: 4 mm. Specify margin: Uncinate. Lymph-vascular invasion: Not identified. Perineural invasion: Identified. Pathologic Staging (pTNM). TNM descriptors: none known. Primary tumor (pT): pT3. Regional lymph nodes (pN): pNo. Number examined: 21. Number involved: 0. Distant metastasis (pM): pMX. Additional pathologic findings: Chronic pancreatitis, duodenal ulcer. with. reactive changes, Submucosal lipoma of duodenum (2nd lesion noted in gross. description). B. Gallbladder, cholecystectomy: Chronic cholecystitis. Two lymph nodes, no evidence of malignancy (0/2). C. Lymph node, portal, resection: Two lymph nodes, no evidence of malignancy (0/2). D. SMA tissue, resection: No evidence of malignancy (2 lymph nodes). The examination of this case material and the preparation of this report were. Intraoperative Consult Diagnosis: FSA: Whipple: FSA1: Bile duct: Negative for carcinoma. FSA2: Uncinate: Negative for carcinoma. FSA3: Neck: Negative for carcinoma. F/S TAT: 33 mins. Gross Description: Received are four containers, all labeled with the patient's name. Part A is received fresh for frozen section diagnosis and additionally labeled. ""Whipple specimen, long black=uncinate, short black=pancreatic neck, blue=bile. duct.'. Specimen (components and dimensions): The specimen is the product of a Whipple. resection, previously sectioned, consisting of a 13.2 x 3.0 cm duodenum with. pancreatic head 4.7 cm in length and additional dimensions of 5.6 X 5.5 cm. Gallbladder: The gallbladder is submitted as a separate specimen (see part. B). Specimen inking pattern: Uncinate/retroperitoneal/posterior black, vascular. groove red, anterior-blue. (Please note the specimen has been previously inked. in focal areas: The bile duct inked blue, uncinate inked yellow, neck inked. black.). Tumor: Location: Pancreatic head. Size: 3.1 X 2.1 X 1.1 cm. Appearance: The tumor is white-tan to tan with ill defined borders and a. decrease in lobular architecture. The tumor is also firm. Gross impression of invasive growth: There is a biliary stent present in the. bile duct. After removal, the tumor appears to abut and obstruct the bile duct. The tumor appears to possibly abut the main pancreatic duct, however, there does. not appear to be any gross involvement and the pancreatic duct is of the usual. caliber. The tumor also appears to abut, but not grossly penetrate through the. vascular groove. Please defer to microscopic diagnosis. Resection margins (closest): Proximal duodenum or stomach: 2.1 cm. Distal duodenum: 7.4 cm. Bile duct: 2.9 cm. Pancreatic neck/duct: 2.3 cm. Uncinate/Retroperitoneum: 1.1 cm. Other findings: The attached portion of duodenum has a pink-tan to brown,. smooth and roughened serosal surface. There appears to be a 1.1 X 0.8 cm. transmural defect located 5.4 cm from the proximal end. Upon opening the. duodenum, the mucosa is pink-tan with the normal mucosal folds. The area of. transmural defect seems to the area opposing where the bile duct stent was. located. This could be a possible area of local trauma. There are two lesions. present on the duodenal mucosal surface. The first lesion is approximately 2.6. cm from the proximal duodenal margin. This lesion is concerning for possible. tumor. The lesion appears separate from the ampulla, located on the posterior. wall of the duodenum. This lesion has dimensions of 1.4 X 1.4 X 0.4 cm. The. lesion is pink-tan with raised borders with a central ulcerated area. Representative sections of the first lesion are placed in cassettes A14 and A15. The second lesion in the duodenum is approximately 4.6 cm from the proximal. surface, also located on the posterior wall of the duodenum. This lesion has. dimensions of 1.4 X 1.3 X 0.8 cm. This lesion is pink-tan with a smooth surface. The cut surface of this lesion is yellow-tan and homogeneous. Representative. sections of this lesion are placed in cassettes A16 and A17. The bile duct is removed and submitted for frozen section diagnosis (FSA1). The. tissue is resubmitted for permanent section in cassette A1. The uncinate margin. is shaved off and submitted for frozen section diagnosis (FSA2) and this tissue. is resubmitted for permanent section in cassette A2. The pancreatic neck is. shaved off and submitted for frozen section diagnosis (FSA3) and this tissue is. resubmitted for permanent section in cassette A3. Block List: A1. bile duct margin;. A2. uncinate margin;. A3. pancreatic neck margin;. A4. proximal duodenal margin;. A5. distal duodenal margin;. A6 ampulla;. A7. mass to vascular groove;. A8-10 representative sections of tumor;. A11. tumor to bile duct;. A12. tumor to pancreatic duct;. A13 tumor to uncinate;. A14-15. representative sections of first lesion in duodenum;. A16-17. representative sections from second lesion in duodenum;. A18. one possible lymph node bisected;. A19. one possible lymph node bisected;. A20. one possible lymph node submitted in toto;. A21. one possible lymph node bisected;. A22. one possible lymph node bisected;. A23. one possible lymph node bisected;. A24. one possible lymph node;. A25. one possible lymph node bisected;. A26. one possible lymph node;. A27. one possible lymph node;. A28. one possible lymph node;. A29. one possible lymph node;. A30. one possible lymph node;. A31. one possible lymph node;. A32. one possible lymph node;. A33. one possible lymph node;. A34. one possible lymph node;. A35. one possible lymph node;. A36. one possible lymph node bisected. Part B is received in formalin additionally labeled ""gallbladder"" and consists. of a gallbladder with overall dimensions of 5.9 x 2.5 x 1.7 cm. The surface is. purple-tan, smooth to roughened. There is a pericystic duct lymph node. identified, having a greatest dimension of 0.6 cm. Opening of the gallbladder. reveals a moderate amount of yellow-green markedly viscid bile. There are no. choleliths identified. The mucosa is pink-tan to brown with focal yellow. stippling. The thickness of the gallbladder wall is 0.3 cm. The cystic duct is. probe patent and appears slightly thickened. The usual sections are submitted in. a single cassette to include the pericystic duct lymph node. Part C is received in formalin additionally labeled ""portal lymph node"" and. consists of one pink-tan irregular fragment of soft tissue, having dimensions of. 1.3 X 0.8 x 0.3 cm. The specimen is submitted in toto in cassette C. Part D is received in formalin additionally labeled ""SMA tissue"" and consists of. two pink-tan irregular fragments of soft tissue, having dimensions of 1.6 X 0.7. X 0.4 cm and 1.9 x 0.5 X 0.3 cm. The specimen is submitted in toto in cassette. D. Microscopic Description: The final diagnosis of each specimen incorporates the microscopic examination. findings. Gender: M."
BIOCUP_00354,pancreas,PAAD,TCGA-3A-A9IZ,TCGA-3A-A9IZ.F6EEF42B-567E-4B13-A155-AD8DDFF9A0C6,"Final Diagnosis. A. LIVER, BIOPSY: Cholestasis with bile plugs, and steatosis, negative for carcinoma. B. LYMPH NODE, BIOPSY: Bile infarct with foeign body giant cells, cholestasis will bile plugs, suggestive of large duct. obstruction. Thick wall vessels present. C. NODULE, PERIPHERAL, BIOPSY: Adipose tissue with fibrosis and giant cell reaction with bile. Negative for malignancy. D. SOFT TISSUE, PORTAL, BIOPSY;. Adipose tissue with histiocytes, negative for carcinoma. E. LIVER, LEFT LATERAL LOBE, BIOPSY: Liver with cholestasis and bile plugs. F. LIVER, LEFT LATERAL LIVER LOBE NODULE, BIOPSY: Cholestasis, with bile plugs, consistent with large duct obstruction. G. LIVER, LEFT LATERAL LIVER LOBE NODULE, DEEP BIOPSY: Cholestasis and giant cells. H. LIVER, LEFT LATERAL NODULE, DEEP, BIOPSY: Fibrous tissue and hepatic parenchyma with cholestasis and bile plugs, consistent with large. duct obstruction. I. LIVER, SEGMENT 8 NODULE, BIOPSY: Cholestasis, with bile plugs, consistent with large duct obstruction. J. LIVER, SEGMENT 8 NODULE, BIOPSY: Cholestasis, with bile plugs, consistent with large duct obstruction. K. LIVER, SEGMENT 8 NODULE NO. 2, CORE BIOPSY: Cholestasis, with bile plugs and focal cholangitis, consistent with large duct obstruction. L. LYMPH NODE, SUPERIOR PANCREATIC NECK, BIOPSY: One lymph node free of metastatic disease (0/1). M. HEAD OF PANCREAS, PORTION OF DUODENUM AND STOMACH: Adenocarcinoma, well differentiated, invasive into adjacent peripancreatic tissue. Tumor size: 4.0 cm. Carcinoma is present on the portal vein groove surface and the superior mesenteric artery. margin. Extensive perineural invasion is identified. Lymphvascular invasion identified. Ampullary adenoma identified. Adjacent pancreas with PanIN 2. Metastatic carcinoma to 3 of 20 lymph nodes (3/20). See synoptic report. I,. the attending pathologist, personally reviewed all. slides and / or materials and rendered the final diagnosis. Electronically. Key Pathological Findings. A: Pancreas Exocrine. SPECIMEN: Head of pancreas. Duodenum. Stomach. PROCEDURE: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Greatest dimension of solid component: 4.0 cm. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades peripancreatic soft tissues. MARGINS: Margin(s) involved by invasive carcinoma. Superior mesenteric artery. Portal vein groove. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy): No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT): pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN): pN1: Regional lymph node metastasis. Number examined: 21. Number involved: 3. DISTANT METASTASIS (pM): pMO: No Distant metatstasis. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN 2). Acute pancreatitis. Pancreatitis with focal fat necrosis and giant cell reaction. CLINICAL HISTORY: Not specified. Specimen(s) Received. A. LIVER LESION FS. B. LEFT LIVER BX FS. C. PERIPORTAL TISSUE FS. D. PERIPORTAL TISSUE. E. LEFT LATERAL LIVER NODULE FS. F. LEFT LATERAL LIVER LOBE NODULE. G. LEFT LATERAL LIVER LOBE NODULE DEEP FS. H. LEFT LATERAL LIVER LOBE NODULE DEEP. I. SEGMENT 8 NODULE. J. SEGMENT 8 NODULE FS. K. SEGMENT 8 NODULE #2 FS. L. SUPERIOR NECK PANCREAS LYMPH NODES. M. WHIPPLE FS. Clinical History. None given. Preoperative Diagnosis. Pancreatic cancer. Intraoperative Consultation. FSA1/FSA2. LIVER LESION: Giant cell granuloma, no evidence of malignancy. FSB1. LEFT NODULE BIOPSY: Fibrosis with thick wall vessels suggestive of vascular malformation. FSC. PERIPHERAL NODE: Giant cell granulomatous reaction with segment of nerve and smooth muscle. No evidence of malignancy. FSE1. LEFT LATERAL LIVER NODULE: Liver, no evidence of malignancy. FSG1. LEFT LATERAL LOBE NODULES DEEP LIVER: No evidence of malignancy. FSJ. SEGMENT 8 NODULE: No evidence of malignancy. FSK1. SEGMENT 8 NODULE 2: No evidence of malignancy. FSM1. PANCREATIC MARGIN: No evidence of malignancy. FSM2. CYST MARGIN: No evidence of malignancy. Comment: These frozen section diagnoses/results was/were communicated to and acknowledged by. I,. D., have performed the intraoperative consultation and issued the above. diagnosis. Gross Description. A. Specimen A is received fresh labeled ""liver lesion."" The specimen consists of an irregular. tan-brown fragment of liver tissue measuring 2.6 X 1.6 x 1.0 cm. The margins of resection are inked. black. The specimen is serially sectioned to reveal a tan-yellow and irregular possible lesion. measuring 0.5 x 0.3 x 0.3 cm. Representative sections of the lesions are entirely submitted for frozen. section diagnosis in FSA1-FSA2. The rest of the specimen is entirely submitted in cassettes labeled. A3. B. Specimen B is received fresh labeled ""left liver nodule."" The specimen consists of two. cylindrical fragments of tan-brown liver cores measuring 2.2 cm in length and 1.2 cm in length. respectively. Both 0.1 cm in greatest diameter. The specimen is entirely submitted for frozen section. diagnosis as FSB1. C. Specimen C is received fresh labeled ""peripheral nodule."" The specimen consists of an. irregular fragment of soft tan-white to tan-pink tissue measuring 1.3 x 1.0 x 0.4 cm. The specimen is. entirely submitted for frozen section diagnosis as FSC1. D. Specimen D is received fresh labeled ""periportal tissue."" The specimen consists of. un-oriented and irregular fragment of soft tan-white to tan-pink tissue measuring 2.0 x 1.8 x 1.0 cm. Revealing a tan-white cut surface grossly consistent with fymph node measuring 1.2 cm in greatest. dimension. The specimen is entirely submitted in cassette D. E. Specimen E is received fresh labeled ""left lateral lobe nodule."" The specimen consists of 2. tiny fragments of soft tan-white to tan-yellow tissue measuring 1.8 cm in length and 0.1 cm in. diameter. The specimen is entirely submitted for frozen section diagnosis in cassette labeled FSE1. F. Specimen F is received fresh labeled ""left lateral liver lobe nodule."" The specimen consists of. cylindrical fragment of soft tan-brown tissue measuring 0.5 cm in length and 0.1 cm in greatest. diameter. The specimen is entirely submitted in cassette F. G. Specimen G is received fresh labeled ""left lateral liver lobe nodule deep."" The specimen. consists of cylindrical fragment of soft tan-brown tissue measuring 0.3 cm in length and 0.1 cm in. greatest diameter. The specimen is entirely submitted for frozen section diagnosis as FSG1. H. Specimen H is received fresh labeled ""left lateral liver nodule deep."" The specimen consists. of cylindrical fragment of soft tan-brown tissue measuring 1.5 cm in length and less than 0.1 cm in. greatest diameter. The specimen is entirely submitted as H1. I. Specimen I is received fresh labeled ""segment 8 nodule."" The specimen consists of. cylindrical fragment of soft tan-white to tan-brown tissue measuring 1.2 cm in length and less than 0.1. cm in greatest diameter. The specimen is entirely submitted in cassette labeled 11. J. Specimen J is received fresh labeled ""segment 8 nodule."" The specimen consists of fragment. of tan soft tissue measuring 1.8 cm in length and 0.1 cm in greatest dimension. The specimen is. entirely submitted for frozen section diagnosis in cassette labeled FSJ1. K. Specimen K is received fresh labeled ""segment 8 nodule #2."" The specimen consists of tan. soft fragment of tissue measuring 1.9 cm in length and 0.1 cm in greatest diameter. The specimen is. entirely submitted for frozen section diagnosis as FSK1. L. Specimen L is received fresh labeled ""superior neck pancreatic lymph node."" The specimen. consists of an irregular fragment of tan-white to tan-yellow tissue measuring 2.0 x 1.2 x 0.7 cm. The. specimen is bisected revealing a tan-white lymph node measuring 1.2 cm in greatest dimension. The. lymph node is entirely submitted in 1 cassette as follows: L1: One bisected lymph node. M. Specimen M is received fresh labeled ""Whipple."" The specimen consists of Whipple. specimen and oriented by the surgeon as follows: Single stitch bowel duct margin, double stitch at. gastric margin, triple stitches pancreatic margin, 4 stitches retroperitoneal margins. The specimen is. inked as follows: Portal vein margin is inked with red, superior mesenteric artery margin is inked in. black, Posterior surface inked orange. Attached to the specimen there is the head of pancreas,. portion of duodenum, and portion of stomach. The gallbladder is not identified. The duodenum. measures 13.0 cm in length. The serosa of the duodenum is smooth, tan to tan-red. On opening, the. lumen does contain bile stained mucus. The mucosa of the duodenum and stomach does not reveal. polyps or ulcers. The bile duct measures 6.5 cm in length and 2.0 cm in greatest diameter (dilated). Sectioning the pancreatic head, a solid tan-white mass with areas of necrosis is noted measuring 4.0 x. 4.0 x 3.0 cm, located at 3.0 cm from bile duct margin of resection and less than 0.1 cm from portal. vein margin of resection. The remaining pancreatic tissue is multilobulated, firm, and grossly. unremarkable. The attached portion of stomach measures 11.0 cm along the greater curvature and. 7.0 cm along the lesser curvature. The gastric mucosa is grossly unremarkable. On examining the. specimen for lymph node, a tan-white to tan-red lymph node (peri-bile duct area) is present measuring. 1.5 cm in greatest dimensions. Sectioning the perigastric omental soft tissue, multiple single lymph. nodes are grossly identified ranging in sizes from 0.2 mm to 0.5 cm in greatest dimensions. Representative fresh tissue is submitted to Tissue Procurement Laboratory. Representative sections. are submitted as follows: FSM1: Tangential pancreatic duct margin of resection. FSM2: Cystic duct margin of resection. M3: Perpendicular section posterior surface of resection. M4: Tangential proximal stomach margin of resection. M5: Tangential distal duodenal margin of resection. M6-M7: Perpendicular section portal vein margin of resection in relation to the tumor. M8: Perpendicular section superior mesenteric artery margin of resection. M9: Tumor in relation to bile duct. M10: Tumor in relation to bile duct. M11: Representative section of ampulla of Vater. M12-M13: Tumor in relation to duodenal mucosa. M14-M17: Entire peripancreatic fat tissue. M18: Lymph node bisected bile duct area. M19: Un-involved pancreatic tissue. M20: Normal gastric mucosa. M21: Normal duodenal mucosa. M22-M33: Multiple single fymph nodes and fibroadipose tissue (omental fat)."
BIOCUP_00355,pancreas,PAAD,TCGA-IB-7889,TCGA-IB-7889.eca003d0-d6e7-4a93-9944-f4fdf6361f74,"Suraical Pathology Report. Numbersit. Collected Date: Received Date/Time: Specimen Description. A. Gallbladder. B. Lymph node of importance. C. Bile duct margin. D. Pancreatic duct margin. E. Whipple's specimen. Clinical Information. Pancroatic adenocarcinoma. Diagnosis. A. Gallbladder: Chronic cholecystitis. Negative for malignancy or dysplasia. Cystic duct not Involved by carcinoma. B. Lymph Node of Importance: One reactive lymph node, negative for malignancy. C. Bile Duct Margin: Negative for malignancy or dysplasia. D. Pancreatic Duct Margin: Negative for malignancy or dysplasia. E. Whipple's Specimen: b. Invasive well differentiated pancreatic ductal carcinoma, 2.5 cm. POSITIVE for extensive perineural invasion. POSITIVE for lymphatic invasion. a. Tumor invaded into peripancreatic fat. Negative for angiovascular invasion. DO. Multifocal pancreatic intraductal neoplasm (PanIN- 1b to 3). Resection margins of pancreas negative for tumor: 1.5 mm distant. from the posterior margin, and 2.0 mm distant from the resection. margin of pancreas. Ampulla and duodenal mucosa not involved by tumor. Three of thirteen (3/13) peripancreatic lymph nodes POSITIVE for. metastatic carc√≠noma. See Synoptic Report. Synoptic Report. E: Pancreas (Exocrine), Macroscopic. SPECIMEN: Head of pancreas. PROCEDURE: Panoreaticoduodeneotomy (Whipple resection), partial pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Greatest dimension: 2.5 cm. Additional dimensions: 2.2 x 1.7 cm. E: Pancreas (Exocrine), Microscopic. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: GI: Well differentlated. MICROSCOPIC TUMOR EXTENSION: Tumor invades peripancreatic soft tissues. Tumor invades retroperitoneal soft tissue. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1.5 mm. Specified margin: Posterior. Margins uninvolved by carcinoma in situ. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy): No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT): pT3: Tumor extends beyond the pancreas but without Involvement of the celiac axis or the superior mesenteric. artery. REGIONAL LYMPH NODES (pN): pN1: Regional lymph node metastasis. Number examined: 13. Number involved: 3. DISTANT METASTASIS (pM): Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN 2 and. 3). Gross Description. Received are specimens A to E. All requisitions and specimen containers are labelled with the patient's name. The cassettos and AP identifiers are labelled with the Surgical Number. A. The specimen is received fresh and consists of an entirely resected gallbladder measuring 8.5 in length and 2.9 cm in. maximum diameter. On the serosal surface the gallbladder appears unremarkable. Upon opening, no gallstones are. present. The cystlo mucosa appears unremarkable. The cystic wall Is thickened, up to 0.3 cm for the thickness. Representative sections are submitted in one cassette. B. The specimen is received In formalin and consists of one lymph node measuring 1.1 cm in greatest dimension. The. lymph node is bisected and submitted in one cassette. c Circular piece of mucosa 1.0 X 1.0 X 0.3 cm. Bisected and both halves submitted for QS. The entire frozen section block remnant is submitted in cassette CQS1. D. Irregular plece of soft tan tissue, 1 x 0.3 x 0.3 cm. All submitted for QS. The entire frozen section block remnant Is submitted in cassette DQS1. E. Received fresh is a Whipple resection specimen encompassing a segment of duodenum, 24 cm in length and 6 cm in. maximal circumference, and a portion of pancreas measuring 4.2 x 3.0 X 2.2 cm, and a portion of bile duct is included, 1.8. cm in length and 0.8 cm in proximal diameter. Merged with this bile duct, the pancreatic duct Is identified, measuring 1.2. cm in length and 0.8 cm in proximal diameter. After the ducts merged, starting at 1.2 cm from the proximal resection. margin of the pancreatlo duct, the common ductal lumen Is significantly narrowed until 0.2 cm from the opening of the. ampulla. Surrounding the common duct is an ill-defined firm mass in the pancreatic head, measuring 2.5 X 2.2 x 1.7 cm. The duodenal mucosa appears unremarkable. The ampulla is not involved by the tumor. The resection margin of the. pancreas is inked in blue, the posterior resection margin of the pancreas is inked in black, the luminal surface of the. pancreatic duct Inked in yellow, the luminal surface of bile duct inked In orange, and the common duct luminal surface. is. inked in purple. Representative sections are submitted in cassettes labelled as follows: E1. bile duct margin. E2-3 -. longitudinal sections through common duct and ampullary opening. E4-5. pancreas with posterior margin, next to sections E2 and E3. E6-8. a single cross section of mass with pancreatic resection margin and common duct. E9-10 -. a single cross section of tumor with both pancreatic and bile duct. E11 -. longitudinal section through the proximal end of pancreatic duct and the surrounding. tumor. E12-. longitudinal section of the proximal end of bile duct with surrounding tumor. E13. bisected lymph node next to the proximal bile duct. E14 -. cross section of tumor with common duct. E15-17 -. a single cross section of tumor through common duct with pancreatic resection margin. E18-22 -. a single cross section through the tumor with common bile duct, pancreatic resection. margin and duodenum. E23-24 -. tumor with pancreatic resection margin. E25. uninvolved pancreas with duodenum. E26 -. distal and proximal resection margins of duodenum. E27-28 -. additional posterior margin. E29 -. lymph node within duodenal mesentery. E30 -. four peripancreatic lymph nodes. E31 -. four peripancreatic lymph nodes. E32 -. tumor nodule within the posterior aspect. Frozen Section Diagnosis. C. Bile Duct Margin: - Negative for tumor. D. Pancreatic Duct Margin: - Negative for tumor."
BIOCUP_00356,pancreas,PAAD,TCGA-IB-AAUW,TCGA-IB-AAUW.64606B7A-008D-459F-8E32-296016364BB1,"CONFIDENTIAL. Nam. Demographics (for. verification purposes). Sex: F. ADDENDUM REPORT. Addendum Report. Collected Date/Time. Received Date/Time. Addendum Reason. Grade listed in the diagnostic line was incorrectly listed as moderately instead of. poorly in the original report. Addendum Diagnosis. PLEASE NOTE: This Addendum Report introduces a potentially significant. change in the diagnosis or a change in patient information. Please clearly. mark the Original Report as having been changed, with a clear reference to. this Addendum Report (e.g. ""Please see additional report""). Diagnosis. A. Lymph Node, Group B, Resection: - Two lymph nodes, negative for malignancy (0/2). B. Gallbladder, Cholecystectomy. - Acute cholecystitis. - Cholelithiasis. c. Lymph Node, Peripancreatic, Resection: - Fibrofatty tissue, negative for malignancy. - Lymphoid tissue not identified. D. Pancreatico-duodenectomy, Whipple Resection: - Invasive pancreatic ductal adenocarcinoma, poorly differentiated,. size, 3.5 x 2.1 cm (see synoptic report). - Adenocarcinoma within 0.2 cm from the vascular bed and 0.1 cm from. the uncinate resection margin. Bile duct resection margin and pancreatic body resection margin,. negative for malignancy. Six lymph nodes, negative for malignancy (0/6). E. Lymph Node, Portal, Resection: - One lymph node, positive for metastatic carcinoma (1/1). - Size of metastatic deposit, 0.5 cm. - Extracapsular invasion identified. Verified: Responsible Resident: Addendum Discussion. The grade was correctly listed as poorly differentiated in the synoptic line but. incorrectly listed as moderately differentiated in the diagnosis line in the original. Collected Date/Time. Received Date/Time. Specimen Description. A. Lymph node group 8 at. B. Gallbladder at. c. Prepancreatic lymph node at. D. Whipple specimen at. E. Protal lymph node at. Clinical Information. Mass in head of pancreas. Diagnosis. A. Lymph Node, Group B, Resection: Two lymph nodes, negative for malignancy (0/2). B. Gallbladder, Cholecystectomy: Acute cholecystitis. - Cholelithiasis. c. Lymph Node, Peripancreatic, Resection: - Fibrofatty tissue, negative for malignancy. - Lymphoid tissue not identified. D. ancreatico-duodenectomy Whipple Resection: - Invasive pancreatic ductal adenocarcinoma, moderately differentiated,. size, 3.5 x 2.1 cm (see synoptic report). Adenocarcinoma within 0.2 cm from the vascular bed and 0.1 cm from. the uncinate resection margin. - Bile duct resection margin and pancreatic body resection margin,. negative for malignancy. - Six lymph nodes, negative for malignancy (0/6). E. Lymph Node, Portal, Resection: - One lymph node, positive for metastatic carcinoma (1/1). - Size of metastatic deposit, 0.5 cm. - Extracapsular invasion identified. Verified: Responsible Resident: Synoptic Report. SPECIMEN: Head of pancreas. Body of pancreas. Duodenum. Common bile duct. Gallbladder. PROCEDURE: Pancreaticoduodenectomy (Whipple resection) . partial pancreatectomy. TUMOR SITE: Pancreatic head. Pancreatic body. TUMOR SIZE: Greatest dimension: 3.5 cm. Additional dimensions: 2.1 x 1.8. cm. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G3: Poorly differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades duodenal wall. Tumor invades retroperitoneal soft tissue. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1.0. mm. Specified margin: uncinate. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy) : No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN) : pN1: Regional lymph node metastasis. Number examined: 9. Number involved: 1. DISTANT METASTASIS (pM) : Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN III. CLINICAL HISTORY: Not specified. Gross Description. Received are specimen containers A to E. Al1 requisitions and specimen containers are. labelled with the patient'e name,. The cassettes and. identifiers are. labelled with the Surgical Number. A. The specimen is received fresh and is subsequently placed into formalin, designated. as ""A - lymph node group 8 at. The specimen consists of an irregular portion of. fibrofatty tissue measuring 2.0 x 1.4 x 0.5 cm. Two possible lymph nodes are identified. ranging in size from 1.2 x 0.8 x 0.3 cm to 1.4 x 0.7 x 0.3 cm. Sections are submitted as. follows: A1. two possible lymph nodes. A2. remainder of tissue submitted in toto. B. The specimen is received fresh and is subsequently placed into formalin, designated. as ""B - gallbladder at. The specimen consists of a brown tan non-intact. gallbladder measuring 11.5 x 4.8 x 2.3 cm. The serosal surface is tan to dark brown,. smooth and congested. A surgical defect is identified at the fundus measuring 2.4 cm in. length. Cystic duct is patent. Cystic duct lymph node is not identified. The lumen. does not contain bile or calculi, however, two calculi are received with the specimen. Both are black and ovoid. The smaller calculus measures 1.0 x 0.7 x 0.5 cm. The larger. calculus measures 4.0 x 2.8 x 2.4 cm. There are tan and hemorrhagic exudate adherent to. the mucosa. The mucosa is brown and fibrotic. The wall is thickened and averages 0.6 cm. in thickness. Sections are submitted as follows: B1. cystic duct margin and representative sections from neck and body. B2. representative sections from fundus including surgical defect. C. The specimen is received fresh and is subsequently placed into formalin, designated. as ""C - prepanreatic lymph node at "" The specimen consists of a rubbery irregular. portion of fibrofatty tissue measuring 2.5 x 1.0 x 0.3 cm. Specimen is submitted in toto. in one cassette. D. The specimen is received fresh and is subsequently placed into formalin, designated. as ""D - Whipple specimen at The specimen consists of a whipple's resection. including a portion of pancreas (7.0 x 4.0 x 1.5 cm), duodenum (25.0 cm in length and. averaging 6.0 cm in circumference) and attached peripancreatic soft tissue extending to. a maximum depth of 2.5 cm, as well as a small portion of attached mesentery extending to. a maximum depth of 2.0 cm. Proximal and distal margins are stapled. Specimen is inked. as follows: Body margin orange, vessel bed margin green, uncinate margin blue. The. common bile duct measures 4.0 cm in length and averages 0.7 cm in circumference. The. body margin of the pancreas measures 2.5 x 1.0 cm. The uncinate margin measures 6.0 x. 2.5 cm. The pancreas is serially sectioned. A firm ill-defined yellow to light tan. variegated lesion is identified surrounding the common bile duct measuring 3.5 x 2.1 x1.8. cm. It is 0.5 cm from the common bile duct margin, 1.0 cm to the body margin, 0.1 cm to. the vessel bed, 1.2 cm to the uncinate margin, 0.3 cm to the posterior surface, 2.5 cm to. the anterior surface, 1.5 cm to the proximal margin, and 18.5 cm to the distal margin. The serosal surface of the duodenum is tan and smooth and appears grossly unremarkable. The mucosa is tan to brown and appears grossly unremarkable. Sections are submitted as. follows: D1. common bile duct margin en face. D2-4. distal margin trisected. D5. proximal margin bisected. D6. shaved section body margin including pancreatic duct margin. D7-8. contiguous section bisected, demonstrating lesion in closest relation to the. vessel bed. margin also including uncinate margin. D9-10. contiguous section bisected, lesion in closest relation to uncinate margin. and posterior. surface which is inked purple. D11-12. contiguous section bisected, lesion underlying duodenal mucosa and including. vessel. bed margin. D13. lesion in relation to anterior surface. D14. lesion in relation to posterior surface. D15. grossly uninvolved pancreas including vessel bed margin. D16. transition from common bile duct through ampulla of Vater. D17. four possible peripancreatic lymph nodes ranging in size from 0.5 x 0.4 x. 0.3 cm to 1.3 x. 0.8 x 0.3 cm. E. The specimen is received fresh and is subsequently placed into formalin, designated. as ""E - portal lymph node"". The specimen consists of an irregular portion of fibrofatty. tissue measuring 2.8 x 1.8 x 0.8 cm. A possible lymph node is identified measuring 2.3 x. 1.4 x 0.8 cm. Possible lymph node is bisected and submitted in toto in cassettes E1 and. E2. Sample and Test Request Deficiency. Minor sample and/or test request deficiency. Location of physician not provided. Pathologist Comment. representative tumour block=D10. Normal block=D15. Encounter Number. Patient Location."
BIOCUP_00357,pancreas,PAAD,TCGA-IB-7891,TCGA-IB-7891.1c80a890-16cd-445f-92ae-811da23d6dfb,"Collected Date: Received Date/Time: Specimen Description. A. Node of importance. B, Pancreatic margin. C. Whipple specimen. Clinical Information. MRI showed a lump on pancreas. Diagnosis. A. Lymph Node (Node of Importance), Excision: 1 lymph node, negative for malignancy (0/1). B. Pancreas (IVlargin), Biopsy: Atrophic pancreas, negative for malignancy. C. Small Bowel, Pancreas, Bile Duct, Whipple excision: Pancreatic well-differentiated ductal adenocarcinoma (see Synoptic. Report). Pancreatic intraepithelial neoplasia, high-grade (PanIN III/III). Lymphovascular space invasion identified. Extensive perineural invasion identified. 1. Metastatic adenocarcinoma in 7/11 lymph nodes. Tumor present < 0,1 cm from bile duct margin, distal pancreatic and. uncinate margin. Ampullary epithelium with reactive atypia and submucosal. fibro-inflammatory response, secondary to stent. Synoptic Report. C: Pancreas (Exocrine), Microscopic. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G1: Well differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades peripancreatic soft tissues. Tumor invades retroperitoneal soft tissue. MARGINS: Distance of invasive carcinoma from closest margin: 1 mm. Specified margin: uncinate, distal pancreas, bile duct margin. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT): pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric. artery. REGIONAL LYMPH NODES (pN): pN1: Regional lymph node melastasis. Number examined: 11. Number involved: 7. ADDITIONAL PATHOLOGIC FINDINGS: Collected Date: Received Date/Time: Pancreatic Intraepithelial neoplasia (highest grade: PanIN 3). C: Pancreas (Exocrine), Macroscopic. SPECIMEN: Head of pancreas. Duodenum. Common bile duct. PROCEDURE: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Greatest dimension: 2.7 cm. Gross Description. Received are specimens A to C. All requisitions and specimen containers are labelled with the patient's name. The cassettes and AP identifiers are labelled with the Surgical Number. The specimens were received fresh, submitted for tumor bank, and photographs were taken. A. The specimen consists of a single fragment of tan and fatty tissue measuring 1.7 X 1.3 X 0.5 cm. The entire specimen. is sectioned and submitted in toto in cassette A1. B. The specimen consists of one piece of tissue measuring 0.8 X 0.7 X 0.1 cm. Submitted in toto for QS,. C. The specimen consists of distal stomach (2.0 cm in length, 5.1 cm in circumference), small bowel (19.0 cm in length,. 7.0 cm in circumference), pancreas head (5.5 X 4.5 X 4.0 cm), and a small length of bile duct (0.5 cm in length X 0.5 x 0.5. cm). Surgical margins are painted as follows: Pancreas uncinate margin in yellow, posterior margin in black, and the. pancreas neck is painted in blue, Distal stomach demonstrates no evidence of ulceration. The wall Is pliable and the. serosa is unremarkable. The length of duodenum demonstrates no nodularities. The serosal surface is smooth and. unremarkable with no nodularities. The wall of the small bowel is pliable and uniform. The mucosal surface demonstrates. a small nodularity and raised mucosal surface over the areas of the ampulla located 2,0 cm from the proximal margin. At. 1.0 cm proximal the ampulla, is another firm nodularity which does not appear to be probed patent. The nodularity of. ampulla of vater measures approximately 1.0 X 1.0 X 1.5 cm. Upon sectioning of the pancreas, there is a firm nodular ill-defined white mass located around the common bile duct as it. enters the pancreas. This mass measures approximately 2.3 X 2.3 X 1.7 cm. The mass does not appear to invade the. Surgical Path√∂lodv Report. Collected Date: Received Date/Time: small bowel grossly. Pancreatic sections are submitted in successive levels from the proximal pancreatic neck margin. towards the uncinate margin in numbered levels cut transversely. Mass comes to within 0.2 cm of the uncinate margin. and grossly appears to approach the posterior margin. Blocks are submitted as follows: C1. bile duct margin. C2. pancreas level 1, representative sections of small bowel. C3-4. pancreas level 2. C5-6. pancreas level 3. C7-9. pancreas level 4. C10-12. pancreas level 5. C13-14. ampulla. C15-16. pancreas level 6. C17-18,. pancreas level 7. C19. bowel specimen margin. C20. four possible lymph nodes, two bivalved. Frozen Section Diagnosis. 8. Pancreatic Margin: Negative for malignancy, chronic pancreatitis. Interdepartmental consult with Dr. Pathologist Comment. Frozen section diagnosis has been confirmed."
BIOCUP_00358,pancreas,PAAD,TCGA-IB-7886,TCGA-IB-7886.5d0f6ae4-a2ad-40bf-a823-11d065d5b1f1,"Suraical Patholoav Report. Collected Date: Received Date/Time: Specimen Description. A. Gallbladder. B. Bile duct margin. C. Pancreatic margin. D. Whipple specimen (sent with tissue bank nurse). E. Para-aortic lymph node. Clinical Information. Pancreatic cancer. Diagnosis. A. Gallbladder: - Chronic cholecystitis, negative for malignancy. B. Bile Duct Margin for Frozen Section: - Chronic inflammation, negative for malignancy. C. Pancreatic Margin: - Negative for malignancy. D. Pancreas (Whipple's Pancreaticoduodenectomy): as. Moderate to poorly-differentiated invasive pancreatic duct carcinoma. Size approximately 6.0 cm, with invasion into peripancreatic. adipose tissue and duodenal wall with ulceration of duodenal. Suraical Patholody Report. Collected Date: Received Date/TIme: mucosa (pT3). - Margins positive at uncinate process and superior and posterior. pancreaticoduodenal soft tissue margins. - Positive for lymphovascular and perineural invasion. Metastatic carcinoma in four of eleven lymph nodes (pN1). E. Para-aortic Lymph Node: - Reactive lymph node tissue, negative for malignancy. Gross Description. Received are specimens A to E. All requisitions and specimen containers are labelled with the patient's name. The cassettes and AP identifiers are labelled with the Surgical Number. A. The specimen consists of an unopened gallbladder, measuring 9.0 cm in length by 3.5 x 2.0 cm. The outer peritoneal. surface is smooth, while the roughened liver bed area Is unremarkable. There is a small defect in the wall with leakage of. green bile. The cystic duct lymph node is not visible. Tho mucosal surface of the gallbladder has a dark green velvely. appearance. The wall ranges in thickness from 0.2 cm up to 0.6 cm. No localized lesions can be identified. No gallstones. are present. Four sections are taken and submitted in two cassettes. B. The specimen consists of a fragment of soft tissue, measuring 0,5 cm, submitted in toto in one cassette. Please Note: Specimen was originally rejected due to ""does not have full Dr. name"". It has since been corrected and. returned. C. The specimen consists of pancreatic margin, 0.8 X 0.8 x 0.1 cm, submitted in toto in one cassette. Surgical Patholoavi Report. Collected Date: Received Date/TIme: D. The specimen consists of a pancreatoduodenectomy specimen, with the segment of distal antrum and duodenum. measuring 27.0 cm in length. There is a shallow indurated ulcerated area, 2.5 cm distal from the pyloric valve, measuring. 1.8 X 1.0 cm. This appears to lie 1.5 cm proximal to the area of the ampulla of Vater. This indurated ulcer appears to be in. continuity with an area tumorous induration in the attached head of pancreas. The head of pancreas measures 6.0 X 4.5 X. 3.0 cm. The uncinate margin and pancreatle neck margin are identified and painted orange and blue respectively. The. common bile duct can be Identified at the superior surface of the pancreas, and continuity cannot be traced through the. dense tumorous tissue in the head of pancreas. At the ampullary reglon, there is a nodular thickening lying beneath the. mucosa, measuring approximately 1.8 X 1,0 X 1.0 cm. Part of the common bile duct can be identified, but the exact orifice. is not clearly evident. Transverse sectioning of the head of pancreas reveals a firm craggy area beneath the area of. duodenal ulceration, this tumorous zone is ill-defined, but measures approximately 2.5 x 1.5 X 2.5 cm. It appears. to. extend. close to the uncinate margin and possibly extend into peripancreatic tissue in the upper pancreaticoduodenal area. The. ulcerated duodenal wall is obscured. Further sectioning reveals small firm lymph nodes in the vicinity of the common bile duct, the superior margin, and the. pancreas as well as in the pancreatoduodenal region. Sections are taken as follows: D1. Pancreatic neck margin. D2,D3. Two halves of the superior transverse section of pancreas. D4,D5. Two halves of next transverse section of pancreas. D6,D7. Two halves of transverse sections through mid zone of pancreas including uncinate. margin. D8. Additional sections of uncinate margin. D9,D10. Two halves of transverse sections through inferior part of pancreas head. D11. Section to include proximal nodular area at ampulla. D12. Section to include distal part of nodular ampulla. D13. Proximal common bile duct margin. D14,D15. Lymph nodes around common bile duct. D16,D17. Lymph nodes from pancreatic duodenal area,. D18. Distal duodenal resection margin. D19. Perpendicular section of pyloric valve margin closest to area of ulceration in the proximal. duodenum. E. The specimen consists of a firm fragment of oval tissue, measuring 1.6 X 1.2 X 0.6 cm. The tissue has a homogeneous. cut surface. The specimen is sectioned into three fragments and Is submitted entirely in two cassettes. Collected Date: Received Date/Time: Frozen Section Diagnosis. FSB. Bile Duct Margin: Negative for malignancy. FSC. Pancreatlc Margin: Negative for malignancy. Microscopic Description. A. The gallbladder shows chronic inflammation with mild irregularity of mucosal architecture. No cytologic atypia Is. present. B. Sections after routine processing confirm the frozen section diagnosis. Only a small segment of bile duct tissue is. present. The surface epithelium is partly denuded but residual epithellum shows no significant atypla and there is no. malignancy in this fragment. C. Sections after routine processing confirm the frozen section diagnosis. D. There is a widespread invasive pancreatic duct adenocarcinoma that shows a varied morphology, ranging from well-. defined angulated ductal structures through to areas where more solid sheets and small nodules and single cells with. prominent nuclear pleomorphism can be seen. The carcinoma erodes the common bile duct and focal areas on ductal. dyplasia are evident. Carcinoma is present in practically all of the sections taken. The extent of carcinoma thus exceeds. the extent of gross induration and It is estimated to have a size of at least 6,0 cm. Furthermore, carcinoma shows. extension beyond the pancreas Into peripancreatic tissue predominantly at the superior margin of the pancreas and in the. zone. between pancreas and duodenum. Carcinoma also invades into and through muscularis propria of the duodenum. and ulcerates the overlying duodenal mucosa, Carcinoma also focally involves the uncinate margin, and there are areas. where carcinoma encroaches on the cauterized soft tissue margin at the superior and posterior pancreaticoduodenal. area. There is prominent perineural invasion, and the section taken of the proximal common bile duct margin includes. carcinoma with perineural growth at this resection odge. There is prominent lymphovascular invasion in areas, and there is metastatic carcinoma in four of eleven lymph nodes. The proximal gastric and distal duodenal margins are unremarkable. The sections of the ampulla of Vater show. prominence of periductal glands and smooth muscle but no cytologic atypia or tumor. ACB: Collected Date: Received Date/Time: E. Sections show lymph node tissue with no evidence of metastatic disease."
BIOCUP_00359,pancreas,PAAD,TCGA-Q3-AA2A,TCGA-Q3-AA2A.610503C8-F430-417D-803C-52B08510F38C,"PAGE: 1. Obtained: CLINICAL HISTORY : PANCREATIC CANCER. SPECIMEN/PROCEDURE: 1. PANCREAS - WHIPPLE. 2. LYMPH NODE - COMMON HEPATIC. 3. JEJUNUM. IMPRESSION. 1). HEAD OF PANCREAS, COMMON BILE DUCT AND DUODENUM, WHIPPLE RESECTION: Invasive ductal adenocaroinoma, well difforentiated, involving peripanareatia. soft tissue (see tumor checklist). Surgical margins of resection are negative, but close; tumor is within 1 mm of. the retroperitoneal resection margin. Negative for vascular space invasion. Perineural invasion present. Metastatic carcinoma involves nine of twenty-six lymph nodes (9/26). LYMPH NODE, COMMON HEPATIC, BIOPSY: One benign lymph node (0/1). 3). JEJUNUM, RESECTION: Small intestinal mugosa with no significant histopathologia changes. PANCREAS (EXOCRINE) : RESECTION CASE SUMMARY. SPECIMEN. Head of pancreas. Duodenum. Common bile duct. PROCEDURE. Panareatiooduodeneatomy (Whipple resection), , partial panareateatomy. TUMOR SITE. Pancreatic head. TUMOR SIZE. Greatest dimension: 3.5 x 3.0 x 1.7 cm. HISTOLOGIC TYPE. Ductal adonocaroinoma. HISTOLOGIC GRADE (DUCTAL CARCINOMA ONLY). G1: Woll difforentiatod. IMPRESSION : (continued). MICROSCOPIC TUMOR EXTENSION. Tumor invades peripanareatio soft tissues. Tumor invades retroperitoneal soft tissue. MARGINS. Margins uninvolved by tumor. Distance of tumor from closest margin: <1 mm. Specify margin (if possible) : Retroperitoneal. TREATMENT EFFECT (APPLICABLE TO CARCINOMAS TREATED WITH NEOADJUVANT THERAPY). No prior treatment. LYMPH-VASCULAR INVASION. Not identified. PERINEURAL INVASION. Present. PATHOLOGIC STAGING (pTNM). PRIMARY TUMOR (pT). pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or. the superior mesenteric artery. REGIONAL LYMPH NODES (pN). pN1: Regional lymph node metastasis. Specify: Number of lymph nodes examined: 26. Number of lymph nodes involved: 9. DISTANT METASTASIS (pM). Not applicable. ADDITIONAL PATHOLOGIC FINDINGS. Pancreatic intraepithelial neoplasia (highest grade) : PanIN 1b. Chronic pancreatitis. ANCILLARY STUDIES. Not performed. CLINICAL HISTORY. None. Pathologic TNM (AJCC 7th Edition) : pT3 N1. Entered: GROSS DESCRIPTION: 1 Received fresh, labeled with the patient's name and ""Whipple"" is a specimen consisting. of duodenum (24 cm in length by 8 cm in open circumference by 0.6 cm wall thickness) and. pancreatic head (3cm from the anterior to posterior, 6 cm in length and 3 cm from superior. to inferior) . There is a poorly defined white-tan mucinous tumor mass (3.5 X 1.7 x 3.0. cm) in the head of the pancreas which obstructs the main pancreatic duct. The bile. duct. is patent and measures 0.6 cm in diameter. The tumor is grossly 1.2 cm from the ampulla. GROSS DESCRIPTION: (continued). of Vater and does not grossly involve the duodenal muscularis mucosa. The tumor is 3.5. cm. from the distal resection margin, which is grossly free of tumor. The. anterior. and. posterior margins are composed of yellow adipose tissue measuring up to 0.5 cm in. thickness and are grossly free of tumor. The remainder of the pancreatic parenchyma is. firm,. tan, and nodular. The cystic duct remnant measures 0.5 cm in length and 0.7 cm in. diameter. The duodenal mucosa is unremarkable. Six probable lymph nodes are found in the. posterior/inferior soft tissue ranging in size from 0.3 x 0.3 x 0.2 cm to 1.0 x 0.7 X 0.5. cm. Eight probable lymph nodes are found in the anterior/superior soft tissue, ranging. in. size from 0.5 X 0.5 x 0.3 cm to 1.0 X 0.7 X 0.7 cm. Three retroperitoneal probable lymph. nodes are found, ranging in size from 0.7 x 0.8 x 0.5. Ink code: Blue-pancreatic resection margin, green-bile duct margin, orange-anterior and. superior margin, yellow-posterior/inferior, black-retroperitoneal margin. CASSETTE SUMMARY: CASSETTE 1A: Bile duct margin. CASSETTE 1B: Perpendicular section the retroperitoneal margin. CASSETTE 1C: Pancreatic resection margin, perpendicular and serially sectioned. CASSETTE 1D: Section showing relationship between ampulla of Vater and tumor. CASSETTE 1E: Ampulla of Vater. CASSETTE 1G: Bile duct and common pancreatic duct. CASSETTE 1H: Tumor with relationship to retroperitoneal margin. CASSETTE 1J: Tumor with relationship to the retroperitoneal margin. CASSETTE 1K: Tumor with relationship to posterior margin. CASSETTE 1L: Tumor with relationship to retroperitoneal and anterior margin. CASSETTE 1M: Proximal duodenal margin. CASSETTE 1N-1P: Distal duodenal margin, bisected. CASEETE 1Q: Two posterior probable lymph nodes. CASSETTE 1R: Four posterior probable lymph nodes. CASSETTE 1S: One probable lymph node, bisected. CASSETTE 1T: One probable lymph node, bisected. CASSETTE 1U: Five anterior probable lymph nodes. CASSETTE 1V: Three probable retroperitoneal lymph nodes. CASSETTE 1W: One possible lymph node (anterior). CASSETTE 1X: Tumor with relationship to duodenal mucosa and retroperitoneal margin. CASSETTE 1Y: One possible lymph node (anterior). CASSETTE 1Z: Three probable retroperitoneal lymph nodes. Received in formalin labeled ""common hepatic lymph node"" and with the patient's name. The. specimen consists of a 2 X 0.8 X 0.8 cm pale tan lymph node. The specimen is serially. sectioned and submitted entirely in one cassette. 3. Received in formalin labeled ""jejunum"" and with the patient's name. The specimen. consists of a 30 cm in length by 1.5 cm in diameter unoriented portion of small bowel. The serosa is tan-pink and predominantly smooth. opening the specimen reveals tan-pink,. folded, grossly unremarkable mucosa. Sectioning reveals an average wall thickness of 0.1. cm. The specimen is representatively submitted as follows: Cassette 3A-3B: Margins. Cassette 3C-3E: Representative sections of bowel. Entered: COPIES TO: CPT Codes : PANCREAS PART/TTL RESECTION/88309. ICD9 Codes : 157.9. Resident Physician: I have personally reviewed the material. (specimen/slide) and approve this final report. Eleatronically Signed by:"
BIOCUP_00360,pancreas,PAAD,TCGA-F2-6879,TCGA-F2-6879.2759d3d4-aabe-49c8-b0cc-0365268dc686,"Diagnosis: FSA : Liver, segment 7, biopsy. - Benign liver with canalicular cholestasis, no carcinoma. identified. FSB: Liver, segment 3, medial, biopsy. - Benign liver with canalicular cholestasis, no carcinoma. identified. FSC: Liver, segment 2, biopsy. - Benign liver with canalicular cholestasis, no carcinoma. identified. FSD: Common bile duct margin, biopsy. - Bile duct, no carcinoma identified. FSE: Pancreatic duct margin, biopsy. - Carcinoma in situ involving pancreatic duct margin, suspicious. for stromal. invasion. FSF: Pancreatic margin, additional, biopsy. - Pancreatic parenchyma and fibrin, no carcinoma identified. - No duct for evaluation. FSG : Pancreatic margin #3, biopsy. - Pancreatic parenchyma and duct, no in situ or invasive. carcinoma identified. H: Gallbladder, cholecystectomy. - Gallbladder, focal chronic cholecystitis, no stones. identified, no carcinoma. identified. I: Stomach, duodenum and pancreas, en bloc Whipple resection. Tumor histologic Type: adenocarcinoma. Histologic grade moderately differentiated. Tumor size: 4.5 cm. Extent of invasion: - Peripancreatic soft tissues : positive (peripancreatic fat, IS,. 16, I15). - Duodenum: wall involved (I11, I12). - Ampulla wall involved (I11). Lymphatic Invasion: not identified. Venous Invasion: not identified. Perineural Invasion: not identified. Surgical margins : - Pancreatic neck: negative (4 mm to inked margin, I13). - Bile duct: negative (I1). - Circumferential/deep : negative (<1 mm to inked margin (I15) ). - Proximal (gastric) : negative (I3, I4). - Distal (duodenal) : negative (I2). Regional lymph nodes: metastatic adenocarcinoma (2/11) larger. metastasis 6 mm diameter, without extracapsular extension. Additional findings focal pancreatic parenchymal fibrosis and. atrophy,. focal peri-common bile duct acute inflammation (I1) . AJCC Stage: pT3 pN1 pMx. Note: This pathologic stage assessment is based on information. available at the. time of this report, and is subject to change pending clinical. review and. additional information. Intraoperative Consult Diagnosis: Frozen sections were requested by Dr. in. year-old. with pancreatic head mass. FSA1 Liver, segment 7, biopsy. - Benign liver with cholestasis, no tumor seen. FSB1 : Liver, segment 3, medial, biopsy. - Benign liver with cholestasis, no tumor seen. FSC1: Liver, segment 2, biopsy. - Benign liver with cholestasis, no tumor seen. FSD1 : Common bile duct margin, biopsy. - No tumor seen. FSE1 : Pancreatic duct margin, biopsy. - At least carcinoma in situ, focally suspicious for invasive. carcinoma. FSF1: Pancreatic margin, additional, biopsy. - Pancreatic parenchyma, no duct for evaluation. FSG1 : Pancreatic margin #3, biopsy. - No tumor seen. Frozen Section Pathologist: Clinical History : Not dictated. Gross Description: Specimen A is received fresh for frozen section and is a 7 X 5 X. 2 mm red/brown. soft tissue fragment, which was frozen as FSA1, NTR. Specimen B is received fresh for frozen section and is a 10 X 7. X 3 mm red/brown. soft tissue fragment, which was frozen as FSB1, NTR. Specimen C is received fresh for frozen section and is a 6 X 1 X. 1 mm red/brown. soft tissue fragment, which was frozen as FSC1, NTR. Specimen D is received fresh for frozen section and is a 9 X 6 X. 4 mm red/brown. soft tissue fragment, which was frozen as FSD1, NTR. Specimen E is received fresh for frozen section and is a 4 x 3 X. 2 mm pink/tan. soft tissue fragment, which was frozen as FSE1, NTR. Specimen F is received fresh for frozen section and is a 6 X 4. X. 2 mm red/tan. soft tissue fragment, which was frozen as FSF1, NTR. Specimen G is received fresh for frozen section and is a 2.5 X. 0. 8 x 0.3 cm. red/tan soft tissue fragment, with a stitch on one side. indicating the true. margin. The surface is inked blue. The specimen was frozen as. FSG1, NTR. Specimen H was received in a formalin-filled - container labeled. ""gallbladder"". Previously opened The presumed cystic duct is widely patent. The remainder. of the gallbladder appears complete. Measurements 10. X 3.6 X 2.0 cm. External surface: Roughened on the hepatic surface, but. otherwise. pink/tan, subtly discolored green, smooth and glistening and. unremarkable. Wall thickness : 2.5 mm on average. Mucosa: Green/brown, velvety and unremarkable with no mucosa. mass. lesions readily identified. Stones present Not identified. Other comments: Gallbladder is partially filled with sticky,. viscous. dark brown/green bile. This bile is adherent to the mucosa. Block # : H1. Specimen I : Specimen fixation: Formalin. Specimen type: Unspecified, but believed to be standard Whipple. Orientation: Inking : common bile duct/yellow, pancreatic. margin/blue, uncinate margin/black, body/green, gastric. margin/orange, duodenal. margin/red. Tumor location: Pancreatic head. Gross appearance of tumor: Solid pale yellow/white mass lesion. encompassing the majority of the pancreatic head. There are no. areas of. necrosis, hemorrhage or calcification readily identified. Tumor dimensions : 4.5 x 2.0 x 3.0 cm. Extent of invasion. Confined/nonconfined to the pancreas: Grossly the tumor appears. to. be invading through the duodenal wall and distorting the. duodenal mucosal. This. occurs in the areas of the ampulla. Involvement of the ampulla: Not grossly involved. Involvement of the duodenum: Present. Involvement of the bile duct : Absent. Involvement of adjacent blood vessels: N/A. Spleen (if applicable) : N/A. Duodenum (if applicable) : N/A. Gallbladder (if applicable) : N/A. Stomach (if applicable) : Not involved. Surgical margins: Pancreas: Blue inked pancreatic surgical margin, focally. close. Bile duct : Negative. Proximal (small bowel or stomach) margin: Negative. Distal (small bowel) margin: Negative. Peripancreatic soft tissues: Green inked pancreatic margin. focally. close. Lymph nodes : Multiple lymph node candidates are identified. from approximately 3 X 3 x 3 mm to 1.0 X 0.6 X 0.4 cm. Other remarkable findings The gastric serosa is red/tan, smooth. and glistening and unremarkable. The gastric wall is 2 mm thick. on average and the mucosa is red/tan with normal architecture. The duodenal serosa is red/tan, smooth and glistening and. unremarkable. The duodenal mucosa is dark brown/tan, glistening. with normal architecture. No duodenal abnormalities are readily. appreciated. There is some chalky yellow/white discoloration to. the pancreatic parenchyma in the distal pancreas, this may. represent fat necrosis. Digital photograph taken : No. Tissue submitted for special investigation: Tumor was given to. tissue. Block Summary : Inking : common bile duct/yellow, pancreatic margin/blue,. uncinate margin/black,. body/green, gastric margin/orange, duodenal margin/red. Il - common bile duct margin en face. I2 - duodenal margin en face. I3 - I4 - majority of gastric margin en face. I5 - I6 - perpendicular section to blue inked pancreatic body. margin. I7 - black inked uncinate margin en face. I8-I10 - - duct from ampulla towards margin, respectively. I11 - tumor involving duodenum. I12 - additional tumor and duodenum. I13 - additional tumor. I14-I15 - - distal pancreas surrounding adipose tissue (? Fat. necrosis. present). I16 - stomach. I17 - duodenum. I18 - one lymph node candidate from area of common bile duct. margin,. sectioned. I19-I20 - one lymph node candidate sectioned (adjacent to. inferior pancreas). I21-I22 - - one peripancreatic lymph node candidate, sectioned. I23 - one lymph node candidate, sectioned. I24 - one lymph node candidate, sectioned. I25 - one lymph node candidate, sectioned. I26 - one lymph node candidate. I27-I29 - - additional adipose tissue. Light Microscopy. Light microscopic examination is performed by Dr. The frozen section diagnoses are confirmed. Pancreatic duct. carcinoma in situ is identified, with associated invasion of. pancreatic parenchyma, with extension into peripancreatic fat. and wall of duodenum near the ampulla of Vater. Metastatic carcinoma is identified in nodes in blocks I18 and. I19."
BIOCUP_00361,liver,LIHC,TCGA-DD-A4NB,TCGA-DD-A4NB.963CA9F8-DA47-4E2E-892E-14E7AB0EB76E,"DIAGNOSIS: A. Lymph node, cystic duct, biopsy: A single cystic duct lymph. node is negative for tumor. B. Cystic duct stump, excision: Negative for tumor. C. Liver, segments VI and VII, polysegmentectomy Fibrolamellar. hepatocellular carcinoma is identified forming a lobulated mass. (10.2 x 8.3 x 7.4 cm) The tumor is confined to the liver. The. liver parenchyma surgical resection margin is negative for tumor. (minimum tumor free margin, 0.5 cm) Macroscopic large vessel. invasion is absent. Microscopic invasion is absent. The. non-neoplastic hepatic parenchyma is unremarkable. D. Lymph nodes, hepatoduodenal ligament, biopsy: Multiple (10). hepatoduodenal ligament lymph nodes are negative for tumor. With available surgical material, [AJCC pT1NO] (7th edition,. Photographed."
BIOCUP_00362,liver,LIHC,TCGA-ZS-A9CG,TCGA-ZS-A9CG.8A0E7BA8-7262-4832-89DA-61893BE4B458,"Nature of Specimen (s). 1. Extended right hepatectomy for presumed primary hepatocellular. carcinoma. 2. Gallbladder. Clinical Information Supplied. Large ?primary liver tumour. Recent sigmoid colectomy for. carcinoma. Per TSS, the path ON the sigmoid colectomy PROCUREMENT DATE. Macro Report. Liver Resection Dataset. Gross description. Type of specimen: Non-anatomic (wedge) resection. Site/Segment of origin: Right. Specimen dimension: 200 x 180 x 110mm. Number of tumours present : 1. Maximum tumour diameter : 85mm. Satellite tumour present : Distance from nearest hepatic. resection margin: 12mm. Macroscopic involvement of vessels : Liver capsule intact and smooth: No, see comment. Invasion of adherent or adjacent. organ: Lymph nodes received: ACKNOWLEDGEMENT OF RECEIPT. WARD SECRETARY. DOCTOR. Comments and block codes. Received is a portion of liver measuring 200x180x up to 110mm. Slicing reveals a tumour closely abutting the serosal surface that. measures approximately 85x70x60mm. The serosal surface is puckered. but there is no evidence of macroscpic invasion through the liver. capsule. The cut surface of the tumour is cream with a green tinge. and appears to have a fibrous capsule. The capsule is puckered but. there is no evidence of macroscopic invasion through the liver. capsule. Throughout the rest of the liver there are multiple. distended vessels within portal tracts that appear to be filled. with cream-coloured tissue similar to that of the tumour. The. tumour lies 12mm away from the resection margin which is inked. blue. The background liver does not appear obviously cirrhotic. Within the background liver a single other cream coloured nodule. is noted that does not seem to be associated with a portal area. that measures 4mm in maximum dimension. Blocks taken: 1A-1H representative sections through the tumour;. 1I section of other nodule noted; 1J-1L representative sections. through the dilated vessels in the background liver; 1M normal. background liver. 2. A gallbladder containing bile with no obvious focal lesions. identified. Histology. Tumour type: Hepatocellular carcinoma NOS. Tumour grade/differentiation. by worse area: Moderate. Tumour cells present at margin: If margin is clear: is clearance >10mm: Yes. Macroscopic vascular invasion. confirmed: ACKNOWLEDGEMENT OF RECEIPT. WARD SECRETARY. DOCTOR. Microscopic vascular invasion. identified: Evidence of response to. preoperative treatment: N/A. Background liver. Fibrosis: : None present. Aetiology : Not known, see comment. Comments. A single tumour is surrounded by a fibrous capsule and consists of. sheets of hepatocytes with loss of the normal liver architecture. There is evidence of cytological atypia and nuclear pleomorphism. In some areas of the tumour there is formation of variably sized. gland like structures. Outwith the tumour multiple foci of. lymphovascular invasion are identified. There is no significant. bile production by the tumour. The features are those of a. hepatocellular carcinoma. Within the surrounding normal liver there is evidence of chronic. inflammation and regenerative liver nodules. Within the portal. areas through the rest of the liver there is evidence of portal. vein distention. The portal vein branches are completely full of a. foreign body giant cell reaction to embolic material. There is no evidence of fibrosis within the background liver. There is some mild steatosis and mild chronic inflammation within. the portal areas. A Perl's stain for iron does reveal scattered. iron deposition within hepatocytes. There is no evidence of any. obvious underlying pathology to suggest the aetiology of this. hepatocellular carcinoma. However, the presence of iron within. hepatocytes does raise the possibility of a iron storage disorder. and clinical correlation is advised. Pathological staging: pT2, pNx, pMx. 2. Sections show a heavily autolysed gallbladder but with no. evidence of malignancy. ACKNOWLEDGEMENT OF RECEIPT. WARD SECRETARY. DOCTOR. Signature of Pathologist (s). ACKNOWLEDGEMENT OF RECEIPT. WARD SECRETARY. DOCTOR."
BIOCUP_00363,liver,LIHC,TCGA-EP-A26S,TCGA-EP-A26S.078A6815-B1E3-47F5-A49B-C06B7D47F5E8,"DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE. Date Coll. SPECIMEN. A. Gastrohepatic lymph node. B. Left lateral segment, stitch anterior. CLINICAL NOTES. PRE-OP DIAGNOSIS: Liver cancer. GROSS DESCRIPTION. A. Received fresh labeled ""gastroheptic lymph node"" are. two rubbery tan-red tissues in keeping with lymph nodes. averaging 1 cm in greatest dimension. The specimens are bisected. and entirely submitted independently in two blocks (one bisected. node per cassette) . B. Received fresh for tissue procurement labeled ""left. lateral segment, stitch anterior"" is a wedge shaped 12. x. 5.8 x 3.5 cm portion of focally cauterized red-brown liver. parenchyma with a single suture designating anterior as stated. previously. A palpable slightly protuberant lesion is noted along. the anterior surface of the specimen. The anterior and posterior. aspects in the vicinity of the mass are inked orange. The hepatic. capsule is focally cauterized smooth to scabrous tan pink-red. On. sectioning, there is a well circumscribed, 4.2 x 3 x 3 cm golden. brown mass lesion which extends to within 1 cm of the inked. cauterized resection margin (blue) and is within 0.25 cm of the. inked capsular surface, both anteriorly (blocks 4 and 5) and. posteriorly (blocks 6 and 7) A portion of tumor and a portion of. normal parenchyma are submitted for tissue procurement as requested. The parenchyma throughout the remainder of the specimen is uniform. red brown without additional mass lesion or abnormality. Representative sections are submitted in ten blocks as labeled. RS-10. BLOCK SUMMARY: 1-3 - Tumor to inked margin of resection; 4-7 -. tumor to inked capsular surface; 8-10 - random from remainder of. specimen. MICROSCOPIC DESCRIPTION. A., B. Microscopic examination of the left lateral segment. of liver partial hepatectomy as well as the separately. submitted gastrohepatic lymph nodes reveals: Histologic type: Hepatocellular carcinoma. Histologic grade: 2 of 4 (moderately-differentiated) . Tumor size: 4.2 cm. in greatest dimension. Primary tumor (pT) : No extension beyond the hepatic parenchyma is. identified. No lymphatic space invasion is identified. (pT1). Margins of resection: Negative for tumor. Vascular invasion: A focal area suggestive of vascular invasion is. identified in slide B1. No staining around tumor cells with CD31,. CD34, or D2-40 immunohistochemical stains was identified. Multiple levels were examined and no diagnostic vascular invasion. was seen. Regional lymph nodes (pN) : The two gastrohepatic lymph nodes. submitted in specimen A are both negative for tumor (pNO) . Distant metastasis (pM) : Cannot evaluate, pMx. Other findings: The tumor is notable for steatosis and bile. accumulation within acini. The background hepatic parenchyma is. notable for some mild non-specific chronic portal inflammation. No. background hepatocellular necrosis is identified. No significant is. background steatosis is identified. No iron accumulation. identified. There is a significant amount of lipofuscin granules. No PAS positive diastase resistant alpha-1 antitripsin globules. are identified. No. hyaline is identified. Trichrome,. reticulin, PAS, PAS with diastase and iron stains were evaluated. on block B9. 3, 4, 18x5, 20x3. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have. not been cleared or approved by the FDA.]. DIAGNOSIS. A. Gastrohepatic lymph nodes, biopsy: Two lymph nodes negative for malignancy. Lipogranulomatous inflammation present. Liver, left lateral segment, partial hepatectomy: Hepatocellular carcinoma, moderately-differentiated (grade. 2). Solitary tumor, 4.2 cm. in size. No lymphovascular space. invasion identified (pT1). Margins of resection negative for tumor. Background hepatic parenchyma with non-specific grade 1 of 4. chronic hepatitis with no significant fibrosis. miscronic Signature). End Of Report ---."
BIOCUP_00364,liver,LIHC,TCGA-DD-AACK,TCGA-DD-AACK.B41B7C44-ED04-46EB-AD41-271456ECA762,"CLINICAL DIAGNOSIS: HCC. Specimen : Liver. Gross Photo : GROSS: 1. Specimen: Liver: 10.0 x 9.5 x 5.5 cm, 169.5gm, unfixed. 8.0 X 6.0 X 5.2 cm, 66.0 gm, unfixed. 2. Tumor location: right. Tumor number: One. Tumor size: 5.3 x 4.9 X 5.5 cm. 3. Satellite nodule: no. 4. Gross type. HCC: expanding nodular. 5. Tumor necrosis: no. 6. Hemorrhage/peliosis: yes (5-10%). 7. Portal vein invasion: no. 8. Bile duct invasion: no. Gross photo present. Blocks. TB, T1-5, tumor mass X 6. NB, A, non-tumorous tissue X 2. RM, resection margin X 1. MICROSCOPIC: 1. Hepatocellular carcinoma: 1-1. Differentiation. The worst differentiation II. The major differentiation II. 1-2. Histologic type: trabecular. 1-3. Cell type: clear. 1-4. Fatty change: no. 2. Fibrous capsule formation: complete capsule. 3. Capsular infiltration: no. 4. Septum formation: yes. 5. Surgical resection margin invasion: no, margin of the clearence (3.0 mm). 6. Serosal invasion: no. 7. Portal vein invasion: no. 8. Bile duct invasion: no. 9. Hepatic vein invasion: no. 10. Hepatic artery invasion: no. 11. Microvessel invasion: yes. 12. Intrahepatic metastasis: no. 13. Multicentric occurrence: no. NOT reported. Gross: Urine, smear, negative. Urine, smear, negative. Urine, smear, negative. Liver, ectomy, hepatocellular carcinoma, cirrhosis. T56000, P10, M81703, M49500. DIAGNOSIS: Liver, right lobe, lobectomy: Hepatocellular carcinoma, well differentiated. Cirrhosis. Suggestion :"
BIOCUP_00365,liver,LIHC,TCGA-BC-A216,TCGA-BC-A216.28CDABB8-3172-4676-8F4A-8B91F2B8D85F,"Diagnosis: A: Liver, right lobe, extended right hepatic lobectomy. - Hepatocellular carcinoma, moderately differentiated, with. subset coagulative. necrosis (20%). - Multifocal, largest nodule 7.5 cm diameter. - Invasive carcinoma involves capsule and margin at focus of. superior gross. capsular disruption (block A9). - Vascular invasion - not identified. - Surgical margins - Focally positive at superior gross capsular. disruption. (block A9), other margins negative (see Light Microscopy). - Non-neoplastic parenchyma - mild portal chronic inflammation,. without. significant fibrosis. - AJCC staging: pT3 pNx pMx. B: Liver, segment 2 margin, excision. - Hepatic parenchyma, no carcinoma identified. C: Liver, segment 3 margin, excision. - Hepatic parenchyma, no carcinoma identified. D: Diaphragm, NOS, excision. - Fibrous tissue and skeletal muscle with granulation tissue and. chronic. inflammation. - No carcinoma identified. E: Gallbladder, cholecystectomy. No specific histologic abnormality. - No carcinoma identified. Clinical History: -year-olo female with HCC in the right liver. Liver tumor. Interval increase. in size of the solitary large right hepatic lobe mass concerning. for. hepatocellular carcinoma with involvement of the right portal. vein. Gross Description: Received are five appropriately labeled containers. Container A is additionally labeled ""extended right lobectomy"". and is a 3,190. gram, 29 X 22 X 10 cm lobe of liver, red/tan, focally. erythematous and adhesed. capsular surface. The capsule is intact with the exception of. three foci of. disruption (2 superior, 1 inferior) that have been inked yellow. The parenchymal. margin is inked blue in addition to an adjacent portion of this. specimen,. containing an embedded staple line that is remarkable for tumor. encapsulated. within thin membranous tissue (true margin ?). Serial sectioning. demonstrates a. 21 X 16.5 x 10.5 cm well-circumscribed necrotic white/yellow. mass with diffuse. hemorrhage and a central 7.5 x 7 X 5.5 cm stellate, firm fibrous. component. The. mass grossly abuts, but is confined by the capsular surface and. at closest. approach, is 0.3 cm from the parenchymal margin. The uninvolved. parenchyma is. yellow/tan with a nutmeg appearance and is remarkable for a 3 X. 2 X 1.5 cm focus. of clustered white/pink, well-circumscribed satellite lesions. The cluster is. located 4.0 cm from the larger mass, 1.0 cm from the parenchymal. margin, and 0.2. cm from the overlying capsule. Block Summary. A1 - Mass with respect to parenchymal margin. A2 - Mass with respect to capsule. A3 - Representative from questionable margin. A4 - Representative fibrous area of mass. A5 - Mass with respect to normal uninvolved. A6-A7 - - Representative central sections of mass. A8 - Representative cluster of lesions. A9 - Representative capsular disruption (one of the two superior. disruptions). A10 - Representative normal uninvolved. A portion of tumor and normal tissue were sent for tissue. Container B is additionally labeled ""segment 2 margin, stitch. marks margin"", and. is a 3.5 X 1.5 x 0.7 cm fragment of tan/red soft tissue. containing a suture on. one of its surfaces indicated as the final margin per the. requisition (inked. blue) . The opposing cut surface is inked black and the specimen. is serially. sectioned to reveal a grossly unremarkable tan/pink cut surface. with no discrete. masses or lesions. The specimen is submitted entirely in blocks. B1 and B2. Container C is additionally labeled ""segment 3 margin, stitch. marks final. margin"", and consists of two fragments of pink/tan soft tissue. containing a. suture on one of their surfaces indicated as the final margin. per the. requisition. The first fragment is 6.2 x 2.7 x 0.3 cm in. dimension. The final. margin is inked blue and the opposing cut surface is inked. black. The second. fragment is 5.9 x 2.6 x 0.4 cm in dimension, The final margin is. inked blue and. the opposing cut surface is inked green. Both fragments are. serially sectioned. to reveal a grossly unremarkable tan/red cut surface with no. identifiable masses. or lesions. The first fragment is submitted entirely in block. C1-C3 and the. second fragment is submitted entirely in block C4-C7. Container D is additionally labeled ""diaphragm"" and is a 2 x 2. 0.6 cm aggregate. of two fragments of red/pink soft tissue. The fragments are. sectioned to reveal. a grossly unremarkable cut surface and are submitted entirely in. blocks D1 and. D2, respectively. Specimen E: Previously opened: No. Measurements: 8.5 x 3.3 X 1.3 cm. External surface: Pink/tan, smooth and glistening with focal. erythema. and gray/green discoloration within the body. Wall thickness: 0.2 cm. Mucosa: Pink/tan and velvety with diffuse yellow/gold stippling. Stones present: No. Other comments: The lumen is filled with a viscous red/orange. fluid. Block #: E1. Light Microscopy: Light microscopic examination is performed by Dr. Hepatocellular carcinoma is present, with trabecular. architecture, plate. expansion, nuclear pleomorphism, and variable nucleolar. prominence. Rare. mitotic figures and apoptotic nuclei are present. Background. liver does not. appear cirrhotic. We do not know whether the superior capsular. disruption. sampled in block A9 is superseded by the separately submitted. diaphragm in D. Resident Physician. Attending Pathologist: MD PHD. I have personally conducted the evaluation of the above. specimens and have. rendered the above diagnosis (es) ."
BIOCUP_00366,liver,LIHC,TCGA-WX-AA47,TCGA-WX-AA47.473868C8-CFDF-42E6-B6DC-48A737697D07,"DEPARTMENT OF. PATHOLOGY. Clinical History and Impression: female for left hepatectomy. Liver mass. Specimen(s) Received: LIVER TUMOR. FINAL DIAGNOSIS. LIVER, 1300 GRAMS, LEFT HEPATECTOMY: - MODERATELY DIFFERENTIATED HEPATOCELLULAR CARCINOMA, AT LEAST. 14 CM, ARISING IN A HEPATOCELLULAR ADENOMA ADENOMA, 17.3. - THE RESECTION MARGIN IS NEGATIVE FOR CARCINOMA; CARCINOMA IS. 0.7CM FROM THE RESECTION MARGIN. CARCINOMA INVADES INTO THE LIVER CAPSULE. - PERICAPSULAR ORGANIZING AND FIBROUS ADHESIONS TO SMOOTH. MUSCLE OF GASTRIC WALL; NO GASTRIC MUCOSA PRESENT. - NO HEPATOCELLULAR CARCINOMA IS SEEN IN THE ORGANIZING FIBROUS. ADHESIONS OR THE GASTRIC WALL. - MULTI-FOCAL SMALL AND LARGE VENOUS INVASION IS PRESENT. - PATHOLOGIC TUMOR STAGE: pT3A Nx Mx Stage IIIA. - NON NEOPLASTIC LIVER. - MILD PORTAL INFLAMMATION. - NO SIGNIFICANT PORTAL FIBROSIS. - MARKED TELANGIECTASIA AND CONGESTION. MICROSCOPIC DESCRIPTION: The specimen is largely replaced by a hepatocellular. neoplasm with a heterogenous appearance, grossly and histologically. The. liver tumor is multinodular with areas of extensive hemorrhage and necrosis. The malignant hepatocytes are arranged in thickened cords with nuclear. atypia and mitosis with some areas of classical trabecular HCC. Areas of. extensive pseudoglandular architecture are also present as are areas of. diffuse intracytoplasmic vacuolar inclusions, resulting in a signet ring cell like. morphology. There are also extensive steatotic neoplastic hepatocytes with. cytoplasmic bile inclusions as well as some malignant cells with Mallory. hyaline. In some of the slightly more peripheral nodules, benign hepatocytes. have areas of FNH like architecture with proliferating ductules along fibrous. septa. In one of these foci, a nodule of definite HCC is present. Multifocal. venous invasion is seen (large and small) with at least one nodule of HCC. adhering to the endothelium. Areas of the nodules lack the cytologic and. architectural atypia to be considered HCC and appear to represent the. background adenoma. Immunohistochemical characterization is similarly heterogenous with areas of. steatotic hepatocytes within the nodule expressing amyloid A stain while other. areas with the FNH like architecture are negative for amyloid A. Glutamine. synthetase has a geographic staining pattern in apparently hepatocellular. adenoma like areas, with strong diffuse staining in steatotic and trabecular. HCC. Glypican 3 is negative throughout, while HSP 70 is positive in trabecular. HCC (focally in the same area as the glutamine synthetase). The non-neoplastic liver has intact architecture (supported by trichrome and. reticulin stains) with mild portal inflammation and patchy portal fibrosis. The. lobules have marked sinusoidal dilatation and congestion without other. significant inflammatory changes or steatosis. DPAS and Iron stains have no. significant positivity. Hepatitis B core and surface antigen stains are negative. INTERPRETATION: The findings are most consistent with hepatocellular carcinoma arising. in a hepatocellular adenoma. The non-neoplastic liver lacks features of chronic. hepatitis or cirrhosis. SYNOPTIC SUMMARY. Procedure: Partial hepatectomy. Major hepatectomy (3 segments or more). Specimen: Liver. Tumor Size: Greatest dimension: 14 cm. Tumor Focality: Solitary. Histologic Type: Hepatocellular carcinoma. Histologic Grade: GII: Moderately differentiated. Tumor Extension: Tumor involves a major branch of the portal vein. Margins: Parenchymal margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 7 mm. Lymphovascular Invasion: Macroscopic Venous (Large Vessel Invasion (V): Present. Microscopic (Small Vessel) Invasion (L): Present. Pathologic Staging (PTNM): Primary Tumor (pT): pT3b: Single tumor or multiple tumors of any size involving a major branch of the portal. vein or hepatic vein. Regional Lymph Nodes (pN): pNX: Cannot be assessed. Pathologic Stage (AJCC 2009, 7th edition): Stage IIIA. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Arises in adenoma. This electronic signature indicates that the pathologist has personally reviewed the available gross and/or microscopic material and has. based the diagnosis on that evaluation. Gross Specimen. Gross Specimen. It. Gross Specimen. Gross Sp√©cimen. Gross Description: Received fresh, labeled with the patient's name and ""liver tumor, stitch=inferior"" is a 1300 gm, 18 x 15 x 8 cm portion of. liver with a stitch designating inferior and a 2.5 x 0.8 x 0.3 cm portion of stomach with a staple line attached to the liver. capsule. The staple line is removed and the resection margin of the stomach is inked blue. The serosal surface is tan-red. and smooth. The resection margin is inked yellow and the specimen is sliced from inferior to superior to reveal a 17.3 x 14. x 8.5 cm heterogenous, well-circumscribed, multinodular tumor. The nodules range from 0.2 cm to 7 cm and are focally. hemorrhagic and necrotic with scarring. The tumor abuts the serosa and is 1.2 cm to the closest resection margin. Multiple. satellite nodules ranging from 0.1 cm to 1 cm are noted around the tumor. Minimal unremarkable liver parenchyma is. present. The specimen is fixed overnight. Representative sections are submitted, as follows: cassettes #1-3=tumor to. resection margin, cassettes #4-16=sections from tumor (with cassettes #5-7=largest nodule and cassettes. #8-9=hemorrhagic and scar area ), cassette #17=sections from tumor, cassettes #18-19=tumor to adjacent liver. parenchyma and cassette #20=uninvolved liver parenchyma. Sections from the stomach to the attached liver is submitted. in cassette #21-22. Summary of Stains Performed and Reviewed. Count. Amyloid A. 2. Amyloid A. 2. Beta Catenin. 2. Diastase PAS. 1. Glutamine Synthetase. 2. Glypican-3. 1. H&E, Recut, Level. 10. Hepatitis B, core antigen. 1. Hepatitis B, surface antigen. 1. HSP-70. 1. Negative Control. 3. Prussian Blue (Iron). 1. Reticulum, Gordon. 2. Trichrome, Klatskin. 1. The immunohistochemical profile may include the use of Analyte Specific Reagents, or Research Agents, whose performance characteristics have not been established by the. supplier. The histochemical tests were developed and their performance charac(eristics were determined by the. It has not been cleared or. approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearence or approval is not necessary for this. test. inese tests are used for clinical. purposes and should not be regarded as investigational or for research. This laboratory is regulated under the Clinical Laboralory improvements Amendments. of. 1988. (CLIA). as. qualified to perform high complexity clinical lesting. External and Internal controls stained appropriately. Summary of Tissue Submitted for Microscopic Examination. Block Detail. # Blocks. Designation. #. Description. Part 1] LIVER TUMOR. 48. [Undes]. (48). (No Description)."
BIOCUP_00367,liver,LIHC,TCGA-MR-A8JO,TCGA-MR-A8JO.DA03F6F5-2579-45B7-954B-8C0F8EFD0F75,"Normal Blood ID: SPECIMEN(S): A: Left lower liver and tumor. B: Lesser curvature lymph nodes. C: Gallbladder. FINAL DIAGNOSIS: A. Left lower liver and tumor, Left hepatectomy: - Hepatocellular carcinoma, fibrolamellar variant, 13.5 cm. - Margins: Negative for carcinoma. - Non-neoplastic liver parenchyma with mild portal inflammation. - See cancer checklist and comment. B. Lesser curvature lymph nodes, excision: - One lymph node, negative for carcinoma (0/1). C. Gallbladder, cholecystectomy: - Chronic cholecystitis. COMMENT: The immunohistochemical stains performed with adequate controls shows. that tumor cells are positive for CK7 and CD68, supporting the above. diagnosis. Cancer checklist: Specimen: Liver. Procedure: Partial hepatectomy. Tumor Size: 13.5 X 12.5 X 8.0 cm. Tumor Focality: Solitary. Histologic Type: Fibrolamellar hepatocellular carcinoma. Histologic Grade: GIII, Poorly differentiated. Tumor Extension: Tumor confined to liver. Margins: Uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest parenchyma margin: 2 cm. Lymph-Vascular Invasion: Not identified. Macroscopic Venous (Large Vessel) Invasion (V): Not identified. Microscopic (Small Vessel) Invasion (L): Not identified. Perineural Invasion: Not identified. Regional Lymph Nodes (pN): Number of Lymph Nodes Examined: 1. Number of Lymph Nodes Involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Mild portal inflammation. Pathologic Staging (pTNM): pT1 NO Mx. CLINICAL HISTORY: The patient is a -year-old male with left renal mass. Operative. Procedure: Partial hepatectomy. GROSS: Three formalin-filled containers are received, each labeled with the. patient's name and hospital identification number. A. The first container is received fresh and subsequently saved. in formalin in the container labeled ""A-left lower liver tumor. short-stitch superior, long-stitch anterior."" The specimen consists of. a 957 gm partial hepatectomy specimen measuring 15.5 cm from medial to. lateral, 15 cm from anterior to posterior, and 8.0 cm from superior to. inferior. The hepatic capsule is yellow-brown, smooth and mostly. occupied by a multinodular large mass. The specimen is oriented with a. short-stitch at superior and long stitch at anterior. On sectioning,. reveals a 13.5 x 12.5 X 8.0 cm, yellow-red variegated large mass. Focal. small cystic areas ranging from 0.1 to 0.5 cm in greatest dimension are. noted. The solid area is mostly yellow and focally red hemorrhages. Multifocal dark red and friable possible thrombi are noted ranging from. 0.5 to 1.0 cm in greatest dimension. The large mass is abutting to the. hepatic capsule surface; however, it is complete and intact. This mass. is moderately well defined and 2.2 cm to the closest parenchymal margin. and 2.7 cm to the hepatic vein and artery margins. This mass is. occupying 90 percent of total specimen and the remaining hepatic. parenchyma is yellow-brown with no cirrhotic changes. The specimen is. photographed and representative sections are submitted. Summary of Sections: A1 - vascular margins. A2-A3 - mass with closest parenchymal margin. A4-A5 - mass with thrombi. A6 - mass with yellow necrosis. A7-A8 - mass with surrounding hepatic parenchyma. A9 - mass. A10 - uninvolved hepatic parenchyma. B. The second container is received fresh for intraoperative. consultation and labeled ""B-lesser curvature lymph node."" The specimen. consists of a 1.2 X 0.8 X 0.6 cm lymph node. The specimen is entirely. submitted for frozen sections and remnants in B1FS. C. The next container is received in formalin and labeled. ""C-gallbladder."" The specimen consists of a 6.3 X 3.5 x 2.5 cm intact. gallbladder. The serosa is red-purple-green and smooth. The adventitia. is red-tan, which is inked black. The gallbladder is opened to reveal. approximately 20 mL dark green viscous bile in the lumen. The mucosa is. dark green and velvety. The cystic duct is patent and unremarkable. The gallbladder wall is 0.2 to 0.3 cm in thickness. No calculi are. identified. Representative sections to include cystic duct, fundus and. neck are submitted in C1. INTRAOPERATIVE CONSULTATION: FROZEN SECTION DIAGNOSIS: AFS1: Lesser curvature lymph node. ""No evidence of carcinoma."". MICROSCOPIC: Permanent sections confirm the frozen section diagnosis."
BIOCUP_00368,liver,LIHC,TCGA-DD-AADK,TCGA-DD-AADK.DD514735-20C6-49AE-BD02-5D08C6C61523,"CLINICAL DIAGNOSIS: R/O HCC. Specimen : liver. Gross Photo : GROSS: Specimen status: Fresh. Operation: Partial resection of the mass located in the segment 3. Wedge resection of the mass located in the segment 7. Organ: Liver. Segment 3 (5.5 X 4.0 X 3.0 cm, 30.0 gm). Segment 7 (4.0 X 2.0 X 1.5 cm, 10.9 gm). Lesions: [Mass 1]. Tumor location: Segment 3. Size: 3.5 X 2.5 X 2.5 cm. Cut surface: Well demarcated, pale tan, solid and lobulated mass. Gross type: Multinodular confluent. Extent: Bulging by mass, but smooth. Resection margin: Not involved, grossly (safety margin: 1.1 cm). [Mass 2]. Tumor location: Segment 7. Size: 0.9 X 0.8 X 0.8 cm. Cut surface: Well demarcated, homogenous, pale tan and solid mass. Gross type: Multinodular confluent. Extent: Bulging by mass, but smooth. Resection margin: Not involved, grossly (safety margin: 0.6 cm). Remaining parenchyme: Cirrhosis. Representative sections submitted. Gross photo: Present. Ink key: Resection margins: Green. Capsular surface: Black. Blocks. T1-4, mass of segment 3 [Mass 1] X 4. T5-6, mass of segment 7 [Mass 2] x 2. RM, resection margin of segment 3 X. 1. L, nontumorous liver parenchyme X 1. X1-2, fibrofatty tissue x 2. MICROSCOPIC: [Mass 1]. Tumor location: Segment 3. Tumor type: Hepatocellular carcinoma. The worst differentiation III. The major differentiation III. Histologic type: Trabecular, insular. Cell type: Hepatic. Fatty change: Yes. Cholangiocarcinoma: No. Fibrous capsule formation: No. Septum formation: Yes. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Vascular invasion: Yes. Bile duct invasion: No. [Mass 2]. Tumor location: Segment 7. Tumor type: Hepatocellular carcinoma. The worst differentiation III. The major differentiation II. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: Yes. Cholangiocarcinomal No. Fibrous capsule formation: No. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Vascular invasion: No. Bile duct invasion: No. Remaining liver parenchyme: Cirrhosis, mixed steatosis, mild. NOT reported. Gross: Cervix, smear, inflammation, atrophy. Cervix, smear, inflammation, atrophy. Cervix, smear, inflammation, atrophy. Cervix, smear, inflammation. Cervix, smear, atrophy. Cervix, smear, atrophy. Cervix, smear, atrophy. stomach,body,scopic,erosion,chronic gastritis. Large intestine, ascending colon, ectomy, hyperplastic polyp. liver,resection,hepatocellular carcinoma. T56000, P17, M81703. DIAGNOSIS: Liver, segment 3, partial resection: Hepatocellular carcinoma. Liver, segment 7, wedge resection: Hepatocellular carcinoma. Suggestion :"
BIOCUP_00369,liver,LIHC,TCGA-G3-A25T,TCGA-G3-A25T.BC6447AE-5740-437A-987E-5ECB891667FE,"LABORATORY SERVICES. Patient ID: PHN: ALT ID: Telephone: Requesting Physician: Encounter: Chart ID: HISTOPATHOLOGY REPORT. Division Head: ORIGINAL REPORT. SPECIMEN: A: Right liver and segment 4. CLINICAL HISTORY: MRI liver mass 12.0 cm x 8.0 cm (subscapular) . DIAGNOSIS: A. RIGHT LIVER AND SEGMENT 4: HEPATOCELLULAR CARCINOMA. GRADE 2, pT3 (TUMOR MEASURES 9.8 CM IN MAXIMUM DIMENSION) . BENIGN CAVERNOUS HEMANGIOMA. BENIGN BILE DUCT HEMATOMA. GALLBLADDER AND LYMPH NODE WITHIN NORMAL LIMITS. SEE MICROSCOPIC DESCRIPTION. 1. (Electronic Signature). GROSS DESCRIPTION: A: The specimen is received fresh and submitted in formalin. The specimen. consists of a 1441 g lobe of liver measuring 17. 0 x 17.4 x 9.8 cm. The surface. of the specimen is smooth with a concave appearing neoplasm infiltrating the. surface of the specimen. This area measures 9.8 x 9.0 cm. This is white in. appearance and slightly necrotic. Surrounding this neoplasm on the surface is. a rim of hemorrhagic area. The specimen is serially sectioned to reveal that. this neoplasm is somewhat well circumscribed and measures 13.0 x 11.8 x 8.0. cm. This neoplasm has a homogeneous white/tan appearance. There is some slight. central necrosis. This neoplasm comes to within 0. cm of the surgical. resection margin, which has been painted black. Adjacent to this neoplasm is. another well circumscribed white/tan neoplasm measuring 1.4 x 1.2 x 1.2 cm. It. is located 1.0 cm from the largest neoplasm and also 1.0 cm from the resection. margin. Also identified attached to the surface of the specimen is a fibrous. cystic structure measuring 2.0 x 1.4 x 1.2 cm, which is open and contains what. appears to be green bile with an inner mucosal surface. Printed: Page 1 CONTINUED. LABORATORY SERVICES. Patient ID: PHN: ALT ID: Telephone: Requesting Physician: Encounter: Chart ID: HISTOPATHOLOGY REPORT. Division Head: GROSS DESCRIPTION: Please note the cections of the tumor and normal portions of liver are taken. for. Tumor Bank. Summary of sections: A1 to A8 - Representative sections of the neoplasm including closest points of. invasion to resection margin and surface of the liver capsule. A9 - Representative section of gallbladder. Portion of tissue attached tot he. liver. A10 - Representative section of the smaller above described nodule in closest. point of invasion to the resection margin. All - Representative section of normal-appearing liver parenchyma. MICROSCOPIC DESCRIPTION: Sections show infiltrative carcinoma with morphologic features of. hepatocellular carcinoma. The overall patterns are a combination of. trabecular and pseudoglandular. The nuclei are slightly enlarged and mildly. pleomorphic, however, the cells still have abundant cytoplasm. This would. correspond to a tumor grade of 2. One large nodule is present measuring 9.8. cm in maximum dimension. The gross appearance would correspond to the diffuse. type. The tumor is 0.7 cm from the nearest surgical resection margin. There. is moderate fibrosis within the tumor. Angiolymphatic invasion is not. identified in these sections. Mitotic rate is 6/10 HPF. The non-malignant. liver is unremarkable. One regional lymph node and the gallbladder are also. unremarkable. RESIDENT: Dr. Procedure:"
BIOCUP_00370,liver,LIHC,TCGA-BC-A10R,TCGA-BC-A10R.65BE2C95-CADA-44FC-9313-14529AFF773E,"CLINICAL INFORMATION. The patient is with a liver biopsy performed at an outside hospital which showed hepatocellular carcinomd. The patient now undergoes right hepatic lobectomy. GROSS DESCRIPTIONS. One appropriately labeled, formalin-filled, container is received. It contains a portion of right lobe of liver. weighing 321.2 grams and measuring 6.5 x 13.2 x 6.2 cm. cm. A small portion of tissue at the medial. side was sent for tissue procurement. The surgical margin is black. There is a 7.2 cm. (lateral to medial),. 3.6 cm. (anterior to posterior), and a 5.2 cm. (superior to inferior) firm, well demarcated mass at the. lateral side of the specimen. The mass is tan/white with focal bile staining. Grossly, the mass approaches. the the capsule on the anterior, posterior, and inferior surfaces, however the capsule appears intact. The. mass is 1.5 cm. away from the surgical margin. There is also a 0.7 cm. well demarcated small nodule. adjacent at the medial site which is separate from the main mass. The remaining liver parenchyma is. unremarkable. The attached gallbladder has been previously opened. The gallbladder appears. unremarkable. No stones are identified. BLOCK SUMMARY. 1 - lesion with lateral capsule. 2 lesion. 3 - lesion adjacent to the gallbladder. 4 - lesion adjacent to the gallbladder. 5 lesion. 6 lesion. 7 - surgical margin, adjacent to the gallbladder. 8-10 - additional section with surgical margin. 11 - smaller nodular lesion. 12 - normal appearing liver. 13 - surgical margin of cystic duct. 14 - representative section of gallbladder and additional. cystic duct section. LIGHT MICROSCOPY. Light microscopic examination is performed. Sections reveal that both of the grossly identified masses are moderately differentiated hepatocellular 1. carcinoma. The tumor cells have a cord-like distribution and display moderate nuclear atypia. The tumor. closely approaches the hepatic capsule, but does not invade through it. Apparent lymphovascular space. invasion is present within the liver in the area of the gallbladder bed. The surrounding, non-neoplastic. liver shows some bile stasis, which is predominantly intrahepatocellular. There is mild bile duct. proliferation and scattered neutrophilic aggregates within portal areas and sinusoids. These findings are. suggestive of a biliary obstruction, possibly secondary to the tumor. Also present are mild portal. lymphocytic infiltrates, consistent with a mild (Grade 1) chronic hepatitis. Viral cytopathic. effect is not noted. An iron stain shows no evidence of iron accumulation within the liver. There is no. evidence of fibrosis or cirrhosis. Small foci of macrovesicular steatosis are noted. DIAGNOSIS. LIVER, RIGHT LOBE, LOBECTOMY - MODERATELY DIFFERENTIATED HEPATOCELLULAR. CARCINOMA, TWO FOCI (7.2 AND 0.7 CM. GREATEST DIMENSIONS). - LYMPHOVASCULAR SPACE INVASION IDENTIFIED. - SURGICAL MARGIN FREE OF TUMOR. GALLBLADDER, TOTAL REMOVAL - NO SPECIFIC PATHOLOGIC ABNORMALITY."
BIOCUP_00371,liver,LIHC,TCGA-WQ-A9G7,TCGA-WQ-A9G7.211B2C4B-7DEB-4031-A3D2-5464A7386245,"SURG PATH #: SPECIMEN CLASS: ALT ID#: SEX: F. DATE RECEIVED: DATE OF PRINTING: Material Received: A: gallbladder. B: right hepatic lobectomy-tumor bank. Historv: -year-old female with a right hepatic mass. Final Diagnosis: A. Gallbladder, ""gallbladder"", cholecystectomy: Focal mild chronic inflammation. B. Liver, ""right hepatic lobectomy-tumor bank"", partial hepatectomy: Poorly differentiated hepatocellular carcinoma. See comment. Minimal steatosis (1%) and focal portal inflammation. Comment: Immunohistochemical studies are performed. The tumor cells are positive for glypican 3, CK7 (focal and weak), MOC-31 and they. are negative for CK20, pCEA, and hepatocyte. Reticulin special stain shows loss of reticulin fiber. Liver (Hepatectomy)-HCC. Specimen Type: Partial hepatectomy. Tumor Size: 12.0 x 11.0 x 9.0 cm and 1.1 x 0.8 x 0.8 cm. Tumor Focality: Multiple (2). Histologic Type: Hepatocellular carcinoma. Histologic Grade: GIII: Poorly differentiated. Tumor Extension: Tumor confined to liver. History of previous treatment (TACE or RFA): No. Treatment Effect: Not applicable. Margins: Assessed margins are uninvolved by carcinoma. Parenchymal Margin: Uninvolved by invasive carcinoma. Vascular Invasion: Macroscopic Venous (Large Vessel) Invasion (V): Not identified. Microscopic (Small Vessel) Invasion (L): Not identified. Lymph Nodes: Number Examined: 0. Number Involved: 0. Date of Printing: SURG PATH #: ALT ID #: Additional Pathologic Findings: Minimal steatosis (1%) and focal portal inflammation. Gross Picture Taken: No. Pathologic Staging: p3aNXMn/a. Primary Tumor (pT). pT3a: Multiple tumors more than 5 cm. Regional Lymph Nodes (pN). pNX: Cannot be assessed. Distant Metastasis (pM). Not applicable. The pathologic stage assigned here should be regarded as provisional, as it reflects only current pathologic data and does not. incorporate full knowledge of the patient's clinical status and/or prior pathology. Pursuant to the. this case has been concurrently reviewed by the following. pathologist: who agrees with the above diagnosis. Attestation: By this signature, I attest that I have personally formulated the final interpretation expressed in this report and that the above diagnosis is based. upon my examination of the slides and/or other material indicated in this report. Interpreted by: Gross Description: A. Received in formalin, labeled with the patient's name and ""gallbladder"" is a 6.9 x 2.5 x 1.4 cm cholecystectomy specimen. The serosa is tan-purple and wrinkled. The gallbladder is opened to reveal a red-brown velvety mucosa with multiple yellow-gold. flecks. No calculi are grossly identified within the gallbladder or accompanying specimen container. The gallbladder wall ranges. in. size from 0.2 to 0.4 cm. The cystic duct remnant contains a metallic staple and appears to be patent. Representative sections. from the gallbladder body and fundus, and a shave of the cystic duct remnant (inked black) are submitted in cassette A1. B. Received fresh labeled with the patient's name and ""right hepatic lobectomy"" is a partial hepatectomy specimen weighs 1180. grams and measures 20.0 x 13.5 x 9.1 cm in dimension. The external surface is tan-brown and glistening with a white tumor. nodule measuring 0.8 x 0.8 x 0.8 cm. On the inferior surface, the serosa is focally bulging with an underlying mass. The area of. firmness. and protrusion measures 10.0 X 9.0 cm. The liver is serially sectioned at 0.5 cm intervals to reveal a smooth, glistening,. tan-brown cut surface. There is a tan-yellow, well circumscribed and encapsulated mass measuring 12.0 x 11.0 x 9.0 cm in. dimension. and is 3.2cm from the parenchymal resection margin. The surface of the tumor is tan-yellow, firm with focal areas of. hemorrhage. The mass extends to the inferior capsule of the right hepatic lobe. The perviously described nodule on the. superior. aspect of the liver upon sectioning measures 0.8 x 0.8 x1.1 cm. Both the large described mass and smaller described mass are. encapsulated and extend to the liver capsule. B1. Representative section of the vascular margin. B2. Representative section of the intrahepatic portal vein. B3. Representative section of grossly unremarkable hepatic tissue. B4. Tumor to inferior liver capsule (larger tumor). B5. Tumor to liver capsule (larger tumor). B6. Representative section of the smaller tumor to tumor capsule. B7-B9. Representative sections of tumor to normal appearing hepatic tissue. B10. One possible lymph node, bisected. If. immunohistochemical stains and/or in situ hybridization are cited in this report, the performance characteristics were determined by the. in compliance with CLIA'88. regulations. Some of these tests rely on the use of ""analyte specific reagents"" and are subject to specific labeling requirements by the FDA. Date of Printing: SURG PATH #: ALT ID #: Known positive and negative control tissues demonstrate appropriate staining. This testing was developed by the. It has not been cleared or approved by the FDA. The FDA has determined that such clearance. or approval is not necessary. Date of Printing:"
BIOCUP_00372,liver,LIHC,TCGA-DD-A1EH,TCGA-DD-A1EH.951E7AFB-F380-4FA8-B213-CB766A60FF5B,"REVISED REPORT (Addendum/Procedure included). TISSUE DESCRIPTION: A1 A2 A3 A4 A5 A6 B1 C1 D1 D2 D3 D4 D5 D6 D7 D8. Right lobe liver (1035 grams, 22.7 X 13.8 X 10.6 cm), tissue. from the left portal vein (thrombus, 1.8 x 1.5 X 0.4 cm),. gallbladder (9.2 x 3.1 x 1.3 cm) and peri-choledochal lymph. nodes (together measuring 4.1 x 2.0 x 1.3 cm). DIAGNOSIS: Liver, right lobe, resection: Grade 3 (of 4) hepatocellular. carcinoma is identified forming a multinodular mass (15.3 x. 13.2 x 7.6 cm) associated with vascular invasion. There are. multiple (7) satellite nodules ranging in size from 0.3 cm to. 2.7 cm in greatest dimension. Tumor extends to within 0.1 cm of. the surgical resection margin. Tumor thrombus is also present. within the vein but the vessel margin is negative. Embolic. material and coils also identified. Assessment of nonneoplastic. liver to be reported in an addendum. Soft tissue, left portal vein, excision: Positive for. hepatocellular carcinoma. Gallbladder, cholecystectomy: Without diagnostic abnormality. Negative for malignancy. Lymph nodes, peri-choledochal, excision: Multiple (6). peri-choledochal lymph nodes are negative for tumor. ADDENDUM: Non-neoplastic liver shows inactive chronic hepatitis with. bridging fibrosis (stage 3), consistent with the patient's known. history of chronic hepatitis B. REVISED REPORT (Addendum/Procedure included). TISSUE DESCRIPTION: A1 A2 A3 A4 A5 A6 B1 C1 D1 D2 D3 D4 D5 D6 D7 D8. Right lobe liver (1035 grams, 22.7 X 13.8 X 10.6 cm), tissue. from the left portal vein (thrombus, 1.8 X 1.5 X 0.4 cm),. gallbladder (9.2 X 3.1 x 1.3 cm) and peri-choledochal lymph. nodes (together measuring 4.1 X 2.0 x 1.3 cm). DIAGNOSIS: Liver, right lobe, resection: Grade 3 (of 4) hepatocellular. carcinoma is identified forming a multinodular mass (15.3. X. 13.2 X 7.6 cm) associated with vascular invasion. There are. multiple (7) satellite nodules ranging in size from 0.3 cm to. 2.7 cm in greatest dimension. Tumor extends to within 0. 1 cm of. the surgical resection margin. Tumor thrombus is also present. within the vein but the vessel margin is negative. Embolic. material and coils also identified. Assessment of nonneoplastic. liver to be reported in an addendum. Soft tissue, left portal vein, excision : Positive for. hepatocellular carcinoma. Gallbladder, cholecystectomy Without diagnostic abnormality. Negative for malignancy. Lymph nodes, peri-choledochal, excision: Multiple (6). peri-choledochal lymph nodes are negative for tumor. ADDENDUM: Non-neoplastic liver shows inactive chronic hepatitis with. bridging fibrosis (stage 3), consistent with the patient's known. history of chronic hepatitis B."
BIOCUP_00373,liver,LIHC,TCGA-G3-AAV5,TCGA-G3-AAV5.A578503A-47F1-4DD4-B3E8-C1642EF89190,"CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. A. Gallbladder. B. Right liver. Clinical Information. Infectious patient: No. Immunocompromised: No. History of neoplasm: Yes. Liver mass. Diagnosis. A. Gallbladder, cholecystectomy: - No evidence of malignancy. - Lymph nodes show reactive changes, no evidence of malignancy. B. Liver, right partial hepatectomy: - Hepatocellular carcinoma, moderately differentiated, see synoptic report. Prominent vascular invasion. - Necrosis involving less than 10% of tumor. Verified: Synoptic Report. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GII: Moderately differentiated. TUMOR EXTENSION (select all that apply) : Tumor confined to liver. PRIMARY TUMOR (pT) : pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. REGIONAL LYMPH NODES (pN) : pNX: Cannot be assessed. DISTANT METASTASIS (pM) : pMX: Cannot be assessed. MARGINS: Parenchymal margin uninvolved by invasive carcinoma. VENOUS (LARGE VESSEL) INVASION (V) : Present. ADDITIONAL PATHOLOGIC FINDINGS: Cirrhosis/fibrosis. Gross Description. Received are specimen containers A to B. All requisitions and specimen containers are. labelled with the patient's name. The cassettes and. identifiers. are labelled with the Surgical. A. Specimen is received fresh. The container is designated ""A. Gallbladder"". The. specimen consists of a bile stained intact gallbladder which measures 9.5 x 3.5 x 3.0 cm. The serosal surface is smooth and glistening. Opening the gallbladder reveals it to be. filled with green bile. No calculi are found in the gallbladder or in the specimen. container. The mucosal surface is green, velvety and the gallbladder wall averages 0.3. cm in thickness. The cystic duct is patent. Adjacent to the cystic duct is a possible. lymph node measuring 2.5 cm in greatest dimension. Three representative sections of. gallbladder submitted in cassette A1. The possible lymph node, bisected, submitted in. toto in A2. Upon handling the specimen, it fragmented into three pieces. B. Specimen is received fresh. The container is designated ""B. Right liver"". The. specimen consists of a 1.4 kg portion of liver which measures 30.0 x 15.0 x 10.0 cm. A. portion of the liver capsule is lobulated which corresponds to a tan lobulated mass. within the liver parenchyma. There are irregular areas of hemorrhage spread throughout. the mass. The mass measures approximately 17.5 x 10.0 x 10.0 cm. Adjacent to the mass. are separate nodules, however it is difficult to ascertain whether these nodules are. truly separate or lobules which connect to the main mass. These nodules range from 0.2. cm up to 1.0 cm in greatest dimension. The liver parenchyma is fibrotic, creating a. nodular appearance. The resection margin of the specimen has been inked blue. The. separate described nodules comes within 1.5 cm of the resection margin. The main mass. comes within 4.5 cm of the blue margin. Sections of the specimen are as follows: B1- - four sections of the large mass and its relationship to the liver capsule. B5. - edge of the large mass with one of the separate described nodules in the liver. parenchyma. B6. - further section of separate described nodules within the fibrotic liver. parenchyma. Sectioning. revealed these nodules come within 0.5 cm of the blue. painted resection margin. B7. - section of a query vessel filled with granular material at the blue painted. resection margin. B8. - further section of blue painted resection margin in an area where the liver. parenchyma. becomes markedly fibrotic. B9. - section of the nodules with surrounding liver parenchyma. Microscopic Description. A. Sections show congested the gallbladder, no evidence of malignancy. The cystic. node shows lipogranulomas, no evidence of malignancy. B. Sections show a hepatocellular neoplasm with a solid and trabecular growth. pattern, as well as confluent areas of necrosis, involving less than 10% of the tumor. The tumor cells show a high degree of atypia, with a high nuclear cytoplasmic ratio,. prominent nucleoli and frequent mitoses. There is prominent vascular invasion. The. adjacent liver parenchyma shows cirrhosis. tumor nodules are also present in surrounding. liver parenchyma. The painted hepatic margins are negative for umor.Embolization. material is seen in a few blood vessels. Encounter Number. Patient Location."
BIOCUP_00374,liver,LIHC,TCGA-5C-A9VG,TCGA-5C-A9VG.9C941E66-614A-49E4-8C60-2C040C591A11,"M. Clinical diagnosis: Primary liver cancer. Sample: histology #. Gross description: Right lobe of the liver and gall bladder single block. 23x17x11,, cm. 1,8 cm from resection line liver parenchyma shows nodular. mass20x12x10 cm partially covered with capsule soft consistency. Section. shows gray color mass with necrotic nests, there is no infiltration of the liver. capsule. Gall bladder 8x5cm with smooth surface, greenish-brownish. Lymphatic. node from common hepatic artery area is 4,5x2,5 cm Section shows dense. consistency cyanotic color. Microscopic description:. Surgical margins are clear Nodular mass shows. signs of hepatocellular cancer with different degree of differentiation (G2) with. polumorphic cells and elements of acinar and clear cells. Tumor infiltrates. hepatic parenchyma and vessels. Hepatic parenchyma shows signs of lymphoid. infiltration. Lymphatic nodes show no signs of tumor growth. Gallbladder shows signs of autolysis. Final diagnosis Hepatocellular carcinoma. Confidential."
BIOCUP_00375,liver,LIHC,TCGA-DD-AAE4,TCGA-DD-AAE4.2DDF43C9-8728-4CD6-977C-ECCE8B0BD322,"CLINICAL DIAGNOSIS: Hepatocellular carcinoma suggested. Specimen : Liver and Liver mass. Gross Photo : GROSS: Specimen status: Fresh. Operation: Partial hepatectomy. Organs: Liver (14.0 X 9.5 X 4.8 cm, 244.5 gm). Lesion: A well-defined red to pale tan round tumor mass (2.5 X 2.5 X 2.3 cm). Cut surface: Red to pale tan firm and solid with area of hemorrhage. Gross type: HCC: Expanding nodular, Multinodular confluent. Resection margin: Not involved grossly (safety margin: 0.5 cm). Others: Satellite nodule: No. Remaining parenchyma: Cirrhosis (stage 4). Representative sections submitted. Gross photo: Present. Blocks. T1-3,TB, tumor mass X 4. L,NB, liver parenchyma X 2. MICROSCOPIC: Hepatocellular carcinoma: Yes. The worst differentiation I. The major differentiation I. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: No. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: No. Multicentric occurrence: No. SPECIAL STAIN: Reticulum (partial loss), Trichrome (+, at peripheral cirrhotic liver). NOT reported. Gross: NOT reported. Gross: cervix,smear,inflammation. Stomach, antrum, scopic, chronic gastritis, H. pylori, associated, erosion. Large intestine, sigmoid colon, scopic, tubular adenoma, low grade, dysplasia. Nasal cavity, nasal septum, biopsy, capillary hemangioma. Nasal cavity, biopsy, fungal ball, consistent with, aspergillus species. Nasal cavity, right, anterior nasal septum, excision, consistent with, lobular capillary. hemangioma, erosion. Liver, ectomy, hepatocellular carcinoma, well differentiated, cirrhosis. T56000, P10, M81703, well differentiated, M49500. DIAGNOSIS: Liver, partial hepatectomy: Hepatocellular carcinoma, well differentiated. Cirrhosis. Suggestion :"
BIOCUP_00376,liver,LIHC,TCGA-DD-AAE9,TCGA-DD-AAE9.64700E97-F031-49DE-83F0-8CCDBDEE23AF,"CLINICAL DIAGNOSIS: Hepatocellular carcinoma suggested. Specimen : Liver and Liver mass. Gross Photo : GROSS: Specimen status: Fresh. Operation: Partial hepatectomy. Organs: Liver (19.0 X 12.5 X 4.3 cm, 374.0 gm). Lesion: A well-defined round firm mass (5.0 x 4.8 x 4.0 cm). Cut surface: Yellowish tan and granular appearance. Gross type: HCC: Expanding nodular. Resection margin: Not involved grossly (safety margin: 1.0 cm). Others: Satellite nodule: No. Representitive sections were submitted. Gross photo: Present. Blocks. T1-4, - TB, tumor mass X 5. NB, L, liver parenchyma X 2. MICROSCOPIC: Hepatocellular carcinoma: Yes. The worst differentiation III. The major differentiation II. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: Complete capsule. Capsular infiltration: No. Septum formation: No. Surgical resection margin invasion: No, safety margin (1.0 cm). Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: Unknown. Multicentric occurrence: Unknown. NOT reported. Gross: liver, ,ectomy, ,hepatocellular carcinoma,Steatohepatitis,milds steatosis,periportal fibrosis. T56000, P10, M81703, Steatohepatitis, mild steatosis, periportal fibrosis. DIAGNOSIS: Liver, partial hepatectomy: Hepatocellular carcinoma, moderately differentiated. Steatohepatitis with mild steatosis and periportal fibrosis (stage 2). Suggestion :"
BIOCUP_00377,liver,LIHC,TCGA-XR-A8TF,TCGA-XR-A8TF.A0557F82-3ACC-43E5-9ED3-902BEDD36939,"Nature of material: Liver. Biopsy number: ANATOMOPATHOLOGIC RESULT. MACROSCOPY. Received liver segment measuring 17.0 X 12.0 x 7.5 cm and weighing 532 grams. To. the cuts there is whitish and friable lesion measuring 6.5 cm in diameter, 0.3 cm away. from surgical margin. The liver surface is slightly irregular. MICROSCOPY. Expendable description. DIAGNOSTIC. Excision product of hepatic segment: -Hepatocellular carcinoma of hepatic type;. -Microscopically surgical margin of 0.59 cm;. -Non-neoplastic liver with moderate periportal fibrosis, but keeping preserved. architecture;. -Angiolymphatic invasion undetected;. -Pathological staging: pT1 (TNM - 7th edition);. -Not observed Schistosoma mansoni eggs. PARTICIPANTS OF APPRAISAL REPORT. - ISSUER. - REVIEWER."
BIOCUP_00378,liver,LIHC,TCGA-ED-A66X,TCGA-ED-A66X.F83A9A75-387A-4A66-9817-084A8E633E37,"JUDD:F83A9A75-387A-4A66-9817-084A8E633E37. Gross Description: Tumor is ill-margins, solid and firm, gray-white in cutting section with 10x8x6cm in. size. Microscopic Description: Tumor cells form the trabecular patterns conecting each other, or acinar or. sheets patterns intervening in begnin tissue. Tumor invades into fibrous stroma. The tumor cells retain. apolygonal shape and have round vesicular nuclei with prominent nucleoli. The amount of cytoplasm. are abundant and the cytoplasm is clear or basophilic Nuclei are irregularly large and hyperchromatic. with prominent nucleioli. Mitoses are present. Tumor is invasion of inflammatory cells and necrotic. Stroma is fibrous and hyaline. Diagnosis Details: Hepatocellular carcinoma, clear cell type, poorly-differentiated. Comments: Formatted Path Reports: LIVER TISSUE CHECKLIST. Specimen type: Wedge resection, lobectomy. Tumor size: 10x8x6cm. Focality: Not specified. Histologic type: Hepatocellular carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Lymph nodes: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Hepatocellular carcinoma, clear cell type. Comments: None."
BIOCUP_00379,liver,LIHC,TCGA-RC-A7SF,TCGA-RC-A7SF.D4F398CC-0003-4C08-989F-3C60762B100F,"Frozen Section(1-2). < Frozen permanent diagnosis >. A. 'IVC mass"" . biopsy: Cavernous hemangioma. B. Liver, segmentectomy : HEPATOCELLULAR CARCINOMA. Tumor number : one. Satellite nodule: no. Location : S8. Gross type: expanding nodular. Size(cm) 4.3x4.2cm. Differentiation: The worst differentiation: Edmondson grade 111. Differentiation: The major differentiation: Edmondson grade 11. Histologic type : microtrabecular. Cell type : hepatic. Tumor necrosis : no. Hemor hage : yes (10 %). Fatty change : no. Fibrous capsule : partia. Infiltration of capsule : no. Septum formation : yes. Surgical margin invasion : no(margin of the clearance 0.5 ‚Ç¨ cn). Serosa invasion: no. Portal vein invasion : no. Bile duct invasion : no. Hepatic vein invasion : no. Hepatic artery invasion : no. Microvessel invasion : no. Intrahepatic metastasis : no. Multicenteric occurrence : no. T stage : pil. Non-tumor liver. Chronic hepatitis : yes. Frozen Section(1-2). Etilogy : HCV. Grade, Tobular : none. Grade, portoperiportal : minimal. Stage(fibrosis) : septal ! ibrosis with early cirrhosis. Dysplastic nodule : no. Ductal epithelial ayspiasia : no. Other liver disease : no. C. Gallbladder cholecystectomy: Cholesterel polyp. < Iinmunohistochemical and special stain results. block 89>. Iron: Negative. Cytokeratin 7: Positive in bile duct. A. The specimen submitted for frozen section consists of a piece of reddish yellow. soft tissue. measuring 0.9x0.4x0.2cm. clinically labeled as ""mass in front IVC"". Entirely embedded. <Frozen diagnosis>. A. Soft tissue. in front IVC. bropsy : Suspicious for lymphangioma (ISP). The diagnosis was informed to. Or. at. 8. The speciment received in formalin consists of a product of iver segmentectomy. measur ing 8x7x5cm and weighing 85gm. The serosa surface shows a subcapsular. mass. On section. there is a expending nodular type mass. measuring 4.2x4x3cm. The cut surface of the mass is yellowish and myxoid with multiple hemorrhagic foci. The mass is 0.5cm apart from parenchyine resection. Remaining parenchyme is. unrenarkable. Reoresentative sections are embedded in nine cassettes. (B1 to 4- one plane. 85 to 8- one plane. 89- normal liver). C. The specimen received in formalin consists of a gallbladder measuring 8. 5cm in. length and 4cm in diameter The serosa surface is grossly unremarkable. The nucosa surface shows pinkish velvety. There is several yellowish small. nodule. measuring up to 0.20m in diameter. Representative sections are embedded. Frozen Section(1-2). H&E(11). MT(1). RTC(1). D-PAS(1). 100. Cytokeratin 7(1)."
BIOCUP_00380,liver,LIHC,TCGA-DD-AADV,TCGA-DD-AADV.750CC634-8874-488C-B20D-6B636978156A,"CLINICAL DIAGNOSIS: R/O HCC in S3. Specimen : Liver. Gross Photo : GROSS: Specimen status: Fresh. Operation: Left lateral sectionectomy. Organs: Liver (12.0 x 4.0 X 3.3 cm and 86.2 gm). Lesion: A well-defined multinodular pale tan firm and solid mass. (2.2 X 2.0 X 1.7 cm). Gross type: HCC: Multinodular confluent. Resection margin: Not involved grossly (safety margin: 2.2 cm). Others: Satellite nodule: No. Remaining parenchyma: Cirrhotic. Representative sections submitted. Gross photo: Present. Blocks. T1a,T1b,T1c,T1d,T2-3,TB, tumor mass X 7. L,NB, liver parenchyma X 2. MICROSCOPIC: Hepatocellular carcinoma: Yes. The worst differentiation III. The major differentiation II. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: Yes (10%). Fibrous capsule formation: Partial capsule. Septum formation: No. Surgical resection margin invasion: No/ safety margin (2.2 cm). Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: Unknown. Multicentric occurrence: Unknown. NOT reported. Gross: NOT reported. Gross: Stomach, body, dissection, tubular adenoma, high grade, dysplasia. Stomach, prepylorus, scopic, chronic gastritis. Stomach, antrum, scopic, chronic gastritis, H. pylori, associated. Liver, legy, ectomy, hepatocellular carcinoma, moderately differentiated, cirrhosis, steatosis. T56000, legy, P10, M81703, moderately differentiated, M49500, M50080. DIAGNOSIS: Liver, segment 3, left lateral sectionectomy: Hepatocellular carcinoma, moderately differentiated. Cirrhosis, mixed. Steatosis, mild. Suggestion :"
BIOCUP_00381,liver,LIHC,TCGA-DD-AADJ,TCGA-DD-AADJ.D087E915-C5DB-40B1-9EDA-B10EA2D6754B,"CLINICAL DIAGNOSIS: Hepatocellular carcinoma. Specimen : Liver. Photo : GROSS: Specimen: Liver (16.0 X 9.5 X 2.5 cm, 250 gm, unfixed). Gallbladder (6.2 cm in length, 3.2 cm in diameter, 0.2 cm in wall thickness,. unfixed). Operation: Partial hepatectomy. Lesion: - A well-defined mass: 2.5 X 2.5 X 2.0 cm at the segment 4. - Cut surface: Round to ovoid, pale tan to yellow, and solid mass with hemorrhage and. necrosis (30-40%). Gross type: HCC: Expanding nodular. Resection margin: Not involved grossly (safety margin: 0.3 cm). Others: Satellite nodule: No. Remaining parenchyma: Cirrhotic. Portal vein invasion: No. Gross photo: Present. Blocks. T1-5, round to ovoid and solid mass and surrounding tissue x. 5. L, cirrhotic liver X 1. RM, blood vessel X 1. GB, gallbladder X 1. MICROSCOPIC: Hepatocellular carcinoma: Yes. Edmondson-Steiner grade. The worst grade III. The major grade II. Histologic type: Trabecular and solid. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: No. Capsular infiltration: No. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: No. Multicentric occurrence: No. NOT reported. Gross: cervix,smear,inflammation. Cervix, smear, atrophy. Cervix, smear, inflammation, atrophy. Large intestine, cecum, scopic, suggestive of, hyperplastic polyp. Liver, ectomy, hepatocellular carcinoma, cirrhosis. T56000, P10, M81703, M49500. Gallbladder, ectomy, chronic cholecystitis. T57000, P10, M43005. DIAGNOSIS: Liver, partial hepatectomy: Hepatocellular carcinoma. Cirrhosis, micronodular. Gallbladder, cholecystectomy: Chronic cholecystitis. Suggestion :"
BIOCUP_00382,liver,LIHC,TCGA-G3-A25S,TCGA-G3-A25S.F4DAEF13-D4B0-4C12-9617-04878D3FC98D,"LABORATORY SERVICES. Patient ID: PHN: ALT ID: UTD:FADAEF13-D4B0-4C12-9617-04878D3FC98D. Telephone: Requesting Physician: Encounter: Chart ID: HISTOPATHOLOGY REPORT. Division Head: ORIGINAL REPORT. SPECIMEN: A. Gallbladder. B. Right liver and diaphragm. CLINICAL HISTORY: Hypervascular lesion in right liver in segment 7. DIAGNOSIS: A. GALLBLADDER, CHOLECYSTECTOMY: CHRONIC CHOLECYSTITIS AND CHOLELITHIASIS. B. RIGHT LIVER AND DIAPHRAGM, RESECTION: HEPATOCELLULAR CARCINOMA, MODERATELY DIFFERENTIATED (GRADE II/III). TUMOR SIZE: 12 X 9. X 2.- CM. INVADING INTO PERI-HEPATIC ADIPOSE TISSUE. PERITUMORAL INTRAVASCULAR INVASION PRESENT. TWO SATELLITE NODULES IDENTIFIED. RESECTION MARGIN IS 1 MM FROM THE SATELLITE NODULE, HOWEVER SMALL. CLUSTERS OF TUMOR CELLS PRESENT AT RESECTION MARGIN. BACKGROUND HEPATIC TISSUE SHOWING CIRRHOSIS AND PERIPORTAL. INFLAMMATION CONSISTING OF SIGNIFICANT NUMBERS OF PLASMA CELLS AND. EOSINOPHILS. (Electronic Signature). GROSS DESCRIPTION: A. The specimen is received fresh and is subsequently placed into formalin,. and consists of a dark tan intact gallbladder which measures 8.0 x 3.0 x 3.0. cm. The serosal surface is smooth and glistening. Opening the gallbladder. reveals it to be filled with a thick green bile and contains round. multifaceted calculi ranging in size from 0. cm up to 0.6 cm in greatest. dimension. The mucosa surface is dark green, velvety and the gallbladder wall. measures 0.2 cm in thickness. Found within the cystic duct are two brown. Page 1 CONTINUED. LABORATORY SERVICES. Patient ID: PHN: ALT ID: Telephone: Requesting Physician: Encounter: Chart ID: HISTOPATHOLOGY REPORT. Division Head: GROSS DESCRIPTION: multifaceted calculi measuring 0.2 cm in greatest dimension. Grossly the. cystic duct lymph node is not identified. Three representative sections are. submitted in one cassette. B. The specimen is received fresh and is subsequently placed into formalin,. and consists of a portion of liver weighing 859 g and measuring 15.0 x 12.0 x. 8.0 cm. The resection margin of the specimen has been inked blue. Sectioning. of the specimen reveals a lobulated necrotic mass occupying approximately 80%. of the liver measuring 12 x 9.6 x 2.4 cm. The border of this mass has an. ill-defined appearance and two small tan nodules are identified within the. liver parenchyma adjacent to this large mass. Both these nodules measures 0.2. cm in greatest dimension. A prominent blood vessel is noted within the liver. parenchyma that contains thrombus material. Grossly the liver capsule has a. lobulated appearance due to invasion of the mass. Grossly the main mass comes. to within approximately 1.5 cm of the blue painted margin. The liver capsule. overlying the normal liver parenchyma has a slightly bumpy appearance. ?cirrhosis. Sections of the specimen is as follows: B1. section of vessel with thrombus at blue painted margin. B2-3. two random sections of blue painted margin. B4-6. section of nodules on liver capsule. B7. section of nodule on liver capsule and small nodule close to. overlying blue painted margin, 0.2 cm. B8-10. three sections from the large mass. B11-12. two random sections from adjacent liver parenchyma. B13. section of small nodule ?satellite lesion in liver parenchyma. MICROSCOPIC DESCRIPTION: The hepatocellular carcinoma is composed of mainly trabecular and. pseudoglandular pattern. The tumor cells are hyperchromatic with easily. identifiable mitoses. Focal tumor necrosis is also present. There are. peritumoral intravascular invasion. The tumor is focally infiltrating into. the perihepatic adipose tissue (? diaphragm) The immunohistochemical stains. demonstrate the nature of the hepatocellular origin. The tumor cells show. canalicular stain for CEA and are strongly positive for Hep-par-1. They are. negative for CK7, CK20, synaptophysin and AFP. The background hepatic tissue. is cirrhotic. The etiology of cirrhosis cannot be determined. However, there. are significant numbers of lymphoplasmacytes and eosinophils in the periportal. area. The hepatocytes show no ground glass change or Mallory bodies. Procedure:"
BIOCUP_00383,liver,LIHC,TCGA-RG-A7D4,TCGA-RG-A7D4.C8724B8E-5FC3-419B-9CC8-E6046D671D96,"Report Name: Surg Path Case - STATUS: Final. SEE NOTE. Collect/Perform: Facility: Physician who Performed Procedure: Requesting Physician: Not specified. Attending Pathologist. DIAGNOSIS: Liver, central hepatectomy: - Histologic Type: Hepatocellular carcinoma. - Histologic Grade: G2 (moderately differentiated) to G3 (poorly. differentiated). - Tumor Size: Greatest dimension: 2.8 cm; other two dimensione: 2.4 x 2.2 cm. - Tumor Focality: Solitary. - Tumor Site: Segment 4b of the liver (by MRI report). - Tumor Extension: Tumor confined to liver. - Margins: Parenchymal Margin: Uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1 mm to 2 mm. from parenchymal resection margin. Other margins: Cannot be assessed. - Lymph-Vascular Invasion: Macroscopic Venous (Large Vessel) Invasion: Not identified. Microscopic (Small Vessel) Invasion: Present. - Perineural Invasion: Not identified. - Regional Lymph Nodes (total number involved/total number identified) : 0/2. (part 2). - Distant Metastasis: Cannot be assessed. - Additional Pathologic Findings: Liver parenchyma shows portal. inflammatory infiltrate, predominantly lymphocytes, with mild interface. activity, and portal and periportal firbosis with some bridging fibrosis. (3/6, trichrome and reticulin stains), consistent with chronic hepatitis. (clinical history of hepatitis C virus infection) No significant. hemosiderosis (iron stain) and no globules of alpha-1 antitrypsin seen. (PASD stain). Small bile duct hamartoma (von. Mayenburg complex, 1mm in. Report Name: : largest dimension) seen. Fibrosis score; None to moderate fibrosis (Ishak score 0-4) (F0). Hepatocellular dysplasia: Not identified. - Ancillary Studies: None. - Clinical History: Hepatitis c virus infection. AJCC Pathologic Staging: pT2 NO M-not applicable. 2. Gallbladder, cholecystectomy: - Chronic cholecystitis with cholelithiasis and cholesterolosis. - Two lymph nodes, negative for carcinoma (0/2). COMMENT: None. This case has been reviewed by one or more pathologists in the Division of. CLINICAL INFORMATION: Liver Cancer. GROSS DESCRIPTION: 1. The specimen is received fresh for intraoperative consult labeled. ""central hepatectomy"" It consists of a 57 g, 7.0 x 4.4 x 2.8 cm. wedge-shaped piece of liver. The capsule is smooth and glistening. The. parenchymal margin ie inked black. Sectioning reveals a. well-circumscribed, nodular, tan tumor, measuring 2.8 x 2.4 x 2.2 cm and. located 0.1 cm from the capaule and 0.2 cm from the parenchymal margin. The surrounding liver parenchyma is tan and grossly unremarkable with. cauterized areas. Representative sections are submitted as follows: 1AFSC: Liver tumor with parenchymal margin, frozen. 1B-1E: Additional sections of liver tumor with parenchymal margin and. capsule. 1F: Grossly uninvolved liver. INTRAOPERATIVE CONSULT: - Focally tumor is 1 to 2 mm to inked parenchymal margin. Reported to. Report Name: Pathology consult: 2. The specimen is received fresh and labeled ""Gallbladder and consiste of. a previously cut gallbladder, measuring 6.6 x 3.0 x 1.2 cm. The serosa is. tan-pink with fibrous adhesion. Sectioning reveals a minimal amount of bile. and a 0.7 x 0.6 x 0.5 cm black calculus. The mucosa is erythematous with. minimal focal yellow flecks. The wall measures up to 0.3 cm thick. The. proximal portion of the cyetic duct is identified and contains no stones in. its lumen, which measures up to 0.2 cm in diameter. There are two firm. lymph nodes adjacent to the cystic duct and measuring 1.4 x 0.6 x 0.6 cm. and 1.5 x 0.8 x 0.7 cm. Sections are submitted as follows: 2A: inked shaved cystic duct margin and sections of gallbladder. 2B: Two bisected lymph nodes (differentially inked black and blue). The following special studies were performed on this case and the. interpretation is incorporated in the diagnostic report above: 1xIRON (NOT BM ASPIRATE), 1xTRICHROME-MASSON, 1xRETICULIN, 1xPAS-DIASTASE. I certify that I personally conducted the diagnostic evaluation of the. above specimen (s) and have rendered the final diagnosis(es). Note: The histology, immunochemistry and in situ hybridization components. for this case were performed at. The Attending Pathologist reviewed this case and made the diagnosis. where applicable, immunohistochemistry and in situ hybridization tests were. developed and the performance characteristice determined by the. These tests. have not been cleared or approved by the US Food and Drug Administration. and the results should be correlated with other clinical and laboratory. data. Appropriate controls were performed for all immunohistochemistry, in. situ hybridization and histochemical tests."
BIOCUP_00384,liver,LIHC,TCGA-DD-AAEG,TCGA-DD-AAEG.B48B65B0-92F9-4B49-B8A8-563EA5AF70F1,"CLINICAL DIAGNOSIS: HCC (S3). Specimen : liver. Gross Photo : GROSS: Specimen state: Liver: 4.3 x 2.0 x 3.0 cm, 21.8 gm (unfixed). Operation: Tumorectomy. Lesion: A well-defined mass (2.0 x 1.3 x 1.3 cm) at segment 3. - Cut surface: Yellowish tan, and granular without necrosis. Gross type. HCC: Expanding nodular. Resection margin: Not involved grossly (safety margin: 1.4 cm). Others: Satellite nodule: No. Remaining parenchyma: Cirrhotic. Portal vein invasion: No. Representative sections submitted. Gross photo: Present. Blocks. T1-4, TB, tumor and surrounding liver parenchyme x 5. NB, remaining parenchyme of liver x 1. MICROSCOPIC: Hepatocellular carcinoma: Yes. Edmondson-Steiner grade. The worst grade III. The major grade III. Histologic type: Trabecular, Pseudoglandular, Compact. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: No. Capsular infiltration: No. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: Portal vein invasion: Microvessel invasion: Intrahepatic metastasis: Multicentric occurrence: NOT reported. Gross: NOT reported. Gross: Vagina, smear, LSIL, HPV infection. Vagina, LSIL, HPV infection. Vagina, smear, suggestive of, bacterial vaginosis. Cervix, punch biopsy, moderate dysplasia. Cervix, LEEP, squamous cell carcinoma in situ, glandular involvement. Liver, segment3, ectomy, hepatocellular carcinoma. T56000, segment3, P10, M81703. DIAGNOSIS: Liver, segment 3, tumorectomy: Hepatocellular carcinoma. Suggestion :"
BIOCUP_00385,liver,LIHC,TCGA-G3-AAV7,TCGA-G3-AAV7.0F368084-04F6-4DCE-9ADF-6B3B94D274AB,"CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. Liver segment 2,3 at. Clinical Information. Hep B. Liver tumor. Hepatocellular carcinoma. Diagnosis. A. Liver segment 2,3, Wedge Resection: Moderately differentiated hepatocellular carcinoma. (please see synoptic report for details) ;. Lymphovascular invasion noted in small vessels;. Tumor present less than 1 mm from hepatic capsule;. Resection margin negative (more than 1 cm). Verified: Responsible Resident: (Resident). Synoptic Report. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GII: Moderately differentiated. TUMOR EXTENSION (select all that apply) : Tumor confined to liver. PRIMARY TUMOR (pT) : pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. REGIONAL LYMPH NODES (pN) : pNX: Cannot be assessed. DISTANT METASTASIS (pM) : pMX: Cannot be assessed. MARGINS: Parenchymal margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 10.0 mm. VENOUS (LARGE VESSEL) INVASION (V) : Absent. ADDITIONAL PATHOLOGIC FINDINGS: Cirrhosis/fibrosis (Fibrosis Score: Ishak score 5 (marked bridging (portal to portal and. portal to central) with occasional nodules)). Hepatitis (specify type) : Hepatitis B (Chronic Hepatitis: Grade 2 (mild periportal. inflammation and piecemeal necrosis or focal hepatocellular necrosis) ). Mild steatosis 1<5% of total liver parenchyma). Gross Description. Received is a single specimen container. The requisition and specimen container are. labelled with the patient's name,. The cassette and identifiers are. labelled with the Surgical Number. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""Liver segment 2, 3"". Specimen consists of a liver segment that weights. 169.3 g and measures 15.0 x 7.5 x 4.0 cm. Serial sections through the liver reveals a. well circumscribed yellow mass beneath the liver capsule, that measures 2.7 x 2.3 x 2.1. cm. The mass is solid, with focal areas of necrosis and punctate hemorrhage. The mass. lies just beneath the liver capsule. The remainder of the liver is deep yellow in color. and grossly nodular. The surgical resection margin has been painted blue and the liver. capsule adjacent to the mass has been painted green. There is a defect in the capsule of. the liver 2.0 cm away from the mass that has been painted yellow. The mass lies more. than 1.0 cm from the surgical resection margin. Sections are submitted as follows: A1 to 10. the liver mass in toto. All. the closest surgical resection margin. A12. uninvolved liver parenchyma. A13. sample of the previously described defect. Microscopic Description. Sections show a well circumscribed moderately differentiated hepatocellular. carcinoma with pushing borders. The carcinoma has a trabecular pattern >4 cells thick. with notable areas of pseudoglandular architecture with pleomorphic hyperchromatic foci. The morphology suggests a mixed hepatocellular-cholangiocarcinoma with stem cell. features. However, the immunoprofile failed to support this diagnosis. The tumor is diffusely and strongly positive for glypican-3 indicating. hepatocellular origin. It shows patchy moderate positivity alpha-1 antitrypsin, very. focal mild HepParl. Other markers of hepatocellular differentiation (alpha fetoprotein,. polyclonal CEA, cytoplasmic TTF-1, BHCG and OCT3/4 are largely negative. Markers of cholangiocytic differentiation (CK7, CK19 and polyclonal CEA). There. is however, patchy strong staining for EMA. Stem cell features are only supported by focal positivity for CD56 while CD19 and. C-KIT are negative. This does not support the presence of any stem cell component. CD30 is negative. Tumor block = A9; Non tumor block = A12. Pathologist Comment. Dr. reviewed this case and rendered his expert opinion. Encounter Number. Patient Location."
BIOCUP_00386,liver,LIHC,TCGA-G3-A5SL,TCGA-G3-A5SL.7DB1AFB2-69C9-4277-904E-4CF9CBAE8360,"Note: If you do not see ""END OF PRINTED REPORT"" at the bottom of the. the report YOU DO NOT HAVE THE ENTIRE REPORT try. Please printir. CONFIDENTIAL. Relevant. Information. Demographics. Date OT birth: (for verification. purposes). Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. A: Gallbladder. B: Right lobe of liver. Clinical Information. Alcoholic liver tumor. Infectious patient:No. Immunocompromised: No. History of neoplasm: yes. Diagnosis. A: Gallbladder: within Normal Limits. B: Right lobe of liver: Moderately Differentiated Hepatocellular Carcinoma (5.5 cm). With Lymphvascular Invasion. Tumor 0.15 cm away from inked margin. Nonneoplastic granulomas. Sarcoid like reactions may be seen in response tumor. liver contains numerous noncaseating sarcoid like to. No definite histologic features present to suggest chronic alconol related. disease. Verified. Gross Description. Received are specimers A and u. nil requisitions and specimen containers are labelled with. the patient's name,. The cassettes and AP identifiers are labelled with. the Surgical Number. A: The specimen consists of an intact gallbladder which measures 9.5 x 5 x 3 cm. Cystic. duct lymph node is not identified with the specimen. Approximately 30 CC of bile are. present within the gallbladder. No gallstones are identified. No masses or polyps are. noted on the mucosal surface. A few yellowish flecks are noted on the mucosal surface. The gallbladder wall measures 0.2 cm in maximum dimension. The gallbladder is grossly. within normal limits. Representative sections of the cystic duct, body, and fundus are. submitted in A1. a specimen consists of a lobe of liver which weighs 671 g and measures 23 x 14 x 9. Surgical resection margin has been painted with blue ink. Within the liver, there. circumscribed greenish tinged nodule which measures 5.5 cm in maximum dimension. to wit? in 1 mm of the inked surgical margin, but does not appear to touch the inked. n. No ther masses or nodules are noted within the liver. The surrounding liver. enchyma. slightly yellow and looks like it might have some areas of possible. congesti. No other abnormalities are noted. Section submitted for tumor bank and. represen. ve sections taken as follows: C'. of non neoplastic liver. of liver tumor and nearest margin. oner representative sections of tumor and adjacent normal liver. Num. Pa. 1. - END OF PRINTED REPORT -."
BIOCUP_00387,liver,LIHC,TCGA-DD-A39X,TCGA-DD-A39X.B9919D23-7D65-4295-84D5-6678B26BEA01,"TISSUE DESCRIPTION: Gallbladder (9 x 3 x 0.8 cm) and liver segments V and VI (220 grams; 10 X 8 x 5.5. cm). A1, B1, B2, B3, B4, B5. DIAGNOSIS: Liver segments V and VI, resection: Grade 2 (of 4) hepatocellular carcinoma. forming a 6.5 X 6 x 5.5 cm mass located in segment V and VI of the liver. The tumor. does not invade through the hepatic capsule. The margins are widely free of tumor. by 2 cm. The non-neoplastic liver is grossly non-cirrhotic. Gallbladder, cholecystectomy: Cholesterolosis. No stones are identified. Negative. for malignancy."
BIOCUP_00388,liver,LIHC,TCGA-DD-AADC,TCGA-DD-AADC.2A33A2FB-4491-43AA-8C6D-8173FB1D2179,"LINICAL DIAGNOSIS: Known HCC. Specimen : liver. Gross Photo : GROSS: Specimen status: Fresh. Operation: Central bissectionectomy (segment 5-8). Organ: Liver (13.1 x 9.5 X 6.2 cm, 267.5 gm). Gallbladder (10.0 cm in length, 4.0 cm in diameter). Tissues, labeled as 'portal vein thrombi'. (1.5 X 1.5 X 0.4 cm in aggregates). Lesion: Heaptic mass. Size: 7.5 X 6.6 X 5.1 cm. Cut surface: Poorly demarcated, pale tan and nodular mass. Gross type: Multinodular confluent. Extent: Confined to the capsule. Resection margin: Not involved, grossly (safety margin: 1.5 cm). Remaining parenchyme: Cirrhosis. [Gallbladder]. Serosal surface: Yellowish pink and smooth. Mucosal surface: Dark geen and velvety, no mural nodule. Representative sections are submitted. Gross photo: Present. Blocks. T1-4, mass of liver x 4. RM, tumor with resection margin x 1. L, nontumorous liver parenchyme x 1. A, labeled as 'portal vein thrombi' x 1. GB, gallbladder X 1. MICROSCOPIC: Tumor type: Hepatocellular carcinoma. Edmondson-Steiner grade. The worst differentiation III. The major differentiation III. Histologic type: Trabecular and nesting. Fatty change: No. Fibrous capsule formation: Partial. Capsular infiltration: Yes. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: Yes (separately submitted tissue, labeled as 'portal vein thrombi'). Vascular invasion: Yes. Bile duct invasion: No. Remaining liver parenchyme: Cirrhosis. NOT reported. Gross: stomach,antrum,scopic,chronic gastritis, h. pylori, associated. Liver, needle ,Chronic hepatitis, HBV associated. liver,ectomy,Hepatocellular carcinoma. T56000, P10, M81703. portal vein thrombi,biopsy,tumor cells present. portal vein thrombi, P50, M80011. gallbladder,ectomy,autolysis. T57000, P10, M54001. DIAGNOSIS: Liver, segment 5-8, central bissectionectomy: Hepatocellular carcinoma. Labeled as 'portal vein thrombi', biopsy: Tumor cells present. Galllbladder, cholecystectomy: Suggestion :"
BIOCUP_00389,liver,LIHC,TCGA-ZP-A9D2,TCGA-ZP-A9D2.260D67D7-9E8C-4A3B-B031-8AB4A05BC688,"Results History. Component. UUTD:26006707-9E8C-4A3B-B031-8AB4A05BC688. Specimen: A. Gallbladder. B. Tumor in border of segment 7 and 8. C. Left lateral segment and section segment 4. Clinical Notes: Liver tumor HCC. C) Fresh tissue saved for. tissue bank. Diagnosis: REVISED REPORT. A. Gallbladder, cholecystectomy. Chronic cholecystitis. - Negative for dysplasia or malignancy. B. Tumor, liver segment 7 and 8, resection: - Multifocal moderately differentiated. hepatocellular carcinoma, completely excised. - AJCC stage: pT2 pNX pMX. See Tumor Characteristics. - Chronic HCV hepatitis with minimal activity and. cirrhosis (grade 1, stage 4). Mild siderosis (+1). C. Liver, left lateral segment and segment 4 section,. resection: - Solitary moderately differentiated hepatocellular. carcinoma with parenchymal margin. involvement. - See specimen B for AJCC staging and Tumor. Characteristics sheet. REVISED REPORT COMMENT: This report is revised to make a. change in the AJCC staging in the diagnosis for specimen B. from pNO to pNX (underlined above) . None of the other. original text has been altered. (Electronically signed bv). Verified: Tumor Characteristics: B: Liver, Resection (AJCC 7th Ed., 2010). MACROSCOPIC. SPECIMEN TYPE: Partial right segmentectomy. FOCALITY: Multiple (specify location) : Segment 7, 8, and 4 (specimen. C). TUMOR SIZE: Greatest Dimension: 3.3 x 2.5 x 2.5 cm (specimen C) . 2.0 x. 2.0 x 1.7 (specimen B, first nodule), 0.5 x 0.5 x 0 5 cm. (specimen B, second nodule), 0.5 x 0.5 x 0.5 cm (specimen B,. third nodule). MICROSCOPIC. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GII: Moderately differentiated. PRIMARY TUMOR (pT) : pT2: Solitary tumor with vascular invasion or multiple. tumors none more than 5 cm. REGIONAL LYMPH NODES (pN) : pNX: Regional lymph nodes cannot be assessed. DISTANT METASTASIS (pM) : Specify site (s), if known: pMX: Cannot be assessed. AJCC STAGING (pTNM) : pT2 pNX pMX. MARGINS: Bile duct margin cannot be assessed. Other margin - specify margin: Parenchymal margin involved. by invasive carcinoma - specimen C (slide C3). LYMPH-VASCULAR INVASION: Macroscopic Venous (Large Vessel) Invasion. Not identified. Microscopic (Small Vessel) Invasion. Not identified. ADDITIONAL PATHOLOGIC FINDINGS: Cirrhosis/fibrosis. Gross: A. The specimen is labeled ""gallbladder. Received in. formalin is a 29 gram, 7. 0 x 3.0 x 2.0 cm, gallbladder. The. cystic duct margin is removed and the specimen is opened to. reveal a pink-tan velvety mucosa with a wall thickness of. 0.1 cm. Representative sections are submitted in cassette. A. Accession #: : B. The specimen is labeled ""tumor in border of segment 7. and 8. "" Received in formalin is a 34.6 gram, 4.8 x 4.5 X. 3.5 cm, portion of liver. The specimen has been previously. incised to reveal three nodules. The first nodule measures. 2.0 X 2.0 x 1.7 cm and is 0.3 cm from the closest. parenchymal margin and 0.5 cm from the closest capsular. margin. The second measures 0.5 x 0.5 x 0.5 cm and abuts. the capsule and is 0.5 cm from the closest parenchymal. margin. The third measures 0.5 x 0.5 x 0.5 cm and is 0.1 cm. from the capsule and 1.6 cm from the closest parenchymal. margin. The parenchymal surface is inked black. Representative sections are submitted as follows: Cassette Designation: B1-2. Representative section of first,. second, and third nodules with closest capsular. margin for all three and. closest parenchymal margin for nodules 2 and 3. B3. Representative section of first. nodule with closest parenchymal margin. C. The specimen is labeled ""left lateral segment and. section segment 4. Received in formalin is a 324 gram,. 16.0 x 12.5 x 3.5 cm, portion of liver. The specimen has. been previously incised to reveal a 3.3 x 2.5 x 2.5 cm firm,. tan, nodular lesion which is 0.5 cm from the capsular margin. and appears to abut the parenchymal margin. The remaining. portion of the liver is grossly unremarkable without. identifiable masses or lesions. The parenchymal margin is. inked black. No large identifiable vessels are noted. Representative sections are submitted as follows: Cassette Designation: C1. Portion of liver nodule with. closest capsular margin. C2-3. Portion of liver lesion abutting. black inked parenchymal surface. C4. Additional representative section. of liver lesion. C5. Representative section of grossly. unremarkable liver. Microscopic: Histological examinations have been performed on specimens. A-C. B and C. The specimens are histologically similar and are. described together. Sections show portions of liver. parenchyma that demonstrate mixed macro- and micronodular. cirrhosis highlighted by a trichrome stain performed on. specimen C. Multiple large nodules of moderately. differentiated hepatocellular carcinoma are present that. exhibit an architecture with small cell change and. pseudocanalicular structures with prominent admixed. vasculature. The tumor cells contain bubbly lipid-laden. cytoplasm and pleomorphic nuclei with vesicular chromatin. and very prominent nucleolus as well as a high nuclear. cytoplasmic ratio. The tumor cells are present as nests and. pseudoglandular structures and exhibit occasional mitotic. figures and apoptoses. The tumor cell infiltrate involves. the cauterized and black inked parenchymal margin for. specimen C. However, the remaining nodules in the specimen. are well-circumscribed by dense fibrous capsule. A. reticulin stain performed on specimen B and C highlight. reticulin fiber loss within the tumor cell nodules and. thickening of cell plates as well as highlighting the. regenerative nodules in the uninvolved liver. The. background liver exhibits mixed macro- and micronodular. cirrhosis with portal areas that exhibit dense. lymphoplasmacytic infiltrate with focal areas of bile duct. proliferation. A Prussian Blue stain for iron demonstrates. mild siderosis (+1) in the form of intrahepatic and kupffer. cell iron. Controls stained appropriately. Administrative Notes: CPT: No charge codes are associated with this case,. Component. Specimen: A. Gallbladder. B. Tumor in border of segment 7 and 8. C. Left lateral segment and section segment 4. Clinical Notes: Liver tumor HCC. C) Fresh tissue saved for. tissue bank. Diagnosis: A. Gallbladder, cholecystectomy: - Chronic cholecystitis. Negative for dysplasia or malignancy. B. Tumor, liver segment 7 and 8, resection: Multifocal moderately differentiated. hepatocellular carcinoma, completely excised. - AJCC stage: pT2 pNO pMX. See Tumor Characteristics. - Chronic HCV hepatitis with minimal activity and. cirrhosis (grade 1, stage 4). Mild siderosis (+1) . C. Liver, left lateral segment and segment 4 section,. resection: - Solitary moderately differentiated hepatocellular. carcinoma with parenchymal margin. involvement. - See specimen B for AJCC staging and Tumor. Characteristics sheet. (Electronically signed by). Verified: Tumor Characteristics: B: Liver, Resection (AJCC 7th Ed., , 2010). MACROSCOPIC. SPECIMEN TYPE: Partial right segmentectomy. FOCALITY: Multiple (specify location) : Segment 7, 8, and 4 (specimen. C). TUMOR SIZE: Greatest Dimension: 3.3 x 2.5 x 2.5 cm (specimen C) . 2.0 X. 2.0 x 1.7 (specimen B, first nodule), 0.5 x 0.5 x 0 .5 cm. (specimen B, second nodule), 0.5 x 0.5 x 0.5 cm (specimen B,. third nodule). MICROSCOPIC. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GII: Moderately differentiated. PRIMARY TUMOR (pT) : pT2: Solitary tumor with vascular invasion or multiple. tumors none more than 5 cm. REGIONAL LYMPH NODES (pN) : pNX: Regional lymph nodes cannot be assessed. DISTANT METASTASIS (pM) : Specify site (s) if known: pMX: Cannot be assessed. AJCC STAGING (pTNM) : pT2 pNX pMX. MARGINS: Bile duct margin cannot be assessed. Other margin - specify margin: Parenchymal margin involved. by invasive carcinoma - specimen C (slide C3). LYMPH-VASCULAR INVASION: Macroscopic Venous (Large Vessel) Invasion. Not identified. Microscopic (Small Vessel) Invasion. Not identified. ADDITIONAL PATHOLOGIC FINDINGS: Cirrhosis/fibrosis. Gross: A. The specimen is labeled ""gallbladder. "" Received in. formalin is a 29 gram, 7.0 x 3.0 x 2.0 cm, gallbladder. The. cystic duct margin is removed and the specimen is opened to. reveal a pink-tan velvety mucosa with a wall thickness of. 0.1 cm. Representative sections are submitted in cassette. A. B. The specimen is labeled ""tumor in border of segment 7. and 8. "" Received in formalin is a 34.6 gram, 4.8 x 4. 5 x. 3.5 cm, portion of liver. The specimen has been previously. incised to reveal three nodules. The first nodule measures. 2.0 x 2.0 x 1.7 cm and is 0.3 cm from the closest. parenchymal margin and 0.5 cm from the closest capsular. margin. The second measures 0.5 x 0.5 x 0.5 cm and abuts. the capsule and is 0.5 cm from the closest parenchymal. margin. The third measures 0.5 x 0.5 x 0.5 cm and is 0.1 cm. from the capsule and 1.6 cm from the closest parenchymal. margin. The parenchymal surface is inked black. Representative sections are submitted as follows: Cassette Designation: B1-2. Representative section of first,. second, and third nodules with closest capsular. margin for all three and. closest parenchymal margin for nodules 2 and 3. B3. Representative section of first. nodule with closest parenchymal margin. C. The specimen is labeled ""left lateral segment and. section segment 4."" Received in formalin is a 324 gram,. 16.0 X 12.5 x 3.5 cm, portion of liver. The specimen has. been previously incised to reveal a 3.3 x 2.5 x 2.5 cm firm,. tan, nodular lesion which is 0.5 cm from the capsular margin. and appears to abut the parenchymal margin. The remaining. portion of the liver is grossly unremarkable without. identifiable masses or lesions. The parenchymal margin is. inked black. No large identifiable vessels are noted. Representative sections are submitted as follows: Cassette Designation: C1. Portion of liver nodule with. closest capsular margin. C2-3. Portion of liver lesion abutting. black inked parenchymal surface. C4. Additional representative section. of liver lesion. C5. Representative section of grossly. unremarkable liver. Microscopic: Histological examinations have been performed on specimens. A-C. B and C. The specimens are histologically similar and are. described together. Sections show portions of liver. parenchyma that demonstrate mixed macro- and micronodular. cirrhosis highlighted by a trichrome stain performed on. specimen C. Multiple large nodules of moderately. differentiated hepatocellular carc√≠noma are present that. exhibit an architecture with small cell change and. pseudocanalicular structures with prominent admixed. vasculature. The tumor cells contain bubbly lipid-laden. cytoplasm and pleomorphic nuclei with vesicular chromatin. and very prominent nucleolus as well as a high nuclear. cytoplasmic ratio. The tumor cells are present as nests and. pseudoglandular structures and exhibit occasional mitotic. figures and apoptoses. The tumor cell infiltrate involves. the cauterized and black inked parenchymal margin for. specimen C. However, the remaining nodules in the specimen. are well-circumscribed by dense fibrous capsule. A. reticulin stain performed on specimen B and C highlight. reticulin fiber loss within the tumor cell nodules and. thickening of cell plates as well as highlighting the. regenerative nodules in the uninvolved liver. The. background liver exhibits mixed macro- and micronodular. cirrhosis with portal areas that exhibit dense. ymphoplasmacytic infiltrate with focal areas of bile duct. proliferation. A Prussian Blue stain for iron demonstrates. mild siderosis (+1) in the form of intrahepatic and kupffer. cell iron. Controls stained appropriately. Administrative Notes: CPT: No charge codes are associated with this case. In process."
BIOCUP_00390,liver,LIHC,TCGA-BD-A3ER,TCGA-BD-A3ER.2CD158D7-48E7-43D6-8E0F-2D56FC6F5256,"FINAL DIAGNOSIS: PART 1: LIVER, RIGHT LOBR 12, RANCOM BIOPSY. BEVERE MIXED MICRO-AND MACROVBSICULAR STEATOSIS INVOLVING 70% OF. THE LIVER PARENCHYMA AND MILD SEPTAL CHRONIC INFLAINATION. ESTABLISNED CIRRHOSIS. THERE IS NO RVIDENCE or MALIGNANCY. PART 2: LIVER, RIGHT LOBE #3, RANDON NEEDLE BIOPSY. SEVERE MIXED MICRO-AND MACROVRSICULAR STRATOSIS INVOLVING. APPROXIMATELY 701 or THE LIVER PARENCHYMA AND MILD SEPTAL CKRONIC. INFLAMMATION. ESTABLISHED CIRRHOSIS. THERE IS NO EVIDENCE OF MALIGNANCY. PART 3: LIVER. RIGHT LOBE TOMOR, SEGMENT e, NESTUS BIOPSY. HEPATOCELLULAR CARCINOMA, MODERATELY DIFPERSNTIATEO (SEE COMMENT). a. BACKGROUND LIVER WITH SEVERE MIXED MICRO-AND MACROVESICULAR STRATOSIS. INVOLVING APPROXIMATELY 70% OF THE LIVER AND ESTABLISHED CIRRHOSIS. PART 4: LIVER, SECMENT ., SEGMENTECTOMY (52 GRAM8). A. STEATOTIC HEPATOCELUOLAR CARCINCIALA, NODERATELY DIFFERENTIATED. SIZZ . 2 7 x 2.0 CM. b. MARGINS = 0.4 CM FROM THE CLOSEST PARENCHYNAL RESECTION MARGIN. c. AJCK: STAGE: PT2, NX, MX. B. BACKCROUND LIVER WITH SEVERE MIXED MICRO-AMD MACROVESICULAR. STEATORIS INVOLVING APFROXIMATELY 70% or THE LIVER PARENCHYNA AND ESTABLISHED. CIRRHOSIS. PART 5: LIVER, SBGMENT 48, WEDGE RESECTION (4 GRAMS). A. SUBCAPSULAR WROGE OF HKPATIC TISSUE WITH FORRIGN BODY GIANT CBLL. REACTION TO NECROTIC FOCI (SEE COMMENT). B. THERS IS NO or VIABLE TUMOR CBLLS. BACKGROUND LIVER WITH SEVERE MIXED MICRO-AND MACROVESTCULAR STEATOSIS. INVOLVING 70% of THE LIVER PARENCHYMA AND ESTABLISHED CIRRHOSIS. PART 6: GALLBLADDER, CHOLBEYSTECTOMY. A. CHRONIC CHOLECYSTITIS. B. THERE IS NO EVIDENCE OF MALIGNANCY. DME/DME. COMMENT: was informed that no specimen was found in container. labelod, ""Random biopay, right lobe #1.'. Parts 1 and 2: Liver, right lobe, #2 and #3, random needle biopsies: Histologie examination of che multiple needle core biopsies of hepatic tissue. reveal severe mixed microvesicular and macrovesicular steatosis involving 70+. of the hepatic parenchyma with established cirrhosis There is no evidence of. malignancy as confirmed using immunohistochemical and special stains There 15. loos of reticulin tramework in steatotic arees, but this is seen in benign. fatty liver, Imarunohistochemical atsin to Glypican 3 is negative CD34 failed. to show sinusoidal capallarization. K167 shows no sigmificant increase in. proliferation rate. According to the electronic medical records, the patient ia heterozygous for. hemochromatosis. No confirmatory molecular studide for hamochrromtocie gene. (HFB) mutation vere secn in the medical recorda and no increased hepatocyts. 1ron deposits were seen using the iron stain. Clinical correlation in. suggeoted. Overall, the histopathological changes of background liver are most consistent. with aus active steatohepatitis, although other causes of liver injury should. be clinically and serologically excluded. gteatohepatitis is a non-specific. pattern of injury seen most commonly with morbid obesity, diabetes, insulin. resistance, and alcohol abuse. However, it can also be associated with. nutritional causes, wuch as protain-calorie malnutrition, starvation, rapid. weight loss, and various intestinal bypase or gastric stapling surgeries. Hepatic ateat0818 and steatnhepatitia can also be the result of medications,. including amiodarone, perhexiline maleate, glucoourticoids, uynthetic. estrogens, calcium channel blockers, tamoxifen, methotrexate, valpreic acid,. cocaine, and anti-viral agente (Zidovudina, Didanosine, and rialuridine). Netabolic disorders can aloo cause steatosis and steatChepatitis: hyperlipidemia, Wilson's disease, adult onnetcitrullinemia (type II),. lipodystrophy, dyabecalipoprotainemie, weber-Christian-Disense, Wolman's. Disease, Cholesterol ester storage disease, and fatty liver of pregnancy. Other causer include inflammatory bovel disease, intestinal bacterial. overgrowth, and exposure to environmental toxins, incinding phosphorous. petrochemicals, toxic mushrooms, and organic scivents. Repatic blood tlow. abnormalities dan also cause hepatic steatosia and steatohepatitia Rxamples. include pre-hepatio portal hypertension, porto-syotemic shunting, and patent. ductus venosus. Part 3: Liver, right lobe tumor, segment s, needle blopsy: The specimen consists of two cores of hepatic tiague. One of which is. steatotic cirrhotic liver, similar to that seen in parts 1+2 of the right lube. needle biopaies. The other core of tiesue 18 composed of eosinophilic cells. arranged in acini and trabeculae with increased nucleax to cytoplasmic ratio. There 18 necrosis involving 15t of this core and thaze in a tocus of stromal. invasion. Immunohiatochemical stain to CD34 shows sinuscidal capillarization. Olypican 3 weakly stains the cells. Ki67 shows a alight increase in. proliferation rate. No loed OF the reticulin franework is neen. Takeu together. these resulto support the diagnosis of well differenciated hepatoccilular. carcinoma. Part 4: Liver, right lobe tumor, segment a, segmentectiony. :U previous biopsy. steatotic nepatoceilular carcinoma ie difficult. -pposting. alight inckeased rate of proliferation in comparison to the cirrhotic. background liver. Aberrant arteries are seen using smooth mueclo actin. staining is scen, AFF and glypican3 are negative. Taken together theae results. support the diagnosis of hepatocellular carcinoma. Losa of beterozygosity. studies are pending and these results will be reported in an addendurs. Part 5: Liver, left lobe, gagment 4B, vedga resection: The spacimen conmusts of a wedge resection with a capsular foreign body giant. cell reaction to necrotic material. No viable tumor cells are deen. None to. equivocal yeast forms are seen on No organisms are seen using gram and. AFB stain The differential diagnoses include infarated tumor foci,. infections, such as histoplasmosia, old subcapsular hematoma, etc. Clinical. correlation requiced. SYNOPTIC DATA - PRIMARY LIVER HEPATOCELLULAR CARCINOMA "" !ORS. SPECIMEN TYPE: Other: Right lobe segment 8. FOCALITY: Multiple: Segment 8 (2 lesions: one was resect: in and other one. was ablated). TUMOR SIZE: Greatest dimension: 2.7 cm. Additional dimensions: 2. .4x2.0 cm. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GII: Moderately differentiated. MACROSCOPIC VENOUS (LARGE VESSEL) INVASION (V) : Not identified. MICROSCOPIC (SMALL VESSEL) INVASION (L): Not identified. IVER-PERINEURAL INVASION: Not identified. TNM DESCRIPTORS: PATHOLOGIC STAGING (pTNM) : pT2. pNX. Number of regional lymph nodes examined: 0. Number of nodes regional lymph involved: 0. pMO. MARGINS: Parenchymal Margin uninvolved by invasive carci ma. Parenchymal Margin: Distance of invasive carcinoma from losest margin: 0.4 mm. ADDITIONAL PATHOLOGIC FINDINGS: Cirrhosis/advanced fibroi 3. Other: steatohepatitis. PATIENT HISTORY: year-old man with history of history of heterozygous hemocis omatosis along. with prostate CA that was diagnosed in. Now with enlargin hypervascular. liver mass. Liver biopsy confirms hepatocellular carcinoma. he patient. denies any history of viral hepatitis. He has moderate socia, drinking but. quit. Denies any history of GI bleed, hepatic ent: phalopathy,. ascites, or jaundice. Imaging shows a solitary 2.5 cm hypervi cular mass in. the right lobe of the liver. Quantitative testing for hepatil 13 C virus is. negative at <25 iu/ml. Quantitative testing for hepatitis B 1. rus infection. gave a viral titer of <300 iu/ml. CT of the abdomen on. 11 showed 3. segment 8 and 1 segment 5 hypervascular hepatic lesions with 11 rsistent portal. venous enhancement. Background liver shows cirrhotic morphol( 7. Liver. function tests on. AST 55, ALT 48, GGTP 138, bilirubin. 0.7. hepatitis C virus antibody negative at 0.09, alpha-feto) otein negative. at 5. CHIEF OMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Liver lesion biopsy, proven. hepatocellular carcinoma, PMH hemochromatosis, prostate cancel. PROCEDURE: Partial right hepatic lobectomy segment 8 tumor, 11 nection of left. lobe segment 4B lesion, open radiofrequency ablation of the It er tumor of the. right lobe x 3, ultrasound guidance for monitoring of tissue I lation, needle. liver biopsy, open cholecystectomy and intraoperative cholang! gram. ADDENDA: Addendum. Molecular Anatomic Pathology Testing: Block 3A, microdisgection target 1 (T1) : A. Losa of heterozygosity is IDENTIFIED at chromosome 5q (378). B. Fractional Allelic Loss is 8% (1 locus with losa/12 informative loci). Block 4B, microdissection target 2 (T2). A. Loss of heterozygosity is IDENTIFIED at chromosome 1p (32%). B. Fractional Allelic Loss is 81 (1 locus with loss/12 informative loci). Note: LOH of high amplitude is considered when more than 75% of cellular DNA is. affected. Loss of heterozygosity of tumor suppressor gene alleles is known to occur in. liver neoplasias and to correlate with tumor progression. As reported in the. literature, benign neoplasme (hepatic adenoma and focal nodular hyperplasia). typically have low frequency of LOH (mean fractional allelic loss ~6$) and. hepatocellular carcinomas (HCC) frequently have higher prevalence of LOH (mean. fractional allele loss -30%) (1,2) Some studies have shown that HCC with. FAL of <30 are associated with indolent biological behavior and FAL of >30%. with an aggressive biological behavior (3-5) LOK mutations are reported as. high amplitude when more than 75% of cellular DNA ie affected. Some HCC with. low amplitude LOH mutations and FAL 25-35 t considered to be indeterminate. biological behavior. However, not all cumors reveal auch a correlation and,. therefore, the LOH profile should be interpreted in the context of the. cytologic and histologic findings and the patient s clinical history. Sample Preparation and LOH Analysis. Manual microdicsection of the tissue sample was performed to include tumor. tissue and normal adjacent tissue (if available) or a blood sampla. DNA was. isclated using standard laboratory procedure. Specimeno with the minimium of. 50% of tumor cells in a microdissection target are accepted for the analysis. Optical density readings were obtained. Eighteen microsatellite markers (listed below) that have been previously found. to be involved in liver neoplasia and/or co-localize with known tumor. suppressor genes were used for analysis. PCR was performed using. fluorescently labeled primers and the products of amplification were detected. using capillary electrophoresis on ABI3730 platform. Relative fluorescence was. determined for individual alleles and the ratio of peaks was calculated. Normal tissue was examined to determine whether the. patient 19 neterozygous at the marker (genetically informative) and neoplastic. tissue was then analyzed to detect loss of heterozygosity. Thresholds for. significant allelic imbalance were determined using normal (non-neoplastic). specimens for every marker. Loss of heterozygosity was determined using (NL /. NS). (TL/TS) formula and reported when allelic ratio for a particular marker. was below 0.5 or above 2.0. When normal tissue was not available, peak height. ratios falling outside of 2 SDs beyond the mean for each polymorphic allele. paring were assessed as showing loss of heterozygosity. D19407. 1p36. CMM/RIZ. D19171. 1p36. CMM/RIZ. D3S1539. 3p26. VHL/OGG1. D3S516. VHL/OGG1. D5S1384. APC. D5S615. APC. D8S254. 8p22. D88261. 8p22. p9$251. 9p21. CDKN2A. 0981748. 9p23. CDKN2A. D10S520. 10g23. PTEN. 010S1173. 10q23. PTEN. D17S974. 17p13. TP53. 01791289. 17p13. TP53. 017S1877. 17q23. Her2/neu. D18S487. 18g21. DCC. 021S1256. 21g22. ETS2. D22S268. 23q13. NF2. 1. Chen YJ, et al. Chromosomal analysis of hepatic adenoma and focal. nodular hyperplasia by comparative genomic hybridization. Genes Chromosome. Cancer. 2002 oct:35(2):138-43. 2. Cha C, Demacteo RP. Molecular mechanisms in hepatocellular. carcinoma development Best Pract Res Clin Gastroenterol 2005 Feb;1 (1) 25-37. Finkelstein SD, et al. Microdissection-based allelotyping. discriminates de novo tumor from intrahepatic spread in hepatocellular. carcinoma. Hepatology. 2003 Apr;37(4) 871-9. 4. Marsh JW, et al. Genotyping of hepatocellular carcinoma in liver. transplant recipients adds predictive power for determining recurrence-free. survival. Liver Transpl. 2003 Jul:9(7):664-7,. Morimoto o. et al. Diagnosis of intrahepatic metastasis and. multicentric carcinogenesis by microsatellite loas of heterozygosity in. patients with multiple and recurrent hepatocellular carcinomas. J. Hepatol. 2003 Aug; 39 ):215-21."
BIOCUP_00391,liver,LIHC,TCGA-DD-AAE6,TCGA-DD-AAE6.1B3F62E9-8E87-43FA-AEA8-00C89D678F8F,"CLINICAL DIAGNOSIS: R/O HCC. Specimen : liver. Gross Photo : GROSS: Specimen status: Fresh. Operation: Left hemihepatectomy. Cholecystectomy. Organs: Liver (21.5 X 14.0 X 6.0 cm, 485.5 gm). Gallbladder (10.7 cm in length, 2.6 cm in diameter, and 0.3 cm in thickness). Lesion: [Liver]. Multinodular conglomerated tumor mass (11.0 X 10.5 X 5.5 cm). Cut surface: Yellowish tan and solid with area of necrosis. Gross type: HCC: Multinodular confluent. Resection margin: Not involved grossly (safety margin: 7.0 cm). Others: Satellite nodule: No. Remaining parenchyma: Cirrhotic. [Gallbladder]. No stone. Representative sections submitted. Gross photo: Present. Blocks. TB, T1-5, tumor mass X 6. L,NB, liver parenchyma X 2. RM, resection margin X 1. GB. gallbladder X 1. MICROSCOPIC: Hepatocellular carcinoma: Yes. The worst differentiation II. The major differentiation II. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: No. Septum formation: Yes. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: Yes. Microvessel invasion: Yes. Intrahepatic metastasis: Yes. Multicentric occurrence: Yes. NOT reported. Gross: Liver, left, ectomy, hepatocellular carcinoma, moderately differentiated. T56000, left, P10, M81703, moderately differentiated. Gallbladder, ectomy, chronic cholecystitis. T57000, P10, M43005. DIAGNOSIS: Liver, segment 2, left hemihepatectomy: Hepatocellular carcinoma, moderately differentiated. Gallbladder, cholecystectomy: Chronic cholecystitis. Suggestion :"
BIOCUP_00392,liver,LIHC,TCGA-2Y-A9H4,TCGA-2Y-A9H4.8A93B07B-8DCC-4DF4-B792-212C80E203FB,"Final Diagnosis. A. GALLBLADDER, CHOLECYSTECTOMY: Chronic cholecystitis. No evidence of malignancy. B. LIVER NODULE NO. 1, LEFT LOBE, CORE NEEDLE BIOPSY: Liver parenchyma with focal scar. No evidence of malignancy. C. LIVER NODULE NO. 2, LEFT LOBE, NEEDLE BIOPSY: Liver parenchyma with focal scar. No evidence of malignancy. D. PORTAL LYMPH NODE: One lymph node (0/1), free of malignancy. E. RIGHT LOBE LIVER, PARTIAL RESECTION: Hepatocellular carcinoma. See Key Pathologic Findings. KEY PATHOLOGICAL FINDINGS: Tumor type: Hepatocellular carcinoma, moderately differentiated. Tumor configuration: Circumscribed. Tumor size: 3.3 x 2.5 x 1.5 cm. Tumor necrosis: Not identified. Extent of invasion: Carcinoma is confined to within hepatic parenchyma. Vascular invasion: Not identified. Perineural invasion: Not identified. Parenchymal and surgical margins: Free of malignancy. Additional findings: Focal steatosis and portal triad chronic inflammation. Pathologic stage: pT1 NO MX. the attending pathologist, personally reviewed all. slides and / or materials and rendered the final diagnosis. Electronically. Specimen(s) Received. A. GALLBLADDER. B. LIVER NODULE #1 LEFT LOBE FS. C. LIVER NODULE #2 LEFT LOBE FS. D. PORTAL LYMPH NODES. E. RIGHT LOBE LIVER. Clinical History. HCC. Preoperative Diagnosis. HCC. Intraoperative Consultation. FSB1. LIVER NODULE, NO. 1, LEFT LOBE: Benign liver with focal scar. FSC1. LIVER NODULE, NO 2, LEFT LOBE: Benign liver with focal scar. Comment: This frozen section diagnosis/result was communicated to and acknowledged by. in person at. I,. have performed the intraoperative consultation (s) and issued the above. diagnosis. Gross Description. A. The specimen is received fresh labeled ""gallbladder"" and consists of a 7.7 x 2.8 x 2.5-cm. intact gallbladder. The serosa is smooth and glistening. The wall averages 0.2 cm in thickness. The. mucosa is velvety. No mass or other lesions are identified. The lumen contains a dark green viscous. bile. No stones are identified. Representative sections are submitted as follows: A1: Cross section of cystic duct margin. A2: Random sections of gallbladder. B. The specimen is received fresh for frozen section consultation labeled ""liver nodule No. 1, left. lobe,"" and consists of a 0.1-cm in diameter elongated portion of tan tissue which is 1.2 cm in length. The tissue is entirely frozen and submitted in FSB1. C. The specimen is received fresh for intraoperative consultation labeled ""liver nodule No. 2, left. lobe,"" and consists of a 0.1-cm in diameter elongated portion of tan tissue which is 1.5 cm in length. The tissue is entirely frozen and submitted in FSC1. D. The specimen is received fresh labeled ""portal lymph nodes"" and consists of a 1.9 X 1.4 x. 0.9-cm firm tan lymph node with surrounding adipose tissue. The tissue is sectioned and entirely. submitted in D1. E. The specimen is received fresh labeled ""right lobe liver"" and consists of a 761.9-g, 17.5 x 16.0. x 7.0-cm lobe of liver. The surgical margin is inked black. The capsule is smooth and without. adhesions. 3.8-cm from the closest surgical margin is a 3.3 x 2.5 X 1.5-cm well-circumscribed soft tan. lobulated mass. The mass is 1.5 cm from the capsule. There is an additional soft discolored pale. area adjacent to the mass. The remaining parenchyma is homogeneous tan without additional. lesions. No frozen section is performed as per. A portion of the tissue is submitted to. Tissue Procurement Laboratory. Representative sections are submitted as follows: E1: Tissue adjacent to tissue submitted for tumor bank. E2: Margin closest to mass, perpendicular. E3-E4: Sections of mass. E5: Mass with surrounding normal parenchyma. E6: Separate pale lesion. E7: Normal parenchyma."
BIOCUP_00393,liver,LIHC,TCGA-2Y-A9GV,TCGA-2Y-A9GV.4979AF79-CF92-4D6C-87FD-158C87B5F059,"F. Additional Phyeicians: Intraop. Pathologist: Performing Phyaiciani. CLINICAL HISTORY: NONE GIVEN. PREOPERATIVE DIAGNOSIS: HEPATOMA RIGHT LODE OF LIVER. EPECIMEN TYPEISI =. A: GALLBLADDER. B: DIAPHRAGMATIC NCDULE FS. C: SECMENT 5 &. FINAL DIAGNOSIS: A. GALLBLADDER;. Benigo gallbladder wall with mild rocal chronte inflammation. No evidence of zalignancy. B. NOUDLE: Fibroadipose tiesue with a tocus or fat necros: and rocal dystrophic. calcurication. No evidence of malignancy. c. LIVER, SEGMENT 5 AND'6, RESECTION: ell dirferenttated tepatodellular careinoma, clear cell pattern. Tumor sizet 6.5 x 5 x 4.2 cm. Histologic gradez grade I (well-dirrerentiated). Inked parenchymal resection margin: Free of carcizoza. Nonneop:astic liver tissue: Portal chronic inflammatory infilirate consistent with changes in. the vicinity or the tuttor maga. there is na evidence of cirrhosis presento. I,. the attending pathologist, personaliy reviewed the entire pathlogy. case and rendered the final d:agnomia. Electronically Signed dut by. OTHER RELATED CLINICAL DATA: NA. INTRAOPERATIVE DIAGNOSIS: PROZEN SECTION AND gROSS DIAGNOSIS. A. CALLBLADDER: Tumor grosaly 1.2.cm away from cargin. Tumor 6.5 cm. PSB. DIAPERAGMATIC NODULE: Benige, conatatent with :3t recrosia. COMMENT: This rrozen mection was comunicated to and acknowledged by. in. have performed the intraoperative. ronsultationia) and desued the above diagnosis. GRCSS DESCRIPTION: The apecimen 18 received frean and labeled ""galibladder. The apecimen consists. or 3 can to alight ly green calibladder measuring 7.5 x 2 x 2 cm. The specimen. containa green bile and gallstones are not present. The galibladder w311 18 fine,. velvety, and measures up to 0.2/cm 10 thickness. Representative tresh tisgue 18 not. aubmitted to Tiague Procurement Laboratory. Representative gections are aubmitted. as tollews: Al: Cuatic duct, Langential: A2: Longitudinal sections including Fundus. R: The specimen 1s received frem and laceled ""1taphragzatic cadule"". The apecimen. consists or a tragment or gort, tar. white to tan- yellow tiesue measuring 5 x 0.5 x. 0.2 cm. The spedimen W38 also entirely submitted 39. FSBL. the repecimen 1s received Treah and labeled gegments 5 and 6. The specimen. consista of a 279.2 gras, 15 x 12.5 x 6 em firm, dark, red brewn segment or liver. The specimen 18 sertally sectioned to reveal an tregular, tan-white to tan-yellow. partially nemorrhagic nodule, 6.5 x 5 x 4.2 em, located 31. 1.2 en from. cargin of resection. The marg:n or resection 18 irregular and is entirely Inked. in. biack. The recatning hepatic 13 dark-red-trowo with Tobular aspects. Representative frem tissue 18 submitted to Tiesue Procurement Laboratory. Representative sections are autaitted as follews: Cl: Perpendicular section Gealon in relation to closest inked. aurgical margin of resection. C2-C7: Lesion. CB: Normal liver parenchyma."
BIOCUP_00394,liver,LIHC,TCGA-DD-AACF,TCGA-DD-AACF.57E9FFF0-F926-4793-AF09-691BDA2248C9,"CLINICAL DIAGNOSIS: HCC (S4). Specimen : liver. Gross Photo : GROSS: 1. Specimen: Liver: 11.5 x 6.8 X 6.2 cm, 208.5 gm, unfixed. Gallbladder: 11.0 cm in length, 4.5 cm in diameter, and 0.4 cm in thickness, unfixed. with cystic lymph node (1.2 X 1.0 X 0.8 cm). 2. Tumor location: segment 4. Tumor number: one. Tumor size: 4.4 X 3.4 X 3.0 cm. Distance to resection margin: 0.2 cm. 3. Satellite nodule: no. 4. Gross type. HCC: expending nodular. 5. Tumor necrosis: no. 6. Hemorrhage/peliosis: yes (50%). 7. Portal vein invasion: no. 8. Bile duct invasion: no. Gross photo present. Blocks x 9. T1- - and TB, tumor mass X 5. RM, resection margin x 1. L and NB, non-tumorous liver parenchyme X 2. GB, gallbladder X 1. LN, cystic lymph node X 1. MICROSCOPIC: 1. Hepatocellular carcinoma: yes. 1-1. Differentiation. The worst differentiation III. The major differentiation II. 1-2. Histologic type: pseudoglandular. 1-3. Cell type: hepatic. 1-4. Fatty change: < 5 %. 2. Cholangiocarcinoma: no. 3. Combined hepatocellular and cholangiocarcinoma: no. 4. Fibrous capsule formation: partial capsule. 5. Capsular infiltration: yes. 6. Septum formation: no. 7. Surgical resection margin invasion: no, margin of the clearence (0.2 cm). 8. Serosal invasion: no. 9. Portal vein invasion: no. 10. Bile duct invasion: no. 11. Hepatic vein invasion: no. 12. Hepatic artery invasion: no. 13. Microvessel invasion: no. 14. Intrahepatic metastasis: no. 15. Multicentric occurrence: no. Non-tumor liver pathology. 1. Chronic hepatitis: yes. 1-1. Etiology: HCV. 1-2. Grade, lobular: minimal. 1-3. Grade, portoperiportal: mild. 1-4. Stage (fibrosis): cirrhosis. 1-5. Cirrhosis: micronodular. 2. Dysplastic nodule: no. 3. Ductal epithelial dysplasia: no. 4. Other liver diseases: no. NOT reported. Gross: NOT reported. Gross: Liver, ectomy, hepatocellular carcinoma, steatosis, cirrhosis. T56000, P10, M81703, M50080, M49500. Gallbladder, ectomy, chronic cholecystitis. T57000, P10, M43005. Lymph node, cystic, ectomy, reactive hyperplasia. T08000, cystic, P10, M72200. DIAGNOSIS: Liver, segment 4, central hepatectomy: Hepatocellular carcinoma, moderately differentiated. Steatosis, mild. Cirrhosis, micronodular. Gallbladder, cholecystectomy: Chronic cholecystitis. Lymph node, cystic, cholecystectomy: Reactive hyperplasia. Suggestion :"
BIOCUP_00395,liver,LIHC,TCGA-ED-A97K,TCGA-ED-A97K.518E0619-1C4F-475C-904E-009300CF1768,"Gross Description: Tumor is ill-margins, solid and firm, gray-white in cutting section with 5x4x4cm in. size. Microscopic Description: Tumor cells form the trabecular patterns or cords or tubules or adenoids. patterns intervening in begnin tissue. Tumor invades into fibrous stroma. The amount of cytoplasm are. abundant and the cytoplasm is clear or basophilic Nuclei are irregularly large and hyperchromatic with. prominent nucleioli. Mitoses are present. Tumor is invasion of inflammatory cells and necrotic. Stroma is. marked fibrous and hyaline. Diagnosis Details: Hepatocellular carcinoma and cholangiocarcinoma, combined. Comments: Formatted Path Reports: LIVER TISSUE CHECKLIST. Specimen. type: Wedge resection, lobectomy & cholangescaremen. Tumor size: 5x4x4cm. Focality: Not specified. Histologic type: Hepatocellular carcinoma and cholangiocarcinoma, combined. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Not specified. Comments: None."
BIOCUP_00396,liver,LIHC,TCGA-DD-A4NE,TCGA-DD-A4NE.8E3E5E19-6A21-44B1-B000-F90EA27F6EE0,"DIAGNOSIS: B. Liver, right lobe and portion of segment 4B, resection: Grade 3. (of 4) hepatocellular carcinoma is identified forming a dominant. mass, 14.5 x 8.7 x 6.8 cm, with innumerable satellite nodules. (ranging in size from 0.1 cm to 4.4 cm in greatest dimension) . The. tumors are confined to the liver. The liver parenchyma resection. margins are negative for tumor (minimum tumor free margin, 0.3 cm) . Macroscopic large vessel (venous) invasion is absent. Microscopic. (small vessel) invasion is absent. Multiple (3) perihepatic lymph. nodes are negative for tumor. A. Gallbladder, cholecystectomy: Chronic cholecystitis. With available surgical material [AJCC pT3aNO] (7th edition,. This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen( (s) . Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report."
BIOCUP_00397,liver,LIHC,TCGA-DD-AADN,TCGA-DD-AADN.043E7A50-2122-42D4-BB6F-9AAC61FE8CBE,"CLINICAL DIAGNOSIS: Hepatocellular carcinoma suggested. Specimen : Liver and Liver mass. Gross Photo : GROSS: Specimen status: Fresh. Operation: Right hemihepatectomy. Organs: Liver (14.5 X 15.0 x 8.0 cm, 798.0 gm). Gallbladder (11.0 cm in length, 3.5 cm in diameter, and 0.3 cm in thickness). Lesion: A well-defined mass (14.5 X 8.0 X 7.0 cm). Cut. surface: Yellowish tan, solid and firm mass with area of hemorrhage. and necrosis. Gross type: Multinodular confluent. Resection margin: Not involved grossly (safety margin: 3.0 cm). Others: Satellite nodule: No. Remaining parenchyma: Cirrhotic. Cross photo: Present. Blocks. T1-5, TB, tumor mass X 6. L, liver parenchyma X 1. RM, resection margin X 1. GB, gallbladder X 1. MICROSCOPIC: Hepatocellular carcinoma: Yes. The worst differentiation IV. The major differentiation II. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: Yes (20%). Fibrous capsule formation: Complete capsule. Capsular infiltration: Yes. Septum formation: No. Surgical resection margin invasion: No, safety margin (3.0 cm). Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: Yes. Intrahepatic metastasis: Unknown. Multicentric occurrence: Unknown. NOT reported. Gross: NOT reported. Gross: Liver, ectomy, hepatocellular carcinoma, cirrhosis. T56000, P10, M81703, M49500. Gallbladder, ectomy, autolysis. T57000, P10, M54001. DIAGNOSIS: Liver, segment 5-8, right hemihepatectomy: Hepatocellular carcinoma (see NOTE). Cirrhosis. Gallbladder, cholecystectomy: Autolysis. NOTE: Recommend to order the IHC stains (Hepatocyte, Glypican3, CD34, p53, CK7, EBV,. and hHCG) on block T1 to differentiate from other malignant tumors. Suggestion :"
BIOCUP_00398,liver,LIHC,TCGA-2Y-A9GU,TCGA-2Y-A9GU.5585C485-B57A-4CA8-A3E3-F093A7E6AC76,"Final Diagnosis. LIVER, SEGMENT V RESECTION: Moderately differentiated hepatocellular carcinoma. The noninvolved liver show macro and microsteatosis with focal dilated sinusoid. No evidence of cirrhosis. See Key Pathological Findings and see comment. KEY PATHOLOGICAL FINDINGS: Specimen type: Liver segmentectomy. Tumor configuration: Lobulated, subcapsular. Tumor size: 11x9x7cm. Histologic type: Hepatocellular carcinoma. Histologic grade: Moderately differentiated. Tumor necrosis: Less than 10%. Parenchymal margin: Free of tumor. Angiolymphatic invasion: Not identified. Pathologic stage: Stage I (T1 Nx Mx ). COMMENT : The liver away from the carcinoma (block A7) show preserved normal framework on. reticulin stain. The trichrome stain show no increase in fibrosis and absence of bridging. iron stain fails. to show any increase in iron deposit. the attending pathologist, personally reviewed the. entire case and rendered the final diagnosis Electronically signed out by. Specimen(s) Received. A. SEGMENT 5 RESECTION FS. Clinical History. None given. Preoperative Diagnosis. Liver cancer. Frozen Section Diagnosis. FSA1. SEGMENT 5 RESECTION: Perpendicular margin is free of tumor. Comment: This frozen section diagnosis/result was communicated to and acknowledged by. in. at. I,. x have performed the intraoperative consultation (s) and issued the above. diagnosis. Gross Description. The specimen is received fresh labeled ""segment 5 resection"". The specimen consists of. 604.0 gram segmentectomy resection of liver which measures 16.0 x 11.0 x 7.0 cm. The capsule of. the specimen is pink-tan to red-brown, focally hemorrhagic, and has bosselated surface. The. parenchymal resection margin is tan-red-brown, focally cauterized and is inked blue. The specimen is. serially sectioned to reveal an irregular, ill-defined lobulated intraparenchymal tumor mass which. measures 11.0 x 9.0 x 7.0 cm. The tumor is bulging capsule and is 1.0 cm from the closest. parenchymal resection margin. The tumor mass is focally hemorrhagic and necrotic. The areas of. necrosis range from 0.1 to 2.5 cm in greatest dimension, and occupy less than 10% of the tumor. Representative section of the tumor in relation to the closest parenchymal resection margin is. submitted for frozen section as FSA1. Representative sections of the specimen are submitted to. the. Tissue Procurement Laboratory. Additional sections of the specimen are submitted in 6 cassettes as. follows: A2-A5: Tumor bulging capsule. A6: Central part of the tumor. A7: Grossly unremarkable liver parenchyma."
BIOCUP_00399,liver,LIHC,TCGA-G3-A3CI,TCGA-G3-A3CI.42613B77-F014-4AE9-AEF8-C5E632125EFA,"PHN: ACB: Telephone: Encounter: Collected Date: Specimen Description. A. Gallbladder. B. Segment 5 and 6 of liver. Clinical Information. Hepatocellular carcinoma. Diagnosis. A. Gallbladder: - Mild chronic cholecystitis, negative for atypia. B. Liver, Segments 5 and 6, Resection: - Hepatocellular carcinoma, moderately differentiated (Gr II). - Subcapsular location, 6.5 cm greatest diameter. - Completely excised, with nearest margin of 0.5 cm. Pathology: Provider - Permanent. Collected Date: Gross Description. Received are specimens A to B. All requisitions and specimen containers are labelled with the patient's name. The cassettes and AP identifiers are labelled with the Surgical Numbe. A. The specimen is received fresh, subsequently placed into formalin and consists of a slightly congested, non intact. gallbladder, measuring 7.0 X 3.0 X 1.5 cm. The serosal surface is smooth and glistening. Opening the gallbladder reveals. green bile and green, velvety mucosa. The gallbladder wall averages 0.2 cm in thickness. The cystic duct is patent. The. cystic duct lymph node is not identified. Three representative sections are submitted in one cassette. B. The specimen is received fresh, subsequently placed into formalin and consists of a portion of liver weighing 245. grams and measuring 15.0 x 5.5 x 7.5 cm. The surgical margin is inked blue. Sectioning of the liver reveals a tan,. lobulated, circumscribed mass measuring 5.5 X 4.5 X 6.5 cm. Grossly, this mass extends to the liver capsule giving the. capsule a lobulated appearance in one area. The mass comes to within 0.5 cm of the blue-painted resection margin. There is a vague nutmeg appearance to the liver parenchyma, otherwise it is unremarkable. Sections of the specimen are as follows: B1,B3. three sections through the lobulated surface on the liver capsule. B4,B5. two sections of the mass in relation to the blue-painted margin. B6,B7. two sections of the mass with adjacent unremarkable liver parenchyma. B8. a section of unremarkable liver parenchyma. Microscopic Description. A. Sections show largely unremarkable gallbladder tissue with only minor patchy chronic inflammation in the mucosa and. focal mild subserosal fibrosis. No atypia is present. B. Sections show a relatively circumscribed but invasive hepatocellular carcinoma that extends to the liver capsule, but. does not show any sign of disruption or breaching of the capsule. The carcinoma grows in sheets with cells showing. relatively abundant cytoplasm but showing variable nuclei with mild to moderate atypia, nucleoli, and patchy. hyperchromasia. Cytoplasmic intranuclear inclusions are also prominent. The tumor cell cytoplasm shows a range of. appearances, from granular eosinophilic to through to areas of clear cell change as well as areas with well developed fatty. change. In places a vague sinusoidal architecture can be seen and intra sinusoidal collections of extramedullary. hemopoiesis are present. Focal areas of hemorrhage, edematous degeneration and focal frank necrosis are present. The interface between the carcinoma and adjacent liver tissue varies, in areas having a circumscribed and almost. encapsulated margin but elsewhere having a vague merging of cancer cells with adjacent parenchyma. No evidence of. vascular invasion can be identified. Pathology: Provider - Permanent. Cunninal Anthalance Report. ‚Çπ. Collected Date: The adjacent liver parenchyma shows mild patchy chronic inflammation in portal tracts (nonspecific portal triaditis) as well. as focal mineral oil lipogranulomas in portal areas. There is no hemosiderin accumulation or other abnormal. intracytoplasmic inclusions. No evidence of significant fibrosis or background cirrhosis is present. Histologic evaluation of. the margin confirms the gross appearance of a clear margin of approximately 0.5 cm. Pathology: Provider - Permanent."
BIOCUP_00400,liver,LIHC,TCGA-XR-A8TD,TCGA-XR-A8TD.DA6BFBB1-CD64-4996-8D5C-73600EBDFE34,"Nature of material: Liver. Biopsy number: ANATOMOPATHOLOGIC RESULT. MACROSCOPY. Received two vials identified as follows: -Lymph nodes of the hepatic hilum: containing fibro-adipose tissue where four nodular and fibro-. elastic fragments were dissected, measuring the largest 4.5 X 3.5 X 0.9 cm and the smallest 1.7. X 0.5 X 0, 3 cm. -Liver: liver segment weighing 2878.0 grams and measuring 21.0 cm in craniocaudal direction,. 21.0 cm in side axle and 11.0 cm anteroposteriorly. The outer surface is smooth and brown with. bloody area measuring 14.0 X 9.0 cm and nodular brownish lesion with 3.5 cm X 3.0 cm. To the. cuts it is note a nodular, withish and soft lesion, measuring 19.5 X 19.0 X 10.0 cm. The. gallbladder measures 9.0 x 2.0 cm with smooth and brown-gray serous and greenish mucous. MICROSCOPY. Expendable description. DIAGNOSTIC. Product of hepatic trisegmentectomy: -Hepatocellular carcinoma with clear cell pattern, grade III Edmonsson & Steiner, with extensive. areas of necrosis, measuring 19.5 X 19 cm in major axis. -Presence of infiltration of Glisson capsule. -Vascular elements, lymph nodes of the hepatic hilum, gallbladder and resection margins free of. neoplasia. -Staging: pt3, pno. PARTICIPANTS OF APPRAISAL REPORT. - ISSUER. - ISSUER. . REVIEWER."
BIOCUP_00401,liver,LIHC,TCGA-FV-A2QR,TCGA-FV-A2QR.DE38B13D-FD4D-4077-ADBE-D034C2F5F003,"Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. :F. GALLBLADDER. PROCEDURE DATE: SPECIMEN DESCRIPTION: A. GALLBLADDER. B. INTRALUMINAL BILE DUCT TUMOR. LEFT LOBE. LIVER. CPC. BILE DUCT MARGIN. PRE-OPERATIVE DIAGNOSIS: Cholangiocarcinoma. POST-OPERATIVE DIAGNOSIS: Same. CLINICAL INFORMATION: None provided. INTRAOPERATIVE CONSULTATION: CPC DIAGNOSIS: ""Tissue submitted for genomics study; margin inked"" by. ====. GROSS DESCRIPTION: A. The specimen consists of a gallbladder. measuring 7.0 cm in length x 3.0. cm in greatest external diameter. The cystic duct is not present. The. opening is irregular and measures 1.0 X 0.6 cm. Approximately 0.5 cm away. from the irregular opening. there is a transmural mechanical defect measuring. 2.0 x 1.2 cm. The serosal surface is smooth and tan-pink. The gallbladder is. inked black and serially sectioned. The mucosal surface is congested and. slightly rough. No discrete mass or ulceration is present. The specimen is. serially sectioned and no discrete lesion is identified. The wall measures. 0.3 cm in thickness. No lymph node is identified externally. Separately. received in the same container are two irregular tan-brown calculi, each. measuring 0.6 x 0.5 X 0.4 cm. On sectioning, the calculi are composed of. tan-brown friable material. Representative sections are submitted in four. cassettes as follows: cassette 1 - opening: cassettes 2 through 4 - random. sections. B. The specimen consists of one portion of irregular tan-pink soft tissue. measuring 1.4 X 0.6 X 0.5 cm. The external surface is rough. No discrete. mucosa is visualized. The entire external surface is inked black and the. specimen 15 serially sectioned. The sections show tan-white firm tissue. The. specimen is totally submitted in one cassette. C/CPC. The specimen consists of the left lobe of liver and measures 9.5 x 9.0. Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. :F. DXSTIC. X. X 6.0 cm. The specimen weighs 390 grams. The capsular surface is tan-brown,. with multiple irregular bosselated tan-white areas. measuring up to 2.0 X 1.5. cm on the superior surface and the inferior surface. The surgical resection. surface reveals tan-brown cauterization. Immediately adjacent to the surgical. resection surface, there is a segment of left hepatic bile duct. measuring 2.8. cm in length x 0.6 cm in diameter. The distal end of the hepatic bile duct is. marked by a blue suture. The hepatic duct has been opened by the surgeon. Approximately 1.7 cm proximal to the surgical resection margin. there is an. adherent. intramural mass, measuring 0.8 X 0.6 x 0.3 cm. (Please note: In. the sections. the tumor appears to be on the outside of the hepatic bile. duct). The liver is serially sectioned and approximately 85% of the specimen. is replaced by an irregular tan-white mass. measuring 9.0 X 7.0 X 5.5 cm. The. mass is composed of lobulated tan-white firm tissue with focal hemorrhage. The. remaining portion of the specimen shows tan-brown hepatic parenchyma with. multiple small satellite lesions. measuring up to 0.6 cm in greatest. dimension. The surgical resection margin is 0.1 cm away from the mass. Multiple intraparenchymal bile duct lumina are completely occluded by the. tan-white firm tumor tissue. Representative sections are submitted in nine. cassettes as follows: cassette 1 - hepatic bile duct margin: cassettes 2 and 3. - possible adherent intraluminal tumor: cassette 4 - surgical resection. margins of the liver; cassettes 5 through 8 - mass; cassette 9 - satellite. lesions. D. The specimen consists of one portion of irregular tan-pink soft tissue. measuring 1.3 x 0.6 x 0.3 cm. The external surface is shaggy. The specimen. cannot be oriented. The entire specimen is submitted intact in one. cassette. MICROSCUPIC DESCRIPTION: A. The gallbladder is appreciably thickened with prominent chromc. inflammation and extensive thickening of the muscularis as well as thickening. of the serosa. It is congested No tumor is seen. B. This consists of tumor without presence of uninvolved tissue. Sheets and. nests of cells have small to medium sized nuclei which are slightly irregular. in contour The cells have predominantly vacuolated cytoplasm. In other. areas it is eosinophilic with little or no vacuolization. Some areas have. increased fibrous stroma. C/CPC. Tumor is present and similar to that previously described. This. frequently has: intervening zones of fibrosis. It consists predominantly of. sheets of cells with mostly clear cytoplasm. Some areas have a somewhat. trabecular arrangement with d slight suggestion of attempted gland-like. formation however this is not well developed. No tumor is seen at the inked. margins. Tumor is present within ductal lumina in slides 7 and 8. The. Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. :F. X. adjacent hepatic tissue has regions of chronic inflammation. Portal fibrosis. is present Cirrhosis is not seen. D. This consists of fibrous tissue with some adipose tissue. Areas of ducts. are present within the fibrous tissue. No tumor is seen. SPECIAL STAINS: Special stains have been performed on block 4. No definite tumor cells have. positive staining for CA19.9 Where present, it is consistent with residual. hepatic ductular elements. The tumor is also negative for pancytokeratin. (AE1/AE3) Where present. positive staining is consistent with residual. ducts. Additional special stain results follow. There is staining of two of three. portions of tumor for CK7 and staining for CK20 predominantly in two of three. portions of tissue with some staining in the third piece. Only small numbers. of tumor cells have staining for HepPar-1. There is strong staining for. CK8/18 (CAM5.2). Staining for vimentin is present within some tumor cells. There is strong staining for alphal-AT in all tumor cells. , INAL AGNOSIS: A. GALLBLADDER: CHRONIC CHOLECYSTITIS WITH CHOLELITHIASIS. B. INTRALUMINAL MASS OF BILE DUCT: HEPATOCELLULAR CARCINOMA. C/CPC. LEFT LOBE OF LIVER, RESECTION: 1. HEPATOCELLULAR CARCINOMA. 2. HISTOLOGIC GRADE: GRADE I. 3. PATHOLOGIC STAGING: pT1. 4. REGIONAL LYMPH NODES: pNX. 5. DISTANT METASTASIS: pMX. 6. MARGINS: UNINVOLVED BY CARCINOMA. 7. BILE DUCT MARGIN: FREE OF TUMOR. 8. SMALL SATELLITE TUMOR. D. BILE DUCT MARGIN: FREE OF TUMOR. A-MAI IGNANT. (ETectronic Signature). ===. PATHOLOGIST COMMENT: The tumor invades bile ducts but has the morphologic pattern of hepatocellular. carcinoma. The lack of elevation or staining for AFP does not mitigate. against the diagnosis of hepatocellular carcinoma because this is seen in only. approximately 30% of hepatocellular carcinomas. No cirrhosis is seen."
BIOCUP_00402,liver,LIHC,TCGA-DD-AACD,TCGA-DD-AACD.0494EF97-6D76-4DC7-8642-880C889C2C24,"CLINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo : 1. GROSS: 1. Specimen: Liver: 21.0 X 16.5 X 10.0 cm, unfixed. Gallbladder: 9.0 cm in length, 3.2 cm in diameter, and 2.0 mm in. wall thickness, unfixed. 2. Tumor location: right. Tumor number: one. Tumor size: 12.0 x 15.0 x 12.0 cm. 3. Satellite nodule: yes. 4. Gross type. HCC: expanding nodular. 5. Tumor necrosis: yes (20 %). 6. Hemorrhage/peliosis: yes (20%). 7. Portal vein invasion: yes. 8. Bile duct invasion: no. Gross photo present. Blocks. T1-7, liver mass X 7. A, non-tumorous lesion X 1. RM, resection margin x 1. MICROSCOPIC: 1. Hepatocellular carcinoma: yes. 1-1. Differentiation. The worst differentiation IV/IV. The major differentiation III. 1-2. Histologic type: trabecular. 1-3. Cell type: hepatic. 1-4. Fatty change: no. 2. Fibrous capsule formation: no. 3. Septum formation: no. 4. Surgical resection margin invasion: no, margin of the clearence (0.7 cm). 5. Serosal invasion: no. 6. Portal vein invasion: yes. 7. Bile duct invasion: no. 8. Hepatic vein invasion: no. 9. Hepatic artery invasion: no. 10. Microvessel invasion: yes. 11. Intrahepatic metastasis: yes. 12. Multicentric occurrence: no. Non-tumor liver pathology. 1. Chronic hepatitis: yes. 1-1. Etiology: HBV. 1-2. Grade, lobular: minimal. 1-3. Grade, portoperiportal: minimal. 1-4. Stage (fibrosis): periportal. 1-5. Cirrhosis: no. 2. Dysplastic nodule: no. 3. Ductal epithelial dysplasia: no. 4. Other liver diseases: no. NOT reported. Gross: NOT reported. Gross: Liver, ectomy, hepatocellular carcinoma. T56000, P10, M81703. Gallbladder, ectomy, chronic cholecystitis. T57000, P10, M43005. Lymph node, regional, biopsy, reactive hyperplasia. T08000, regional, P50, M72200. DIAGNOSIS: Liver, right, hemihepatectomy: Hepatocellular carcinoma, moderately differentiated. Gallbladder, cholecystectomy: Chronic cholecystitis. Lymph node, regional, biopsy: Reactive hyperplasia (0/1). NOTE: Recommend to order the IHC stains (Hepatocyte, CK7 and CK19) for block T2. Suggestion :"
BIOCUP_00403,liver,LIHC,TCGA-EP-A2KC,TCGA-EP-A2KC.F45A4E99-3856-4455-BF21-B767A0A4FA82,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Right coronary ligament, biopsy: Dense fibrous connective tissue. B. Liver, segment 7, resection: Hepatocellular carcinoma, poorly differentiated, 3.0 cm, margins. uninvolved. Cirrhosis. Microscopic Description: Microscopic examination performed. A. Sections of the right coronary ligament demonstrate dense fibrous. connective tissue. B. Histologic type: Hepatocellular carcinoma. Histologic grade: poorly differentiated. Tumor size: 3.0 cm. Primary tumor (pT) : pT1. Margins of resection: Negative. Vascular invasion: Not identified. Regional lymph nodes (pN) : None submitted with this specimen, pNX. Distant metastasis (pM) : Cannot be evaluated by the specimen, pMX. Other findings: The carcinoma is arising in a background of cirrhosis. Specimen. A. Right coronary ligament. B. Hepatoma segment 7. Clinical Information. Hepatocellular cancer. Gross Description. A. Received in formalin labeled ""right coronary ligament"" is an. irregular, 1.0 x 0.3 x 0.3 cm fragment of rubbery tan-pink-gold tissue. The specimen is inked, sectioned, and entirely submitted in one block. B. Received fresh for tissue procurement labeled ""hepatoma segment 7"". is a wedge shaped, 7.8 x 6.8 x 4.0 cm portion of liver parenchyma. The. capsule is diffusely bosselated tan-pink-gold. The cauterized margin. of resection is inked black and the specimen is sectioned. There is. a. moderately well circumscribed, 3.0 x 2.9 x 2.5 cm pale yellow-white to. tan gold nodular lesion which is present within 0.05 cm of the capsular. surface and 1.5 cm of the inked margin of resection. The remaining. parenchyma is finely nodular tan gold-pink. A portion of tumor and a. portion of normal parenchyma are submitted for tissue procurement. RS. Summary: 1 through 4-tumor to capsular surface; 5 and 6-tumor to inked. margin of resection; 7 and 8 random from remainder."
BIOCUP_00404,liver,LIHC,TCGA-DD-A3A0,TCGA-DD-A3A0.C9E146D4-77FF-4877-8DA6-2E5D912F33C6,"Surgical date: : TISSUE DESCRIPTION: Left gastric lymph node (3.2 x 1.2 x 0.8 cm), diaphragm biopsy (1.1 x 1 x 0.7 cm). and segment III and IV liver (675 grams; 22 x 13 X 7 cm). A1,B1,C1,C2,. C3, C4, C5. DIAGNOSIS: Liver, segment III and IV, resection: Grade 2 (of 4) hepatocellular carcinoma forms. a 8 x 6 x 2 cm partially necrotic mass. The margins of resection are free of tumor by. at least 1 cm. There is no vascular invasion. The uninvolved liver parenchyma is. noncirrhotic. Lymph node, left gastric, excision: Reactive lymphoid hyperplasia. Diaphragm, biopsy: Calcified fibrous nodule."
BIOCUP_00405,liver,LIHC,TCGA-EP-A3JL,TCGA-EP-A3JL.B277ACF9-B233-474B-975A-52FDE44F27E3,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Submitted as lymph node, biopsy: Benign soft tissue; lymph node. not identified. B. Gallbladder, cholecystectomy: Chronic cholecystitis. C. Liver, partial resection: Hepatocellular carcinoma,. oderately-differentiated, 2.5 cm in greatest dimension without. vascular invasion; negative margins of excision. Microscopic Description: Histologic type: Hepatocellular carcinoma. Histologic grade: Moderately-differentiated. Tumor size: Solitary tumor mass, 2.5 cm in greatest dimension. Primary tumor: pT1. Margins of resection: Negative (carcinoma is 5 mm from closest. resection margin). Vascular invasion: Negative. Regional lymph nodes (pN) : None submitted. Distant metastasis (pM) : Unknown. Comment: The presence of hepatocellular carcinoma (HCC) is confirmed. by reticulin staining, which shows loss of the normal hepatic. architecture with the nodular tumor, and by positive immunostaining by. HepParl. Stains for CK7, CK20, and CDX-2 are negative. 4, 3, 2, 18, 20x4. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA.]. Specimen. A. Lymph node. B. Gallbladder. C. Liver mass. Clinical Information. Liver cancer. Gross Description. A. Received unfixed, labeled lymph node, is a 0.7 x 0.7 x 0.5 cm tan. soft tissue fragment without discrete lymph node identified, entirely. submitted in one block. AS1. B. Received in formalin labeled ""gallbladder"" is a 5.5 x 2.0 X 1.2 cm. intact gallbladder. The serosa is pink-tan, smooth and glistening. The. cystic duct is patent. The specimen is opened and partially filled with. green-brown viscid bile. The mucosa is pink-tan and velvety. No. choleliths are identified in the specimen or the specimen container. The average wall thickness is 0.3 cm. Greater than 50% of the specimen. is submitted in 2 cassettes including cystic duct which is inked. RS 2. C. Received unfixed for tissue procurement, labeled liver mass, is a 5. x 5 x 4 cm wedge-shaped partial liver resection specimen, with. cauterized surface. There is a nodular, firm tan mass lesion, 2.5 cm. in greatest dimension and 0.5 cm from the resection margin. A portion. of tumor and uninvolved liver tissue is submitted for tissue. procurement. Representative sections in 4 blocks."
BIOCUP_00406,liver,LIHC,TCGA-FV-A496,TCGA-FV-A496.358A0018-5731-45D3-97B8-502A3BF95FA8,"GROSS AND MICROSCOPIC SURGICAL PANEL. Specimen Information. SURGICAL PANEL: DIRUNUS 10. PARTIAL LIVER RESECTION (SEGMENTS 5 AND 6) WITH GALLBLADDER AND CYSTIC. DUCT: 1. Hepatocellular carcinoma, grade 2 of 3, forming an 11.5 cm mass (see. staging parameters for details). 2. Background liver without diagnostic abnormality. 3. Resection margins free of tumor. 4. Gallbladder and cystic duct without diagnostic abnormality. 2010 LIVER HEPATOCELLULAR CANCER STAGING PARAMETERS. Final TNM: pT1NXMO. stage : I. MACROSCOPIC. SPECIMEN TYPE. Segmentectomies. Segments 5 and 6. TUMOR TYPE. Single without satellites. TUMOR SIZE. 11.5 X 8 X 7 cm. MICROSCOPIC. HISTOLOGIC TYPE. Hepatocellular carcinoma. HISTOLOGIC GRADE. Nuclear grade 2 of 3 (Lauwers grade). MARGINS. Uninvolved by tumor. Distance to nearest margin is 1 cm. LIVER CAPSULE. No tumor present. LYMPHATIC/VASCULAR INVASION. Absent : Lymph-vascular invasion not present/Not identified. TUMOR EXTENSION. Tumor confined to liver. MITOTIC ACTIVITY. 2.5/10 HPF. HEPATOCELLULAR PROGNOSTIC INDEX. Fair prognosis - Grade 2 without vascular invasion. PATHOLOGIC STAGING. EXTENT OF INVASION. pTl. (Solitary tumor without vascular invasion). REGIONAL LYMPH NODES. pNX. (Cannot be assessed). DISTANT METASTASIS. pMO (No distant metastasis). PATHOLOGIC STAGE Summary. Final TNM: pT1NXM0. stage : I. The pathologic stage presumes no distant metastasis. PROGNOSTIC FACTORS (SITE SPECIFIC FACTORS). CIRRHOSIS. Absent. SMALL CELL DYSPLASIA. Absent. FIBROSIS SCORE. 0. Attending Pathologist : CLINICAL INFORMATION. History of hepatocellular carcinoma. SPECIMEN/GROSS DESCRIPTION. u. A) SOURCE: Partial Tiver resection, section 5 and 6, frozen for margin. The specimen is received fresh from the OR labeled ""partial liver. resection, sections 5 and 6 - frozen for margin. "" It consists of a 520. gram, 14 x 9.8 x 7.5 cm partial liver resection. The smooth capsular. surface displays an 11.5 x 8 x 7 cm bosselated tan tumor bulging from its. external surface. The margin is inked blue and the tissue is serially cross. sectioned. INTRAOPERATIVE PATHOLOGY CONSULTATION: ""Tumor grossly 1 cm from cauterized. margin"" is rendered by. The tumor has variegated, lobulated, yellow, tan, pink and brown cut. surfaces with predominantly well-defined edges. The tumor grossly abuts the. gallbladder bed. Extension through the capsule and into the gallbladder bed. is not seen. No other lesions are seen on the red-brown hepatic parenchyma. The attached 8.7 cm in length and 3 cm in diameter intact distended. gallbladder has smooth glistening serosal surfaces which are mildly. edematous. Received within the gallbladder lumen are numerous 0. cm in. average diameter dark green, black multifaceted choleliths aggregating to. 6.5 x 4.5 x 0.7 cm. On opening the mucosa displays two components. One. component extending to the cystic duct margin for a length of 2 cm. is. red-tan and velvety. The remaining component of the mucosa is pink-tan. flat to velvety with a slightly thickened wall up to 0.2-0.3 cm thick and. measuring approximately 1.8 cm in greatest dimension. The remaining mucosa. at the body and fundus is tan with thin trabeculations. Representative sections are submitted in eight cassettes labeled: 1-2. Liver tumor with closest blue -inked margin. 3-4. Tumor with adjacent hepatic parenchyma. 5-6. Tumor with capsule. Gallbladder neck at the transition of thickened wall to relatively. normal-appearing - wall at the cystic duct. 8. En face cystic duct margin, and fundic wall. Note: The gross specimen was photographed A portion of the tumor,. paranormal and normal parenchyma were banked for possible ancillary study. This case is accessioned in. MICROSCOPIC. The microscopic appearance substantiates the diagnosis. Dictation by : cranscribed by: Interpreted at. ACCESSIONED. IGNED: Lab and Collection. GROSS AND MICROSCOPIC SURGICAL PANEL. Lab and Collection. Information. Result History. GROSS AND MICROSCOPIC SURGICAL PANEL. Result Date and Time. Provider Status. Parent Order ID. Child Order ID. Specimen Information. Specimen Source. Other. Audit Trail. Action. User. Date/Time. MyChart Status: This result is currently not released to. GROSS AND MICROSCOPIC SURGICAL PANEL."
BIOCUP_00407,liver,LIHC,TCGA-DD-AACM,TCGA-DD-AACM.ADABA595-4FA3-4D34-BB61-6B1EB345331C,"CLINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo. GROSS: 1. Specimen: Liver: 17.0 X 12.0 x 4.5 cm, 262.5 gm (unfixed). 2. Tumor location: left. Tumor number: three. Tumor size: 1.5 X 1.5 X 1.2 cm, 1.8 x 1.5 X 1.5 cm, 1.3 x 1.2 x 1.2 cm. Distance to resection margin: 1.8 cm. 3. Satellite nodule: no. 4. Gross type. HCC: expanding nodular. 5. Tumor necrosis: yes (10 %). 6. Hemorrhage/peliosis no. 7. Portal vein invasion: no. 8. Bile duct invasion: no. Gross photo present. Blocks. T1-6, tumor mass and surrounding parenchyme X 6. RM, resection margin X 1. L, remaining parenchyme X 1. MICROSCOPIC: 1. Hepatocellular carcinoma: yes. 1-1. Differentiation. The worst differentiation III. The major differentiation III. 1-2. Histologic type: trabecular. 1-3. Cell type: hepatic. 1-4. Fatty change: no. 2. Fibrous capsule formation: partial capsule. 3. Capsular infiltration: yes. 4. Septum formation: yes. 5. Surgical resection margin invasion: no, margin of the clearence (1.8 cm). 6. Serosal invasion: Glisson's capsule. 7. Portal vein invasion: no. 8. Bile duct invasion: no. 9. Multicentric occurrence: yes. Non-tumor liver pathology. 1. Chronic hepatitis: yes. 1-1. Etiology: HBV. 1-2. Grade, lobular: minimal. 1-3. Grade, portoperiportal: mild. 1-4. Stage (fibrosis): periportal to septal. 1-5. Cirrhosis: no. 2. Dysplastic nodule: no. 3. Ductal epithelial dysplasia: no. 4. Other liver diseases: no. SPECIAL STAIN: Trichrome stain shows septal fibrosis. NOT reported. Gross: NOT reported. Gross: NOT reported. Gross: Liver, needle, Hepatocellular carcinoma , cholangiocytic differentiation. Liver, ectomy, suggestive of, hepatocellular carcinoma, chronic hepatitis, precirrhotic fibrosis. Gallbladder, ectomy, chronic cholecystitis. Lymph node, biosy, no tumor. Skin, wrist, biopsy, chronic dermatitis. Liver, ectomy, hepatocellular carcinoma. T56000, P10, M81703. DIAGNOSIS: Liver, left, lobectomy: Hepatocellular carcinoma, multiple (#3). Suggestion :"
BIOCUP_00408,liver,LIHC,TCGA-G3-AAV1,TCGA-G3-AAV1.0124A3C7-B294-464E-831D-3E4738E3F305,"1. CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: Sex: M. ADDENDUM REPORT. Addendum Report. Collected Date/Time. Received Date/Time. Addendum Reason. results of special stains. Addendum Diagnosis. A. Liver, Segment 6, Partial Hepatectomy: Hepatocellular carcinoma, poorly differentiated, 5.0 x 4.5 x 4.5 cm. Tumor perforates visceral peritoneum (pT4). Venous and lymphatic space invasion present. Intralymphatic carcinoma present within 0.24 cm of parenchymal. resection margin. Background liver with cirrhosis, consistent with the known history. of hepatitis B. Focal non-necrotizing granuloma, special stains negative for. infectious organisms. Please see comment and synoptic report. B. Right Diaphragm, Excision: Skeletal muscle and fibroadipose tissue with adherent fibrinous. debris and reactive mesothelial hyperplasia. Rare detached cauterized fragments of hepatocellular carcinoma,. present within adherent blood clot. No tissue invasion by tumor identified. c. ""Adrenal Gland"", Right Excision. Intravenous embolus of hepatocellular carcinoma, involving a large. vein within adipose tissue. No adrenal gland identified. Please see comment. Verified: Addendum Discussion. An addendum is issued to report the results of special stains for microorganisms, done to. evaluate a non-necrotizing granuloma (block A10). Ziehl-Neelsen and Grocott's stains are negative for acid-fast bacilli and fungi,. respectively. However, negative stains do not rule out the possibility of an infectious. etiology. There are no other changes to the original report. Please refer to the comment section. of the original report for additional details. Surgical Pathologv R. Collected Date/Time. Received Date/Time. Specimen Description. A. Liver segment 6 at 0. B. Right diaphragm and tumor at. C. Right adrenal at. Clinical Information. Hepatitis B+, hepatocellular carcinoma. Diagnosis. A. Liver, Segment 6, Partial Hepatectomy: Hepatocellular carcinoma, poorly differentiated, 5.0 x 4.5 x 4.5 cm. Tumor perforates visceral peritoneum (pT4). Venous and lymphatic space invasion present. Intralymphatic carcinoma present within 0.24 cm of parenchymal. resection margin. Background liver with cirrhosis, consistent with the known history. of hepatitis B. Focal non-necrotizing granuloma, pending special stains. Please see comment and synoptic report. B. Right Diaphragm, Excision: Skeletal muscle and fibroadipose tissue with adherent fibrinous. debris and reactive mesothelial hyperplasia. Rare detached cauterized fragments of hepatocellular carcinoma,. present within adherent blood clot. No tissue invasion by tumor identified. C. ""Adrenal Gland"", Right Excision. Intravenous embolus of hepatocellular carcinoma, involving a large. vein within adipose tissue. No adrenal gland identified. Please see comment. Verified: Synoptic Report. Specimen: Liver. PROCEDURE: Partial hepatectomy. Minor hepatectomy (less than 3 segments). TUMOR SIZE: Greatest dimension: 5.0. cm. Additional dimensions: 4.5 x 4.5 cm. TUMOR FOCALITY: Solitary (specify location) : segment 6. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GIII: Poorly differentiated. TUMOR EXTENSION (select all that apply) : Tumor directly invades other adjacent organs: tumor penetrates through visceral. peritoneum, and was adherent to diaphragm and periadrenal adipose tissue intra-. operatively. PRIMARY TUMOR (pT) : pT4: Tumor (s) with direct invasion of adjacent organs other than the gallbladder or. perforation of visceral peritoneum. REGIONAL LYMPH NODES (pN) : pNX: Cannot be assessed. DISTANT METASTASIS (pM) : pMX: Cannot be assessed. MARGINS: Parenchymal margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 2.4. mm. Bile duct margin cannot be assessed. VENOUS (LARGE VESSEL) INVASION (V) : Present. ADDITIONAL PATHOLOGIC FINDINGS: Cirrhosis/fibrosi. Hepatitis (specify type) : hepatitis B. non-necrotizing granuloma. COMMENT (s) : please see comment in main report. Gross Description. Received are specimen containers A in . requisitions and specimen containers are. labelled with the patient's name,. The cassettes and identifiers are. labelled with the Surgical Number. A. The specimen is received fresh and is subsequently placed into formalin, designated. as ""A - liver segment 6"". The specimen consists of a 131.8 gram, 10.0 x 5.6 x 5.9 cm. portion of liver. The capsular surface is smooth and predominantly tan with a focal. hemorrhagic area. The resection margin is painted blue. Sectioning reveals a 5.0 x 4.5. x 4.5 cm well demarcated multinodular mass which replaces most of the resected liver. The nodules are variably yellow green to tan with foci of hemorrhage and necrosis. The. mass comes to within 1.0 cm to the parenchymal resection margin. The remaining liver. parenchyma is brown, tan, slightly firm, and nodular. Sections are submitted as follows: A1-4. mass in relation to parenchymal resection margin with A1 demonstrating area. of necrosis. A5-7. lesion in relation to the capsule, A5-6 demonstrating areas of hemorrhage. A8-10. representative sections from remaining liver parenchyma. B. The specimen is received fresh and is subsequently placed into formalin, designated. as ""B - right diaphragm and tumor"" The specimen consists of a 4.5 x 3.3 x 0.9 cm. irregular portion of grey-tan to dark brown tissue. One surface is grey-tan and smooth. The opposite surface is dark brown and roughened. Sectioning reveals a central area that. is light brown and homogeneous. Six representative sections are submitted in B1-B3. The. remaining specimen is submitted in toto following initial histologic examination in B4-. B6. C. The specimen is received fresh and is subsequently placed into formalin, designated. as ""C - right adrenal. The specimen consists of multiple portions of fibrofatty tissue. measuring in aggregate 5.0 x 3.0 x 1.0 cm. The cut surface shows predominantly yellow. adipose tissue with areas of semi firm tan to hemorrhagic friable tissue. A definitive. adrenal gland is not identified. Sections are submitted as follows: C1. slightly firm tan to hemorrhagic tissue submitted in toto. C2-3. remainder of tissue submitted in toto. Pathologist Comment. The hepatocellular carcinoma shows a classical trabecular / sinusoidal growth pattern. with a few foci of acinar growth. The tumor is morphologically heterogeneous, ranging. from moderately differentiated to poorly differentiated with anaplastic cytology. While. the main tumor mass is excised with a 7 mm margin, there is extensive lymphovascular. invasion beyond the tumor capsule, and intralymphatic tumor is present within 2.4 mm of. the parenchymal resection margin. Cauterized fragments of tumor are present in blood. clot adherent to the diaphragm, but these may represent intraoperative artifact, and no. true invasion of the diaphragm is identified. Finally, the specimen designated ""adrenal"". shows adipose tissue with a large intravenous tumor embolus. No adrenal gland is. identified. Per discussion with Dr. this tissue was taken from the fat plane. between the liver and the adrenal, and therefore this may represent local extension of. tumor. Finally, the background liver shows cirrhosis (consistent with the known history of. hepatitis B) as well as a single well-formed non-necrotizing granuloma. Special stains. for infectious organisms are pending, and will be reported as an addendum. In case ancillary studies are desired, tumor block information is 'listed below: Best tumor block: A6. Best normal block: A8. Encounter Number. Patient Location."
BIOCUP_00409,liver,LIHC,TCGA-5R-AAAM,TCGA-5R-AAAM.B07C5DBA-634E-4028-A32D-61FE7445BDEE,"years / F. go 5/21/14. Procedure: Resection of the liver. Preoperative diagnosis: CARCINOMA OF THE LIVER. Postoperative diagnosis: SEE MICROSCOPIC DIAGNOSIS BELOW. Specimen(s): 1. LIVER, SEGMENT I 2. HILAR LYMPH NODES. Diagnosis: 1. LIVER, SEGMENT I: Moderately differentiated hepatocellular carcinoma. Satellites. Vascular invasion is present. Remaining hepatic tissue shows micronodular cirrhosis (Metavir fibrosis score 4,. Knodell histological activity index score 4, Ishak fibrosis score 6). Resection margin is free of tumor. 2. HILAR LYMPH NODES: Lymph node is negative for metastatic carcinoma. Gross description: 1. LIVER, SEGMENT I: Received fresh, is a part of the liver 7.5 x 5.0 x 2.0 cm in dimensions. At a distance of 1.5 cm. from the resection margin the well-circumscribed lobulated brown-gray tumor 3.2 x 2.2 x 3.0 cm. in dimensions is present. In the surrounding hepatic tissue there are two similar lesions 0.3 and. 0.7 cm in diameter. The remaining hepatic tissue consists of firm brownish nodules ranging from. 0.1 to 0.3 cm in diameter. 2. HILAR LYMPH NODES: Received fresh, is a portion of adipose tissue with a lymph node 1.3 cm in greatest dimension."
BIOCUP_00410,liver,LIHC,TCGA-G3-A25U,TCGA-G3-A25U.2781ABF5-FC79-4973-BE15-037BC685FAFC,"LABORATORY SERVICES. Accession # : Patient ID: PHN: ALT ID: Telephone: Requesting Physician: Encounter: Chart ID: HISTOPATHOLOGY REPORT. Division Head: ORIGINAL REPORT. SPECIMEN: A: Gallbladder. B: Portal lymph node. C: Right liver - 423 gm. CLINICAL HISTORY: Hepatocellular cancer. DIAGNOSIS: A: GALLBLADDER, CHOLECYSTECTOMY: NEGATIVE FOR MALIGNANCY. B: PORTAL LYMPH NODE, BIOPSY: ONE LYMPH NODE, NEGATIVE FOR MALIGNANCY. C: RIGHT LIVER, PARTIAL RESECTION: HEPATOCELLULAR CARCINOMA, 7.3 X 6.0 X 5.8 CM. TUMOR IS ABOUT 0.9 CM FROM THE LIVER RESECTION MARGIN. FOREIGN BODY TYPE REACTIONS PRESENT IN NUMEROUS INTRAHEPATIC VESSELS,. LIKELY DUE TO REACTIONS TO THE EMBOLIC PROCEDURE. BACKGROUND LIVER SHOW FOCAL MICROSTEATOSIS, PORTAL LYMPHOCYTIC. AGGREGATION AND INFLAMMATION. THE INFLAMMATION MAY BE THE RESULT OF. EMBOLIC PROCEDURE. CLINICAL CORRELATION REQUIRED. (Electronic Signature,. GROSS DESCRIPTION: A: The specimen consists of a collapsed gallbladder measuring 6.4 x 2.9 x 0.7. cm. The serosa is tan and smooth apart from where it attaches to the liver. bed, where it appears roughened and light green. There is a focal area of. puckering the distal end of the gallbladder. It contains a minimal amount of. viscous green bile. No calculi are identified. The mucosa is dark green and. velvety without signs of cholesterolosis. The wall thickness measures up to. 0.4 cm. Representative sections of the gallbladder, including the puckered. area of the wall. Page 1 CONTINUED. ABORATORY SERVICES. Patient ID: PHN: ALT ID: Telephone: Requesting Physician: Encounter: Chart ID: HISTOPATHOLOGY REPORT. Division Head: GROSS DESCRIPTION: B: The specimen consists of a portion of fibrofatty tissue measuring 1.4 x 1.1. x 0.2 cm. Within it is a lymph node with a maximal dimension of 0.9 cm. Entirely submitted in cassette B. C: The specimen consists of a portion of liver weighing 423 gm and measuring. 16.8 x 8.9 x 7.4 cm. The outer capsule is smooth with a slightly micronodular. appearance. The specimen has previously been treated with silver nitrate and. the surgical margin has been inked black. The surgical m√§rgin measures 11. 3 x. 7.1 cm. Within the liver is a well circumscribed tan yellow nodule measuring. 6.0 x 5.8 x 7.3 cm. It has a soft rubbery consistency with a central area of. irregular hemorrhage. Within uninvolved parenchyma there are small areas. suspicious for tumor within the vascular space. The uninvolved parenchyma is. smooth, tan and has a subtle micronodular appearance. The closest tumor to the. surgical margin is 0.9 cm and is within 1 mm of the capsule. Cassette submitted as follows: C1 through C11 - shaved margin of the surgical margin closest and farthest. away. C12 through C14 - sections of tumor with capsule. C15 and C16 - suspicious for tumor emboli. C17 through C19 - background liver. Procedure:"
BIOCUP_00411,liver,LIHC,TCGA-WJ-A86L,TCGA-WJ-A86L.2C93F65E-88FD-405F-86F1-0E35C7F46DC2,"PATHOLOGY EXAMINATION. CLIENT: soc. SEC. #: ADDITIONAL: Page 1 ar. SPECIMEN(S) RECEIVED: A: Segment 6 partial liver resection. B: Gallbladder. CLINICAL DATA/HISTORY: HCC on biopsy. No known hepatitis or alcohol history. pepatocellular carcinoma, high-grade. with clear cells and giant cell features. Cystic lesion of gallbladder plus near hepatic resection for HCC. FINAL PATHOLOGIC DIAGNOSIS: A. LIVER, SEGMENT 6, PARTIAL RESECTION: MODERATELY DIFFERENTIATED HEPATOCELLULAR CARCINOMA, WITH CLEAR CELL AND GIANT. CELL FEATURES. MARGIN NEGATIVE FOR MALIGNANCY. SEE SYNOPTIC REPORT AND COMMENT. B. GALLBLADDER, CHOLECYSTECTOMY: BENIGN SIMPLE CYST. BENIGN GALLBLADDER WITH MINIMAL CHRONIC INFLAMMATION. SYNOPTIC REPORT: SPECIMEN: LIVER AND GALLBLADDER. PROCEDURE: PARTIAL HEPATECTOMY. TUMOR SIZE: 3.5 CM IN GREATEST DIMENSION. TUMOR FOCALITY: SOLITARY (SEGMENT 6). HISTOLOGIC TYPE: HEPATOCELLULAR CARCINOMA. HISTOLOGIC GRADE: G2 (MODERATELY DIFFERENTIATED). TUMOR EXTENSION: TUMOR CONFINED TO LIVER. MARGINS: PARENCHYMAL MARGIN UNINVOLVED BY INVASIVE CARCINOMA. LYMPHOVASCULAR INVASION: MACROSCOPIC VENOUS INVASION: NOT IDENTIFIED. MICROSCOPIC INVASION: NOT IDENTIFIED. PATHOLOGIC STAGING: pT1. NO NODES SUBMITTED. COMMENT: The background liver is non-cirrhotic and without any apparent fibrosis. The case was reviewed. Consultant: Dr. POSS DESCRIPTION: A. Segment 6 partial liver resection: Received fresh labeled,. segment 6 partial liver resection,"" is. an 85-gram lobe of liver measuring 7x 7 6 cm. The surface of the liver is faintly bosselated. The resection margin. is marked with green ink, and the specimen is serially sectioned revealing an ill-defined tan-white soft mass. measuring 3.5 x 2.8 x 2.5 cm. The mass lies 0.7 cm from the closest resection margin and within 0.1 cm of the. serosal surface of the liver. The remaining cut surfaces shows a grossly normal brown liver parenchyma. Representative sections of the mass and norma liver are submitted for tissue banking. Gross photographs of the. intact and sectioned specimen are taken. Representative sections of the specimen are submitted for permanent. section: A1) Mass and serosal surface. A2) Mass at closest miragin. 1A3-A4) Mass. A5) Nonneoplastic liver. B. Gallbladder: Received in formalin labeled. Gallbladder"" and consists of an intact. gallbladder measuring 10 x 4 cm. The cystic duct marginis marked with yellow ink and is shaved and submitted en. face. The gallbladder serosa is purple-tan, smooth and glistening. On the hepatic aspect of the gallbladder near. the. serosa is a raised soft cyst-like area measuring 0.5 cm in greatest dimension. This area is overmarked with green. ink. The gallbladder mucosa is tan and velvety with no distinct masses, polyps, or plaques. The gallbladder wall. has an average thickness of 0.2 cm. The cystic duct is nondilated. No galistones are identified with the gallbladder. lumen or specimen container. Representative sections including the cyst-like area in its entirety are submitted. B1). Cystic duct and random sections. B2) Cyst-like area. MICROSCOPIC DESCRIPTION: A. Sections show a nodular mass with areas of fibrous septation. The nodules are composed of sheets and. focal trabecular arrangements of atypical cells. The mostly polygonal cells show marked variability in size. There. are many very large cells with bizarre nuclei. Most of the cells show clear cytoplasm with distinct cell borders. In the. more trabecular areas, the cells are smaller with more eosinophilic cytoplasm. Mitotic figures, including atypical. ones, are common. The parenchymal resection margin is negative for tumor. No lymphovascular Invasion is seen. The tumor abuts, but does not penetrate, the liver capsule. The hepatic parenchyma away from the mass shows a. minimal lymphocytic infiltrate of the portal tracts. No notable fibrosis is seen by H&E. There is no suggestion of. nodularity. No lobular activity is appreciated. Many of the hepatocytes have brown granular pigment. B. Along the serosal surface, adjacent to a minimal amount of hepatic parenchyma, is a thin, fibrous cyst wall. which is lined by a single layer of low cuboidal to flattened, bland epithelial cells. The gallbladder mucosa shows a. minimal lymphocytic infiltrate. There is no dysplasia or malignancy."
BIOCUP_00412,liver,LIHC,TCGA-FV-A3I0,TCGA-FV-A3I0.B4DB59E9-FFBB-4716-9235-90A1DF17455B,"Results History. GROSSAND MICROSCOPIC SURGICAL PANEL. Entrv Date and Time. SURGICAL PANEL: LAB: DIAGNOSIS. A) LIVER, SEGMENT 3, BIOPSY: 1. Normal liver. 2. No evidence of malignancy. B) GALLBLADDER, RESECTION: 1. Mild chronic cholecystitis. 2. No cholelithiasis. 3. No evidence of dysplasia or malignancy. C) LIVER, RIGHT LOBE, LAPAROSCOPIC HAND-ASSISTED RIGHT HEPATIC LOBECTOMY. (SEGMENTS 5, 6, 7 AND 8): 1. Intrahepatic cholangiocarcinoma characterized by: a. 12 cm lesion with 12 intrahepatic metastatic foci (range from 0.5-2. cm). b. Moderately differentiated. c. Margins: Negative (2 cm from bile duct margin and 2 cm from the. nearest hepatic resection margin). 2. Background liver with reactive changes but no evidence of primary. chronic liver disease. 3. Please see staging parameters. 2010 INTRAHEPATIC BILE DUCT CANCER STAGING PARAMETERS. Final TNM: pT2aNXM0. 2010 stage: II. MACROSCOPIC. SPECIMEN TYPE. Lobectomy. TUMOR TYPE. Single with satellites. TUMOR SIZE. Single tumor measuring 12 X X cm, with 12 satellite tumor(s). measuring 0.5-2.0 cm. MICROSCOPIC. HISTOLOGIC TYPE. Intrahepatic cholangiocarcinoma, mass forming tumor growth. pattern. HISTOLOGIC GRADE. Grade 2 of 4 Moderately differentiated. MARGINS. Uninvolved by tumor; Distance to nearest margin is 2 cm. LIVER CAPSULE. No tumor present. LYMPHATIC/VASCULAR INVASION. Present: Lymph-vascular invasion present/Identified. PATHOLOGIC STAGING. EXTENT OF INVASION. pT2a. (Solitary tumor with vascular invasion). REGIONAL LYMPH NODES. pNX. (Cannot be assessed). DISTANT METASTASIS. pMO. (No distant metastasis). PATHOLOGIC STAGE Summary. Final TNM: pT2aNXM0. 2010 stage: II. The pathologic stage presumes no lymph node metastasis. The pathologic stage presumes no distant metastasis. PROGNOSTIC FACTORS (SITE SPECIFIC) AND ANCILLARY STUDIES. CIRRHOSIS. Absent. PRIMARY SCLEROSING CHOLANGITIS. Absent. CLINICAL INFORMATION. History of cholangiocarcinoma. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Liver segment 3. The specimen is received fresh from the OR labeled ""liver segment 3"" and. consists of a 0.5 x 0.5 x 0.1 cm discoid tan-brown tissue which is bisected. and entirely frozen on one block. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""No evidence of. malignancy"" ist. B) SOURCE: Gallbladder. Labeled ""gallbladder"" is a pink-purple, 7 x 2.5 x 2 cm gallbladder. The. serosal surface is smooth and glistening. The cystic duct is identified. with a 0.2 cm luminal diameter. The specimen is opened revealing a. tan-green, velvety mucosa with multiple yellow flecks consistent with. cholesterolosis. The average wall thickness is 0.1 cm. No calculi are. grossly identified. Multiple representative sections of gallbladder wall. and en face cystic duct margin are submitted in a single cassette. C) SOURCE: Liver, right lobe. Labeled ""right lobe liver"" and received fresh from the OR is a 1198 g, 19 X. 14 x 9 cm liver lobe. The liver capsule is red-brown with a 12 x 6 cm. white-pink protruding area present. The resection margin is inked black. The specimen is serially sectioned revealing multiple (approximately 12-15). white-tan firm tumor nodules ranging from 0.5-12 cm in greatest dimension. The nearest tumor nodule measures 2 cm to the bile duct margin and 2 cm to. the resection margin. The remaining liver parenchyma is red-brown and. unremarkable. A representative section of the bile duct margin designated by surgeon,. is submitted on a single chuck for frozen section diagnosis. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Margin. identified by surgeon benign"" is rendere. Representative sections are submitted in 11 cassettes labeled: CFS1. Frozen section bile duct margin. 2-4. Representative largest tumor to capsule. 5. Tumor nearest resection margin (black). 6. Remainder of bile duct margin. 7. Tumor to adjacent normal liver parenchyma. 8-9. Representative smaller tumors. 10-11. Random liver. Photographs are taken of the specimen. Representative tissue is taken for further possible studies. This case is accessioned i. MICROSCOPIC. A-C) The microscopic appearance substantiates the diagnosis. Dictation by: Interpreted at. ACCESSIONED: in process. 4. In process. In process."
BIOCUP_00413,liver,LIHC,TCGA-BC-A110,TCGA-BC-A110.DCC8DAE3-E0AF-4B37-8E5F-A2004ACA1F9B,"Diagnosis: Liver, partial resection. - Well differentiated hepatocellular carcinoma(grade 1 of 4), surgical margins free. - Incidental sclerotic subcapsular hemangioma. Comment: There is mild parenchymal fibrosis adjacent to the tumor, but the liver at some distance from the tumor. shows no evidence for fibrosis or cirrhosis. Dr. has reviewed this case and concurs with the diagnostic opinion. Clinical History;. The patient is in for liver resection with the clinical diagnosis of HCC. 1. Gross Description: Received is one appropriately labeled container, additionally labeled ""liver section"". The specimen consists. of a 1100 g, 17.5 x 16.5 x 5.4 cm liver resection. The capsule is dark red, smooth and glistening with focal. fibrinous adhesions. There are no areas of puckering identified. The surgical margin is inked black. Sectioning exhibits a 4.8 x 4.8 x 4.5 cm, well-circumscribed, encapsulated solitary mass with a soft,. variegated red/yellow hemorrhagic cut surface. There are focal cystic areas, each approximately 0.5 cm in. greatest diameter. This lesion is 4.8 cm from the black inked surgical resection margin. The lesion is 0.2 cm. from the capsule. Located 6.2 cm away from the large mass there is a subcapsular 0.8 x 0.6 x. 0.4 cm white nodule with a granular cut surface. This nodule is at least 8 cm from the black inked surgical. resection margin. A wedge of normal liver was given for research purposes, a section of tumor and. additional section of normal liver was given to Tissue Procurement. A1 - margin closest to largest mass. A2-A5 - representative mass and adjacent liver. A6 - tan subcapsular nodule. A7 - normal liver. Light Microscopy: Light microscopic examination is performed. I have personally conducted the evaluation of the above specimens and have rendered the above. diagnosis(es)."
BIOCUP_00414,liver,LIHC,TCGA-ED-A7PY,TCGA-ED-A7PY.B6D3F89E-C1A5-445A-B9BD-047B2FB92E4C,"Gross Description: Tumor is located in a hepatic lobe, ill-margins with 5x4.5x4.2cm in size, firm, solid,. yellow-white in cutting section. Microscopic Description: Tumor cells form the trabecular patterns, or acinar or sheets patterns. The. tumor cells retain apolygonal shape and have round vesicular nuclei with prominent nucleoli. The. amount of cytoplasm are moderate and the cytoplasm is basophilic or vascuolated. Nuclei are very. irregularly large and hyperchromatic with prominent nucleioli. Mitoses are present. Tumor is invasion of. lymphocyte. Diagnosis carcinoma,. Details: Hepatocellular poorly-differentiated Carcinoma, hepatocilling 817013 NOS. Comments: Formatted Path Reports: LIVER TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor size: 5 X 4.5 X 4.2 cm. Focality: Single -. Histologic type: Hepatocellular carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Single tumor with vascular invasion. Lymph nodes: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None."
BIOCUP_00415,liver,LIHC,TCGA-DD-AACX,TCGA-DD-AACX.0911F16A-EA5A-45F4-906E-4F2163096A78,"LINICAL DIAGNOSIS: R/O HCC. Specimen : liver. Gross Photo : GROSS: The gross specimen consists of three cores of pale tan fragmented needle-biopsied liver tissue,. 1.6 x 0.2 X 0.1 cm in aggregates. Entirely submitted. Block X 1. SPECIAL STAIN: Mucicarmine and trichrome stains reveal no significant change. Reticulin stain reveals disruption of reticulin frame work. NOT reported. Gross: NOT reported. Gross: Stomach, antrum, scopic, atypical glands. Stomach, antrum, scopic, chronic gastritis. ver,needle, ,hepatocellular carcinoma. T56000, P28, M81703. DIAGNOSIS: Liver, CT guided needle biopsy: Hepatocellular carcinoma, well differentiated (see NOTE). (Edmondson-steiner grade (1/4). NOTE: This case was consulted to Dr. Suggestion :"
BIOCUP_00416,liver,LIHC,TCGA-ED-A7PX,TCGA-ED-A7PX.AF42396C-2DC9-4885-B7B1-D59BA1D2949A,"Gross Description: Tumor is located in a lobe, ill-margins with 5x4x4cm in size, soft, solid, yellow-white. in cutting section. Microscopic Description: Tumor cells form the trabecular patterns, or acinar or sheets patterns,. infiltrating capsule or vessels or nerves. The tumor cells retain apolygonal shape and have round. vesicular nuclei with prominent nucleoli. The amount of cytoplasm are moderate and the cytoplasm is. basophilic or vascuolated. Nuclei are very irregularly large and hyperchromatic with prominent nucleioli. Mitoses are present. Tumor is necrotic. Stroma is marked fibrous and change. Diagnosis Details: Hepatocellular carcinoma, poorly-differentiated. Comments: Formatted Path Reports: LIVER TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor size: 5x4x4cm. Focality: Single -. Histologic type: Hepatocellular carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Single tumor with vascular invasion. Lymph nodes: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None."
BIOCUP_00417,liver,LIHC,TCGA-KR-A7K0,TCGA-KR-A7K0.34BFDBBD-A66F-4436-AD51-D6AA979F2CD3,"PREVIOUS DIAGNOSIS INQUIRY. 10. REPORT DATE: SEX: M. ADM DATE: BIRTHDATE: OPER DATE: PROCEDURE: SPHS. Liver cancer. Operative Procedure/Tissue Submitted: Laparoscopic assisted. liver resection. PROCEDURE: SPGD. 1. ""Gallbladder."" Received in formalin in a medium container is a previously. disrupted 11.8 x 4.6 x 1.6 cm gallbladder with focally adhesed serosa. The. Lumen is devoid of content. The mucosa is red-tan, velvety with a 0.2 cm. average wall thickness. The cystic duct is patent and there are no separate. stones in the container. 1A. Gallbladder. 2. ""Segment 5-6 liver resection, gross margins."" A 5.5 x 5.0 x 4.8 cm, 65 gm. resection of liver with nodular capsular surface. The margin is inked black. A. 2.1 cm nodule is 1.9 cm from the margin. The nodular mass comes to within 0.1. cm of the capsule. The remaining parenchyma has multiple nodules that average. 0.4 cm in greatest dimension. The diffuse nodular parenchyma is focally. fibrous. 2A-D. Mass with nodular parenchyma and surgical margin. INTRAOPERATIVE GROSS: PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 11. SEX: M. BIRTHDATE: ADM DATE: OPER DATE: 2. A 2.1 cm nodule is 1.9 cm from margin. PROCEDURE: SPMI. LIVER: HEPATOCELLULAR CARCINOMA. WAS THE TUMOR PREVIOUSLY TREATED?: No. TUMOR TYPE: Ordinary. SINGLE OR MULTIPLE MASSES: Single. MAXIMUM DIAMETER OF LARGEST MASS: 2.1 cm. ARE THE MARGINS OF RESECTION FREE OF TUMOR?: Yes. VASCULAR INVASION?: No. INVASION THROUGH THE CAPSULE TO THE SEROSAL SURFACE?: No. LYMPH NODE METASTASES?: Unknown. DISTANT METASTASES?: Unknown. IS THE LIVER CIRRHOTIC?: Yes, cryptogenic. pT1 NX. PROCEDURE: SPDX. 1. Gallbladder, resection: No significant abnormality. 2. Liver, segments 5 and 6, resection: Well-differentiated hepatocellular. carcinoma (2.1cm). Margins negative. Cryptogenic cirrhosis. Please see. TEMPLATE for details."
BIOCUP_00418,liver,LIHC,TCGA-RC-A6M6,TCGA-RC-A6M6.210AAA2E-0B18-4C08-815D-BC523FF2A7D5,"Temporary Copy. ;eneral Surgery. Clinical History. Not provided. Diagnosis. 1. ""GALLBLADDER"", (CHOLECYSTECTOMY) : - GALLBLADDER WITH ROKITANSKY -ASCHOFF SINUSES. - NO EVIDENCE OF SIGNIFICANT INFLAMMATION. - NO EVIDENCE OF NEOPLASTIC CHANGE. 2. ""CENTRAL HEPATECTOMY SECTIONS 4, 5, 8"", (PARTIAL HEPATECTOMY) : - POORLY DIFFERENTIATED CARCINOMA MOST CONSISTENT WITH. HEPATOCELLULAR CARCINOMA. - CARCINOMA MEASURES 11.5 x 6. 8 X 6.0 CM. - CARCINOMA SHOWS EXTENSIVE LYMPHOVASCULAR INVASION. CARCINOMA IN NONREACTIVE WITH ANTIBODIES DIRECTED AGAINST CK7, CK20,. AND HSA. CARCINOMA EXTENDS FOCALLY TO HEPATIC RESECTION LINE (BLACK INK SLIDE. 2E). - CARCINOMA IS MULTINODULAR WITH NODULES EXTENDING BEYOND MAIN TUMOR. MASS. - CARCINOMA ARISES IN BACKGROUND OF CIRRHOSIS WITH MILD TO MODERATE. STEATOSIS. - SCATTERED BILE DUCT HAMARTOMAS PRESENT. - PLEASE SEE SYNOPTIC REPORT. I certify that I personally conducted the. diagnostic evaluation on the above specimens. and have rendered the above diagnosis (es). For questions regarding this case, call. Gross Description. Received are two specimens, in formalin, each labeled with the patient's name and. specimen identification. Specimen one is labeled ""gallbladder"", and consists of an intact, 6.8 x 3.5 x 3.0. cm_bile-stainedgallbladder. The serosa is smooth and unremarkable; hepatic. surface is unremarkable. The specimen is opened and releases approximately 15 CC. of green viscus bile and reveals a black-green bile stained mucosal surface, which. is overall velvety and unremarkable. The specimen is absent of gallstones. Representative tissue to include neck margin is submitted in cassette 1A. The. Temporary Copy,. Di. Location:"". remaining specimen is returned to formalin. Specimen two is labeled ""central hepatectomy section 4, 5 , 8"" , and consists of a. 450. 0 g, 17.0 x 9.5 x 7.0 cm segment of unoriented liver. The hepatic capsule of. the anterior surface is intact and the central surface has a bulging, multinodular. tumor mass, 11.0 x 7.5 and protruding 1.3 cm above the uninvolved anterior surface,. the opposing surface consisting of surgical resection margin is peppered with. surgical staples and multiple linear surgical resection lines extending from. 3.5-6.5 cm in length. Vasculature is amputated flush to the hepatic margin. The. specimen is inked, is serially sectioned, and has an ill-demarkated, irregular,. 11.5 x 6.8 x 6.0 cm tumor mass approaching to within 0.1 cm of the hepatic capsule. margin and 0.4 cm from the hepatic resection margin. The tumor has a multinodular,. yellow-white to pink-tan, bulging, solid cut surface with scattered peripheral. nodules. Ink code is as follows: Anterior capsule margin - yellow; surgically. stapled resection line - blue; hepatic resection line - black. Representative. tissue is submitted as follows: 2A-2G - tumor approaching nearest surgical. resection margins and hepatic capsule margin; 2H-2I - tumor. The remaining. specimen is returned to formalin. Microscopic Examination. Performed. Synoptic Report. Based on AJCC/UICC TNM, 7th edition. Protocol web posting date: Hepatocellular carcinoma: Hepatic resection. Specimen: Liver segments 4, 5 and 8. Procedure: Partial Hepatectomy. Major hepatectomy (three segments). Tumor size: Greatest dimension: 11.5 cm. Additional dimensions: 6.8 x 6.0 cm. Tumor focality: Multiple foci in segments 4, 5 and 8. Histologic type: Other: poorly differentiated carcinoma favor hepatocellular carcinoma. Histologic grade: G3: Poorly differentiated. Tumor extension: Confined to liver. Margins: Parenchymal margin: Involved by invasive carcinoma (section 2E). Lymphovascular invasion: Present. Microscopic small vessel invasion: Indeterminate. Perineural invasion: indeterminate. Pathologic staging (pTNM) : Primary tumortpt) : pT2. Regional lymph nodes (pN) : pNX: Cannot be assessed. Distant metastasis (pM) : Not applicable. Ancillary studies: Temporary Copy. 3 of 3. Da. Specify: Immunohistochemistry for CK7, CK20, and HSA nonreactive in sections. studied. Addendum Report. Temporary-Copy. Page T of. Addendum Discussion. At the request of. the material was re-reviewed for margin status. Carcinoma cells are present at the black-inked operative margin. This operative. margin is designated as hepatic resection line in the gross description. Thus. malignant cells are present at the hepatic resection line. I certify that I personally conducted the. diagnostic evaluation on the above specimen (s). and have rendered the above diagnosis (es) :"
BIOCUP_00419,liver,LIHC,TCGA-5R-AA1C,TCGA-5R-AA1C.AF0BACCE-3975-4E9F-9272-404229EC77C9,"Procedure: Right hemihepatectomy, cholecystectomy. Preoperative diagnosis: CARCINOMA OF THE LIVER. Postoperative diagnosis: SEE MICROSCOPIC DIAGNOSIS BELOW. Specimen(s): 1. LIVER, RIGHT LOBE 2. GALLBLADDER 3. HEPATODUODENAL. LYMPH NODES. rCGA-5R-AA1C-01A-PR. Diagnosis: 1. LIVER, RIGHT LOBE: Moderately differentiated hepatocellular carcinoma. Vascular invasion is present. Remaining hepatic tissue shows fatty dystrophy. Metavir fibrosis score 1, Knodell histological activity index score 1, Ishak fibrosis. score 1. Resection margin is free of tumor. 2. GALLBLADDER: Autolysis of the mucosa. 3. HEPATODUODENAL LYMPH NODES: Lymph node is negative for metastatic carcinoma. Gross description: 1. LIVER, RIGHT LOBE: Received fresh, is a right lobe of the liver 22.5 x 20.0 x 8.5 cm in dimensions. At a distance of. 2.5 cm from the resection margin the flabby lobulated yellowish-brown tumor 15.0 x 9.5 x 9.5. cm in dimensions is present. The remaining hepatic tissue is flabby and yellowish-brown. 2. GALLBLADDER: Received fresh, is a gallbladder 8.0 X 5.0 X 2.0 cm in dimensions with a smooth greenish serosa. and a plush greenish mucosa. The gallbladder contains greenish bile. 3. HEPATODUODENAL LYMPH NODES: Received fresh, is a portion of adipose tissue with a lymph node 0.7 cm in diameter."
BIOCUP_00420,liver,LIHC,TCGA-ED-A627,TCGA-ED-A627.104D5D1C-E6E3-4806-9E6C-4C949865F713,"Gross Description: Microscopic Description: Diagnosis Details: Comments: Formatted Path Reports: LIVER TISSUE CHECKLIST. Specimen type: Hepatectomy. Tumor size: 7.5 X 7.5 X 7.5 cm. Focality: Not specified. Histologic type: Hepatocellular carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: CD10+, Hepar+, AFP+. Comments: None."
